data_2kr2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kr2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 CA--C 1.563 1.458 0 N-CA-C 113.041 0.756 . . . . 1.0900000000000001 113.041 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.28 -24.78 65.22 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.957 1.703 . . . . 1.04 115.251 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.24 -12.02 47.97 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 113.665 0.987 . . . . 0.32000000000000001 113.665 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 47.4 mttm -107.45 -18.1 13.95 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 113.954 1.094 . . . . 2.2599999999999998 113.954 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -56.93 135.93 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.88 0 N-CA-C 114.905 1.446 . . . . 1.01 114.905 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.49 -28.53 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 115.394 -0.821 . . . . 1.0600000000000001 112.495 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.439 ' O ' HG22 ' A' ' 172' ' ' ILE . 69.3 t90 -162.83 117.9 1.77 Allowed 'General case' 0 CA--C 1.559 1.325 0 CA-C-N 117.872 0.306 . . . . 0.67000000000000004 111.277 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.1 129.59 25.78 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.508 -0.745 . . . . 1.0800000000000001 111.635 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.55 133.81 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 N-CA-C 112.928 0.714 . . . . 1.6699999999999999 112.928 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -114.07 112.94 24.05 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.056 -1.461 . . . . 2.6400000000000001 107.056 172.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -79.88 97.5 6.72 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-O 121.577 0.704 . . . . 1.28 111.947 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 176.28 -68.72 0.09 OUTLIER Glycine 0 C--N 1.358 1.758 0 CA-C-N 114.416 -1.266 . . . . 0.70999999999999996 115.369 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.65 -116.23 3.66 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 114.651 0.62 . . . . 0.87 114.651 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -170.53 118.71 0.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.206 0.527 . . . . 2.1200000000000001 111.389 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER 51.47 107.75 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.525 2.417 . . . . 1.5 117.525 177.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.507 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 79.7 t60 -137.08 134.98 37.07 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.869 1.063 . . . . 0.52000000000000002 113.869 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.9 t -104.76 114.51 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 CA-C-N 113.813 -1.539 . . . . 2.0699999999999998 107.214 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.48 161.15 17.17 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 119.521 -0.276 . . . . 1.8500000000000001 111.558 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -45.06 -25.37 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.074 0 N-CA-C 119.12 3.007 . . . . 1.3700000000000001 119.12 -176.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -92.04 -21.12 20.66 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 118.082 0.401 . . . . 0.56999999999999995 111.427 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.86 39.64 1.28 Allowed Glycine 0 C--N 1.356 1.683 0 C-N-CA 124.288 0.947 . . . . 0.37 113.983 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.9 mm -105.85 124.98 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 109.094 -0.706 . . . . 1.25 109.094 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.7 t-160 -115.82 132.96 56.49 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 115.693 1.738 . . . . 1.71 115.693 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.8 144.78 27.05 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.726 -1.125 . . . . 3.1499999999999999 108.999 174.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -67.31 -104.78 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.317 1.969 . . . . 3.5099999999999998 116.317 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.1 tttt 176.8 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.233 1.013 . . . . 2.8100000000000001 111.62 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 46.46 58.09 16.6 Favored Pre-proline 0 N--CA 1.533 3.705 0 N-CA-C 117.152 2.279 . . . . 1.1699999999999999 117.152 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 CA--C 1.563 1.937 0 C-N-CA 123.066 2.511 . . . . 1.45 117.146 -177.501 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.401 ' HB3' ' CD ' ' A' ' 58' ' ' GLN . 38.7 Cg_exo . . . . . 0 N--CA 1.502 1.982 0 N-CA-C 116.908 1.849 . . . . 1.8600000000000001 116.908 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.278 1.2 mp -86.95 133.21 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.273 0 CA-C-N 115.353 -0.839 . . . . 1.28 109.791 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.39 -18.39 36.25 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.944 2.201 . . . . 1.9299999999999999 116.944 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -103.97 23.78 12.38 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.1 1.148 . . . . 1.79 114.1 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -138.11 -166.85 2.05 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.018 0.914 . . . . 1.49 112.803 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.652 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.3 t30 -94.69 -178.59 0.82 Allowed Pre-proline 0 CA--C 1.571 1.772 0 C-N-CA 125.586 1.555 . . . . 1.6799999999999999 110.934 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.439 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.3 Cg_exo -72.31 -45.62 0.6 Allowed 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 122.91 2.406 . . . . 1.1599999999999999 112.018 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -68.71 -52.32 32.05 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 113.32 -1.764 . . . . 2.04 111.863 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -75.65 -6.71 51.79 Favored 'General case' 0 CA--C 1.589 2.471 0 CA-C-N 115.353 -0.84 . . . . 1.6200000000000001 112.692 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.652 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 4.2 tt0 -72.5 -42.31 65.0 Favored 'General case' 0 C--N 1.387 2.232 0 C-N-CA 125.631 1.573 . . . . 2.4300000000000002 108.046 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.09 -42.34 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.045 0 C-N-CA 124.466 1.107 . . . . 1.46 109.341 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 169' ' ' ALA . 3.9 tp -81.37 -6.35 58.82 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 113.946 1.091 . . . . 1.6699999999999999 113.946 176.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -123.63 20.5 9.43 Favored 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 124.64 1.176 . . . . 1.3300000000000001 112.173 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.67 -35.04 0.31 Allowed 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 116.134 1.902 . . . . 1.4099999999999999 116.134 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.1 p -70.99 130.17 40.9 Favored 'General case' 0 N--CA 1.529 3.508 0 N-CA-C 115.011 1.486 . . . . 1.28 115.011 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 3.5 pt-20 . . . . . 0 N--CA 1.503 2.178 0 C-N-CA 124.55 1.14 . . . . 1.53 111.019 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 119.908 -0.092 . . . . 2.1499999999999999 111.073 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.631 ' H ' HD22 ' A' ' 164' ' ' ASN . 0.2 OUTLIER 55.03 89.51 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 125.805 1.642 . . . . 1.25 113.648 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -150.45 160.9 43.43 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.114 1.153 . . . . 1.1499999999999999 114.114 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -176.93 -173.05 42.15 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 116.429 1.332 . . . . 0.59999999999999998 116.429 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -107.93 171.99 7.09 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.35 1.982 . . . . 1.4099999999999999 116.35 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.16 121.2 28.93 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 113.108 -1.86 . . . . 0.51000000000000001 111.188 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.82 106.41 49.97 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 123.339 0.656 . . . . 1.0600000000000001 109.262 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.05 117.54 2.24 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 122.08 1.853 . . . . 0.17999999999999999 114.825 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.78 157.47 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 122.084 0.945 . . . . 1.0600000000000001 110.981 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -146.83 20.05 1.28 Allowed 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.667 -1.151 . . . . 3.1099999999999999 111.824 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -131.85 159.71 37.77 Favored 'General case' 0 C--N 1.362 1.15 0 CA-C-O 121.29 0.567 . . . . 2.1200000000000001 111.897 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -116.62 148.17 41.2 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.869 1.063 . . . . 0.41999999999999998 113.869 -178.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.78 -138.08 5.52 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.117 -1.401 . . . . 0.25 112.38 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 36.4 mm-40 -115.56 104.05 11.34 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-N 118.082 0.941 . . . . 1.75 110.898 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -99.73 128.27 45.83 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.174 0.512 . . . . 0.90000000000000002 110.882 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -113.32 123.48 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.418 0.628 . . . . 1.0700000000000001 111.004 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 tt -108.69 105.26 14.78 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.728 -1.124 . . . . 1.47 110.109 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 1.7 t -114.54 122.27 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.134 -1.393 . . . . 1.27 107.633 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -131.7 136.73 47.88 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.661 -0.7 . . . . 1.8899999999999999 111.8 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -97.66 123.64 41.66 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.622 0.725 . . . . 2.8999999999999999 112.519 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -105.78 133.21 50.88 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.847 -1.07 . . . . 0.48999999999999999 109.887 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.15 158.99 43.21 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.792 -0.64 . . . . 1.1000000000000001 111.599 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -124.12 170.18 10.96 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-O 121.454 0.645 . . . . 2.6099999999999999 112.667 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.95 -73.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 115.884 -0.598 . . . . 2.6099999999999999 112.423 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.85 67.28 1.51 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.14 0.495 . . . . 2.71 111.927 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -144.59 102.32 3.8 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.866 -0.606 . . . . 1.6899999999999999 110.279 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.88 100.51 10.01 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 122.329 1.061 . . . . 1.4299999999999999 111.856 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -166.43 139.88 4.02 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 114.73 -1.123 . . . . 2.9700000000000002 111.748 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.4 m -125.46 116.25 21.53 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.701 -0.681 . . . . 1.6599999999999999 111.81 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 73.24 49.45 0.15 Allowed 'General case' 0 N--CA 1.508 2.463 0 C-N-CA 125.673 1.589 . . . . 2.02 113.055 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -151.36 -40.99 0.12 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.24 1.416 . . . . 2.5600000000000001 109.212 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -100.59 78.88 2.03 Favored 'General case' 0 C--N 1.365 1.268 0 N-CA-C 108.468 -0.938 . . . . 3.1499999999999999 108.468 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.8 130.19 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 114.677 -1.147 . . . . 1.3600000000000001 111.456 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -115.66 172.77 6.91 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.996 1.48 . . . . 0.84999999999999998 114.996 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -122.87 137.83 54.83 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.855 -0.611 . . . . 1.3300000000000001 111.702 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -131.75 128.04 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.483 0 CA-C-N 115.273 -0.876 . . . . 1.1699999999999999 110.012 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -129.22 151.81 49.48 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.366 1.617 . . . . 1.9399999999999999 115.366 -177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.3 OUTLIER -130.1 113.05 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 C-N-CA 123.355 0.662 . . . . 1.29 112.382 177.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.11 25.61 12.49 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 127.013 2.125 . . . . 1.8200000000000001 114.095 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.53 -16.13 52.53 Favored Glycine 0 CA--C 1.548 2.154 0 CA-C-N 115.6 -0.727 . . . . 0.32000000000000001 113.682 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 94.0 m-70 -83.75 144.68 29.17 Favored 'General case' 0 C--N 1.365 1.241 0 C-N-CA 125.53 1.532 . . . . 0.56999999999999995 114.496 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.94 126.88 42.39 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.326 0.584 . . . . 1.1899999999999999 110.863 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.95 -58.63 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 115.098 -0.956 . . . . 1.73 113.13 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.06 89.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.263 -1.014 . . . . 1.25 108.263 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.65 73.69 0.86 Allowed 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 123.134 1.445 . . . . 2.75 112.317 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 p30 158.14 62.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 127.871 2.468 . . . . 2.48 107.243 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.2 tp -101.92 100.93 11.28 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.184 1.179 . . . . 1.78 114.184 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -112.71 108.61 17.7 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-N 113.401 -1.727 . . . . 2.3500000000000001 109.675 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -26.69 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.547 0 N-CA-C 114.725 1.38 . . . . 1.27 114.725 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -76.3 -42.73 44.29 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 123.303 0.641 . . . . 0.83999999999999997 112.335 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -73.91 -26.37 60.49 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 124.176 0.99 . . . . 0.91000000000000003 113.563 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -78.65 -57.7 3.63 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.765 1.024 . . . . 2.98 113.765 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -31.45 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 114.712 1.375 . . . . 1.53 114.712 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.23 -114.94 2.4 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 118.578 0.626 . . . . 0.84999999999999998 112.945 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -114.76 107.58 15.63 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.216 0.531 . . . . 3.9700000000000002 110.545 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 73.32 -128.62 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 125.59 1.556 . . . . 2.0800000000000001 111.933 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.3 p 58.26 -171.02 0.11 Allowed 'General case' 0 N--CA 1.535 3.798 0 C-N-CA 126.159 1.783 . . . . 1.22 115.474 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.77 129.29 54.66 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 112.968 0.729 . . . . 1.2 112.968 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -105.72 136.54 45.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.249 0.619 . . . . 0.41999999999999998 109.575 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -128.13 133.89 49.03 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.825 1.417 . . . . 2.5 114.825 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.16 118.74 32.7 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.418 -1.264 . . . . 1.5800000000000001 110.844 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.02 112.21 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 115.19 -0.913 . . . . 1.25 110.636 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.75 93.01 43.38 Favored Pre-proline 0 CA--C 1.568 1.669 0 CA-C-N 115.532 -0.758 . . . . 1.5 110.709 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -74.33 138.27 24.55 Favored 'Trans proline' 0 C--N 1.397 3.097 0 C-N-CA 123.032 2.488 . . . . 0.22 113.686 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.11 146.94 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 CA-C-N 115.276 -0.875 . . . . 1.1200000000000001 110.504 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.8 p -131.75 111.83 11.99 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.566 -0.743 . . . . 1.8600000000000001 111.626 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.483 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.6 mt -111.59 122.83 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 108.539 -0.911 . . . . 1.0700000000000001 108.539 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -142.5 130.24 21.56 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.857 -0.611 . . . . 2.6400000000000001 111.192 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt 67.54 15.25 9.77 Favored 'General case' 0 N--CA 1.515 2.822 0 C-N-CA 125.096 1.358 . . . . 4.0199999999999996 114.405 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.14 15.6 35.34 Favored Glycine 0 CA--C 1.549 2.17 0 CA-C-O 119.143 -0.809 . . . . 0.39000000000000001 114.806 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 30.9 mtmt -128.89 155.6 45.0 Favored 'General case' 0 C--N 1.367 1.348 0 CA-C-N 118.442 1.121 . . . . 2.0299999999999998 112.924 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.46 148.52 26.36 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.36 1.244 . . . . 1.0800000000000001 114.36 -176.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.8 m -134.77 112.28 10.61 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.601 -1.181 . . . . 1.23 110.573 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 p -112.21 92.42 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.636 0 CA-C-O 121.196 0.522 . . . . 1.1899999999999999 109.876 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 63.06 -84.26 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.866 0 C-N-CA 125.581 1.553 . . . . 1.8200000000000001 114.241 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.64 28.1 4.53 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 116.206 -0.452 . . . . 0.51000000000000001 113.768 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -137.05 119.23 15.54 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.25 0.62 . . . . 1.8200000000000001 110.048 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.75 132.6 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 CA-C-O 121.57 0.7 . . . . 1.5900000000000001 112.185 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -150.53 -179.31 7.12 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.043 -0.98 . . . . 1.1699999999999999 109.818 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.262 12.8 t -103.14 138.22 40.26 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 113.628 0.974 . . . . 1.71 113.628 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -82.8 123.72 29.61 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.396 1.078 . . . . 0.29999999999999999 111.288 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.19 91.22 3.28 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.804 0.668 . . . . 1.8700000000000001 112.804 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.81 -63.87 3.41 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 119.014 2.366 . . . . 0.91000000000000003 119.014 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.535 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -132.85 161.16 34.91 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.834 1.05 . . . . 1.6799999999999999 113.834 -176.269 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.535 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -107.09 143.32 35.4 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 113.764 -1.562 . . . . 1.3700000000000001 109.593 177.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 t -124.81 142.63 51.3 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.643 1.349 . . . . 0.94999999999999996 114.643 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.417 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.93 97.43 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 106.926 -1.509 . . . . 1.3799999999999999 106.926 176.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -113.72 118.44 34.33 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.758 -0.655 . . . . 1.6699999999999999 111.968 -177.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.41 133.09 55.98 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-O 122.31 1.052 . . . . 2.2999999999999998 111.191 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.22 145.77 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 113.018 -1.901 . . . . 1.29 110.548 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.431 ' HB3' ' OD1' ' A' ' 164' ' ' ASN . 41.0 pttt -58.16 151.17 19.63 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 116.97 2.211 . . . . 2.6200000000000001 116.97 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.67 -60.34 0.56 Allowed Glycine 0 CA--C 1.539 1.533 0 CA-C-N 115.093 -0.958 . . . . 1.0600000000000001 113.68 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -141.52 -61.0 0.47 Allowed 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.967 0.384 . . . . 3.1000000000000001 111.717 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -117.49 -49.49 2.56 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.939 0.496 . . . . 4.0800000000000001 112.077 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.35 178.57 4.55 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.464 0.705 . . . . 1.74 111.459 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.631 HD22 ' H ' ' A' ' 70' ' ' SER . 5.3 m-20 -118.28 -85.93 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.045 0 CA-C-O 117.356 -1.307 . . . . 1.6799999999999999 110.275 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -87.49 -37.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.398 3.176 0 CA-C-N 123.648 2.338 . . . . 2.8199999999999998 114.436 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? 79.86 -94.02 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 126.495 1.918 . . . . 3.4100000000000001 110.366 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.5 t -106.42 131.29 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.413 -1.328 . . . . 1.3799999999999999 107.413 174.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.2 t -134.59 129.94 35.74 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.94 -1.027 . . . . 1.75 112.841 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 60' ' ' LEU 0.268 . . -122.87 47.89 1.88 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.71 1.745 . . . . 1.1299999999999999 115.71 -177.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -40.38 127.26 2.34 Favored 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 116.051 1.871 . . . . 1.3999999999999999 116.051 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 4.8 t80 -147.55 100.88 3.29 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.912 -0.585 . . . . 0.26000000000000001 111.101 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 12' ' ' TRP 0.305 10.1 tt -109.86 121.3 62.55 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.061 0 CA-C-O 122.427 1.108 . . . . 1.1000000000000001 111.011 175.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -123.34 165.35 17.15 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 113.873 -1.512 . . . . 1.0600000000000001 110.734 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 18.7 ptmt -122.14 159.35 27.37 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 118.139 2.644 . . . . 1.8300000000000001 118.139 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.62 -41.59 2.11 Favored Glycine 0 CA--C 1.544 1.859 0 CA-C-N 110.11 -3.223 . . . . 0.17000000000000001 119.053 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.61 154.18 0.94 Allowed 'General case' 0 N--CA 1.52 3.058 0 CA-C-N 120.782 2.291 . . . . 1.05 113.156 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.77 -13.33 59.87 Favored 'General case' 0 CA--C 1.58 2.125 0 C-N-CA 124.836 1.255 . . . . 0.98999999999999999 114.353 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.55 4.78 45.59 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 113.86 1.059 . . . . 0.55000000000000004 113.86 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.58 -9.89 15.28 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 114.312 1.227 . . . . 0.59999999999999998 114.312 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.516 2.847 0 C-N-CA 124.424 1.09 . . . . 1.1799999999999999 113.358 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 tp . . . . . 0 CA--C 1.566 1.584 0 N-CA-C 112.947 0.721 . . . . 1.0900000000000001 112.947 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.4 -23.09 65.56 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 126.101 1.76 . . . . 1.04 115.274 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -11.65 51.71 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.727 1.01 . . . . 0.32000000000000001 113.727 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 2.1 mmpt? -108.57 -19.23 13.51 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 113.514 0.931 . . . . 2.2599999999999998 113.514 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.03 135.75 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.936 0 N-CA-C 115.257 1.577 . . . . 1.01 115.257 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.5 -29.83 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 115.287 -0.869 . . . . 1.0600000000000001 112.095 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.476 ' O ' HG21 ' A' ' 172' ' ' ILE . 58.3 t90 -163.07 123.3 2.28 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-O 120.572 0.225 . . . . 0.67000000000000004 110.953 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -140.93 128.55 21.46 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.351 -0.843 . . . . 1.0800000000000001 110.777 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.1 t -136.57 131.06 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.507 0.928 . . . . 1.6699999999999999 113.507 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -116.7 110.88 19.03 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.304 -0.999 . . . . 2.6400000000000001 108.304 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.59 100.11 9.95 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-O 122.223 1.011 . . . . 1.28 110.437 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.507 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -179.74 -57.54 0.08 OUTLIER Glycine 0 C--N 1.348 1.232 0 CA-C-N 113.594 -1.639 . . . . 0.70999999999999996 115.528 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.4 -115.9 3.29 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 120.038 -0.312 . . . . 0.87 113.795 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -165.11 117.73 1.2 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.359 0.264 . . . . 2.1200000000000001 111.565 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 2.8 m 41.71 106.04 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.155 0 N-CA-C 118.075 2.62 . . . . 1.5 118.075 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.598 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 82.7 t60 -134.07 138.3 45.21 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.041 1.126 . . . . 0.52000000000000002 114.041 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.261 8.0 p -108.64 117.48 54.2 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.073 0 CA-C-N 114.202 -1.363 . . . . 2.0699999999999998 110.254 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.07 156.97 23.05 Favored 'General case' 0 CA--C 1.571 1.757 0 CA-C-N 114.343 -1.298 . . . . 1.8500000000000001 110.676 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 m -41.4 -32.69 0.36 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.153 0 N-CA-C 119.113 3.005 . . . . 1.3700000000000001 119.113 -176.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -88.42 -26.87 21.9 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.312 0.505 . . . . 0.56999999999999995 110.909 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.94 43.43 0.41 Allowed Glycine 0 C--N 1.35 1.334 0 CA-C-N 114.994 -1.003 . . . . 0.37 114.701 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.8 mm -106.79 112.66 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 N-CA-C 109.687 -0.486 . . . . 1.25 109.687 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.598 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.74 134.85 48.19 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 115.189 1.552 . . . . 1.71 115.189 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.614 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -96.14 143.09 27.57 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.731 -1.122 . . . . 3.1499999999999999 110.08 176.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -97.44 103.37 15.3 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.226 1.011 . . . . 3.5099999999999998 113.381 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -33.79 116.7 0.28 Allowed 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 118.51 2.781 . . . . 2.8100000000000001 118.51 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 40.37 73.43 0.85 Allowed Pre-proline 0 N--CA 1.525 3.318 0 N-CA-C 118.178 2.658 . . . . 1.1699999999999999 118.178 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 CA--C 1.56 1.777 0 C-N-CA 122.281 1.987 . . . . 1.45 116.69 179.404 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo . . . . . 0 N--CA 1.491 1.379 0 N-CA-C 117.042 1.901 . . . . 1.8600000000000001 117.042 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.25 1.3 mp -91.45 136.72 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.243 0 CA-C-N 114.748 -1.114 . . . . 1.28 110.039 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.1 -10.45 33.3 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 115.991 1.848 . . . . 1.9299999999999999 115.991 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -108.25 20.94 18.03 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 114.302 1.223 . . . . 1.79 114.302 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.53 -166.63 2.1 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 121.71 0.767 . . . . 1.49 112.789 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.838 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.8 t30 -90.25 177.7 2.25 Favored Pre-proline 0 N--CA 1.498 1.952 0 C-N-CA 125.411 1.484 . . . . 1.6799999999999999 110.959 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -71.71 -46.99 0.51 Allowed 'Trans proline' 0 C--N 1.394 2.942 0 C-N-CA 122.998 2.465 . . . . 1.1599999999999999 112.592 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -69.75 -44.11 70.87 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 113.786 -1.552 . . . . 2.04 112.034 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 5.3 t0 -80.14 -7.21 58.81 Favored 'General case' 0 CA--C 1.587 2.371 0 CA-C-N 115.11 -0.95 . . . . 1.6200000000000001 111.758 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.838 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.6 tt0 -73.31 -37.81 66.05 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 125.684 1.594 . . . . 2.4300000000000002 108.737 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -64.01 -47.78 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.871 0 C-N-CA 125.777 1.631 . . . . 1.46 109.042 173.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 1.6 tp -80.12 -4.58 53.48 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.69 1.366 . . . . 1.6699999999999999 114.69 177.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 4.0 m-30 -113.17 3.46 16.06 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 124.639 1.176 . . . . 1.3300000000000001 110.222 175.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.77 -115.95 0.14 Allowed 'General case' 0 CA--C 1.568 1.658 0 C-N-CA 124.479 1.112 . . . . 1.4099999999999999 111.703 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.289 2.9 p 56.67 -84.48 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.12 0 C-N-CA 127.33 2.252 . . . . 1.28 116.144 -174.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.507 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 20.6 tt0 . . . . . 0 N--CA 1.526 3.351 0 C-N-CA 125.361 1.465 . . . . 1.53 114.227 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 112.355 0.502 . . . . 2.1499999999999999 112.355 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.51 107.62 1.17 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 124.522 1.129 . . . . 1.25 112.35 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -100.45 129.28 46.39 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.403 -1.271 . . . . 1.1499999999999999 110.651 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -133.73 132.88 6.64 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 118.716 2.247 . . . . 0.59999999999999998 118.716 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -103.1 145.61 29.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.28 0.844 . . . . 1.4099999999999999 113.28 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.9 117.96 32.13 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.383 -1.281 . . . . 0.51000000000000001 111.897 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.51 97.69 51.01 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.275 -0.875 . . . . 1.0600000000000001 109.048 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -83.03 118.84 2.74 Favored 'Trans proline' 0 CA--C 1.558 1.705 0 C-N-CA 122.16 1.906 . . . . 0.17999999999999999 114.755 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.92 159.18 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 CA-C-O 122.119 0.962 . . . . 1.0600000000000001 111.433 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -146.36 17.97 1.35 Allowed 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 114.315 -1.311 . . . . 3.1099999999999999 111.935 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -128.99 163.22 25.83 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 121.269 0.557 . . . . 2.1200000000000001 111.466 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -124.18 146.65 48.55 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.8 1.037 . . . . 0.41999999999999998 113.8 -178.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.72 -133.93 3.61 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.068 -1.423 . . . . 0.25 112.094 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 21.5 mt-10 -118.52 106.46 12.69 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 118.479 1.139 . . . . 1.75 111.106 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -98.97 128.85 45.21 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.485 0.66 . . . . 0.90000000000000002 111.331 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.46 118.23 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-N 115.328 -0.851 . . . . 1.0700000000000001 111.045 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 tt -107.83 105.06 14.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.228 -1.351 . . . . 1.47 109.81 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.88 125.41 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 114.229 -1.35 . . . . 1.27 108.741 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.14 137.17 54.16 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 112.762 0.652 . . . . 1.8899999999999999 112.762 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -101.17 115.73 31.17 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.076 -0.965 . . . . 2.8999999999999999 110.196 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -105.01 134.38 48.22 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.957 -0.565 . . . . 0.48999999999999999 110.156 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.72 152.75 51.66 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.614 0.721 . . . . 1.1000000000000001 111.899 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -126.1 150.59 48.09 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.3 -0.863 . . . . 2.6099999999999999 110.449 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.96 -76.03 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 114.186 1.18 . . . . 2.6099999999999999 114.186 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -124.27 73.17 1.22 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.059 0.763 . . . . 2.71 113.059 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -154.29 109.29 3.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.711 0.804 . . . . 1.6899999999999999 109.668 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.42 104.78 14.21 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 122.192 0.996 . . . . 1.4299999999999999 112.495 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -171.84 140.02 1.23 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.884 -1.053 . . . . 2.9700000000000002 111.716 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.4 m -129.07 118.57 22.72 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.571 -0.74 . . . . 1.6599999999999999 111.835 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 72.97 49.94 0.15 Allowed 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 125.793 1.637 . . . . 2.02 112.508 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -151.33 -40.48 0.12 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.476 1.111 . . . . 2.5600000000000001 110.278 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -109.04 83.73 1.8 Allowed 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.464 -0.939 . . . . 3.1499999999999999 108.464 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.85 126.57 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 113.888 -1.505 . . . . 1.3600000000000001 111.651 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.54 -176.4 3.07 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.205 1.558 . . . . 0.84999999999999998 115.205 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -128.42 136.98 51.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.092 -0.38 . . . . 1.3300000000000001 111.29 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.9 t -130.23 125.26 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.279 0 C-N-CA 123.482 0.713 . . . . 1.1699999999999999 109.918 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.3 mtt180 -121.97 153.26 38.76 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.406 1.632 . . . . 1.9399999999999999 115.406 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.55 102.83 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 114.928 -1.033 . . . . 1.29 112.373 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.464 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.31 27.21 13.76 Favored 'General case' 0 N--CA 1.524 3.252 0 C-N-CA 126.876 2.07 . . . . 1.8200000000000001 113.895 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.32 -18.59 35.63 Favored Glycine 0 CA--C 1.547 2.032 0 C-N-CA 121.375 -0.441 . . . . 0.32000000000000001 113.235 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -86.07 173.8 9.62 Favored 'General case' 0 C--N 1.368 1.384 0 C-N-CA 125.491 1.517 . . . . 0.56999999999999995 113.53 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.7 p -126.57 126.24 43.32 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.175 0.512 . . . . 1.1899999999999999 111.278 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.263 9.1 p -112.41 -45.12 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 CA-C-N 115.263 -0.88 . . . . 1.73 111.072 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.66 89.19 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 109.013 -0.736 . . . . 1.25 109.013 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -105.74 90.68 3.47 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-O 122.986 1.374 . . . . 2.75 110.366 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 127.65 78.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 110.01 -3.268 . . . . 2.48 108.508 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.06 110.86 22.94 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 121.744 0.783 . . . . 1.78 112.916 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -119.0 98.84 6.38 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 106.899 -1.519 . . . . 2.3500000000000001 106.899 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -25.54 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.32 0 N-CA-C 113.925 1.083 . . . . 1.27 113.925 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -75.71 -40.29 55.93 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.022 0.929 . . . . 0.83999999999999997 112.311 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -73.26 -26.85 61.26 Favored 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 124.672 1.189 . . . . 0.91000000000000003 113.388 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -80.66 -57.77 3.41 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.692 0.997 . . . . 2.98 113.692 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.33 -34.7 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 N-CA-C 114.864 1.431 . . . . 1.53 114.864 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 123.68 -109.22 1.28 Allowed Glycine 0 C--N 1.356 1.669 0 CA-C-N 118.764 0.711 . . . . 0.84999999999999998 113.578 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -114.61 106.87 14.75 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.757 0.313 . . . . 3.9700000000000002 110.707 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.8 m 68.09 -124.09 0.18 Allowed 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 125.379 1.471 . . . . 2.0800000000000001 112.825 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.3 p 56.07 -164.09 0.14 Allowed 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 126.461 1.904 . . . . 1.22 115.134 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -111.34 132.3 54.51 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 113.102 0.778 . . . . 1.2 113.102 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -107.72 143.69 35.89 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.035 0.534 . . . . 0.41999999999999998 109.829 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.28 131.85 19.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.185 1.18 . . . . 2.5 114.185 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -119.94 134.14 55.34 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 115.145 -0.934 . . . . 1.5800000000000001 110.827 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.47 122.36 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 114.652 -1.158 . . . . 1.25 110.835 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.78 86.24 58.78 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-N 115.361 -0.836 . . . . 1.5 110.823 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -73.88 126.23 10.52 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 123.015 2.477 . . . . 0.22 112.634 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -112.21 149.45 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.565 0 CA-C-N 115.153 -0.931 . . . . 1.1200000000000001 111.428 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 p -130.33 110.63 11.67 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.1 -0.954 . . . . 1.8600000000000001 111.661 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.2 mt -114.15 122.73 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 N-CA-C 108.477 -0.934 . . . . 1.0700000000000001 108.477 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -141.04 127.36 19.78 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.658 -0.701 . . . . 2.6400000000000001 110.76 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp 68.0 14.35 9.33 Favored 'General case' 0 N--CA 1.514 2.759 0 C-N-CA 125.287 1.435 . . . . 4.0199999999999996 113.961 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 17.47 30.1 Favored Glycine 0 CA--C 1.547 2.059 0 CA-C-O 119.213 -0.771 . . . . 0.39000000000000001 114.786 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 55.5 mtpt -124.42 146.38 48.93 Favored 'General case' 0 C--N 1.367 1.35 0 CA-C-N 118.378 1.089 . . . . 2.0299999999999998 112.46 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.18 144.7 30.39 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.275 1.213 . . . . 1.0800000000000001 114.275 -175.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.27 113.44 11.29 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.824 -1.08 . . . . 1.23 110.467 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.3 p -107.81 94.0 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.571 0 CA-C-N 115.929 -0.578 . . . . 1.1899999999999999 110.226 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 66.95 -83.29 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.778 0 C-N-CA 125.527 1.531 . . . . 1.8200000000000001 113.871 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.24 26.05 4.76 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 116.094 -0.503 . . . . 0.51000000000000001 113.628 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -128.71 131.79 47.95 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 123.364 0.666 . . . . 1.8200000000000001 110.57 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -116.14 130.62 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 CA-C-O 121.64 0.733 . . . . 1.5900000000000001 111.981 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m -150.84 -179.1 6.99 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.975 -1.011 . . . . 1.1699999999999999 109.592 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.271 14.1 t -104.25 138.79 40.19 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 113.425 0.898 . . . . 1.71 113.425 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -82.53 122.03 27.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 124.18 0.992 . . . . 0.29999999999999999 111.349 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.79 90.53 3.26 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.48 0.548 . . . . 1.8700000000000001 112.48 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.5 -62.69 2.69 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 118.92 2.328 . . . . 0.91000000000000003 118.92 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.501 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -134.0 158.86 42.45 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.079 1.14 . . . . 1.6799999999999999 114.079 -176.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.501 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -104.61 137.75 41.97 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.523 -1.671 . . . . 1.3700000000000001 109.107 176.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.0 t -124.13 128.29 49.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.772 1.397 . . . . 0.94999999999999996 114.772 -177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 3.2 t -106.56 101.42 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 106.689 -1.597 . . . . 1.3799999999999999 106.689 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -117.64 120.71 38.84 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.882 -1.054 . . . . 1.6699999999999999 112.746 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -113.74 126.93 55.78 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-O 122.177 0.989 . . . . 2.2999999999999998 111.223 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.78 146.02 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-N 112.947 -1.933 . . . . 1.29 111.242 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -91.14 149.94 21.59 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 114.853 -1.067 . . . . 2.6200000000000001 113.165 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -89.41 -43.98 5.09 Favored Glycine 0 CA--C 1.545 1.954 0 CA-C-N 115.634 -0.712 . . . . 1.0600000000000001 114.859 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -128.99 -71.99 0.62 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.694 0.398 . . . . 3.1000000000000001 110.992 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.599 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 6.8 t80 -146.65 120.42 9.24 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.319 0.647 . . . . 4.0800000000000001 109.5 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 0.5 OUTLIER 90.64 151.93 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 125.033 1.333 . . . . 1.74 112.067 -178.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.65 -168.32 0.15 Allowed Pre-proline 0 CA--C 1.572 1.795 0 CA-C-N 113.994 -1.457 . . . . 1.6799999999999999 109.434 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -57.76 -17.92 31.57 Favored 'Trans proline' 0 C--N 1.403 3.436 0 C-N-CA 122.937 2.425 . . . . 2.8199999999999998 115.181 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 63.0 tttt 81.91 -63.99 0.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 126.665 1.986 . . . . 3.4100000000000001 115.513 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.61 134.27 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.602 1.092 . . . . 1.3799999999999999 110.594 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.57 132.33 38.96 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 114.779 -1.101 . . . . 1.75 113.262 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 60' ' ' LEU . . . -128.68 48.48 2.32 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.081 1.511 . . . . 1.1299999999999999 115.081 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.93 135.36 4.15 Favored 'General case' 0 N--CA 1.515 2.808 0 N-CA-C 116.663 2.097 . . . . 1.3999999999999999 116.663 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -150.02 108.84 3.86 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.804 -0.635 . . . . 0.26000000000000001 111.068 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.476 HG21 ' O ' ' A' ' 12' ' ' TRP 0.308 6.6 tt -117.49 123.26 71.51 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.15 0 CA-C-O 122.439 1.114 . . . . 1.1000000000000001 111.685 175.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 10.5 ptm -123.33 166.79 14.71 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 113.924 -1.489 . . . . 1.0600000000000001 111.274 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.2 ptmm? -123.16 157.59 32.64 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 118.2 2.667 . . . . 1.8300000000000001 118.2 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.65 -42.36 1.91 Allowed Glycine 0 CA--C 1.542 1.728 0 CA-C-N 110.604 -2.998 . . . . 0.17000000000000001 119.085 173.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.57 152.44 0.81 Allowed 'General case' 0 N--CA 1.516 2.864 0 CA-C-N 120.419 2.11 . . . . 1.05 112.762 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.91 -15.5 59.66 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.437 1.273 . . . . 0.98999999999999999 114.437 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.62 4.5 43.59 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.101 1.148 . . . . 0.55000000000000004 114.101 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.99 -10.87 17.77 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 113.624 0.972 . . . . 0.59999999999999998 113.624 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.516 2.871 0 C-N-CA 125.325 1.45 . . . . 1.1799999999999999 111.489 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 CA--C 1.564 1.49 0 N-CA-C 113.248 0.833 . . . . 1.0900000000000001 113.248 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.37 -22.77 61.85 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 125.951 1.7 . . . . 1.04 115.161 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.46 -12.34 49.29 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 113.596 0.961 . . . . 0.32000000000000001 113.596 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -105.65 -21.64 13.15 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.285 0.846 . . . . 2.2599999999999998 113.285 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.24 135.68 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.926 0 N-CA-C 115.317 1.599 . . . . 1.01 115.317 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -124.13 -29.39 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 115.24 -0.891 . . . . 1.0600000000000001 112.258 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.452 ' O ' HG22 ' A' ' 172' ' ' ILE . 62.5 t90 -162.38 116.99 1.83 Allowed 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 120.545 0.212 . . . . 0.67000000000000004 111.328 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.82 129.0 31.77 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.483 -0.761 . . . . 1.0800000000000001 111.365 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -136.81 130.99 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 113.214 0.82 . . . . 1.6699999999999999 113.214 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -114.1 105.33 13.08 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 107.663 -1.236 . . . . 2.6400000000000001 107.663 172.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.22 105.56 11.59 Favored 'General case' 0 C--O 1.274 2.38 0 CA-C-O 121.802 0.811 . . . . 1.28 110.39 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.578 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 168.98 -58.32 0.2 Allowed Glycine 0 C--N 1.358 1.786 0 CA-C-N 112.026 -2.352 . . . . 0.70999999999999996 114.037 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.96 -128.24 5.94 Favored Glycine 0 N--CA 1.478 1.464 0 CA-C-O 119.303 -0.721 . . . . 0.87 113.121 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.909 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 40.3 mt-10 -162.09 117.22 1.93 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.645 0.723 . . . . 2.1200000000000001 111.86 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 55.61 108.94 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 117.358 2.355 . . . . 1.5 117.358 177.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.463 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 83.8 t60 -144.59 139.05 27.87 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 114.071 1.137 . . . . 0.52000000000000002 114.071 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.268 9.9 p -107.63 118.84 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.085 0 CA-C-N 114.829 -1.078 . . . . 2.0699999999999998 110.886 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.23 156.01 22.21 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 114.395 -1.275 . . . . 1.8500000000000001 110.856 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 m -41.82 -32.16 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.258 0 N-CA-C 119.087 2.995 . . . . 1.3700000000000001 119.087 -176.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -87.16 -23.84 24.68 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.413 0.551 . . . . 0.56999999999999995 111.374 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.73 40.94 0.69 Allowed Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.114 -0.948 . . . . 0.37 114.403 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -106.91 113.35 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 N-CA-C 109.755 -0.461 . . . . 1.25 109.755 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.463 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.3 132.67 51.21 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 115.34 1.608 . . . . 1.71 115.34 -177.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.909 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -93.17 146.65 23.51 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 114.849 -1.069 . . . . 3.1499999999999999 109.911 175.247 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -58.16 -111.71 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 127.505 2.322 . . . . 3.5099999999999998 116.688 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -178.63 79.63 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 113.229 0.826 . . . . 2.8100000000000001 113.229 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.446 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 0.3 OUTLIER 65.14 46.31 0.53 Allowed Pre-proline 0 N--CA 1.517 2.894 0 N-CA-C 117.695 2.48 . . . . 1.1699999999999999 117.695 176.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 43.0 Cg_endo . . . . . 0 C--N 1.373 1.829 0 C-N-CA 123.072 2.515 . . . . 1.45 114.579 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.432 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 31.8 Cg_exo . . . . . 0 N--CA 1.501 1.963 0 N-CA-C 117.051 1.904 . . . . 1.8600000000000001 117.051 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.273 1.1 mp -87.75 124.51 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.09 0 CA-C-N 115.22 -0.9 . . . . 1.28 108.981 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -81.19 -19.34 43.52 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.421 2.008 . . . . 1.9299999999999999 116.421 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -94.97 24.0 5.16 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 113.736 1.013 . . . . 1.79 113.736 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.16 -173.18 4.18 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.828 0.851 . . . . 1.49 110.954 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.69 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.87 -176.91 0.58 Allowed Pre-proline 0 N--CA 1.512 2.64 0 CA-C-O 118.449 -0.786 . . . . 1.6799999999999999 109.421 178.128 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -69.17 -39.49 7.56 Favored 'Trans proline' 0 C--N 1.398 3.165 0 C-N-CA 122.613 2.209 . . . . 1.1599999999999999 113.279 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -69.25 -49.24 58.05 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 125.322 1.449 . . . . 2.04 112.015 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -79.65 -5.42 55.06 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 114.914 -1.039 . . . . 1.6200000000000001 112.625 177.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.69 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 1.1 tt0 -74.02 -41.84 61.22 Favored 'General case' 0 C--N 1.38 1.929 0 C-N-CA 125.617 1.567 . . . . 2.4300000000000002 107.952 173.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.8 t -61.4 -45.04 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 C-N-CA 124.304 1.042 . . . . 1.46 109.541 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 1.5 tp -79.98 -5.56 55.92 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 114.35 1.241 . . . . 1.6699999999999999 114.35 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 6.5 m-30 -123.81 20.66 9.27 Favored 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 124.477 1.111 . . . . 1.3300000000000001 111.909 176.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -148.16 -28.04 0.33 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 116.878 2.177 . . . . 1.4099999999999999 116.878 -176.272 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.0 p -73.29 137.54 44.92 Favored 'General case' 0 N--CA 1.533 3.725 0 N-CA-C 114.206 1.187 . . . . 1.28 114.206 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.578 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 7.9 pt-20 . . . . . 0 N--CA 1.507 2.387 0 N-CA-C 117.004 2.224 . . . . 1.53 117.004 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 113.678 0.992 . . . . 2.1499999999999999 113.678 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.31 109.94 1.12 Allowed 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 124.957 1.303 . . . . 1.25 112.091 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.63 154.06 49.78 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 114.942 -1.026 . . . . 1.1499999999999999 112.965 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.84 -174.63 37.63 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.077 -0.965 . . . . 0.59999999999999998 115.124 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.47 171.67 7.38 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 114.782 1.401 . . . . 1.4099999999999999 114.782 -177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.15 129.33 49.94 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 113.573 -1.649 . . . . 0.51000000000000001 111.768 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -122.87 100.93 39.85 Favored Pre-proline 0 CA--C 1.568 1.666 0 C-N-CA 123.011 0.524 . . . . 1.0600000000000001 109.597 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -83.5 116.85 2.34 Favored 'Trans proline' 0 CA--C 1.566 2.097 0 C-N-CA 122.251 1.967 . . . . 0.17999999999999999 114.729 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.59 158.37 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.979 0.895 . . . . 1.0600000000000001 110.851 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -143.02 19.86 1.95 Allowed 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 114.844 -1.071 . . . . 3.1099999999999999 112.13 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -125.84 161.71 26.8 Favored 'General case' 0 C--N 1.362 1.114 0 CA-C-O 121.297 0.57 . . . . 2.1200000000000001 111.786 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.5 OUTLIER -120.29 140.59 51.01 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.445 0.906 . . . . 0.41999999999999998 113.445 -179.044 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.14 -137.77 4.92 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.123 -1.399 . . . . 0.25 112.332 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.1 mt-10 -117.66 106.37 13.01 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 118.334 1.067 . . . . 1.75 111.105 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -99.36 129.9 45.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.179 0.514 . . . . 0.90000000000000002 111.256 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.99 118.94 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.798 0.808 . . . . 1.0700000000000001 110.731 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 tt -106.98 105.3 15.26 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.118 -1.401 . . . . 1.47 109.956 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.05 127.57 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 114.471 -1.241 . . . . 1.27 108.705 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.95 137.49 52.28 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.04 0.756 . . . . 1.8899999999999999 113.04 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -102.96 115.99 31.67 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.361 -0.836 . . . . 2.8999999999999999 110.723 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -105.74 134.87 48.16 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.95 -0.568 . . . . 0.48999999999999999 110.379 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.6 156.34 48.17 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.248 0.547 . . . . 1.1000000000000001 112.26 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -121.33 133.19 55.11 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.803 0.841 . . . . 2.6099999999999999 111.147 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.49 27.04 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 114.645 1.35 . . . . 2.6099999999999999 114.645 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.19 -37.11 0.06 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 114.535 1.309 . . . . 2.71 114.535 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.31 130.44 56.03 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.075 0.768 . . . . 1.6899999999999999 113.075 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.17 95.28 5.21 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-O 122.494 1.14 . . . . 1.4299999999999999 110.805 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -154.15 149.36 26.99 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.107 -0.951 . . . . 2.9700000000000002 112.661 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.0 m -124.97 125.96 44.72 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.649 -0.705 . . . . 1.6599999999999999 112.865 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 68.16 49.06 0.87 Allowed 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 125.695 1.598 . . . . 2.02 113.179 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -145.8 -41.14 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.602 1.161 . . . . 2.5600000000000001 109.788 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -112.13 82.68 1.67 Allowed 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.462 -0.94 . . . . 3.1499999999999999 108.462 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.59 115.3 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 113.997 -1.456 . . . . 1.3600000000000001 110.321 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.451 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 34.1 m-85 -97.46 175.97 6.04 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.381 1.623 . . . . 0.84999999999999998 115.381 -175.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -123.0 135.16 54.36 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 116.531 -0.304 . . . . 1.3300000000000001 110.509 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.12 124.99 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.35 0 CA-C-O 121.338 0.589 . . . . 1.1699999999999999 110.144 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 37.3 mtt180 -122.57 153.37 39.35 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.028 1.492 . . . . 1.9399999999999999 115.028 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.0 OUTLIER -132.71 104.54 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 115.334 -0.848 . . . . 1.29 112.831 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.507 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.78 27.0 13.03 Favored 'General case' 0 N--CA 1.522 3.14 0 C-N-CA 126.9 2.08 . . . . 1.8200000000000001 113.689 -179.004 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.63 -19.66 33.23 Favored Glycine 0 CA--C 1.547 2.05 0 CA-C-N 116.107 -0.497 . . . . 0.32000000000000001 113.317 -176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 93.3 m-70 -82.95 171.59 13.69 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 125.345 1.458 . . . . 0.56999999999999995 113.848 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.85 123.08 39.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 122.182 -0.324 . . . . 1.1899999999999999 110.94 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.279 9.9 p -113.36 -48.65 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.144 0 CA-C-N 116.209 -0.451 . . . . 1.73 111.533 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.47 90.53 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-O 121.324 0.583 . . . . 1.25 109.741 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -107.13 90.44 3.3 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-O 123.013 1.387 . . . . 2.75 111.232 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 127.27 77.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 129.845 3.258 . . . . 2.48 106.828 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -107.14 104.81 14.55 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.963 -1.017 . . . . 1.78 113.541 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -114.62 111.33 21.17 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 113.61 -1.632 . . . . 2.3500000000000001 108.579 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.58 -33.54 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 114.628 1.344 . . . . 1.27 114.628 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -75.1 -34.97 61.79 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 112.905 0.705 . . . . 0.83999999999999997 112.905 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -75.05 -27.46 60.02 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 124.12 0.968 . . . . 0.91000000000000003 113.285 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -79.06 -55.51 5.07 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.35 0.871 . . . . 2.98 113.35 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.52 -40.18 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 N-CA-C 114.021 1.119 . . . . 1.53 114.021 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.65 -72.05 0.2 Allowed Glycine 0 C--N 1.359 1.849 0 CA-C-N 118.217 0.462 . . . . 0.84999999999999998 113.919 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -102.16 174.79 5.77 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.31 1.044 . . . . 3.9700000000000002 111.709 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.6 m -70.43 90.85 0.73 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.784 1.031 . . . . 2.0800000000000001 113.784 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.78 -162.68 1.51 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.745 -1.57 . . . . 1.22 109.888 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.89 134.08 43.31 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 113.509 0.929 . . . . 1.2 113.509 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -105.87 142.92 34.77 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.194 0.598 . . . . 0.41999999999999998 110.115 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -146.41 137.66 24.45 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.928 1.085 . . . . 2.5 113.928 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -128.34 135.36 49.47 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.928 -1.033 . . . . 1.5800000000000001 110.774 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.93 125.18 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.02 -0.991 . . . . 1.25 111.107 -178.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -129.05 89.01 49.84 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-N 115.464 -0.789 . . . . 1.5 110.927 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -74.95 129.82 12.75 Favored 'Trans proline' 0 C--N 1.394 2.953 0 C-N-CA 122.984 2.456 . . . . 0.22 112.943 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.53 149.51 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.507 0 CA-C-N 115.177 -0.92 . . . . 1.1200000000000001 111.107 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.3 t -134.26 117.16 16.14 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.553 0.692 . . . . 1.8600000000000001 111.106 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.4 mt -115.61 126.35 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 CA-C-N 114.69 -1.141 . . . . 1.0700000000000001 108.381 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -140.15 125.3 18.67 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.479 -0.782 . . . . 2.6400000000000001 110.995 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? 66.56 15.21 10.05 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 125.297 1.439 . . . . 4.0199999999999996 114.548 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.65 19.44 22.53 Favored Glycine 0 CA--C 1.547 2.053 0 CA-C-O 119.165 -0.797 . . . . 0.39000000000000001 114.923 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 23.3 mtpp -126.61 143.82 51.1 Favored 'General case' 0 C--N 1.368 1.385 0 CA-C-N 118.435 1.117 . . . . 2.0299999999999998 112.399 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.38 146.3 27.78 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.262 1.208 . . . . 1.0800000000000001 114.262 -175.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.3 t -140.93 117.32 10.76 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.916 -1.038 . . . . 1.23 110.625 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.253 2.3 p -110.56 98.98 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.514 0 CA-C-N 115.325 -0.852 . . . . 1.1899999999999999 110.302 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 69.47 -81.91 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 125.324 1.45 . . . . 1.8200000000000001 113.488 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.95 26.07 3.3 Favored Glycine 0 CA--C 1.543 1.802 0 CA-C-N 116.022 -0.536 . . . . 0.51000000000000001 113.668 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -129.72 118.52 22.01 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.079 0.552 . . . . 1.8200000000000001 110.5 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.46 137.37 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.759 0.79 . . . . 1.5900000000000001 112.626 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 m -153.88 -170.75 3.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.31 -1.314 . . . . 1.1699999999999999 108.792 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.259 6.3 t -103.12 146.16 28.81 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 113.216 0.821 . . . . 1.71 113.216 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -89.88 132.67 35.16 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.098 0.951 . . . . 0.29999999999999999 111.596 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.2 p -97.73 -163.09 1.01 Allowed 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 113.9 -1.5 . . . . 1.8700000000000001 108.888 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.45 7.29 65.19 Favored Glycine 0 CA--C 1.56 2.855 0 O-C-N 120.236 -1.54 . . . . 0.91000000000000003 116.895 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.455 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -160.45 152.89 20.71 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-O 122.303 1.049 . . . . 1.6799999999999999 112.499 178.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.507 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -108.42 137.62 46.07 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 113.81 -1.541 . . . . 1.3700000000000001 108.854 177.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 t -118.56 145.12 45.61 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.438 1.644 . . . . 0.94999999999999996 115.438 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.05 97.3 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 106.225 -1.769 . . . . 1.3799999999999999 106.225 174.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -117.97 124.42 48.15 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 112.645 0.609 . . . . 1.6699999999999999 112.645 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.21 134.81 54.69 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-O 122.356 1.074 . . . . 2.2999999999999998 112.321 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.2 t -107.3 144.51 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 112.77 -2.013 . . . . 1.29 110.326 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -93.02 150.15 20.73 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.785 1.031 . . . . 2.6200000000000001 113.785 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.04 -36.03 4.85 Favored Glycine 0 CA--C 1.545 1.962 0 CA-C-N 115.149 -0.932 . . . . 1.0600000000000001 114.923 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -127.48 -80.87 0.6 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 117.466 0.633 . . . . 3.1000000000000001 112.256 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -127.96 -50.72 1.33 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.034 0.534 . . . . 4.0800000000000001 111.827 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.451 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -85.76 150.04 24.85 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.806 1.243 . . . . 1.74 112.124 178.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -112.11 -171.28 0.21 Allowed Pre-proline 0 CA--C 1.561 1.393 0 CA-C-N 113.384 -1.735 . . . . 1.6799999999999999 108.236 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -65.27 96.88 0.29 Allowed 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.141 1.894 . . . . 2.8199999999999998 111.567 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -51.08 -57.33 8.97 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 127.104 2.162 . . . . 3.4100000000000001 116.619 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.95 131.55 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 118.96 0.8 . . . . 1.3799999999999999 108.899 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.9 t -132.86 125.06 29.13 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 124.004 0.815 . . . . 1.75 112.146 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . 0.289 . . -120.53 48.33 1.62 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.279 1.955 . . . . 1.1299999999999999 116.279 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.77 134.51 2.51 Favored 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 116.238 1.94 . . . . 1.3999999999999999 116.238 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -151.02 102.6 2.98 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.421 -0.809 . . . . 0.26000000000000001 110.821 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 12' ' ' TRP 0.296 7.7 tt -112.77 121.77 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.186 0 CA-C-O 122.276 1.036 . . . . 1.1000000000000001 111.361 176.033 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -124.4 165.59 17.46 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.057 -1.429 . . . . 1.0600000000000001 110.479 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -122.24 159.16 27.89 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 118.914 2.931 . . . . 1.8300000000000001 118.914 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.27 -41.47 2.14 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-N 109.9 -3.318 . . . . 0.17000000000000001 118.973 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.35 154.54 1.03 Allowed 'General case' 0 N--CA 1.516 2.851 0 CA-C-N 120.211 2.005 . . . . 1.05 113.011 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.49 -15.22 59.95 Favored 'General case' 0 CA--C 1.581 2.148 0 C-N-CA 124.859 1.264 . . . . 0.98999999999999999 114.354 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.9 3.19 49.44 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 113.921 1.082 . . . . 0.55000000000000004 113.921 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.45 -2.38 17.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.435 0.902 . . . . 0.59999999999999998 113.435 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.468 0 C-N-CA 124.552 1.141 . . . . 1.1799999999999999 110.998 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.3 tp . . . . . 0 CA--C 1.565 1.557 0 N-CA-C 113.148 0.796 . . . . 1.0900000000000001 113.148 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.46 -24.58 63.68 Favored 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 126.005 1.722 . . . . 1.04 115.504 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.59 -9.53 55.88 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.582 0.956 . . . . 0.32000000000000001 113.582 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 26.0 mmtp -107.16 -24.97 11.74 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.561 0.948 . . . . 2.2599999999999998 113.561 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.69 134.91 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.056 0 N-CA-C 115.494 1.665 . . . . 1.01 115.494 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -120.09 -30.65 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 115.244 -0.889 . . . . 1.0600000000000001 112.123 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.543 ' O ' HG23 ' A' ' 172' ' ' ILE . 61.9 t90 -161.37 119.48 2.36 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 120.507 0.194 . . . . 0.67000000000000004 111.177 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -138.22 127.85 25.02 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.158 -0.964 . . . . 1.0800000000000001 111.301 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.3 t -137.22 129.74 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.098 0 N-CA-C 113.679 0.992 . . . . 1.6699999999999999 113.679 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -115.9 106.1 13.42 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.582 -1.266 . . . . 2.6400000000000001 107.582 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.48 100.48 6.89 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.06 0.933 . . . . 1.28 111.592 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.508 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 178.16 -55.86 0.09 OUTLIER Glycine 0 C--N 1.349 1.295 0 CA-C-N 113.946 -1.479 . . . . 0.70999999999999996 115.859 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.6 -116.18 3.55 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 114.297 0.479 . . . . 0.87 114.297 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -165.45 116.26 1.09 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.011 0.524 . . . . 2.1200000000000001 111.55 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER 43.73 108.62 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 118.452 2.76 . . . . 1.5 118.452 178.227 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.582 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 74.0 t60 -135.27 132.91 38.37 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.939 1.088 . . . . 0.52000000000000002 113.939 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.5 p -108.01 114.64 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.003 0 CA-C-N 113.884 -1.507 . . . . 2.0699999999999998 109.022 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -84.62 167.29 16.39 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-N 115.322 -0.854 . . . . 1.8500000000000001 113.039 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -43.47 -34.48 0.78 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 N-CA-C 118.716 2.858 . . . . 1.3700000000000001 118.716 -176.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -87.31 -26.53 23.36 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.204 0.526 . . . . 0.56999999999999995 110.95 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.64 45.16 0.48 Allowed Glycine 0 C--N 1.354 1.541 0 CA-C-N 114.854 -1.066 . . . . 0.37 114.346 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.7 mm -107.11 116.25 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 CA-C-O 120.94 0.4 . . . . 1.25 110.085 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.1 t-160 -108.44 133.58 52.41 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 115.095 1.517 . . . . 1.71 115.095 -177.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.601 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.33 140.56 31.61 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-N 114.794 -1.093 . . . . 3.1499999999999999 110.718 176.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -90.24 130.46 36.36 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 124.974 1.31 . . . . 3.5099999999999998 112.4 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -56.61 115.26 2.43 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 118.996 2.961 . . . . 2.8100000000000001 118.996 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 40.59 57.46 7.97 Favored Pre-proline 0 N--CA 1.526 3.349 0 N-CA-C 118.549 2.796 . . . . 1.1699999999999999 118.549 176.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo . . . . . 0 CA--C 1.569 2.232 0 C-N-CA 122.79 2.327 . . . . 1.45 116.218 -179.39 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 44.7 Cg_exo . . . . . 0 N--CA 1.513 2.633 0 N-CA-C 117.522 2.085 . . . . 1.8600000000000001 117.522 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.75 130.05 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.291 0 CA-C-N 114.815 -1.084 . . . . 1.28 108.125 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.1 mt -83.48 -9.68 58.83 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.719 2.118 . . . . 1.9299999999999999 116.719 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -105.88 8.02 32.47 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 114.329 1.233 . . . . 1.79 114.329 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.8 -177.82 4.6 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-O 121.7 0.762 . . . . 1.49 112.309 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.692 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -93.85 169.48 9.93 Favored Pre-proline 0 N--CA 1.514 2.768 0 C-N-CA 124.606 1.162 . . . . 1.6799999999999999 110.044 178.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.78 -41.86 51.11 Favored 'Trans proline' 0 N--CA 1.53 3.642 0 C-N-CA 123.289 2.66 . . . . 1.1599999999999999 116.298 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -68.03 -52.51 34.64 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 124.439 1.095 . . . . 2.04 112.119 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 5.8 t0 -78.11 -1.97 35.13 Favored 'General case' 0 CA--C 1.59 2.505 0 CA-C-N 115.225 -0.898 . . . . 1.6200000000000001 112.174 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.692 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 14.5 tt0 -75.69 -40.66 55.49 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 126.132 1.773 . . . . 2.4300000000000002 108.122 174.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.5 t -63.71 -43.1 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.106 0 C-N-CA 124.635 1.174 . . . . 1.46 108.574 172.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.509 ' O ' ' HB1' ' A' ' 169' ' ' ALA . 4.4 tp -79.86 -5.27 55.16 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 113.59 0.959 . . . . 1.6699999999999999 113.59 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 4.2 m-30 -122.46 20.08 10.41 Favored 'General case' 0 CA--C 1.577 1.995 0 C-N-CA 124.786 1.235 . . . . 1.3300000000000001 111.887 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -148.01 -29.01 0.32 Allowed 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 116.399 2.0 . . . . 1.4099999999999999 116.399 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.4 p -74.99 132.0 41.05 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 115.085 1.513 . . . . 1.28 115.085 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.508 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.09 0 C-N-CA 124.221 1.008 . . . . 1.53 112.687 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 111.354 0.131 . . . . 2.1499999999999999 111.354 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.24 88.3 0.04 OUTLIER 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 125.722 1.609 . . . . 1.25 114.067 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -148.58 156.22 42.14 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.283 0.846 . . . . 1.1499999999999999 113.283 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -173.14 -171.99 38.29 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 116.039 1.176 . . . . 0.59999999999999998 116.039 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.56 173.17 6.45 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.866 1.432 . . . . 1.4099999999999999 114.866 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -129.38 133.48 47.4 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 114.219 -1.355 . . . . 0.51000000000000001 111.992 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.57 100.47 34.79 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 109.074 -0.713 . . . . 1.0600000000000001 109.074 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.38 118.06 2.19 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.084 1.856 . . . . 0.17999999999999999 115.036 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.67 159.71 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 122.043 0.925 . . . . 1.0600000000000001 111.134 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -143.91 20.18 1.8 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.888 -1.051 . . . . 3.1099999999999999 112.331 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -128.58 158.45 38.44 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-O 121.963 0.887 . . . . 2.1200000000000001 111.117 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.89 139.85 50.14 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.887 1.069 . . . . 0.41999999999999998 113.887 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.9 -125.35 1.35 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 113.961 -1.472 . . . . 0.25 112.393 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -126.31 118.63 25.48 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.085 0.469 . . . . 1.75 111.178 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -118.83 139.92 50.81 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.788 -0.642 . . . . 0.90000000000000002 109.907 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 172' ' ' ILE . 2.5 t -120.59 127.59 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.366 0.603 . . . . 1.0700000000000001 110.896 -177.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.7 107.9 18.96 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.068 -0.969 . . . . 1.47 109.861 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.64 128.5 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 109.045 -0.724 . . . . 1.27 109.045 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.64 146.31 49.42 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.81 1.041 . . . . 1.8899999999999999 113.81 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.43 ' HD3' ' C ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -108.75 122.47 47.21 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 115.441 -0.8 . . . . 2.8999999999999999 110.314 176.145 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -109.28 136.72 48.27 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.871 -1.059 . . . . 0.48999999999999999 110.415 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.77 157.14 44.59 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 124.192 0.997 . . . . 1.1000000000000001 111.307 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -169.92 127.38 0.88 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.353 0.661 . . . . 2.6099999999999999 110.917 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.83 73.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.664 -0.698 . . . . 2.6099999999999999 111.27 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -160.19 -47.35 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.959 -0.564 . . . . 2.71 112.126 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -115.19 116.87 29.07 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.803 0.441 . . . . 1.6899999999999999 111.169 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.24 99.06 8.9 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.646 1.213 . . . . 1.4299999999999999 112.11 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -159.19 160.66 35.71 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.465 -1.243 . . . . 2.9700000000000002 111.061 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 m -108.31 -78.66 0.59 Allowed 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.047 1.128 . . . . 1.6599999999999999 114.047 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -95.47 70.47 3.11 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.296 1.046 . . . . 2.02 111.407 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -159.23 -40.06 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.639 -1.619 . . . . 2.5600000000000001 109.346 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -106.02 79.25 1.39 Allowed 'General case' 0 C--N 1.368 1.375 0 CA-C-O 121.838 0.828 . . . . 3.1499999999999999 109.086 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.24 123.09 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 114.439 -1.255 . . . . 1.3600000000000001 111.395 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.538 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 30.2 m-85 -106.1 171.41 7.36 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 114.395 1.257 . . . . 0.84999999999999998 114.395 -177.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -124.88 135.71 53.13 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.828 -0.434 . . . . 1.3300000000000001 109.828 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.0 t -130.07 125.8 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 CA-C-N 116.104 -0.498 . . . . 1.1699999999999999 109.846 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.655 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 23.0 mtt180 -124.55 148.57 47.72 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.236 1.569 . . . . 1.9399999999999999 115.236 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 154' ' ' SER . 5.1 m -125.56 112.38 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 113.095 0.776 . . . . 1.29 113.095 177.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.429 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 63.62 25.99 14.49 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 126.551 1.94 . . . . 1.8200000000000001 113.894 -178.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.36 -14.33 54.59 Favored Glycine 0 CA--C 1.552 2.389 0 C-N-CA 121.456 -0.402 . . . . 0.32000000000000001 113.804 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.655 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 91.3 m-70 -87.93 172.56 9.5 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 126.059 1.744 . . . . 0.56999999999999995 113.362 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.89 132.31 54.5 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.584 0.707 . . . . 1.1899999999999999 112.082 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.75 -55.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 114.775 -1.102 . . . . 1.73 113.141 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.23 89.46 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.877 . . . . 1.25 108.631 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -106.45 108.68 20.31 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.905 1.336 . . . . 2.75 110.572 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 105.14 70.63 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 110.868 -2.878 . . . . 2.48 108.259 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.27 99.5 12.47 Favored 'General case' 0 C--N 1.359 0.983 0 CA-C-N 115.333 -0.849 . . . . 1.78 112.36 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -109.83 91.84 3.81 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.545 -1.661 . . . . 2.3500000000000001 108.755 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -31.25 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 N-CA-C 116.746 2.128 . . . . 1.27 116.746 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -74.0 -40.54 62.87 Favored 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 124.014 0.926 . . . . 0.83999999999999997 112.445 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -26.1 59.97 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 124.443 1.097 . . . . 0.91000000000000003 113.374 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -78.21 -58.09 3.44 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.573 0.953 . . . . 2.98 113.573 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.26 -32.91 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 N-CA-C 114.921 1.452 . . . . 1.53 114.921 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.23 -118.11 2.74 Favored Glycine 0 C--N 1.356 1.639 0 CA-C-N 118.757 0.708 . . . . 0.84999999999999998 113.006 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -115.1 107.44 15.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.297 0.57 . . . . 3.9700000000000002 111.173 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.0 m 70.69 -134.57 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 125.592 1.557 . . . . 2.0800000000000001 113.128 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.8 p 60.4 -151.48 0.4 Allowed 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 126.179 1.792 . . . . 1.22 114.382 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -112.13 130.37 55.92 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 114.141 1.163 . . . . 1.2 114.141 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -108.65 124.38 50.43 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.402 -0.962 . . . . 0.41999999999999998 108.402 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.41 129.18 24.7 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.038 0.755 . . . . 2.5 113.038 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -116.03 134.91 54.45 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.047 -0.978 . . . . 1.5800000000000001 111.492 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.25 114.01 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 113.884 -1.507 . . . . 1.25 109.999 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.23 98.0 33.54 Favored Pre-proline 0 CA--C 1.574 1.866 0 CA-C-N 115.871 -0.604 . . . . 1.5 111.146 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -73.59 144.55 35.96 Favored 'Trans proline' 0 C--N 1.399 3.205 0 C-N-CA 123.293 2.662 . . . . 0.22 114.652 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.59 146.38 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 CA-C-N 115.135 -0.938 . . . . 1.1200000000000001 110.854 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 p -131.41 112.58 12.82 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.495 -0.775 . . . . 1.8600000000000001 111.406 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.98 121.64 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 CA-C-N 115.38 -0.827 . . . . 1.0700000000000001 108.882 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -141.94 130.74 22.91 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 116.274 -0.421 . . . . 2.6400000000000001 111.273 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp 70.67 9.04 6.78 Favored 'General case' 0 N--CA 1.518 2.972 0 C-N-CA 125.033 1.333 . . . . 4.0199999999999996 114.219 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.07 18.1 25.53 Favored Glycine 0 CA--C 1.544 1.859 0 C-N-CA 124.19 0.9 . . . . 0.39000000000000001 113.997 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -127.16 146.68 50.31 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-N 117.768 0.784 . . . . 2.0299999999999998 112.746 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.08 141.72 31.48 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.234 1.198 . . . . 1.0800000000000001 114.234 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.8 m -130.01 113.42 14.55 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.626 -1.17 . . . . 1.23 110.155 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.252 9.1 p -121.48 97.03 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.369 0 CA-C-N 116.004 -0.544 . . . . 1.1899999999999999 110.901 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 67.55 -85.45 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.682 0 C-N-CA 125.658 1.583 . . . . 1.8200000000000001 113.874 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.03 29.3 3.53 Favored Glycine 0 CA--C 1.542 1.737 0 CA-C-N 115.994 -0.548 . . . . 0.51000000000000001 112.979 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -133.17 125.72 30.06 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 123.507 0.723 . . . . 1.8200000000000001 110.651 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.11 126.02 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.303 0 CA-C-O 121.46 0.648 . . . . 1.5900000000000001 111.07 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 m -145.93 -178.89 6.35 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.285 -0.871 . . . . 1.1699999999999999 109.969 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.273 12.4 t -103.14 137.03 41.85 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 113.414 0.894 . . . . 1.71 113.414 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -83.43 125.37 31.64 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.434 1.094 . . . . 0.29999999999999999 112.011 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.81 91.22 2.95 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 112.649 0.611 . . . . 1.8700000000000001 112.649 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.46 -66.22 3.53 Favored Glycine 0 C--N 1.358 1.786 0 N-CA-C 119.03 2.372 . . . . 0.91000000000000003 119.03 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.17 156.87 44.57 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.142 1.164 . . . . 1.6799999999999999 114.142 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.429 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -105.98 133.45 50.68 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 113.035 -1.893 . . . . 1.3700000000000001 108.545 176.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.6 t -120.14 143.7 48.05 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.737 1.754 . . . . 0.94999999999999996 115.737 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.425 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -115.51 100.29 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.945 -1.132 . . . . 1.3799999999999999 107.945 176.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.81 125.28 49.21 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.978 -0.555 . . . . 1.6699999999999999 111.952 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.81 132.73 56.62 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.09 0.947 . . . . 2.2999999999999998 111.771 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 t -110.35 143.28 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.911 0 CA-C-N 113.381 -1.736 . . . . 1.29 109.674 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 151.85 22.19 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.756 1.391 . . . . 2.6200000000000001 114.756 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.78 -26.64 7.05 Favored Glycine 0 CA--C 1.55 2.253 0 CA-C-N 115.027 -0.988 . . . . 1.0600000000000001 115.254 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -132.01 -78.81 0.51 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.045 0.922 . . . . 3.1000000000000001 112.616 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -135.87 -49.41 0.69 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.078 0.551 . . . . 4.0800000000000001 111.518 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.538 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -94.42 135.43 35.85 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.591 1.156 . . . . 1.74 111.521 178.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -94.26 -169.83 0.21 Allowed Pre-proline 0 CA--C 1.568 1.667 0 CA-C-N 113.979 -1.464 . . . . 1.6799999999999999 108.576 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -66.55 99.99 0.46 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 CA-C-N 122.311 1.861 . . . . 2.8199999999999998 111.3 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -57.18 -49.92 74.48 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.498 1.666 . . . . 3.4100000000000001 115.498 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.0 t -110.56 130.99 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.076 -0.713 . . . . 1.3799999999999999 109.076 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -136.9 124.72 22.56 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 113.597 -1.638 . . . . 1.75 111.482 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 60' ' ' LEU 0.256 . . -121.31 49.97 1.44 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.75 1.759 . . . . 1.1299999999999999 115.75 -176.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.69 135.15 2.98 Favored 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 116.175 1.917 . . . . 1.3999999999999999 116.175 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -153.6 100.67 2.42 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.38 -0.827 . . . . 0.26000000000000001 110.6 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 12' ' ' TRP 0.308 5.2 tt -109.26 122.48 63.96 Favored 'Isoleucine or valine' 0 C--O 1.27 2.156 0 CA-C-O 122.346 1.069 . . . . 1.1000000000000001 111.383 176.136 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -120.27 154.2 35.28 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 113.755 -1.566 . . . . 1.0600000000000001 112.221 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 50.5 tttm -105.92 150.0 26.07 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 118.09 2.626 . . . . 1.8300000000000001 118.09 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.43 -39.59 2.77 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 110.98 -2.827 . . . . 0.17000000000000001 119.805 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.73 164.12 1.21 Allowed 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 121.218 2.509 . . . . 1.05 112.571 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.88 -16.07 48.98 Favored 'General case' 0 CA--C 1.579 2.085 0 C-N-CA 124.722 1.209 . . . . 0.98999999999999999 113.8 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.36 4.65 45.42 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.363 1.246 . . . . 0.55000000000000004 114.363 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -11.89 17.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.27 1.211 . . . . 0.59999999999999998 114.27 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.513 2.713 0 C-N-CA 124.036 0.934 . . . . 1.1799999999999999 113.08 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.6 tp . . . . . 0 CA--C 1.564 1.482 0 N-CA-C 113.22 0.822 . . . . 1.0900000000000001 113.22 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.51 -23.07 64.26 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 125.807 1.643 . . . . 1.04 114.965 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.49 -12.53 48.65 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 113.632 0.975 . . . . 0.32000000000000001 113.632 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -104.19 -23.58 13.24 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-O 118.211 -0.9 . . . . 2.2599999999999998 113.227 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.49 133.36 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 N-CA-C 115.094 1.516 . . . . 1.01 115.094 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pt -120.52 -28.28 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.183 -0.917 . . . . 1.0600000000000001 112.264 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.454 ' O ' HG22 ' A' ' 172' ' ' ILE . 62.4 t90 -163.97 116.91 1.43 Allowed 'General case' 0 CA--C 1.558 1.27 0 CA-C-O 120.583 0.23 . . . . 0.67000000000000004 111.141 -177.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.32 130.87 35.71 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.569 -0.707 . . . . 1.0800000000000001 111.202 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.74 129.69 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.422 0.897 . . . . 1.6699999999999999 113.422 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -117.05 105.23 12.06 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.01 -1.478 . . . . 2.6400000000000001 107.01 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.17 108.22 12.51 Favored 'General case' 0 C--O 1.254 1.305 0 CA-C-O 121.639 0.733 . . . . 1.28 111.553 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.2 -43.71 0.37 Allowed Glycine 0 C--N 1.351 1.374 0 CA-C-N 114.265 -1.334 . . . . 0.70999999999999996 115.652 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -115.15 -121.25 3.45 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 117.564 0.682 . . . . 0.87 113.892 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 18.1 mt-10 -164.83 115.36 1.16 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.295 0.638 . . . . 2.1200000000000001 111.133 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 1.1 m 42.85 110.15 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 118.589 2.811 . . . . 1.5 118.589 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.55 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 78.1 t60 -136.58 131.79 34.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.358 1.244 . . . . 0.52000000000000002 114.358 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.401 ' HB ' ' ND1' ' A' ' 28' ' ' HIS . 9.6 p -104.93 114.48 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 113.958 -1.474 . . . . 2.0699999999999998 108.967 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -85.21 165.83 17.06 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 115.107 -0.951 . . . . 1.8500000000000001 113.155 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -44.59 -30.46 0.67 Allowed 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 N-CA-C 118.667 2.84 . . . . 1.3700000000000001 118.667 -176.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -89.17 -27.04 20.96 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.233 0.539 . . . . 0.56999999999999995 110.936 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.54 42.66 0.57 Allowed Glycine 0 C--N 1.351 1.393 0 CA-C-N 114.82 -1.082 . . . . 0.37 114.059 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.2 mm -107.54 117.05 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-O 121.107 0.48 . . . . 1.25 110.195 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.4 t60 -106.52 131.61 53.48 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.882 1.438 . . . . 1.71 114.882 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.556 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -93.07 137.41 32.45 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 124.058 0.943 . . . . 3.1499999999999999 109.639 175.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 33' ' ' PRO . 12.9 ptm180 -99.0 105.86 18.06 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 114.54 -1.209 . . . . 3.5099999999999998 113.335 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -23.14 119.84 0.04 OUTLIER 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 120.57 3.545 . . . . 2.8100000000000001 120.57 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 34.42 54.17 1.59 Allowed Pre-proline 0 N--CA 1.536 3.868 0 N-CA-C 119.576 3.176 . . . . 1.1699999999999999 119.576 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.569 2.268 0 C-N-CA 123.423 2.749 . . . . 1.45 116.908 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo . . . . . 0 N--CA 1.512 2.603 0 N-CA-C 117.288 1.995 . . . . 1.8600000000000001 117.288 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 61' ' ' TYR 0.262 1.0 OUTLIER -93.85 123.28 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.777 0 CA-C-N 115.237 -0.892 . . . . 1.28 109.472 178.908 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 7.3 mt -89.22 101.71 14.37 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.871 0.843 . . . . 1.9299999999999999 112.374 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 1.5 mpt_? 148.01 -13.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.158 2.183 . . . . 1.79 110.578 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.54 -179.01 3.56 Favored 'General case' 0 CA--C 1.567 1.599 0 C-N-CA 123.767 0.827 . . . . 1.49 113.09 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -95.77 -176.88 0.58 Allowed Pre-proline 0 N--CA 1.51 2.556 0 C-N-CA 124.402 1.081 . . . . 1.6799999999999999 109.421 178.467 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.445 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 31.3 Cg_exo -68.51 -39.13 9.91 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.679 2.253 . . . . 1.1599999999999999 113.963 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -67.2 -54.28 22.55 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 125.04 1.336 . . . . 2.04 112.124 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -5.37 47.34 Favored 'General case' 0 CA--C 1.576 1.947 0 CA-C-N 114.979 -1.01 . . . . 1.6200000000000001 112.746 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 27.5 tt0 -71.64 -44.14 64.86 Favored 'General case' 0 C--N 1.382 2.015 0 C-N-CA 125.539 1.536 . . . . 2.4300000000000002 108.07 173.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.37 -38.89 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 C-N-CA 124.055 0.942 . . . . 1.46 109.481 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -82.54 -8.36 59.61 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 114.116 1.154 . . . . 1.6699999999999999 114.116 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.418 ' O ' HG12 ' A' ' 50' ' ' ILE . 20.4 m-85 -125.02 21.36 8.16 Favored 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.222 1.009 . . . . 1.3300000000000001 112.928 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.416 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -143.8 -31.53 0.46 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 115.27 1.582 . . . . 1.4099999999999999 115.27 -177.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.8 p -73.12 134.23 44.4 Favored 'General case' 0 N--CA 1.524 3.231 0 N-CA-C 114.3 1.222 . . . . 1.28 114.3 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 114.672 1.36 . . . . 1.53 114.672 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.337 -0.616 . . . . 2.1499999999999999 109.337 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.83 86.53 0.12 Allowed 'General case' 0 N--CA 1.517 2.885 0 C-N-CA 124.717 1.207 . . . . 1.25 111.674 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -140.51 149.74 42.85 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.998 0.904 . . . . 1.1499999999999999 112.68 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.87 -176.75 31.27 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 114.303 -1.317 . . . . 0.59999999999999998 115.821 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 169.55 10.16 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 114.117 -1.042 . . . . 1.4099999999999999 113.729 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.06 131.16 52.2 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.662 -1.154 . . . . 0.51000000000000001 111.895 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.1 103.12 33.47 Favored Pre-proline 0 CA--C 1.57 1.719 0 C-N-CA 123.107 0.563 . . . . 1.0600000000000001 109.567 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -84.15 117.18 2.16 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.264 1.976 . . . . 0.17999999999999999 114.657 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.26 157.94 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.625 0 CA-C-O 122.053 0.93 . . . . 1.0600000000000001 111.112 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -146.13 24.38 1.3 Allowed 'General case' 0 CA--C 1.557 1.236 0 CA-C-N 114.654 -1.157 . . . . 3.1099999999999999 112.008 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -128.62 160.16 33.3 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 121.268 0.556 . . . . 2.1200000000000001 111.194 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.04 142.02 50.21 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.069 1.137 . . . . 0.41999999999999998 114.069 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.85 -137.34 4.91 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 113.696 -1.593 . . . . 0.25 112.121 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -115.63 112.13 21.67 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 118.436 1.118 . . . . 1.75 111.276 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.467 ' HH ' ' HE2' ' A' ' 174' ' ' LYS . 79.7 m-85 -104.49 128.37 52.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.147 -0.479 . . . . 0.90000000000000002 110.896 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -110.35 119.33 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 121.977 0.894 . . . . 1.0700000000000001 110.427 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 tt -107.34 104.61 14.24 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.79 -1.55 . . . . 1.47 109.648 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.95 126.42 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 CA-C-N 114.367 -1.288 . . . . 1.27 108.57 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.52 135.52 49.52 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.594 -0.73 . . . . 1.8899999999999999 112.418 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.4 tppt? -101.5 118.2 36.46 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.447 0.641 . . . . 2.8999999999999999 110.556 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -105.54 134.54 48.5 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.256 -0.884 . . . . 0.48999999999999999 110.571 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.39 151.53 41.94 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.182 0.515 . . . . 1.1000000000000001 112.266 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -147.83 135.23 20.65 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.118 0.567 . . . . 2.6099999999999999 110.967 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.275 7.5 p -147.06 86.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.388 0 CA-C-O 121.591 0.71 . . . . 2.6099999999999999 111.851 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -175.12 -46.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.602 -0.726 . . . . 2.71 112.139 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -115.56 139.52 50.0 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 121.193 0.52 . . . . 1.6899999999999999 112.008 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -112.85 99.68 8.08 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.191 0.996 . . . . 1.4299999999999999 111.004 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -158.74 140.85 13.89 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.317 -0.856 . . . . 2.9700000000000002 112.313 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.7 m -120.74 130.45 54.05 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.341 -0.845 . . . . 1.6599999999999999 112.219 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 80.53 10.51 1.09 Allowed 'General case' 0 N--CA 1.519 2.987 0 C-N-CA 125.857 1.663 . . . . 2.02 114.494 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -117.49 -25.71 6.88 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.711 0.804 . . . . 2.5600000000000001 112.259 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -107.03 79.41 1.32 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.484 0.714 . . . . 3.1499999999999999 109.393 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . 0.261 1.2 t -109.81 126.6 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 CA-C-N 114.998 -1.001 . . . . 1.3600000000000001 110.091 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -118.87 174.31 6.37 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 114.652 1.352 . . . . 0.84999999999999998 114.652 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.93 136.34 54.92 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.921 -0.487 . . . . 1.3300000000000001 111.19 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.2 t -124.99 123.65 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 C-N-CA 123.056 0.543 . . . . 1.1699999999999999 110.07 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 51.8 mtt180 -121.14 147.13 45.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.653 1.353 . . . . 1.9399999999999999 114.653 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 154' ' ' SER . 50.8 t -130.56 109.75 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.252 0 N-CA-C 107.68 -1.23 . . . . 1.29 107.68 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.43 26.89 16.03 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 126.992 2.117 . . . . 1.8200000000000001 114.574 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.12 -19.58 40.14 Favored Glycine 0 CA--C 1.548 2.097 0 N-CA-C 114.554 0.582 . . . . 0.32000000000000001 114.554 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -91.01 154.51 19.38 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 124.837 1.255 . . . . 0.56999999999999995 113.375 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.3 p -102.93 127.9 49.95 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.609 0.718 . . . . 1.1899999999999999 111.638 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.07 -50.63 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.582 -1.19 . . . . 1.73 110.342 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.43 88.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 119.996 -0.682 . . . . 1.25 110.237 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -106.92 119.23 38.79 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-O 122.41 1.1 . . . . 2.75 110.076 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 102.96 59.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 128.434 2.694 . . . . 2.48 107.6 -175.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.34 96.9 10.76 Favored 'General case' 0 C--N 1.373 1.596 0 CA-C-O 121.634 0.731 . . . . 1.78 112.714 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -107.64 97.81 7.49 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 113.652 -1.613 . . . . 2.3500000000000001 107.448 175.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.08 -30.01 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.458 0 N-CA-C 114.244 1.201 . . . . 1.27 114.244 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -73.89 -41.88 61.5 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 123.481 0.712 . . . . 0.83999999999999997 112.218 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -72.24 -25.84 61.78 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 124.537 1.135 . . . . 0.91000000000000003 113.55 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -79.53 -57.8 3.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 113.701 1.0 . . . . 2.98 113.701 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.48 -37.89 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.515 0 N-CA-C 114.516 1.302 . . . . 1.53 114.516 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.62 -115.36 1.89 Allowed Glycine 0 C--N 1.354 1.557 0 C-N-CA 121.194 -0.527 . . . . 0.84999999999999998 113.38 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -114.87 108.06 16.23 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.957 0.408 . . . . 3.9700000000000002 110.422 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.7 m 73.33 -126.2 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 125.466 1.506 . . . . 2.0800000000000001 111.845 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.6 p 57.54 -165.6 0.15 Allowed 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 126.066 1.746 . . . . 1.22 115.343 177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.99 127.57 56.01 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 112.684 0.624 . . . . 1.2 112.684 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -103.53 138.83 39.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.465 -0.569 . . . . 0.41999999999999998 109.465 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -144.59 129.37 18.28 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.78 1.03 . . . . 2.5 113.78 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -117.41 129.94 56.17 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-N 114.759 -1.11 . . . . 1.5800000000000001 110.939 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.53 111.59 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 114.493 -1.231 . . . . 1.25 110.658 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.5 mm -115.8 92.11 32.97 Favored Pre-proline 0 CA--C 1.582 2.178 0 CA-C-N 115.639 -0.71 . . . . 1.5 110.706 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -77.19 126.33 8.47 Favored 'Trans proline' 0 C--N 1.392 2.824 0 C-N-CA 122.568 2.178 . . . . 0.22 113.032 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.88 150.81 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 C-N-CA 123.991 0.916 . . . . 1.1200000000000001 111.067 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.0 t -136.7 118.0 14.6 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.524 0.678 . . . . 1.8600000000000001 111.775 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -116.98 126.05 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 CA-C-N 114.759 -1.11 . . . . 1.0700000000000001 108.446 178.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -139.37 122.74 17.13 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.622 -0.717 . . . . 2.6400000000000001 110.817 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt 67.67 16.16 9.78 Favored 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 125.279 1.432 . . . . 4.0199999999999996 114.431 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.75 15.93 35.37 Favored Glycine 0 CA--C 1.547 2.067 0 CA-C-O 119.348 -0.696 . . . . 0.39000000000000001 114.67 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 36.8 mtpt -122.02 145.34 48.23 Favored 'General case' 0 C--N 1.363 1.19 0 CA-C-N 118.088 0.944 . . . . 2.0299999999999998 111.759 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.31 150.81 23.4 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.116 1.525 . . . . 1.0800000000000001 115.116 -175.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.32 109.81 6.6 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 113.92 -1.491 . . . . 1.23 109.335 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.1 p -111.1 94.84 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.5 0 CA-C-N 116.025 -0.534 . . . . 1.1899999999999999 110.625 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 67.81 -84.73 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.74 0 C-N-CA 125.416 1.486 . . . . 1.8200000000000001 113.799 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.09 24.62 5.35 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 115.981 -0.554 . . . . 0.51000000000000001 113.263 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -125.7 147.07 49.48 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.726 0.811 . . . . 1.8200000000000001 111.606 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.0 p -129.18 125.87 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.157 0 CA-C-N 115.583 -0.735 . . . . 1.5900000000000001 110.936 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.4 m -149.23 -175.72 5.09 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.225 -0.898 . . . . 1.1699999999999999 110.129 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.0 p -103.8 138.16 40.8 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 112.95 0.722 . . . . 1.71 112.95 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -85.93 123.75 31.61 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 123.548 0.739 . . . . 0.29999999999999999 111.114 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.0 t -129.21 90.94 3.1 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.533 0.682 . . . . 1.8700000000000001 112.733 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.35 -63.36 2.96 Favored Glycine 0 C--N 1.359 1.832 0 N-CA-C 119.043 2.377 . . . . 0.91000000000000003 119.043 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.542 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -130.64 157.15 43.53 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.277 1.214 . . . . 1.6799999999999999 114.277 -176.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.542 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 1.8 tp -104.13 140.81 37.27 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 112.805 -1.998 . . . . 1.3700000000000001 109.41 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.6 t -122.95 144.03 49.51 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.939 1.459 . . . . 0.94999999999999996 114.939 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -120.3 96.57 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.764 -1.199 . . . . 1.3799999999999999 107.764 176.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -118.92 123.5 44.78 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 112.537 0.569 . . . . 1.6699999999999999 112.537 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -115.07 130.64 56.98 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 122.273 1.035 . . . . 2.2999999999999998 111.416 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.14 144.8 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-N 112.724 -2.035 . . . . 1.29 110.867 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.6 150.2 25.34 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 113.991 -1.459 . . . . 2.6200000000000001 114.38 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -100.71 -55.58 0.94 Allowed Glycine 0 CA--C 1.541 1.676 0 CA-C-N 115.281 -0.872 . . . . 1.0600000000000001 114.004 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -128.13 -85.98 0.57 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.031 0.416 . . . . 3.1000000000000001 111.535 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.563 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 61.6 m-85 -133.82 120.6 20.67 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.391 0.676 . . . . 4.0800000000000001 109.792 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 1.0 OUTLIER 87.68 136.54 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 124.86 1.264 . . . . 1.74 111.233 -177.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.52 -168.56 0.19 Allowed Pre-proline 0 CA--C 1.58 2.104 0 CA-C-N 114.621 -1.172 . . . . 1.6799999999999999 110.404 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.07 -15.51 34.1 Favored 'Trans proline' 0 N--CA 1.523 3.206 0 C-N-CA 122.675 2.25 . . . . 2.8199999999999998 115.581 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 77.6 tttt 79.91 -65.1 0.19 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 126.444 1.897 . . . . 3.4100000000000001 114.229 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 38.9 t -106.76 132.27 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 109.791 -0.448 . . . . 1.3799999999999999 109.791 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -135.95 120.58 18.3 Favored 'General case' 0 C--N 1.358 0.943 0 CA-C-N 114.413 -1.267 . . . . 1.75 111.052 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -115.23 49.22 1.08 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.276 1.954 . . . . 1.1299999999999999 116.276 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.75 132.34 3.8 Favored 'General case' 0 N--CA 1.514 2.725 0 N-CA-C 116.069 1.877 . . . . 1.3999999999999999 116.069 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -150.43 100.35 2.86 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.368 -0.833 . . . . 0.26000000000000001 110.525 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 12' ' ' TRP 0.308 13.7 tt -110.3 121.81 63.77 Favored 'Isoleucine or valine' 0 C--O 1.266 1.929 0 CA-C-O 122.42 1.105 . . . . 1.1000000000000001 111.42 176.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -123.5 155.06 38.26 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 113.675 -1.602 . . . . 1.0600000000000001 111.325 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.467 ' HE2' ' HH ' ' A' ' 83' ' ' TYR . 60.1 tttm -104.91 148.21 26.93 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 119.252 3.056 . . . . 1.8300000000000001 119.252 -173.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 105.02 -42.36 1.92 Allowed Glycine 0 CA--C 1.541 1.715 0 CA-C-N 110.316 -3.129 . . . . 0.17000000000000001 120.582 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.73 157.78 1.25 Allowed 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 121.177 2.489 . . . . 1.05 113.371 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.7 -13.09 60.07 Favored 'General case' 0 CA--C 1.581 2.172 0 C-N-CA 124.897 1.279 . . . . 0.98999999999999999 114.421 177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.0 2.42 51.81 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 113.953 1.094 . . . . 0.55000000000000004 113.953 177.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.26 -5.78 17.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.629 0.974 . . . . 0.59999999999999998 113.629 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.506 2.346 0 C-N-CA 124.265 1.026 . . . . 1.1799999999999999 111.916 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.6 tp . . . . . 0 CA--C 1.564 1.517 0 N-CA-C 113.323 0.86 . . . . 1.0900000000000001 113.323 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.64 -23.45 63.04 Favored 'General case' 0 N--CA 1.509 2.505 0 C-N-CA 125.899 1.68 . . . . 1.04 114.971 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.39 -11.96 50.53 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 113.621 0.971 . . . . 0.32000000000000001 113.621 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 46.2 mmtt -105.39 -22.25 13.07 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 113.342 0.867 . . . . 2.2599999999999998 113.342 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.02 135.7 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 115.103 1.52 . . . . 1.01 115.103 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.86 -28.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.455 -0.793 . . . . 1.0600000000000001 112.035 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.484 ' O ' HG23 ' A' ' 172' ' ' ILE . 66.4 t90 -162.52 118.81 1.93 Allowed 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 120.657 0.265 . . . . 0.67000000000000004 111.116 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.72 129.63 24.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.41 -0.806 . . . . 1.0800000000000001 111.62 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 t -133.36 124.55 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.404 0.621 . . . . 1.6699999999999999 110.064 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -113.96 88.71 2.91 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.105 -1.072 . . . . 2.6400000000000001 108.105 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.66 114.02 10.33 Favored 'General case' 0 C--O 1.274 2.356 0 N-CA-C 115.833 1.79 . . . . 1.28 115.833 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.61 -46.28 0.63 Allowed Glycine 0 C--N 1.368 2.309 0 CA-C-N 112.079 -2.328 . . . . 0.70999999999999996 114.438 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.44 -123.96 3.04 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 123.641 0.639 . . . . 0.87 114.029 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -170.0 112.33 0.46 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.809 1.243 . . . . 2.1200000000000001 108.951 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.605 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 1.1 m 40.85 97.21 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.11 0 N-CA-C 116.968 2.211 . . . . 1.5 116.968 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 70.4 t60 -126.92 132.16 50.94 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.705 1.372 . . . . 0.52000000000000002 114.705 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 27' ' ' ILE 0.255 8.8 p -106.33 114.07 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.867 0 CA-C-N 114.135 -1.393 . . . . 2.0699999999999998 110.023 177.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.408 ' OD2' ' HB ' ' A' ' 27' ' ' ILE . 1.7 p-10 -82.85 160.78 22.11 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.674 -1.148 . . . . 1.8500000000000001 113.063 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 m -43.51 -24.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 N-CA-C 118.816 2.895 . . . . 1.3700000000000001 118.816 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -90.7 -29.54 17.64 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 121.164 0.507 . . . . 0.56999999999999995 110.695 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 41.09 0.57 Allowed Glycine 0 C--N 1.353 1.512 0 CA-C-N 114.953 -1.021 . . . . 0.37 114.606 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 22' ' ' VAL . 30.7 mm -107.95 124.33 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 N-CA-C 109.504 -0.554 . . . . 1.25 109.504 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.4 t-160 -114.02 130.48 56.55 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.201 1.556 . . . . 1.71 115.201 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -83.87 136.93 33.92 Favored 'General case' 0 C--N 1.372 1.573 0 C-N-CA 124.019 0.928 . . . . 3.1499999999999999 110.778 175.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -88.89 101.98 14.59 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.716 1.26 . . . . 3.5099999999999998 112.86 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -31.06 98.28 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 129.07 2.948 . . . . 2.8100000000000001 118.792 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.64 72.45 1.21 Allowed Pre-proline 0 N--CA 1.523 3.219 0 N-CA-C 117.489 2.403 . . . . 1.1699999999999999 117.489 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo . . . . . 0 CA--C 1.564 1.983 0 C-N-CA 122.556 2.171 . . . . 1.45 116.812 179.61 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 N--CA 1.514 2.709 0 N-CA-C 116.818 1.815 . . . . 1.8600000000000001 116.818 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.261 1.2 mp -88.72 131.16 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.158 0 CA-C-O 121.779 0.799 . . . . 1.28 110.156 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mt -90.83 -11.6 38.87 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 116.384 1.994 . . . . 1.9299999999999999 116.384 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -101.12 9.04 42.47 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 114.414 1.264 . . . . 1.79 114.414 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.97 -169.79 2.23 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 121.426 0.631 . . . . 1.49 112.603 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.788 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -94.23 -179.84 1.08 Allowed Pre-proline 0 N--CA 1.516 2.831 0 C-N-CA 124.453 1.101 . . . . 1.6799999999999999 109.351 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -69.63 -39.57 6.59 Favored 'Trans proline' 0 C--N 1.398 3.166 0 C-N-CA 122.637 2.224 . . . . 1.1599999999999999 112.772 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -66.56 -52.84 41.11 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 125.988 1.715 . . . . 2.04 111.73 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.609 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -80.69 3.95 20.4 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 113.166 -1.834 . . . . 1.6200000000000001 113.183 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.788 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 32.4 tt0 -85.99 -40.71 15.54 Favored 'General case' 0 C--N 1.371 1.513 0 C-N-CA 125.868 1.667 . . . . 2.4300000000000002 107.773 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -63.17 -43.02 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 C-N-CA 125.038 1.335 . . . . 1.46 110.12 174.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.25 -42.9 54.13 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 118.441 0.564 . . . . 1.6699999999999999 111.786 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.609 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 2.8 m-30 -74.47 1.08 12.69 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 124.456 1.103 . . . . 1.3300000000000001 112.822 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.439 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 3.2 tt0 -131.98 -127.13 0.19 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.538 0.735 . . . . 1.4099999999999999 110.51 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.6 p 52.15 -145.59 0.54 Allowed 'General case' 0 N--CA 1.533 3.713 0 C-N-CA 126.076 1.751 . . . . 1.28 112.98 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.513 2.69 0 CA-C-N 120.633 1.561 . . . . 1.53 114.036 176.824 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.231 0.062 . . . . 2.1499999999999999 110.921 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.541 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER 69.58 83.31 0.15 Allowed 'General case' 0 N--CA 1.511 2.607 0 C-N-CA 125.147 1.379 . . . . 1.25 112.399 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -147.61 153.41 39.36 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.873 0.694 . . . . 1.1499999999999999 112.873 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.61 179.4 47.63 Favored Glycine 0 C--N 1.349 1.282 0 N-CA-C 116.259 1.264 . . . . 0.59999999999999998 116.259 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -100.35 173.64 6.5 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 117.357 2.354 . . . . 1.4099999999999999 117.357 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.02 120.95 23.11 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 112.617 -2.083 . . . . 0.51000000000000001 111.006 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.03 109.4 52.29 Favored Pre-proline 0 CA--C 1.568 1.672 0 C-N-CA 123.371 0.668 . . . . 1.0600000000000001 109.606 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -84.79 118.2 2.07 Favored 'Trans proline' 0 CA--C 1.566 2.125 0 C-N-CA 121.918 1.746 . . . . 0.17999999999999999 114.427 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.97 159.23 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 CA-C-O 122.052 0.93 . . . . 1.0600000000000001 111.638 -179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -150.33 23.19 0.83 Allowed 'General case' 0 CA--C 1.56 1.343 0 CA-C-N 114.51 -1.223 . . . . 3.1099999999999999 111.859 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -129.25 158.74 38.21 Favored 'General case' 0 C--N 1.362 1.136 0 CA-C-O 121.166 0.508 . . . . 2.1200000000000001 111.344 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -120.33 144.3 47.92 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.743 1.016 . . . . 0.41999999999999998 113.743 -178.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.86 -135.64 4.01 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 113.751 -1.568 . . . . 0.25 111.953 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -118.73 107.31 13.51 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 118.23 1.015 . . . . 1.75 111.101 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -99.35 128.38 45.46 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.252 0.549 . . . . 0.90000000000000002 111.041 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 t -112.02 124.01 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 115.674 -0.694 . . . . 1.0700000000000001 110.548 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 tt -107.87 106.44 16.72 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.675 -1.148 . . . . 1.47 109.858 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.62 128.06 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 113.947 -1.479 . . . . 1.27 108.492 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.58 141.34 47.64 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.432 -0.804 . . . . 1.8899999999999999 112.6 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.499 ' HD3' ' C ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -107.11 123.52 48.36 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 122.022 0.915 . . . . 2.8999999999999999 110.331 176.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.53 137.07 46.22 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 114.16 -1.382 . . . . 0.48999999999999999 110.238 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.14 151.84 51.04 Favored 'General case' 0 C--O 1.266 1.922 0 CA-C-N 114.979 -1.009 . . . . 1.1000000000000001 110.916 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -124.12 123.89 41.31 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 123.788 0.835 . . . . 2.6099999999999999 110.705 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.265 5.4 p -138.02 41.19 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.766 0 N-CA-C 112.567 0.58 . . . . 2.6099999999999999 112.567 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -161.8 -42.86 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.75 0.648 . . . . 2.71 112.75 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -115.36 119.48 36.42 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.218 0.451 . . . . 1.6899999999999999 112.218 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.81 86.17 2.35 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-O 122.73 1.253 . . . . 1.4299999999999999 111.134 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -158.57 160.57 36.76 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.89 -1.05 . . . . 2.9700000000000002 112.034 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.3 m -121.84 125.52 46.65 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.6 -0.727 . . . . 1.6599999999999999 112.625 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 74.49 56.7 0.08 Allowed 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 125.878 1.671 . . . . 2.02 113.074 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -157.73 -41.76 0.07 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.709 -1.132 . . . . 2.5600000000000001 109.41 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -105.83 82.78 1.83 Allowed 'General case' 0 C--N 1.361 1.1 0 CA-C-O 121.79 0.805 . . . . 3.1499999999999999 108.848 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.88 122.5 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 114.397 -1.274 . . . . 1.3600000000000001 111.729 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -107.36 164.09 12.48 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.9 1.444 . . . . 0.84999999999999998 114.9 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -120.23 136.51 54.62 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.379 0.609 . . . . 1.3300000000000001 111.109 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.0 t -126.13 127.12 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.205 0 CA-C-N 115.411 -0.813 . . . . 1.1699999999999999 109.828 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 57.9 mtt180 -127.33 148.89 50.25 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.509 1.67 . . . . 1.9399999999999999 115.509 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.8 m -129.48 113.5 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 N-CA-C 112.783 0.66 . . . . 1.29 112.783 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.34 25.05 14.5 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 126.306 1.842 . . . . 1.8200000000000001 114.164 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.54 -17.29 46.86 Favored Glycine 0 CA--C 1.551 2.282 0 CA-C-N 115.896 -0.593 . . . . 0.32000000000000001 113.626 -176.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 95.2 m-70 -85.79 175.98 8.38 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.544 1.537 . . . . 0.56999999999999995 114.0 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.48 139.83 51.45 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.948 0.88 . . . . 1.1899999999999999 112.171 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.84 -57.16 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 114.016 -1.447 . . . . 1.73 112.792 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.81 89.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.57 0.7 . . . . 1.25 109.35 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -100.55 119.45 38.54 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 114.651 -1.159 . . . . 2.75 110.531 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 88.29 62.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 127.395 2.278 . . . . 2.48 110.78 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.13 105.05 15.57 Favored 'General case' 0 C--N 1.366 1.286 0 N-CA-C 113.425 0.898 . . . . 1.78 113.425 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -111.46 99.31 8.11 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 113.781 -1.554 . . . . 2.3500000000000001 107.426 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -32.15 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 N-CA-C 114.675 1.361 . . . . 1.27 114.675 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -75.01 -37.49 61.79 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.495 0.718 . . . . 0.83999999999999997 112.892 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -74.06 -26.7 60.54 Favored 'General case' 0 CA--C 1.575 1.911 0 C-N-CA 124.359 1.064 . . . . 0.91000000000000003 113.477 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -80.99 -57.92 3.31 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.246 0.832 . . . . 2.98 113.246 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.43 -38.94 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 N-CA-C 114.091 1.145 . . . . 1.53 114.091 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.04 -66.41 0.24 Allowed Glycine 0 C--N 1.358 1.794 0 CA-C-N 118.372 0.533 . . . . 0.84999999999999998 114.222 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -106.6 173.3 6.38 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.016 0.927 . . . . 3.9700000000000002 111.78 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.1 m -81.14 84.22 6.59 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.641 0.978 . . . . 2.0800000000000001 113.641 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.2 p -131.56 -131.37 0.19 Allowed 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 114.264 -1.335 . . . . 1.22 108.315 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.64 130.29 56.78 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 114.425 1.269 . . . . 1.2 114.425 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -107.52 129.46 54.96 Favored 'General case' 0 C--N 1.371 1.526 0 N-CA-C 108.697 -0.853 . . . . 0.41999999999999998 108.697 174.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.1 129.06 18.5 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.014 0.746 . . . . 2.5 113.014 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -112.92 129.27 56.53 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 115.081 -0.963 . . . . 1.5800000000000001 111.361 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.97 110.34 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 114.27 -1.332 . . . . 1.25 109.429 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.6 102.16 29.61 Favored Pre-proline 0 CA--C 1.571 1.761 0 N-CA-C 112.482 0.549 . . . . 1.5 112.482 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -74.77 144.3 30.96 Favored 'Trans proline' 0 C--N 1.398 3.16 0 C-N-CA 123.096 2.531 . . . . 0.22 114.882 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.09 147.99 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 C-N-CA 124.567 1.147 . . . . 1.1200000000000001 109.043 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 t -134.3 116.97 15.88 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.438 0.637 . . . . 1.8600000000000001 112.003 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.422 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.2 mt -114.47 127.19 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 114.836 -1.075 . . . . 1.0700000000000001 108.826 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -138.8 123.29 18.4 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.463 -0.789 . . . . 2.6400000000000001 110.756 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt 67.88 13.65 9.22 Favored 'General case' 0 N--CA 1.521 3.092 0 N-CA-C 115.226 1.565 . . . . 4.0199999999999996 115.226 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.94 15.13 31.96 Favored Glycine 0 CA--C 1.548 2.109 0 N-CA-C 114.732 0.653 . . . . 0.39000000000000001 114.732 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -121.8 145.27 48.22 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 117.87 0.835 . . . . 2.0299999999999998 112.194 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.84 146.64 27.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.439 1.274 . . . . 1.0800000000000001 114.439 -176.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.24 111.02 9.91 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.38 -1.282 . . . . 1.23 110.077 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.0 p -111.4 93.28 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.619 0 CA-C-N 115.598 -0.728 . . . . 1.1899999999999999 110.11 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 66.33 -83.48 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.882 0 C-N-CA 125.288 1.435 . . . . 1.8200000000000001 113.689 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.73 25.94 3.9 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 115.996 -0.547 . . . . 0.51000000000000001 113.741 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -133.2 118.58 18.79 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.18 0.592 . . . . 1.8200000000000001 110.128 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.7 p -105.92 132.76 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.329 0 CA-C-O 121.55 0.691 . . . . 1.5900000000000001 112.07 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.8 m -148.33 -175.42 4.9 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.014 -0.994 . . . . 1.1699999999999999 110.106 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 35.6 p -101.81 137.94 39.45 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 113.055 0.761 . . . . 1.71 113.055 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -87.1 122.76 31.36 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.469 0.707 . . . . 0.29999999999999999 110.447 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.9 t -129.24 91.65 3.23 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 113.006 0.743 . . . . 1.8700000000000001 113.006 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.22 -64.09 3.8 Favored Glycine 0 C--N 1.357 1.725 0 N-CA-C 119.007 2.363 . . . . 0.91000000000000003 119.007 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.14 158.05 43.78 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.3 1.222 . . . . 1.6799999999999999 114.3 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.68 141.0 37.88 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.308 -1.769 . . . . 1.3700000000000001 109.332 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.9 t -123.95 141.61 51.88 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.972 1.471 . . . . 0.94999999999999996 114.972 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -116.56 100.45 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.33 -1.359 . . . . 1.3799999999999999 107.33 176.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -113.48 126.3 55.17 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.77 -0.65 . . . . 1.6699999999999999 112.375 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.6 124.61 52.75 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.503 -0.771 . . . . 2.2999999999999998 110.406 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.441 ' C ' ' HB3' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -107.99 144.85 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 113.982 -1.463 . . . . 1.29 111.027 -177.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.514 ' HB3' ' OD1' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -78.25 149.18 33.64 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 125.224 1.41 . . . . 2.6200000000000001 114.673 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.42 -53.09 0.57 Allowed Glycine 0 CA--C 1.537 1.464 0 CA-C-N 115.097 -0.956 . . . . 1.0600000000000001 113.392 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -128.39 -48.52 1.3 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 122.937 0.495 . . . . 3.1000000000000001 112.049 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.78 -46.32 0.54 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.814 0.672 . . . . 4.0800000000000001 112.814 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.46 160.5 17.71 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.437 0.637 . . . . 1.74 112.569 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.541 ' ND2' ' H ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -120.17 -51.81 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 115.751 -0.658 . . . . 1.6799999999999999 111.296 -179.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -103.49 -59.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.669 2.246 . . . . 2.8199999999999998 115.143 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.0 tptm 88.34 -106.22 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 126.823 2.049 . . . . 3.4100000000000001 110.492 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.07 134.1 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.005 -1.109 . . . . 1.3799999999999999 108.005 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.0 t -132.65 137.64 47.05 Favored 'General case' 0 C--N 1.366 1.297 0 N-CA-C 115.159 1.54 . . . . 1.75 115.159 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . 0.256 . . -130.15 47.27 2.53 Favored 'General case' 0 CA--C 1.589 2.465 0 N-CA-C 115.524 1.675 . . . . 1.1299999999999999 115.524 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.85 137.07 5.84 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 116.506 2.039 . . . . 1.3999999999999999 116.506 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -154.06 106.04 2.78 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 115.668 -0.696 . . . . 0.26000000000000001 111.298 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 12' ' ' TRP 0.325 7.8 tt -114.65 122.3 68.49 Favored 'Isoleucine or valine' 0 C--O 1.27 2.165 0 CA-C-O 122.44 1.114 . . . . 1.1000000000000001 111.465 175.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -124.31 165.26 17.98 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 113.924 -1.489 . . . . 1.0600000000000001 111.146 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.3 ptmm? -121.87 157.46 31.1 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 118.223 2.675 . . . . 1.8300000000000001 118.223 -175.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.04 -40.96 2.27 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 110.343 -3.117 . . . . 0.17000000000000001 118.967 173.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.04 159.43 1.67 Allowed 'General case' 0 N--CA 1.514 2.77 0 CA-C-N 120.412 2.106 . . . . 1.05 113.059 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.79 -13.64 59.7 Favored 'General case' 0 CA--C 1.58 2.118 0 C-N-CA 125.141 1.376 . . . . 0.98999999999999999 114.046 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.01 3.28 49.39 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 113.663 0.986 . . . . 0.55000000000000004 113.663 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.87 -8.94 19.34 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.575 0.954 . . . . 0.59999999999999998 113.575 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.537 0 C-N-CA 123.971 0.908 . . . . 1.1799999999999999 112.457 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.2 tp . . . . . 0 CA--C 1.565 1.538 0 N-CA-C 113.558 0.947 . . . . 1.0900000000000001 113.558 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -22.48 61.35 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 115.412 1.634 . . . . 1.04 115.412 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.46 -12.51 48.8 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 113.751 1.019 . . . . 0.32000000000000001 113.751 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 16.4 mtpt -108.38 -18.91 13.63 Favored 'General case' 0 C--N 1.365 1.274 0 N-CA-C 113.583 0.957 . . . . 2.2599999999999998 113.583 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.25 138.84 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.967 0 N-CA-C 115.156 1.539 . . . . 1.01 115.156 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -122.34 -28.09 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 115.34 -0.846 . . . . 1.0600000000000001 112.124 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.477 ' O ' HG21 ' A' ' 172' ' ' ILE . 60.5 t90 -165.32 119.7 1.26 Allowed 'General case' 0 CA--C 1.563 1.443 0 N-CA-C 111.543 0.201 . . . . 0.67000000000000004 111.543 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -138.31 130.51 28.7 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.302 -0.874 . . . . 1.0800000000000001 111.724 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -138.9 134.59 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 N-CA-C 113.642 0.978 . . . . 1.6699999999999999 113.642 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -115.93 106.0 13.3 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.595 -1.261 . . . . 2.6400000000000001 107.595 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.99 106.64 9.99 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 121.525 0.678 . . . . 1.28 111.683 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.453 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 165.84 -47.73 0.27 Allowed Glycine 0 C--N 1.355 1.588 0 CA-C-N 114.613 -1.176 . . . . 0.70999999999999996 115.689 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.58 -119.09 3.07 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-O 119.743 -0.476 . . . . 0.87 113.368 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.82 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 6.8 pt-20 -167.51 117.64 0.84 Allowed 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 117.311 0.555 . . . . 2.1200000000000001 112.214 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER 48.07 112.01 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 118.339 2.718 . . . . 1.5 118.339 178.22 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.409 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 82.3 t60 -144.83 137.4 26.32 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.049 1.129 . . . . 0.52000000000000002 114.049 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.39 119.93 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-N 114.423 -1.262 . . . . 2.0699999999999998 110.172 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.57 157.86 24.61 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-N 114.707 -1.133 . . . . 1.8500000000000001 110.302 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 m -42.19 -28.15 0.23 Allowed 'Isoleucine or valine' 1 N--CA 1.543 4.186 0 N-CA-C 119.261 3.06 . . . . 1.3700000000000001 119.261 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -93.47 -16.41 24.55 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 118.281 0.491 . . . . 0.56999999999999995 111.513 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.68 41.88 1.29 Allowed Glycine 0 C--N 1.357 1.719 0 C-N-CA 124.391 0.996 . . . . 0.37 114.561 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.8 mm -106.21 117.97 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 N-CA-C 109.335 -0.617 . . . . 1.25 109.335 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.409 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.74 135.49 47.06 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.846 1.795 . . . . 1.71 115.846 -175.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.82 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -95.3 137.71 33.98 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.261 -1.336 . . . . 3.1499999999999999 110.157 175.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.448 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 31.8 mtt180 -99.48 107.05 19.15 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.581 -1.191 . . . . 3.5099999999999998 112.898 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -28.08 113.75 0.07 Allowed 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 120.2 3.407 . . . . 2.8100000000000001 120.2 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 32.25 58.72 1.33 Allowed Pre-proline 0 N--CA 1.535 3.796 0 N-CA-C 117.883 2.549 . . . . 1.1699999999999999 117.883 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 20.4 Cg_endo . . . . . 0 CA--C 1.563 1.961 0 C-N-CA 123.071 2.514 . . . . 1.45 116.303 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . 31.0 Cg_exo . . . . . 0 N--CA 1.511 2.552 0 N-CA-C 116.371 1.643 . . . . 1.8600000000000001 116.371 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 61' ' ' TYR 0.269 1.4 mp -88.65 135.97 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.342 0 C-N-CA 123.69 0.796 . . . . 1.28 110.113 179.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.41 -20.55 23.81 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 116.791 2.145 . . . . 1.9299999999999999 116.791 -176.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -99.03 18.64 16.8 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.15 1.167 . . . . 1.79 114.15 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.66 -175.7 4.04 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-O 121.426 0.631 . . . . 1.49 111.934 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.763 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -93.56 -177.83 0.75 Allowed Pre-proline 0 N--CA 1.511 2.625 0 C-N-CA 123.889 0.876 . . . . 1.6799999999999999 109.543 178.301 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -68.93 -39.28 8.4 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.54 2.16 . . . . 1.1599999999999999 113.588 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.59 -50.95 47.72 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 125.309 1.444 . . . . 2.04 112.167 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -6.29 55.19 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-N 115.018 -0.992 . . . . 1.6200000000000001 112.667 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.763 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.0 tt0 -74.29 -39.96 62.6 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 125.162 1.385 . . . . 2.4300000000000002 108.408 173.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.77 -43.55 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 C-N-CA 124.213 1.005 . . . . 1.46 108.939 173.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 tp -80.37 -6.21 57.66 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 114.546 1.313 . . . . 1.6699999999999999 114.546 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.434 ' O ' HG12 ' A' ' 50' ' ' ILE . 18.9 m-85 -125.22 21.8 7.95 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 123.777 0.831 . . . . 1.3300000000000001 112.865 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.516 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 29.0 tt0 -143.86 -37.36 0.33 Allowed 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 115.338 1.607 . . . . 1.4099999999999999 115.338 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.1 p -68.57 133.79 49.05 Favored 'General case' 0 N--CA 1.53 3.558 0 N-CA-C 114.849 1.425 . . . . 1.28 114.849 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.453 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 3.7 pt-20 . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 115.012 1.486 . . . . 1.53 115.012 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.465 ' HA ' HD22 ' A' ' 164' ' ' ASN . 5.1 m-20 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 110.704 -0.11 . . . . 2.1499999999999999 110.704 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.488 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.3 OUTLIER 70.69 82.13 0.16 Allowed 'General case' 0 N--CA 1.515 2.812 0 C-N-CA 124.762 1.225 . . . . 1.25 110.869 -178.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -144.85 153.9 42.08 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.78 -0.646 . . . . 1.1499999999999999 112.654 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.79 -163.91 16.58 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 116.007 1.163 . . . . 0.59999999999999998 116.007 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -122.76 164.94 17.4 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 113.607 -1.296 . . . . 1.4099999999999999 113.413 -177.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.22 130.37 52.66 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.425 -1.261 . . . . 0.51000000000000001 112.126 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.21 102.07 37.42 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.504 0.722 . . . . 1.0600000000000001 109.426 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -84.32 121.03 2.6 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.003 1.802 . . . . 0.17999999999999999 114.691 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.39 161.99 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 CA-C-O 122.099 0.952 . . . . 1.0600000000000001 110.946 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -153.63 22.45 0.53 Allowed 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 114.55 -1.205 . . . . 3.1099999999999999 111.626 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.14 156.78 44.0 Favored 'General case' 0 C--N 1.362 1.127 0 C-N-CA 123.167 0.587 . . . . 2.1200000000000001 110.788 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -118.37 147.41 43.56 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.388 1.255 . . . . 0.41999999999999998 114.388 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.12 -137.64 5.15 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 113.619 -1.628 . . . . 0.25 111.885 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.0 mt-10 -116.22 106.42 13.67 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-N 118.728 1.264 . . . . 1.75 110.819 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -99.58 128.4 45.68 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.251 0.548 . . . . 0.90000000000000002 110.893 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.53 121.77 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.807 0.813 . . . . 1.0700000000000001 110.835 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.36 106.99 17.85 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.118 -1.401 . . . . 1.47 109.854 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.06 125.67 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.755 -0.657 . . . . 1.27 110.927 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.73 144.64 51.12 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.449 0.907 . . . . 1.8899999999999999 113.449 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 127' ' ' HIS . 4.5 tppt? -104.94 120.57 41.77 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.71 -0.677 . . . . 2.8999999999999999 111.383 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -105.56 134.48 48.6 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.561 -0.745 . . . . 0.48999999999999999 109.994 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.68 155.3 47.47 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.252 0.548 . . . . 1.1000000000000001 111.784 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.9 171.85 7.4 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.561 0.745 . . . . 2.6099999999999999 112.281 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.84 -77.61 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 112.498 0.555 . . . . 2.6099999999999999 112.498 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -129.69 70.17 1.43 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.311 0.577 . . . . 2.71 111.76 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -148.42 109.83 4.4 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.747 -0.66 . . . . 1.6899999999999999 110.943 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.22 88.02 2.63 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 123.171 1.463 . . . . 1.4299999999999999 111.271 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -169.12 155.41 6.55 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 113.886 -1.506 . . . . 2.9700000000000002 110.475 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.3 m -118.61 -68.49 0.91 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.44 1.274 . . . . 1.6599999999999999 114.44 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -98.56 68.61 1.84 Allowed 'General case' 0 CA--C 1.558 1.281 0 CA-C-O 121.998 0.904 . . . . 2.02 111.366 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -154.32 -45.41 0.09 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.142 -1.39 . . . . 2.5600000000000001 109.34 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -113.56 86.96 2.5 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 121.683 0.754 . . . . 3.1499999999999999 109.022 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.05 131.4 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 114.524 -1.216 . . . . 1.3600000000000001 111.651 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -103.86 166.93 10.1 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.975 1.472 . . . . 0.84999999999999998 114.975 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.17 137.15 54.93 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.91 -0.586 . . . . 1.3300000000000001 111.353 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.8 t -134.52 129.49 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.278 0 CA-C-N 115.941 -0.572 . . . . 1.1699999999999999 111.116 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -133.82 144.58 49.06 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.681 1.363 . . . . 1.9399999999999999 114.681 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.8 m -115.91 106.53 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 114.228 -1.351 . . . . 1.29 112.783 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.52 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 6.0 t30 62.75 27.03 15.93 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 126.906 2.082 . . . . 1.8200000000000001 114.417 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.93 -20.47 31.24 Favored Glycine 0 CA--C 1.549 2.185 0 CA-C-N 115.503 -0.771 . . . . 0.32000000000000001 113.773 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -84.82 137.55 33.1 Favored 'General case' 0 C--N 1.365 1.254 0 C-N-CA 125.59 1.556 . . . . 0.56999999999999995 114.018 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.69 129.22 42.97 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.694 0.759 . . . . 1.1899999999999999 112.433 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.13 -51.46 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 114.389 -1.278 . . . . 1.73 113.21 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.6 89.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.97 -0.752 . . . . 1.25 108.97 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -110.78 75.69 0.94 Allowed 'General case' 0 C--N 1.361 1.07 0 CA-C-O 123.68 1.705 . . . . 2.75 112.446 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 152.89 67.16 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 110.094 -3.23 . . . . 2.48 108.23 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.29 101.62 13.36 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 122.161 0.981 . . . . 1.78 112.824 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.64 100.09 8.94 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 112.865 -1.971 . . . . 2.3500000000000001 107.701 176.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.22 -22.11 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.379 0 N-CA-C 114.109 1.151 . . . . 1.27 114.109 -176.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -77.28 -42.95 35.05 Favored 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 123.978 0.911 . . . . 0.83999999999999997 112.012 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.32 -27.23 60.61 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.892 1.071 . . . . 0.91000000000000003 113.892 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -80.18 -53.07 7.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.926 1.084 . . . . 2.98 113.926 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.277 4.1 p -102.61 -36.24 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.99 0 N-CA-C 113.997 1.11 . . . . 1.53 113.997 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.5 -121.1 3.03 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-N 118.691 0.678 . . . . 0.84999999999999998 113.047 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -113.27 107.65 16.19 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.252 0.549 . . . . 3.9700000000000002 110.826 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.3 m 72.81 -121.21 0.06 Allowed 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 125.558 1.543 . . . . 2.0800000000000001 111.669 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.6 p 51.55 -165.88 0.05 OUTLIER 'General case' 0 N--CA 1.535 3.795 0 N-CA-C 116.315 1.968 . . . . 1.22 116.315 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -109.08 127.06 53.82 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.128 0.788 . . . . 1.2 113.128 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 8.8 t60 -105.0 140.41 38.23 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.423 0.689 . . . . 0.41999999999999998 109.506 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -144.6 128.5 17.41 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.656 0.613 . . . . 2.5 112.656 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -116.14 136.83 52.67 Favored 'General case' 0 C--O 1.255 1.371 0 CA-C-N 115.019 -0.991 . . . . 1.5800000000000001 111.348 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.92 118.92 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 CA-C-N 113.719 -1.582 . . . . 1.25 110.741 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.19 88.79 50.04 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-N 115.498 -0.774 . . . . 1.5 109.724 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -73.54 139.26 28.16 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 123.183 2.589 . . . . 0.22 113.921 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -122.35 150.83 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-N 115.348 -0.842 . . . . 1.1200000000000001 110.825 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.4 t -135.15 109.32 8.28 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.157 -0.929 . . . . 1.8600000000000001 110.525 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -108.9 124.75 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.569 0 CA-C-N 115.057 -0.974 . . . . 1.0700000000000001 108.811 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -141.27 125.56 17.5 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.245 -0.889 . . . . 2.6400000000000001 110.778 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp 67.23 16.0 10.09 Favored 'General case' 0 N--CA 1.51 2.574 0 C-N-CA 125.444 1.498 . . . . 4.0199999999999996 114.23 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.68 16.83 32.63 Favored Glycine 0 CA--C 1.549 2.203 0 CA-C-O 119.323 -0.71 . . . . 0.39000000000000001 114.591 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 58.2 mttt -120.74 142.56 49.43 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-N 118.003 0.902 . . . . 2.0299999999999998 112.847 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.54 132.51 47.13 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.271 0.841 . . . . 1.0800000000000001 113.271 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.08 112.81 18.2 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.2 -0.909 . . . . 1.23 110.74 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.68 93.13 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.646 0 CA-C-N 115.44 -0.8 . . . . 1.1899999999999999 110.096 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 64.67 -85.17 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.949 0 C-N-CA 125.36 1.464 . . . . 1.8200000000000001 113.711 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.41 29.93 3.95 Favored Glycine 0 CA--C 1.544 1.898 0 CA-C-N 116.004 -0.544 . . . . 0.51000000000000001 113.288 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -133.77 119.96 19.92 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 123.74 0.816 . . . . 1.8200000000000001 110.544 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.9 p -107.76 133.19 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.351 0 CA-C-O 121.481 0.658 . . . . 1.5900000000000001 111.806 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m -151.39 -177.04 5.83 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.161 -0.927 . . . . 1.1699999999999999 110.403 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.8 p -101.87 137.03 40.71 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.282 0.845 . . . . 1.71 113.282 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -86.74 121.47 29.29 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.456 0.702 . . . . 0.29999999999999999 110.144 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.2 t -126.39 91.25 3.33 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 113.03 0.752 . . . . 1.8700000000000001 113.03 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.56 -62.7 3.11 Favored Glycine 0 C--N 1.36 1.885 0 N-CA-C 118.542 2.177 . . . . 0.91000000000000003 118.542 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.49 159.89 38.08 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 122.061 0.934 . . . . 1.6799999999999999 113.31 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.52 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -106.46 134.12 50.09 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.448 -1.705 . . . . 1.3700000000000001 108.721 176.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 t -121.52 123.45 42.03 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 114.521 1.304 . . . . 0.94999999999999996 114.521 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.51 102.81 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.567 -0.901 . . . . 1.3799999999999999 108.567 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.15 150.15 52.27 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.061 0.934 . . . . 1.6699999999999999 111.633 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.23 141.72 48.66 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 114.198 -1.365 . . . . 2.2999999999999998 112.274 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.97 145.53 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-N 112.704 -2.044 . . . . 1.29 110.769 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -70.3 150.04 46.77 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 115.803 1.779 . . . . 2.6200000000000001 115.803 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.3 -55.62 0.5 Allowed Glycine 0 CA--C 1.538 1.484 0 CA-C-N 114.89 -1.05 . . . . 1.0600000000000001 112.606 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.86 -56.14 0.99 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.38 0.672 . . . . 3.1000000000000001 111.049 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -132.27 -41.67 0.98 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.253 0.621 . . . . 4.0800000000000001 112.394 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.37 155.25 24.46 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.33 0.652 . . . . 1.74 112.303 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.488 ' ND2' ' H ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -118.1 -48.02 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 115.693 -0.685 . . . . 1.6799999999999999 110.212 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -106.62 -69.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.553 2.169 . . . . 2.8199999999999998 115.939 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt 92.72 -92.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 127.47 2.308 . . . . 3.4100000000000001 109.32 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.9 t -113.42 131.62 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 107.775 -1.194 . . . . 1.3799999999999999 107.775 174.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.8 t -136.34 127.04 27.23 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 115.667 -0.697 . . . . 1.75 112.515 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . 0.26 . . -119.43 50.2 1.27 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.858 1.799 . . . . 1.1299999999999999 115.858 -177.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -41.01 131.52 2.53 Favored 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 115.887 1.81 . . . . 1.3999999999999999 115.887 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -151.13 100.84 2.81 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.186 -0.916 . . . . 0.26000000000000001 110.275 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.477 HG21 ' O ' ' A' ' 12' ' ' TRP 0.312 8.5 tt -110.12 123.14 65.77 Favored 'Isoleucine or valine' 0 C--O 1.267 2.001 0 CA-C-O 122.412 1.101 . . . . 1.1000000000000001 112.025 175.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -124.08 162.96 22.45 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 113.553 -1.658 . . . . 1.0600000000000001 110.862 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 18.0 ptmt -121.56 159.99 25.24 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 118.585 2.809 . . . . 1.8300000000000001 118.585 -175.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.51 -42.04 2.0 Allowed Glycine 0 CA--C 1.541 1.685 0 CA-C-N 110.001 -3.272 . . . . 0.17000000000000001 118.688 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.07 153.27 0.97 Allowed 'General case' 0 N--CA 1.515 2.815 0 CA-C-N 120.131 1.966 . . . . 1.05 112.678 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.68 -12.89 60.04 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.631 1.345 . . . . 0.98999999999999999 114.631 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.42 4.56 45.97 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 114.349 1.24 . . . . 0.55000000000000004 114.349 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.11 -13.27 15.21 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 114.445 1.276 . . . . 0.59999999999999998 114.445 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.519 3.004 0 C-N-CA 124.238 1.015 . . . . 1.1799999999999999 112.944 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.8 tp . . . . . 0 CA--C 1.564 1.518 0 N-CA-C 113.505 0.928 . . . . 1.0900000000000001 113.505 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.99 -23.11 61.54 Favored 'General case' 0 N--CA 1.511 2.601 0 C-N-CA 125.704 1.602 . . . . 1.04 115.209 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.82 -12.17 48.77 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 113.661 0.986 . . . . 0.32000000000000001 113.661 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 47.8 mmtt -104.69 -22.02 13.29 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.399 0.889 . . . . 2.2599999999999998 113.399 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.21 134.69 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 N-CA-C 115.172 1.545 . . . . 1.01 115.172 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -122.88 -29.95 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-N 115.575 -0.739 . . . . 1.0600000000000001 112.343 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' O ' HG23 ' A' ' 172' ' ' ILE . 73.9 t90 -161.16 117.49 2.22 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 121.029 0.442 . . . . 0.67000000000000004 111.244 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.8 142.25 40.85 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.621 -0.674 . . . . 1.0800000000000001 111.316 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.334 8.9 p -145.38 134.03 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.937 0 CA-C-O 122.425 1.107 . . . . 1.6699999999999999 113.461 178.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.649 ' H ' HD21 ' A' ' 15' ' ' ASN . 0.0 OUTLIER -100.92 91.02 4.39 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-N 113.195 -1.82 . . . . 2.6400000000000001 109.325 178.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.02 103.24 11.52 Favored 'General case' 0 C--O 1.265 1.88 0 CA-C-O 123.414 1.578 . . . . 1.28 113.158 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.52 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 162.99 -50.48 0.31 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-N 111.394 -2.639 . . . . 0.70999999999999996 111.374 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.63 -126.03 4.16 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.497 -1.041 . . . . 0.87 110.497 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -168.4 117.36 0.73 Allowed 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 117.666 0.733 . . . . 2.1200000000000001 112.095 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 6.3 m 62.8 115.68 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 116.896 2.184 . . . . 1.5 116.896 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -159.8 139.57 11.46 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.369 0.604 . . . . 0.52000000000000002 112.176 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.14 122.66 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-N 115.57 -0.741 . . . . 2.0699999999999998 110.651 176.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -85.2 155.98 21.19 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.562 -0.745 . . . . 1.8500000000000001 111.183 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . 0.265 0.7 OUTLIER -45.1 -16.9 0.07 OUTLIER 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 N-CA-C 119.99 3.33 . . . . 1.3700000000000001 119.99 -175.39 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -95.8 -20.85 18.51 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 118.766 0.712 . . . . 0.56999999999999995 111.295 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.68 38.8 1.26 Allowed Glycine 0 C--N 1.356 1.652 0 C-N-CA 124.414 1.007 . . . . 0.37 114.488 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.8 mm -105.6 121.58 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 N-CA-C 108.994 -0.743 . . . . 1.25 108.994 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -101.23 125.29 47.84 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.641 0.608 . . . . 1.71 112.641 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.654 ' O ' ' HA ' ' A' ' 20' ' ' SER . 41.7 m-85 -95.77 137.97 34.08 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.275 -0.875 . . . . 3.1499999999999999 111.09 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -72.26 159.97 33.18 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.929 2.196 . . . . 3.5099999999999998 116.929 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -94.92 87.19 4.88 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.001 -1.909 . . . . 2.8100000000000001 115.399 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 49.41 78.29 0.41 Allowed Pre-proline 0 N--CA 1.529 3.489 0 N-CA-C 115.594 1.701 . . . . 1.1699999999999999 115.594 177.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo . . . . . 0 CA--C 1.563 1.939 0 N-CA-C 118.971 2.643 . . . . 1.45 118.971 -177.426 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo . . . . . 0 N--CA 1.495 1.573 0 N-CA-C 116.906 1.849 . . . . 1.8600000000000001 116.906 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.26 1.3 mp -87.51 134.8 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.317 0 C-N-CA 123.82 0.848 . . . . 1.28 109.892 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.69 -18.34 25.22 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.106 1.891 . . . . 1.9299999999999999 116.106 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -103.55 26.02 8.99 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 114.427 1.269 . . . . 1.79 114.427 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.37 -165.56 1.94 Allowed 'General case' 0 CA--C 1.565 1.537 0 CA-C-O 122.32 1.057 . . . . 1.49 112.725 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.868 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 2.1 t30 -88.85 172.6 7.26 Favored Pre-proline 0 CA--C 1.569 1.699 0 C-N-CA 126.488 1.915 . . . . 1.6799999999999999 110.54 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.48 -43.31 1.01 Allowed 'Trans proline' 0 N--CA 1.513 2.63 0 C-N-CA 122.444 2.096 . . . . 1.1599999999999999 113.822 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.37 -41.57 47.57 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 125.223 1.409 . . . . 2.04 111.893 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -86.47 3.96 41.74 Favored 'General case' 0 CA--C 1.578 2.047 0 CA-C-N 114.443 -1.253 . . . . 1.6200000000000001 111.708 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.868 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.3 tt0 -83.25 -40.36 19.69 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 126.659 1.984 . . . . 2.4300000000000002 106.08 171.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.93 -45.99 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.283 0 C-N-CA 125.296 1.438 . . . . 1.46 109.52 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -39.42 68.81 Favored 'General case' 0 CA--C 1.601 2.907 0 N-CA-C 112.781 0.659 . . . . 1.6699999999999999 112.781 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -90.88 20.48 4.77 Favored 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 114.746 1.387 . . . . 1.3300000000000001 114.746 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.08 -42.01 0.65 Allowed 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 115.408 1.633 . . . . 1.4099999999999999 115.408 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.1 p -63.2 137.71 58.31 Favored 'General case' 0 N--CA 1.537 3.882 0 N-CA-C 114.989 1.477 . . . . 1.28 114.989 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.52 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 14.9 pt-20 . . . . . 0 N--CA 1.5 2.055 0 N-CA-C 115.08 1.511 . . . . 1.53 115.08 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 110.373 -0.232 . . . . 2.1499999999999999 110.373 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.657 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.3 OUTLIER 68.82 87.7 0.12 Allowed 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 125.341 1.456 . . . . 1.25 111.802 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -149.14 163.35 37.84 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.445 0.906 . . . . 1.1499999999999999 113.445 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.48 -155.09 10.82 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 116.912 1.525 . . . . 0.59999999999999998 116.912 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.15 168.61 15.88 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.099 1.148 . . . . 1.4099999999999999 114.099 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -126.05 133.68 51.64 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.357 -1.292 . . . . 0.51000000000000001 112.082 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -126.07 100.52 30.05 Favored Pre-proline 0 CA--C 1.569 1.695 0 C-N-CA 123.167 0.587 . . . . 1.0600000000000001 109.642 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.16 117.54 2.2 Favored 'Trans proline' 0 CA--C 1.563 1.925 0 C-N-CA 122.187 1.925 . . . . 0.17999999999999999 114.978 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.18 160.66 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 CA-C-O 122.04 0.924 . . . . 1.0600000000000001 111.409 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -148.51 23.18 1.02 Allowed 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 114.56 -1.2 . . . . 3.1099999999999999 111.528 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -128.85 158.94 37.32 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-O 121.14 0.495 . . . . 2.1200000000000001 110.892 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -120.6 144.94 47.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.601 1.334 . . . . 0.41999999999999998 114.601 -177.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.36 -138.56 5.44 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 113.674 -1.603 . . . . 0.25 112.401 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.5 mt-10 -113.7 105.47 13.34 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 118.521 1.16 . . . . 1.75 111.294 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -99.1 128.43 45.23 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.116 0.484 . . . . 0.90000000000000002 110.899 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 t -113.58 123.79 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.34 0.591 . . . . 1.0700000000000001 110.509 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 tt -108.0 107.6 18.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.982 -1.008 . . . . 1.47 110.401 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.66 125.79 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 114.004 -1.453 . . . . 1.27 107.968 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.45 140.23 44.71 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 116.043 -0.526 . . . . 1.8899999999999999 112.292 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -95.32 120.77 36.12 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.664 -0.698 . . . . 2.8999999999999999 112.693 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -107.05 132.99 52.35 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.055 -0.975 . . . . 0.48999999999999999 109.977 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.15 149.96 47.63 Favored 'General case' 0 C--O 1.262 1.719 0 CA-C-O 121.333 0.587 . . . . 1.1000000000000001 111.372 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -118.52 142.0 48.02 Favored 'General case' 0 C--N 1.36 1.028 0 CA-C-N 115.175 -0.921 . . . . 2.6099999999999999 111.844 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 -45.58 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-N 115.617 -0.72 . . . . 2.6099999999999999 112.632 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -121.11 137.9 54.44 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.126 0.417 . . . . 2.71 112.126 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 89.41 104.6 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 126.356 1.863 . . . . 1.6899999999999999 111.43 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.13 87.19 4.14 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 123.295 1.521 . . . . 1.4299999999999999 111.929 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -146.04 157.47 43.86 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.73 -1.577 . . . . 2.9700000000000002 111.726 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.4 m -115.05 -74.39 0.61 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.063 1.134 . . . . 1.6599999999999999 114.063 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.28 64.12 1.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.225 1.012 . . . . 2.02 111.918 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -151.92 -41.66 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.573 1.549 . . . . 2.5600000000000001 109.033 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -108.28 79.3 1.24 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-O 121.96 0.886 . . . . 3.1499999999999999 109.137 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.38 120.88 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 114.564 -1.198 . . . . 1.3600000000000001 110.639 -178.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -101.51 170.7 8.03 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.362 1.615 . . . . 0.84999999999999998 115.362 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.22 136.72 54.86 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.063 0.458 . . . . 1.3300000000000001 111.052 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.18 125.73 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.306 0 CA-C-N 115.826 -0.625 . . . . 1.1699999999999999 109.899 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 46.2 mtt180 -125.72 151.34 46.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.645 1.72 . . . . 1.9399999999999999 115.645 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.7 m -127.46 110.92 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 123.24 0.616 . . . . 1.29 112.577 177.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.47 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.51 26.43 13.38 Favored 'General case' 0 N--CA 1.526 3.374 0 C-N-CA 126.664 1.986 . . . . 1.8200000000000001 113.95 -178.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.43 -11.93 56.79 Favored Glycine 0 CA--C 1.552 2.367 0 C-N-CA 121.482 -0.39 . . . . 0.32000000000000001 113.834 -176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.496 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 89.3 m-70 -89.72 164.89 14.5 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 125.944 1.698 . . . . 0.56999999999999995 113.488 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.04 134.89 54.32 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.494 0.664 . . . . 1.1899999999999999 112.016 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.51 -58.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 114.916 -1.038 . . . . 1.73 112.784 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.06 88.64 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.881 -1.155 . . . . 1.25 107.881 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -107.74 100.16 9.57 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-O 123.11 1.433 . . . . 2.75 111.778 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 117.62 72.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 129.438 3.095 . . . . 2.48 108.015 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.11 104.96 16.85 Favored 'General case' 0 C--N 1.359 0.98 0 CA-C-O 121.979 0.895 . . . . 1.78 112.713 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -112.11 99.15 7.84 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 112.851 -1.977 . . . . 2.3500000000000001 107.973 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -24.11 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.364 0 N-CA-C 113.964 1.098 . . . . 1.27 113.964 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -75.65 -41.35 54.29 Favored 'General case' 0 CA--C 1.568 1.668 0 C-N-CA 124.108 0.963 . . . . 0.83999999999999997 111.96 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.75 -26.38 59.74 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.278 1.031 . . . . 0.91000000000000003 113.444 176.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -77.39 -57.93 3.55 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.555 0.946 . . . . 2.98 113.555 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.84 -32.07 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 N-CA-C 114.906 1.447 . . . . 1.53 114.906 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.46 -115.77 2.35 Favored Glycine 0 C--N 1.357 1.729 0 CA-C-N 118.655 0.661 . . . . 0.84999999999999998 113.011 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -114.8 107.5 15.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.246 0.546 . . . . 3.9700000000000002 110.716 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.0 m 72.51 -130.52 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 125.487 1.515 . . . . 2.0800000000000001 112.313 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.2 p 58.15 -162.13 0.22 Allowed 'General case' 0 N--CA 1.53 3.528 0 C-N-CA 126.237 1.815 . . . . 1.22 115.017 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.91 135.71 53.69 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 113.495 0.924 . . . . 1.2 113.495 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -109.32 144.91 36.86 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.542 0.737 . . . . 0.41999999999999998 109.163 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.15 124.19 18.88 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.704 1.001 . . . . 2.5 113.704 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -112.72 120.33 41.15 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.288 -0.869 . . . . 1.5800000000000001 111.538 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.47 115.68 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-N 114.742 -1.117 . . . . 1.25 110.499 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 100.76 15.88 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 119.075 -0.488 . . . . 1.5 111.791 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -74.6 142.47 29.26 Favored 'Trans proline' 0 C--N 1.4 3.266 0 C-N-CA 123.062 2.508 . . . . 0.22 114.281 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.29 146.24 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.597 0 C-N-CA 123.934 0.894 . . . . 1.1200000000000001 109.983 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.1 p -128.89 110.42 12.1 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.222 0.534 . . . . 1.8600000000000001 112.145 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.435 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.0 mt -112.83 124.31 69.35 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.57 0 CA-C-N 115.277 -0.874 . . . . 1.0700000000000001 108.952 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -140.22 124.22 17.53 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.47 -0.786 . . . . 2.6400000000000001 111.223 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt 65.75 16.24 10.4 Favored 'General case' 0 N--CA 1.516 2.843 0 C-N-CA 125.43 1.492 . . . . 4.0199999999999996 114.886 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.93 21.78 17.46 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 114.512 0.565 . . . . 0.39000000000000001 114.512 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -129.81 137.84 50.71 Favored 'General case' 0 C--N 1.363 1.159 0 CA-C-N 117.636 0.718 . . . . 2.0299999999999998 111.545 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.36 141.7 31.8 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.077 1.14 . . . . 1.0800000000000001 114.077 -176.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.21 114.53 13.92 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.704 -1.135 . . . . 1.23 110.109 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.253 8.7 p -119.58 95.55 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 CA-C-N 115.841 -0.618 . . . . 1.1899999999999999 111.019 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 67.23 -85.18 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 125.714 1.606 . . . . 1.8200000000000001 113.968 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.44 28.38 3.81 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.093 -0.503 . . . . 0.51000000000000001 113.156 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -134.75 127.23 30.53 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 123.647 0.779 . . . . 1.8200000000000001 110.473 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.3 p -114.27 139.72 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.361 0 CA-C-O 121.278 0.561 . . . . 1.5900000000000001 111.451 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.8 m -158.73 176.04 12.87 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.577 0.751 . . . . 1.1699999999999999 109.87 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.3 p -101.32 137.32 39.81 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.073 0.768 . . . . 1.71 113.073 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -82.8 124.86 30.67 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.074 0.949 . . . . 0.29999999999999999 112.016 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.9 t -131.32 91.08 2.96 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-O 121.643 0.735 . . . . 1.8700000000000001 112.574 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.0 -65.37 3.27 Favored Glycine 0 C--N 1.358 1.752 0 N-CA-C 118.986 2.355 . . . . 0.91000000000000003 118.986 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.508 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -131.16 156.6 45.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.291 1.219 . . . . 1.6799999999999999 114.291 -175.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.508 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -107.15 137.95 44.25 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 113.133 -1.849 . . . . 1.3700000000000001 109.071 176.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.1 t -120.61 143.34 48.71 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.411 1.634 . . . . 0.94999999999999996 115.411 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.38 99.04 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.169 -1.419 . . . . 1.3799999999999999 107.169 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -117.58 123.17 45.56 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.996 -0.547 . . . . 1.6699999999999999 112.316 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.01 136.24 53.13 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 122.53 1.157 . . . . 2.2999999999999998 112.029 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.51 144.78 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 CA-C-N 112.529 -2.123 . . . . 1.29 109.814 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -58.8 150.84 22.76 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.504 2.038 . . . . 2.6200000000000001 116.504 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.91 -63.95 0.51 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 115.541 -0.754 . . . . 1.0600000000000001 114.028 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -130.7 -64.85 0.82 Allowed 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.962 0.381 . . . . 3.1000000000000001 111.811 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -120.17 -46.56 2.41 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.769 0.428 . . . . 4.0800000000000001 111.953 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -100.99 177.09 5.05 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.47 0.708 . . . . 1.74 111.222 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.657 ' ND2' ' H ' ' A' ' 70' ' ' SER . 4.5 m-20 -115.0 -85.46 0.0 OUTLIER Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 117.441 -1.266 . . . . 1.6799999999999999 110.679 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -88.59 -36.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.393 2.911 0 CA-C-N 123.774 2.384 . . . . 2.8199999999999998 114.256 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm 79.79 -88.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 126.845 2.058 . . . . 3.4100000000000001 110.675 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.8 t -111.77 131.81 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.327 -0.99 . . . . 1.3799999999999999 108.327 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.8 t -138.26 132.49 31.8 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.052 -0.977 . . . . 1.75 111.801 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -129.6 51.11 2.1 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 114.96 1.467 . . . . 1.1299999999999999 114.96 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.25 138.14 1.25 Allowed 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 117.803 2.52 . . . . 1.3999999999999999 117.803 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -153.78 104.22 2.67 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 115.666 -0.697 . . . . 0.26000000000000001 111.504 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 12' ' ' TRP 0.316 10.3 tt -113.88 122.06 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.183 0 CA-C-O 122.384 1.088 . . . . 1.1000000000000001 111.119 175.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -122.7 165.47 16.48 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.145 -1.389 . . . . 1.0600000000000001 111.092 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.6 ptmt -121.74 157.89 29.97 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 118.239 2.681 . . . . 1.8300000000000001 118.239 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.24 -40.39 2.45 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 110.212 -3.176 . . . . 0.17000000000000001 119.066 173.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.11 157.64 1.85 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 120.265 2.033 . . . . 1.05 113.101 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.86 -11.52 59.58 Favored 'General case' 0 CA--C 1.58 2.132 0 C-N-CA 124.91 1.284 . . . . 0.98999999999999999 113.984 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.68 3.52 47.57 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.0 1.111 . . . . 0.55000000000000004 114.0 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.02 -20.47 14.78 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.388 0.885 . . . . 0.59999999999999998 113.388 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.579 2.072 0 C-N-CA 124.343 1.057 . . . . 1.1799999999999999 112.262 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 CA--C 1.566 1.586 0 N-CA-C 113.328 0.862 . . . . 1.0900000000000001 113.328 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.99 -23.32 63.54 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 125.896 1.678 . . . . 1.04 115.269 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.69 -12.17 49.11 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 113.575 0.954 . . . . 0.32000000000000001 113.575 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -106.13 -19.36 13.74 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 113.324 0.861 . . . . 2.2599999999999998 113.324 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -56.67 134.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.851 0 N-CA-C 114.705 1.372 . . . . 1.01 114.705 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -119.7 -29.77 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 115.581 -0.736 . . . . 1.0600000000000001 112.214 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.468 ' O ' HG22 ' A' ' 172' ' ' ILE . 75.7 t90 -160.43 115.95 2.3 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 120.696 0.284 . . . . 0.67000000000000004 110.951 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.08 122.19 22.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.602 -0.686 . . . . 1.0800000000000001 111.397 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.636 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 30.8 t -131.25 116.63 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 122.097 0.951 . . . . 1.6699999999999999 109.663 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.471 HD21 ' HB2' ' A' ' 169' ' ' ALA . 11.4 m120 -114.01 88.01 2.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.828 -1.078 . . . . 2.6400000000000001 108.996 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.6 120.13 17.79 Favored 'General case' 0 C--O 1.277 2.516 0 N-CA-C 115.757 1.762 . . . . 1.28 115.757 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.482 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 151.88 -10.22 0.67 Allowed Glycine 0 C--N 1.359 1.816 0 CA-C-N 111.731 -2.486 . . . . 0.70999999999999996 115.693 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.12 -119.81 1.23 Allowed Glycine 0 N--CA 1.468 0.82 0 CA-C-N 117.645 0.723 . . . . 0.87 112.511 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -169.07 118.08 0.67 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.068 0.547 . . . . 2.1200000000000001 110.697 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 68.1 p 42.95 100.45 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.681 0 N-CA-C 117.92 2.563 . . . . 1.5 117.92 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.509 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 84.0 t60 -132.94 136.24 46.0 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 118.615 -1.234 . . . . 0.52000000000000002 114.171 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.267 10.0 p -103.39 117.76 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 CA-C-N 114.117 -1.401 . . . . 2.0699999999999998 110.917 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -83.12 152.51 25.27 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-N 113.578 -1.646 . . . . 1.8500000000000001 110.046 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.7 m -41.25 -28.77 0.16 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.27 0 N-CA-C 119.192 3.034 . . . . 1.3700000000000001 119.192 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -87.36 -25.96 23.59 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.184 0.516 . . . . 0.56999999999999995 111.277 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.63 38.85 0.75 Allowed Glycine 0 C--N 1.352 1.422 0 CA-C-N 114.983 -1.008 . . . . 0.37 114.445 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.6 mm -107.09 114.16 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 N-CA-C 109.68 -0.489 . . . . 1.25 109.68 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.509 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -107.08 132.46 52.95 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 115.359 1.614 . . . . 1.71 115.359 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -89.12 147.27 24.3 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.871 0.869 . . . . 3.1499999999999999 109.93 174.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 20' ' ' SER . 0.0 OUTLIER -60.49 -107.88 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 117.075 2.25 . . . . 3.5099999999999998 117.075 -177.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -175.72 71.55 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 124.221 1.008 . . . . 2.8100000000000001 112.958 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.407 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 19.3 m-20 65.52 47.57 0.58 Allowed Pre-proline 0 N--CA 1.519 3.009 0 N-CA-C 118.291 2.7 . . . . 1.1699999999999999 118.291 175.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 41.4 Cg_endo . . . . . 0 C--N 1.374 1.91 0 C-N-CA 123.214 2.609 . . . . 1.45 114.391 177.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo . . . . . 0 N--CA 1.501 1.921 0 N-CA-C 117.379 2.03 . . . . 1.8600000000000001 117.379 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.265 1.2 mp -89.8 128.11 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.226 0 CA-C-N 114.986 -1.006 . . . . 1.28 109.191 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mp -85.49 -12.01 52.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.924 1.824 . . . . 1.9299999999999999 115.924 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -102.63 22.59 13.36 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 113.694 0.998 . . . . 1.79 113.694 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -143.03 -163.33 1.61 Allowed 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 121.773 0.797 . . . . 1.49 111.993 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.591 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.2 t30 -95.55 -179.96 1.04 Allowed Pre-proline 0 CA--C 1.572 1.823 0 C-N-CA 125.302 1.441 . . . . 1.6799999999999999 111.138 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.563 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 24.5 Cg_exo -71.82 -45.64 0.7 Allowed 'Trans proline' 0 C--N 1.394 2.969 0 C-N-CA 123.076 2.518 . . . . 1.1599999999999999 111.891 174.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -70.07 -43.78 70.45 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.438 -1.71 . . . . 2.04 111.56 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.01 1.51 43.45 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 114.912 -1.04 . . . . 1.6200000000000001 112.438 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 3.4 tt0 -77.71 -42.94 32.65 Favored 'General case' 0 C--N 1.381 1.938 0 C-N-CA 125.853 1.661 . . . . 2.4300000000000002 106.853 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.07 -44.45 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.869 0 C-N-CA 124.519 1.127 . . . . 1.46 109.108 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.9 tp -68.22 -29.67 68.55 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 114.723 1.379 . . . . 1.6699999999999999 114.723 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -105.53 14.88 27.92 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 114.121 1.156 . . . . 1.3300000000000001 114.121 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.14 -23.48 1.13 Allowed 'General case' 0 N--CA 1.513 2.713 0 N-CA-C 115.883 1.809 . . . . 1.4099999999999999 115.883 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.457 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 41.7 p -80.88 135.95 36.0 Favored 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 113.378 0.881 . . . . 1.28 113.378 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.482 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.1 pt-20 . . . . . 0 N--CA 1.511 2.606 0 N-CA-C 115.894 1.813 . . . . 1.53 115.894 -176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 110.58 -0.155 . . . . 2.1499999999999999 110.58 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.409 ' H ' HD22 ' A' ' 164' ' ' ASN . 0.3 OUTLIER 72.72 83.99 0.12 Allowed 'General case' 0 N--CA 1.514 2.75 0 C-N-CA 124.952 1.301 . . . . 1.25 111.042 -178.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -147.29 152.84 38.93 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.502 -0.772 . . . . 1.1499999999999999 113.062 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -165.51 -171.68 32.01 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 115.842 1.097 . . . . 0.59999999999999998 115.842 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.27 172.43 7.08 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.438 1.273 . . . . 1.4099999999999999 114.438 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.09 132.33 51.92 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.393 -1.276 . . . . 0.51000000000000001 112.228 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.27 102.22 30.65 Favored Pre-proline 0 CA--C 1.567 1.613 0 C-N-CA 123.446 0.698 . . . . 1.0600000000000001 109.408 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.84 119.58 2.22 Favored 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 122.098 1.865 . . . . 0.17999999999999999 114.925 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.36 162.7 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.654 0 CA-C-O 122.003 0.906 . . . . 1.0600000000000001 111.089 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -150.63 19.76 0.82 Allowed 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 114.716 -1.129 . . . . 3.1099999999999999 111.781 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.53 159.78 35.25 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-O 121.32 0.581 . . . . 2.1200000000000001 111.572 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.507 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -118.32 147.96 42.96 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.199 1.185 . . . . 0.41999999999999998 114.199 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.82 -139.6 6.26 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 113.827 -1.533 . . . . 0.25 112.165 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.9 mt-10 -115.1 104.63 12.06 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 118.46 1.13 . . . . 1.75 110.823 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -98.88 128.4 45.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.159 0.504 . . . . 0.90000000000000002 110.759 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -112.93 122.91 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-O 121.612 0.72 . . . . 1.0700000000000001 110.848 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 tt -108.34 105.35 14.99 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.391 -1.277 . . . . 1.47 110.304 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.19 125.13 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 114.082 -1.417 . . . . 1.27 107.913 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -135.52 135.34 40.33 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.728 -0.669 . . . . 1.8899999999999999 111.837 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.43 ' HD3' ' O ' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -96.09 121.21 37.62 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.498 -0.774 . . . . 2.8999999999999999 112.051 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -107.34 133.96 51.11 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.058 -0.974 . . . . 0.48999999999999999 109.945 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.33 152.92 48.92 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.433 0.635 . . . . 1.1000000000000001 112.499 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.68 157.12 16.7 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.41 1.084 . . . . 2.6099999999999999 112.309 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.257 4.4 p -144.52 -39.48 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.585 0 N-CA-C 114.227 1.195 . . . . 2.6099999999999999 114.227 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -130.01 -2.04 4.63 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 115.442 1.645 . . . . 2.71 115.442 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -128.6 114.0 16.14 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.537 1.062 . . . . 1.6899999999999999 112.311 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.0 92.7 4.15 Favored 'General case' 0 CA--C 1.563 1.471 0 CA-C-O 122.617 1.198 . . . . 1.4299999999999999 111.061 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.492 HE22 ' HZ1' ' A' ' 100' ' ' LYS . 15.0 mt-30 -152.12 149.62 29.0 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.815 -1.084 . . . . 2.9700000000000002 112.103 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.1 m -123.71 117.83 25.85 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.585 0.587 . . . . 1.6599999999999999 112.585 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 71.47 55.38 0.2 Allowed 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 126.244 1.818 . . . . 2.02 113.058 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -154.56 -40.08 0.09 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.194 -1.366 . . . . 2.5600000000000001 109.579 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HZ1' HE22 ' A' ' 96' ' ' GLN . 14.7 mptt -107.61 80.84 1.44 Allowed 'General case' 0 C--N 1.364 1.237 0 N-CA-C 108.643 -0.873 . . . . 3.1499999999999999 108.643 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.52 129.3 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 114.627 -1.169 . . . . 1.3600000000000001 111.466 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -115.51 171.76 7.52 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.014 1.487 . . . . 0.84999999999999998 115.014 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.52 136.12 54.01 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.415 0.626 . . . . 1.3300000000000001 111.774 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.2 123.32 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.936 0 CA-C-N 115.315 -0.857 . . . . 1.1699999999999999 110.102 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -129.83 149.42 51.57 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.953 1.464 . . . . 1.9399999999999999 114.953 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.3 OUTLIER -126.56 108.26 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 114.636 -1.165 . . . . 1.29 111.704 176.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.454 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 65.18 26.08 12.37 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 126.759 2.023 . . . . 1.8200000000000001 113.277 -177.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.41 -13.91 51.06 Favored Glycine 0 CA--C 1.553 2.435 0 CA-C-N 116.157 -0.474 . . . . 0.32000000000000001 114.139 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -89.85 131.21 35.9 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 125.456 1.502 . . . . 0.56999999999999995 114.044 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -97.85 126.0 43.0 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.429 -0.794 . . . . 1.1899999999999999 112.705 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.26 -48.2 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-N 114.214 -1.357 . . . . 1.73 110.256 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.06 88.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 120.26 -0.576 . . . . 1.25 109.744 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.02 72.27 0.81 Allowed 'General case' 0 C--N 1.36 1.03 0 CA-C-O 123.494 1.616 . . . . 2.75 111.411 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.7 p30 160.07 60.4 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 111.005 -2.816 . . . . 2.48 108.52 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.89 103.18 15.75 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 113.749 1.018 . . . . 1.78 113.749 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -119.07 102.87 9.05 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 112.88 -1.963 . . . . 2.3500000000000001 106.067 175.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -27.05 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.319 0 N-CA-C 114.547 1.314 . . . . 1.27 114.547 -176.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.59 -37.77 55.96 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.684 0.793 . . . . 0.83999999999999997 112.194 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.22 -26.58 60.33 Favored 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 124.665 1.186 . . . . 0.91000000000000003 113.229 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -80.22 -57.96 3.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.482 0.919 . . . . 2.98 113.482 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.28 -36.22 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.532 0 N-CA-C 114.196 1.184 . . . . 1.53 114.196 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.01 -73.12 0.2 Allowed Glycine 0 C--N 1.361 1.922 0 CA-C-N 118.306 0.503 . . . . 0.84999999999999998 113.969 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -102.76 175.43 5.49 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.345 1.058 . . . . 3.9700000000000002 111.753 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 m -71.6 87.68 0.93 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.997 0.903 . . . . 2.0800000000000001 113.428 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.34 -162.22 1.3 Allowed 'General case' 0 CA--C 1.563 1.445 0 CA-C-N 113.918 -1.492 . . . . 1.22 110.024 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.94 130.3 45.3 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 113.421 0.897 . . . . 1.2 113.421 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.43 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 22.4 t60 -103.51 141.72 35.51 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.463 -0.569 . . . . 0.41999999999999998 109.463 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -134.15 124.17 25.62 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.377 1.251 . . . . 2.5 114.377 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -111.39 118.84 36.93 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.748 -1.114 . . . . 1.5800000000000001 110.684 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.62 120.91 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.735 -1.12 . . . . 1.25 111.448 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.29 95.45 27.49 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-N 115.842 -0.617 . . . . 1.5 111.062 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -75.37 131.91 14.37 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.787 2.324 . . . . 0.22 112.711 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.3 mt -115.1 146.7 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 CA-C-N 115.443 -0.799 . . . . 1.1200000000000001 111.137 -176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.6 p -129.18 109.94 11.57 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.264 -0.88 . . . . 1.8600000000000001 111.515 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.507 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.5 mt -112.14 123.33 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.502 0 N-CA-C 108.336 -0.987 . . . . 1.0700000000000001 108.336 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -138.78 124.43 19.62 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.373 -0.83 . . . . 2.6400000000000001 110.792 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.28 17.86 10.25 Favored 'General case' 0 N--CA 1.515 2.784 0 C-N-CA 125.35 1.46 . . . . 4.0199999999999996 114.168 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.54 13.8 43.2 Favored Glycine 0 CA--C 1.546 2.01 0 CA-C-O 119.163 -0.798 . . . . 0.39000000000000001 115.025 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 54.8 mtpt -122.46 147.02 46.83 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-N 118.523 1.161 . . . . 2.0299999999999998 112.57 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.82 143.98 31.74 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.125 1.157 . . . . 1.0800000000000001 114.125 -175.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.43 114.65 11.59 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.919 -1.037 . . . . 1.23 110.653 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.278 0.4 OUTLIER -116.81 105.17 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-O 121.144 0.497 . . . . 1.1899999999999999 110.382 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 66.32 -84.29 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.706 0 C-N-CA 125.701 1.601 . . . . 1.8200000000000001 113.981 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.75 31.82 2.52 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.001 -0.545 . . . . 0.51000000000000001 112.859 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -134.85 126.66 29.24 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 123.603 0.761 . . . . 1.8200000000000001 110.239 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -112.5 133.02 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 CA-C-O 121.673 0.749 . . . . 1.5900000000000001 112.21 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.2 m -149.95 179.54 7.97 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.83 -1.077 . . . . 1.1699999999999999 109.346 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.275 15.1 t -104.15 139.05 39.76 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 113.476 0.917 . . . . 1.71 113.476 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -82.87 122.19 27.92 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.068 0.947 . . . . 0.29999999999999999 111.367 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.56 91.24 3.26 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 112.556 0.576 . . . . 1.8700000000000001 112.556 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.96 -64.82 3.33 Favored Glycine 0 C--N 1.358 1.802 0 N-CA-C 118.715 2.246 . . . . 0.91000000000000003 118.715 177.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -132.38 157.79 43.63 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 114.251 1.204 . . . . 1.6799999999999999 114.251 -176.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.518 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -104.62 139.04 40.06 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.202 -1.817 . . . . 1.3700000000000001 109.063 176.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 t -121.35 142.48 49.94 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.352 1.612 . . . . 0.94999999999999996 115.352 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.405 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.14 97.27 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.451 -1.314 . . . . 1.3799999999999999 107.451 176.267 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 33.4 mt-10 -112.65 128.04 56.28 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.384 0.883 . . . . 1.6699999999999999 113.384 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -114.05 126.18 54.83 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 115.738 -0.664 . . . . 2.2999999999999998 110.192 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.07 144.37 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 114.652 -1.158 . . . . 1.29 110.53 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -72.45 150.45 43.3 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.646 2.091 . . . . 2.6200000000000001 116.646 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -114.97 -47.88 0.55 Allowed Glycine 0 CA--C 1.541 1.691 0 CA-C-N 114.066 -1.424 . . . . 1.0600000000000001 112.941 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -131.88 -76.82 0.51 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 122.739 0.415 . . . . 3.1000000000000001 111.951 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -138.17 -53.97 0.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.949 0.5 . . . . 4.0800000000000001 111.421 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.05 119.66 31.39 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.606 1.162 . . . . 1.74 110.772 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.409 HD22 ' H ' ' A' ' 70' ' ' SER . 1.3 m-20 -81.13 -170.67 0.26 Allowed Pre-proline 0 CA--C 1.572 1.809 0 C-N-CA 124.848 1.259 . . . . 1.6799999999999999 110.524 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -61.8 104.93 0.34 Allowed 'Trans proline' 0 C--N 1.394 2.922 0 CA-C-N 122.304 1.858 . . . . 2.8199999999999998 112.215 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -63.52 1.27 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.336 1.976 . . . . 3.4100000000000001 116.336 -174.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 66.0 t -96.38 131.44 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 CA-C-N 119.367 0.985 . . . . 1.3799999999999999 109.991 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.25 123.27 23.99 Favored 'General case' 0 C--N 1.363 1.169 0 CA-C-N 114.443 -1.253 . . . . 1.75 111.834 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.471 ' HB2' HD21 ' A' ' 15' ' ' ASN . . . -120.72 48.02 1.69 Allowed 'General case' 0 CA--C 1.585 2.302 0 N-CA-C 115.643 1.719 . . . . 1.1299999999999999 115.643 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.636 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -45.23 131.74 7.73 Favored 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 116.64 2.089 . . . . 1.3999999999999999 116.64 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -151.31 105.4 3.19 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 115.19 -0.914 . . . . 0.26000000000000001 111.051 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 12' ' ' TRP 0.298 9.1 tt -113.66 122.32 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 CA-C-O 122.283 1.04 . . . . 1.1000000000000001 111.258 175.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -122.67 165.24 16.82 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 113.906 -1.497 . . . . 1.0600000000000001 110.789 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -122.13 158.93 28.22 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 118.283 2.698 . . . . 1.8300000000000001 118.283 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.89 -41.31 2.17 Favored Glycine 0 CA--C 1.541 1.7 0 CA-C-N 110.351 -3.113 . . . . 0.17000000000000001 119.256 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.59 154.53 1.25 Allowed 'General case' 0 N--CA 1.518 2.927 0 CA-C-N 120.494 2.147 . . . . 1.05 113.227 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.25 -14.43 58.42 Favored 'General case' 0 CA--C 1.581 2.169 0 C-N-CA 124.75 1.22 . . . . 0.98999999999999999 114.092 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.8 2.99 49.9 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.143 1.164 . . . . 0.55000000000000004 114.143 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.0 -5.79 15.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.726 1.01 . . . . 0.59999999999999998 113.726 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.622 0 C-N-CA 124.397 1.079 . . . . 1.1799999999999999 111.752 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.4 tp . . . . . 0 CA--C 1.565 1.553 0 N-CA-C 112.938 0.718 . . . . 1.0900000000000001 112.938 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.43 63.56 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 125.855 1.662 . . . . 1.04 114.797 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.7 -11.43 51.24 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 113.667 0.988 . . . . 0.32000000000000001 113.667 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 20.8 mmtp -105.47 -23.28 12.84 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.379 0.881 . . . . 2.2599999999999998 113.379 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.67 136.55 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 N-CA-C 115.472 1.656 . . . . 1.01 115.472 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.9 -28.4 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 115.195 -0.911 . . . . 1.0600000000000001 112.236 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.483 ' O ' HG22 ' A' ' 172' ' ' ILE . 64.7 t90 -163.09 118.76 1.76 Allowed 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 117.929 0.331 . . . . 0.67000000000000004 111.882 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.26 131.82 30.76 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.273 -0.892 . . . . 1.0800000000000001 111.876 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -139.75 130.66 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 N-CA-C 113.113 0.783 . . . . 1.6699999999999999 113.113 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -115.83 106.61 14.03 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.117 -1.438 . . . . 2.6400000000000001 107.117 171.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.33 105.83 9.84 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.614 0.721 . . . . 1.28 111.664 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 168.79 -63.54 0.19 Allowed Glycine 0 C--N 1.355 1.635 0 CA-C-N 114.189 -1.369 . . . . 0.70999999999999996 114.821 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -95.16 -116.3 2.96 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 114.716 0.646 . . . . 0.87 114.716 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.657 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 18.4 mt-10 -170.08 114.16 0.49 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.889 0.876 . . . . 2.1200000000000001 109.884 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 46.39 111.95 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.003 0 N-CA-C 118.328 2.714 . . . . 1.5 118.328 178.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.443 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 82.1 t60 -136.59 136.4 39.19 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.97 1.1 . . . . 0.52000000000000002 113.97 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.82 109.29 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 CA-C-N 113.765 -1.561 . . . . 2.0699999999999998 107.04 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.67 160.1 18.26 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 112.171 0.434 . . . . 1.8500000000000001 112.171 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -41.48 -26.41 0.11 Allowed 'Isoleucine or valine' 1 N--CA 1.547 4.383 0 N-CA-C 120.072 3.36 . . . . 1.3700000000000001 120.072 -174.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -93.35 -11.33 32.59 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 118.84 0.746 . . . . 0.56999999999999995 112.44 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.82 38.0 3.28 Favored Glycine 0 C--N 1.361 1.929 0 C-N-CA 124.16 0.886 . . . . 0.37 114.158 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 mm -105.38 135.55 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.618 0 N-CA-C 108.555 -0.906 . . . . 1.25 108.555 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.443 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.9 t-160 -123.34 132.38 53.97 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.612 1.338 . . . . 1.71 114.612 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.657 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -93.73 137.21 33.22 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.123 -0.944 . . . . 3.1499999999999999 109.94 175.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -100.29 104.76 16.25 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 113.465 0.913 . . . . 3.5099999999999998 113.465 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -36.6 122.12 0.77 Allowed 'General case' 0 N--CA 1.528 3.434 0 N-CA-C 119.051 2.982 . . . . 2.8100000000000001 119.051 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 39.03 64.69 3.66 Favored Pre-proline 0 N--CA 1.529 3.49 0 N-CA-C 117.131 2.271 . . . . 1.1699999999999999 117.131 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 CA--C 1.563 1.957 0 C-N-CA 122.755 2.303 . . . . 1.45 118.058 -178.82 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo . . . . . 0 N--CA 1.511 2.529 0 N-CA-C 117.45 2.058 . . . . 1.8600000000000001 117.45 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.256 1.3 mp -86.76 124.89 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.466 0 C-N-CA 124.366 1.066 . . . . 1.28 108.389 177.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.62 -11.71 59.01 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.602 2.075 . . . . 1.9299999999999999 116.602 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -102.5 17.08 24.52 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 113.745 1.017 . . . . 1.79 113.745 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.421 ' OG ' ' HD2' ' A' ' 61' ' ' TYR . 1.2 t -137.32 -164.04 1.53 Allowed 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.856 0.836 . . . . 1.49 112.578 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.727 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.5 t30 -95.95 -179.27 0.89 Allowed Pre-proline 0 CA--C 1.573 1.858 0 C-N-CA 125.617 1.567 . . . . 1.6799999999999999 111.367 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.501 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.5 Cg_exo -72.34 -46.44 0.49 Allowed 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 123.175 2.584 . . . . 1.1599999999999999 112.535 174.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -70.01 -47.02 63.81 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 113.905 -1.498 . . . . 2.04 111.731 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -8.88 58.12 Favored 'General case' 0 CA--C 1.585 2.324 0 CA-C-N 114.916 -1.038 . . . . 1.6200000000000001 111.955 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.727 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 3.3 tt0 -70.81 -42.28 70.46 Favored 'General case' 0 C--N 1.39 2.354 0 C-N-CA 125.716 1.607 . . . . 2.4300000000000002 108.187 172.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -59.69 -42.56 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.217 0 C-N-CA 124.663 1.185 . . . . 1.46 109.463 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 tp -80.02 -8.81 59.56 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 114.328 1.233 . . . . 1.6699999999999999 114.328 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.421 ' HD2' ' OG ' ' A' ' 53' ' ' SER . 20.3 m-85 -125.05 22.75 7.9 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.98 0.912 . . . . 1.3300000000000001 113.357 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.38 -38.24 0.33 Allowed 'General case' 0 N--CA 1.513 2.686 0 N-CA-C 115.245 1.572 . . . . 1.4099999999999999 115.245 -177.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.8 p -67.85 134.02 50.18 Favored 'General case' 0 N--CA 1.533 3.716 0 N-CA-C 114.456 1.28 . . . . 1.28 114.456 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 . . . . . 0 N--CA 1.502 2.149 0 N-CA-C 115.386 1.624 . . . . 1.53 115.386 -177.345 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.691 -0.485 . . . . 2.1499999999999999 109.691 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 71.66 84.67 0.13 Allowed 'General case' 0 N--CA 1.51 2.546 0 C-N-CA 124.86 1.264 . . . . 1.25 111.962 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.62 141.77 45.12 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.978 0.894 . . . . 1.1499999999999999 112.176 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -140.03 175.93 21.58 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 116.407 1.323 . . . . 0.59999999999999998 116.407 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.86 163.17 17.3 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.839 -1.18 . . . . 1.4099999999999999 113.227 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -122.21 129.33 52.16 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.604 -1.18 . . . . 0.51000000000000001 112.435 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -123.21 101.42 38.18 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 108.91 -0.774 . . . . 1.0600000000000001 108.91 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -84.26 119.64 2.43 Favored 'Trans proline' 0 CA--C 1.563 1.945 0 C-N-CA 121.998 1.799 . . . . 0.17999999999999999 114.747 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.84 160.42 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 CA-C-O 122.035 0.922 . . . . 1.0600000000000001 111.308 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -148.66 21.02 1.03 Allowed 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.605 -1.179 . . . . 3.1099999999999999 111.865 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.06 160.35 33.98 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-O 121.312 0.577 . . . . 2.1200000000000001 111.415 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -119.29 145.51 46.06 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.437 0.903 . . . . 0.41999999999999998 113.437 -179.203 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.5 -138.3 5.45 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.341 -1.299 . . . . 0.25 112.498 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 30.6 mm-40 -114.8 105.0 12.51 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 118.228 1.014 . . . . 1.75 111.144 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -99.45 127.51 45.5 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.321 0.582 . . . . 0.90000000000000002 110.853 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -109.22 121.5 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-O 121.894 0.854 . . . . 1.0700000000000001 110.878 -176.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.34 107.41 18.41 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 113.801 -1.545 . . . . 1.47 110.446 178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 t -115.64 125.2 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.91 -0.774 . . . . 1.27 108.91 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.92 141.79 48.56 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.756 0.65 . . . . 1.8899999999999999 112.756 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.07 119.3 39.01 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.668 -0.696 . . . . 2.8999999999999999 111.277 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 12.4 m-85 -106.68 134.61 49.56 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.467 -0.788 . . . . 0.48999999999999999 110.581 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.23 146.6 42.78 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.246 0.546 . . . . 1.1000000000000001 111.527 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -136.23 120.64 18.08 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.253 0.621 . . . . 2.6099999999999999 110.893 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 76.21 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 112.828 0.677 . . . . 2.6099999999999999 112.828 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -171.95 -52.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.735 0.643 . . . . 2.71 112.735 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -115.27 142.77 46.22 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.622 0.601 . . . . 1.6899999999999999 112.622 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.53 101.18 10.15 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.513 1.149 . . . . 1.4299999999999999 111.656 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -163.55 150.75 12.49 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 114.603 -1.181 . . . . 2.9700000000000002 111.047 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.2 m -110.77 -75.19 0.62 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.954 1.094 . . . . 1.6599999999999999 113.954 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -94.44 70.08 3.64 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.103 0.954 . . . . 2.02 111.159 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -156.22 -41.95 0.08 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.936 -1.484 . . . . 2.5600000000000001 109.207 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -109.83 82.47 1.6 Allowed 'General case' 0 C--N 1.364 1.22 0 CA-C-O 121.827 0.823 . . . . 3.1499999999999999 109.172 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.78 121.26 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 114.375 -1.284 . . . . 1.3600000000000001 110.557 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -106.94 173.54 6.28 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.317 1.599 . . . . 0.84999999999999998 115.317 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -124.64 136.98 54.38 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 122.065 0.936 . . . . 1.3300000000000001 111.019 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.82 124.81 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-N 114.145 -1.389 . . . . 1.1699999999999999 109.499 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.8 mtt180 -119.61 143.3 47.74 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.384 1.624 . . . . 1.9399999999999999 115.384 -176.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 5.8 m -120.71 101.01 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 115.345 -0.843 . . . . 1.29 112.184 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.553 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.2 t30 64.9 28.74 12.66 Favored 'General case' 0 N--CA 1.52 3.059 0 C-N-CA 126.494 1.917 . . . . 1.8200000000000001 114.561 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.38 -18.83 32.51 Favored Glycine 0 CA--C 1.549 2.199 0 CA-C-N 115.831 -0.622 . . . . 0.32000000000000001 113.602 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -86.34 161.76 18.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.092 1.757 . . . . 0.56999999999999995 113.125 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -118.68 129.69 55.43 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.166 0.984 . . . . 1.1899999999999999 111.249 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.07 -47.07 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 113.518 -1.673 . . . . 1.73 112.825 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.74 89.32 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.904 -1.147 . . . . 1.25 107.904 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.98 75.49 0.92 Allowed 'General case' 0 C--N 1.359 0.988 0 CA-C-O 123.577 1.655 . . . . 2.75 112.522 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 p30 154.79 63.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 110.474 -3.057 . . . . 2.48 108.032 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.69 99.65 12.51 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 113.563 0.949 . . . . 1.78 113.563 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 3.6 p30 -112.6 94.56 4.97 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 113.017 -1.901 . . . . 2.3500000000000001 107.786 175.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -26.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 N-CA-C 114.739 1.385 . . . . 1.27 114.739 -176.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -74.61 -39.39 62.2 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.828 0.851 . . . . 0.83999999999999997 112.042 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.72 -26.68 59.98 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.71 1.204 . . . . 0.91000000000000003 113.376 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 23.6 mmm180 -77.81 -55.05 5.65 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 113.639 0.978 . . . . 2.98 113.639 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.65 -37.5 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 114.59 1.33 . . . . 1.53 114.59 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.64 -109.44 1.11 Allowed Glycine 0 C--N 1.354 1.558 0 CA-C-N 118.391 0.541 . . . . 0.84999999999999998 113.271 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -114.52 107.46 15.54 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.517 0.327 . . . . 3.9700000000000002 110.433 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 t 70.11 -130.61 0.07 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 125.301 1.441 . . . . 2.0800000000000001 112.304 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.9 p 56.68 -174.39 0.07 Allowed 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 116.635 2.087 . . . . 1.22 116.635 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -100.05 128.45 46.14 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.312 0.856 . . . . 1.2 113.312 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 9.1 t60 -102.79 139.34 38.5 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.141 -0.688 . . . . 0.41999999999999998 109.141 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -137.51 125.85 23.31 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.273 1.212 . . . . 2.5 114.273 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -119.75 127.16 52.56 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 115.077 -0.965 . . . . 1.5800000000000001 110.602 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.99 126.58 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 114.141 -1.39 . . . . 1.25 111.115 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.56 92.22 28.1 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-N 115.263 -0.881 . . . . 1.5 110.567 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -75.02 132.77 15.77 Favored 'Trans proline' 0 C--N 1.394 2.934 0 C-N-CA 122.917 2.412 . . . . 0.22 113.074 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.82 150.26 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 CA-C-N 115.446 -0.797 . . . . 1.1200000000000001 111.145 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.7 p -132.9 109.24 9.46 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.326 -0.852 . . . . 1.8600000000000001 111.799 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.475 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.5 mt -109.19 124.46 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 108.566 -0.901 . . . . 1.0700000000000001 108.566 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.71 126.13 21.77 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.532 -0.758 . . . . 2.6400000000000001 110.75 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt 66.6 16.93 10.53 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 125.272 1.429 . . . . 4.0199999999999996 114.595 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.29 14.77 40.54 Favored Glycine 0 CA--C 1.547 2.056 0 CA-C-O 119.183 -0.787 . . . . 0.39000000000000001 114.803 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 23.6 mtpp -123.9 147.3 47.79 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 118.225 1.012 . . . . 2.0299999999999998 112.419 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.47 139.07 37.63 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.994 1.109 . . . . 1.0800000000000001 113.994 -176.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.49 115.47 18.93 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.929 -1.032 . . . . 1.23 109.989 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.46 93.58 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.486 0 CA-C-N 115.716 -0.675 . . . . 1.1899999999999999 110.878 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 64.75 -84.94 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 125.555 1.542 . . . . 1.8200000000000001 114.135 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.06 26.2 4.25 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-N 116.234 -0.439 . . . . 0.51000000000000001 113.835 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -137.88 117.58 13.11 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.19 0.596 . . . . 1.8200000000000001 109.983 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.25 133.74 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.374 0 CA-C-O 121.65 0.738 . . . . 1.5900000000000001 112.152 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 m -147.62 -179.46 6.89 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.841 -1.072 . . . . 1.1699999999999999 109.543 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.276 14.9 t -103.98 138.89 39.89 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 113.456 0.91 . . . . 1.71 113.456 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -81.96 122.55 27.92 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.233 1.013 . . . . 0.29999999999999999 111.493 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.97 90.98 3.29 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.762 0.653 . . . . 1.8700000000000001 112.762 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.96 -63.78 2.77 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 118.597 2.199 . . . . 0.91000000000000003 118.597 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.551 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -130.58 161.93 30.44 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.837 0.827 . . . . 1.6799999999999999 113.128 -177.095 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.553 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -111.15 137.52 48.72 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.841 -1.527 . . . . 1.3700000000000001 109.221 177.187 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.6 t -116.93 142.31 47.1 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.64 1.348 . . . . 0.94999999999999996 114.64 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 39.6 t -121.57 97.25 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.22 -2.141 . . . . 1.3799999999999999 105.22 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -113.62 124.92 53.49 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.138 -0.937 . . . . 1.6699999999999999 112.913 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -111.68 128.75 56.17 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 122.233 1.016 . . . . 2.2999999999999998 112.058 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.8 144.34 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-N 112.859 -1.973 . . . . 1.29 110.362 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -78.88 149.46 32.43 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 115.659 1.725 . . . . 2.6200000000000001 115.659 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -103.8 -35.25 3.54 Favored Glycine 0 CA--C 1.545 1.921 0 CA-C-N 114.525 -1.216 . . . . 1.0600000000000001 113.132 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -130.57 -83.6 0.53 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.213 0.605 . . . . 3.1000000000000001 110.435 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -170.65 64.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.279 0.631 . . . . 4.0800000000000001 110.656 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -166.98 -39.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.926 0.713 . . . . 1.74 112.926 -178.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.52 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 4.3 m-20 84.32 -177.77 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.439 0 C-N-CA 124.58 1.152 . . . . 1.6799999999999999 110.838 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -65.38 -9.55 22.65 Favored 'Trans proline' 0 N--CA 1.522 3.2 0 C-N-CA 122.641 2.227 . . . . 2.8199999999999998 116.385 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.0 mttm 80.05 -73.6 0.06 Allowed 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 126.442 1.897 . . . . 3.4100000000000001 114.065 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.37 132.04 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.048 0.452 . . . . 1.3799999999999999 110.237 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.0 t -137.34 121.65 18.14 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 114.114 -1.403 . . . . 1.75 110.889 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -115.6 49.78 1.06 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.138 1.903 . . . . 1.1299999999999999 116.138 -176.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -41.06 129.23 2.79 Favored 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 116.061 1.875 . . . . 1.3999999999999999 116.061 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -150.71 103.09 3.06 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.703 -0.681 . . . . 0.26000000000000001 110.305 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 12' ' ' TRP 0.315 7.2 tt -113.92 122.83 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 CA-C-O 122.262 1.03 . . . . 1.1000000000000001 112.169 176.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -123.53 163.6 20.61 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.849 -1.523 . . . . 1.0600000000000001 111.023 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.6 ptmm? -121.91 159.92 25.86 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 118.489 2.774 . . . . 1.8300000000000001 118.489 -175.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.62 -42.06 1.99 Allowed Glycine 0 CA--C 1.543 1.803 0 CA-C-N 110.007 -3.27 . . . . 0.17000000000000001 118.929 174.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.5 153.83 0.94 Allowed 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 120.31 2.055 . . . . 1.05 112.924 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.49 -11.71 59.92 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 114.72 1.378 . . . . 0.98999999999999999 114.72 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.95 3.39 48.83 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.081 1.141 . . . . 0.55000000000000004 114.081 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.28 -10.34 16.44 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 113.749 1.018 . . . . 0.59999999999999998 113.749 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.526 0 C-N-CA 124.078 0.951 . . . . 1.1799999999999999 112.216 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.9 tp . . . . . 0 CA--C 1.563 1.46 0 N-CA-C 112.411 0.523 . . . . 1.0900000000000001 112.411 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.9 -22.74 65.83 Favored 'General case' 0 CA--C 1.583 2.244 0 C-N-CA 125.63 1.572 . . . . 1.04 114.436 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.15 -12.05 50.96 Favored 'General case' 0 C--N 1.375 1.695 0 N-CA-C 113.638 0.977 . . . . 0.32000000000000001 113.638 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 45.3 mmtt -105.67 -22.62 12.93 Favored 'General case' 0 C--N 1.364 1.212 0 CA-C-O 118.353 -0.832 . . . . 2.2599999999999998 113.203 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.34 135.91 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.844 0 N-CA-C 115.221 1.563 . . . . 1.01 115.221 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -122.22 -29.1 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.227 -0.897 . . . . 1.0600000000000001 111.908 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.497 ' O ' HG22 ' A' ' 172' ' ' ILE . 64.1 t90 -163.68 116.95 1.5 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 120.738 0.304 . . . . 0.67000000000000004 111.414 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -135.19 128.91 32.89 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.296 -0.877 . . . . 1.0800000000000001 110.226 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.2 t -137.84 133.56 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 113.203 0.816 . . . . 1.6699999999999999 113.203 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -118.99 111.09 17.89 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.082 -1.451 . . . . 2.6400000000000001 107.082 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.37 101.75 10.02 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.387 1.089 . . . . 1.28 111.436 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.58 -32.61 0.17 Allowed Glycine 0 C--N 1.344 1.018 0 CA-C-N 113.345 -1.752 . . . . 0.70999999999999996 116.011 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -135.22 -128.33 2.78 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.233 -0.984 . . . . 0.87 114.643 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.461 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 63.0 mt-10 -151.04 115.33 5.08 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.455 0.169 . . . . 2.1200000000000001 111.3 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.712 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.6 m 31.82 116.01 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.887 0 N-CA-C 120.286 3.439 . . . . 1.5 120.286 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -138.67 139.02 38.31 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.15 0.976 . . . . 0.52000000000000002 112.636 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.89 117.18 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 114.049 -1.432 . . . . 2.0699999999999998 109.714 177.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -83.21 166.1 18.88 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.646 -0.707 . . . . 1.8500000000000001 112.238 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -43.09 -29.15 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.547 4.41 0 N-CA-C 119.225 3.046 . . . . 1.3700000000000001 119.225 -176.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -93.38 -14.68 26.53 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 118.357 0.526 . . . . 0.56999999999999995 111.691 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.04 42.69 1.62 Allowed Glycine 0 C--N 1.358 1.764 0 C-N-CA 124.393 0.997 . . . . 0.37 114.461 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.2 mm -105.72 120.26 56.27 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.738 0 N-CA-C 109.51 -0.552 . . . . 1.25 109.51 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -104.62 128.19 52.57 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.796 1.406 . . . . 1.71 114.796 -176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.712 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -98.04 148.2 23.75 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.254 -0.885 . . . . 3.1499999999999999 110.645 176.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -96.64 168.37 10.57 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.696 1.236 . . . . 3.5099999999999998 113.613 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -84.38 100.22 11.15 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.401 2.0 . . . . 2.8100000000000001 116.401 -174.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 28.63 56.62 0.6 Allowed Pre-proline 1 N--CA 1.543 4.176 0 C-N-CA 128.066 2.546 . . . . 1.1699999999999999 117.468 177.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 CA--C 1.569 2.246 0 N-CA-C 119.637 2.899 . . . . 1.45 119.637 -174.251 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 50.0 Cg_exo . . . . . 0 N--CA 1.515 2.765 0 N-CA-C 117.681 2.147 . . . . 1.8600000000000001 117.681 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 mp -92.72 130.4 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.214 0 CA-C-N 114.883 -1.053 . . . . 1.28 108.486 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mt -86.03 -10.14 55.54 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.567 2.062 . . . . 1.9299999999999999 116.567 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -103.49 8.59 37.83 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 114.299 1.222 . . . . 1.79 114.299 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.44 -164.73 1.52 Allowed 'General case' 0 CA--C 1.566 1.579 0 CA-C-O 121.544 0.687 . . . . 1.49 112.096 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.833 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.8 t30 -95.69 179.17 1.21 Allowed Pre-proline 0 CA--C 1.575 1.91 0 C-N-CA 124.715 1.206 . . . . 1.6799999999999999 111.17 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -71.61 -44.77 0.93 Allowed 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 123.202 2.601 . . . . 1.1599999999999999 112.474 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -71.16 -47.4 57.96 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 113.894 -1.503 . . . . 2.04 111.545 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -77.25 -6.0 51.45 Favored 'General case' 0 CA--C 1.595 2.68 0 CA-C-N 115.466 -0.788 . . . . 1.6200000000000001 111.536 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.833 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 11.5 tt0 -72.68 -39.25 67.2 Favored 'General case' 0 C--N 1.387 2.217 0 C-N-CA 126.167 1.787 . . . . 2.4300000000000002 108.463 173.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.0 t -65.59 -41.05 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.151 0 CA-C-N 114.538 -1.21 . . . . 1.46 108.712 172.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.421 ' O ' ' HB1' ' A' ' 169' ' ' ALA . 2.4 tt -75.74 -9.43 58.58 Favored 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 112.662 0.616 . . . . 1.6699999999999999 112.662 174.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.474 ' O ' ' HE3' ' A' ' 88' ' ' LYS . 3.5 m-30 -121.24 17.34 11.51 Favored 'General case' 0 CA--C 1.578 2.027 0 C-N-CA 125.175 1.39 . . . . 1.3300000000000001 113.233 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -146.74 -21.36 0.42 Allowed 'General case' 0 N--CA 1.51 2.533 0 N-CA-C 116.656 2.095 . . . . 1.4099999999999999 116.656 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.3 p -79.5 127.79 32.57 Favored 'General case' 0 N--CA 1.518 2.947 0 N-CA-C 115.71 1.744 . . . . 1.28 115.71 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 N--CA 1.507 2.394 0 C-N-CA 124.876 1.27 . . . . 1.53 111.847 179.688 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 110.764 -0.088 . . . . 2.1499999999999999 110.764 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.23 86.55 0.11 Allowed 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.368 1.467 . . . . 1.25 113.639 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -150.78 154.76 37.91 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.754 0.788 . . . . 1.1499999999999999 112.993 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.99 -172.51 38.66 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 114.788 -1.097 . . . . 0.59999999999999998 115.279 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.23 172.55 6.82 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.465 1.283 . . . . 1.4099999999999999 114.465 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -129.47 133.9 47.53 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 114.113 -1.403 . . . . 0.51000000000000001 111.846 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.67 102.24 32.55 Favored Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 123.538 0.735 . . . . 1.0600000000000001 109.495 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -84.79 120.58 2.36 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 121.97 1.78 . . . . 0.17999999999999999 114.641 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.09 161.48 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.61 0 CA-C-O 122.093 0.949 . . . . 1.0600000000000001 111.281 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -148.82 19.24 1.01 Allowed 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.553 -1.203 . . . . 3.1099999999999999 111.922 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -129.93 159.21 37.34 Favored 'General case' 0 C--N 1.363 1.169 0 CA-C-O 121.313 0.577 . . . . 2.1200000000000001 111.423 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -119.12 147.86 43.7 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.23 1.196 . . . . 0.41999999999999998 114.23 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.85 -137.53 5.24 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 113.883 -1.508 . . . . 0.25 112.333 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.4 mm-40 -114.86 105.62 13.22 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-N 118.345 1.073 . . . . 1.75 110.848 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -99.66 130.34 45.87 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.129 0.49 . . . . 0.90000000000000002 111.174 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -113.24 121.87 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.666 0.746 . . . . 1.0700000000000001 110.748 -176.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -109.43 104.92 14.09 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.346 -1.297 . . . . 1.47 110.313 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.29 129.72 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 114.825 -1.08 . . . . 1.27 108.766 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.61 139.56 50.41 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.077 0.769 . . . . 1.8899999999999999 113.077 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.592 ' HZ1' ' H ' ' A' ' 127' ' ' HIS . 6.0 tmtm? -105.82 118.41 36.53 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.945 0.879 . . . . 2.8999999999999999 110.145 176.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -106.39 134.45 49.51 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 114.728 -1.124 . . . . 0.48999999999999999 109.487 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.52 146.83 51.42 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 123.079 0.551 . . . . 1.1000000000000001 111.736 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -139.71 108.91 6.08 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 116.003 -0.544 . . . . 2.6099999999999999 110.726 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.22 69.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 116.153 -0.476 . . . . 2.6099999999999999 111.594 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -162.74 -52.28 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.976 -0.556 . . . . 2.71 111.829 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -119.1 130.15 55.43 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 122.889 0.476 . . . . 1.6899999999999999 111.407 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.03 104.92 14.95 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 122.152 0.977 . . . . 1.4299999999999999 111.958 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -162.01 145.21 11.91 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.178 -0.919 . . . . 2.9700000000000002 112.153 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -125.27 123.81 40.3 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.654 -0.703 . . . . 1.6599999999999999 112.187 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 72.16 53.87 0.18 Allowed 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 125.73 1.612 . . . . 2.02 112.787 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -152.38 -40.87 0.11 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.383 -1.281 . . . . 2.5600000000000001 109.719 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -108.19 80.91 1.41 Allowed 'General case' 0 C--N 1.361 1.096 0 CA-C-O 121.892 0.853 . . . . 3.1499999999999999 108.716 177.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.99 121.82 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 114.249 -1.341 . . . . 1.3600000000000001 111.142 -177.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -109.37 165.55 11.55 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.587 1.699 . . . . 0.84999999999999998 115.587 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.52 135.58 53.94 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.829 -0.544 . . . . 1.3300000000000001 110.828 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.79 126.93 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.475 0 CA-C-N 115.918 -0.583 . . . . 1.1699999999999999 109.908 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 46.7 mtt180 -125.9 151.63 46.66 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.621 1.712 . . . . 1.9399999999999999 115.621 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.2 m -126.71 109.97 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.569 0 N-CA-C 113.047 0.758 . . . . 1.29 113.047 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.426 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 62.43 26.53 15.81 Favored 'General case' 0 N--CA 1.524 3.275 0 C-N-CA 126.669 1.988 . . . . 1.8200000000000001 114.271 -179.113 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.8 -22.17 28.52 Favored Glycine 0 CA--C 1.548 2.109 0 C-N-CA 121.259 -0.496 . . . . 0.32000000000000001 113.546 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 90.2 m-70 -80.71 160.5 24.94 Favored 'General case' 0 C--N 1.366 1.312 0 C-N-CA 125.829 1.651 . . . . 0.56999999999999995 114.157 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.77 132.49 54.15 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.238 0.542 . . . . 1.1899999999999999 111.154 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.62 -60.89 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 115.233 -0.894 . . . . 1.73 113.172 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.76 88.85 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 1.25 108.2 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 2.1 ptpp? -107.72 96.74 6.6 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 123.155 1.455 . . . . 2.75 111.551 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 0.5 OUTLIER 121.09 75.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 110.488 -3.051 . . . . 2.48 107.783 -178.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.33 104.77 16.83 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 113.111 0.782 . . . . 1.78 113.111 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -117.16 102.49 9.34 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 113.723 -1.58 . . . . 2.3500000000000001 106.974 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.25 -31.28 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 C-N-CA 125.003 1.321 . . . . 1.27 114.262 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -74.63 -40.84 61.26 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.685 0.794 . . . . 0.83999999999999997 112.484 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -73.82 -25.83 60.3 Favored 'General case' 0 CA--C 1.578 2.048 0 C-N-CA 124.357 1.063 . . . . 0.91000000000000003 113.487 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -78.62 -56.61 4.29 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.618 0.97 . . . . 2.98 113.618 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.11 -34.84 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 N-CA-C 114.593 1.331 . . . . 1.53 114.593 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.07 -114.07 1.98 Allowed Glycine 0 C--N 1.354 1.537 0 CA-C-N 118.25 0.477 . . . . 0.84999999999999998 112.935 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -115.47 106.69 14.25 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.929 0.395 . . . . 3.9700000000000002 110.4 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.48 -143.26 0.09 Allowed 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 125.466 1.507 . . . . 2.0800000000000001 113.416 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.9 p 66.76 -158.96 0.24 Allowed 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 126.234 1.814 . . . . 1.22 113.718 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.438 ' HA ' ' NZ ' ' A' ' 88' ' ' LYS . . . -108.58 128.96 55.28 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 114.55 1.315 . . . . 1.2 114.55 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.592 ' H ' ' HZ1' ' A' ' 88' ' ' LYS . 5.5 t60 -104.52 122.65 46.0 Favored 'General case' 0 C--N 1.369 1.432 0 N-CA-C 108.08 -1.082 . . . . 0.41999999999999998 108.08 174.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.55 127.05 20.09 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.417 0.895 . . . . 2.5 113.417 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -114.51 134.73 54.81 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-N 115.033 -0.985 . . . . 1.5800000000000001 111.369 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.45 111.31 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 114.369 -1.287 . . . . 1.25 110.374 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.4 mm -115.52 91.23 28.45 Favored Pre-proline 0 CA--C 1.579 2.077 0 CA-C-N 115.287 -0.87 . . . . 1.5 110.421 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -73.11 137.93 27.16 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 122.996 2.464 . . . . 0.22 113.883 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.81 149.89 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 C-N-CA 123.573 0.749 . . . . 1.1200000000000001 110.842 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.2 p -133.88 111.48 10.51 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.638 -0.71 . . . . 1.8600000000000001 111.856 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.474 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.4 mt -112.69 124.68 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 N-CA-C 108.59 -0.892 . . . . 1.0700000000000001 108.59 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -141.83 126.45 17.92 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.838 -0.619 . . . . 2.6400000000000001 110.992 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 67.97 15.71 9.52 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 125.432 1.493 . . . . 4.0199999999999996 114.109 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.55 14.87 39.4 Favored Glycine 0 CA--C 1.547 2.089 0 CA-C-O 119.181 -0.788 . . . . 0.39000000000000001 114.773 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 56.4 mtpt -122.59 148.19 45.52 Favored 'General case' 0 C--N 1.365 1.252 0 CA-C-N 118.413 1.107 . . . . 2.0299999999999998 112.429 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.66 141.94 35.18 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.058 1.133 . . . . 1.0800000000000001 114.058 -176.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 m -133.55 110.44 9.93 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 114.504 -1.226 . . . . 1.23 110.301 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.272 2.4 p -106.23 90.52 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.589 2.467 0 CA-C-O 121.621 0.724 . . . . 1.1899999999999999 110.068 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 59.68 -81.4 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 126.077 1.751 . . . . 1.8200000000000001 115.06 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -118.45 26.74 7.59 Favored Glycine 0 CA--C 1.547 2.076 0 N-CA-C 114.2 0.44 . . . . 0.51000000000000001 114.2 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -135.14 140.79 45.7 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.533 0.733 . . . . 1.8200000000000001 110.996 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.18 130.82 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.294 0 CA-C-O 121.513 0.673 . . . . 1.5900000000000001 111.867 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 m -154.6 -179.43 7.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.157 -0.929 . . . . 1.1699999999999999 109.537 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.274 14.8 t -104.76 139.37 39.65 Favored 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 113.365 0.876 . . . . 1.71 113.365 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -82.72 122.1 27.72 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 123.959 0.904 . . . . 0.29999999999999999 111.523 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.38 90.91 3.15 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.336 0.495 . . . . 1.8700000000000001 112.336 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.22 -65.45 3.33 Favored Glycine 0 C--N 1.358 1.784 0 N-CA-C 118.652 2.221 . . . . 0.91000000000000003 118.652 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 156.25 46.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.199 1.185 . . . . 1.6799999999999999 114.199 -176.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.426 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -103.27 135.36 45.06 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 113.064 -1.88 . . . . 1.3700000000000001 108.585 176.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.8 t -120.67 142.29 49.61 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.529 1.678 . . . . 0.94999999999999996 115.529 -176.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -116.59 99.19 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.334 -1.358 . . . . 1.3799999999999999 107.334 176.469 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -118.52 126.99 53.19 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.779 -0.646 . . . . 1.6699999999999999 112.314 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.86 129.08 56.64 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-O 122.278 1.037 . . . . 2.2999999999999998 111.278 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.17 145.48 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 112.722 -2.035 . . . . 1.29 110.762 -177.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.93 149.64 32.3 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.934 1.457 . . . . 2.6200000000000001 114.934 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -115.64 -28.11 2.84 Favored Glycine 0 CA--C 1.545 1.931 0 CA-C-N 115.064 -0.971 . . . . 1.0600000000000001 114.932 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -130.42 -67.07 0.74 Allowed 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 117.746 0.773 . . . . 3.1000000000000001 111.88 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -140.81 -52.45 0.47 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 112.341 0.497 . . . . 4.0800000000000001 112.341 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -104.06 178.02 4.68 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.161 0.981 . . . . 1.74 112.742 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -116.79 -177.92 0.49 Allowed Pre-proline 0 CA--C 1.568 1.638 0 CA-C-N 114.389 -1.278 . . . . 1.6799999999999999 109.273 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.67 131.36 43.71 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.947 2.431 . . . . 2.8199999999999998 113.968 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -72.18 -62.59 1.38 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.81 1.411 . . . . 3.4100000000000001 114.81 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 43.0 t -108.49 132.36 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 118.376 0.535 . . . . 1.3799999999999999 109.713 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.3 t -133.41 116.09 15.62 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 113.911 -1.495 . . . . 1.75 110.618 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 60' ' ' LEU . . . -115.02 49.51 1.05 Allowed 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.183 1.919 . . . . 1.1299999999999999 116.183 -174.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.56 137.75 2.77 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 116.653 2.094 . . . . 1.3999999999999999 116.653 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -152.75 100.3 2.52 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.271 -0.877 . . . . 0.26000000000000001 110.526 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 12' ' ' TRP 0.319 12.6 tt -110.61 121.86 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-O 122.546 1.165 . . . . 1.1000000000000001 111.553 175.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -123.67 165.03 17.92 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 113.572 -1.649 . . . . 1.0600000000000001 110.554 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.4 ptmt -121.71 159.98 25.46 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 118.734 2.864 . . . . 1.8300000000000001 118.734 -174.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.22 -42.54 1.87 Allowed Glycine 0 CA--C 1.542 1.737 0 CA-C-N 109.815 -3.357 . . . . 0.17000000000000001 118.66 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.37 156.74 0.75 Allowed 'General case' 0 N--CA 1.52 3.061 0 CA-C-N 119.973 1.886 . . . . 1.05 112.565 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.32 -15.79 60.47 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.547 1.314 . . . . 0.98999999999999999 114.547 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.06 4.04 46.73 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.066 1.135 . . . . 0.55000000000000004 114.066 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.71 -3.86 18.74 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 114.031 1.123 . . . . 0.59999999999999998 114.031 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.543 0 C-N-CA 124.48 1.112 . . . . 1.1799999999999999 111.63 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.6 tp . . . . . 0 CA--C 1.566 1.586 0 N-CA-C 113.282 0.845 . . . . 1.0900000000000001 113.282 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -25.0 63.84 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 125.982 1.713 . . . . 1.04 115.388 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.65 -10.01 54.76 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.577 0.954 . . . . 0.32000000000000001 113.577 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 25.3 mmtp -104.67 -25.61 12.64 Favored 'General case' 0 C--N 1.363 1.168 0 N-CA-C 113.243 0.831 . . . . 2.2599999999999998 113.243 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -52.93 135.22 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 N-CA-C 115.541 1.682 . . . . 1.01 115.541 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -123.07 -28.46 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 115.01 -0.995 . . . . 1.0600000000000001 112.229 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.526 ' O ' HG21 ' A' ' 172' ' ' ILE . 72.2 t90 -162.95 116.93 1.67 Allowed 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 118.055 0.389 . . . . 0.67000000000000004 111.558 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -136.55 130.73 32.85 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.156 -0.965 . . . . 1.0800000000000001 111.649 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.3 t -136.26 130.96 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 CA-C-O 121.036 0.446 . . . . 1.6699999999999999 112.149 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -114.71 100.46 8.27 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.819 -1.178 . . . . 2.6400000000000001 107.819 173.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.96 104.18 7.31 Favored 'General case' 0 C--O 1.274 2.365 0 CA-C-O 122.005 0.907 . . . . 1.28 111.623 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 169.07 -49.51 0.22 Allowed Glycine 0 C--N 1.36 1.893 0 CA-C-N 111.964 -2.38 . . . . 0.70999999999999996 114.693 -178.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.53 -116.65 3.05 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 114.476 0.551 . . . . 0.87 114.476 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -168.62 118.79 0.74 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.377 0.51 . . . . 2.1200000000000001 112.377 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.9 m 42.39 111.74 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.226 0 N-CA-C 118.515 2.783 . . . . 1.5 118.515 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.561 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 43.1 t60 -137.26 139.43 40.96 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.768 1.025 . . . . 0.52000000000000002 113.768 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.3 t -106.36 111.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 N-CA-C 106.791 -1.559 . . . . 2.0699999999999998 106.791 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.38 163.07 15.46 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 112.768 0.655 . . . . 1.8500000000000001 112.768 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -43.3 -34.59 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 118.811 2.893 . . . . 1.3700000000000001 118.811 -175.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -90.76 -17.31 26.88 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 120.924 0.393 . . . . 0.56999999999999995 111.509 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.18 41.85 1.24 Allowed Glycine 0 C--N 1.357 1.736 0 C-N-CA 124.361 0.981 . . . . 0.37 113.742 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.9 mm -105.88 121.96 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 N-CA-C 109.391 -0.596 . . . . 1.25 109.391 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 6.9 t-160 -110.27 132.8 53.85 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 115.32 1.6 . . . . 1.71 115.32 -175.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.617 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -97.76 138.01 35.77 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.638 -1.164 . . . . 3.1499999999999999 109.302 175.442 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -102.68 100.7 10.77 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 113.544 0.942 . . . . 3.5099999999999998 113.544 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.529 ' H ' ' HG ' ' A' ' 20' ' ' SER . 31.5 ttpt -28.69 115.44 0.09 Allowed 'General case' 0 N--CA 1.517 2.888 0 N-CA-C 118.687 2.847 . . . . 2.8100000000000001 118.687 177.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 41.59 74.97 0.66 Allowed Pre-proline 0 N--CA 1.528 3.446 0 N-CA-C 117.169 2.285 . . . . 1.1699999999999999 117.169 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo . . . . . 0 CA--C 1.56 1.787 0 C-N-CA 122.509 2.14 . . . . 1.45 117.434 -178.839 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.508 2.357 0 N-CA-C 116.939 1.861 . . . . 1.8600000000000001 116.939 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.4 133.86 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.354 0 CA-C-N 115.074 -0.966 . . . . 1.28 108.691 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mt -82.24 -9.28 59.55 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.816 2.154 . . . . 1.9299999999999999 116.816 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -109.17 16.67 22.32 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 114.111 1.152 . . . . 1.79 114.111 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.04 177.37 8.02 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 121.755 0.788 . . . . 1.49 113.06 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 5.7 p-10 -88.96 178.83 1.83 Allowed Pre-proline 0 N--CA 1.51 2.57 0 C-N-CA 124.978 1.311 . . . . 1.6799999999999999 111.094 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -64.57 -43.01 14.4 Favored 'Trans proline' 0 N--CA 1.527 3.449 0 C-N-CA 122.824 2.349 . . . . 1.1599999999999999 114.989 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -69.41 -41.94 75.71 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 124.471 1.108 . . . . 2.04 111.978 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.713 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 18.7 t0 -86.93 -0.71 57.0 Favored 'General case' 0 CA--C 1.583 2.232 0 CA-C-N 115.857 -0.611 . . . . 1.6200000000000001 111.983 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 5.3 tt0 -74.28 -46.02 43.97 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 125.195 1.398 . . . . 2.4300000000000002 108.025 173.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.253 11.7 p -71.21 -37.75 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.982 0 CA-C-N 115.161 -0.927 . . . . 1.46 111.042 174.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 5.7 tp -83.41 -3.25 57.38 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 114.194 1.183 . . . . 1.6699999999999999 114.194 177.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.713 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 3.8 m-30 -113.67 -2.01 13.87 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.002 1.321 . . . . 1.3300000000000001 109.831 174.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -130.48 -130.82 0.2 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.331 1.052 . . . . 1.4099999999999999 110.739 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.472 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 43.15 120.86 0.0 OUTLIER 'General case' 1 N--CA 1.548 4.458 0 C-N-CA 127.775 2.43 . . . . 1.28 115.48 -172.755 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 12.9 pt-20 . . . . . 0 N--CA 1.5 2.071 0 N-CA-C 116.338 1.977 . . . . 1.53 116.338 -175.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.318 0.104 . . . . 2.1499999999999999 110.796 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 3.4 t 70.38 76.72 0.2 Allowed 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 124.464 1.106 . . . . 1.25 110.939 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.7 135.87 48.23 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.004 -0.998 . . . . 1.1499999999999999 112.285 -176.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.56 163.01 24.13 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 116.216 1.246 . . . . 0.59999999999999998 116.216 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -111.17 160.7 16.68 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.023 -1.089 . . . . 1.4099999999999999 113.062 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.48 126.66 48.32 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.895 -1.048 . . . . 0.51000000000000001 112.652 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.25 98.07 42.07 Favored Pre-proline 0 CA--C 1.566 1.589 0 N-CA-C 108.668 -0.864 . . . . 1.0600000000000001 108.668 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -82.82 116.27 2.5 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 122.06 1.84 . . . . 0.17999999999999999 115.322 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.07 155.64 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 CA-C-O 121.938 0.875 . . . . 1.0600000000000001 110.648 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -141.86 24.35 2.03 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 114.774 -1.103 . . . . 3.1099999999999999 112.034 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.88 152.67 49.1 Favored 'General case' 0 C--N 1.359 1.009 0 CA-C-O 121.231 0.539 . . . . 2.1200000000000001 111.305 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.07 137.73 50.98 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.097 1.147 . . . . 0.41999999999999998 114.097 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.47 -127.48 1.63 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 114.018 -1.447 . . . . 0.25 112.597 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -123.55 118.62 27.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.264 0.554 . . . . 1.75 111.398 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -118.58 137.74 53.04 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.463 -0.789 . . . . 0.90000000000000002 109.639 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 172' ' ' ILE . 1.9 t -117.82 126.5 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.466 0.65 . . . . 1.0700000000000001 111.004 -177.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.06 105.13 15.38 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.753 -1.112 . . . . 1.47 109.731 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.75 117.64 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.077 -1.083 . . . . 1.27 108.077 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -130.16 135.05 47.76 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.503 0.668 . . . . 1.8899999999999999 112.384 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -98.29 122.96 42.1 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 114.959 -1.019 . . . . 2.8999999999999999 111.307 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -106.95 136.12 47.35 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.58 -0.737 . . . . 0.48999999999999999 110.948 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.94 150.12 52.19 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 115.681 -0.69 . . . . 1.1000000000000001 111.367 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -146.88 113.68 6.08 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.36 0.664 . . . . 2.6099999999999999 110.076 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.33 68.12 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 112.711 0.634 . . . . 2.6099999999999999 112.711 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -167.07 -45.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.58 0.585 . . . . 2.71 112.58 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -112.89 126.67 55.72 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.102 0.477 . . . . 1.6899999999999999 112.219 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.16 96.07 6.11 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.486 1.136 . . . . 1.4299999999999999 111.241 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.439 ' OE1' ' HD3' ' A' ' 100' ' ' LYS . 9.5 pt20 -160.79 143.74 13.02 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.89 -1.05 . . . . 2.9700000000000002 112.152 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.8 m -122.57 125.27 45.36 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.426 -0.806 . . . . 1.6599999999999999 112.267 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 73.03 51.74 0.14 Allowed 'General case' 0 N--CA 1.512 2.636 0 C-N-CA 125.644 1.577 . . . . 2.02 112.697 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -150.99 -42.02 0.12 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.384 1.074 . . . . 2.5600000000000001 110.076 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.439 ' HD3' ' OE1' ' A' ' 96' ' ' GLN . 14.0 mptt -108.27 83.49 1.79 Allowed 'General case' 0 C--N 1.36 1.06 0 N-CA-C 108.691 -0.855 . . . . 3.1499999999999999 108.691 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.45 126.54 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 114.488 -1.233 . . . . 1.3600000000000001 111.214 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -114.07 174.48 5.92 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.405 1.631 . . . . 0.84999999999999998 115.405 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.22 137.05 54.97 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.372 0.606 . . . . 1.3300000000000001 111.974 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.6 t -132.71 126.0 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.247 0 CA-C-N 115.161 -0.927 . . . . 1.1699999999999999 109.671 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 43.0 mtt180 -125.56 149.39 48.39 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.653 1.353 . . . . 1.9399999999999999 114.653 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.55 104.28 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 115.389 -0.823 . . . . 1.29 112.802 178.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.586 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 6.9 t30 64.28 26.48 13.71 Favored 'General case' 0 N--CA 1.518 2.952 0 C-N-CA 126.636 1.974 . . . . 1.8200000000000001 114.31 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.92 -22.22 23.83 Favored Glycine 0 CA--C 1.548 2.117 0 CA-C-N 115.582 -0.735 . . . . 0.32000000000000001 113.603 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -79.94 148.03 31.39 Favored 'General case' 0 C--N 1.367 1.365 0 C-N-CA 125.63 1.572 . . . . 0.56999999999999995 114.007 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.44 127.52 49.44 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.283 0.563 . . . . 1.1899999999999999 110.977 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -120.22 -57.2 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 115.256 -0.884 . . . . 1.73 113.254 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.33 88.26 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.165 -1.05 . . . . 1.25 108.165 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -111.17 75.77 0.94 Allowed 'General case' 0 C--N 1.354 0.779 0 CA-C-O 123.37 1.557 . . . . 2.75 112.133 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.9 p30 157.78 61.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 110.789 -2.914 . . . . 2.48 108.117 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.94 101.04 13.38 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 114.095 1.146 . . . . 1.78 114.095 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 1.2 t70 -116.75 97.2 5.85 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 113.132 -1.849 . . . . 2.3500000000000001 106.582 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -28.56 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.477 0 N-CA-C 114.569 1.322 . . . . 1.27 114.569 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -75.84 -36.78 59.51 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.24 0.616 . . . . 0.83999999999999997 112.323 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -74.72 -26.74 60.01 Favored 'General case' 0 CA--C 1.577 1.99 0 C-N-CA 124.466 1.106 . . . . 0.91000000000000003 113.096 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 25.3 mmm180 -77.66 -55.09 5.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.236 0.828 . . . . 2.98 113.236 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.82 -40.59 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 N-CA-C 113.966 1.098 . . . . 1.53 113.966 177.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.84 -69.51 0.21 Allowed Glycine 0 C--N 1.359 1.844 0 CA-C-N 118.186 0.448 . . . . 0.84999999999999998 113.652 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -104.72 175.27 5.55 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.447 1.099 . . . . 3.9700000000000002 111.381 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 m -73.55 84.31 1.54 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 122.007 0.908 . . . . 2.0800000000000001 113.214 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.9 p -131.24 -154.35 0.62 Allowed 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 113.92 -1.491 . . . . 1.22 109.301 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.49 129.38 54.46 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 121.468 -0.77 . . . . 1.2 112.324 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -100.43 142.39 31.97 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.645 -0.502 . . . . 0.41999999999999998 109.645 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -135.5 128.2 30.95 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.711 1.374 . . . . 2.5 114.711 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -118.0 118.1 31.04 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 114.36 -1.291 . . . . 1.5800000000000001 109.905 176.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.11 121.05 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 114.644 -1.162 . . . . 1.25 111.513 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.12 95.11 19.0 Favored Pre-proline 0 CA--C 1.572 1.819 0 CA-C-N 115.49 -0.777 . . . . 1.5 110.694 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -75.87 137.55 19.97 Favored 'Trans proline' 0 C--N 1.395 3.003 0 C-N-CA 122.802 2.335 . . . . 0.22 113.325 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.49 145.62 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.393 0 CA-C-O 121.737 0.78 . . . . 1.1200000000000001 111.665 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.9 p -129.86 112.29 13.42 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.85 -1.068 . . . . 1.8600000000000001 110.817 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.6 mt -113.64 121.43 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.511 0 CA-C-N 115.228 -0.896 . . . . 1.0700000000000001 108.841 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -141.76 129.64 21.81 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.128 0.489 . . . . 2.6400000000000001 111.903 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 66.38 15.19 10.02 Favored 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 114.827 1.417 . . . . 4.0199999999999996 114.827 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 17.91 28.79 Favored Glycine 0 CA--C 1.548 2.149 0 CA-C-O 119.385 -0.675 . . . . 0.39000000000000001 114.562 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -128.73 143.38 50.91 Favored 'General case' 0 C--N 1.364 1.239 0 CA-C-N 118.036 0.918 . . . . 2.0299999999999998 112.426 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.09 143.34 29.48 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.823 1.046 . . . . 1.0800000000000001 113.823 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 114.0 12.61 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.864 -1.062 . . . . 1.23 110.865 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.271 0.3 OUTLIER -118.14 108.17 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.257 0 CA-C-N 115.989 -0.551 . . . . 1.1899999999999999 110.533 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 67.06 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.745 0 C-N-CA 125.588 1.555 . . . . 1.8200000000000001 113.762 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -140.9 31.79 2.17 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-N 115.777 -0.647 . . . . 0.51000000000000001 112.765 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -133.73 128.14 34.3 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.641 0.776 . . . . 1.8200000000000001 110.573 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -115.68 131.23 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.298 0 CA-C-O 121.551 0.691 . . . . 1.5900000000000001 111.786 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 m -147.18 -169.09 3.22 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.094 -0.957 . . . . 1.1699999999999999 110.174 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.5 t -101.79 141.09 35.18 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 112.998 0.74 . . . . 1.71 112.998 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -88.44 133.0 34.24 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.875 0.845 . . . . 0.29999999999999999 111.894 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 p -98.27 -164.01 1.1 Allowed 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 113.976 -1.465 . . . . 1.8700000000000001 109.369 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.39 7.07 69.59 Favored Glycine 0 CA--C 1.561 2.929 0 N-CA-C 116.991 1.556 . . . . 0.91000000000000003 116.991 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -159.98 152.49 21.06 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-O 121.704 0.764 . . . . 1.6799999999999999 111.565 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.586 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -108.09 138.08 44.96 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.208 -1.36 . . . . 1.3700000000000001 109.163 177.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 t -119.41 145.72 45.99 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.966 1.839 . . . . 0.94999999999999996 115.966 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -120.09 97.96 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.672 -1.233 . . . . 1.3799999999999999 107.672 175.602 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -107.07 125.91 51.67 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.212 0.819 . . . . 1.6699999999999999 113.212 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 70' ' ' SER . 1.5 m-30 -107.46 120.89 43.42 Favored 'General case' 0 C--O 1.25 1.126 0 CA-C-N 115.177 -0.919 . . . . 2.2999999999999998 110.247 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.46 143.66 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 114.588 -1.187 . . . . 1.29 109.587 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -85.77 150.38 24.61 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.681 1.734 . . . . 2.6200000000000001 115.681 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.04 -32.45 4.99 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-N 114.178 -1.374 . . . . 1.0600000000000001 113.048 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -131.01 -84.06 0.52 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.494 0.718 . . . . 3.1000000000000001 110.511 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -170.99 66.27 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.123 0.569 . . . . 4.0800000000000001 110.927 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -166.51 -45.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.071 0.767 . . . . 1.74 113.071 -179.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 1.4 m-20 82.75 -177.47 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.695 0 C-N-CA 124.546 1.138 . . . . 1.6799999999999999 110.796 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.93 -21.35 70.75 Favored 'Trans proline' 0 N--CA 1.524 3.322 0 C-N-CA 122.977 2.451 . . . . 2.8199999999999998 115.992 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? 83.58 -68.69 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 126.36 1.864 . . . . 3.4100000000000001 115.085 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.4 133.57 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-N 118.984 0.811 . . . . 1.3799999999999999 111.301 -178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.6 t -132.9 138.44 46.98 Favored 'General case' 0 C--N 1.367 1.362 0 N-CA-C 114.11 1.152 . . . . 1.75 114.11 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 60' ' ' LEU . . . -130.17 45.07 2.87 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.547 1.684 . . . . 1.1299999999999999 115.547 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.92 132.72 3.85 Favored 'General case' 0 N--CA 1.524 3.241 0 N-CA-C 116.233 1.938 . . . . 1.3999999999999999 116.233 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -152.45 102.95 2.78 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 116.054 -0.521 . . . . 0.26000000000000001 111.329 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.526 HG21 ' O ' ' A' ' 12' ' ' TRP 0.313 4.9 tt -110.03 123.25 65.76 Favored 'Isoleucine or valine' 0 C--O 1.27 2.168 0 CA-C-O 122.28 1.038 . . . . 1.1000000000000001 111.406 175.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -123.62 152.69 41.67 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 113.389 -1.732 . . . . 1.0600000000000001 112.025 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 75.9 tttt -104.27 152.51 22.13 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 118.28 2.696 . . . . 1.8300000000000001 118.28 -174.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.62 -41.47 2.14 Favored Glycine 0 CA--C 1.541 1.694 0 CA-C-N 110.704 -2.953 . . . . 0.17000000000000001 119.86 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 178.06 164.44 0.69 Allowed 'General case' 0 N--CA 1.519 2.981 0 CA-C-N 121.165 2.482 . . . . 1.05 112.228 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.95 -16.09 54.46 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 113.915 1.08 . . . . 0.98999999999999999 113.915 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.53 3.51 50.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.151 1.167 . . . . 0.55000000000000004 114.151 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.84 -3.07 20.74 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.205 1.187 . . . . 0.59999999999999998 114.205 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.586 0 C-N-CA 124.375 1.07 . . . . 1.1799999999999999 111.643 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 113.344 0.868 . . . . 1.0900000000000001 113.344 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.27 -22.53 18.86 Favored 'General case' 0 CA--C 1.591 2.543 0 N-CA-C 115.176 1.547 . . . . 1.04 115.176 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.17 -18.81 29.51 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 124.337 1.055 . . . . 0.32000000000000001 113.401 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 55.5 mttt -104.49 -8.87 18.77 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 113.958 1.096 . . . . 2.2599999999999998 113.958 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.44 135.11 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.794 0 C-N-CA 124.027 0.931 . . . . 1.01 112.797 176.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -118.52 -28.59 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 113.357 0.873 . . . . 1.0600000000000001 113.357 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.438 ' O ' HG22 ' A' ' 172' ' ' ILE . 70.0 t90 -163.94 119.0 1.55 Allowed 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 118.43 0.559 . . . . 0.67000000000000004 112.066 -177.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.92 131.53 33.2 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.658 -0.651 . . . . 1.0800000000000001 111.958 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.27 133.21 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 CA-C-O 121.42 0.629 . . . . 1.6699999999999999 112.62 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -117.98 111.4 18.91 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.108 -1.441 . . . . 2.6400000000000001 107.108 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.84 102.59 8.27 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 121.898 0.856 . . . . 1.28 111.383 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.55 -14.12 0.35 Allowed Glycine 0 C--N 1.351 1.362 0 N-CA-C 117.127 1.611 . . . . 0.70999999999999996 117.127 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.04 -131.79 2.32 Favored Glycine 0 N--CA 1.472 1.059 0 C-N-CA 119.271 -1.442 . . . . 0.87 116.06 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.541 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 19.9 tt0 -148.16 116.26 6.47 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 114.931 -0.634 . . . . 2.1200000000000001 110.89 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 14.7 m 21.78 120.4 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 120.199 3.407 . . . . 1.5 120.199 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -140.52 143.02 35.19 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.521 1.153 . . . . 0.52000000000000002 113.407 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.88 115.74 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-N 113.217 -1.811 . . . . 2.0699999999999998 110.789 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -74.99 155.65 37.12 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 113.341 -1.754 . . . . 1.8500000000000001 111.316 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -42.8 -23.92 0.1 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.152 0 N-CA-C 119.048 2.981 . . . . 1.3700000000000001 119.048 -178.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -96.88 -19.36 18.9 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 118.588 0.631 . . . . 0.56999999999999995 110.735 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.81 42.42 0.86 Allowed Glycine 0 C--N 1.358 1.8 0 C-N-CA 124.569 1.08 . . . . 0.37 114.534 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.5 mt -105.73 121.55 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-O 120.883 0.373 . . . . 1.25 110.002 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -102.85 125.99 49.82 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.286 1.217 . . . . 1.71 114.286 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.47 152.68 18.19 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.793 -0.64 . . . . 3.1499999999999999 111.755 176.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -100.35 149.34 23.73 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.006 1.113 . . . . 3.5099999999999998 114.006 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.403 ' HD2' ' O ' ' A' ' 31' ' ' LYS . 1.1 tmmt? -75.14 102.6 5.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.781 2.141 . . . . 2.8100000000000001 116.781 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 45.42 45.66 2.47 Favored Pre-proline 0 N--CA 1.526 3.355 0 N-CA-C 119.128 3.01 . . . . 1.1699999999999999 119.128 174.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo . . . . . 0 CA--C 1.566 2.093 0 C-N-CA 122.766 2.311 . . . . 1.45 116.209 -179.98 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo . . . . . 0 N--CA 1.494 1.54 0 N-CA-C 117.708 2.157 . . . . 1.8600000000000001 117.708 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.254 1.2 mp -98.11 132.82 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.27 0 CA-C-N 113.865 -1.516 . . . . 1.28 108.269 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mt -86.91 -10.91 52.21 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.743 2.127 . . . . 1.9299999999999999 116.743 -176.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -106.75 22.21 16.27 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.532 0.938 . . . . 1.79 113.532 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.91 -172.81 3.64 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-O 121.432 0.634 . . . . 1.49 111.294 178.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.629 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.88 -176.72 0.57 Allowed Pre-proline 0 N--CA 1.509 2.51 0 C-N-CA 123.819 0.848 . . . . 1.6799999999999999 109.557 178.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.478 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 32.8 Cg_exo -69.52 -40.42 5.72 Favored 'Trans proline' 0 C--N 1.4 3.26 0 C-N-CA 122.679 2.253 . . . . 1.1599999999999999 113.045 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -67.98 -49.52 61.14 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.27 1.428 . . . . 2.04 111.866 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.19 -3.54 49.43 Favored 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 114.86 -1.064 . . . . 1.6200000000000001 112.812 177.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.629 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 3.4 tt0 -73.03 -42.41 63.19 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 125.649 1.579 . . . . 2.4300000000000002 107.391 173.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.6 t -63.72 -40.29 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 C-N-CA 124.195 0.998 . . . . 1.46 109.638 173.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.4 ' O ' ' HB1' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -74.91 -17.38 60.58 Favored 'General case' 0 CA--C 1.587 2.393 0 N-CA-C 114.247 1.203 . . . . 1.6699999999999999 114.247 174.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -123.65 22.75 9.0 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 114.372 1.249 . . . . 1.3300000000000001 114.372 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.417 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -137.89 -36.31 0.62 Allowed 'General case' 0 N--CA 1.51 2.558 0 N-CA-C 114.84 1.422 . . . . 1.4099999999999999 114.84 -178.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.1 p -65.94 126.31 28.15 Favored 'General case' 0 N--CA 1.526 3.353 0 N-CA-C 115.293 1.59 . . . . 1.28 115.293 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.127 0 N-CA-C 113.463 0.912 . . . . 1.53 113.463 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 113.434 0.901 . . . . 2.1499999999999999 113.434 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.28 109.87 3.29 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.608 1.163 . . . . 1.25 112.344 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.81 157.34 43.93 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.739 -1.119 . . . . 1.1499999999999999 113.157 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.66 -176.27 39.34 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 115.739 1.055 . . . . 0.59999999999999998 115.739 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.6 172.31 6.92 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.357 1.243 . . . . 1.4099999999999999 114.357 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.06 130.32 50.89 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 114.092 -1.413 . . . . 0.51000000000000001 111.995 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.73 99.61 38.57 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 123.282 0.633 . . . . 1.0600000000000001 109.379 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -84.17 121.63 2.76 Favored 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 122.061 1.841 . . . . 0.17999999999999999 114.65 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.03 160.4 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 CA-C-O 122.016 0.913 . . . . 1.0600000000000001 111.455 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -146.62 17.42 1.3 Allowed 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 114.616 -1.175 . . . . 3.1099999999999999 112.051 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -126.65 160.33 31.04 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-O 121.292 0.568 . . . . 2.1200000000000001 111.5 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -121.25 144.55 48.55 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.72 1.008 . . . . 0.41999999999999998 113.72 -178.816 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.32 -134.31 3.49 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 113.961 -1.472 . . . . 0.25 112.012 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.7 mt-10 -119.1 106.91 12.86 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 118.521 1.16 . . . . 1.75 111.158 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -101.37 128.74 47.41 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.093 0.473 . . . . 0.90000000000000002 110.76 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.77 125.77 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.528 0.68 . . . . 1.0700000000000001 110.543 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.71 105.89 17.28 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 114.563 -1.199 . . . . 1.47 109.687 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.23 123.31 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.044 -1.095 . . . . 1.27 108.044 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -138.37 140.24 39.34 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.973 0.731 . . . . 1.8899999999999999 112.973 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -101.46 120.37 40.18 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.711 0.767 . . . . 2.8999999999999999 111.794 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -105.07 133.5 49.74 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.399 -0.819 . . . . 0.48999999999999999 109.655 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.59 158.92 43.27 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.306 0.574 . . . . 1.1000000000000001 112.207 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -122.8 161.63 23.64 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.512 0.725 . . . . 2.6099999999999999 111.844 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.13 -69.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 112.579 0.585 . . . . 2.6099999999999999 112.579 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -132.11 63.38 1.62 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.621 0.6 . . . . 2.71 112.621 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -148.68 97.44 2.73 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.283 0.633 . . . . 1.6899999999999999 109.707 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.37 105.91 16.22 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.171 0.986 . . . . 1.4299999999999999 112.397 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -167.4 140.54 3.45 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.874 -1.057 . . . . 2.9700000000000002 111.464 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.1 m -127.08 123.18 36.29 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.782 0.66 . . . . 1.6599999999999999 112.782 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 68.16 47.49 1.02 Allowed 'General case' 0 N--CA 1.51 2.56 0 C-N-CA 125.819 1.648 . . . . 2.02 113.894 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -149.74 -39.27 0.14 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.589 1.156 . . . . 2.5600000000000001 110.053 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -107.81 79.61 1.3 Allowed 'General case' 0 C--N 1.362 1.118 0 N-CA-C 108.123 -1.066 . . . . 3.1499999999999999 108.123 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.24 120.71 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 114.111 -1.404 . . . . 1.3600000000000001 111.146 -176.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -99.41 176.62 5.45 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 114.166 -1.379 . . . . 0.84999999999999998 114.583 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.5 135.25 50.11 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 122.09 -0.381 . . . . 1.3300000000000001 110.332 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.79 124.22 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.439 0 CA-C-O 121.208 0.528 . . . . 1.1699999999999999 109.641 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.672 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 20.0 mtt180 -122.11 150.48 42.11 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.467 1.654 . . . . 1.9399999999999999 115.467 -176.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 154' ' ' SER . 7.2 m -126.05 111.87 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 N-CA-C 113.072 0.767 . . . . 1.29 113.072 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.429 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 62.86 25.93 15.32 Favored 'General case' 0 N--CA 1.526 3.345 0 C-N-CA 126.607 1.963 . . . . 1.8200000000000001 114.06 -179.042 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.22 -14.05 51.7 Favored Glycine 0 CA--C 1.552 2.37 0 C-N-CA 121.348 -0.453 . . . . 0.32000000000000001 113.768 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.672 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 92.3 m-70 -89.29 173.99 8.08 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 125.914 1.686 . . . . 0.56999999999999995 113.185 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.66 133.56 54.51 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.582 0.706 . . . . 1.1899999999999999 112.047 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.69 -57.17 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-N 114.701 -1.136 . . . . 1.73 113.038 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.09 88.98 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.295 -1.002 . . . . 1.25 108.295 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 13.4 ptpt -108.31 98.55 8.07 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 122.919 1.342 . . . . 2.75 111.793 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 0.6 OUTLIER 121.48 74.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 129.245 3.018 . . . . 2.48 108.018 -179.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.47 106.61 18.66 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 113.228 0.825 . . . . 1.78 113.228 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -116.86 102.53 9.47 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.728 -1.578 . . . . 2.3500000000000001 106.806 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -25.59 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.335 0 N-CA-C 114.4 1.259 . . . . 1.27 114.4 -176.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -75.27 -41.96 56.09 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.831 0.853 . . . . 0.83999999999999997 112.324 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -73.9 -26.13 60.37 Favored 'General case' 0 CA--C 1.577 1.986 0 C-N-CA 124.403 1.081 . . . . 0.91000000000000003 113.497 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -78.19 -56.1 4.74 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 113.711 1.004 . . . . 2.98 113.711 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.21 -36.95 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 N-CA-C 114.44 1.274 . . . . 1.53 114.44 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.05 -109.29 1.07 Allowed Glycine 0 C--N 1.355 1.619 0 CA-C-N 118.523 0.601 . . . . 0.84999999999999998 113.25 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -114.94 106.95 14.75 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.731 0.301 . . . . 3.9700000000000002 110.63 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 67.56 -130.07 0.14 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 125.285 1.434 . . . . 2.0800000000000001 112.582 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 66.7 p 60.39 -163.24 0.25 Allowed 'General case' 0 N--CA 1.529 3.511 0 C-N-CA 126.293 1.837 . . . . 1.22 115.182 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -112.74 129.93 56.24 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 112.692 0.626 . . . . 1.2 112.692 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -103.08 137.82 40.74 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.077 -0.712 . . . . 0.41999999999999998 109.077 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -134.71 126.14 28.44 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.88 1.437 . . . . 2.5 114.88 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.06 125.32 52.27 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 115.138 -0.937 . . . . 1.5800000000000001 111.156 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.63 114.72 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 114.272 -1.331 . . . . 1.25 110.199 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.3 101.4 17.69 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.953 -0.546 . . . . 1.5 111.582 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -74.13 143.01 31.6 Favored 'Trans proline' 0 C--N 1.399 3.237 0 C-N-CA 123.049 2.499 . . . . 0.22 114.729 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.3 mt -124.9 150.46 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 CA-C-N 115.03 -0.987 . . . . 1.1200000000000001 109.916 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.6 t -136.21 113.41 10.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.454 0.645 . . . . 1.8600000000000001 111.275 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -111.56 124.28 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-N 114.931 -1.031 . . . . 1.0700000000000001 108.61 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -143.69 130.4 20.27 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.791 -0.64 . . . . 2.6400000000000001 110.979 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.35 14.24 9.14 Favored 'General case' 0 N--CA 1.515 2.803 0 C-N-CA 125.186 1.394 . . . . 4.0199999999999996 113.623 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.99 17.64 31.78 Favored Glycine 0 CA--C 1.549 2.162 0 CA-C-O 119.158 -0.801 . . . . 0.39000000000000001 114.566 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 7.1 mtpm? -127.28 150.58 49.5 Favored 'General case' 0 C--N 1.367 1.364 0 CA-C-N 118.443 1.122 . . . . 2.0299999999999998 113.046 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.79 141.06 36.77 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.07 1.137 . . . . 1.0800000000000001 114.07 -176.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.73 112.32 11.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.884 -1.053 . . . . 1.23 110.054 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.255 8.6 p -115.95 95.16 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.457 0 CA-C-O 121.309 0.576 . . . . 1.1899999999999999 111.314 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 67.81 -86.37 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 C-N-CA 125.673 1.589 . . . . 1.8200000000000001 113.608 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.83 26.68 5.32 Favored Glycine 0 CA--C 1.543 1.821 0 CA-C-N 115.923 -0.581 . . . . 0.51000000000000001 112.79 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -126.12 137.35 53.59 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 124.067 0.947 . . . . 1.8200000000000001 111.013 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.75 126.04 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.167 0 CA-C-O 121.516 0.675 . . . . 1.5900000000000001 111.05 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 m -150.2 -179.72 7.42 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.188 -0.915 . . . . 1.1699999999999999 109.933 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.269 15.4 t -103.84 138.18 40.79 Favored 'General case' 0 CA--C 1.577 1.981 0 N-CA-C 113.152 0.797 . . . . 1.71 113.152 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -83.74 121.81 27.79 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.987 0.915 . . . . 0.29999999999999999 111.38 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.41 91.27 3.21 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 112.38 0.511 . . . . 1.8700000000000001 112.38 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.89 -66.29 3.4 Favored Glycine 0 C--N 1.357 1.74 0 N-CA-C 118.738 2.255 . . . . 0.91000000000000003 118.738 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.528 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -133.58 156.89 47.01 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.326 1.232 . . . . 1.6799999999999999 114.326 -176.365 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.528 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -104.84 137.3 42.84 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.107 -1.86 . . . . 1.3700000000000001 109.188 177.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.1 t -120.47 143.28 48.6 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.284 1.587 . . . . 0.94999999999999996 115.284 -177.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.92 97.44 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.986 -1.487 . . . . 1.3799999999999999 106.986 175.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -117.76 124.11 47.65 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.993 -0.549 . . . . 1.6699999999999999 112.077 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.91 135.27 54.15 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 122.329 1.062 . . . . 2.2999999999999998 112.015 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.4 t -104.74 140.24 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-N 112.631 -2.077 . . . . 1.29 109.283 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 150.32 21.77 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.741 1.386 . . . . 2.6200000000000001 114.741 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.91 -34.23 4.1 Favored Glycine 0 CA--C 1.545 1.964 0 CA-C-N 114.779 -1.1 . . . . 1.0600000000000001 114.483 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -126.2 -88.01 0.59 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 117.357 0.579 . . . . 3.1000000000000001 112.372 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -131.04 -51.33 1.03 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.996 0.518 . . . . 4.0800000000000001 112.015 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.03 122.61 37.87 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.172 0.989 . . . . 1.74 111.245 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -81.97 -169.09 0.21 Allowed Pre-proline 0 CA--C 1.574 1.888 0 C-N-CA 125.54 1.536 . . . . 1.6799999999999999 110.554 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -62.7 99.98 0.22 Allowed 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 122.159 1.906 . . . . 2.8199999999999998 111.461 174.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -55.65 -55.18 35.21 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.295 1.961 . . . . 3.4100000000000001 116.295 -173.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 38.8 t -105.61 130.02 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.52 -0.919 . . . . 1.3799999999999999 108.52 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.8 t -135.41 113.82 11.56 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.053 -1.431 . . . . 1.75 110.648 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 60' ' ' LEU . . . -109.61 47.2 0.95 Allowed 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.688 2.107 . . . . 1.1299999999999999 116.688 -175.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.17 130.92 3.62 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 117.13 2.27 . . . . 1.3999999999999999 117.13 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -150.92 105.37 3.25 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.7 -1.136 . . . . 0.26000000000000001 109.597 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 12' ' ' TRP 0.298 7.2 tt -112.76 122.04 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-O 122.255 1.026 . . . . 1.1000000000000001 111.091 175.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -116.3 164.29 14.74 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 113.707 -1.588 . . . . 1.0600000000000001 111.153 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 8.6 ptmm? -123.0 156.18 35.32 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.577 2.436 . . . . 1.8300000000000001 117.577 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.42 -41.57 2.11 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 110.55 -3.023 . . . . 0.17000000000000001 118.909 174.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.04 160.36 1.77 Allowed 'General case' 0 N--CA 1.517 2.885 0 CA-C-N 120.683 2.242 . . . . 1.05 113.391 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -83.29 -13.65 54.71 Favored 'General case' 0 CA--C 1.578 2.03 0 C-N-CA 124.882 1.273 . . . . 0.98999999999999999 114.016 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.38 2.91 49.01 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 114.502 1.297 . . . . 0.55000000000000004 114.502 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.55 -10.26 15.73 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.762 1.023 . . . . 0.59999999999999998 113.762 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.431 0 C-N-CA 123.917 0.887 . . . . 1.1799999999999999 112.727 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 CA--C 1.564 1.506 0 N-CA-C 113.314 0.857 . . . . 1.0900000000000001 113.314 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.46 -23.53 62.79 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.822 1.649 . . . . 1.04 115.134 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.97 -10.46 53.15 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 113.62 0.97 . . . . 0.32000000000000001 113.62 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -105.26 -25.21 12.53 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-O 118.235 -0.888 . . . . 2.2599999999999998 113.349 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -51.03 133.8 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 N-CA-C 115.508 1.67 . . . . 1.01 115.508 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.26 -29.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 115.267 -0.879 . . . . 1.0600000000000001 112.071 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -162.45 118.6 1.94 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.583 0.353 . . . . 0.67000000000000004 111.62 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.8 128.58 20.48 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.523 -0.735 . . . . 1.0800000000000001 111.181 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.11 135.66 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 113.986 1.106 . . . . 1.6699999999999999 113.986 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -116.04 102.34 9.55 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 106.906 -1.516 . . . . 2.6400000000000001 106.906 172.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -75.37 98.55 3.89 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.949 0.881 . . . . 1.28 111.764 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 172.3 -33.03 0.13 Allowed Glycine 0 C--N 1.348 1.234 0 N-CA-C 117.374 1.71 . . . . 0.70999999999999996 117.374 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.07 -114.87 1.9 Allowed Glycine 0 N--CA 1.471 1.01 0 C-N-CA 120.219 -0.991 . . . . 0.87 115.288 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.75 117.04 1.07 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.118 0.567 . . . . 2.1200000000000001 110.593 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.4 m 33.25 108.01 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 118.593 2.812 . . . . 1.5 118.593 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.476 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 63.3 t60 -133.21 133.94 43.39 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.76 1.022 . . . . 0.52000000000000002 113.76 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.57 117.59 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 114.743 -1.117 . . . . 2.0699999999999998 109.143 175.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -86.37 163.25 17.75 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 115.157 -0.929 . . . . 1.8500000000000001 111.542 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -43.73 -24.96 0.21 Allowed 'Isoleucine or valine' 1 N--CA 1.541 4.092 0 N-CA-C 119.681 3.215 . . . . 1.3700000000000001 119.681 -175.035 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -98.02 -9.98 25.16 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 118.543 0.611 . . . . 0.56999999999999995 111.457 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.8 40.32 2.73 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.811 1.196 . . . . 0.37 114.036 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.6 mm -105.15 119.17 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.681 0 N-CA-C 109.21 -0.663 . . . . 1.25 109.21 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.476 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.0 t-160 -105.7 135.28 47.4 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.579 1.696 . . . . 1.71 115.579 -175.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -94.84 134.35 37.56 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.3 -1.318 . . . . 3.1499999999999999 109.392 174.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.41 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 68.8 mtt180 -90.79 106.03 18.23 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.956 -1.02 . . . . 3.5099999999999998 113.307 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -41.89 109.84 0.14 Allowed 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 118.374 2.731 . . . . 2.8100000000000001 118.374 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.08 59.75 16.33 Favored Pre-proline 0 N--CA 1.528 3.466 0 N-CA-C 118.325 2.713 . . . . 1.1699999999999999 118.325 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 10.0 Cg_endo . . . . . 0 CA--C 1.565 2.068 0 C-N-CA 122.992 2.461 . . . . 1.45 115.685 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 38.6 Cg_exo . . . . . 0 N--CA 1.509 2.389 0 N-CA-C 117.211 1.966 . . . . 1.8600000000000001 117.211 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.3 136.87 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.951 0 CA-C-N 114.703 -1.135 . . . . 1.28 109.405 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.52 -17.14 54.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.241 1.571 . . . . 1.9299999999999999 115.241 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -101.49 7.41 42.43 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.478 0.918 . . . . 1.79 113.478 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.2 p -118.52 -177.98 3.42 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.14 1.163 . . . . 1.49 114.14 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.708 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 2.6 t30 -97.44 -176.18 0.5 Allowed Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 125.652 1.581 . . . . 1.6799999999999999 109.574 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -72.05 -43.99 1.02 Allowed 'Trans proline' 0 C--N 1.393 2.901 0 C-N-CA 122.766 2.311 . . . . 1.1599999999999999 111.414 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -69.31 -47.68 63.76 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.005 -1.907 . . . . 2.04 111.617 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 17.4 t0 -75.7 -12.27 60.16 Favored 'General case' 0 CA--C 1.583 2.241 0 CA-C-N 115.327 -0.851 . . . . 1.6200000000000001 112.378 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.708 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 10.8 tt0 -67.7 -43.16 80.76 Favored 'General case' 0 C--N 1.379 1.851 0 C-N-CA 125.432 1.493 . . . . 2.4300000000000002 109.179 173.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.8 -45.06 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.338 0 C-N-CA 124.327 1.051 . . . . 1.46 109.853 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.76 -5.18 49.83 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.227 1.195 . . . . 1.6699999999999999 114.227 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 4.6 m-30 -123.54 10.35 9.11 Favored 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 124.509 1.124 . . . . 1.3300000000000001 112.402 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -136.55 -28.64 0.99 Allowed 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 116.502 2.038 . . . . 1.4099999999999999 116.502 -176.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.7 p -74.74 131.85 41.16 Favored 'General case' 0 N--CA 1.519 2.99 0 N-CA-C 114.008 1.114 . . . . 1.28 114.008 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 3.5 pt-20 . . . . . 0 N--CA 1.505 2.3 0 N-CA-C 114.95 1.463 . . . . 1.53 114.95 -176.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 111.368 0.136 . . . . 2.1499999999999999 111.368 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.2 t 67.56 85.19 0.14 Allowed 'General case' 0 N--CA 1.513 2.714 0 C-N-CA 124.769 1.228 . . . . 1.25 112.487 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.406 ' CE1' ' ND2' ' A' ' 164' ' ' ASN . 3.3 p90 -144.56 157.03 44.41 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.384 0.611 . . . . 1.1499999999999999 112.564 -178.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.52 174.47 44.47 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 115.571 0.989 . . . . 0.59999999999999998 115.571 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.99 166.32 10.46 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.482 1.289 . . . . 1.4099999999999999 114.482 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -120.74 132.08 54.86 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.15 -1.387 . . . . 0.51000000000000001 112.162 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -124.51 99.47 36.2 Favored Pre-proline 0 CA--C 1.567 1.627 0 C-N-CA 123.142 0.577 . . . . 1.0600000000000001 109.916 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.08 122.12 3.27 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.231 1.954 . . . . 0.17999999999999999 115.014 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.14 159.26 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.64 0 CA-C-O 121.997 0.904 . . . . 1.0600000000000001 111.26 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -147.86 22.15 1.12 Allowed 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 114.632 -1.167 . . . . 3.1099999999999999 111.791 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -129.9 159.37 36.84 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 121.3 0.572 . . . . 2.1200000000000001 111.449 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -119.0 144.77 46.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.742 1.016 . . . . 0.41999999999999998 113.742 -178.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.48 -138.73 5.77 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 113.974 -1.467 . . . . 0.25 112.17 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 54.3 mm-40 -113.65 108.26 16.89 Favored 'General case' 0 C--N 1.359 1.008 0 CA-C-N 118.113 0.956 . . . . 1.75 111.292 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -102.84 129.84 49.65 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.81 -0.556 . . . . 0.90000000000000002 110.599 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -110.02 122.36 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.841 0.829 . . . . 1.0700000000000001 111.013 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.61 105.75 16.3 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 113.907 -1.497 . . . . 1.47 110.202 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.69 126.65 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.142 -0.688 . . . . 1.27 109.142 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 146.07 48.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.599 0.963 . . . . 1.8899999999999999 113.599 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -105.18 121.54 44.05 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.311 -0.859 . . . . 2.8999999999999999 111.296 177.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.549 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 15.6 m-85 -108.49 134.86 50.69 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.414 -0.812 . . . . 0.48999999999999999 109.735 176.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.18 148.5 48.18 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 123.868 0.867 . . . . 1.1000000000000001 110.425 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -106.38 -71.21 0.76 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.816 0.447 . . . . 2.6099999999999999 111.768 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.325 2.8 m 48.29 53.57 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 C-N-CA 127.113 2.165 . . . . 2.6099999999999999 116.677 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.98 -53.63 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.79 0.663 . . . . 2.71 112.79 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -118.29 139.23 51.64 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.31 0.576 . . . . 1.6899999999999999 112.349 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.18 103.31 12.47 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-O 122.209 1.004 . . . . 1.4299999999999999 111.987 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -162.83 140.89 8.27 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.125 -0.943 . . . . 2.9700000000000002 111.642 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 m -123.45 122.38 38.1 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.962 0.727 . . . . 1.6599999999999999 112.962 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 69.2 58.21 0.35 Allowed 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 125.933 1.693 . . . . 2.02 113.266 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -156.96 -40.94 0.07 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.128 -1.396 . . . . 2.5600000000000001 108.606 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -103.42 82.67 2.07 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.361 -0.977 . . . . 3.1499999999999999 108.361 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.43 132.89 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 114.516 -1.22 . . . . 1.3600000000000001 111.509 -177.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.439 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 61.7 m-85 -115.5 174.26 6.1 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 115.185 1.55 . . . . 0.84999999999999998 115.185 -176.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.27 136.08 52.34 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.869 0.842 . . . . 1.3300000000000001 110.923 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.3 124.39 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.285 0 CA-C-N 114.361 -1.291 . . . . 1.1699999999999999 110.38 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.3 OUTLIER -121.02 141.56 50.63 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.473 1.286 . . . . 1.9399999999999999 114.473 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 m -117.72 99.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 115.111 -0.95 . . . . 1.29 112.063 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.436 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.1 t30 64.85 26.89 12.92 Favored 'General case' 0 N--CA 1.522 3.169 0 C-N-CA 126.892 2.077 . . . . 1.8200000000000001 113.659 -177.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.89 -19.65 32.6 Favored Glycine 0 CA--C 1.549 2.19 0 CA-C-N 115.141 -0.936 . . . . 0.32000000000000001 113.702 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -88.32 121.93 31.27 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 125.505 1.522 . . . . 0.56999999999999995 113.669 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -87.7 125.69 34.55 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.591 1.186 . . . . 1.1899999999999999 113.134 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.22 -43.39 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 112.428 -2.169 . . . . 1.73 112.916 -177.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.38 90.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.466 -0.568 . . . . 1.25 109.466 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -111.55 75.88 0.94 Allowed 'General case' 0 C--N 1.359 1.013 0 CA-C-O 123.944 1.831 . . . . 2.75 112.52 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 154.46 61.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 109.818 -3.356 . . . . 2.48 107.48 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.3 tp -98.91 99.16 10.18 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 113.727 1.01 . . . . 1.78 113.727 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -111.86 111.5 22.49 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 113.172 -1.831 . . . . 2.3500000000000001 109.742 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -34.26 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 114.545 1.313 . . . . 1.27 114.545 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -76.32 -37.5 57.31 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.806 0.669 . . . . 0.83999999999999997 112.806 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -74.08 -27.0 60.68 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 124.371 1.068 . . . . 0.91000000000000003 113.422 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -80.33 -57.78 3.44 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.311 0.856 . . . . 2.98 113.311 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.78 -36.79 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 N-CA-C 114.313 1.227 . . . . 1.53 114.313 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.37 -71.13 0.21 Allowed Glycine 0 C--N 1.36 1.908 0 CA-C-N 118.534 0.606 . . . . 0.84999999999999998 113.999 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -102.97 174.39 5.89 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.25 1.02 . . . . 3.9700000000000002 111.802 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.0 m -75.9 81.26 2.8 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 113.846 1.054 . . . . 2.0800000000000001 113.846 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.6 p -127.99 -137.43 0.24 Allowed 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 114.708 -1.133 . . . . 1.22 109.139 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.8 128.09 56.27 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 114.055 1.132 . . . . 1.2 114.055 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -106.2 126.68 52.51 Favored 'General case' 0 C--N 1.363 1.183 0 N-CA-C 108.399 -0.963 . . . . 0.41999999999999998 108.399 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.25 136.76 36.84 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.5 0.926 . . . . 2.5 113.5 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -120.37 134.46 55.26 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 114.806 -1.088 . . . . 1.5800000000000001 111.174 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.8 115.66 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 CA-C-N 114.255 -1.339 . . . . 1.25 109.833 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.9 90.86 49.49 Favored Pre-proline 0 CA--C 1.573 1.851 0 CA-C-N 115.208 -0.906 . . . . 1.5 110.15 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -73.87 136.64 23.25 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 123.052 2.501 . . . . 0.22 113.71 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -119.04 151.38 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 115.167 -0.924 . . . . 1.1200000000000001 111.053 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.5 p -134.21 108.73 8.43 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.215 -0.902 . . . . 1.8600000000000001 111.744 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.2 mt -108.82 122.79 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.593 0 N-CA-C 108.441 -0.948 . . . . 1.0700000000000001 108.441 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -141.76 129.49 21.64 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.696 -0.684 . . . . 2.6400000000000001 110.996 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 67.49 14.87 9.73 Favored 'General case' 0 N--CA 1.515 2.821 0 C-N-CA 125.113 1.365 . . . . 4.0199999999999996 114.367 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.38 16.44 32.1 Favored Glycine 0 CA--C 1.549 2.168 0 CA-C-O 119.143 -0.809 . . . . 0.39000000000000001 114.962 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 94.6 mttt -126.82 150.4 49.21 Favored 'General case' 0 C--N 1.367 1.329 0 CA-C-N 118.498 1.149 . . . . 2.0299999999999998 113.038 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.53 139.0 37.78 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.554 0.946 . . . . 1.0800000000000001 113.554 -176.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.67 112.42 14.82 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.128 -0.942 . . . . 1.23 110.406 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.81 92.75 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.604 0 CA-C-N 115.589 -0.732 . . . . 1.1899999999999999 109.982 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 65.39 -83.75 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 C-N-CA 125.369 1.468 . . . . 1.8200000000000001 113.796 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -129.61 25.95 4.4 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-N 116.099 -0.5 . . . . 0.51000000000000001 113.866 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -132.38 119.31 20.51 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 123.165 0.586 . . . . 1.8200000000000001 110.078 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 p -105.74 131.61 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.298 0 CA-C-O 121.696 0.76 . . . . 1.5900000000000001 112.415 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -149.08 -178.11 6.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.815 -1.084 . . . . 1.1699999999999999 109.565 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.268 13.0 t -103.48 138.65 39.9 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 113.547 0.943 . . . . 1.71 113.547 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -82.12 122.68 28.16 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 124.192 0.997 . . . . 0.29999999999999999 111.343 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.65 90.77 3.31 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.788 0.662 . . . . 1.8700000000000001 112.788 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.19 -61.74 2.64 Favored Glycine 0 C--N 1.362 2.005 0 N-CA-C 118.835 2.294 . . . . 0.91000000000000003 118.835 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.55 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -133.11 163.83 28.39 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.649 0.981 . . . . 1.6799999999999999 113.649 -176.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.55 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -112.14 134.6 53.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.692 -1.594 . . . . 1.3700000000000001 108.488 176.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.2 t -121.86 130.58 53.49 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 115.246 1.573 . . . . 0.94999999999999996 115.246 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.2 t -106.35 99.85 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.704 -1.591 . . . . 1.3799999999999999 106.704 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.2 tt0 -114.85 125.23 53.43 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 113.905 -1.498 . . . . 1.6699999999999999 111.9 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -116.15 131.97 56.79 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 122.217 1.008 . . . . 2.2999999999999998 111.923 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.51 144.47 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 112.875 -1.966 . . . . 1.29 110.83 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.468 ' O ' ' HD3' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -95.19 150.45 20.2 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.676 -1.147 . . . . 2.6200000000000001 113.612 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.32 -32.65 5.98 Favored Glycine 0 CA--C 1.548 2.112 0 N-CA-C 115.236 0.855 . . . . 1.0600000000000001 115.236 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -125.17 -80.56 0.62 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.606 0.703 . . . . 3.1000000000000001 112.395 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -132.2 -44.94 0.93 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.087 0.555 . . . . 4.0800000000000001 112.203 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.439 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -92.84 157.17 16.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.659 1.184 . . . . 1.74 112.109 179.085 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.406 ' ND2' ' CE1' ' A' ' 71' ' ' PHE . 1.2 m-20 -101.19 -167.45 0.13 Allowed Pre-proline 0 CA--C 1.572 1.809 0 CA-C-N 113.614 -1.63 . . . . 1.6799999999999999 108.979 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -61.26 -10.5 15.83 Favored 'Trans proline' 0 N--CA 1.52 3.081 0 C-N-CA 122.49 2.127 . . . . 2.8199999999999998 115.533 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? 78.93 -71.71 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 126.561 1.944 . . . . 3.4100000000000001 114.211 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.2 t -106.34 132.72 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.621 -0.511 . . . . 1.3799999999999999 109.621 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.6 125.82 27.96 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 114.155 -1.384 . . . . 1.75 111.479 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . 0.268 . . -120.34 50.88 1.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 115.744 1.757 . . . . 1.1299999999999999 115.744 -176.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.81 129.3 2.62 Favored 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 126.169 1.787 . . . . 1.3999999999999999 115.502 178.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -149.61 99.31 2.87 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.26000000000000001 110.019 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.311 8.0 tt -115.67 121.78 68.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.673 0 CA-C-O 122.651 1.215 . . . . 1.1000000000000001 111.801 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -118.72 171.2 8.37 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 113.701 -1.59 . . . . 1.0600000000000001 112.171 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -120.15 148.15 44.0 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 117.783 2.512 . . . . 1.8300000000000001 117.783 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.22 -41.74 2.08 Favored Glycine 0 CA--C 1.543 1.823 0 CA-C-N 110.786 -2.915 . . . . 0.17000000000000001 120.087 172.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.08 156.64 1.04 Allowed 'General case' 0 N--CA 1.521 3.115 0 CA-C-N 121.114 2.457 . . . . 1.05 113.383 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.45 -12.12 59.99 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 114.478 1.288 . . . . 0.98999999999999999 114.478 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.1 4.47 45.25 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 113.694 0.998 . . . . 0.55000000000000004 113.694 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.13 -10.32 15.91 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 113.701 1.0 . . . . 0.59999999999999998 113.701 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.509 2.503 0 C-N-CA 123.932 0.893 . . . . 1.1799999999999999 112.74 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.7 tp . . . . . 0 CA--C 1.561 1.382 0 N-CA-C 113.294 0.85 . . . . 1.0900000000000001 113.294 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.69 -23.15 62.89 Favored 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 125.647 1.579 . . . . 1.04 114.979 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.1 -15.17 39.3 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 124.146 0.978 . . . . 0.32000000000000001 113.626 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -105.19 -18.05 14.27 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.907 1.077 . . . . 2.2599999999999998 113.907 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.34 134.79 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.78 0 N-CA-C 114.625 1.343 . . . . 1.01 114.625 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -121.27 -28.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 115.328 -0.851 . . . . 1.0600000000000001 112.446 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.44 ' O ' HG23 ' A' ' 172' ' ' ILE . 65.4 t90 -162.63 117.08 1.77 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 117.827 0.285 . . . . 0.67000000000000004 111.493 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.84 130.85 32.42 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.516 -0.74 . . . . 1.0800000000000001 111.445 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.0 t -137.97 129.32 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 N-CA-C 113.481 0.919 . . . . 1.6699999999999999 113.481 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -116.44 104.22 11.23 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 106.946 -1.501 . . . . 2.6400000000000001 106.946 171.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.29 101.88 7.38 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.084 0.945 . . . . 1.28 111.861 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.508 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 175.59 -57.33 0.11 Allowed Glycine 0 C--N 1.349 1.305 0 CA-C-N 113.71 -1.587 . . . . 0.70999999999999996 114.349 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.13 -117.09 4.3 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-O 119.93 -0.372 . . . . 0.87 113.975 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -172.12 118.88 0.4 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.172 0.589 . . . . 2.1200000000000001 111.17 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 48.39 107.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 117.205 2.298 . . . . 1.5 117.205 178.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.778 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 25.7 t60 -142.41 132.51 24.6 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.461 -1.296 . . . . 0.52000000000000002 114.49 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -97.04 112.24 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.362 0 CA-C-N 114.28 -1.327 . . . . 2.0699999999999998 110.089 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.29 164.92 19.76 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.527 1.131 . . . . 1.8500000000000001 112.559 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 m -42.53 -35.17 0.63 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.159 0 N-CA-C 118.947 2.943 . . . . 1.3700000000000001 118.947 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -88.98 -23.32 22.66 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.213 0.53 . . . . 0.56999999999999995 111.26 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.85 41.06 0.73 Allowed Glycine 0 C--N 1.351 1.394 0 CA-C-N 114.817 -1.083 . . . . 0.37 113.81 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -108.45 112.8 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 C-N-CA 122.569 0.348 . . . . 1.25 110.581 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.778 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 5.1 p-80 -109.29 147.83 32.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.983 1.845 . . . . 1.71 115.983 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.612 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.8 151.31 20.32 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 112.467 -2.151 . . . . 3.1499999999999999 109.419 176.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -70.27 -99.82 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 116.04 1.867 . . . . 3.5099999999999998 116.04 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp 178.19 84.04 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.89 0.876 . . . . 2.8100000000000001 111.986 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 52.69 55.33 14.26 Favored Pre-proline 0 N--CA 1.528 3.457 0 N-CA-C 117.283 2.327 . . . . 1.1699999999999999 117.283 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 CA--C 1.568 2.193 0 C-N-CA 123.307 2.672 . . . . 1.45 116.432 -179.195 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.5 ' HD2' ' NE2' ' A' ' 62' ' ' GLN . 21.7 Cg_exo . . . . . 0 N--CA 1.495 1.577 0 N-CA-C 119.496 2.844 . . . . 1.8600000000000001 119.496 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 61' ' ' TYR 0.319 1.8 mp -92.78 107.02 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 CA-C-O 123.085 1.421 . . . . 1.28 109.59 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt -90.24 -7.13 54.26 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 111.821 -2.445 . . . . 1.9299999999999999 116.387 -175.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -103.86 16.46 26.29 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 112.263 0.468 . . . . 1.79 112.263 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.84 159.36 42.37 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.224 1.01 . . . . 1.49 111.51 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.86 158.32 62.26 Favored Pre-proline 0 N--CA 1.517 2.876 0 CA-C-O 118.138 -0.934 . . . . 1.6799999999999999 110.974 178.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -41.19 -40.13 4.08 Favored 'Trans proline' 0 N--CA 1.535 3.971 0 C-N-CA 125.162 3.908 . . . . 1.1599999999999999 120.05 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.79 -50.02 13.17 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.511 0.672 . . . . 2.04 111.96 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -78.23 -7.5 57.22 Favored 'General case' 0 CA--C 1.584 2.287 0 N-CA-C 113.121 0.786 . . . . 1.6200000000000001 113.121 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.627 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 7.7 tt0 -74.3 -37.06 63.75 Favored 'General case' 0 C--N 1.38 1.919 0 C-N-CA 125.923 1.689 . . . . 2.4300000000000002 107.547 172.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.36 -43.88 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 C-N-CA 124.214 1.005 . . . . 1.46 109.289 172.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' A' ' 169' ' ' ALA . 8.1 tp -79.93 -4.63 53.21 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 113.965 1.098 . . . . 1.6699999999999999 113.965 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.415 ' O ' HG12 ' A' ' 50' ' ' ILE . 6.8 m-30 -121.69 13.77 10.85 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 125.131 1.373 . . . . 1.3300000000000001 112.641 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 4.8 tt0 -140.8 -38.9 0.42 Allowed 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 117.175 2.287 . . . . 1.4099999999999999 117.175 -174.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.8 p -64.19 128.06 34.16 Favored 'General case' 0 N--CA 1.528 3.435 0 N-CA-C 115.343 1.609 . . . . 1.28 115.343 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.508 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 2.4 pt-20 . . . . . 0 N--CA 1.503 2.213 0 C-N-CA 124.617 1.167 . . . . 1.53 112.58 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 110.732 -0.099 . . . . 2.1499999999999999 110.732 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.91 89.57 0.06 Allowed 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 125.383 1.473 . . . . 1.25 113.692 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -153.53 159.24 42.18 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.841 1.052 . . . . 1.1499999999999999 113.841 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.7 -172.01 40.13 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 115.879 1.112 . . . . 0.59999999999999998 115.879 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -111.27 173.32 6.4 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.026 1.491 . . . . 1.4099999999999999 115.026 -176.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -127.61 132.2 49.82 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 113.98 -1.464 . . . . 0.51000000000000001 111.757 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.91 103.61 30.62 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.023 0.529 . . . . 1.0600000000000001 109.957 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -84.34 120.64 2.54 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 122.282 1.988 . . . . 0.17999999999999999 114.958 177.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.24 162.81 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 122.041 0.924 . . . . 1.0600000000000001 110.931 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -152.13 27.95 0.59 Allowed 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 114.801 -1.091 . . . . 3.1099999999999999 111.816 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -132.71 155.62 48.5 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-O 121.24 0.543 . . . . 2.1200000000000001 110.965 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.77 141.87 47.65 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.009 1.114 . . . . 0.41999999999999998 114.009 -178.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.83 -139.08 5.69 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 113.712 -1.585 . . . . 0.25 112.061 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.2 mt-10 -113.9 110.13 19.61 Favored 'General case' 0 C--N 1.36 1.023 0 CA-C-N 118.312 1.056 . . . . 1.75 111.299 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -104.41 131.2 52.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.996 0.427 . . . . 0.90000000000000002 110.523 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.81 124.46 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.408 0.623 . . . . 1.0700000000000001 110.551 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tt -109.15 106.19 15.97 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.793 -1.094 . . . . 1.47 109.806 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -112.48 129.17 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 113.929 -1.487 . . . . 1.27 108.543 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.72 139.11 50.26 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 115.684 -0.689 . . . . 1.8899999999999999 112.502 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -104.33 114.75 29.19 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.295 -0.866 . . . . 2.8999999999999999 109.855 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 11.1 m-85 -105.22 137.05 43.62 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.852 -0.613 . . . . 0.48999999999999999 111.255 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.79 151.54 45.84 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.757 -0.656 . . . . 1.1000000000000001 111.458 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -145.87 123.46 11.8 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.671 0.389 . . . . 2.6099999999999999 111.687 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.3 77.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 116.019 -0.537 . . . . 2.6099999999999999 111.727 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -171.05 -47.42 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.43 0.53 . . . . 2.71 112.43 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -116.19 127.34 54.7 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.65 0.38 . . . . 1.6899999999999999 111.577 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.96 103.14 12.94 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.252 1.025 . . . . 1.4299999999999999 111.992 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -160.79 141.84 11.79 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.947 -1.024 . . . . 2.9700000000000002 111.651 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 m -127.7 122.09 32.05 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.764 0.653 . . . . 1.6599999999999999 112.764 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 67.85 55.62 0.58 Allowed 'General case' 0 N--CA 1.513 2.72 0 C-N-CA 125.724 1.61 . . . . 2.02 113.142 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -157.68 -39.15 0.07 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.617 -1.174 . . . . 2.5600000000000001 109.44 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -108.06 83.24 1.76 Allowed 'General case' 0 C--N 1.361 1.097 0 N-CA-C 108.03 -1.1 . . . . 3.1499999999999999 108.03 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.41 130.45 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 114.419 -1.264 . . . . 1.3600000000000001 111.539 -176.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -108.02 170.53 7.94 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.331 1.604 . . . . 0.84999999999999998 115.331 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -119.85 136.65 54.4 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.236 -0.893 . . . . 1.3300000000000001 110.846 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.38 127.89 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.471 0 N-CA-C 109.58 -0.526 . . . . 1.1699999999999999 109.58 -178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 53.9 mtt180 -128.58 153.32 47.35 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.708 1.744 . . . . 1.9399999999999999 115.708 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.7 OUTLIER -129.73 112.32 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-N 115.545 -0.752 . . . . 1.29 112.758 176.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.47 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 63.39 27.05 15.18 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 126.864 2.066 . . . . 1.8200000000000001 114.157 -178.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.31 -19.35 40.13 Favored Glycine 0 CA--C 1.548 2.136 0 C-N-CA 121.463 -0.399 . . . . 0.32000000000000001 113.8 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.482 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 86.7 m-70 -83.79 156.91 22.28 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.654 1.582 . . . . 0.56999999999999995 114.454 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.49 131.29 53.84 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.375 0.607 . . . . 1.1899999999999999 111.094 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.2 -57.86 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 115.129 -0.942 . . . . 1.73 113.104 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.74 90.02 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.713 -0.847 . . . . 1.25 108.713 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -109.37 77.85 1.09 Allowed 'General case' 0 C--N 1.351 0.636 0 CA-C-O 122.835 1.303 . . . . 2.75 111.985 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 152.34 65.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 128.523 2.729 . . . . 2.48 107.868 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.0 tp -105.17 99.35 8.96 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 113.782 1.03 . . . . 1.78 113.782 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -113.32 107.05 15.35 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 113.24 -1.8 . . . . 2.3500000000000001 108.042 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.13 -33.25 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 114.542 1.312 . . . . 1.27 114.542 -177.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -75.13 -36.1 61.64 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 123.376 0.671 . . . . 0.83999999999999997 112.242 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -74.71 -27.46 60.39 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 124.436 1.094 . . . . 0.91000000000000003 113.27 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.69 -56.93 4.17 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.163 0.801 . . . . 2.98 113.163 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.9 -40.68 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 113.753 1.019 . . . . 1.53 113.753 177.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.45 -64.09 0.3 Allowed Glycine 0 C--N 1.361 1.935 0 N-CA-C 114.353 0.501 . . . . 0.84999999999999998 114.353 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -103.26 174.2 5.97 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.316 1.046 . . . . 3.9700000000000002 111.634 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -73.35 89.86 1.63 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 123.543 0.737 . . . . 2.0800000000000001 112.249 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.8 p -141.02 -146.25 0.19 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.115 0.966 . . . . 1.22 109.209 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.94 134.8 54.6 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 113.475 0.917 . . . . 1.2 113.475 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 10.4 t60 -110.75 145.79 37.47 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.884 0.474 . . . . 0.41999999999999998 109.77 177.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -145.33 143.97 30.46 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.881 1.067 . . . . 2.5 113.881 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -137.43 125.71 23.21 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 114.293 -1.321 . . . . 1.5800000000000001 110.471 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.45 121.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 114.896 -1.047 . . . . 1.25 110.768 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.98 99.45 15.05 Favored Pre-proline 0 CA--C 1.571 1.759 0 CA-C-O 119.009 -0.52 . . . . 1.5 112.208 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -74.7 143.95 30.8 Favored 'Trans proline' 0 C--N 1.4 3.277 0 C-N-CA 123.052 2.501 . . . . 0.22 114.326 176.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -124.28 149.25 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 124.023 0.929 . . . . 1.1200000000000001 110.423 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.6 p -132.48 111.37 11.21 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.924 -0.58 . . . . 1.8600000000000001 112.349 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.4 mt -112.01 122.67 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 N-CA-C 108.492 -0.929 . . . . 1.0700000000000001 108.492 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -142.56 130.09 21.32 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.66 -0.7 . . . . 2.6400000000000001 110.873 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt 69.38 10.14 7.61 Favored 'General case' 0 N--CA 1.518 2.963 0 N-CA-C 114.677 1.362 . . . . 4.0199999999999996 114.677 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.66 18.45 23.11 Favored Glycine 0 CA--C 1.548 2.108 0 C-N-CA 123.738 0.685 . . . . 0.39000000000000001 114.384 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 95.4 mttt -128.25 151.09 49.69 Favored 'General case' 0 C--N 1.367 1.337 0 CA-C-N 117.978 0.889 . . . . 2.0299999999999998 112.799 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.75 144.9 30.5 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.811 1.041 . . . . 1.0800000000000001 113.811 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.1 m -134.35 114.09 12.6 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.783 -1.099 . . . . 1.23 110.712 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.274 0.8 OUTLIER -114.54 96.12 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.568 0 CA-C-O 121.304 0.573 . . . . 1.1899999999999999 110.434 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 68.24 -85.34 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 125.41 1.484 . . . . 1.8200000000000001 113.594 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.08 26.74 4.16 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 115.969 -0.559 . . . . 0.51000000000000001 113.405 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -129.21 127.98 42.39 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.497 0.719 . . . . 1.8200000000000001 110.453 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.0 p -113.39 130.75 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.315 0 CA-C-O 121.649 0.738 . . . . 1.5900000000000001 111.772 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 m -148.65 178.58 8.51 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.946 -1.025 . . . . 1.1699999999999999 109.735 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.27 13.4 t -103.34 137.61 41.22 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 113.366 0.876 . . . . 1.71 113.366 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -84.14 123.44 30.08 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.243 1.017 . . . . 0.29999999999999999 111.597 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.2 90.82 3.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.476 0.547 . . . . 1.8700000000000001 112.476 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.28 -64.64 3.15 Favored Glycine 0 C--N 1.359 1.816 0 N-CA-C 118.847 2.299 . . . . 0.91000000000000003 118.847 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.514 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -129.75 158.03 40.52 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.442 1.275 . . . . 1.6799999999999999 114.442 -176.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.514 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -106.98 138.97 42.13 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 113.285 -1.779 . . . . 1.3700000000000001 109.269 177.032 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 t -121.23 143.97 48.86 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.567 1.692 . . . . 0.94999999999999996 115.567 -177.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.26 98.2 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.308 -1.367 . . . . 1.3799999999999999 107.308 175.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -118.29 124.91 48.97 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.334 0.588 . . . . 1.6699999999999999 112.407 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.0 133.39 56.07 Favored 'General case' 0 C--O 1.252 1.211 0 CA-C-O 122.22 1.009 . . . . 2.2999999999999998 111.482 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.4 t -106.36 143.91 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 113.094 -1.867 . . . . 1.29 110.442 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.64 150.53 24.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.539 1.311 . . . . 2.6200000000000001 114.539 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.93 -51.78 0.99 Allowed Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.055 -0.975 . . . . 1.0600000000000001 113.928 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -129.49 -84.46 0.55 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.912 0.356 . . . . 3.1000000000000001 111.739 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.506 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 0.4 OUTLIER -140.64 122.7 15.64 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.984 0.514 . . . . 4.0800000000000001 110.224 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 0.9 OUTLIER 85.54 114.94 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 C-N-CA 124.975 1.31 . . . . 1.74 111.064 -177.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -82.32 -172.26 0.35 Allowed Pre-proline 0 CA--C 1.574 1.876 0 C-N-CA 124.536 1.134 . . . . 1.6799999999999999 110.464 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -61.64 101.06 0.2 Allowed 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 122.247 1.965 . . . . 2.8199999999999998 111.994 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -59.56 -49.42 77.83 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.199 1.926 . . . . 3.4100000000000001 116.199 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.8 t -108.43 131.88 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.777 -0.823 . . . . 1.3799999999999999 108.777 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.4 t -136.88 124.18 21.89 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.639 -1.164 . . . . 1.75 112.094 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 60' ' ' LEU 0.267 . . -119.84 48.32 1.57 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.897 1.814 . . . . 1.1299999999999999 115.897 -177.235 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.83 135.53 2.28 Favored 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.489 2.033 . . . . 1.3999999999999999 116.489 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -152.43 106.42 3.12 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.376 -0.829 . . . . 0.26000000000000001 110.974 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 12' ' ' TRP 0.294 9.9 tt -115.72 122.68 69.96 Favored 'Isoleucine or valine' 0 C--O 1.27 2.15 0 CA-C-O 122.16 0.981 . . . . 1.1000000000000001 111.147 175.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -120.42 167.83 11.94 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.322 -1.308 . . . . 1.0600000000000001 111.859 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -118.58 145.63 45.23 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 117.813 2.523 . . . . 1.8300000000000001 117.813 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.42 -40.99 2.28 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 110.672 -2.967 . . . . 0.17000000000000001 120.151 172.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.71 160.92 2.0 Favored 'General case' 0 N--CA 1.518 2.932 0 CA-C-N 121.265 2.533 . . . . 1.05 113.587 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.37 -10.06 59.75 Favored 'General case' 0 CA--C 1.583 2.212 0 C-N-CA 124.994 1.318 . . . . 0.98999999999999999 114.126 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.1 1.64 52.31 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.234 1.198 . . . . 0.55000000000000004 114.234 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.05 -10.84 15.8 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.467 0.914 . . . . 0.59999999999999998 113.467 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.379 0 C-N-CA 124.119 0.968 . . . . 1.1799999999999999 112.424 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.9 tp . . . . . 0 CA--C 1.565 1.553 0 N-CA-C 113.036 0.754 . . . . 1.0900000000000001 113.036 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.28 -22.91 63.68 Favored 'General case' 0 N--CA 1.508 2.462 0 C-N-CA 125.925 1.69 . . . . 1.04 115.249 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -11.53 51.11 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 113.792 1.034 . . . . 0.32000000000000001 113.792 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -108.9 -19.37 13.42 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 113.728 1.01 . . . . 2.2599999999999998 113.728 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.41 138.26 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 N-CA-C 115.142 1.534 . . . . 1.01 115.142 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -122.32 -30.33 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 115.717 -0.674 . . . . 1.0600000000000001 112.44 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.51 ' O ' HG23 ' A' ' 172' ' ' ILE . 68.0 t90 -162.02 116.29 1.88 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 120.815 0.34 . . . . 0.67000000000000004 111.07 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.07 135.57 35.95 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.397 -0.815 . . . . 1.0800000000000001 111.526 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.269 5.3 p -148.17 146.15 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 N-CA-C 114.571 1.323 . . . . 1.6699999999999999 114.571 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.578 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 1.9 t-20 -116.9 107.91 15.17 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.168 -1.378 . . . . 2.6400000000000001 108.145 175.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.6 102.11 5.98 Favored 'General case' 0 C--O 1.268 2.078 0 CA-C-O 122.246 1.022 . . . . 1.28 111.668 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.469 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 153.98 -1.66 0.22 Allowed Glycine 0 C--N 1.353 1.5 0 CA-C-N 111.561 -2.563 . . . . 0.70999999999999996 115.998 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.51 -141.43 3.13 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 118.91 1.355 . . . . 0.87 114.705 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -147.25 116.67 7.01 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 112.485 0.55 . . . . 2.1200000000000001 112.485 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.709 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 2.3 m 35.54 123.18 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.877 0 N-CA-C 121.087 3.736 . . . . 1.5 121.087 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -154.2 150.21 27.85 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.662 0.744 . . . . 0.52000000000000002 111.768 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.56 128.22 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 115.361 -0.836 . . . . 2.0699999999999998 111.71 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -85.73 153.36 22.38 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 113.994 -1.457 . . . . 1.8500000000000001 110.157 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.1 m -44.04 -22.77 0.15 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 118.956 2.947 . . . . 1.3700000000000001 118.956 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -94.19 -21.55 18.99 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 123.004 0.522 . . . . 0.56999999999999995 111.103 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.58 39.21 1.12 Allowed Glycine 0 C--N 1.353 1.501 0 C-N-CA 124.4 1.0 . . . . 0.37 114.43 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 mm -105.98 119.68 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 109.239 -0.652 . . . . 1.25 109.239 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -100.66 130.92 46.77 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.179 1.177 . . . . 1.71 114.179 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.709 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -96.33 140.45 30.98 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.985 -1.007 . . . . 3.1499999999999999 110.604 177.398 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -83.6 176.42 9.02 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 115.856 1.798 . . . . 3.5099999999999998 115.856 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -107.53 96.97 6.78 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.83 1.789 . . . . 2.8100000000000001 115.83 -175.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 46.95 58.6 17.02 Favored Pre-proline 0 N--CA 1.52 3.036 0 N-CA-C 117.701 2.482 . . . . 1.1699999999999999 117.701 175.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 CA--C 1.557 1.654 0 C-N-CA 122.62 2.213 . . . . 1.45 115.93 179.592 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo . . . . . 0 N--CA 1.499 1.816 0 N-CA-C 116.053 1.52 . . . . 1.8600000000000001 116.053 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.257 1.1 mp -97.18 136.9 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.23 0 CA-C-N 114.6 -1.182 . . . . 1.28 109.726 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 mt -89.73 -12.27 39.89 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 116.381 1.993 . . . . 1.9299999999999999 116.381 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -100.48 15.86 26.53 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.87 1.063 . . . . 1.79 113.87 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -132.62 -165.46 1.6 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.29 0.636 . . . . 1.49 111.433 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.18 174.09 3.68 Favored Pre-proline 0 N--CA 1.505 2.31 0 C-N-CA 123.087 0.555 . . . . 1.6799999999999999 111.583 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -70.2 -28.14 23.51 Favored 'Trans proline' 0 C--N 1.401 3.32 0 C-N-CA 123.164 2.576 . . . . 1.1599999999999999 113.797 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.05 -37.22 19.12 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.954 0.902 . . . . 2.04 112.712 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.0 8.78 42.77 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.171 1.175 . . . . 1.6200000000000001 114.171 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -72.75 -26.21 61.47 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 123.751 0.82 . . . . 2.4300000000000002 110.606 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.1 t -68.86 -50.55 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 C-N-CA 126.458 1.903 . . . . 1.46 108.226 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.578 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 7.9 tp -74.39 -9.67 58.82 Favored 'General case' 0 C--N 1.383 2.047 0 N-CA-C 114.013 1.116 . . . . 1.6699999999999999 114.013 176.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -108.08 1.08 22.1 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.336 0.655 . . . . 1.3300000000000001 110.854 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -128.26 -115.0 0.26 Allowed 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.395 1.078 . . . . 1.4099999999999999 110.849 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.2 p 35.32 134.16 0.0 OUTLIER 'General case' 1 N--CA 1.56 5.06 0 C-N-CA 128.342 2.657 . . . . 1.28 117.928 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.469 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 5.8 pt-20 . . . . . 0 N--CA 1.516 2.873 0 N-CA-C 116.974 2.213 . . . . 1.53 116.974 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 111.839 0.311 . . . . 2.1499999999999999 111.839 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 t 66.67 83.7 0.16 Allowed 'General case' 0 N--CA 1.506 2.331 0 C-N-CA 124.907 1.283 . . . . 1.25 113.006 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -141.92 138.5 32.07 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 121.605 0.717 . . . . 1.1499999999999999 111.929 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.69 -167.63 15.7 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.603 1.401 . . . . 0.59999999999999998 116.603 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.1 172.27 8.68 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 113.499 -1.351 . . . . 1.4099999999999999 113.986 -177.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -128.22 134.14 48.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.399 -1.273 . . . . 0.51000000000000001 112.219 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.32 103.54 22.7 Favored Pre-proline 0 CA--C 1.567 1.607 0 C-N-CA 123.326 0.65 . . . . 1.0600000000000001 109.499 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -84.57 120.1 2.38 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.233 1.955 . . . . 0.17999999999999999 114.783 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.84 160.16 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 CA-C-O 121.977 0.894 . . . . 1.0600000000000001 111.232 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -149.3 24.05 0.91 Allowed 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 114.748 -1.115 . . . . 3.1099999999999999 111.867 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -130.09 161.66 30.54 Favored 'General case' 0 C--N 1.364 1.238 0 CA-C-O 121.296 0.57 . . . . 2.1200000000000001 111.5 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -120.34 144.33 47.91 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.799 1.037 . . . . 0.41999999999999998 113.799 -178.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.29 -139.53 6.08 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 114.117 -1.401 . . . . 0.25 112.596 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 80.9 mm-40 -113.65 105.0 12.8 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-N 118.092 0.946 . . . . 1.75 110.963 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -99.52 128.27 45.62 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.124 0.488 . . . . 0.90000000000000002 110.895 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -112.34 123.66 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.346 0.593 . . . . 1.0700000000000001 110.755 -176.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.5 tt -110.27 108.38 18.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.923 -1.035 . . . . 1.47 110.069 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.25 132.26 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 114.199 -1.364 . . . . 1.27 108.557 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.21 140.79 47.73 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 115.514 -0.766 . . . . 1.8899999999999999 112.394 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 tptt -104.01 113.33 26.8 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.043 -0.98 . . . . 2.8999999999999999 109.657 177.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -106.84 134.68 49.61 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.685 -0.689 . . . . 0.48999999999999999 111.146 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.76 148.05 38.34 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.4 0.619 . . . . 1.1000000000000001 111.24 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -132.36 117.9 18.71 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 116.171 -0.468 . . . . 2.6099999999999999 111.228 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.08 69.02 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 116.179 -0.464 . . . . 2.6099999999999999 112.048 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.39 -49.11 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.899 0.479 . . . . 2.71 111.995 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -123.14 129.64 51.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.711 0.404 . . . . 1.6899999999999999 111.143 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.83 105.46 15.5 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 122.194 0.997 . . . . 1.4299999999999999 112.421 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -162.69 144.82 10.58 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.009 -0.996 . . . . 2.9700000000000002 112.179 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.9 m -122.8 125.68 45.94 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.495 -0.775 . . . . 1.6599999999999999 112.595 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 70.48 49.75 0.41 Allowed 'General case' 0 N--CA 1.515 2.777 0 C-N-CA 125.553 1.541 . . . . 2.02 112.473 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -148.66 -45.72 0.15 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.679 1.192 . . . . 2.5600000000000001 109.565 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.98 87.54 2.53 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.679 -0.86 . . . . 3.1499999999999999 108.679 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.93 120.81 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 114.048 -1.433 . . . . 1.3600000000000001 110.743 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.437 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 45.5 m-85 -101.02 177.37 4.97 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.417 1.636 . . . . 0.84999999999999998 115.417 -175.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -128.21 136.9 51.71 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.214 0.531 . . . . 1.3300000000000001 111.483 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.95 126.09 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.448 0 CA-C-N 115.689 -0.687 . . . . 1.1699999999999999 109.994 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -132.43 151.34 51.92 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.083 1.512 . . . . 1.9399999999999999 115.083 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 154' ' ' SER . 1.2 m -125.08 113.32 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 C-N-CA 124.357 1.063 . . . . 1.29 112.754 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.503 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 64.69 25.85 13.08 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 126.69 1.996 . . . . 1.8200000000000001 113.614 -178.326 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.99 -3.63 60.52 Favored Glycine 0 CA--C 1.555 2.577 0 CA-C-N 116.168 -0.469 . . . . 0.32000000000000001 114.099 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.48 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 86.0 m-70 -99.56 139.61 34.96 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 125.65 1.58 . . . . 0.56999999999999995 112.951 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.33 130.51 40.61 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.879 0.847 . . . . 1.1899999999999999 113.075 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.09 -56.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 114.0 -1.454 . . . . 1.73 112.606 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.43 88.6 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.242 -1.022 . . . . 1.25 108.242 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -109.17 95.1 5.41 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 123.094 1.426 . . . . 2.75 111.964 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 127.96 71.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 129.619 3.168 . . . . 2.48 107.865 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.26 103.41 15.26 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-O 121.863 0.839 . . . . 1.78 112.481 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -111.59 94.71 5.1 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 113.538 -1.664 . . . . 2.3500000000000001 107.647 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -63.52 -28.73 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.496 0 C-N-CA 125.046 1.339 . . . . 1.27 114.465 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -77.69 -37.08 50.42 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.31 0.644 . . . . 0.83999999999999997 112.469 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -74.45 -27.13 60.46 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 124.594 1.158 . . . . 0.91000000000000003 113.836 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -86.65 -50.57 6.7 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.455 0.909 . . . . 2.98 113.455 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.282 1.4 p -91.53 -38.76 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.966 0 N-CA-C 113.383 0.883 . . . . 1.53 113.383 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.37 -78.81 0.25 Allowed Glycine 0 C--N 1.36 1.883 0 CA-C-N 118.444 0.566 . . . . 0.84999999999999998 114.497 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -102.92 174.75 5.73 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.1 0.96 . . . . 3.9700000000000002 112.507 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.7 m -74.18 81.14 1.79 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.723 1.009 . . . . 2.0800000000000001 113.723 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 34.9 p -133.01 -137.49 0.18 Allowed 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 114.441 -1.254 . . . . 1.22 109.032 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -115.01 131.55 56.89 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.046 0.758 . . . . 1.2 113.046 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -105.48 147.93 27.77 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.446 -0.576 . . . . 0.41999999999999998 109.446 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -142.49 129.86 21.14 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.663 1.357 . . . . 2.5 114.663 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -123.77 123.92 41.55 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.737 -1.12 . . . . 1.5800000000000001 110.661 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.49 120.88 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-N 114.488 -1.233 . . . . 1.25 110.899 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.62 99.99 15.22 Favored Pre-proline 0 CA--C 1.569 1.702 0 CA-C-O 119.024 -0.512 . . . . 1.5 111.976 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -75.05 142.6 27.89 Favored 'Trans proline' 0 C--N 1.398 3.177 0 C-N-CA 123.082 2.521 . . . . 0.22 114.2 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.17 149.48 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 CA-C-N 115.125 -0.943 . . . . 1.1200000000000001 109.971 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.9 t -136.0 117.16 14.44 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.502 0.668 . . . . 1.8600000000000001 111.365 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.4 mt -113.93 125.5 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 CA-C-N 114.713 -1.131 . . . . 1.0700000000000001 108.286 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -138.97 124.33 19.25 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.599 -0.728 . . . . 2.6400000000000001 110.567 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 67.61 17.1 9.93 Favored 'General case' 0 N--CA 1.517 2.902 0 C-N-CA 125.341 1.456 . . . . 4.0199999999999996 114.121 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.51 13.18 45.48 Favored Glycine 0 CA--C 1.547 2.038 0 CA-C-O 119.203 -0.776 . . . . 0.39000000000000001 114.936 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 52.8 mtpt -122.03 147.44 46.08 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-N 118.378 1.089 . . . . 2.0299999999999998 112.656 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.99 145.31 29.45 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.46 1.281 . . . . 1.0800000000000001 114.46 -175.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.83 114.32 10.34 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.689 -1.142 . . . . 1.23 109.987 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.262 9.9 p -119.36 95.82 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.446 0 CA-C-O 121.287 0.565 . . . . 1.1899999999999999 111.357 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 67.88 -85.47 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 125.646 1.578 . . . . 1.8200000000000001 113.757 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.25 25.32 5.75 Favored Glycine 0 CA--C 1.543 1.813 0 CA-C-N 116.005 -0.543 . . . . 0.51000000000000001 112.999 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -125.27 141.18 52.24 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.856 0.862 . . . . 1.8200000000000001 111.376 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.6 p -130.7 124.85 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.132 0 CA-C-N 115.669 -0.696 . . . . 1.5900000000000001 110.896 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -150.69 179.86 7.84 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.247 -0.888 . . . . 1.1699999999999999 109.848 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.269 15.2 t -103.93 137.65 41.62 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 113.203 0.816 . . . . 1.71 113.203 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -81.82 122.9 28.29 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.112 0.965 . . . . 0.29999999999999999 111.66 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.95 91.4 3.2 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.707 0.632 . . . . 1.8700000000000001 112.707 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.58 -65.33 3.45 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 118.79 2.276 . . . . 0.91000000000000003 118.79 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.526 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -132.44 158.45 42.0 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.143 1.164 . . . . 1.6799999999999999 114.143 -176.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.526 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -108.26 138.83 43.88 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.242 -1.799 . . . . 1.3700000000000001 109.097 176.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.6 t -120.5 143.11 48.72 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.301 1.593 . . . . 0.94999999999999996 115.301 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.62 99.42 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.348 -0.982 . . . . 1.3799999999999999 108.348 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.79 128.37 56.38 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.631 -0.713 . . . . 1.6699999999999999 112.847 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -118.79 125.81 50.43 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-O 122.198 0.999 . . . . 2.2999999999999998 111.103 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.32 144.08 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 113.323 -1.762 . . . . 1.29 110.699 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.29 150.28 21.13 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 113.102 0.778 . . . . 2.6200000000000001 113.102 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.69 -32.97 6.31 Favored Glycine 0 CA--C 1.547 2.053 0 N-CA-C 115.937 1.135 . . . . 1.0600000000000001 115.937 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -123.5 -78.63 0.6 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.977 0.889 . . . . 3.1000000000000001 112.412 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -133.16 -44.35 0.85 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.113 0.565 . . . . 4.0800000000000001 112.132 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.437 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -94.88 158.08 15.64 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.462 1.105 . . . . 1.74 112.447 179.383 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.74 -166.58 0.1 OUTLIER Pre-proline 0 CA--C 1.576 1.97 0 CA-C-N 113.679 -1.601 . . . . 1.6799999999999999 108.334 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -62.51 -9.78 16.88 Favored 'Trans proline' 0 N--CA 1.523 3.217 0 CA-C-N 123.277 2.206 . . . . 2.8199999999999998 115.85 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.6 tttp 79.65 -76.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.639 1.976 . . . . 3.4100000000000001 114.013 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . 0.259 3.8 m -108.4 135.24 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-N 119.678 1.126 . . . . 1.3799999999999999 111.278 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.437 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.5 t -127.8 132.06 49.52 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 113.105 0.78 . . . . 1.75 113.105 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -119.45 49.83 1.31 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.212 2.301 . . . . 1.1299999999999999 117.212 -175.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.27 138.81 2.9 Favored 'General case' 0 N--CA 1.518 2.965 0 N-CA-C 117.039 2.237 . . . . 1.3999999999999999 117.039 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -154.69 101.99 2.35 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.476 -0.784 . . . . 0.26000000000000001 111.038 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 12' ' ' TRP 0.32 9.0 tt -111.97 121.7 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 CA-C-O 122.456 1.122 . . . . 1.1000000000000001 111.369 175.554 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -124.12 164.27 19.79 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.017 -1.447 . . . . 1.0600000000000001 110.74 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -121.73 159.21 27.09 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 118.225 2.676 . . . . 1.8300000000000001 118.225 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.85 -41.48 2.14 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-N 110.043 -3.253 . . . . 0.17000000000000001 118.998 174.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -177.44 154.73 1.03 Allowed 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 120.673 2.236 . . . . 1.05 113.425 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.14 -12.48 59.22 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 125.053 1.341 . . . . 0.98999999999999999 113.896 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.22 4.9 44.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.959 1.096 . . . . 0.55000000000000004 113.959 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.82 -16.22 14.37 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 114.065 1.135 . . . . 0.59999999999999998 114.065 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.581 2.146 0 C-N-CA 124.108 0.963 . . . . 1.1799999999999999 112.851 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.3 tp . . . . . 0 CA--C 1.566 1.577 0 N-CA-C 113.356 0.872 . . . . 1.0900000000000001 113.356 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.17 -23.38 62.16 Favored 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 125.863 1.665 . . . . 1.04 115.087 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.72 -10.35 53.87 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 113.668 0.988 . . . . 0.32000000000000001 113.668 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -106.07 -22.02 12.98 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.315 0.858 . . . . 2.2599999999999998 113.315 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -53.21 135.65 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 N-CA-C 115.288 1.588 . . . . 1.01 115.288 177.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.6 -31.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-N 115.335 -0.848 . . . . 1.0600000000000001 112.161 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -159.33 117.46 2.81 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.888 0.475 . . . . 0.67000000000000004 110.751 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.86 128.96 20.87 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.482 -0.761 . . . . 1.0800000000000001 112.15 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.76 138.68 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 CA-C-O 122.331 1.062 . . . . 1.6699999999999999 113.183 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -116.17 102.56 9.7 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 113.373 -1.74 . . . . 2.6400000000000001 106.725 171.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.87 103.87 5.26 Favored 'General case' 0 C--O 1.254 1.34 0 CA-C-O 122.21 1.005 . . . . 1.28 111.363 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.408 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 172.54 -57.22 0.16 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 113.153 -1.84 . . . . 0.70999999999999996 114.937 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.95 -121.96 5.0 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 119.773 -0.459 . . . . 0.87 113.506 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.62 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 46.0 mt-10 -165.05 117.81 1.21 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.598 0.759 . . . . 2.1200000000000001 110.809 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 49.35 110.14 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.959 0 N-CA-C 118.406 2.743 . . . . 1.5 118.406 178.045 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 70.3 t60 -140.95 132.46 26.96 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.026 0.751 . . . . 0.52000000000000002 113.026 177.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.272 9.8 p -105.95 116.04 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.881 0 CA-C-N 115.178 -0.919 . . . . 2.0699999999999998 109.531 176.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -87.62 160.94 17.97 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 114.684 -1.143 . . . . 1.8500000000000001 112.577 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -43.17 -32.05 0.55 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 N-CA-C 119.163 3.023 . . . . 1.3700000000000001 119.163 -175.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -88.37 -19.66 26.33 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 121.227 0.537 . . . . 0.56999999999999995 111.474 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.61 40.13 1.25 Allowed Glycine 0 C--N 1.354 1.551 0 C-N-CA 124.722 1.153 . . . . 0.37 114.009 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.7 mm -106.84 114.49 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-O 121.124 0.487 . . . . 1.25 110.088 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.8 t-160 -104.45 132.63 50.49 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 115.587 1.699 . . . . 1.71 115.587 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.62 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -92.84 143.83 25.88 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 114.733 -1.121 . . . . 3.1499999999999999 108.135 174.259 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 78.7 mtp180 -62.42 -105.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 116.9 2.185 . . . . 3.5099999999999998 116.9 -177.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 30' ' ' ARG . 7.0 ttmm 176.23 71.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.549 0.74 . . . . 2.8100000000000001 111.712 -177.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 56.98 61.68 6.47 Favored Pre-proline 0 N--CA 1.534 3.732 0 C-N-CA 124.196 0.998 . . . . 1.1699999999999999 113.677 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo . . . . . 0 CA--C 1.56 1.776 0 N-CA-C 120.154 3.098 . . . . 1.45 120.154 -174.509 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo . . . . . 0 N--CA 1.504 2.134 0 N-CA-C 117.048 1.903 . . . . 1.8600000000000001 117.048 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.65 143.12 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.201 0 CA-C-N 115.041 -0.981 . . . . 1.28 109.444 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.51 -23.52 46.26 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.463 1.653 . . . . 1.9299999999999999 115.463 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -106.27 20.81 18.4 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.917 1.08 . . . . 1.79 113.917 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.5 p -124.57 175.97 6.83 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.057 0.932 . . . . 1.49 112.913 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.62 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.2 m-20 -97.46 -174.8 0.4 Allowed Pre-proline 0 N--CA 1.507 2.377 0 N-CA-C 107.74 -1.208 . . . . 1.6799999999999999 107.74 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -70.16 -40.25 4.89 Favored 'Trans proline' 0 N--CA 1.518 2.946 0 CA-C-N 123.165 2.166 . . . . 1.1599999999999999 111.871 174.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -69.94 -50.98 36.6 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.266 -1.788 . . . . 2.04 111.982 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -75.93 -8.48 57.02 Favored 'General case' 0 CA--C 1.588 2.439 0 CA-C-N 114.789 -1.096 . . . . 1.6200000000000001 112.81 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.62 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 27.0 tt0 -72.42 -46.32 55.65 Favored 'General case' 0 C--N 1.378 1.835 0 C-N-CA 125.204 1.402 . . . . 2.4300000000000002 107.962 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.12 -41.68 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 C-N-CA 124.44 1.096 . . . . 1.46 110.417 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.93 -11.48 60.0 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.428 1.27 . . . . 1.6699999999999999 114.428 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -124.82 20.43 8.44 Favored 'General case' 0 CA--C 1.575 1.906 0 C-N-CA 123.332 0.653 . . . . 1.3300000000000001 112.494 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.581 HE21 HE21 ' A' ' 58' ' ' GLN . 0.0 OUTLIER -137.95 -27.82 0.89 Allowed 'General case' 0 N--CA 1.51 2.56 0 N-CA-C 115.876 1.806 . . . . 1.4099999999999999 115.876 -177.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.2 p -77.94 131.17 37.32 Favored 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 113.66 0.985 . . . . 1.28 113.66 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.408 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.6 pt-20 . . . . . 0 N--CA 1.505 2.284 0 N-CA-C 115.5 1.667 . . . . 1.53 115.5 -176.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 110.407 -0.22 . . . . 2.1499999999999999 110.407 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.648 ' H ' HD22 ' A' ' 164' ' ' ASN . 0.1 OUTLIER 74.8 80.86 0.11 Allowed 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 125.397 1.479 . . . . 1.25 109.895 -177.611 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -142.84 156.51 44.95 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.284 0.846 . . . . 1.1499999999999999 113.284 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.73 -161.16 12.48 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.28 -0.873 . . . . 0.59999999999999998 115.056 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.32 163.66 28.84 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.782 0.801 . . . . 1.4099999999999999 112.796 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -117.87 131.36 56.55 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.603 -1.18 . . . . 0.51000000000000001 112.791 -178.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -124.5 99.9 35.72 Favored Pre-proline 0 CA--C 1.566 1.588 0 C-N-CA 123.19 0.596 . . . . 1.0600000000000001 109.742 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.26 118.1 2.57 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.14 1.894 . . . . 0.17999999999999999 114.501 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.89 157.35 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 CA-C-O 122.063 0.935 . . . . 1.0600000000000001 111.369 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -144.97 16.15 1.56 Allowed 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.538 -1.21 . . . . 3.1099999999999999 111.954 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -128.29 162.47 26.96 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-O 121.334 0.588 . . . . 2.1200000000000001 111.754 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -120.95 148.8 43.59 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.665 0.987 . . . . 0.41999999999999998 113.665 -179.298 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.85 -134.16 3.9 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 113.981 -1.463 . . . . 0.25 111.839 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -121.99 106.66 11.42 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 118.335 1.067 . . . . 1.75 111.231 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.674 ' O ' HG13 ' A' ' 133' ' ' ILE . 36.2 m-85 -99.4 127.8 45.46 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.623 0.725 . . . . 0.90000000000000002 110.687 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.67 130.13 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 115.31 -0.859 . . . . 1.0700000000000001 111.848 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 mp -107.62 110.26 22.1 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.376 -1.283 . . . . 1.47 110.325 177.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.8 105.52 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.601 -1.259 . . . . 1.27 107.601 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.18 134.97 53.41 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.896 -0.593 . . . . 1.8899999999999999 112.314 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -104.31 116.01 31.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.806 0.813 . . . . 2.8999999999999999 111.343 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.67 134.04 48.5 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.067 -1.424 . . . . 0.48999999999999999 110.256 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.97 153.52 45.63 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.745 -0.661 . . . . 1.1000000000000001 111.627 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -139.54 131.58 27.92 Favored 'General case' 0 C--N 1.363 1.175 0 CA-C-N 116.031 -0.532 . . . . 2.6099999999999999 112.221 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.571 ' H ' ' HZ3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -140.96 63.2 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 115.962 -0.563 . . . . 2.6099999999999999 111.75 179.213 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -162.65 -49.5 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.562 0.579 . . . . 2.71 112.562 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.79 130.84 56.92 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.051 0.453 . . . . 1.6899999999999999 112.212 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.29 96.11 5.93 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.339 1.066 . . . . 1.4299999999999999 111.016 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -162.31 146.65 12.18 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.148 -0.933 . . . . 2.9700000000000002 112.21 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.1 p -122.19 121.22 36.35 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.481 -0.782 . . . . 1.6599999999999999 111.903 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 75.12 57.26 0.07 Allowed 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 125.893 1.677 . . . . 2.02 112.543 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -156.71 -43.62 0.07 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.284 -1.326 . . . . 2.5600000000000001 108.983 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -105.41 83.89 2.02 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-O 121.794 0.807 . . . . 3.1499999999999999 108.98 176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.06 129.95 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 114.754 -1.112 . . . . 1.3600000000000001 111.63 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -114.37 170.99 7.89 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.065 1.505 . . . . 0.84999999999999998 115.065 -176.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.37 137.73 54.76 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.359 0.6 . . . . 1.3300000000000001 112.337 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -134.18 129.27 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.406 0 CA-C-N 115.34 -0.846 . . . . 1.1699999999999999 110.236 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.64 147.92 51.49 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 114.536 1.31 . . . . 1.9399999999999999 114.536 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.79 110.27 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 C-N-CA 123.73 0.812 . . . . 1.29 112.93 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.83 26.64 14.39 Favored 'General case' 0 N--CA 1.523 3.181 0 C-N-CA 126.614 1.966 . . . . 1.8200000000000001 113.618 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.93 -20.06 39.51 Favored Glycine 0 CA--C 1.547 2.07 0 CA-C-N 116.344 -0.389 . . . . 0.32000000000000001 113.676 -176.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -83.24 139.04 33.34 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.417 1.487 . . . . 0.56999999999999995 113.673 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.57 129.73 44.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.603 0.715 . . . . 1.1899999999999999 112.43 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.19 -54.41 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 114.501 -1.227 . . . . 1.73 113.355 -178.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.57 88.87 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.878 -0.786 . . . . 1.25 108.878 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -112.29 75.57 0.93 Allowed 'General case' 0 C--N 1.356 0.853 0 CA-C-O 123.709 1.718 . . . . 2.75 112.147 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 157.26 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 110.238 -3.165 . . . . 2.48 108.216 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.72 97.88 11.06 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 113.702 1.001 . . . . 1.78 113.702 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -113.52 96.54 5.93 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 113.073 -1.876 . . . . 2.3500000000000001 107.509 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.22 -26.06 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.56 0 N-CA-C 114.632 1.345 . . . . 1.27 114.632 -176.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -75.71 -39.8 56.75 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.576 0.75 . . . . 0.83999999999999997 112.003 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -74.03 -26.35 60.37 Favored 'General case' 0 CA--C 1.577 1.989 0 C-N-CA 124.776 1.23 . . . . 0.91000000000000003 113.17 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -77.98 -56.37 4.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.651 0.982 . . . . 2.98 113.651 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.76 -37.21 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 114.541 1.311 . . . . 1.53 114.541 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.76 -107.62 0.92 Allowed Glycine 0 C--N 1.354 1.528 0 CA-C-N 118.465 0.575 . . . . 0.84999999999999998 113.426 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -114.95 107.07 14.9 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.588 0.355 . . . . 3.9700000000000002 110.919 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.1 m 66.69 -127.89 0.21 Allowed 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 125.392 1.477 . . . . 2.0800000000000001 112.92 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 43.5 p 58.6 -163.32 0.21 Allowed 'General case' 0 N--CA 1.526 3.363 0 C-N-CA 126.365 1.866 . . . . 1.22 115.375 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -109.75 130.19 55.54 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.293 0.637 . . . . 1.2 112.69 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -104.44 135.57 45.62 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.436 -0.579 . . . . 0.41999999999999998 109.436 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -129.95 128.42 42.08 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.494 1.294 . . . . 2.5 114.494 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -115.01 118.03 32.27 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 114.699 -1.137 . . . . 1.5800000000000001 110.279 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 114.84 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 114.798 -1.092 . . . . 1.25 110.816 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.13 93.12 42.36 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-N 114.928 -1.033 . . . . 1.5 109.994 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -82.82 136.18 8.12 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.577 2.185 . . . . 0.22 113.27 176.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -120.95 149.93 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.626 0.727 . . . . 1.1200000000000001 112.228 -179.52 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.1 t -126.1 113.35 16.95 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.079 -0.964 . . . . 1.8600000000000001 110.959 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.9 mt -110.94 122.99 66.42 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.605 0 CA-C-N 114.237 -1.347 . . . . 1.0700000000000001 108.436 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -139.21 126.28 21.16 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.955 -0.566 . . . . 2.6400000000000001 111.068 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? 67.39 17.26 10.12 Favored 'General case' 0 N--CA 1.516 2.843 0 C-N-CA 125.312 1.445 . . . . 4.0199999999999996 114.324 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.64 12.68 46.73 Favored Glycine 0 CA--C 1.547 2.041 0 CA-C-O 119.147 -0.807 . . . . 0.39000000000000001 114.893 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 27.2 mtmt -123.06 148.97 45.01 Favored 'General case' 0 C--N 1.365 1.268 0 CA-C-N 118.35 1.075 . . . . 2.0299999999999998 112.432 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.19 144.93 30.68 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.635 1.346 . . . . 1.0800000000000001 114.635 -175.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.51 109.09 8.48 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.903 -1.044 . . . . 1.23 110.445 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.29 92.57 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.627 0 CA-C-N 115.808 -0.633 . . . . 1.1899999999999999 109.864 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 66.24 -82.1 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.784 0 C-N-CA 125.26 1.424 . . . . 1.8200000000000001 113.836 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.08 25.03 4.17 Favored Glycine 0 CA--C 1.545 1.969 0 CA-C-N 116.073 -0.512 . . . . 0.51000000000000001 113.869 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -130.48 118.42 21.1 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 117.339 0.569 . . . . 1.8200000000000001 110.053 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.1 p -105.91 131.45 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.32 0 CA-C-O 121.721 0.772 . . . . 1.5900000000000001 112.479 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 m -151.9 -178.69 6.9 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.776 -1.102 . . . . 1.1699999999999999 109.624 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.261 12.8 t -103.04 139.11 39.01 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 113.57 0.952 . . . . 1.71 113.57 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -80.83 123.89 28.63 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 124.534 1.134 . . . . 0.29999999999999999 111.427 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.47 90.49 3.23 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.647 0.61 . . . . 1.8700000000000001 112.647 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.69 -61.75 2.43 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 119.412 2.525 . . . . 0.91000000000000003 119.412 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.492 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -135.92 157.26 47.28 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.254 1.205 . . . . 1.6799999999999999 114.254 -176.14 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.492 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 1.0 OUTLIER -103.61 140.05 38.08 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 113.527 -1.67 . . . . 1.3700000000000001 109.598 176.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.4 t -122.02 132.25 54.42 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.306 1.225 . . . . 0.94999999999999996 114.306 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.41 97.55 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.021 -1.844 . . . . 1.3799999999999999 106.021 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.0 132.43 56.71 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.311 -1.313 . . . . 1.6699999999999999 113.001 -176.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.83 135.93 54.92 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-O 122.448 1.118 . . . . 2.2999999999999998 111.735 177.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.16 143.58 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-N 112.484 -2.144 . . . . 1.29 110.325 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 150.11 26.13 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.509 1.3 . . . . 2.6200000000000001 114.509 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.32 -47.01 1.17 Allowed Glycine 0 CA--C 1.543 1.84 0 CA-C-N 115.196 -0.911 . . . . 1.0600000000000001 114.035 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.3 -61.07 1.17 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.9 0.48 . . . . 3.1000000000000001 111.933 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -129.35 -43.57 1.28 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.757 0.651 . . . . 4.0800000000000001 112.757 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -107.92 173.81 6.16 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.509 0.724 . . . . 1.74 112.454 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.648 HD22 ' H ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -132.07 -58.27 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 CA-C-N 115.975 -0.557 . . . . 1.6799999999999999 109.994 178.638 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -101.56 -55.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.089 1.859 . . . . 2.8199999999999998 115.906 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.571 ' HZ3' ' H ' ' A' ' 92' ' ' VAL . 30.4 tttm 81.56 -90.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 127.076 2.15 . . . . 3.4100000000000001 109.616 -176.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.89 129.11 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 106.976 -1.491 . . . . 1.3799999999999999 106.976 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.01 123.28 19.36 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 112.98 0.733 . . . . 1.75 112.98 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -116.76 49.67 1.14 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.637 1.575 . . . . 1.1299999999999999 113.922 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.9 tp -61.47 102.23 0.23 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 122.653 1.216 . . . . 1.3999999999999999 113.576 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -113.78 100.56 8.55 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 112.556 -2.111 . . . . 0.26000000000000001 110.008 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.32 15.8 tt -108.34 121.78 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.155 0 CA-C-O 122.942 1.353 . . . . 1.1000000000000001 111.945 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -121.09 170.47 9.51 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 113.291 -1.777 . . . . 1.0600000000000001 111.284 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -123.23 158.5 30.73 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 118.45 2.759 . . . . 1.8300000000000001 118.45 -176.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.72 -41.95 2.01 Favored Glycine 0 CA--C 1.541 1.688 0 CA-C-N 110.465 -3.061 . . . . 0.17000000000000001 119.208 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.21 157.02 1.31 Allowed 'General case' 0 N--CA 1.515 2.816 0 CA-C-N 120.449 2.125 . . . . 1.05 112.942 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.03 -13.54 59.84 Favored 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 124.917 1.287 . . . . 0.98999999999999999 114.366 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.97 3.52 48.39 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 113.954 1.094 . . . . 0.55000000000000004 113.954 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.88 -7.6 17.02 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 113.815 1.043 . . . . 0.59999999999999998 113.815 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.544 0 C-N-CA 124.012 0.925 . . . . 1.1799999999999999 112.804 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.1 tp . . . . . 0 CA--C 1.565 1.546 0 N-CA-C 113.454 0.909 . . . . 1.0900000000000001 113.454 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.33 63.48 Favored 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 125.766 1.626 . . . . 1.04 115.105 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.06 -11.63 49.71 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 113.577 0.954 . . . . 0.32000000000000001 113.577 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -104.15 -23.9 13.23 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 113.298 0.851 . . . . 2.2599999999999998 113.298 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.62 134.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 115.166 1.543 . . . . 1.01 115.166 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -121.83 -29.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 115.354 -0.839 . . . . 1.0600000000000001 112.345 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.515 ' O ' HG23 ' A' ' 172' ' ' ILE . 70.8 t90 -161.43 116.9 2.09 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 117.698 0.226 . . . . 0.67000000000000004 111.502 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.42 135.08 31.68 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.258 -0.901 . . . . 1.0800000000000001 112.503 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 170' ' ' LEU 0.25 11.3 p -149.35 142.91 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 N-CA-C 113.756 1.021 . . . . 1.6699999999999999 113.756 178.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -116.02 117.96 31.56 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.198 -1.408 . . . . 2.6400000000000001 107.198 173.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -81.73 97.09 7.78 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-O 121.784 0.802 . . . . 1.28 111.251 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.554 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 173.4 -37.67 0.13 Allowed Glycine 0 C--N 1.353 1.486 0 CA-C-N 114.102 -1.408 . . . . 0.70999999999999996 116.541 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -135.65 -125.6 2.51 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 117.873 0.837 . . . . 0.87 114.318 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.518 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 34.8 mt-10 -150.13 116.34 5.7 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.812 0.445 . . . . 2.1200000000000001 111.701 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.703 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.2 m 31.69 124.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.121 0 N-CA-C 121.036 3.717 . . . . 1.5 121.036 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.415 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 23.3 t60 -149.89 148.51 29.22 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.853 0.835 . . . . 0.52000000000000002 112.092 176.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.2 126.6 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 114.916 -1.038 . . . . 2.0699999999999998 111.615 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -85.27 155.73 21.25 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 114.024 -1.443 . . . . 1.8500000000000001 110.234 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.5 m -44.8 -23.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 N-CA-C 118.943 2.942 . . . . 1.3700000000000001 118.943 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -95.57 -18.43 20.6 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 122.874 0.47 . . . . 0.56999999999999995 111.051 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.85 41.06 1.23 Allowed Glycine 0 C--N 1.356 1.668 0 C-N-CA 124.643 1.116 . . . . 0.37 114.462 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.2 mm -106.06 120.5 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 N-CA-C 109.516 -0.55 . . . . 1.25 109.516 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -102.25 129.18 48.59 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.256 1.206 . . . . 1.71 114.256 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.703 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.3 142.36 27.79 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.299 -0.864 . . . . 3.1499999999999999 110.596 177.024 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -88.12 168.43 12.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 115.662 1.727 . . . . 3.5099999999999998 115.662 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -98.91 100.25 11.41 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.19 1.552 . . . . 2.8100000000000001 115.19 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 36.73 62.46 3.11 Favored Pre-proline 1 N--CA 1.542 4.134 0 N-CA-C 115.85 1.796 . . . . 1.1699999999999999 115.85 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo . . . . . 0 CA--C 1.564 2.016 0 N-CA-C 119.591 2.881 . . . . 1.45 119.591 -175.537 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . 95.6 Cg_endo . . . . . 0 N--CA 1.498 1.759 0 N-CA-C 116.335 1.629 . . . . 1.8600000000000001 116.335 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 61' ' ' TYR 0.251 1.2 mp -89.74 135.64 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.823 0 C-N-CA 124.037 0.935 . . . . 1.28 111.711 -178.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 5.1 mt -104.84 101.93 11.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.901 -1.045 . . . . 1.9299999999999999 111.305 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER 150.12 -22.1 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.205 1.802 . . . . 1.79 110.891 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.421 ' OG ' ' HD2' ' A' ' 61' ' ' TYR . 2.3 t -101.27 -160.85 0.82 Allowed 'General case' 0 CA--C 1.575 1.929 0 C-N-CA 123.555 0.742 . . . . 1.49 113.0 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -95.51 170.32 7.95 Favored Pre-proline 0 CA--C 1.573 1.838 0 C-N-CA 124.736 1.214 . . . . 1.6799999999999999 112.569 -179.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -71.98 -34.82 7.99 Favored 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 123.25 2.633 . . . . 1.1599999999999999 112.835 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -85.25 -36.36 20.97 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.517 -1.22 . . . . 2.04 112.703 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.22 1.59 56.31 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.737 1.384 . . . . 1.6200000000000001 114.737 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.556 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 3.5 pt20 -71.19 -24.4 62.22 Favored 'General case' 0 C--N 1.381 1.945 0 O-C-N 121.822 -0.549 . . . . 2.4300000000000002 110.369 175.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.35 -47.29 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.872 0 C-N-CA 125.957 1.703 . . . . 1.46 108.853 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.1 tp -73.99 -12.85 60.76 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 113.435 0.902 . . . . 1.6699999999999999 113.435 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.425 ' O ' HG12 ' A' ' 50' ' ' ILE . 26.4 m-85 -122.47 20.53 10.37 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 113.557 0.947 . . . . 1.3300000000000001 113.557 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.556 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 12.1 tt0 -141.35 -36.48 0.44 Allowed 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 115.474 1.657 . . . . 1.4099999999999999 115.474 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.2 p -67.81 134.69 51.38 Favored 'General case' 0 N--CA 1.528 3.449 0 N-CA-C 115.272 1.582 . . . . 1.28 115.272 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.554 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 5.8 pt-20 . . . . . 0 N--CA 1.505 2.285 0 C-N-CA 124.195 0.998 . . . . 1.53 112.479 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.427 0.156 . . . . 2.1499999999999999 111.334 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.24 85.01 0.09 Allowed 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 125.555 1.542 . . . . 1.25 114.397 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -143.52 152.94 42.08 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.531 0.682 . . . . 1.1499999999999999 112.242 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.24 -153.21 7.44 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 115.653 1.021 . . . . 0.59999999999999998 115.653 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.79 166.62 22.22 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 115.037 1.495 . . . . 1.4099999999999999 115.037 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.93 119.32 27.43 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.585 -1.643 . . . . 0.51000000000000001 111.144 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.48 100.36 53.49 Favored Pre-proline 0 CA--C 1.568 1.645 0 N-CA-C 109.581 -0.526 . . . . 1.0600000000000001 109.581 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -82.93 116.66 2.5 Favored 'Trans proline' 0 CA--C 1.563 1.926 0 C-N-CA 122.25 1.967 . . . . 0.17999999999999999 115.103 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.6 157.46 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.926 0.869 . . . . 1.0600000000000001 111.038 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -143.27 24.01 1.8 Allowed 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 114.648 -1.16 . . . . 3.1099999999999999 112.084 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -127.84 157.36 40.67 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 121.347 0.594 . . . . 2.1200000000000001 111.134 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.73 136.65 53.22 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.713 1.005 . . . . 0.41999999999999998 113.713 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 166.55 -140.17 6.18 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 113.962 -1.472 . . . . 0.25 112.569 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 23.8 mt-10 -112.36 109.02 18.4 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-N 118.473 1.136 . . . . 1.75 111.627 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -103.52 129.77 50.77 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.048 0.451 . . . . 0.90000000000000002 110.521 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.69 121.72 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.864 0.84 . . . . 1.0700000000000001 110.795 -176.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.0 105.59 17.28 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 113.931 -1.486 . . . . 1.47 109.572 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -111.9 124.96 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.8 -0.815 . . . . 1.27 108.8 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.94 140.2 43.82 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 112.735 0.643 . . . . 1.8899999999999999 112.735 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.87 120.39 40.52 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.039 -0.982 . . . . 2.8999999999999999 110.133 177.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -105.82 133.27 50.83 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.106 -0.497 . . . . 0.48999999999999999 110.392 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.37 152.32 50.51 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 112.549 0.574 . . . . 1.1000000000000001 112.549 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -138.71 119.64 14.35 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 123.662 0.785 . . . . 2.6099999999999999 111.102 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.18 65.33 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 112.597 0.592 . . . . 2.6099999999999999 112.597 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -171.3 -37.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 112.982 0.734 . . . . 2.71 112.982 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -115.94 130.81 56.98 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.226 0.454 . . . . 1.6899999999999999 112.226 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.27 96.93 6.42 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.43 1.11 . . . . 1.4299999999999999 111.474 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.4 ' NE2' ' NE2' ' A' ' 99' ' ' GLN . 3.4 pt20 -165.37 141.43 5.38 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 114.968 -1.014 . . . . 2.9700000000000002 112.323 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.5 m -122.41 124.93 44.79 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.382 -0.826 . . . . 1.6599999999999999 112.436 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 72.59 54.95 0.15 Allowed 'General case' 0 N--CA 1.514 2.725 0 C-N-CA 125.713 1.605 . . . . 2.02 112.523 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.4 ' NE2' ' NE2' ' A' ' 96' ' ' GLN . 4.4 tt0 -157.31 -38.43 0.07 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.803 -1.089 . . . . 2.5600000000000001 109.974 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -106.9 81.79 1.61 Allowed 'General case' 0 C--N 1.362 1.152 0 N-CA-C 108.384 -0.969 . . . . 3.1499999999999999 108.384 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.88 122.76 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 114.331 -1.304 . . . . 1.3600000000000001 111.306 -177.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -106.57 175.73 5.4 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 115.572 1.693 . . . . 0.84999999999999998 115.572 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -126.03 137.27 53.64 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.343 0.592 . . . . 1.3300000000000001 110.941 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.21 123.76 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.511 0 CA-C-N 115.237 -0.892 . . . . 1.1699999999999999 109.366 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.639 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 26.3 mtt180 -123.26 148.64 45.68 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.981 1.475 . . . . 1.9399999999999999 114.981 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 6.4 m -123.81 107.8 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 N-CA-C 113.437 0.903 . . . . 1.29 113.437 177.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.59 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.9 t30 63.81 27.32 14.56 Favored 'General case' 0 N--CA 1.519 2.988 0 C-N-CA 126.845 2.058 . . . . 1.8200000000000001 114.456 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.87 -14.86 45.06 Favored Glycine 0 CA--C 1.55 2.264 0 CA-C-N 115.574 -0.739 . . . . 0.32000000000000001 113.612 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.639 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 94.6 m-70 -87.49 171.15 10.74 Favored 'General case' 0 C--N 1.361 1.088 0 C-N-CA 125.953 1.701 . . . . 0.56999999999999995 113.166 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.01 132.72 54.67 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.546 0.689 . . . . 1.1899999999999999 112.015 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.61 -58.96 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.82 -1.082 . . . . 1.73 113.324 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.22 89.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.627 -0.879 . . . . 1.25 108.627 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -106.97 101.51 10.93 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 122.881 1.324 . . . . 2.75 110.283 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 114.25 74.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 110.542 -3.026 . . . . 2.48 108.898 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.2 105.8 18.01 Favored 'General case' 0 C--N 1.361 1.084 0 CA-C-O 121.612 0.72 . . . . 1.78 112.593 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -115.07 97.4 6.19 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 106.678 -1.601 . . . . 2.3500000000000001 106.678 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.06 -26.77 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.479 0 N-CA-C 114.028 1.122 . . . . 1.27 114.028 -176.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -76.22 -38.83 55.93 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.629 0.771 . . . . 0.83999999999999997 112.095 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -72.95 -26.74 61.48 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.847 1.259 . . . . 0.91000000000000003 113.296 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -80.5 -56.25 4.3 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.767 1.025 . . . . 2.98 113.767 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.73 -36.04 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 N-CA-C 114.592 1.33 . . . . 1.53 114.592 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.2 -110.04 1.37 Allowed Glycine 0 C--N 1.354 1.581 0 CA-C-N 118.35 0.523 . . . . 0.84999999999999998 113.417 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -114.84 107.46 15.45 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.841 0.353 . . . . 3.9700000000000002 110.243 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 69.42 -133.69 0.07 Allowed 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 125.345 1.458 . . . . 2.0800000000000001 112.614 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.3 p 62.15 -163.38 0.26 Allowed 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 126.222 1.809 . . . . 1.22 114.578 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.8 130.94 56.4 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 112.899 0.703 . . . . 1.2 112.899 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -101.66 147.21 26.71 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.262 -0.644 . . . . 0.41999999999999998 109.262 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.6 124.68 25.79 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.994 1.479 . . . . 2.5 114.994 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -124.18 121.91 36.38 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 115.247 -0.888 . . . . 1.5800000000000001 110.305 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.83 128.48 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 114.27 -1.332 . . . . 1.25 111.545 -178.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.21 93.77 19.03 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-N 115.637 -0.711 . . . . 1.5 111.187 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -76.55 133.3 14.19 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 122.672 2.248 . . . . 0.22 113.103 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.62 148.81 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.592 0 CA-C-N 115.553 -0.749 . . . . 1.1200000000000001 111.474 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.8 p -130.52 107.16 9.01 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.392 -0.822 . . . . 1.8600000000000001 111.82 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 mt -109.65 121.71 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 N-CA-C 108.518 -0.919 . . . . 1.0700000000000001 108.518 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -143.1 130.72 21.29 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.681 -0.69 . . . . 2.6400000000000001 110.964 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp 69.8 7.87 6.44 Favored 'General case' 0 N--CA 1.519 3.016 0 N-CA-C 114.684 1.364 . . . . 4.0199999999999996 114.684 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.14 22.22 13.63 Favored Glycine 0 CA--C 1.548 2.128 0 C-N-CA 123.633 0.635 . . . . 0.39000000000000001 113.802 -177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -130.52 144.83 51.66 Favored 'General case' 0 C--N 1.366 1.299 0 CA-C-N 117.548 0.674 . . . . 2.0299999999999998 112.128 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.75 141.11 32.99 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.912 1.078 . . . . 1.0800000000000001 113.912 -177.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.0 m -130.97 115.36 16.4 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.664 -1.153 . . . . 1.23 110.656 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.45 95.14 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.372 0 CA-C-O 121.101 0.477 . . . . 1.1899999999999999 110.728 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 67.26 -85.24 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 125.546 1.538 . . . . 1.8200000000000001 113.558 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.36 27.74 4.41 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.011 -0.541 . . . . 0.51000000000000001 113.404 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -131.38 128.4 39.52 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.444 0.698 . . . . 1.8200000000000001 110.77 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.8 p -118.29 130.01 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.343 0 CA-C-O 121.333 0.587 . . . . 1.5900000000000001 111.185 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.8 m -149.85 -170.63 3.69 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.487 -0.778 . . . . 1.1699999999999999 110.446 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 11.4 t -101.76 141.42 34.65 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 112.792 0.664 . . . . 1.71 112.792 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -87.91 132.63 34.14 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.985 0.898 . . . . 0.29999999999999999 111.815 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.9 p -97.34 -164.3 1.13 Allowed 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 114.046 -1.433 . . . . 1.8700000000000001 109.395 177.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.59 7.52 68.79 Favored Glycine 0 CA--C 1.56 2.876 0 N-CA-C 116.937 1.535 . . . . 0.91000000000000003 116.937 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -160.11 152.53 20.86 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-O 121.7 0.762 . . . . 1.6799999999999999 111.421 178.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.59 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -109.3 136.09 49.32 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.307 -1.315 . . . . 1.3700000000000001 109.236 177.405 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.5 t -117.82 144.11 45.67 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.671 1.73 . . . . 0.94999999999999996 115.671 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.1 t -118.44 97.58 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.087 -1.82 . . . . 1.3799999999999999 106.087 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -114.12 121.48 43.93 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 115.905 -0.589 . . . . 1.6699999999999999 112.46 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.73 132.1 56.55 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-O 122.062 0.934 . . . . 2.2999999999999998 111.238 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 14.0 t -107.25 143.74 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.991 0 CA-C-N 113.341 -1.754 . . . . 1.29 110.01 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 163' ' ' ASP . 34.4 ttpt -71.49 149.98 45.3 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.939 1.696 . . . . 2.6200000000000001 114.665 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.1 -55.26 0.73 Allowed Glycine 0 CA--C 1.542 1.778 0 CA-C-N 115.26 -0.882 . . . . 1.0600000000000001 114.378 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -130.18 -71.34 0.6 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.301 0.551 . . . . 3.1000000000000001 112.306 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.36 -44.7 2.66 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.513 0.561 . . . . 4.0800000000000001 112.513 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' ' 159' ' ' LYS . 0.8 OUTLIER -98.99 171.24 8.17 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.773 0.829 . . . . 1.74 111.46 178.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . 0.285 56.7 t-20 -125.75 -93.15 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.451 0 CA-C-O 116.715 -1.612 . . . . 1.6799999999999999 109.993 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -87.1 -36.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.389 2.686 0 CA-C-N 124.851 2.768 . . . . 2.8199999999999998 114.757 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.2 tptm 80.29 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 126.2 1.8 . . . . 3.4100000000000001 110.543 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 36.2 t -115.2 131.5 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.358 -1.349 . . . . 1.3799999999999999 107.358 175.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.1 t -136.21 124.96 23.87 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.489 -0.778 . . . . 1.75 112.196 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -115.27 51.46 0.92 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 116.366 1.988 . . . . 1.1299999999999999 116.366 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 2.8 mm? -43.65 131.54 5.19 Favored 'General case' 0 N--CA 1.519 2.999 0 N-CA-C 116.368 1.988 . . . . 1.3999999999999999 116.368 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -154.45 104.04 2.54 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.825 -0.625 . . . . 0.26000000000000001 110.283 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 12' ' ' TRP 0.307 6.2 tt -114.47 123.11 69.83 Favored 'Isoleucine or valine' 0 C--O 1.268 2.064 0 CA-C-O 122.125 0.964 . . . . 1.1000000000000001 111.825 176.076 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -119.53 168.19 11.24 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.191 -1.368 . . . . 1.0600000000000001 112.17 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -118.48 146.42 44.52 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 118.06 2.615 . . . . 1.8300000000000001 118.06 -173.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.69 -41.02 2.26 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-N 110.605 -2.998 . . . . 0.17000000000000001 120.264 172.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.45 159.5 1.95 Allowed 'General case' 0 N--CA 1.517 2.904 0 CA-C-N 120.951 2.375 . . . . 1.05 113.239 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -77.73 -14.17 59.68 Favored 'General case' 0 CA--C 1.582 2.185 0 C-N-CA 124.784 1.234 . . . . 0.98999999999999999 114.227 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.02 2.6 51.43 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 113.957 1.095 . . . . 0.55000000000000004 113.957 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.8 -8.73 21.42 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.761 1.023 . . . . 0.59999999999999998 113.761 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.386 0 C-N-CA 124.035 0.934 . . . . 1.1799999999999999 112.576 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.2 tp . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 112.116 0.413 . . . . 1.0900000000000001 112.116 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.05 -22.91 67.18 Favored 'General case' 0 CA--C 1.583 2.248 0 C-N-CA 125.663 1.585 . . . . 1.04 114.029 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.9 -11.9 49.32 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 113.606 0.965 . . . . 0.32000000000000001 113.606 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 31.2 mttm -108.16 -19.33 13.52 Favored 'General case' 0 C--N 1.364 1.233 0 N-CA-C 113.716 1.006 . . . . 2.2599999999999998 113.716 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.32 136.65 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.866 0 N-CA-C 114.967 1.469 . . . . 1.01 114.967 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.76 -31.33 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 115.295 -0.866 . . . . 1.0600000000000001 111.998 178.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -161.05 119.53 2.47 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 111.954 0.353 . . . . 0.67000000000000004 111.954 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.81 129.66 24.72 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.673 -0.642 . . . . 1.0800000000000001 111.366 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.61 140.75 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.764 0.793 . . . . 1.6699999999999999 112.524 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -114.43 110.24 19.55 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 106.599 -1.63 . . . . 2.6400000000000001 106.599 172.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.53 94.63 3.18 Favored 'General case' 0 C--O 1.274 2.386 0 CA-C-O 122.217 1.008 . . . . 1.28 110.859 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.445 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 159.27 -0.08 0.08 OUTLIER Glycine 0 C--N 1.362 2.008 0 CA-C-N 110.943 -2.844 . . . . 0.70999999999999996 117.983 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.52 -136.22 1.97 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-N 120.635 2.218 . . . . 0.87 117.273 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -129.09 134.75 48.21 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 113.861 -1.17 . . . . 2.1200000000000001 111.218 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.6 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 26.2 m -14.14 122.28 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.958 0 N-CA-C 119.556 3.169 . . . . 1.5 119.556 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -140.83 141.91 34.65 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.132 0.968 . . . . 0.52000000000000002 112.446 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.259 10.0 p -106.01 119.4 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 CA-C-N 114.063 -1.426 . . . . 2.0699999999999998 110.36 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -86.72 169.04 13.0 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 114.77 -1.105 . . . . 1.8500000000000001 113.451 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -39.61 -52.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 C-N-CA 129.222 3.009 . . . . 1.3700000000000001 117.458 -174.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -75.82 -20.59 58.05 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 112.888 0.699 . . . . 0.56999999999999995 112.888 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.8 44.36 0.76 Allowed Glycine 0 C--N 1.355 1.625 0 N-CA-C 115.194 0.838 . . . . 0.37 115.194 176.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 mm -108.51 125.12 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 N-CA-C 110.088 -0.338 . . . . 1.25 110.088 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -108.35 128.09 54.46 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 114.461 1.282 . . . . 1.71 114.461 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.6 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -94.24 150.1 20.62 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 124.419 1.088 . . . . 3.1499999999999999 110.604 177.366 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -105.88 147.3 28.88 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.574 1.324 . . . . 3.5099999999999998 114.574 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -68.76 108.44 3.42 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 117.535 2.42 . . . . 2.8100000000000001 117.535 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.417 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 0.6 OUTLIER 39.85 54.42 5.9 Favored Pre-proline 0 N--CA 1.525 3.316 0 N-CA-C 118.767 2.877 . . . . 1.1699999999999999 118.767 175.077 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 0.5 OUTLIER . . . . . 0 CA--C 1.566 2.113 0 C-N-CA 123.014 2.476 . . . . 1.45 116.174 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 N--CA 1.509 2.409 0 N-CA-C 116.317 1.622 . . . . 1.8600000000000001 116.317 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.295 1.2 mp -86.84 121.05 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-O 121.818 0.818 . . . . 1.28 109.866 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 mt -76.67 -14.47 59.96 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.191 2.293 . . . . 1.9299999999999999 117.191 -175.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -99.96 15.73 26.2 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.151 0.797 . . . . 1.79 113.151 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 t -132.31 -159.58 0.98 Allowed 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 121.659 0.742 . . . . 1.49 111.773 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.11 168.75 9.72 Favored Pre-proline 0 CA--C 1.569 1.706 0 C-N-CA 125.11 1.364 . . . . 1.6799999999999999 113.077 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -72.58 -30.29 12.25 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 123.266 2.644 . . . . 1.1599999999999999 113.34 176.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -85.32 -38.54 18.68 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.685 1.194 . . . . 2.04 112.272 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.39 1.83 56.84 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 114.574 1.324 . . . . 1.6200000000000001 114.574 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -68.36 -30.11 68.98 Favored 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 123.964 0.906 . . . . 2.4300000000000002 110.999 176.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.37 -48.17 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.035 0 C-N-CA 126.03 1.732 . . . . 1.46 109.054 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.6 tp -71.54 -13.34 61.77 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 113.952 1.093 . . . . 1.6699999999999999 113.952 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -123.23 21.69 9.56 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 113.233 0.827 . . . . 1.3300000000000001 113.233 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.5 -32.72 0.49 Allowed 'General case' 0 N--CA 1.513 2.679 0 N-CA-C 116.03 1.863 . . . . 1.4099999999999999 116.03 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.8 p -70.98 136.68 48.55 Favored 'General case' 0 N--CA 1.535 3.807 0 N-CA-C 115.008 1.485 . . . . 1.28 115.008 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.445 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.3 pt-20 . . . . . 0 N--CA 1.508 2.438 0 N-CA-C 115.662 1.726 . . . . 1.53 115.662 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.435 0.636 . . . . 2.1499999999999999 111.527 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 1.6 t -88.51 97.83 11.3 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.18 0.992 . . . . 1.25 108.477 175.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -136.75 146.11 45.4 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.181 1.178 . . . . 1.1499999999999999 114.181 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.04 -173.07 38.53 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 114.262 -1.335 . . . . 0.59999999999999998 115.325 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.55 162.63 12.88 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.599 1.333 . . . . 1.4099999999999999 114.599 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -120.98 124.74 45.62 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.181 -1.372 . . . . 0.51000000000000001 110.825 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.07 101.87 54.35 Favored Pre-proline 0 CA--C 1.564 1.514 0 CA-C-N 115.487 -0.779 . . . . 1.0600000000000001 110.305 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.41 122.67 3.68 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 121.831 1.687 . . . . 0.17999999999999999 114.862 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.42 163.45 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-N 114.986 -1.006 . . . . 1.0600000000000001 110.899 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -151.82 24.51 0.67 Allowed 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 114.534 -1.212 . . . . 3.1099999999999999 111.666 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -133.24 156.85 46.79 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 123.09 0.556 . . . . 2.1200000000000001 111.111 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.5 OUTLIER -118.06 145.39 44.86 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.523 0.934 . . . . 0.41999999999999998 113.523 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.44 -136.48 4.43 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.189 -1.369 . . . . 0.25 112.191 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 38.3 mm-40 -116.91 106.67 13.7 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 118.292 1.046 . . . . 1.75 110.927 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -100.99 132.19 46.52 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.295 0.569 . . . . 0.90000000000000002 110.994 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.7 122.98 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 121.709 0.766 . . . . 1.0700000000000001 110.947 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.66 106.11 16.52 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.063 -1.426 . . . . 1.47 109.885 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.39 122.67 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.625 -0.509 . . . . 1.27 109.625 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.24 144.16 49.59 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.029 0.751 . . . . 1.8899999999999999 113.029 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -106.66 123.33 47.96 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.448 -0.796 . . . . 2.8999999999999999 110.848 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.424 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 16.9 m-85 -106.15 135.48 47.54 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.733 -0.667 . . . . 0.48999999999999999 110.444 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.82 149.67 42.32 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 116.016 -0.538 . . . . 1.1000000000000001 111.944 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -148.13 121.52 9.05 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 123.167 0.587 . . . . 2.6099999999999999 110.724 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.26 72.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 112.24 0.459 . . . . 2.6099999999999999 112.24 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.14 -42.51 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.734 0.642 . . . . 2.71 112.734 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -117.54 131.85 56.63 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.61 0.596 . . . . 1.6899999999999999 112.61 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -110.57 97.46 6.89 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 122.402 1.096 . . . . 1.4299999999999999 111.12 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.41 ' NE2' ' HZ1' ' A' ' 100' ' ' LYS . 17.6 pt20 -160.67 142.03 12.09 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.982 -1.008 . . . . 2.9700000000000002 112.054 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.8 m -122.16 124.06 42.98 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.596 -0.729 . . . . 1.6599999999999999 112.331 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 73.07 53.38 0.13 Allowed 'General case' 0 N--CA 1.512 2.629 0 C-N-CA 125.721 1.609 . . . . 2.02 112.148 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -152.31 -41.85 0.11 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.541 1.136 . . . . 2.5600000000000001 110.025 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.41 ' HZ1' ' NE2' ' A' ' 96' ' ' GLN . 30.5 mmtp -106.9 82.26 1.67 Allowed 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.794 -0.817 . . . . 3.1499999999999999 108.794 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.34 126.01 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.605 -1.18 . . . . 1.3600000000000001 111.23 -177.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -113.86 176.99 4.79 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.404 1.631 . . . . 0.84999999999999998 115.404 -175.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -125.32 139.13 53.96 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 121.897 0.856 . . . . 1.3300000000000001 111.489 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.01 126.84 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.071 0 CA-C-N 114.181 -1.372 . . . . 1.1699999999999999 110.103 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -131.27 142.52 50.15 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.229 1.566 . . . . 1.9399999999999999 115.229 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.2 m -113.74 106.34 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 113.882 -1.508 . . . . 1.29 112.199 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.462 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 65.21 25.87 12.32 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 126.479 1.912 . . . . 1.8200000000000001 113.367 -177.207 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.62 -10.82 56.29 Favored Glycine 0 CA--C 1.555 2.552 0 CA-C-N 116.055 -0.52 . . . . 0.32000000000000001 114.121 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -94.93 130.11 41.69 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 125.394 1.477 . . . . 0.56999999999999995 113.457 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -90.74 133.97 34.77 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 122.481 1.134 . . . . 1.1899999999999999 113.562 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.24 -47.42 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 112.818 -1.992 . . . . 1.73 112.163 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.19 89.14 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.27 -1.011 . . . . 1.25 108.27 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -111.03 74.92 0.89 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-O 123.334 1.54 . . . . 2.75 110.994 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 156.06 64.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 110.429 -3.078 . . . . 2.48 108.445 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.18 100.81 12.55 Favored 'General case' 0 C--N 1.36 1.056 0 N-CA-C 114.032 1.123 . . . . 1.78 114.032 -178.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.56 101.49 8.65 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 112.815 -1.993 . . . . 2.3500000000000001 106.706 175.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.63 -29.4 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.48 0 C-N-CA 124.605 1.162 . . . . 1.27 114.114 -176.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -76.94 -37.34 55.48 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.341 0.656 . . . . 0.83999999999999997 112.403 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -74.21 -26.44 60.26 Favored 'General case' 0 CA--C 1.576 1.946 0 C-N-CA 124.557 1.143 . . . . 0.91000000000000003 113.195 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -78.55 -56.26 4.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.327 0.862 . . . . 2.98 113.327 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.79 -39.88 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 N-CA-C 113.998 1.11 . . . . 1.53 113.998 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.85 -67.3 0.24 Allowed Glycine 0 C--N 1.358 1.777 0 CA-C-N 118.269 0.486 . . . . 0.84999999999999998 114.162 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -106.49 173.91 6.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.946 0.899 . . . . 3.9700000000000002 112.161 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 m -75.95 84.13 2.86 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.281 0.845 . . . . 2.0800000000000001 113.281 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.4 p -135.7 -137.05 0.15 Allowed 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 114.414 -1.266 . . . . 1.22 109.127 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -115.96 132.69 56.57 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 113.315 0.857 . . . . 1.2 113.315 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.424 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 7.4 t60 -108.37 138.2 45.06 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.109 -0.701 . . . . 0.41999999999999998 109.109 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -141.49 130.95 23.78 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.696 0.998 . . . . 2.5 113.696 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -120.2 130.68 54.66 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-N 114.498 -1.228 . . . . 1.5800000000000001 110.87 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.51 124.14 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 114.455 -1.248 . . . . 1.25 110.629 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.49 94.23 26.84 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-N 115.619 -0.719 . . . . 1.5 110.859 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -74.65 139.32 25.13 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.977 2.452 . . . . 0.22 113.481 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.95 150.75 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.492 0 CA-C-O 121.654 0.74 . . . . 1.1200000000000001 111.216 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.2 p -132.29 112.69 12.44 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.268 -0.878 . . . . 1.8600000000000001 111.323 178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.474 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.6 mt -112.01 123.18 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 108.505 -0.924 . . . . 1.0700000000000001 108.505 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -139.24 127.99 23.35 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.102 -0.954 . . . . 2.6400000000000001 110.88 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? 66.05 15.52 10.11 Favored 'General case' 0 N--CA 1.517 2.89 0 N-CA-C 114.88 1.437 . . . . 4.0199999999999996 114.88 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.53 19.52 24.95 Favored Glycine 0 CA--C 1.55 2.271 0 CA-C-O 119.315 -0.714 . . . . 0.39000000000000001 114.709 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 25.0 mtpp -126.77 141.83 51.72 Favored 'General case' 0 C--N 1.366 1.301 0 CA-C-N 118.181 0.991 . . . . 2.0299999999999998 112.2 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.68 136.85 39.9 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.487 0.921 . . . . 1.0800000000000001 113.487 -177.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.4 t -133.63 120.84 21.2 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.71 -0.677 . . . . 1.23 111.843 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 p -105.47 95.05 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.674 0 CA-C-N 114.965 -1.016 . . . . 1.1899999999999999 110.087 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 69.46 -81.66 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 125.4 1.48 . . . . 1.8200000000000001 113.34 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -129.71 23.43 4.75 Favored Glycine 0 CA--C 1.544 1.899 0 CA-C-N 116.092 -0.504 . . . . 0.51000000000000001 113.685 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -125.04 121.92 35.74 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.33 0.652 . . . . 1.8200000000000001 110.78 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.8 134.24 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.466 0.65 . . . . 1.5900000000000001 111.843 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 m -149.54 -170.27 3.59 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.918 -1.037 . . . . 1.1699999999999999 110.74 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.24 138.14 38.66 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.394 0.887 . . . . 1.71 113.394 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -94.45 119.88 33.84 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.493 -0.776 . . . . 0.29999999999999999 109.036 175.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.89 92.24 3.1 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.335 0.588 . . . . 1.8700000000000001 112.092 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.92 -71.51 2.98 Favored Glycine 0 C--N 1.358 1.779 0 N-CA-C 116.954 1.542 . . . . 0.91000000000000003 116.954 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.78 171.94 12.9 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 123.285 1.517 . . . . 1.6799999999999999 114.577 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.462 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -110.28 126.39 54.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 111.31 -2.677 . . . . 1.3700000000000001 107.439 176.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.6 t -117.18 122.23 43.45 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 118.309 -1.357 . . . . 0.94999999999999996 114.287 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.79 101.36 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 114.676 -1.147 . . . . 1.3799999999999999 108.407 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -133.28 143.72 49.25 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.05 -0.977 . . . . 1.6699999999999999 111.386 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -115.59 142.5 46.64 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 114.546 -1.206 . . . . 2.2999999999999998 112.72 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -102.73 137.0 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.247 -1.797 . . . . 1.29 108.778 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -81.82 148.82 28.66 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 115.135 1.532 . . . . 2.6200000000000001 115.135 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -104.37 -29.94 5.2 Favored Glycine 0 CA--C 1.545 1.922 0 CA-C-N 114.675 -1.148 . . . . 1.0600000000000001 114.143 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -128.49 -80.54 0.58 Allowed 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 117.258 0.529 . . . . 3.1000000000000001 110.919 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -171.88 48.92 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.87 0.468 . . . . 4.0800000000000001 112.036 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -160.04 -43.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.605 0.965 . . . . 1.74 113.605 -178.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 1.3 m-20 84.17 -173.16 0.02 OUTLIER Pre-proline 0 N--CA 1.511 2.607 0 C-N-CA 124.493 1.117 . . . . 1.6799999999999999 110.461 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -64.43 -19.19 65.1 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.586 2.191 . . . . 2.8199999999999998 115.74 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 31.0 tptt 82.69 -67.1 0.09 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 126.025 1.73 . . . . 3.4100000000000001 115.045 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 45.0 t -100.2 131.03 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 119.062 0.846 . . . . 1.3799999999999999 110.034 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.3 t -134.06 126.8 30.9 Favored 'General case' 0 C--N 1.367 1.342 0 O-C-N 124.074 0.859 . . . . 1.75 111.635 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . 0.256 . . -115.03 51.1 0.93 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.43 2.011 . . . . 1.1299999999999999 116.43 -176.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.84 128.18 8.65 Favored 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.702 1.601 . . . . 1.3999999999999999 115.053 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -149.14 98.17 2.78 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.777 -1.102 . . . . 0.26000000000000001 109.294 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.319 8.4 tt -112.9 122.68 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.808 0 CA-C-O 122.84 1.305 . . . . 1.1000000000000001 112.276 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -123.56 167.61 13.7 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 113.094 -1.866 . . . . 1.0600000000000001 111.131 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.9 ptmt -122.19 159.49 27.14 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 118.223 2.675 . . . . 1.8300000000000001 118.223 -175.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.38 -42.53 1.87 Allowed Glycine 0 CA--C 1.542 1.781 0 CA-C-N 110.041 -3.254 . . . . 0.17000000000000001 118.779 174.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.37 153.92 0.78 Allowed 'General case' 0 N--CA 1.52 3.038 0 CA-C-N 120.296 2.048 . . . . 1.05 112.94 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.79 -20.74 58.0 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 114.742 1.386 . . . . 0.98999999999999999 114.742 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.36 4.68 45.33 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.007 1.114 . . . . 0.55000000000000004 114.007 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.57 3.3 16.65 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.389 1.255 . . . . 0.59999999999999998 114.389 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . 0.257 1.6 m . . . . . 0 N--CA 1.525 3.298 0 N-CA-C 116.856 2.169 . . . . 1.1799999999999999 116.856 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.2 tp . . . . . 0 CA--C 1.564 1.483 0 N-CA-C 113.145 0.794 . . . . 1.0900000000000001 113.145 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.57 -23.81 64.94 Favored 'General case' 0 N--CA 1.506 2.331 0 C-N-CA 125.506 1.522 . . . . 1.04 114.414 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.89 -9.92 54.59 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 113.606 0.965 . . . . 0.32000000000000001 113.606 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 48.8 mmtt -104.47 -27.02 12.16 Favored 'General case' 0 C--N 1.364 1.23 0 N-CA-C 113.327 0.862 . . . . 2.2599999999999998 113.327 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.33 137.01 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.077 0 N-CA-C 115.764 1.764 . . . . 1.01 115.764 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pt -122.06 -30.09 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 115.559 -0.746 . . . . 1.0600000000000001 112.409 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.414 ' O ' HG22 ' A' ' 172' ' ' ILE . 75.3 t90 -164.36 116.7 1.32 Allowed 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 120.654 0.264 . . . . 0.67000000000000004 111.302 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.98 136.42 38.5 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.602 -0.686 . . . . 1.0800000000000001 111.719 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.304 14.9 p -150.02 137.65 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.555 0 N-CA-C 115.796 1.776 . . . . 1.6699999999999999 115.796 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 59.2 t30 -114.18 111.34 21.4 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-N 115.264 -0.88 . . . . 2.6400000000000001 108.726 174.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.96 106.8 13.25 Favored 'General case' 0 C--O 1.271 2.211 0 CA-C-O 121.455 0.645 . . . . 1.28 110.323 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.497 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 171.92 -61.42 0.16 Allowed Glycine 0 C--N 1.362 1.998 0 CA-C-N 112.445 -2.161 . . . . 0.70999999999999996 114.358 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.01 -110.45 3.37 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 114.371 0.508 . . . . 0.87 114.371 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -170.92 117.85 0.48 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.834 0.454 . . . . 2.1200000000000001 111.782 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.1 m 43.95 114.38 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.368 0 N-CA-C 119.235 3.05 . . . . 1.5 119.235 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -144.97 139.81 27.77 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 113.399 0.888 . . . . 0.52000000000000002 113.399 177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.267 8.2 p -106.02 114.23 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 CA-C-N 115.015 -0.993 . . . . 2.0699999999999998 110.124 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -84.59 162.7 19.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.776 -1.102 . . . . 1.8500000000000001 113.12 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 m -41.38 -28.79 0.18 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.266 0 N-CA-C 119.868 3.285 . . . . 1.3700000000000001 119.868 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -90.15 -19.76 23.88 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.856 0.753 . . . . 0.56999999999999995 111.87 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.65 39.32 1.47 Allowed Glycine 0 C--N 1.353 1.517 0 C-N-CA 124.443 1.021 . . . . 0.37 113.868 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.1 mm -106.83 124.91 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 C-N-CA 123.096 0.558 . . . . 1.25 109.597 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -110.26 130.7 55.5 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 114.656 1.354 . . . . 1.71 114.656 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -84.15 136.74 33.86 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 124.479 1.111 . . . . 3.1499999999999999 110.413 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.89 100.34 12.82 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 124.78 1.3 . . . . 3.5099999999999998 114.266 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -38.79 110.96 0.15 Allowed 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 128.133 2.573 . . . . 2.8100000000000001 117.846 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 46.34 76.16 0.58 Allowed Pre-proline 0 N--CA 1.525 3.317 0 N-CA-C 117.099 2.259 . . . . 1.1699999999999999 117.099 177.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo . . . . . 0 CA--C 1.56 1.803 0 N-CA-C 117.584 2.109 . . . . 1.45 117.584 -179.856 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 51.1 Cg_exo . . . . . 0 N--CA 1.503 2.059 0 N-CA-C 117.196 1.96 . . . . 1.8600000000000001 117.196 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.279 1.2 mp -89.65 125.91 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.12 0 CA-C-N 114.98 -1.009 . . . . 1.28 109.277 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.39 -19.01 43.53 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.478 2.029 . . . . 1.9299999999999999 116.478 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.38 24.66 7.79 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 113.957 1.095 . . . . 1.79 113.957 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.36 -175.07 4.57 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-O 121.451 0.643 . . . . 1.49 111.7 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.772 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.56 -176.87 0.58 Allowed Pre-proline 0 N--CA 1.511 2.588 0 C-N-CA 123.985 0.914 . . . . 1.6799999999999999 109.198 177.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -68.86 -39.95 7.6 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.48 2.12 . . . . 1.1599999999999999 113.719 176.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -68.88 -49.18 60.43 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 125.298 1.439 . . . . 2.04 112.549 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -6.57 58.76 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-N 114.921 -1.036 . . . . 1.6200000000000001 112.57 177.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.772 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 22.1 tt0 -73.54 -40.49 63.93 Favored 'General case' 0 C--N 1.381 1.952 0 C-N-CA 125.278 1.431 . . . . 2.4300000000000002 108.075 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.5 t -61.35 -44.57 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.068 0 C-N-CA 124.353 1.061 . . . . 1.46 109.094 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.9 tp -75.97 -11.91 60.04 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 114.77 1.396 . . . . 1.6699999999999999 114.77 177.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -124.22 22.16 8.66 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 123.672 0.789 . . . . 1.3300000000000001 112.534 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -143.89 -27.4 0.53 Allowed 'General case' 0 N--CA 1.52 3.032 0 N-CA-C 115.813 1.783 . . . . 1.4099999999999999 115.813 -177.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 p -75.29 130.82 39.72 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 113.614 0.968 . . . . 1.28 113.614 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.497 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.246 0 N-CA-C 115.306 1.595 . . . . 1.53 115.306 -176.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.45 -0.574 . . . . 2.1499999999999999 109.45 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.611 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.3 OUTLIER 75.58 79.49 0.1 Allowed 'General case' 0 N--CA 1.515 2.778 0 C-N-CA 125.083 1.353 . . . . 1.25 109.963 -177.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -135.44 141.31 45.39 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.276 -0.875 . . . . 1.1499999999999999 113.13 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -134.48 174.36 21.02 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 116.62 1.408 . . . . 0.59999999999999998 116.62 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.448 ' HH ' ' HG ' ' A' ' 168' ' ' CYS . 19.0 m-85 -113.94 156.55 23.8 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 113.814 -1.193 . . . . 1.4099999999999999 113.375 -177.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.83 125.4 47.44 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.024 -0.989 . . . . 0.51000000000000001 111.904 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.77 102.69 38.09 Favored Pre-proline 0 CA--C 1.566 1.561 0 CA-C-N 115.458 -0.792 . . . . 1.0600000000000001 108.957 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -84.0 117.53 2.26 Favored 'Trans proline' 0 CA--C 1.562 1.884 0 C-N-CA 122.155 1.903 . . . . 0.17999999999999999 114.44 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.05 157.48 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 CA-C-O 122.068 0.937 . . . . 1.0600000000000001 111.511 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -144.46 14.66 1.61 Allowed 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 114.542 -1.208 . . . . 3.1099999999999999 112.61 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -125.04 172.88 9.09 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-N 118.711 0.687 . . . . 2.1200000000000001 112.489 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -130.83 144.05 51.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.814 0.816 . . . . 0.41999999999999998 112.822 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.1 -135.4 4.29 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.436 -1.256 . . . . 0.25 112.322 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.576 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 40.6 mm-40 -114.12 112.56 23.4 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 118.039 0.92 . . . . 1.75 111.266 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -104.64 133.57 49.26 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 122.075 -0.391 . . . . 0.90000000000000002 110.826 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -118.66 124.04 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.703 0.763 . . . . 1.0700000000000001 111.202 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.48 110.5 22.45 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.168 -1.378 . . . . 1.47 110.699 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.412 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 0.2 OUTLIER -119.22 129.09 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 115.266 -0.879 . . . . 1.27 108.707 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.28 137.4 46.01 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.117 0.784 . . . . 1.8899999999999999 113.117 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 127' ' ' HIS . 3.0 tppt? -101.69 114.06 27.77 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.759 -0.655 . . . . 2.8999999999999999 109.907 176.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -103.63 134.46 46.94 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.381 -0.827 . . . . 0.48999999999999999 110.339 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.44 151.54 47.53 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.629 -0.714 . . . . 1.1000000000000001 111.253 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -128.16 142.93 51.04 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-O 121.271 0.558 . . . . 2.6099999999999999 112.254 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.18 -36.02 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 115.59 -0.732 . . . . 2.6099999999999999 112.678 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.62 142.04 51.43 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.192 0.597 . . . . 2.71 111.707 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 92.75 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 126.477 1.911 . . . . 1.6899999999999999 111.248 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.17 85.39 2.65 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-O 123.002 1.382 . . . . 1.4299999999999999 111.529 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -151.17 145.04 25.15 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.318 -1.31 . . . . 2.9700000000000002 112.292 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.1 m -120.84 120.27 35.08 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.507 -0.769 . . . . 1.6599999999999999 112.223 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 72.33 56.64 0.15 Allowed 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 125.899 1.68 . . . . 2.02 112.531 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -157.19 -41.97 0.07 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.286 1.434 . . . . 2.5600000000000001 109.092 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -105.1 83.39 1.97 Allowed 'General case' 0 C--N 1.361 1.086 0 N-CA-C 108.383 -0.969 . . . . 3.1499999999999999 108.383 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.85 132.71 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 114.748 -1.114 . . . . 1.3600000000000001 111.675 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -114.58 178.54 4.24 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.353 1.612 . . . . 0.84999999999999998 115.353 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -126.5 141.72 51.78 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.604 0.594 . . . . 1.3300000000000001 112.604 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.71 125.01 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.368 0 C-N-CA 123.686 0.794 . . . . 1.1699999999999999 109.302 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.604 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 25.6 mtt180 -124.51 146.91 48.71 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.097 1.518 . . . . 1.9399999999999999 115.097 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 2.5 m -120.21 106.8 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.833 0 N-CA-C 112.996 0.739 . . . . 1.29 112.996 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.38 25.07 13.35 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 126.49 1.916 . . . . 1.8200000000000001 114.736 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.85 -12.91 45.93 Favored Glycine 0 CA--C 1.55 2.261 0 CA-C-N 115.827 -0.624 . . . . 0.32000000000000001 113.446 -176.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.604 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 96.8 m-70 -87.35 169.34 12.35 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.078 1.751 . . . . 0.56999999999999995 112.784 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.28 133.6 55.14 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.573 0.702 . . . . 1.1899999999999999 112.462 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.94 -55.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 114.731 -1.122 . . . . 1.73 112.898 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.14 88.89 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.021 -1.103 . . . . 1.25 108.021 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -111.14 77.6 1.05 Allowed 'General case' 0 C--N 1.354 0.775 0 CA-C-O 122.867 1.318 . . . . 2.75 110.588 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 152.44 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 111.205 -2.725 . . . . 2.48 108.578 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.35 99.93 12.36 Favored 'General case' 0 C--N 1.362 1.117 0 N-CA-C 113.708 1.003 . . . . 1.78 113.708 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -114.26 99.49 7.64 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 113.175 -1.83 . . . . 2.3500000000000001 107.565 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.74 -29.89 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.441 0 N-CA-C 114.313 1.227 . . . . 1.27 114.313 -176.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -75.45 -37.17 60.49 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.539 0.736 . . . . 0.83999999999999997 112.415 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.54 -26.9 60.27 Favored 'General case' 0 CA--C 1.577 1.987 0 C-N-CA 124.533 1.133 . . . . 0.91000000000000003 113.262 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -77.33 -55.27 5.54 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.386 0.884 . . . . 2.98 113.386 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.18 -39.04 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 N-CA-C 113.985 1.105 . . . . 1.53 113.985 177.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.46 -70.86 0.21 Allowed Glycine 0 C--N 1.359 1.849 0 CA-C-N 118.206 0.457 . . . . 0.84999999999999998 113.556 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -106.28 175.56 5.46 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.467 1.107 . . . . 3.9700000000000002 111.232 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.1 m -70.87 85.95 0.69 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 113.692 0.997 . . . . 2.0800000000000001 113.692 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.9 p -134.76 -156.64 0.74 Allowed 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 114.028 -1.442 . . . . 1.22 109.476 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -105.83 128.36 53.69 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 113.15 0.796 . . . . 1.2 113.15 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.466 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 7.9 t60 -101.82 139.43 37.47 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.265 0.626 . . . . 0.41999999999999998 109.322 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -144.79 130.43 19.01 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.28 0.845 . . . . 2.5 113.28 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -121.75 136.69 54.94 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 115.304 -0.862 . . . . 1.5800000000000001 111.317 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.81 126.45 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 114.718 -1.128 . . . . 1.25 110.767 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.6 mp -132.88 92.53 25.92 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-N 115.472 -0.785 . . . . 1.5 110.498 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -76.5 131.19 12.39 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 122.875 2.383 . . . . 0.22 113.175 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.23 153.34 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 C-N-CA 124.194 0.998 . . . . 1.1200000000000001 111.115 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.1 p -136.09 117.62 14.83 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.633 0.605 . . . . 1.8600000000000001 112.633 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.5 mt -116.16 127.62 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 N-CA-C 108.769 -0.826 . . . . 1.0700000000000001 108.769 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -140.84 126.0 18.48 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.923 -0.58 . . . . 2.6400000000000001 110.984 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? 68.8 14.91 8.98 Favored 'General case' 0 N--CA 1.516 2.853 0 C-N-CA 125.205 1.402 . . . . 4.0199999999999996 114.151 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.12 16.13 36.39 Favored Glycine 0 CA--C 1.546 1.988 0 CA-C-O 119.291 -0.727 . . . . 0.39000000000000001 114.359 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -125.38 144.57 50.44 Favored 'General case' 0 C--N 1.366 1.283 0 CA-C-N 118.175 0.988 . . . . 2.0299999999999998 112.48 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 148.21 23.28 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.798 1.406 . . . . 1.0800000000000001 114.798 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.6 114.12 9.71 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.234 -1.348 . . . . 1.23 110.201 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.2 p -121.67 96.01 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.334 0 CA-C-N 115.999 -0.546 . . . . 1.1899999999999999 110.705 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 68.39 -83.94 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 C-N-CA 125.586 1.554 . . . . 1.8200000000000001 113.751 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.69 26.81 3.79 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.891 -0.595 . . . . 0.51000000000000001 113.129 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -130.12 123.56 30.66 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 123.532 0.733 . . . . 1.8200000000000001 110.346 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.4 p -118.4 130.05 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.237 0 CA-C-O 121.48 0.657 . . . . 1.5900000000000001 111.51 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.9 p -151.49 -173.3 4.47 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.202 -0.908 . . . . 1.1699999999999999 110.344 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.272 14.3 t -104.35 138.29 40.98 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 113.661 0.986 . . . . 1.71 113.661 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -84.73 126.38 33.35 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.441 1.096 . . . . 0.29999999999999999 111.19 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.77 91.77 3.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.216 0.821 . . . . 1.8700000000000001 113.216 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.18 -64.8 3.69 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 119.192 2.437 . . . . 0.91000000000000003 119.192 176.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -135.33 159.28 42.05 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.466 0.913 . . . . 1.6799999999999999 113.466 -176.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.522 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -105.27 142.59 34.77 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.952 -1.476 . . . . 1.3700000000000001 109.816 177.319 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 t -124.53 127.22 47.1 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 114.023 1.119 . . . . 0.94999999999999996 114.023 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 16.3 t -106.59 97.19 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 105.862 -1.903 . . . . 1.3799999999999999 105.862 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.74 122.7 44.42 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.971 -1.013 . . . . 1.6699999999999999 112.594 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -107.13 119.03 38.28 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 114.474 -1.239 . . . . 2.2999999999999998 109.766 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.14 137.31 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 CA-C-N 113.579 -1.646 . . . . 1.29 109.649 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -58.37 151.2 20.33 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 127.509 2.323 . . . . 2.6200000000000001 116.756 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -109.5 -62.7 0.53 Allowed Glycine 0 CA--C 1.538 1.478 0 CA-C-N 115.193 -0.912 . . . . 1.0600000000000001 113.365 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -135.13 -71.34 0.48 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.781 0.659 . . . . 3.1000000000000001 112.781 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -112.19 -59.29 2.02 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 122.775 0.43 . . . . 4.0800000000000001 112.056 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.4 156.33 16.39 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.692 0.797 . . . . 1.74 110.388 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.611 ' ND2' ' H ' ' A' ' 70' ' ' SER . 11.9 m-20 -97.71 -94.8 0.0 OUTLIER Pre-proline 0 CA--C 1.58 2.126 0 CA-C-O 116.512 -1.708 . . . . 1.6799999999999999 110.898 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.51 -37.21 0.11 Allowed 'Trans proline' 0 C--N 1.402 3.355 0 CA-C-N 124.886 2.781 . . . . 2.8199999999999998 115.004 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.4 tptt 82.06 -81.74 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 126.261 1.825 . . . . 3.4100000000000001 108.859 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 45.5 t -112.51 129.53 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.716 -1.216 . . . . 1.3799999999999999 107.716 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 8.8 t -135.37 116.79 14.69 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.928 0.768 . . . . 1.75 112.341 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . 0.274 . . -109.44 47.51 0.93 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.337 2.347 . . . . 1.1299999999999999 117.337 -176.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.25 134.1 1.68 Allowed 'General case' 0 N--CA 1.516 2.846 0 N-CA-C 116.109 1.892 . . . . 1.3999999999999999 116.109 177.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 3.1 t80 -151.6 100.46 2.71 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.068 -0.514 . . . . 0.26000000000000001 110.906 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 12' ' ' TRP 0.3 5.5 tt -111.52 121.87 64.88 Favored 'Isoleucine or valine' 0 C--O 1.269 2.088 0 CA-C-O 122.268 1.032 . . . . 1.1000000000000001 110.969 176.188 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -122.34 168.68 11.77 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.528 -1.215 . . . . 1.0600000000000001 112.08 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 24.9 tptp -113.4 141.67 46.8 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 118.298 2.703 . . . . 1.8300000000000001 118.298 -173.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.576 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.12 -40.49 2.45 Favored Glycine 0 CA--C 1.542 1.735 0 N-CA-C 121.213 3.245 . . . . 0.17000000000000001 121.213 171.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.93 157.17 1.42 Allowed 'General case' 0 N--CA 1.525 3.291 0 CA-C-N 121.622 2.711 . . . . 1.05 113.91 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.16 -13.22 59.95 Favored 'General case' 0 CA--C 1.58 2.108 0 C-N-CA 124.954 1.301 . . . . 0.98999999999999999 114.087 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.34 2.49 50.15 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 113.692 0.997 . . . . 0.55000000000000004 113.692 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.11 -8.89 17.23 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.98 0.912 . . . . 0.59999999999999998 113.29 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.223 0 C-N-CA 123.866 0.866 . . . . 1.1799999999999999 112.102 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.482 -0.247 . . . . 9.3599999999999994 112.482 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.92 129.88 56.03 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 121.588 0.709 . . . . 6.8499999999999996 111.979 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.5 mmt -132.1 111.19 11.26 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.686 -0.688 . . . . 8.0 111.252 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 m -136.93 114.19 10.79 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.73 -0.668 . . . . 4.1500000000000004 111.592 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.22 93.37 0.09 OUTLIER Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.815 -0.63 . . . . 1.6000000000000001 113.219 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.6 tp -87.82 -48.73 7.6 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 123.637 0.775 . . . . 1.0900000000000001 113.041 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.28 -24.78 65.22 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.957 1.703 . . . . 1.04 115.251 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.24 -12.02 47.97 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 113.665 0.987 . . . . 0.32000000000000001 113.665 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 47.4 mttm -107.45 -18.1 13.95 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 113.954 1.094 . . . . 2.2599999999999998 113.954 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -56.93 135.93 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.88 0 N-CA-C 114.905 1.446 . . . . 1.01 114.905 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.49 -28.53 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 115.394 -0.821 . . . . 1.0600000000000001 112.495 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.439 ' O ' HG22 ' A' ' 172' ' ' ILE . 69.3 t90 -162.83 117.9 1.77 Allowed 'General case' 0 CA--C 1.559 1.325 0 CA-C-N 117.872 0.306 . . . . 0.67000000000000004 111.277 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.1 129.59 25.78 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.508 -0.745 . . . . 1.0800000000000001 111.635 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.55 133.81 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 N-CA-C 112.928 0.714 . . . . 1.6699999999999999 112.928 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -114.07 112.94 24.05 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.056 -1.461 . . . . 2.6400000000000001 107.056 172.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -79.88 97.5 6.72 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-O 121.577 0.704 . . . . 1.28 111.947 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.513 ' HA2' ' N ' ' A' ' 65' ' ' ARG . . . 176.28 -68.72 0.09 OUTLIER Glycine 0 C--N 1.358 1.758 0 CA-C-N 114.416 -1.266 . . . . 0.70999999999999996 115.369 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.65 -116.23 3.66 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 114.651 0.62 . . . . 0.87 114.651 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -170.53 118.71 0.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.206 0.527 . . . . 2.1200000000000001 111.389 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER 51.47 107.75 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.525 2.417 . . . . 1.5 117.525 177.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.507 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 79.7 t60 -137.08 134.98 37.07 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.869 1.063 . . . . 0.52000000000000002 113.869 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.9 t -104.76 114.51 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 CA-C-N 113.813 -1.539 . . . . 2.0699999999999998 107.214 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.48 161.15 17.17 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 119.521 -0.276 . . . . 1.8500000000000001 111.558 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -45.06 -25.37 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.074 0 N-CA-C 119.12 3.007 . . . . 1.3700000000000001 119.12 -176.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -92.04 -21.12 20.66 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 118.082 0.401 . . . . 0.56999999999999995 111.427 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.86 39.64 1.28 Allowed Glycine 0 C--N 1.356 1.683 0 C-N-CA 124.288 0.947 . . . . 0.37 113.983 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.9 mm -105.85 124.98 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 109.094 -0.706 . . . . 1.25 109.094 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.7 t-160 -115.82 132.96 56.49 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 115.693 1.738 . . . . 1.71 115.693 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.8 144.78 27.05 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.726 -1.125 . . . . 3.1499999999999999 108.999 174.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -67.31 -104.78 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.317 1.969 . . . . 3.5099999999999998 116.317 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.1 tttt 176.8 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.233 1.013 . . . . 2.8100000000000001 111.62 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 46.46 58.09 16.6 Favored Pre-proline 0 N--CA 1.533 3.705 0 N-CA-C 117.152 2.279 . . . . 1.1699999999999999 117.152 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -98.53 33.51 0.11 Allowed 'Trans proline' 0 CA--C 1.563 1.937 0 C-N-CA 123.066 2.511 . . . . 1.45 117.146 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.08 -51.01 0.53 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.629 0.603 . . . . 2.2400000000000002 112.629 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -109.58 98.4 7.78 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.731 0.776 . . . . 4.8399999999999999 112.037 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.34 -30.8 9.49 Favored Glycine 0 CA--C 1.541 1.673 0 CA-C-N 114.304 -1.317 . . . . 2.9700000000000002 113.412 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 77.09 -46.08 0.49 Allowed 'General case' 0 N--CA 1.511 2.606 0 C-N-CA 126.476 1.91 . . . . 4.79 114.862 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.95 116.49 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 122.971 0.508 . . . . 3.1499999999999999 110.349 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.49 -133.77 1.56 Allowed Glycine 0 C--N 1.342 0.915 0 C-N-CA 120.99 -0.624 . . . . 2.7200000000000002 114.246 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -138.04 -168.41 2.35 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 112.858 0.688 . . . . 5.9500000000000002 112.858 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.55 137.01 32.73 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.558 1.143 . . . . 1.78 112.87 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.4 m -128.66 120.81 27.24 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.233 -0.894 . . . . 1.6599999999999999 110.413 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.29 100.76 5.29 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.84 -0.618 . . . . 2.3300000000000001 111.233 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -105.65 75.24 1.12 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.056 0.931 . . . . 3.3300000000000001 110.174 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.58 65.83 0.21 Allowed Glycine 0 CA--C 1.528 0.9 0 CA-C-N 113.945 -1.479 . . . . 1.7 110.416 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.1 ttt -92.21 1.19 57.37 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 115.452 1.649 . . . . 2.0800000000000001 115.452 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -111.7 47.13 1.06 Allowed 'General case' 0 CA--C 1.561 1.387 0 CA-C-O 121.779 0.799 . . . . 4.6200000000000001 111.709 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 tp -146.67 73.91 12.51 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 114.684 -1.143 . . . . 3.1600000000000001 108.186 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.401 ' HB3' ' CD ' ' A' ' 58' ' ' GLN . 38.7 Cg_exo -68.17 158.66 56.53 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.559 2.839 . . . . 1.8600000000000001 116.908 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.278 1.2 mp -86.95 133.21 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.273 0 CA-C-N 115.353 -0.839 . . . . 1.28 109.791 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.39 -18.39 36.25 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.944 2.201 . . . . 1.9299999999999999 116.944 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -103.97 23.78 12.38 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.1 1.148 . . . . 1.79 114.1 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -138.11 -166.85 2.05 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.018 0.914 . . . . 1.49 112.803 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.652 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.3 t30 -94.69 -178.59 0.82 Allowed Pre-proline 0 CA--C 1.571 1.772 0 C-N-CA 125.586 1.555 . . . . 1.6799999999999999 110.934 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.439 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.3 Cg_exo -72.31 -45.62 0.6 Allowed 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 122.91 2.406 . . . . 1.1599999999999999 112.018 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -68.71 -52.32 32.05 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 113.32 -1.764 . . . . 2.04 111.863 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -75.65 -6.71 51.79 Favored 'General case' 0 CA--C 1.589 2.471 0 CA-C-N 115.353 -0.84 . . . . 1.6200000000000001 112.692 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.652 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 4.2 tt0 -72.5 -42.31 65.0 Favored 'General case' 0 C--N 1.387 2.232 0 C-N-CA 125.631 1.573 . . . . 2.4300000000000002 108.046 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.09 -42.34 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.045 0 C-N-CA 124.466 1.107 . . . . 1.46 109.341 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 169' ' ' ALA . 3.9 tp -81.37 -6.35 58.82 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 113.946 1.091 . . . . 1.6699999999999999 113.946 176.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -123.63 20.5 9.43 Favored 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 124.64 1.176 . . . . 1.3300000000000001 112.173 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.67 -35.04 0.31 Allowed 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 116.134 1.902 . . . . 1.4099999999999999 116.134 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.1 p -70.99 130.17 40.9 Favored 'General case' 0 N--CA 1.529 3.508 0 N-CA-C 115.011 1.486 . . . . 1.28 115.011 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 3.5 pt-20 -127.51 141.04 51.76 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 124.55 1.14 . . . . 1.53 111.019 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.513 ' N ' ' HA2' ' A' ' 17' ' ' GLY . 5.9 ptt180 -100.57 -81.3 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.165 0.802 . . . . 3.8300000000000001 113.165 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.73 165.83 34.75 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.238 0.926 . . . . 3.7599999999999998 113.069 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.402 HD22 ' H ' ' A' ' 166' ' ' LYS . 50.0 m-20 -131.67 159.46 38.28 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.317 0.858 . . . . 5.3700000000000001 113.317 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -141.43 -106.54 0.14 Allowed 'General case' 0 CA--C 1.564 1.489 0 CA-C-N 115.564 -0.743 . . . . 2.5499999999999998 111.002 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.66 121.56 3.73 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.017 0.527 . . . . 2.1499999999999999 111.073 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.631 ' H ' HD22 ' A' ' 164' ' ' ASN . 0.2 OUTLIER 55.03 89.51 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 125.805 1.642 . . . . 1.25 113.648 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -150.45 160.9 43.43 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.114 1.153 . . . . 1.1499999999999999 114.114 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -176.93 -173.05 42.15 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 116.429 1.332 . . . . 0.59999999999999998 116.429 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -107.93 171.99 7.09 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.35 1.982 . . . . 1.4099999999999999 116.35 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.16 121.2 28.93 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 113.108 -1.86 . . . . 0.51000000000000001 111.188 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.82 106.41 49.97 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 123.339 0.656 . . . . 1.0600000000000001 109.262 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.05 117.54 2.24 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 122.08 1.853 . . . . 0.17999999999999999 114.825 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.78 157.47 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 122.084 0.945 . . . . 1.0600000000000001 110.981 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -146.83 20.05 1.28 Allowed 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.667 -1.151 . . . . 3.1099999999999999 111.824 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -131.85 159.71 37.77 Favored 'General case' 0 C--N 1.362 1.15 0 CA-C-O 121.29 0.567 . . . . 2.1200000000000001 111.897 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -116.62 148.17 41.2 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.869 1.063 . . . . 0.41999999999999998 113.869 -178.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.78 -138.08 5.52 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.117 -1.401 . . . . 0.25 112.38 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 36.4 mm-40 -115.56 104.05 11.34 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-N 118.082 0.941 . . . . 1.75 110.898 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -99.73 128.27 45.83 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.174 0.512 . . . . 0.90000000000000002 110.882 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -113.32 123.48 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.418 0.628 . . . . 1.0700000000000001 111.004 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 tt -108.69 105.26 14.78 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.728 -1.124 . . . . 1.47 110.109 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 1.7 t -114.54 122.27 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.134 -1.393 . . . . 1.27 107.633 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -131.7 136.73 47.88 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.661 -0.7 . . . . 1.8899999999999999 111.8 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.1 tppt? -97.66 123.64 41.66 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.622 0.725 . . . . 2.8999999999999999 112.519 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -105.78 133.21 50.88 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.847 -1.07 . . . . 0.48999999999999999 109.887 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.15 158.99 43.21 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.792 -0.64 . . . . 1.1000000000000001 111.599 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -124.12 170.18 10.96 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-O 121.454 0.645 . . . . 2.6099999999999999 112.667 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.95 -73.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 115.884 -0.598 . . . . 2.6099999999999999 112.423 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.85 67.28 1.51 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.14 0.495 . . . . 2.71 111.927 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -144.59 102.32 3.8 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.866 -0.606 . . . . 1.6899999999999999 110.279 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.88 100.51 10.01 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 122.329 1.061 . . . . 1.4299999999999999 111.856 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -166.43 139.88 4.02 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 114.73 -1.123 . . . . 2.9700000000000002 111.748 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.4 m -125.46 116.25 21.53 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.701 -0.681 . . . . 1.6599999999999999 111.81 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 73.24 49.45 0.15 Allowed 'General case' 0 N--CA 1.508 2.463 0 C-N-CA 125.673 1.589 . . . . 2.02 113.055 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -151.36 -40.99 0.12 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.24 1.416 . . . . 2.5600000000000001 109.212 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -100.59 78.88 2.03 Favored 'General case' 0 C--N 1.365 1.268 0 N-CA-C 108.468 -0.938 . . . . 3.1499999999999999 108.468 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.8 130.19 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 114.677 -1.147 . . . . 1.3600000000000001 111.456 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -115.66 172.77 6.91 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.996 1.48 . . . . 0.84999999999999998 114.996 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -122.87 137.83 54.83 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.855 -0.611 . . . . 1.3300000000000001 111.702 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -131.75 128.04 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.483 0 CA-C-N 115.273 -0.876 . . . . 1.1699999999999999 110.012 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -129.22 151.81 49.48 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.366 1.617 . . . . 1.9399999999999999 115.366 -177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.3 OUTLIER -130.1 113.05 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 C-N-CA 123.355 0.662 . . . . 1.29 112.382 177.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.11 25.61 12.49 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 127.013 2.125 . . . . 1.8200000000000001 114.095 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.53 -16.13 52.53 Favored Glycine 0 CA--C 1.548 2.154 0 CA-C-N 115.6 -0.727 . . . . 0.32000000000000001 113.682 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 94.0 m-70 -83.75 144.68 29.17 Favored 'General case' 0 C--N 1.365 1.241 0 C-N-CA 125.53 1.532 . . . . 0.56999999999999995 114.496 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.94 126.88 42.39 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.326 0.584 . . . . 1.1899999999999999 110.863 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.95 -58.63 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 115.098 -0.956 . . . . 1.73 113.13 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.06 89.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.263 -1.014 . . . . 1.25 108.263 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.65 73.69 0.86 Allowed 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 123.134 1.445 . . . . 2.75 112.317 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 p30 158.14 62.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 127.871 2.468 . . . . 2.48 107.243 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.2 tp -101.92 100.93 11.28 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.184 1.179 . . . . 1.78 114.184 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -112.71 108.61 17.7 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-N 113.401 -1.727 . . . . 2.3500000000000001 109.675 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -26.69 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.547 0 N-CA-C 114.725 1.38 . . . . 1.27 114.725 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -76.3 -42.73 44.29 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 123.303 0.641 . . . . 0.83999999999999997 112.335 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -73.91 -26.37 60.49 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 124.176 0.99 . . . . 0.91000000000000003 113.563 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -78.65 -57.7 3.63 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.765 1.024 . . . . 2.98 113.765 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -31.45 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 114.712 1.375 . . . . 1.53 114.712 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.23 -114.94 2.4 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 118.578 0.626 . . . . 0.84999999999999998 112.945 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -114.76 107.58 15.63 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.216 0.531 . . . . 3.9700000000000002 110.545 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 73.32 -128.62 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 125.59 1.556 . . . . 2.0800000000000001 111.933 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.3 p 58.26 -171.02 0.11 Allowed 'General case' 0 N--CA 1.535 3.798 0 C-N-CA 126.159 1.783 . . . . 1.22 115.474 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.77 129.29 54.66 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 112.968 0.729 . . . . 1.2 112.968 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -105.72 136.54 45.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.249 0.619 . . . . 0.41999999999999998 109.575 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -128.13 133.89 49.03 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.825 1.417 . . . . 2.5 114.825 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.16 118.74 32.7 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.418 -1.264 . . . . 1.5800000000000001 110.844 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.02 112.21 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 115.19 -0.913 . . . . 1.25 110.636 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.75 93.01 43.38 Favored Pre-proline 0 CA--C 1.568 1.669 0 CA-C-N 115.532 -0.758 . . . . 1.5 110.709 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -74.33 138.27 24.55 Favored 'Trans proline' 0 C--N 1.397 3.097 0 C-N-CA 123.032 2.488 . . . . 0.22 113.686 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.11 146.94 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 CA-C-N 115.276 -0.875 . . . . 1.1200000000000001 110.504 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.8 p -131.75 111.83 11.99 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.566 -0.743 . . . . 1.8600000000000001 111.626 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.483 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.6 mt -111.59 122.83 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 108.539 -0.911 . . . . 1.0700000000000001 108.539 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -142.5 130.24 21.56 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.857 -0.611 . . . . 2.6400000000000001 111.192 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt 67.54 15.25 9.77 Favored 'General case' 0 N--CA 1.515 2.822 0 C-N-CA 125.096 1.358 . . . . 4.0199999999999996 114.405 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.14 15.6 35.34 Favored Glycine 0 CA--C 1.549 2.17 0 CA-C-O 119.143 -0.809 . . . . 0.39000000000000001 114.806 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 30.9 mtmt -128.89 155.6 45.0 Favored 'General case' 0 C--N 1.367 1.348 0 CA-C-N 118.442 1.121 . . . . 2.0299999999999998 112.924 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.46 148.52 26.36 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.36 1.244 . . . . 1.0800000000000001 114.36 -176.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.8 m -134.77 112.28 10.61 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.601 -1.181 . . . . 1.23 110.573 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 p -112.21 92.42 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.636 0 CA-C-O 121.196 0.522 . . . . 1.1899999999999999 109.876 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 63.06 -84.26 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.866 0 C-N-CA 125.581 1.553 . . . . 1.8200000000000001 114.241 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.64 28.1 4.53 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 116.206 -0.452 . . . . 0.51000000000000001 113.768 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -137.05 119.23 15.54 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.25 0.62 . . . . 1.8200000000000001 110.048 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.75 132.6 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 CA-C-O 121.57 0.7 . . . . 1.5900000000000001 112.185 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -150.53 -179.31 7.12 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.043 -0.98 . . . . 1.1699999999999999 109.818 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.262 12.8 t -103.14 138.22 40.26 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 113.628 0.974 . . . . 1.71 113.628 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -82.8 123.72 29.61 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.396 1.078 . . . . 0.29999999999999999 111.288 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.19 91.22 3.28 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.804 0.668 . . . . 1.8700000000000001 112.804 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.81 -63.87 3.41 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 119.014 2.366 . . . . 0.91000000000000003 119.014 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.535 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -132.85 161.16 34.91 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.834 1.05 . . . . 1.6799999999999999 113.834 -176.269 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.535 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -107.09 143.32 35.4 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 113.764 -1.562 . . . . 1.3700000000000001 109.593 177.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 t -124.81 142.63 51.3 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.643 1.349 . . . . 0.94999999999999996 114.643 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.417 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.93 97.43 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 106.926 -1.509 . . . . 1.3799999999999999 106.926 176.091 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -113.72 118.44 34.33 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.758 -0.655 . . . . 1.6699999999999999 111.968 -177.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.41 133.09 55.98 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-O 122.31 1.052 . . . . 2.2999999999999998 111.191 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.22 145.77 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 113.018 -1.901 . . . . 1.29 110.548 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.431 ' HB3' ' OD1' ' A' ' 164' ' ' ASN . 41.0 pttt -58.16 151.17 19.63 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 116.97 2.211 . . . . 2.6200000000000001 116.97 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.67 -60.34 0.56 Allowed Glycine 0 CA--C 1.539 1.533 0 CA-C-N 115.093 -0.958 . . . . 1.0600000000000001 113.68 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -141.52 -61.0 0.47 Allowed 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.967 0.384 . . . . 3.1000000000000001 111.717 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -117.49 -49.49 2.56 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.939 0.496 . . . . 4.0800000000000001 112.077 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.35 178.57 4.55 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.464 0.705 . . . . 1.74 111.459 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.631 HD22 ' H ' ' A' ' 70' ' ' SER . 5.3 m-20 -118.28 -85.93 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.045 0 CA-C-O 117.356 -1.307 . . . . 1.6799999999999999 110.275 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -87.49 -37.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.398 3.176 0 CA-C-N 123.648 2.338 . . . . 2.8199999999999998 114.436 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.402 ' H ' HD22 ' A' ' 67' ' ' ASN . 3.1 ttpm? 79.86 -94.02 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 126.495 1.918 . . . . 3.4100000000000001 110.366 -177.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.5 t -106.42 131.29 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.413 -1.328 . . . . 1.3799999999999999 107.413 174.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.2 t -134.59 129.94 35.74 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.94 -1.027 . . . . 1.75 112.841 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 60' ' ' LEU 0.268 . . -122.87 47.89 1.88 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.71 1.745 . . . . 1.1299999999999999 115.71 -177.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -40.38 127.26 2.34 Favored 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 116.051 1.871 . . . . 1.3999999999999999 116.051 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 4.8 t80 -147.55 100.88 3.29 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.912 -0.585 . . . . 0.26000000000000001 111.101 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.439 HG22 ' O ' ' A' ' 12' ' ' TRP 0.305 10.1 tt -109.86 121.3 62.55 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.061 0 CA-C-O 122.427 1.108 . . . . 1.1000000000000001 111.011 175.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -123.34 165.35 17.15 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 113.873 -1.512 . . . . 1.0600000000000001 110.734 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 18.7 ptmt -122.14 159.35 27.37 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 118.139 2.644 . . . . 1.8300000000000001 118.139 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.62 -41.59 2.11 Favored Glycine 0 CA--C 1.544 1.859 0 CA-C-N 110.11 -3.223 . . . . 0.17000000000000001 119.053 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.61 154.18 0.94 Allowed 'General case' 0 N--CA 1.52 3.058 0 CA-C-N 120.782 2.291 . . . . 1.05 113.156 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.77 -13.33 59.87 Favored 'General case' 0 CA--C 1.58 2.125 0 C-N-CA 124.836 1.255 . . . . 0.98999999999999999 114.353 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.55 4.78 45.59 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 113.86 1.059 . . . . 0.55000000000000004 113.86 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.705 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -108.58 -9.89 15.28 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 114.312 1.227 . . . . 0.59999999999999998 114.312 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.9 95.15 0.27 Allowed Pre-proline 0 N--CA 1.516 2.847 0 C-N-CA 124.424 1.09 . . . . 1.1799999999999999 113.358 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.705 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 72.7 Cg_endo -95.83 140.39 0.9 Allowed 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 122.822 2.348 . . . . 2.0299999999999998 114.306 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 15.0 ptt? -142.81 111.25 6.18 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.754 -0.657 . . . . 5.3399999999999999 111.568 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.7 mt -136.95 162.9 31.99 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 122.063 0.935 . . . . 4.0 112.572 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -104.4 154.47 38.33 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-N 114.606 -1.179 . . . . 6.7000000000000002 110.532 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.18 121.4 8.7 Favored 'Trans proline' 0 C--N 1.394 2.963 0 C-N-CA 122.544 2.163 . . . . 6.9400000000000004 115.338 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.601 ' HD1' ' H ' ' A' ' 188' ' ' GLY . 16.7 t-80 -136.18 135.33 20.99 Favored Pre-proline 0 CA--C 1.568 1.662 0 CA-C-N 114.618 -1.174 . . . . 5.5099999999999998 111.01 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.82 -27.26 7.34 Favored 'Trans proline' 0 C--N 1.394 2.956 0 C-N-CA 123.534 2.823 . . . . 7.1600000000000001 116.388 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.601 ' H ' ' HD1' ' A' ' 186' ' ' HIS . . . -118.8 129.39 8.11 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 114.433 0.533 . . . . 7.0199999999999996 114.433 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.3 mt -118.45 103.83 10.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.723 0.409 . . . . 9.3000000000000007 112.006 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.182 -0.913 . . . . 10.6 110.456 179.691 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.575 -0.21 . . . . 9.3599999999999994 112.575 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.85 -39.92 5.19 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.136 0.791 . . . . 6.8499999999999996 113.136 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -118.87 -68.56 0.91 Allowed 'General case' 0 C--N 1.363 1.171 0 C-N-CA 122.647 0.379 . . . . 8.0 111.782 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 m -135.98 -69.77 0.48 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.595 0.358 . . . . 4.1500000000000004 111.908 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.11 95.47 0.11 Allowed Glycine 0 C--N 1.349 1.285 0 C-N-CA 121.411 -0.423 . . . . 1.6000000000000001 113.224 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.0 tp -88.36 -49.91 6.66 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 123.815 0.846 . . . . 1.0900000000000001 112.947 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.4 -23.09 65.56 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 126.101 1.76 . . . . 1.04 115.274 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -11.65 51.71 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.727 1.01 . . . . 0.32000000000000001 113.727 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 2.1 mmpt? -108.57 -19.23 13.51 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 113.514 0.931 . . . . 2.2599999999999998 113.514 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.03 135.75 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.936 0 N-CA-C 115.257 1.577 . . . . 1.01 115.257 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.5 -29.83 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 115.287 -0.869 . . . . 1.0600000000000001 112.095 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.476 ' O ' HG21 ' A' ' 172' ' ' ILE . 58.3 t90 -163.07 123.3 2.28 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-O 120.572 0.225 . . . . 0.67000000000000004 110.953 -178.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -140.93 128.55 21.46 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.351 -0.843 . . . . 1.0800000000000001 110.777 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.1 t -136.57 131.06 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.507 0.928 . . . . 1.6699999999999999 113.507 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -116.7 110.88 19.03 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.304 -0.999 . . . . 2.6400000000000001 108.304 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.59 100.11 9.95 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-O 122.223 1.011 . . . . 1.28 110.437 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.507 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -179.74 -57.54 0.08 OUTLIER Glycine 0 C--N 1.348 1.232 0 CA-C-N 113.594 -1.639 . . . . 0.70999999999999996 115.528 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.4 -115.9 3.29 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 120.038 -0.312 . . . . 0.87 113.795 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -165.11 117.73 1.2 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.359 0.264 . . . . 2.1200000000000001 111.565 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 2.8 m 41.71 106.04 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.155 0 N-CA-C 118.075 2.62 . . . . 1.5 118.075 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.598 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 82.7 t60 -134.07 138.3 45.21 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.041 1.126 . . . . 0.52000000000000002 114.041 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.261 8.0 p -108.64 117.48 54.2 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.073 0 CA-C-N 114.202 -1.363 . . . . 2.0699999999999998 110.254 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.07 156.97 23.05 Favored 'General case' 0 CA--C 1.571 1.757 0 CA-C-N 114.343 -1.298 . . . . 1.8500000000000001 110.676 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 m -41.4 -32.69 0.36 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.153 0 N-CA-C 119.113 3.005 . . . . 1.3700000000000001 119.113 -176.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 63.8 m-70 -88.42 -26.87 21.9 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.312 0.505 . . . . 0.56999999999999995 110.909 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.94 43.43 0.41 Allowed Glycine 0 C--N 1.35 1.334 0 CA-C-N 114.994 -1.003 . . . . 0.37 114.701 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.8 mm -106.79 112.66 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 N-CA-C 109.687 -0.486 . . . . 1.25 109.687 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.598 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.74 134.85 48.19 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 115.189 1.552 . . . . 1.71 115.189 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.614 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -96.14 143.09 27.57 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.731 -1.122 . . . . 3.1499999999999999 110.08 176.378 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -97.44 103.37 15.3 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.226 1.011 . . . . 3.5099999999999998 113.381 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -33.79 116.7 0.28 Allowed 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 118.51 2.781 . . . . 2.8100000000000001 118.51 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 40.37 73.43 0.85 Allowed Pre-proline 0 N--CA 1.525 3.318 0 N-CA-C 118.178 2.658 . . . . 1.1699999999999999 118.178 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -99.9 -12.21 0.26 Allowed 'Trans proline' 0 CA--C 1.56 1.777 0 C-N-CA 122.281 1.987 . . . . 1.45 116.69 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.4 tp -133.91 -52.13 0.85 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.574 0.583 . . . . 2.2400000000000002 112.574 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -91.29 97.75 11.3 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.983 0.896 . . . . 4.8399999999999999 112.44 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.2 -31.81 6.93 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-N 113.604 -1.635 . . . . 2.9700000000000002 112.908 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 74.99 -56.13 0.64 Allowed 'General case' 0 N--CA 1.511 2.576 0 C-N-CA 126.428 1.891 . . . . 4.79 114.408 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.58 116.64 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 123.46 0.704 . . . . 3.1499999999999999 110.222 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.87 -132.24 1.71 Allowed Glycine 0 C--N 1.341 0.858 0 C-N-CA 121.216 -0.516 . . . . 2.7200000000000002 113.729 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -150.25 -126.07 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 111.969 0.359 . . . . 5.9500000000000002 111.969 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.88 136.7 47.99 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.801 0.84 . . . . 1.78 112.396 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.9 m -132.9 99.05 4.47 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.333 -0.849 . . . . 1.6599999999999999 109.953 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.91 107.77 18.72 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 112.892 0.701 . . . . 2.3300000000000001 112.892 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -110.42 75.34 0.92 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.913 0.863 . . . . 3.3300000000000001 110.072 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.99 71.66 0.37 Allowed Glycine 0 C--N 1.344 0.992 0 CA-C-N 114.306 -1.316 . . . . 1.7 110.566 -177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -92.35 0.66 57.46 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 115.615 1.709 . . . . 2.0800000000000001 115.615 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.81 42.02 1.95 Allowed 'General case' 0 CA--C 1.561 1.387 0 CA-C-O 121.872 0.844 . . . . 4.6200000000000001 112.434 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.4 mt -140.0 75.77 29.06 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 125.057 1.343 . . . . 3.1600000000000001 107.794 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.35 167.06 17.74 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.956 2.437 . . . . 1.8600000000000001 117.042 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.25 1.3 mp -91.45 136.72 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.243 0 CA-C-N 114.748 -1.114 . . . . 1.28 110.039 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.1 -10.45 33.3 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 115.991 1.848 . . . . 1.9299999999999999 115.991 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -108.25 20.94 18.03 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 114.302 1.223 . . . . 1.79 114.302 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.53 -166.63 2.1 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 121.71 0.767 . . . . 1.49 112.789 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.838 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.8 t30 -90.25 177.7 2.25 Favored Pre-proline 0 N--CA 1.498 1.952 0 C-N-CA 125.411 1.484 . . . . 1.6799999999999999 110.959 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -71.71 -46.99 0.51 Allowed 'Trans proline' 0 C--N 1.394 2.942 0 C-N-CA 122.998 2.465 . . . . 1.1599999999999999 112.592 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -69.75 -44.11 70.87 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 113.786 -1.552 . . . . 2.04 112.034 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 5.3 t0 -80.14 -7.21 58.81 Favored 'General case' 0 CA--C 1.587 2.371 0 CA-C-N 115.11 -0.95 . . . . 1.6200000000000001 111.758 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.838 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.6 tt0 -73.31 -37.81 66.05 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 125.684 1.594 . . . . 2.4300000000000002 108.737 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -64.01 -47.78 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.871 0 C-N-CA 125.777 1.631 . . . . 1.46 109.042 173.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.563 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 1.6 tp -80.12 -4.58 53.48 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.69 1.366 . . . . 1.6699999999999999 114.69 177.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 4.0 m-30 -113.17 3.46 16.06 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 124.639 1.176 . . . . 1.3300000000000001 110.222 175.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.77 -115.95 0.14 Allowed 'General case' 0 CA--C 1.568 1.658 0 C-N-CA 124.479 1.112 . . . . 1.4099999999999999 111.703 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.289 2.9 p 56.67 -84.48 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.12 0 C-N-CA 127.33 2.252 . . . . 1.28 116.144 -174.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.507 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 20.6 tt0 82.08 133.7 0.06 Allowed 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 125.361 1.465 . . . . 1.53 114.227 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 35.7 mtp85 -100.23 -75.48 0.58 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 111.92 0.341 . . . . 3.8300000000000001 111.92 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.06 161.78 33.99 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.748 0.785 . . . . 3.7599999999999998 112.886 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' A' ' 166' ' ' LYS . 1.3 m-20 -119.88 134.02 55.38 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.126 -0.943 . . . . 5.3700000000000001 111.133 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -157.12 -62.62 0.09 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.395 1.257 . . . . 2.5499999999999998 114.395 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.1 -160.07 1.12 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.575 0.625 . . . . 2.1499999999999999 112.355 -175.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.51 107.62 1.17 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 124.522 1.129 . . . . 1.25 112.35 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -100.45 129.28 46.39 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.403 -1.271 . . . . 1.1499999999999999 110.651 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -133.73 132.88 6.64 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 118.716 2.247 . . . . 0.59999999999999998 118.716 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -103.1 145.61 29.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.28 0.844 . . . . 1.4099999999999999 113.28 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.9 117.96 32.13 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.383 -1.281 . . . . 0.51000000000000001 111.897 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.51 97.69 51.01 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.275 -0.875 . . . . 1.0600000000000001 109.048 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -83.03 118.84 2.74 Favored 'Trans proline' 0 CA--C 1.558 1.705 0 C-N-CA 122.16 1.906 . . . . 0.17999999999999999 114.755 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.92 159.18 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 CA-C-O 122.119 0.962 . . . . 1.0600000000000001 111.433 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -146.36 17.97 1.35 Allowed 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 114.315 -1.311 . . . . 3.1099999999999999 111.935 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -128.99 163.22 25.83 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 121.269 0.557 . . . . 2.1200000000000001 111.466 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -124.18 146.65 48.55 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.8 1.037 . . . . 0.41999999999999998 113.8 -178.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.72 -133.93 3.61 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.068 -1.423 . . . . 0.25 112.094 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 21.5 mt-10 -118.52 106.46 12.69 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 118.479 1.139 . . . . 1.75 111.106 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -98.97 128.85 45.21 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.485 0.66 . . . . 0.90000000000000002 111.331 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.46 118.23 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-N 115.328 -0.851 . . . . 1.0700000000000001 111.045 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.6 tt -107.83 105.06 14.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.228 -1.351 . . . . 1.47 109.81 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.88 125.41 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 114.229 -1.35 . . . . 1.27 108.741 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.14 137.17 54.16 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 112.762 0.652 . . . . 1.8899999999999999 112.762 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -101.17 115.73 31.17 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.076 -0.965 . . . . 2.8999999999999999 110.196 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -105.01 134.38 48.22 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.957 -0.565 . . . . 0.48999999999999999 110.156 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.72 152.75 51.66 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.614 0.721 . . . . 1.1000000000000001 111.899 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -126.1 150.59 48.09 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.3 -0.863 . . . . 2.6099999999999999 110.449 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.96 -76.03 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 114.186 1.18 . . . . 2.6099999999999999 114.186 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -124.27 73.17 1.22 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.059 0.763 . . . . 2.71 113.059 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -154.29 109.29 3.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.711 0.804 . . . . 1.6899999999999999 109.668 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.42 104.78 14.21 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 122.192 0.996 . . . . 1.4299999999999999 112.495 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -171.84 140.02 1.23 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.884 -1.053 . . . . 2.9700000000000002 111.716 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.4 m -129.07 118.57 22.72 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.571 -0.74 . . . . 1.6599999999999999 111.835 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 72.97 49.94 0.15 Allowed 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 125.793 1.637 . . . . 2.02 112.508 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -151.33 -40.48 0.12 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.476 1.111 . . . . 2.5600000000000001 110.278 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -109.04 83.73 1.8 Allowed 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.464 -0.939 . . . . 3.1499999999999999 108.464 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.85 126.57 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 113.888 -1.505 . . . . 1.3600000000000001 111.651 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.54 -176.4 3.07 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.205 1.558 . . . . 0.84999999999999998 115.205 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -128.42 136.98 51.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.092 -0.38 . . . . 1.3300000000000001 111.29 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.9 t -130.23 125.26 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.279 0 C-N-CA 123.482 0.713 . . . . 1.1699999999999999 109.918 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.3 mtt180 -121.97 153.26 38.76 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.406 1.632 . . . . 1.9399999999999999 115.406 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.55 102.83 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 114.928 -1.033 . . . . 1.29 112.373 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.464 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.31 27.21 13.76 Favored 'General case' 0 N--CA 1.524 3.252 0 C-N-CA 126.876 2.07 . . . . 1.8200000000000001 113.895 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.32 -18.59 35.63 Favored Glycine 0 CA--C 1.547 2.032 0 C-N-CA 121.375 -0.441 . . . . 0.32000000000000001 113.235 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -86.07 173.8 9.62 Favored 'General case' 0 C--N 1.368 1.384 0 C-N-CA 125.491 1.517 . . . . 0.56999999999999995 113.53 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.7 p -126.57 126.24 43.32 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.175 0.512 . . . . 1.1899999999999999 111.278 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.263 9.1 p -112.41 -45.12 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 CA-C-N 115.263 -0.88 . . . . 1.73 111.072 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.66 89.19 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 109.013 -0.736 . . . . 1.25 109.013 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -105.74 90.68 3.47 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-O 122.986 1.374 . . . . 2.75 110.366 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 127.65 78.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 110.01 -3.268 . . . . 2.48 108.508 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.06 110.86 22.94 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 121.744 0.783 . . . . 1.78 112.916 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -119.0 98.84 6.38 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 106.899 -1.519 . . . . 2.3500000000000001 106.899 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -25.54 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.32 0 N-CA-C 113.925 1.083 . . . . 1.27 113.925 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -75.71 -40.29 55.93 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.022 0.929 . . . . 0.83999999999999997 112.311 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -73.26 -26.85 61.26 Favored 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 124.672 1.189 . . . . 0.91000000000000003 113.388 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -80.66 -57.77 3.41 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.692 0.997 . . . . 2.98 113.692 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.33 -34.7 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 N-CA-C 114.864 1.431 . . . . 1.53 114.864 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 123.68 -109.22 1.28 Allowed Glycine 0 C--N 1.356 1.669 0 CA-C-N 118.764 0.711 . . . . 0.84999999999999998 113.578 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -114.61 106.87 14.75 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.757 0.313 . . . . 3.9700000000000002 110.707 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.8 m 68.09 -124.09 0.18 Allowed 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 125.379 1.471 . . . . 2.0800000000000001 112.825 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.3 p 56.07 -164.09 0.14 Allowed 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 126.461 1.904 . . . . 1.22 115.134 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -111.34 132.3 54.51 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 113.102 0.778 . . . . 1.2 113.102 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -107.72 143.69 35.89 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.035 0.534 . . . . 0.41999999999999998 109.829 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.28 131.85 19.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.185 1.18 . . . . 2.5 114.185 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -119.94 134.14 55.34 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 115.145 -0.934 . . . . 1.5800000000000001 110.827 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.47 122.36 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 114.652 -1.158 . . . . 1.25 110.835 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.78 86.24 58.78 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-N 115.361 -0.836 . . . . 1.5 110.823 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -73.88 126.23 10.52 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 123.015 2.477 . . . . 0.22 112.634 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -112.21 149.45 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.565 0 CA-C-N 115.153 -0.931 . . . . 1.1200000000000001 111.428 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 p -130.33 110.63 11.67 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.1 -0.954 . . . . 1.8600000000000001 111.661 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.2 mt -114.15 122.73 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 N-CA-C 108.477 -0.934 . . . . 1.0700000000000001 108.477 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -141.04 127.36 19.78 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.658 -0.701 . . . . 2.6400000000000001 110.76 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp 68.0 14.35 9.33 Favored 'General case' 0 N--CA 1.514 2.759 0 C-N-CA 125.287 1.435 . . . . 4.0199999999999996 113.961 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 17.47 30.1 Favored Glycine 0 CA--C 1.547 2.059 0 CA-C-O 119.213 -0.771 . . . . 0.39000000000000001 114.786 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 55.5 mtpt -124.42 146.38 48.93 Favored 'General case' 0 C--N 1.367 1.35 0 CA-C-N 118.378 1.089 . . . . 2.0299999999999998 112.46 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.18 144.7 30.39 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.275 1.213 . . . . 1.0800000000000001 114.275 -175.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.27 113.44 11.29 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.824 -1.08 . . . . 1.23 110.467 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.3 p -107.81 94.0 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.571 0 CA-C-N 115.929 -0.578 . . . . 1.1899999999999999 110.226 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 66.95 -83.29 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.778 0 C-N-CA 125.527 1.531 . . . . 1.8200000000000001 113.871 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.24 26.05 4.76 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 116.094 -0.503 . . . . 0.51000000000000001 113.628 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -128.71 131.79 47.95 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 123.364 0.666 . . . . 1.8200000000000001 110.57 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -116.14 130.62 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 CA-C-O 121.64 0.733 . . . . 1.5900000000000001 111.981 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m -150.84 -179.1 6.99 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.975 -1.011 . . . . 1.1699999999999999 109.592 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.271 14.1 t -104.25 138.79 40.19 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 113.425 0.898 . . . . 1.71 113.425 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -82.53 122.03 27.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 124.18 0.992 . . . . 0.29999999999999999 111.349 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.79 90.53 3.26 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.48 0.548 . . . . 1.8700000000000001 112.48 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.5 -62.69 2.69 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 118.92 2.328 . . . . 0.91000000000000003 118.92 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.501 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -134.0 158.86 42.45 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.079 1.14 . . . . 1.6799999999999999 114.079 -176.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.501 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -104.61 137.75 41.97 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.523 -1.671 . . . . 1.3700000000000001 109.107 176.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.0 t -124.13 128.29 49.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.772 1.397 . . . . 0.94999999999999996 114.772 -177.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 3.2 t -106.56 101.42 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 106.689 -1.597 . . . . 1.3799999999999999 106.689 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -117.64 120.71 38.84 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.882 -1.054 . . . . 1.6699999999999999 112.746 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -113.74 126.93 55.78 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-O 122.177 0.989 . . . . 2.2999999999999998 111.223 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.78 146.02 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-N 112.947 -1.933 . . . . 1.29 111.242 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -91.14 149.94 21.59 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 114.853 -1.067 . . . . 2.6200000000000001 113.165 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -89.41 -43.98 5.09 Favored Glycine 0 CA--C 1.545 1.954 0 CA-C-N 115.634 -0.712 . . . . 1.0600000000000001 114.859 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -128.99 -71.99 0.62 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.694 0.398 . . . . 3.1000000000000001 110.992 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.599 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 6.8 t80 -146.65 120.42 9.24 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.319 0.647 . . . . 4.0800000000000001 109.5 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 0.5 OUTLIER 90.64 151.93 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 125.033 1.333 . . . . 1.74 112.067 -178.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.65 -168.32 0.15 Allowed Pre-proline 0 CA--C 1.572 1.795 0 CA-C-N 113.994 -1.457 . . . . 1.6799999999999999 109.434 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -57.76 -17.92 31.57 Favored 'Trans proline' 0 C--N 1.403 3.436 0 C-N-CA 122.937 2.425 . . . . 2.8199999999999998 115.181 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.513 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 63.0 tttt 81.91 -63.99 0.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 126.665 1.986 . . . . 3.4100000000000001 115.513 174.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.61 134.27 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.602 1.092 . . . . 1.3799999999999999 110.594 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.57 132.33 38.96 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 114.779 -1.101 . . . . 1.75 113.262 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 60' ' ' LEU . . . -128.68 48.48 2.32 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.081 1.511 . . . . 1.1299999999999999 115.081 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.93 135.36 4.15 Favored 'General case' 0 N--CA 1.515 2.808 0 N-CA-C 116.663 2.097 . . . . 1.3999999999999999 116.663 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -150.02 108.84 3.86 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.804 -0.635 . . . . 0.26000000000000001 111.068 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.476 HG21 ' O ' ' A' ' 12' ' ' TRP 0.308 6.6 tt -117.49 123.26 71.51 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.15 0 CA-C-O 122.439 1.114 . . . . 1.1000000000000001 111.685 175.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 10.5 ptm -123.33 166.79 14.71 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 113.924 -1.489 . . . . 1.0600000000000001 111.274 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.2 ptmm? -123.16 157.59 32.64 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 118.2 2.667 . . . . 1.8300000000000001 118.2 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.65 -42.36 1.91 Allowed Glycine 0 CA--C 1.542 1.728 0 CA-C-N 110.604 -2.998 . . . . 0.17000000000000001 119.085 173.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.57 152.44 0.81 Allowed 'General case' 0 N--CA 1.516 2.864 0 CA-C-N 120.419 2.11 . . . . 1.05 112.762 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.91 -15.5 59.66 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.437 1.273 . . . . 0.98999999999999999 114.437 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.62 4.5 43.59 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.101 1.148 . . . . 0.55000000000000004 114.101 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.628 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -103.99 -10.87 17.77 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 113.624 0.972 . . . . 0.59999999999999998 113.624 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.52 98.9 0.29 Allowed Pre-proline 0 N--CA 1.516 2.871 0 C-N-CA 125.325 1.45 . . . . 1.1799999999999999 111.489 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.628 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 93.6 Cg_endo -95.63 103.92 0.1 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.799 2.333 . . . . 2.0299999999999998 114.397 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.95 118.23 7.84 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.53 -0.759 . . . . 5.3399999999999999 110.899 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.2 mt -130.28 168.9 16.14 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.082 0.944 . . . . 4.0 112.79 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -105.09 154.93 38.41 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-N 114.577 -1.192 . . . . 6.7000000000000002 110.841 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.73 120.66 7.42 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 122.29 1.993 . . . . 6.9400000000000004 114.413 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -135.71 143.68 45.73 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-N 114.672 -1.149 . . . . 5.5099999999999998 111.355 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -88.07 -154.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 122.944 2.429 . . . . 7.1600000000000001 113.905 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 168.31 101.11 0.15 Allowed Glycine 0 C--N 1.341 0.839 0 C-N-CA 121.049 -0.596 . . . . 7.0199999999999996 113.258 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.82 121.25 39.59 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.154 0.502 . . . . 9.3000000000000007 112.074 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.28 -0.867 . . . . 10.6 111.055 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.48 -0.248 . . . . 9.3599999999999994 112.48 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.86 131.94 55.03 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.557 0.694 . . . . 6.8499999999999996 111.881 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.5 mtt -126.9 -67.9 0.83 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.716 -0.675 . . . . 8.0 111.63 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.9 m -137.9 107.25 6.11 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.943 0.402 . . . . 4.1500000000000004 111.241 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.73 91.02 0.1 OUTLIER Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.753 -0.658 . . . . 1.6000000000000001 113.09 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.6 tp -88.07 -47.37 8.56 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 113.248 0.833 . . . . 1.0900000000000001 113.248 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.37 -22.77 61.85 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 125.951 1.7 . . . . 1.04 115.161 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.46 -12.34 49.29 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 113.596 0.961 . . . . 0.32000000000000001 113.596 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -105.65 -21.64 13.15 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.285 0.846 . . . . 2.2599999999999998 113.285 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.24 135.68 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.926 0 N-CA-C 115.317 1.599 . . . . 1.01 115.317 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -124.13 -29.39 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 115.24 -0.891 . . . . 1.0600000000000001 112.258 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.452 ' O ' HG22 ' A' ' 172' ' ' ILE . 62.5 t90 -162.38 116.99 1.83 Allowed 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 120.545 0.212 . . . . 0.67000000000000004 111.328 -177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.82 129.0 31.77 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.483 -0.761 . . . . 1.0800000000000001 111.365 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -136.81 130.99 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 113.214 0.82 . . . . 1.6699999999999999 113.214 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -114.1 105.33 13.08 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 107.663 -1.236 . . . . 2.6400000000000001 107.663 172.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.22 105.56 11.59 Favored 'General case' 0 C--O 1.274 2.38 0 CA-C-O 121.802 0.811 . . . . 1.28 110.39 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.578 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 168.98 -58.32 0.2 Allowed Glycine 0 C--N 1.358 1.786 0 CA-C-N 112.026 -2.352 . . . . 0.70999999999999996 114.037 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -106.96 -128.24 5.94 Favored Glycine 0 N--CA 1.478 1.464 0 CA-C-O 119.303 -0.721 . . . . 0.87 113.121 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.909 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 40.3 mt-10 -162.09 117.22 1.93 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.645 0.723 . . . . 2.1200000000000001 111.86 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 55.61 108.94 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 117.358 2.355 . . . . 1.5 117.358 177.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.463 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 83.8 t60 -144.59 139.05 27.87 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 114.071 1.137 . . . . 0.52000000000000002 114.071 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.268 9.9 p -107.63 118.84 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.085 0 CA-C-N 114.829 -1.078 . . . . 2.0699999999999998 110.886 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.23 156.01 22.21 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 114.395 -1.275 . . . . 1.8500000000000001 110.856 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 m -41.82 -32.16 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.258 0 N-CA-C 119.087 2.995 . . . . 1.3700000000000001 119.087 -176.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -87.16 -23.84 24.68 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.413 0.551 . . . . 0.56999999999999995 111.374 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.73 40.94 0.69 Allowed Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.114 -0.948 . . . . 0.37 114.403 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -106.91 113.35 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 N-CA-C 109.755 -0.461 . . . . 1.25 109.755 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.463 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.3 132.67 51.21 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 115.34 1.608 . . . . 1.71 115.34 -177.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.909 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -93.17 146.65 23.51 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 114.849 -1.069 . . . . 3.1499999999999999 109.911 175.247 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -58.16 -111.71 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 127.505 2.322 . . . . 3.5099999999999998 116.688 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -178.63 79.63 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 113.229 0.826 . . . . 2.8100000000000001 113.229 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.446 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 0.3 OUTLIER 65.14 46.31 0.53 Allowed Pre-proline 0 N--CA 1.517 2.894 0 N-CA-C 117.695 2.48 . . . . 1.1699999999999999 117.695 176.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.446 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 43.0 Cg_endo -107.87 154.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 123.072 2.515 . . . . 1.45 114.579 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.05 -85.74 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.453 -1.249 . . . . 2.2400000000000002 109.796 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -151.98 52.99 0.81 Allowed 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 113.402 0.89 . . . . 4.8399999999999999 113.402 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.72 2.57 30.55 Favored Glycine 0 CA--C 1.545 1.943 0 N-CA-C 115.735 1.054 . . . . 2.9700000000000002 115.735 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -117.52 87.45 2.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.719 0.808 . . . . 4.79 112.33 -176.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.88 128.55 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.343 0 CA-C-N 115.025 -0.989 . . . . 3.1499999999999999 110.978 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.49 -108.78 0.32 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.742 -0.663 . . . . 2.7200000000000002 113.613 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -133.76 -174.27 3.48 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 121.565 0.698 . . . . 5.9500000000000002 112.785 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.12 132.49 34.69 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.283 1.033 . . . . 1.78 112.807 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.0 m -120.61 125.07 46.83 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.254 -0.884 . . . . 1.6599999999999999 111.652 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.51 94.49 3.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.492 -0.776 . . . . 2.3300000000000001 110.673 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -104.72 76.14 1.26 Allowed 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 122.039 0.923 . . . . 3.3300000000000001 110.084 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 122.84 69.07 0.23 Allowed Glycine 0 C--N 1.342 0.912 0 CA-C-N 113.991 -1.459 . . . . 1.7 110.191 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -92.15 0.23 57.45 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 115.477 1.658 . . . . 2.0800000000000001 115.477 -177.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -111.06 64.15 0.61 Allowed 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.918 0.866 . . . . 4.6200000000000001 110.941 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 tp -167.48 73.68 0.98 Allowed Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 114.591 -1.186 . . . . 3.1600000000000001 108.075 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.432 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 31.8 Cg_exo -66.49 157.86 58.4 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.729 2.953 . . . . 1.8600000000000001 117.051 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.273 1.1 mp -87.75 124.51 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.09 0 CA-C-N 115.22 -0.9 . . . . 1.28 108.981 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -81.19 -19.34 43.52 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.421 2.008 . . . . 1.9299999999999999 116.421 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -94.97 24.0 5.16 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 113.736 1.013 . . . . 1.79 113.736 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.16 -173.18 4.18 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.828 0.851 . . . . 1.49 110.954 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.69 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.87 -176.91 0.58 Allowed Pre-proline 0 N--CA 1.512 2.64 0 CA-C-O 118.449 -0.786 . . . . 1.6799999999999999 109.421 178.128 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -69.17 -39.49 7.56 Favored 'Trans proline' 0 C--N 1.398 3.165 0 C-N-CA 122.613 2.209 . . . . 1.1599999999999999 113.279 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -69.25 -49.24 58.05 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 125.322 1.449 . . . . 2.04 112.015 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -79.65 -5.42 55.06 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 114.914 -1.039 . . . . 1.6200000000000001 112.625 177.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.69 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 1.1 tt0 -74.02 -41.84 61.22 Favored 'General case' 0 C--N 1.38 1.929 0 C-N-CA 125.617 1.567 . . . . 2.4300000000000002 107.952 173.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.8 t -61.4 -45.04 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 C-N-CA 124.304 1.042 . . . . 1.46 109.541 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 1.5 tp -79.98 -5.56 55.92 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 114.35 1.241 . . . . 1.6699999999999999 114.35 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 6.5 m-30 -123.81 20.66 9.27 Favored 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 124.477 1.111 . . . . 1.3300000000000001 111.909 176.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -148.16 -28.04 0.33 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 116.878 2.177 . . . . 1.4099999999999999 116.878 -176.272 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.0 p -73.29 137.54 44.92 Favored 'General case' 0 N--CA 1.533 3.725 0 N-CA-C 114.206 1.187 . . . . 1.28 114.206 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.578 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 7.9 pt-20 -112.6 139.4 48.22 Favored 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 117.004 2.224 . . . . 1.53 117.004 -175.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -127.11 114.75 18.15 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 114.692 -1.14 . . . . 3.8300000000000001 109.034 175.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -122.4 147.26 46.51 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.225 0.824 . . . . 3.7599999999999998 113.225 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -127.47 -93.77 0.46 Allowed 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 115.454 -0.794 . . . . 5.3700000000000001 111.64 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -161.31 -48.59 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.221 1.934 . . . . 2.5499999999999998 116.221 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.6 -160.05 0.86 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.678 0.992 . . . . 2.1499999999999999 113.678 -175.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.31 109.94 1.12 Allowed 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 124.957 1.303 . . . . 1.25 112.091 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.63 154.06 49.78 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 114.942 -1.026 . . . . 1.1499999999999999 112.965 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.84 -174.63 37.63 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.077 -0.965 . . . . 0.59999999999999998 115.124 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.47 171.67 7.38 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 114.782 1.401 . . . . 1.4099999999999999 114.782 -177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.15 129.33 49.94 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 113.573 -1.649 . . . . 0.51000000000000001 111.768 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -122.87 100.93 39.85 Favored Pre-proline 0 CA--C 1.568 1.666 0 C-N-CA 123.011 0.524 . . . . 1.0600000000000001 109.597 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -83.5 116.85 2.34 Favored 'Trans proline' 0 CA--C 1.566 2.097 0 C-N-CA 122.251 1.967 . . . . 0.17999999999999999 114.729 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.59 158.37 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.979 0.895 . . . . 1.0600000000000001 110.851 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -143.02 19.86 1.95 Allowed 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 114.844 -1.071 . . . . 3.1099999999999999 112.13 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -125.84 161.71 26.8 Favored 'General case' 0 C--N 1.362 1.114 0 CA-C-O 121.297 0.57 . . . . 2.1200000000000001 111.786 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.5 OUTLIER -120.29 140.59 51.01 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.445 0.906 . . . . 0.41999999999999998 113.445 -179.044 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.14 -137.77 4.92 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.123 -1.399 . . . . 0.25 112.332 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.1 mt-10 -117.66 106.37 13.01 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 118.334 1.067 . . . . 1.75 111.105 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -99.36 129.9 45.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.179 0.514 . . . . 0.90000000000000002 111.256 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.99 118.94 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.798 0.808 . . . . 1.0700000000000001 110.731 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 tt -106.98 105.3 15.26 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.118 -1.401 . . . . 1.47 109.956 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.05 127.57 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 114.471 -1.241 . . . . 1.27 108.705 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.95 137.49 52.28 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.04 0.756 . . . . 1.8899999999999999 113.04 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.7 tptt -102.96 115.99 31.67 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.361 -0.836 . . . . 2.8999999999999999 110.723 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -105.74 134.87 48.16 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.95 -0.568 . . . . 0.48999999999999999 110.379 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.6 156.34 48.17 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.248 0.547 . . . . 1.1000000000000001 112.26 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -121.33 133.19 55.11 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.803 0.841 . . . . 2.6099999999999999 111.147 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.49 27.04 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 114.645 1.35 . . . . 2.6099999999999999 114.645 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.19 -37.11 0.06 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 114.535 1.309 . . . . 2.71 114.535 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.31 130.44 56.03 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.075 0.768 . . . . 1.6899999999999999 113.075 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.17 95.28 5.21 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-O 122.494 1.14 . . . . 1.4299999999999999 110.805 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -154.15 149.36 26.99 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.107 -0.951 . . . . 2.9700000000000002 112.661 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.0 m -124.97 125.96 44.72 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.649 -0.705 . . . . 1.6599999999999999 112.865 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 68.16 49.06 0.87 Allowed 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 125.695 1.598 . . . . 2.02 113.179 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -145.8 -41.14 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.602 1.161 . . . . 2.5600000000000001 109.788 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -112.13 82.68 1.67 Allowed 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.462 -0.94 . . . . 3.1499999999999999 108.462 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.59 115.3 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 113.997 -1.456 . . . . 1.3600000000000001 110.321 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.451 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 34.1 m-85 -97.46 175.97 6.04 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.381 1.623 . . . . 0.84999999999999998 115.381 -175.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -123.0 135.16 54.36 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 116.531 -0.304 . . . . 1.3300000000000001 110.509 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.12 124.99 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.35 0 CA-C-O 121.338 0.589 . . . . 1.1699999999999999 110.144 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.418 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 37.3 mtt180 -122.57 153.37 39.35 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.028 1.492 . . . . 1.9399999999999999 115.028 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.0 OUTLIER -132.71 104.54 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 115.334 -0.848 . . . . 1.29 112.831 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.507 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.78 27.0 13.03 Favored 'General case' 0 N--CA 1.522 3.14 0 C-N-CA 126.9 2.08 . . . . 1.8200000000000001 113.689 -179.004 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.63 -19.66 33.23 Favored Glycine 0 CA--C 1.547 2.05 0 CA-C-N 116.107 -0.497 . . . . 0.32000000000000001 113.317 -176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 93.3 m-70 -82.95 171.59 13.69 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 125.345 1.458 . . . . 0.56999999999999995 113.848 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.85 123.08 39.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 122.182 -0.324 . . . . 1.1899999999999999 110.94 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.279 9.9 p -113.36 -48.65 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.144 0 CA-C-N 116.209 -0.451 . . . . 1.73 111.533 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.47 90.53 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-O 121.324 0.583 . . . . 1.25 109.741 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -107.13 90.44 3.3 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-O 123.013 1.387 . . . . 2.75 111.232 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 127.27 77.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 129.845 3.258 . . . . 2.48 106.828 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -107.14 104.81 14.55 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.963 -1.017 . . . . 1.78 113.541 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -114.62 111.33 21.17 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 113.61 -1.632 . . . . 2.3500000000000001 108.579 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.58 -33.54 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 114.628 1.344 . . . . 1.27 114.628 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -75.1 -34.97 61.79 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 112.905 0.705 . . . . 0.83999999999999997 112.905 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -75.05 -27.46 60.02 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 124.12 0.968 . . . . 0.91000000000000003 113.285 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -79.06 -55.51 5.07 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.35 0.871 . . . . 2.98 113.35 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.52 -40.18 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 N-CA-C 114.021 1.119 . . . . 1.53 114.021 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.65 -72.05 0.2 Allowed Glycine 0 C--N 1.359 1.849 0 CA-C-N 118.217 0.462 . . . . 0.84999999999999998 113.919 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -102.16 174.79 5.77 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.31 1.044 . . . . 3.9700000000000002 111.709 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.6 m -70.43 90.85 0.73 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.784 1.031 . . . . 2.0800000000000001 113.784 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.78 -162.68 1.51 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.745 -1.57 . . . . 1.22 109.888 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.89 134.08 43.31 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 113.509 0.929 . . . . 1.2 113.509 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -105.87 142.92 34.77 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.194 0.598 . . . . 0.41999999999999998 110.115 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -146.41 137.66 24.45 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.928 1.085 . . . . 2.5 113.928 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -128.34 135.36 49.47 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.928 -1.033 . . . . 1.5800000000000001 110.774 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.93 125.18 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.02 -0.991 . . . . 1.25 111.107 -178.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -129.05 89.01 49.84 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-N 115.464 -0.789 . . . . 1.5 110.927 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -74.95 129.82 12.75 Favored 'Trans proline' 0 C--N 1.394 2.953 0 C-N-CA 122.984 2.456 . . . . 0.22 112.943 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.53 149.51 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.507 0 CA-C-N 115.177 -0.92 . . . . 1.1200000000000001 111.107 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.3 t -134.26 117.16 16.14 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.553 0.692 . . . . 1.8600000000000001 111.106 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.4 mt -115.61 126.35 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 CA-C-N 114.69 -1.141 . . . . 1.0700000000000001 108.381 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -140.15 125.3 18.67 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.479 -0.782 . . . . 2.6400000000000001 110.995 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? 66.56 15.21 10.05 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 125.297 1.439 . . . . 4.0199999999999996 114.548 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.65 19.44 22.53 Favored Glycine 0 CA--C 1.547 2.053 0 CA-C-O 119.165 -0.797 . . . . 0.39000000000000001 114.923 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 23.3 mtpp -126.61 143.82 51.1 Favored 'General case' 0 C--N 1.368 1.385 0 CA-C-N 118.435 1.117 . . . . 2.0299999999999998 112.399 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.38 146.3 27.78 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.262 1.208 . . . . 1.0800000000000001 114.262 -175.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.3 t -140.93 117.32 10.76 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.916 -1.038 . . . . 1.23 110.625 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.253 2.3 p -110.56 98.98 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.514 0 CA-C-N 115.325 -0.852 . . . . 1.1899999999999999 110.302 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 69.47 -81.91 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 125.324 1.45 . . . . 1.8200000000000001 113.488 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.95 26.07 3.3 Favored Glycine 0 CA--C 1.543 1.802 0 CA-C-N 116.022 -0.536 . . . . 0.51000000000000001 113.668 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -129.72 118.52 22.01 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.079 0.552 . . . . 1.8200000000000001 110.5 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.46 137.37 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.759 0.79 . . . . 1.5900000000000001 112.626 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 m -153.88 -170.75 3.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.31 -1.314 . . . . 1.1699999999999999 108.792 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.259 6.3 t -103.12 146.16 28.81 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 113.216 0.821 . . . . 1.71 113.216 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -89.88 132.67 35.16 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.098 0.951 . . . . 0.29999999999999999 111.596 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.2 p -97.73 -163.09 1.01 Allowed 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 113.9 -1.5 . . . . 1.8700000000000001 108.888 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.45 7.29 65.19 Favored Glycine 0 CA--C 1.56 2.855 0 O-C-N 120.236 -1.54 . . . . 0.91000000000000003 116.895 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.455 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -160.45 152.89 20.71 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-O 122.303 1.049 . . . . 1.6799999999999999 112.499 178.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.507 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -108.42 137.62 46.07 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 113.81 -1.541 . . . . 1.3700000000000001 108.854 177.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 t -118.56 145.12 45.61 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.438 1.644 . . . . 0.94999999999999996 115.438 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.05 97.3 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 106.225 -1.769 . . . . 1.3799999999999999 106.225 174.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -117.97 124.42 48.15 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 112.645 0.609 . . . . 1.6699999999999999 112.645 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.21 134.81 54.69 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-O 122.356 1.074 . . . . 2.2999999999999998 112.321 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.2 t -107.3 144.51 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 112.77 -2.013 . . . . 1.29 110.326 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -93.02 150.15 20.73 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.785 1.031 . . . . 2.6200000000000001 113.785 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.04 -36.03 4.85 Favored Glycine 0 CA--C 1.545 1.962 0 CA-C-N 115.149 -0.932 . . . . 1.0600000000000001 114.923 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -127.48 -80.87 0.6 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 117.466 0.633 . . . . 3.1000000000000001 112.256 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -127.96 -50.72 1.33 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.034 0.534 . . . . 4.0800000000000001 111.827 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.451 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -85.76 150.04 24.85 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.806 1.243 . . . . 1.74 112.124 178.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -112.11 -171.28 0.21 Allowed Pre-proline 0 CA--C 1.561 1.393 0 CA-C-N 113.384 -1.735 . . . . 1.6799999999999999 108.236 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -65.27 96.88 0.29 Allowed 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.141 1.894 . . . . 2.8199999999999998 111.567 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -51.08 -57.33 8.97 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 127.104 2.162 . . . . 3.4100000000000001 116.619 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.95 131.55 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 118.96 0.8 . . . . 1.3799999999999999 108.899 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.9 t -132.86 125.06 29.13 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 124.004 0.815 . . . . 1.75 112.146 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . 0.289 . . -120.53 48.33 1.62 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.279 1.955 . . . . 1.1299999999999999 116.279 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.77 134.51 2.51 Favored 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 116.238 1.94 . . . . 1.3999999999999999 116.238 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -151.02 102.6 2.98 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.421 -0.809 . . . . 0.26000000000000001 110.821 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 12' ' ' TRP 0.296 7.7 tt -112.77 121.77 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.186 0 CA-C-O 122.276 1.036 . . . . 1.1000000000000001 111.361 176.033 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -124.4 165.59 17.46 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.057 -1.429 . . . . 1.0600000000000001 110.479 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -122.24 159.16 27.89 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 118.914 2.931 . . . . 1.8300000000000001 118.914 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.27 -41.47 2.14 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-N 109.9 -3.318 . . . . 0.17000000000000001 118.973 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.35 154.54 1.03 Allowed 'General case' 0 N--CA 1.516 2.851 0 CA-C-N 120.211 2.005 . . . . 1.05 113.011 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.49 -15.22 59.95 Favored 'General case' 0 CA--C 1.581 2.148 0 C-N-CA 124.859 1.264 . . . . 0.98999999999999999 114.354 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.9 3.19 49.44 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 113.921 1.082 . . . . 0.55000000000000004 113.921 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.64 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 1.0 OUTLIER -109.45 -2.38 17.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.435 0.902 . . . . 0.59999999999999998 113.435 179.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.18 92.64 0.48 Allowed Pre-proline 0 N--CA 1.508 2.468 0 C-N-CA 124.552 1.141 . . . . 1.1799999999999999 110.998 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.64 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 57.0 Cg_endo -93.5 145.09 2.13 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 122.827 2.351 . . . . 2.0299999999999998 114.654 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 12.8 tpt -146.27 113.63 6.28 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.925 -0.58 . . . . 5.3399999999999999 111.311 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 12.5 mt -134.42 156.25 48.88 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.703 0.764 . . . . 4.0 111.864 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -101.29 160.35 26.85 Favored Pre-proline 0 CA--C 1.561 1.381 0 CA-C-N 115.341 -0.845 . . . . 6.7000000000000002 111.896 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -64.39 121.95 9.72 Favored 'Trans proline' 0 C--N 1.399 3.205 0 C-N-CA 122.987 2.458 . . . . 6.9400000000000004 114.963 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -135.34 142.2 40.58 Favored Pre-proline 0 CA--C 1.565 1.554 0 CA-C-N 115.044 -0.98 . . . . 5.5099999999999998 111.096 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -87.39 -156.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 122.999 2.466 . . . . 7.1600000000000001 114.128 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 164.87 102.15 0.16 Allowed Glycine 0 C--N 1.34 0.778 0 C-N-CA 120.96 -0.638 . . . . 7.0199999999999996 113.211 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.9 mt -118.44 101.58 8.27 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.002 0.429 . . . . 9.3000000000000007 111.577 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.282 -0.866 . . . . 10.6 111.062 -179.827 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.521 -0.232 . . . . 9.3599999999999994 112.521 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.46 131.0 55.53 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.54 0.686 . . . . 6.8499999999999996 112.022 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.1 ttt -137.03 -66.67 0.51 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.704 -0.68 . . . . 8.0 111.465 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.4 m -134.34 118.93 18.04 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.635 0.374 . . . . 4.1500000000000004 111.682 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.65 86.46 0.11 Allowed Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.769 -0.65 . . . . 1.6000000000000001 113.325 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.3 tp -88.69 -48.02 7.83 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 123.921 0.889 . . . . 1.0900000000000001 113.148 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.46 -24.58 63.68 Favored 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 126.005 1.722 . . . . 1.04 115.504 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.59 -9.53 55.88 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.582 0.956 . . . . 0.32000000000000001 113.582 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 26.0 mmtp -107.16 -24.97 11.74 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.561 0.948 . . . . 2.2599999999999998 113.561 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.69 134.91 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.056 0 N-CA-C 115.494 1.665 . . . . 1.01 115.494 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -120.09 -30.65 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 115.244 -0.889 . . . . 1.0600000000000001 112.123 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.543 ' O ' HG23 ' A' ' 172' ' ' ILE . 61.9 t90 -161.37 119.48 2.36 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 120.507 0.194 . . . . 0.67000000000000004 111.177 -178.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -138.22 127.85 25.02 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.158 -0.964 . . . . 1.0800000000000001 111.301 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.3 t -137.22 129.74 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.098 0 N-CA-C 113.679 0.992 . . . . 1.6699999999999999 113.679 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -115.9 106.1 13.42 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.582 -1.266 . . . . 2.6400000000000001 107.582 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.48 100.48 6.89 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.06 0.933 . . . . 1.28 111.592 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.508 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 178.16 -55.86 0.09 OUTLIER Glycine 0 C--N 1.349 1.295 0 CA-C-N 113.946 -1.479 . . . . 0.70999999999999996 115.859 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -111.6 -116.18 3.55 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 114.297 0.479 . . . . 0.87 114.297 -177.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -165.45 116.26 1.09 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.011 0.524 . . . . 2.1200000000000001 111.55 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER 43.73 108.62 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 118.452 2.76 . . . . 1.5 118.452 178.227 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.582 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 74.0 t60 -135.27 132.91 38.37 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.939 1.088 . . . . 0.52000000000000002 113.939 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.5 p -108.01 114.64 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.003 0 CA-C-N 113.884 -1.507 . . . . 2.0699999999999998 109.022 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -84.62 167.29 16.39 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-N 115.322 -0.854 . . . . 1.8500000000000001 113.039 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -43.47 -34.48 0.78 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 N-CA-C 118.716 2.858 . . . . 1.3700000000000001 118.716 -176.324 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -87.31 -26.53 23.36 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.204 0.526 . . . . 0.56999999999999995 110.95 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.64 45.16 0.48 Allowed Glycine 0 C--N 1.354 1.541 0 CA-C-N 114.854 -1.066 . . . . 0.37 114.346 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.7 mm -107.11 116.25 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 CA-C-O 120.94 0.4 . . . . 1.25 110.085 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.1 t-160 -108.44 133.58 52.41 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 115.095 1.517 . . . . 1.71 115.095 -177.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.601 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.33 140.56 31.61 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-N 114.794 -1.093 . . . . 3.1499999999999999 110.718 176.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -90.24 130.46 36.36 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 124.974 1.31 . . . . 3.5099999999999998 112.4 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -56.61 115.26 2.43 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 118.996 2.961 . . . . 2.8100000000000001 118.996 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 40.59 57.46 7.97 Favored Pre-proline 0 N--CA 1.526 3.349 0 N-CA-C 118.549 2.796 . . . . 1.1699999999999999 118.549 176.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -102.64 59.64 0.03 OUTLIER 'Trans proline' 0 CA--C 1.569 2.232 0 C-N-CA 122.79 2.327 . . . . 1.45 116.218 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.72 -66.01 0.31 Allowed 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 112.684 0.624 . . . . 2.2400000000000002 112.684 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.596 ' H ' HH22 ' A' ' 65' ' ' ARG . 12.1 mt-10 -106.98 96.8 6.69 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.504 0.669 . . . . 4.8399999999999999 112.667 -178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.31 -30.8 8.88 Favored Glycine 0 CA--C 1.543 1.834 0 CA-C-N 114.674 -1.148 . . . . 2.9700000000000002 113.962 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? 77.91 -19.36 0.44 Allowed 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 115.833 1.79 . . . . 4.79 115.833 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.99 117.08 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.072 0.549 . . . . 3.1499999999999999 110.61 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.65 -139.87 2.74 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.085 -0.579 . . . . 2.7200000000000002 114.182 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.69 -171.62 3.19 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 121.53 0.681 . . . . 5.9500000000000002 112.306 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.93 130.93 44.16 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.923 0.889 . . . . 1.78 111.983 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -121.28 130.08 53.47 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.288 -0.869 . . . . 1.6599999999999999 111.405 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -129.51 103.38 6.85 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.885 -0.598 . . . . 2.3300000000000001 112.026 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -113.49 65.52 0.65 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.437 -0.801 . . . . 3.3300000000000001 110.142 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.04 71.7 0.1 Allowed Glycine 0 C--N 1.344 1.015 0 CA-C-N 114.615 -1.175 . . . . 1.7 111.444 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.61 -25.14 18.44 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.116 1.154 . . . . 2.0800000000000001 114.116 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.45 71.11 1.07 Allowed 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 122.138 0.97 . . . . 4.6200000000000001 111.037 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.91 72.72 0.55 Allowed Pre-proline 0 CA--C 1.552 1.057 0 CA-C-N 113.312 -1.767 . . . . 3.1600000000000001 107.406 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 44.7 Cg_exo -65.01 159.21 47.57 Favored 'Trans proline' 0 N--CA 1.513 2.633 0 C-N-CA 124.534 3.489 . . . . 1.8600000000000001 117.522 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.75 130.05 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.291 0 CA-C-N 114.815 -1.084 . . . . 1.28 108.125 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.1 mt -83.48 -9.68 58.83 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.719 2.118 . . . . 1.9299999999999999 116.719 -176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -105.88 8.02 32.47 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 114.329 1.233 . . . . 1.79 114.329 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.8 -177.82 4.6 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-O 121.7 0.762 . . . . 1.49 112.309 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.692 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -93.85 169.48 9.93 Favored Pre-proline 0 N--CA 1.514 2.768 0 C-N-CA 124.606 1.162 . . . . 1.6799999999999999 110.044 178.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.78 -41.86 51.11 Favored 'Trans proline' 0 N--CA 1.53 3.642 0 C-N-CA 123.289 2.66 . . . . 1.1599999999999999 116.298 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -68.03 -52.51 34.64 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 124.439 1.095 . . . . 2.04 112.119 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 5.8 t0 -78.11 -1.97 35.13 Favored 'General case' 0 CA--C 1.59 2.505 0 CA-C-N 115.225 -0.898 . . . . 1.6200000000000001 112.174 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.692 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 14.5 tt0 -75.69 -40.66 55.49 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 126.132 1.773 . . . . 2.4300000000000002 108.122 174.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.5 t -63.71 -43.1 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.106 0 C-N-CA 124.635 1.174 . . . . 1.46 108.574 172.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.509 ' O ' ' HB1' ' A' ' 169' ' ' ALA . 4.4 tp -79.86 -5.27 55.16 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 113.59 0.959 . . . . 1.6699999999999999 113.59 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 4.2 m-30 -122.46 20.08 10.41 Favored 'General case' 0 CA--C 1.577 1.995 0 C-N-CA 124.786 1.235 . . . . 1.3300000000000001 111.887 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -148.01 -29.01 0.32 Allowed 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 116.399 2.0 . . . . 1.4099999999999999 116.399 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.4 p -74.99 132.0 41.05 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 115.085 1.513 . . . . 1.28 115.085 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.508 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -123.05 148.38 45.64 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 124.221 1.008 . . . . 1.53 112.687 -178.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.596 HH22 ' H ' ' A' ' 35' ' ' GLU . 13.5 mtp180 -98.73 -84.83 0.39 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 112.759 0.651 . . . . 3.8300000000000001 112.759 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.88 167.76 28.61 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.526 0.679 . . . . 3.7599999999999998 112.742 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -126.63 139.93 52.81 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 115.612 -0.722 . . . . 5.3700000000000001 112.733 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -138.63 -109.42 0.17 Allowed 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 115.831 -0.622 . . . . 2.5499999999999998 110.939 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.19 121.14 3.83 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 118.351 0.523 . . . . 2.1499999999999999 111.354 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.24 88.3 0.04 OUTLIER 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 125.722 1.609 . . . . 1.25 114.067 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -148.58 156.22 42.14 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.283 0.846 . . . . 1.1499999999999999 113.283 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -173.14 -171.99 38.29 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 116.039 1.176 . . . . 0.59999999999999998 116.039 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.56 173.17 6.45 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.866 1.432 . . . . 1.4099999999999999 114.866 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -129.38 133.48 47.4 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 114.219 -1.355 . . . . 0.51000000000000001 111.992 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.57 100.47 34.79 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 109.074 -0.713 . . . . 1.0600000000000001 109.074 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.38 118.06 2.19 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.084 1.856 . . . . 0.17999999999999999 115.036 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.67 159.71 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 122.043 0.925 . . . . 1.0600000000000001 111.134 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -143.91 20.18 1.8 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.888 -1.051 . . . . 3.1099999999999999 112.331 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -128.58 158.45 38.44 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-O 121.963 0.887 . . . . 2.1200000000000001 111.117 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.89 139.85 50.14 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.887 1.069 . . . . 0.41999999999999998 113.887 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.9 -125.35 1.35 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 113.961 -1.472 . . . . 0.25 112.393 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -126.31 118.63 25.48 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.085 0.469 . . . . 1.75 111.178 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -118.83 139.92 50.81 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.788 -0.642 . . . . 0.90000000000000002 109.907 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.496 ' O ' HG13 ' A' ' 172' ' ' ILE . 2.5 t -120.59 127.59 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.366 0.603 . . . . 1.0700000000000001 110.896 -177.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.7 107.9 18.96 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.068 -0.969 . . . . 1.47 109.861 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.64 128.5 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 109.045 -0.724 . . . . 1.27 109.045 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.64 146.31 49.42 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.81 1.041 . . . . 1.8899999999999999 113.81 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.43 ' HD3' ' C ' ' A' ' 88' ' ' LYS . 0.1 OUTLIER -108.75 122.47 47.21 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 115.441 -0.8 . . . . 2.8999999999999999 110.314 176.145 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -109.28 136.72 48.27 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.871 -1.059 . . . . 0.48999999999999999 110.415 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -143.77 157.14 44.59 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 124.192 0.997 . . . . 1.1000000000000001 111.307 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -169.92 127.38 0.88 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.353 0.661 . . . . 2.6099999999999999 110.917 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.83 73.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.664 -0.698 . . . . 2.6099999999999999 111.27 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -160.19 -47.35 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.959 -0.564 . . . . 2.71 112.126 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -115.19 116.87 29.07 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.803 0.441 . . . . 1.6899999999999999 111.169 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.24 99.06 8.9 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.646 1.213 . . . . 1.4299999999999999 112.11 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -159.19 160.66 35.71 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.465 -1.243 . . . . 2.9700000000000002 111.061 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 m -108.31 -78.66 0.59 Allowed 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.047 1.128 . . . . 1.6599999999999999 114.047 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -95.47 70.47 3.11 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.296 1.046 . . . . 2.02 111.407 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -159.23 -40.06 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.639 -1.619 . . . . 2.5600000000000001 109.346 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -106.02 79.25 1.39 Allowed 'General case' 0 C--N 1.368 1.375 0 CA-C-O 121.838 0.828 . . . . 3.1499999999999999 109.086 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.24 123.09 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 114.439 -1.255 . . . . 1.3600000000000001 111.395 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.538 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 30.2 m-85 -106.1 171.41 7.36 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 114.395 1.257 . . . . 0.84999999999999998 114.395 -177.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -124.88 135.71 53.13 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.828 -0.434 . . . . 1.3300000000000001 109.828 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.0 t -130.07 125.8 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 CA-C-N 116.104 -0.498 . . . . 1.1699999999999999 109.846 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.655 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 23.0 mtt180 -124.55 148.57 47.72 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.236 1.569 . . . . 1.9399999999999999 115.236 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 154' ' ' SER . 5.1 m -125.56 112.38 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 113.095 0.776 . . . . 1.29 113.095 177.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.429 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 63.62 25.99 14.49 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 126.551 1.94 . . . . 1.8200000000000001 113.894 -178.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.36 -14.33 54.59 Favored Glycine 0 CA--C 1.552 2.389 0 C-N-CA 121.456 -0.402 . . . . 0.32000000000000001 113.804 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.655 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 91.3 m-70 -87.93 172.56 9.5 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 126.059 1.744 . . . . 0.56999999999999995 113.362 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.89 132.31 54.5 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.584 0.707 . . . . 1.1899999999999999 112.082 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.75 -55.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 114.775 -1.102 . . . . 1.73 113.141 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.23 89.46 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.877 . . . . 1.25 108.631 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -106.45 108.68 20.31 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.905 1.336 . . . . 2.75 110.572 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 105.14 70.63 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 110.868 -2.878 . . . . 2.48 108.259 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.27 99.5 12.47 Favored 'General case' 0 C--N 1.359 0.983 0 CA-C-N 115.333 -0.849 . . . . 1.78 112.36 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -109.83 91.84 3.81 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.545 -1.661 . . . . 2.3500000000000001 108.755 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -31.25 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 N-CA-C 116.746 2.128 . . . . 1.27 116.746 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -74.0 -40.54 62.87 Favored 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 124.014 0.926 . . . . 0.83999999999999997 112.445 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -26.1 59.97 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 124.443 1.097 . . . . 0.91000000000000003 113.374 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -78.21 -58.09 3.44 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.573 0.953 . . . . 2.98 113.573 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.26 -32.91 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 N-CA-C 114.921 1.452 . . . . 1.53 114.921 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.23 -118.11 2.74 Favored Glycine 0 C--N 1.356 1.639 0 CA-C-N 118.757 0.708 . . . . 0.84999999999999998 113.006 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -115.1 107.44 15.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.297 0.57 . . . . 3.9700000000000002 111.173 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.0 m 70.69 -134.57 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 125.592 1.557 . . . . 2.0800000000000001 113.128 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 67.8 p 60.4 -151.48 0.4 Allowed 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 126.179 1.792 . . . . 1.22 114.382 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -112.13 130.37 55.92 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 114.141 1.163 . . . . 1.2 114.141 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -108.65 124.38 50.43 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.402 -0.962 . . . . 0.41999999999999998 108.402 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.41 129.18 24.7 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.038 0.755 . . . . 2.5 113.038 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -116.03 134.91 54.45 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.047 -0.978 . . . . 1.5800000000000001 111.492 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.25 114.01 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 113.884 -1.507 . . . . 1.25 109.999 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.23 98.0 33.54 Favored Pre-proline 0 CA--C 1.574 1.866 0 CA-C-N 115.871 -0.604 . . . . 1.5 111.146 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -73.59 144.55 35.96 Favored 'Trans proline' 0 C--N 1.399 3.205 0 C-N-CA 123.293 2.662 . . . . 0.22 114.652 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.59 146.38 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 CA-C-N 115.135 -0.938 . . . . 1.1200000000000001 110.854 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 p -131.41 112.58 12.82 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.495 -0.775 . . . . 1.8600000000000001 111.406 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.98 121.64 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 CA-C-N 115.38 -0.827 . . . . 1.0700000000000001 108.882 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -141.94 130.74 22.91 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 116.274 -0.421 . . . . 2.6400000000000001 111.273 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp 70.67 9.04 6.78 Favored 'General case' 0 N--CA 1.518 2.972 0 C-N-CA 125.033 1.333 . . . . 4.0199999999999996 114.219 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.07 18.1 25.53 Favored Glycine 0 CA--C 1.544 1.859 0 C-N-CA 124.19 0.9 . . . . 0.39000000000000001 113.997 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -127.16 146.68 50.31 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-N 117.768 0.784 . . . . 2.0299999999999998 112.746 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.08 141.72 31.48 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.234 1.198 . . . . 1.0800000000000001 114.234 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.8 m -130.01 113.42 14.55 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.626 -1.17 . . . . 1.23 110.155 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.252 9.1 p -121.48 97.03 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.369 0 CA-C-N 116.004 -0.544 . . . . 1.1899999999999999 110.901 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 67.55 -85.45 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.682 0 C-N-CA 125.658 1.583 . . . . 1.8200000000000001 113.874 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.03 29.3 3.53 Favored Glycine 0 CA--C 1.542 1.737 0 CA-C-N 115.994 -0.548 . . . . 0.51000000000000001 112.979 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -133.17 125.72 30.06 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 123.507 0.723 . . . . 1.8200000000000001 110.651 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.11 126.02 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.303 0 CA-C-O 121.46 0.648 . . . . 1.5900000000000001 111.07 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 m -145.93 -178.89 6.35 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.285 -0.871 . . . . 1.1699999999999999 109.969 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.273 12.4 t -103.14 137.03 41.85 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 113.414 0.894 . . . . 1.71 113.414 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -83.43 125.37 31.64 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.434 1.094 . . . . 0.29999999999999999 112.011 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.81 91.22 2.95 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 112.649 0.611 . . . . 1.8700000000000001 112.649 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.46 -66.22 3.53 Favored Glycine 0 C--N 1.358 1.786 0 N-CA-C 119.03 2.372 . . . . 0.91000000000000003 119.03 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.17 156.87 44.57 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.142 1.164 . . . . 1.6799999999999999 114.142 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.429 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -105.98 133.45 50.68 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 113.035 -1.893 . . . . 1.3700000000000001 108.545 176.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.6 t -120.14 143.7 48.05 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.737 1.754 . . . . 0.94999999999999996 115.737 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.425 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -115.51 100.29 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.945 -1.132 . . . . 1.3799999999999999 107.945 176.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.81 125.28 49.21 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.978 -0.555 . . . . 1.6699999999999999 111.952 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.81 132.73 56.62 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.09 0.947 . . . . 2.2999999999999998 111.771 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 t -110.35 143.28 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.911 0 CA-C-N 113.381 -1.736 . . . . 1.29 109.674 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 151.85 22.19 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.756 1.391 . . . . 2.6200000000000001 114.756 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.78 -26.64 7.05 Favored Glycine 0 CA--C 1.55 2.253 0 CA-C-N 115.027 -0.988 . . . . 1.0600000000000001 115.254 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -132.01 -78.81 0.51 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.045 0.922 . . . . 3.1000000000000001 112.616 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -135.87 -49.41 0.69 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.078 0.551 . . . . 4.0800000000000001 111.518 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.538 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -94.42 135.43 35.85 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.591 1.156 . . . . 1.74 111.521 178.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -94.26 -169.83 0.21 Allowed Pre-proline 0 CA--C 1.568 1.667 0 CA-C-N 113.979 -1.464 . . . . 1.6799999999999999 108.576 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -66.55 99.99 0.46 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 CA-C-N 122.311 1.861 . . . . 2.8199999999999998 111.3 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -57.18 -49.92 74.48 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.498 1.666 . . . . 3.4100000000000001 115.498 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.0 t -110.56 130.99 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.076 -0.713 . . . . 1.3799999999999999 109.076 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -136.9 124.72 22.56 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 113.597 -1.638 . . . . 1.75 111.482 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 60' ' ' LEU 0.256 . . -121.31 49.97 1.44 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.75 1.759 . . . . 1.1299999999999999 115.75 -176.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.69 135.15 2.98 Favored 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 116.175 1.917 . . . . 1.3999999999999999 116.175 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -153.6 100.67 2.42 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.38 -0.827 . . . . 0.26000000000000001 110.6 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 12' ' ' TRP 0.308 5.2 tt -109.26 122.48 63.96 Favored 'Isoleucine or valine' 0 C--O 1.27 2.156 0 CA-C-O 122.346 1.069 . . . . 1.1000000000000001 111.383 176.136 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -120.27 154.2 35.28 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 113.755 -1.566 . . . . 1.0600000000000001 112.221 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 50.5 tttm -105.92 150.0 26.07 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 118.09 2.626 . . . . 1.8300000000000001 118.09 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.43 -39.59 2.77 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 110.98 -2.827 . . . . 0.17000000000000001 119.805 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.73 164.12 1.21 Allowed 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 121.218 2.509 . . . . 1.05 112.571 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.88 -16.07 48.98 Favored 'General case' 0 CA--C 1.579 2.085 0 C-N-CA 124.722 1.209 . . . . 0.98999999999999999 113.8 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.36 4.65 45.42 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.363 1.246 . . . . 0.55000000000000004 114.363 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.531 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -103.3 -11.89 17.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.27 1.211 . . . . 0.59999999999999998 114.27 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.44 99.82 0.7 Allowed Pre-proline 0 N--CA 1.513 2.713 0 C-N-CA 124.036 0.934 . . . . 1.1799999999999999 113.08 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 8.7 Cg_exo -79.64 131.23 9.2 Favored 'Trans proline' 0 C--N 1.401 3.308 0 C-N-CA 123.025 2.483 . . . . 2.0299999999999998 114.309 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 15.6 ttt -145.69 117.63 8.25 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.818 -0.628 . . . . 5.3399999999999999 111.058 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.1 mt -131.04 163.48 27.52 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 122.058 0.932 . . . . 4.0 112.665 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -104.72 158.05 32.83 Favored Pre-proline 0 CA--C 1.558 1.28 0 CA-C-N 114.608 -1.178 . . . . 6.7000000000000002 110.841 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.5 121.67 8.79 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 122.479 2.119 . . . . 6.9400000000000004 115.034 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.649 ' HD1' ' H ' ' A' ' 188' ' ' GLY . 40.3 t-80 -135.79 136.49 23.54 Favored Pre-proline 0 CA--C 1.569 1.675 0 CA-C-N 114.86 -1.063 . . . . 5.5099999999999998 111.134 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.52 -19.21 13.22 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 123.702 2.935 . . . . 7.1600000000000001 116.674 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.649 ' H ' ' HD1' ' A' ' 186' ' ' HIS . . . -108.6 -69.71 0.66 Allowed Glycine 0 CA--C 1.534 1.258 0 N-CA-C 115.07 0.788 . . . . 7.0199999999999996 115.07 -177.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.0 tp -117.6 133.65 55.72 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.226 0.536 . . . . 9.3000000000000007 112.205 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.332 -0.842 . . . . 10.6 111.267 -179.784 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.514 -0.234 . . . . 9.3599999999999994 112.514 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.47 127.96 55.85 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.631 0.729 . . . . 6.8499999999999996 111.945 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -133.42 110.14 9.8 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.6 -0.727 . . . . 8.0 111.194 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 m -135.96 117.38 14.72 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.781 -0.645 . . . . 4.1500000000000004 111.789 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.26 92.65 0.09 OUTLIER Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.683 -0.689 . . . . 1.6000000000000001 113.158 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.6 tp -87.73 -45.43 10.36 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.22 0.822 . . . . 1.0900000000000001 113.22 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.51 -23.07 64.26 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 125.807 1.643 . . . . 1.04 114.965 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.49 -12.53 48.65 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 113.632 0.975 . . . . 0.32000000000000001 113.632 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -104.19 -23.58 13.24 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-O 118.211 -0.9 . . . . 2.2599999999999998 113.227 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.49 133.36 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 N-CA-C 115.094 1.516 . . . . 1.01 115.094 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pt -120.52 -28.28 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.183 -0.917 . . . . 1.0600000000000001 112.264 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.454 ' O ' HG22 ' A' ' 172' ' ' ILE . 62.4 t90 -163.97 116.91 1.43 Allowed 'General case' 0 CA--C 1.558 1.27 0 CA-C-O 120.583 0.23 . . . . 0.67000000000000004 111.141 -177.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.32 130.87 35.71 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.569 -0.707 . . . . 1.0800000000000001 111.202 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.74 129.69 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.422 0.897 . . . . 1.6699999999999999 113.422 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -117.05 105.23 12.06 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.01 -1.478 . . . . 2.6400000000000001 107.01 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.17 108.22 12.51 Favored 'General case' 0 C--O 1.254 1.305 0 CA-C-O 121.639 0.733 . . . . 1.28 111.553 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.2 -43.71 0.37 Allowed Glycine 0 C--N 1.351 1.374 0 CA-C-N 114.265 -1.334 . . . . 0.70999999999999996 115.652 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -115.15 -121.25 3.45 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 117.564 0.682 . . . . 0.87 113.892 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 18.1 mt-10 -164.83 115.36 1.16 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.295 0.638 . . . . 2.1200000000000001 111.133 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 1.1 m 42.85 110.15 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 118.589 2.811 . . . . 1.5 118.589 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.55 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 78.1 t60 -136.58 131.79 34.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.358 1.244 . . . . 0.52000000000000002 114.358 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.401 ' HB ' ' ND1' ' A' ' 28' ' ' HIS . 9.6 p -104.93 114.48 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 113.958 -1.474 . . . . 2.0699999999999998 108.967 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -85.21 165.83 17.06 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 115.107 -0.951 . . . . 1.8500000000000001 113.155 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -44.59 -30.46 0.67 Allowed 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 N-CA-C 118.667 2.84 . . . . 1.3700000000000001 118.667 -176.532 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -89.17 -27.04 20.96 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.233 0.539 . . . . 0.56999999999999995 110.936 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.54 42.66 0.57 Allowed Glycine 0 C--N 1.351 1.393 0 CA-C-N 114.82 -1.082 . . . . 0.37 114.059 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.2 mm -107.54 117.05 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-O 121.107 0.48 . . . . 1.25 110.195 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.55 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.4 t60 -106.52 131.61 53.48 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.882 1.438 . . . . 1.71 114.882 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.556 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -93.07 137.41 32.45 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 124.058 0.943 . . . . 3.1499999999999999 109.639 175.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.464 ' O ' ' HG3' ' A' ' 33' ' ' PRO . 12.9 ptm180 -99.0 105.86 18.06 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 114.54 -1.209 . . . . 3.5099999999999998 113.335 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -23.14 119.84 0.04 OUTLIER 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 120.57 3.545 . . . . 2.8100000000000001 120.57 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 34.42 54.17 1.59 Allowed Pre-proline 0 N--CA 1.536 3.868 0 N-CA-C 119.576 3.176 . . . . 1.1699999999999999 119.576 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -110.65 104.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.569 2.268 0 C-N-CA 123.423 2.749 . . . . 1.45 116.908 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.64 -90.58 0.53 Allowed 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.598 -0.728 . . . . 2.2400000000000002 110.253 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.42 58.81 0.95 Allowed 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 112.755 0.65 . . . . 4.8399999999999999 112.755 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.94 1.62 28.57 Favored Glycine 0 CA--C 1.547 2.041 0 N-CA-C 115.594 0.997 . . . . 2.9700000000000002 115.594 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.401 ' HD2' ' N ' ' A' ' 37' ' ' ARG . 2.6 mpt_? -104.42 77.35 1.38 Allowed 'General case' 0 C--N 1.356 0.87 0 CA-C-N 117.793 0.797 . . . . 4.79 111.841 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.73 116.08 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 115.769 -0.651 . . . . 3.1499999999999999 112.405 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.01 50.43 0.73 Allowed Glycine 0 CA--C 1.538 1.523 0 N-CA-C 115.233 0.853 . . . . 2.7200000000000002 115.233 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -162.14 97.3 1.02 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 117.625 0.713 . . . . 5.9500000000000002 111.102 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.66 136.64 46.1 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.565 0.746 . . . . 1.78 111.602 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.1 m -122.6 107.97 12.59 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-O 121.313 0.577 . . . . 1.6599999999999999 112.382 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -124.66 71.39 1.16 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.365 -0.834 . . . . 2.3300000000000001 110.616 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -110.82 72.72 0.79 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.99 -1.004 . . . . 3.3300000000000001 110.527 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.85 63.37 0.02 OUTLIER Glycine 0 CA--C 1.528 0.861 0 CA-C-N 114.933 -1.03 . . . . 1.7 113.334 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 5.8 mmt -92.75 -0.09 57.33 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.149 0.796 . . . . 2.0800000000000001 113.149 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -105.91 24.21 12.72 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 113.679 0.992 . . . . 4.6200000000000001 113.679 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.0 mt -139.59 74.59 33.38 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.888 -1.152 . . . . 3.1600000000000001 107.888 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -62.45 166.65 12.8 Favored 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 124.666 3.577 . . . . 1.8600000000000001 117.288 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 61' ' ' TYR 0.262 1.0 OUTLIER -93.85 123.28 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.777 0 CA-C-N 115.237 -0.892 . . . . 1.28 109.472 178.908 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 7.3 mt -89.22 101.71 14.37 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.871 0.843 . . . . 1.9299999999999999 112.374 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 1.5 mpt_? 148.01 -13.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.158 2.183 . . . . 1.79 110.578 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.54 -179.01 3.56 Favored 'General case' 0 CA--C 1.567 1.599 0 C-N-CA 123.767 0.827 . . . . 1.49 113.09 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -95.77 -176.88 0.58 Allowed Pre-proline 0 N--CA 1.51 2.556 0 C-N-CA 124.402 1.081 . . . . 1.6799999999999999 109.421 178.467 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.445 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 31.3 Cg_exo -68.51 -39.13 9.91 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.679 2.253 . . . . 1.1599999999999999 113.963 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -67.2 -54.28 22.55 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 125.04 1.336 . . . . 2.04 112.124 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.55 -5.37 47.34 Favored 'General case' 0 CA--C 1.576 1.947 0 CA-C-N 114.979 -1.01 . . . . 1.6200000000000001 112.746 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.508 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 27.5 tt0 -71.64 -44.14 64.86 Favored 'General case' 0 C--N 1.382 2.015 0 C-N-CA 125.539 1.536 . . . . 2.4300000000000002 108.07 173.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.37 -38.89 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 C-N-CA 124.055 0.942 . . . . 1.46 109.481 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -82.54 -8.36 59.61 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 114.116 1.154 . . . . 1.6699999999999999 114.116 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.418 ' O ' HG12 ' A' ' 50' ' ' ILE . 20.4 m-85 -125.02 21.36 8.16 Favored 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.222 1.009 . . . . 1.3300000000000001 112.928 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.416 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -143.8 -31.53 0.46 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 115.27 1.582 . . . . 1.4099999999999999 115.27 -177.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.8 p -73.12 134.23 44.4 Favored 'General case' 0 N--CA 1.524 3.231 0 N-CA-C 114.3 1.222 . . . . 1.28 114.3 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.94 140.49 52.94 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 114.672 1.36 . . . . 1.53 114.672 -176.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 ttp85 -110.24 142.45 41.82 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.617 -1.174 . . . . 3.8300000000000001 111.151 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -108.21 130.9 55.12 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.545 0.572 . . . . 3.7599999999999998 112.545 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -125.1 -89.52 0.57 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.491 -0.777 . . . . 5.3700000000000001 111.339 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -162.58 -79.27 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 112.398 0.518 . . . . 2.5499999999999998 112.398 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -170.45 123.52 0.67 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.283 1.033 . . . . 2.1499999999999999 109.337 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.83 86.53 0.12 Allowed 'General case' 0 N--CA 1.517 2.885 0 C-N-CA 124.717 1.207 . . . . 1.25 111.674 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -140.51 149.74 42.85 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.998 0.904 . . . . 1.1499999999999999 112.68 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.87 -176.75 31.27 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 114.303 -1.317 . . . . 0.59999999999999998 115.821 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 169.55 10.16 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 114.117 -1.042 . . . . 1.4099999999999999 113.729 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.06 131.16 52.2 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.662 -1.154 . . . . 0.51000000000000001 111.895 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.1 103.12 33.47 Favored Pre-proline 0 CA--C 1.57 1.719 0 C-N-CA 123.107 0.563 . . . . 1.0600000000000001 109.567 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -84.15 117.18 2.16 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.264 1.976 . . . . 0.17999999999999999 114.657 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.26 157.94 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.625 0 CA-C-O 122.053 0.93 . . . . 1.0600000000000001 111.112 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -146.13 24.38 1.3 Allowed 'General case' 0 CA--C 1.557 1.236 0 CA-C-N 114.654 -1.157 . . . . 3.1099999999999999 112.008 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -128.62 160.16 33.3 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 121.268 0.556 . . . . 2.1200000000000001 111.194 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.04 142.02 50.21 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.069 1.137 . . . . 0.41999999999999998 114.069 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.85 -137.34 4.91 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 113.696 -1.593 . . . . 0.25 112.121 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -115.63 112.13 21.67 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 118.436 1.118 . . . . 1.75 111.276 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.467 ' HH ' ' HE2' ' A' ' 174' ' ' LYS . 79.7 m-85 -104.49 128.37 52.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.147 -0.479 . . . . 0.90000000000000002 110.896 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -110.35 119.33 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 121.977 0.894 . . . . 1.0700000000000001 110.427 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 tt -107.34 104.61 14.24 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.79 -1.55 . . . . 1.47 109.648 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.95 126.42 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 CA-C-N 114.367 -1.288 . . . . 1.27 108.57 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.52 135.52 49.52 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.594 -0.73 . . . . 1.8899999999999999 112.418 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.4 tppt? -101.5 118.2 36.46 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.447 0.641 . . . . 2.8999999999999999 110.556 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -105.54 134.54 48.5 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.256 -0.884 . . . . 0.48999999999999999 110.571 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.39 151.53 41.94 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.182 0.515 . . . . 1.1000000000000001 112.266 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -147.83 135.23 20.65 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.118 0.567 . . . . 2.6099999999999999 110.967 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.275 7.5 p -147.06 86.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.388 0 CA-C-O 121.591 0.71 . . . . 2.6099999999999999 111.851 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -175.12 -46.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.602 -0.726 . . . . 2.71 112.139 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -115.56 139.52 50.0 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 121.193 0.52 . . . . 1.6899999999999999 112.008 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -112.85 99.68 8.08 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.191 0.996 . . . . 1.4299999999999999 111.004 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -158.74 140.85 13.89 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.317 -0.856 . . . . 2.9700000000000002 112.313 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.7 m -120.74 130.45 54.05 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.341 -0.845 . . . . 1.6599999999999999 112.219 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 80.53 10.51 1.09 Allowed 'General case' 0 N--CA 1.519 2.987 0 C-N-CA 125.857 1.663 . . . . 2.02 114.494 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -117.49 -25.71 6.88 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.711 0.804 . . . . 2.5600000000000001 112.259 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -107.03 79.41 1.32 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.484 0.714 . . . . 3.1499999999999999 109.393 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . 0.261 1.2 t -109.81 126.6 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 CA-C-N 114.998 -1.001 . . . . 1.3600000000000001 110.091 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -118.87 174.31 6.37 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 114.652 1.352 . . . . 0.84999999999999998 114.652 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.93 136.34 54.92 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.921 -0.487 . . . . 1.3300000000000001 111.19 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.2 t -124.99 123.65 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 C-N-CA 123.056 0.543 . . . . 1.1699999999999999 110.07 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 51.8 mtt180 -121.14 147.13 45.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.653 1.353 . . . . 1.9399999999999999 114.653 -178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 154' ' ' SER . 50.8 t -130.56 109.75 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.252 0 N-CA-C 107.68 -1.23 . . . . 1.29 107.68 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.43 26.89 16.03 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 126.992 2.117 . . . . 1.8200000000000001 114.574 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.12 -19.58 40.14 Favored Glycine 0 CA--C 1.548 2.097 0 N-CA-C 114.554 0.582 . . . . 0.32000000000000001 114.554 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -91.01 154.51 19.38 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 124.837 1.255 . . . . 0.56999999999999995 113.375 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.3 p -102.93 127.9 49.95 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.609 0.718 . . . . 1.1899999999999999 111.638 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.07 -50.63 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.582 -1.19 . . . . 1.73 110.342 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.43 88.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 119.996 -0.682 . . . . 1.25 110.237 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -106.92 119.23 38.79 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-O 122.41 1.1 . . . . 2.75 110.076 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 102.96 59.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 128.434 2.694 . . . . 2.48 107.6 -175.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.34 96.9 10.76 Favored 'General case' 0 C--N 1.373 1.596 0 CA-C-O 121.634 0.731 . . . . 1.78 112.714 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -107.64 97.81 7.49 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 113.652 -1.613 . . . . 2.3500000000000001 107.448 175.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.08 -30.01 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.458 0 N-CA-C 114.244 1.201 . . . . 1.27 114.244 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -73.89 -41.88 61.5 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 123.481 0.712 . . . . 0.83999999999999997 112.218 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -72.24 -25.84 61.78 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 124.537 1.135 . . . . 0.91000000000000003 113.55 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -79.53 -57.8 3.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 113.701 1.0 . . . . 2.98 113.701 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.48 -37.89 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.515 0 N-CA-C 114.516 1.302 . . . . 1.53 114.516 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.62 -115.36 1.89 Allowed Glycine 0 C--N 1.354 1.557 0 C-N-CA 121.194 -0.527 . . . . 0.84999999999999998 113.38 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -114.87 108.06 16.23 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.957 0.408 . . . . 3.9700000000000002 110.422 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.7 m 73.33 -126.2 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 125.466 1.506 . . . . 2.0800000000000001 111.845 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.6 p 57.54 -165.6 0.15 Allowed 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 126.066 1.746 . . . . 1.22 115.343 177.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.99 127.57 56.01 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 112.684 0.624 . . . . 1.2 112.684 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -103.53 138.83 39.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.465 -0.569 . . . . 0.41999999999999998 109.465 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -144.59 129.37 18.28 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.78 1.03 . . . . 2.5 113.78 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -117.41 129.94 56.17 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-N 114.759 -1.11 . . . . 1.5800000000000001 110.939 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.53 111.59 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 114.493 -1.231 . . . . 1.25 110.658 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.5 mm -115.8 92.11 32.97 Favored Pre-proline 0 CA--C 1.582 2.178 0 CA-C-N 115.639 -0.71 . . . . 1.5 110.706 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -77.19 126.33 8.47 Favored 'Trans proline' 0 C--N 1.392 2.824 0 C-N-CA 122.568 2.178 . . . . 0.22 113.032 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.88 150.81 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 C-N-CA 123.991 0.916 . . . . 1.1200000000000001 111.067 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.0 t -136.7 118.0 14.6 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.524 0.678 . . . . 1.8600000000000001 111.775 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -116.98 126.05 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 CA-C-N 114.759 -1.11 . . . . 1.0700000000000001 108.446 178.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -139.37 122.74 17.13 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.622 -0.717 . . . . 2.6400000000000001 110.817 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt 67.67 16.16 9.78 Favored 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 125.279 1.432 . . . . 4.0199999999999996 114.431 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.75 15.93 35.37 Favored Glycine 0 CA--C 1.547 2.067 0 CA-C-O 119.348 -0.696 . . . . 0.39000000000000001 114.67 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 36.8 mtpt -122.02 145.34 48.23 Favored 'General case' 0 C--N 1.363 1.19 0 CA-C-N 118.088 0.944 . . . . 2.0299999999999998 111.759 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.31 150.81 23.4 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.116 1.525 . . . . 1.0800000000000001 115.116 -175.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.32 109.81 6.6 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 113.92 -1.491 . . . . 1.23 109.335 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.1 p -111.1 94.84 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.5 0 CA-C-N 116.025 -0.534 . . . . 1.1899999999999999 110.625 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 67.81 -84.73 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.74 0 C-N-CA 125.416 1.486 . . . . 1.8200000000000001 113.799 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.09 24.62 5.35 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 115.981 -0.554 . . . . 0.51000000000000001 113.263 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -125.7 147.07 49.48 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.726 0.811 . . . . 1.8200000000000001 111.606 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.0 p -129.18 125.87 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.157 0 CA-C-N 115.583 -0.735 . . . . 1.5900000000000001 110.936 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.4 m -149.23 -175.72 5.09 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.225 -0.898 . . . . 1.1699999999999999 110.129 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.0 p -103.8 138.16 40.8 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 112.95 0.722 . . . . 1.71 112.95 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -85.93 123.75 31.61 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 123.548 0.739 . . . . 0.29999999999999999 111.114 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.0 t -129.21 90.94 3.1 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.533 0.682 . . . . 1.8700000000000001 112.733 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.35 -63.36 2.96 Favored Glycine 0 C--N 1.359 1.832 0 N-CA-C 119.043 2.377 . . . . 0.91000000000000003 119.043 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.542 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -130.64 157.15 43.53 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.277 1.214 . . . . 1.6799999999999999 114.277 -176.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.542 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 1.8 tp -104.13 140.81 37.27 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 112.805 -1.998 . . . . 1.3700000000000001 109.41 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.6 t -122.95 144.03 49.51 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.939 1.459 . . . . 0.94999999999999996 114.939 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -120.3 96.57 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.764 -1.199 . . . . 1.3799999999999999 107.764 176.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -118.92 123.5 44.78 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 112.537 0.569 . . . . 1.6699999999999999 112.537 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -115.07 130.64 56.98 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 122.273 1.035 . . . . 2.2999999999999998 111.416 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.14 144.8 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-N 112.724 -2.035 . . . . 1.29 110.867 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.6 150.2 25.34 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 113.991 -1.459 . . . . 2.6200000000000001 114.38 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -100.71 -55.58 0.94 Allowed Glycine 0 CA--C 1.541 1.676 0 CA-C-N 115.281 -0.872 . . . . 1.0600000000000001 114.004 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -128.13 -85.98 0.57 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.031 0.416 . . . . 3.1000000000000001 111.535 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.563 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 61.6 m-85 -133.82 120.6 20.67 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.391 0.676 . . . . 4.0800000000000001 109.792 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 1.0 OUTLIER 87.68 136.54 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 124.86 1.264 . . . . 1.74 111.233 -177.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.52 -168.56 0.19 Allowed Pre-proline 0 CA--C 1.58 2.104 0 CA-C-N 114.621 -1.172 . . . . 1.6799999999999999 110.404 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.07 -15.51 34.1 Favored 'Trans proline' 0 N--CA 1.523 3.206 0 C-N-CA 122.675 2.25 . . . . 2.8199999999999998 115.581 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 77.6 tttt 79.91 -65.1 0.19 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 126.444 1.897 . . . . 3.4100000000000001 114.229 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 38.9 t -106.76 132.27 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 109.791 -0.448 . . . . 1.3799999999999999 109.791 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -135.95 120.58 18.3 Favored 'General case' 0 C--N 1.358 0.943 0 CA-C-N 114.413 -1.267 . . . . 1.75 111.052 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -115.23 49.22 1.08 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.276 1.954 . . . . 1.1299999999999999 116.276 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.75 132.34 3.8 Favored 'General case' 0 N--CA 1.514 2.725 0 N-CA-C 116.069 1.877 . . . . 1.3999999999999999 116.069 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -150.43 100.35 2.86 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.368 -0.833 . . . . 0.26000000000000001 110.525 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 12' ' ' TRP 0.308 13.7 tt -110.3 121.81 63.77 Favored 'Isoleucine or valine' 0 C--O 1.266 1.929 0 CA-C-O 122.42 1.105 . . . . 1.1000000000000001 111.42 176.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -123.5 155.06 38.26 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 113.675 -1.602 . . . . 1.0600000000000001 111.325 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' HE2' ' HH ' ' A' ' 83' ' ' TYR . 60.1 tttm -104.91 148.21 26.93 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 119.252 3.056 . . . . 1.8300000000000001 119.252 -173.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 105.02 -42.36 1.92 Allowed Glycine 0 CA--C 1.541 1.715 0 CA-C-N 110.316 -3.129 . . . . 0.17000000000000001 120.582 171.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.73 157.78 1.25 Allowed 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 121.177 2.489 . . . . 1.05 113.371 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.7 -13.09 60.07 Favored 'General case' 0 CA--C 1.581 2.172 0 C-N-CA 124.897 1.279 . . . . 0.98999999999999999 114.421 177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.0 2.42 51.81 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 113.953 1.094 . . . . 0.55000000000000004 113.953 177.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.585 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.9 OUTLIER -107.26 -5.78 17.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.629 0.974 . . . . 0.59999999999999998 113.629 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.31 93.35 0.66 Allowed Pre-proline 0 N--CA 1.506 2.346 0 C-N-CA 124.265 1.026 . . . . 1.1799999999999999 111.916 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 68.8 Cg_endo -92.05 149.36 3.17 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 122.92 2.413 . . . . 2.0299999999999998 114.578 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 8.6 tpt -135.86 119.9 17.59 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.766 -0.652 . . . . 5.3399999999999999 111.278 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.1 mt -129.78 164.31 24.33 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 122.051 0.929 . . . . 4.0 112.637 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -107.02 160.86 24.82 Favored Pre-proline 0 CA--C 1.564 1.514 0 CA-C-N 114.658 -1.155 . . . . 6.7000000000000002 110.857 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -66.73 122.3 9.66 Favored 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 122.593 2.195 . . . . 6.9400000000000004 114.722 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -135.7 133.42 20.11 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-N 115.32 -0.855 . . . . 5.5099999999999998 111.242 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -85.53 -156.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.387 2.725 . . . . 7.1600000000000001 114.069 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 169.6 104.71 0.18 Allowed Glycine 0 C--N 1.341 0.829 0 C-N-CA 121.084 -0.579 . . . . 7.0199999999999996 113.149 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.6 mt -118.49 109.58 16.38 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.025 0.44 . . . . 9.3000000000000007 111.773 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.268 -0.872 . . . . 10.6 111.024 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 112.487 -0.245 . . . . 9.3599999999999994 112.487 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.56 132.32 54.62 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.509 0.671 . . . . 6.8499999999999996 111.835 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.5 mtt -130.11 113.49 14.57 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.825 -0.625 . . . . 8.0 111.595 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 m -136.51 109.68 7.78 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.597 -0.729 . . . . 4.1500000000000004 111.571 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.86 89.51 0.08 OUTLIER Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.628 -0.714 . . . . 1.6000000000000001 112.897 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.6 tp -87.93 -45.67 10.04 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 113.323 0.86 . . . . 1.0900000000000001 113.323 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.64 -23.45 63.04 Favored 'General case' 0 N--CA 1.509 2.505 0 C-N-CA 125.899 1.68 . . . . 1.04 114.971 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.39 -11.96 50.53 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 113.621 0.971 . . . . 0.32000000000000001 113.621 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 46.2 mmtt -105.39 -22.25 13.07 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 113.342 0.867 . . . . 2.2599999999999998 113.342 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.02 135.7 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 115.103 1.52 . . . . 1.01 115.103 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.86 -28.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.455 -0.793 . . . . 1.0600000000000001 112.035 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.484 ' O ' HG23 ' A' ' 172' ' ' ILE . 66.4 t90 -162.52 118.81 1.93 Allowed 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 120.657 0.265 . . . . 0.67000000000000004 111.116 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.72 129.63 24.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.41 -0.806 . . . . 1.0800000000000001 111.62 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 t -133.36 124.55 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.404 0.621 . . . . 1.6699999999999999 110.064 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -113.96 88.71 2.91 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.105 -1.072 . . . . 2.6400000000000001 108.105 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.66 114.02 10.33 Favored 'General case' 0 C--O 1.274 2.356 0 N-CA-C 115.833 1.79 . . . . 1.28 115.833 -174.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.61 -46.28 0.63 Allowed Glycine 0 C--N 1.368 2.309 0 CA-C-N 112.079 -2.328 . . . . 0.70999999999999996 114.438 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.44 -123.96 3.04 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 123.641 0.639 . . . . 0.87 114.029 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -170.0 112.33 0.46 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.809 1.243 . . . . 2.1200000000000001 108.951 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.605 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 1.1 m 40.85 97.21 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.11 0 N-CA-C 116.968 2.211 . . . . 1.5 116.968 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 70.4 t60 -126.92 132.16 50.94 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.705 1.372 . . . . 0.52000000000000002 114.705 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 27' ' ' ILE 0.255 8.8 p -106.33 114.07 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.867 0 CA-C-N 114.135 -1.393 . . . . 2.0699999999999998 110.023 177.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.408 ' OD2' ' HB ' ' A' ' 27' ' ' ILE . 1.7 p-10 -82.85 160.78 22.11 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.674 -1.148 . . . . 1.8500000000000001 113.063 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 m -43.51 -24.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 N-CA-C 118.816 2.895 . . . . 1.3700000000000001 118.816 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -90.7 -29.54 17.64 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 121.164 0.507 . . . . 0.56999999999999995 110.695 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 41.09 0.57 Allowed Glycine 0 C--N 1.353 1.512 0 CA-C-N 114.953 -1.021 . . . . 0.37 114.606 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 22' ' ' VAL . 30.7 mm -107.95 124.33 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 N-CA-C 109.504 -0.554 . . . . 1.25 109.504 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.499 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.4 t-160 -114.02 130.48 56.55 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.201 1.556 . . . . 1.71 115.201 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.605 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -83.87 136.93 33.92 Favored 'General case' 0 C--N 1.372 1.573 0 C-N-CA 124.019 0.928 . . . . 3.1499999999999999 110.778 175.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -88.89 101.98 14.59 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.716 1.26 . . . . 3.5099999999999998 112.86 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -31.06 98.28 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 129.07 2.948 . . . . 2.8100000000000001 118.792 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.599 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.3 OUTLIER 44.64 72.45 1.21 Allowed Pre-proline 0 N--CA 1.523 3.219 0 N-CA-C 117.489 2.403 . . . . 1.1699999999999999 117.489 178.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -101.65 15.85 0.33 Allowed 'Trans proline' 0 CA--C 1.564 1.983 0 C-N-CA 122.556 2.171 . . . . 1.45 116.812 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 24.2 tp -143.01 -60.5 0.43 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.518 0.932 . . . . 2.2400000000000002 113.518 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -90.33 84.77 6.07 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.408 0.892 . . . . 4.8399999999999999 113.408 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.89 -32.17 7.8 Favored Glycine 0 CA--C 1.542 1.744 0 CA-C-N 114.2 -1.364 . . . . 2.9700000000000002 114.083 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 45.77 53.18 9.02 Favored 'General case' 0 N--CA 1.518 2.965 0 C-N-CA 127.498 2.319 . . . . 4.79 116.077 -179.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.92 179.29 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 124.386 1.074 . . . . 3.1499999999999999 110.829 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.35 81.45 0.85 Allowed Glycine 0 C--N 1.353 1.51 0 N-CA-C 114.4 0.52 . . . . 2.7200000000000002 114.4 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -154.27 136.31 14.68 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.311 0.576 . . . . 5.9500000000000002 111.591 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.29 136.65 41.74 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.858 0.863 . . . . 1.78 111.688 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.447 ' H ' HH21 ' A' ' 65' ' ' ARG . 29.9 m -113.28 104.05 11.94 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.825 -0.625 . . . . 1.6599999999999999 110.995 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.2 90.35 3.25 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.198 -0.91 . . . . 2.3300000000000001 110.345 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -94.92 -36.96 11.4 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.705 0.632 . . . . 3.3300000000000001 112.705 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.22 68.07 0.24 Allowed Glycine 0 C--N 1.353 1.478 0 N-CA-C 111.329 -0.708 . . . . 1.7 111.329 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.3 ttt -93.25 1.12 57.17 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 115.11 1.522 . . . . 2.0800000000000001 115.11 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.1 36.14 2.89 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 112.878 0.696 . . . . 4.6200000000000001 112.878 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.2 mt -152.08 72.92 7.82 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.639 1.175 . . . . 3.1600000000000001 108.344 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -65.08 162.14 34.1 Favored 'Trans proline' 0 N--CA 1.514 2.709 0 C-N-CA 124.421 3.414 . . . . 1.8600000000000001 116.818 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.261 1.2 mp -88.72 131.16 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.158 0 CA-C-O 121.779 0.799 . . . . 1.28 110.156 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mt -90.83 -11.6 38.87 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 116.384 1.994 . . . . 1.9299999999999999 116.384 -176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -101.12 9.04 42.47 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 114.414 1.264 . . . . 1.79 114.414 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.97 -169.79 2.23 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 121.426 0.631 . . . . 1.49 112.603 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.788 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -94.23 -179.84 1.08 Allowed Pre-proline 0 N--CA 1.516 2.831 0 C-N-CA 124.453 1.101 . . . . 1.6799999999999999 109.351 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -69.63 -39.57 6.59 Favored 'Trans proline' 0 C--N 1.398 3.166 0 C-N-CA 122.637 2.224 . . . . 1.1599999999999999 112.772 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -66.56 -52.84 41.11 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 125.988 1.715 . . . . 2.04 111.73 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.609 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -80.69 3.95 20.4 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 113.166 -1.834 . . . . 1.6200000000000001 113.183 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.788 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 32.4 tt0 -85.99 -40.71 15.54 Favored 'General case' 0 C--N 1.371 1.513 0 C-N-CA 125.868 1.667 . . . . 2.4300000000000002 107.773 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -63.17 -43.02 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 C-N-CA 125.038 1.335 . . . . 1.46 110.12 174.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.25 -42.9 54.13 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 118.441 0.564 . . . . 1.6699999999999999 111.786 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.609 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 2.8 m-30 -74.47 1.08 12.69 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 124.456 1.103 . . . . 1.3300000000000001 112.822 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.439 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 3.2 tt0 -131.98 -127.13 0.19 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.538 0.735 . . . . 1.4099999999999999 110.51 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.6 p 52.15 -145.59 0.54 Allowed 'General case' 0 N--CA 1.533 3.713 0 C-N-CA 126.076 1.751 . . . . 1.28 112.98 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 175.28 123.13 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.69 0 CA-C-N 120.633 1.561 . . . . 1.53 114.036 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.447 HH21 ' H ' ' A' ' 42' ' ' SER . 0.3 OUTLIER -117.35 125.24 50.7 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.634 -1.166 . . . . 3.8300000000000001 110.355 177.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -133.76 145.96 50.3 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.942 0.719 . . . . 3.7599999999999998 112.942 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -130.01 -87.29 0.52 Allowed 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.695 -0.684 . . . . 5.3700000000000001 112.406 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -150.52 -87.76 0.07 Allowed 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 113.227 0.825 . . . . 2.5499999999999998 113.227 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -161.31 125.96 3.51 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.436 0.695 . . . . 2.1499999999999999 110.921 -176.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.541 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER 69.58 83.31 0.15 Allowed 'General case' 0 N--CA 1.511 2.607 0 C-N-CA 125.147 1.379 . . . . 1.25 112.399 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -147.61 153.41 39.36 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.873 0.694 . . . . 1.1499999999999999 112.873 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.61 179.4 47.63 Favored Glycine 0 C--N 1.349 1.282 0 N-CA-C 116.259 1.264 . . . . 0.59999999999999998 116.259 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -100.35 173.64 6.5 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 117.357 2.354 . . . . 1.4099999999999999 117.357 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.02 120.95 23.11 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 112.617 -2.083 . . . . 0.51000000000000001 111.006 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.03 109.4 52.29 Favored Pre-proline 0 CA--C 1.568 1.672 0 C-N-CA 123.371 0.668 . . . . 1.0600000000000001 109.606 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -84.79 118.2 2.07 Favored 'Trans proline' 0 CA--C 1.566 2.125 0 C-N-CA 121.918 1.746 . . . . 0.17999999999999999 114.427 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.97 159.23 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 CA-C-O 122.052 0.93 . . . . 1.0600000000000001 111.638 -179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -150.33 23.19 0.83 Allowed 'General case' 0 CA--C 1.56 1.343 0 CA-C-N 114.51 -1.223 . . . . 3.1099999999999999 111.859 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -129.25 158.74 38.21 Favored 'General case' 0 C--N 1.362 1.136 0 CA-C-O 121.166 0.508 . . . . 2.1200000000000001 111.344 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.422 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -120.33 144.3 47.92 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.743 1.016 . . . . 0.41999999999999998 113.743 -178.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.86 -135.64 4.01 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 113.751 -1.568 . . . . 0.25 111.953 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -118.73 107.31 13.51 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 118.23 1.015 . . . . 1.75 111.101 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -99.35 128.38 45.46 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.252 0.549 . . . . 0.90000000000000002 111.041 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 t -112.02 124.01 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 115.674 -0.694 . . . . 1.0700000000000001 110.548 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.1 tt -107.87 106.44 16.72 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.675 -1.148 . . . . 1.47 109.858 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.62 128.06 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 113.947 -1.479 . . . . 1.27 108.492 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.58 141.34 47.64 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.432 -0.804 . . . . 1.8899999999999999 112.6 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.499 ' HD3' ' C ' ' A' ' 88' ' ' LYS . 0.5 OUTLIER -107.11 123.52 48.36 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 122.022 0.915 . . . . 2.8999999999999999 110.331 176.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.53 137.07 46.22 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 114.16 -1.382 . . . . 0.48999999999999999 110.238 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -131.14 151.84 51.04 Favored 'General case' 0 C--O 1.266 1.922 0 CA-C-N 114.979 -1.009 . . . . 1.1000000000000001 110.916 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -124.12 123.89 41.31 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 123.788 0.835 . . . . 2.6099999999999999 110.705 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.265 5.4 p -138.02 41.19 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.766 0 N-CA-C 112.567 0.58 . . . . 2.6099999999999999 112.567 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -161.8 -42.86 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.75 0.648 . . . . 2.71 112.75 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -115.36 119.48 36.42 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.218 0.451 . . . . 1.6899999999999999 112.218 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.81 86.17 2.35 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-O 122.73 1.253 . . . . 1.4299999999999999 111.134 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -158.57 160.57 36.76 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.89 -1.05 . . . . 2.9700000000000002 112.034 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.3 m -121.84 125.52 46.65 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.6 -0.727 . . . . 1.6599999999999999 112.625 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 74.49 56.7 0.08 Allowed 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 125.878 1.671 . . . . 2.02 113.074 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -157.73 -41.76 0.07 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.709 -1.132 . . . . 2.5600000000000001 109.41 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -105.83 82.78 1.83 Allowed 'General case' 0 C--N 1.361 1.1 0 CA-C-O 121.79 0.805 . . . . 3.1499999999999999 108.848 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.88 122.5 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 114.397 -1.274 . . . . 1.3600000000000001 111.729 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -107.36 164.09 12.48 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.9 1.444 . . . . 0.84999999999999998 114.9 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -120.23 136.51 54.62 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.379 0.609 . . . . 1.3300000000000001 111.109 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.0 t -126.13 127.12 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.205 0 CA-C-N 115.411 -0.813 . . . . 1.1699999999999999 109.828 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 57.9 mtt180 -127.33 148.89 50.25 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.509 1.67 . . . . 1.9399999999999999 115.509 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.8 m -129.48 113.5 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 N-CA-C 112.783 0.66 . . . . 1.29 112.783 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.34 25.05 14.5 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 126.306 1.842 . . . . 1.8200000000000001 114.164 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.54 -17.29 46.86 Favored Glycine 0 CA--C 1.551 2.282 0 CA-C-N 115.896 -0.593 . . . . 0.32000000000000001 113.626 -176.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 95.2 m-70 -85.79 175.98 8.38 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.544 1.537 . . . . 0.56999999999999995 114.0 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.48 139.83 51.45 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.948 0.88 . . . . 1.1899999999999999 112.171 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.84 -57.16 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 114.016 -1.447 . . . . 1.73 112.792 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.81 89.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.57 0.7 . . . . 1.25 109.35 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -100.55 119.45 38.54 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 114.651 -1.159 . . . . 2.75 110.531 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 88.29 62.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 127.395 2.278 . . . . 2.48 110.78 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.13 105.05 15.57 Favored 'General case' 0 C--N 1.366 1.286 0 N-CA-C 113.425 0.898 . . . . 1.78 113.425 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -111.46 99.31 8.11 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 113.781 -1.554 . . . . 2.3500000000000001 107.426 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -32.15 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 N-CA-C 114.675 1.361 . . . . 1.27 114.675 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -75.01 -37.49 61.79 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.495 0.718 . . . . 0.83999999999999997 112.892 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -74.06 -26.7 60.54 Favored 'General case' 0 CA--C 1.575 1.911 0 C-N-CA 124.359 1.064 . . . . 0.91000000000000003 113.477 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -80.99 -57.92 3.31 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.246 0.832 . . . . 2.98 113.246 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.43 -38.94 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 N-CA-C 114.091 1.145 . . . . 1.53 114.091 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.04 -66.41 0.24 Allowed Glycine 0 C--N 1.358 1.794 0 CA-C-N 118.372 0.533 . . . . 0.84999999999999998 114.222 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -106.6 173.3 6.38 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.016 0.927 . . . . 3.9700000000000002 111.78 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.1 m -81.14 84.22 6.59 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.641 0.978 . . . . 2.0800000000000001 113.641 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 22.2 p -131.56 -131.37 0.19 Allowed 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 114.264 -1.335 . . . . 1.22 108.315 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.64 130.29 56.78 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 114.425 1.269 . . . . 1.2 114.425 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -107.52 129.46 54.96 Favored 'General case' 0 C--N 1.371 1.526 0 N-CA-C 108.697 -0.853 . . . . 0.41999999999999998 108.697 174.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.1 129.06 18.5 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.014 0.746 . . . . 2.5 113.014 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -112.92 129.27 56.53 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 115.081 -0.963 . . . . 1.5800000000000001 111.361 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.97 110.34 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 114.27 -1.332 . . . . 1.25 109.429 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.6 102.16 29.61 Favored Pre-proline 0 CA--C 1.571 1.761 0 N-CA-C 112.482 0.549 . . . . 1.5 112.482 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -74.77 144.3 30.96 Favored 'Trans proline' 0 C--N 1.398 3.16 0 C-N-CA 123.096 2.531 . . . . 0.22 114.882 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.09 147.99 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 C-N-CA 124.567 1.147 . . . . 1.1200000000000001 109.043 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 t -134.3 116.97 15.88 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.438 0.637 . . . . 1.8600000000000001 112.003 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.422 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.2 mt -114.47 127.19 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 114.836 -1.075 . . . . 1.0700000000000001 108.826 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -138.8 123.29 18.4 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.463 -0.789 . . . . 2.6400000000000001 110.756 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt 67.88 13.65 9.22 Favored 'General case' 0 N--CA 1.521 3.092 0 N-CA-C 115.226 1.565 . . . . 4.0199999999999996 115.226 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.94 15.13 31.96 Favored Glycine 0 CA--C 1.548 2.109 0 N-CA-C 114.732 0.653 . . . . 0.39000000000000001 114.732 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -121.8 145.27 48.22 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 117.87 0.835 . . . . 2.0299999999999998 112.194 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.84 146.64 27.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.439 1.274 . . . . 1.0800000000000001 114.439 -176.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.24 111.02 9.91 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.38 -1.282 . . . . 1.23 110.077 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.0 p -111.4 93.28 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.619 0 CA-C-N 115.598 -0.728 . . . . 1.1899999999999999 110.11 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 66.33 -83.48 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.882 0 C-N-CA 125.288 1.435 . . . . 1.8200000000000001 113.689 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.73 25.94 3.9 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 115.996 -0.547 . . . . 0.51000000000000001 113.741 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -133.2 118.58 18.79 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.18 0.592 . . . . 1.8200000000000001 110.128 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.7 p -105.92 132.76 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.329 0 CA-C-O 121.55 0.691 . . . . 1.5900000000000001 112.07 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.8 m -148.33 -175.42 4.9 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.014 -0.994 . . . . 1.1699999999999999 110.106 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 35.6 p -101.81 137.94 39.45 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 113.055 0.761 . . . . 1.71 113.055 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -87.1 122.76 31.36 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.469 0.707 . . . . 0.29999999999999999 110.447 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.9 t -129.24 91.65 3.23 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 113.006 0.743 . . . . 1.8700000000000001 113.006 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.22 -64.09 3.8 Favored Glycine 0 C--N 1.357 1.725 0 N-CA-C 119.007 2.363 . . . . 0.91000000000000003 119.007 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.14 158.05 43.78 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.3 1.222 . . . . 1.6799999999999999 114.3 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.68 141.0 37.88 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.308 -1.769 . . . . 1.3700000000000001 109.332 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.9 t -123.95 141.61 51.88 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.972 1.471 . . . . 0.94999999999999996 114.972 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -116.56 100.45 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.33 -1.359 . . . . 1.3799999999999999 107.33 176.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -113.48 126.3 55.17 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.77 -0.65 . . . . 1.6699999999999999 112.375 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.6 124.61 52.75 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.503 -0.771 . . . . 2.2999999999999998 110.406 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.441 ' C ' ' HB3' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -107.99 144.85 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 113.982 -1.463 . . . . 1.29 111.027 -177.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.514 ' HB3' ' OD1' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -78.25 149.18 33.64 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 125.224 1.41 . . . . 2.6200000000000001 114.673 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.42 -53.09 0.57 Allowed Glycine 0 CA--C 1.537 1.464 0 CA-C-N 115.097 -0.956 . . . . 1.0600000000000001 113.392 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -128.39 -48.52 1.3 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 122.937 0.495 . . . . 3.1000000000000001 112.049 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.78 -46.32 0.54 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.814 0.672 . . . . 4.0800000000000001 112.814 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.46 160.5 17.71 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.437 0.637 . . . . 1.74 112.569 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.541 ' ND2' ' H ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -120.17 -51.81 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 115.751 -0.658 . . . . 1.6799999999999999 111.296 -179.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -103.49 -59.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.669 2.246 . . . . 2.8199999999999998 115.143 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.0 tptm 88.34 -106.22 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 126.823 2.049 . . . . 3.4100000000000001 110.492 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.07 134.1 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.005 -1.109 . . . . 1.3799999999999999 108.005 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.0 t -132.65 137.64 47.05 Favored 'General case' 0 C--N 1.366 1.297 0 N-CA-C 115.159 1.54 . . . . 1.75 115.159 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . 0.256 . . -130.15 47.27 2.53 Favored 'General case' 0 CA--C 1.589 2.465 0 N-CA-C 115.524 1.675 . . . . 1.1299999999999999 115.524 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.85 137.07 5.84 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 116.506 2.039 . . . . 1.3999999999999999 116.506 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -154.06 106.04 2.78 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 115.668 -0.696 . . . . 0.26000000000000001 111.298 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 12' ' ' TRP 0.325 7.8 tt -114.65 122.3 68.49 Favored 'Isoleucine or valine' 0 C--O 1.27 2.165 0 CA-C-O 122.44 1.114 . . . . 1.1000000000000001 111.465 175.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -124.31 165.26 17.98 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 113.924 -1.489 . . . . 1.0600000000000001 111.146 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.3 ptmm? -121.87 157.46 31.1 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 118.223 2.675 . . . . 1.8300000000000001 118.223 -175.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.04 -40.96 2.27 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 110.343 -3.117 . . . . 0.17000000000000001 118.967 173.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.04 159.43 1.67 Allowed 'General case' 0 N--CA 1.514 2.77 0 CA-C-N 120.412 2.106 . . . . 1.05 113.059 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.79 -13.64 59.7 Favored 'General case' 0 CA--C 1.58 2.118 0 C-N-CA 125.141 1.376 . . . . 0.98999999999999999 114.046 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.01 3.28 49.39 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 113.663 0.986 . . . . 0.55000000000000004 113.663 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.619 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -103.87 -8.94 19.34 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.575 0.954 . . . . 0.59999999999999998 113.575 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.72 90.54 0.43 Allowed Pre-proline 0 N--CA 1.51 2.537 0 C-N-CA 123.971 0.908 . . . . 1.1799999999999999 112.457 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.619 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 43.8 Cg_endo -94.66 149.2 1.8 Allowed 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.764 2.31 . . . . 2.0299999999999998 114.924 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 65.1 mtt -133.54 101.05 4.99 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.733 -0.667 . . . . 5.3399999999999999 110.805 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.3 mt -136.98 172.16 13.43 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.175 0.988 . . . . 4.0 112.883 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -112.46 159.95 32.17 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 114.52 -1.218 . . . . 6.7000000000000002 110.775 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.71 120.64 7.24 Favored 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 122.338 2.026 . . . . 6.9400000000000004 114.63 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -136.5 144.17 46.25 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-N 114.506 -1.225 . . . . 5.5099999999999998 111.222 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -87.68 -153.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 122.845 2.363 . . . . 7.1600000000000001 113.704 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 171.73 86.77 0.06 OUTLIER Glycine 0 C--N 1.34 0.798 0 C-N-CA 120.837 -0.697 . . . . 7.0199999999999996 113.349 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.5 mt -119.41 116.76 26.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.767 0.427 . . . . 9.3000000000000007 112.005 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.198 -0.906 . . . . 10.6 111.064 179.913 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.597 -0.201 . . . . 9.3599999999999994 112.597 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.7 128.32 56.04 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.52 0.676 . . . . 6.8499999999999996 111.854 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.0 mtt -134.84 110.95 9.51 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.757 -0.656 . . . . 8.0 111.376 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -140.85 116.69 10.37 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.925 -0.579 . . . . 4.1500000000000004 111.836 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.19 87.57 0.07 OUTLIER Glycine 0 C--N 1.341 0.81 0 CA-C-N 115.788 -0.642 . . . . 1.6000000000000001 113.084 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.2 tp -88.22 -49.29 7.09 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.558 0.947 . . . . 1.0900000000000001 113.558 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -22.48 61.35 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 115.412 1.634 . . . . 1.04 115.412 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.46 -12.51 48.8 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 113.751 1.019 . . . . 0.32000000000000001 113.751 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 16.4 mtpt -108.38 -18.91 13.63 Favored 'General case' 0 C--N 1.365 1.274 0 N-CA-C 113.583 0.957 . . . . 2.2599999999999998 113.583 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.25 138.84 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.967 0 N-CA-C 115.156 1.539 . . . . 1.01 115.156 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -122.34 -28.09 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 115.34 -0.846 . . . . 1.0600000000000001 112.124 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.477 ' O ' HG21 ' A' ' 172' ' ' ILE . 60.5 t90 -165.32 119.7 1.26 Allowed 'General case' 0 CA--C 1.563 1.443 0 N-CA-C 111.543 0.201 . . . . 0.67000000000000004 111.543 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -138.31 130.51 28.7 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.302 -0.874 . . . . 1.0800000000000001 111.724 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -138.9 134.59 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 N-CA-C 113.642 0.978 . . . . 1.6699999999999999 113.642 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -115.93 106.0 13.3 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.595 -1.261 . . . . 2.6400000000000001 107.595 172.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.99 106.64 9.99 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 121.525 0.678 . . . . 1.28 111.683 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.453 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 165.84 -47.73 0.27 Allowed Glycine 0 C--N 1.355 1.588 0 CA-C-N 114.613 -1.176 . . . . 0.70999999999999996 115.689 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.58 -119.09 3.07 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-O 119.743 -0.476 . . . . 0.87 113.368 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.82 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 6.8 pt-20 -167.51 117.64 0.84 Allowed 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 117.311 0.555 . . . . 2.1200000000000001 112.214 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER 48.07 112.01 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 118.339 2.718 . . . . 1.5 118.339 178.22 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.409 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 82.3 t60 -144.83 137.4 26.32 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.049 1.129 . . . . 0.52000000000000002 114.049 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.39 119.93 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-N 114.423 -1.262 . . . . 2.0699999999999998 110.172 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.57 157.86 24.61 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-N 114.707 -1.133 . . . . 1.8500000000000001 110.302 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 m -42.19 -28.15 0.23 Allowed 'Isoleucine or valine' 1 N--CA 1.543 4.186 0 N-CA-C 119.261 3.06 . . . . 1.3700000000000001 119.261 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -93.47 -16.41 24.55 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 118.281 0.491 . . . . 0.56999999999999995 111.513 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.68 41.88 1.29 Allowed Glycine 0 C--N 1.357 1.719 0 C-N-CA 124.391 0.996 . . . . 0.37 114.561 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.8 mm -106.21 117.97 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 N-CA-C 109.335 -0.617 . . . . 1.25 109.335 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.409 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.74 135.49 47.06 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.846 1.795 . . . . 1.71 115.846 -175.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.82 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -95.3 137.71 33.98 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.261 -1.336 . . . . 3.1499999999999999 110.157 175.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.448 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 31.8 mtt180 -99.48 107.05 19.15 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.581 -1.191 . . . . 3.5099999999999998 112.898 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -28.08 113.75 0.07 Allowed 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 120.2 3.407 . . . . 2.8100000000000001 120.2 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 6.9 m-20 32.25 58.72 1.33 Allowed Pre-proline 0 N--CA 1.535 3.796 0 N-CA-C 117.883 2.549 . . . . 1.1699999999999999 117.883 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 20.4 Cg_endo -95.05 49.8 0.2 Allowed 'Trans proline' 0 CA--C 1.563 1.961 0 C-N-CA 123.071 2.514 . . . . 1.45 116.303 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.4 mp -122.92 -68.11 0.91 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.286 0.847 . . . . 2.2400000000000002 113.286 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -109.46 96.52 6.33 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.078 0.77 . . . . 4.8399999999999999 113.078 -177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.55 -31.46 8.67 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-N 114.928 -1.033 . . . . 2.9700000000000002 114.631 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 69.37 63.98 0.27 Allowed 'General case' 0 N--CA 1.504 2.228 0 C-N-CA 126.047 1.739 . . . . 4.79 113.208 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -127.9 179.64 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-N 115.436 -0.802 . . . . 3.1499999999999999 111.907 -178.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.85 98.09 0.57 Allowed Glycine 0 C--N 1.348 1.229 0 C-N-CA 121.287 -0.482 . . . . 2.7200000000000002 113.707 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -154.73 136.75 14.65 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.355 0.598 . . . . 5.9500000000000002 111.941 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.95 137.1 40.68 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.691 0.796 . . . . 1.78 111.448 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.7 m -115.62 -73.34 0.65 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.101 -0.499 . . . . 1.6599999999999999 112.144 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 77.91 99.21 0.06 Allowed 'General case' 0 N--CA 1.504 2.265 0 C-N-CA 125.106 1.362 . . . . 2.3300000000000001 113.499 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -107.02 68.87 0.74 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.925 0.869 . . . . 3.3300000000000001 110.067 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.29 70.31 0.19 Allowed Glycine 0 C--N 1.343 0.952 0 CA-C-N 114.133 -1.394 . . . . 1.7 110.623 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.6 ttt -92.31 1.53 57.17 Favored 'General case' 0 CA--C 1.563 1.443 0 N-CA-C 115.231 1.567 . . . . 2.0800000000000001 115.231 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -109.58 35.09 3.46 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 112.513 0.56 . . . . 4.6200000000000001 112.513 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.73 73.48 54.1 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.386 1.074 . . . . 3.1600000000000001 108.516 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . 31.0 Cg_exo -68.77 157.04 63.47 Favored 'Trans proline' 0 C--N 1.389 2.694 0 C-N-CA 124.274 3.316 . . . . 1.8600000000000001 116.371 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 61' ' ' TYR 0.269 1.4 mp -88.65 135.97 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.342 0 C-N-CA 123.69 0.796 . . . . 1.28 110.113 179.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.41 -20.55 23.81 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 116.791 2.145 . . . . 1.9299999999999999 116.791 -176.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -99.03 18.64 16.8 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.15 1.167 . . . . 1.79 114.15 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.66 -175.7 4.04 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-O 121.426 0.631 . . . . 1.49 111.934 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.763 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -93.56 -177.83 0.75 Allowed Pre-proline 0 N--CA 1.511 2.625 0 C-N-CA 123.889 0.876 . . . . 1.6799999999999999 109.543 178.301 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -68.93 -39.28 8.4 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.54 2.16 . . . . 1.1599999999999999 113.588 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.59 -50.95 47.72 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 125.309 1.444 . . . . 2.04 112.167 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -6.29 55.19 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-N 115.018 -0.992 . . . . 1.6200000000000001 112.667 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.763 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.0 tt0 -74.29 -39.96 62.6 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 125.162 1.385 . . . . 2.4300000000000002 108.408 173.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.77 -43.55 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 C-N-CA 124.213 1.005 . . . . 1.46 108.939 173.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 tp -80.37 -6.21 57.66 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 114.546 1.313 . . . . 1.6699999999999999 114.546 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.434 ' O ' HG12 ' A' ' 50' ' ' ILE . 18.9 m-85 -125.22 21.8 7.95 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 123.777 0.831 . . . . 1.3300000000000001 112.865 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.516 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 29.0 tt0 -143.86 -37.36 0.33 Allowed 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 115.338 1.607 . . . . 1.4099999999999999 115.338 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.1 p -68.57 133.79 49.05 Favored 'General case' 0 N--CA 1.53 3.558 0 N-CA-C 114.849 1.425 . . . . 1.28 114.849 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.453 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 3.7 pt-20 -122.13 144.92 48.64 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.012 1.486 . . . . 1.53 115.012 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -113.38 136.79 52.38 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 113.992 -1.458 . . . . 3.8300000000000001 111.111 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -119.63 135.66 54.71 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.235 0.457 . . . . 3.7599999999999998 112.235 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.55 -86.52 0.33 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 112.49 0.552 . . . . 5.3700000000000001 112.49 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -147.06 -101.53 0.09 Allowed 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 113.144 0.794 . . . . 2.5499999999999998 113.144 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.465 ' HA ' HD22 ' A' ' 164' ' ' ASN . 5.1 m-20 -155.45 129.4 8.69 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.512 0.725 . . . . 2.1499999999999999 110.704 -177.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.488 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.3 OUTLIER 70.69 82.13 0.16 Allowed 'General case' 0 N--CA 1.515 2.812 0 C-N-CA 124.762 1.225 . . . . 1.25 110.869 -178.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -144.85 153.9 42.08 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.78 -0.646 . . . . 1.1499999999999999 112.654 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.79 -163.91 16.58 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 116.007 1.163 . . . . 0.59999999999999998 116.007 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -122.76 164.94 17.4 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 113.607 -1.296 . . . . 1.4099999999999999 113.413 -177.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.22 130.37 52.66 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.425 -1.261 . . . . 0.51000000000000001 112.126 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.21 102.07 37.42 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.504 0.722 . . . . 1.0600000000000001 109.426 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -84.32 121.03 2.6 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.003 1.802 . . . . 0.17999999999999999 114.691 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.39 161.99 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 CA-C-O 122.099 0.952 . . . . 1.0600000000000001 110.946 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -153.63 22.45 0.53 Allowed 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 114.55 -1.205 . . . . 3.1099999999999999 111.626 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.14 156.78 44.0 Favored 'General case' 0 C--N 1.362 1.127 0 C-N-CA 123.167 0.587 . . . . 2.1200000000000001 110.788 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -118.37 147.41 43.56 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.388 1.255 . . . . 0.41999999999999998 114.388 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.12 -137.64 5.15 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 113.619 -1.628 . . . . 0.25 111.885 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.0 mt-10 -116.22 106.42 13.67 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-N 118.728 1.264 . . . . 1.75 110.819 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -99.58 128.4 45.68 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.251 0.548 . . . . 0.90000000000000002 110.893 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.53 121.77 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.807 0.813 . . . . 1.0700000000000001 110.835 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.36 106.99 17.85 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.118 -1.401 . . . . 1.47 109.854 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.06 125.67 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.755 -0.657 . . . . 1.27 110.927 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.73 144.64 51.12 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.449 0.907 . . . . 1.8899999999999999 113.449 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 127' ' ' HIS . 4.5 tppt? -104.94 120.57 41.77 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.71 -0.677 . . . . 2.8999999999999999 111.383 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -105.56 134.48 48.6 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.561 -0.745 . . . . 0.48999999999999999 109.994 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.68 155.3 47.47 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.252 0.548 . . . . 1.1000000000000001 111.784 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.9 171.85 7.4 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.561 0.745 . . . . 2.6099999999999999 112.281 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.84 -77.61 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 112.498 0.555 . . . . 2.6099999999999999 112.498 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -129.69 70.17 1.43 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.311 0.577 . . . . 2.71 111.76 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -148.42 109.83 4.4 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.747 -0.66 . . . . 1.6899999999999999 110.943 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.22 88.02 2.63 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 123.171 1.463 . . . . 1.4299999999999999 111.271 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -169.12 155.41 6.55 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 113.886 -1.506 . . . . 2.9700000000000002 110.475 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.3 m -118.61 -68.49 0.91 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.44 1.274 . . . . 1.6599999999999999 114.44 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -98.56 68.61 1.84 Allowed 'General case' 0 CA--C 1.558 1.281 0 CA-C-O 121.998 0.904 . . . . 2.02 111.366 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -154.32 -45.41 0.09 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.142 -1.39 . . . . 2.5600000000000001 109.34 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -113.56 86.96 2.5 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 121.683 0.754 . . . . 3.1499999999999999 109.022 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.05 131.4 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 114.524 -1.216 . . . . 1.3600000000000001 111.651 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -103.86 166.93 10.1 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.975 1.472 . . . . 0.84999999999999998 114.975 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.17 137.15 54.93 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.91 -0.586 . . . . 1.3300000000000001 111.353 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.8 t -134.52 129.49 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.278 0 CA-C-N 115.941 -0.572 . . . . 1.1699999999999999 111.116 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -133.82 144.58 49.06 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.681 1.363 . . . . 1.9399999999999999 114.681 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.8 m -115.91 106.53 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 114.228 -1.351 . . . . 1.29 112.783 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.52 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 6.0 t30 62.75 27.03 15.93 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 126.906 2.082 . . . . 1.8200000000000001 114.417 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.93 -20.47 31.24 Favored Glycine 0 CA--C 1.549 2.185 0 CA-C-N 115.503 -0.771 . . . . 0.32000000000000001 113.773 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -84.82 137.55 33.1 Favored 'General case' 0 C--N 1.365 1.254 0 C-N-CA 125.59 1.556 . . . . 0.56999999999999995 114.018 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.69 129.22 42.97 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.694 0.759 . . . . 1.1899999999999999 112.433 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.13 -51.46 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 114.389 -1.278 . . . . 1.73 113.21 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.6 89.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.97 -0.752 . . . . 1.25 108.97 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -110.78 75.69 0.94 Allowed 'General case' 0 C--N 1.361 1.07 0 CA-C-O 123.68 1.705 . . . . 2.75 112.446 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 152.89 67.16 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 110.094 -3.23 . . . . 2.48 108.23 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.29 101.62 13.36 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 122.161 0.981 . . . . 1.78 112.824 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.64 100.09 8.94 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 112.865 -1.971 . . . . 2.3500000000000001 107.701 176.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.22 -22.11 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.379 0 N-CA-C 114.109 1.151 . . . . 1.27 114.109 -176.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -77.28 -42.95 35.05 Favored 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 123.978 0.911 . . . . 0.83999999999999997 112.012 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.32 -27.23 60.61 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.892 1.071 . . . . 0.91000000000000003 113.892 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -80.18 -53.07 7.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.926 1.084 . . . . 2.98 113.926 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.277 4.1 p -102.61 -36.24 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.99 0 N-CA-C 113.997 1.11 . . . . 1.53 113.997 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.5 -121.1 3.03 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-N 118.691 0.678 . . . . 0.84999999999999998 113.047 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -113.27 107.65 16.19 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.252 0.549 . . . . 3.9700000000000002 110.826 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.3 m 72.81 -121.21 0.06 Allowed 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 125.558 1.543 . . . . 2.0800000000000001 111.669 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.6 p 51.55 -165.88 0.05 OUTLIER 'General case' 0 N--CA 1.535 3.795 0 N-CA-C 116.315 1.968 . . . . 1.22 116.315 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -109.08 127.06 53.82 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.128 0.788 . . . . 1.2 113.128 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.425 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 8.8 t60 -105.0 140.41 38.23 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.423 0.689 . . . . 0.41999999999999998 109.506 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -144.6 128.5 17.41 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.656 0.613 . . . . 2.5 112.656 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -116.14 136.83 52.67 Favored 'General case' 0 C--O 1.255 1.371 0 CA-C-N 115.019 -0.991 . . . . 1.5800000000000001 111.348 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.92 118.92 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 CA-C-N 113.719 -1.582 . . . . 1.25 110.741 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.19 88.79 50.04 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-N 115.498 -0.774 . . . . 1.5 109.724 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -73.54 139.26 28.16 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 123.183 2.589 . . . . 0.22 113.921 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -122.35 150.83 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-N 115.348 -0.842 . . . . 1.1200000000000001 110.825 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.4 t -135.15 109.32 8.28 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.157 -0.929 . . . . 1.8600000000000001 110.525 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -108.9 124.75 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.569 0 CA-C-N 115.057 -0.974 . . . . 1.0700000000000001 108.811 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -141.27 125.56 17.5 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.245 -0.889 . . . . 2.6400000000000001 110.778 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp 67.23 16.0 10.09 Favored 'General case' 0 N--CA 1.51 2.574 0 C-N-CA 125.444 1.498 . . . . 4.0199999999999996 114.23 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.68 16.83 32.63 Favored Glycine 0 CA--C 1.549 2.203 0 CA-C-O 119.323 -0.71 . . . . 0.39000000000000001 114.591 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 58.2 mttt -120.74 142.56 49.43 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-N 118.003 0.902 . . . . 2.0299999999999998 112.847 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.54 132.51 47.13 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.271 0.841 . . . . 1.0800000000000001 113.271 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.08 112.81 18.2 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.2 -0.909 . . . . 1.23 110.74 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.68 93.13 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.646 0 CA-C-N 115.44 -0.8 . . . . 1.1899999999999999 110.096 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 64.67 -85.17 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.949 0 C-N-CA 125.36 1.464 . . . . 1.8200000000000001 113.711 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.41 29.93 3.95 Favored Glycine 0 CA--C 1.544 1.898 0 CA-C-N 116.004 -0.544 . . . . 0.51000000000000001 113.288 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -133.77 119.96 19.92 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 123.74 0.816 . . . . 1.8200000000000001 110.544 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.9 p -107.76 133.19 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.351 0 CA-C-O 121.481 0.658 . . . . 1.5900000000000001 111.806 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m -151.39 -177.04 5.83 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.161 -0.927 . . . . 1.1699999999999999 110.403 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.8 p -101.87 137.03 40.71 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.282 0.845 . . . . 1.71 113.282 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -86.74 121.47 29.29 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.456 0.702 . . . . 0.29999999999999999 110.144 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.2 t -126.39 91.25 3.33 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 113.03 0.752 . . . . 1.8700000000000001 113.03 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.56 -62.7 3.11 Favored Glycine 0 C--N 1.36 1.885 0 N-CA-C 118.542 2.177 . . . . 0.91000000000000003 118.542 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.49 159.89 38.08 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 122.061 0.934 . . . . 1.6799999999999999 113.31 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.52 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -106.46 134.12 50.09 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.448 -1.705 . . . . 1.3700000000000001 108.721 176.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.6 t -121.52 123.45 42.03 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 114.521 1.304 . . . . 0.94999999999999996 114.521 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.51 102.81 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.567 -0.901 . . . . 1.3799999999999999 108.567 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.15 150.15 52.27 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.061 0.934 . . . . 1.6699999999999999 111.633 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.23 141.72 48.66 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 114.198 -1.365 . . . . 2.2999999999999998 112.274 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.97 145.53 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-N 112.704 -2.044 . . . . 1.29 110.769 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -70.3 150.04 46.77 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 115.803 1.779 . . . . 2.6200000000000001 115.803 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.3 -55.62 0.5 Allowed Glycine 0 CA--C 1.538 1.484 0 CA-C-N 114.89 -1.05 . . . . 1.0600000000000001 112.606 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.86 -56.14 0.99 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.38 0.672 . . . . 3.1000000000000001 111.049 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -132.27 -41.67 0.98 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.253 0.621 . . . . 4.0800000000000001 112.394 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.37 155.25 24.46 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.33 0.652 . . . . 1.74 112.303 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.488 ' ND2' ' H ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -118.1 -48.02 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 115.693 -0.685 . . . . 1.6799999999999999 110.212 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -106.62 -69.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.553 2.169 . . . . 2.8199999999999998 115.939 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt 92.72 -92.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 127.47 2.308 . . . . 3.4100000000000001 109.32 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.9 t -113.42 131.62 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 107.775 -1.194 . . . . 1.3799999999999999 107.775 174.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.8 t -136.34 127.04 27.23 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 115.667 -0.697 . . . . 1.75 112.515 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . 0.26 . . -119.43 50.2 1.27 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.858 1.799 . . . . 1.1299999999999999 115.858 -177.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -41.01 131.52 2.53 Favored 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 115.887 1.81 . . . . 1.3999999999999999 115.887 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -151.13 100.84 2.81 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.186 -0.916 . . . . 0.26000000000000001 110.275 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.477 HG21 ' O ' ' A' ' 12' ' ' TRP 0.312 8.5 tt -110.12 123.14 65.77 Favored 'Isoleucine or valine' 0 C--O 1.267 2.001 0 CA-C-O 122.412 1.101 . . . . 1.1000000000000001 112.025 175.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -124.08 162.96 22.45 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 113.553 -1.658 . . . . 1.0600000000000001 110.862 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 18.0 ptmt -121.56 159.99 25.24 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 118.585 2.809 . . . . 1.8300000000000001 118.585 -175.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.51 -42.04 2.0 Allowed Glycine 0 CA--C 1.541 1.685 0 CA-C-N 110.001 -3.272 . . . . 0.17000000000000001 118.688 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.07 153.27 0.97 Allowed 'General case' 0 N--CA 1.515 2.815 0 CA-C-N 120.131 1.966 . . . . 1.05 112.678 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.68 -12.89 60.04 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.631 1.345 . . . . 0.98999999999999999 114.631 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.42 4.56 45.97 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 114.349 1.24 . . . . 0.55000000000000004 114.349 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.497 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -107.11 -13.27 15.21 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 114.445 1.276 . . . . 0.59999999999999998 114.445 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.08 100.24 0.4 Allowed Pre-proline 0 N--CA 1.519 3.004 0 C-N-CA 124.238 1.015 . . . . 1.1799999999999999 112.944 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 4.2 Cg_exo -81.83 143.31 13.11 Favored 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 123.027 2.485 . . . . 2.0299999999999998 114.383 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 11.0 tpt -145.08 113.03 6.41 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.804 -0.635 . . . . 5.3399999999999999 111.012 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.25 166.96 21.57 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 122.085 0.945 . . . . 4.0 112.782 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -110.29 159.55 31.65 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-N 114.509 -1.223 . . . . 6.7000000000000002 110.973 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.68 123.41 11.02 Favored 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.779 2.32 . . . . 6.9400000000000004 115.221 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.543 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 26.5 t60 -134.54 134.22 22.15 Favored Pre-proline 0 CA--C 1.568 1.659 0 CA-C-N 114.976 -1.011 . . . . 5.5099999999999998 111.278 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.543 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 86.4 Cg_endo -76.3 -23.49 11.69 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 123.584 2.856 . . . . 7.1600000000000001 116.462 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -123.14 -141.3 5.86 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 114.748 0.659 . . . . 7.0199999999999996 114.748 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.2 mt -119.36 115.38 24.0 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.1 0.407 . . . . 9.3000000000000007 112.1 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.135 -0.936 . . . . 10.6 110.484 179.639 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.122 0 N-CA-C 112.599 -0.201 . . . . 9.3599999999999994 112.599 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.85 -42.19 4.07 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 112.955 0.724 . . . . 6.8499999999999996 112.955 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.0 mmt -134.28 -73.74 0.48 Allowed 'General case' 0 C--N 1.362 1.151 0 CA-C-N 118.092 0.405 . . . . 8.0 111.558 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -140.45 117.13 10.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.983 0.421 . . . . 4.1500000000000004 111.706 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.58 84.42 0.14 Allowed Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.705 -0.68 . . . . 1.6000000000000001 112.926 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.8 tp -87.97 -46.79 9.06 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 113.505 0.928 . . . . 1.0900000000000001 113.505 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.99 -23.11 61.54 Favored 'General case' 0 N--CA 1.511 2.601 0 C-N-CA 125.704 1.602 . . . . 1.04 115.209 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.82 -12.17 48.77 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 113.661 0.986 . . . . 0.32000000000000001 113.661 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 47.8 mmtt -104.69 -22.02 13.29 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.399 0.889 . . . . 2.2599999999999998 113.399 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.21 134.69 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 N-CA-C 115.172 1.545 . . . . 1.01 115.172 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -122.88 -29.95 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-N 115.575 -0.739 . . . . 1.0600000000000001 112.343 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' O ' HG23 ' A' ' 172' ' ' ILE . 73.9 t90 -161.16 117.49 2.22 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 121.029 0.442 . . . . 0.67000000000000004 111.244 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.8 142.25 40.85 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.621 -0.674 . . . . 1.0800000000000001 111.316 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.334 8.9 p -145.38 134.03 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.937 0 CA-C-O 122.425 1.107 . . . . 1.6699999999999999 113.461 178.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.649 ' H ' HD21 ' A' ' 15' ' ' ASN . 0.0 OUTLIER -100.92 91.02 4.39 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-N 113.195 -1.82 . . . . 2.6400000000000001 109.325 178.041 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.02 103.24 11.52 Favored 'General case' 0 C--O 1.265 1.88 0 CA-C-O 123.414 1.578 . . . . 1.28 113.158 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.52 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 162.99 -50.48 0.31 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-N 111.394 -2.639 . . . . 0.70999999999999996 111.374 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.63 -126.03 4.16 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.497 -1.041 . . . . 0.87 110.497 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -168.4 117.36 0.73 Allowed 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 117.666 0.733 . . . . 2.1200000000000001 112.095 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 6.3 m 62.8 115.68 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 116.896 2.184 . . . . 1.5 116.896 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -159.8 139.57 11.46 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.369 0.604 . . . . 0.52000000000000002 112.176 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.14 122.66 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-N 115.57 -0.741 . . . . 2.0699999999999998 110.651 176.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -85.2 155.98 21.19 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.562 -0.745 . . . . 1.8500000000000001 111.183 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . 0.265 0.7 OUTLIER -45.1 -16.9 0.07 OUTLIER 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 N-CA-C 119.99 3.33 . . . . 1.3700000000000001 119.99 -175.39 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -95.8 -20.85 18.51 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 118.766 0.712 . . . . 0.56999999999999995 111.295 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.68 38.8 1.26 Allowed Glycine 0 C--N 1.356 1.652 0 C-N-CA 124.414 1.007 . . . . 0.37 114.488 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.8 mm -105.6 121.58 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 N-CA-C 108.994 -0.743 . . . . 1.25 108.994 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -101.23 125.29 47.84 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.641 0.608 . . . . 1.71 112.641 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.654 ' O ' ' HA ' ' A' ' 20' ' ' SER . 41.7 m-85 -95.77 137.97 34.08 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.275 -0.875 . . . . 3.1499999999999999 111.09 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -72.26 159.97 33.18 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.929 2.196 . . . . 3.5099999999999998 116.929 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -94.92 87.19 4.88 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.001 -1.909 . . . . 2.8100000000000001 115.399 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER 49.41 78.29 0.41 Allowed Pre-proline 0 N--CA 1.529 3.489 0 N-CA-C 115.594 1.701 . . . . 1.1699999999999999 115.594 177.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -90.45 3.88 4.7 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 N-CA-C 118.971 2.643 . . . . 1.45 118.971 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.7 -33.28 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.176 1.917 . . . . 2.2400000000000002 116.176 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.512 ' HB3' ' OD1' ' A' ' 67' ' ' ASN . 8.3 pt-20 -89.21 65.52 7.34 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 120.533 1.515 . . . . 4.8399999999999999 113.51 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . 100.54 -21.47 43.96 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-N 115.813 -0.631 . . . . 2.9700000000000002 113.949 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.614 ' HA ' ' O ' ' A' ' 32' ' ' ASP 0.25 0.0 OUTLIER 56.76 56.66 5.3 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 127.617 2.367 . . . . 4.79 114.432 -178.981 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.22 179.99 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-N 114.109 -1.405 . . . . 3.1499999999999999 110.616 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.26 93.1 1.85 Allowed Glycine 0 C--N 1.355 1.594 0 N-CA-C 115.101 0.8 . . . . 2.7200000000000002 115.101 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -143.08 117.61 9.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.23 0.612 . . . . 5.9500000000000002 111.516 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.41 137.68 45.96 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.662 0.785 . . . . 1.78 111.732 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 m -125.81 135.07 51.58 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.693 -0.685 . . . . 1.6599999999999999 112.192 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.8 -66.88 0.74 Allowed 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.378 -0.828 . . . . 2.3300000000000001 111.333 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.2 t80 80.57 -68.62 0.11 Allowed 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 125.917 1.687 . . . . 3.3300000000000001 111.653 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.88 91.33 0.57 Allowed Glycine 0 C--N 1.351 1.384 0 N-CA-C 109.965 -1.254 . . . . 1.7 109.965 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.5 ttm -87.26 1.91 51.73 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 115.694 1.739 . . . . 2.0800000000000001 115.694 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.34 39.34 1.76 Allowed 'General case' 0 CA--C 1.564 1.498 0 CA-C-O 121.742 0.782 . . . . 4.6200000000000001 112.916 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.84 76.86 64.48 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.111 1.364 . . . . 3.1600000000000001 107.809 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.65 162.43 19.06 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.135 2.557 . . . . 1.8600000000000001 116.906 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.26 1.3 mp -87.51 134.8 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.317 0 C-N-CA 123.82 0.848 . . . . 1.28 109.892 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -90.69 -18.34 25.22 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.106 1.891 . . . . 1.9299999999999999 116.106 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -103.55 26.02 8.99 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 114.427 1.269 . . . . 1.79 114.427 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -140.37 -165.56 1.94 Allowed 'General case' 0 CA--C 1.565 1.537 0 CA-C-O 122.32 1.057 . . . . 1.49 112.725 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.868 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 2.1 t30 -88.85 172.6 7.26 Favored Pre-proline 0 CA--C 1.569 1.699 0 C-N-CA 126.488 1.915 . . . . 1.6799999999999999 110.54 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.48 -43.31 1.01 Allowed 'Trans proline' 0 N--CA 1.513 2.63 0 C-N-CA 122.444 2.096 . . . . 1.1599999999999999 113.822 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.37 -41.57 47.57 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 125.223 1.409 . . . . 2.04 111.893 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -86.47 3.96 41.74 Favored 'General case' 0 CA--C 1.578 2.047 0 CA-C-N 114.443 -1.253 . . . . 1.6200000000000001 111.708 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.868 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.3 tt0 -83.25 -40.36 19.69 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 126.659 1.984 . . . . 2.4300000000000002 106.08 171.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.93 -45.99 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.283 0 C-N-CA 125.296 1.438 . . . . 1.46 109.52 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -39.42 68.81 Favored 'General case' 0 CA--C 1.601 2.907 0 N-CA-C 112.781 0.659 . . . . 1.6699999999999999 112.781 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -90.88 20.48 4.77 Favored 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 114.746 1.387 . . . . 1.3300000000000001 114.746 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.08 -42.01 0.65 Allowed 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 115.408 1.633 . . . . 1.4099999999999999 115.408 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.1 p -63.2 137.71 58.31 Favored 'General case' 0 N--CA 1.537 3.882 0 N-CA-C 114.989 1.477 . . . . 1.28 114.989 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.52 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 14.9 pt-20 -114.68 144.73 42.97 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.08 1.511 . . . . 1.53 115.08 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.8 mtp-105 -113.99 157.08 22.94 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 115.001 -1.0 . . . . 3.8300000000000001 111.787 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -129.99 140.25 50.93 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 112.759 0.652 . . . . 3.7599999999999998 112.759 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.512 ' OD1' ' HB3' ' A' ' 35' ' ' GLU . 0.9 OUTLIER -135.61 -95.16 0.25 Allowed 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.853 -0.612 . . . . 5.3700000000000001 111.62 179.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -160.19 -92.11 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 118.159 0.436 . . . . 2.5499999999999998 112.071 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -155.62 124.4 6.05 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.483 0.713 . . . . 2.1499999999999999 110.373 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.657 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.3 OUTLIER 68.82 87.7 0.12 Allowed 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 125.341 1.456 . . . . 1.25 111.802 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -149.14 163.35 37.84 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.445 0.906 . . . . 1.1499999999999999 113.445 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.48 -155.09 10.82 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 116.912 1.525 . . . . 0.59999999999999998 116.912 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.15 168.61 15.88 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.099 1.148 . . . . 1.4099999999999999 114.099 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -126.05 133.68 51.64 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.357 -1.292 . . . . 0.51000000000000001 112.082 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -126.07 100.52 30.05 Favored Pre-proline 0 CA--C 1.569 1.695 0 C-N-CA 123.167 0.587 . . . . 1.0600000000000001 109.642 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.16 117.54 2.2 Favored 'Trans proline' 0 CA--C 1.563 1.925 0 C-N-CA 122.187 1.925 . . . . 0.17999999999999999 114.978 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.18 160.66 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 CA-C-O 122.04 0.924 . . . . 1.0600000000000001 111.409 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -148.51 23.18 1.02 Allowed 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 114.56 -1.2 . . . . 3.1099999999999999 111.528 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -128.85 158.94 37.32 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-O 121.14 0.495 . . . . 2.1200000000000001 110.892 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -120.6 144.94 47.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.601 1.334 . . . . 0.41999999999999998 114.601 -177.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.36 -138.56 5.44 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 113.674 -1.603 . . . . 0.25 112.401 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.5 mt-10 -113.7 105.47 13.34 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 118.521 1.16 . . . . 1.75 111.294 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -99.1 128.43 45.23 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.116 0.484 . . . . 0.90000000000000002 110.899 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 t -113.58 123.79 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.34 0.591 . . . . 1.0700000000000001 110.509 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 tt -108.0 107.6 18.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.982 -1.008 . . . . 1.47 110.401 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.66 125.79 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 114.004 -1.453 . . . . 1.27 107.968 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.45 140.23 44.71 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 116.043 -0.526 . . . . 1.8899999999999999 112.292 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -95.32 120.77 36.12 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.664 -0.698 . . . . 2.8999999999999999 112.693 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -107.05 132.99 52.35 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.055 -0.975 . . . . 0.48999999999999999 109.977 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.15 149.96 47.63 Favored 'General case' 0 C--O 1.262 1.719 0 CA-C-O 121.333 0.587 . . . . 1.1000000000000001 111.372 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -118.52 142.0 48.02 Favored 'General case' 0 C--N 1.36 1.028 0 CA-C-N 115.175 -0.921 . . . . 2.6099999999999999 111.844 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 -45.58 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-N 115.617 -0.72 . . . . 2.6099999999999999 112.632 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -121.11 137.9 54.44 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.126 0.417 . . . . 2.71 112.126 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 89.41 104.6 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 126.356 1.863 . . . . 1.6899999999999999 111.43 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.13 87.19 4.14 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 123.295 1.521 . . . . 1.4299999999999999 111.929 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -146.04 157.47 43.86 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.73 -1.577 . . . . 2.9700000000000002 111.726 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.4 m -115.05 -74.39 0.61 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.063 1.134 . . . . 1.6599999999999999 114.063 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.28 64.12 1.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.225 1.012 . . . . 2.02 111.918 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -151.92 -41.66 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.573 1.549 . . . . 2.5600000000000001 109.033 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -108.28 79.3 1.24 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-O 121.96 0.886 . . . . 3.1499999999999999 109.137 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.38 120.88 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 114.564 -1.198 . . . . 1.3600000000000001 110.639 -178.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -101.51 170.7 8.03 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.362 1.615 . . . . 0.84999999999999998 115.362 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.22 136.72 54.86 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.063 0.458 . . . . 1.3300000000000001 111.052 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.18 125.73 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.306 0 CA-C-N 115.826 -0.625 . . . . 1.1699999999999999 109.899 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 46.2 mtt180 -125.72 151.34 46.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.645 1.72 . . . . 1.9399999999999999 115.645 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.7 m -127.46 110.92 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 123.24 0.616 . . . . 1.29 112.577 177.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.47 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.51 26.43 13.38 Favored 'General case' 0 N--CA 1.526 3.374 0 C-N-CA 126.664 1.986 . . . . 1.8200000000000001 113.95 -178.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.43 -11.93 56.79 Favored Glycine 0 CA--C 1.552 2.367 0 C-N-CA 121.482 -0.39 . . . . 0.32000000000000001 113.834 -176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.496 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 89.3 m-70 -89.72 164.89 14.5 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 125.944 1.698 . . . . 0.56999999999999995 113.488 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.04 134.89 54.32 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.494 0.664 . . . . 1.1899999999999999 112.016 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.51 -58.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 114.916 -1.038 . . . . 1.73 112.784 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.06 88.64 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.881 -1.155 . . . . 1.25 107.881 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -107.74 100.16 9.57 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-O 123.11 1.433 . . . . 2.75 111.778 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 117.62 72.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 129.438 3.095 . . . . 2.48 108.015 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.11 104.96 16.85 Favored 'General case' 0 C--N 1.359 0.98 0 CA-C-O 121.979 0.895 . . . . 1.78 112.713 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -112.11 99.15 7.84 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 112.851 -1.977 . . . . 2.3500000000000001 107.973 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -24.11 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.364 0 N-CA-C 113.964 1.098 . . . . 1.27 113.964 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -75.65 -41.35 54.29 Favored 'General case' 0 CA--C 1.568 1.668 0 C-N-CA 124.108 0.963 . . . . 0.83999999999999997 111.96 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.75 -26.38 59.74 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.278 1.031 . . . . 0.91000000000000003 113.444 176.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -77.39 -57.93 3.55 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.555 0.946 . . . . 2.98 113.555 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.84 -32.07 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 N-CA-C 114.906 1.447 . . . . 1.53 114.906 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.46 -115.77 2.35 Favored Glycine 0 C--N 1.357 1.729 0 CA-C-N 118.655 0.661 . . . . 0.84999999999999998 113.011 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -114.8 107.5 15.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.246 0.546 . . . . 3.9700000000000002 110.716 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.0 m 72.51 -130.52 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 125.487 1.515 . . . . 2.0800000000000001 112.313 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.2 p 58.15 -162.13 0.22 Allowed 'General case' 0 N--CA 1.53 3.528 0 C-N-CA 126.237 1.815 . . . . 1.22 115.017 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.91 135.71 53.69 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 113.495 0.924 . . . . 1.2 113.495 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -109.32 144.91 36.86 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.542 0.737 . . . . 0.41999999999999998 109.163 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.15 124.19 18.88 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.704 1.001 . . . . 2.5 113.704 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -112.72 120.33 41.15 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.288 -0.869 . . . . 1.5800000000000001 111.538 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.47 115.68 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-N 114.742 -1.117 . . . . 1.25 110.499 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 100.76 15.88 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 119.075 -0.488 . . . . 1.5 111.791 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -74.6 142.47 29.26 Favored 'Trans proline' 0 C--N 1.4 3.266 0 C-N-CA 123.062 2.508 . . . . 0.22 114.281 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.29 146.24 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.597 0 C-N-CA 123.934 0.894 . . . . 1.1200000000000001 109.983 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.1 p -128.89 110.42 12.1 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.222 0.534 . . . . 1.8600000000000001 112.145 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.435 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.0 mt -112.83 124.31 69.35 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.57 0 CA-C-N 115.277 -0.874 . . . . 1.0700000000000001 108.952 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -140.22 124.22 17.53 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.47 -0.786 . . . . 2.6400000000000001 111.223 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt 65.75 16.24 10.4 Favored 'General case' 0 N--CA 1.516 2.843 0 C-N-CA 125.43 1.492 . . . . 4.0199999999999996 114.886 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.93 21.78 17.46 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 114.512 0.565 . . . . 0.39000000000000001 114.512 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -129.81 137.84 50.71 Favored 'General case' 0 C--N 1.363 1.159 0 CA-C-N 117.636 0.718 . . . . 2.0299999999999998 111.545 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.36 141.7 31.8 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.077 1.14 . . . . 1.0800000000000001 114.077 -176.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.21 114.53 13.92 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.704 -1.135 . . . . 1.23 110.109 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.253 8.7 p -119.58 95.55 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 CA-C-N 115.841 -0.618 . . . . 1.1899999999999999 111.019 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 67.23 -85.18 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 125.714 1.606 . . . . 1.8200000000000001 113.968 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.44 28.38 3.81 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.093 -0.503 . . . . 0.51000000000000001 113.156 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -134.75 127.23 30.53 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 123.647 0.779 . . . . 1.8200000000000001 110.473 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.3 p -114.27 139.72 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.361 0 CA-C-O 121.278 0.561 . . . . 1.5900000000000001 111.451 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.8 m -158.73 176.04 12.87 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.577 0.751 . . . . 1.1699999999999999 109.87 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.3 p -101.32 137.32 39.81 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.073 0.768 . . . . 1.71 113.073 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -82.8 124.86 30.67 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.074 0.949 . . . . 0.29999999999999999 112.016 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.9 t -131.32 91.08 2.96 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-O 121.643 0.735 . . . . 1.8700000000000001 112.574 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.0 -65.37 3.27 Favored Glycine 0 C--N 1.358 1.752 0 N-CA-C 118.986 2.355 . . . . 0.91000000000000003 118.986 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.508 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -131.16 156.6 45.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.291 1.219 . . . . 1.6799999999999999 114.291 -175.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.508 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -107.15 137.95 44.25 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 113.133 -1.849 . . . . 1.3700000000000001 109.071 176.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.1 t -120.61 143.34 48.71 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.411 1.634 . . . . 0.94999999999999996 115.411 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.38 99.04 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.169 -1.419 . . . . 1.3799999999999999 107.169 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -117.58 123.17 45.56 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.996 -0.547 . . . . 1.6699999999999999 112.316 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.01 136.24 53.13 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 122.53 1.157 . . . . 2.2999999999999998 112.029 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.51 144.78 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 CA-C-N 112.529 -2.123 . . . . 1.29 109.814 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -58.8 150.84 22.76 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.504 2.038 . . . . 2.6200000000000001 116.504 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.91 -63.95 0.51 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 115.541 -0.754 . . . . 1.0600000000000001 114.028 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -130.7 -64.85 0.82 Allowed 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.962 0.381 . . . . 3.1000000000000001 111.811 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -120.17 -46.56 2.41 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.769 0.428 . . . . 4.0800000000000001 111.953 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -100.99 177.09 5.05 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.47 0.708 . . . . 1.74 111.222 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.657 ' ND2' ' H ' ' A' ' 70' ' ' SER . 4.5 m-20 -115.0 -85.46 0.0 OUTLIER Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 117.441 -1.266 . . . . 1.6799999999999999 110.679 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -88.59 -36.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.393 2.911 0 CA-C-N 123.774 2.384 . . . . 2.8199999999999998 114.256 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm 79.79 -88.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 126.845 2.058 . . . . 3.4100000000000001 110.675 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.8 t -111.77 131.81 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.327 -0.99 . . . . 1.3799999999999999 108.327 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.8 t -138.26 132.49 31.8 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.052 -0.977 . . . . 1.75 111.801 -178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -129.6 51.11 2.1 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 114.96 1.467 . . . . 1.1299999999999999 114.96 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.25 138.14 1.25 Allowed 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 117.803 2.52 . . . . 1.3999999999999999 117.803 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -153.78 104.22 2.67 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 115.666 -0.697 . . . . 0.26000000000000001 111.504 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.536 HG23 ' O ' ' A' ' 12' ' ' TRP 0.316 10.3 tt -113.88 122.06 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.183 0 CA-C-O 122.384 1.088 . . . . 1.1000000000000001 111.119 175.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -122.7 165.47 16.48 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.145 -1.389 . . . . 1.0600000000000001 111.092 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.6 ptmt -121.74 157.89 29.97 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 118.239 2.681 . . . . 1.8300000000000001 118.239 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.24 -40.39 2.45 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 110.212 -3.176 . . . . 0.17000000000000001 119.066 173.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.11 157.64 1.85 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 120.265 2.033 . . . . 1.05 113.101 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.86 -11.52 59.58 Favored 'General case' 0 CA--C 1.58 2.132 0 C-N-CA 124.91 1.284 . . . . 0.98999999999999999 113.984 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.68 3.52 47.57 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.0 1.111 . . . . 0.55000000000000004 114.0 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.02 -20.47 14.78 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.388 0.885 . . . . 0.59999999999999998 113.388 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.56 152.14 59.88 Favored Pre-proline 0 CA--C 1.579 2.072 0 C-N-CA 124.343 1.057 . . . . 1.1799999999999999 112.262 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -60.06 117.89 4.7 Favored 'Trans proline' 0 N--CA 1.522 3.168 0 C-N-CA 124.935 3.757 . . . . 2.0299999999999998 115.87 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 14.8 ttt -145.52 118.28 8.67 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.974 -0.557 . . . . 5.3399999999999999 111.345 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.6 mt -130.9 159.58 37.0 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.956 0.884 . . . . 4.0 112.492 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -105.85 162.35 19.99 Favored Pre-proline 0 CA--C 1.562 1.43 0 CA-C-N 114.768 -1.105 . . . . 6.7000000000000002 110.929 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -65.15 122.16 9.83 Favored 'Trans proline' 0 C--N 1.397 3.09 0 C-N-CA 122.696 2.264 . . . . 6.9400000000000004 114.425 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.531 ' HD1' ' H ' ' A' ' 188' ' ' GLY . 12.6 t-80 -135.23 134.75 21.66 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-N 115.452 -0.795 . . . . 5.5099999999999998 111.374 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.76 -29.41 7.1 Favored 'Trans proline' 0 C--N 1.394 2.95 0 C-N-CA 123.555 2.837 . . . . 7.1600000000000001 116.318 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.531 ' H ' ' HD1' ' A' ' 186' ' ' HIS . . . -135.25 121.52 2.58 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 121.21 -0.519 . . . . 7.0199999999999996 114.324 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.4 mt -118.79 111.39 18.39 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.879 0.472 . . . . 9.3000000000000007 111.821 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.33 -0.843 . . . . 10.6 111.073 -179.962 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.092 0 N-CA-C 112.466 -0.254 . . . . 9.3599999999999994 112.466 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.13 -39.72 4.67 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 113.014 0.746 . . . . 6.8499999999999996 113.014 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 mmt -133.0 115.14 14.82 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-O 120.978 0.418 . . . . 8.0 111.567 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 m -137.65 106.5 5.94 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.772 -0.649 . . . . 4.1500000000000004 111.448 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.32 81.37 0.05 OUTLIER Glycine 0 C--N 1.341 0.842 0 CA-C-N 115.726 -0.67 . . . . 1.6000000000000001 113.123 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.6 tp -88.37 -45.84 9.67 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 113.328 0.862 . . . . 1.0900000000000001 113.328 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.99 -23.32 63.54 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 125.896 1.678 . . . . 1.04 115.269 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.69 -12.17 49.11 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 113.575 0.954 . . . . 0.32000000000000001 113.575 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -106.13 -19.36 13.74 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 113.324 0.861 . . . . 2.2599999999999998 113.324 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -56.67 134.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.851 0 N-CA-C 114.705 1.372 . . . . 1.01 114.705 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -119.7 -29.77 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 115.581 -0.736 . . . . 1.0600000000000001 112.214 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.468 ' O ' HG22 ' A' ' 172' ' ' ILE . 75.7 t90 -160.43 115.95 2.3 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 120.696 0.284 . . . . 0.67000000000000004 110.951 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.08 122.19 22.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.602 -0.686 . . . . 1.0800000000000001 111.397 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.636 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 30.8 t -131.25 116.63 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 122.097 0.951 . . . . 1.6699999999999999 109.663 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.471 HD21 ' HB2' ' A' ' 169' ' ' ALA . 11.4 m120 -114.01 88.01 2.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.828 -1.078 . . . . 2.6400000000000001 108.996 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.6 120.13 17.79 Favored 'General case' 0 C--O 1.277 2.516 0 N-CA-C 115.757 1.762 . . . . 1.28 115.757 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.482 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 151.88 -10.22 0.67 Allowed Glycine 0 C--N 1.359 1.816 0 CA-C-N 111.731 -2.486 . . . . 0.70999999999999996 115.693 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.12 -119.81 1.23 Allowed Glycine 0 N--CA 1.468 0.82 0 CA-C-N 117.645 0.723 . . . . 0.87 112.511 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -169.07 118.08 0.67 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.068 0.547 . . . . 2.1200000000000001 110.697 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 68.1 p 42.95 100.45 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.681 0 N-CA-C 117.92 2.563 . . . . 1.5 117.92 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.509 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 84.0 t60 -132.94 136.24 46.0 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 118.615 -1.234 . . . . 0.52000000000000002 114.171 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.267 10.0 p -103.39 117.76 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 CA-C-N 114.117 -1.401 . . . . 2.0699999999999998 110.917 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -83.12 152.51 25.27 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-N 113.578 -1.646 . . . . 1.8500000000000001 110.046 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.7 m -41.25 -28.77 0.16 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.27 0 N-CA-C 119.192 3.034 . . . . 1.3700000000000001 119.192 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -87.36 -25.96 23.59 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.184 0.516 . . . . 0.56999999999999995 111.277 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.63 38.85 0.75 Allowed Glycine 0 C--N 1.352 1.422 0 CA-C-N 114.983 -1.008 . . . . 0.37 114.445 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.6 mm -107.09 114.16 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 N-CA-C 109.68 -0.489 . . . . 1.25 109.68 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.509 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -107.08 132.46 52.95 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 115.359 1.614 . . . . 1.71 115.359 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -89.12 147.27 24.3 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.871 0.869 . . . . 3.1499999999999999 109.93 174.274 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.423 ' O ' ' HB3' ' A' ' 20' ' ' SER . 0.0 OUTLIER -60.49 -107.88 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 117.075 2.25 . . . . 3.5099999999999998 117.075 -177.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -175.72 71.55 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 124.221 1.008 . . . . 2.8100000000000001 112.958 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.407 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 19.3 m-20 65.52 47.57 0.58 Allowed Pre-proline 0 N--CA 1.519 3.009 0 N-CA-C 118.291 2.7 . . . . 1.1699999999999999 118.291 175.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 41.4 Cg_endo -106.77 160.44 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.214 2.609 . . . . 1.45 114.391 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.45 -86.77 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.5 1.12 . . . . 2.2400000000000002 110.039 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 72' ' ' GLY . 45.6 mt-10 -141.26 60.48 1.5 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.514 0.561 . . . . 4.8399999999999999 112.514 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.79 0.33 60.53 Favored Glycine 0 CA--C 1.549 2.158 0 N-CA-C 115.886 1.115 . . . . 2.9700000000000002 115.886 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.49 87.68 2.56 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 121.737 0.78 . . . . 4.79 111.763 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.46 117.01 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 114.545 -1.207 . . . . 3.1499999999999999 110.901 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.96 -103.63 0.18 Allowed Glycine 0 C--N 1.342 0.899 0 C-N-CA 120.866 -0.683 . . . . 2.7200000000000002 114.018 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -120.7 177.02 5.23 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.512 0.93 . . . . 5.9500000000000002 113.512 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.63 147.45 24.3 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.481 1.112 . . . . 1.78 112.638 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.0 m -113.77 84.62 2.06 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-O 121.411 0.624 . . . . 1.6599999999999999 111.639 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.67 82.93 1.96 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.468 -0.787 . . . . 2.3300000000000001 111.226 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.2 81.1 1.67 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 122.003 0.906 . . . . 3.3300000000000001 110.213 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.42 70.11 0.19 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 113.886 -1.506 . . . . 1.7 109.999 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.06 0.63 57.47 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 115.591 1.7 . . . . 2.0800000000000001 115.591 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.406 ' HE3' ' O ' ' A' ' 47' ' ' LYS . 1.8 ttpp -112.71 67.61 0.66 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.203 1.001 . . . . 4.6200000000000001 110.849 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.7 tp -163.66 72.2 1.82 Allowed Pre-proline 0 C--O 1.238 0.483 0 CA-C-N 114.179 -1.373 . . . . 3.1600000000000001 107.516 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -66.98 158.38 57.07 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.697 2.932 . . . . 1.8600000000000001 117.379 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.265 1.2 mp -89.8 128.11 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.226 0 CA-C-N 114.986 -1.006 . . . . 1.28 109.191 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mp -85.49 -12.01 52.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.924 1.824 . . . . 1.9299999999999999 115.924 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -102.63 22.59 13.36 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 113.694 0.998 . . . . 1.79 113.694 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -143.03 -163.33 1.61 Allowed 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 121.773 0.797 . . . . 1.49 111.993 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.591 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.2 t30 -95.55 -179.96 1.04 Allowed Pre-proline 0 CA--C 1.572 1.823 0 C-N-CA 125.302 1.441 . . . . 1.6799999999999999 111.138 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.563 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 24.5 Cg_exo -71.82 -45.64 0.7 Allowed 'Trans proline' 0 C--N 1.394 2.969 0 C-N-CA 123.076 2.518 . . . . 1.1599999999999999 111.891 174.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -70.07 -43.78 70.45 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.438 -1.71 . . . . 2.04 111.56 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.01 1.51 43.45 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 114.912 -1.04 . . . . 1.6200000000000001 112.438 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.591 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 3.4 tt0 -77.71 -42.94 32.65 Favored 'General case' 0 C--N 1.381 1.938 0 C-N-CA 125.853 1.661 . . . . 2.4300000000000002 106.853 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.07 -44.45 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.869 0 C-N-CA 124.519 1.127 . . . . 1.46 109.108 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.9 tp -68.22 -29.67 68.55 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 114.723 1.379 . . . . 1.6699999999999999 114.723 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -105.53 14.88 27.92 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 114.121 1.156 . . . . 1.3300000000000001 114.121 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.14 -23.48 1.13 Allowed 'General case' 0 N--CA 1.513 2.713 0 N-CA-C 115.883 1.809 . . . . 1.4099999999999999 115.883 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.457 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 41.7 p -80.88 135.95 36.0 Favored 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 113.378 0.881 . . . . 1.28 113.378 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.482 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.1 pt-20 -117.57 145.38 44.32 Favored 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 115.894 1.813 . . . . 1.53 115.894 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.464 HH12 HD22 ' A' ' 67' ' ' ASN . 38.0 ttt-85 -130.22 105.91 8.23 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.611 -1.177 . . . . 3.8300000000000001 109.75 176.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -119.9 140.77 50.35 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.246 0.546 . . . . 3.7599999999999998 112.398 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.464 HD22 HH12 ' A' ' 65' ' ' ARG . 3.9 m-80 -113.87 -76.49 0.58 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.099 0.778 . . . . 5.3700000000000001 113.099 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -142.69 -91.6 0.13 Allowed 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 113.094 0.776 . . . . 2.5499999999999998 113.094 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -159.54 125.99 4.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.479 0.712 . . . . 2.1499999999999999 110.58 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.409 ' H ' HD22 ' A' ' 164' ' ' ASN . 0.3 OUTLIER 72.72 83.99 0.12 Allowed 'General case' 0 N--CA 1.514 2.75 0 C-N-CA 124.952 1.301 . . . . 1.25 111.042 -178.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -147.29 152.84 38.93 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.502 -0.772 . . . . 1.1499999999999999 113.062 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.519 ' O ' ' HG3' ' A' ' 35' ' ' GLU . . . -165.51 -171.68 32.01 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 115.842 1.097 . . . . 0.59999999999999998 115.842 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.27 172.43 7.08 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.438 1.273 . . . . 1.4099999999999999 114.438 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.09 132.33 51.92 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.393 -1.276 . . . . 0.51000000000000001 112.228 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.27 102.22 30.65 Favored Pre-proline 0 CA--C 1.567 1.613 0 C-N-CA 123.446 0.698 . . . . 1.0600000000000001 109.408 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.84 119.58 2.22 Favored 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 122.098 1.865 . . . . 0.17999999999999999 114.925 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.36 162.7 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.654 0 CA-C-O 122.003 0.906 . . . . 1.0600000000000001 111.089 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -150.63 19.76 0.82 Allowed 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 114.716 -1.129 . . . . 3.1099999999999999 111.781 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.53 159.78 35.25 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-O 121.32 0.581 . . . . 2.1200000000000001 111.572 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.507 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -118.32 147.96 42.96 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.199 1.185 . . . . 0.41999999999999998 114.199 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.82 -139.6 6.26 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 113.827 -1.533 . . . . 0.25 112.165 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.9 mt-10 -115.1 104.63 12.06 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 118.46 1.13 . . . . 1.75 110.823 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -98.88 128.4 45.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.159 0.504 . . . . 0.90000000000000002 110.759 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -112.93 122.91 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-O 121.612 0.72 . . . . 1.0700000000000001 110.848 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 tt -108.34 105.35 14.99 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.391 -1.277 . . . . 1.47 110.304 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.19 125.13 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 114.082 -1.417 . . . . 1.27 107.913 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -135.52 135.34 40.33 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.728 -0.669 . . . . 1.8899999999999999 111.837 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.43 ' HD3' ' O ' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -96.09 121.21 37.62 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.498 -0.774 . . . . 2.8999999999999999 112.051 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -107.34 133.96 51.11 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.058 -0.974 . . . . 0.48999999999999999 109.945 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.33 152.92 48.92 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.433 0.635 . . . . 1.1000000000000001 112.499 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.68 157.12 16.7 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.41 1.084 . . . . 2.6099999999999999 112.309 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.257 4.4 p -144.52 -39.48 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.585 0 N-CA-C 114.227 1.195 . . . . 2.6099999999999999 114.227 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -130.01 -2.04 4.63 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 115.442 1.645 . . . . 2.71 115.442 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -128.6 114.0 16.14 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.537 1.062 . . . . 1.6899999999999999 112.311 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.0 92.7 4.15 Favored 'General case' 0 CA--C 1.563 1.471 0 CA-C-O 122.617 1.198 . . . . 1.4299999999999999 111.061 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.492 HE22 ' HZ1' ' A' ' 100' ' ' LYS . 15.0 mt-30 -152.12 149.62 29.0 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.815 -1.084 . . . . 2.9700000000000002 112.103 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.1 m -123.71 117.83 25.85 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.585 0.587 . . . . 1.6599999999999999 112.585 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 71.47 55.38 0.2 Allowed 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 126.244 1.818 . . . . 2.02 113.058 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -154.56 -40.08 0.09 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.194 -1.366 . . . . 2.5600000000000001 109.579 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HZ1' HE22 ' A' ' 96' ' ' GLN . 14.7 mptt -107.61 80.84 1.44 Allowed 'General case' 0 C--N 1.364 1.237 0 N-CA-C 108.643 -0.873 . . . . 3.1499999999999999 108.643 177.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.52 129.3 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 114.627 -1.169 . . . . 1.3600000000000001 111.466 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -115.51 171.76 7.52 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.014 1.487 . . . . 0.84999999999999998 115.014 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.52 136.12 54.01 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.415 0.626 . . . . 1.3300000000000001 111.774 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.2 123.32 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.936 0 CA-C-N 115.315 -0.857 . . . . 1.1699999999999999 110.102 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -129.83 149.42 51.57 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.953 1.464 . . . . 1.9399999999999999 114.953 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.3 OUTLIER -126.56 108.26 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 114.636 -1.165 . . . . 1.29 111.704 176.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.454 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 65.18 26.08 12.37 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 126.759 2.023 . . . . 1.8200000000000001 113.277 -177.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.41 -13.91 51.06 Favored Glycine 0 CA--C 1.553 2.435 0 CA-C-N 116.157 -0.474 . . . . 0.32000000000000001 114.139 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -89.85 131.21 35.9 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 125.456 1.502 . . . . 0.56999999999999995 114.044 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -97.85 126.0 43.0 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.429 -0.794 . . . . 1.1899999999999999 112.705 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.26 -48.2 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-N 114.214 -1.357 . . . . 1.73 110.256 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.06 88.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 120.26 -0.576 . . . . 1.25 109.744 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.02 72.27 0.81 Allowed 'General case' 0 C--N 1.36 1.03 0 CA-C-O 123.494 1.616 . . . . 2.75 111.411 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.7 p30 160.07 60.4 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 111.005 -2.816 . . . . 2.48 108.52 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.89 103.18 15.75 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 113.749 1.018 . . . . 1.78 113.749 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -119.07 102.87 9.05 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 112.88 -1.963 . . . . 2.3500000000000001 106.067 175.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -27.05 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.319 0 N-CA-C 114.547 1.314 . . . . 1.27 114.547 -176.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.59 -37.77 55.96 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.684 0.793 . . . . 0.83999999999999997 112.194 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.22 -26.58 60.33 Favored 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 124.665 1.186 . . . . 0.91000000000000003 113.229 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -80.22 -57.96 3.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.482 0.919 . . . . 2.98 113.482 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.28 -36.22 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.532 0 N-CA-C 114.196 1.184 . . . . 1.53 114.196 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.01 -73.12 0.2 Allowed Glycine 0 C--N 1.361 1.922 0 CA-C-N 118.306 0.503 . . . . 0.84999999999999998 113.969 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -102.76 175.43 5.49 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.345 1.058 . . . . 3.9700000000000002 111.753 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 m -71.6 87.68 0.93 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.997 0.903 . . . . 2.0800000000000001 113.428 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.34 -162.22 1.3 Allowed 'General case' 0 CA--C 1.563 1.445 0 CA-C-N 113.918 -1.492 . . . . 1.22 110.024 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.94 130.3 45.3 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 113.421 0.897 . . . . 1.2 113.421 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.43 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 22.4 t60 -103.51 141.72 35.51 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.463 -0.569 . . . . 0.41999999999999998 109.463 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -134.15 124.17 25.62 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.377 1.251 . . . . 2.5 114.377 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -111.39 118.84 36.93 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.748 -1.114 . . . . 1.5800000000000001 110.684 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.62 120.91 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.735 -1.12 . . . . 1.25 111.448 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.29 95.45 27.49 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-N 115.842 -0.617 . . . . 1.5 111.062 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -75.37 131.91 14.37 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.787 2.324 . . . . 0.22 112.711 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.3 mt -115.1 146.7 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 CA-C-N 115.443 -0.799 . . . . 1.1200000000000001 111.137 -176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.6 p -129.18 109.94 11.57 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.264 -0.88 . . . . 1.8600000000000001 111.515 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.507 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.5 mt -112.14 123.33 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.502 0 N-CA-C 108.336 -0.987 . . . . 1.0700000000000001 108.336 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -138.78 124.43 19.62 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.373 -0.83 . . . . 2.6400000000000001 110.792 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.28 17.86 10.25 Favored 'General case' 0 N--CA 1.515 2.784 0 C-N-CA 125.35 1.46 . . . . 4.0199999999999996 114.168 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.54 13.8 43.2 Favored Glycine 0 CA--C 1.546 2.01 0 CA-C-O 119.163 -0.798 . . . . 0.39000000000000001 115.025 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 54.8 mtpt -122.46 147.02 46.83 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-N 118.523 1.161 . . . . 2.0299999999999998 112.57 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.82 143.98 31.74 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.125 1.157 . . . . 1.0800000000000001 114.125 -175.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.43 114.65 11.59 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.919 -1.037 . . . . 1.23 110.653 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.278 0.4 OUTLIER -116.81 105.17 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-O 121.144 0.497 . . . . 1.1899999999999999 110.382 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 66.32 -84.29 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.706 0 C-N-CA 125.701 1.601 . . . . 1.8200000000000001 113.981 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.75 31.82 2.52 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.001 -0.545 . . . . 0.51000000000000001 112.859 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -134.85 126.66 29.24 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 123.603 0.761 . . . . 1.8200000000000001 110.239 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -112.5 133.02 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 CA-C-O 121.673 0.749 . . . . 1.5900000000000001 112.21 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.2 m -149.95 179.54 7.97 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.83 -1.077 . . . . 1.1699999999999999 109.346 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.275 15.1 t -104.15 139.05 39.76 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 113.476 0.917 . . . . 1.71 113.476 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -82.87 122.19 27.92 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.068 0.947 . . . . 0.29999999999999999 111.367 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.56 91.24 3.26 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 112.556 0.576 . . . . 1.8700000000000001 112.556 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.96 -64.82 3.33 Favored Glycine 0 C--N 1.358 1.802 0 N-CA-C 118.715 2.246 . . . . 0.91000000000000003 118.715 177.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.518 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -132.38 157.79 43.63 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 114.251 1.204 . . . . 1.6799999999999999 114.251 -176.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.518 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -104.62 139.04 40.06 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.202 -1.817 . . . . 1.3700000000000001 109.063 176.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 t -121.35 142.48 49.94 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.352 1.612 . . . . 0.94999999999999996 115.352 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.405 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.14 97.27 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.451 -1.314 . . . . 1.3799999999999999 107.451 176.267 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 33.4 mt-10 -112.65 128.04 56.28 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.384 0.883 . . . . 1.6699999999999999 113.384 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -114.05 126.18 54.83 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 115.738 -0.664 . . . . 2.2999999999999998 110.192 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.07 144.37 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 114.652 -1.158 . . . . 1.29 110.53 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -72.45 150.45 43.3 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.646 2.091 . . . . 2.6200000000000001 116.646 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -114.97 -47.88 0.55 Allowed Glycine 0 CA--C 1.541 1.691 0 CA-C-N 114.066 -1.424 . . . . 1.0600000000000001 112.941 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -131.88 -76.82 0.51 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 122.739 0.415 . . . . 3.1000000000000001 111.951 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -138.17 -53.97 0.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.949 0.5 . . . . 4.0800000000000001 111.421 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.05 119.66 31.39 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.606 1.162 . . . . 1.74 110.772 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.409 HD22 ' H ' ' A' ' 70' ' ' SER . 1.3 m-20 -81.13 -170.67 0.26 Allowed Pre-proline 0 CA--C 1.572 1.809 0 C-N-CA 124.848 1.259 . . . . 1.6799999999999999 110.524 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -61.8 104.93 0.34 Allowed 'Trans proline' 0 C--N 1.394 2.922 0 CA-C-N 122.304 1.858 . . . . 2.8199999999999998 112.215 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -63.52 1.27 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.336 1.976 . . . . 3.4100000000000001 116.336 -174.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 66.0 t -96.38 131.44 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 CA-C-N 119.367 0.985 . . . . 1.3799999999999999 109.991 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.25 123.27 23.99 Favored 'General case' 0 C--N 1.363 1.169 0 CA-C-N 114.443 -1.253 . . . . 1.75 111.834 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.471 ' HB2' HD21 ' A' ' 15' ' ' ASN . . . -120.72 48.02 1.69 Allowed 'General case' 0 CA--C 1.585 2.302 0 N-CA-C 115.643 1.719 . . . . 1.1299999999999999 115.643 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.636 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -45.23 131.74 7.73 Favored 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 116.64 2.089 . . . . 1.3999999999999999 116.64 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -151.31 105.4 3.19 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 115.19 -0.914 . . . . 0.26000000000000001 111.051 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 12' ' ' TRP 0.298 9.1 tt -113.66 122.32 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 CA-C-O 122.283 1.04 . . . . 1.1000000000000001 111.258 175.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -122.67 165.24 16.82 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 113.906 -1.497 . . . . 1.0600000000000001 110.789 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -122.13 158.93 28.22 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 118.283 2.698 . . . . 1.8300000000000001 118.283 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.89 -41.31 2.17 Favored Glycine 0 CA--C 1.541 1.7 0 CA-C-N 110.351 -3.113 . . . . 0.17000000000000001 119.256 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.59 154.53 1.25 Allowed 'General case' 0 N--CA 1.518 2.927 0 CA-C-N 120.494 2.147 . . . . 1.05 113.227 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.25 -14.43 58.42 Favored 'General case' 0 CA--C 1.581 2.169 0 C-N-CA 124.75 1.22 . . . . 0.98999999999999999 114.092 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.8 2.99 49.9 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.143 1.164 . . . . 0.55000000000000004 114.143 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.653 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -110.0 -5.79 15.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.726 1.01 . . . . 0.59999999999999998 113.726 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.51 93.69 0.41 Allowed Pre-proline 0 N--CA 1.511 2.622 0 C-N-CA 124.397 1.079 . . . . 1.1799999999999999 111.752 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.653 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 53.7 Cg_endo -95.26 146.54 1.46 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.988 2.459 . . . . 2.0299999999999998 114.717 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 24.0 mmt -138.01 111.6 8.16 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.901 -0.591 . . . . 5.3399999999999999 111.4 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.8 161.06 38.46 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.982 0.896 . . . . 4.0 112.656 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -111.26 161.14 26.47 Favored Pre-proline 0 CA--C 1.56 1.332 0 CA-C-N 114.774 -1.103 . . . . 6.7000000000000002 110.934 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.6 120.51 7.81 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.791 2.328 . . . . 6.9400000000000004 114.771 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.51 ' HD1' ' H ' ' A' ' 188' ' ' GLY . 42.3 t-80 -136.86 141.76 36.17 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-N 114.861 -1.063 . . . . 5.5099999999999998 111.071 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.97 -28.58 3.83 Favored 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 123.098 2.532 . . . . 7.1600000000000001 116.15 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.51 ' H ' ' HD1' ' A' ' 186' ' ' HIS . . . -135.06 -140.35 4.21 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 114.34 0.496 . . . . 7.0199999999999996 114.34 -178.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.8 mt -119.2 115.5 24.34 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.021 0.378 . . . . 9.3000000000000007 112.021 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.165 -0.921 . . . . 10.6 110.639 179.73 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.641 -0.184 . . . . 9.3599999999999994 112.641 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.2 117.81 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 127.546 2.338 . . . . 6.8499999999999996 114.984 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.8 tpt -141.37 115.84 9.53 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.469 -0.787 . . . . 8.0 111.007 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.6 m -131.2 -66.41 0.74 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.911 -0.586 . . . . 4.1500000000000004 112.254 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.27 95.95 0.1 Allowed Glycine 0 C--N 1.348 1.222 0 C-N-CA 121.426 -0.416 . . . . 1.6000000000000001 113.225 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.4 tp -87.42 -42.4 12.86 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 112.938 0.718 . . . . 1.0900000000000001 112.938 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.43 63.56 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 125.855 1.662 . . . . 1.04 114.797 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.7 -11.43 51.24 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 113.667 0.988 . . . . 0.32000000000000001 113.667 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 20.8 mmtp -105.47 -23.28 12.84 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.379 0.881 . . . . 2.2599999999999998 113.379 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.67 136.55 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 N-CA-C 115.472 1.656 . . . . 1.01 115.472 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.9 -28.4 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 115.195 -0.911 . . . . 1.0600000000000001 112.236 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.483 ' O ' HG22 ' A' ' 172' ' ' ILE . 64.7 t90 -163.09 118.76 1.76 Allowed 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 117.929 0.331 . . . . 0.67000000000000004 111.882 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.26 131.82 30.76 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.273 -0.892 . . . . 1.0800000000000001 111.876 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -139.75 130.66 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 N-CA-C 113.113 0.783 . . . . 1.6699999999999999 113.113 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -115.83 106.61 14.03 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.117 -1.438 . . . . 2.6400000000000001 107.117 171.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.33 105.83 9.84 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.614 0.721 . . . . 1.28 111.664 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 168.79 -63.54 0.19 Allowed Glycine 0 C--N 1.355 1.635 0 CA-C-N 114.189 -1.369 . . . . 0.70999999999999996 114.821 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -95.16 -116.3 2.96 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 114.716 0.646 . . . . 0.87 114.716 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.657 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 18.4 mt-10 -170.08 114.16 0.49 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.889 0.876 . . . . 2.1200000000000001 109.884 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 46.39 111.95 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.003 0 N-CA-C 118.328 2.714 . . . . 1.5 118.328 178.831 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.443 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 82.1 t60 -136.59 136.4 39.19 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.97 1.1 . . . . 0.52000000000000002 113.97 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.82 109.29 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 CA-C-N 113.765 -1.561 . . . . 2.0699999999999998 107.04 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.67 160.1 18.26 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 112.171 0.434 . . . . 1.8500000000000001 112.171 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -41.48 -26.41 0.11 Allowed 'Isoleucine or valine' 1 N--CA 1.547 4.383 0 N-CA-C 120.072 3.36 . . . . 1.3700000000000001 120.072 -174.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -93.35 -11.33 32.59 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 118.84 0.746 . . . . 0.56999999999999995 112.44 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.82 38.0 3.28 Favored Glycine 0 C--N 1.361 1.929 0 C-N-CA 124.16 0.886 . . . . 0.37 114.158 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.6 mm -105.38 135.55 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.618 0 N-CA-C 108.555 -0.906 . . . . 1.25 108.555 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.443 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.9 t-160 -123.34 132.38 53.97 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.612 1.338 . . . . 1.71 114.612 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.657 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -93.73 137.21 33.22 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.123 -0.944 . . . . 3.1499999999999999 109.94 175.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -100.29 104.76 16.25 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 113.465 0.913 . . . . 3.5099999999999998 113.465 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -36.6 122.12 0.77 Allowed 'General case' 0 N--CA 1.528 3.434 0 N-CA-C 119.051 2.982 . . . . 2.8100000000000001 119.051 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.58 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER 39.03 64.69 3.66 Favored Pre-proline 0 N--CA 1.529 3.49 0 N-CA-C 117.131 2.271 . . . . 1.1699999999999999 117.131 177.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -89.73 -8.09 4.46 Favored 'Trans proline' 0 CA--C 1.563 1.957 0 C-N-CA 122.755 2.303 . . . . 1.45 118.058 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.91 -26.86 0.78 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.468 1.655 . . . . 2.2400000000000002 115.468 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -99.11 76.01 2.07 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 119.702 1.137 . . . . 4.8399999999999999 112.306 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.37 -30.04 10.86 Favored Glycine 0 CA--C 1.543 1.785 0 CA-C-N 115.396 -0.82 . . . . 2.9700000000000002 114.521 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.58 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 50.3 55.31 9.66 Favored 'General case' 0 N--CA 1.516 2.859 0 C-N-CA 127.328 2.251 . . . . 4.79 115.779 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.48 179.6 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-N 114.686 -1.143 . . . . 3.1499999999999999 110.654 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.2 82.27 0.87 Allowed Glycine 0 CA--C 1.538 1.498 0 O-C-N 121.756 -0.59 . . . . 2.7200000000000002 114.449 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -148.38 134.5 19.29 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.372 0.606 . . . . 5.9500000000000002 112.355 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.25 132.71 53.38 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.965 0.906 . . . . 1.78 111.012 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 m -116.91 107.25 14.36 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.689 -0.687 . . . . 1.6599999999999999 111.328 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.68 109.83 8.87 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.564 -0.744 . . . . 2.3300000000000001 111.552 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -105.45 -33.58 8.09 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.248 -0.887 . . . . 3.3300000000000001 111.891 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -114.39 75.67 0.24 Allowed Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.337 -0.705 . . . . 1.7 111.337 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.95 -19.8 22.05 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 114.451 1.278 . . . . 2.0800000000000001 114.451 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.22 35.18 2.78 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 112.84 0.681 . . . . 4.6200000000000001 112.84 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.29 71.7 71.96 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.635 1.574 . . . . 3.1600000000000001 106.972 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -67.81 158.77 55.78 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 124.175 3.25 . . . . 1.8600000000000001 117.45 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.256 1.3 mp -86.76 124.89 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.466 0 C-N-CA 124.366 1.066 . . . . 1.28 108.389 177.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.62 -11.71 59.01 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.602 2.075 . . . . 1.9299999999999999 116.602 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -102.5 17.08 24.52 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 113.745 1.017 . . . . 1.79 113.745 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.421 ' OG ' ' HD2' ' A' ' 61' ' ' TYR . 1.2 t -137.32 -164.04 1.53 Allowed 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.856 0.836 . . . . 1.49 112.578 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.727 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.5 t30 -95.95 -179.27 0.89 Allowed Pre-proline 0 CA--C 1.573 1.858 0 C-N-CA 125.617 1.567 . . . . 1.6799999999999999 111.367 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.501 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.5 Cg_exo -72.34 -46.44 0.49 Allowed 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 123.175 2.584 . . . . 1.1599999999999999 112.535 174.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -70.01 -47.02 63.81 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 113.905 -1.498 . . . . 2.04 111.731 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -8.88 58.12 Favored 'General case' 0 CA--C 1.585 2.324 0 CA-C-N 114.916 -1.038 . . . . 1.6200000000000001 111.955 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.727 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 3.3 tt0 -70.81 -42.28 70.46 Favored 'General case' 0 C--N 1.39 2.354 0 C-N-CA 125.716 1.607 . . . . 2.4300000000000002 108.187 172.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -59.69 -42.56 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.217 0 C-N-CA 124.663 1.185 . . . . 1.46 109.463 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 tp -80.02 -8.81 59.56 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 114.328 1.233 . . . . 1.6699999999999999 114.328 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.421 ' HD2' ' OG ' ' A' ' 53' ' ' SER . 20.3 m-85 -125.05 22.75 7.9 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.98 0.912 . . . . 1.3300000000000001 113.357 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.38 -38.24 0.33 Allowed 'General case' 0 N--CA 1.513 2.686 0 N-CA-C 115.245 1.572 . . . . 1.4099999999999999 115.245 -177.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.8 p -67.85 134.02 50.18 Favored 'General case' 0 N--CA 1.533 3.716 0 N-CA-C 114.456 1.28 . . . . 1.28 114.456 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -123.63 141.77 51.69 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 115.386 1.624 . . . . 1.53 115.386 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -124.2 121.4 34.97 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 113.965 -1.47 . . . . 3.8300000000000001 110.496 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -128.02 137.43 52.2 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.992 0.425 . . . . 3.7599999999999998 112.032 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.42 -70.92 0.75 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.62 0.97 . . . . 5.3700000000000001 113.62 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -135.4 -87.59 0.35 Allowed 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 114.054 1.131 . . . . 2.5499999999999998 114.054 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -173.6 124.72 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.657 0.783 . . . . 2.1499999999999999 109.691 -175.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 71.66 84.67 0.13 Allowed 'General case' 0 N--CA 1.51 2.546 0 C-N-CA 124.86 1.264 . . . . 1.25 111.962 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.62 141.77 45.12 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.978 0.894 . . . . 1.1499999999999999 112.176 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -140.03 175.93 21.58 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 116.407 1.323 . . . . 0.59999999999999998 116.407 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.86 163.17 17.3 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.839 -1.18 . . . . 1.4099999999999999 113.227 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -122.21 129.33 52.16 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.604 -1.18 . . . . 0.51000000000000001 112.435 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -123.21 101.42 38.18 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 108.91 -0.774 . . . . 1.0600000000000001 108.91 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -84.26 119.64 2.43 Favored 'Trans proline' 0 CA--C 1.563 1.945 0 C-N-CA 121.998 1.799 . . . . 0.17999999999999999 114.747 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.84 160.42 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 CA-C-O 122.035 0.922 . . . . 1.0600000000000001 111.308 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -148.66 21.02 1.03 Allowed 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.605 -1.179 . . . . 3.1099999999999999 111.865 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.06 160.35 33.98 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-O 121.312 0.577 . . . . 2.1200000000000001 111.415 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -119.29 145.51 46.06 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.437 0.903 . . . . 0.41999999999999998 113.437 -179.203 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.5 -138.3 5.45 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.341 -1.299 . . . . 0.25 112.498 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 30.6 mm-40 -114.8 105.0 12.51 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 118.228 1.014 . . . . 1.75 111.144 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -99.45 127.51 45.5 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.321 0.582 . . . . 0.90000000000000002 110.853 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -109.22 121.5 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-O 121.894 0.854 . . . . 1.0700000000000001 110.878 -176.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.34 107.41 18.41 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 113.801 -1.545 . . . . 1.47 110.446 178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 t -115.64 125.2 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.91 -0.774 . . . . 1.27 108.91 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.92 141.79 48.56 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.756 0.65 . . . . 1.8899999999999999 112.756 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.07 119.3 39.01 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.668 -0.696 . . . . 2.8999999999999999 111.277 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 12.4 m-85 -106.68 134.61 49.56 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.467 -0.788 . . . . 0.48999999999999999 110.581 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.23 146.6 42.78 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.246 0.546 . . . . 1.1000000000000001 111.527 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -136.23 120.64 18.08 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.253 0.621 . . . . 2.6099999999999999 110.893 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 76.21 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 112.828 0.677 . . . . 2.6099999999999999 112.828 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -171.95 -52.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.735 0.643 . . . . 2.71 112.735 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -115.27 142.77 46.22 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.622 0.601 . . . . 1.6899999999999999 112.622 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.53 101.18 10.15 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.513 1.149 . . . . 1.4299999999999999 111.656 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -163.55 150.75 12.49 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 114.603 -1.181 . . . . 2.9700000000000002 111.047 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.2 m -110.77 -75.19 0.62 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.954 1.094 . . . . 1.6599999999999999 113.954 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -94.44 70.08 3.64 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.103 0.954 . . . . 2.02 111.159 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -156.22 -41.95 0.08 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.936 -1.484 . . . . 2.5600000000000001 109.207 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -109.83 82.47 1.6 Allowed 'General case' 0 C--N 1.364 1.22 0 CA-C-O 121.827 0.823 . . . . 3.1499999999999999 109.172 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.78 121.26 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 114.375 -1.284 . . . . 1.3600000000000001 110.557 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -106.94 173.54 6.28 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.317 1.599 . . . . 0.84999999999999998 115.317 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -124.64 136.98 54.38 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 122.065 0.936 . . . . 1.3300000000000001 111.019 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.82 124.81 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-N 114.145 -1.389 . . . . 1.1699999999999999 109.499 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.8 mtt180 -119.61 143.3 47.74 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.384 1.624 . . . . 1.9399999999999999 115.384 -176.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 5.8 m -120.71 101.01 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 115.345 -0.843 . . . . 1.29 112.184 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.553 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.2 t30 64.9 28.74 12.66 Favored 'General case' 0 N--CA 1.52 3.059 0 C-N-CA 126.494 1.917 . . . . 1.8200000000000001 114.561 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.38 -18.83 32.51 Favored Glycine 0 CA--C 1.549 2.199 0 CA-C-N 115.831 -0.622 . . . . 0.32000000000000001 113.602 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -86.34 161.76 18.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.092 1.757 . . . . 0.56999999999999995 113.125 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -118.68 129.69 55.43 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.166 0.984 . . . . 1.1899999999999999 111.249 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.07 -47.07 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 113.518 -1.673 . . . . 1.73 112.825 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.74 89.32 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.904 -1.147 . . . . 1.25 107.904 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.98 75.49 0.92 Allowed 'General case' 0 C--N 1.359 0.988 0 CA-C-O 123.577 1.655 . . . . 2.75 112.522 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 p30 154.79 63.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 110.474 -3.057 . . . . 2.48 108.032 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.69 99.65 12.51 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 113.563 0.949 . . . . 1.78 113.563 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 3.6 p30 -112.6 94.56 4.97 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 113.017 -1.901 . . . . 2.3500000000000001 107.786 175.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -26.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 N-CA-C 114.739 1.385 . . . . 1.27 114.739 -176.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -74.61 -39.39 62.2 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.828 0.851 . . . . 0.83999999999999997 112.042 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.72 -26.68 59.98 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.71 1.204 . . . . 0.91000000000000003 113.376 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 23.6 mmm180 -77.81 -55.05 5.65 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 113.639 0.978 . . . . 2.98 113.639 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.65 -37.5 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 114.59 1.33 . . . . 1.53 114.59 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.64 -109.44 1.11 Allowed Glycine 0 C--N 1.354 1.558 0 CA-C-N 118.391 0.541 . . . . 0.84999999999999998 113.271 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -114.52 107.46 15.54 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.517 0.327 . . . . 3.9700000000000002 110.433 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 t 70.11 -130.61 0.07 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 125.301 1.441 . . . . 2.0800000000000001 112.304 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.9 p 56.68 -174.39 0.07 Allowed 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 116.635 2.087 . . . . 1.22 116.635 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -100.05 128.45 46.14 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.312 0.856 . . . . 1.2 113.312 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 9.1 t60 -102.79 139.34 38.5 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.141 -0.688 . . . . 0.41999999999999998 109.141 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -137.51 125.85 23.31 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.273 1.212 . . . . 2.5 114.273 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -119.75 127.16 52.56 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 115.077 -0.965 . . . . 1.5800000000000001 110.602 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.99 126.58 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 114.141 -1.39 . . . . 1.25 111.115 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.56 92.22 28.1 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-N 115.263 -0.881 . . . . 1.5 110.567 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -75.02 132.77 15.77 Favored 'Trans proline' 0 C--N 1.394 2.934 0 C-N-CA 122.917 2.412 . . . . 0.22 113.074 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.82 150.26 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 CA-C-N 115.446 -0.797 . . . . 1.1200000000000001 111.145 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.7 p -132.9 109.24 9.46 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.326 -0.852 . . . . 1.8600000000000001 111.799 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.475 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.5 mt -109.19 124.46 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 108.566 -0.901 . . . . 1.0700000000000001 108.566 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.71 126.13 21.77 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.532 -0.758 . . . . 2.6400000000000001 110.75 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt 66.6 16.93 10.53 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 125.272 1.429 . . . . 4.0199999999999996 114.595 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.29 14.77 40.54 Favored Glycine 0 CA--C 1.547 2.056 0 CA-C-O 119.183 -0.787 . . . . 0.39000000000000001 114.803 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 23.6 mtpp -123.9 147.3 47.79 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 118.225 1.012 . . . . 2.0299999999999998 112.419 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.47 139.07 37.63 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.994 1.109 . . . . 1.0800000000000001 113.994 -176.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.49 115.47 18.93 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.929 -1.032 . . . . 1.23 109.989 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.46 93.58 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.486 0 CA-C-N 115.716 -0.675 . . . . 1.1899999999999999 110.878 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 64.75 -84.94 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 125.555 1.542 . . . . 1.8200000000000001 114.135 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.06 26.2 4.25 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-N 116.234 -0.439 . . . . 0.51000000000000001 113.835 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -137.88 117.58 13.11 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.19 0.596 . . . . 1.8200000000000001 109.983 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.25 133.74 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.374 0 CA-C-O 121.65 0.738 . . . . 1.5900000000000001 112.152 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 m -147.62 -179.46 6.89 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.841 -1.072 . . . . 1.1699999999999999 109.543 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.276 14.9 t -103.98 138.89 39.89 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 113.456 0.91 . . . . 1.71 113.456 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -81.96 122.55 27.92 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.233 1.013 . . . . 0.29999999999999999 111.493 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.97 90.98 3.29 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.762 0.653 . . . . 1.8700000000000001 112.762 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.96 -63.78 2.77 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 118.597 2.199 . . . . 0.91000000000000003 118.597 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.551 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -130.58 161.93 30.44 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.837 0.827 . . . . 1.6799999999999999 113.128 -177.095 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.553 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -111.15 137.52 48.72 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.841 -1.527 . . . . 1.3700000000000001 109.221 177.187 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.6 t -116.93 142.31 47.1 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.64 1.348 . . . . 0.94999999999999996 114.64 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 39.6 t -121.57 97.25 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.22 -2.141 . . . . 1.3799999999999999 105.22 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -113.62 124.92 53.49 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.138 -0.937 . . . . 1.6699999999999999 112.913 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -111.68 128.75 56.17 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 122.233 1.016 . . . . 2.2999999999999998 112.058 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.8 144.34 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-N 112.859 -1.973 . . . . 1.29 110.362 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -78.88 149.46 32.43 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 115.659 1.725 . . . . 2.6200000000000001 115.659 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -103.8 -35.25 3.54 Favored Glycine 0 CA--C 1.545 1.921 0 CA-C-N 114.525 -1.216 . . . . 1.0600000000000001 113.132 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -130.57 -83.6 0.53 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.213 0.605 . . . . 3.1000000000000001 110.435 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -170.65 64.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.279 0.631 . . . . 4.0800000000000001 110.656 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -166.98 -39.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.926 0.713 . . . . 1.74 112.926 -178.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.52 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 4.3 m-20 84.32 -177.77 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.439 0 C-N-CA 124.58 1.152 . . . . 1.6799999999999999 110.838 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -65.38 -9.55 22.65 Favored 'Trans proline' 0 N--CA 1.522 3.2 0 C-N-CA 122.641 2.227 . . . . 2.8199999999999998 116.385 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.415 ' HZ3' ' HO3' ' A' ' 191' ' ' GLC . 59.0 mttm 80.05 -73.6 0.06 Allowed 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 126.442 1.897 . . . . 3.4100000000000001 114.065 177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.37 132.04 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.048 0.452 . . . . 1.3799999999999999 110.237 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.0 t -137.34 121.65 18.14 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 114.114 -1.403 . . . . 1.75 110.889 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -115.6 49.78 1.06 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.138 1.903 . . . . 1.1299999999999999 116.138 -176.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -41.06 129.23 2.79 Favored 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 116.061 1.875 . . . . 1.3999999999999999 116.061 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -150.71 103.09 3.06 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.703 -0.681 . . . . 0.26000000000000001 110.305 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.483 HG22 ' O ' ' A' ' 12' ' ' TRP 0.315 7.2 tt -113.92 122.83 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 CA-C-O 122.262 1.03 . . . . 1.1000000000000001 112.169 176.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -123.53 163.6 20.61 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.849 -1.523 . . . . 1.0600000000000001 111.023 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.6 ptmm? -121.91 159.92 25.86 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 118.489 2.774 . . . . 1.8300000000000001 118.489 -175.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.62 -42.06 1.99 Allowed Glycine 0 CA--C 1.543 1.803 0 CA-C-N 110.007 -3.27 . . . . 0.17000000000000001 118.929 174.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.5 153.83 0.94 Allowed 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 120.31 2.055 . . . . 1.05 112.924 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.49 -11.71 59.92 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 114.72 1.378 . . . . 0.98999999999999999 114.72 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.95 3.39 48.83 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.081 1.141 . . . . 0.55000000000000004 114.081 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.629 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -106.28 -10.34 16.44 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 113.749 1.018 . . . . 0.59999999999999998 113.749 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.66 94.12 0.51 Allowed Pre-proline 0 N--CA 1.51 2.526 0 C-N-CA 124.078 0.951 . . . . 1.1799999999999999 112.216 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.629 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 51.7 Cg_endo -94.94 162.2 1.71 Allowed 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 122.757 2.305 . . . . 2.0299999999999998 114.998 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.8 mmt -131.85 118.76 20.29 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.459 -0.792 . . . . 5.3399999999999999 111.25 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.6 mt -127.37 162.37 26.46 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 122.055 0.931 . . . . 4.0 112.818 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -103.61 158.49 31.74 Favored Pre-proline 0 CA--C 1.559 1.291 0 CA-C-N 114.505 -1.225 . . . . 6.7000000000000002 110.728 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.54 121.27 8.35 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.449 2.099 . . . . 6.9400000000000004 115.267 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.678 ' HD1' ' H ' ' A' ' 188' ' ' GLY . 32.9 t-80 -136.11 135.95 22.07 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-N 114.846 -1.07 . . . . 5.5099999999999998 111.122 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -78.13 -19.17 12.31 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 123.637 2.892 . . . . 7.1600000000000001 116.665 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.678 ' H ' ' HD1' ' A' ' 186' ' ' HIS . . . -111.79 -68.24 0.54 Allowed Glycine 0 CA--C 1.534 1.266 0 N-CA-C 115.327 0.891 . . . . 7.0199999999999996 115.327 -177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.9 tp -116.28 130.97 57.05 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.244 0.545 . . . . 9.3000000000000007 112.438 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.331 -0.843 . . . . 10.6 111.25 -179.857 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . 0.415 ' HO3' ' HZ3' ' A' ' 166' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.471 -0.252 . . . . 9.3599999999999994 112.471 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.19 125.55 54.26 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-O 121.692 0.758 . . . . 6.8499999999999996 111.876 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.1 mtt -139.05 115.19 10.28 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.554 -0.748 . . . . 8.0 111.182 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.5 m -134.58 117.95 16.72 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.846 -0.615 . . . . 4.1500000000000004 111.773 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.32 -51.96 0.04 OUTLIER Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.685 -0.689 . . . . 1.6000000000000001 114.089 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.9 tp -85.67 -43.89 13.04 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.495 0.718 . . . . 1.0900000000000001 112.411 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.9 -22.74 65.83 Favored 'General case' 0 CA--C 1.583 2.244 0 C-N-CA 125.63 1.572 . . . . 1.04 114.436 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.15 -12.05 50.96 Favored 'General case' 0 C--N 1.375 1.695 0 N-CA-C 113.638 0.977 . . . . 0.32000000000000001 113.638 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 45.3 mmtt -105.67 -22.62 12.93 Favored 'General case' 0 C--N 1.364 1.212 0 CA-C-O 118.353 -0.832 . . . . 2.2599999999999998 113.203 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.34 135.91 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.844 0 N-CA-C 115.221 1.563 . . . . 1.01 115.221 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -122.22 -29.1 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.227 -0.897 . . . . 1.0600000000000001 111.908 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.497 ' O ' HG22 ' A' ' 172' ' ' ILE . 64.1 t90 -163.68 116.95 1.5 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 120.738 0.304 . . . . 0.67000000000000004 111.414 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -135.19 128.91 32.89 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.296 -0.877 . . . . 1.0800000000000001 110.226 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.2 t -137.84 133.56 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 113.203 0.816 . . . . 1.6699999999999999 113.203 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -118.99 111.09 17.89 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.082 -1.451 . . . . 2.6400000000000001 107.082 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.37 101.75 10.02 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.387 1.089 . . . . 1.28 111.436 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.58 -32.61 0.17 Allowed Glycine 0 C--N 1.344 1.018 0 CA-C-N 113.345 -1.752 . . . . 0.70999999999999996 116.011 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -135.22 -128.33 2.78 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.233 -0.984 . . . . 0.87 114.643 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.461 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 63.0 mt-10 -151.04 115.33 5.08 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.455 0.169 . . . . 2.1200000000000001 111.3 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.712 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.6 m 31.82 116.01 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.887 0 N-CA-C 120.286 3.439 . . . . 1.5 120.286 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -138.67 139.02 38.31 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.15 0.976 . . . . 0.52000000000000002 112.636 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.89 117.18 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 114.049 -1.432 . . . . 2.0699999999999998 109.714 177.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -83.21 166.1 18.88 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.646 -0.707 . . . . 1.8500000000000001 112.238 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -43.09 -29.15 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.547 4.41 0 N-CA-C 119.225 3.046 . . . . 1.3700000000000001 119.225 -176.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -93.38 -14.68 26.53 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 118.357 0.526 . . . . 0.56999999999999995 111.691 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.04 42.69 1.62 Allowed Glycine 0 C--N 1.358 1.764 0 C-N-CA 124.393 0.997 . . . . 0.37 114.461 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.2 mm -105.72 120.26 56.27 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.738 0 N-CA-C 109.51 -0.552 . . . . 1.25 109.51 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -104.62 128.19 52.57 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.796 1.406 . . . . 1.71 114.796 -176.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.712 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -98.04 148.2 23.75 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.254 -0.885 . . . . 3.1499999999999999 110.645 176.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -96.64 168.37 10.57 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.696 1.236 . . . . 3.5099999999999998 113.613 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -84.38 100.22 11.15 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.401 2.0 . . . . 2.8100000000000001 116.401 -174.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.75 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 37.4 m-20 28.63 56.62 0.6 Allowed Pre-proline 1 N--CA 1.543 4.176 0 C-N-CA 128.066 2.546 . . . . 1.1699999999999999 117.468 177.403 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -94.44 81.31 0.15 Allowed 'Trans proline' 0 CA--C 1.569 2.246 0 N-CA-C 119.637 2.899 . . . . 1.45 119.637 -174.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -151.73 -80.72 0.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.338 0.655 . . . . 2.2400000000000002 109.971 174.126 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.4 116.66 6.94 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 122.837 0.455 . . . . 4.8399999999999999 110.486 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.14 5.64 26.59 Favored Glycine 0 CA--C 1.545 1.964 0 C-N-CA 120.699 -0.762 . . . . 2.9700000000000002 114.068 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.75 ' HB3' ' O ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -72.03 64.56 0.53 Allowed 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.272 1.952 . . . . 4.79 116.272 -177.347 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.96 115.23 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 114.937 -1.028 . . . . 3.1499999999999999 109.528 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.19 -111.43 0.95 Allowed Glycine 0 C--N 1.343 0.936 0 C-N-CA 121.216 -0.516 . . . . 2.7200000000000002 113.742 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -151.59 -146.36 0.2 Allowed 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 120.996 0.427 . . . . 5.9500000000000002 111.956 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.51 137.33 36.62 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.617 1.167 . . . . 1.78 112.156 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.5 m -118.68 130.15 55.68 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.456 -0.793 . . . . 1.6599999999999999 110.996 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -131.26 110.73 11.32 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.307 0.575 . . . . 2.3300000000000001 112.468 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -115.15 70.62 0.74 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.455 -0.793 . . . . 3.3300000000000001 110.125 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.62 69.42 0.17 Allowed Glycine 0 C--N 1.344 0.979 0 CA-C-N 114.598 -1.183 . . . . 1.7 111.303 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.62 -24.43 18.68 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.515 1.302 . . . . 2.0800000000000001 114.515 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.581 ' HE2' ' O ' ' A' ' 47' ' ' LYS . 4.6 ttpt -100.45 66.29 1.25 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 121.83 0.824 . . . . 4.6200000000000001 111.824 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.1 72.96 1.71 Allowed Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 107.041 -1.466 . . . . 3.1600000000000001 107.041 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.484 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 50.0 Cg_exo -61.65 155.03 56.04 Favored 'Trans proline' 0 N--CA 1.515 2.765 0 C-N-CA 124.661 3.574 . . . . 1.8600000000000001 117.681 -177.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 mp -92.72 130.4 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.214 0 CA-C-N 114.883 -1.053 . . . . 1.28 108.486 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mt -86.03 -10.14 55.54 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.567 2.062 . . . . 1.9299999999999999 116.567 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -103.49 8.59 37.83 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 114.299 1.222 . . . . 1.79 114.299 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.44 -164.73 1.52 Allowed 'General case' 0 CA--C 1.566 1.579 0 CA-C-O 121.544 0.687 . . . . 1.49 112.096 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.833 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.8 t30 -95.69 179.17 1.21 Allowed Pre-proline 0 CA--C 1.575 1.91 0 C-N-CA 124.715 1.206 . . . . 1.6799999999999999 111.17 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -71.61 -44.77 0.93 Allowed 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 123.202 2.601 . . . . 1.1599999999999999 112.474 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -71.16 -47.4 57.96 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 113.894 -1.503 . . . . 2.04 111.545 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -77.25 -6.0 51.45 Favored 'General case' 0 CA--C 1.595 2.68 0 CA-C-N 115.466 -0.788 . . . . 1.6200000000000001 111.536 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.833 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 11.5 tt0 -72.68 -39.25 67.2 Favored 'General case' 0 C--N 1.387 2.217 0 C-N-CA 126.167 1.787 . . . . 2.4300000000000002 108.463 173.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.0 t -65.59 -41.05 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.151 0 CA-C-N 114.538 -1.21 . . . . 1.46 108.712 172.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.421 ' O ' ' HB1' ' A' ' 169' ' ' ALA . 2.4 tt -75.74 -9.43 58.58 Favored 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 112.662 0.616 . . . . 1.6699999999999999 112.662 174.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.474 ' O ' ' HE3' ' A' ' 88' ' ' LYS . 3.5 m-30 -121.24 17.34 11.51 Favored 'General case' 0 CA--C 1.578 2.027 0 C-N-CA 125.175 1.39 . . . . 1.3300000000000001 113.233 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -146.74 -21.36 0.42 Allowed 'General case' 0 N--CA 1.51 2.533 0 N-CA-C 116.656 2.095 . . . . 1.4099999999999999 116.656 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.3 p -79.5 127.79 32.57 Favored 'General case' 0 N--CA 1.518 2.947 0 N-CA-C 115.71 1.744 . . . . 1.28 115.71 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -123.33 148.98 45.44 Favored 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 124.876 1.27 . . . . 1.53 111.847 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.403 ' HD2' ' CG ' ' A' ' 32' ' ' ASP . 2.0 ptm180 -104.0 -93.64 0.34 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 112.582 0.586 . . . . 3.8300000000000001 112.582 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.66 157.55 44.57 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.545 0.688 . . . . 3.7599999999999998 112.414 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -122.5 141.15 51.96 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.095 0.776 . . . . 5.3700000000000001 113.095 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -134.78 -103.67 0.23 Allowed 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 115.447 -0.797 . . . . 2.5499999999999998 110.479 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -163.9 121.73 1.82 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.085 0.554 . . . . 2.1499999999999999 110.764 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.23 86.55 0.11 Allowed 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.368 1.467 . . . . 1.25 113.639 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -150.78 154.76 37.91 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.754 0.788 . . . . 1.1499999999999999 112.993 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 34' ' ' LEU . . . -172.99 -172.51 38.66 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 114.788 -1.097 . . . . 0.59999999999999998 115.279 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.23 172.55 6.82 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.465 1.283 . . . . 1.4099999999999999 114.465 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -129.47 133.9 47.53 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 114.113 -1.403 . . . . 0.51000000000000001 111.846 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.67 102.24 32.55 Favored Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 123.538 0.735 . . . . 1.0600000000000001 109.495 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -84.79 120.58 2.36 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 121.97 1.78 . . . . 0.17999999999999999 114.641 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.09 161.48 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.61 0 CA-C-O 122.093 0.949 . . . . 1.0600000000000001 111.281 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -148.82 19.24 1.01 Allowed 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.553 -1.203 . . . . 3.1099999999999999 111.922 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -129.93 159.21 37.34 Favored 'General case' 0 C--N 1.363 1.169 0 CA-C-O 121.313 0.577 . . . . 2.1200000000000001 111.423 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -119.12 147.86 43.7 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.23 1.196 . . . . 0.41999999999999998 114.23 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.85 -137.53 5.24 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 113.883 -1.508 . . . . 0.25 112.333 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.4 mm-40 -114.86 105.62 13.22 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-N 118.345 1.073 . . . . 1.75 110.848 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -99.66 130.34 45.87 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.129 0.49 . . . . 0.90000000000000002 111.174 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -113.24 121.87 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.666 0.746 . . . . 1.0700000000000001 110.748 -176.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -109.43 104.92 14.09 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.346 -1.297 . . . . 1.47 110.313 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.29 129.72 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 114.825 -1.08 . . . . 1.27 108.766 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.61 139.56 50.41 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.077 0.769 . . . . 1.8899999999999999 113.077 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.592 ' HZ1' ' H ' ' A' ' 127' ' ' HIS . 6.0 tmtm? -105.82 118.41 36.53 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.945 0.879 . . . . 2.8999999999999999 110.145 176.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -106.39 134.45 49.51 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 114.728 -1.124 . . . . 0.48999999999999999 109.487 178.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -133.52 146.83 51.42 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 123.079 0.551 . . . . 1.1000000000000001 111.736 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -139.71 108.91 6.08 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 116.003 -0.544 . . . . 2.6099999999999999 110.726 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.22 69.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 116.153 -0.476 . . . . 2.6099999999999999 111.594 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -162.74 -52.28 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.976 -0.556 . . . . 2.71 111.829 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -119.1 130.15 55.43 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 122.889 0.476 . . . . 1.6899999999999999 111.407 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.03 104.92 14.95 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 122.152 0.977 . . . . 1.4299999999999999 111.958 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -162.01 145.21 11.91 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.178 -0.919 . . . . 2.9700000000000002 112.153 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -125.27 123.81 40.3 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.654 -0.703 . . . . 1.6599999999999999 112.187 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 72.16 53.87 0.18 Allowed 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 125.73 1.612 . . . . 2.02 112.787 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -152.38 -40.87 0.11 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.383 -1.281 . . . . 2.5600000000000001 109.719 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -108.19 80.91 1.41 Allowed 'General case' 0 C--N 1.361 1.096 0 CA-C-O 121.892 0.853 . . . . 3.1499999999999999 108.716 177.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.99 121.82 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 114.249 -1.341 . . . . 1.3600000000000001 111.142 -177.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -109.37 165.55 11.55 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.587 1.699 . . . . 0.84999999999999998 115.587 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.52 135.58 53.94 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.829 -0.544 . . . . 1.3300000000000001 110.828 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.79 126.93 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.475 0 CA-C-N 115.918 -0.583 . . . . 1.1699999999999999 109.908 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 46.7 mtt180 -125.9 151.63 46.66 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.621 1.712 . . . . 1.9399999999999999 115.621 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.2 m -126.71 109.97 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.569 0 N-CA-C 113.047 0.758 . . . . 1.29 113.047 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.426 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 62.43 26.53 15.81 Favored 'General case' 0 N--CA 1.524 3.275 0 C-N-CA 126.669 1.988 . . . . 1.8200000000000001 114.271 -179.113 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.8 -22.17 28.52 Favored Glycine 0 CA--C 1.548 2.109 0 C-N-CA 121.259 -0.496 . . . . 0.32000000000000001 113.546 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 90.2 m-70 -80.71 160.5 24.94 Favored 'General case' 0 C--N 1.366 1.312 0 C-N-CA 125.829 1.651 . . . . 0.56999999999999995 114.157 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.77 132.49 54.15 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.238 0.542 . . . . 1.1899999999999999 111.154 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.62 -60.89 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 115.233 -0.894 . . . . 1.73 113.172 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.76 88.85 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 1.25 108.2 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 2.1 ptpp? -107.72 96.74 6.6 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 123.155 1.455 . . . . 2.75 111.551 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 0.5 OUTLIER 121.09 75.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 110.488 -3.051 . . . . 2.48 107.783 -178.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.33 104.77 16.83 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 113.111 0.782 . . . . 1.78 113.111 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -117.16 102.49 9.34 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 113.723 -1.58 . . . . 2.3500000000000001 106.974 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.25 -31.28 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 C-N-CA 125.003 1.321 . . . . 1.27 114.262 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -74.63 -40.84 61.26 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.685 0.794 . . . . 0.83999999999999997 112.484 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -73.82 -25.83 60.3 Favored 'General case' 0 CA--C 1.578 2.048 0 C-N-CA 124.357 1.063 . . . . 0.91000000000000003 113.487 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -78.62 -56.61 4.29 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.618 0.97 . . . . 2.98 113.618 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.11 -34.84 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 N-CA-C 114.593 1.331 . . . . 1.53 114.593 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.07 -114.07 1.98 Allowed Glycine 0 C--N 1.354 1.537 0 CA-C-N 118.25 0.477 . . . . 0.84999999999999998 112.935 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -115.47 106.69 14.25 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.929 0.395 . . . . 3.9700000000000002 110.4 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.48 -143.26 0.09 Allowed 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 125.466 1.507 . . . . 2.0800000000000001 113.416 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.9 p 66.76 -158.96 0.24 Allowed 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 126.234 1.814 . . . . 1.22 113.718 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.438 ' HA ' ' NZ ' ' A' ' 88' ' ' LYS . . . -108.58 128.96 55.28 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 114.55 1.315 . . . . 1.2 114.55 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.592 ' H ' ' HZ1' ' A' ' 88' ' ' LYS . 5.5 t60 -104.52 122.65 46.0 Favored 'General case' 0 C--N 1.369 1.432 0 N-CA-C 108.08 -1.082 . . . . 0.41999999999999998 108.08 174.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.55 127.05 20.09 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.417 0.895 . . . . 2.5 113.417 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -114.51 134.73 54.81 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-N 115.033 -0.985 . . . . 1.5800000000000001 111.369 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.45 111.31 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 114.369 -1.287 . . . . 1.25 110.374 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.4 mm -115.52 91.23 28.45 Favored Pre-proline 0 CA--C 1.579 2.077 0 CA-C-N 115.287 -0.87 . . . . 1.5 110.421 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -73.11 137.93 27.16 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 122.996 2.464 . . . . 0.22 113.883 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.81 149.89 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 C-N-CA 123.573 0.749 . . . . 1.1200000000000001 110.842 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.2 p -133.88 111.48 10.51 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.638 -0.71 . . . . 1.8600000000000001 111.856 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.474 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.4 mt -112.69 124.68 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 N-CA-C 108.59 -0.892 . . . . 1.0700000000000001 108.59 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -141.83 126.45 17.92 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.838 -0.619 . . . . 2.6400000000000001 110.992 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 67.97 15.71 9.52 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 125.432 1.493 . . . . 4.0199999999999996 114.109 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.55 14.87 39.4 Favored Glycine 0 CA--C 1.547 2.089 0 CA-C-O 119.181 -0.788 . . . . 0.39000000000000001 114.773 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 56.4 mtpt -122.59 148.19 45.52 Favored 'General case' 0 C--N 1.365 1.252 0 CA-C-N 118.413 1.107 . . . . 2.0299999999999998 112.429 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.66 141.94 35.18 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.058 1.133 . . . . 1.0800000000000001 114.058 -176.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 m -133.55 110.44 9.93 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 114.504 -1.226 . . . . 1.23 110.301 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.272 2.4 p -106.23 90.52 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.589 2.467 0 CA-C-O 121.621 0.724 . . . . 1.1899999999999999 110.068 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 59.68 -81.4 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 126.077 1.751 . . . . 1.8200000000000001 115.06 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -118.45 26.74 7.59 Favored Glycine 0 CA--C 1.547 2.076 0 N-CA-C 114.2 0.44 . . . . 0.51000000000000001 114.2 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -135.14 140.79 45.7 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.533 0.733 . . . . 1.8200000000000001 110.996 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.18 130.82 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.294 0 CA-C-O 121.513 0.673 . . . . 1.5900000000000001 111.867 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 m -154.6 -179.43 7.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.157 -0.929 . . . . 1.1699999999999999 109.537 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.274 14.8 t -104.76 139.37 39.65 Favored 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 113.365 0.876 . . . . 1.71 113.365 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -82.72 122.1 27.72 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 123.959 0.904 . . . . 0.29999999999999999 111.523 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.38 90.91 3.15 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.336 0.495 . . . . 1.8700000000000001 112.336 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.22 -65.45 3.33 Favored Glycine 0 C--N 1.358 1.784 0 N-CA-C 118.652 2.221 . . . . 0.91000000000000003 118.652 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 156.25 46.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.199 1.185 . . . . 1.6799999999999999 114.199 -176.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.426 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -103.27 135.36 45.06 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 113.064 -1.88 . . . . 1.3700000000000001 108.585 176.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.8 t -120.67 142.29 49.61 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.529 1.678 . . . . 0.94999999999999996 115.529 -176.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -116.59 99.19 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.334 -1.358 . . . . 1.3799999999999999 107.334 176.469 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -118.52 126.99 53.19 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.779 -0.646 . . . . 1.6699999999999999 112.314 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.86 129.08 56.64 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-O 122.278 1.037 . . . . 2.2999999999999998 111.278 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.17 145.48 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 112.722 -2.035 . . . . 1.29 110.762 -177.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.93 149.64 32.3 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.934 1.457 . . . . 2.6200000000000001 114.934 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -115.64 -28.11 2.84 Favored Glycine 0 CA--C 1.545 1.931 0 CA-C-N 115.064 -0.971 . . . . 1.0600000000000001 114.932 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -130.42 -67.07 0.74 Allowed 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 117.746 0.773 . . . . 3.1000000000000001 111.88 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -140.81 -52.45 0.47 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 112.341 0.497 . . . . 4.0800000000000001 112.341 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -104.06 178.02 4.68 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.161 0.981 . . . . 1.74 112.742 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -116.79 -177.92 0.49 Allowed Pre-proline 0 CA--C 1.568 1.638 0 CA-C-N 114.389 -1.278 . . . . 1.6799999999999999 109.273 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.67 131.36 43.71 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.947 2.431 . . . . 2.8199999999999998 113.968 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -72.18 -62.59 1.38 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.81 1.411 . . . . 3.4100000000000001 114.81 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 43.0 t -108.49 132.36 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 118.376 0.535 . . . . 1.3799999999999999 109.713 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.3 t -133.41 116.09 15.62 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 113.911 -1.495 . . . . 1.75 110.618 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 60' ' ' LEU . . . -115.02 49.51 1.05 Allowed 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.183 1.919 . . . . 1.1299999999999999 116.183 -174.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.56 137.75 2.77 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 116.653 2.094 . . . . 1.3999999999999999 116.653 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -152.75 100.3 2.52 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.271 -0.877 . . . . 0.26000000000000001 110.526 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 12' ' ' TRP 0.319 12.6 tt -110.61 121.86 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-O 122.546 1.165 . . . . 1.1000000000000001 111.553 175.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -123.67 165.03 17.92 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 113.572 -1.649 . . . . 1.0600000000000001 110.554 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.4 ptmt -121.71 159.98 25.46 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 118.734 2.864 . . . . 1.8300000000000001 118.734 -174.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.549 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.22 -42.54 1.87 Allowed Glycine 0 CA--C 1.542 1.737 0 CA-C-N 109.815 -3.357 . . . . 0.17000000000000001 118.66 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.37 156.74 0.75 Allowed 'General case' 0 N--CA 1.52 3.061 0 CA-C-N 119.973 1.886 . . . . 1.05 112.565 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.32 -15.79 60.47 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.547 1.314 . . . . 0.98999999999999999 114.547 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.06 4.04 46.73 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.066 1.135 . . . . 0.55000000000000004 114.066 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.669 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.1 OUTLIER -107.71 -3.86 18.74 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 114.031 1.123 . . . . 0.59999999999999998 114.031 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.37 93.05 0.41 Allowed Pre-proline 0 N--CA 1.51 2.543 0 C-N-CA 124.48 1.112 . . . . 1.1799999999999999 111.63 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.669 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 56.9 Cg_endo -95.38 119.98 0.25 Allowed 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 122.875 2.384 . . . . 2.0299999999999998 114.777 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 44.1 mtt -144.36 109.82 5.2 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.823 -0.626 . . . . 5.3399999999999999 111.224 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.6 163.56 29.85 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 122.16 0.981 . . . . 4.0 112.641 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -108.55 159.74 29.75 Favored Pre-proline 0 CA--C 1.557 1.247 0 CA-C-N 114.463 -1.244 . . . . 6.7000000000000002 110.806 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.86 122.11 9.41 Favored 'Trans proline' 0 C--N 1.394 2.939 0 C-N-CA 122.566 2.178 . . . . 6.9400000000000004 115.18 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -135.69 135.55 22.14 Favored Pre-proline 0 CA--C 1.564 1.5 0 CA-C-N 114.76 -1.109 . . . . 5.5099999999999998 111.062 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -85.02 -157.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.389 2.659 0 C-N-CA 123.398 2.732 . . . . 7.1600000000000001 114.239 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.69 -128.88 1.55 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 121.113 -0.565 . . . . 7.0199999999999996 113.421 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.0 mt -118.84 124.19 46.57 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.008 0.433 . . . . 9.3000000000000007 111.976 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.263 -0.875 . . . . 10.6 111.222 179.996 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.439 -0.265 . . . . 9.3599999999999994 112.439 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.06 117.54 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.453 0 C-N-CA 127.556 2.342 . . . . 6.8499999999999996 114.97 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.0 tpt -141.67 105.1 4.66 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.45 -0.795 . . . . 8.0 110.731 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 m -138.06 113.16 9.22 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.804 -0.635 . . . . 4.1500000000000004 111.605 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.6 86.26 0.07 OUTLIER Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.787 -0.642 . . . . 1.6000000000000001 113.109 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.6 tp -88.32 -46.5 9.14 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.9 0.88 . . . . 1.0900000000000001 113.282 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -25.0 63.84 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 125.982 1.713 . . . . 1.04 115.388 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.65 -10.01 54.76 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.577 0.954 . . . . 0.32000000000000001 113.577 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 25.3 mmtp -104.67 -25.61 12.64 Favored 'General case' 0 C--N 1.363 1.168 0 N-CA-C 113.243 0.831 . . . . 2.2599999999999998 113.243 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -52.93 135.22 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 N-CA-C 115.541 1.682 . . . . 1.01 115.541 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -123.07 -28.46 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 115.01 -0.995 . . . . 1.0600000000000001 112.229 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.526 ' O ' HG21 ' A' ' 172' ' ' ILE . 72.2 t90 -162.95 116.93 1.67 Allowed 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 118.055 0.389 . . . . 0.67000000000000004 111.558 -178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.446 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -136.55 130.73 32.85 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.156 -0.965 . . . . 1.0800000000000001 111.649 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.3 t -136.26 130.96 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 CA-C-O 121.036 0.446 . . . . 1.6699999999999999 112.149 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -114.71 100.46 8.27 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.819 -1.178 . . . . 2.6400000000000001 107.819 173.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.96 104.18 7.31 Favored 'General case' 0 C--O 1.274 2.365 0 CA-C-O 122.005 0.907 . . . . 1.28 111.623 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 169.07 -49.51 0.22 Allowed Glycine 0 C--N 1.36 1.893 0 CA-C-N 111.964 -2.38 . . . . 0.70999999999999996 114.693 -178.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.53 -116.65 3.05 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 114.476 0.551 . . . . 0.87 114.476 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -168.62 118.79 0.74 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.377 0.51 . . . . 2.1200000000000001 112.377 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.9 m 42.39 111.74 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.226 0 N-CA-C 118.515 2.783 . . . . 1.5 118.515 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.561 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 43.1 t60 -137.26 139.43 40.96 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.768 1.025 . . . . 0.52000000000000002 113.768 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.3 t -106.36 111.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 N-CA-C 106.791 -1.559 . . . . 2.0699999999999998 106.791 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.38 163.07 15.46 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 112.768 0.655 . . . . 1.8500000000000001 112.768 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -43.3 -34.59 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 118.811 2.893 . . . . 1.3700000000000001 118.811 -175.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -90.76 -17.31 26.88 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 120.924 0.393 . . . . 0.56999999999999995 111.509 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.18 41.85 1.24 Allowed Glycine 0 C--N 1.357 1.736 0 C-N-CA 124.361 0.981 . . . . 0.37 113.742 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.9 mm -105.88 121.96 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 N-CA-C 109.391 -0.596 . . . . 1.25 109.391 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.561 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 6.9 t-160 -110.27 132.8 53.85 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 115.32 1.6 . . . . 1.71 115.32 -175.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.617 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -97.76 138.01 35.77 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.638 -1.164 . . . . 3.1499999999999999 109.302 175.442 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -102.68 100.7 10.77 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 113.544 0.942 . . . . 3.5099999999999998 113.544 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.529 ' H ' ' HG ' ' A' ' 20' ' ' SER . 31.5 ttpt -28.69 115.44 0.09 Allowed 'General case' 0 N--CA 1.517 2.888 0 N-CA-C 118.687 2.847 . . . . 2.8100000000000001 118.687 177.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 41.59 74.97 0.66 Allowed Pre-proline 0 N--CA 1.528 3.446 0 N-CA-C 117.169 2.285 . . . . 1.1699999999999999 117.169 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -94.45 -12.26 1.07 Allowed 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 122.509 2.14 . . . . 1.45 117.434 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.44 -22.89 0.81 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 114.447 1.277 . . . . 2.2400000000000002 114.447 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -96.96 73.25 2.56 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.277 0.56 . . . . 4.8399999999999999 112.422 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.07 -29.12 13.12 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 115.56 -0.746 . . . . 2.9700000000000002 114.4 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.7 49.53 20.63 Favored 'General case' 0 N--CA 1.516 2.831 0 C-N-CA 127.176 2.19 . . . . 4.79 115.465 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.77 -179.8 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 124.977 1.311 . . . . 3.1499999999999999 110.251 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.81 86.05 1.25 Allowed Glycine 0 CA--C 1.539 1.58 0 O-C-N 121.695 -0.628 . . . . 2.7200000000000002 114.488 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -144.57 128.42 17.37 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.482 0.658 . . . . 5.9500000000000002 112.488 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.65 138.24 51.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.309 1.044 . . . . 1.78 110.783 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m -118.78 97.05 5.53 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 115.603 -0.726 . . . . 1.6599999999999999 110.772 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -114.28 62.96 0.66 Allowed 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 115.638 -0.71 . . . . 2.3300000000000001 111.457 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -102.1 73.1 1.35 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 122.054 0.93 . . . . 3.3300000000000001 109.831 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.38 52.74 0.07 OUTLIER Glycine 0 CA--C 1.529 0.965 0 CA-C-N 113.79 -1.55 . . . . 1.7 111.237 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.2 ttt -92.59 -0.07 57.36 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 113.805 1.039 . . . . 2.0800000000000001 113.805 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.18 64.35 0.62 Allowed 'General case' 0 CA--C 1.557 1.249 0 CA-C-O 122.431 1.11 . . . . 4.6200000000000001 110.303 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 mt -166.78 70.41 1.06 Allowed Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 113.456 -1.702 . . . . 3.1600000000000001 107.111 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.92 157.86 57.02 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 124.349 3.366 . . . . 1.8600000000000001 116.939 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.4 133.86 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.354 0 CA-C-N 115.074 -0.966 . . . . 1.28 108.691 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mt -82.24 -9.28 59.55 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.816 2.154 . . . . 1.9299999999999999 116.816 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -109.17 16.67 22.32 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 114.111 1.152 . . . . 1.79 114.111 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.04 177.37 8.02 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 121.755 0.788 . . . . 1.49 113.06 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 5.7 p-10 -88.96 178.83 1.83 Allowed Pre-proline 0 N--CA 1.51 2.57 0 C-N-CA 124.978 1.311 . . . . 1.6799999999999999 111.094 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -64.57 -43.01 14.4 Favored 'Trans proline' 0 N--CA 1.527 3.449 0 C-N-CA 122.824 2.349 . . . . 1.1599999999999999 114.989 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -69.41 -41.94 75.71 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 124.471 1.108 . . . . 2.04 111.978 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.713 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 18.7 t0 -86.93 -0.71 57.0 Favored 'General case' 0 CA--C 1.583 2.232 0 CA-C-N 115.857 -0.611 . . . . 1.6200000000000001 111.983 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 5.3 tt0 -74.28 -46.02 43.97 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 125.195 1.398 . . . . 2.4300000000000002 108.025 173.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.253 11.7 p -71.21 -37.75 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.982 0 CA-C-N 115.161 -0.927 . . . . 1.46 111.042 174.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.7 tp -83.41 -3.25 57.38 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 114.194 1.183 . . . . 1.6699999999999999 114.194 177.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.713 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 3.8 m-30 -113.67 -2.01 13.87 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.002 1.321 . . . . 1.3300000000000001 109.831 174.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -130.48 -130.82 0.2 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.331 1.052 . . . . 1.4099999999999999 110.739 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.472 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 43.15 120.86 0.0 OUTLIER 'General case' 1 N--CA 1.548 4.458 0 C-N-CA 127.775 2.43 . . . . 1.28 115.48 -172.755 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 12.9 pt-20 -110.37 142.19 42.38 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.338 1.977 . . . . 1.53 116.338 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -114.12 152.45 31.09 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 114.972 -1.013 . . . . 3.8300000000000001 111.8 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -124.62 129.83 51.3 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.911 -0.586 . . . . 3.7599999999999998 112.085 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.36 -86.28 0.34 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.737 -0.665 . . . . 5.3700000000000001 111.693 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -154.18 -91.32 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 113.122 0.786 . . . . 2.5499999999999998 113.122 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -174.74 136.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.755 0.822 . . . . 2.1499999999999999 110.796 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 3.4 t 70.38 76.72 0.2 Allowed 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 124.464 1.106 . . . . 1.25 110.939 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.7 135.87 48.23 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.004 -0.998 . . . . 1.1499999999999999 112.285 -176.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.56 163.01 24.13 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 116.216 1.246 . . . . 0.59999999999999998 116.216 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -111.17 160.7 16.68 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.023 -1.089 . . . . 1.4099999999999999 113.062 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.48 126.66 48.32 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.895 -1.048 . . . . 0.51000000000000001 112.652 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.25 98.07 42.07 Favored Pre-proline 0 CA--C 1.566 1.589 0 N-CA-C 108.668 -0.864 . . . . 1.0600000000000001 108.668 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -82.82 116.27 2.5 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 122.06 1.84 . . . . 0.17999999999999999 115.322 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.07 155.64 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 CA-C-O 121.938 0.875 . . . . 1.0600000000000001 110.648 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -141.86 24.35 2.03 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 114.774 -1.103 . . . . 3.1099999999999999 112.034 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.88 152.67 49.1 Favored 'General case' 0 C--N 1.359 1.009 0 CA-C-O 121.231 0.539 . . . . 2.1200000000000001 111.305 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.07 137.73 50.98 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.097 1.147 . . . . 0.41999999999999998 114.097 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.47 -127.48 1.63 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 114.018 -1.447 . . . . 0.25 112.597 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -123.55 118.62 27.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.264 0.554 . . . . 1.75 111.398 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -118.58 137.74 53.04 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.463 -0.789 . . . . 0.90000000000000002 109.639 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 172' ' ' ILE . 1.9 t -117.82 126.5 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.466 0.65 . . . . 1.0700000000000001 111.004 -177.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.06 105.13 15.38 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.753 -1.112 . . . . 1.47 109.731 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.75 117.64 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.077 -1.083 . . . . 1.27 108.077 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -130.16 135.05 47.76 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.503 0.668 . . . . 1.8899999999999999 112.384 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -98.29 122.96 42.1 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 114.959 -1.019 . . . . 2.8999999999999999 111.307 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -106.95 136.12 47.35 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.58 -0.737 . . . . 0.48999999999999999 110.948 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.94 150.12 52.19 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 115.681 -0.69 . . . . 1.1000000000000001 111.367 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -146.88 113.68 6.08 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.36 0.664 . . . . 2.6099999999999999 110.076 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.33 68.12 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 112.711 0.634 . . . . 2.6099999999999999 112.711 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -167.07 -45.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.58 0.585 . . . . 2.71 112.58 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -112.89 126.67 55.72 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.102 0.477 . . . . 1.6899999999999999 112.219 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.16 96.07 6.11 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.486 1.136 . . . . 1.4299999999999999 111.241 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.439 ' OE1' ' HD3' ' A' ' 100' ' ' LYS . 9.5 pt20 -160.79 143.74 13.02 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.89 -1.05 . . . . 2.9700000000000002 112.152 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.8 m -122.57 125.27 45.36 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.426 -0.806 . . . . 1.6599999999999999 112.267 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 73.03 51.74 0.14 Allowed 'General case' 0 N--CA 1.512 2.636 0 C-N-CA 125.644 1.577 . . . . 2.02 112.697 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -150.99 -42.02 0.12 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.384 1.074 . . . . 2.5600000000000001 110.076 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.439 ' HD3' ' OE1' ' A' ' 96' ' ' GLN . 14.0 mptt -108.27 83.49 1.79 Allowed 'General case' 0 C--N 1.36 1.06 0 N-CA-C 108.691 -0.855 . . . . 3.1499999999999999 108.691 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.45 126.54 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 114.488 -1.233 . . . . 1.3600000000000001 111.214 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -114.07 174.48 5.92 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.405 1.631 . . . . 0.84999999999999998 115.405 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.22 137.05 54.97 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.372 0.606 . . . . 1.3300000000000001 111.974 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.6 t -132.71 126.0 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.247 0 CA-C-N 115.161 -0.927 . . . . 1.1699999999999999 109.671 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 43.0 mtt180 -125.56 149.39 48.39 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.653 1.353 . . . . 1.9399999999999999 114.653 -177.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.55 104.28 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 115.389 -0.823 . . . . 1.29 112.802 178.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.586 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 6.9 t30 64.28 26.48 13.71 Favored 'General case' 0 N--CA 1.518 2.952 0 C-N-CA 126.636 1.974 . . . . 1.8200000000000001 114.31 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.92 -22.22 23.83 Favored Glycine 0 CA--C 1.548 2.117 0 CA-C-N 115.582 -0.735 . . . . 0.32000000000000001 113.603 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -79.94 148.03 31.39 Favored 'General case' 0 C--N 1.367 1.365 0 C-N-CA 125.63 1.572 . . . . 0.56999999999999995 114.007 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.44 127.52 49.44 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.283 0.563 . . . . 1.1899999999999999 110.977 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -120.22 -57.2 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 115.256 -0.884 . . . . 1.73 113.254 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.33 88.26 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.165 -1.05 . . . . 1.25 108.165 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -111.17 75.77 0.94 Allowed 'General case' 0 C--N 1.354 0.779 0 CA-C-O 123.37 1.557 . . . . 2.75 112.133 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.9 p30 157.78 61.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 110.789 -2.914 . . . . 2.48 108.117 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.94 101.04 13.38 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 114.095 1.146 . . . . 1.78 114.095 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 1.2 t70 -116.75 97.2 5.85 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 113.132 -1.849 . . . . 2.3500000000000001 106.582 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -28.56 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.477 0 N-CA-C 114.569 1.322 . . . . 1.27 114.569 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -75.84 -36.78 59.51 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.24 0.616 . . . . 0.83999999999999997 112.323 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -74.72 -26.74 60.01 Favored 'General case' 0 CA--C 1.577 1.99 0 C-N-CA 124.466 1.106 . . . . 0.91000000000000003 113.096 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 25.3 mmm180 -77.66 -55.09 5.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.236 0.828 . . . . 2.98 113.236 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.82 -40.59 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 N-CA-C 113.966 1.098 . . . . 1.53 113.966 177.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.84 -69.51 0.21 Allowed Glycine 0 C--N 1.359 1.844 0 CA-C-N 118.186 0.448 . . . . 0.84999999999999998 113.652 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -104.72 175.27 5.55 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.447 1.099 . . . . 3.9700000000000002 111.381 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 m -73.55 84.31 1.54 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 122.007 0.908 . . . . 2.0800000000000001 113.214 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 17.9 p -131.24 -154.35 0.62 Allowed 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 113.92 -1.491 . . . . 1.22 109.301 -178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.49 129.38 54.46 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 121.468 -0.77 . . . . 1.2 112.324 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -100.43 142.39 31.97 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.645 -0.502 . . . . 0.41999999999999998 109.645 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -135.5 128.2 30.95 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.711 1.374 . . . . 2.5 114.711 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -118.0 118.1 31.04 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 114.36 -1.291 . . . . 1.5800000000000001 109.905 176.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.11 121.05 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 114.644 -1.162 . . . . 1.25 111.513 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.12 95.11 19.0 Favored Pre-proline 0 CA--C 1.572 1.819 0 CA-C-N 115.49 -0.777 . . . . 1.5 110.694 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -75.87 137.55 19.97 Favored 'Trans proline' 0 C--N 1.395 3.003 0 C-N-CA 122.802 2.335 . . . . 0.22 113.325 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.49 145.62 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.393 0 CA-C-O 121.737 0.78 . . . . 1.1200000000000001 111.665 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.9 p -129.86 112.29 13.42 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.85 -1.068 . . . . 1.8600000000000001 110.817 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.6 mt -113.64 121.43 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.511 0 CA-C-N 115.228 -0.896 . . . . 1.0700000000000001 108.841 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -141.76 129.64 21.81 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.128 0.489 . . . . 2.6400000000000001 111.903 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 66.38 15.19 10.02 Favored 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 114.827 1.417 . . . . 4.0199999999999996 114.827 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 17.91 28.79 Favored Glycine 0 CA--C 1.548 2.149 0 CA-C-O 119.385 -0.675 . . . . 0.39000000000000001 114.562 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -128.73 143.38 50.91 Favored 'General case' 0 C--N 1.364 1.239 0 CA-C-N 118.036 0.918 . . . . 2.0299999999999998 112.426 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.09 143.34 29.48 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.823 1.046 . . . . 1.0800000000000001 113.823 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 114.0 12.61 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.864 -1.062 . . . . 1.23 110.865 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.271 0.3 OUTLIER -118.14 108.17 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.257 0 CA-C-N 115.989 -0.551 . . . . 1.1899999999999999 110.533 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 67.06 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.745 0 C-N-CA 125.588 1.555 . . . . 1.8200000000000001 113.762 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -140.9 31.79 2.17 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-N 115.777 -0.647 . . . . 0.51000000000000001 112.765 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -133.73 128.14 34.3 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.641 0.776 . . . . 1.8200000000000001 110.573 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -115.68 131.23 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.298 0 CA-C-O 121.551 0.691 . . . . 1.5900000000000001 111.786 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 m -147.18 -169.09 3.22 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.094 -0.957 . . . . 1.1699999999999999 110.174 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.5 t -101.79 141.09 35.18 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 112.998 0.74 . . . . 1.71 112.998 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -88.44 133.0 34.24 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.875 0.845 . . . . 0.29999999999999999 111.894 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 p -98.27 -164.01 1.1 Allowed 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 113.976 -1.465 . . . . 1.8700000000000001 109.369 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.39 7.07 69.59 Favored Glycine 0 CA--C 1.561 2.929 0 N-CA-C 116.991 1.556 . . . . 0.91000000000000003 116.991 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -159.98 152.49 21.06 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-O 121.704 0.764 . . . . 1.6799999999999999 111.565 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.586 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -108.09 138.08 44.96 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.208 -1.36 . . . . 1.3700000000000001 109.163 177.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 t -119.41 145.72 45.99 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.966 1.839 . . . . 0.94999999999999996 115.966 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -120.09 97.96 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.672 -1.233 . . . . 1.3799999999999999 107.672 175.602 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -107.07 125.91 51.67 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.212 0.819 . . . . 1.6699999999999999 113.212 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 70' ' ' SER . 1.5 m-30 -107.46 120.89 43.42 Favored 'General case' 0 C--O 1.25 1.126 0 CA-C-N 115.177 -0.919 . . . . 2.2999999999999998 110.247 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.46 143.66 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 114.588 -1.187 . . . . 1.29 109.587 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -85.77 150.38 24.61 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.681 1.734 . . . . 2.6200000000000001 115.681 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.04 -32.45 4.99 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-N 114.178 -1.374 . . . . 1.0600000000000001 113.048 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -131.01 -84.06 0.52 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.494 0.718 . . . . 3.1000000000000001 110.511 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -170.99 66.27 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.123 0.569 . . . . 4.0800000000000001 110.927 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -166.51 -45.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.071 0.767 . . . . 1.74 113.071 -179.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 1.4 m-20 82.75 -177.47 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.695 0 C-N-CA 124.546 1.138 . . . . 1.6799999999999999 110.796 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.93 -21.35 70.75 Favored 'Trans proline' 0 N--CA 1.524 3.322 0 C-N-CA 122.977 2.451 . . . . 2.8199999999999998 115.992 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? 83.58 -68.69 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 126.36 1.864 . . . . 3.4100000000000001 115.085 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.4 133.57 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-N 118.984 0.811 . . . . 1.3799999999999999 111.301 -178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.6 t -132.9 138.44 46.98 Favored 'General case' 0 C--N 1.367 1.362 0 N-CA-C 114.11 1.152 . . . . 1.75 114.11 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 60' ' ' LEU . . . -130.17 45.07 2.87 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.547 1.684 . . . . 1.1299999999999999 115.547 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.92 132.72 3.85 Favored 'General case' 0 N--CA 1.524 3.241 0 N-CA-C 116.233 1.938 . . . . 1.3999999999999999 116.233 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -152.45 102.95 2.78 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 116.054 -0.521 . . . . 0.26000000000000001 111.329 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.526 HG21 ' O ' ' A' ' 12' ' ' TRP 0.313 4.9 tt -110.03 123.25 65.76 Favored 'Isoleucine or valine' 0 C--O 1.27 2.168 0 CA-C-O 122.28 1.038 . . . . 1.1000000000000001 111.406 175.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -123.62 152.69 41.67 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 113.389 -1.732 . . . . 1.0600000000000001 112.025 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 75.9 tttt -104.27 152.51 22.13 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 118.28 2.696 . . . . 1.8300000000000001 118.28 -174.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.62 -41.47 2.14 Favored Glycine 0 CA--C 1.541 1.694 0 CA-C-N 110.704 -2.953 . . . . 0.17000000000000001 119.86 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 178.06 164.44 0.69 Allowed 'General case' 0 N--CA 1.519 2.981 0 CA-C-N 121.165 2.482 . . . . 1.05 112.228 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.95 -16.09 54.46 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 113.915 1.08 . . . . 0.98999999999999999 113.915 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.53 3.51 50.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.151 1.167 . . . . 0.55000000000000004 114.151 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.615 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 1.0 OUTLIER -106.84 -3.07 20.74 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.205 1.187 . . . . 0.59999999999999998 114.205 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.5 96.53 0.59 Allowed Pre-proline 0 N--CA 1.511 2.586 0 C-N-CA 124.375 1.07 . . . . 1.1799999999999999 111.643 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.615 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 81.0 Cg_endo -94.03 150.21 2.12 Favored 'Trans proline' 0 C--N 1.387 2.59 0 C-N-CA 122.85 2.367 . . . . 2.0299999999999998 114.783 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.7 ttt -142.49 119.49 11.32 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.622 -0.717 . . . . 5.3399999999999999 111.069 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.8 mt -131.35 164.9 24.63 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.001 0.905 . . . . 4.0 112.747 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -105.37 158.7 31.62 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-N 114.626 -1.17 . . . . 6.7000000000000002 110.887 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.8 120.63 7.38 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.321 2.014 . . . . 6.9400000000000004 114.966 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.453 ' HD1' ' H ' ' A' ' 188' ' ' GLY . 47.6 t-80 -136.15 142.15 38.9 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-N 114.261 -1.336 . . . . 5.5099999999999998 110.585 -178.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.37 -29.95 3.58 Favored 'Trans proline' 0 C--N 1.393 2.877 0 C-N-CA 123.082 2.521 . . . . 7.1600000000000001 116.308 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.453 ' H ' ' HD1' ' A' ' 186' ' ' HIS . . . -137.64 -144.39 4.72 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 114.598 0.599 . . . . 7.0199999999999996 114.598 -178.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.9 mt -119.56 124.9 47.5 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.214 0.45 . . . . 9.3000000000000007 112.214 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.423 -0.798 . . . . 10.6 110.647 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.398 -0.281 . . . . 9.3599999999999994 112.398 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.38 130.72 55.6 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.503 0.668 . . . . 6.8499999999999996 112.053 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.9 mtt -132.19 106.18 7.8 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.796 -0.638 . . . . 8.0 111.364 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.9 m -139.81 109.73 6.41 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.814 -0.63 . . . . 4.1500000000000004 111.527 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.47 84.08 0.05 OUTLIER Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.842 -0.617 . . . . 1.6000000000000001 113.148 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 tp -87.93 -47.69 8.37 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.344 0.868 . . . . 1.0900000000000001 113.344 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.27 -22.53 18.86 Favored 'General case' 0 CA--C 1.591 2.543 0 N-CA-C 115.176 1.547 . . . . 1.04 115.176 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.17 -18.81 29.51 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 124.337 1.055 . . . . 0.32000000000000001 113.401 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 55.5 mttt -104.49 -8.87 18.77 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 113.958 1.096 . . . . 2.2599999999999998 113.958 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.3 p -61.44 135.11 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.794 0 C-N-CA 124.027 0.931 . . . . 1.01 112.797 176.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -118.52 -28.59 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 113.357 0.873 . . . . 1.0600000000000001 113.357 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.438 ' O ' HG22 ' A' ' 172' ' ' ILE . 70.0 t90 -163.94 119.0 1.55 Allowed 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 118.43 0.559 . . . . 0.67000000000000004 112.066 -177.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.92 131.53 33.2 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.658 -0.651 . . . . 1.0800000000000001 111.958 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.27 133.21 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 CA-C-O 121.42 0.629 . . . . 1.6699999999999999 112.62 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -117.98 111.4 18.91 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.108 -1.441 . . . . 2.6400000000000001 107.108 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.84 102.59 8.27 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 121.898 0.856 . . . . 1.28 111.383 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.55 -14.12 0.35 Allowed Glycine 0 C--N 1.351 1.362 0 N-CA-C 117.127 1.611 . . . . 0.70999999999999996 117.127 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.04 -131.79 2.32 Favored Glycine 0 N--CA 1.472 1.059 0 C-N-CA 119.271 -1.442 . . . . 0.87 116.06 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.541 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 19.9 tt0 -148.16 116.26 6.47 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 114.931 -0.634 . . . . 2.1200000000000001 110.89 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 14.7 m 21.78 120.4 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 120.199 3.407 . . . . 1.5 120.199 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -140.52 143.02 35.19 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.521 1.153 . . . . 0.52000000000000002 113.407 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.88 115.74 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-N 113.217 -1.811 . . . . 2.0699999999999998 110.789 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -74.99 155.65 37.12 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 113.341 -1.754 . . . . 1.8500000000000001 111.316 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -42.8 -23.92 0.1 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.152 0 N-CA-C 119.048 2.981 . . . . 1.3700000000000001 119.048 -178.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -96.88 -19.36 18.9 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 118.588 0.631 . . . . 0.56999999999999995 110.735 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.81 42.42 0.86 Allowed Glycine 0 C--N 1.358 1.8 0 C-N-CA 124.569 1.08 . . . . 0.37 114.534 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.5 mt -105.73 121.55 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-O 120.883 0.373 . . . . 1.25 110.002 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -102.85 125.99 49.82 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.286 1.217 . . . . 1.71 114.286 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.47 152.68 18.19 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.793 -0.64 . . . . 3.1499999999999999 111.755 176.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -100.35 149.34 23.73 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.006 1.113 . . . . 3.5099999999999998 114.006 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.403 ' HD2' ' O ' ' A' ' 31' ' ' LYS . 1.1 tmmt? -75.14 102.6 5.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.781 2.141 . . . . 2.8100000000000001 116.781 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 45.42 45.66 2.47 Favored Pre-proline 0 N--CA 1.526 3.355 0 N-CA-C 119.128 3.01 . . . . 1.1699999999999999 119.128 174.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -100.72 63.85 0.04 OUTLIER 'Trans proline' 0 CA--C 1.566 2.093 0 C-N-CA 122.766 2.311 . . . . 1.45 116.209 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -90.11 -71.88 0.59 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.594 0.357 . . . . 2.2400000000000002 111.281 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -142.21 47.51 1.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.374 1.25 . . . . 4.8399999999999999 114.374 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.27 1.84 47.81 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 115.647 1.019 . . . . 2.9700000000000002 115.647 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -92.05 65.94 4.87 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 113.162 0.801 . . . . 4.79 113.162 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.77 117.19 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 116.101 -0.499 . . . . 3.1499999999999999 111.658 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 166.92 -69.43 0.18 Allowed Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.687 -0.688 . . . . 2.7200000000000002 113.735 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -124.48 158.51 32.68 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.507 0.929 . . . . 5.9500000000000002 113.507 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.08 142.79 33.53 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 114.822 -1.081 . . . . 1.78 111.657 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.9 m -110.57 76.62 0.99 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.42 0.628 . . . . 1.6599999999999999 112.298 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.02 -61.53 1.46 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.345 -0.843 . . . . 2.3300000000000001 111.835 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 79.82 -64.19 0.22 Allowed 'General case' 0 N--CA 1.511 2.584 0 C-N-CA 125.567 1.547 . . . . 3.3300000000000001 113.307 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.63 121.0 2.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.048 -0.524 . . . . 1.7 112.459 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 59.9 mtt -91.9 3.87 54.21 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.73 1.011 . . . . 2.0800000000000001 113.73 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.91 24.87 0.86 Allowed 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 115.422 1.638 . . . . 4.6200000000000001 115.422 -178.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.69 75.98 78.0 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 106.652 -1.61 . . . . 3.1600000000000001 106.652 177.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.21 173.59 11.59 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.285 2.657 . . . . 1.8600000000000001 117.708 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.254 1.2 mp -98.11 132.82 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.27 0 CA-C-N 113.865 -1.516 . . . . 1.28 108.269 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 mt -86.91 -10.91 52.21 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.743 2.127 . . . . 1.9299999999999999 116.743 -176.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -106.75 22.21 16.27 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.532 0.938 . . . . 1.79 113.532 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.91 -172.81 3.64 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-O 121.432 0.634 . . . . 1.49 111.294 178.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.629 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.88 -176.72 0.57 Allowed Pre-proline 0 N--CA 1.509 2.51 0 C-N-CA 123.819 0.848 . . . . 1.6799999999999999 109.557 178.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.478 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 32.8 Cg_exo -69.52 -40.42 5.72 Favored 'Trans proline' 0 C--N 1.4 3.26 0 C-N-CA 122.679 2.253 . . . . 1.1599999999999999 113.045 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -67.98 -49.52 61.14 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.27 1.428 . . . . 2.04 111.866 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.19 -3.54 49.43 Favored 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 114.86 -1.064 . . . . 1.6200000000000001 112.812 177.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.629 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 3.4 tt0 -73.03 -42.41 63.19 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 125.649 1.579 . . . . 2.4300000000000002 107.391 173.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.6 t -63.72 -40.29 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 C-N-CA 124.195 0.998 . . . . 1.46 109.638 173.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.4 ' O ' ' HB1' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -74.91 -17.38 60.58 Favored 'General case' 0 CA--C 1.587 2.393 0 N-CA-C 114.247 1.203 . . . . 1.6699999999999999 114.247 174.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -123.65 22.75 9.0 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 114.372 1.249 . . . . 1.3300000000000001 114.372 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.417 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -137.89 -36.31 0.62 Allowed 'General case' 0 N--CA 1.51 2.558 0 N-CA-C 114.84 1.422 . . . . 1.4099999999999999 114.84 -178.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.1 p -65.94 126.31 28.15 Favored 'General case' 0 N--CA 1.526 3.353 0 N-CA-C 115.293 1.59 . . . . 1.28 115.293 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.41 148.06 42.93 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 113.463 0.912 . . . . 1.53 113.463 -178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.9 ttp85 -99.29 -150.76 0.38 Allowed 'General case' 0 CA--C 1.568 1.658 0 C-N-CA 124.08 0.952 . . . . 3.8300000000000001 111.355 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -107.08 136.64 46.59 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.557 -0.715 . . . . 3.7599999999999998 111.377 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -116.76 151.23 36.86 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.809 1.04 . . . . 5.3700000000000001 113.809 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -159.57 -66.37 0.08 Allowed 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 113.726 1.01 . . . . 2.5499999999999998 113.726 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.66 -162.99 1.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.434 0.901 . . . . 2.1499999999999999 113.434 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.28 109.87 3.29 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.608 1.163 . . . . 1.25 112.344 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.81 157.34 43.93 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.739 -1.119 . . . . 1.1499999999999999 113.157 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.66 -176.27 39.34 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 115.739 1.055 . . . . 0.59999999999999998 115.739 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.6 172.31 6.92 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.357 1.243 . . . . 1.4099999999999999 114.357 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.06 130.32 50.89 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 114.092 -1.413 . . . . 0.51000000000000001 111.995 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.73 99.61 38.57 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 123.282 0.633 . . . . 1.0600000000000001 109.379 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -84.17 121.63 2.76 Favored 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 122.061 1.841 . . . . 0.17999999999999999 114.65 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.03 160.4 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 CA-C-O 122.016 0.913 . . . . 1.0600000000000001 111.455 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -146.62 17.42 1.3 Allowed 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 114.616 -1.175 . . . . 3.1099999999999999 112.051 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -126.65 160.33 31.04 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-O 121.292 0.568 . . . . 2.1200000000000001 111.5 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -121.25 144.55 48.55 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.72 1.008 . . . . 0.41999999999999998 113.72 -178.816 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.32 -134.31 3.49 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 113.961 -1.472 . . . . 0.25 112.012 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.7 mt-10 -119.1 106.91 12.86 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 118.521 1.16 . . . . 1.75 111.158 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -101.37 128.74 47.41 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.093 0.473 . . . . 0.90000000000000002 110.76 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.77 125.77 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.528 0.68 . . . . 1.0700000000000001 110.543 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.71 105.89 17.28 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 114.563 -1.199 . . . . 1.47 109.687 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.23 123.31 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.044 -1.095 . . . . 1.27 108.044 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -138.37 140.24 39.34 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.973 0.731 . . . . 1.8899999999999999 112.973 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -101.46 120.37 40.18 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.711 0.767 . . . . 2.8999999999999999 111.794 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -105.07 133.5 49.74 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.399 -0.819 . . . . 0.48999999999999999 109.655 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.59 158.92 43.27 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.306 0.574 . . . . 1.1000000000000001 112.207 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -122.8 161.63 23.64 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.512 0.725 . . . . 2.6099999999999999 111.844 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.13 -69.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 112.579 0.585 . . . . 2.6099999999999999 112.579 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -132.11 63.38 1.62 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.621 0.6 . . . . 2.71 112.621 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -148.68 97.44 2.73 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.283 0.633 . . . . 1.6899999999999999 109.707 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.37 105.91 16.22 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.171 0.986 . . . . 1.4299999999999999 112.397 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -167.4 140.54 3.45 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.874 -1.057 . . . . 2.9700000000000002 111.464 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.1 m -127.08 123.18 36.29 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.782 0.66 . . . . 1.6599999999999999 112.782 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 68.16 47.49 1.02 Allowed 'General case' 0 N--CA 1.51 2.56 0 C-N-CA 125.819 1.648 . . . . 2.02 113.894 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -149.74 -39.27 0.14 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.589 1.156 . . . . 2.5600000000000001 110.053 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -107.81 79.61 1.3 Allowed 'General case' 0 C--N 1.362 1.118 0 N-CA-C 108.123 -1.066 . . . . 3.1499999999999999 108.123 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.24 120.71 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 114.111 -1.404 . . . . 1.3600000000000001 111.146 -176.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -99.41 176.62 5.45 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 114.166 -1.379 . . . . 0.84999999999999998 114.583 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.5 135.25 50.11 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 122.09 -0.381 . . . . 1.3300000000000001 110.332 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.79 124.22 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.439 0 CA-C-O 121.208 0.528 . . . . 1.1699999999999999 109.641 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.672 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 20.0 mtt180 -122.11 150.48 42.11 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.467 1.654 . . . . 1.9399999999999999 115.467 -176.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 154' ' ' SER . 7.2 m -126.05 111.87 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 N-CA-C 113.072 0.767 . . . . 1.29 113.072 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.429 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 62.86 25.93 15.32 Favored 'General case' 0 N--CA 1.526 3.345 0 C-N-CA 126.607 1.963 . . . . 1.8200000000000001 114.06 -179.042 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.22 -14.05 51.7 Favored Glycine 0 CA--C 1.552 2.37 0 C-N-CA 121.348 -0.453 . . . . 0.32000000000000001 113.768 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.672 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 92.3 m-70 -89.29 173.99 8.08 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 125.914 1.686 . . . . 0.56999999999999995 113.185 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.66 133.56 54.51 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.582 0.706 . . . . 1.1899999999999999 112.047 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.69 -57.17 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-N 114.701 -1.136 . . . . 1.73 113.038 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.09 88.98 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.295 -1.002 . . . . 1.25 108.295 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 13.4 ptpt -108.31 98.55 8.07 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 122.919 1.342 . . . . 2.75 111.793 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 0.6 OUTLIER 121.48 74.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 129.245 3.018 . . . . 2.48 108.018 -179.409 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.47 106.61 18.66 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 113.228 0.825 . . . . 1.78 113.228 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -116.86 102.53 9.47 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.728 -1.578 . . . . 2.3500000000000001 106.806 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -25.59 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.335 0 N-CA-C 114.4 1.259 . . . . 1.27 114.4 -176.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -75.27 -41.96 56.09 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.831 0.853 . . . . 0.83999999999999997 112.324 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -73.9 -26.13 60.37 Favored 'General case' 0 CA--C 1.577 1.986 0 C-N-CA 124.403 1.081 . . . . 0.91000000000000003 113.497 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -78.19 -56.1 4.74 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 113.711 1.004 . . . . 2.98 113.711 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.21 -36.95 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 N-CA-C 114.44 1.274 . . . . 1.53 114.44 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.05 -109.29 1.07 Allowed Glycine 0 C--N 1.355 1.619 0 CA-C-N 118.523 0.601 . . . . 0.84999999999999998 113.25 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -114.94 106.95 14.75 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.731 0.301 . . . . 3.9700000000000002 110.63 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 67.56 -130.07 0.14 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 125.285 1.434 . . . . 2.0800000000000001 112.582 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 66.7 p 60.39 -163.24 0.25 Allowed 'General case' 0 N--CA 1.529 3.511 0 C-N-CA 126.293 1.837 . . . . 1.22 115.182 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -112.74 129.93 56.24 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 112.692 0.626 . . . . 1.2 112.692 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -103.08 137.82 40.74 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.077 -0.712 . . . . 0.41999999999999998 109.077 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -134.71 126.14 28.44 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.88 1.437 . . . . 2.5 114.88 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.06 125.32 52.27 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 115.138 -0.937 . . . . 1.5800000000000001 111.156 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.63 114.72 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 114.272 -1.331 . . . . 1.25 110.199 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.3 101.4 17.69 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.953 -0.546 . . . . 1.5 111.582 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -74.13 143.01 31.6 Favored 'Trans proline' 0 C--N 1.399 3.237 0 C-N-CA 123.049 2.499 . . . . 0.22 114.729 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.3 mt -124.9 150.46 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 CA-C-N 115.03 -0.987 . . . . 1.1200000000000001 109.916 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.6 t -136.21 113.41 10.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.454 0.645 . . . . 1.8600000000000001 111.275 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -111.56 124.28 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-N 114.931 -1.031 . . . . 1.0700000000000001 108.61 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -143.69 130.4 20.27 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.791 -0.64 . . . . 2.6400000000000001 110.979 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.35 14.24 9.14 Favored 'General case' 0 N--CA 1.515 2.803 0 C-N-CA 125.186 1.394 . . . . 4.0199999999999996 113.623 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.99 17.64 31.78 Favored Glycine 0 CA--C 1.549 2.162 0 CA-C-O 119.158 -0.801 . . . . 0.39000000000000001 114.566 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 7.1 mtpm? -127.28 150.58 49.5 Favored 'General case' 0 C--N 1.367 1.364 0 CA-C-N 118.443 1.122 . . . . 2.0299999999999998 113.046 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.79 141.06 36.77 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.07 1.137 . . . . 1.0800000000000001 114.07 -176.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.73 112.32 11.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.884 -1.053 . . . . 1.23 110.054 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.255 8.6 p -115.95 95.16 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.457 0 CA-C-O 121.309 0.576 . . . . 1.1899999999999999 111.314 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 67.81 -86.37 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 C-N-CA 125.673 1.589 . . . . 1.8200000000000001 113.608 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.83 26.68 5.32 Favored Glycine 0 CA--C 1.543 1.821 0 CA-C-N 115.923 -0.581 . . . . 0.51000000000000001 112.79 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -126.12 137.35 53.59 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 124.067 0.947 . . . . 1.8200000000000001 111.013 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.75 126.04 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.167 0 CA-C-O 121.516 0.675 . . . . 1.5900000000000001 111.05 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 m -150.2 -179.72 7.42 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.188 -0.915 . . . . 1.1699999999999999 109.933 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.269 15.4 t -103.84 138.18 40.79 Favored 'General case' 0 CA--C 1.577 1.981 0 N-CA-C 113.152 0.797 . . . . 1.71 113.152 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -83.74 121.81 27.79 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.987 0.915 . . . . 0.29999999999999999 111.38 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.41 91.27 3.21 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 112.38 0.511 . . . . 1.8700000000000001 112.38 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.89 -66.29 3.4 Favored Glycine 0 C--N 1.357 1.74 0 N-CA-C 118.738 2.255 . . . . 0.91000000000000003 118.738 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.528 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -133.58 156.89 47.01 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.326 1.232 . . . . 1.6799999999999999 114.326 -176.365 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.528 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -104.84 137.3 42.84 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.107 -1.86 . . . . 1.3700000000000001 109.188 177.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.1 t -120.47 143.28 48.6 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.284 1.587 . . . . 0.94999999999999996 115.284 -177.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.92 97.44 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.986 -1.487 . . . . 1.3799999999999999 106.986 175.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -117.76 124.11 47.65 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.993 -0.549 . . . . 1.6699999999999999 112.077 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.91 135.27 54.15 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 122.329 1.062 . . . . 2.2999999999999998 112.015 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.4 t -104.74 140.24 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-N 112.631 -2.077 . . . . 1.29 109.283 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 150.32 21.77 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.741 1.386 . . . . 2.6200000000000001 114.741 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.91 -34.23 4.1 Favored Glycine 0 CA--C 1.545 1.964 0 CA-C-N 114.779 -1.1 . . . . 1.0600000000000001 114.483 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -126.2 -88.01 0.59 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 117.357 0.579 . . . . 3.1000000000000001 112.372 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -131.04 -51.33 1.03 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.996 0.518 . . . . 4.0800000000000001 112.015 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.03 122.61 37.87 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.172 0.989 . . . . 1.74 111.245 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -81.97 -169.09 0.21 Allowed Pre-proline 0 CA--C 1.574 1.888 0 C-N-CA 125.54 1.536 . . . . 1.6799999999999999 110.554 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -62.7 99.98 0.22 Allowed 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 122.159 1.906 . . . . 2.8199999999999998 111.461 174.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -55.65 -55.18 35.21 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.295 1.961 . . . . 3.4100000000000001 116.295 -173.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 38.8 t -105.61 130.02 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.52 -0.919 . . . . 1.3799999999999999 108.52 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.8 t -135.41 113.82 11.56 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.053 -1.431 . . . . 1.75 110.648 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 60' ' ' LEU . . . -109.61 47.2 0.95 Allowed 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.688 2.107 . . . . 1.1299999999999999 116.688 -175.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.17 130.92 3.62 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 117.13 2.27 . . . . 1.3999999999999999 117.13 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -150.92 105.37 3.25 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.7 -1.136 . . . . 0.26000000000000001 109.597 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 12' ' ' TRP 0.298 7.2 tt -112.76 122.04 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-O 122.255 1.026 . . . . 1.1000000000000001 111.091 175.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -116.3 164.29 14.74 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 113.707 -1.588 . . . . 1.0600000000000001 111.153 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 8.6 ptmm? -123.0 156.18 35.32 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.577 2.436 . . . . 1.8300000000000001 117.577 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.42 -41.57 2.11 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 110.55 -3.023 . . . . 0.17000000000000001 118.909 174.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.04 160.36 1.77 Allowed 'General case' 0 N--CA 1.517 2.885 0 CA-C-N 120.683 2.242 . . . . 1.05 113.391 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -83.29 -13.65 54.71 Favored 'General case' 0 CA--C 1.578 2.03 0 C-N-CA 124.882 1.273 . . . . 0.98999999999999999 114.016 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.38 2.91 49.01 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 114.502 1.297 . . . . 0.55000000000000004 114.502 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.62 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.9 OUTLIER -107.55 -10.26 15.73 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.762 1.023 . . . . 0.59999999999999998 113.762 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.53 94.66 0.55 Allowed Pre-proline 0 N--CA 1.508 2.431 0 C-N-CA 123.917 0.887 . . . . 1.1799999999999999 112.727 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.62 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 65.5 Cg_endo -95.05 159.62 1.7 Allowed 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 122.713 2.275 . . . . 2.0299999999999998 114.284 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.4 tpt -135.36 114.45 12.22 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.064 -0.517 . . . . 5.3399999999999999 111.448 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.76 163.85 31.79 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.091 0.948 . . . . 4.0 112.524 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -111.24 161.75 23.82 Favored Pre-proline 0 CA--C 1.563 1.459 0 CA-C-N 114.538 -1.21 . . . . 6.7000000000000002 110.621 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -67.25 121.11 8.21 Favored 'Trans proline' 0 C--N 1.396 3.041 0 C-N-CA 122.356 2.037 . . . . 6.9400000000000004 114.453 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -136.62 134.77 19.73 Favored Pre-proline 0 CA--C 1.562 1.433 0 CA-C-N 115.374 -0.83 . . . . 5.5099999999999998 111.634 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -85.02 -155.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.257 2.638 . . . . 7.1600000000000001 113.845 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 170.01 87.63 0.07 OUTLIER Glycine 0 C--N 1.342 0.873 0 C-N-CA 120.846 -0.692 . . . . 7.0199999999999996 113.357 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.7 mt -119.13 115.34 24.05 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.726 0.41 . . . . 9.3000000000000007 111.877 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.292 -0.861 . . . . 10.6 111.143 179.958 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.473 -0.251 . . . . 9.3599999999999994 112.473 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.4 130.85 55.47 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.493 0.663 . . . . 6.8499999999999996 111.904 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.7 mtt -130.59 -67.67 0.72 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.751 -0.658 . . . . 8.0 111.792 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.0 m -134.91 116.14 14.4 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.877 0.37 . . . . 4.1500000000000004 111.7 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.69 89.07 0.1 OUTLIER Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.783 -0.644 . . . . 1.6000000000000001 113.101 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.3 tp -87.92 -45.02 10.62 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 113.314 0.857 . . . . 1.0900000000000001 113.314 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.46 -23.53 62.79 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.822 1.649 . . . . 1.04 115.134 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.97 -10.46 53.15 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 113.62 0.97 . . . . 0.32000000000000001 113.62 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -105.26 -25.21 12.53 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-O 118.235 -0.888 . . . . 2.2599999999999998 113.349 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -51.03 133.8 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 N-CA-C 115.508 1.67 . . . . 1.01 115.508 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.26 -29.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 115.267 -0.879 . . . . 1.0600000000000001 112.071 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -162.45 118.6 1.94 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.583 0.353 . . . . 0.67000000000000004 111.62 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.8 128.58 20.48 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.523 -0.735 . . . . 1.0800000000000001 111.181 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.11 135.66 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 113.986 1.106 . . . . 1.6699999999999999 113.986 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -116.04 102.34 9.55 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 106.906 -1.516 . . . . 2.6400000000000001 106.906 172.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -75.37 98.55 3.89 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.949 0.881 . . . . 1.28 111.764 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.481 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 172.3 -33.03 0.13 Allowed Glycine 0 C--N 1.348 1.234 0 N-CA-C 117.374 1.71 . . . . 0.70999999999999996 117.374 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.07 -114.87 1.9 Allowed Glycine 0 N--CA 1.471 1.01 0 C-N-CA 120.219 -0.991 . . . . 0.87 115.288 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.75 117.04 1.07 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.118 0.567 . . . . 2.1200000000000001 110.593 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.4 m 33.25 108.01 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 118.593 2.812 . . . . 1.5 118.593 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.476 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 63.3 t60 -133.21 133.94 43.39 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.76 1.022 . . . . 0.52000000000000002 113.76 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.57 117.59 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 114.743 -1.117 . . . . 2.0699999999999998 109.143 175.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -86.37 163.25 17.75 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 115.157 -0.929 . . . . 1.8500000000000001 111.542 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -43.73 -24.96 0.21 Allowed 'Isoleucine or valine' 1 N--CA 1.541 4.092 0 N-CA-C 119.681 3.215 . . . . 1.3700000000000001 119.681 -175.035 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -98.02 -9.98 25.16 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 118.543 0.611 . . . . 0.56999999999999995 111.457 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.8 40.32 2.73 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.811 1.196 . . . . 0.37 114.036 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.6 mm -105.15 119.17 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.681 0 N-CA-C 109.21 -0.663 . . . . 1.25 109.21 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.476 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.0 t-160 -105.7 135.28 47.4 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.579 1.696 . . . . 1.71 115.579 -175.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.573 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -94.84 134.35 37.56 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.3 -1.318 . . . . 3.1499999999999999 109.392 174.697 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.41 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 68.8 mtt180 -90.79 106.03 18.23 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.956 -1.02 . . . . 3.5099999999999998 113.307 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -41.89 109.84 0.14 Allowed 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 118.374 2.731 . . . . 2.8100000000000001 118.374 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.08 59.75 16.33 Favored Pre-proline 0 N--CA 1.528 3.466 0 N-CA-C 118.325 2.713 . . . . 1.1699999999999999 118.325 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 10.0 Cg_endo -105.83 56.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.565 2.068 0 C-N-CA 122.992 2.461 . . . . 1.45 115.685 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.53 -67.88 0.46 Allowed 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 113.106 0.78 . . . . 2.2400000000000002 113.106 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -99.19 89.44 4.24 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 112.98 0.733 . . . . 4.8399999999999999 112.98 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.79 -29.63 11.67 Favored Glycine 0 CA--C 1.545 1.929 0 CA-C-N 115.458 -0.792 . . . . 2.9700000000000002 114.503 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 80.89 2.75 1.69 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 126.605 1.962 . . . . 4.79 114.816 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.93 117.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 123.923 0.889 . . . . 3.1499999999999999 109.807 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.84 -140.79 2.96 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 120.765 -0.731 . . . . 2.7200000000000002 114.453 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -139.81 -177.86 5.17 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.893 0.854 . . . . 5.9500000000000002 112.831 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.49 129.81 45.08 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.234 1.013 . . . . 1.78 111.878 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.4 m -126.37 122.92 36.74 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.244 -0.889 . . . . 1.6599999999999999 111.142 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.96 108.74 9.57 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.95 -0.568 . . . . 2.3300000000000001 111.458 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -105.59 72.18 0.95 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.88 0.848 . . . . 3.3300000000000001 110.299 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.17 75.74 0.48 Allowed Glycine 0 C--N 1.347 1.142 0 CA-C-N 114.399 -1.273 . . . . 1.7 110.716 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.33 0.31 57.44 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.766 1.765 . . . . 2.0800000000000001 115.766 -177.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.54 46.47 1.72 Allowed 'General case' 0 CA--C 1.559 1.315 0 CA-C-O 121.632 0.73 . . . . 4.6200000000000001 112.119 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -129.72 72.74 81.89 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.551 1.141 . . . . 3.1600000000000001 108.395 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 38.6 Cg_exo -67.4 159.78 50.79 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 124.03 3.153 . . . . 1.8600000000000001 117.211 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.3 136.87 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.951 0 CA-C-N 114.703 -1.135 . . . . 1.28 109.405 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mt -79.52 -17.14 54.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.241 1.571 . . . . 1.9299999999999999 115.241 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -101.49 7.41 42.43 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.478 0.918 . . . . 1.79 113.478 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.2 p -118.52 -177.98 3.42 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.14 1.163 . . . . 1.49 114.14 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.708 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 2.6 t30 -97.44 -176.18 0.5 Allowed Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 125.652 1.581 . . . . 1.6799999999999999 109.574 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -72.05 -43.99 1.02 Allowed 'Trans proline' 0 C--N 1.393 2.901 0 C-N-CA 122.766 2.311 . . . . 1.1599999999999999 111.414 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -69.31 -47.68 63.76 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.005 -1.907 . . . . 2.04 111.617 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 17.4 t0 -75.7 -12.27 60.16 Favored 'General case' 0 CA--C 1.583 2.241 0 CA-C-N 115.327 -0.851 . . . . 1.6200000000000001 112.378 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.708 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 10.8 tt0 -67.7 -43.16 80.76 Favored 'General case' 0 C--N 1.379 1.851 0 C-N-CA 125.432 1.493 . . . . 2.4300000000000002 109.179 173.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.8 -45.06 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.338 0 C-N-CA 124.327 1.051 . . . . 1.46 109.853 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.76 -5.18 49.83 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.227 1.195 . . . . 1.6699999999999999 114.227 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 4.6 m-30 -123.54 10.35 9.11 Favored 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 124.509 1.124 . . . . 1.3300000000000001 112.402 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -136.55 -28.64 0.99 Allowed 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 116.502 2.038 . . . . 1.4099999999999999 116.502 -176.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.7 p -74.74 131.85 41.16 Favored 'General case' 0 N--CA 1.519 2.99 0 N-CA-C 114.008 1.114 . . . . 1.28 114.008 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 16' ' ' ALA . 3.5 pt-20 -127.53 144.93 51.01 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 114.95 1.463 . . . . 1.53 114.95 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.481 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 63.9 mtp180 -98.43 177.41 5.36 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.467 0.707 . . . . 3.8300000000000001 112.673 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -125.11 125.87 44.43 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.792 -0.64 . . . . 3.7599999999999998 111.067 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -132.36 -105.09 0.26 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 118.96 -0.543 . . . . 5.3700000000000001 112.236 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -164.62 -77.54 0.03 OUTLIER 'General case' 0 C--N 1.364 1.2 0 N-CA-C 113.564 0.95 . . . . 2.5499999999999998 113.564 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.65 124.69 0.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.188 0.595 . . . . 2.1499999999999999 111.368 -176.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.2 t 67.56 85.19 0.14 Allowed 'General case' 0 N--CA 1.513 2.714 0 C-N-CA 124.769 1.228 . . . . 1.25 112.487 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.406 ' CE1' ' ND2' ' A' ' 164' ' ' ASN . 3.3 p90 -144.56 157.03 44.41 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.384 0.611 . . . . 1.1499999999999999 112.564 -178.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.52 174.47 44.47 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 115.571 0.989 . . . . 0.59999999999999998 115.571 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.99 166.32 10.46 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.482 1.289 . . . . 1.4099999999999999 114.482 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -120.74 132.08 54.86 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.15 -1.387 . . . . 0.51000000000000001 112.162 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -124.51 99.47 36.2 Favored Pre-proline 0 CA--C 1.567 1.627 0 C-N-CA 123.142 0.577 . . . . 1.0600000000000001 109.916 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.08 122.12 3.27 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.231 1.954 . . . . 0.17999999999999999 115.014 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.14 159.26 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.64 0 CA-C-O 121.997 0.904 . . . . 1.0600000000000001 111.26 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -147.86 22.15 1.12 Allowed 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 114.632 -1.167 . . . . 3.1099999999999999 111.791 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -129.9 159.37 36.84 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 121.3 0.572 . . . . 2.1200000000000001 111.449 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -119.0 144.77 46.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.742 1.016 . . . . 0.41999999999999998 113.742 -178.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.48 -138.73 5.77 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 113.974 -1.467 . . . . 0.25 112.17 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.501 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 54.3 mm-40 -113.65 108.26 16.89 Favored 'General case' 0 C--N 1.359 1.008 0 CA-C-N 118.113 0.956 . . . . 1.75 111.292 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -102.84 129.84 49.65 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.81 -0.556 . . . . 0.90000000000000002 110.599 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -110.02 122.36 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.841 0.829 . . . . 1.0700000000000001 111.013 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.61 105.75 16.3 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 113.907 -1.497 . . . . 1.47 110.202 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.69 126.65 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.142 -0.688 . . . . 1.27 109.142 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 146.07 48.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.599 0.963 . . . . 1.8899999999999999 113.599 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -105.18 121.54 44.05 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.311 -0.859 . . . . 2.8999999999999999 111.296 177.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.549 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 15.6 m-85 -108.49 134.86 50.69 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.414 -0.812 . . . . 0.48999999999999999 109.735 176.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.18 148.5 48.18 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 123.868 0.867 . . . . 1.1000000000000001 110.425 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -106.38 -71.21 0.76 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.816 0.447 . . . . 2.6099999999999999 111.768 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.325 2.8 m 48.29 53.57 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 C-N-CA 127.113 2.165 . . . . 2.6099999999999999 116.677 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.98 -53.63 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.79 0.663 . . . . 2.71 112.79 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -118.29 139.23 51.64 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.31 0.576 . . . . 1.6899999999999999 112.349 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.18 103.31 12.47 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-O 122.209 1.004 . . . . 1.4299999999999999 111.987 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -162.83 140.89 8.27 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.125 -0.943 . . . . 2.9700000000000002 111.642 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 m -123.45 122.38 38.1 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.962 0.727 . . . . 1.6599999999999999 112.962 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 69.2 58.21 0.35 Allowed 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 125.933 1.693 . . . . 2.02 113.266 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -156.96 -40.94 0.07 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.128 -1.396 . . . . 2.5600000000000001 108.606 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -103.42 82.67 2.07 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.361 -0.977 . . . . 3.1499999999999999 108.361 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.43 132.89 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 114.516 -1.22 . . . . 1.3600000000000001 111.509 -177.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.439 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 61.7 m-85 -115.5 174.26 6.1 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 115.185 1.55 . . . . 0.84999999999999998 115.185 -176.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.27 136.08 52.34 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.869 0.842 . . . . 1.3300000000000001 110.923 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.3 124.39 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.285 0 CA-C-N 114.361 -1.291 . . . . 1.1699999999999999 110.38 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.3 OUTLIER -121.02 141.56 50.63 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.473 1.286 . . . . 1.9399999999999999 114.473 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 m -117.72 99.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 115.111 -0.95 . . . . 1.29 112.063 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.436 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.1 t30 64.85 26.89 12.92 Favored 'General case' 0 N--CA 1.522 3.169 0 C-N-CA 126.892 2.077 . . . . 1.8200000000000001 113.659 -177.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.89 -19.65 32.6 Favored Glycine 0 CA--C 1.549 2.19 0 CA-C-N 115.141 -0.936 . . . . 0.32000000000000001 113.702 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -88.32 121.93 31.27 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 125.505 1.522 . . . . 0.56999999999999995 113.669 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -87.7 125.69 34.55 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.591 1.186 . . . . 1.1899999999999999 113.134 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.22 -43.39 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 112.428 -2.169 . . . . 1.73 112.916 -177.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.38 90.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.466 -0.568 . . . . 1.25 109.466 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -111.55 75.88 0.94 Allowed 'General case' 0 C--N 1.359 1.013 0 CA-C-O 123.944 1.831 . . . . 2.75 112.52 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 154.46 61.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 109.818 -3.356 . . . . 2.48 107.48 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.3 tp -98.91 99.16 10.18 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 113.727 1.01 . . . . 1.78 113.727 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -111.86 111.5 22.49 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 113.172 -1.831 . . . . 2.3500000000000001 109.742 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -34.26 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 114.545 1.313 . . . . 1.27 114.545 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -76.32 -37.5 57.31 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.806 0.669 . . . . 0.83999999999999997 112.806 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -74.08 -27.0 60.68 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 124.371 1.068 . . . . 0.91000000000000003 113.422 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -80.33 -57.78 3.44 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.311 0.856 . . . . 2.98 113.311 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.78 -36.79 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 N-CA-C 114.313 1.227 . . . . 1.53 114.313 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.37 -71.13 0.21 Allowed Glycine 0 C--N 1.36 1.908 0 CA-C-N 118.534 0.606 . . . . 0.84999999999999998 113.999 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -102.97 174.39 5.89 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.25 1.02 . . . . 3.9700000000000002 111.802 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.0 m -75.9 81.26 2.8 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 113.846 1.054 . . . . 2.0800000000000001 113.846 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 46.6 p -127.99 -137.43 0.24 Allowed 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 114.708 -1.133 . . . . 1.22 109.139 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.8 128.09 56.27 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 114.055 1.132 . . . . 1.2 114.055 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -106.2 126.68 52.51 Favored 'General case' 0 C--N 1.363 1.183 0 N-CA-C 108.399 -0.963 . . . . 0.41999999999999998 108.399 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.25 136.76 36.84 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.5 0.926 . . . . 2.5 113.5 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -120.37 134.46 55.26 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 114.806 -1.088 . . . . 1.5800000000000001 111.174 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.8 115.66 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 CA-C-N 114.255 -1.339 . . . . 1.25 109.833 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.9 90.86 49.49 Favored Pre-proline 0 CA--C 1.573 1.851 0 CA-C-N 115.208 -0.906 . . . . 1.5 110.15 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -73.87 136.64 23.25 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 123.052 2.501 . . . . 0.22 113.71 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -119.04 151.38 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 115.167 -0.924 . . . . 1.1200000000000001 111.053 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.5 p -134.21 108.73 8.43 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.215 -0.902 . . . . 1.8600000000000001 111.744 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.2 mt -108.82 122.79 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.593 0 N-CA-C 108.441 -0.948 . . . . 1.0700000000000001 108.441 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -141.76 129.49 21.64 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.696 -0.684 . . . . 2.6400000000000001 110.996 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 67.49 14.87 9.73 Favored 'General case' 0 N--CA 1.515 2.821 0 C-N-CA 125.113 1.365 . . . . 4.0199999999999996 114.367 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.38 16.44 32.1 Favored Glycine 0 CA--C 1.549 2.168 0 CA-C-O 119.143 -0.809 . . . . 0.39000000000000001 114.962 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 94.6 mttt -126.82 150.4 49.21 Favored 'General case' 0 C--N 1.367 1.329 0 CA-C-N 118.498 1.149 . . . . 2.0299999999999998 113.038 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.53 139.0 37.78 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.554 0.946 . . . . 1.0800000000000001 113.554 -176.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.67 112.42 14.82 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.128 -0.942 . . . . 1.23 110.406 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.81 92.75 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.604 0 CA-C-N 115.589 -0.732 . . . . 1.1899999999999999 109.982 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 65.39 -83.75 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 C-N-CA 125.369 1.468 . . . . 1.8200000000000001 113.796 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -129.61 25.95 4.4 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-N 116.099 -0.5 . . . . 0.51000000000000001 113.866 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -132.38 119.31 20.51 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 123.165 0.586 . . . . 1.8200000000000001 110.078 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 p -105.74 131.61 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.298 0 CA-C-O 121.696 0.76 . . . . 1.5900000000000001 112.415 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -149.08 -178.11 6.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.815 -1.084 . . . . 1.1699999999999999 109.565 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.268 13.0 t -103.48 138.65 39.9 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 113.547 0.943 . . . . 1.71 113.547 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -82.12 122.68 28.16 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 124.192 0.997 . . . . 0.29999999999999999 111.343 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.65 90.77 3.31 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.788 0.662 . . . . 1.8700000000000001 112.788 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.19 -61.74 2.64 Favored Glycine 0 C--N 1.362 2.005 0 N-CA-C 118.835 2.294 . . . . 0.91000000000000003 118.835 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.55 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -133.11 163.83 28.39 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.649 0.981 . . . . 1.6799999999999999 113.649 -176.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.55 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -112.14 134.6 53.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.692 -1.594 . . . . 1.3700000000000001 108.488 176.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.2 t -121.86 130.58 53.49 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 115.246 1.573 . . . . 0.94999999999999996 115.246 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.2 t -106.35 99.85 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.704 -1.591 . . . . 1.3799999999999999 106.704 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.2 tt0 -114.85 125.23 53.43 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 113.905 -1.498 . . . . 1.6699999999999999 111.9 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -116.15 131.97 56.79 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 122.217 1.008 . . . . 2.2999999999999998 111.923 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.51 144.47 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 112.875 -1.966 . . . . 1.29 110.83 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -95.19 150.45 20.2 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.676 -1.147 . . . . 2.6200000000000001 113.612 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.32 -32.65 5.98 Favored Glycine 0 CA--C 1.548 2.112 0 N-CA-C 115.236 0.855 . . . . 1.0600000000000001 115.236 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -125.17 -80.56 0.62 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.606 0.703 . . . . 3.1000000000000001 112.395 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -132.2 -44.94 0.93 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.087 0.555 . . . . 4.0800000000000001 112.203 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.439 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -92.84 157.17 16.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.659 1.184 . . . . 1.74 112.109 179.085 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.406 ' ND2' ' CE1' ' A' ' 71' ' ' PHE . 1.2 m-20 -101.19 -167.45 0.13 Allowed Pre-proline 0 CA--C 1.572 1.809 0 CA-C-N 113.614 -1.63 . . . . 1.6799999999999999 108.979 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -61.26 -10.5 15.83 Favored 'Trans proline' 0 N--CA 1.52 3.081 0 C-N-CA 122.49 2.127 . . . . 2.8199999999999998 115.533 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? 78.93 -71.71 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 126.561 1.944 . . . . 3.4100000000000001 114.211 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.2 t -106.34 132.72 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.621 -0.511 . . . . 1.3799999999999999 109.621 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.6 125.82 27.96 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 114.155 -1.384 . . . . 1.75 111.479 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . 0.268 . . -120.34 50.88 1.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 115.744 1.757 . . . . 1.1299999999999999 115.744 -176.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.81 129.3 2.62 Favored 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 126.169 1.787 . . . . 1.3999999999999999 115.502 178.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -149.61 99.31 2.87 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.26000000000000001 110.019 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.311 8.0 tt -115.67 121.78 68.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.673 0 CA-C-O 122.651 1.215 . . . . 1.1000000000000001 111.801 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -118.72 171.2 8.37 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 113.701 -1.59 . . . . 1.0600000000000001 112.171 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -120.15 148.15 44.0 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 117.783 2.512 . . . . 1.8300000000000001 117.783 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.22 -41.74 2.08 Favored Glycine 0 CA--C 1.543 1.823 0 CA-C-N 110.786 -2.915 . . . . 0.17000000000000001 120.087 172.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.08 156.64 1.04 Allowed 'General case' 0 N--CA 1.521 3.115 0 CA-C-N 121.114 2.457 . . . . 1.05 113.383 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.45 -12.12 59.99 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 114.478 1.288 . . . . 0.98999999999999999 114.478 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.1 4.47 45.25 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 113.694 0.998 . . . . 0.55000000000000004 113.694 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.611 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -107.13 -10.32 15.91 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 113.701 1.0 . . . . 0.59999999999999998 113.701 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.32 93.69 0.45 Allowed Pre-proline 0 N--CA 1.509 2.503 0 C-N-CA 123.932 0.893 . . . . 1.1799999999999999 112.74 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.611 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 2.7 Cg_exo -83.08 106.74 1.43 Allowed 'Trans proline' 0 C--N 1.398 3.159 0 C-N-CA 122.858 2.372 . . . . 2.0299999999999998 114.083 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.8 mmt -138.39 110.54 7.33 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.642 -0.708 . . . . 5.3399999999999999 111.206 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.1 mt -133.29 164.28 27.43 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.974 0.892 . . . . 4.0 112.557 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -104.76 154.43 38.57 Favored Pre-proline 0 CA--C 1.562 1.415 0 CA-C-N 114.629 -1.169 . . . . 6.7000000000000002 110.537 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.46 121.8 9.32 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.569 2.179 . . . . 6.9400000000000004 115.466 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -135.69 135.83 22.62 Favored Pre-proline 0 CA--C 1.565 1.531 0 CA-C-N 114.779 -1.1 . . . . 5.5099999999999998 111.165 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -84.88 -155.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.346 2.697 . . . . 7.1600000000000001 114.293 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.93 104.9 0.18 Allowed Glycine 0 C--N 1.341 0.806 0 C-N-CA 121.136 -0.555 . . . . 7.0199999999999996 113.036 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.5 mt -118.64 108.32 14.79 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.009 0.433 . . . . 9.3000000000000007 111.84 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.277 -0.868 . . . . 10.6 110.998 179.88 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.564 -0.214 . . . . 9.3599999999999994 112.564 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.67 128.1 56.3 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.604 0.716 . . . . 6.8499999999999996 111.884 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.7 mtt -134.19 106.3 7.09 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.626 -0.715 . . . . 8.0 110.991 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 m -135.95 117.7 15.06 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.797 -0.638 . . . . 4.1500000000000004 111.741 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -165.93 87.29 0.1 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 115.665 -0.698 . . . . 1.6000000000000001 113.054 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.7 tp -87.54 -47.76 8.46 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 113.294 0.85 . . . . 1.0900000000000001 113.294 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.69 -23.15 62.89 Favored 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 125.647 1.579 . . . . 1.04 114.979 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.1 -15.17 39.3 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 124.146 0.978 . . . . 0.32000000000000001 113.626 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -105.19 -18.05 14.27 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.907 1.077 . . . . 2.2599999999999998 113.907 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.34 134.79 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.78 0 N-CA-C 114.625 1.343 . . . . 1.01 114.625 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -121.27 -28.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 115.328 -0.851 . . . . 1.0600000000000001 112.446 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.44 ' O ' HG23 ' A' ' 172' ' ' ILE . 65.4 t90 -162.63 117.08 1.77 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 117.827 0.285 . . . . 0.67000000000000004 111.493 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.84 130.85 32.42 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.516 -0.74 . . . . 1.0800000000000001 111.445 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.0 t -137.97 129.32 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 N-CA-C 113.481 0.919 . . . . 1.6699999999999999 113.481 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -116.44 104.22 11.23 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 106.946 -1.501 . . . . 2.6400000000000001 106.946 171.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.29 101.88 7.38 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.084 0.945 . . . . 1.28 111.861 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.508 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 175.59 -57.33 0.11 Allowed Glycine 0 C--N 1.349 1.305 0 CA-C-N 113.71 -1.587 . . . . 0.70999999999999996 114.349 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.13 -117.09 4.3 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-O 119.93 -0.372 . . . . 0.87 113.975 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -172.12 118.88 0.4 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.172 0.589 . . . . 2.1200000000000001 111.17 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.612 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 48.39 107.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 117.205 2.298 . . . . 1.5 117.205 178.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.778 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 25.7 t60 -142.41 132.51 24.6 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.461 -1.296 . . . . 0.52000000000000002 114.49 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -97.04 112.24 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.362 0 CA-C-N 114.28 -1.327 . . . . 2.0699999999999998 110.089 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.29 164.92 19.76 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.527 1.131 . . . . 1.8500000000000001 112.559 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 m -42.53 -35.17 0.63 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.159 0 N-CA-C 118.947 2.943 . . . . 1.3700000000000001 118.947 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -88.98 -23.32 22.66 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.213 0.53 . . . . 0.56999999999999995 111.26 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.85 41.06 0.73 Allowed Glycine 0 C--N 1.351 1.394 0 CA-C-N 114.817 -1.083 . . . . 0.37 113.81 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -108.45 112.8 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 C-N-CA 122.569 0.348 . . . . 1.25 110.581 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.778 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 5.1 p-80 -109.29 147.83 32.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.983 1.845 . . . . 1.71 115.983 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.612 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.8 151.31 20.32 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 112.467 -2.151 . . . . 3.1499999999999999 109.419 176.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -70.27 -99.82 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 116.04 1.867 . . . . 3.5099999999999998 116.04 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp 178.19 84.04 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.89 0.876 . . . . 2.8100000000000001 111.986 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 52.69 55.33 14.26 Favored Pre-proline 0 N--CA 1.528 3.457 0 N-CA-C 117.283 2.327 . . . . 1.1699999999999999 117.283 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -101.67 61.37 0.03 OUTLIER 'Trans proline' 0 CA--C 1.568 2.193 0 C-N-CA 123.307 2.672 . . . . 1.45 116.432 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.47 -60.8 0.41 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.345 0.498 . . . . 2.2400000000000002 112.345 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -114.22 98.69 7.1 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 121.329 0.585 . . . . 4.8399999999999999 111.639 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.21 -32.34 7.59 Favored Glycine 0 CA--C 1.542 1.772 0 CA-C-N 115.221 -0.899 . . . . 2.9700000000000002 115.128 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 64.46 40.68 6.12 Favored 'General case' 0 N--CA 1.509 2.519 0 C-N-CA 126.139 1.776 . . . . 4.79 114.616 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.61 177.46 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 C-N-CA 123.439 0.696 . . . . 3.1499999999999999 111.52 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -99.22 96.24 1.66 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 115.088 0.795 . . . . 2.7200000000000002 115.088 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -144.08 115.28 7.95 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.313 0.645 . . . . 5.9500000000000002 110.877 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.66 134.23 46.37 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.508 0.67 . . . . 1.78 112.65 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.3 m -131.89 88.41 2.56 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.686 -0.688 . . . . 1.6599999999999999 111.447 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.36 114.41 27.55 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.598 -0.728 . . . . 2.3300000000000001 110.99 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -104.2 -61.61 1.42 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 112.564 0.579 . . . . 3.3300000000000001 112.564 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -110.52 62.72 0.29 Allowed Glycine 0 C--N 1.354 1.565 0 N-CA-C 112.123 -0.391 . . . . 1.7 112.123 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.27 9.76 40.06 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.028 1.862 . . . . 2.0800000000000001 116.028 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -61.19 -77.97 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.786 1.773 . . . . 4.6200000000000001 115.786 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.645 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 1.7 pp -138.88 40.8 0.44 Allowed Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 113.52 0.933 . . . . 3.1600000000000001 113.52 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.645 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 21.7 Cg_exo -68.43 -37.51 13.17 Favored 'Trans proline' 0 C--N 1.377 2.037 0 N-CA-C 119.496 2.844 . . . . 1.8600000000000001 119.496 -177.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 61' ' ' TYR 0.319 1.8 mp -92.78 107.02 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 CA-C-O 123.085 1.421 . . . . 1.28 109.59 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt -90.24 -7.13 54.26 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 111.821 -2.445 . . . . 1.9299999999999999 116.387 -175.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -103.86 16.46 26.29 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 112.263 0.468 . . . . 1.79 112.263 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.84 159.36 42.37 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.224 1.01 . . . . 1.49 111.51 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.86 158.32 62.26 Favored Pre-proline 0 N--CA 1.517 2.876 0 CA-C-O 118.138 -0.934 . . . . 1.6799999999999999 110.974 178.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -41.19 -40.13 4.08 Favored 'Trans proline' 0 N--CA 1.535 3.971 0 C-N-CA 125.162 3.908 . . . . 1.1599999999999999 120.05 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.79 -50.02 13.17 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.511 0.672 . . . . 2.04 111.96 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -78.23 -7.5 57.22 Favored 'General case' 0 CA--C 1.584 2.287 0 N-CA-C 113.121 0.786 . . . . 1.6200000000000001 113.121 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.627 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 7.7 tt0 -74.3 -37.06 63.75 Favored 'General case' 0 C--N 1.38 1.919 0 C-N-CA 125.923 1.689 . . . . 2.4300000000000002 107.547 172.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.36 -43.88 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 C-N-CA 124.214 1.005 . . . . 1.46 109.289 172.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' A' ' 169' ' ' ALA . 8.1 tp -79.93 -4.63 53.21 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 113.965 1.098 . . . . 1.6699999999999999 113.965 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.415 ' O ' HG12 ' A' ' 50' ' ' ILE . 6.8 m-30 -121.69 13.77 10.85 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 125.131 1.373 . . . . 1.3300000000000001 112.641 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.627 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 4.8 tt0 -140.8 -38.9 0.42 Allowed 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 117.175 2.287 . . . . 1.4099999999999999 117.175 -174.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.8 p -64.19 128.06 34.16 Favored 'General case' 0 N--CA 1.528 3.435 0 N-CA-C 115.343 1.609 . . . . 1.28 115.343 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.508 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 2.4 pt-20 -117.96 146.11 44.23 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 124.617 1.167 . . . . 1.53 112.58 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -102.22 -83.85 0.46 Allowed 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.355 0.872 . . . . 3.8300000000000001 113.355 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.22 163.73 38.81 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.541 0.686 . . . . 3.7599999999999998 112.842 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.422 ' OD1' ' HA ' ' A' ' 166' ' ' LYS . 3.2 m120 -127.41 138.94 53.11 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.442 -0.799 . . . . 5.3700000000000001 112.927 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -138.12 -119.83 0.14 Allowed 'General case' 0 CA--C 1.564 1.499 0 CA-C-N 115.472 -0.785 . . . . 2.5499999999999998 110.337 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -152.76 121.24 6.35 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.39 0.541 . . . . 2.1499999999999999 110.732 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.91 89.57 0.06 Allowed 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 125.383 1.473 . . . . 1.25 113.692 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -153.53 159.24 42.18 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.841 1.052 . . . . 1.1499999999999999 113.841 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.7 -172.01 40.13 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 115.879 1.112 . . . . 0.59999999999999998 115.879 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -111.27 173.32 6.4 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.026 1.491 . . . . 1.4099999999999999 115.026 -176.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -127.61 132.2 49.82 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 113.98 -1.464 . . . . 0.51000000000000001 111.757 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.91 103.61 30.62 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.023 0.529 . . . . 1.0600000000000001 109.957 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -84.34 120.64 2.54 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 122.282 1.988 . . . . 0.17999999999999999 114.958 177.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.24 162.81 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 122.041 0.924 . . . . 1.0600000000000001 110.931 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -152.13 27.95 0.59 Allowed 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 114.801 -1.091 . . . . 3.1099999999999999 111.816 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -132.71 155.62 48.5 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-O 121.24 0.543 . . . . 2.1200000000000001 110.965 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.77 141.87 47.65 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.009 1.114 . . . . 0.41999999999999998 114.009 -178.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.83 -139.08 5.69 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 113.712 -1.585 . . . . 0.25 112.061 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.2 mt-10 -113.9 110.13 19.61 Favored 'General case' 0 C--N 1.36 1.023 0 CA-C-N 118.312 1.056 . . . . 1.75 111.299 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -104.41 131.2 52.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.996 0.427 . . . . 0.90000000000000002 110.523 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.81 124.46 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.408 0.623 . . . . 1.0700000000000001 110.551 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.2 tt -109.15 106.19 15.97 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.793 -1.094 . . . . 1.47 109.806 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -112.48 129.17 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 113.929 -1.487 . . . . 1.27 108.543 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.72 139.11 50.26 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 115.684 -0.689 . . . . 1.8899999999999999 112.502 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -104.33 114.75 29.19 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.295 -0.866 . . . . 2.8999999999999999 109.855 176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 11.1 m-85 -105.22 137.05 43.62 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.852 -0.613 . . . . 0.48999999999999999 111.255 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.79 151.54 45.84 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.757 -0.656 . . . . 1.1000000000000001 111.458 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -145.87 123.46 11.8 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.671 0.389 . . . . 2.6099999999999999 111.687 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.3 77.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 116.019 -0.537 . . . . 2.6099999999999999 111.727 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -171.05 -47.42 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.43 0.53 . . . . 2.71 112.43 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -116.19 127.34 54.7 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.65 0.38 . . . . 1.6899999999999999 111.577 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.96 103.14 12.94 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.252 1.025 . . . . 1.4299999999999999 111.992 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -160.79 141.84 11.79 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.947 -1.024 . . . . 2.9700000000000002 111.651 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 m -127.7 122.09 32.05 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.764 0.653 . . . . 1.6599999999999999 112.764 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 67.85 55.62 0.58 Allowed 'General case' 0 N--CA 1.513 2.72 0 C-N-CA 125.724 1.61 . . . . 2.02 113.142 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -157.68 -39.15 0.07 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.617 -1.174 . . . . 2.5600000000000001 109.44 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -108.06 83.24 1.76 Allowed 'General case' 0 C--N 1.361 1.097 0 N-CA-C 108.03 -1.1 . . . . 3.1499999999999999 108.03 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.41 130.45 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 114.419 -1.264 . . . . 1.3600000000000001 111.539 -176.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -108.02 170.53 7.94 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.331 1.604 . . . . 0.84999999999999998 115.331 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -119.85 136.65 54.4 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.236 -0.893 . . . . 1.3300000000000001 110.846 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.38 127.89 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.471 0 N-CA-C 109.58 -0.526 . . . . 1.1699999999999999 109.58 -178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 53.9 mtt180 -128.58 153.32 47.35 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.708 1.744 . . . . 1.9399999999999999 115.708 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.7 OUTLIER -129.73 112.32 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-N 115.545 -0.752 . . . . 1.29 112.758 176.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.47 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 63.39 27.05 15.18 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 126.864 2.066 . . . . 1.8200000000000001 114.157 -178.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.31 -19.35 40.13 Favored Glycine 0 CA--C 1.548 2.136 0 C-N-CA 121.463 -0.399 . . . . 0.32000000000000001 113.8 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.482 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 86.7 m-70 -83.79 156.91 22.28 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.654 1.582 . . . . 0.56999999999999995 114.454 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.49 131.29 53.84 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.375 0.607 . . . . 1.1899999999999999 111.094 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.2 -57.86 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 115.129 -0.942 . . . . 1.73 113.104 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.74 90.02 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.713 -0.847 . . . . 1.25 108.713 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -109.37 77.85 1.09 Allowed 'General case' 0 C--N 1.351 0.636 0 CA-C-O 122.835 1.303 . . . . 2.75 111.985 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 152.34 65.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 128.523 2.729 . . . . 2.48 107.868 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.0 tp -105.17 99.35 8.96 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 113.782 1.03 . . . . 1.78 113.782 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -113.32 107.05 15.35 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 113.24 -1.8 . . . . 2.3500000000000001 108.042 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.13 -33.25 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 114.542 1.312 . . . . 1.27 114.542 -177.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -75.13 -36.1 61.64 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 123.376 0.671 . . . . 0.83999999999999997 112.242 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -74.71 -27.46 60.39 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 124.436 1.094 . . . . 0.91000000000000003 113.27 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.69 -56.93 4.17 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.163 0.801 . . . . 2.98 113.163 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.9 -40.68 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 113.753 1.019 . . . . 1.53 113.753 177.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.45 -64.09 0.3 Allowed Glycine 0 C--N 1.361 1.935 0 N-CA-C 114.353 0.501 . . . . 0.84999999999999998 114.353 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -103.26 174.2 5.97 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.316 1.046 . . . . 3.9700000000000002 111.634 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -73.35 89.86 1.63 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 123.543 0.737 . . . . 2.0800000000000001 112.249 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.8 p -141.02 -146.25 0.19 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.115 0.966 . . . . 1.22 109.209 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.94 134.8 54.6 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 113.475 0.917 . . . . 1.2 113.475 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 10.4 t60 -110.75 145.79 37.47 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.884 0.474 . . . . 0.41999999999999998 109.77 177.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -145.33 143.97 30.46 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.881 1.067 . . . . 2.5 113.881 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -137.43 125.71 23.21 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 114.293 -1.321 . . . . 1.5800000000000001 110.471 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.45 121.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 114.896 -1.047 . . . . 1.25 110.768 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.98 99.45 15.05 Favored Pre-proline 0 CA--C 1.571 1.759 0 CA-C-O 119.009 -0.52 . . . . 1.5 112.208 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -74.7 143.95 30.8 Favored 'Trans proline' 0 C--N 1.4 3.277 0 C-N-CA 123.052 2.501 . . . . 0.22 114.326 176.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -124.28 149.25 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 124.023 0.929 . . . . 1.1200000000000001 110.423 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.6 p -132.48 111.37 11.21 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.924 -0.58 . . . . 1.8600000000000001 112.349 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.4 mt -112.01 122.67 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 N-CA-C 108.492 -0.929 . . . . 1.0700000000000001 108.492 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -142.56 130.09 21.32 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.66 -0.7 . . . . 2.6400000000000001 110.873 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt 69.38 10.14 7.61 Favored 'General case' 0 N--CA 1.518 2.963 0 N-CA-C 114.677 1.362 . . . . 4.0199999999999996 114.677 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.66 18.45 23.11 Favored Glycine 0 CA--C 1.548 2.108 0 C-N-CA 123.738 0.685 . . . . 0.39000000000000001 114.384 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 95.4 mttt -128.25 151.09 49.69 Favored 'General case' 0 C--N 1.367 1.337 0 CA-C-N 117.978 0.889 . . . . 2.0299999999999998 112.799 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.75 144.9 30.5 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.811 1.041 . . . . 1.0800000000000001 113.811 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.1 m -134.35 114.09 12.6 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.783 -1.099 . . . . 1.23 110.712 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.274 0.8 OUTLIER -114.54 96.12 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.568 0 CA-C-O 121.304 0.573 . . . . 1.1899999999999999 110.434 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 68.24 -85.34 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 125.41 1.484 . . . . 1.8200000000000001 113.594 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.08 26.74 4.16 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 115.969 -0.559 . . . . 0.51000000000000001 113.405 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -129.21 127.98 42.39 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.497 0.719 . . . . 1.8200000000000001 110.453 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.0 p -113.39 130.75 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.315 0 CA-C-O 121.649 0.738 . . . . 1.5900000000000001 111.772 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 m -148.65 178.58 8.51 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.946 -1.025 . . . . 1.1699999999999999 109.735 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.27 13.4 t -103.34 137.61 41.22 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 113.366 0.876 . . . . 1.71 113.366 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -84.14 123.44 30.08 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.243 1.017 . . . . 0.29999999999999999 111.597 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.2 90.82 3.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.476 0.547 . . . . 1.8700000000000001 112.476 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.28 -64.64 3.15 Favored Glycine 0 C--N 1.359 1.816 0 N-CA-C 118.847 2.299 . . . . 0.91000000000000003 118.847 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.514 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -129.75 158.03 40.52 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.442 1.275 . . . . 1.6799999999999999 114.442 -176.246 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.514 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -106.98 138.97 42.13 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 113.285 -1.779 . . . . 1.3700000000000001 109.269 177.032 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 t -121.23 143.97 48.86 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.567 1.692 . . . . 0.94999999999999996 115.567 -177.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.26 98.2 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.308 -1.367 . . . . 1.3799999999999999 107.308 175.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -118.29 124.91 48.97 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.334 0.588 . . . . 1.6699999999999999 112.407 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.0 133.39 56.07 Favored 'General case' 0 C--O 1.252 1.211 0 CA-C-O 122.22 1.009 . . . . 2.2999999999999998 111.482 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.4 t -106.36 143.91 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 113.094 -1.867 . . . . 1.29 110.442 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.64 150.53 24.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.539 1.311 . . . . 2.6200000000000001 114.539 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.93 -51.78 0.99 Allowed Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.055 -0.975 . . . . 1.0600000000000001 113.928 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -129.49 -84.46 0.55 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.912 0.356 . . . . 3.1000000000000001 111.739 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.506 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 0.4 OUTLIER -140.64 122.7 15.64 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.984 0.514 . . . . 4.0800000000000001 110.224 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 0.9 OUTLIER 85.54 114.94 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 C-N-CA 124.975 1.31 . . . . 1.74 111.064 -177.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -82.32 -172.26 0.35 Allowed Pre-proline 0 CA--C 1.574 1.876 0 C-N-CA 124.536 1.134 . . . . 1.6799999999999999 110.464 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -61.64 101.06 0.2 Allowed 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 122.247 1.965 . . . . 2.8199999999999998 111.994 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.422 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 67.3 tttt -59.56 -49.42 77.83 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.199 1.926 . . . . 3.4100000000000001 116.199 -174.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.8 t -108.43 131.88 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.777 -0.823 . . . . 1.3799999999999999 108.777 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.4 t -136.88 124.18 21.89 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.639 -1.164 . . . . 1.75 112.094 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 60' ' ' LEU 0.267 . . -119.84 48.32 1.57 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.897 1.814 . . . . 1.1299999999999999 115.897 -177.235 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.83 135.53 2.28 Favored 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.489 2.033 . . . . 1.3999999999999999 116.489 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -152.43 106.42 3.12 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.376 -0.829 . . . . 0.26000000000000001 110.974 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 12' ' ' TRP 0.294 9.9 tt -115.72 122.68 69.96 Favored 'Isoleucine or valine' 0 C--O 1.27 2.15 0 CA-C-O 122.16 0.981 . . . . 1.1000000000000001 111.147 175.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -120.42 167.83 11.94 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.322 -1.308 . . . . 1.0600000000000001 111.859 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -118.58 145.63 45.23 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 117.813 2.523 . . . . 1.8300000000000001 117.813 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.42 -40.99 2.28 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 110.672 -2.967 . . . . 0.17000000000000001 120.151 172.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.71 160.92 2.0 Favored 'General case' 0 N--CA 1.518 2.932 0 CA-C-N 121.265 2.533 . . . . 1.05 113.587 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.37 -10.06 59.75 Favored 'General case' 0 CA--C 1.583 2.212 0 C-N-CA 124.994 1.318 . . . . 0.98999999999999999 114.126 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.1 1.64 52.31 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.234 1.198 . . . . 0.55000000000000004 114.234 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.594 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -107.05 -10.84 15.8 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.467 0.914 . . . . 0.59999999999999998 113.467 179.46 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.0 93.35 0.53 Allowed Pre-proline 0 N--CA 1.507 2.379 0 C-N-CA 124.119 0.968 . . . . 1.1799999999999999 112.424 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.594 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 68.7 Cg_endo -92.75 144.56 2.44 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 122.673 2.249 . . . . 2.0299999999999998 114.428 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 24.1 mmt -129.38 122.16 28.9 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.825 -0.625 . . . . 5.3399999999999999 111.785 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -118.28 179.64 4.05 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.985 0.898 . . . . 4.0 112.54 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -105.91 155.97 37.44 Favored Pre-proline 0 CA--C 1.558 1.276 0 CA-C-N 114.91 -1.041 . . . . 6.7000000000000002 110.539 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.96 120.45 7.35 Favored 'Trans proline' 0 C--N 1.393 2.877 0 C-N-CA 122.227 1.951 . . . . 6.9400000000000004 115.041 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -137.71 137.26 21.33 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-N 114.807 -1.088 . . . . 5.5099999999999998 111.53 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -84.08 -152.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.639 0 C-N-CA 123.363 2.709 . . . . 7.1600000000000001 113.326 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 166.96 -126.88 1.5 Allowed Glycine 0 C--N 1.341 0.861 0 C-N-CA 120.379 -0.915 . . . . 7.0199999999999996 114.229 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.2 mt -118.21 108.55 15.29 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.18 -0.51 . . . . 9.3000000000000007 111.744 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.334 -0.841 . . . . 10.6 111.017 179.967 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.486 -0.246 . . . . 9.3599999999999994 112.486 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.77 -37.7 5.58 Favored 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 112.969 0.729 . . . . 6.8499999999999996 112.969 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -129.22 106.24 8.7 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 122.624 0.37 . . . . 8.0 111.06 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.4 m -133.7 -67.86 0.59 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.965 -0.561 . . . . 4.1500000000000004 112.403 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.62 95.25 0.1 OUTLIER Glycine 0 C--N 1.348 1.231 0 C-N-CA 121.312 -0.471 . . . . 1.6000000000000001 113.271 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.9 tp -87.86 -48.72 7.59 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 123.895 0.878 . . . . 1.0900000000000001 113.036 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.28 -22.91 63.68 Favored 'General case' 0 N--CA 1.508 2.462 0 C-N-CA 125.925 1.69 . . . . 1.04 115.249 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -11.53 51.11 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 113.792 1.034 . . . . 0.32000000000000001 113.792 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -108.9 -19.37 13.42 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 113.728 1.01 . . . . 2.2599999999999998 113.728 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.41 138.26 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 N-CA-C 115.142 1.534 . . . . 1.01 115.142 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -122.32 -30.33 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 115.717 -0.674 . . . . 1.0600000000000001 112.44 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.51 ' O ' HG23 ' A' ' 172' ' ' ILE . 68.0 t90 -162.02 116.29 1.88 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 120.815 0.34 . . . . 0.67000000000000004 111.07 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.07 135.57 35.95 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.397 -0.815 . . . . 1.0800000000000001 111.526 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.269 5.3 p -148.17 146.15 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 N-CA-C 114.571 1.323 . . . . 1.6699999999999999 114.571 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.578 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 1.9 t-20 -116.9 107.91 15.17 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.168 -1.378 . . . . 2.6400000000000001 108.145 175.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.609 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . . . -76.6 102.11 5.98 Favored 'General case' 0 C--O 1.268 2.078 0 CA-C-O 122.246 1.022 . . . . 1.28 111.668 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.469 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 153.98 -1.66 0.22 Allowed Glycine 0 C--N 1.353 1.5 0 CA-C-N 111.561 -2.563 . . . . 0.70999999999999996 115.998 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.51 -141.43 3.13 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 118.91 1.355 . . . . 0.87 114.705 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -147.25 116.67 7.01 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 112.485 0.55 . . . . 2.1200000000000001 112.485 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.709 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 2.3 m 35.54 123.18 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.877 0 N-CA-C 121.087 3.736 . . . . 1.5 121.087 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -154.2 150.21 27.85 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.662 0.744 . . . . 0.52000000000000002 111.768 175.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.56 128.22 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 115.361 -0.836 . . . . 2.0699999999999998 111.71 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -85.73 153.36 22.38 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 113.994 -1.457 . . . . 1.8500000000000001 110.157 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.1 m -44.04 -22.77 0.15 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 118.956 2.947 . . . . 1.3700000000000001 118.956 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -94.19 -21.55 18.99 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 123.004 0.522 . . . . 0.56999999999999995 111.103 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.58 39.21 1.12 Allowed Glycine 0 C--N 1.353 1.501 0 C-N-CA 124.4 1.0 . . . . 0.37 114.43 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 mm -105.98 119.68 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 109.239 -0.652 . . . . 1.25 109.239 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -100.66 130.92 46.77 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.179 1.177 . . . . 1.71 114.179 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.709 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -96.33 140.45 30.98 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.985 -1.007 . . . . 3.1499999999999999 110.604 177.398 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -83.6 176.42 9.02 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 115.856 1.798 . . . . 3.5099999999999998 115.856 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -107.53 96.97 6.78 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.83 1.789 . . . . 2.8100000000000001 115.83 -175.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.695 ' HB3' ' O ' ' A' ' 37' ' ' ARG . 0.4 OUTLIER 46.95 58.6 17.02 Favored Pre-proline 0 N--CA 1.52 3.036 0 N-CA-C 117.701 2.482 . . . . 1.1699999999999999 117.701 175.678 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -107.73 56.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.654 0 C-N-CA 122.62 2.213 . . . . 1.45 115.93 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.73 -87.35 0.33 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 116.718 -0.219 . . . . 2.2400000000000002 111.171 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 12.6 pt-20 -156.6 88.51 1.06 Allowed 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.107 1.151 . . . . 4.8399999999999999 114.107 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.3 58.26 Favored Glycine 0 CA--C 1.541 1.717 0 N-CA-C 116.362 1.305 . . . . 2.9700000000000002 116.362 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.695 ' O ' ' HB3' ' A' ' 32' ' ' ASP . 4.2 ptp180 -122.81 84.4 2.26 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 117.622 0.711 . . . . 4.79 112.828 -175.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.77 114.3 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.156 0.503 . . . . 3.1499999999999999 111.761 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.25 46.82 3.72 Favored Glycine 0 CA--C 1.544 1.878 0 N-CA-C 115.569 0.988 . . . . 2.7200000000000002 115.569 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -157.58 118.92 3.61 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.862 0.831 . . . . 5.9500000000000002 112.188 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.26 129.74 54.84 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.689 0.796 . . . . 1.78 110.846 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.4 p -115.1 82.62 1.77 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.582 0.706 . . . . 1.6599999999999999 112.062 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -116.56 97.28 5.92 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.094 -0.957 . . . . 2.3300000000000001 110.253 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -102.73 69.15 1.06 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.431 0.634 . . . . 3.3300000000000001 111.508 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.08 93.86 1.06 Allowed Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.291 -0.868 . . . . 1.7 112.956 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.0 mtt -92.4 0.99 57.49 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.22 0.822 . . . . 2.0800000000000001 113.22 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 27.25 3.64 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 114.366 1.247 . . . . 4.6200000000000001 114.366 -178.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.27 67.93 61.61 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 107.434 -1.321 . . . . 3.1600000000000001 107.434 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -77.11 178.03 8.14 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 123.746 2.964 . . . . 1.8600000000000001 116.053 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.257 1.1 mp -97.18 136.9 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.23 0 CA-C-N 114.6 -1.182 . . . . 1.28 109.726 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.7 mt -89.73 -12.27 39.89 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 116.381 1.993 . . . . 1.9299999999999999 116.381 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -100.48 15.86 26.53 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.87 1.063 . . . . 1.79 113.87 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -132.62 -165.46 1.6 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.29 0.636 . . . . 1.49 111.433 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.18 174.09 3.68 Favored Pre-proline 0 N--CA 1.505 2.31 0 C-N-CA 123.087 0.555 . . . . 1.6799999999999999 111.583 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -70.2 -28.14 23.51 Favored 'Trans proline' 0 C--N 1.401 3.32 0 C-N-CA 123.164 2.576 . . . . 1.1599999999999999 113.797 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.05 -37.22 19.12 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.954 0.902 . . . . 2.04 112.712 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.0 8.78 42.77 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.171 1.175 . . . . 1.6200000000000001 114.171 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -72.75 -26.21 61.47 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 123.751 0.82 . . . . 2.4300000000000002 110.606 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.1 t -68.86 -50.55 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 C-N-CA 126.458 1.903 . . . . 1.46 108.226 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.578 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 7.9 tp -74.39 -9.67 58.82 Favored 'General case' 0 C--N 1.383 2.047 0 N-CA-C 114.013 1.116 . . . . 1.6699999999999999 114.013 176.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -108.08 1.08 22.1 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.336 0.655 . . . . 1.3300000000000001 110.854 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -128.26 -115.0 0.26 Allowed 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.395 1.078 . . . . 1.4099999999999999 110.849 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.2 p 35.32 134.16 0.0 OUTLIER 'General case' 1 N--CA 1.56 5.06 0 C-N-CA 128.342 2.657 . . . . 1.28 117.928 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 5.8 pt-20 -113.39 132.95 55.42 Favored 'General case' 0 N--CA 1.516 2.873 0 N-CA-C 116.974 2.213 . . . . 1.53 116.974 -176.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.609 ' CZ ' ' HA ' ' A' ' 16' ' ' ALA . 7.5 ttm180 -123.79 95.77 4.7 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.679 -1.23 . . . . 3.8300000000000001 107.679 175.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -106.46 138.6 42.35 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.94 1.089 . . . . 3.7599999999999998 113.94 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -120.52 -87.72 0.63 Allowed 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 114.971 -1.013 . . . . 5.3700000000000001 110.747 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -164.9 -57.35 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 113.751 1.019 . . . . 2.5499999999999998 113.751 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -170.65 125.0 0.7 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.866 0.466 . . . . 2.1499999999999999 111.839 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 t 66.67 83.7 0.16 Allowed 'General case' 0 N--CA 1.506 2.331 0 C-N-CA 124.907 1.283 . . . . 1.25 113.006 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -141.92 138.5 32.07 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 121.605 0.717 . . . . 1.1499999999999999 111.929 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.69 -167.63 15.7 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.603 1.401 . . . . 0.59999999999999998 116.603 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.1 172.27 8.68 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 113.499 -1.351 . . . . 1.4099999999999999 113.986 -177.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -128.22 134.14 48.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.399 -1.273 . . . . 0.51000000000000001 112.219 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.32 103.54 22.7 Favored Pre-proline 0 CA--C 1.567 1.607 0 C-N-CA 123.326 0.65 . . . . 1.0600000000000001 109.499 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -84.57 120.1 2.38 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.233 1.955 . . . . 0.17999999999999999 114.783 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.84 160.16 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 CA-C-O 121.977 0.894 . . . . 1.0600000000000001 111.232 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -149.3 24.05 0.91 Allowed 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 114.748 -1.115 . . . . 3.1099999999999999 111.867 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -130.09 161.66 30.54 Favored 'General case' 0 C--N 1.364 1.238 0 CA-C-O 121.296 0.57 . . . . 2.1200000000000001 111.5 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -120.34 144.33 47.91 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.799 1.037 . . . . 0.41999999999999998 113.799 -178.821 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.29 -139.53 6.08 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 114.117 -1.401 . . . . 0.25 112.596 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 80.9 mm-40 -113.65 105.0 12.8 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-N 118.092 0.946 . . . . 1.75 110.963 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -99.52 128.27 45.62 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.124 0.488 . . . . 0.90000000000000002 110.895 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -112.34 123.66 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.346 0.593 . . . . 1.0700000000000001 110.755 -176.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.5 tt -110.27 108.38 18.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.923 -1.035 . . . . 1.47 110.069 178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.25 132.26 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 114.199 -1.364 . . . . 1.27 108.557 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.21 140.79 47.73 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 115.514 -0.766 . . . . 1.8899999999999999 112.394 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 tptt -104.01 113.33 26.8 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.043 -0.98 . . . . 2.8999999999999999 109.657 177.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -106.84 134.68 49.61 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.685 -0.689 . . . . 0.48999999999999999 111.146 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.76 148.05 38.34 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.4 0.619 . . . . 1.1000000000000001 111.24 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -132.36 117.9 18.71 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 116.171 -0.468 . . . . 2.6099999999999999 111.228 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.08 69.02 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 116.179 -0.464 . . . . 2.6099999999999999 112.048 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.39 -49.11 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.899 0.479 . . . . 2.71 111.995 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -123.14 129.64 51.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.711 0.404 . . . . 1.6899999999999999 111.143 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.83 105.46 15.5 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 122.194 0.997 . . . . 1.4299999999999999 112.421 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -162.69 144.82 10.58 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.009 -0.996 . . . . 2.9700000000000002 112.179 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.9 m -122.8 125.68 45.94 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.495 -0.775 . . . . 1.6599999999999999 112.595 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 70.48 49.75 0.41 Allowed 'General case' 0 N--CA 1.515 2.777 0 C-N-CA 125.553 1.541 . . . . 2.02 112.473 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -148.66 -45.72 0.15 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.679 1.192 . . . . 2.5600000000000001 109.565 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.98 87.54 2.53 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.679 -0.86 . . . . 3.1499999999999999 108.679 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.93 120.81 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 114.048 -1.433 . . . . 1.3600000000000001 110.743 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.437 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 45.5 m-85 -101.02 177.37 4.97 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.417 1.636 . . . . 0.84999999999999998 115.417 -175.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -128.21 136.9 51.71 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.214 0.531 . . . . 1.3300000000000001 111.483 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.95 126.09 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.448 0 CA-C-N 115.689 -0.687 . . . . 1.1699999999999999 109.994 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -132.43 151.34 51.92 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.083 1.512 . . . . 1.9399999999999999 115.083 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 154' ' ' SER . 1.2 m -125.08 113.32 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 C-N-CA 124.357 1.063 . . . . 1.29 112.754 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.503 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 64.69 25.85 13.08 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 126.69 1.996 . . . . 1.8200000000000001 113.614 -178.326 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.99 -3.63 60.52 Favored Glycine 0 CA--C 1.555 2.577 0 CA-C-N 116.168 -0.469 . . . . 0.32000000000000001 114.099 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.48 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 86.0 m-70 -99.56 139.61 34.96 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 125.65 1.58 . . . . 0.56999999999999995 112.951 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.33 130.51 40.61 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.879 0.847 . . . . 1.1899999999999999 113.075 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.09 -56.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 114.0 -1.454 . . . . 1.73 112.606 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.43 88.6 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.242 -1.022 . . . . 1.25 108.242 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -109.17 95.1 5.41 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 123.094 1.426 . . . . 2.75 111.964 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 127.96 71.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 129.619 3.168 . . . . 2.48 107.865 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.26 103.41 15.26 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-O 121.863 0.839 . . . . 1.78 112.481 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -111.59 94.71 5.1 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 113.538 -1.664 . . . . 2.3500000000000001 107.647 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -63.52 -28.73 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.496 0 C-N-CA 125.046 1.339 . . . . 1.27 114.465 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -77.69 -37.08 50.42 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.31 0.644 . . . . 0.83999999999999997 112.469 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -74.45 -27.13 60.46 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 124.594 1.158 . . . . 0.91000000000000003 113.836 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -86.65 -50.57 6.7 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.455 0.909 . . . . 2.98 113.455 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.282 1.4 p -91.53 -38.76 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.966 0 N-CA-C 113.383 0.883 . . . . 1.53 113.383 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.37 -78.81 0.25 Allowed Glycine 0 C--N 1.36 1.883 0 CA-C-N 118.444 0.566 . . . . 0.84999999999999998 114.497 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -102.92 174.75 5.73 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.1 0.96 . . . . 3.9700000000000002 112.507 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.7 m -74.18 81.14 1.79 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.723 1.009 . . . . 2.0800000000000001 113.723 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 34.9 p -133.01 -137.49 0.18 Allowed 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 114.441 -1.254 . . . . 1.22 109.032 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -115.01 131.55 56.89 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.046 0.758 . . . . 1.2 113.046 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -105.48 147.93 27.77 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.446 -0.576 . . . . 0.41999999999999998 109.446 176.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -142.49 129.86 21.14 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.663 1.357 . . . . 2.5 114.663 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -123.77 123.92 41.55 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.737 -1.12 . . . . 1.5800000000000001 110.661 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.49 120.88 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-N 114.488 -1.233 . . . . 1.25 110.899 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.62 99.99 15.22 Favored Pre-proline 0 CA--C 1.569 1.702 0 CA-C-O 119.024 -0.512 . . . . 1.5 111.976 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -75.05 142.6 27.89 Favored 'Trans proline' 0 C--N 1.398 3.177 0 C-N-CA 123.082 2.521 . . . . 0.22 114.2 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.17 149.48 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 CA-C-N 115.125 -0.943 . . . . 1.1200000000000001 109.971 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.9 t -136.0 117.16 14.44 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.502 0.668 . . . . 1.8600000000000001 111.365 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.4 mt -113.93 125.5 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 CA-C-N 114.713 -1.131 . . . . 1.0700000000000001 108.286 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -138.97 124.33 19.25 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.599 -0.728 . . . . 2.6400000000000001 110.567 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 67.61 17.1 9.93 Favored 'General case' 0 N--CA 1.517 2.902 0 C-N-CA 125.341 1.456 . . . . 4.0199999999999996 114.121 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.51 13.18 45.48 Favored Glycine 0 CA--C 1.547 2.038 0 CA-C-O 119.203 -0.776 . . . . 0.39000000000000001 114.936 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 52.8 mtpt -122.03 147.44 46.08 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-N 118.378 1.089 . . . . 2.0299999999999998 112.656 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.99 145.31 29.45 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.46 1.281 . . . . 1.0800000000000001 114.46 -175.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.83 114.32 10.34 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.689 -1.142 . . . . 1.23 109.987 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.262 9.9 p -119.36 95.82 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.446 0 CA-C-O 121.287 0.565 . . . . 1.1899999999999999 111.357 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 67.88 -85.47 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 125.646 1.578 . . . . 1.8200000000000001 113.757 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.25 25.32 5.75 Favored Glycine 0 CA--C 1.543 1.813 0 CA-C-N 116.005 -0.543 . . . . 0.51000000000000001 112.999 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -125.27 141.18 52.24 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.856 0.862 . . . . 1.8200000000000001 111.376 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.6 p -130.7 124.85 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.132 0 CA-C-N 115.669 -0.696 . . . . 1.5900000000000001 110.896 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -150.69 179.86 7.84 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.247 -0.888 . . . . 1.1699999999999999 109.848 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.269 15.2 t -103.93 137.65 41.62 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 113.203 0.816 . . . . 1.71 113.203 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -81.82 122.9 28.29 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.112 0.965 . . . . 0.29999999999999999 111.66 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.95 91.4 3.2 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.707 0.632 . . . . 1.8700000000000001 112.707 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.58 -65.33 3.45 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 118.79 2.276 . . . . 0.91000000000000003 118.79 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.526 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -132.44 158.45 42.0 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.143 1.164 . . . . 1.6799999999999999 114.143 -176.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.526 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -108.26 138.83 43.88 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.242 -1.799 . . . . 1.3700000000000001 109.097 176.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.6 t -120.5 143.11 48.72 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.301 1.593 . . . . 0.94999999999999996 115.301 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.62 99.42 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.348 -0.982 . . . . 1.3799999999999999 108.348 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.79 128.37 56.38 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.631 -0.713 . . . . 1.6699999999999999 112.847 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -118.79 125.81 50.43 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-O 122.198 0.999 . . . . 2.2999999999999998 111.103 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.32 144.08 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 113.323 -1.762 . . . . 1.29 110.699 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.29 150.28 21.13 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 113.102 0.778 . . . . 2.6200000000000001 113.102 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.69 -32.97 6.31 Favored Glycine 0 CA--C 1.547 2.053 0 N-CA-C 115.937 1.135 . . . . 1.0600000000000001 115.937 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -123.5 -78.63 0.6 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.977 0.889 . . . . 3.1000000000000001 112.412 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -133.16 -44.35 0.85 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.113 0.565 . . . . 4.0800000000000001 112.132 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.437 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -94.88 158.08 15.64 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.462 1.105 . . . . 1.74 112.447 179.383 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.74 -166.58 0.1 OUTLIER Pre-proline 0 CA--C 1.576 1.97 0 CA-C-N 113.679 -1.601 . . . . 1.6799999999999999 108.334 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -62.51 -9.78 16.88 Favored 'Trans proline' 0 N--CA 1.523 3.217 0 CA-C-N 123.277 2.206 . . . . 2.8199999999999998 115.85 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.6 tttp 79.65 -76.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.639 1.976 . . . . 3.4100000000000001 114.013 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . 0.259 3.8 m -108.4 135.24 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-N 119.678 1.126 . . . . 1.3799999999999999 111.278 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.437 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.5 t -127.8 132.06 49.52 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 113.105 0.78 . . . . 1.75 113.105 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 60' ' ' LEU . . . -119.45 49.83 1.31 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.212 2.301 . . . . 1.1299999999999999 117.212 -175.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.27 138.81 2.9 Favored 'General case' 0 N--CA 1.518 2.965 0 N-CA-C 117.039 2.237 . . . . 1.3999999999999999 117.039 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -154.69 101.99 2.35 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.476 -0.784 . . . . 0.26000000000000001 111.038 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.51 HG23 ' O ' ' A' ' 12' ' ' TRP 0.32 9.0 tt -111.97 121.7 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 CA-C-O 122.456 1.122 . . . . 1.1000000000000001 111.369 175.554 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -124.12 164.27 19.79 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.017 -1.447 . . . . 1.0600000000000001 110.74 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -121.73 159.21 27.09 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 118.225 2.676 . . . . 1.8300000000000001 118.225 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.85 -41.48 2.14 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-N 110.043 -3.253 . . . . 0.17000000000000001 118.998 174.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -177.44 154.73 1.03 Allowed 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 120.673 2.236 . . . . 1.05 113.425 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.14 -12.48 59.22 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 125.053 1.341 . . . . 0.98999999999999999 113.896 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.22 4.9 44.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.959 1.096 . . . . 0.55000000000000004 113.959 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.82 -16.22 14.37 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 114.065 1.135 . . . . 0.59999999999999998 114.065 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.75 149.39 74.23 Favored Pre-proline 0 CA--C 1.581 2.146 0 C-N-CA 124.108 0.963 . . . . 1.1799999999999999 112.851 178.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.64 119.53 6.71 Favored 'Trans proline' 0 N--CA 1.521 3.093 0 C-N-CA 125.133 3.889 . . . . 2.0299999999999998 116.334 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 21.2 mmt -141.92 102.71 4.2 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.788 -0.642 . . . . 5.3399999999999999 110.819 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.0 mt -136.73 171.66 14.16 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 122.114 0.959 . . . . 4.0 112.941 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -106.28 158.04 33.51 Favored Pre-proline 0 CA--C 1.559 1.292 0 CA-C-N 114.497 -1.229 . . . . 6.7000000000000002 110.71 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.56 121.85 8.98 Favored 'Trans proline' 0 C--N 1.394 2.937 0 C-N-CA 122.607 2.204 . . . . 6.9400000000000004 115.23 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -136.33 136.86 23.03 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-N 114.993 -1.003 . . . . 5.5099999999999998 111.483 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -84.5 -154.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 123.399 2.733 . . . . 7.1600000000000001 113.779 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 166.15 -129.75 2.0 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 120.82 -0.705 . . . . 7.0199999999999996 113.908 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.2 mt -118.52 112.66 20.2 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.83 0.452 . . . . 9.3000000000000007 111.656 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.351 -0.833 . . . . 10.6 111.173 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.522 -0.231 . . . . 9.3599999999999994 112.522 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.84 129.38 55.88 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.545 0.688 . . . . 6.8499999999999996 111.875 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 41.7 mtm -134.61 114.38 12.7 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.684 -0.689 . . . . 8.0 111.635 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -141.89 115.87 9.3 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.856 -0.611 . . . . 4.1500000000000004 111.629 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.01 89.41 0.07 OUTLIER Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.923 -0.581 . . . . 1.6000000000000001 113.204 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.3 tp -88.31 -44.34 10.88 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 113.356 0.872 . . . . 1.0900000000000001 113.356 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.17 -23.38 62.16 Favored 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 125.863 1.665 . . . . 1.04 115.087 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.72 -10.35 53.87 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 113.668 0.988 . . . . 0.32000000000000001 113.668 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -106.07 -22.02 12.98 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.315 0.858 . . . . 2.2599999999999998 113.315 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -53.21 135.65 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 N-CA-C 115.288 1.588 . . . . 1.01 115.288 177.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.6 -31.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-N 115.335 -0.848 . . . . 1.0600000000000001 112.161 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -159.33 117.46 2.81 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.888 0.475 . . . . 0.67000000000000004 110.751 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.86 128.96 20.87 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.482 -0.761 . . . . 1.0800000000000001 112.15 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.76 138.68 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 CA-C-O 122.331 1.062 . . . . 1.6699999999999999 113.183 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -116.17 102.56 9.7 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 113.373 -1.74 . . . . 2.6400000000000001 106.725 171.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.87 103.87 5.26 Favored 'General case' 0 C--O 1.254 1.34 0 CA-C-O 122.21 1.005 . . . . 1.28 111.363 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.408 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 172.54 -57.22 0.16 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 113.153 -1.84 . . . . 0.70999999999999996 114.937 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.95 -121.96 5.0 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 119.773 -0.459 . . . . 0.87 113.506 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.62 ' HA ' ' HH ' ' A' ' 29' ' ' TYR . 46.0 mt-10 -165.05 117.81 1.21 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.598 0.759 . . . . 2.1200000000000001 110.809 178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 49.35 110.14 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.959 0 N-CA-C 118.406 2.743 . . . . 1.5 118.406 178.045 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 70.3 t60 -140.95 132.46 26.96 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.026 0.751 . . . . 0.52000000000000002 113.026 177.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.272 9.8 p -105.95 116.04 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.881 0 CA-C-N 115.178 -0.919 . . . . 2.0699999999999998 109.531 176.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -87.62 160.94 17.97 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 114.684 -1.143 . . . . 1.8500000000000001 112.577 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -43.17 -32.05 0.55 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 N-CA-C 119.163 3.023 . . . . 1.3700000000000001 119.163 -175.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -88.37 -19.66 26.33 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 121.227 0.537 . . . . 0.56999999999999995 111.474 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.61 40.13 1.25 Allowed Glycine 0 C--N 1.354 1.551 0 C-N-CA 124.722 1.153 . . . . 0.37 114.009 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.7 mm -106.84 114.49 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-O 121.124 0.487 . . . . 1.25 110.088 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.8 t-160 -104.45 132.63 50.49 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 115.587 1.699 . . . . 1.71 115.587 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.62 ' HH ' ' HA ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -92.84 143.83 25.88 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 114.733 -1.121 . . . . 3.1499999999999999 108.135 174.259 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.404 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 78.7 mtp180 -62.42 -105.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 116.9 2.185 . . . . 3.5099999999999998 116.9 -177.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 30' ' ' ARG . 7.0 ttmm 176.23 71.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.549 0.74 . . . . 2.8100000000000001 111.712 -177.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 56.98 61.68 6.47 Favored Pre-proline 0 N--CA 1.534 3.732 0 C-N-CA 124.196 0.998 . . . . 1.1699999999999999 113.677 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -92.69 16.62 1.33 Allowed 'Trans proline' 0 CA--C 1.56 1.776 0 N-CA-C 120.154 3.098 . . . . 1.45 120.154 -174.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.313 0.0 OUTLIER -126.56 -41.33 1.87 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 120.505 1.502 . . . . 2.2400000000000002 114.431 178.203 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -126.89 105.0 8.33 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-N 119.275 0.943 . . . . 4.8399999999999999 112.184 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.3 -32.77 6.24 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-N 114.09 -1.414 . . . . 2.9700000000000002 113.564 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 74.69 -59.83 0.54 Allowed 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 126.679 1.992 . . . . 4.79 114.716 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.08 117.32 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.176 0.59 . . . . 3.1499999999999999 110.562 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.61 -120.09 0.61 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 121.084 -0.579 . . . . 2.7200000000000002 113.932 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -137.88 -177.36 4.78 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 121.889 0.852 . . . . 5.9500000000000002 112.771 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.09 133.38 40.43 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.207 1.003 . . . . 1.78 111.99 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 m -110.37 110.68 21.56 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.525 -0.761 . . . . 1.6599999999999999 111.046 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.7 103.24 5.15 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.721 -0.672 . . . . 2.3300000000000001 111.347 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -106.47 73.73 0.98 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.893 0.854 . . . . 3.3300000000000001 110.236 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 122.51 73.35 0.29 Allowed Glycine 0 C--N 1.344 1.004 0 CA-C-N 114.284 -1.325 . . . . 1.7 110.457 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.33 -0.02 57.41 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 115.609 1.707 . . . . 2.0800000000000001 115.609 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -116.29 57.9 0.76 Allowed 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 121.883 0.849 . . . . 4.6200000000000001 111.196 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.31 73.28 9.17 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 114.222 -1.354 . . . . 3.1600000000000001 107.63 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -67.73 164.09 32.72 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 123.673 2.916 . . . . 1.8600000000000001 117.048 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.65 143.12 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.201 0 CA-C-N 115.041 -0.981 . . . . 1.28 109.444 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.51 -23.52 46.26 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.463 1.653 . . . . 1.9299999999999999 115.463 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -106.27 20.81 18.4 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.917 1.08 . . . . 1.79 113.917 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.5 p -124.57 175.97 6.83 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.057 0.932 . . . . 1.49 112.913 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.62 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.2 m-20 -97.46 -174.8 0.4 Allowed Pre-proline 0 N--CA 1.507 2.377 0 N-CA-C 107.74 -1.208 . . . . 1.6799999999999999 107.74 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -70.16 -40.25 4.89 Favored 'Trans proline' 0 N--CA 1.518 2.946 0 CA-C-N 123.165 2.166 . . . . 1.1599999999999999 111.871 174.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -69.94 -50.98 36.6 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.266 -1.788 . . . . 2.04 111.982 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -75.93 -8.48 57.02 Favored 'General case' 0 CA--C 1.588 2.439 0 CA-C-N 114.789 -1.096 . . . . 1.6200000000000001 112.81 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.62 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 27.0 tt0 -72.42 -46.32 55.65 Favored 'General case' 0 C--N 1.378 1.835 0 C-N-CA 125.204 1.402 . . . . 2.4300000000000002 107.962 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.12 -41.68 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 C-N-CA 124.44 1.096 . . . . 1.46 110.417 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.93 -11.48 60.0 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.428 1.27 . . . . 1.6699999999999999 114.428 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -124.82 20.43 8.44 Favored 'General case' 0 CA--C 1.575 1.906 0 C-N-CA 123.332 0.653 . . . . 1.3300000000000001 112.494 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.581 HE21 HE21 ' A' ' 58' ' ' GLN . 0.0 OUTLIER -137.95 -27.82 0.89 Allowed 'General case' 0 N--CA 1.51 2.56 0 N-CA-C 115.876 1.806 . . . . 1.4099999999999999 115.876 -177.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.2 p -77.94 131.17 37.32 Favored 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 113.66 0.985 . . . . 1.28 113.66 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.408 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.6 pt-20 -118.3 140.28 50.06 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 115.5 1.667 . . . . 1.53 115.5 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -116.13 129.52 56.37 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.888 -1.051 . . . . 3.8300000000000001 111.495 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -125.56 131.44 52.74 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.117 -0.492 . . . . 3.7599999999999998 111.322 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -134.9 -73.87 0.47 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.285 0.846 . . . . 5.3700000000000001 113.285 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -134.96 -118.56 0.18 Allowed 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 113.124 0.787 . . . . 2.5499999999999998 113.124 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -155.01 129.0 8.77 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.911 0.885 . . . . 2.1499999999999999 110.407 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.648 ' H ' HD22 ' A' ' 164' ' ' ASN . 0.1 OUTLIER 74.8 80.86 0.11 Allowed 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 125.397 1.479 . . . . 1.25 109.895 -177.611 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -142.84 156.51 44.95 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.284 0.846 . . . . 1.1499999999999999 113.284 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.73 -161.16 12.48 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.28 -0.873 . . . . 0.59999999999999998 115.056 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.32 163.66 28.84 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.782 0.801 . . . . 1.4099999999999999 112.796 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -117.87 131.36 56.55 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.603 -1.18 . . . . 0.51000000000000001 112.791 -178.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -124.5 99.9 35.72 Favored Pre-proline 0 CA--C 1.566 1.588 0 C-N-CA 123.19 0.596 . . . . 1.0600000000000001 109.742 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.26 118.1 2.57 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.14 1.894 . . . . 0.17999999999999999 114.501 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.89 157.35 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 CA-C-O 122.063 0.935 . . . . 1.0600000000000001 111.369 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -144.97 16.15 1.56 Allowed 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.538 -1.21 . . . . 3.1099999999999999 111.954 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -128.29 162.47 26.96 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-O 121.334 0.588 . . . . 2.1200000000000001 111.754 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -120.95 148.8 43.59 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.665 0.987 . . . . 0.41999999999999998 113.665 -179.298 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.85 -134.16 3.9 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 113.981 -1.463 . . . . 0.25 111.839 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -121.99 106.66 11.42 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 118.335 1.067 . . . . 1.75 111.231 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.674 ' O ' HG13 ' A' ' 133' ' ' ILE . 36.2 m-85 -99.4 127.8 45.46 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.623 0.725 . . . . 0.90000000000000002 110.687 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.67 130.13 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 115.31 -0.859 . . . . 1.0700000000000001 111.848 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 mp -107.62 110.26 22.1 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.376 -1.283 . . . . 1.47 110.325 177.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.8 105.52 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.601 -1.259 . . . . 1.27 107.601 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.18 134.97 53.41 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.896 -0.593 . . . . 1.8899999999999999 112.314 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -104.31 116.01 31.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.806 0.813 . . . . 2.8999999999999999 111.343 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.67 134.04 48.5 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.067 -1.424 . . . . 0.48999999999999999 110.256 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.97 153.52 45.63 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.745 -0.661 . . . . 1.1000000000000001 111.627 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -139.54 131.58 27.92 Favored 'General case' 0 C--N 1.363 1.175 0 CA-C-N 116.031 -0.532 . . . . 2.6099999999999999 112.221 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.571 ' H ' ' HZ3' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -140.96 63.2 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 115.962 -0.563 . . . . 2.6099999999999999 111.75 179.213 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -162.65 -49.5 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.562 0.579 . . . . 2.71 112.562 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.79 130.84 56.92 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.051 0.453 . . . . 1.6899999999999999 112.212 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.29 96.11 5.93 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.339 1.066 . . . . 1.4299999999999999 111.016 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -162.31 146.65 12.18 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.148 -0.933 . . . . 2.9700000000000002 112.21 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.1 p -122.19 121.22 36.35 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.481 -0.782 . . . . 1.6599999999999999 111.903 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 75.12 57.26 0.07 Allowed 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 125.893 1.677 . . . . 2.02 112.543 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -156.71 -43.62 0.07 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.284 -1.326 . . . . 2.5600000000000001 108.983 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -105.41 83.89 2.02 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-O 121.794 0.807 . . . . 3.1499999999999999 108.98 176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.06 129.95 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 114.754 -1.112 . . . . 1.3600000000000001 111.63 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -114.37 170.99 7.89 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.065 1.505 . . . . 0.84999999999999998 115.065 -176.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.37 137.73 54.76 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.359 0.6 . . . . 1.3300000000000001 112.337 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -134.18 129.27 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.406 0 CA-C-N 115.34 -0.846 . . . . 1.1699999999999999 110.236 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.64 147.92 51.49 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 114.536 1.31 . . . . 1.9399999999999999 114.536 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.79 110.27 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 C-N-CA 123.73 0.812 . . . . 1.29 112.93 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.83 26.64 14.39 Favored 'General case' 0 N--CA 1.523 3.181 0 C-N-CA 126.614 1.966 . . . . 1.8200000000000001 113.618 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.93 -20.06 39.51 Favored Glycine 0 CA--C 1.547 2.07 0 CA-C-N 116.344 -0.389 . . . . 0.32000000000000001 113.676 -176.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -83.24 139.04 33.34 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.417 1.487 . . . . 0.56999999999999995 113.673 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.57 129.73 44.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.603 0.715 . . . . 1.1899999999999999 112.43 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.19 -54.41 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 114.501 -1.227 . . . . 1.73 113.355 -178.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.57 88.87 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.878 -0.786 . . . . 1.25 108.878 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -112.29 75.57 0.93 Allowed 'General case' 0 C--N 1.356 0.853 0 CA-C-O 123.709 1.718 . . . . 2.75 112.147 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 157.26 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 110.238 -3.165 . . . . 2.48 108.216 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.72 97.88 11.06 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 113.702 1.001 . . . . 1.78 113.702 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -113.52 96.54 5.93 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 113.073 -1.876 . . . . 2.3500000000000001 107.509 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.22 -26.06 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.56 0 N-CA-C 114.632 1.345 . . . . 1.27 114.632 -176.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -75.71 -39.8 56.75 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.576 0.75 . . . . 0.83999999999999997 112.003 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -74.03 -26.35 60.37 Favored 'General case' 0 CA--C 1.577 1.989 0 C-N-CA 124.776 1.23 . . . . 0.91000000000000003 113.17 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -77.98 -56.37 4.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.651 0.982 . . . . 2.98 113.651 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.76 -37.21 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 114.541 1.311 . . . . 1.53 114.541 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.76 -107.62 0.92 Allowed Glycine 0 C--N 1.354 1.528 0 CA-C-N 118.465 0.575 . . . . 0.84999999999999998 113.426 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -114.95 107.07 14.9 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.588 0.355 . . . . 3.9700000000000002 110.919 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.1 m 66.69 -127.89 0.21 Allowed 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 125.392 1.477 . . . . 2.0800000000000001 112.92 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 43.5 p 58.6 -163.32 0.21 Allowed 'General case' 0 N--CA 1.526 3.363 0 C-N-CA 126.365 1.866 . . . . 1.22 115.375 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -109.75 130.19 55.54 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.293 0.637 . . . . 1.2 112.69 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -104.44 135.57 45.62 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.436 -0.579 . . . . 0.41999999999999998 109.436 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -129.95 128.42 42.08 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.494 1.294 . . . . 2.5 114.494 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -115.01 118.03 32.27 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 114.699 -1.137 . . . . 1.5800000000000001 110.279 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 114.84 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 114.798 -1.092 . . . . 1.25 110.816 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.13 93.12 42.36 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-N 114.928 -1.033 . . . . 1.5 109.994 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -82.82 136.18 8.12 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.577 2.185 . . . . 0.22 113.27 176.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -120.95 149.93 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.626 0.727 . . . . 1.1200000000000001 112.228 -179.52 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.1 t -126.1 113.35 16.95 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.079 -0.964 . . . . 1.8600000000000001 110.959 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.472 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.9 mt -110.94 122.99 66.42 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.605 0 CA-C-N 114.237 -1.347 . . . . 1.0700000000000001 108.436 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -139.21 126.28 21.16 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.955 -0.566 . . . . 2.6400000000000001 111.068 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? 67.39 17.26 10.12 Favored 'General case' 0 N--CA 1.516 2.843 0 C-N-CA 125.312 1.445 . . . . 4.0199999999999996 114.324 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.64 12.68 46.73 Favored Glycine 0 CA--C 1.547 2.041 0 CA-C-O 119.147 -0.807 . . . . 0.39000000000000001 114.893 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 27.2 mtmt -123.06 148.97 45.01 Favored 'General case' 0 C--N 1.365 1.268 0 CA-C-N 118.35 1.075 . . . . 2.0299999999999998 112.432 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.19 144.93 30.68 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.635 1.346 . . . . 1.0800000000000001 114.635 -175.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.51 109.09 8.48 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.903 -1.044 . . . . 1.23 110.445 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.29 92.57 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.627 0 CA-C-N 115.808 -0.633 . . . . 1.1899999999999999 109.864 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 66.24 -82.1 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.784 0 C-N-CA 125.26 1.424 . . . . 1.8200000000000001 113.836 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.08 25.03 4.17 Favored Glycine 0 CA--C 1.545 1.969 0 CA-C-N 116.073 -0.512 . . . . 0.51000000000000001 113.869 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -130.48 118.42 21.1 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 117.339 0.569 . . . . 1.8200000000000001 110.053 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.1 p -105.91 131.45 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.32 0 CA-C-O 121.721 0.772 . . . . 1.5900000000000001 112.479 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 m -151.9 -178.69 6.9 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.776 -1.102 . . . . 1.1699999999999999 109.624 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.261 12.8 t -103.04 139.11 39.01 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 113.57 0.952 . . . . 1.71 113.57 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -80.83 123.89 28.63 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 124.534 1.134 . . . . 0.29999999999999999 111.427 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.47 90.49 3.23 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.647 0.61 . . . . 1.8700000000000001 112.647 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.69 -61.75 2.43 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 119.412 2.525 . . . . 0.91000000000000003 119.412 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.492 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -135.92 157.26 47.28 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.254 1.205 . . . . 1.6799999999999999 114.254 -176.14 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.492 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 1.0 OUTLIER -103.61 140.05 38.08 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 113.527 -1.67 . . . . 1.3700000000000001 109.598 176.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.4 t -122.02 132.25 54.42 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.306 1.225 . . . . 0.94999999999999996 114.306 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.41 97.55 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.021 -1.844 . . . . 1.3799999999999999 106.021 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.0 132.43 56.71 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.311 -1.313 . . . . 1.6699999999999999 113.001 -176.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.83 135.93 54.92 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-O 122.448 1.118 . . . . 2.2999999999999998 111.735 177.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.16 143.58 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-N 112.484 -2.144 . . . . 1.29 110.325 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 150.11 26.13 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.509 1.3 . . . . 2.6200000000000001 114.509 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.32 -47.01 1.17 Allowed Glycine 0 CA--C 1.543 1.84 0 CA-C-N 115.196 -0.911 . . . . 1.0600000000000001 114.035 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.3 -61.07 1.17 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.9 0.48 . . . . 3.1000000000000001 111.933 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -129.35 -43.57 1.28 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.757 0.651 . . . . 4.0800000000000001 112.757 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -107.92 173.81 6.16 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.509 0.724 . . . . 1.74 112.454 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.648 HD22 ' H ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -132.07 -58.27 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 CA-C-N 115.975 -0.557 . . . . 1.6799999999999999 109.994 178.638 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -101.56 -55.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.089 1.859 . . . . 2.8199999999999998 115.906 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.571 ' HZ3' ' H ' ' A' ' 92' ' ' VAL . 30.4 tttm 81.56 -90.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 127.076 2.15 . . . . 3.4100000000000001 109.616 -176.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.89 129.11 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 106.976 -1.491 . . . . 1.3799999999999999 106.976 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.01 123.28 19.36 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 112.98 0.733 . . . . 1.75 112.98 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -116.76 49.67 1.14 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.637 1.575 . . . . 1.1299999999999999 113.922 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.9 tp -61.47 102.23 0.23 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 122.653 1.216 . . . . 1.3999999999999999 113.576 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -113.78 100.56 8.55 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 112.556 -2.111 . . . . 0.26000000000000001 110.008 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.32 15.8 tt -108.34 121.78 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.155 0 CA-C-O 122.942 1.353 . . . . 1.1000000000000001 111.945 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -121.09 170.47 9.51 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 113.291 -1.777 . . . . 1.0600000000000001 111.284 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -123.23 158.5 30.73 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 118.45 2.759 . . . . 1.8300000000000001 118.45 -176.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.72 -41.95 2.01 Favored Glycine 0 CA--C 1.541 1.688 0 CA-C-N 110.465 -3.061 . . . . 0.17000000000000001 119.208 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.21 157.02 1.31 Allowed 'General case' 0 N--CA 1.515 2.816 0 CA-C-N 120.449 2.125 . . . . 1.05 112.942 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.03 -13.54 59.84 Favored 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 124.917 1.287 . . . . 0.98999999999999999 114.366 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.97 3.52 48.39 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 113.954 1.094 . . . . 0.55000000000000004 113.954 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.64 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -106.88 -7.6 17.02 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 113.815 1.043 . . . . 0.59999999999999998 113.815 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.51 91.51 0.43 Allowed Pre-proline 0 N--CA 1.51 2.544 0 C-N-CA 124.012 0.925 . . . . 1.1799999999999999 112.804 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.64 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 42.9 Cg_endo -96.14 147.4 1.2 Allowed 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.84 2.36 . . . . 2.0299999999999998 114.447 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.25 110.37 6.23 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.217 0.532 . . . . 5.3399999999999999 111.418 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.47 166.11 23.62 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.03 0.919 . . . . 4.0 112.636 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -106.42 161.57 22.43 Favored Pre-proline 0 CA--C 1.56 1.342 0 CA-C-N 114.729 -1.123 . . . . 6.7000000000000002 110.931 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.53 121.3 8.22 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 122.435 2.09 . . . . 6.9400000000000004 114.489 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -136.33 134.24 19.84 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-N 115.396 -0.82 . . . . 5.5099999999999998 111.279 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -84.99 -158.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 123.281 2.654 . . . . 7.1600000000000001 114.123 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 165.42 98.2 0.12 Allowed Glycine 0 C--N 1.34 0.753 0 C-N-CA 120.997 -0.62 . . . . 7.0199999999999996 113.216 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.7 tp -118.87 114.98 23.45 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.987 0.422 . . . . 9.3000000000000007 111.51 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.261 -0.876 . . . . 10.6 111.058 -179.848 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.551 -0.22 . . . . 9.3599999999999994 112.551 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.94 -36.61 5.84 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 113.02 0.748 . . . . 6.8499999999999996 113.02 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.4 ttt -131.64 106.62 8.28 Favored 'General case' 0 C--N 1.362 1.136 0 CA-C-O 120.932 0.396 . . . . 8.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -137.85 109.47 7.04 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.727 -0.669 . . . . 4.1500000000000004 111.442 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.81 86.53 0.07 OUTLIER Glycine 0 C--N 1.34 0.782 0 CA-C-N 115.649 -0.705 . . . . 1.6000000000000001 113.023 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.1 tp -87.94 -44.35 11.09 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 113.454 0.909 . . . . 1.0900000000000001 113.454 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.33 63.48 Favored 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 125.766 1.626 . . . . 1.04 115.105 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.06 -11.63 49.71 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 113.577 0.954 . . . . 0.32000000000000001 113.577 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -104.15 -23.9 13.23 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 113.298 0.851 . . . . 2.2599999999999998 113.298 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.62 134.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 115.166 1.543 . . . . 1.01 115.166 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -121.83 -29.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 115.354 -0.839 . . . . 1.0600000000000001 112.345 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.515 ' O ' HG23 ' A' ' 172' ' ' ILE . 70.8 t90 -161.43 116.9 2.09 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 117.698 0.226 . . . . 0.67000000000000004 111.502 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.42 135.08 31.68 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.258 -0.901 . . . . 1.0800000000000001 112.503 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 170' ' ' LEU 0.25 11.3 p -149.35 142.91 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 N-CA-C 113.756 1.021 . . . . 1.6699999999999999 113.756 178.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -116.02 117.96 31.56 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.198 -1.408 . . . . 2.6400000000000001 107.198 173.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -81.73 97.09 7.78 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-O 121.784 0.802 . . . . 1.28 111.251 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.554 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 173.4 -37.67 0.13 Allowed Glycine 0 C--N 1.353 1.486 0 CA-C-N 114.102 -1.408 . . . . 0.70999999999999996 116.541 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -135.65 -125.6 2.51 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 117.873 0.837 . . . . 0.87 114.318 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.518 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 34.8 mt-10 -150.13 116.34 5.7 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.812 0.445 . . . . 2.1200000000000001 111.701 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.703 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.2 m 31.69 124.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.121 0 N-CA-C 121.036 3.717 . . . . 1.5 121.036 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.415 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 23.3 t60 -149.89 148.51 29.22 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.853 0.835 . . . . 0.52000000000000002 112.092 176.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.2 126.6 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 114.916 -1.038 . . . . 2.0699999999999998 111.615 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -85.27 155.73 21.25 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 114.024 -1.443 . . . . 1.8500000000000001 110.234 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.5 m -44.8 -23.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 N-CA-C 118.943 2.942 . . . . 1.3700000000000001 118.943 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -95.57 -18.43 20.6 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 122.874 0.47 . . . . 0.56999999999999995 111.051 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.85 41.06 1.23 Allowed Glycine 0 C--N 1.356 1.668 0 C-N-CA 124.643 1.116 . . . . 0.37 114.462 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.2 mm -106.06 120.5 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 N-CA-C 109.516 -0.55 . . . . 1.25 109.516 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -102.25 129.18 48.59 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.256 1.206 . . . . 1.71 114.256 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.703 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.3 142.36 27.79 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.299 -0.864 . . . . 3.1499999999999999 110.596 177.024 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -88.12 168.43 12.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 115.662 1.727 . . . . 3.5099999999999998 115.662 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -98.91 100.25 11.41 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.19 1.552 . . . . 2.8100000000000001 115.19 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 36.73 62.46 3.11 Favored Pre-proline 1 N--CA 1.542 4.134 0 N-CA-C 115.85 1.796 . . . . 1.1699999999999999 115.85 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -90.02 28.03 0.45 Allowed 'Trans proline' 0 CA--C 1.564 2.016 0 N-CA-C 119.591 2.881 . . . . 1.45 119.591 -175.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -142.25 -15.22 0.77 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.429 1.27 . . . . 2.2400000000000002 114.429 176.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -103.51 55.45 0.74 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-N 118.863 0.756 . . . . 4.8399999999999999 112.808 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . 111.52 -28.69 9.3 Favored Glycine 0 CA--C 1.542 1.76 0 N-CA-C 114.488 0.555 . . . . 2.9700000000000002 114.488 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 2.0 mpp_? 81.7 67.8 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 126.014 1.725 . . . . 4.79 112.528 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 p -148.42 176.93 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.593 2.614 0 CA-C-N 115.115 -0.948 . . . . 3.1499999999999999 110.108 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -113.0 103.58 1.43 Allowed Glycine 0 C--N 1.349 1.27 0 O-C-N 122.094 -0.378 . . . . 2.7200000000000002 113.931 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -144.07 128.54 17.99 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.164 0.507 . . . . 5.9500000000000002 111.698 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.2 141.34 38.65 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.428 0.691 . . . . 1.78 111.806 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 3.2 m -120.32 -62.0 1.52 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.976 0.732 . . . . 1.6599999999999999 112.976 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 42' ' ' SER . 0.4 OUTLIER 84.28 -81.06 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.422 0 C-N-CA 125.386 1.475 . . . . 2.3300000000000001 113.041 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 70.82 55.45 0.24 Allowed 'General case' 0 N--CA 1.513 2.689 0 C-N-CA 125.533 1.533 . . . . 3.3300000000000001 112.615 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 122.44 81.42 0.57 Allowed Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.04 -0.982 . . . . 1.7 110.786 -177.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.12 0.22 57.46 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 115.326 1.602 . . . . 2.0800000000000001 115.326 -177.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -117.15 39.16 3.32 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-O 121.504 0.669 . . . . 4.6200000000000001 112.432 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 mt -146.09 74.66 13.07 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.587 1.155 . . . . 3.1600000000000001 107.979 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . 95.6 Cg_endo -78.82 176.73 9.53 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.284 2.656 . . . . 1.8600000000000001 116.335 -177.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.425 HG12 ' O ' ' A' ' 61' ' ' TYR 0.251 1.2 mp -89.74 135.64 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.823 0 C-N-CA 124.037 0.935 . . . . 1.28 111.711 -178.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 5.1 mt -104.84 101.93 11.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.901 -1.045 . . . . 1.9299999999999999 111.305 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER 150.12 -22.1 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.205 1.802 . . . . 1.79 110.891 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.421 ' OG ' ' HD2' ' A' ' 61' ' ' TYR . 2.3 t -101.27 -160.85 0.82 Allowed 'General case' 0 CA--C 1.575 1.929 0 C-N-CA 123.555 0.742 . . . . 1.49 113.0 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -95.51 170.32 7.95 Favored Pre-proline 0 CA--C 1.573 1.838 0 C-N-CA 124.736 1.214 . . . . 1.6799999999999999 112.569 -179.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -71.98 -34.82 7.99 Favored 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 123.25 2.633 . . . . 1.1599999999999999 112.835 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -85.25 -36.36 20.97 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.517 -1.22 . . . . 2.04 112.703 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.22 1.59 56.31 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.737 1.384 . . . . 1.6200000000000001 114.737 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.556 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 3.5 pt20 -71.19 -24.4 62.22 Favored 'General case' 0 C--N 1.381 1.945 0 O-C-N 121.822 -0.549 . . . . 2.4300000000000002 110.369 175.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.35 -47.29 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.872 0 C-N-CA 125.957 1.703 . . . . 1.46 108.853 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.1 tp -73.99 -12.85 60.76 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 113.435 0.902 . . . . 1.6699999999999999 113.435 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.425 ' O ' HG12 ' A' ' 50' ' ' ILE . 26.4 m-85 -122.47 20.53 10.37 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 113.557 0.947 . . . . 1.3300000000000001 113.557 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.556 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 12.1 tt0 -141.35 -36.48 0.44 Allowed 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 115.474 1.657 . . . . 1.4099999999999999 115.474 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.2 p -67.81 134.69 51.38 Favored 'General case' 0 N--CA 1.528 3.449 0 N-CA-C 115.272 1.582 . . . . 1.28 115.272 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.554 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 5.8 pt-20 -128.93 147.5 50.84 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 124.195 0.998 . . . . 1.53 112.479 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 32.7 mtm105 -89.13 -90.68 0.13 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 112.809 0.67 . . . . 3.8300000000000001 112.809 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -153.94 166.64 32.34 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.223 0.609 . . . . 3.7599999999999998 110.968 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.548 ' ND2' ' H ' ' A' ' 164' ' ' ASN . 8.6 m120 -116.6 131.01 57.06 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.158 0.799 . . . . 5.3700000000000001 113.158 -178.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -133.81 -109.37 0.23 Allowed 'General case' 0 CA--C 1.56 1.335 0 CA-C-N 115.634 -0.712 . . . . 2.5499999999999998 111.028 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.05 122.36 1.32 Allowed 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 118.364 0.529 . . . . 2.1499999999999999 111.334 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.24 85.01 0.09 Allowed 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 125.555 1.542 . . . . 1.25 114.397 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -143.52 152.94 42.08 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.531 0.682 . . . . 1.1499999999999999 112.242 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.24 -153.21 7.44 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 115.653 1.021 . . . . 0.59999999999999998 115.653 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.79 166.62 22.22 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 115.037 1.495 . . . . 1.4099999999999999 115.037 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.93 119.32 27.43 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.585 -1.643 . . . . 0.51000000000000001 111.144 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.48 100.36 53.49 Favored Pre-proline 0 CA--C 1.568 1.645 0 N-CA-C 109.581 -0.526 . . . . 1.0600000000000001 109.581 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -82.93 116.66 2.5 Favored 'Trans proline' 0 CA--C 1.563 1.926 0 C-N-CA 122.25 1.967 . . . . 0.17999999999999999 115.103 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.6 157.46 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.926 0.869 . . . . 1.0600000000000001 111.038 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -143.27 24.01 1.8 Allowed 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 114.648 -1.16 . . . . 3.1099999999999999 112.084 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -127.84 157.36 40.67 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 121.347 0.594 . . . . 2.1200000000000001 111.134 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.73 136.65 53.22 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.713 1.005 . . . . 0.41999999999999998 113.713 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 166.55 -140.17 6.18 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 113.962 -1.472 . . . . 0.25 112.569 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 23.8 mt-10 -112.36 109.02 18.4 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-N 118.473 1.136 . . . . 1.75 111.627 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -103.52 129.77 50.77 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.048 0.451 . . . . 0.90000000000000002 110.521 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.69 121.72 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.864 0.84 . . . . 1.0700000000000001 110.795 -176.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.0 105.59 17.28 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 113.931 -1.486 . . . . 1.47 109.572 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -111.9 124.96 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.8 -0.815 . . . . 1.27 108.8 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.94 140.2 43.82 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 112.735 0.643 . . . . 1.8899999999999999 112.735 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.87 120.39 40.52 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.039 -0.982 . . . . 2.8999999999999999 110.133 177.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -105.82 133.27 50.83 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.106 -0.497 . . . . 0.48999999999999999 110.392 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.37 152.32 50.51 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 112.549 0.574 . . . . 1.1000000000000001 112.549 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -138.71 119.64 14.35 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 123.662 0.785 . . . . 2.6099999999999999 111.102 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.18 65.33 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 112.597 0.592 . . . . 2.6099999999999999 112.597 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -171.3 -37.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 112.982 0.734 . . . . 2.71 112.982 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -115.94 130.81 56.98 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.226 0.454 . . . . 1.6899999999999999 112.226 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.27 96.93 6.42 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.43 1.11 . . . . 1.4299999999999999 111.474 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.4 ' NE2' ' NE2' ' A' ' 99' ' ' GLN . 3.4 pt20 -165.37 141.43 5.38 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 114.968 -1.014 . . . . 2.9700000000000002 112.323 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.5 m -122.41 124.93 44.79 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.382 -0.826 . . . . 1.6599999999999999 112.436 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 72.59 54.95 0.15 Allowed 'General case' 0 N--CA 1.514 2.725 0 C-N-CA 125.713 1.605 . . . . 2.02 112.523 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.4 ' NE2' ' NE2' ' A' ' 96' ' ' GLN . 4.4 tt0 -157.31 -38.43 0.07 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.803 -1.089 . . . . 2.5600000000000001 109.974 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -106.9 81.79 1.61 Allowed 'General case' 0 C--N 1.362 1.152 0 N-CA-C 108.384 -0.969 . . . . 3.1499999999999999 108.384 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.88 122.76 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 114.331 -1.304 . . . . 1.3600000000000001 111.306 -177.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -106.57 175.73 5.4 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 115.572 1.693 . . . . 0.84999999999999998 115.572 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -126.03 137.27 53.64 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.343 0.592 . . . . 1.3300000000000001 110.941 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.21 123.76 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.511 0 CA-C-N 115.237 -0.892 . . . . 1.1699999999999999 109.366 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.639 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 26.3 mtt180 -123.26 148.64 45.68 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.981 1.475 . . . . 1.9399999999999999 114.981 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 6.4 m -123.81 107.8 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 N-CA-C 113.437 0.903 . . . . 1.29 113.437 177.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.59 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.9 t30 63.81 27.32 14.56 Favored 'General case' 0 N--CA 1.519 2.988 0 C-N-CA 126.845 2.058 . . . . 1.8200000000000001 114.456 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.87 -14.86 45.06 Favored Glycine 0 CA--C 1.55 2.264 0 CA-C-N 115.574 -0.739 . . . . 0.32000000000000001 113.612 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.639 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 94.6 m-70 -87.49 171.15 10.74 Favored 'General case' 0 C--N 1.361 1.088 0 C-N-CA 125.953 1.701 . . . . 0.56999999999999995 113.166 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.01 132.72 54.67 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.546 0.689 . . . . 1.1899999999999999 112.015 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.61 -58.96 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.82 -1.082 . . . . 1.73 113.324 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.22 89.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.627 -0.879 . . . . 1.25 108.627 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -106.97 101.51 10.93 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 122.881 1.324 . . . . 2.75 110.283 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 114.25 74.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 110.542 -3.026 . . . . 2.48 108.898 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.2 105.8 18.01 Favored 'General case' 0 C--N 1.361 1.084 0 CA-C-O 121.612 0.72 . . . . 1.78 112.593 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -115.07 97.4 6.19 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 106.678 -1.601 . . . . 2.3500000000000001 106.678 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.06 -26.77 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.479 0 N-CA-C 114.028 1.122 . . . . 1.27 114.028 -176.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -76.22 -38.83 55.93 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.629 0.771 . . . . 0.83999999999999997 112.095 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -72.95 -26.74 61.48 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.847 1.259 . . . . 0.91000000000000003 113.296 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -80.5 -56.25 4.3 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.767 1.025 . . . . 2.98 113.767 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.73 -36.04 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 N-CA-C 114.592 1.33 . . . . 1.53 114.592 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.2 -110.04 1.37 Allowed Glycine 0 C--N 1.354 1.581 0 CA-C-N 118.35 0.523 . . . . 0.84999999999999998 113.417 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -114.84 107.46 15.45 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.841 0.353 . . . . 3.9700000000000002 110.243 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 69.42 -133.69 0.07 Allowed 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 125.345 1.458 . . . . 2.0800000000000001 112.614 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.3 p 62.15 -163.38 0.26 Allowed 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 126.222 1.809 . . . . 1.22 114.578 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.8 130.94 56.4 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 112.899 0.703 . . . . 1.2 112.899 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -101.66 147.21 26.71 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.262 -0.644 . . . . 0.41999999999999998 109.262 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.6 124.68 25.79 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.994 1.479 . . . . 2.5 114.994 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -124.18 121.91 36.38 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 115.247 -0.888 . . . . 1.5800000000000001 110.305 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.83 128.48 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 114.27 -1.332 . . . . 1.25 111.545 -178.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.21 93.77 19.03 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-N 115.637 -0.711 . . . . 1.5 111.187 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -76.55 133.3 14.19 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 122.672 2.248 . . . . 0.22 113.103 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.62 148.81 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.592 0 CA-C-N 115.553 -0.749 . . . . 1.1200000000000001 111.474 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.8 p -130.52 107.16 9.01 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.392 -0.822 . . . . 1.8600000000000001 111.82 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 mt -109.65 121.71 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 N-CA-C 108.518 -0.919 . . . . 1.0700000000000001 108.518 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -143.1 130.72 21.29 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.681 -0.69 . . . . 2.6400000000000001 110.964 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp 69.8 7.87 6.44 Favored 'General case' 0 N--CA 1.519 3.016 0 N-CA-C 114.684 1.364 . . . . 4.0199999999999996 114.684 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.14 22.22 13.63 Favored Glycine 0 CA--C 1.548 2.128 0 C-N-CA 123.633 0.635 . . . . 0.39000000000000001 113.802 -177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -130.52 144.83 51.66 Favored 'General case' 0 C--N 1.366 1.299 0 CA-C-N 117.548 0.674 . . . . 2.0299999999999998 112.128 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.75 141.11 32.99 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.912 1.078 . . . . 1.0800000000000001 113.912 -177.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.0 m -130.97 115.36 16.4 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.664 -1.153 . . . . 1.23 110.656 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.45 95.14 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.372 0 CA-C-O 121.101 0.477 . . . . 1.1899999999999999 110.728 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 67.26 -85.24 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 125.546 1.538 . . . . 1.8200000000000001 113.558 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.36 27.74 4.41 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.011 -0.541 . . . . 0.51000000000000001 113.404 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -131.38 128.4 39.52 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.444 0.698 . . . . 1.8200000000000001 110.77 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.8 p -118.29 130.01 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.343 0 CA-C-O 121.333 0.587 . . . . 1.5900000000000001 111.185 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.8 m -149.85 -170.63 3.69 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.487 -0.778 . . . . 1.1699999999999999 110.446 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 11.4 t -101.76 141.42 34.65 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 112.792 0.664 . . . . 1.71 112.792 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -87.91 132.63 34.14 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.985 0.898 . . . . 0.29999999999999999 111.815 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.9 p -97.34 -164.3 1.13 Allowed 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 114.046 -1.433 . . . . 1.8700000000000001 109.395 177.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.59 7.52 68.79 Favored Glycine 0 CA--C 1.56 2.876 0 N-CA-C 116.937 1.535 . . . . 0.91000000000000003 116.937 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.438 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -160.11 152.53 20.86 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-O 121.7 0.762 . . . . 1.6799999999999999 111.421 178.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.59 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -109.3 136.09 49.32 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.307 -1.315 . . . . 1.3700000000000001 109.236 177.405 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.5 t -117.82 144.11 45.67 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.671 1.73 . . . . 0.94999999999999996 115.671 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.1 t -118.44 97.58 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.087 -1.82 . . . . 1.3799999999999999 106.087 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -114.12 121.48 43.93 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 115.905 -0.589 . . . . 1.6699999999999999 112.46 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.73 132.1 56.55 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-O 122.062 0.934 . . . . 2.2999999999999998 111.238 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 14.0 t -107.25 143.74 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.991 0 CA-C-N 113.341 -1.754 . . . . 1.29 110.01 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 163' ' ' ASP . 34.4 ttpt -71.49 149.98 45.3 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.939 1.696 . . . . 2.6200000000000001 114.665 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.1 -55.26 0.73 Allowed Glycine 0 CA--C 1.542 1.778 0 CA-C-N 115.26 -0.882 . . . . 1.0600000000000001 114.378 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -130.18 -71.34 0.6 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.301 0.551 . . . . 3.1000000000000001 112.306 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.36 -44.7 2.66 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.513 0.561 . . . . 4.0800000000000001 112.513 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.495 ' O ' ' HG3' ' A' ' 159' ' ' LYS . 0.8 OUTLIER -98.99 171.24 8.17 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.773 0.829 . . . . 1.74 111.46 178.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.548 ' H ' ' ND2' ' A' ' 67' ' ' ASN 0.285 56.7 t-20 -125.75 -93.15 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.451 0 CA-C-O 116.715 -1.612 . . . . 1.6799999999999999 109.993 -179.209 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -87.1 -36.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.389 2.686 0 CA-C-N 124.851 2.768 . . . . 2.8199999999999998 114.757 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.2 tptm 80.29 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 126.2 1.8 . . . . 3.4100000000000001 110.543 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 36.2 t -115.2 131.5 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.358 -1.349 . . . . 1.3799999999999999 107.358 175.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.1 t -136.21 124.96 23.87 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.489 -0.778 . . . . 1.75 112.196 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -115.27 51.46 0.92 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 116.366 1.988 . . . . 1.1299999999999999 116.366 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 2.8 mm? -43.65 131.54 5.19 Favored 'General case' 0 N--CA 1.519 2.999 0 N-CA-C 116.368 1.988 . . . . 1.3999999999999999 116.368 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -154.45 104.04 2.54 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.825 -0.625 . . . . 0.26000000000000001 110.283 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 12' ' ' TRP 0.307 6.2 tt -114.47 123.11 69.83 Favored 'Isoleucine or valine' 0 C--O 1.268 2.064 0 CA-C-O 122.125 0.964 . . . . 1.1000000000000001 111.825 176.076 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -119.53 168.19 11.24 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.191 -1.368 . . . . 1.0600000000000001 112.17 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -118.48 146.42 44.52 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 118.06 2.615 . . . . 1.8300000000000001 118.06 -173.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.69 -41.02 2.26 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-N 110.605 -2.998 . . . . 0.17000000000000001 120.264 172.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.45 159.5 1.95 Allowed 'General case' 0 N--CA 1.517 2.904 0 CA-C-N 120.951 2.375 . . . . 1.05 113.239 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -77.73 -14.17 59.68 Favored 'General case' 0 CA--C 1.582 2.185 0 C-N-CA 124.784 1.234 . . . . 0.98999999999999999 114.227 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.02 2.6 51.43 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 113.957 1.095 . . . . 0.55000000000000004 113.957 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.606 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -101.8 -8.73 21.42 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.761 1.023 . . . . 0.59999999999999998 113.761 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.78 90.87 0.45 Allowed Pre-proline 0 N--CA 1.507 2.386 0 C-N-CA 124.035 0.934 . . . . 1.1799999999999999 112.576 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 45.0 Cg_endo -94.59 149.37 1.84 Allowed 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.742 2.294 . . . . 2.0299999999999998 114.37 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.9 mmt -132.18 107.99 8.96 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.018 -0.537 . . . . 5.3399999999999999 111.436 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.1 mt -134.45 173.84 11.2 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 122.196 0.998 . . . . 4.0 112.584 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -109.61 156.81 39.02 Favored Pre-proline 0 CA--C 1.558 1.267 0 CA-C-N 114.548 -1.205 . . . . 6.7000000000000002 110.633 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.03 122.99 10.13 Favored 'Trans proline' 0 C--N 1.392 2.821 0 C-N-CA 122.626 2.217 . . . . 6.9400000000000004 114.717 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.409 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 21.5 t60 -133.87 129.82 20.34 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-N 115.113 -0.949 . . . . 5.5099999999999998 112.028 -178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.409 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 8.2 Cg_endo -89.05 -157.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.691 0 C-N-CA 123.057 2.504 . . . . 7.1600000000000001 113.468 177.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 169.24 91.79 0.08 OUTLIER Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.122 -0.561 . . . . 7.0199999999999996 113.044 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.5 tp -118.9 114.67 22.97 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.875 0.369 . . . . 9.3000000000000007 111.763 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.218 -0.896 . . . . 10.6 110.979 179.717 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.57 -0.212 . . . . 9.3599999999999994 112.57 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.9 128.42 56.14 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.542 0.686 . . . . 6.8499999999999996 111.954 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.0 tpt -144.12 95.74 2.77 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.83 -0.623 . . . . 8.0 110.885 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m -146.75 112.73 5.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.92 -0.582 . . . . 4.1500000000000004 111.498 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.34 -62.26 0.04 OUTLIER Glycine 0 C--N 1.341 0.812 0 CA-C-N 115.758 -0.655 . . . . 1.6000000000000001 113.777 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.2 tp -85.26 -40.89 16.09 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.076 0.55 . . . . 1.0900000000000001 112.116 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.05 -22.91 67.18 Favored 'General case' 0 CA--C 1.583 2.248 0 C-N-CA 125.663 1.585 . . . . 1.04 114.029 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.9 -11.9 49.32 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 113.606 0.965 . . . . 0.32000000000000001 113.606 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 31.2 mttm -108.16 -19.33 13.52 Favored 'General case' 0 C--N 1.364 1.233 0 N-CA-C 113.716 1.006 . . . . 2.2599999999999998 113.716 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.32 136.65 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.866 0 N-CA-C 114.967 1.469 . . . . 1.01 114.967 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.76 -31.33 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 115.295 -0.866 . . . . 1.0600000000000001 111.998 178.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -161.05 119.53 2.47 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 111.954 0.353 . . . . 0.67000000000000004 111.954 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.81 129.66 24.72 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.673 -0.642 . . . . 1.0800000000000001 111.366 179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.61 140.75 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.764 0.793 . . . . 1.6699999999999999 112.524 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -114.43 110.24 19.55 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 106.599 -1.63 . . . . 2.6400000000000001 106.599 172.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.488 ' HA ' ' HE ' ' A' ' 65' ' ' ARG . . . -75.53 94.63 3.18 Favored 'General case' 0 C--O 1.274 2.386 0 CA-C-O 122.217 1.008 . . . . 1.28 110.859 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.445 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 159.27 -0.08 0.08 OUTLIER Glycine 0 C--N 1.362 2.008 0 CA-C-N 110.943 -2.844 . . . . 0.70999999999999996 117.983 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.52 -136.22 1.97 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-N 120.635 2.218 . . . . 0.87 117.273 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -129.09 134.75 48.21 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 113.861 -1.17 . . . . 2.1200000000000001 111.218 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.6 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 26.2 m -14.14 122.28 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.958 0 N-CA-C 119.556 3.169 . . . . 1.5 119.556 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -140.83 141.91 34.65 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.132 0.968 . . . . 0.52000000000000002 112.446 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.259 10.0 p -106.01 119.4 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 CA-C-N 114.063 -1.426 . . . . 2.0699999999999998 110.36 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -86.72 169.04 13.0 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 114.77 -1.105 . . . . 1.8500000000000001 113.451 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -39.61 -52.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 C-N-CA 129.222 3.009 . . . . 1.3700000000000001 117.458 -174.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -75.82 -20.59 58.05 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 112.888 0.699 . . . . 0.56999999999999995 112.888 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.8 44.36 0.76 Allowed Glycine 0 C--N 1.355 1.625 0 N-CA-C 115.194 0.838 . . . . 0.37 115.194 176.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.5 mm -108.51 125.12 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 N-CA-C 110.088 -0.338 . . . . 1.25 110.088 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -108.35 128.09 54.46 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 114.461 1.282 . . . . 1.71 114.461 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.6 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -94.24 150.1 20.62 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 124.419 1.088 . . . . 3.1499999999999999 110.604 177.366 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -105.88 147.3 28.88 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.574 1.324 . . . . 3.5099999999999998 114.574 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -68.76 108.44 3.42 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 117.535 2.42 . . . . 2.8100000000000001 117.535 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER 39.85 54.42 5.9 Favored Pre-proline 0 N--CA 1.525 3.316 0 N-CA-C 118.767 2.877 . . . . 1.1699999999999999 118.767 175.077 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 0.5 OUTLIER -106.59 65.12 0.02 OUTLIER 'Trans proline' 0 CA--C 1.566 2.113 0 C-N-CA 123.014 2.476 . . . . 1.45 116.174 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.3 mt -98.26 -83.32 0.41 Allowed 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.901 -0.5 . . . . 2.2400000000000002 111.029 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -148.35 60.19 1.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 113.021 0.748 . . . . 4.8399999999999999 113.021 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.35 1.28 40.95 Favored Glycine 0 CA--C 1.542 1.727 0 N-CA-C 115.804 1.082 . . . . 2.9700000000000002 115.804 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.526 ' O ' ' HB3' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -96.92 72.44 2.54 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-N 117.806 0.803 . . . . 4.79 112.959 -178.368 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.22 116.8 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-N 115.455 -0.793 . . . . 3.1499999999999999 111.377 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 137.58 -58.18 0.64 Allowed Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.587 -0.733 . . . . 2.7200000000000002 113.403 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -118.49 135.25 54.49 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.372 0.606 . . . . 5.9500000000000002 112.183 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.2 -40.92 10.19 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.662 0.986 . . . . 1.78 113.662 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.6 m 78.7 81.54 0.07 Allowed 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 125.392 1.477 . . . . 1.6599999999999999 112.471 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -95.58 91.41 6.13 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.294 0.637 . . . . 2.3300000000000001 112.189 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -110.96 74.23 0.86 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.931 0.872 . . . . 3.3300000000000001 110.526 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.14 60.52 0.05 OUTLIER Glycine 0 CA--C 1.529 0.959 0 CA-C-N 114.088 -1.415 . . . . 1.7 111.605 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.19 -24.41 19.06 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.84 1.052 . . . . 2.0800000000000001 113.84 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -103.39 61.16 0.77 Allowed 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 122.429 1.109 . . . . 4.6200000000000001 110.883 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -169.92 70.66 0.63 Allowed Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 113.316 -1.765 . . . . 3.1600000000000001 107.252 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -66.44 164.69 27.53 Favored 'Trans proline' 0 C--N 1.389 2.665 0 C-N-CA 124.022 3.148 . . . . 1.8600000000000001 116.317 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.295 1.2 mp -86.84 121.05 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-O 121.818 0.818 . . . . 1.28 109.866 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 mt -76.67 -14.47 59.96 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.191 2.293 . . . . 1.9299999999999999 117.191 -175.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -99.96 15.73 26.2 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.151 0.797 . . . . 1.79 113.151 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.9 t -132.31 -159.58 0.98 Allowed 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 121.659 0.742 . . . . 1.49 111.773 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.11 168.75 9.72 Favored Pre-proline 0 CA--C 1.569 1.706 0 C-N-CA 125.11 1.364 . . . . 1.6799999999999999 113.077 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -72.58 -30.29 12.25 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 123.266 2.644 . . . . 1.1599999999999999 113.34 176.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -85.32 -38.54 18.68 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.685 1.194 . . . . 2.04 112.272 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.39 1.83 56.84 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 114.574 1.324 . . . . 1.6200000000000001 114.574 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -68.36 -30.11 68.98 Favored 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 123.964 0.906 . . . . 2.4300000000000002 110.999 176.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.37 -48.17 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.035 0 C-N-CA 126.03 1.732 . . . . 1.46 109.054 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.6 tp -71.54 -13.34 61.77 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 113.952 1.093 . . . . 1.6699999999999999 113.952 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -123.23 21.69 9.56 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 113.233 0.827 . . . . 1.3300000000000001 113.233 177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.5 -32.72 0.49 Allowed 'General case' 0 N--CA 1.513 2.679 0 N-CA-C 116.03 1.863 . . . . 1.4099999999999999 116.03 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.8 p -70.98 136.68 48.55 Favored 'General case' 0 N--CA 1.535 3.807 0 N-CA-C 115.008 1.485 . . . . 1.28 115.008 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.445 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.3 pt-20 -123.0 145.64 48.32 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 115.662 1.726 . . . . 1.53 115.662 -176.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.488 ' HE ' ' HA ' ' A' ' 16' ' ' ALA . 12.4 mtm180 -105.25 150.08 25.44 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.055 0.942 . . . . 3.8300000000000001 109.983 176.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -105.42 130.63 53.47 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.402 1.63 . . . . 3.7599999999999998 115.402 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -170.07 -179.12 3.06 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.049 1.339 . . . . 5.3700000000000001 110.849 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -155.88 66.83 0.6 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.513 1.301 . . . . 2.5499999999999998 114.513 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.78 -160.68 0.12 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.435 0.636 . . . . 2.1499999999999999 111.527 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 1.6 t -88.51 97.83 11.3 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.18 0.992 . . . . 1.25 108.477 175.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -136.75 146.11 45.4 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.181 1.178 . . . . 1.1499999999999999 114.181 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.04 -173.07 38.53 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 114.262 -1.335 . . . . 0.59999999999999998 115.325 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.55 162.63 12.88 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.599 1.333 . . . . 1.4099999999999999 114.599 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -120.98 124.74 45.62 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.181 -1.372 . . . . 0.51000000000000001 110.825 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.07 101.87 54.35 Favored Pre-proline 0 CA--C 1.564 1.514 0 CA-C-N 115.487 -0.779 . . . . 1.0600000000000001 110.305 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.41 122.67 3.68 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 121.831 1.687 . . . . 0.17999999999999999 114.862 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.42 163.45 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-N 114.986 -1.006 . . . . 1.0600000000000001 110.899 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -151.82 24.51 0.67 Allowed 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 114.534 -1.212 . . . . 3.1099999999999999 111.666 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -133.24 156.85 46.79 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 123.09 0.556 . . . . 2.1200000000000001 111.111 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.5 OUTLIER -118.06 145.39 44.86 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.523 0.934 . . . . 0.41999999999999998 113.523 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.44 -136.48 4.43 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.189 -1.369 . . . . 0.25 112.191 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 38.3 mm-40 -116.91 106.67 13.7 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 118.292 1.046 . . . . 1.75 110.927 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -100.99 132.19 46.52 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.295 0.569 . . . . 0.90000000000000002 110.994 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.7 122.98 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 121.709 0.766 . . . . 1.0700000000000001 110.947 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.66 106.11 16.52 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.063 -1.426 . . . . 1.47 109.885 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.39 122.67 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.625 -0.509 . . . . 1.27 109.625 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.24 144.16 49.59 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.029 0.751 . . . . 1.8899999999999999 113.029 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -106.66 123.33 47.96 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.448 -0.796 . . . . 2.8999999999999999 110.848 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.424 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 16.9 m-85 -106.15 135.48 47.54 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.733 -0.667 . . . . 0.48999999999999999 110.444 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.82 149.67 42.32 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 116.016 -0.538 . . . . 1.1000000000000001 111.944 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -148.13 121.52 9.05 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 123.167 0.587 . . . . 2.6099999999999999 110.724 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.26 72.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 112.24 0.459 . . . . 2.6099999999999999 112.24 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.14 -42.51 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.734 0.642 . . . . 2.71 112.734 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -117.54 131.85 56.63 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.61 0.596 . . . . 1.6899999999999999 112.61 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -110.57 97.46 6.89 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 122.402 1.096 . . . . 1.4299999999999999 111.12 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.41 ' NE2' ' HZ1' ' A' ' 100' ' ' LYS . 17.6 pt20 -160.67 142.03 12.09 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.982 -1.008 . . . . 2.9700000000000002 112.054 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.8 m -122.16 124.06 42.98 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.596 -0.729 . . . . 1.6599999999999999 112.331 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 73.07 53.38 0.13 Allowed 'General case' 0 N--CA 1.512 2.629 0 C-N-CA 125.721 1.609 . . . . 2.02 112.148 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -152.31 -41.85 0.11 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.541 1.136 . . . . 2.5600000000000001 110.025 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.41 ' HZ1' ' NE2' ' A' ' 96' ' ' GLN . 30.5 mmtp -106.9 82.26 1.67 Allowed 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.794 -0.817 . . . . 3.1499999999999999 108.794 177.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.34 126.01 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.605 -1.18 . . . . 1.3600000000000001 111.23 -177.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -113.86 176.99 4.79 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.404 1.631 . . . . 0.84999999999999998 115.404 -175.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -125.32 139.13 53.96 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 121.897 0.856 . . . . 1.3300000000000001 111.489 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.01 126.84 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.071 0 CA-C-N 114.181 -1.372 . . . . 1.1699999999999999 110.103 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -131.27 142.52 50.15 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.229 1.566 . . . . 1.9399999999999999 115.229 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.2 m -113.74 106.34 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 113.882 -1.508 . . . . 1.29 112.199 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.462 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 65.21 25.87 12.32 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 126.479 1.912 . . . . 1.8200000000000001 113.367 -177.207 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.62 -10.82 56.29 Favored Glycine 0 CA--C 1.555 2.552 0 CA-C-N 116.055 -0.52 . . . . 0.32000000000000001 114.121 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -94.93 130.11 41.69 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 125.394 1.477 . . . . 0.56999999999999995 113.457 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -90.74 133.97 34.77 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 122.481 1.134 . . . . 1.1899999999999999 113.562 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.24 -47.42 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 112.818 -1.992 . . . . 1.73 112.163 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.19 89.14 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.27 -1.011 . . . . 1.25 108.27 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -111.03 74.92 0.89 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-O 123.334 1.54 . . . . 2.75 110.994 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 156.06 64.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 110.429 -3.078 . . . . 2.48 108.445 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.18 100.81 12.55 Favored 'General case' 0 C--N 1.36 1.056 0 N-CA-C 114.032 1.123 . . . . 1.78 114.032 -178.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.56 101.49 8.65 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 112.815 -1.993 . . . . 2.3500000000000001 106.706 175.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.63 -29.4 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.48 0 C-N-CA 124.605 1.162 . . . . 1.27 114.114 -176.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -76.94 -37.34 55.48 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.341 0.656 . . . . 0.83999999999999997 112.403 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -74.21 -26.44 60.26 Favored 'General case' 0 CA--C 1.576 1.946 0 C-N-CA 124.557 1.143 . . . . 0.91000000000000003 113.195 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -78.55 -56.26 4.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.327 0.862 . . . . 2.98 113.327 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.79 -39.88 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 N-CA-C 113.998 1.11 . . . . 1.53 113.998 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.85 -67.3 0.24 Allowed Glycine 0 C--N 1.358 1.777 0 CA-C-N 118.269 0.486 . . . . 0.84999999999999998 114.162 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -106.49 173.91 6.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.946 0.899 . . . . 3.9700000000000002 112.161 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 m -75.95 84.13 2.86 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.281 0.845 . . . . 2.0800000000000001 113.281 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 23.4 p -135.7 -137.05 0.15 Allowed 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 114.414 -1.266 . . . . 1.22 109.127 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -115.96 132.69 56.57 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 113.315 0.857 . . . . 1.2 113.315 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.424 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 7.4 t60 -108.37 138.2 45.06 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.109 -0.701 . . . . 0.41999999999999998 109.109 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -141.49 130.95 23.78 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.696 0.998 . . . . 2.5 113.696 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -120.2 130.68 54.66 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-N 114.498 -1.228 . . . . 1.5800000000000001 110.87 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.51 124.14 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 114.455 -1.248 . . . . 1.25 110.629 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.49 94.23 26.84 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-N 115.619 -0.719 . . . . 1.5 110.859 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -74.65 139.32 25.13 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.977 2.452 . . . . 0.22 113.481 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.95 150.75 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.492 0 CA-C-O 121.654 0.74 . . . . 1.1200000000000001 111.216 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.2 p -132.29 112.69 12.44 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.268 -0.878 . . . . 1.8600000000000001 111.323 178.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.474 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.6 mt -112.01 123.18 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 108.505 -0.924 . . . . 1.0700000000000001 108.505 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -139.24 127.99 23.35 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.102 -0.954 . . . . 2.6400000000000001 110.88 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? 66.05 15.52 10.11 Favored 'General case' 0 N--CA 1.517 2.89 0 N-CA-C 114.88 1.437 . . . . 4.0199999999999996 114.88 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.53 19.52 24.95 Favored Glycine 0 CA--C 1.55 2.271 0 CA-C-O 119.315 -0.714 . . . . 0.39000000000000001 114.709 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 25.0 mtpp -126.77 141.83 51.72 Favored 'General case' 0 C--N 1.366 1.301 0 CA-C-N 118.181 0.991 . . . . 2.0299999999999998 112.2 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.68 136.85 39.9 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.487 0.921 . . . . 1.0800000000000001 113.487 -177.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.4 t -133.63 120.84 21.2 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.71 -0.677 . . . . 1.23 111.843 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 p -105.47 95.05 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.674 0 CA-C-N 114.965 -1.016 . . . . 1.1899999999999999 110.087 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 69.46 -81.66 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 125.4 1.48 . . . . 1.8200000000000001 113.34 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -129.71 23.43 4.75 Favored Glycine 0 CA--C 1.544 1.899 0 CA-C-N 116.092 -0.504 . . . . 0.51000000000000001 113.685 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -125.04 121.92 35.74 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.33 0.652 . . . . 1.8200000000000001 110.78 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.8 134.24 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.466 0.65 . . . . 1.5900000000000001 111.843 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 m -149.54 -170.27 3.59 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.918 -1.037 . . . . 1.1699999999999999 110.74 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.24 138.14 38.66 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.394 0.887 . . . . 1.71 113.394 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -94.45 119.88 33.84 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.493 -0.776 . . . . 0.29999999999999999 109.036 175.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.89 92.24 3.1 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.335 0.588 . . . . 1.8700000000000001 112.092 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.92 -71.51 2.98 Favored Glycine 0 C--N 1.358 1.779 0 N-CA-C 116.954 1.542 . . . . 0.91000000000000003 116.954 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.78 171.94 12.9 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 123.285 1.517 . . . . 1.6799999999999999 114.577 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.462 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -110.28 126.39 54.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 111.31 -2.677 . . . . 1.3700000000000001 107.439 176.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.6 t -117.18 122.23 43.45 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 118.309 -1.357 . . . . 0.94999999999999996 114.287 -175.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.79 101.36 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 114.676 -1.147 . . . . 1.3799999999999999 108.407 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -133.28 143.72 49.25 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.05 -0.977 . . . . 1.6699999999999999 111.386 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -115.59 142.5 46.64 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 114.546 -1.206 . . . . 2.2999999999999998 112.72 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -102.73 137.0 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.247 -1.797 . . . . 1.29 108.778 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -81.82 148.82 28.66 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 115.135 1.532 . . . . 2.6200000000000001 115.135 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -104.37 -29.94 5.2 Favored Glycine 0 CA--C 1.545 1.922 0 CA-C-N 114.675 -1.148 . . . . 1.0600000000000001 114.143 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -128.49 -80.54 0.58 Allowed 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 117.258 0.529 . . . . 3.1000000000000001 110.919 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -171.88 48.92 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.87 0.468 . . . . 4.0800000000000001 112.036 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -160.04 -43.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.605 0.965 . . . . 1.74 113.605 -178.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 1.3 m-20 84.17 -173.16 0.02 OUTLIER Pre-proline 0 N--CA 1.511 2.607 0 C-N-CA 124.493 1.117 . . . . 1.6799999999999999 110.461 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -64.43 -19.19 65.1 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.586 2.191 . . . . 2.8199999999999998 115.74 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 31.0 tptt 82.69 -67.1 0.09 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 126.025 1.73 . . . . 3.4100000000000001 115.045 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 45.0 t -100.2 131.03 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 119.062 0.846 . . . . 1.3799999999999999 110.034 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.3 t -134.06 126.8 30.9 Favored 'General case' 0 C--N 1.367 1.342 0 O-C-N 124.074 0.859 . . . . 1.75 111.635 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . 0.256 . . -115.03 51.1 0.93 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.43 2.011 . . . . 1.1299999999999999 116.43 -176.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.84 128.18 8.65 Favored 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.702 1.601 . . . . 1.3999999999999999 115.053 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -149.14 98.17 2.78 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.777 -1.102 . . . . 0.26000000000000001 109.294 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.319 8.4 tt -112.9 122.68 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.808 0 CA-C-O 122.84 1.305 . . . . 1.1000000000000001 112.276 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -123.56 167.61 13.7 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 113.094 -1.866 . . . . 1.0600000000000001 111.131 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.9 ptmt -122.19 159.49 27.14 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 118.223 2.675 . . . . 1.8300000000000001 118.223 -175.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.38 -42.53 1.87 Allowed Glycine 0 CA--C 1.542 1.781 0 CA-C-N 110.041 -3.254 . . . . 0.17000000000000001 118.779 174.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.37 153.92 0.78 Allowed 'General case' 0 N--CA 1.52 3.038 0 CA-C-N 120.296 2.048 . . . . 1.05 112.94 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.79 -20.74 58.0 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 114.742 1.386 . . . . 0.98999999999999999 114.742 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.36 4.68 45.33 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.007 1.114 . . . . 0.55000000000000004 114.007 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.57 3.3 16.65 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.389 1.255 . . . . 0.59999999999999998 114.389 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . 0.257 1.6 m -59.73 -35.77 32.7 Favored Pre-proline 0 N--CA 1.525 3.298 0 N-CA-C 116.856 2.169 . . . . 1.1799999999999999 116.856 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -97.58 167.01 0.84 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.382 2.055 . . . . 2.0299999999999998 113.931 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 tpt -144.64 113.67 6.88 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.192 -0.458 . . . . 5.3399999999999999 111.002 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 10.2 mt -132.26 167.54 19.65 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.1 0.952 . . . . 4.0 112.686 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -103.91 158.66 31.42 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-N 114.591 -1.186 . . . . 6.7000000000000002 111.098 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.24 122.28 9.53 Favored 'Trans proline' 0 C--N 1.394 2.962 0 C-N-CA 122.618 2.212 . . . . 6.9400000000000004 115.123 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -135.87 136.23 22.97 Favored Pre-proline 0 CA--C 1.564 1.502 0 CA-C-N 114.861 -1.063 . . . . 5.5099999999999998 111.16 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -84.45 -156.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 123.362 2.708 . . . . 7.1600000000000001 114.049 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 165.22 104.7 0.18 Allowed Glycine 0 C--N 1.341 0.812 0 C-N-CA 120.776 -0.726 . . . . 7.0199999999999996 113.442 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.75 119.73 35.27 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.029 0.442 . . . . 9.3000000000000007 111.714 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.403 -0.808 . . . . 10.6 111.164 -179.812 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.52 -0.232 . . . . 9.3599999999999994 112.52 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.27 129.82 55.86 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.528 0.68 . . . . 6.8499999999999996 111.818 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.5 mtt -132.4 120.09 21.54 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.77 -0.65 . . . . 8.0 111.709 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 m -137.23 110.09 7.64 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.66 -0.7 . . . . 4.1500000000000004 111.311 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.11 -46.79 0.03 OUTLIER Glycine 0 C--N 1.341 0.818 0 N-CA-C 114.755 0.662 . . . . 1.6000000000000001 114.755 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.2 tp -85.29 -39.73 17.38 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.145 0.794 . . . . 1.0900000000000001 113.145 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.57 -23.81 64.94 Favored 'General case' 0 N--CA 1.506 2.331 0 C-N-CA 125.506 1.522 . . . . 1.04 114.414 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.89 -9.92 54.59 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 113.606 0.965 . . . . 0.32000000000000001 113.606 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 48.8 mmtt -104.47 -27.02 12.16 Favored 'General case' 0 C--N 1.364 1.23 0 N-CA-C 113.327 0.862 . . . . 2.2599999999999998 113.327 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.33 137.01 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.077 0 N-CA-C 115.764 1.764 . . . . 1.01 115.764 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pt -122.06 -30.09 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 115.559 -0.746 . . . . 1.0600000000000001 112.409 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.414 ' O ' HG22 ' A' ' 172' ' ' ILE . 75.3 t90 -164.36 116.7 1.32 Allowed 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 120.654 0.264 . . . . 0.67000000000000004 111.302 -178.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.98 136.42 38.5 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.602 -0.686 . . . . 1.0800000000000001 111.719 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.304 14.9 p -150.02 137.65 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.555 0 N-CA-C 115.796 1.776 . . . . 1.6699999999999999 115.796 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 59.2 t30 -114.18 111.34 21.4 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-N 115.264 -0.88 . . . . 2.6400000000000001 108.726 174.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.96 106.8 13.25 Favored 'General case' 0 C--O 1.271 2.211 0 CA-C-O 121.455 0.645 . . . . 1.28 110.323 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.497 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 171.92 -61.42 0.16 Allowed Glycine 0 C--N 1.362 1.998 0 CA-C-N 112.445 -2.161 . . . . 0.70999999999999996 114.358 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.01 -110.45 3.37 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 114.371 0.508 . . . . 0.87 114.371 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -170.92 117.85 0.48 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.834 0.454 . . . . 2.1200000000000001 111.782 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.1 m 43.95 114.38 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.368 0 N-CA-C 119.235 3.05 . . . . 1.5 119.235 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -144.97 139.81 27.77 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 113.399 0.888 . . . . 0.52000000000000002 113.399 177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.267 8.2 p -106.02 114.23 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 CA-C-N 115.015 -0.993 . . . . 2.0699999999999998 110.124 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -84.59 162.7 19.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.776 -1.102 . . . . 1.8500000000000001 113.12 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 m -41.38 -28.79 0.18 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.266 0 N-CA-C 119.868 3.285 . . . . 1.3700000000000001 119.868 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -90.15 -19.76 23.88 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.856 0.753 . . . . 0.56999999999999995 111.87 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.65 39.32 1.47 Allowed Glycine 0 C--N 1.353 1.517 0 C-N-CA 124.443 1.021 . . . . 0.37 113.868 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.1 mm -106.83 124.91 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 C-N-CA 123.096 0.558 . . . . 1.25 109.597 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -110.26 130.7 55.5 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 114.656 1.354 . . . . 1.71 114.656 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -84.15 136.74 33.86 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 124.479 1.111 . . . . 3.1499999999999999 110.413 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.89 100.34 12.82 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 124.78 1.3 . . . . 3.5099999999999998 114.266 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -38.79 110.96 0.15 Allowed 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 128.133 2.573 . . . . 2.8100000000000001 117.846 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER 46.34 76.16 0.58 Allowed Pre-proline 0 N--CA 1.525 3.317 0 N-CA-C 117.099 2.259 . . . . 1.1699999999999999 117.099 177.376 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -95.07 -12.15 0.9 Allowed 'Trans proline' 0 CA--C 1.56 1.803 0 N-CA-C 117.584 2.109 . . . . 1.45 117.584 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.7 -24.22 1.54 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.849 1.796 . . . . 2.2400000000000002 115.849 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -99.72 70.12 1.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 119.551 1.068 . . . . 4.8399999999999999 112.562 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.436 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . 105.85 -29.3 11.51 Favored Glycine 0 CA--C 1.542 1.752 0 CA-C-N 115.685 -0.689 . . . . 2.9700000000000002 114.782 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 52.64 53.08 12.79 Favored 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 127.219 2.208 . . . . 4.79 115.375 -179.064 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.18 179.82 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 C-N-CA 124.772 1.229 . . . . 3.1499999999999999 110.442 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.94 94.48 1.93 Allowed Glycine 0 N--CA 1.478 1.495 0 O-C-N 121.611 -0.68 . . . . 2.7200000000000002 114.754 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 -153.41 131.75 12.03 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.312 0.577 . . . . 5.9500000000000002 111.963 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.34 137.19 50.84 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.181 0.992 . . . . 1.78 111.323 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 m -124.62 121.7 35.47 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.711 -0.677 . . . . 1.6599999999999999 111.66 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.1 104.34 4.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.821 -0.627 . . . . 2.3300000000000001 110.559 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -97.77 -45.83 6.19 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.866 -0.606 . . . . 3.3300000000000001 111.875 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -108.99 73.07 0.2 Allowed Glycine 0 C--N 1.354 1.541 0 N-CA-C 111.053 -0.819 . . . . 1.7 111.053 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.9 ttt -92.78 0.07 57.35 Favored 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 115.473 1.657 . . . . 2.0800000000000001 115.473 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.06 35.24 3.33 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 112.936 0.717 . . . . 4.6200000000000001 112.936 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.6 tp -137.27 77.05 42.64 Favored Pre-proline 0 C--N 1.35 0.602 0 C-N-CA 124.171 0.988 . . . . 3.1600000000000001 108.431 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 51.1 Cg_exo -63.34 155.05 64.33 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.862 3.041 . . . . 1.8600000000000001 117.196 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.279 1.2 mp -89.65 125.91 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.12 0 CA-C-N 114.98 -1.009 . . . . 1.28 109.277 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.39 -19.01 43.53 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.478 2.029 . . . . 1.9299999999999999 116.478 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.38 24.66 7.79 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 113.957 1.095 . . . . 1.79 113.957 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.36 -175.07 4.57 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-O 121.451 0.643 . . . . 1.49 111.7 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.772 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.56 -176.87 0.58 Allowed Pre-proline 0 N--CA 1.511 2.588 0 C-N-CA 123.985 0.914 . . . . 1.6799999999999999 109.198 177.975 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -68.86 -39.95 7.6 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.48 2.12 . . . . 1.1599999999999999 113.719 176.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -68.88 -49.18 60.43 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 125.298 1.439 . . . . 2.04 112.549 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -6.57 58.76 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-N 114.921 -1.036 . . . . 1.6200000000000001 112.57 177.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.772 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 22.1 tt0 -73.54 -40.49 63.93 Favored 'General case' 0 C--N 1.381 1.952 0 C-N-CA 125.278 1.431 . . . . 2.4300000000000002 108.075 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.5 t -61.35 -44.57 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.068 0 C-N-CA 124.353 1.061 . . . . 1.46 109.094 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.9 tp -75.97 -11.91 60.04 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 114.77 1.396 . . . . 1.6699999999999999 114.77 177.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -124.22 22.16 8.66 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 123.672 0.789 . . . . 1.3300000000000001 112.534 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -143.89 -27.4 0.53 Allowed 'General case' 0 N--CA 1.52 3.032 0 N-CA-C 115.813 1.783 . . . . 1.4099999999999999 115.813 -177.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 p -75.29 130.82 39.72 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 113.614 0.968 . . . . 1.28 113.614 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.497 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -116.71 139.64 50.32 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 115.306 1.595 . . . . 1.53 115.306 -176.576 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.49 128.45 55.0 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.11 -0.95 . . . . 3.8300000000000001 111.496 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -132.04 124.86 30.12 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 116.033 -0.53 . . . . 3.7599999999999998 110.963 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.9 -61.47 0.49 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 113.812 1.041 . . . . 5.3700000000000001 113.812 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -123.81 -135.14 0.28 Allowed 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 113.807 1.04 . . . . 2.5499999999999998 113.807 -177.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.64 124.68 5.6 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.58 1.152 . . . . 2.1499999999999999 109.45 -177.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.611 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.3 OUTLIER 75.58 79.49 0.1 Allowed 'General case' 0 N--CA 1.515 2.778 0 C-N-CA 125.083 1.353 . . . . 1.25 109.963 -177.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -135.44 141.31 45.39 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.276 -0.875 . . . . 1.1499999999999999 113.13 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -134.48 174.36 21.02 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 116.62 1.408 . . . . 0.59999999999999998 116.62 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.448 ' HH ' ' HG ' ' A' ' 168' ' ' CYS . 19.0 m-85 -113.94 156.55 23.8 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 113.814 -1.193 . . . . 1.4099999999999999 113.375 -177.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.83 125.4 47.44 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.024 -0.989 . . . . 0.51000000000000001 111.904 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.77 102.69 38.09 Favored Pre-proline 0 CA--C 1.566 1.561 0 CA-C-N 115.458 -0.792 . . . . 1.0600000000000001 108.957 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -84.0 117.53 2.26 Favored 'Trans proline' 0 CA--C 1.562 1.884 0 C-N-CA 122.155 1.903 . . . . 0.17999999999999999 114.44 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.05 157.48 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 CA-C-O 122.068 0.937 . . . . 1.0600000000000001 111.511 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -144.46 14.66 1.61 Allowed 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 114.542 -1.208 . . . . 3.1099999999999999 112.61 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -125.04 172.88 9.09 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-N 118.711 0.687 . . . . 2.1200000000000001 112.489 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -130.83 144.05 51.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.814 0.816 . . . . 0.41999999999999998 112.822 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.1 -135.4 4.29 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.436 -1.256 . . . . 0.25 112.322 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.576 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 40.6 mm-40 -114.12 112.56 23.4 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 118.039 0.92 . . . . 1.75 111.266 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -104.64 133.57 49.26 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 122.075 -0.391 . . . . 0.90000000000000002 110.826 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -118.66 124.04 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.703 0.763 . . . . 1.0700000000000001 111.202 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.48 110.5 22.45 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.168 -1.378 . . . . 1.47 110.699 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.412 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 0.2 OUTLIER -119.22 129.09 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 115.266 -0.879 . . . . 1.27 108.707 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.28 137.4 46.01 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.117 0.784 . . . . 1.8899999999999999 113.117 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 127' ' ' HIS . 3.0 tppt? -101.69 114.06 27.77 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.759 -0.655 . . . . 2.8999999999999999 109.907 176.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -103.63 134.46 46.94 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.381 -0.827 . . . . 0.48999999999999999 110.339 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.44 151.54 47.53 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.629 -0.714 . . . . 1.1000000000000001 111.253 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -128.16 142.93 51.04 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-O 121.271 0.558 . . . . 2.6099999999999999 112.254 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.18 -36.02 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 115.59 -0.732 . . . . 2.6099999999999999 112.678 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.62 142.04 51.43 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.192 0.597 . . . . 2.71 111.707 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 92.75 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 126.477 1.911 . . . . 1.6899999999999999 111.248 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.17 85.39 2.65 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-O 123.002 1.382 . . . . 1.4299999999999999 111.529 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -151.17 145.04 25.15 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.318 -1.31 . . . . 2.9700000000000002 112.292 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.1 m -120.84 120.27 35.08 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.507 -0.769 . . . . 1.6599999999999999 112.223 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 72.33 56.64 0.15 Allowed 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 125.899 1.68 . . . . 2.02 112.531 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -157.19 -41.97 0.07 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.286 1.434 . . . . 2.5600000000000001 109.092 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -105.1 83.39 1.97 Allowed 'General case' 0 C--N 1.361 1.086 0 N-CA-C 108.383 -0.969 . . . . 3.1499999999999999 108.383 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.85 132.71 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 114.748 -1.114 . . . . 1.3600000000000001 111.675 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -114.58 178.54 4.24 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.353 1.612 . . . . 0.84999999999999998 115.353 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -126.5 141.72 51.78 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.604 0.594 . . . . 1.3300000000000001 112.604 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.71 125.01 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.368 0 C-N-CA 123.686 0.794 . . . . 1.1699999999999999 109.302 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.604 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 25.6 mtt180 -124.51 146.91 48.71 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.097 1.518 . . . . 1.9399999999999999 115.097 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 2.5 m -120.21 106.8 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.833 0 N-CA-C 112.996 0.739 . . . . 1.29 112.996 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.38 25.07 13.35 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 126.49 1.916 . . . . 1.8200000000000001 114.736 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.85 -12.91 45.93 Favored Glycine 0 CA--C 1.55 2.261 0 CA-C-N 115.827 -0.624 . . . . 0.32000000000000001 113.446 -176.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.604 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 96.8 m-70 -87.35 169.34 12.35 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.078 1.751 . . . . 0.56999999999999995 112.784 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.28 133.6 55.14 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.573 0.702 . . . . 1.1899999999999999 112.462 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.94 -55.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 114.731 -1.122 . . . . 1.73 112.898 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.14 88.89 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.021 -1.103 . . . . 1.25 108.021 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -111.14 77.6 1.05 Allowed 'General case' 0 C--N 1.354 0.775 0 CA-C-O 122.867 1.318 . . . . 2.75 110.588 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 152.44 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 111.205 -2.725 . . . . 2.48 108.578 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.35 99.93 12.36 Favored 'General case' 0 C--N 1.362 1.117 0 N-CA-C 113.708 1.003 . . . . 1.78 113.708 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -114.26 99.49 7.64 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 113.175 -1.83 . . . . 2.3500000000000001 107.565 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.74 -29.89 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.441 0 N-CA-C 114.313 1.227 . . . . 1.27 114.313 -176.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -75.45 -37.17 60.49 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.539 0.736 . . . . 0.83999999999999997 112.415 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.54 -26.9 60.27 Favored 'General case' 0 CA--C 1.577 1.987 0 C-N-CA 124.533 1.133 . . . . 0.91000000000000003 113.262 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -77.33 -55.27 5.54 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.386 0.884 . . . . 2.98 113.386 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.18 -39.04 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 N-CA-C 113.985 1.105 . . . . 1.53 113.985 177.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.46 -70.86 0.21 Allowed Glycine 0 C--N 1.359 1.849 0 CA-C-N 118.206 0.457 . . . . 0.84999999999999998 113.556 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -106.28 175.56 5.46 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.467 1.107 . . . . 3.9700000000000002 111.232 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.1 m -70.87 85.95 0.69 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 113.692 0.997 . . . . 2.0800000000000001 113.692 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.9 p -134.76 -156.64 0.74 Allowed 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 114.028 -1.442 . . . . 1.22 109.476 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -105.83 128.36 53.69 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 113.15 0.796 . . . . 1.2 113.15 179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.466 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 7.9 t60 -101.82 139.43 37.47 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.265 0.626 . . . . 0.41999999999999998 109.322 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -144.79 130.43 19.01 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.28 0.845 . . . . 2.5 113.28 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -121.75 136.69 54.94 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 115.304 -0.862 . . . . 1.5800000000000001 111.317 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.81 126.45 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 114.718 -1.128 . . . . 1.25 110.767 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.6 mp -132.88 92.53 25.92 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-N 115.472 -0.785 . . . . 1.5 110.498 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -76.5 131.19 12.39 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 122.875 2.383 . . . . 0.22 113.175 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.23 153.34 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 C-N-CA 124.194 0.998 . . . . 1.1200000000000001 111.115 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.1 p -136.09 117.62 14.83 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.633 0.605 . . . . 1.8600000000000001 112.633 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.5 mt -116.16 127.62 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 N-CA-C 108.769 -0.826 . . . . 1.0700000000000001 108.769 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -140.84 126.0 18.48 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.923 -0.58 . . . . 2.6400000000000001 110.984 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? 68.8 14.91 8.98 Favored 'General case' 0 N--CA 1.516 2.853 0 C-N-CA 125.205 1.402 . . . . 4.0199999999999996 114.151 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.12 16.13 36.39 Favored Glycine 0 CA--C 1.546 1.988 0 CA-C-O 119.291 -0.727 . . . . 0.39000000000000001 114.359 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -125.38 144.57 50.44 Favored 'General case' 0 C--N 1.366 1.283 0 CA-C-N 118.175 0.988 . . . . 2.0299999999999998 112.48 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 148.21 23.28 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.798 1.406 . . . . 1.0800000000000001 114.798 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.6 114.12 9.71 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.234 -1.348 . . . . 1.23 110.201 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.2 p -121.67 96.01 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.334 0 CA-C-N 115.999 -0.546 . . . . 1.1899999999999999 110.705 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 68.39 -83.94 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 C-N-CA 125.586 1.554 . . . . 1.8200000000000001 113.751 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.69 26.81 3.79 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.891 -0.595 . . . . 0.51000000000000001 113.129 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -130.12 123.56 30.66 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 123.532 0.733 . . . . 1.8200000000000001 110.346 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.4 p -118.4 130.05 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.237 0 CA-C-O 121.48 0.657 . . . . 1.5900000000000001 111.51 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.9 p -151.49 -173.3 4.47 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.202 -0.908 . . . . 1.1699999999999999 110.344 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.272 14.3 t -104.35 138.29 40.98 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 113.661 0.986 . . . . 1.71 113.661 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -84.73 126.38 33.35 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.441 1.096 . . . . 0.29999999999999999 111.19 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.77 91.77 3.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.216 0.821 . . . . 1.8700000000000001 113.216 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.18 -64.8 3.69 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 119.192 2.437 . . . . 0.91000000000000003 119.192 176.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.522 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -135.33 159.28 42.05 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.466 0.913 . . . . 1.6799999999999999 113.466 -176.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.522 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -105.27 142.59 34.77 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.952 -1.476 . . . . 1.3700000000000001 109.816 177.319 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 t -124.53 127.22 47.1 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 114.023 1.119 . . . . 0.94999999999999996 114.023 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 16.3 t -106.59 97.19 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 105.862 -1.903 . . . . 1.3799999999999999 105.862 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.74 122.7 44.42 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.971 -1.013 . . . . 1.6699999999999999 112.594 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -107.13 119.03 38.28 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 114.474 -1.239 . . . . 2.2999999999999998 109.766 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.14 137.31 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 CA-C-N 113.579 -1.646 . . . . 1.29 109.649 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -58.37 151.2 20.33 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 127.509 2.323 . . . . 2.6200000000000001 116.756 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -109.5 -62.7 0.53 Allowed Glycine 0 CA--C 1.538 1.478 0 CA-C-N 115.193 -0.912 . . . . 1.0600000000000001 113.365 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -135.13 -71.34 0.48 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.781 0.659 . . . . 3.1000000000000001 112.781 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -112.19 -59.29 2.02 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 122.775 0.43 . . . . 4.0800000000000001 112.056 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.4 156.33 16.39 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.692 0.797 . . . . 1.74 110.388 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.611 ' ND2' ' H ' ' A' ' 70' ' ' SER . 11.9 m-20 -97.71 -94.8 0.0 OUTLIER Pre-proline 0 CA--C 1.58 2.126 0 CA-C-O 116.512 -1.708 . . . . 1.6799999999999999 110.898 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.51 -37.21 0.11 Allowed 'Trans proline' 0 C--N 1.402 3.355 0 CA-C-N 124.886 2.781 . . . . 2.8199999999999998 115.004 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.4 tptt 82.06 -81.74 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 126.261 1.825 . . . . 3.4100000000000001 108.859 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 45.5 t -112.51 129.53 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.716 -1.216 . . . . 1.3799999999999999 107.716 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 8.8 t -135.37 116.79 14.69 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.928 0.768 . . . . 1.75 112.341 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . 0.274 . . -109.44 47.51 0.93 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.337 2.347 . . . . 1.1299999999999999 117.337 -176.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.25 134.1 1.68 Allowed 'General case' 0 N--CA 1.516 2.846 0 N-CA-C 116.109 1.892 . . . . 1.3999999999999999 116.109 177.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 3.1 t80 -151.6 100.46 2.71 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.068 -0.514 . . . . 0.26000000000000001 110.906 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 12' ' ' TRP 0.3 5.5 tt -111.52 121.87 64.88 Favored 'Isoleucine or valine' 0 C--O 1.269 2.088 0 CA-C-O 122.268 1.032 . . . . 1.1000000000000001 110.969 176.188 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -122.34 168.68 11.77 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.528 -1.215 . . . . 1.0600000000000001 112.08 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 24.9 tptp -113.4 141.67 46.8 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 118.298 2.703 . . . . 1.8300000000000001 118.298 -173.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.576 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.12 -40.49 2.45 Favored Glycine 0 CA--C 1.542 1.735 0 N-CA-C 121.213 3.245 . . . . 0.17000000000000001 121.213 171.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.93 157.17 1.42 Allowed 'General case' 0 N--CA 1.525 3.291 0 CA-C-N 121.622 2.711 . . . . 1.05 113.91 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.16 -13.22 59.95 Favored 'General case' 0 CA--C 1.58 2.108 0 C-N-CA 124.954 1.301 . . . . 0.98999999999999999 114.087 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.34 2.49 50.15 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 113.692 0.997 . . . . 0.55000000000000004 113.692 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -106.11 -8.89 17.23 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.98 0.912 . . . . 0.59999999999999998 113.29 179.211 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.42 89.11 0.56 Allowed Pre-proline 0 N--CA 1.503 2.223 0 C-N-CA 123.866 0.866 . . . . 1.1799999999999999 112.102 178.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 41.4 Cg_endo -93.5 153.71 2.43 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.631 2.22 . . . . 2.0299999999999998 114.88 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 67.6 mtt -133.18 104.91 6.72 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.708 -0.678 . . . . 5.3399999999999999 110.863 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.7 mt -129.36 170.16 13.99 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.134 0.968 . . . . 4.0 113.029 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -111.21 159.52 32.5 Favored Pre-proline 0 CA--C 1.557 1.243 0 CA-C-N 114.456 -1.247 . . . . 6.7000000000000002 111.061 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.34 123.62 11.42 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 122.954 2.436 . . . . 6.9400000000000004 115.039 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.437 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 31.6 t60 -133.51 131.86 21.59 Favored Pre-proline 0 CA--C 1.565 1.542 0 CA-C-N 115.194 -0.912 . . . . 5.5099999999999998 111.912 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.437 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 11.8 Cg_endo -87.36 -157.58 0.07 OUTLIER 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 123.112 2.541 . . . . 7.1600000000000001 113.267 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 172.35 -130.96 2.02 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 120.697 -0.763 . . . . 7.0199999999999996 113.974 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.3 mt -118.95 111.65 18.62 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.163 0.431 . . . . 9.3000000000000007 112.163 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.449 -0.786 . . . . 10.6 110.53 179.608 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.548 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.6 tp . . . . . 0 CA--C 1.563 1.458 0 N-CA-C 113.041 0.756 . . . . 0.34999999999999998 113.041 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.28 -24.78 65.22 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.957 1.703 . . . . 0.20000000000000001 115.251 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.24 -12.02 47.97 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 113.665 0.987 . . . . 0.32000000000000001 113.665 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 47.4 mttm -107.45 -18.1 13.95 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 113.954 1.094 . . . . 1.73 113.954 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -56.93 135.93 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.88 0 N-CA-C 114.905 1.446 . . . . 0.11 114.905 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.49 -28.53 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 115.394 -0.821 . . . . 0.16 112.495 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 69.3 t90 -162.83 117.9 1.77 Allowed 'General case' 0 CA--C 1.559 1.325 0 CA-C-N 117.872 0.306 . . . . 0.54000000000000004 111.277 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -139.1 129.59 25.78 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.508 -0.745 . . . . 0.19 111.635 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.55 133.81 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 N-CA-C 112.928 0.714 . . . . 1.05 112.928 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 169' ' ' ALA . 6.0 t-20 -114.07 112.94 24.05 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.056 -1.461 . . . . 2.1099999999999999 107.056 172.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -79.88 97.5 6.72 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-O 121.577 0.704 . . . . 0.63 111.947 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.434 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 176.28 -68.72 0.09 OUTLIER Glycine 0 C--N 1.358 1.758 0 CA-C-N 114.416 -1.266 . . . . 0.70999999999999996 115.369 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.65 -116.23 3.66 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 114.651 0.62 . . . . 0.80000000000000004 114.651 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -170.53 118.71 0.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.206 0.527 . . . . 1.6299999999999999 111.389 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER 51.47 107.75 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.525 2.417 . . . . 1.0 117.525 177.439 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.553 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 79.7 t60 -137.08 134.98 37.07 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.869 1.063 . . . . 0.45000000000000001 113.869 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.9 t -104.76 114.51 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 CA-C-N 113.813 -1.539 . . . . 1.3899999999999999 107.214 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.48 161.15 17.17 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 119.521 -0.276 . . . . 1.8500000000000001 111.558 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -45.06 -25.37 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.074 0 N-CA-C 119.12 3.007 . . . . 0.71999999999999997 119.12 -176.509 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -92.04 -21.12 20.66 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 118.082 0.401 . . . . 0.51000000000000001 111.427 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.86 39.64 1.28 Allowed Glycine 0 C--N 1.356 1.683 0 C-N-CA 124.288 0.947 . . . . 0.34000000000000002 113.983 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.548 HD11 ' HG ' ' A' ' 6' ' ' LEU . 19.9 mm -105.85 124.98 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 109.094 -0.706 . . . . 0.55000000000000004 109.094 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.553 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.7 t-160 -115.82 132.96 56.49 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 115.693 1.738 . . . . 1.3400000000000001 115.693 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.8 144.78 27.05 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.726 -1.125 . . . . 2.79 108.999 174.368 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -67.31 -104.78 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.317 1.969 . . . . 3.0 116.317 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.1 tttt 176.8 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.233 1.013 . . . . 2.2999999999999998 111.62 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 46.46 58.09 16.6 Favored Pre-proline 0 N--CA 1.533 3.705 0 N-CA-C 117.152 2.279 . . . . 1.1699999999999999 117.152 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 CA--C 1.563 1.937 0 C-N-CA 123.066 2.511 . . . . 1.45 117.146 -177.501 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.401 ' HB3' ' CD ' ' A' ' 58' ' ' GLN . 38.7 Cg_exo . . . . . 0 N--CA 1.502 1.982 0 N-CA-C 116.908 1.849 . . . . 1.3700000000000001 116.908 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.278 1.2 mp -86.95 133.21 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.273 0 CA-C-N 115.353 -0.839 . . . . 0.68999999999999995 109.791 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.39 -18.39 36.25 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.944 2.201 . . . . 1.28 116.944 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -103.97 23.78 12.38 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.1 1.148 . . . . 1.51 114.1 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -138.11 -166.85 2.05 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.018 0.914 . . . . 1.0900000000000001 112.803 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.658 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.3 t30 -94.69 -178.59 0.82 Allowed Pre-proline 0 CA--C 1.571 1.772 0 C-N-CA 125.586 1.555 . . . . 1.27 110.934 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.448 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.3 Cg_exo -72.31 -45.62 0.6 Allowed 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 122.91 2.406 . . . . 0.94999999999999996 112.018 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -68.71 -52.32 32.05 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 113.32 -1.764 . . . . 2.04 111.863 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -75.65 -6.71 51.79 Favored 'General case' 0 CA--C 1.589 2.471 0 CA-C-N 115.353 -0.84 . . . . 1.6200000000000001 112.692 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.658 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 4.2 tt0 -72.5 -42.31 65.0 Favored 'General case' 0 C--N 1.387 2.232 0 C-N-CA 125.631 1.573 . . . . 1.77 108.046 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.09 -42.34 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.045 0 C-N-CA 124.466 1.107 . . . . 0.81000000000000005 109.341 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.9 tp -81.37 -6.35 58.82 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 113.946 1.091 . . . . 1.1499999999999999 113.946 176.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -123.63 20.5 9.43 Favored 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 124.64 1.176 . . . . 0.92000000000000004 112.173 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.67 -35.04 0.31 Allowed 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 116.134 1.902 . . . . 1.3300000000000001 116.134 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.1 p -70.99 130.17 40.9 Favored 'General case' 0 N--CA 1.529 3.508 0 N-CA-C 115.011 1.486 . . . . 1.28 115.011 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.608 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.5 pt-20 . . . . . 0 N--CA 1.503 2.178 0 C-N-CA 124.55 1.14 . . . . 1.53 111.019 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 119.908 -0.092 . . . . 2.1499999999999999 111.073 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.665 ' H ' HD21 ' A' ' 164' ' ' ASN . 0.2 OUTLIER 55.03 89.51 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 125.805 1.642 . . . . 0.77000000000000002 113.648 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -150.45 160.9 43.43 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.114 1.153 . . . . 0.81000000000000005 114.114 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -176.93 -173.05 42.15 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 116.429 1.332 . . . . 0.46999999999999997 116.429 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -107.93 171.99 7.09 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.35 1.982 . . . . 0.89000000000000001 116.35 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.16 121.2 28.93 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 113.108 -1.86 . . . . 0.51000000000000001 111.188 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.82 106.41 49.97 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 123.339 0.656 . . . . 0.14999999999999999 109.262 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.05 117.54 2.24 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 122.08 1.853 . . . . 0.14999999999999999 114.825 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.78 157.47 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 122.084 0.945 . . . . 0.19 110.981 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -146.83 20.05 1.28 Allowed 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.667 -1.151 . . . . 2.5299999999999998 111.824 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -131.85 159.71 37.77 Favored 'General case' 0 C--N 1.362 1.15 0 CA-C-O 121.29 0.567 . . . . 2.1200000000000001 111.897 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -116.62 148.17 41.2 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.869 1.063 . . . . 0.41999999999999998 113.869 -178.591 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.78 -138.08 5.52 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.117 -1.401 . . . . 0.23000000000000001 112.38 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 36.4 mm-40 -115.56 104.05 11.34 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-N 118.082 0.941 . . . . 1.75 110.898 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -99.73 128.27 45.83 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.174 0.512 . . . . 0.20999999999999999 110.882 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -113.32 123.48 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.418 0.628 . . . . 0.20000000000000001 111.004 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.47 HD12 HD12 ' A' ' 172' ' ' ILE . 2.6 tt -108.69 105.26 14.78 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.728 -1.124 . . . . 0.78000000000000003 110.109 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 1.7 t -114.54 122.27 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.134 -1.393 . . . . 0.44 107.633 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -131.7 136.73 47.88 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.661 -0.7 . . . . 1.25 111.8 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 5.1 tppt? -97.66 123.64 41.66 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.622 0.725 . . . . 2.52 112.519 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -105.78 133.21 50.88 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.847 -1.07 . . . . 0.40000000000000002 109.887 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.15 158.99 43.21 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.792 -0.64 . . . . 0.40999999999999998 111.599 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -124.12 170.18 10.96 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-O 121.454 0.645 . . . . 2.6099999999999999 112.667 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.95 -73.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 115.884 -0.598 . . . . 2.1299999999999999 112.423 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.85 67.28 1.51 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.14 0.495 . . . . 2.27 111.927 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -144.59 102.32 3.8 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.866 -0.606 . . . . 1.46 110.279 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.88 100.51 10.01 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 122.329 1.061 . . . . 0.83999999999999997 111.856 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -166.43 139.88 4.02 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 114.73 -1.123 . . . . 2.4500000000000002 111.748 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.4 m -125.46 116.25 21.53 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.701 -0.681 . . . . 1.6599999999999999 111.81 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 73.24 49.45 0.15 Allowed 'General case' 0 N--CA 1.508 2.463 0 C-N-CA 125.673 1.589 . . . . 1.8899999999999999 113.055 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -151.36 -40.99 0.12 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.24 1.416 . . . . 2.5600000000000001 109.212 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -100.59 78.88 2.03 Favored 'General case' 0 C--N 1.365 1.268 0 N-CA-C 108.468 -0.938 . . . . 2.7599999999999998 108.468 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.8 130.19 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 114.677 -1.147 . . . . 0.68999999999999995 111.456 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -115.66 172.77 6.91 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.996 1.48 . . . . 0.69999999999999996 114.996 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -122.87 137.83 54.83 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.855 -0.611 . . . . 1.3300000000000001 111.702 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -131.75 128.04 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.483 0 CA-C-N 115.273 -0.876 . . . . 0.47999999999999998 110.012 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -129.22 151.81 49.48 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.366 1.617 . . . . 1.6899999999999999 115.366 -177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.3 OUTLIER -130.1 113.05 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 C-N-CA 123.355 0.662 . . . . 0.59999999999999998 112.382 177.101 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.11 25.61 12.49 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 127.013 2.125 . . . . 1.1200000000000001 114.095 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.53 -16.13 52.53 Favored Glycine 0 CA--C 1.548 2.154 0 CA-C-N 115.6 -0.727 . . . . 0.32000000000000001 113.682 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 94.0 m-70 -83.75 144.68 29.17 Favored 'General case' 0 C--N 1.365 1.241 0 C-N-CA 125.53 1.532 . . . . 0.56999999999999995 114.496 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.94 126.88 42.39 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.326 0.584 . . . . 0.55000000000000004 110.863 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.95 -58.63 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 115.098 -0.956 . . . . 1.0600000000000001 113.13 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.06 89.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.263 -1.014 . . . . 0.44 108.263 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.65 73.69 0.86 Allowed 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 123.134 1.445 . . . . 2.2999999999999998 112.317 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 p30 158.14 62.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 127.871 2.468 . . . . 2.48 107.243 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.2 tp -101.92 100.93 11.28 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.184 1.179 . . . . 1.1299999999999999 114.184 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -112.71 108.61 17.7 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-N 113.401 -1.727 . . . . 2.3500000000000001 109.675 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -26.69 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.547 0 N-CA-C 114.725 1.38 . . . . 0.68000000000000005 114.725 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -76.3 -42.73 44.29 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 123.303 0.641 . . . . 0.77000000000000002 112.335 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -73.91 -26.37 60.49 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 124.176 0.99 . . . . 0.91000000000000003 113.563 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -78.65 -57.7 3.63 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.765 1.024 . . . . 2.4300000000000002 113.765 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -31.45 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 114.712 1.375 . . . . 0.93000000000000005 114.712 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.23 -114.94 2.4 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 118.578 0.626 . . . . 0.84999999999999998 112.945 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -114.76 107.58 15.63 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.216 0.531 . . . . 3.1800000000000002 110.545 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 73.32 -128.62 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 125.59 1.556 . . . . 2.0800000000000001 111.933 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.3 p 58.26 -171.02 0.11 Allowed 'General case' 0 N--CA 1.535 3.798 0 C-N-CA 126.159 1.783 . . . . 0.62 115.474 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.77 129.29 54.66 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 112.968 0.729 . . . . 0.46000000000000002 112.968 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -105.72 136.54 45.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.249 0.619 . . . . 0.38 109.575 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -128.13 133.89 49.03 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.825 1.417 . . . . 2.5 114.825 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.16 118.74 32.7 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.418 -1.264 . . . . 1.5600000000000001 110.844 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.02 112.21 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 115.19 -0.913 . . . . 0.45000000000000001 110.636 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.75 93.01 43.38 Favored Pre-proline 0 CA--C 1.568 1.669 0 CA-C-N 115.532 -0.758 . . . . 0.83999999999999997 110.709 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -74.33 138.27 24.55 Favored 'Trans proline' 0 C--N 1.397 3.097 0 C-N-CA 123.032 2.488 . . . . 0.16 113.686 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.11 146.94 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 CA-C-N 115.276 -0.875 . . . . 0.38 110.504 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.8 p -131.75 111.83 11.99 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.566 -0.743 . . . . 1.3100000000000001 111.626 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.494 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.6 mt -111.59 122.83 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 108.539 -0.911 . . . . 0.25 108.539 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -142.5 130.24 21.56 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.857 -0.611 . . . . 2.0499999999999998 111.192 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt 67.54 15.25 9.77 Favored 'General case' 0 N--CA 1.515 2.822 0 C-N-CA 125.096 1.358 . . . . 3.5499999999999998 114.405 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.14 15.6 35.34 Favored Glycine 0 CA--C 1.549 2.17 0 CA-C-O 119.143 -0.809 . . . . 0.37 114.806 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 30.9 mtmt -128.89 155.6 45.0 Favored 'General case' 0 C--N 1.367 1.348 0 CA-C-N 118.442 1.121 . . . . 1.5600000000000001 112.924 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.46 148.52 26.36 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.36 1.244 . . . . 0.34000000000000002 114.36 -176.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.8 m -134.77 112.28 10.61 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.601 -1.181 . . . . 0.64000000000000001 110.573 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 p -112.21 92.42 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.636 0 CA-C-O 121.196 0.522 . . . . 0.46000000000000002 109.876 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 63.06 -84.26 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.866 0 C-N-CA 125.581 1.553 . . . . 1.5600000000000001 114.241 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.64 28.1 4.53 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 116.206 -0.452 . . . . 0.48999999999999999 113.768 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -137.05 119.23 15.54 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.25 0.62 . . . . 1.8200000000000001 110.048 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.75 132.6 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 CA-C-O 121.57 0.7 . . . . 1.02 112.185 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -150.53 -179.31 7.12 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.043 -0.98 . . . . 0.56000000000000005 109.818 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.262 12.8 t -103.14 138.22 40.26 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 113.628 0.974 . . . . 1.25 113.628 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -82.8 123.72 29.61 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.396 1.078 . . . . 0.28999999999999998 111.288 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.19 91.22 3.28 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.804 0.668 . . . . 1.4199999999999999 112.804 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.81 -63.87 3.41 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 119.014 2.366 . . . . 0.41999999999999998 119.014 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.539 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -132.85 161.16 34.91 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.834 1.05 . . . . 1.1000000000000001 113.834 -176.269 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.539 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -107.09 143.32 35.4 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 113.764 -1.562 . . . . 0.67000000000000004 109.593 177.033 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 t -124.81 142.63 51.3 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.643 1.349 . . . . 0.35999999999999999 114.643 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.446 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.93 97.43 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 106.926 -1.509 . . . . 0.73999999999999999 106.926 176.091 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -113.72 118.44 34.33 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.758 -0.655 . . . . 1.6699999999999999 111.968 -177.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.41 133.09 55.98 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-O 122.31 1.052 . . . . 1.8 111.191 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.22 145.77 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 113.018 -1.901 . . . . 0.57999999999999996 110.548 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.437 ' HB3' ' OD1' ' A' ' 164' ' ' ASN . 41.0 pttt -58.16 151.17 19.63 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 116.97 2.211 . . . . 2.1800000000000002 116.97 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.67 -60.34 0.56 Allowed Glycine 0 CA--C 1.539 1.533 0 CA-C-N 115.093 -0.958 . . . . 1.02 113.68 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -141.52 -61.0 0.47 Allowed 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.967 0.384 . . . . 2.8599999999999999 111.717 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -117.49 -49.49 2.56 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.939 0.496 . . . . 3.9100000000000001 112.077 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.35 178.57 4.55 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.464 0.705 . . . . 1.74 111.459 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.665 HD21 ' H ' ' A' ' 70' ' ' SER . 5.3 m-20 -118.28 -85.93 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.045 0 CA-C-O 117.356 -1.307 . . . . 1.6799999999999999 110.275 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -87.49 -37.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.398 3.176 0 CA-C-N 123.648 2.338 . . . . 2.0600000000000001 114.436 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? 79.86 -94.02 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 126.495 1.918 . . . . 3.0 110.366 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 64' ' ' GLU . 17.5 t -106.42 131.29 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.413 -1.328 . . . . 0.80000000000000004 107.413 174.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.2 t -134.59 129.94 35.74 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.94 -1.027 . . . . 0.87 112.841 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.268 . . -122.87 47.89 1.88 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.71 1.745 . . . . 0.34000000000000002 115.71 -177.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -40.38 127.26 2.34 Favored 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 116.051 1.871 . . . . 0.69999999999999996 116.051 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.475 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 4.8 t80 -147.55 100.88 3.29 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.912 -0.585 . . . . 0.20999999999999999 111.101 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.47 HD12 HD12 ' A' ' 85' ' ' LEU 0.305 10.1 tt -109.86 121.3 62.55 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.061 0 CA-C-O 122.427 1.108 . . . . 0.31 111.011 175.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -123.34 165.35 17.15 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 113.873 -1.512 . . . . 0.44 110.734 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 18.7 ptmt -122.14 159.35 27.37 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 118.139 2.644 . . . . 1.26 118.139 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.62 -41.59 2.11 Favored Glycine 0 CA--C 1.544 1.859 0 CA-C-N 110.11 -3.223 . . . . 0.17000000000000001 119.053 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.61 154.18 0.94 Allowed 'General case' 0 N--CA 1.52 3.058 0 CA-C-N 120.782 2.291 . . . . 0.14999999999999999 113.156 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.77 -13.33 59.87 Favored 'General case' 0 CA--C 1.58 2.125 0 C-N-CA 124.836 1.255 . . . . 0.17000000000000001 114.353 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.55 4.78 45.59 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 113.86 1.059 . . . . 0.55000000000000004 113.86 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.58 -9.89 15.28 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 114.312 1.227 . . . . 0.59999999999999998 114.312 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.516 2.847 0 C-N-CA 124.424 1.09 . . . . 0.94999999999999996 113.358 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.508 ' HG ' HD11 ' A' ' 27' ' ' ILE . 15.0 tp . . . . . 0 CA--C 1.566 1.584 0 N-CA-C 112.947 0.721 . . . . 0.34999999999999998 112.947 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.4 -23.09 65.56 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 126.101 1.76 . . . . 0.20000000000000001 115.274 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -11.65 51.71 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.727 1.01 . . . . 0.32000000000000001 113.727 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 2.1 mmpt? -108.57 -19.23 13.51 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 113.514 0.931 . . . . 1.73 113.514 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.03 135.75 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.936 0 N-CA-C 115.257 1.577 . . . . 0.11 115.257 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.5 -29.83 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 115.287 -0.869 . . . . 0.16 112.095 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -163.07 123.3 2.28 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-O 120.572 0.225 . . . . 0.54000000000000004 110.953 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -140.93 128.55 21.46 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.351 -0.843 . . . . 0.19 110.777 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.1 t -136.57 131.06 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.507 0.928 . . . . 1.05 113.507 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -116.7 110.88 19.03 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.304 -0.999 . . . . 2.1099999999999999 108.304 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.59 100.11 9.95 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-O 122.223 1.011 . . . . 0.63 110.437 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.51 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -179.74 -57.54 0.08 OUTLIER Glycine 0 C--N 1.348 1.232 0 CA-C-N 113.594 -1.639 . . . . 0.70999999999999996 115.528 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.4 -115.9 3.29 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 120.038 -0.312 . . . . 0.80000000000000004 113.795 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -165.11 117.73 1.2 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.359 0.264 . . . . 1.6299999999999999 111.565 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 2.8 m 41.71 106.04 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.155 0 N-CA-C 118.075 2.62 . . . . 1.0 118.075 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.636 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 82.7 t60 -134.07 138.3 45.21 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.041 1.126 . . . . 0.45000000000000001 114.041 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.261 8.0 p -108.64 117.48 54.2 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.073 0 CA-C-N 114.202 -1.363 . . . . 1.3899999999999999 110.254 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.07 156.97 23.05 Favored 'General case' 0 CA--C 1.571 1.757 0 CA-C-N 114.343 -1.298 . . . . 1.8500000000000001 110.676 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 m -41.4 -32.69 0.36 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.153 0 N-CA-C 119.113 3.005 . . . . 0.71999999999999997 119.113 -176.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.41 ' HB2' HD23 ' A' ' 6' ' ' LEU . 63.8 m-70 -88.42 -26.87 21.9 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.312 0.505 . . . . 0.51000000000000001 110.909 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.94 43.43 0.41 Allowed Glycine 0 C--N 1.35 1.334 0 CA-C-N 114.994 -1.003 . . . . 0.34000000000000002 114.701 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.508 HD11 ' HG ' ' A' ' 6' ' ' LEU . 15.8 mm -106.79 112.66 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 N-CA-C 109.687 -0.486 . . . . 0.55000000000000004 109.687 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.636 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.74 134.85 48.19 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 115.189 1.552 . . . . 1.3400000000000001 115.189 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -96.14 143.09 27.57 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.731 -1.122 . . . . 2.79 110.08 176.378 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -97.44 103.37 15.3 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.226 1.011 . . . . 3.0 113.381 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -33.79 116.7 0.28 Allowed 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 118.51 2.781 . . . . 2.2999999999999998 118.51 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 40.37 73.43 0.85 Allowed Pre-proline 0 N--CA 1.525 3.318 0 N-CA-C 118.178 2.658 . . . . 1.1699999999999999 118.178 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 CA--C 1.56 1.777 0 C-N-CA 122.281 1.987 . . . . 1.45 116.69 179.404 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo . . . . . 0 N--CA 1.491 1.379 0 N-CA-C 117.042 1.901 . . . . 1.3700000000000001 117.042 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.25 1.3 mp -91.45 136.72 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.243 0 CA-C-N 114.748 -1.114 . . . . 0.68999999999999995 110.039 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.1 -10.45 33.3 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 115.991 1.848 . . . . 1.28 115.991 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -108.25 20.94 18.03 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 114.302 1.223 . . . . 1.51 114.302 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.53 -166.63 2.1 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 121.71 0.767 . . . . 1.0900000000000001 112.789 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.85 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.8 t30 -90.25 177.7 2.25 Favored Pre-proline 0 N--CA 1.498 1.952 0 C-N-CA 125.411 1.484 . . . . 1.27 110.959 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -71.71 -46.99 0.51 Allowed 'Trans proline' 0 C--N 1.394 2.942 0 C-N-CA 122.998 2.465 . . . . 0.94999999999999996 112.592 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 56' ' ' GLU . 3.6 pt-20 -69.75 -44.11 70.87 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 113.786 -1.552 . . . . 2.04 112.034 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -80.14 -7.21 58.81 Favored 'General case' 0 CA--C 1.587 2.371 0 CA-C-N 115.11 -0.95 . . . . 1.6200000000000001 111.758 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.85 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.6 tt0 -73.31 -37.81 66.05 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 125.684 1.594 . . . . 1.77 108.737 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -64.01 -47.78 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.871 0 C-N-CA 125.777 1.631 . . . . 0.81000000000000005 109.042 173.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.611 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 1.6 tp -80.12 -4.58 53.48 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.69 1.366 . . . . 1.1499999999999999 114.69 177.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -113.17 3.46 16.06 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 124.639 1.176 . . . . 0.92000000000000004 110.222 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.77 -115.95 0.14 Allowed 'General case' 0 CA--C 1.568 1.658 0 C-N-CA 124.479 1.112 . . . . 1.3300000000000001 111.703 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.289 2.9 p 56.67 -84.48 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.12 0 C-N-CA 127.33 2.252 . . . . 1.28 116.144 -174.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.532 ' HB2' HG22 ' A' ' 167' ' ' VAL . 20.6 tt0 . . . . . 0 N--CA 1.526 3.351 0 C-N-CA 125.361 1.465 . . . . 1.53 114.227 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 112.355 0.502 . . . . 2.1499999999999999 112.355 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.51 107.62 1.17 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 124.522 1.129 . . . . 0.77000000000000002 112.35 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -100.45 129.28 46.39 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.403 -1.271 . . . . 0.81000000000000005 110.651 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -133.73 132.88 6.64 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 118.716 2.247 . . . . 0.46999999999999997 118.716 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -103.1 145.61 29.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.28 0.844 . . . . 0.89000000000000001 113.28 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.9 117.96 32.13 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.383 -1.281 . . . . 0.51000000000000001 111.897 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.45 HG21 HG21 ' A' ' 172' ' ' ILE . 3.2 mp -117.51 97.69 51.01 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.275 -0.875 . . . . 0.14999999999999999 109.048 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -83.03 118.84 2.74 Favored 'Trans proline' 0 CA--C 1.558 1.705 0 C-N-CA 122.16 1.906 . . . . 0.14999999999999999 114.755 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.92 159.18 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 CA-C-O 122.119 0.962 . . . . 0.19 111.433 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -146.36 17.97 1.35 Allowed 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 114.315 -1.311 . . . . 2.5299999999999998 111.935 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -128.99 163.22 25.83 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 121.269 0.557 . . . . 2.1200000000000001 111.466 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -124.18 146.65 48.55 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.8 1.037 . . . . 0.41999999999999998 113.8 -178.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.72 -133.93 3.61 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.068 -1.423 . . . . 0.23000000000000001 112.094 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 21.5 mt-10 -118.52 106.46 12.69 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 118.479 1.139 . . . . 1.75 111.106 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -98.97 128.85 45.21 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.485 0.66 . . . . 0.20999999999999999 111.331 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.46 118.23 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-N 115.328 -0.851 . . . . 0.20000000000000001 111.045 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.535 HD12 HD12 ' A' ' 172' ' ' ILE . 1.6 tt -107.83 105.06 14.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.228 -1.351 . . . . 0.78000000000000003 109.81 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.88 125.41 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 114.229 -1.35 . . . . 0.44 108.741 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.14 137.17 54.16 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 112.762 0.652 . . . . 1.25 112.762 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 5.3 tptp -101.17 115.73 31.17 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.076 -0.965 . . . . 2.52 110.196 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -105.01 134.38 48.22 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.957 -0.565 . . . . 0.40000000000000002 110.156 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.72 152.75 51.66 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.614 0.721 . . . . 0.40999999999999998 111.899 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -126.1 150.59 48.09 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.3 -0.863 . . . . 2.6099999999999999 110.449 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.96 -76.03 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 114.186 1.18 . . . . 2.1299999999999999 114.186 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -124.27 73.17 1.22 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.059 0.763 . . . . 2.27 113.059 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -154.29 109.29 3.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.711 0.804 . . . . 1.46 109.668 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.42 104.78 14.21 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 122.192 0.996 . . . . 0.83999999999999997 112.495 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -171.84 140.02 1.23 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.884 -1.053 . . . . 2.4500000000000002 111.716 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.4 m -129.07 118.57 22.72 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.571 -0.74 . . . . 1.6599999999999999 111.835 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 72.97 49.94 0.15 Allowed 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 125.793 1.637 . . . . 1.8899999999999999 112.508 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -151.33 -40.48 0.12 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.476 1.111 . . . . 2.5600000000000001 110.278 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -109.04 83.73 1.8 Allowed 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.464 -0.939 . . . . 2.7599999999999998 108.464 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.85 126.57 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 113.888 -1.505 . . . . 0.68999999999999995 111.651 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.54 -176.4 3.07 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.205 1.558 . . . . 0.69999999999999996 115.205 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -128.42 136.98 51.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.092 -0.38 . . . . 1.3300000000000001 111.29 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.9 t -130.23 125.26 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.279 0 C-N-CA 123.482 0.713 . . . . 0.47999999999999998 109.918 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.3 mtt180 -121.97 153.26 38.76 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.406 1.632 . . . . 1.6899999999999999 115.406 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.55 102.83 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 114.928 -1.033 . . . . 0.59999999999999998 112.373 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.5 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.31 27.21 13.76 Favored 'General case' 0 N--CA 1.524 3.252 0 C-N-CA 126.876 2.07 . . . . 1.1200000000000001 113.895 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.32 -18.59 35.63 Favored Glycine 0 CA--C 1.547 2.032 0 C-N-CA 121.375 -0.441 . . . . 0.32000000000000001 113.235 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -86.07 173.8 9.62 Favored 'General case' 0 C--N 1.368 1.384 0 C-N-CA 125.491 1.517 . . . . 0.56999999999999995 113.53 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.7 p -126.57 126.24 43.32 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.175 0.512 . . . . 0.55000000000000004 111.278 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.263 9.1 p -112.41 -45.12 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 CA-C-N 115.263 -0.88 . . . . 1.0600000000000001 111.072 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.66 89.19 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 109.013 -0.736 . . . . 0.44 109.013 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -105.74 90.68 3.47 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-O 122.986 1.374 . . . . 2.2999999999999998 110.366 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 127.65 78.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 110.01 -3.268 . . . . 2.48 108.508 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.06 110.86 22.94 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 121.744 0.783 . . . . 1.1299999999999999 112.916 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -119.0 98.84 6.38 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 106.899 -1.519 . . . . 2.3500000000000001 106.899 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -25.54 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.32 0 N-CA-C 113.925 1.083 . . . . 0.68000000000000005 113.925 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -75.71 -40.29 55.93 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.022 0.929 . . . . 0.77000000000000002 112.311 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -73.26 -26.85 61.26 Favored 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 124.672 1.189 . . . . 0.91000000000000003 113.388 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -80.66 -57.77 3.41 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.692 0.997 . . . . 2.4300000000000002 113.692 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.33 -34.7 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 N-CA-C 114.864 1.431 . . . . 0.93000000000000005 114.864 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 123.68 -109.22 1.28 Allowed Glycine 0 C--N 1.356 1.669 0 CA-C-N 118.764 0.711 . . . . 0.84999999999999998 113.578 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -114.61 106.87 14.75 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.757 0.313 . . . . 3.1800000000000002 110.707 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.8 m 68.09 -124.09 0.18 Allowed 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 125.379 1.471 . . . . 2.0800000000000001 112.825 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.3 p 56.07 -164.09 0.14 Allowed 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 126.461 1.904 . . . . 0.62 115.134 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.449 ' HB1' ' HZ2' ' A' ' 88' ' ' LYS . . . -111.34 132.3 54.51 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 113.102 0.778 . . . . 0.46000000000000002 113.102 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -107.72 143.69 35.89 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.035 0.534 . . . . 0.38 109.829 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.28 131.85 19.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.185 1.18 . . . . 2.5 114.185 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -119.94 134.14 55.34 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 115.145 -0.934 . . . . 1.5600000000000001 110.827 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.47 122.36 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 114.652 -1.158 . . . . 0.45000000000000001 110.835 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.78 86.24 58.78 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-N 115.361 -0.836 . . . . 0.83999999999999997 110.823 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -73.88 126.23 10.52 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 123.015 2.477 . . . . 0.16 112.634 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -112.21 149.45 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.565 0 CA-C-N 115.153 -0.931 . . . . 0.38 111.428 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 p -130.33 110.63 11.67 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.1 -0.954 . . . . 1.3100000000000001 111.661 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.2 mt -114.15 122.73 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 N-CA-C 108.477 -0.934 . . . . 0.25 108.477 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -141.04 127.36 19.78 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.658 -0.701 . . . . 2.0499999999999998 110.76 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp 68.0 14.35 9.33 Favored 'General case' 0 N--CA 1.514 2.759 0 C-N-CA 125.287 1.435 . . . . 3.5499999999999998 113.961 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 17.47 30.1 Favored Glycine 0 CA--C 1.547 2.059 0 CA-C-O 119.213 -0.771 . . . . 0.37 114.786 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 55.5 mtpt -124.42 146.38 48.93 Favored 'General case' 0 C--N 1.367 1.35 0 CA-C-N 118.378 1.089 . . . . 1.5600000000000001 112.46 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.18 144.7 30.39 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.275 1.213 . . . . 0.34000000000000002 114.275 -175.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.27 113.44 11.29 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.824 -1.08 . . . . 0.64000000000000001 110.467 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.3 p -107.81 94.0 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.571 0 CA-C-N 115.929 -0.578 . . . . 0.46000000000000002 110.226 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 66.95 -83.29 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.778 0 C-N-CA 125.527 1.531 . . . . 1.5600000000000001 113.871 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.24 26.05 4.76 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 116.094 -0.503 . . . . 0.48999999999999999 113.628 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -128.71 131.79 47.95 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 123.364 0.666 . . . . 1.8200000000000001 110.57 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -116.14 130.62 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 CA-C-O 121.64 0.733 . . . . 1.02 111.981 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m -150.84 -179.1 6.99 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.975 -1.011 . . . . 0.56000000000000005 109.592 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.271 14.1 t -104.25 138.79 40.19 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 113.425 0.898 . . . . 1.25 113.425 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -82.53 122.03 27.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 124.18 0.992 . . . . 0.28999999999999998 111.349 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.79 90.53 3.26 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.48 0.548 . . . . 1.4199999999999999 112.48 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.5 -62.69 2.69 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 118.92 2.328 . . . . 0.41999999999999998 118.92 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.51 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -134.0 158.86 42.45 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.079 1.14 . . . . 1.1000000000000001 114.079 -176.605 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.51 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -104.61 137.75 41.97 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.523 -1.671 . . . . 0.67000000000000004 109.107 176.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.407 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.0 t -124.13 128.29 49.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.772 1.397 . . . . 0.35999999999999999 114.772 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 3.2 t -106.56 101.42 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 106.689 -1.597 . . . . 0.73999999999999999 106.689 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -117.64 120.71 38.84 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.882 -1.054 . . . . 1.6699999999999999 112.746 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -113.74 126.93 55.78 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-O 122.177 0.989 . . . . 1.8 111.223 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.78 146.02 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-N 112.947 -1.933 . . . . 0.57999999999999996 111.242 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -91.14 149.94 21.59 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 114.853 -1.067 . . . . 2.1800000000000002 113.165 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -89.41 -43.98 5.09 Favored Glycine 0 CA--C 1.545 1.954 0 CA-C-N 115.634 -0.712 . . . . 1.02 114.859 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -128.99 -71.99 0.62 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.694 0.398 . . . . 2.8599999999999999 110.992 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.605 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 6.8 t80 -146.65 120.42 9.24 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.319 0.647 . . . . 3.9100000000000001 109.5 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 0.5 OUTLIER 90.64 151.93 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 125.033 1.333 . . . . 1.74 112.067 -178.183 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.65 -168.32 0.15 Allowed Pre-proline 0 CA--C 1.572 1.795 0 CA-C-N 113.994 -1.457 . . . . 1.6799999999999999 109.434 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -57.76 -17.92 31.57 Favored 'Trans proline' 0 C--N 1.403 3.436 0 C-N-CA 122.937 2.425 . . . . 2.0600000000000001 115.181 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 63.0 tttt 81.91 -63.99 0.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 126.665 1.986 . . . . 3.0 115.513 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 64' ' ' GLU . 4.0 t -102.61 134.27 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.602 1.092 . . . . 0.80000000000000004 110.594 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.57 132.33 38.96 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 114.779 -1.101 . . . . 0.87 113.262 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -128.68 48.48 2.32 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.081 1.511 . . . . 0.34000000000000002 115.081 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.93 135.36 4.15 Favored 'General case' 0 N--CA 1.515 2.808 0 N-CA-C 116.663 2.097 . . . . 0.69999999999999996 116.663 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -150.02 108.84 3.86 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.804 -0.635 . . . . 0.20999999999999999 111.068 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.535 HD12 HD12 ' A' ' 85' ' ' LEU 0.308 6.6 tt -117.49 123.26 71.51 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.15 0 CA-C-O 122.439 1.114 . . . . 0.31 111.685 175.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 10.5 ptm -123.33 166.79 14.71 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 113.924 -1.489 . . . . 0.44 111.274 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.2 ptmm? -123.16 157.59 32.64 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 118.2 2.667 . . . . 1.26 118.2 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.65 -42.36 1.91 Allowed Glycine 0 CA--C 1.542 1.728 0 CA-C-N 110.604 -2.998 . . . . 0.17000000000000001 119.085 173.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.57 152.44 0.81 Allowed 'General case' 0 N--CA 1.516 2.864 0 CA-C-N 120.419 2.11 . . . . 0.14999999999999999 112.762 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.91 -15.5 59.66 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.437 1.273 . . . . 0.17000000000000001 114.437 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.62 4.5 43.59 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.101 1.148 . . . . 0.55000000000000004 114.101 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.99 -10.87 17.77 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 113.624 0.972 . . . . 0.59999999999999998 113.624 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.516 2.871 0 C-N-CA 125.325 1.45 . . . . 0.94999999999999996 111.489 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.559 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.6 tp . . . . . 0 CA--C 1.564 1.49 0 N-CA-C 113.248 0.833 . . . . 0.34999999999999998 113.248 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.37 -22.77 61.85 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 125.951 1.7 . . . . 0.20000000000000001 115.161 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.46 -12.34 49.29 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 113.596 0.961 . . . . 0.32000000000000001 113.596 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -105.65 -21.64 13.15 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.285 0.846 . . . . 1.73 113.285 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.24 135.68 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.926 0 N-CA-C 115.317 1.599 . . . . 0.11 115.317 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -124.13 -29.39 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 115.24 -0.891 . . . . 0.16 112.258 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 62.5 t90 -162.38 116.99 1.83 Allowed 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 120.545 0.212 . . . . 0.54000000000000004 111.328 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.82 129.0 31.77 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.483 -0.761 . . . . 0.19 111.365 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -136.81 130.99 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 113.214 0.82 . . . . 1.05 113.214 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 8.2 t-20 -114.1 105.33 13.08 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 107.663 -1.236 . . . . 2.1099999999999999 107.663 172.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.22 105.56 11.59 Favored 'General case' 0 C--O 1.274 2.38 0 CA-C-O 121.802 0.811 . . . . 0.63 110.39 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.596 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 168.98 -58.32 0.2 Allowed Glycine 0 C--N 1.358 1.786 0 CA-C-N 112.026 -2.352 . . . . 0.70999999999999996 114.037 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -106.96 -128.24 5.94 Favored Glycine 0 N--CA 1.478 1.464 0 CA-C-O 119.303 -0.721 . . . . 0.80000000000000004 113.121 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.496 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 40.3 mt-10 -162.09 117.22 1.93 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.645 0.723 . . . . 1.6299999999999999 111.86 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 55.61 108.94 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 117.358 2.355 . . . . 1.0 117.358 177.634 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 52.2 t-80 -144.59 139.05 27.87 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 114.071 1.137 . . . . 0.45000000000000001 114.071 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.268 9.9 p -107.63 118.84 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.085 0 CA-C-N 114.829 -1.078 . . . . 1.3899999999999999 110.886 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.23 156.01 22.21 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 114.395 -1.275 . . . . 1.8500000000000001 110.856 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 m -41.82 -32.16 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.258 0 N-CA-C 119.087 2.995 . . . . 0.71999999999999997 119.087 -176.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -87.16 -23.84 24.68 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.413 0.551 . . . . 0.51000000000000001 111.374 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.73 40.94 0.69 Allowed Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.114 -0.948 . . . . 0.34000000000000002 114.403 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.559 HD11 ' HG ' ' A' ' 6' ' ' LEU . 22.7 mm -106.91 113.35 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 N-CA-C 109.755 -0.461 . . . . 0.55000000000000004 109.755 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.3 132.67 51.21 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 115.34 1.608 . . . . 1.3400000000000001 115.34 -177.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.496 ' OH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -93.17 146.65 23.51 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 114.849 -1.069 . . . . 2.79 109.911 175.247 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -58.16 -111.71 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 127.505 2.322 . . . . 3.0 116.688 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -178.63 79.63 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 113.229 0.826 . . . . 2.2999999999999998 113.229 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.454 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 0.3 OUTLIER 65.14 46.31 0.53 Allowed Pre-proline 0 N--CA 1.517 2.894 0 N-CA-C 117.695 2.48 . . . . 1.1699999999999999 117.695 176.55 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 43.0 Cg_endo . . . . . 0 C--N 1.373 1.829 0 C-N-CA 123.072 2.515 . . . . 1.45 114.579 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 31.8 Cg_exo . . . . . 0 N--CA 1.501 1.963 0 N-CA-C 117.051 1.904 . . . . 1.3700000000000001 117.051 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.273 1.1 mp -87.75 124.51 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.09 0 CA-C-N 115.22 -0.9 . . . . 0.68999999999999995 108.981 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -81.19 -19.34 43.52 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.421 2.008 . . . . 1.28 116.421 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -94.97 24.0 5.16 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 113.736 1.013 . . . . 1.51 113.736 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.16 -173.18 4.18 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.828 0.851 . . . . 1.0900000000000001 110.954 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.696 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.87 -176.91 0.58 Allowed Pre-proline 0 N--CA 1.512 2.64 0 CA-C-O 118.449 -0.786 . . . . 1.27 109.421 178.128 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -69.17 -39.49 7.56 Favored 'Trans proline' 0 C--N 1.398 3.165 0 C-N-CA 122.613 2.209 . . . . 0.94999999999999996 113.279 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 56' ' ' GLU . 6.3 pt-20 -69.25 -49.24 58.05 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 125.322 1.449 . . . . 2.04 112.015 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -79.65 -5.42 55.06 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 114.914 -1.039 . . . . 1.6200000000000001 112.625 177.232 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.696 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 1.1 tt0 -74.02 -41.84 61.22 Favored 'General case' 0 C--N 1.38 1.929 0 C-N-CA 125.617 1.567 . . . . 1.77 107.952 173.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.8 t -61.4 -45.04 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 C-N-CA 124.304 1.042 . . . . 0.81000000000000005 109.541 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 1.5 tp -79.98 -5.56 55.92 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 114.35 1.241 . . . . 1.1499999999999999 114.35 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 6.5 m-30 -123.81 20.66 9.27 Favored 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 124.477 1.111 . . . . 0.92000000000000004 111.909 176.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -148.16 -28.04 0.33 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 116.878 2.177 . . . . 1.3300000000000001 116.878 -176.272 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.0 p -73.29 137.54 44.92 Favored 'General case' 0 N--CA 1.533 3.725 0 N-CA-C 114.206 1.187 . . . . 1.28 114.206 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.596 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 7.9 pt-20 . . . . . 0 N--CA 1.507 2.387 0 N-CA-C 117.004 2.224 . . . . 1.53 117.004 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 113.678 0.992 . . . . 2.1499999999999999 113.678 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.31 109.94 1.12 Allowed 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 124.957 1.303 . . . . 0.77000000000000002 112.091 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.63 154.06 49.78 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 114.942 -1.026 . . . . 0.81000000000000005 112.965 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.84 -174.63 37.63 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.077 -0.965 . . . . 0.46999999999999997 115.124 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.47 171.67 7.38 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 114.782 1.401 . . . . 0.89000000000000001 114.782 -177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.15 129.33 49.94 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 113.573 -1.649 . . . . 0.51000000000000001 111.768 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -122.87 100.93 39.85 Favored Pre-proline 0 CA--C 1.568 1.666 0 C-N-CA 123.011 0.524 . . . . 0.14999999999999999 109.597 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -83.5 116.85 2.34 Favored 'Trans proline' 0 CA--C 1.566 2.097 0 C-N-CA 122.251 1.967 . . . . 0.14999999999999999 114.729 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.59 158.37 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.979 0.895 . . . . 0.19 110.851 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -143.02 19.86 1.95 Allowed 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 114.844 -1.071 . . . . 2.5299999999999998 112.13 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -125.84 161.71 26.8 Favored 'General case' 0 C--N 1.362 1.114 0 CA-C-O 121.297 0.57 . . . . 2.1200000000000001 111.786 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.5 OUTLIER -120.29 140.59 51.01 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.445 0.906 . . . . 0.41999999999999998 113.445 -179.044 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.14 -137.77 4.92 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.123 -1.399 . . . . 0.23000000000000001 112.332 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.1 mt-10 -117.66 106.37 13.01 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 118.334 1.067 . . . . 1.75 111.105 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -99.36 129.9 45.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.179 0.514 . . . . 0.20999999999999999 111.256 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.99 118.94 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.798 0.808 . . . . 0.20000000000000001 110.731 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.472 HD12 HD12 ' A' ' 172' ' ' ILE . 1.5 tt -106.98 105.3 15.26 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.118 -1.401 . . . . 0.78000000000000003 109.956 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.05 127.57 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 114.471 -1.241 . . . . 0.44 108.705 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.95 137.49 52.28 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.04 0.756 . . . . 1.25 113.04 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 17.7 tptt -102.96 115.99 31.67 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.361 -0.836 . . . . 2.52 110.723 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 15.0 m-85 -105.74 134.87 48.16 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.95 -0.568 . . . . 0.40000000000000002 110.379 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.6 156.34 48.17 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.248 0.547 . . . . 0.40999999999999998 112.26 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -121.33 133.19 55.11 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.803 0.841 . . . . 2.6099999999999999 111.147 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.49 27.04 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 114.645 1.35 . . . . 2.1299999999999999 114.645 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.19 -37.11 0.06 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 114.535 1.309 . . . . 2.27 114.535 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.31 130.44 56.03 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.075 0.768 . . . . 1.46 113.075 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.17 95.28 5.21 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-O 122.494 1.14 . . . . 0.83999999999999997 110.805 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -154.15 149.36 26.99 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.107 -0.951 . . . . 2.4500000000000002 112.661 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.0 m -124.97 125.96 44.72 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.649 -0.705 . . . . 1.6599999999999999 112.865 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 68.16 49.06 0.87 Allowed 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 125.695 1.598 . . . . 1.8899999999999999 113.179 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -145.8 -41.14 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.602 1.161 . . . . 2.5600000000000001 109.788 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -112.13 82.68 1.67 Allowed 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.462 -0.94 . . . . 2.7599999999999998 108.462 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.59 115.3 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 113.997 -1.456 . . . . 0.68999999999999995 110.321 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.443 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 34.1 m-85 -97.46 175.97 6.04 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.381 1.623 . . . . 0.69999999999999996 115.381 -175.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -123.0 135.16 54.36 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 116.531 -0.304 . . . . 1.3300000000000001 110.509 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.12 124.99 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.35 0 CA-C-O 121.338 0.589 . . . . 0.47999999999999998 110.144 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 37.3 mtt180 -122.57 153.37 39.35 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.028 1.492 . . . . 1.6899999999999999 115.028 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.0 OUTLIER -132.71 104.54 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 115.334 -0.848 . . . . 0.59999999999999998 112.831 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.537 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.78 27.0 13.03 Favored 'General case' 0 N--CA 1.522 3.14 0 C-N-CA 126.9 2.08 . . . . 1.1200000000000001 113.689 -179.004 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.63 -19.66 33.23 Favored Glycine 0 CA--C 1.547 2.05 0 CA-C-N 116.107 -0.497 . . . . 0.32000000000000001 113.317 -176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 93.3 m-70 -82.95 171.59 13.69 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 125.345 1.458 . . . . 0.56999999999999995 113.848 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.85 123.08 39.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 122.182 -0.324 . . . . 0.55000000000000004 110.94 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.279 9.9 p -113.36 -48.65 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.144 0 CA-C-N 116.209 -0.451 . . . . 1.0600000000000001 111.533 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.47 90.53 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-O 121.324 0.583 . . . . 0.44 109.741 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -107.13 90.44 3.3 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-O 123.013 1.387 . . . . 2.2999999999999998 111.232 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 127.27 77.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 129.845 3.258 . . . . 2.48 106.828 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -107.14 104.81 14.55 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.963 -1.017 . . . . 1.1299999999999999 113.541 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -114.62 111.33 21.17 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 113.61 -1.632 . . . . 2.3500000000000001 108.579 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.58 -33.54 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 114.628 1.344 . . . . 0.68000000000000005 114.628 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -75.1 -34.97 61.79 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 112.905 0.705 . . . . 0.77000000000000002 112.905 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -75.05 -27.46 60.02 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 124.12 0.968 . . . . 0.91000000000000003 113.285 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -79.06 -55.51 5.07 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.35 0.871 . . . . 2.4300000000000002 113.35 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.52 -40.18 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 N-CA-C 114.021 1.119 . . . . 0.93000000000000005 114.021 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.65 -72.05 0.2 Allowed Glycine 0 C--N 1.359 1.849 0 CA-C-N 118.217 0.462 . . . . 0.84999999999999998 113.919 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -102.16 174.79 5.77 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.31 1.044 . . . . 3.1800000000000002 111.709 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.6 m -70.43 90.85 0.73 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.784 1.031 . . . . 2.0800000000000001 113.784 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 126' ' ' ALA . 0.6 OUTLIER -143.78 -162.68 1.51 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.745 -1.57 . . . . 0.62 109.888 -178.293 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.401 ' H ' ' HB ' ' A' ' 125' ' ' THR . . . -99.89 134.08 43.31 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 113.509 0.929 . . . . 0.46000000000000002 113.509 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 6.1 t60 -105.87 142.92 34.77 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.194 0.598 . . . . 0.38 110.115 177.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -146.41 137.66 24.45 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.928 1.085 . . . . 2.5 113.928 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -128.34 135.36 49.47 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.928 -1.033 . . . . 1.5600000000000001 110.774 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.93 125.18 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.02 -0.991 . . . . 0.45000000000000001 111.107 -178.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -129.05 89.01 49.84 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-N 115.464 -0.789 . . . . 0.83999999999999997 110.927 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -74.95 129.82 12.75 Favored 'Trans proline' 0 C--N 1.394 2.953 0 C-N-CA 122.984 2.456 . . . . 0.16 112.943 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.53 149.51 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.507 0 CA-C-N 115.177 -0.92 . . . . 0.38 111.107 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.3 t -134.26 117.16 16.14 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.553 0.692 . . . . 1.3100000000000001 111.106 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.477 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.4 mt -115.61 126.35 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 CA-C-N 114.69 -1.141 . . . . 0.25 108.381 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -140.15 125.3 18.67 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.479 -0.782 . . . . 2.0499999999999998 110.995 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? 66.56 15.21 10.05 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 125.297 1.439 . . . . 3.5499999999999998 114.548 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.65 19.44 22.53 Favored Glycine 0 CA--C 1.547 2.053 0 CA-C-O 119.165 -0.797 . . . . 0.37 114.923 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 23.3 mtpp -126.61 143.82 51.1 Favored 'General case' 0 C--N 1.368 1.385 0 CA-C-N 118.435 1.117 . . . . 1.5600000000000001 112.399 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.38 146.3 27.78 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.262 1.208 . . . . 0.34000000000000002 114.262 -175.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.3 t -140.93 117.32 10.76 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.916 -1.038 . . . . 0.64000000000000001 110.625 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.253 2.3 p -110.56 98.98 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.514 0 CA-C-N 115.325 -0.852 . . . . 0.46000000000000002 110.302 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 69.47 -81.91 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 125.324 1.45 . . . . 1.5600000000000001 113.488 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.95 26.07 3.3 Favored Glycine 0 CA--C 1.543 1.802 0 CA-C-N 116.022 -0.536 . . . . 0.48999999999999999 113.668 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -129.72 118.52 22.01 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.079 0.552 . . . . 1.8200000000000001 110.5 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.46 137.37 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.759 0.79 . . . . 1.02 112.626 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 m -153.88 -170.75 3.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.31 -1.314 . . . . 0.56000000000000005 108.792 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.259 6.3 t -103.12 146.16 28.81 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 113.216 0.821 . . . . 1.25 113.216 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.408 ' H ' ' HA ' ' A' ' 139' ' ' LYS . 41.5 t80 -89.88 132.67 35.16 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.098 0.951 . . . . 0.28999999999999998 111.596 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.2 p -97.73 -163.09 1.01 Allowed 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 113.9 -1.5 . . . . 1.4199999999999999 108.888 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.45 7.29 65.19 Favored Glycine 0 CA--C 1.56 2.855 0 O-C-N 120.236 -1.54 . . . . 0.41999999999999998 116.895 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.466 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -160.45 152.89 20.71 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-O 122.303 1.049 . . . . 1.1000000000000001 112.499 178.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.537 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -108.42 137.62 46.07 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 113.81 -1.541 . . . . 0.67000000000000004 108.854 177.009 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 t -118.56 145.12 45.61 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.438 1.644 . . . . 0.35999999999999999 115.438 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.05 97.3 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 106.225 -1.769 . . . . 0.73999999999999999 106.225 174.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -117.97 124.42 48.15 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 112.645 0.609 . . . . 1.6699999999999999 112.645 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.21 134.81 54.69 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-O 122.356 1.074 . . . . 1.8 112.321 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.2 t -107.3 144.51 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 112.77 -2.013 . . . . 0.57999999999999996 110.326 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -93.02 150.15 20.73 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.785 1.031 . . . . 2.1800000000000002 113.785 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.04 -36.03 4.85 Favored Glycine 0 CA--C 1.545 1.962 0 CA-C-N 115.149 -0.932 . . . . 1.02 114.923 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -127.48 -80.87 0.6 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 117.466 0.633 . . . . 2.8599999999999999 112.256 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -127.96 -50.72 1.33 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.034 0.534 . . . . 3.9100000000000001 111.827 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.443 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -85.76 150.04 24.85 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.806 1.243 . . . . 1.74 112.124 178.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -112.11 -171.28 0.21 Allowed Pre-proline 0 CA--C 1.561 1.393 0 CA-C-N 113.384 -1.735 . . . . 1.6799999999999999 108.236 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -65.27 96.88 0.29 Allowed 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.141 1.894 . . . . 2.0600000000000001 111.567 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -51.08 -57.33 8.97 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 127.104 2.162 . . . . 3.0 116.619 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.95 131.55 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 118.96 0.8 . . . . 0.80000000000000004 108.899 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.9 t -132.86 125.06 29.13 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 124.004 0.815 . . . . 0.87 112.146 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.289 . . -120.53 48.33 1.62 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.279 1.955 . . . . 0.34000000000000002 116.279 -177.082 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.77 134.51 2.51 Favored 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 116.238 1.94 . . . . 0.69999999999999996 116.238 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -151.02 102.6 2.98 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.421 -0.809 . . . . 0.20999999999999999 110.821 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.472 HD12 HD12 ' A' ' 85' ' ' LEU 0.296 7.7 tt -112.77 121.77 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.186 0 CA-C-O 122.276 1.036 . . . . 0.31 111.361 176.033 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -124.4 165.59 17.46 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.057 -1.429 . . . . 0.44 110.479 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -122.24 159.16 27.89 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 118.914 2.931 . . . . 1.26 118.914 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.27 -41.47 2.14 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-N 109.9 -3.318 . . . . 0.17000000000000001 118.973 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.35 154.54 1.03 Allowed 'General case' 0 N--CA 1.516 2.851 0 CA-C-N 120.211 2.005 . . . . 0.14999999999999999 113.011 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.49 -15.22 59.95 Favored 'General case' 0 CA--C 1.581 2.148 0 C-N-CA 124.859 1.264 . . . . 0.17000000000000001 114.354 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.9 3.19 49.44 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 113.921 1.082 . . . . 0.55000000000000004 113.921 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.45 -2.38 17.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.435 0.902 . . . . 0.59999999999999998 113.435 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.468 0 C-N-CA 124.552 1.141 . . . . 0.94999999999999996 110.998 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.52 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.3 tp . . . . . 0 CA--C 1.565 1.557 0 N-CA-C 113.148 0.796 . . . . 0.34999999999999998 113.148 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.46 -24.58 63.68 Favored 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 126.005 1.722 . . . . 0.20000000000000001 115.504 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.59 -9.53 55.88 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.582 0.956 . . . . 0.32000000000000001 113.582 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 26.0 mmtp -107.16 -24.97 11.74 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.561 0.948 . . . . 1.73 113.561 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.69 134.91 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.056 0 N-CA-C 115.494 1.665 . . . . 0.11 115.494 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -120.09 -30.65 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 115.244 -0.889 . . . . 0.16 112.123 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -161.37 119.48 2.36 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 120.507 0.194 . . . . 0.54000000000000004 111.177 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -138.22 127.85 25.02 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.158 -0.964 . . . . 0.19 111.301 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.3 t -137.22 129.74 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.098 0 N-CA-C 113.679 0.992 . . . . 1.05 113.679 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -115.9 106.1 13.42 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.582 -1.266 . . . . 2.1099999999999999 107.582 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.48 100.48 6.89 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.06 0.933 . . . . 0.63 111.592 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.517 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 178.16 -55.86 0.09 OUTLIER Glycine 0 C--N 1.349 1.295 0 CA-C-N 113.946 -1.479 . . . . 0.70999999999999996 115.859 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -111.6 -116.18 3.55 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 114.297 0.479 . . . . 0.80000000000000004 114.297 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 13.9 mt-10 -165.45 116.26 1.09 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.011 0.524 . . . . 1.6299999999999999 111.55 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER 43.73 108.62 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 118.452 2.76 . . . . 1.0 118.452 178.227 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.634 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 74.0 t60 -135.27 132.91 38.37 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.939 1.088 . . . . 0.45000000000000001 113.939 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.5 p -108.01 114.64 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.003 0 CA-C-N 113.884 -1.507 . . . . 1.3899999999999999 109.022 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -84.62 167.29 16.39 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-N 115.322 -0.854 . . . . 1.8500000000000001 113.039 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -43.47 -34.48 0.78 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 N-CA-C 118.716 2.858 . . . . 0.71999999999999997 118.716 -176.324 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -87.31 -26.53 23.36 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.204 0.526 . . . . 0.51000000000000001 110.95 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.64 45.16 0.48 Allowed Glycine 0 C--N 1.354 1.541 0 CA-C-N 114.854 -1.066 . . . . 0.34000000000000002 114.346 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.52 HD11 ' HG ' ' A' ' 6' ' ' LEU . 15.7 mm -107.11 116.25 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 CA-C-O 120.94 0.4 . . . . 0.55000000000000004 110.085 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.634 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.1 t-160 -108.44 133.58 52.41 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 115.095 1.517 . . . . 1.3400000000000001 115.095 -177.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.33 140.56 31.61 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-N 114.794 -1.093 . . . . 2.79 110.718 176.558 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -90.24 130.46 36.36 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 124.974 1.31 . . . . 3.0 112.4 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -56.61 115.26 2.43 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 118.996 2.961 . . . . 2.2999999999999998 118.996 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 40.59 57.46 7.97 Favored Pre-proline 0 N--CA 1.526 3.349 0 N-CA-C 118.549 2.796 . . . . 1.1699999999999999 118.549 176.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo . . . . . 0 CA--C 1.569 2.232 0 C-N-CA 122.79 2.327 . . . . 1.45 116.218 -179.39 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 44.7 Cg_exo . . . . . 0 N--CA 1.513 2.633 0 N-CA-C 117.522 2.085 . . . . 1.3700000000000001 117.522 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.75 130.05 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.291 0 CA-C-N 114.815 -1.084 . . . . 0.68999999999999995 108.125 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.44 ' HB2' HG22 ' A' ' 125' ' ' THR . 7.1 mt -83.48 -9.68 58.83 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.719 2.118 . . . . 1.28 116.719 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -105.88 8.02 32.47 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 114.329 1.233 . . . . 1.51 114.329 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.8 -177.82 4.6 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-O 121.7 0.762 . . . . 1.0900000000000001 112.309 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.701 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -93.85 169.48 9.93 Favored Pre-proline 0 N--CA 1.514 2.768 0 C-N-CA 124.606 1.162 . . . . 1.27 110.044 178.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.78 -41.86 51.11 Favored 'Trans proline' 0 N--CA 1.53 3.642 0 C-N-CA 123.289 2.66 . . . . 0.94999999999999996 116.298 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -68.03 -52.51 34.64 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 124.439 1.095 . . . . 2.04 112.119 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 5.8 t0 -78.11 -1.97 35.13 Favored 'General case' 0 CA--C 1.59 2.505 0 CA-C-N 115.225 -0.898 . . . . 1.6200000000000001 112.174 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.701 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 14.5 tt0 -75.69 -40.66 55.49 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 126.132 1.773 . . . . 1.77 108.122 174.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.5 t -63.71 -43.1 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.106 0 C-N-CA 124.635 1.174 . . . . 0.81000000000000005 108.574 172.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.467 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.4 tp -79.86 -5.27 55.16 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 113.59 0.959 . . . . 1.1499999999999999 113.59 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 4.2 m-30 -122.46 20.08 10.41 Favored 'General case' 0 CA--C 1.577 1.995 0 C-N-CA 124.786 1.235 . . . . 0.92000000000000004 111.887 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -148.01 -29.01 0.32 Allowed 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 116.399 2.0 . . . . 1.3300000000000001 116.399 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.4 p -74.99 132.0 41.05 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 115.085 1.513 . . . . 1.28 115.085 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.517 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.09 0 C-N-CA 124.221 1.008 . . . . 1.53 112.687 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 111.354 0.131 . . . . 2.1499999999999999 111.354 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.24 88.3 0.04 OUTLIER 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 125.722 1.609 . . . . 0.77000000000000002 114.067 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -148.58 156.22 42.14 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.283 0.846 . . . . 0.81000000000000005 113.283 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -173.14 -171.99 38.29 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 116.039 1.176 . . . . 0.46999999999999997 116.039 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.56 173.17 6.45 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.866 1.432 . . . . 0.89000000000000001 114.866 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -129.38 133.48 47.4 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 114.219 -1.355 . . . . 0.51000000000000001 111.992 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.57 100.47 34.79 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 109.074 -0.713 . . . . 0.14999999999999999 109.074 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.38 118.06 2.19 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.084 1.856 . . . . 0.14999999999999999 115.036 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.67 159.71 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 122.043 0.925 . . . . 0.19 111.134 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -143.91 20.18 1.8 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.888 -1.051 . . . . 2.5299999999999998 112.331 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -128.58 158.45 38.44 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-O 121.963 0.887 . . . . 2.1200000000000001 111.117 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.89 139.85 50.14 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.887 1.069 . . . . 0.41999999999999998 113.887 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.9 -125.35 1.35 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 113.961 -1.472 . . . . 0.23000000000000001 112.393 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -126.31 118.63 25.48 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.085 0.469 . . . . 1.75 111.178 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -118.83 139.92 50.81 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.788 -0.642 . . . . 0.20999999999999999 109.907 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 172' ' ' ILE . 2.5 t -120.59 127.59 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.366 0.603 . . . . 0.20000000000000001 110.896 -177.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.7 107.9 18.96 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.068 -0.969 . . . . 0.78000000000000003 109.861 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.64 128.5 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 109.045 -0.724 . . . . 0.44 109.045 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.64 146.31 49.42 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.81 1.041 . . . . 1.25 113.81 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -108.75 122.47 47.21 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 115.441 -0.8 . . . . 2.52 110.314 176.145 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -109.28 136.72 48.27 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.871 -1.059 . . . . 0.40000000000000002 110.415 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.598 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . -143.77 157.14 44.59 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 124.192 0.997 . . . . 0.40999999999999998 111.307 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -169.92 127.38 0.88 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.353 0.661 . . . . 2.6099999999999999 110.917 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.83 73.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.664 -0.698 . . . . 2.1299999999999999 111.27 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -160.19 -47.35 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.959 -0.564 . . . . 2.27 112.126 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -115.19 116.87 29.07 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.803 0.441 . . . . 1.46 111.169 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.24 99.06 8.9 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.646 1.213 . . . . 0.83999999999999997 112.11 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -159.19 160.66 35.71 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.465 -1.243 . . . . 2.4500000000000002 111.061 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 m -108.31 -78.66 0.59 Allowed 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.047 1.128 . . . . 1.6599999999999999 114.047 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -95.47 70.47 3.11 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.296 1.046 . . . . 1.8899999999999999 111.407 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -159.23 -40.06 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.639 -1.619 . . . . 2.5600000000000001 109.346 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -106.02 79.25 1.39 Allowed 'General case' 0 C--N 1.368 1.375 0 CA-C-O 121.838 0.828 . . . . 2.7599999999999998 109.086 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.24 123.09 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 114.439 -1.255 . . . . 0.68999999999999995 111.395 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.554 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 30.2 m-85 -106.1 171.41 7.36 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 114.395 1.257 . . . . 0.69999999999999996 114.395 -177.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -124.88 135.71 53.13 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.828 -0.434 . . . . 1.3300000000000001 109.828 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.0 t -130.07 125.8 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 CA-C-N 116.104 -0.498 . . . . 0.47999999999999998 109.846 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.66 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 23.0 mtt180 -124.55 148.57 47.72 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.236 1.569 . . . . 1.6899999999999999 115.236 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 154' ' ' SER . 5.1 m -125.56 112.38 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 113.095 0.776 . . . . 0.59999999999999998 113.095 177.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.465 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 63.62 25.99 14.49 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 126.551 1.94 . . . . 1.1200000000000001 113.894 -178.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.36 -14.33 54.59 Favored Glycine 0 CA--C 1.552 2.389 0 C-N-CA 121.456 -0.402 . . . . 0.32000000000000001 113.804 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.66 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 91.3 m-70 -87.93 172.56 9.5 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 126.059 1.744 . . . . 0.56999999999999995 113.362 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.89 132.31 54.5 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.584 0.707 . . . . 0.55000000000000004 112.082 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.75 -55.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 114.775 -1.102 . . . . 1.0600000000000001 113.141 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.23 89.46 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.877 . . . . 0.44 108.631 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -106.45 108.68 20.31 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.905 1.336 . . . . 2.2999999999999998 110.572 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 105.14 70.63 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 110.868 -2.878 . . . . 2.48 108.259 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.27 99.5 12.47 Favored 'General case' 0 C--N 1.359 0.983 0 CA-C-N 115.333 -0.849 . . . . 1.1299999999999999 112.36 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -109.83 91.84 3.81 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.545 -1.661 . . . . 2.3500000000000001 108.755 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -31.25 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 N-CA-C 116.746 2.128 . . . . 0.68000000000000005 116.746 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -74.0 -40.54 62.87 Favored 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 124.014 0.926 . . . . 0.77000000000000002 112.445 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -26.1 59.97 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 124.443 1.097 . . . . 0.91000000000000003 113.374 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -78.21 -58.09 3.44 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.573 0.953 . . . . 2.4300000000000002 113.573 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.26 -32.91 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 N-CA-C 114.921 1.452 . . . . 0.93000000000000005 114.921 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.23 -118.11 2.74 Favored Glycine 0 C--N 1.356 1.639 0 CA-C-N 118.757 0.708 . . . . 0.84999999999999998 113.006 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -115.1 107.44 15.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.297 0.57 . . . . 3.1800000000000002 111.173 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.0 m 70.69 -134.57 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 125.592 1.557 . . . . 2.0800000000000001 113.128 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.44 HG22 ' HB2' ' A' ' 51' ' ' LEU . 67.8 p 60.4 -151.48 0.4 Allowed 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 126.179 1.792 . . . . 0.62 114.382 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -112.13 130.37 55.92 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 114.141 1.163 . . . . 0.46000000000000002 114.141 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -108.65 124.38 50.43 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.402 -0.962 . . . . 0.38 108.402 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.41 129.18 24.7 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.038 0.755 . . . . 2.5 113.038 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -116.03 134.91 54.45 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.047 -0.978 . . . . 1.5600000000000001 111.492 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.25 114.01 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 113.884 -1.507 . . . . 0.45000000000000001 109.999 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.23 98.0 33.54 Favored Pre-proline 0 CA--C 1.574 1.866 0 CA-C-N 115.871 -0.604 . . . . 0.83999999999999997 111.146 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -73.59 144.55 35.96 Favored 'Trans proline' 0 C--N 1.399 3.205 0 C-N-CA 123.293 2.662 . . . . 0.16 114.652 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.59 146.38 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 CA-C-N 115.135 -0.938 . . . . 0.38 110.854 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 p -131.41 112.58 12.82 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.495 -0.775 . . . . 1.3100000000000001 111.406 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.98 121.64 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 CA-C-N 115.38 -0.827 . . . . 0.25 108.882 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -141.94 130.74 22.91 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 116.274 -0.421 . . . . 2.0499999999999998 111.273 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp 70.67 9.04 6.78 Favored 'General case' 0 N--CA 1.518 2.972 0 C-N-CA 125.033 1.333 . . . . 3.5499999999999998 114.219 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.07 18.1 25.53 Favored Glycine 0 CA--C 1.544 1.859 0 C-N-CA 124.19 0.9 . . . . 0.37 113.997 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -127.16 146.68 50.31 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-N 117.768 0.784 . . . . 1.5600000000000001 112.746 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.08 141.72 31.48 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.234 1.198 . . . . 0.34000000000000002 114.234 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.8 m -130.01 113.42 14.55 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.626 -1.17 . . . . 0.64000000000000001 110.155 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.252 9.1 p -121.48 97.03 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.369 0 CA-C-N 116.004 -0.544 . . . . 0.46000000000000002 110.901 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 67.55 -85.45 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.682 0 C-N-CA 125.658 1.583 . . . . 1.5600000000000001 113.874 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.03 29.3 3.53 Favored Glycine 0 CA--C 1.542 1.737 0 CA-C-N 115.994 -0.548 . . . . 0.48999999999999999 112.979 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -133.17 125.72 30.06 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 123.507 0.723 . . . . 1.8200000000000001 110.651 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.11 126.02 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.303 0 CA-C-O 121.46 0.648 . . . . 1.02 111.07 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 m -145.93 -178.89 6.35 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.285 -0.871 . . . . 0.56000000000000005 109.969 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.273 12.4 t -103.14 137.03 41.85 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 113.414 0.894 . . . . 1.25 113.414 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -83.43 125.37 31.64 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.434 1.094 . . . . 0.28999999999999998 112.011 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.81 91.22 2.95 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 112.649 0.611 . . . . 1.4199999999999999 112.649 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.46 -66.22 3.53 Favored Glycine 0 C--N 1.358 1.786 0 N-CA-C 119.03 2.372 . . . . 0.41999999999999998 119.03 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.17 156.87 44.57 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.142 1.164 . . . . 1.1000000000000001 114.142 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.465 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -105.98 133.45 50.68 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 113.035 -1.893 . . . . 0.67000000000000004 108.545 176.236 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.6 t -120.14 143.7 48.05 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.737 1.754 . . . . 0.35999999999999999 115.737 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.451 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -115.51 100.29 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.945 -1.132 . . . . 0.73999999999999999 107.945 176.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.81 125.28 49.21 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.978 -0.555 . . . . 1.6699999999999999 111.952 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.81 132.73 56.62 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.09 0.947 . . . . 1.8 111.771 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 t -110.35 143.28 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.911 0 CA-C-N 113.381 -1.736 . . . . 0.57999999999999996 109.674 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 151.85 22.19 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.756 1.391 . . . . 2.1800000000000002 114.756 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.78 -26.64 7.05 Favored Glycine 0 CA--C 1.55 2.253 0 CA-C-N 115.027 -0.988 . . . . 1.02 115.254 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -132.01 -78.81 0.51 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.045 0.922 . . . . 2.8599999999999999 112.616 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -135.87 -49.41 0.69 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.078 0.551 . . . . 3.9100000000000001 111.518 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.554 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -94.42 135.43 35.85 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.591 1.156 . . . . 1.74 111.521 178.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -94.26 -169.83 0.21 Allowed Pre-proline 0 CA--C 1.568 1.667 0 CA-C-N 113.979 -1.464 . . . . 1.6799999999999999 108.576 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -66.55 99.99 0.46 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 CA-C-N 122.311 1.861 . . . . 2.0600000000000001 111.3 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -57.18 -49.92 74.48 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.498 1.666 . . . . 3.0 115.498 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 64' ' ' GLU . 19.0 t -110.56 130.99 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.076 -0.713 . . . . 0.80000000000000004 109.076 177.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -136.9 124.72 22.56 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 113.597 -1.638 . . . . 0.87 111.482 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.256 . . -121.31 49.97 1.44 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.75 1.759 . . . . 0.34000000000000002 115.75 -176.655 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.69 135.15 2.98 Favored 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 116.175 1.917 . . . . 0.69999999999999996 116.175 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -153.6 100.67 2.42 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.38 -0.827 . . . . 0.20999999999999999 110.6 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 84' ' ' VAL 0.308 5.2 tt -109.26 122.48 63.96 Favored 'Isoleucine or valine' 0 C--O 1.27 2.156 0 CA-C-O 122.346 1.069 . . . . 0.31 111.383 176.136 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -120.27 154.2 35.28 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 113.755 -1.566 . . . . 0.44 112.221 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 50.5 tttm -105.92 150.0 26.07 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 118.09 2.626 . . . . 1.26 118.09 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.43 -39.59 2.77 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 110.98 -2.827 . . . . 0.17000000000000001 119.805 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.73 164.12 1.21 Allowed 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 121.218 2.509 . . . . 0.14999999999999999 112.571 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.88 -16.07 48.98 Favored 'General case' 0 CA--C 1.579 2.085 0 C-N-CA 124.722 1.209 . . . . 0.17000000000000001 113.8 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.36 4.65 45.42 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.363 1.246 . . . . 0.55000000000000004 114.363 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -11.89 17.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.27 1.211 . . . . 0.59999999999999998 114.27 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.513 2.713 0 C-N-CA 124.036 0.934 . . . . 0.94999999999999996 113.08 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.57 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.6 tp . . . . . 0 CA--C 1.564 1.482 0 N-CA-C 113.22 0.822 . . . . 0.34999999999999998 113.22 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.51 -23.07 64.26 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 125.807 1.643 . . . . 0.20000000000000001 114.965 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.49 -12.53 48.65 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 113.632 0.975 . . . . 0.32000000000000001 113.632 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -104.19 -23.58 13.24 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-O 118.211 -0.9 . . . . 1.73 113.227 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.49 133.36 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 N-CA-C 115.094 1.516 . . . . 0.11 115.094 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pt -120.52 -28.28 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.183 -0.917 . . . . 0.16 112.264 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -163.97 116.91 1.43 Allowed 'General case' 0 CA--C 1.558 1.27 0 CA-C-O 120.583 0.23 . . . . 0.54000000000000004 111.141 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.32 130.87 35.71 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.569 -0.707 . . . . 0.19 111.202 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.74 129.69 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.422 0.897 . . . . 1.05 113.422 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -117.05 105.23 12.06 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.01 -1.478 . . . . 2.1099999999999999 107.01 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.17 108.22 12.51 Favored 'General case' 0 C--O 1.254 1.305 0 CA-C-O 121.639 0.733 . . . . 0.63 111.553 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.2 -43.71 0.37 Allowed Glycine 0 C--N 1.351 1.374 0 CA-C-N 114.265 -1.334 . . . . 0.70999999999999996 115.652 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -115.15 -121.25 3.45 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 117.564 0.682 . . . . 0.80000000000000004 113.892 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 18.1 mt-10 -164.83 115.36 1.16 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.295 0.638 . . . . 1.6299999999999999 111.133 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 1.1 m 42.85 110.15 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 118.589 2.811 . . . . 1.0 118.589 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.586 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 78.1 t60 -136.58 131.79 34.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.358 1.244 . . . . 0.45000000000000001 114.358 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.6 p -104.93 114.48 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 113.958 -1.474 . . . . 1.3899999999999999 108.967 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -85.21 165.83 17.06 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 115.107 -0.951 . . . . 1.8500000000000001 113.155 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -44.59 -30.46 0.67 Allowed 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 N-CA-C 118.667 2.84 . . . . 0.71999999999999997 118.667 -176.532 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -89.17 -27.04 20.96 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.233 0.539 . . . . 0.51000000000000001 110.936 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.54 42.66 0.57 Allowed Glycine 0 C--N 1.351 1.393 0 CA-C-N 114.82 -1.082 . . . . 0.34000000000000002 114.059 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.57 HD11 ' HG ' ' A' ' 6' ' ' LEU . 20.2 mm -107.54 117.05 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-O 121.107 0.48 . . . . 0.55000000000000004 110.195 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.4 t60 -106.52 131.61 53.48 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.882 1.438 . . . . 1.3400000000000001 114.882 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -93.07 137.41 32.45 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 124.058 0.943 . . . . 2.79 109.639 175.772 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.473 ' O ' ' HG3' ' A' ' 33' ' ' PRO . 12.9 ptm180 -99.0 105.86 18.06 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 114.54 -1.209 . . . . 3.0 113.335 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -23.14 119.84 0.04 OUTLIER 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 120.57 3.545 . . . . 2.2999999999999998 120.57 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 34.42 54.17 1.59 Allowed Pre-proline 0 N--CA 1.536 3.868 0 N-CA-C 119.576 3.176 . . . . 1.1699999999999999 119.576 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.473 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.569 2.268 0 C-N-CA 123.423 2.749 . . . . 1.45 116.908 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo . . . . . 0 N--CA 1.512 2.603 0 N-CA-C 117.288 1.995 . . . . 1.3700000000000001 117.288 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.437 HG23 ' HB2' ' A' ' 126' ' ' ALA 0.262 1.0 OUTLIER -93.85 123.28 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.777 0 CA-C-N 115.237 -0.892 . . . . 0.68999999999999995 109.472 178.908 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 7.3 mt -89.22 101.71 14.37 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.871 0.843 . . . . 1.28 112.374 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 1.5 mpt_? 148.01 -13.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.158 2.183 . . . . 1.51 110.578 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -116.54 -179.01 3.56 Favored 'General case' 0 CA--C 1.567 1.599 0 C-N-CA 123.767 0.827 . . . . 1.0900000000000001 113.09 -179.135 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -95.77 -176.88 0.58 Allowed Pre-proline 0 N--CA 1.51 2.556 0 C-N-CA 124.402 1.081 . . . . 1.27 109.421 178.467 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.456 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 31.3 Cg_exo -68.51 -39.13 9.91 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.679 2.253 . . . . 0.94999999999999996 113.963 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -67.2 -54.28 22.55 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 125.04 1.336 . . . . 2.04 112.124 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.413 ' HB3' ' OG ' ' A' ' 53' ' ' SER . 0.4 OUTLIER -76.55 -5.37 47.34 Favored 'General case' 0 CA--C 1.576 1.947 0 CA-C-N 114.979 -1.01 . . . . 1.6200000000000001 112.746 178.144 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.514 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 27.5 tt0 -71.64 -44.14 64.86 Favored 'General case' 0 C--N 1.382 2.015 0 C-N-CA 125.539 1.536 . . . . 1.77 108.07 173.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.37 -38.89 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 C-N-CA 124.055 0.942 . . . . 0.81000000000000005 109.481 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -82.54 -8.36 59.61 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 114.116 1.154 . . . . 1.1499999999999999 114.116 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.415 ' O ' HG12 ' A' ' 50' ' ' ILE . 20.4 m-85 -125.02 21.36 8.16 Favored 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.222 1.009 . . . . 0.92000000000000004 112.928 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.416 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -143.8 -31.53 0.46 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 115.27 1.582 . . . . 1.3300000000000001 115.27 -177.311 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.8 p -73.12 134.23 44.4 Favored 'General case' 0 N--CA 1.524 3.231 0 N-CA-C 114.3 1.222 . . . . 1.28 114.3 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 114.672 1.36 . . . . 1.53 114.672 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.337 -0.616 . . . . 2.1499999999999999 109.337 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.83 86.53 0.12 Allowed 'General case' 0 N--CA 1.517 2.885 0 C-N-CA 124.717 1.207 . . . . 0.77000000000000002 111.674 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -140.51 149.74 42.85 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.998 0.904 . . . . 0.81000000000000005 112.68 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.87 -176.75 31.27 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 114.303 -1.317 . . . . 0.46999999999999997 115.821 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 169.55 10.16 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 114.117 -1.042 . . . . 0.89000000000000001 113.729 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.06 131.16 52.2 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.662 -1.154 . . . . 0.51000000000000001 111.895 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.1 103.12 33.47 Favored Pre-proline 0 CA--C 1.57 1.719 0 C-N-CA 123.107 0.563 . . . . 0.14999999999999999 109.567 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -84.15 117.18 2.16 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.264 1.976 . . . . 0.14999999999999999 114.657 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.26 157.94 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.625 0 CA-C-O 122.053 0.93 . . . . 0.19 111.112 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -146.13 24.38 1.3 Allowed 'General case' 0 CA--C 1.557 1.236 0 CA-C-N 114.654 -1.157 . . . . 2.5299999999999998 112.008 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -128.62 160.16 33.3 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 121.268 0.556 . . . . 2.1200000000000001 111.194 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -121.04 142.02 50.21 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.069 1.137 . . . . 0.41999999999999998 114.069 -178.403 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.85 -137.34 4.91 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 113.696 -1.593 . . . . 0.23000000000000001 112.121 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.3 mt-10 -115.63 112.13 21.67 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 118.436 1.118 . . . . 1.75 111.276 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -104.49 128.37 52.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.147 -0.479 . . . . 0.20999999999999999 110.896 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -110.35 119.33 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 121.977 0.894 . . . . 0.20000000000000001 110.427 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 tt -107.34 104.61 14.24 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.79 -1.55 . . . . 0.78000000000000003 109.648 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.95 126.42 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 CA-C-N 114.367 -1.288 . . . . 0.44 108.57 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.52 135.52 49.52 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.594 -0.73 . . . . 1.25 112.418 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 4.4 tppt? -101.5 118.2 36.46 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.447 0.641 . . . . 2.52 110.556 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -105.54 134.54 48.5 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.256 -0.884 . . . . 0.40000000000000002 110.571 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.39 151.53 41.94 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.182 0.515 . . . . 0.40999999999999998 112.266 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -147.83 135.23 20.65 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.118 0.567 . . . . 2.6099999999999999 110.967 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.275 7.5 p -147.06 86.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.388 0 CA-C-O 121.591 0.71 . . . . 2.1299999999999999 111.851 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -175.12 -46.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.602 -0.726 . . . . 2.27 112.139 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -115.56 139.52 50.0 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 121.193 0.52 . . . . 1.46 112.008 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -112.85 99.68 8.08 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.191 0.996 . . . . 0.83999999999999997 111.004 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -158.74 140.85 13.89 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.317 -0.856 . . . . 2.4500000000000002 112.313 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.7 m -120.74 130.45 54.05 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.341 -0.845 . . . . 1.6599999999999999 112.219 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 80.53 10.51 1.09 Allowed 'General case' 0 N--CA 1.519 2.987 0 C-N-CA 125.857 1.663 . . . . 1.8899999999999999 114.494 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -117.49 -25.71 6.88 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.711 0.804 . . . . 2.5600000000000001 112.259 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -107.03 79.41 1.32 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.484 0.714 . . . . 2.7599999999999998 109.393 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 114' ' ' ASP 0.261 1.2 t -109.81 126.6 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 CA-C-N 114.998 -1.001 . . . . 0.68999999999999995 110.091 -177.173 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -118.87 174.31 6.37 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 114.652 1.352 . . . . 0.69999999999999996 114.652 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.93 136.34 54.92 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.921 -0.487 . . . . 1.3300000000000001 111.19 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.2 t -124.99 123.65 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 C-N-CA 123.056 0.543 . . . . 0.47999999999999998 110.07 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -121.14 147.13 45.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.653 1.353 . . . . 1.6899999999999999 114.653 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 154' ' ' SER . 50.8 t -130.56 109.75 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.252 0 N-CA-C 107.68 -1.23 . . . . 0.59999999999999998 107.68 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.43 26.89 16.03 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 126.992 2.117 . . . . 1.1200000000000001 114.574 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.12 -19.58 40.14 Favored Glycine 0 CA--C 1.548 2.097 0 N-CA-C 114.554 0.582 . . . . 0.32000000000000001 114.554 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -91.01 154.51 19.38 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 124.837 1.255 . . . . 0.56999999999999995 113.375 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.3 p -102.93 127.9 49.95 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.609 0.718 . . . . 0.55000000000000004 111.638 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.07 -50.63 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.582 -1.19 . . . . 1.0600000000000001 110.342 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.43 88.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 119.996 -0.682 . . . . 0.44 110.237 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -106.92 119.23 38.79 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-O 122.41 1.1 . . . . 2.2999999999999998 110.076 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.479 ' HA ' HG13 ' A' ' 101' ' ' VAL . 1.0 OUTLIER 102.96 59.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 128.434 2.694 . . . . 2.48 107.6 -175.414 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.34 96.9 10.76 Favored 'General case' 0 C--N 1.373 1.596 0 CA-C-O 121.634 0.731 . . . . 1.1299999999999999 112.714 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -107.64 97.81 7.49 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 113.652 -1.613 . . . . 2.3500000000000001 107.448 175.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.08 -30.01 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.458 0 N-CA-C 114.244 1.201 . . . . 0.68000000000000005 114.244 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -73.89 -41.88 61.5 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 123.481 0.712 . . . . 0.77000000000000002 112.218 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -72.24 -25.84 61.78 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 124.537 1.135 . . . . 0.91000000000000003 113.55 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -79.53 -57.8 3.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 113.701 1.0 . . . . 2.4300000000000002 113.701 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.48 -37.89 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.515 0 N-CA-C 114.516 1.302 . . . . 0.93000000000000005 114.516 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.62 -115.36 1.89 Allowed Glycine 0 C--N 1.354 1.557 0 C-N-CA 121.194 -0.527 . . . . 0.84999999999999998 113.38 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -114.87 108.06 16.23 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.957 0.408 . . . . 3.1800000000000002 110.422 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.7 m 73.33 -126.2 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 125.466 1.506 . . . . 2.0800000000000001 111.845 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.6 p 57.54 -165.6 0.15 Allowed 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 126.066 1.746 . . . . 0.62 115.343 177.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' A' ' 50' ' ' ILE . . . -113.99 127.57 56.01 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 112.684 0.624 . . . . 0.46000000000000002 112.684 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -103.53 138.83 39.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.465 -0.569 . . . . 0.38 109.465 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -144.59 129.37 18.28 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.78 1.03 . . . . 2.5 113.78 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -117.41 129.94 56.17 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-N 114.759 -1.11 . . . . 1.5600000000000001 110.939 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.53 111.59 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 114.493 -1.231 . . . . 0.45000000000000001 110.658 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.5 mm -115.8 92.11 32.97 Favored Pre-proline 0 CA--C 1.582 2.178 0 CA-C-N 115.639 -0.71 . . . . 0.83999999999999997 110.706 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -77.19 126.33 8.47 Favored 'Trans proline' 0 C--N 1.392 2.824 0 C-N-CA 122.568 2.178 . . . . 0.16 113.032 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.88 150.81 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 C-N-CA 123.991 0.916 . . . . 0.38 111.067 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.0 t -136.7 118.0 14.6 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.524 0.678 . . . . 1.3100000000000001 111.775 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -116.98 126.05 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 CA-C-N 114.759 -1.11 . . . . 0.25 108.446 178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -139.37 122.74 17.13 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.622 -0.717 . . . . 2.0499999999999998 110.817 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt 67.67 16.16 9.78 Favored 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 125.279 1.432 . . . . 3.5499999999999998 114.431 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.75 15.93 35.37 Favored Glycine 0 CA--C 1.547 2.067 0 CA-C-O 119.348 -0.696 . . . . 0.37 114.67 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 36.8 mtpt -122.02 145.34 48.23 Favored 'General case' 0 C--N 1.363 1.19 0 CA-C-N 118.088 0.944 . . . . 1.5600000000000001 111.759 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.31 150.81 23.4 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.116 1.525 . . . . 0.34000000000000002 115.116 -175.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.32 109.81 6.6 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 113.92 -1.491 . . . . 0.64000000000000001 109.335 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.1 p -111.1 94.84 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.5 0 CA-C-N 116.025 -0.534 . . . . 0.46000000000000002 110.625 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 67.81 -84.73 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.74 0 C-N-CA 125.416 1.486 . . . . 1.5600000000000001 113.799 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.09 24.62 5.35 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 115.981 -0.554 . . . . 0.48999999999999999 113.263 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -125.7 147.07 49.48 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.726 0.811 . . . . 1.8200000000000001 111.606 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.0 p -129.18 125.87 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.157 0 CA-C-N 115.583 -0.735 . . . . 1.02 110.936 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.4 m -149.23 -175.72 5.09 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.225 -0.898 . . . . 0.56000000000000005 110.129 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.0 p -103.8 138.16 40.8 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 112.95 0.722 . . . . 1.25 112.95 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -85.93 123.75 31.61 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 123.548 0.739 . . . . 0.28999999999999998 111.114 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.0 t -129.21 90.94 3.1 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.533 0.682 . . . . 1.4199999999999999 112.733 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.35 -63.36 2.96 Favored Glycine 0 C--N 1.359 1.832 0 N-CA-C 119.043 2.377 . . . . 0.41999999999999998 119.043 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.543 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -130.64 157.15 43.53 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.277 1.214 . . . . 1.1000000000000001 114.277 -176.029 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.543 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 1.8 tp -104.13 140.81 37.27 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 112.805 -1.998 . . . . 0.67000000000000004 109.41 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.6 t -122.95 144.03 49.51 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.939 1.459 . . . . 0.35999999999999999 114.939 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.3 96.57 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.764 -1.199 . . . . 0.73999999999999999 107.764 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -118.92 123.5 44.78 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 112.537 0.569 . . . . 1.6699999999999999 112.537 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -115.07 130.64 56.98 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 122.273 1.035 . . . . 1.8 111.416 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.14 144.8 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-N 112.724 -2.035 . . . . 0.57999999999999996 110.867 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.6 150.2 25.34 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 113.991 -1.459 . . . . 2.1800000000000002 114.38 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -100.71 -55.58 0.94 Allowed Glycine 0 CA--C 1.541 1.676 0 CA-C-N 115.281 -0.872 . . . . 1.02 114.004 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -128.13 -85.98 0.57 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.031 0.416 . . . . 2.8599999999999999 111.535 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.563 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 61.6 m-85 -133.82 120.6 20.67 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.391 0.676 . . . . 3.9100000000000001 109.792 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 1.0 OUTLIER 87.68 136.54 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 124.86 1.264 . . . . 1.74 111.233 -177.569 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.52 -168.56 0.19 Allowed Pre-proline 0 CA--C 1.58 2.104 0 CA-C-N 114.621 -1.172 . . . . 1.6799999999999999 110.404 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.07 -15.51 34.1 Favored 'Trans proline' 0 N--CA 1.523 3.206 0 C-N-CA 122.675 2.25 . . . . 2.0600000000000001 115.581 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 77.6 tttt 79.91 -65.1 0.19 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 126.444 1.897 . . . . 3.0 114.229 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 38.9 t -106.76 132.27 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 109.791 -0.448 . . . . 0.80000000000000004 109.791 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -135.95 120.58 18.3 Favored 'General case' 0 C--N 1.358 0.943 0 CA-C-N 114.413 -1.267 . . . . 0.87 111.052 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -115.23 49.22 1.08 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.276 1.954 . . . . 0.34000000000000002 116.276 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.75 132.34 3.8 Favored 'General case' 0 N--CA 1.514 2.725 0 N-CA-C 116.069 1.877 . . . . 0.69999999999999996 116.069 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -150.43 100.35 2.86 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.368 -0.833 . . . . 0.20999999999999999 110.525 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.308 13.7 tt -110.3 121.81 63.77 Favored 'Isoleucine or valine' 0 C--O 1.266 1.929 0 CA-C-O 122.42 1.105 . . . . 0.31 111.42 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -123.5 155.06 38.26 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 113.675 -1.602 . . . . 0.44 111.325 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -104.91 148.21 26.93 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 119.252 3.056 . . . . 1.26 119.252 -173.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.02 -42.36 1.92 Allowed Glycine 0 CA--C 1.541 1.715 0 CA-C-N 110.316 -3.129 . . . . 0.17000000000000001 120.582 171.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.73 157.78 1.25 Allowed 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 121.177 2.489 . . . . 0.14999999999999999 113.371 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.7 -13.09 60.07 Favored 'General case' 0 CA--C 1.581 2.172 0 C-N-CA 124.897 1.279 . . . . 0.17000000000000001 114.421 177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.0 2.42 51.81 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 113.953 1.094 . . . . 0.55000000000000004 113.953 177.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.26 -5.78 17.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.629 0.974 . . . . 0.59999999999999998 113.629 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.506 2.346 0 C-N-CA 124.265 1.026 . . . . 0.94999999999999996 111.916 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.587 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.6 tp . . . . . 0 CA--C 1.564 1.517 0 N-CA-C 113.323 0.86 . . . . 0.34999999999999998 113.323 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.64 -23.45 63.04 Favored 'General case' 0 N--CA 1.509 2.505 0 C-N-CA 125.899 1.68 . . . . 0.20000000000000001 114.971 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.39 -11.96 50.53 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 113.621 0.971 . . . . 0.32000000000000001 113.621 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 46.2 mmtt -105.39 -22.25 13.07 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 113.342 0.867 . . . . 1.73 113.342 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.02 135.7 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 115.103 1.52 . . . . 0.11 115.103 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.86 -28.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.455 -0.793 . . . . 0.16 112.035 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 66.4 t90 -162.52 118.81 1.93 Allowed 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 120.657 0.265 . . . . 0.54000000000000004 111.116 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.72 129.63 24.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.41 -0.806 . . . . 0.19 111.62 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 t -133.36 124.55 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.404 0.621 . . . . 1.05 110.064 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -113.96 88.71 2.91 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.105 -1.072 . . . . 2.1099999999999999 108.105 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -72.66 114.02 10.33 Favored 'General case' 0 C--O 1.274 2.356 0 N-CA-C 115.833 1.79 . . . . 0.63 115.833 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.61 -46.28 0.63 Allowed Glycine 0 C--N 1.368 2.309 0 CA-C-N 112.079 -2.328 . . . . 0.70999999999999996 114.438 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.44 -123.96 3.04 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 123.641 0.639 . . . . 0.80000000000000004 114.029 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -170.0 112.33 0.46 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.809 1.243 . . . . 1.6299999999999999 108.951 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 1.1 m 40.85 97.21 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.11 0 N-CA-C 116.968 2.211 . . . . 1.0 116.968 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.546 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 70.4 t60 -126.92 132.16 50.94 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.705 1.372 . . . . 0.45000000000000001 114.705 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 27' ' ' ILE 0.255 8.8 p -106.33 114.07 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.867 0 CA-C-N 114.135 -1.393 . . . . 1.3899999999999999 110.023 177.536 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.407 ' OD2' ' HB ' ' A' ' 27' ' ' ILE . 1.7 p-10 -82.85 160.78 22.11 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.674 -1.148 . . . . 1.8500000000000001 113.063 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 m -43.51 -24.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 N-CA-C 118.816 2.895 . . . . 0.71999999999999997 118.816 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -90.7 -29.54 17.64 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 121.164 0.507 . . . . 0.51000000000000001 110.695 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 41.09 0.57 Allowed Glycine 0 C--N 1.353 1.512 0 CA-C-N 114.953 -1.021 . . . . 0.34000000000000002 114.606 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.587 HD11 ' HG ' ' A' ' 6' ' ' LEU . 30.7 mm -107.95 124.33 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 N-CA-C 109.504 -0.554 . . . . 0.55000000000000004 109.504 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.4 t-160 -114.02 130.48 56.55 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.201 1.556 . . . . 1.3400000000000001 115.201 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.601 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -83.87 136.93 33.92 Favored 'General case' 0 C--N 1.372 1.573 0 C-N-CA 124.019 0.928 . . . . 2.79 110.778 175.117 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -88.89 101.98 14.59 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.716 1.26 . . . . 3.0 112.86 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -31.06 98.28 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 129.07 2.948 . . . . 2.2999999999999998 118.792 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.64 72.45 1.21 Allowed Pre-proline 0 N--CA 1.523 3.219 0 N-CA-C 117.489 2.403 . . . . 1.1699999999999999 117.489 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo . . . . . 0 CA--C 1.564 1.983 0 C-N-CA 122.556 2.171 . . . . 1.45 116.812 179.61 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 N--CA 1.514 2.709 0 N-CA-C 116.818 1.815 . . . . 1.3700000000000001 116.818 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.261 1.2 mp -88.72 131.16 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.158 0 CA-C-O 121.779 0.799 . . . . 0.68999999999999995 110.156 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.517 ' HB2' HG22 ' A' ' 125' ' ' THR . 4.5 mt -90.83 -11.6 38.87 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 116.384 1.994 . . . . 1.28 116.384 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -101.12 9.04 42.47 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 114.414 1.264 . . . . 1.51 114.414 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.97 -169.79 2.23 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 121.426 0.631 . . . . 1.0900000000000001 112.603 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.797 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -94.23 -179.84 1.08 Allowed Pre-proline 0 N--CA 1.516 2.831 0 C-N-CA 124.453 1.101 . . . . 1.27 109.351 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -69.63 -39.57 6.59 Favored 'Trans proline' 0 C--N 1.398 3.166 0 C-N-CA 122.637 2.224 . . . . 0.94999999999999996 112.772 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -66.56 -52.84 41.11 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 125.988 1.715 . . . . 2.04 111.73 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.61 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -80.69 3.95 20.4 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 113.166 -1.834 . . . . 1.6200000000000001 113.183 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.797 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 32.4 tt0 -85.99 -40.71 15.54 Favored 'General case' 0 C--N 1.371 1.513 0 C-N-CA 125.868 1.667 . . . . 1.77 107.773 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -63.17 -43.02 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 C-N-CA 125.038 1.335 . . . . 0.81000000000000005 110.12 174.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.25 -42.9 54.13 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 118.441 0.564 . . . . 1.1499999999999999 111.786 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 2.8 m-30 -74.47 1.08 12.69 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 124.456 1.103 . . . . 0.92000000000000004 112.822 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.439 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 3.2 tt0 -131.98 -127.13 0.19 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.538 0.735 . . . . 1.3300000000000001 110.51 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.6 p 52.15 -145.59 0.54 Allowed 'General case' 0 N--CA 1.533 3.713 0 C-N-CA 126.076 1.751 . . . . 1.28 112.98 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.513 2.69 0 CA-C-N 120.633 1.561 . . . . 1.53 114.036 176.824 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.231 0.062 . . . . 2.1499999999999999 110.921 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.58 83.31 0.15 Allowed 'General case' 0 N--CA 1.511 2.607 0 C-N-CA 125.147 1.379 . . . . 0.77000000000000002 112.399 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -147.61 153.41 39.36 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.873 0.694 . . . . 0.81000000000000005 112.873 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -176.61 179.4 47.63 Favored Glycine 0 C--N 1.349 1.282 0 N-CA-C 116.259 1.264 . . . . 0.46999999999999997 116.259 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -100.35 173.64 6.5 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 117.357 2.354 . . . . 0.89000000000000001 117.357 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.02 120.95 23.11 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 112.617 -2.083 . . . . 0.51000000000000001 111.006 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.03 109.4 52.29 Favored Pre-proline 0 CA--C 1.568 1.672 0 C-N-CA 123.371 0.668 . . . . 0.14999999999999999 109.606 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -84.79 118.2 2.07 Favored 'Trans proline' 0 CA--C 1.566 2.125 0 C-N-CA 121.918 1.746 . . . . 0.14999999999999999 114.427 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.97 159.23 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 CA-C-O 122.052 0.93 . . . . 0.19 111.638 -179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -150.33 23.19 0.83 Allowed 'General case' 0 CA--C 1.56 1.343 0 CA-C-N 114.51 -1.223 . . . . 2.5299999999999998 111.859 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -129.25 158.74 38.21 Favored 'General case' 0 C--N 1.362 1.136 0 CA-C-O 121.166 0.508 . . . . 2.1200000000000001 111.344 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -120.33 144.3 47.92 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.743 1.016 . . . . 0.41999999999999998 113.743 -178.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.86 -135.64 4.01 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 113.751 -1.568 . . . . 0.23000000000000001 111.953 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -118.73 107.31 13.51 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 118.23 1.015 . . . . 1.75 111.101 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -99.35 128.38 45.46 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.252 0.549 . . . . 0.20999999999999999 111.041 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 t -112.02 124.01 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 115.674 -0.694 . . . . 0.20000000000000001 110.548 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.412 HD12 HD12 ' A' ' 172' ' ' ILE . 1.1 tt -107.87 106.44 16.72 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.675 -1.148 . . . . 0.78000000000000003 109.858 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.62 128.06 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 113.947 -1.479 . . . . 0.44 108.492 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.58 141.34 47.64 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.432 -0.804 . . . . 1.25 112.6 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -107.11 123.52 48.36 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 122.022 0.915 . . . . 2.52 110.331 176.093 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.53 137.07 46.22 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 114.16 -1.382 . . . . 0.40000000000000002 110.238 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.627 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . -131.14 151.84 51.04 Favored 'General case' 0 C--O 1.266 1.922 0 CA-C-N 114.979 -1.009 . . . . 0.40999999999999998 110.916 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -124.12 123.89 41.31 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 123.788 0.835 . . . . 2.6099999999999999 110.705 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.265 5.4 p -138.02 41.19 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.766 0 N-CA-C 112.567 0.58 . . . . 2.1299999999999999 112.567 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -161.8 -42.86 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.75 0.648 . . . . 2.27 112.75 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -115.36 119.48 36.42 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.218 0.451 . . . . 1.46 112.218 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.81 86.17 2.35 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-O 122.73 1.253 . . . . 0.83999999999999997 111.134 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -158.57 160.57 36.76 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.89 -1.05 . . . . 2.4500000000000002 112.034 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.3 m -121.84 125.52 46.65 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.6 -0.727 . . . . 1.6599999999999999 112.625 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 74.49 56.7 0.08 Allowed 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 125.878 1.671 . . . . 1.8899999999999999 113.074 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -157.73 -41.76 0.07 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.709 -1.132 . . . . 2.5600000000000001 109.41 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -105.83 82.78 1.83 Allowed 'General case' 0 C--N 1.361 1.1 0 CA-C-O 121.79 0.805 . . . . 2.7599999999999998 108.848 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.88 122.5 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 114.397 -1.274 . . . . 0.68999999999999995 111.729 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -107.36 164.09 12.48 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.9 1.444 . . . . 0.69999999999999996 114.9 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -120.23 136.51 54.62 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.379 0.609 . . . . 1.3300000000000001 111.109 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.0 t -126.13 127.12 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.205 0 CA-C-N 115.411 -0.813 . . . . 0.47999999999999998 109.828 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 57.9 mtt180 -127.33 148.89 50.25 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.509 1.67 . . . . 1.6899999999999999 115.509 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.8 m -129.48 113.5 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 N-CA-C 112.783 0.66 . . . . 0.59999999999999998 112.783 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.34 25.05 14.5 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 126.306 1.842 . . . . 1.1200000000000001 114.164 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.54 -17.29 46.86 Favored Glycine 0 CA--C 1.551 2.282 0 CA-C-N 115.896 -0.593 . . . . 0.32000000000000001 113.626 -176.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 95.2 m-70 -85.79 175.98 8.38 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.544 1.537 . . . . 0.56999999999999995 114.0 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.48 139.83 51.45 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.948 0.88 . . . . 0.55000000000000004 112.171 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.84 -57.16 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 114.016 -1.447 . . . . 1.0600000000000001 112.792 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.81 89.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.57 0.7 . . . . 0.44 109.35 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -100.55 119.45 38.54 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 114.651 -1.159 . . . . 2.2999999999999998 110.531 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 88.29 62.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 127.395 2.278 . . . . 2.48 110.78 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.13 105.05 15.57 Favored 'General case' 0 C--N 1.366 1.286 0 N-CA-C 113.425 0.898 . . . . 1.1299999999999999 113.425 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -111.46 99.31 8.11 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 113.781 -1.554 . . . . 2.3500000000000001 107.426 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -32.15 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 N-CA-C 114.675 1.361 . . . . 0.68000000000000005 114.675 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -75.01 -37.49 61.79 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.495 0.718 . . . . 0.77000000000000002 112.892 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -74.06 -26.7 60.54 Favored 'General case' 0 CA--C 1.575 1.911 0 C-N-CA 124.359 1.064 . . . . 0.91000000000000003 113.477 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -80.99 -57.92 3.31 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.246 0.832 . . . . 2.4300000000000002 113.246 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.43 -38.94 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 N-CA-C 114.091 1.145 . . . . 0.93000000000000005 114.091 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.04 -66.41 0.24 Allowed Glycine 0 C--N 1.358 1.794 0 CA-C-N 118.372 0.533 . . . . 0.84999999999999998 114.222 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -106.6 173.3 6.38 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.016 0.927 . . . . 3.1800000000000002 111.78 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.1 m -81.14 84.22 6.59 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.641 0.978 . . . . 2.0800000000000001 113.641 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.517 HG22 ' HB2' ' A' ' 51' ' ' LEU . 22.2 p -131.56 -131.37 0.19 Allowed 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 114.264 -1.335 . . . . 0.62 108.315 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.64 130.29 56.78 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 114.425 1.269 . . . . 0.46000000000000002 114.425 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -107.52 129.46 54.96 Favored 'General case' 0 C--N 1.371 1.526 0 N-CA-C 108.697 -0.853 . . . . 0.38 108.697 174.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.1 129.06 18.5 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.014 0.746 . . . . 2.5 113.014 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -112.92 129.27 56.53 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 115.081 -0.963 . . . . 1.5600000000000001 111.361 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.97 110.34 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 114.27 -1.332 . . . . 0.45000000000000001 109.429 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.6 102.16 29.61 Favored Pre-proline 0 CA--C 1.571 1.761 0 N-CA-C 112.482 0.549 . . . . 0.83999999999999997 112.482 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -74.77 144.3 30.96 Favored 'Trans proline' 0 C--N 1.398 3.16 0 C-N-CA 123.096 2.531 . . . . 0.16 114.882 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.09 147.99 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 C-N-CA 124.567 1.147 . . . . 0.38 109.043 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 t -134.3 116.97 15.88 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.438 0.637 . . . . 1.3100000000000001 112.003 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.2 mt -114.47 127.19 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 114.836 -1.075 . . . . 0.25 108.826 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -138.8 123.29 18.4 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.463 -0.789 . . . . 2.0499999999999998 110.756 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt 67.88 13.65 9.22 Favored 'General case' 0 N--CA 1.521 3.092 0 N-CA-C 115.226 1.565 . . . . 3.5499999999999998 115.226 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.94 15.13 31.96 Favored Glycine 0 CA--C 1.548 2.109 0 N-CA-C 114.732 0.653 . . . . 0.37 114.732 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 98.4 mttt -121.8 145.27 48.22 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 117.87 0.835 . . . . 1.5600000000000001 112.194 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.84 146.64 27.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.439 1.274 . . . . 0.34000000000000002 114.439 -176.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.24 111.02 9.91 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.38 -1.282 . . . . 0.64000000000000001 110.077 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.0 p -111.4 93.28 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.619 0 CA-C-N 115.598 -0.728 . . . . 0.46000000000000002 110.11 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 66.33 -83.48 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.882 0 C-N-CA 125.288 1.435 . . . . 1.5600000000000001 113.689 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.73 25.94 3.9 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 115.996 -0.547 . . . . 0.48999999999999999 113.741 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -133.2 118.58 18.79 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.18 0.592 . . . . 1.8200000000000001 110.128 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.7 p -105.92 132.76 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.329 0 CA-C-O 121.55 0.691 . . . . 1.02 112.07 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.8 m -148.33 -175.42 4.9 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.014 -0.994 . . . . 0.56000000000000005 110.106 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.418 HG22 ' HG2' ' A' ' 139' ' ' LYS . 35.6 p -101.81 137.94 39.45 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 113.055 0.761 . . . . 1.25 113.055 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -87.1 122.76 31.36 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.469 0.707 . . . . 0.28999999999999998 110.447 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.9 t -129.24 91.65 3.23 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 113.006 0.743 . . . . 1.4199999999999999 113.006 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.22 -64.09 3.8 Favored Glycine 0 C--N 1.357 1.725 0 N-CA-C 119.007 2.363 . . . . 0.41999999999999998 119.007 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.14 158.05 43.78 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.3 1.222 . . . . 1.1000000000000001 114.3 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.68 141.0 37.88 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.308 -1.769 . . . . 0.67000000000000004 109.332 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.9 t -123.95 141.61 51.88 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.972 1.471 . . . . 0.35999999999999999 114.972 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -116.56 100.45 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.33 -1.359 . . . . 0.73999999999999999 107.33 176.666 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -113.48 126.3 55.17 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.77 -0.65 . . . . 1.6699999999999999 112.375 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.6 124.61 52.75 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.503 -0.771 . . . . 1.8 110.406 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.45 ' C ' ' HB3' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -107.99 144.85 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 113.982 -1.463 . . . . 0.57999999999999996 111.027 -177.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.678 ' HB3' ' ND2' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -78.25 149.18 33.64 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 125.224 1.41 . . . . 2.1800000000000002 114.673 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.42 -53.09 0.57 Allowed Glycine 0 CA--C 1.537 1.464 0 CA-C-N 115.097 -0.956 . . . . 1.02 113.392 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -128.39 -48.52 1.3 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 122.937 0.495 . . . . 2.8599999999999999 112.049 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.78 -46.32 0.54 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.814 0.672 . . . . 3.9100000000000001 112.814 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.46 160.5 17.71 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.437 0.637 . . . . 1.74 112.569 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.678 ' ND2' ' HB3' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -120.17 -51.81 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 115.751 -0.658 . . . . 1.6799999999999999 111.296 -179.042 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -103.49 -59.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.669 2.246 . . . . 2.0600000000000001 115.143 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.0 tptm 88.34 -106.22 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 126.823 2.049 . . . . 3.0 110.492 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.07 134.1 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.005 -1.109 . . . . 0.80000000000000004 108.005 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 4.0 t -132.65 137.64 47.05 Favored 'General case' 0 C--N 1.366 1.297 0 N-CA-C 115.159 1.54 . . . . 0.87 115.159 -174.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.256 . . -130.15 47.27 2.53 Favored 'General case' 0 CA--C 1.589 2.465 0 N-CA-C 115.524 1.675 . . . . 0.34000000000000002 115.524 -179.262 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.85 137.07 5.84 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 116.506 2.039 . . . . 0.69999999999999996 116.506 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -154.06 106.04 2.78 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 115.668 -0.696 . . . . 0.20999999999999999 111.298 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.412 HD12 HD12 ' A' ' 85' ' ' LEU 0.325 7.8 tt -114.65 122.3 68.49 Favored 'Isoleucine or valine' 0 C--O 1.27 2.165 0 CA-C-O 122.44 1.114 . . . . 0.31 111.465 175.369 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -124.31 165.26 17.98 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 113.924 -1.489 . . . . 0.44 111.146 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.3 ptmm? -121.87 157.46 31.1 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 118.223 2.675 . . . . 1.26 118.223 -175.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.04 -40.96 2.27 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 110.343 -3.117 . . . . 0.17000000000000001 118.967 173.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.04 159.43 1.67 Allowed 'General case' 0 N--CA 1.514 2.77 0 CA-C-N 120.412 2.106 . . . . 0.14999999999999999 113.059 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.79 -13.64 59.7 Favored 'General case' 0 CA--C 1.58 2.118 0 C-N-CA 125.141 1.376 . . . . 0.17000000000000001 114.046 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.01 3.28 49.39 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 113.663 0.986 . . . . 0.55000000000000004 113.663 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.87 -8.94 19.34 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.575 0.954 . . . . 0.59999999999999998 113.575 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.537 0 C-N-CA 123.971 0.908 . . . . 0.94999999999999996 112.457 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.462 ' HG ' HD11 ' A' ' 27' ' ' ILE . 15.2 tp . . . . . 0 CA--C 1.565 1.538 0 N-CA-C 113.558 0.947 . . . . 0.34999999999999998 113.558 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -22.48 61.35 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 115.412 1.634 . . . . 0.20000000000000001 115.412 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.46 -12.51 48.8 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 113.751 1.019 . . . . 0.32000000000000001 113.751 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 16.4 mtpt -108.38 -18.91 13.63 Favored 'General case' 0 C--N 1.365 1.274 0 N-CA-C 113.583 0.957 . . . . 1.73 113.583 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.25 138.84 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.967 0 N-CA-C 115.156 1.539 . . . . 0.11 115.156 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -122.34 -28.09 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 115.34 -0.846 . . . . 0.16 112.124 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -165.32 119.7 1.26 Allowed 'General case' 0 CA--C 1.563 1.443 0 N-CA-C 111.543 0.201 . . . . 0.54000000000000004 111.543 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -138.31 130.51 28.7 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.302 -0.874 . . . . 0.19 111.724 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -138.9 134.59 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 N-CA-C 113.642 0.978 . . . . 1.05 113.642 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.427 HD22 ' HA ' ' A' ' 169' ' ' ALA . 6.1 t-20 -115.93 106.0 13.3 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.595 -1.261 . . . . 2.1099999999999999 107.595 172.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.99 106.64 9.99 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 121.525 0.678 . . . . 0.63 111.683 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.459 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 165.84 -47.73 0.27 Allowed Glycine 0 C--N 1.355 1.588 0 CA-C-N 114.613 -1.176 . . . . 0.70999999999999996 115.689 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.58 -119.09 3.07 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-O 119.743 -0.476 . . . . 0.80000000000000004 113.368 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.407 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 6.8 pt-20 -167.51 117.64 0.84 Allowed 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 117.311 0.555 . . . . 1.6299999999999999 112.214 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER 48.07 112.01 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 118.339 2.718 . . . . 1.0 118.339 178.22 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 54.3 t-80 -144.83 137.4 26.32 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.049 1.129 . . . . 0.45000000000000001 114.049 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.39 119.93 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-N 114.423 -1.262 . . . . 1.3899999999999999 110.172 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.57 157.86 24.61 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-N 114.707 -1.133 . . . . 1.8500000000000001 110.302 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 m -42.19 -28.15 0.23 Allowed 'Isoleucine or valine' 1 N--CA 1.543 4.186 0 N-CA-C 119.261 3.06 . . . . 0.71999999999999997 119.261 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -93.47 -16.41 24.55 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 118.281 0.491 . . . . 0.51000000000000001 111.513 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.68 41.88 1.29 Allowed Glycine 0 C--N 1.357 1.719 0 C-N-CA 124.391 0.996 . . . . 0.34000000000000002 114.561 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.462 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.8 mm -106.21 117.97 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 N-CA-C 109.335 -0.617 . . . . 0.55000000000000004 109.335 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.448 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.74 135.49 47.06 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.846 1.795 . . . . 1.3400000000000001 115.846 -175.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.3 137.71 33.98 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.261 -1.336 . . . . 2.79 110.157 175.094 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.442 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 31.8 mtt180 -99.48 107.05 19.15 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.581 -1.191 . . . . 3.0 112.898 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -28.08 113.75 0.07 Allowed 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 120.2 3.407 . . . . 2.2999999999999998 120.2 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 32.25 58.72 1.33 Allowed Pre-proline 0 N--CA 1.535 3.796 0 N-CA-C 117.883 2.549 . . . . 1.1699999999999999 117.883 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 20.4 Cg_endo . . . . . 0 CA--C 1.563 1.961 0 C-N-CA 123.071 2.514 . . . . 1.45 116.303 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . 31.0 Cg_exo . . . . . 0 N--CA 1.511 2.552 0 N-CA-C 116.371 1.643 . . . . 1.3700000000000001 116.371 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 61' ' ' TYR 0.269 1.4 mp -88.65 135.97 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.342 0 C-N-CA 123.69 0.796 . . . . 0.68999999999999995 110.113 179.095 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.41 -20.55 23.81 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 116.791 2.145 . . . . 1.28 116.791 -176.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -99.03 18.64 16.8 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.15 1.167 . . . . 1.51 114.15 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.66 -175.7 4.04 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-O 121.426 0.631 . . . . 1.0900000000000001 111.934 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.779 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -93.56 -177.83 0.75 Allowed Pre-proline 0 N--CA 1.511 2.625 0 C-N-CA 123.889 0.876 . . . . 1.27 109.543 178.301 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -68.93 -39.28 8.4 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.54 2.16 . . . . 0.94999999999999996 113.588 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.59 -50.95 47.72 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 125.309 1.444 . . . . 2.04 112.167 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -6.29 55.19 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-N 115.018 -0.992 . . . . 1.6200000000000001 112.667 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.779 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.0 tt0 -74.29 -39.96 62.6 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 125.162 1.385 . . . . 1.77 108.408 173.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.77 -43.55 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 C-N-CA 124.213 1.005 . . . . 0.81000000000000005 108.939 173.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.45 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 tp -80.37 -6.21 57.66 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 114.546 1.313 . . . . 1.1499999999999999 114.546 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.426 ' O ' HG12 ' A' ' 50' ' ' ILE . 18.9 m-85 -125.22 21.8 7.95 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 123.777 0.831 . . . . 0.92000000000000004 112.865 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 29.0 tt0 -143.86 -37.36 0.33 Allowed 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 115.338 1.607 . . . . 1.3300000000000001 115.338 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.1 p -68.57 133.79 49.05 Favored 'General case' 0 N--CA 1.53 3.558 0 N-CA-C 114.849 1.425 . . . . 1.28 114.849 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.52 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.7 pt-20 . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 115.012 1.486 . . . . 1.53 115.012 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 110.704 -0.11 . . . . 2.1499999999999999 110.704 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.69 82.13 0.16 Allowed 'General case' 0 N--CA 1.515 2.812 0 C-N-CA 124.762 1.225 . . . . 0.77000000000000002 110.869 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -144.85 153.9 42.08 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.78 -0.646 . . . . 0.81000000000000005 112.654 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.79 -163.91 16.58 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 116.007 1.163 . . . . 0.46999999999999997 116.007 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -122.76 164.94 17.4 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 113.607 -1.296 . . . . 0.89000000000000001 113.413 -177.427 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.22 130.37 52.66 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.425 -1.261 . . . . 0.51000000000000001 112.126 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.21 102.07 37.42 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.504 0.722 . . . . 0.14999999999999999 109.426 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -84.32 121.03 2.6 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.003 1.802 . . . . 0.14999999999999999 114.691 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.39 161.99 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 CA-C-O 122.099 0.952 . . . . 0.19 110.946 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -153.63 22.45 0.53 Allowed 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 114.55 -1.205 . . . . 2.5299999999999998 111.626 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.14 156.78 44.0 Favored 'General case' 0 C--N 1.362 1.127 0 C-N-CA 123.167 0.587 . . . . 2.1200000000000001 110.788 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -118.37 147.41 43.56 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.388 1.255 . . . . 0.41999999999999998 114.388 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.12 -137.64 5.15 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 113.619 -1.628 . . . . 0.23000000000000001 111.885 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.0 mt-10 -116.22 106.42 13.67 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-N 118.728 1.264 . . . . 1.75 110.819 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -99.58 128.4 45.68 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.251 0.548 . . . . 0.20999999999999999 110.893 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.53 121.77 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.807 0.813 . . . . 0.20000000000000001 110.835 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.36 106.99 17.85 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.118 -1.401 . . . . 0.78000000000000003 109.854 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.06 125.67 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.755 -0.657 . . . . 0.44 110.927 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.73 144.64 51.12 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.449 0.907 . . . . 1.25 113.449 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 4.5 tppt? -104.94 120.57 41.77 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.71 -0.677 . . . . 2.52 111.383 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 7.5 m-85 -105.56 134.48 48.6 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.561 -0.745 . . . . 0.40000000000000002 109.994 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.68 155.3 47.47 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.252 0.548 . . . . 0.40999999999999998 111.784 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.9 171.85 7.4 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.561 0.745 . . . . 2.6099999999999999 112.281 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.84 -77.61 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 112.498 0.555 . . . . 2.1299999999999999 112.498 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -129.69 70.17 1.43 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.311 0.577 . . . . 2.27 111.76 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -148.42 109.83 4.4 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.747 -0.66 . . . . 1.46 110.943 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.22 88.02 2.63 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 123.171 1.463 . . . . 0.83999999999999997 111.271 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -169.12 155.41 6.55 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 113.886 -1.506 . . . . 2.4500000000000002 110.475 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.3 m -118.61 -68.49 0.91 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.44 1.274 . . . . 1.6599999999999999 114.44 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -98.56 68.61 1.84 Allowed 'General case' 0 CA--C 1.558 1.281 0 CA-C-O 121.998 0.904 . . . . 1.8899999999999999 111.366 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -154.32 -45.41 0.09 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.142 -1.39 . . . . 2.5600000000000001 109.34 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -113.56 86.96 2.5 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 121.683 0.754 . . . . 2.7599999999999998 109.022 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.05 131.4 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 114.524 -1.216 . . . . 0.68999999999999995 111.651 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -103.86 166.93 10.1 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.975 1.472 . . . . 0.69999999999999996 114.975 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.17 137.15 54.93 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.91 -0.586 . . . . 1.3300000000000001 111.353 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.8 t -134.52 129.49 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.278 0 CA-C-N 115.941 -0.572 . . . . 0.47999999999999998 111.116 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -133.82 144.58 49.06 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.681 1.363 . . . . 1.6899999999999999 114.681 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.8 m -115.91 106.53 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 114.228 -1.351 . . . . 0.59999999999999998 112.783 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 6.0 t30 62.75 27.03 15.93 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 126.906 2.082 . . . . 1.1200000000000001 114.417 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.93 -20.47 31.24 Favored Glycine 0 CA--C 1.549 2.185 0 CA-C-N 115.503 -0.771 . . . . 0.32000000000000001 113.773 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -84.82 137.55 33.1 Favored 'General case' 0 C--N 1.365 1.254 0 C-N-CA 125.59 1.556 . . . . 0.56999999999999995 114.018 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.69 129.22 42.97 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.694 0.759 . . . . 0.55000000000000004 112.433 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.13 -51.46 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 114.389 -1.278 . . . . 1.0600000000000001 113.21 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.6 89.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.97 -0.752 . . . . 0.44 108.97 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -110.78 75.69 0.94 Allowed 'General case' 0 C--N 1.361 1.07 0 CA-C-O 123.68 1.705 . . . . 2.2999999999999998 112.446 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 152.89 67.16 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 110.094 -3.23 . . . . 2.48 108.23 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.29 101.62 13.36 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 122.161 0.981 . . . . 1.1299999999999999 112.824 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.64 100.09 8.94 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 112.865 -1.971 . . . . 2.3500000000000001 107.701 176.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.22 -22.11 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.379 0 N-CA-C 114.109 1.151 . . . . 0.68000000000000005 114.109 -176.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -77.28 -42.95 35.05 Favored 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 123.978 0.911 . . . . 0.77000000000000002 112.012 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.32 -27.23 60.61 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.892 1.071 . . . . 0.91000000000000003 113.892 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -80.18 -53.07 7.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.926 1.084 . . . . 2.4300000000000002 113.926 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.277 4.1 p -102.61 -36.24 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.99 0 N-CA-C 113.997 1.11 . . . . 0.93000000000000005 113.997 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.5 -121.1 3.03 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-N 118.691 0.678 . . . . 0.84999999999999998 113.047 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -113.27 107.65 16.19 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.252 0.549 . . . . 3.1800000000000002 110.826 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.3 m 72.81 -121.21 0.06 Allowed 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 125.558 1.543 . . . . 2.0800000000000001 111.669 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.6 p 51.55 -165.88 0.05 OUTLIER 'General case' 0 N--CA 1.535 3.795 0 N-CA-C 116.315 1.968 . . . . 0.62 116.315 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -109.08 127.06 53.82 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.128 0.788 . . . . 0.46000000000000002 113.128 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 8.8 t60 -105.0 140.41 38.23 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.423 0.689 . . . . 0.38 109.506 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -144.6 128.5 17.41 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.656 0.613 . . . . 2.5 112.656 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -116.14 136.83 52.67 Favored 'General case' 0 C--O 1.255 1.371 0 CA-C-N 115.019 -0.991 . . . . 1.5600000000000001 111.348 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.92 118.92 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 CA-C-N 113.719 -1.582 . . . . 0.45000000000000001 110.741 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.19 88.79 50.04 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-N 115.498 -0.774 . . . . 0.83999999999999997 109.724 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -73.54 139.26 28.16 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 123.183 2.589 . . . . 0.16 113.921 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -122.35 150.83 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-N 115.348 -0.842 . . . . 0.38 110.825 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.4 t -135.15 109.32 8.28 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.157 -0.929 . . . . 1.3100000000000001 110.525 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.536 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -108.9 124.75 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.569 0 CA-C-N 115.057 -0.974 . . . . 0.25 108.811 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -141.27 125.56 17.5 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.245 -0.889 . . . . 2.0499999999999998 110.778 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp 67.23 16.0 10.09 Favored 'General case' 0 N--CA 1.51 2.574 0 C-N-CA 125.444 1.498 . . . . 3.5499999999999998 114.23 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.68 16.83 32.63 Favored Glycine 0 CA--C 1.549 2.203 0 CA-C-O 119.323 -0.71 . . . . 0.37 114.591 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 58.2 mttt -120.74 142.56 49.43 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-N 118.003 0.902 . . . . 1.5600000000000001 112.847 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.54 132.51 47.13 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.271 0.841 . . . . 0.34000000000000002 113.271 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.08 112.81 18.2 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.2 -0.909 . . . . 0.64000000000000001 110.74 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.68 93.13 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.646 0 CA-C-N 115.44 -0.8 . . . . 0.46000000000000002 110.096 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 64.67 -85.17 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.949 0 C-N-CA 125.36 1.464 . . . . 1.5600000000000001 113.711 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.41 29.93 3.95 Favored Glycine 0 CA--C 1.544 1.898 0 CA-C-N 116.004 -0.544 . . . . 0.48999999999999999 113.288 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -133.77 119.96 19.92 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 123.74 0.816 . . . . 1.8200000000000001 110.544 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.9 p -107.76 133.19 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.351 0 CA-C-O 121.481 0.658 . . . . 1.02 111.806 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m -151.39 -177.04 5.83 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.161 -0.927 . . . . 0.56000000000000005 110.403 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.8 p -101.87 137.03 40.71 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.282 0.845 . . . . 1.25 113.282 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -86.74 121.47 29.29 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.456 0.702 . . . . 0.28999999999999998 110.144 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.2 t -126.39 91.25 3.33 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 113.03 0.752 . . . . 1.4199999999999999 113.03 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.56 -62.7 3.11 Favored Glycine 0 C--N 1.36 1.885 0 N-CA-C 118.542 2.177 . . . . 0.41999999999999998 118.542 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.49 159.89 38.08 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 122.061 0.934 . . . . 1.1000000000000001 113.31 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.523 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -106.46 134.12 50.09 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.448 -1.705 . . . . 0.67000000000000004 108.721 176.79 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.417 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.6 t -121.52 123.45 42.03 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 114.521 1.304 . . . . 0.35999999999999999 114.521 -176.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.51 102.81 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.567 -0.901 . . . . 0.73999999999999999 108.567 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.15 150.15 52.27 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.061 0.934 . . . . 1.6699999999999999 111.633 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.23 141.72 48.66 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 114.198 -1.365 . . . . 1.8 112.274 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.97 145.53 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-N 112.704 -2.044 . . . . 0.57999999999999996 110.769 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.493 ' HB3' ' ND2' ' A' ' 164' ' ' ASN . 21.0 pttp -70.3 150.04 46.77 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 115.803 1.779 . . . . 2.1800000000000002 115.803 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.3 -55.62 0.5 Allowed Glycine 0 CA--C 1.538 1.484 0 CA-C-N 114.89 -1.05 . . . . 1.02 112.606 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.86 -56.14 0.99 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.38 0.672 . . . . 2.8599999999999999 111.049 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -132.27 -41.67 0.98 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.253 0.621 . . . . 3.9100000000000001 112.394 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.37 155.25 24.46 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.33 0.652 . . . . 1.74 112.303 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.493 ' ND2' ' HB3' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -118.1 -48.02 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 115.693 -0.685 . . . . 1.6799999999999999 110.212 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -106.62 -69.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.553 2.169 . . . . 2.0600000000000001 115.939 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt 92.72 -92.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 127.47 2.308 . . . . 3.0 109.32 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 64' ' ' GLU . 41.9 t -113.42 131.62 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 107.775 -1.194 . . . . 0.80000000000000004 107.775 174.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.8 t -136.34 127.04 27.23 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 115.667 -0.697 . . . . 0.87 112.515 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.26 . . -119.43 50.2 1.27 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.858 1.799 . . . . 0.34000000000000002 115.858 -177.374 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -41.01 131.52 2.53 Favored 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 115.887 1.81 . . . . 0.69999999999999996 115.887 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -151.13 100.84 2.81 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.186 -0.916 . . . . 0.20999999999999999 110.275 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.312 8.5 tt -110.12 123.14 65.77 Favored 'Isoleucine or valine' 0 C--O 1.267 2.001 0 CA-C-O 122.412 1.101 . . . . 0.31 112.025 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -124.08 162.96 22.45 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 113.553 -1.658 . . . . 0.44 110.862 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 18.0 ptmt -121.56 159.99 25.24 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 118.585 2.809 . . . . 1.26 118.585 -175.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.51 -42.04 2.0 Allowed Glycine 0 CA--C 1.541 1.685 0 CA-C-N 110.001 -3.272 . . . . 0.17000000000000001 118.688 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.07 153.27 0.97 Allowed 'General case' 0 N--CA 1.515 2.815 0 CA-C-N 120.131 1.966 . . . . 0.14999999999999999 112.678 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.68 -12.89 60.04 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.631 1.345 . . . . 0.17000000000000001 114.631 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.42 4.56 45.97 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 114.349 1.24 . . . . 0.55000000000000004 114.349 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.11 -13.27 15.21 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 114.445 1.276 . . . . 0.59999999999999998 114.445 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.519 3.004 0 C-N-CA 124.238 1.015 . . . . 0.94999999999999996 112.944 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.64 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.8 tp . . . . . 0 CA--C 1.564 1.518 0 N-CA-C 113.505 0.928 . . . . 0.34999999999999998 113.505 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.99 -23.11 61.54 Favored 'General case' 0 N--CA 1.511 2.601 0 C-N-CA 125.704 1.602 . . . . 0.20000000000000001 115.209 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.82 -12.17 48.77 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 113.661 0.986 . . . . 0.32000000000000001 113.661 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 47.8 mmtt -104.69 -22.02 13.29 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.399 0.889 . . . . 1.73 113.399 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.21 134.69 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 N-CA-C 115.172 1.545 . . . . 0.11 115.172 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -122.88 -29.95 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-N 115.575 -0.739 . . . . 0.16 112.343 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 73.9 t90 -161.16 117.49 2.22 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 121.029 0.442 . . . . 0.54000000000000004 111.244 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.8 142.25 40.85 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.621 -0.674 . . . . 0.19 111.316 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.44 HG21 ' HG3' ' A' ' 33' ' ' PRO 0.334 8.9 p -145.38 134.03 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.937 0 CA-C-O 122.425 1.107 . . . . 1.05 113.461 178.053 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.47 ' N ' ' HB3' ' A' ' 29' ' ' TYR . 28.8 p-10 -100.92 91.02 4.39 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-N 113.195 -1.82 . . . . 2.1099999999999999 109.325 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -82.02 103.24 11.52 Favored 'General case' 0 C--O 1.265 1.88 0 CA-C-O 123.414 1.578 . . . . 0.63 113.158 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.536 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 162.99 -50.48 0.31 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-N 111.394 -2.639 . . . . 0.70999999999999996 111.374 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.63 -126.03 4.16 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.497 -1.041 . . . . 0.80000000000000004 110.497 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -168.4 117.36 0.73 Allowed 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 117.666 0.733 . . . . 1.6299999999999999 112.095 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.679 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 6.3 m 62.8 115.68 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 116.896 2.184 . . . . 1.0 116.896 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -159.8 139.57 11.46 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.369 0.604 . . . . 0.45000000000000001 112.176 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.14 122.66 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-N 115.57 -0.741 . . . . 1.3899999999999999 110.651 176.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -85.2 155.98 21.19 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.562 -0.745 . . . . 1.8500000000000001 111.183 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . 0.265 0.7 OUTLIER -45.1 -16.9 0.07 OUTLIER 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 N-CA-C 119.99 3.33 . . . . 0.71999999999999997 119.99 -175.39 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -95.8 -20.85 18.51 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 118.766 0.712 . . . . 0.51000000000000001 111.295 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.68 38.8 1.26 Allowed Glycine 0 C--N 1.356 1.652 0 C-N-CA 124.414 1.007 . . . . 0.34000000000000002 114.488 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.64 HD11 ' HG ' ' A' ' 6' ' ' LEU . 38.8 mm -105.6 121.58 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 N-CA-C 108.994 -0.743 . . . . 0.55000000000000004 108.994 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -101.23 125.29 47.84 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.641 0.608 . . . . 1.3400000000000001 112.641 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 20' ' ' SER . 41.7 m-85 -95.77 137.97 34.08 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.275 -0.875 . . . . 2.79 111.09 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -72.26 159.97 33.18 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.929 2.196 . . . . 3.0 116.929 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -94.92 87.19 4.88 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.001 -1.909 . . . . 2.2999999999999998 115.399 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 49.41 78.29 0.41 Allowed Pre-proline 0 N--CA 1.529 3.489 0 N-CA-C 115.594 1.701 . . . . 1.1699999999999999 115.594 177.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HG3' HG21 ' A' ' 14' ' ' VAL . 44.9 Cg_endo . . . . . 0 CA--C 1.563 1.939 0 N-CA-C 118.971 2.643 . . . . 1.45 118.971 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo . . . . . 0 N--CA 1.495 1.573 0 N-CA-C 116.906 1.849 . . . . 1.3700000000000001 116.906 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.26 1.3 mp -87.51 134.8 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.317 0 C-N-CA 123.82 0.848 . . . . 0.68999999999999995 109.892 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.404 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.3 mm? -90.69 -18.34 25.22 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.106 1.891 . . . . 1.28 116.106 -176.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -103.55 26.02 8.99 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 114.427 1.269 . . . . 1.51 114.427 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.449 ' HG ' ' HD2' ' A' ' 61' ' ' TYR . 1.0 OUTLIER -140.37 -165.56 1.94 Allowed 'General case' 0 CA--C 1.565 1.537 0 CA-C-O 122.32 1.057 . . . . 1.0900000000000001 112.725 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.888 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 2.1 t30 -88.85 172.6 7.26 Favored Pre-proline 0 CA--C 1.569 1.699 0 C-N-CA 126.488 1.915 . . . . 1.27 110.54 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.48 -43.31 1.01 Allowed 'Trans proline' 0 N--CA 1.513 2.63 0 C-N-CA 122.444 2.096 . . . . 0.94999999999999996 113.822 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.37 -41.57 47.57 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 125.223 1.409 . . . . 2.04 111.893 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -86.47 3.96 41.74 Favored 'General case' 0 CA--C 1.578 2.047 0 CA-C-N 114.443 -1.253 . . . . 1.6200000000000001 111.708 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.888 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.3 tt0 -83.25 -40.36 19.69 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 126.659 1.984 . . . . 1.77 106.08 171.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.93 -45.99 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.283 0 C-N-CA 125.296 1.438 . . . . 0.81000000000000005 109.52 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -39.42 68.81 Favored 'General case' 0 CA--C 1.601 2.907 0 N-CA-C 112.781 0.659 . . . . 1.1499999999999999 112.781 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.449 ' HD2' ' HG ' ' A' ' 53' ' ' SER . 12.2 m-30 -90.88 20.48 4.77 Favored 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 114.746 1.387 . . . . 0.92000000000000004 114.746 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.08 -42.01 0.65 Allowed 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 115.408 1.633 . . . . 1.3300000000000001 115.408 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.426 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 48.1 p -63.2 137.71 58.31 Favored 'General case' 0 N--CA 1.537 3.882 0 N-CA-C 114.989 1.477 . . . . 1.28 114.989 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.536 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 14.9 pt-20 . . . . . 0 N--CA 1.5 2.055 0 N-CA-C 115.08 1.511 . . . . 1.53 115.08 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 110.373 -0.232 . . . . 2.1499999999999999 110.373 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.82 87.7 0.12 Allowed 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 125.341 1.456 . . . . 0.77000000000000002 111.802 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -149.14 163.35 37.84 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.445 0.906 . . . . 0.81000000000000005 113.445 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.48 -155.09 10.82 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 116.912 1.525 . . . . 0.46999999999999997 116.912 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.15 168.61 15.88 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.099 1.148 . . . . 0.89000000000000001 114.099 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -126.05 133.68 51.64 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.357 -1.292 . . . . 0.51000000000000001 112.082 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -126.07 100.52 30.05 Favored Pre-proline 0 CA--C 1.569 1.695 0 C-N-CA 123.167 0.587 . . . . 0.14999999999999999 109.642 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.16 117.54 2.2 Favored 'Trans proline' 0 CA--C 1.563 1.925 0 C-N-CA 122.187 1.925 . . . . 0.14999999999999999 114.978 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.18 160.66 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 CA-C-O 122.04 0.924 . . . . 0.19 111.409 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -148.51 23.18 1.02 Allowed 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 114.56 -1.2 . . . . 2.5299999999999998 111.528 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -128.85 158.94 37.32 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-O 121.14 0.495 . . . . 2.1200000000000001 110.892 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -120.6 144.94 47.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.601 1.334 . . . . 0.41999999999999998 114.601 -177.678 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.36 -138.56 5.44 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 113.674 -1.603 . . . . 0.23000000000000001 112.401 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.5 mt-10 -113.7 105.47 13.34 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 118.521 1.16 . . . . 1.75 111.294 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -99.1 128.43 45.23 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.116 0.484 . . . . 0.20999999999999999 110.899 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 t -113.58 123.79 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.34 0.591 . . . . 0.20000000000000001 110.509 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.408 HD12 HD12 ' A' ' 172' ' ' ILE . 3.4 tt -108.0 107.6 18.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.982 -1.008 . . . . 0.78000000000000003 110.401 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.66 125.79 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 114.004 -1.453 . . . . 0.44 107.968 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.45 140.23 44.71 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 116.043 -0.526 . . . . 1.25 112.292 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 16.8 tptt -95.32 120.77 36.12 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.664 -0.698 . . . . 2.52 112.693 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -107.05 132.99 52.35 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.055 -0.975 . . . . 0.40000000000000002 109.977 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.15 149.96 47.63 Favored 'General case' 0 C--O 1.262 1.719 0 CA-C-O 121.333 0.587 . . . . 0.40999999999999998 111.372 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -118.52 142.0 48.02 Favored 'General case' 0 C--N 1.36 1.028 0 CA-C-N 115.175 -0.921 . . . . 2.6099999999999999 111.844 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 -45.58 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-N 115.617 -0.72 . . . . 2.1299999999999999 112.632 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -121.11 137.9 54.44 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.126 0.417 . . . . 2.27 112.126 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 89.41 104.6 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 126.356 1.863 . . . . 1.46 111.43 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.13 87.19 4.14 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 123.295 1.521 . . . . 0.83999999999999997 111.929 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -146.04 157.47 43.86 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.73 -1.577 . . . . 2.4500000000000002 111.726 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.4 m -115.05 -74.39 0.61 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.063 1.134 . . . . 1.6599999999999999 114.063 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.28 64.12 1.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.225 1.012 . . . . 1.8899999999999999 111.918 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -151.92 -41.66 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.573 1.549 . . . . 2.5600000000000001 109.033 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -108.28 79.3 1.24 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-O 121.96 0.886 . . . . 2.7599999999999998 109.137 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.38 120.88 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 114.564 -1.198 . . . . 0.68999999999999995 110.639 -178.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -101.51 170.7 8.03 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.362 1.615 . . . . 0.69999999999999996 115.362 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.22 136.72 54.86 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.063 0.458 . . . . 1.3300000000000001 111.052 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.18 125.73 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.306 0 CA-C-N 115.826 -0.625 . . . . 0.47999999999999998 109.899 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 46.2 mtt180 -125.72 151.34 46.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.645 1.72 . . . . 1.6899999999999999 115.645 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.7 m -127.46 110.92 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 123.24 0.616 . . . . 0.59999999999999998 112.577 177.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.506 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.51 26.43 13.38 Favored 'General case' 0 N--CA 1.526 3.374 0 C-N-CA 126.664 1.986 . . . . 1.1200000000000001 113.95 -178.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.43 -11.93 56.79 Favored Glycine 0 CA--C 1.552 2.367 0 C-N-CA 121.482 -0.39 . . . . 0.32000000000000001 113.834 -176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.492 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 89.3 m-70 -89.72 164.89 14.5 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 125.944 1.698 . . . . 0.56999999999999995 113.488 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.04 134.89 54.32 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.494 0.664 . . . . 0.55000000000000004 112.016 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.51 -58.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 114.916 -1.038 . . . . 1.0600000000000001 112.784 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.06 88.64 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.881 -1.155 . . . . 0.44 107.881 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -107.74 100.16 9.57 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-O 123.11 1.433 . . . . 2.2999999999999998 111.778 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 117.62 72.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 129.438 3.095 . . . . 2.48 108.015 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.11 104.96 16.85 Favored 'General case' 0 C--N 1.359 0.98 0 CA-C-O 121.979 0.895 . . . . 1.1299999999999999 112.713 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -112.11 99.15 7.84 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 112.851 -1.977 . . . . 2.3500000000000001 107.973 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -24.11 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.364 0 N-CA-C 113.964 1.098 . . . . 0.68000000000000005 113.964 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -75.65 -41.35 54.29 Favored 'General case' 0 CA--C 1.568 1.668 0 C-N-CA 124.108 0.963 . . . . 0.77000000000000002 111.96 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.75 -26.38 59.74 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.278 1.031 . . . . 0.91000000000000003 113.444 176.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -77.39 -57.93 3.55 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.555 0.946 . . . . 2.4300000000000002 113.555 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.84 -32.07 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 N-CA-C 114.906 1.447 . . . . 0.93000000000000005 114.906 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.46 -115.77 2.35 Favored Glycine 0 C--N 1.357 1.729 0 CA-C-N 118.655 0.661 . . . . 0.84999999999999998 113.011 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -114.8 107.5 15.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.246 0.546 . . . . 3.1800000000000002 110.716 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.0 m 72.51 -130.52 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 125.487 1.515 . . . . 2.0800000000000001 112.313 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 51' ' ' LEU . 73.2 p 58.15 -162.13 0.22 Allowed 'General case' 0 N--CA 1.53 3.528 0 C-N-CA 126.237 1.815 . . . . 0.62 115.017 178.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.91 135.71 53.69 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 113.495 0.924 . . . . 0.46000000000000002 113.495 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -109.32 144.91 36.86 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.542 0.737 . . . . 0.38 109.163 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.15 124.19 18.88 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.704 1.001 . . . . 2.5 113.704 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -112.72 120.33 41.15 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.288 -0.869 . . . . 1.5600000000000001 111.538 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.47 115.68 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-N 114.742 -1.117 . . . . 0.45000000000000001 110.499 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 100.76 15.88 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 119.075 -0.488 . . . . 0.83999999999999997 111.791 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -74.6 142.47 29.26 Favored 'Trans proline' 0 C--N 1.4 3.266 0 C-N-CA 123.062 2.508 . . . . 0.16 114.281 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.29 146.24 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.597 0 C-N-CA 123.934 0.894 . . . . 0.38 109.983 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.1 p -128.89 110.42 12.1 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.222 0.534 . . . . 1.3100000000000001 112.145 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.0 mt -112.83 124.31 69.35 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.57 0 CA-C-N 115.277 -0.874 . . . . 0.25 108.952 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -140.22 124.22 17.53 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.47 -0.786 . . . . 2.0499999999999998 111.223 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt 65.75 16.24 10.4 Favored 'General case' 0 N--CA 1.516 2.843 0 C-N-CA 125.43 1.492 . . . . 3.5499999999999998 114.886 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.93 21.78 17.46 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 114.512 0.565 . . . . 0.37 114.512 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 19.0 ttmm -129.81 137.84 50.71 Favored 'General case' 0 C--N 1.363 1.159 0 CA-C-N 117.636 0.718 . . . . 1.5600000000000001 111.545 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.36 141.7 31.8 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.077 1.14 . . . . 0.34000000000000002 114.077 -176.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.21 114.53 13.92 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.704 -1.135 . . . . 0.64000000000000001 110.109 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.253 8.7 p -119.58 95.55 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 CA-C-N 115.841 -0.618 . . . . 0.46000000000000002 111.019 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 67.23 -85.18 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 125.714 1.606 . . . . 1.5600000000000001 113.968 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.44 28.38 3.81 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.093 -0.503 . . . . 0.48999999999999999 113.156 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -134.75 127.23 30.53 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 123.647 0.779 . . . . 1.8200000000000001 110.473 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.3 p -114.27 139.72 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.361 0 CA-C-O 121.278 0.561 . . . . 1.02 111.451 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.8 m -158.73 176.04 12.87 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.577 0.751 . . . . 0.56000000000000005 109.87 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.3 p -101.32 137.32 39.81 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.073 0.768 . . . . 1.25 113.073 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -82.8 124.86 30.67 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.074 0.949 . . . . 0.28999999999999998 112.016 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.9 t -131.32 91.08 2.96 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-O 121.643 0.735 . . . . 1.4199999999999999 112.574 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.0 -65.37 3.27 Favored Glycine 0 C--N 1.358 1.752 0 N-CA-C 118.986 2.355 . . . . 0.41999999999999998 118.986 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.511 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -131.16 156.6 45.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.291 1.219 . . . . 1.1000000000000001 114.291 -175.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.511 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -107.15 137.95 44.25 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 113.133 -1.849 . . . . 0.67000000000000004 109.071 176.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.1 t -120.61 143.34 48.71 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.411 1.634 . . . . 0.35999999999999999 115.411 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.38 99.04 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.169 -1.419 . . . . 0.73999999999999999 107.169 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -117.58 123.17 45.56 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.996 -0.547 . . . . 1.6699999999999999 112.316 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.01 136.24 53.13 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 122.53 1.157 . . . . 1.8 112.029 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.51 144.78 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 CA-C-N 112.529 -2.123 . . . . 0.57999999999999996 109.814 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.535 ' HB3' HD22 ' A' ' 164' ' ' ASN . 22.1 pttp -58.8 150.84 22.76 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.504 2.038 . . . . 2.1800000000000002 116.504 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.91 -63.95 0.51 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 115.541 -0.754 . . . . 1.02 114.028 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -130.7 -64.85 0.82 Allowed 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.962 0.381 . . . . 2.8599999999999999 111.811 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -120.17 -46.56 2.41 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.769 0.428 . . . . 3.9100000000000001 111.953 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -100.99 177.09 5.05 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.47 0.708 . . . . 1.74 111.222 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.535 HD22 ' HB3' ' A' ' 159' ' ' LYS . 0.9 OUTLIER -115.0 -85.46 0.0 OUTLIER Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 117.441 -1.266 . . . . 1.6799999999999999 110.679 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -88.59 -36.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.393 2.911 0 CA-C-N 123.774 2.384 . . . . 2.0600000000000001 114.256 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm 79.79 -88.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 126.845 2.058 . . . . 3.0 110.675 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.511 HG22 ' HB3' ' A' ' 64' ' ' GLU . 22.8 t -111.77 131.81 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.327 -0.99 . . . . 0.80000000000000004 108.327 175.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 3.8 t -138.26 132.49 31.8 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.052 -0.977 . . . . 0.87 111.801 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -129.6 51.11 2.1 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 114.96 1.467 . . . . 0.34000000000000002 114.96 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.25 138.14 1.25 Allowed 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 117.803 2.52 . . . . 0.69999999999999996 117.803 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -153.78 104.22 2.67 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 115.666 -0.697 . . . . 0.20999999999999999 111.504 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.408 HD12 HD12 ' A' ' 85' ' ' LEU 0.316 10.3 tt -113.88 122.06 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.183 0 CA-C-O 122.384 1.088 . . . . 0.31 111.119 175.049 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -122.7 165.47 16.48 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.145 -1.389 . . . . 0.44 111.092 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.6 ptmt -121.74 157.89 29.97 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 118.239 2.681 . . . . 1.26 118.239 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.24 -40.39 2.45 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 110.212 -3.176 . . . . 0.17000000000000001 119.066 173.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.11 157.64 1.85 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 120.265 2.033 . . . . 0.14999999999999999 113.101 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.86 -11.52 59.58 Favored 'General case' 0 CA--C 1.58 2.132 0 C-N-CA 124.91 1.284 . . . . 0.17000000000000001 113.984 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.68 3.52 47.57 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.0 1.111 . . . . 0.55000000000000004 114.0 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.02 -20.47 14.78 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.388 0.885 . . . . 0.59999999999999998 113.388 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.579 2.072 0 C-N-CA 124.343 1.057 . . . . 0.94999999999999996 112.262 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.445 ' HG ' HD11 ' A' ' 27' ' ' ILE . 17.6 tp . . . . . 0 CA--C 1.566 1.586 0 N-CA-C 113.328 0.862 . . . . 0.34999999999999998 113.328 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.99 -23.32 63.54 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 125.896 1.678 . . . . 0.20000000000000001 115.269 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.69 -12.17 49.11 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 113.575 0.954 . . . . 0.32000000000000001 113.575 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -106.13 -19.36 13.74 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 113.324 0.861 . . . . 1.73 113.324 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -56.67 134.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.851 0 N-CA-C 114.705 1.372 . . . . 0.11 114.705 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -119.7 -29.77 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 115.581 -0.736 . . . . 0.16 112.214 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -160.43 115.95 2.3 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 120.696 0.284 . . . . 0.54000000000000004 110.951 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.08 122.19 22.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.602 -0.686 . . . . 0.19 111.397 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 30.8 t -131.25 116.63 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 122.097 0.951 . . . . 1.05 109.663 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.549 HD22 ' HB1' ' A' ' 169' ' ' ALA . 11.4 m120 -114.01 88.01 2.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.828 -1.078 . . . . 2.1099999999999999 108.996 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.6 120.13 17.79 Favored 'General case' 0 C--O 1.277 2.516 0 N-CA-C 115.757 1.762 . . . . 0.63 115.757 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.505 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 151.88 -10.22 0.67 Allowed Glycine 0 C--N 1.359 1.816 0 CA-C-N 111.731 -2.486 . . . . 0.70999999999999996 115.693 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.12 -119.81 1.23 Allowed Glycine 0 N--CA 1.468 0.82 0 CA-C-N 117.645 0.723 . . . . 0.80000000000000004 112.511 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -169.07 118.08 0.67 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.068 0.547 . . . . 1.6299999999999999 110.697 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.668 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 68.1 p 42.95 100.45 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.681 0 N-CA-C 117.92 2.563 . . . . 1.0 117.92 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 54.6 t-80 -132.94 136.24 46.0 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 118.615 -1.234 . . . . 0.45000000000000001 114.171 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.267 10.0 p -103.39 117.76 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 CA-C-N 114.117 -1.401 . . . . 1.3899999999999999 110.917 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -83.12 152.51 25.27 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-N 113.578 -1.646 . . . . 1.8500000000000001 110.046 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.7 m -41.25 -28.77 0.16 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.27 0 N-CA-C 119.192 3.034 . . . . 0.71999999999999997 119.192 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -87.36 -25.96 23.59 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.184 0.516 . . . . 0.51000000000000001 111.277 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.63 38.85 0.75 Allowed Glycine 0 C--N 1.352 1.422 0 CA-C-N 114.983 -1.008 . . . . 0.34000000000000002 114.445 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.445 HD11 ' HG ' ' A' ' 6' ' ' LEU . 20.6 mm -107.09 114.16 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 N-CA-C 109.68 -0.489 . . . . 0.55000000000000004 109.68 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.537 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -107.08 132.46 52.95 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 115.359 1.614 . . . . 1.3400000000000001 115.359 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -89.12 147.27 24.3 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.871 0.869 . . . . 2.79 109.93 174.274 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 20' ' ' SER . 0.0 OUTLIER -60.49 -107.88 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 117.075 2.25 . . . . 3.0 117.075 -177.116 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -175.72 71.55 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 124.221 1.008 . . . . 2.2999999999999998 112.958 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.415 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 19.3 m-20 65.52 47.57 0.58 Allowed Pre-proline 0 N--CA 1.519 3.009 0 N-CA-C 118.291 2.7 . . . . 1.1699999999999999 118.291 175.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 41.4 Cg_endo . . . . . 0 C--N 1.374 1.91 0 C-N-CA 123.214 2.609 . . . . 1.45 114.391 177.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo . . . . . 0 N--CA 1.501 1.921 0 N-CA-C 117.379 2.03 . . . . 1.3700000000000001 117.379 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.265 1.2 mp -89.8 128.11 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.226 0 CA-C-N 114.986 -1.006 . . . . 0.68999999999999995 109.191 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mp -85.49 -12.01 52.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.924 1.824 . . . . 1.28 115.924 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -102.63 22.59 13.36 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 113.694 0.998 . . . . 1.51 113.694 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -143.03 -163.33 1.61 Allowed 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 121.773 0.797 . . . . 1.0900000000000001 111.993 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.2 t30 -95.55 -179.96 1.04 Allowed Pre-proline 0 CA--C 1.572 1.823 0 C-N-CA 125.302 1.441 . . . . 1.27 111.138 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.575 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 24.5 Cg_exo -71.82 -45.64 0.7 Allowed 'Trans proline' 0 C--N 1.394 2.969 0 C-N-CA 123.076 2.518 . . . . 0.94999999999999996 111.891 174.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -70.07 -43.78 70.45 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.438 -1.71 . . . . 2.04 111.56 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.01 1.51 43.45 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 114.912 -1.04 . . . . 1.6200000000000001 112.438 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.595 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 3.4 tt0 -77.71 -42.94 32.65 Favored 'General case' 0 C--N 1.381 1.938 0 C-N-CA 125.853 1.661 . . . . 1.77 106.853 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.07 -44.45 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.869 0 C-N-CA 124.519 1.127 . . . . 0.81000000000000005 109.108 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.9 tp -68.22 -29.67 68.55 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 114.723 1.379 . . . . 1.1499999999999999 114.723 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -105.53 14.88 27.92 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 114.121 1.156 . . . . 0.92000000000000004 114.121 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.14 -23.48 1.13 Allowed 'General case' 0 N--CA 1.513 2.713 0 N-CA-C 115.883 1.809 . . . . 1.3300000000000001 115.883 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.473 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 41.7 p -80.88 135.95 36.0 Favored 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 113.378 0.881 . . . . 1.28 113.378 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.505 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.1 pt-20 . . . . . 0 N--CA 1.511 2.606 0 N-CA-C 115.894 1.813 . . . . 1.53 115.894 -176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 110.58 -0.155 . . . . 2.1499999999999999 110.58 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.499 ' H ' HD21 ' A' ' 164' ' ' ASN . 0.3 OUTLIER 72.72 83.99 0.12 Allowed 'General case' 0 N--CA 1.514 2.75 0 C-N-CA 124.952 1.301 . . . . 0.77000000000000002 111.042 -178.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -147.29 152.84 38.93 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.502 -0.772 . . . . 0.81000000000000005 113.062 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -165.51 -171.68 32.01 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 115.842 1.097 . . . . 0.46999999999999997 115.842 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.27 172.43 7.08 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.438 1.273 . . . . 0.89000000000000001 114.438 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.09 132.33 51.92 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.393 -1.276 . . . . 0.51000000000000001 112.228 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.27 102.22 30.65 Favored Pre-proline 0 CA--C 1.567 1.613 0 C-N-CA 123.446 0.698 . . . . 0.14999999999999999 109.408 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.84 119.58 2.22 Favored 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 122.098 1.865 . . . . 0.14999999999999999 114.925 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.36 162.7 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.654 0 CA-C-O 122.003 0.906 . . . . 0.19 111.089 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -150.63 19.76 0.82 Allowed 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 114.716 -1.129 . . . . 2.5299999999999998 111.781 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.53 159.78 35.25 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-O 121.32 0.581 . . . . 2.1200000000000001 111.572 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.517 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -118.32 147.96 42.96 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.199 1.185 . . . . 0.41999999999999998 114.199 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.82 -139.6 6.26 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 113.827 -1.533 . . . . 0.23000000000000001 112.165 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.9 mt-10 -115.1 104.63 12.06 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 118.46 1.13 . . . . 1.75 110.823 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -98.88 128.4 45.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.159 0.504 . . . . 0.20999999999999999 110.759 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -112.93 122.91 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-O 121.612 0.72 . . . . 0.20000000000000001 110.848 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.468 HD12 HD12 ' A' ' 172' ' ' ILE . 2.0 tt -108.34 105.35 14.99 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.391 -1.277 . . . . 0.78000000000000003 110.304 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.19 125.13 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 114.082 -1.417 . . . . 0.44 107.913 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -135.52 135.34 40.33 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.728 -0.669 . . . . 1.25 111.837 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -96.09 121.21 37.62 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.498 -0.774 . . . . 2.52 112.051 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -107.34 133.96 51.11 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.058 -0.974 . . . . 0.40000000000000002 109.945 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.33 152.92 48.92 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.433 0.635 . . . . 0.40999999999999998 112.499 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.68 157.12 16.7 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.41 1.084 . . . . 2.6099999999999999 112.309 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.257 4.4 p -144.52 -39.48 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.585 0 N-CA-C 114.227 1.195 . . . . 2.1299999999999999 114.227 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -130.01 -2.04 4.63 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 115.442 1.645 . . . . 2.27 115.442 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -128.6 114.0 16.14 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.537 1.062 . . . . 1.46 112.311 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.0 92.7 4.15 Favored 'General case' 0 CA--C 1.563 1.471 0 CA-C-O 122.617 1.198 . . . . 0.83999999999999997 111.061 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -152.12 149.62 29.0 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.815 -1.084 . . . . 2.4500000000000002 112.103 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.1 m -123.71 117.83 25.85 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.585 0.587 . . . . 1.6599999999999999 112.585 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 71.47 55.38 0.2 Allowed 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 126.244 1.818 . . . . 1.8899999999999999 113.058 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -154.56 -40.08 0.09 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.194 -1.366 . . . . 2.5600000000000001 109.579 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -107.61 80.84 1.44 Allowed 'General case' 0 C--N 1.364 1.237 0 N-CA-C 108.643 -0.873 . . . . 2.7599999999999998 108.643 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.52 129.3 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 114.627 -1.169 . . . . 0.68999999999999995 111.466 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -115.51 171.76 7.52 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.014 1.487 . . . . 0.69999999999999996 115.014 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.52 136.12 54.01 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.415 0.626 . . . . 1.3300000000000001 111.774 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.2 123.32 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.936 0 CA-C-N 115.315 -0.857 . . . . 0.47999999999999998 110.102 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -129.83 149.42 51.57 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.953 1.464 . . . . 1.6899999999999999 114.953 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.3 OUTLIER -126.56 108.26 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 114.636 -1.165 . . . . 0.59999999999999998 111.704 176.993 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.49 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 65.18 26.08 12.37 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 126.759 2.023 . . . . 1.1200000000000001 113.277 -177.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.41 -13.91 51.06 Favored Glycine 0 CA--C 1.553 2.435 0 CA-C-N 116.157 -0.474 . . . . 0.32000000000000001 114.139 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -89.85 131.21 35.9 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 125.456 1.502 . . . . 0.56999999999999995 114.044 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -97.85 126.0 43.0 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.429 -0.794 . . . . 0.55000000000000004 112.705 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.26 -48.2 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-N 114.214 -1.357 . . . . 1.0600000000000001 110.256 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.06 88.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 120.26 -0.576 . . . . 0.44 109.744 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.02 72.27 0.81 Allowed 'General case' 0 C--N 1.36 1.03 0 CA-C-O 123.494 1.616 . . . . 2.2999999999999998 111.411 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.7 p30 160.07 60.4 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 111.005 -2.816 . . . . 2.48 108.52 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.89 103.18 15.75 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 113.749 1.018 . . . . 1.1299999999999999 113.749 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -119.07 102.87 9.05 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 112.88 -1.963 . . . . 2.3500000000000001 106.067 175.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -27.05 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.319 0 N-CA-C 114.547 1.314 . . . . 0.68000000000000005 114.547 -176.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.59 -37.77 55.96 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.684 0.793 . . . . 0.77000000000000002 112.194 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.22 -26.58 60.33 Favored 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 124.665 1.186 . . . . 0.91000000000000003 113.229 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -80.22 -57.96 3.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.482 0.919 . . . . 2.4300000000000002 113.482 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.28 -36.22 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.532 0 N-CA-C 114.196 1.184 . . . . 0.93000000000000005 114.196 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.01 -73.12 0.2 Allowed Glycine 0 C--N 1.361 1.922 0 CA-C-N 118.306 0.503 . . . . 0.84999999999999998 113.969 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -102.76 175.43 5.49 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.345 1.058 . . . . 3.1800000000000002 111.753 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 m -71.6 87.68 0.93 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.997 0.903 . . . . 2.0800000000000001 113.428 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.34 -162.22 1.3 Allowed 'General case' 0 CA--C 1.563 1.445 0 CA-C-N 113.918 -1.492 . . . . 0.62 110.024 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.94 130.3 45.3 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 113.421 0.897 . . . . 0.46000000000000002 113.421 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.431 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 22.4 t60 -103.51 141.72 35.51 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.463 -0.569 . . . . 0.38 109.463 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -134.15 124.17 25.62 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.377 1.251 . . . . 2.5 114.377 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -111.39 118.84 36.93 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.748 -1.114 . . . . 1.5600000000000001 110.684 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.62 120.91 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.735 -1.12 . . . . 0.45000000000000001 111.448 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.29 95.45 27.49 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-N 115.842 -0.617 . . . . 0.83999999999999997 111.062 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -75.37 131.91 14.37 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.787 2.324 . . . . 0.16 112.711 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.3 mt -115.1 146.7 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 CA-C-N 115.443 -0.799 . . . . 0.38 111.137 -176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.6 p -129.18 109.94 11.57 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.264 -0.88 . . . . 1.3100000000000001 111.515 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.517 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.5 mt -112.14 123.33 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.502 0 N-CA-C 108.336 -0.987 . . . . 0.25 108.336 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -138.78 124.43 19.62 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.373 -0.83 . . . . 2.0499999999999998 110.792 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.28 17.86 10.25 Favored 'General case' 0 N--CA 1.515 2.784 0 C-N-CA 125.35 1.46 . . . . 3.5499999999999998 114.168 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.54 13.8 43.2 Favored Glycine 0 CA--C 1.546 2.01 0 CA-C-O 119.163 -0.798 . . . . 0.37 115.025 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 54.8 mtpt -122.46 147.02 46.83 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-N 118.523 1.161 . . . . 1.5600000000000001 112.57 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.82 143.98 31.74 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.125 1.157 . . . . 0.34000000000000002 114.125 -175.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.43 114.65 11.59 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.919 -1.037 . . . . 0.64000000000000001 110.653 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.278 0.4 OUTLIER -116.81 105.17 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-O 121.144 0.497 . . . . 0.46000000000000002 110.382 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 66.32 -84.29 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.706 0 C-N-CA 125.701 1.601 . . . . 1.5600000000000001 113.981 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.75 31.82 2.52 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.001 -0.545 . . . . 0.48999999999999999 112.859 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -134.85 126.66 29.24 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 123.603 0.761 . . . . 1.8200000000000001 110.239 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -112.5 133.02 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 CA-C-O 121.673 0.749 . . . . 1.02 112.21 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.2 m -149.95 179.54 7.97 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.83 -1.077 . . . . 0.56000000000000005 109.346 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.275 15.1 t -104.15 139.05 39.76 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 113.476 0.917 . . . . 1.25 113.476 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -82.87 122.19 27.92 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.068 0.947 . . . . 0.28999999999999998 111.367 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.56 91.24 3.26 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 112.556 0.576 . . . . 1.4199999999999999 112.556 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.96 -64.82 3.33 Favored Glycine 0 C--N 1.358 1.802 0 N-CA-C 118.715 2.246 . . . . 0.41999999999999998 118.715 177.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.52 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -132.38 157.79 43.63 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 114.251 1.204 . . . . 1.1000000000000001 114.251 -176.495 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.52 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -104.62 139.04 40.06 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.202 -1.817 . . . . 0.67000000000000004 109.063 176.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 t -121.35 142.48 49.94 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.352 1.612 . . . . 0.35999999999999999 115.352 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.419 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.14 97.27 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.451 -1.314 . . . . 0.73999999999999999 107.451 176.267 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 33.4 mt-10 -112.65 128.04 56.28 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.384 0.883 . . . . 1.6699999999999999 113.384 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -114.05 126.18 54.83 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 115.738 -0.664 . . . . 1.8 110.192 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.07 144.37 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 114.652 -1.158 . . . . 0.57999999999999996 110.53 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -72.45 150.45 43.3 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.646 2.091 . . . . 2.1800000000000002 116.646 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -114.97 -47.88 0.55 Allowed Glycine 0 CA--C 1.541 1.691 0 CA-C-N 114.066 -1.424 . . . . 1.02 112.941 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -131.88 -76.82 0.51 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 122.739 0.415 . . . . 2.8599999999999999 111.951 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -138.17 -53.97 0.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.949 0.5 . . . . 3.9100000000000001 111.421 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.05 119.66 31.39 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.606 1.162 . . . . 1.74 110.772 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.499 HD21 ' H ' ' A' ' 70' ' ' SER . 1.3 m-20 -81.13 -170.67 0.26 Allowed Pre-proline 0 CA--C 1.572 1.809 0 C-N-CA 124.848 1.259 . . . . 1.6799999999999999 110.524 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -61.8 104.93 0.34 Allowed 'Trans proline' 0 C--N 1.394 2.922 0 CA-C-N 122.304 1.858 . . . . 2.0600000000000001 112.215 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -63.52 1.27 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.336 1.976 . . . . 3.0 116.336 -174.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 66.0 t -96.38 131.44 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 CA-C-N 119.367 0.985 . . . . 0.80000000000000004 109.991 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.25 123.27 23.99 Favored 'General case' 0 C--N 1.363 1.169 0 CA-C-N 114.443 -1.253 . . . . 0.87 111.834 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.549 ' HB1' HD22 ' A' ' 15' ' ' ASN . . . -120.72 48.02 1.69 Allowed 'General case' 0 CA--C 1.585 2.302 0 N-CA-C 115.643 1.719 . . . . 0.34000000000000002 115.643 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.642 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -45.23 131.74 7.73 Favored 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 116.64 2.089 . . . . 0.69999999999999996 116.64 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -151.31 105.4 3.19 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 115.19 -0.914 . . . . 0.20999999999999999 111.051 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.468 HD12 HD12 ' A' ' 85' ' ' LEU 0.298 9.1 tt -113.66 122.32 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 CA-C-O 122.283 1.04 . . . . 0.31 111.258 175.651 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -122.67 165.24 16.82 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 113.906 -1.497 . . . . 0.44 110.789 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -122.13 158.93 28.22 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 118.283 2.698 . . . . 1.26 118.283 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.89 -41.31 2.17 Favored Glycine 0 CA--C 1.541 1.7 0 CA-C-N 110.351 -3.113 . . . . 0.17000000000000001 119.256 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.59 154.53 1.25 Allowed 'General case' 0 N--CA 1.518 2.927 0 CA-C-N 120.494 2.147 . . . . 0.14999999999999999 113.227 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.25 -14.43 58.42 Favored 'General case' 0 CA--C 1.581 2.169 0 C-N-CA 124.75 1.22 . . . . 0.17000000000000001 114.092 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.8 2.99 49.9 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.143 1.164 . . . . 0.55000000000000004 114.143 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.0 -5.79 15.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.726 1.01 . . . . 0.59999999999999998 113.726 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.622 0 C-N-CA 124.397 1.079 . . . . 0.94999999999999996 111.752 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.657 ' HG ' HD11 ' A' ' 27' ' ' ILE . 19.4 tp . . . . . 0 CA--C 1.565 1.553 0 N-CA-C 112.938 0.718 . . . . 0.34999999999999998 112.938 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.43 63.56 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 125.855 1.662 . . . . 0.20000000000000001 114.797 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.7 -11.43 51.24 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 113.667 0.988 . . . . 0.32000000000000001 113.667 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 20.8 mmtp -105.47 -23.28 12.84 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.379 0.881 . . . . 1.73 113.379 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.67 136.55 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 N-CA-C 115.472 1.656 . . . . 0.11 115.472 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.9 -28.4 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 115.195 -0.911 . . . . 0.16 112.236 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -163.09 118.76 1.76 Allowed 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 117.929 0.331 . . . . 0.54000000000000004 111.882 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.26 131.82 30.76 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.273 -0.892 . . . . 0.19 111.876 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -139.75 130.66 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 N-CA-C 113.113 0.783 . . . . 1.05 113.113 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -115.83 106.61 14.03 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.117 -1.438 . . . . 2.1099999999999999 107.117 171.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.33 105.83 9.84 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.614 0.721 . . . . 0.63 111.664 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 168.79 -63.54 0.19 Allowed Glycine 0 C--N 1.355 1.635 0 CA-C-N 114.189 -1.369 . . . . 0.70999999999999996 114.821 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -95.16 -116.3 2.96 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 114.716 0.646 . . . . 0.80000000000000004 114.716 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 18.4 mt-10 -170.08 114.16 0.49 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.889 0.876 . . . . 1.6299999999999999 109.884 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 46.39 111.95 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.003 0 N-CA-C 118.328 2.714 . . . . 1.0 118.328 178.831 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.483 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 56.8 t-80 -136.59 136.4 39.19 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.97 1.1 . . . . 0.45000000000000001 113.97 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.82 109.29 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 CA-C-N 113.765 -1.561 . . . . 1.3899999999999999 107.04 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.67 160.1 18.26 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 112.171 0.434 . . . . 1.8500000000000001 112.171 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -41.48 -26.41 0.11 Allowed 'Isoleucine or valine' 1 N--CA 1.547 4.383 0 N-CA-C 120.072 3.36 . . . . 0.71999999999999997 120.072 -174.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -93.35 -11.33 32.59 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 118.84 0.746 . . . . 0.51000000000000001 112.44 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.82 38.0 3.28 Favored Glycine 0 C--N 1.361 1.929 0 C-N-CA 124.16 0.886 . . . . 0.34000000000000002 114.158 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.657 HD11 ' HG ' ' A' ' 6' ' ' LEU . 28.6 mm -105.38 135.55 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.618 0 N-CA-C 108.555 -0.906 . . . . 0.55000000000000004 108.555 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.483 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.9 t-160 -123.34 132.38 53.97 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.612 1.338 . . . . 1.3400000000000001 114.612 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -93.73 137.21 33.22 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.123 -0.944 . . . . 2.79 109.94 175.436 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -100.29 104.76 16.25 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 113.465 0.913 . . . . 3.0 113.465 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HG3' ' OG ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -36.6 122.12 0.77 Allowed 'General case' 0 N--CA 1.528 3.434 0 N-CA-C 119.051 2.982 . . . . 2.2999999999999998 119.051 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 39.03 64.69 3.66 Favored Pre-proline 0 N--CA 1.529 3.49 0 N-CA-C 117.131 2.271 . . . . 1.1699999999999999 117.131 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 CA--C 1.563 1.957 0 C-N-CA 122.755 2.303 . . . . 1.45 118.058 -178.82 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo . . . . . 0 N--CA 1.511 2.529 0 N-CA-C 117.45 2.058 . . . . 1.3700000000000001 117.45 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.256 1.3 mp -86.76 124.89 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.466 0 C-N-CA 124.366 1.066 . . . . 0.68999999999999995 108.389 177.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.62 -11.71 59.01 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.602 2.075 . . . . 1.28 116.602 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -102.5 17.08 24.52 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 113.745 1.017 . . . . 1.51 113.745 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.425 ' OG ' ' HD2' ' A' ' 61' ' ' TYR . 1.2 t -137.32 -164.04 1.53 Allowed 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.856 0.836 . . . . 1.0900000000000001 112.578 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.732 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.5 t30 -95.95 -179.27 0.89 Allowed Pre-proline 0 CA--C 1.573 1.858 0 C-N-CA 125.617 1.567 . . . . 1.27 111.367 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.517 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.5 Cg_exo -72.34 -46.44 0.49 Allowed 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 123.175 2.584 . . . . 0.94999999999999996 112.535 174.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -70.01 -47.02 63.81 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 113.905 -1.498 . . . . 2.04 111.731 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -8.88 58.12 Favored 'General case' 0 CA--C 1.585 2.324 0 CA-C-N 114.916 -1.038 . . . . 1.6200000000000001 111.955 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.732 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 13.4 tt0 -70.81 -42.28 70.46 Favored 'General case' 0 C--N 1.39 2.354 0 C-N-CA 125.716 1.607 . . . . 1.77 108.187 172.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -59.69 -42.56 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.217 0 C-N-CA 124.663 1.185 . . . . 0.81000000000000005 109.463 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.9 tp -80.02 -8.81 59.56 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 114.328 1.233 . . . . 1.1499999999999999 114.328 176.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.425 ' HD2' ' OG ' ' A' ' 53' ' ' SER . 20.3 m-85 -125.05 22.75 7.9 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.98 0.912 . . . . 0.92000000000000004 113.357 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.38 -38.24 0.33 Allowed 'General case' 0 N--CA 1.513 2.686 0 N-CA-C 115.245 1.572 . . . . 1.3300000000000001 115.245 -177.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.8 p -67.85 134.02 50.18 Favored 'General case' 0 N--CA 1.533 3.716 0 N-CA-C 114.456 1.28 . . . . 1.28 114.456 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.449 ' HB3' HG22 ' A' ' 167' ' ' VAL . 2.7 pt-20 . . . . . 0 N--CA 1.502 2.149 0 N-CA-C 115.386 1.624 . . . . 1.53 115.386 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.691 -0.485 . . . . 2.1499999999999999 109.691 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 71.66 84.67 0.13 Allowed 'General case' 0 N--CA 1.51 2.546 0 C-N-CA 124.86 1.264 . . . . 0.77000000000000002 111.962 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.62 141.77 45.12 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.978 0.894 . . . . 0.81000000000000005 112.176 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -140.03 175.93 21.58 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 116.407 1.323 . . . . 0.46999999999999997 116.407 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.86 163.17 17.3 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.839 -1.18 . . . . 0.89000000000000001 113.227 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -122.21 129.33 52.16 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.604 -1.18 . . . . 0.51000000000000001 112.435 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -123.21 101.42 38.18 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 108.91 -0.774 . . . . 0.14999999999999999 108.91 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -84.26 119.64 2.43 Favored 'Trans proline' 0 CA--C 1.563 1.945 0 C-N-CA 121.998 1.799 . . . . 0.14999999999999999 114.747 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.84 160.42 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 CA-C-O 122.035 0.922 . . . . 0.19 111.308 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -148.66 21.02 1.03 Allowed 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.605 -1.179 . . . . 2.5299999999999998 111.865 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.06 160.35 33.98 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-O 121.312 0.577 . . . . 2.1200000000000001 111.415 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -119.29 145.51 46.06 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.437 0.903 . . . . 0.41999999999999998 113.437 -179.203 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.5 -138.3 5.45 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.341 -1.299 . . . . 0.23000000000000001 112.498 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 30.6 mm-40 -114.8 105.0 12.51 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 118.228 1.014 . . . . 1.75 111.144 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -99.45 127.51 45.5 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.321 0.582 . . . . 0.20999999999999999 110.853 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -109.22 121.5 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-O 121.894 0.854 . . . . 0.20000000000000001 110.878 -176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.34 107.41 18.41 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 113.801 -1.545 . . . . 0.78000000000000003 110.446 178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 t -115.64 125.2 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.91 -0.774 . . . . 0.44 108.91 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.92 141.79 48.56 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.756 0.65 . . . . 1.25 112.756 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.4 OUTLIER -107.07 119.3 39.01 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.668 -0.696 . . . . 2.52 111.277 177.63 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.436 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 12.4 m-85 -106.68 134.61 49.56 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.467 -0.788 . . . . 0.40000000000000002 110.581 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.23 146.6 42.78 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.246 0.546 . . . . 0.40999999999999998 111.527 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -136.23 120.64 18.08 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.253 0.621 . . . . 2.6099999999999999 110.893 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 76.21 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 112.828 0.677 . . . . 2.1299999999999999 112.828 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -171.95 -52.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.735 0.643 . . . . 2.27 112.735 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -115.27 142.77 46.22 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.622 0.601 . . . . 1.46 112.622 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.53 101.18 10.15 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.513 1.149 . . . . 0.83999999999999997 111.656 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -163.55 150.75 12.49 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 114.603 -1.181 . . . . 2.4500000000000002 111.047 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.2 m -110.77 -75.19 0.62 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.954 1.094 . . . . 1.6599999999999999 113.954 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -94.44 70.08 3.64 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.103 0.954 . . . . 1.8899999999999999 111.159 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -156.22 -41.95 0.08 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.936 -1.484 . . . . 2.5600000000000001 109.207 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -109.83 82.47 1.6 Allowed 'General case' 0 C--N 1.364 1.22 0 CA-C-O 121.827 0.823 . . . . 2.7599999999999998 109.172 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.78 121.26 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 114.375 -1.284 . . . . 0.68999999999999995 110.557 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -106.94 173.54 6.28 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.317 1.599 . . . . 0.69999999999999996 115.317 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -124.64 136.98 54.38 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 122.065 0.936 . . . . 1.3300000000000001 111.019 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.82 124.81 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-N 114.145 -1.389 . . . . 0.47999999999999998 109.499 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.8 mtt180 -119.61 143.3 47.74 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.384 1.624 . . . . 1.6899999999999999 115.384 -176.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 5.8 m -120.71 101.01 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 115.345 -0.843 . . . . 0.59999999999999998 112.184 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.563 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.2 t30 64.9 28.74 12.66 Favored 'General case' 0 N--CA 1.52 3.059 0 C-N-CA 126.494 1.917 . . . . 1.1200000000000001 114.561 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.38 -18.83 32.51 Favored Glycine 0 CA--C 1.549 2.199 0 CA-C-N 115.831 -0.622 . . . . 0.32000000000000001 113.602 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -86.34 161.76 18.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.092 1.757 . . . . 0.56999999999999995 113.125 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -118.68 129.69 55.43 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.166 0.984 . . . . 0.55000000000000004 111.249 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.07 -47.07 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 113.518 -1.673 . . . . 1.0600000000000001 112.825 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.74 89.32 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.904 -1.147 . . . . 0.44 107.904 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.98 75.49 0.92 Allowed 'General case' 0 C--N 1.359 0.988 0 CA-C-O 123.577 1.655 . . . . 2.2999999999999998 112.522 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 p30 154.79 63.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 110.474 -3.057 . . . . 2.48 108.032 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.69 99.65 12.51 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 113.563 0.949 . . . . 1.1299999999999999 113.563 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 3.6 p30 -112.6 94.56 4.97 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 113.017 -1.901 . . . . 2.3500000000000001 107.786 175.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -26.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 N-CA-C 114.739 1.385 . . . . 0.68000000000000005 114.739 -176.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -74.61 -39.39 62.2 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.828 0.851 . . . . 0.77000000000000002 112.042 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.72 -26.68 59.98 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.71 1.204 . . . . 0.91000000000000003 113.376 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 23.6 mmm180 -77.81 -55.05 5.65 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 113.639 0.978 . . . . 2.4300000000000002 113.639 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.65 -37.5 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 114.59 1.33 . . . . 0.93000000000000005 114.59 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.64 -109.44 1.11 Allowed Glycine 0 C--N 1.354 1.558 0 CA-C-N 118.391 0.541 . . . . 0.84999999999999998 113.271 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -114.52 107.46 15.54 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.517 0.327 . . . . 3.1800000000000002 110.433 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 t 70.11 -130.61 0.07 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 125.301 1.441 . . . . 2.0800000000000001 112.304 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.9 p 56.68 -174.39 0.07 Allowed 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 116.635 2.087 . . . . 0.62 116.635 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -100.05 128.45 46.14 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.312 0.856 . . . . 0.46000000000000002 113.312 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.436 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 9.1 t60 -102.79 139.34 38.5 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.141 -0.688 . . . . 0.38 109.141 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -137.51 125.85 23.31 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.273 1.212 . . . . 2.5 114.273 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -119.75 127.16 52.56 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 115.077 -0.965 . . . . 1.5600000000000001 110.602 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.99 126.58 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 114.141 -1.39 . . . . 0.45000000000000001 111.115 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.56 92.22 28.1 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-N 115.263 -0.881 . . . . 0.83999999999999997 110.567 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -75.02 132.77 15.77 Favored 'Trans proline' 0 C--N 1.394 2.934 0 C-N-CA 122.917 2.412 . . . . 0.16 113.074 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.82 150.26 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 CA-C-N 115.446 -0.797 . . . . 0.38 111.145 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.7 p -132.9 109.24 9.46 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.326 -0.852 . . . . 1.3100000000000001 111.799 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.5 mt -109.19 124.46 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 108.566 -0.901 . . . . 0.25 108.566 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.71 126.13 21.77 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.532 -0.758 . . . . 2.0499999999999998 110.75 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt 66.6 16.93 10.53 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 125.272 1.429 . . . . 3.5499999999999998 114.595 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.29 14.77 40.54 Favored Glycine 0 CA--C 1.547 2.056 0 CA-C-O 119.183 -0.787 . . . . 0.37 114.803 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 23.6 mtpp -123.9 147.3 47.79 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 118.225 1.012 . . . . 1.5600000000000001 112.419 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.47 139.07 37.63 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.994 1.109 . . . . 0.34000000000000002 113.994 -176.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.49 115.47 18.93 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.929 -1.032 . . . . 0.64000000000000001 109.989 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.46 93.58 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.486 0 CA-C-N 115.716 -0.675 . . . . 0.46000000000000002 110.878 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 64.75 -84.94 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 125.555 1.542 . . . . 1.5600000000000001 114.135 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.06 26.2 4.25 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-N 116.234 -0.439 . . . . 0.48999999999999999 113.835 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -137.88 117.58 13.11 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.19 0.596 . . . . 1.8200000000000001 109.983 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.25 133.74 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.374 0 CA-C-O 121.65 0.738 . . . . 1.02 112.152 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 m -147.62 -179.46 6.89 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.841 -1.072 . . . . 0.56000000000000005 109.543 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.276 14.9 t -103.98 138.89 39.89 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 113.456 0.91 . . . . 1.25 113.456 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -81.96 122.55 27.92 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.233 1.013 . . . . 0.28999999999999998 111.493 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.97 90.98 3.29 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.762 0.653 . . . . 1.4199999999999999 112.762 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.96 -63.78 2.77 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 118.597 2.199 . . . . 0.41999999999999998 118.597 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.552 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -130.58 161.93 30.44 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.837 0.827 . . . . 1.1000000000000001 113.128 -177.095 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.563 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -111.15 137.52 48.72 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.841 -1.527 . . . . 0.67000000000000004 109.221 177.187 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.6 t -116.93 142.31 47.1 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.64 1.348 . . . . 0.35999999999999999 114.64 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 39.6 t -121.57 97.25 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.22 -2.141 . . . . 0.73999999999999999 105.22 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -113.62 124.92 53.49 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.138 -0.937 . . . . 1.6699999999999999 112.913 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -111.68 128.75 56.17 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 122.233 1.016 . . . . 1.8 112.058 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.8 144.34 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-N 112.859 -1.973 . . . . 0.57999999999999996 110.362 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -78.88 149.46 32.43 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 115.659 1.725 . . . . 2.1800000000000002 115.659 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -103.8 -35.25 3.54 Favored Glycine 0 CA--C 1.545 1.921 0 CA-C-N 114.525 -1.216 . . . . 1.02 113.132 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -130.57 -83.6 0.53 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.213 0.605 . . . . 2.8599999999999999 110.435 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -170.65 64.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.279 0.631 . . . . 3.9100000000000001 110.656 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -166.98 -39.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.926 0.713 . . . . 1.74 112.926 -178.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 4.3 m-20 84.32 -177.77 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.439 0 C-N-CA 124.58 1.152 . . . . 1.6799999999999999 110.838 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -65.38 -9.55 22.65 Favored 'Trans proline' 0 N--CA 1.522 3.2 0 C-N-CA 122.641 2.227 . . . . 2.0600000000000001 116.385 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.0 mttm 80.05 -73.6 0.06 Allowed 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 126.442 1.897 . . . . 3.0 114.065 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 64' ' ' GLU . 21.3 t -103.37 132.04 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.048 0.452 . . . . 0.80000000000000004 110.237 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.0 t -137.34 121.65 18.14 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 114.114 -1.403 . . . . 0.87 110.889 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.506 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -115.6 49.78 1.06 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.138 1.903 . . . . 0.34000000000000002 116.138 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -41.06 129.23 2.79 Favored 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 116.061 1.875 . . . . 0.69999999999999996 116.061 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -150.71 103.09 3.06 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.703 -0.681 . . . . 0.20999999999999999 110.305 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.315 7.2 tt -113.92 122.83 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 CA-C-O 122.262 1.03 . . . . 0.31 112.169 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -123.53 163.6 20.61 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.849 -1.523 . . . . 0.44 111.023 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.6 ptmm? -121.91 159.92 25.86 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 118.489 2.774 . . . . 1.26 118.489 -175.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.62 -42.06 1.99 Allowed Glycine 0 CA--C 1.543 1.803 0 CA-C-N 110.007 -3.27 . . . . 0.17000000000000001 118.929 174.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.5 153.83 0.94 Allowed 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 120.31 2.055 . . . . 0.14999999999999999 112.924 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.49 -11.71 59.92 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 114.72 1.378 . . . . 0.17000000000000001 114.72 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.95 3.39 48.83 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.081 1.141 . . . . 0.55000000000000004 114.081 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.28 -10.34 16.44 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 113.749 1.018 . . . . 0.59999999999999998 113.749 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.526 0 C-N-CA 124.078 0.951 . . . . 0.94999999999999996 112.216 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.549 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.9 tp . . . . . 0 CA--C 1.563 1.46 0 N-CA-C 112.411 0.523 . . . . 0.34999999999999998 112.411 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.9 -22.74 65.83 Favored 'General case' 0 CA--C 1.583 2.244 0 C-N-CA 125.63 1.572 . . . . 0.20000000000000001 114.436 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.15 -12.05 50.96 Favored 'General case' 0 C--N 1.375 1.695 0 N-CA-C 113.638 0.977 . . . . 0.32000000000000001 113.638 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 45.3 mmtt -105.67 -22.62 12.93 Favored 'General case' 0 C--N 1.364 1.212 0 CA-C-O 118.353 -0.832 . . . . 1.73 113.203 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.34 135.91 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.844 0 N-CA-C 115.221 1.563 . . . . 0.11 115.221 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -122.22 -29.1 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.227 -0.897 . . . . 0.16 111.908 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 64.1 t90 -163.68 116.95 1.5 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 120.738 0.304 . . . . 0.54000000000000004 111.414 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -135.19 128.91 32.89 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.296 -0.877 . . . . 0.19 110.226 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.2 t -137.84 133.56 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 113.203 0.816 . . . . 1.05 113.203 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -118.99 111.09 17.89 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.082 -1.451 . . . . 2.1099999999999999 107.082 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.37 101.75 10.02 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.387 1.089 . . . . 0.63 111.436 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.58 -32.61 0.17 Allowed Glycine 0 C--N 1.344 1.018 0 CA-C-N 113.345 -1.752 . . . . 0.70999999999999996 116.011 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -135.22 -128.33 2.78 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.233 -0.984 . . . . 0.80000000000000004 114.643 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.461 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 63.0 mt-10 -151.04 115.33 5.08 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.455 0.169 . . . . 1.6299999999999999 111.3 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.665 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.6 m 31.82 116.01 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.887 0 N-CA-C 120.286 3.439 . . . . 1.0 120.286 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 62.0 t60 -138.67 139.02 38.31 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.15 0.976 . . . . 0.45000000000000001 112.636 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.89 117.18 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 114.049 -1.432 . . . . 1.3899999999999999 109.714 177.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -83.21 166.1 18.88 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.646 -0.707 . . . . 1.8500000000000001 112.238 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -43.09 -29.15 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.547 4.41 0 N-CA-C 119.225 3.046 . . . . 0.71999999999999997 119.225 -176.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -93.38 -14.68 26.53 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 118.357 0.526 . . . . 0.51000000000000001 111.691 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.04 42.69 1.62 Allowed Glycine 0 C--N 1.358 1.764 0 C-N-CA 124.393 0.997 . . . . 0.34000000000000002 114.461 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.549 HD11 ' HG ' ' A' ' 6' ' ' LEU . 14.2 mm -105.72 120.26 56.27 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.738 0 N-CA-C 109.51 -0.552 . . . . 0.55000000000000004 109.51 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.0 t60 -104.62 128.19 52.57 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.796 1.406 . . . . 1.3400000000000001 114.796 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.665 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -98.04 148.2 23.75 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.254 -0.885 . . . . 2.79 110.645 176.834 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -96.64 168.37 10.57 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.696 1.236 . . . . 3.0 113.613 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -84.38 100.22 11.15 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.401 2.0 . . . . 2.2999999999999998 116.401 -174.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 28.63 56.62 0.6 Allowed Pre-proline 1 N--CA 1.543 4.176 0 C-N-CA 128.066 2.546 . . . . 1.1699999999999999 117.468 177.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 CA--C 1.569 2.246 0 N-CA-C 119.637 2.899 . . . . 1.45 119.637 -174.251 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 50.0 Cg_exo . . . . . 0 N--CA 1.515 2.765 0 N-CA-C 117.681 2.147 . . . . 1.3700000000000001 117.681 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 mp -92.72 130.4 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.214 0 CA-C-N 114.883 -1.053 . . . . 0.68999999999999995 108.486 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mt -86.03 -10.14 55.54 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.567 2.062 . . . . 1.28 116.567 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -103.49 8.59 37.83 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 114.299 1.222 . . . . 1.51 114.299 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.44 -164.73 1.52 Allowed 'General case' 0 CA--C 1.566 1.579 0 CA-C-O 121.544 0.687 . . . . 1.0900000000000001 112.096 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.841 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.8 t30 -95.69 179.17 1.21 Allowed Pre-proline 0 CA--C 1.575 1.91 0 C-N-CA 124.715 1.206 . . . . 1.27 111.17 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -71.61 -44.77 0.93 Allowed 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 123.202 2.601 . . . . 0.94999999999999996 112.474 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -71.16 -47.4 57.96 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 113.894 -1.503 . . . . 2.04 111.545 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -77.25 -6.0 51.45 Favored 'General case' 0 CA--C 1.595 2.68 0 CA-C-N 115.466 -0.788 . . . . 1.6200000000000001 111.536 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.841 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 11.5 tt0 -72.68 -39.25 67.2 Favored 'General case' 0 C--N 1.387 2.217 0 C-N-CA 126.167 1.787 . . . . 1.77 108.463 173.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.0 t -65.59 -41.05 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.151 0 CA-C-N 114.538 -1.21 . . . . 0.81000000000000005 108.712 172.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 tt -75.74 -9.43 58.58 Favored 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 112.662 0.616 . . . . 1.1499999999999999 112.662 174.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.492 ' O ' ' HE3' ' A' ' 88' ' ' LYS . 3.5 m-30 -121.24 17.34 11.51 Favored 'General case' 0 CA--C 1.578 2.027 0 C-N-CA 125.175 1.39 . . . . 0.92000000000000004 113.233 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -146.74 -21.36 0.42 Allowed 'General case' 0 N--CA 1.51 2.533 0 N-CA-C 116.656 2.095 . . . . 1.3300000000000001 116.656 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.3 p -79.5 127.79 32.57 Favored 'General case' 0 N--CA 1.518 2.947 0 N-CA-C 115.71 1.744 . . . . 1.28 115.71 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.496 ' HB3' HG22 ' A' ' 167' ' ' VAL . 5.2 pt-20 . . . . . 0 N--CA 1.507 2.394 0 C-N-CA 124.876 1.27 . . . . 1.53 111.847 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 110.764 -0.088 . . . . 2.1499999999999999 110.764 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.23 86.55 0.11 Allowed 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.368 1.467 . . . . 0.77000000000000002 113.639 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -150.78 154.76 37.91 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.754 0.788 . . . . 0.81000000000000005 112.993 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.99 -172.51 38.66 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 114.788 -1.097 . . . . 0.46999999999999997 115.279 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.23 172.55 6.82 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.465 1.283 . . . . 0.89000000000000001 114.465 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -129.47 133.9 47.53 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 114.113 -1.403 . . . . 0.51000000000000001 111.846 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.67 102.24 32.55 Favored Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 123.538 0.735 . . . . 0.14999999999999999 109.495 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -84.79 120.58 2.36 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 121.97 1.78 . . . . 0.14999999999999999 114.641 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.09 161.48 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.61 0 CA-C-O 122.093 0.949 . . . . 0.19 111.281 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -148.82 19.24 1.01 Allowed 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.553 -1.203 . . . . 2.5299999999999998 111.922 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -129.93 159.21 37.34 Favored 'General case' 0 C--N 1.363 1.169 0 CA-C-O 121.313 0.577 . . . . 2.1200000000000001 111.423 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -119.12 147.86 43.7 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.23 1.196 . . . . 0.41999999999999998 114.23 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.85 -137.53 5.24 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 113.883 -1.508 . . . . 0.23000000000000001 112.333 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.4 mm-40 -114.86 105.62 13.22 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-N 118.345 1.073 . . . . 1.75 110.848 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -99.66 130.34 45.87 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.129 0.49 . . . . 0.20999999999999999 111.174 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -113.24 121.87 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.666 0.746 . . . . 0.20000000000000001 110.748 -176.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -109.43 104.92 14.09 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.346 -1.297 . . . . 0.78000000000000003 110.313 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.29 129.72 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 114.825 -1.08 . . . . 0.44 108.766 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.61 139.56 50.41 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.077 0.769 . . . . 1.25 113.077 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.69 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 6.0 tmtm? -105.82 118.41 36.53 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.945 0.879 . . . . 2.52 110.145 176.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.41 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 21.5 m-85 -106.39 134.45 49.51 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 114.728 -1.124 . . . . 0.40000000000000002 109.487 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.409 ' HB2' ' NZ ' ' A' ' 88' ' ' LYS . . . -133.52 146.83 51.42 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 123.079 0.551 . . . . 0.40999999999999998 111.736 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -139.71 108.91 6.08 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 116.003 -0.544 . . . . 2.6099999999999999 110.726 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.22 69.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 116.153 -0.476 . . . . 2.1299999999999999 111.594 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -162.74 -52.28 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.976 -0.556 . . . . 2.27 111.829 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -119.1 130.15 55.43 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 122.889 0.476 . . . . 1.46 111.407 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.03 104.92 14.95 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 122.152 0.977 . . . . 0.83999999999999997 111.958 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -162.01 145.21 11.91 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.178 -0.919 . . . . 2.4500000000000002 112.153 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -125.27 123.81 40.3 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.654 -0.703 . . . . 1.6599999999999999 112.187 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 72.16 53.87 0.18 Allowed 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 125.73 1.612 . . . . 1.8899999999999999 112.787 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -152.38 -40.87 0.11 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.383 -1.281 . . . . 2.5600000000000001 109.719 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -108.19 80.91 1.41 Allowed 'General case' 0 C--N 1.361 1.096 0 CA-C-O 121.892 0.853 . . . . 2.7599999999999998 108.716 177.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.99 121.82 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 114.249 -1.341 . . . . 0.68999999999999995 111.142 -177.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -109.37 165.55 11.55 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.587 1.699 . . . . 0.69999999999999996 115.587 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.52 135.58 53.94 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.829 -0.544 . . . . 1.3300000000000001 110.828 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.79 126.93 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.475 0 CA-C-N 115.918 -0.583 . . . . 0.47999999999999998 109.908 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 46.7 mtt180 -125.9 151.63 46.66 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.621 1.712 . . . . 1.6899999999999999 115.621 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.2 m -126.71 109.97 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.569 0 N-CA-C 113.047 0.758 . . . . 0.59999999999999998 113.047 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.464 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 62.43 26.53 15.81 Favored 'General case' 0 N--CA 1.524 3.275 0 C-N-CA 126.669 1.988 . . . . 1.1200000000000001 114.271 -179.113 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.8 -22.17 28.52 Favored Glycine 0 CA--C 1.548 2.109 0 C-N-CA 121.259 -0.496 . . . . 0.32000000000000001 113.546 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.458 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 90.2 m-70 -80.71 160.5 24.94 Favored 'General case' 0 C--N 1.366 1.312 0 C-N-CA 125.829 1.651 . . . . 0.56999999999999995 114.157 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.77 132.49 54.15 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.238 0.542 . . . . 0.55000000000000004 111.154 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.62 -60.89 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 115.233 -0.894 . . . . 1.0600000000000001 113.172 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.76 88.85 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.44 108.2 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -107.72 96.74 6.6 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 123.155 1.455 . . . . 2.2999999999999998 111.551 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 121.09 75.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 110.488 -3.051 . . . . 2.48 107.783 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.33 104.77 16.83 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 113.111 0.782 . . . . 1.1299999999999999 113.111 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -117.16 102.49 9.34 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 113.723 -1.58 . . . . 2.3500000000000001 106.974 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.25 -31.28 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 C-N-CA 125.003 1.321 . . . . 0.68000000000000005 114.262 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -74.63 -40.84 61.26 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.685 0.794 . . . . 0.77000000000000002 112.484 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -73.82 -25.83 60.3 Favored 'General case' 0 CA--C 1.578 2.048 0 C-N-CA 124.357 1.063 . . . . 0.91000000000000003 113.487 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -78.62 -56.61 4.29 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.618 0.97 . . . . 2.4300000000000002 113.618 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.11 -34.84 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 N-CA-C 114.593 1.331 . . . . 0.93000000000000005 114.593 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.07 -114.07 1.98 Allowed Glycine 0 C--N 1.354 1.537 0 CA-C-N 118.25 0.477 . . . . 0.84999999999999998 112.935 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -115.47 106.69 14.25 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.929 0.395 . . . . 3.1800000000000002 110.4 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.48 -143.26 0.09 Allowed 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 125.466 1.507 . . . . 2.0800000000000001 113.416 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.9 p 66.76 -158.96 0.24 Allowed 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 126.234 1.814 . . . . 0.62 113.718 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.536 ' HA ' ' HZ3' ' A' ' 88' ' ' LYS . . . -108.58 128.96 55.28 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 114.55 1.315 . . . . 0.46000000000000002 114.55 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.536 ' H ' ' HZ3' ' A' ' 88' ' ' LYS . 5.5 t60 -104.52 122.65 46.0 Favored 'General case' 0 C--N 1.369 1.432 0 N-CA-C 108.08 -1.082 . . . . 0.38 108.08 174.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.55 127.05 20.09 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.417 0.895 . . . . 2.5 113.417 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -114.51 134.73 54.81 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-N 115.033 -0.985 . . . . 1.5600000000000001 111.369 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.45 111.31 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 114.369 -1.287 . . . . 0.45000000000000001 110.374 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.4 mm -115.52 91.23 28.45 Favored Pre-proline 0 CA--C 1.579 2.077 0 CA-C-N 115.287 -0.87 . . . . 0.83999999999999997 110.421 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -73.11 137.93 27.16 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 122.996 2.464 . . . . 0.16 113.883 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.81 149.89 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 C-N-CA 123.573 0.749 . . . . 0.38 110.842 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.2 p -133.88 111.48 10.51 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.638 -0.71 . . . . 1.3100000000000001 111.856 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.4 mt -112.69 124.68 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 N-CA-C 108.59 -0.892 . . . . 0.25 108.59 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -141.83 126.45 17.92 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.838 -0.619 . . . . 2.0499999999999998 110.992 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 67.97 15.71 9.52 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 125.432 1.493 . . . . 3.5499999999999998 114.109 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.55 14.87 39.4 Favored Glycine 0 CA--C 1.547 2.089 0 CA-C-O 119.181 -0.788 . . . . 0.37 114.773 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 56.4 mtpt -122.59 148.19 45.52 Favored 'General case' 0 C--N 1.365 1.252 0 CA-C-N 118.413 1.107 . . . . 1.5600000000000001 112.429 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.66 141.94 35.18 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.058 1.133 . . . . 0.34000000000000002 114.058 -176.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 m -133.55 110.44 9.93 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 114.504 -1.226 . . . . 0.64000000000000001 110.301 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.272 2.4 p -106.23 90.52 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.589 2.467 0 CA-C-O 121.621 0.724 . . . . 0.46000000000000002 110.068 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 59.68 -81.4 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 126.077 1.751 . . . . 1.5600000000000001 115.06 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -118.45 26.74 7.59 Favored Glycine 0 CA--C 1.547 2.076 0 N-CA-C 114.2 0.44 . . . . 0.48999999999999999 114.2 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -135.14 140.79 45.7 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.533 0.733 . . . . 1.8200000000000001 110.996 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.18 130.82 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.294 0 CA-C-O 121.513 0.673 . . . . 1.02 111.867 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 m -154.6 -179.43 7.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.157 -0.929 . . . . 0.56000000000000005 109.537 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.274 14.8 t -104.76 139.37 39.65 Favored 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 113.365 0.876 . . . . 1.25 113.365 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -82.72 122.1 27.72 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 123.959 0.904 . . . . 0.28999999999999998 111.523 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.38 90.91 3.15 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.336 0.495 . . . . 1.4199999999999999 112.336 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.22 -65.45 3.33 Favored Glycine 0 C--N 1.358 1.784 0 N-CA-C 118.652 2.221 . . . . 0.41999999999999998 118.652 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 156.25 46.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.199 1.185 . . . . 1.1000000000000001 114.199 -176.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.464 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -103.27 135.36 45.06 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 113.064 -1.88 . . . . 0.67000000000000004 108.585 176.574 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.8 t -120.67 142.29 49.61 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.529 1.678 . . . . 0.35999999999999999 115.529 -176.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.59 99.19 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.334 -1.358 . . . . 0.73999999999999999 107.334 176.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -118.52 126.99 53.19 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.779 -0.646 . . . . 1.6699999999999999 112.314 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.86 129.08 56.64 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-O 122.278 1.037 . . . . 1.8 111.278 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.17 145.48 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 112.722 -2.035 . . . . 0.57999999999999996 110.762 -177.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.93 149.64 32.3 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.934 1.457 . . . . 2.1800000000000002 114.934 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -115.64 -28.11 2.84 Favored Glycine 0 CA--C 1.545 1.931 0 CA-C-N 115.064 -0.971 . . . . 1.02 114.932 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -130.42 -67.07 0.74 Allowed 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 117.746 0.773 . . . . 2.8599999999999999 111.88 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -140.81 -52.45 0.47 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 112.341 0.497 . . . . 3.9100000000000001 112.341 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -104.06 178.02 4.68 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.161 0.981 . . . . 1.74 112.742 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -116.79 -177.92 0.49 Allowed Pre-proline 0 CA--C 1.568 1.638 0 CA-C-N 114.389 -1.278 . . . . 1.6799999999999999 109.273 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.67 131.36 43.71 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.947 2.431 . . . . 2.0600000000000001 113.968 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -72.18 -62.59 1.38 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.81 1.411 . . . . 3.0 114.81 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 64' ' ' GLU . 43.0 t -108.49 132.36 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 118.376 0.535 . . . . 0.80000000000000004 109.713 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.3 t -133.41 116.09 15.62 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 113.911 -1.495 . . . . 0.87 110.618 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.69 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -115.02 49.51 1.05 Allowed 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.183 1.919 . . . . 0.34000000000000002 116.183 -174.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.56 137.75 2.77 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 116.653 2.094 . . . . 0.69999999999999996 116.653 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -152.75 100.3 2.52 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.271 -0.877 . . . . 0.20999999999999999 110.526 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.319 12.6 tt -110.61 121.86 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-O 122.546 1.165 . . . . 0.31 111.553 175.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -123.67 165.03 17.92 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 113.572 -1.649 . . . . 0.44 110.554 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.4 ptmt -121.71 159.98 25.46 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 118.734 2.864 . . . . 1.26 118.734 -174.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.22 -42.54 1.87 Allowed Glycine 0 CA--C 1.542 1.737 0 CA-C-N 109.815 -3.357 . . . . 0.17000000000000001 118.66 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.37 156.74 0.75 Allowed 'General case' 0 N--CA 1.52 3.061 0 CA-C-N 119.973 1.886 . . . . 0.14999999999999999 112.565 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.32 -15.79 60.47 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.547 1.314 . . . . 0.17000000000000001 114.547 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.06 4.04 46.73 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.066 1.135 . . . . 0.55000000000000004 114.066 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.71 -3.86 18.74 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 114.031 1.123 . . . . 0.59999999999999998 114.031 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.543 0 C-N-CA 124.48 1.112 . . . . 0.94999999999999996 111.63 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.535 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.6 tp . . . . . 0 CA--C 1.566 1.586 0 N-CA-C 113.282 0.845 . . . . 0.34999999999999998 113.282 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -25.0 63.84 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 125.982 1.713 . . . . 0.20000000000000001 115.388 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.65 -10.01 54.76 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.577 0.954 . . . . 0.32000000000000001 113.577 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 25.3 mmtp -104.67 -25.61 12.64 Favored 'General case' 0 C--N 1.363 1.168 0 N-CA-C 113.243 0.831 . . . . 1.73 113.243 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -52.93 135.22 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 N-CA-C 115.541 1.682 . . . . 0.11 115.541 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -123.07 -28.46 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 115.01 -0.995 . . . . 0.16 112.229 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -162.95 116.93 1.67 Allowed 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 118.055 0.389 . . . . 0.54000000000000004 111.558 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -136.55 130.73 32.85 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.156 -0.965 . . . . 0.19 111.649 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.3 t -136.26 130.96 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 CA-C-O 121.036 0.446 . . . . 1.05 112.149 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -114.71 100.46 8.27 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.819 -1.178 . . . . 2.1099999999999999 107.819 173.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.96 104.18 7.31 Favored 'General case' 0 C--O 1.274 2.365 0 CA-C-O 122.005 0.907 . . . . 0.63 111.623 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 169.07 -49.51 0.22 Allowed Glycine 0 C--N 1.36 1.893 0 CA-C-N 111.964 -2.38 . . . . 0.70999999999999996 114.693 -178.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.53 -116.65 3.05 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 114.476 0.551 . . . . 0.80000000000000004 114.476 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -168.62 118.79 0.74 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.377 0.51 . . . . 1.6299999999999999 112.377 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.9 m 42.39 111.74 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.226 0 N-CA-C 118.515 2.783 . . . . 1.0 118.515 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.601 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 43.1 t60 -137.26 139.43 40.96 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.768 1.025 . . . . 0.45000000000000001 113.768 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.3 t -106.36 111.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 N-CA-C 106.791 -1.559 . . . . 1.3899999999999999 106.791 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.38 163.07 15.46 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 112.768 0.655 . . . . 1.8500000000000001 112.768 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -43.3 -34.59 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 118.811 2.893 . . . . 0.71999999999999997 118.811 -175.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -90.76 -17.31 26.88 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 120.924 0.393 . . . . 0.51000000000000001 111.509 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.18 41.85 1.24 Allowed Glycine 0 C--N 1.357 1.736 0 C-N-CA 124.361 0.981 . . . . 0.34000000000000002 113.742 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.535 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.9 mm -105.88 121.96 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 N-CA-C 109.391 -0.596 . . . . 0.55000000000000004 109.391 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 6.9 t-160 -110.27 132.8 53.85 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 115.32 1.6 . . . . 1.3400000000000001 115.32 -175.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -97.76 138.01 35.77 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.638 -1.164 . . . . 2.79 109.302 175.442 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -102.68 100.7 10.77 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 113.544 0.942 . . . . 3.0 113.544 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -28.69 115.44 0.09 Allowed 'General case' 0 N--CA 1.517 2.888 0 N-CA-C 118.687 2.847 . . . . 2.2999999999999998 118.687 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 41.59 74.97 0.66 Allowed Pre-proline 0 N--CA 1.528 3.446 0 N-CA-C 117.169 2.285 . . . . 1.1699999999999999 117.169 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo . . . . . 0 CA--C 1.56 1.787 0 C-N-CA 122.509 2.14 . . . . 1.45 117.434 -178.839 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.508 2.357 0 N-CA-C 116.939 1.861 . . . . 1.3700000000000001 116.939 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.4 133.86 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.354 0 CA-C-N 115.074 -0.966 . . . . 0.68999999999999995 108.691 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.5 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.9 mt -82.24 -9.28 59.55 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.816 2.154 . . . . 1.28 116.816 -176.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -109.17 16.67 22.32 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 114.111 1.152 . . . . 1.51 114.111 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.04 177.37 8.02 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 121.755 0.788 . . . . 1.0900000000000001 113.06 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 5.7 p-10 -88.96 178.83 1.83 Allowed Pre-proline 0 N--CA 1.51 2.57 0 C-N-CA 124.978 1.311 . . . . 1.27 111.094 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 52.3 Cg_exo -64.57 -43.01 14.4 Favored 'Trans proline' 0 N--CA 1.527 3.449 0 C-N-CA 122.824 2.349 . . . . 0.94999999999999996 114.989 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -69.41 -41.94 75.71 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 124.471 1.108 . . . . 2.04 111.978 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.701 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 18.7 t0 -86.93 -0.71 57.0 Favored 'General case' 0 CA--C 1.583 2.232 0 CA-C-N 115.857 -0.611 . . . . 1.6200000000000001 111.983 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 27.8 tt0 -74.28 -46.02 43.97 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 125.195 1.398 . . . . 1.77 108.025 173.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.253 11.7 p -71.21 -37.75 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.982 0 CA-C-N 115.161 -0.927 . . . . 0.81000000000000005 111.042 174.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.7 tp -83.41 -3.25 57.38 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 114.194 1.183 . . . . 1.1499999999999999 114.194 177.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.701 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 3.8 m-30 -113.67 -2.01 13.87 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.002 1.321 . . . . 0.92000000000000004 109.831 174.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -130.48 -130.82 0.2 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.331 1.052 . . . . 1.3300000000000001 110.739 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.514 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 43.15 120.86 0.0 OUTLIER 'General case' 1 N--CA 1.548 4.458 0 C-N-CA 127.775 2.43 . . . . 1.28 115.48 -172.755 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.695 ' HB3' HG22 ' A' ' 167' ' ' VAL . 12.9 pt-20 . . . . . 0 N--CA 1.5 2.071 0 N-CA-C 116.338 1.977 . . . . 1.53 116.338 -175.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.318 0.104 . . . . 2.1499999999999999 110.796 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.442 ' H ' HD21 ' A' ' 164' ' ' ASN . 3.4 t 70.38 76.72 0.2 Allowed 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 124.464 1.106 . . . . 0.77000000000000002 110.939 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.7 135.87 48.23 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.004 -0.998 . . . . 0.81000000000000005 112.285 -176.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.56 163.01 24.13 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 116.216 1.246 . . . . 0.46999999999999997 116.216 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.427 ' HB2' HG23 ' A' ' 155' ' ' VAL . 1.4 m-85 -111.17 160.7 16.68 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.023 -1.089 . . . . 0.89000000000000001 113.062 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.48 126.66 48.32 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.895 -1.048 . . . . 0.51000000000000001 112.652 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.25 98.07 42.07 Favored Pre-proline 0 CA--C 1.566 1.589 0 N-CA-C 108.668 -0.864 . . . . 0.14999999999999999 108.668 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -82.82 116.27 2.5 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 122.06 1.84 . . . . 0.14999999999999999 115.322 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.07 155.64 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 CA-C-O 121.938 0.875 . . . . 0.19 110.648 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -141.86 24.35 2.03 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 114.774 -1.103 . . . . 2.5299999999999998 112.034 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.88 152.67 49.1 Favored 'General case' 0 C--N 1.359 1.009 0 CA-C-O 121.231 0.539 . . . . 2.1200000000000001 111.305 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.07 137.73 50.98 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.097 1.147 . . . . 0.41999999999999998 114.097 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.47 -127.48 1.63 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 114.018 -1.447 . . . . 0.23000000000000001 112.597 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -123.55 118.62 27.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.264 0.554 . . . . 1.75 111.398 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -118.58 137.74 53.04 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.463 -0.789 . . . . 0.20999999999999999 109.639 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 172' ' ' ILE . 1.9 t -117.82 126.5 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.466 0.65 . . . . 0.20000000000000001 111.004 -177.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.06 105.13 15.38 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.753 -1.112 . . . . 0.78000000000000003 109.731 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.75 117.64 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.077 -1.083 . . . . 0.44 108.077 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -130.16 135.05 47.76 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.503 0.668 . . . . 1.25 112.384 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 14.3 tptt -98.29 122.96 42.1 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 114.959 -1.019 . . . . 2.52 111.307 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -106.95 136.12 47.35 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.58 -0.737 . . . . 0.40000000000000002 110.948 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.94 150.12 52.19 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 115.681 -0.69 . . . . 0.40999999999999998 111.367 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -146.88 113.68 6.08 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.36 0.664 . . . . 2.6099999999999999 110.076 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.33 68.12 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 112.711 0.634 . . . . 2.1299999999999999 112.711 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -167.07 -45.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.58 0.585 . . . . 2.27 112.58 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -112.89 126.67 55.72 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.102 0.477 . . . . 1.46 112.219 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.16 96.07 6.11 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.486 1.136 . . . . 0.83999999999999997 111.241 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.45 ' OE1' ' HD3' ' A' ' 100' ' ' LYS . 9.5 pt20 -160.79 143.74 13.02 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.89 -1.05 . . . . 2.4500000000000002 112.152 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.8 m -122.57 125.27 45.36 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.426 -0.806 . . . . 1.6599999999999999 112.267 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 73.03 51.74 0.14 Allowed 'General case' 0 N--CA 1.512 2.636 0 C-N-CA 125.644 1.577 . . . . 1.8899999999999999 112.697 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -150.99 -42.02 0.12 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.384 1.074 . . . . 2.5600000000000001 110.076 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.45 ' HD3' ' OE1' ' A' ' 96' ' ' GLN . 14.0 mptt -108.27 83.49 1.79 Allowed 'General case' 0 C--N 1.36 1.06 0 N-CA-C 108.691 -0.855 . . . . 2.7599999999999998 108.691 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.45 126.54 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 114.488 -1.233 . . . . 0.68999999999999995 111.214 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -114.07 174.48 5.92 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.405 1.631 . . . . 0.69999999999999996 115.405 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.22 137.05 54.97 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.372 0.606 . . . . 1.3300000000000001 111.974 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.6 t -132.71 126.0 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.247 0 CA-C-N 115.161 -0.927 . . . . 0.47999999999999998 109.671 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -125.56 149.39 48.39 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.653 1.353 . . . . 1.6899999999999999 114.653 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.55 104.28 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 115.389 -0.823 . . . . 0.59999999999999998 112.802 178.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.584 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 6.9 t30 64.28 26.48 13.71 Favored 'General case' 0 N--CA 1.518 2.952 0 C-N-CA 126.636 1.974 . . . . 1.1200000000000001 114.31 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.92 -22.22 23.83 Favored Glycine 0 CA--C 1.548 2.117 0 CA-C-N 115.582 -0.735 . . . . 0.32000000000000001 113.603 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -79.94 148.03 31.39 Favored 'General case' 0 C--N 1.367 1.365 0 C-N-CA 125.63 1.572 . . . . 0.56999999999999995 114.007 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.44 127.52 49.44 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.283 0.563 . . . . 0.55000000000000004 110.977 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -120.22 -57.2 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 115.256 -0.884 . . . . 1.0600000000000001 113.254 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.33 88.26 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.165 -1.05 . . . . 0.44 108.165 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -111.17 75.77 0.94 Allowed 'General case' 0 C--N 1.354 0.779 0 CA-C-O 123.37 1.557 . . . . 2.2999999999999998 112.133 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.9 p30 157.78 61.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 110.789 -2.914 . . . . 2.48 108.117 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.94 101.04 13.38 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 114.095 1.146 . . . . 1.1299999999999999 114.095 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 1.2 t70 -116.75 97.2 5.85 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 113.132 -1.849 . . . . 2.3500000000000001 106.582 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -28.56 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.477 0 N-CA-C 114.569 1.322 . . . . 0.68000000000000005 114.569 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -75.84 -36.78 59.51 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.24 0.616 . . . . 0.77000000000000002 112.323 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -74.72 -26.74 60.01 Favored 'General case' 0 CA--C 1.577 1.99 0 C-N-CA 124.466 1.106 . . . . 0.91000000000000003 113.096 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 25.3 mmm180 -77.66 -55.09 5.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.236 0.828 . . . . 2.4300000000000002 113.236 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.82 -40.59 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 N-CA-C 113.966 1.098 . . . . 0.93000000000000005 113.966 177.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.84 -69.51 0.21 Allowed Glycine 0 C--N 1.359 1.844 0 CA-C-N 118.186 0.448 . . . . 0.84999999999999998 113.652 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -104.72 175.27 5.55 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.447 1.099 . . . . 3.1800000000000002 111.381 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 m -73.55 84.31 1.54 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 122.007 0.908 . . . . 2.0800000000000001 113.214 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 51' ' ' LEU . 17.9 p -131.24 -154.35 0.62 Allowed 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 113.92 -1.491 . . . . 0.62 109.301 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.49 129.38 54.46 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 121.468 -0.77 . . . . 0.46000000000000002 112.324 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -100.43 142.39 31.97 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.645 -0.502 . . . . 0.38 109.645 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -135.5 128.2 30.95 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.711 1.374 . . . . 2.5 114.711 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -118.0 118.1 31.04 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 114.36 -1.291 . . . . 1.5600000000000001 109.905 176.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.11 121.05 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 114.644 -1.162 . . . . 0.45000000000000001 111.513 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.12 95.11 19.0 Favored Pre-proline 0 CA--C 1.572 1.819 0 CA-C-N 115.49 -0.777 . . . . 0.83999999999999997 110.694 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -75.87 137.55 19.97 Favored 'Trans proline' 0 C--N 1.395 3.003 0 C-N-CA 122.802 2.335 . . . . 0.16 113.325 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.49 145.62 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.393 0 CA-C-O 121.737 0.78 . . . . 0.38 111.665 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.9 p -129.86 112.29 13.42 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.85 -1.068 . . . . 1.3100000000000001 110.817 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.6 mt -113.64 121.43 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.511 0 CA-C-N 115.228 -0.896 . . . . 0.25 108.841 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -141.76 129.64 21.81 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.128 0.489 . . . . 2.0499999999999998 111.903 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 66.38 15.19 10.02 Favored 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 114.827 1.417 . . . . 3.5499999999999998 114.827 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 17.91 28.79 Favored Glycine 0 CA--C 1.548 2.149 0 CA-C-O 119.385 -0.675 . . . . 0.37 114.562 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -128.73 143.38 50.91 Favored 'General case' 0 C--N 1.364 1.239 0 CA-C-N 118.036 0.918 . . . . 1.5600000000000001 112.426 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.09 143.34 29.48 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.823 1.046 . . . . 0.34000000000000002 113.823 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 114.0 12.61 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.864 -1.062 . . . . 0.64000000000000001 110.865 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.271 0.3 OUTLIER -118.14 108.17 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.257 0 CA-C-N 115.989 -0.551 . . . . 0.46000000000000002 110.533 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 67.06 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.745 0 C-N-CA 125.588 1.555 . . . . 1.5600000000000001 113.762 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -140.9 31.79 2.17 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-N 115.777 -0.647 . . . . 0.48999999999999999 112.765 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -133.73 128.14 34.3 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.641 0.776 . . . . 1.8200000000000001 110.573 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -115.68 131.23 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.298 0 CA-C-O 121.551 0.691 . . . . 1.02 111.786 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 m -147.18 -169.09 3.22 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.094 -0.957 . . . . 0.56000000000000005 110.174 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.5 t -101.79 141.09 35.18 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 112.998 0.74 . . . . 1.25 112.998 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -88.44 133.0 34.24 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.875 0.845 . . . . 0.28999999999999998 111.894 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 p -98.27 -164.01 1.1 Allowed 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 113.976 -1.465 . . . . 1.4199999999999999 109.369 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.39 7.07 69.59 Favored Glycine 0 CA--C 1.561 2.929 0 N-CA-C 116.991 1.556 . . . . 0.41999999999999998 116.991 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.472 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -159.98 152.49 21.06 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-O 121.704 0.764 . . . . 1.1000000000000001 111.565 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.584 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -108.09 138.08 44.96 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.208 -1.36 . . . . 0.67000000000000004 109.163 177.652 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 t -119.41 145.72 45.99 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.966 1.839 . . . . 0.35999999999999999 115.966 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -120.09 97.96 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.672 -1.233 . . . . 0.73999999999999999 107.672 175.602 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -107.07 125.91 51.67 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.212 0.819 . . . . 1.6699999999999999 113.212 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -107.46 120.89 43.42 Favored 'General case' 0 C--O 1.25 1.126 0 CA-C-N 115.177 -0.919 . . . . 1.8 110.247 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.46 143.66 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 114.588 -1.187 . . . . 0.57999999999999996 109.587 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -85.77 150.38 24.61 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.681 1.734 . . . . 2.1800000000000002 115.681 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.04 -32.45 4.99 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-N 114.178 -1.374 . . . . 1.02 113.048 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -131.01 -84.06 0.52 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.494 0.718 . . . . 2.8599999999999999 110.511 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -170.99 66.27 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.123 0.569 . . . . 3.9100000000000001 110.927 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -166.51 -45.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.071 0.767 . . . . 1.74 113.071 -179.35 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.442 HD21 ' H ' ' A' ' 70' ' ' SER . 1.4 m-20 82.75 -177.47 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.695 0 C-N-CA 124.546 1.138 . . . . 1.6799999999999999 110.796 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.93 -21.35 70.75 Favored 'Trans proline' 0 N--CA 1.524 3.322 0 C-N-CA 122.977 2.451 . . . . 2.0600000000000001 115.992 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? 83.58 -68.69 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 126.36 1.864 . . . . 3.0 115.085 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.695 HG22 ' HB3' ' A' ' 64' ' ' GLU . 3.1 t -102.4 133.57 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-N 118.984 0.811 . . . . 0.80000000000000004 111.301 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.6 t -132.9 138.44 46.98 Favored 'General case' 0 C--N 1.367 1.362 0 N-CA-C 114.11 1.152 . . . . 0.87 114.11 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -130.17 45.07 2.87 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.547 1.684 . . . . 0.34000000000000002 115.547 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.92 132.72 3.85 Favored 'General case' 0 N--CA 1.524 3.241 0 N-CA-C 116.233 1.938 . . . . 0.69999999999999996 116.233 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -152.45 102.95 2.78 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 116.054 -0.521 . . . . 0.20999999999999999 111.329 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 84' ' ' VAL 0.313 4.9 tt -110.03 123.25 65.76 Favored 'Isoleucine or valine' 0 C--O 1.27 2.168 0 CA-C-O 122.28 1.038 . . . . 0.31 111.406 175.889 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -123.62 152.69 41.67 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 113.389 -1.732 . . . . 0.44 112.025 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 75.9 tttt -104.27 152.51 22.13 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 118.28 2.696 . . . . 1.26 118.28 -174.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.62 -41.47 2.14 Favored Glycine 0 CA--C 1.541 1.694 0 CA-C-N 110.704 -2.953 . . . . 0.17000000000000001 119.86 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 178.06 164.44 0.69 Allowed 'General case' 0 N--CA 1.519 2.981 0 CA-C-N 121.165 2.482 . . . . 0.14999999999999999 112.228 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.95 -16.09 54.46 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 113.915 1.08 . . . . 0.17000000000000001 113.915 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.53 3.51 50.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.151 1.167 . . . . 0.55000000000000004 114.151 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.84 -3.07 20.74 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.205 1.187 . . . . 0.59999999999999998 114.205 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.586 0 C-N-CA 124.375 1.07 . . . . 0.94999999999999996 111.643 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 113.344 0.868 . . . . 0.34999999999999998 113.344 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.27 -22.53 18.86 Favored 'General case' 0 CA--C 1.591 2.543 0 N-CA-C 115.176 1.547 . . . . 0.20000000000000001 115.176 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.17 -18.81 29.51 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 124.337 1.055 . . . . 0.32000000000000001 113.401 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 55.5 mttt -104.49 -8.87 18.77 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 113.958 1.096 . . . . 1.73 113.958 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.514 HG21 HG23 ' A' ' 27' ' ' ILE . 11.3 p -61.44 135.11 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.794 0 C-N-CA 124.027 0.931 . . . . 0.11 112.797 176.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -118.52 -28.59 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 113.357 0.873 . . . . 0.16 113.357 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -163.94 119.0 1.55 Allowed 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 118.43 0.559 . . . . 0.54000000000000004 112.066 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.92 131.53 33.2 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.658 -0.651 . . . . 0.19 111.958 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.27 133.21 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 CA-C-O 121.42 0.629 . . . . 1.05 112.62 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -117.98 111.4 18.91 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.108 -1.441 . . . . 2.1099999999999999 107.108 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.84 102.59 8.27 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 121.898 0.856 . . . . 0.63 111.383 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.55 -14.12 0.35 Allowed Glycine 0 C--N 1.351 1.362 0 N-CA-C 117.127 1.611 . . . . 0.70999999999999996 117.127 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.04 -131.79 2.32 Favored Glycine 0 N--CA 1.472 1.059 0 C-N-CA 119.271 -1.442 . . . . 0.80000000000000004 116.06 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.541 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 19.9 tt0 -148.16 116.26 6.47 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 114.931 -0.634 . . . . 1.6299999999999999 110.89 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 14.7 m 21.78 120.4 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 120.199 3.407 . . . . 1.0 120.199 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -140.52 143.02 35.19 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.521 1.153 . . . . 0.45000000000000001 113.407 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.88 115.74 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-N 113.217 -1.811 . . . . 1.3899999999999999 110.789 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -74.99 155.65 37.12 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 113.341 -1.754 . . . . 1.8500000000000001 111.316 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -42.8 -23.92 0.1 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.152 0 N-CA-C 119.048 2.981 . . . . 0.71999999999999997 119.048 -178.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -96.88 -19.36 18.9 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 118.588 0.631 . . . . 0.51000000000000001 110.735 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.81 42.42 0.86 Allowed Glycine 0 C--N 1.358 1.8 0 C-N-CA 124.569 1.08 . . . . 0.34000000000000002 114.534 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.514 HG23 HG21 ' A' ' 10' ' ' VAL . 3.5 mt -105.73 121.55 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-O 120.883 0.373 . . . . 0.55000000000000004 110.002 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -102.85 125.99 49.82 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.286 1.217 . . . . 1.3400000000000001 114.286 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.47 152.68 18.19 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.793 -0.64 . . . . 2.79 111.755 176.838 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -100.35 149.34 23.73 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.006 1.113 . . . . 3.0 114.006 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' A' ' 31' ' ' LYS . 1.1 tmmt? -75.14 102.6 5.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.781 2.141 . . . . 2.2999999999999998 116.781 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.403 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 3.9 m-20 45.42 45.66 2.47 Favored Pre-proline 0 N--CA 1.526 3.355 0 N-CA-C 119.128 3.01 . . . . 1.1699999999999999 119.128 174.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.403 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 6.5 Cg_endo . . . . . 0 CA--C 1.566 2.093 0 C-N-CA 122.766 2.311 . . . . 1.45 116.209 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo . . . . . 0 N--CA 1.494 1.54 0 N-CA-C 117.708 2.157 . . . . 1.3700000000000001 117.708 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.254 1.2 mp -98.11 132.82 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.27 0 CA-C-N 113.865 -1.516 . . . . 0.68999999999999995 108.269 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.456 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.8 mt -86.91 -10.91 52.21 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.743 2.127 . . . . 1.28 116.743 -176.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -106.75 22.21 16.27 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.532 0.938 . . . . 1.51 113.532 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -141.91 -172.81 3.64 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-O 121.432 0.634 . . . . 1.0900000000000001 111.294 178.56 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.633 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.88 -176.72 0.57 Allowed Pre-proline 0 N--CA 1.509 2.51 0 C-N-CA 123.819 0.848 . . . . 1.27 109.557 178.528 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.493 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 32.8 Cg_exo -69.52 -40.42 5.72 Favored 'Trans proline' 0 C--N 1.4 3.26 0 C-N-CA 122.679 2.253 . . . . 0.94999999999999996 113.045 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -67.98 -49.52 61.14 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.27 1.428 . . . . 2.04 111.866 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.409 ' HB3' ' OG ' ' A' ' 53' ' ' SER . 0.3 OUTLIER -80.19 -3.54 49.43 Favored 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 114.86 -1.064 . . . . 1.6200000000000001 112.812 177.438 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.633 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 3.4 tt0 -73.03 -42.41 63.19 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 125.649 1.579 . . . . 1.77 107.391 173.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.6 t -63.72 -40.29 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 C-N-CA 124.195 0.998 . . . . 0.81000000000000005 109.638 173.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -17.38 60.58 Favored 'General case' 0 CA--C 1.587 2.393 0 N-CA-C 114.247 1.203 . . . . 1.1499999999999999 114.247 174.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -123.65 22.75 9.0 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 114.372 1.249 . . . . 0.92000000000000004 114.372 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.43 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -137.89 -36.31 0.62 Allowed 'General case' 0 N--CA 1.51 2.558 0 N-CA-C 114.84 1.422 . . . . 1.3300000000000001 114.84 -178.275 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.1 p -65.94 126.31 28.15 Favored 'General case' 0 N--CA 1.526 3.353 0 N-CA-C 115.293 1.59 . . . . 1.28 115.293 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.127 0 N-CA-C 113.463 0.912 . . . . 1.53 113.463 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 113.434 0.901 . . . . 2.1499999999999999 113.434 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.28 109.87 3.29 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.608 1.163 . . . . 0.77000000000000002 112.344 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.81 157.34 43.93 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.739 -1.119 . . . . 0.81000000000000005 113.157 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -169.66 -176.27 39.34 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 115.739 1.055 . . . . 0.46999999999999997 115.739 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.6 172.31 6.92 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.357 1.243 . . . . 0.89000000000000001 114.357 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.06 130.32 50.89 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 114.092 -1.413 . . . . 0.51000000000000001 111.995 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.73 99.61 38.57 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 123.282 0.633 . . . . 0.14999999999999999 109.379 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -84.17 121.63 2.76 Favored 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 122.061 1.841 . . . . 0.14999999999999999 114.65 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.03 160.4 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 CA-C-O 122.016 0.913 . . . . 0.19 111.455 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -146.62 17.42 1.3 Allowed 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 114.616 -1.175 . . . . 2.5299999999999998 112.051 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -126.65 160.33 31.04 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-O 121.292 0.568 . . . . 2.1200000000000001 111.5 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -121.25 144.55 48.55 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.72 1.008 . . . . 0.41999999999999998 113.72 -178.816 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.32 -134.31 3.49 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 113.961 -1.472 . . . . 0.23000000000000001 112.012 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.7 mt-10 -119.1 106.91 12.86 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 118.521 1.16 . . . . 1.75 111.158 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -101.37 128.74 47.41 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.093 0.473 . . . . 0.20999999999999999 110.76 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.77 125.77 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.528 0.68 . . . . 0.20000000000000001 110.543 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.71 105.89 17.28 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 114.563 -1.199 . . . . 0.78000000000000003 109.687 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.23 123.31 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.044 -1.095 . . . . 0.44 108.044 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -138.37 140.24 39.34 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.973 0.731 . . . . 1.25 112.973 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -101.46 120.37 40.18 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.711 0.767 . . . . 2.52 111.794 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -105.07 133.5 49.74 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.399 -0.819 . . . . 0.40000000000000002 109.655 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.59 158.92 43.27 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.306 0.574 . . . . 0.40999999999999998 112.207 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -122.8 161.63 23.64 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.512 0.725 . . . . 2.6099999999999999 111.844 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.13 -69.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 112.579 0.585 . . . . 2.1299999999999999 112.579 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -132.11 63.38 1.62 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.621 0.6 . . . . 2.27 112.621 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -148.68 97.44 2.73 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.283 0.633 . . . . 1.46 109.707 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.37 105.91 16.22 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.171 0.986 . . . . 0.83999999999999997 112.397 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -167.4 140.54 3.45 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.874 -1.057 . . . . 2.4500000000000002 111.464 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.1 m -127.08 123.18 36.29 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.782 0.66 . . . . 1.6599999999999999 112.782 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 68.16 47.49 1.02 Allowed 'General case' 0 N--CA 1.51 2.56 0 C-N-CA 125.819 1.648 . . . . 1.8899999999999999 113.894 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -149.74 -39.27 0.14 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.589 1.156 . . . . 2.5600000000000001 110.053 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -107.81 79.61 1.3 Allowed 'General case' 0 C--N 1.362 1.118 0 N-CA-C 108.123 -1.066 . . . . 2.7599999999999998 108.123 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.24 120.71 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 114.111 -1.404 . . . . 0.68999999999999995 111.146 -176.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -99.41 176.62 5.45 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 114.166 -1.379 . . . . 0.69999999999999996 114.583 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.5 135.25 50.11 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 122.09 -0.381 . . . . 1.3300000000000001 110.332 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.79 124.22 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.439 0 CA-C-O 121.208 0.528 . . . . 0.47999999999999998 109.641 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.678 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 20.0 mtt180 -122.11 150.48 42.11 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.467 1.654 . . . . 1.6899999999999999 115.467 -176.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 154' ' ' SER . 7.2 m -126.05 111.87 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 N-CA-C 113.072 0.767 . . . . 0.59999999999999998 113.072 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.468 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 62.86 25.93 15.32 Favored 'General case' 0 N--CA 1.526 3.345 0 C-N-CA 126.607 1.963 . . . . 1.1200000000000001 114.06 -179.042 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.22 -14.05 51.7 Favored Glycine 0 CA--C 1.552 2.37 0 C-N-CA 121.348 -0.453 . . . . 0.32000000000000001 113.768 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.678 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 92.3 m-70 -89.29 173.99 8.08 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 125.914 1.686 . . . . 0.56999999999999995 113.185 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.66 133.56 54.51 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.582 0.706 . . . . 0.55000000000000004 112.047 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.69 -57.17 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-N 114.701 -1.136 . . . . 1.0600000000000001 113.038 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.09 88.98 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.295 -1.002 . . . . 0.44 108.295 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 13.4 ptpt -108.31 98.55 8.07 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 122.919 1.342 . . . . 2.2999999999999998 111.793 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 0.6 OUTLIER 121.48 74.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 129.245 3.018 . . . . 2.48 108.018 -179.409 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.47 106.61 18.66 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 113.228 0.825 . . . . 1.1299999999999999 113.228 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -116.86 102.53 9.47 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.728 -1.578 . . . . 2.3500000000000001 106.806 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -25.59 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.335 0 N-CA-C 114.4 1.259 . . . . 0.68000000000000005 114.4 -176.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -75.27 -41.96 56.09 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.831 0.853 . . . . 0.77000000000000002 112.324 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -73.9 -26.13 60.37 Favored 'General case' 0 CA--C 1.577 1.986 0 C-N-CA 124.403 1.081 . . . . 0.91000000000000003 113.497 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -78.19 -56.1 4.74 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 113.711 1.004 . . . . 2.4300000000000002 113.711 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.21 -36.95 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 N-CA-C 114.44 1.274 . . . . 0.93000000000000005 114.44 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.05 -109.29 1.07 Allowed Glycine 0 C--N 1.355 1.619 0 CA-C-N 118.523 0.601 . . . . 0.84999999999999998 113.25 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -114.94 106.95 14.75 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.731 0.301 . . . . 3.1800000000000002 110.63 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 67.56 -130.07 0.14 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 125.285 1.434 . . . . 2.0800000000000001 112.582 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.456 HG22 ' HB2' ' A' ' 51' ' ' LEU . 66.7 p 60.39 -163.24 0.25 Allowed 'General case' 0 N--CA 1.529 3.511 0 C-N-CA 126.293 1.837 . . . . 0.62 115.182 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -112.74 129.93 56.24 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 112.692 0.626 . . . . 0.46000000000000002 112.692 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -103.08 137.82 40.74 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.077 -0.712 . . . . 0.38 109.077 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -134.71 126.14 28.44 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.88 1.437 . . . . 2.5 114.88 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.06 125.32 52.27 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 115.138 -0.937 . . . . 1.5600000000000001 111.156 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.63 114.72 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 114.272 -1.331 . . . . 0.45000000000000001 110.199 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.3 101.4 17.69 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.953 -0.546 . . . . 0.83999999999999997 111.582 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -74.13 143.01 31.6 Favored 'Trans proline' 0 C--N 1.399 3.237 0 C-N-CA 123.049 2.499 . . . . 0.16 114.729 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.3 mt -124.9 150.46 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 CA-C-N 115.03 -0.987 . . . . 0.38 109.916 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.6 t -136.21 113.41 10.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.454 0.645 . . . . 1.3100000000000001 111.275 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -111.56 124.28 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-N 114.931 -1.031 . . . . 0.25 108.61 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -143.69 130.4 20.27 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.791 -0.64 . . . . 2.0499999999999998 110.979 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.35 14.24 9.14 Favored 'General case' 0 N--CA 1.515 2.803 0 C-N-CA 125.186 1.394 . . . . 3.5499999999999998 113.623 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.99 17.64 31.78 Favored Glycine 0 CA--C 1.549 2.162 0 CA-C-O 119.158 -0.801 . . . . 0.37 114.566 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 7.1 mtpm? -127.28 150.58 49.5 Favored 'General case' 0 C--N 1.367 1.364 0 CA-C-N 118.443 1.122 . . . . 1.5600000000000001 113.046 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.79 141.06 36.77 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.07 1.137 . . . . 0.34000000000000002 114.07 -176.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.73 112.32 11.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.884 -1.053 . . . . 0.64000000000000001 110.054 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.255 8.6 p -115.95 95.16 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.457 0 CA-C-O 121.309 0.576 . . . . 0.46000000000000002 111.314 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 67.81 -86.37 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 C-N-CA 125.673 1.589 . . . . 1.5600000000000001 113.608 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.83 26.68 5.32 Favored Glycine 0 CA--C 1.543 1.821 0 CA-C-N 115.923 -0.581 . . . . 0.48999999999999999 112.79 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -126.12 137.35 53.59 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 124.067 0.947 . . . . 1.8200000000000001 111.013 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.75 126.04 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.167 0 CA-C-O 121.516 0.675 . . . . 1.02 111.05 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 m -150.2 -179.72 7.42 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.188 -0.915 . . . . 0.56000000000000005 109.933 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.269 15.4 t -103.84 138.18 40.79 Favored 'General case' 0 CA--C 1.577 1.981 0 N-CA-C 113.152 0.797 . . . . 1.25 113.152 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -83.74 121.81 27.79 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.987 0.915 . . . . 0.28999999999999998 111.38 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.41 91.27 3.21 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 112.38 0.511 . . . . 1.4199999999999999 112.38 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.89 -66.29 3.4 Favored Glycine 0 C--N 1.357 1.74 0 N-CA-C 118.738 2.255 . . . . 0.41999999999999998 118.738 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.528 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -133.58 156.89 47.01 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.326 1.232 . . . . 1.1000000000000001 114.326 -176.365 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.528 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -104.84 137.3 42.84 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.107 -1.86 . . . . 0.67000000000000004 109.188 177.117 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.1 t -120.47 143.28 48.6 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.284 1.587 . . . . 0.35999999999999999 115.284 -177.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.411 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.92 97.44 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.986 -1.487 . . . . 0.73999999999999999 106.986 175.736 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -117.76 124.11 47.65 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.993 -0.549 . . . . 1.6699999999999999 112.077 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.91 135.27 54.15 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 122.329 1.062 . . . . 1.8 112.015 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.4 t -104.74 140.24 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-N 112.631 -2.077 . . . . 0.57999999999999996 109.283 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 150.32 21.77 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.741 1.386 . . . . 2.1800000000000002 114.741 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.91 -34.23 4.1 Favored Glycine 0 CA--C 1.545 1.964 0 CA-C-N 114.779 -1.1 . . . . 1.02 114.483 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -126.2 -88.01 0.59 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 117.357 0.579 . . . . 2.8599999999999999 112.372 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -131.04 -51.33 1.03 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.996 0.518 . . . . 3.9100000000000001 112.015 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.03 122.61 37.87 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.172 0.989 . . . . 1.74 111.245 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -81.97 -169.09 0.21 Allowed Pre-proline 0 CA--C 1.574 1.888 0 C-N-CA 125.54 1.536 . . . . 1.6799999999999999 110.554 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -62.7 99.98 0.22 Allowed 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 122.159 1.906 . . . . 2.0600000000000001 111.461 174.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -55.65 -55.18 35.21 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.295 1.961 . . . . 3.0 116.295 -173.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 38.8 t -105.61 130.02 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.52 -0.919 . . . . 0.80000000000000004 108.52 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.8 t -135.41 113.82 11.56 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.053 -1.431 . . . . 0.87 110.648 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -109.61 47.2 0.95 Allowed 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.688 2.107 . . . . 0.34000000000000002 116.688 -175.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.17 130.92 3.62 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 117.13 2.27 . . . . 0.69999999999999996 117.13 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -150.92 105.37 3.25 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.7 -1.136 . . . . 0.20999999999999999 109.597 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.298 7.2 tt -112.76 122.04 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-O 122.255 1.026 . . . . 0.31 111.091 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -116.3 164.29 14.74 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 113.707 -1.588 . . . . 0.44 111.153 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 8.6 ptmm? -123.0 156.18 35.32 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.577 2.436 . . . . 1.26 117.577 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.42 -41.57 2.11 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 110.55 -3.023 . . . . 0.17000000000000001 118.909 174.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.04 160.36 1.77 Allowed 'General case' 0 N--CA 1.517 2.885 0 CA-C-N 120.683 2.242 . . . . 0.14999999999999999 113.391 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -83.29 -13.65 54.71 Favored 'General case' 0 CA--C 1.578 2.03 0 C-N-CA 124.882 1.273 . . . . 0.17000000000000001 114.016 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.38 2.91 49.01 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 114.502 1.297 . . . . 0.55000000000000004 114.502 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.55 -10.26 15.73 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.762 1.023 . . . . 0.59999999999999998 113.762 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.431 0 C-N-CA 123.917 0.887 . . . . 0.94999999999999996 112.727 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 27' ' ' ILE . 17.3 tp . . . . . 0 CA--C 1.564 1.506 0 N-CA-C 113.314 0.857 . . . . 0.34999999999999998 113.314 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.46 -23.53 62.79 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.822 1.649 . . . . 0.20000000000000001 115.134 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.97 -10.46 53.15 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 113.62 0.97 . . . . 0.32000000000000001 113.62 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 54.9 mmtt -105.26 -25.21 12.53 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-O 118.235 -0.888 . . . . 1.73 113.349 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -51.03 133.8 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 N-CA-C 115.508 1.67 . . . . 0.11 115.508 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.26 -29.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 115.267 -0.879 . . . . 0.16 112.071 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -162.45 118.6 1.94 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.583 0.353 . . . . 0.54000000000000004 111.62 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.8 128.58 20.48 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.523 -0.735 . . . . 0.19 111.181 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.11 135.66 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 113.986 1.106 . . . . 1.05 113.986 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -116.04 102.34 9.55 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 106.906 -1.516 . . . . 2.1099999999999999 106.906 172.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -75.37 98.55 3.89 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.949 0.881 . . . . 0.63 111.764 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 172.3 -33.03 0.13 Allowed Glycine 0 C--N 1.348 1.234 0 N-CA-C 117.374 1.71 . . . . 0.70999999999999996 117.374 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.07 -114.87 1.9 Allowed Glycine 0 N--CA 1.471 1.01 0 C-N-CA 120.219 -0.991 . . . . 0.80000000000000004 115.288 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.75 117.04 1.07 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.118 0.567 . . . . 1.6299999999999999 110.593 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.4 m 33.25 108.01 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 118.593 2.812 . . . . 1.0 118.593 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.519 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 63.3 t60 -133.21 133.94 43.39 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.76 1.022 . . . . 0.45000000000000001 113.76 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.57 117.59 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 114.743 -1.117 . . . . 1.3899999999999999 109.143 175.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -86.37 163.25 17.75 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 115.157 -0.929 . . . . 1.8500000000000001 111.542 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -43.73 -24.96 0.21 Allowed 'Isoleucine or valine' 1 N--CA 1.541 4.092 0 N-CA-C 119.681 3.215 . . . . 0.71999999999999997 119.681 -175.035 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -98.02 -9.98 25.16 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 118.543 0.611 . . . . 0.51000000000000001 111.457 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.8 40.32 2.73 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.811 1.196 . . . . 0.34000000000000002 114.036 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.55 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.6 mm -105.15 119.17 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.681 0 N-CA-C 109.21 -0.663 . . . . 0.55000000000000004 109.21 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.519 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.0 t-160 -105.7 135.28 47.4 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.579 1.696 . . . . 1.3400000000000001 115.579 -175.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -94.84 134.35 37.56 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.3 -1.318 . . . . 2.79 109.392 174.697 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.4 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 68.8 mtt180 -90.79 106.03 18.23 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.956 -1.02 . . . . 3.0 113.307 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -41.89 109.84 0.14 Allowed 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 118.374 2.731 . . . . 2.2999999999999998 118.374 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.08 59.75 16.33 Favored Pre-proline 0 N--CA 1.528 3.466 0 N-CA-C 118.325 2.713 . . . . 1.1699999999999999 118.325 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 10.0 Cg_endo . . . . . 0 CA--C 1.565 2.068 0 C-N-CA 122.992 2.461 . . . . 1.45 115.685 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 38.6 Cg_exo . . . . . 0 N--CA 1.509 2.389 0 N-CA-C 117.211 1.966 . . . . 1.3700000000000001 117.211 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.3 136.87 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.951 0 CA-C-N 114.703 -1.135 . . . . 0.68999999999999995 109.405 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.55 ' HB2' HG22 ' A' ' 125' ' ' THR . 4.0 mt -79.52 -17.14 54.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.241 1.571 . . . . 1.28 115.241 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -101.49 7.41 42.43 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.478 0.918 . . . . 1.51 113.478 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.2 p -118.52 -177.98 3.42 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.14 1.163 . . . . 1.0900000000000001 114.14 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.717 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 2.6 t30 -97.44 -176.18 0.5 Allowed Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 125.652 1.581 . . . . 1.27 109.574 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -72.05 -43.99 1.02 Allowed 'Trans proline' 0 C--N 1.393 2.901 0 C-N-CA 122.766 2.311 . . . . 0.94999999999999996 111.414 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -69.31 -47.68 63.76 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.005 -1.907 . . . . 2.04 111.617 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 17.4 t0 -75.7 -12.27 60.16 Favored 'General case' 0 CA--C 1.583 2.241 0 CA-C-N 115.327 -0.851 . . . . 1.6200000000000001 112.378 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.717 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 10.8 tt0 -67.7 -43.16 80.76 Favored 'General case' 0 C--N 1.379 1.851 0 C-N-CA 125.432 1.493 . . . . 1.77 109.179 173.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.8 -45.06 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.338 0 C-N-CA 124.327 1.051 . . . . 0.81000000000000005 109.853 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.76 -5.18 49.83 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.227 1.195 . . . . 1.1499999999999999 114.227 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.496 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 4.6 m-30 -123.54 10.35 9.11 Favored 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 124.509 1.124 . . . . 0.92000000000000004 112.402 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -136.55 -28.64 0.99 Allowed 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 116.502 2.038 . . . . 1.3300000000000001 116.502 -176.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.7 p -74.74 131.85 41.16 Favored 'General case' 0 N--CA 1.519 2.99 0 N-CA-C 114.008 1.114 . . . . 1.28 114.008 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.597 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.5 pt-20 . . . . . 0 N--CA 1.505 2.3 0 N-CA-C 114.95 1.463 . . . . 1.53 114.95 -176.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 111.368 0.136 . . . . 2.1499999999999999 111.368 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.2 t 67.56 85.19 0.14 Allowed 'General case' 0 N--CA 1.513 2.714 0 C-N-CA 124.769 1.228 . . . . 0.77000000000000002 112.487 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.406 ' CE1' ' ND2' ' A' ' 164' ' ' ASN . 3.3 p90 -144.56 157.03 44.41 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.384 0.611 . . . . 0.81000000000000005 112.564 -178.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.52 174.47 44.47 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 115.571 0.989 . . . . 0.46999999999999997 115.571 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.99 166.32 10.46 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.482 1.289 . . . . 0.89000000000000001 114.482 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -120.74 132.08 54.86 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.15 -1.387 . . . . 0.51000000000000001 112.162 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -124.51 99.47 36.2 Favored Pre-proline 0 CA--C 1.567 1.627 0 C-N-CA 123.142 0.577 . . . . 0.14999999999999999 109.916 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.08 122.12 3.27 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.231 1.954 . . . . 0.14999999999999999 115.014 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.14 159.26 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.64 0 CA-C-O 121.997 0.904 . . . . 0.19 111.26 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -147.86 22.15 1.12 Allowed 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 114.632 -1.167 . . . . 2.5299999999999998 111.791 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -129.9 159.37 36.84 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 121.3 0.572 . . . . 2.1200000000000001 111.449 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -119.0 144.77 46.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.742 1.016 . . . . 0.41999999999999998 113.742 -178.864 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.48 -138.73 5.77 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 113.974 -1.467 . . . . 0.23000000000000001 112.17 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 54.3 mm-40 -113.65 108.26 16.89 Favored 'General case' 0 C--N 1.359 1.008 0 CA-C-N 118.113 0.956 . . . . 1.75 111.292 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -102.84 129.84 49.65 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.81 -0.556 . . . . 0.20999999999999999 110.599 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -110.02 122.36 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.841 0.829 . . . . 0.20000000000000001 111.013 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.61 105.75 16.3 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 113.907 -1.497 . . . . 0.78000000000000003 110.202 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.69 126.65 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.142 -0.688 . . . . 0.44 109.142 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 146.07 48.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.599 0.963 . . . . 1.25 113.599 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -105.18 121.54 44.05 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.311 -0.859 . . . . 2.52 111.296 177.466 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 15.6 m-85 -108.49 134.86 50.69 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.414 -0.812 . . . . 0.40000000000000002 109.735 176.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.51 ' HB2' ' HE3' ' A' ' 88' ' ' LYS . . . -136.18 148.5 48.18 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 123.868 0.867 . . . . 0.40999999999999998 110.425 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -106.38 -71.21 0.76 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.816 0.447 . . . . 2.6099999999999999 111.768 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.325 2.8 m 48.29 53.57 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 C-N-CA 127.113 2.165 . . . . 2.1299999999999999 116.677 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.98 -53.63 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.79 0.663 . . . . 2.27 112.79 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -118.29 139.23 51.64 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.31 0.576 . . . . 1.46 112.349 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.18 103.31 12.47 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-O 122.209 1.004 . . . . 0.83999999999999997 111.987 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -162.83 140.89 8.27 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.125 -0.943 . . . . 2.4500000000000002 111.642 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 m -123.45 122.38 38.1 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.962 0.727 . . . . 1.6599999999999999 112.962 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 69.2 58.21 0.35 Allowed 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 125.933 1.693 . . . . 1.8899999999999999 113.266 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -156.96 -40.94 0.07 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.128 -1.396 . . . . 2.5600000000000001 108.606 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -103.42 82.67 2.07 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.361 -0.977 . . . . 2.7599999999999998 108.361 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.43 132.89 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 114.516 -1.22 . . . . 0.68999999999999995 111.509 -177.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.476 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 61.7 m-85 -115.5 174.26 6.1 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 115.185 1.55 . . . . 0.69999999999999996 115.185 -176.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.27 136.08 52.34 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.869 0.842 . . . . 1.3300000000000001 110.923 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.3 124.39 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.285 0 CA-C-N 114.361 -1.291 . . . . 0.47999999999999998 110.38 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.3 OUTLIER -121.02 141.56 50.63 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.473 1.286 . . . . 1.6899999999999999 114.473 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 m -117.72 99.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 115.111 -0.95 . . . . 0.59999999999999998 112.063 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.428 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.1 t30 64.85 26.89 12.92 Favored 'General case' 0 N--CA 1.522 3.169 0 C-N-CA 126.892 2.077 . . . . 1.1200000000000001 113.659 -177.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.89 -19.65 32.6 Favored Glycine 0 CA--C 1.549 2.19 0 CA-C-N 115.141 -0.936 . . . . 0.32000000000000001 113.702 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -88.32 121.93 31.27 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 125.505 1.522 . . . . 0.56999999999999995 113.669 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -87.7 125.69 34.55 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.591 1.186 . . . . 0.55000000000000004 113.134 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.22 -43.39 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 112.428 -2.169 . . . . 1.0600000000000001 112.916 -177.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.38 90.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.466 -0.568 . . . . 0.44 109.466 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -111.55 75.88 0.94 Allowed 'General case' 0 C--N 1.359 1.013 0 CA-C-O 123.944 1.831 . . . . 2.2999999999999998 112.52 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 154.46 61.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 109.818 -3.356 . . . . 2.48 107.48 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.3 tp -98.91 99.16 10.18 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 113.727 1.01 . . . . 1.1299999999999999 113.727 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -111.86 111.5 22.49 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 113.172 -1.831 . . . . 2.3500000000000001 109.742 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -34.26 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 114.545 1.313 . . . . 0.68000000000000005 114.545 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -76.32 -37.5 57.31 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.806 0.669 . . . . 0.77000000000000002 112.806 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -74.08 -27.0 60.68 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 124.371 1.068 . . . . 0.91000000000000003 113.422 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -80.33 -57.78 3.44 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.311 0.856 . . . . 2.4300000000000002 113.311 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.78 -36.79 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 N-CA-C 114.313 1.227 . . . . 0.93000000000000005 114.313 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.37 -71.13 0.21 Allowed Glycine 0 C--N 1.36 1.908 0 CA-C-N 118.534 0.606 . . . . 0.84999999999999998 113.999 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -102.97 174.39 5.89 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.25 1.02 . . . . 3.1800000000000002 111.802 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.0 m -75.9 81.26 2.8 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 113.846 1.054 . . . . 2.0800000000000001 113.846 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.55 HG22 ' HB2' ' A' ' 51' ' ' LEU . 46.6 p -127.99 -137.43 0.24 Allowed 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 114.708 -1.133 . . . . 0.62 109.139 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.8 128.09 56.27 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 114.055 1.132 . . . . 0.46000000000000002 114.055 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -106.2 126.68 52.51 Favored 'General case' 0 C--N 1.363 1.183 0 N-CA-C 108.399 -0.963 . . . . 0.38 108.399 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.25 136.76 36.84 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.5 0.926 . . . . 2.5 113.5 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -120.37 134.46 55.26 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 114.806 -1.088 . . . . 1.5600000000000001 111.174 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.8 115.66 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 CA-C-N 114.255 -1.339 . . . . 0.45000000000000001 109.833 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.9 90.86 49.49 Favored Pre-proline 0 CA--C 1.573 1.851 0 CA-C-N 115.208 -0.906 . . . . 0.83999999999999997 110.15 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -73.87 136.64 23.25 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 123.052 2.501 . . . . 0.16 113.71 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -119.04 151.38 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 115.167 -0.924 . . . . 0.38 111.053 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.5 p -134.21 108.73 8.43 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.215 -0.902 . . . . 1.3100000000000001 111.744 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.2 mt -108.82 122.79 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.593 0 N-CA-C 108.441 -0.948 . . . . 0.25 108.441 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -141.76 129.49 21.64 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.696 -0.684 . . . . 2.0499999999999998 110.996 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 67.49 14.87 9.73 Favored 'General case' 0 N--CA 1.515 2.821 0 C-N-CA 125.113 1.365 . . . . 3.5499999999999998 114.367 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.38 16.44 32.1 Favored Glycine 0 CA--C 1.549 2.168 0 CA-C-O 119.143 -0.809 . . . . 0.37 114.962 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 94.6 mttt -126.82 150.4 49.21 Favored 'General case' 0 C--N 1.367 1.329 0 CA-C-N 118.498 1.149 . . . . 1.5600000000000001 113.038 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.53 139.0 37.78 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.554 0.946 . . . . 0.34000000000000002 113.554 -176.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.67 112.42 14.82 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.128 -0.942 . . . . 0.64000000000000001 110.406 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.81 92.75 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.604 0 CA-C-N 115.589 -0.732 . . . . 0.46000000000000002 109.982 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 65.39 -83.75 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 C-N-CA 125.369 1.468 . . . . 1.5600000000000001 113.796 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -129.61 25.95 4.4 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-N 116.099 -0.5 . . . . 0.48999999999999999 113.866 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -132.38 119.31 20.51 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 123.165 0.586 . . . . 1.8200000000000001 110.078 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 p -105.74 131.61 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.298 0 CA-C-O 121.696 0.76 . . . . 1.02 112.415 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -149.08 -178.11 6.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.815 -1.084 . . . . 0.56000000000000005 109.565 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.268 13.0 t -103.48 138.65 39.9 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 113.547 0.943 . . . . 1.25 113.547 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -82.12 122.68 28.16 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 124.192 0.997 . . . . 0.28999999999999998 111.343 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.65 90.77 3.31 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.788 0.662 . . . . 1.4199999999999999 112.788 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.19 -61.74 2.64 Favored Glycine 0 C--N 1.362 2.005 0 N-CA-C 118.835 2.294 . . . . 0.41999999999999998 118.835 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.554 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -133.11 163.83 28.39 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.649 0.981 . . . . 1.1000000000000001 113.649 -176.813 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.554 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -112.14 134.6 53.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.692 -1.594 . . . . 0.67000000000000004 108.488 176.763 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.2 t -121.86 130.58 53.49 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 115.246 1.573 . . . . 0.35999999999999999 115.246 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.2 t -106.35 99.85 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.704 -1.591 . . . . 0.73999999999999999 106.704 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.2 tt0 -114.85 125.23 53.43 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 113.905 -1.498 . . . . 1.6699999999999999 111.9 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -116.15 131.97 56.79 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 122.217 1.008 . . . . 1.8 111.923 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.51 144.47 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 112.875 -1.966 . . . . 0.57999999999999996 110.83 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -95.19 150.45 20.2 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.676 -1.147 . . . . 2.1800000000000002 113.612 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.32 -32.65 5.98 Favored Glycine 0 CA--C 1.548 2.112 0 N-CA-C 115.236 0.855 . . . . 1.02 115.236 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -125.17 -80.56 0.62 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.606 0.703 . . . . 2.8599999999999999 112.395 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -132.2 -44.94 0.93 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.087 0.555 . . . . 3.9100000000000001 112.203 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.476 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -92.84 157.17 16.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.659 1.184 . . . . 1.74 112.109 179.085 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.406 ' ND2' ' CE1' ' A' ' 71' ' ' PHE . 1.2 m-20 -101.19 -167.45 0.13 Allowed Pre-proline 0 CA--C 1.572 1.809 0 CA-C-N 113.614 -1.63 . . . . 1.6799999999999999 108.979 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -61.26 -10.5 15.83 Favored 'Trans proline' 0 N--CA 1.52 3.081 0 C-N-CA 122.49 2.127 . . . . 2.0600000000000001 115.533 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? 78.93 -71.71 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 126.561 1.944 . . . . 3.0 114.211 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.597 HG22 ' HB3' ' A' ' 64' ' ' GLU . 25.2 t -106.34 132.72 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.621 -0.511 . . . . 0.80000000000000004 109.621 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.6 125.82 27.96 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 114.155 -1.384 . . . . 0.87 111.479 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.268 . . -120.34 50.88 1.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 115.744 1.757 . . . . 0.34000000000000002 115.744 -176.724 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.81 129.3 2.62 Favored 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 126.169 1.787 . . . . 0.69999999999999996 115.502 178.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -149.61 99.31 2.87 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.20999999999999999 110.019 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.311 8.0 tt -115.67 121.78 68.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.673 0 CA-C-O 122.651 1.215 . . . . 0.31 111.801 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -118.72 171.2 8.37 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 113.701 -1.59 . . . . 0.44 112.171 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 54.7 tttm -120.15 148.15 44.0 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 117.783 2.512 . . . . 1.26 117.783 -174.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.22 -41.74 2.08 Favored Glycine 0 CA--C 1.543 1.823 0 CA-C-N 110.786 -2.915 . . . . 0.17000000000000001 120.087 172.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.08 156.64 1.04 Allowed 'General case' 0 N--CA 1.521 3.115 0 CA-C-N 121.114 2.457 . . . . 0.14999999999999999 113.383 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.45 -12.12 59.99 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 114.478 1.288 . . . . 0.17000000000000001 114.478 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.1 4.47 45.25 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 113.694 0.998 . . . . 0.55000000000000004 113.694 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.13 -10.32 15.91 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 113.701 1.0 . . . . 0.59999999999999998 113.701 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.509 2.503 0 C-N-CA 123.932 0.893 . . . . 0.94999999999999996 112.74 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.588 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.7 tp . . . . . 0 CA--C 1.561 1.382 0 N-CA-C 113.294 0.85 . . . . 0.34999999999999998 113.294 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.69 -23.15 62.89 Favored 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 125.647 1.579 . . . . 0.20000000000000001 114.979 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.1 -15.17 39.3 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 124.146 0.978 . . . . 0.32000000000000001 113.626 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -105.19 -18.05 14.27 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.907 1.077 . . . . 1.73 113.907 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.34 134.79 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.78 0 N-CA-C 114.625 1.343 . . . . 0.11 114.625 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -121.27 -28.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 115.328 -0.851 . . . . 0.16 112.446 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -162.63 117.08 1.77 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 117.827 0.285 . . . . 0.54000000000000004 111.493 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -136.84 130.85 32.42 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.516 -0.74 . . . . 0.19 111.445 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.0 t -137.97 129.32 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 N-CA-C 113.481 0.919 . . . . 1.05 113.481 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -116.44 104.22 11.23 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 106.946 -1.501 . . . . 2.1099999999999999 106.946 171.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.29 101.88 7.38 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.084 0.945 . . . . 0.63 111.861 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.526 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 175.59 -57.33 0.11 Allowed Glycine 0 C--N 1.349 1.305 0 CA-C-N 113.71 -1.587 . . . . 0.70999999999999996 114.349 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.13 -117.09 4.3 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-O 119.93 -0.372 . . . . 0.80000000000000004 113.975 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -172.12 118.88 0.4 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.172 0.589 . . . . 1.6299999999999999 111.17 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 48.39 107.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 117.205 2.298 . . . . 1.0 117.205 178.473 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.761 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 20.2 t-80 -142.41 132.51 24.6 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.461 -1.296 . . . . 0.45000000000000001 114.49 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -97.04 112.24 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.362 0 CA-C-N 114.28 -1.327 . . . . 1.3899999999999999 110.089 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.29 164.92 19.76 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.527 1.131 . . . . 1.8500000000000001 112.559 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 m -42.53 -35.17 0.63 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.159 0 N-CA-C 118.947 2.943 . . . . 0.71999999999999997 118.947 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -88.98 -23.32 22.66 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.213 0.53 . . . . 0.51000000000000001 111.26 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.85 41.06 0.73 Allowed Glycine 0 C--N 1.351 1.394 0 CA-C-N 114.817 -1.083 . . . . 0.34000000000000002 113.81 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.588 HD11 ' HG ' ' A' ' 6' ' ' LEU . 22.7 mm -108.45 112.8 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 C-N-CA 122.569 0.348 . . . . 0.55000000000000004 110.581 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.761 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 5.1 p-80 -109.29 147.83 32.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.983 1.845 . . . . 1.3400000000000001 115.983 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.8 151.31 20.32 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 112.467 -2.151 . . . . 2.79 109.419 176.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -70.27 -99.82 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 116.04 1.867 . . . . 3.0 116.04 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp 178.19 84.04 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.89 0.876 . . . . 2.2999999999999998 111.986 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 52.69 55.33 14.26 Favored Pre-proline 0 N--CA 1.528 3.457 0 N-CA-C 117.283 2.327 . . . . 1.1699999999999999 117.283 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 CA--C 1.568 2.193 0 C-N-CA 123.307 2.672 . . . . 1.45 116.432 -179.195 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo . . . . . 0 N--CA 1.495 1.577 0 N-CA-C 119.496 2.844 . . . . 1.3700000000000001 119.496 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 126' ' ' ALA 0.319 1.8 mp -92.78 107.02 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 CA-C-O 123.085 1.421 . . . . 0.68999999999999995 109.59 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.459 ' HB2' HG22 ' A' ' 125' ' ' THR . 89.3 mt -90.24 -7.13 54.26 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 111.821 -2.445 . . . . 1.28 116.387 -175.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -103.86 16.46 26.29 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 112.263 0.468 . . . . 1.51 112.263 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.84 159.36 42.37 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.224 1.01 . . . . 1.0900000000000001 111.51 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.86 158.32 62.26 Favored Pre-proline 0 N--CA 1.517 2.876 0 CA-C-O 118.138 -0.934 . . . . 1.27 110.974 178.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -41.19 -40.13 4.08 Favored 'Trans proline' 0 N--CA 1.535 3.971 0 C-N-CA 125.162 3.908 . . . . 0.94999999999999996 120.05 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.79 -50.02 13.17 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.511 0.672 . . . . 2.04 111.96 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -78.23 -7.5 57.22 Favored 'General case' 0 CA--C 1.584 2.287 0 N-CA-C 113.121 0.786 . . . . 1.6200000000000001 113.121 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.66 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 37.0 tt0 -74.3 -37.06 63.75 Favored 'General case' 0 C--N 1.38 1.919 0 C-N-CA 125.923 1.689 . . . . 1.77 107.547 172.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.36 -43.88 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 C-N-CA 124.214 1.005 . . . . 0.81000000000000005 109.289 172.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.1 tp -79.93 -4.63 53.21 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 113.965 1.098 . . . . 1.1499999999999999 113.965 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.427 ' O ' HG12 ' A' ' 50' ' ' ILE . 6.8 m-30 -121.69 13.77 10.85 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 125.131 1.373 . . . . 0.92000000000000004 112.641 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.66 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 5.7 tt0 -140.8 -38.9 0.42 Allowed 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 117.175 2.287 . . . . 1.3300000000000001 117.175 -174.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.8 p -64.19 128.06 34.16 Favored 'General case' 0 N--CA 1.528 3.435 0 N-CA-C 115.343 1.609 . . . . 1.28 115.343 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.527 ' HB3' HG22 ' A' ' 167' ' ' VAL . 2.4 pt-20 . . . . . 0 N--CA 1.503 2.213 0 C-N-CA 124.617 1.167 . . . . 1.53 112.58 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 110.732 -0.099 . . . . 2.1499999999999999 110.732 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.91 89.57 0.06 Allowed 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 125.383 1.473 . . . . 0.77000000000000002 113.692 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -153.53 159.24 42.18 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.841 1.052 . . . . 0.81000000000000005 113.841 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -175.7 -172.01 40.13 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 115.879 1.112 . . . . 0.46999999999999997 115.879 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -111.27 173.32 6.4 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.026 1.491 . . . . 0.89000000000000001 115.026 -176.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -127.61 132.2 49.82 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 113.98 -1.464 . . . . 0.51000000000000001 111.757 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.91 103.61 30.62 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.023 0.529 . . . . 0.14999999999999999 109.957 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -84.34 120.64 2.54 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 122.282 1.988 . . . . 0.14999999999999999 114.958 177.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.24 162.81 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 122.041 0.924 . . . . 0.19 110.931 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -152.13 27.95 0.59 Allowed 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 114.801 -1.091 . . . . 2.5299999999999998 111.816 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -132.71 155.62 48.5 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-O 121.24 0.543 . . . . 2.1200000000000001 110.965 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -116.77 141.87 47.65 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.009 1.114 . . . . 0.41999999999999998 114.009 -178.48 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.83 -139.08 5.69 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 113.712 -1.585 . . . . 0.23000000000000001 112.061 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.2 mt-10 -113.9 110.13 19.61 Favored 'General case' 0 C--N 1.36 1.023 0 CA-C-N 118.312 1.056 . . . . 1.75 111.299 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -104.41 131.2 52.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.996 0.427 . . . . 0.20999999999999999 110.523 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.81 124.46 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.408 0.623 . . . . 0.20000000000000001 110.551 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.429 HD12 HD12 ' A' ' 172' ' ' ILE . 2.2 tt -109.15 106.19 15.97 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.793 -1.094 . . . . 0.78000000000000003 109.806 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -112.48 129.17 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 113.929 -1.487 . . . . 0.44 108.543 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.72 139.11 50.26 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 115.684 -0.689 . . . . 1.25 112.502 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 4.9 tptm -104.33 114.75 29.19 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.295 -0.866 . . . . 2.52 109.855 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.491 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 11.1 m-85 -105.22 137.05 43.62 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.852 -0.613 . . . . 0.40000000000000002 111.255 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.79 151.54 45.84 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.757 -0.656 . . . . 0.40999999999999998 111.458 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -145.87 123.46 11.8 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.671 0.389 . . . . 2.6099999999999999 111.687 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.3 77.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 116.019 -0.537 . . . . 2.1299999999999999 111.727 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -171.05 -47.42 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.43 0.53 . . . . 2.27 112.43 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -116.19 127.34 54.7 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.65 0.38 . . . . 1.46 111.577 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.96 103.14 12.94 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.252 1.025 . . . . 0.83999999999999997 111.992 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -160.79 141.84 11.79 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.947 -1.024 . . . . 2.4500000000000002 111.651 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 m -127.7 122.09 32.05 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.764 0.653 . . . . 1.6599999999999999 112.764 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 67.85 55.62 0.58 Allowed 'General case' 0 N--CA 1.513 2.72 0 C-N-CA 125.724 1.61 . . . . 1.8899999999999999 113.142 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -157.68 -39.15 0.07 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.617 -1.174 . . . . 2.5600000000000001 109.44 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -108.06 83.24 1.76 Allowed 'General case' 0 C--N 1.361 1.097 0 N-CA-C 108.03 -1.1 . . . . 2.7599999999999998 108.03 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.41 130.45 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 114.419 -1.264 . . . . 0.68999999999999995 111.539 -176.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -108.02 170.53 7.94 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.331 1.604 . . . . 0.69999999999999996 115.331 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -119.85 136.65 54.4 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.236 -0.893 . . . . 1.3300000000000001 110.846 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.38 127.89 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.471 0 N-CA-C 109.58 -0.526 . . . . 0.47999999999999998 109.58 -178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 53.9 mtt180 -128.58 153.32 47.35 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.708 1.744 . . . . 1.6899999999999999 115.708 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.7 OUTLIER -129.73 112.32 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-N 115.545 -0.752 . . . . 0.59999999999999998 112.758 176.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.505 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 63.39 27.05 15.18 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 126.864 2.066 . . . . 1.1200000000000001 114.157 -178.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.31 -19.35 40.13 Favored Glycine 0 CA--C 1.548 2.136 0 C-N-CA 121.463 -0.399 . . . . 0.32000000000000001 113.8 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.481 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 86.7 m-70 -83.79 156.91 22.28 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.654 1.582 . . . . 0.56999999999999995 114.454 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.49 131.29 53.84 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.375 0.607 . . . . 0.55000000000000004 111.094 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.2 -57.86 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 115.129 -0.942 . . . . 1.0600000000000001 113.104 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.74 90.02 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.713 -0.847 . . . . 0.44 108.713 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -109.37 77.85 1.09 Allowed 'General case' 0 C--N 1.351 0.636 0 CA-C-O 122.835 1.303 . . . . 2.2999999999999998 111.985 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 152.34 65.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 128.523 2.729 . . . . 2.48 107.868 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.0 tp -105.17 99.35 8.96 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 113.782 1.03 . . . . 1.1299999999999999 113.782 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -113.32 107.05 15.35 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 113.24 -1.8 . . . . 2.3500000000000001 108.042 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.13 -33.25 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 114.542 1.312 . . . . 0.68000000000000005 114.542 -177.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -75.13 -36.1 61.64 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 123.376 0.671 . . . . 0.77000000000000002 112.242 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -74.71 -27.46 60.39 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 124.436 1.094 . . . . 0.91000000000000003 113.27 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.69 -56.93 4.17 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.163 0.801 . . . . 2.4300000000000002 113.163 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.9 -40.68 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 113.753 1.019 . . . . 0.93000000000000005 113.753 177.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.45 -64.09 0.3 Allowed Glycine 0 C--N 1.361 1.935 0 N-CA-C 114.353 0.501 . . . . 0.84999999999999998 114.353 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -103.26 174.2 5.97 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.316 1.046 . . . . 3.1800000000000002 111.634 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -73.35 89.86 1.63 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 123.543 0.737 . . . . 2.0800000000000001 112.249 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 51' ' ' LEU . 40.8 p -141.02 -146.25 0.19 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.115 0.966 . . . . 0.62 109.209 -176.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.534 ' HB2' HG23 ' A' ' 50' ' ' ILE . . . -113.94 134.8 54.6 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 113.475 0.917 . . . . 0.46000000000000002 113.475 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.491 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 10.4 t60 -110.75 145.79 37.47 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.884 0.474 . . . . 0.38 109.77 177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -145.33 143.97 30.46 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.881 1.067 . . . . 2.5 113.881 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -137.43 125.71 23.21 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 114.293 -1.321 . . . . 1.5600000000000001 110.471 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.45 121.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 114.896 -1.047 . . . . 0.45000000000000001 110.768 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.98 99.45 15.05 Favored Pre-proline 0 CA--C 1.571 1.759 0 CA-C-O 119.009 -0.52 . . . . 0.83999999999999997 112.208 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -74.7 143.95 30.8 Favored 'Trans proline' 0 C--N 1.4 3.277 0 C-N-CA 123.052 2.501 . . . . 0.16 114.326 176.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -124.28 149.25 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 124.023 0.929 . . . . 0.38 110.423 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.6 p -132.48 111.37 11.21 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.924 -0.58 . . . . 1.3100000000000001 112.349 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.4 mt -112.01 122.67 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 N-CA-C 108.492 -0.929 . . . . 0.25 108.492 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -142.56 130.09 21.32 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.66 -0.7 . . . . 2.0499999999999998 110.873 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt 69.38 10.14 7.61 Favored 'General case' 0 N--CA 1.518 2.963 0 N-CA-C 114.677 1.362 . . . . 3.5499999999999998 114.677 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.66 18.45 23.11 Favored Glycine 0 CA--C 1.548 2.108 0 C-N-CA 123.738 0.685 . . . . 0.37 114.384 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 95.4 mttt -128.25 151.09 49.69 Favored 'General case' 0 C--N 1.367 1.337 0 CA-C-N 117.978 0.889 . . . . 1.5600000000000001 112.799 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.75 144.9 30.5 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.811 1.041 . . . . 0.34000000000000002 113.811 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.1 m -134.35 114.09 12.6 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.783 -1.099 . . . . 0.64000000000000001 110.712 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.274 0.8 OUTLIER -114.54 96.12 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.568 0 CA-C-O 121.304 0.573 . . . . 0.46000000000000002 110.434 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 68.24 -85.34 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 125.41 1.484 . . . . 1.5600000000000001 113.594 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.08 26.74 4.16 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 115.969 -0.559 . . . . 0.48999999999999999 113.405 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -129.21 127.98 42.39 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.497 0.719 . . . . 1.8200000000000001 110.453 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.0 p -113.39 130.75 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.315 0 CA-C-O 121.649 0.738 . . . . 1.02 111.772 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 m -148.65 178.58 8.51 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.946 -1.025 . . . . 0.56000000000000005 109.735 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.27 13.4 t -103.34 137.61 41.22 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 113.366 0.876 . . . . 1.25 113.366 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -84.14 123.44 30.08 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.243 1.017 . . . . 0.28999999999999998 111.597 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.2 90.82 3.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.476 0.547 . . . . 1.4199999999999999 112.476 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.28 -64.64 3.15 Favored Glycine 0 C--N 1.359 1.816 0 N-CA-C 118.847 2.299 . . . . 0.41999999999999998 118.847 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.517 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -129.75 158.03 40.52 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.442 1.275 . . . . 1.1000000000000001 114.442 -176.246 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.517 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -106.98 138.97 42.13 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 113.285 -1.779 . . . . 0.67000000000000004 109.269 177.032 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 t -121.23 143.97 48.86 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.567 1.692 . . . . 0.35999999999999999 115.567 -177.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.421 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -116.26 98.2 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.308 -1.367 . . . . 0.73999999999999999 107.308 175.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -118.29 124.91 48.97 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.334 0.588 . . . . 1.6699999999999999 112.407 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.0 133.39 56.07 Favored 'General case' 0 C--O 1.252 1.211 0 CA-C-O 122.22 1.009 . . . . 1.8 111.482 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.4 t -106.36 143.91 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 113.094 -1.867 . . . . 0.57999999999999996 110.442 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.489 ' HD3' ' H ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -85.64 150.53 24.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.539 1.311 . . . . 2.1800000000000002 114.539 -178.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.93 -51.78 0.99 Allowed Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.055 -0.975 . . . . 1.02 113.928 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -129.49 -84.46 0.55 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.912 0.356 . . . . 2.8599999999999999 111.739 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.508 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 0.4 OUTLIER -140.64 122.7 15.64 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.984 0.514 . . . . 3.9100000000000001 110.224 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 0.9 OUTLIER 85.54 114.94 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 C-N-CA 124.975 1.31 . . . . 1.74 111.064 -177.862 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -82.32 -172.26 0.35 Allowed Pre-proline 0 CA--C 1.574 1.876 0 C-N-CA 124.536 1.134 . . . . 1.6799999999999999 110.464 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -61.64 101.06 0.2 Allowed 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 122.247 1.965 . . . . 2.0600000000000001 111.994 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -59.56 -49.42 77.83 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.199 1.926 . . . . 3.0 116.199 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 64' ' ' GLU . 25.8 t -108.43 131.88 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.777 -0.823 . . . . 0.80000000000000004 108.777 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.4 t -136.88 124.18 21.89 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.639 -1.164 . . . . 0.87 112.094 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.267 . . -119.84 48.32 1.57 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.897 1.814 . . . . 0.34000000000000002 115.897 -177.235 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.83 135.53 2.28 Favored 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.489 2.033 . . . . 0.69999999999999996 116.489 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -152.43 106.42 3.12 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.376 -0.829 . . . . 0.20999999999999999 110.974 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.429 HD12 HD12 ' A' ' 85' ' ' LEU 0.294 9.9 tt -115.72 122.68 69.96 Favored 'Isoleucine or valine' 0 C--O 1.27 2.15 0 CA-C-O 122.16 0.981 . . . . 0.31 111.147 175.689 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -120.42 167.83 11.94 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.322 -1.308 . . . . 0.44 111.859 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -118.58 145.63 45.23 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 117.813 2.523 . . . . 1.26 117.813 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.42 -40.99 2.28 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 110.672 -2.967 . . . . 0.17000000000000001 120.151 172.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.71 160.92 2.0 Favored 'General case' 0 N--CA 1.518 2.932 0 CA-C-N 121.265 2.533 . . . . 0.14999999999999999 113.587 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.37 -10.06 59.75 Favored 'General case' 0 CA--C 1.583 2.212 0 C-N-CA 124.994 1.318 . . . . 0.17000000000000001 114.126 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.1 1.64 52.31 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.234 1.198 . . . . 0.55000000000000004 114.234 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.05 -10.84 15.8 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.467 0.914 . . . . 0.59999999999999998 113.467 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.379 0 C-N-CA 124.119 0.968 . . . . 0.94999999999999996 112.424 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.525 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.9 tp . . . . . 0 CA--C 1.565 1.553 0 N-CA-C 113.036 0.754 . . . . 0.34999999999999998 113.036 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.28 -22.91 63.68 Favored 'General case' 0 N--CA 1.508 2.462 0 C-N-CA 125.925 1.69 . . . . 0.20000000000000001 115.249 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -11.53 51.11 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 113.792 1.034 . . . . 0.32000000000000001 113.792 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -108.9 -19.37 13.42 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 113.728 1.01 . . . . 1.73 113.728 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.41 138.26 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 N-CA-C 115.142 1.534 . . . . 0.11 115.142 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -122.32 -30.33 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 115.717 -0.674 . . . . 0.16 112.44 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -162.02 116.29 1.88 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 120.815 0.34 . . . . 0.54000000000000004 111.07 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.07 135.57 35.95 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.397 -0.815 . . . . 0.19 111.526 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.269 5.3 p -148.17 146.15 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 N-CA-C 114.571 1.323 . . . . 1.05 114.571 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.623 ' HB2' HD12 ' A' ' 60' ' ' LEU . 1.9 t-20 -116.9 107.91 15.17 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.168 -1.378 . . . . 2.1099999999999999 108.145 175.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.6 102.11 5.98 Favored 'General case' 0 C--O 1.268 2.078 0 CA-C-O 122.246 1.022 . . . . 0.63 111.668 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.496 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 153.98 -1.66 0.22 Allowed Glycine 0 C--N 1.353 1.5 0 CA-C-N 111.561 -2.563 . . . . 0.70999999999999996 115.998 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.51 -141.43 3.13 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 118.91 1.355 . . . . 0.80000000000000004 114.705 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -147.25 116.67 7.01 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 112.485 0.55 . . . . 1.6299999999999999 112.485 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 2.3 m 35.54 123.18 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.877 0 N-CA-C 121.087 3.736 . . . . 1.0 121.087 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.439 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 38.4 t60 -154.2 150.21 27.85 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.662 0.744 . . . . 0.45000000000000001 111.768 175.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.56 128.22 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 115.361 -0.836 . . . . 1.3899999999999999 111.71 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -85.73 153.36 22.38 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 113.994 -1.457 . . . . 1.8500000000000001 110.157 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.1 m -44.04 -22.77 0.15 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 118.956 2.947 . . . . 0.71999999999999997 118.956 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -94.19 -21.55 18.99 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 123.004 0.522 . . . . 0.51000000000000001 111.103 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.58 39.21 1.12 Allowed Glycine 0 C--N 1.353 1.501 0 C-N-CA 124.4 1.0 . . . . 0.34000000000000002 114.43 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.525 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.9 mm -105.98 119.68 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 109.239 -0.652 . . . . 0.55000000000000004 109.239 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -100.66 130.92 46.77 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.179 1.177 . . . . 1.3400000000000001 114.179 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.662 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -96.33 140.45 30.98 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.985 -1.007 . . . . 2.79 110.604 177.398 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -83.6 176.42 9.02 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 115.856 1.798 . . . . 3.0 115.856 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -107.53 96.97 6.78 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.83 1.789 . . . . 2.2999999999999998 115.83 -175.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 46.95 58.6 17.02 Favored Pre-proline 0 N--CA 1.52 3.036 0 N-CA-C 117.701 2.482 . . . . 1.1699999999999999 117.701 175.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 CA--C 1.557 1.654 0 C-N-CA 122.62 2.213 . . . . 1.45 115.93 179.592 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo . . . . . 0 N--CA 1.499 1.816 0 N-CA-C 116.053 1.52 . . . . 1.3700000000000001 116.053 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.257 1.1 mp -97.18 136.9 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.23 0 CA-C-N 114.6 -1.182 . . . . 0.68999999999999995 109.726 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.56 ' HB2' HG22 ' A' ' 125' ' ' THR . 5.7 mt -89.73 -12.27 39.89 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 116.381 1.993 . . . . 1.28 116.381 -177.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -100.48 15.86 26.53 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.87 1.063 . . . . 1.51 113.87 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -132.62 -165.46 1.6 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.29 0.636 . . . . 1.0900000000000001 111.433 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.18 174.09 3.68 Favored Pre-proline 0 N--CA 1.505 2.31 0 C-N-CA 123.087 0.555 . . . . 1.27 111.583 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -70.2 -28.14 23.51 Favored 'Trans proline' 0 C--N 1.401 3.32 0 C-N-CA 123.164 2.576 . . . . 0.94999999999999996 113.797 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.05 -37.22 19.12 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.954 0.902 . . . . 2.04 112.712 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.0 8.78 42.77 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.171 1.175 . . . . 1.6200000000000001 114.171 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -72.75 -26.21 61.47 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 123.751 0.82 . . . . 1.77 110.606 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.1 t -68.86 -50.55 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 C-N-CA 126.458 1.903 . . . . 0.81000000000000005 108.226 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' A' ' 15' ' ' ASN . 7.9 tp -74.39 -9.67 58.82 Favored 'General case' 0 C--N 1.383 2.047 0 N-CA-C 114.013 1.116 . . . . 1.1499999999999999 114.013 176.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -108.08 1.08 22.1 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.336 0.655 . . . . 0.92000000000000004 110.854 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -128.26 -115.0 0.26 Allowed 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.395 1.078 . . . . 1.3300000000000001 110.849 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.2 p 35.32 134.16 0.0 OUTLIER 'General case' 1 N--CA 1.56 5.06 0 C-N-CA 128.342 2.657 . . . . 1.28 117.928 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.5 ' HB3' HG12 ' A' ' 167' ' ' VAL . 5.8 pt-20 . . . . . 0 N--CA 1.516 2.873 0 N-CA-C 116.974 2.213 . . . . 1.53 116.974 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 111.839 0.311 . . . . 2.1499999999999999 111.839 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 t 66.67 83.7 0.16 Allowed 'General case' 0 N--CA 1.506 2.331 0 C-N-CA 124.907 1.283 . . . . 0.77000000000000002 113.006 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -141.92 138.5 32.07 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 121.605 0.717 . . . . 0.81000000000000005 111.929 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.69 -167.63 15.7 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.603 1.401 . . . . 0.46999999999999997 116.603 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.1 172.27 8.68 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 113.499 -1.351 . . . . 0.89000000000000001 113.986 -177.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -128.22 134.14 48.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.399 -1.273 . . . . 0.51000000000000001 112.219 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.32 103.54 22.7 Favored Pre-proline 0 CA--C 1.567 1.607 0 C-N-CA 123.326 0.65 . . . . 0.14999999999999999 109.499 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -84.57 120.1 2.38 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.233 1.955 . . . . 0.14999999999999999 114.783 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.84 160.16 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 CA-C-O 121.977 0.894 . . . . 0.19 111.232 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -149.3 24.05 0.91 Allowed 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 114.748 -1.115 . . . . 2.5299999999999998 111.867 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -130.09 161.66 30.54 Favored 'General case' 0 C--N 1.364 1.238 0 CA-C-O 121.296 0.57 . . . . 2.1200000000000001 111.5 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -120.34 144.33 47.91 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.799 1.037 . . . . 0.41999999999999998 113.799 -178.821 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.29 -139.53 6.08 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 114.117 -1.401 . . . . 0.23000000000000001 112.596 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 80.9 mm-40 -113.65 105.0 12.8 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-N 118.092 0.946 . . . . 1.75 110.963 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -99.52 128.27 45.62 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.124 0.488 . . . . 0.20999999999999999 110.895 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -112.34 123.66 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.346 0.593 . . . . 0.20000000000000001 110.755 -176.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.417 HD12 HD12 ' A' ' 172' ' ' ILE . 2.5 tt -110.27 108.38 18.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.923 -1.035 . . . . 0.78000000000000003 110.069 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.25 132.26 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 114.199 -1.364 . . . . 0.44 108.557 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.21 140.79 47.73 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 115.514 -0.766 . . . . 1.25 112.394 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 15.4 tptt -104.01 113.33 26.8 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.043 -0.98 . . . . 2.52 109.657 177.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 11.4 m-85 -106.84 134.68 49.61 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.685 -0.689 . . . . 0.40000000000000002 111.146 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.76 148.05 38.34 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.4 0.619 . . . . 0.40999999999999998 111.24 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -132.36 117.9 18.71 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 116.171 -0.468 . . . . 2.6099999999999999 111.228 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.08 69.02 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 116.179 -0.464 . . . . 2.1299999999999999 112.048 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.39 -49.11 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.899 0.479 . . . . 2.27 111.995 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -123.14 129.64 51.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.711 0.404 . . . . 1.46 111.143 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.83 105.46 15.5 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 122.194 0.997 . . . . 0.83999999999999997 112.421 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -162.69 144.82 10.58 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.009 -0.996 . . . . 2.4500000000000002 112.179 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.9 m -122.8 125.68 45.94 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.495 -0.775 . . . . 1.6599999999999999 112.595 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 70.48 49.75 0.41 Allowed 'General case' 0 N--CA 1.515 2.777 0 C-N-CA 125.553 1.541 . . . . 1.8899999999999999 112.473 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -148.66 -45.72 0.15 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.679 1.192 . . . . 2.5600000000000001 109.565 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.98 87.54 2.53 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.679 -0.86 . . . . 2.7599999999999998 108.679 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.93 120.81 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 114.048 -1.433 . . . . 0.68999999999999995 110.743 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.52 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 45.5 m-85 -101.02 177.37 4.97 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.417 1.636 . . . . 0.69999999999999996 115.417 -175.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -128.21 136.9 51.71 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.214 0.531 . . . . 1.3300000000000001 111.483 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.95 126.09 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.448 0 CA-C-N 115.689 -0.687 . . . . 0.47999999999999998 109.994 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -132.43 151.34 51.92 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.083 1.512 . . . . 1.6899999999999999 115.083 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 154' ' ' SER . 1.2 m -125.08 113.32 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 C-N-CA 124.357 1.063 . . . . 0.59999999999999998 112.754 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.539 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 64.69 25.85 13.08 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 126.69 1.996 . . . . 1.1200000000000001 113.614 -178.326 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.99 -3.63 60.52 Favored Glycine 0 CA--C 1.555 2.577 0 CA-C-N 116.168 -0.469 . . . . 0.32000000000000001 114.099 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 86.0 m-70 -99.56 139.61 34.96 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 125.65 1.58 . . . . 0.56999999999999995 112.951 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.33 130.51 40.61 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.879 0.847 . . . . 0.55000000000000004 113.075 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.09 -56.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 114.0 -1.454 . . . . 1.0600000000000001 112.606 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.43 88.6 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.242 -1.022 . . . . 0.44 108.242 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -109.17 95.1 5.41 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 123.094 1.426 . . . . 2.2999999999999998 111.964 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 127.96 71.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 129.619 3.168 . . . . 2.48 107.865 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.26 103.41 15.26 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-O 121.863 0.839 . . . . 1.1299999999999999 112.481 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -111.59 94.71 5.1 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 113.538 -1.664 . . . . 2.3500000000000001 107.647 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -63.52 -28.73 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.496 0 C-N-CA 125.046 1.339 . . . . 0.68000000000000005 114.465 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -77.69 -37.08 50.42 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.31 0.644 . . . . 0.77000000000000002 112.469 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -74.45 -27.13 60.46 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 124.594 1.158 . . . . 0.91000000000000003 113.836 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -86.65 -50.57 6.7 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.455 0.909 . . . . 2.4300000000000002 113.455 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.282 1.4 p -91.53 -38.76 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.966 0 N-CA-C 113.383 0.883 . . . . 0.93000000000000005 113.383 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.37 -78.81 0.25 Allowed Glycine 0 C--N 1.36 1.883 0 CA-C-N 118.444 0.566 . . . . 0.84999999999999998 114.497 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -102.92 174.75 5.73 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.1 0.96 . . . . 3.1800000000000002 112.507 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.7 m -74.18 81.14 1.79 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.723 1.009 . . . . 2.0800000000000001 113.723 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.56 HG22 ' HB2' ' A' ' 51' ' ' LEU . 34.9 p -133.01 -137.49 0.18 Allowed 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 114.441 -1.254 . . . . 0.62 109.032 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -115.01 131.55 56.89 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.046 0.758 . . . . 0.46000000000000002 113.046 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 18.8 t60 -105.48 147.93 27.77 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.446 -0.576 . . . . 0.38 109.446 176.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -142.49 129.86 21.14 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.663 1.357 . . . . 2.5 114.663 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -123.77 123.92 41.55 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.737 -1.12 . . . . 1.5600000000000001 110.661 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.49 120.88 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-N 114.488 -1.233 . . . . 0.45000000000000001 110.899 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.62 99.99 15.22 Favored Pre-proline 0 CA--C 1.569 1.702 0 CA-C-O 119.024 -0.512 . . . . 0.83999999999999997 111.976 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -75.05 142.6 27.89 Favored 'Trans proline' 0 C--N 1.398 3.177 0 C-N-CA 123.082 2.521 . . . . 0.16 114.2 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.17 149.48 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 CA-C-N 115.125 -0.943 . . . . 0.38 109.971 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.9 t -136.0 117.16 14.44 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.502 0.668 . . . . 1.3100000000000001 111.365 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.4 mt -113.93 125.5 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 CA-C-N 114.713 -1.131 . . . . 0.25 108.286 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -138.97 124.33 19.25 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.599 -0.728 . . . . 2.0499999999999998 110.567 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 67.61 17.1 9.93 Favored 'General case' 0 N--CA 1.517 2.902 0 C-N-CA 125.341 1.456 . . . . 3.5499999999999998 114.121 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.51 13.18 45.48 Favored Glycine 0 CA--C 1.547 2.038 0 CA-C-O 119.203 -0.776 . . . . 0.37 114.936 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 52.8 mtpt -122.03 147.44 46.08 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-N 118.378 1.089 . . . . 1.5600000000000001 112.656 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.99 145.31 29.45 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.46 1.281 . . . . 0.34000000000000002 114.46 -175.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.83 114.32 10.34 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.689 -1.142 . . . . 0.64000000000000001 109.987 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.262 9.9 p -119.36 95.82 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.446 0 CA-C-O 121.287 0.565 . . . . 0.46000000000000002 111.357 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 67.88 -85.47 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 125.646 1.578 . . . . 1.5600000000000001 113.757 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.25 25.32 5.75 Favored Glycine 0 CA--C 1.543 1.813 0 CA-C-N 116.005 -0.543 . . . . 0.48999999999999999 112.999 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -125.27 141.18 52.24 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.856 0.862 . . . . 1.8200000000000001 111.376 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.6 p -130.7 124.85 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.132 0 CA-C-N 115.669 -0.696 . . . . 1.02 110.896 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -150.69 179.86 7.84 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.247 -0.888 . . . . 0.56000000000000005 109.848 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.269 15.2 t -103.93 137.65 41.62 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 113.203 0.816 . . . . 1.25 113.203 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -81.82 122.9 28.29 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.112 0.965 . . . . 0.28999999999999998 111.66 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.95 91.4 3.2 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.707 0.632 . . . . 1.4199999999999999 112.707 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.58 -65.33 3.45 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 118.79 2.276 . . . . 0.41999999999999998 118.79 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.53 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -132.44 158.45 42.0 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.143 1.164 . . . . 1.1000000000000001 114.143 -176.343 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.539 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -108.26 138.83 43.88 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.242 -1.799 . . . . 0.67000000000000004 109.097 176.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.6 t -120.5 143.11 48.72 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.301 1.593 . . . . 0.35999999999999999 115.301 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.62 99.42 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.348 -0.982 . . . . 0.73999999999999999 108.348 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.79 128.37 56.38 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.631 -0.713 . . . . 1.6699999999999999 112.847 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -118.79 125.81 50.43 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-O 122.198 0.999 . . . . 1.8 111.103 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.32 144.08 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 113.323 -1.762 . . . . 0.57999999999999996 110.699 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.29 150.28 21.13 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 113.102 0.778 . . . . 2.1800000000000002 113.102 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.69 -32.97 6.31 Favored Glycine 0 CA--C 1.547 2.053 0 N-CA-C 115.937 1.135 . . . . 1.02 115.937 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -123.5 -78.63 0.6 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.977 0.889 . . . . 2.8599999999999999 112.412 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -133.16 -44.35 0.85 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.113 0.565 . . . . 3.9100000000000001 112.132 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.52 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -94.88 158.08 15.64 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.462 1.105 . . . . 1.74 112.447 179.383 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.74 -166.58 0.1 OUTLIER Pre-proline 0 CA--C 1.576 1.97 0 CA-C-N 113.679 -1.601 . . . . 1.6799999999999999 108.334 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -62.51 -9.78 16.88 Favored 'Trans proline' 0 N--CA 1.523 3.217 0 CA-C-N 123.277 2.206 . . . . 2.0600000000000001 115.85 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.6 tttp 79.65 -76.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.639 1.976 . . . . 3.0 114.013 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' A' ' 64' ' ' GLU 0.259 3.8 m -108.4 135.24 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-N 119.678 1.126 . . . . 0.80000000000000004 111.278 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.437 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.5 t -127.8 132.06 49.52 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 113.105 0.78 . . . . 0.87 113.105 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -119.45 49.83 1.31 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.212 2.301 . . . . 0.34000000000000002 117.212 -175.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.27 138.81 2.9 Favored 'General case' 0 N--CA 1.518 2.965 0 N-CA-C 117.039 2.237 . . . . 0.69999999999999996 117.039 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -154.69 101.99 2.35 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.476 -0.784 . . . . 0.20999999999999999 111.038 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.417 HD12 HD12 ' A' ' 85' ' ' LEU 0.32 9.0 tt -111.97 121.7 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 CA-C-O 122.456 1.122 . . . . 0.31 111.369 175.554 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -124.12 164.27 19.79 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.017 -1.447 . . . . 0.44 110.74 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -121.73 159.21 27.09 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 118.225 2.676 . . . . 1.26 118.225 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.85 -41.48 2.14 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-N 110.043 -3.253 . . . . 0.17000000000000001 118.998 174.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -177.44 154.73 1.03 Allowed 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 120.673 2.236 . . . . 0.14999999999999999 113.425 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.14 -12.48 59.22 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 125.053 1.341 . . . . 0.17000000000000001 113.896 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.22 4.9 44.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.959 1.096 . . . . 0.55000000000000004 113.959 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.82 -16.22 14.37 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 114.065 1.135 . . . . 0.59999999999999998 114.065 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.581 2.146 0 C-N-CA 124.108 0.963 . . . . 0.94999999999999996 112.851 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.447 ' HG ' HD11 ' A' ' 27' ' ' ILE . 19.3 tp . . . . . 0 CA--C 1.566 1.577 0 N-CA-C 113.356 0.872 . . . . 0.34999999999999998 113.356 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.17 -23.38 62.16 Favored 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 125.863 1.665 . . . . 0.20000000000000001 115.087 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.72 -10.35 53.87 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 113.668 0.988 . . . . 0.32000000000000001 113.668 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -106.07 -22.02 12.98 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.315 0.858 . . . . 1.73 113.315 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -53.21 135.65 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 N-CA-C 115.288 1.588 . . . . 0.11 115.288 177.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.6 -31.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-N 115.335 -0.848 . . . . 0.16 112.161 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -159.33 117.46 2.81 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.888 0.475 . . . . 0.54000000000000004 110.751 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.86 128.96 20.87 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.482 -0.761 . . . . 0.19 112.15 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.76 138.68 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 CA-C-O 122.331 1.062 . . . . 1.05 113.183 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -116.17 102.56 9.7 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 113.373 -1.74 . . . . 2.1099999999999999 106.725 171.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.87 103.87 5.26 Favored 'General case' 0 C--O 1.254 1.34 0 CA-C-O 122.21 1.005 . . . . 0.63 111.363 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 172.54 -57.22 0.16 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 113.153 -1.84 . . . . 0.70999999999999996 114.937 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.95 -121.96 5.0 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 119.773 -0.459 . . . . 0.80000000000000004 113.506 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -165.05 117.81 1.21 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.598 0.759 . . . . 1.6299999999999999 110.809 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 49.35 110.14 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.959 0 N-CA-C 118.406 2.743 . . . . 1.0 118.406 178.045 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.494 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 70.3 t60 -140.95 132.46 26.96 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.026 0.751 . . . . 0.45000000000000001 113.026 177.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.272 9.8 p -105.95 116.04 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.881 0 CA-C-N 115.178 -0.919 . . . . 1.3899999999999999 109.531 176.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -87.62 160.94 17.97 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 114.684 -1.143 . . . . 1.8500000000000001 112.577 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -43.17 -32.05 0.55 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 N-CA-C 119.163 3.023 . . . . 0.71999999999999997 119.163 -175.589 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -88.37 -19.66 26.33 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 121.227 0.537 . . . . 0.51000000000000001 111.474 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.61 40.13 1.25 Allowed Glycine 0 C--N 1.354 1.551 0 C-N-CA 124.722 1.153 . . . . 0.34000000000000002 114.009 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.447 HD11 ' HG ' ' A' ' 6' ' ' LEU . 14.7 mm -106.84 114.49 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-O 121.124 0.487 . . . . 0.55000000000000004 110.088 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.8 t-160 -104.45 132.63 50.49 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 115.587 1.699 . . . . 1.3400000000000001 115.587 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -92.84 143.83 25.88 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 114.733 -1.121 . . . . 2.79 108.135 174.259 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 78.7 mtp180 -62.42 -105.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 116.9 2.185 . . . . 3.0 116.9 -177.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 30' ' ' ARG . 7.0 ttmm 176.23 71.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.549 0.74 . . . . 2.2999999999999998 111.712 -177.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 56.98 61.68 6.47 Favored Pre-proline 0 N--CA 1.534 3.732 0 C-N-CA 124.196 0.998 . . . . 1.1699999999999999 113.677 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo . . . . . 0 CA--C 1.56 1.776 0 N-CA-C 120.154 3.098 . . . . 1.45 120.154 -174.509 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo . . . . . 0 N--CA 1.504 2.134 0 N-CA-C 117.048 1.903 . . . . 1.3700000000000001 117.048 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.65 143.12 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.201 0 CA-C-N 115.041 -0.981 . . . . 0.68999999999999995 109.444 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.53 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.9 mm? -78.51 -23.52 46.26 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.463 1.653 . . . . 1.28 115.463 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -106.27 20.81 18.4 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.917 1.08 . . . . 1.51 113.917 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.5 p -124.57 175.97 6.83 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.057 0.932 . . . . 1.0900000000000001 112.913 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.624 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.2 m-20 -97.46 -174.8 0.4 Allowed Pre-proline 0 N--CA 1.507 2.377 0 N-CA-C 107.74 -1.208 . . . . 1.27 107.74 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -70.16 -40.25 4.89 Favored 'Trans proline' 0 N--CA 1.518 2.946 0 CA-C-N 123.165 2.166 . . . . 0.94999999999999996 111.871 174.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -69.94 -50.98 36.6 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.266 -1.788 . . . . 2.04 111.982 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -75.93 -8.48 57.02 Favored 'General case' 0 CA--C 1.588 2.439 0 CA-C-N 114.789 -1.096 . . . . 1.6200000000000001 112.81 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.624 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 27.0 tt0 -72.42 -46.32 55.65 Favored 'General case' 0 C--N 1.378 1.835 0 C-N-CA 125.204 1.402 . . . . 1.77 107.962 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.12 -41.68 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 C-N-CA 124.44 1.096 . . . . 0.81000000000000005 110.417 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.93 -11.48 60.0 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.428 1.27 . . . . 1.1499999999999999 114.428 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -124.82 20.43 8.44 Favored 'General case' 0 CA--C 1.575 1.906 0 C-N-CA 123.332 0.653 . . . . 0.92000000000000004 112.494 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.42 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -137.95 -27.82 0.89 Allowed 'General case' 0 N--CA 1.51 2.56 0 N-CA-C 115.876 1.806 . . . . 1.3300000000000001 115.876 -177.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.2 p -77.94 131.17 37.32 Favored 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 113.66 0.985 . . . . 1.28 113.66 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.419 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.6 pt-20 . . . . . 0 N--CA 1.505 2.284 0 N-CA-C 115.5 1.667 . . . . 1.53 115.5 -176.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 110.407 -0.22 . . . . 2.1499999999999999 110.407 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.701 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.1 OUTLIER 74.8 80.86 0.11 Allowed 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 125.397 1.479 . . . . 0.77000000000000002 109.895 -177.611 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -142.84 156.51 44.95 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.284 0.846 . . . . 0.81000000000000005 113.284 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.73 -161.16 12.48 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.28 -0.873 . . . . 0.46999999999999997 115.056 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.32 163.66 28.84 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.782 0.801 . . . . 0.89000000000000001 112.796 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -117.87 131.36 56.55 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.603 -1.18 . . . . 0.51000000000000001 112.791 -178.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -124.5 99.9 35.72 Favored Pre-proline 0 CA--C 1.566 1.588 0 C-N-CA 123.19 0.596 . . . . 0.14999999999999999 109.742 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.26 118.1 2.57 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.14 1.894 . . . . 0.14999999999999999 114.501 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.89 157.35 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 CA-C-O 122.063 0.935 . . . . 0.19 111.369 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -144.97 16.15 1.56 Allowed 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.538 -1.21 . . . . 2.5299999999999998 111.954 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -128.29 162.47 26.96 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-O 121.334 0.588 . . . . 2.1200000000000001 111.754 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -120.95 148.8 43.59 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.665 0.987 . . . . 0.41999999999999998 113.665 -179.298 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.85 -134.16 3.9 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 113.981 -1.463 . . . . 0.23000000000000001 111.839 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -121.99 106.66 11.42 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 118.335 1.067 . . . . 1.75 111.231 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.682 ' O ' HG13 ' A' ' 133' ' ' ILE . 36.2 m-85 -99.4 127.8 45.46 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.623 0.725 . . . . 0.20999999999999999 110.687 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.67 130.13 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 115.31 -0.859 . . . . 0.20000000000000001 111.848 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.476 ' HG ' HD12 ' A' ' 172' ' ' ILE . 2.6 mp -107.62 110.26 22.1 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.376 -1.283 . . . . 0.78000000000000003 110.325 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.8 105.52 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.601 -1.259 . . . . 0.44 107.601 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.18 134.97 53.41 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.896 -0.593 . . . . 1.25 112.314 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -104.31 116.01 31.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.806 0.813 . . . . 2.52 111.343 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.67 134.04 48.5 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.067 -1.424 . . . . 0.40000000000000002 110.256 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.97 153.52 45.63 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.745 -0.661 . . . . 0.40999999999999998 111.627 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -139.54 131.58 27.92 Favored 'General case' 0 C--N 1.363 1.175 0 CA-C-N 116.031 -0.532 . . . . 2.6099999999999999 112.221 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.541 ' H ' ' NZ ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -140.96 63.2 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 115.962 -0.563 . . . . 2.1299999999999999 111.75 179.213 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -162.65 -49.5 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.562 0.579 . . . . 2.27 112.562 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.79 130.84 56.92 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.051 0.453 . . . . 1.46 112.212 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.29 96.11 5.93 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.339 1.066 . . . . 0.83999999999999997 111.016 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -162.31 146.65 12.18 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.148 -0.933 . . . . 2.4500000000000002 112.21 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.1 p -122.19 121.22 36.35 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.481 -0.782 . . . . 1.6599999999999999 111.903 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 75.12 57.26 0.07 Allowed 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 125.893 1.677 . . . . 1.8899999999999999 112.543 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -156.71 -43.62 0.07 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.284 -1.326 . . . . 2.5600000000000001 108.983 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -105.41 83.89 2.02 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-O 121.794 0.807 . . . . 2.7599999999999998 108.98 176.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.06 129.95 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 114.754 -1.112 . . . . 0.68999999999999995 111.63 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -114.37 170.99 7.89 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.065 1.505 . . . . 0.69999999999999996 115.065 -176.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.37 137.73 54.76 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.359 0.6 . . . . 1.3300000000000001 112.337 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -134.18 129.27 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.406 0 CA-C-N 115.34 -0.846 . . . . 0.47999999999999998 110.236 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.64 147.92 51.49 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 114.536 1.31 . . . . 1.6899999999999999 114.536 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.79 110.27 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 C-N-CA 123.73 0.812 . . . . 0.59999999999999998 112.93 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.83 26.64 14.39 Favored 'General case' 0 N--CA 1.523 3.181 0 C-N-CA 126.614 1.966 . . . . 1.1200000000000001 113.618 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.93 -20.06 39.51 Favored Glycine 0 CA--C 1.547 2.07 0 CA-C-N 116.344 -0.389 . . . . 0.32000000000000001 113.676 -176.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -83.24 139.04 33.34 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.417 1.487 . . . . 0.56999999999999995 113.673 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.57 129.73 44.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.603 0.715 . . . . 0.55000000000000004 112.43 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.19 -54.41 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 114.501 -1.227 . . . . 1.0600000000000001 113.355 -178.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.57 88.87 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.878 -0.786 . . . . 0.44 108.878 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -112.29 75.57 0.93 Allowed 'General case' 0 C--N 1.356 0.853 0 CA-C-O 123.709 1.718 . . . . 2.2999999999999998 112.147 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 157.26 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 110.238 -3.165 . . . . 2.48 108.216 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.72 97.88 11.06 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 113.702 1.001 . . . . 1.1299999999999999 113.702 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -113.52 96.54 5.93 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 113.073 -1.876 . . . . 2.3500000000000001 107.509 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.22 -26.06 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.56 0 N-CA-C 114.632 1.345 . . . . 0.68000000000000005 114.632 -176.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -75.71 -39.8 56.75 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.576 0.75 . . . . 0.77000000000000002 112.003 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -74.03 -26.35 60.37 Favored 'General case' 0 CA--C 1.577 1.989 0 C-N-CA 124.776 1.23 . . . . 0.91000000000000003 113.17 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -77.98 -56.37 4.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.651 0.982 . . . . 2.4300000000000002 113.651 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.76 -37.21 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 114.541 1.311 . . . . 0.93000000000000005 114.541 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.76 -107.62 0.92 Allowed Glycine 0 C--N 1.354 1.528 0 CA-C-N 118.465 0.575 . . . . 0.84999999999999998 113.426 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -114.95 107.07 14.9 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.588 0.355 . . . . 3.1800000000000002 110.919 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.1 m 66.69 -127.89 0.21 Allowed 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 125.392 1.477 . . . . 2.0800000000000001 112.92 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.53 HG22 ' HB2' ' A' ' 51' ' ' LEU . 43.5 p 58.6 -163.32 0.21 Allowed 'General case' 0 N--CA 1.526 3.363 0 C-N-CA 126.365 1.866 . . . . 0.62 115.375 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -109.75 130.19 55.54 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.293 0.637 . . . . 0.46000000000000002 112.69 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -104.44 135.57 45.62 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.436 -0.579 . . . . 0.38 109.436 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -129.95 128.42 42.08 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.494 1.294 . . . . 2.5 114.494 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -115.01 118.03 32.27 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 114.699 -1.137 . . . . 1.5600000000000001 110.279 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 114.84 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 114.798 -1.092 . . . . 0.45000000000000001 110.816 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.13 93.12 42.36 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-N 114.928 -1.033 . . . . 0.83999999999999997 109.994 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -82.82 136.18 8.12 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.577 2.185 . . . . 0.16 113.27 176.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.682 HG13 ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -120.95 149.93 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.626 0.727 . . . . 0.38 112.228 -179.52 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.1 t -126.1 113.35 16.95 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.079 -0.964 . . . . 1.3100000000000001 110.959 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.483 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.9 mt -110.94 122.99 66.42 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.605 0 CA-C-N 114.237 -1.347 . . . . 0.25 108.436 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -139.21 126.28 21.16 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.955 -0.566 . . . . 2.0499999999999998 111.068 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? 67.39 17.26 10.12 Favored 'General case' 0 N--CA 1.516 2.843 0 C-N-CA 125.312 1.445 . . . . 3.5499999999999998 114.324 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.64 12.68 46.73 Favored Glycine 0 CA--C 1.547 2.041 0 CA-C-O 119.147 -0.807 . . . . 0.37 114.893 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 27.2 mtmt -123.06 148.97 45.01 Favored 'General case' 0 C--N 1.365 1.268 0 CA-C-N 118.35 1.075 . . . . 1.5600000000000001 112.432 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.19 144.93 30.68 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.635 1.346 . . . . 0.34000000000000002 114.635 -175.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.51 109.09 8.48 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.903 -1.044 . . . . 0.64000000000000001 110.445 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.29 92.57 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.627 0 CA-C-N 115.808 -0.633 . . . . 0.46000000000000002 109.864 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 66.24 -82.1 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.784 0 C-N-CA 125.26 1.424 . . . . 1.5600000000000001 113.836 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.08 25.03 4.17 Favored Glycine 0 CA--C 1.545 1.969 0 CA-C-N 116.073 -0.512 . . . . 0.48999999999999999 113.869 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -130.48 118.42 21.1 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 117.339 0.569 . . . . 1.8200000000000001 110.053 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.1 p -105.91 131.45 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.32 0 CA-C-O 121.721 0.772 . . . . 1.02 112.479 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 m -151.9 -178.69 6.9 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.776 -1.102 . . . . 0.56000000000000005 109.624 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.261 12.8 t -103.04 139.11 39.01 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 113.57 0.952 . . . . 1.25 113.57 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -80.83 123.89 28.63 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 124.534 1.134 . . . . 0.28999999999999998 111.427 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.47 90.49 3.23 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.647 0.61 . . . . 1.4199999999999999 112.647 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.69 -61.75 2.43 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 119.412 2.525 . . . . 0.41999999999999998 119.412 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.494 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -135.92 157.26 47.28 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.254 1.205 . . . . 1.1000000000000001 114.254 -176.14 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.494 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 1.0 OUTLIER -103.61 140.05 38.08 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 113.527 -1.67 . . . . 0.67000000000000004 109.598 176.801 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.4 t -122.02 132.25 54.42 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.306 1.225 . . . . 0.35999999999999999 114.306 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.41 97.55 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.021 -1.844 . . . . 0.73999999999999999 106.021 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.0 132.43 56.71 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.311 -1.313 . . . . 1.6699999999999999 113.001 -176.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.83 135.93 54.92 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-O 122.448 1.118 . . . . 1.8 111.735 177.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.16 143.58 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-N 112.484 -2.144 . . . . 0.57999999999999996 110.325 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 150.11 26.13 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.509 1.3 . . . . 2.1800000000000002 114.509 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.32 -47.01 1.17 Allowed Glycine 0 CA--C 1.543 1.84 0 CA-C-N 115.196 -0.911 . . . . 1.02 114.035 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.3 -61.07 1.17 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.9 0.48 . . . . 2.8599999999999999 111.933 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -129.35 -43.57 1.28 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.757 0.651 . . . . 3.9100000000000001 112.757 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -107.92 173.81 6.16 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.509 0.724 . . . . 1.74 112.454 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.701 ' ND2' ' H ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -132.07 -58.27 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 CA-C-N 115.975 -0.557 . . . . 1.6799999999999999 109.994 178.638 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -101.56 -55.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.089 1.859 . . . . 2.0600000000000001 115.906 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.541 ' NZ ' ' H ' ' A' ' 92' ' ' VAL . 30.4 tttm 81.56 -90.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 127.076 2.15 . . . . 3.0 109.616 -176.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.89 129.11 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 106.976 -1.491 . . . . 0.80000000000000004 106.976 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.01 123.28 19.36 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 112.98 0.733 . . . . 0.87 112.98 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -116.76 49.67 1.14 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.637 1.575 . . . . 0.34000000000000002 113.922 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.9 tp -61.47 102.23 0.23 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 122.653 1.216 . . . . 0.69999999999999996 113.576 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -113.78 100.56 8.55 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 112.556 -2.111 . . . . 0.20999999999999999 110.008 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.476 HD12 ' HG ' ' A' ' 85' ' ' LEU 0.32 15.8 tt -108.34 121.78 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.155 0 CA-C-O 122.942 1.353 . . . . 0.31 111.945 177.408 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -121.09 170.47 9.51 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 113.291 -1.777 . . . . 0.44 111.284 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -123.23 158.5 30.73 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 118.45 2.759 . . . . 1.26 118.45 -176.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.72 -41.95 2.01 Favored Glycine 0 CA--C 1.541 1.688 0 CA-C-N 110.465 -3.061 . . . . 0.17000000000000001 119.208 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.21 157.02 1.31 Allowed 'General case' 0 N--CA 1.515 2.816 0 CA-C-N 120.449 2.125 . . . . 0.14999999999999999 112.942 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.03 -13.54 59.84 Favored 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 124.917 1.287 . . . . 0.17000000000000001 114.366 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.97 3.52 48.39 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 113.954 1.094 . . . . 0.55000000000000004 113.954 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.88 -7.6 17.02 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 113.815 1.043 . . . . 0.59999999999999998 113.815 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.544 0 C-N-CA 124.012 0.925 . . . . 0.94999999999999996 112.804 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.537 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.1 tp . . . . . 0 CA--C 1.565 1.546 0 N-CA-C 113.454 0.909 . . . . 0.34999999999999998 113.454 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.33 63.48 Favored 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 125.766 1.626 . . . . 0.20000000000000001 115.105 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.06 -11.63 49.71 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 113.577 0.954 . . . . 0.32000000000000001 113.577 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -104.15 -23.9 13.23 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 113.298 0.851 . . . . 1.73 113.298 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.62 134.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 115.166 1.543 . . . . 0.11 115.166 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -121.83 -29.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 115.354 -0.839 . . . . 0.16 112.345 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -161.43 116.9 2.09 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 117.698 0.226 . . . . 0.54000000000000004 111.502 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.42 135.08 31.68 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.258 -0.901 . . . . 0.19 112.503 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 170' ' ' LEU 0.25 11.3 p -149.35 142.91 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 N-CA-C 113.756 1.021 . . . . 1.05 113.756 178.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.602 ' HB2' HD12 ' A' ' 60' ' ' LEU . 65.8 t30 -116.02 117.96 31.56 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.198 -1.408 . . . . 2.1099999999999999 107.198 173.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -81.73 97.09 7.78 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-O 121.784 0.802 . . . . 0.63 111.251 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.572 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 173.4 -37.67 0.13 Allowed Glycine 0 C--N 1.353 1.486 0 CA-C-N 114.102 -1.408 . . . . 0.70999999999999996 116.541 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -135.65 -125.6 2.51 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 117.873 0.837 . . . . 0.80000000000000004 114.318 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.518 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 34.8 mt-10 -150.13 116.34 5.7 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.812 0.445 . . . . 1.6299999999999999 111.701 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.2 m 31.69 124.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.121 0 N-CA-C 121.036 3.717 . . . . 1.0 121.036 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.456 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 23.3 t60 -149.89 148.51 29.22 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.853 0.835 . . . . 0.45000000000000001 112.092 176.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.2 126.6 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 114.916 -1.038 . . . . 1.3899999999999999 111.615 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -85.27 155.73 21.25 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 114.024 -1.443 . . . . 1.8500000000000001 110.234 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.5 m -44.8 -23.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 N-CA-C 118.943 2.942 . . . . 0.71999999999999997 118.943 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -95.57 -18.43 20.6 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 122.874 0.47 . . . . 0.51000000000000001 111.051 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.85 41.06 1.23 Allowed Glycine 0 C--N 1.356 1.668 0 C-N-CA 124.643 1.116 . . . . 0.34000000000000002 114.462 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.537 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.2 mm -106.06 120.5 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 N-CA-C 109.516 -0.55 . . . . 0.55000000000000004 109.516 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -102.25 129.18 48.59 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.256 1.206 . . . . 1.3400000000000001 114.256 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.623 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.3 142.36 27.79 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.299 -0.864 . . . . 2.79 110.596 177.024 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -88.12 168.43 12.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 115.662 1.727 . . . . 3.0 115.662 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -98.91 100.25 11.41 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.19 1.552 . . . . 2.2999999999999998 115.19 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 36.73 62.46 3.11 Favored Pre-proline 1 N--CA 1.542 4.134 0 N-CA-C 115.85 1.796 . . . . 1.1699999999999999 115.85 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo . . . . . 0 CA--C 1.564 2.016 0 N-CA-C 119.591 2.881 . . . . 1.45 119.591 -175.537 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo . . . . . 0 N--CA 1.498 1.759 0 N-CA-C 116.335 1.629 . . . . 1.3700000000000001 116.335 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 61' ' ' TYR 0.251 1.2 mp -89.74 135.64 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.823 0 C-N-CA 124.037 0.935 . . . . 0.68999999999999995 111.711 -178.771 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 5.1 mt -104.84 101.93 11.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.901 -1.045 . . . . 1.28 111.305 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER 150.12 -22.1 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.205 1.802 . . . . 1.51 110.891 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.657 ' HG ' ' HD2' ' A' ' 61' ' ' TYR . 2.3 t -101.27 -160.85 0.82 Allowed 'General case' 0 CA--C 1.575 1.929 0 C-N-CA 123.555 0.742 . . . . 1.0900000000000001 113.0 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -95.51 170.32 7.95 Favored Pre-proline 0 CA--C 1.573 1.838 0 C-N-CA 124.736 1.214 . . . . 1.27 112.569 -179.306 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -71.98 -34.82 7.99 Favored 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 123.25 2.633 . . . . 0.94999999999999996 112.835 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -85.25 -36.36 20.97 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.517 -1.22 . . . . 2.04 112.703 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.22 1.59 56.31 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.737 1.384 . . . . 1.6200000000000001 114.737 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 3.5 pt20 -71.19 -24.4 62.22 Favored 'General case' 0 C--N 1.381 1.945 0 O-C-N 121.822 -0.549 . . . . 1.77 110.369 175.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.35 -47.29 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.872 0 C-N-CA 125.957 1.703 . . . . 0.81000000000000005 108.853 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' A' ' 15' ' ' ASN . 14.1 tp -73.99 -12.85 60.76 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 113.435 0.902 . . . . 1.1499999999999999 113.435 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.657 ' HD2' ' HG ' ' A' ' 53' ' ' SER . 26.4 m-85 -122.47 20.53 10.37 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 113.557 0.947 . . . . 0.92000000000000004 113.557 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.581 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 12.1 tt0 -141.35 -36.48 0.44 Allowed 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 115.474 1.657 . . . . 1.3300000000000001 115.474 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.2 p -67.81 134.69 51.38 Favored 'General case' 0 N--CA 1.528 3.449 0 N-CA-C 115.272 1.582 . . . . 1.28 115.272 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.572 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 5.8 pt-20 . . . . . 0 N--CA 1.505 2.285 0 C-N-CA 124.195 0.998 . . . . 1.53 112.479 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.427 0.156 . . . . 2.1499999999999999 111.334 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.24 85.01 0.09 Allowed 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 125.555 1.542 . . . . 0.77000000000000002 114.397 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -143.52 152.94 42.08 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.531 0.682 . . . . 0.81000000000000005 112.242 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.24 -153.21 7.44 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 115.653 1.021 . . . . 0.46999999999999997 115.653 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.79 166.62 22.22 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 115.037 1.495 . . . . 0.89000000000000001 115.037 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.93 119.32 27.43 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.585 -1.643 . . . . 0.51000000000000001 111.144 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.48 100.36 53.49 Favored Pre-proline 0 CA--C 1.568 1.645 0 N-CA-C 109.581 -0.526 . . . . 0.14999999999999999 109.581 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -82.93 116.66 2.5 Favored 'Trans proline' 0 CA--C 1.563 1.926 0 C-N-CA 122.25 1.967 . . . . 0.14999999999999999 115.103 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.6 157.46 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.926 0.869 . . . . 0.19 111.038 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -143.27 24.01 1.8 Allowed 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 114.648 -1.16 . . . . 2.5299999999999998 112.084 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -127.84 157.36 40.67 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 121.347 0.594 . . . . 2.1200000000000001 111.134 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.73 136.65 53.22 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.713 1.005 . . . . 0.41999999999999998 113.713 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 166.55 -140.17 6.18 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 113.962 -1.472 . . . . 0.23000000000000001 112.569 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 23.8 mt-10 -112.36 109.02 18.4 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-N 118.473 1.136 . . . . 1.75 111.627 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -103.52 129.77 50.77 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.048 0.451 . . . . 0.20999999999999999 110.521 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.69 121.72 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.864 0.84 . . . . 0.20000000000000001 110.795 -176.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.402 ' HG ' HD12 ' A' ' 172' ' ' ILE . 0.3 OUTLIER -100.0 105.59 17.28 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 113.931 -1.486 . . . . 0.78000000000000003 109.572 177.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -111.9 124.96 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.8 -0.815 . . . . 0.44 108.8 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.94 140.2 43.82 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 112.735 0.643 . . . . 1.25 112.735 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -102.87 120.39 40.52 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.039 -0.982 . . . . 2.52 110.133 177.163 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -105.82 133.27 50.83 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.106 -0.497 . . . . 0.40000000000000002 110.392 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.37 152.32 50.51 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 112.549 0.574 . . . . 0.40999999999999998 112.549 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -138.71 119.64 14.35 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 123.662 0.785 . . . . 2.6099999999999999 111.102 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.18 65.33 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 112.597 0.592 . . . . 2.1299999999999999 112.597 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -171.3 -37.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 112.982 0.734 . . . . 2.27 112.982 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -115.94 130.81 56.98 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.226 0.454 . . . . 1.46 112.226 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.27 96.93 6.42 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.43 1.11 . . . . 0.83999999999999997 111.474 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -165.37 141.43 5.38 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 114.968 -1.014 . . . . 2.4500000000000002 112.323 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.5 m -122.41 124.93 44.79 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.382 -0.826 . . . . 1.6599999999999999 112.436 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 72.59 54.95 0.15 Allowed 'General case' 0 N--CA 1.514 2.725 0 C-N-CA 125.713 1.605 . . . . 1.8899999999999999 112.523 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -157.31 -38.43 0.07 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.803 -1.089 . . . . 2.5600000000000001 109.974 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -106.9 81.79 1.61 Allowed 'General case' 0 C--N 1.362 1.152 0 N-CA-C 108.384 -0.969 . . . . 2.7599999999999998 108.384 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.88 122.76 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 114.331 -1.304 . . . . 0.68999999999999995 111.306 -177.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -106.57 175.73 5.4 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 115.572 1.693 . . . . 0.69999999999999996 115.572 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -126.03 137.27 53.64 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.343 0.592 . . . . 1.3300000000000001 110.941 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.21 123.76 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.511 0 CA-C-N 115.237 -0.892 . . . . 0.47999999999999998 109.366 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.644 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 26.3 mtt180 -123.26 148.64 45.68 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.981 1.475 . . . . 1.6899999999999999 114.981 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 6.4 m -123.81 107.8 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 N-CA-C 113.437 0.903 . . . . 0.59999999999999998 113.437 177.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.587 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.9 t30 63.81 27.32 14.56 Favored 'General case' 0 N--CA 1.519 2.988 0 C-N-CA 126.845 2.058 . . . . 1.1200000000000001 114.456 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.87 -14.86 45.06 Favored Glycine 0 CA--C 1.55 2.264 0 CA-C-N 115.574 -0.739 . . . . 0.32000000000000001 113.612 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.644 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 94.6 m-70 -87.49 171.15 10.74 Favored 'General case' 0 C--N 1.361 1.088 0 C-N-CA 125.953 1.701 . . . . 0.56999999999999995 113.166 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.01 132.72 54.67 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.546 0.689 . . . . 0.55000000000000004 112.015 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.61 -58.96 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.82 -1.082 . . . . 1.0600000000000001 113.324 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.22 89.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.627 -0.879 . . . . 0.44 108.627 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -106.97 101.51 10.93 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 122.881 1.324 . . . . 2.2999999999999998 110.283 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 114.25 74.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 110.542 -3.026 . . . . 2.48 108.898 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.2 105.8 18.01 Favored 'General case' 0 C--N 1.361 1.084 0 CA-C-O 121.612 0.72 . . . . 1.1299999999999999 112.593 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -115.07 97.4 6.19 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 106.678 -1.601 . . . . 2.3500000000000001 106.678 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.06 -26.77 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.479 0 N-CA-C 114.028 1.122 . . . . 0.68000000000000005 114.028 -176.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -76.22 -38.83 55.93 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.629 0.771 . . . . 0.77000000000000002 112.095 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -72.95 -26.74 61.48 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.847 1.259 . . . . 0.91000000000000003 113.296 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -80.5 -56.25 4.3 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.767 1.025 . . . . 2.4300000000000002 113.767 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.73 -36.04 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 N-CA-C 114.592 1.33 . . . . 0.93000000000000005 114.592 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.2 -110.04 1.37 Allowed Glycine 0 C--N 1.354 1.581 0 CA-C-N 118.35 0.523 . . . . 0.84999999999999998 113.417 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -114.84 107.46 15.45 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.841 0.353 . . . . 3.1800000000000002 110.243 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 69.42 -133.69 0.07 Allowed 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 125.345 1.458 . . . . 2.0800000000000001 112.614 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.3 p 62.15 -163.38 0.26 Allowed 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 126.222 1.809 . . . . 0.62 114.578 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.8 130.94 56.4 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 112.899 0.703 . . . . 0.46000000000000002 112.899 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -101.66 147.21 26.71 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.262 -0.644 . . . . 0.38 109.262 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.6 124.68 25.79 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.994 1.479 . . . . 2.5 114.994 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -124.18 121.91 36.38 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 115.247 -0.888 . . . . 1.5600000000000001 110.305 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.83 128.48 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 114.27 -1.332 . . . . 0.45000000000000001 111.545 -178.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.21 93.77 19.03 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-N 115.637 -0.711 . . . . 0.83999999999999997 111.187 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -76.55 133.3 14.19 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 122.672 2.248 . . . . 0.16 113.103 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.62 148.81 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.592 0 CA-C-N 115.553 -0.749 . . . . 0.38 111.474 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.8 p -130.52 107.16 9.01 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.392 -0.822 . . . . 1.3100000000000001 111.82 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 mt -109.65 121.71 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 N-CA-C 108.518 -0.919 . . . . 0.25 108.518 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -143.1 130.72 21.29 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.681 -0.69 . . . . 2.0499999999999998 110.964 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp 69.8 7.87 6.44 Favored 'General case' 0 N--CA 1.519 3.016 0 N-CA-C 114.684 1.364 . . . . 3.5499999999999998 114.684 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.14 22.22 13.63 Favored Glycine 0 CA--C 1.548 2.128 0 C-N-CA 123.633 0.635 . . . . 0.37 113.802 -177.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -130.52 144.83 51.66 Favored 'General case' 0 C--N 1.366 1.299 0 CA-C-N 117.548 0.674 . . . . 1.5600000000000001 112.128 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.75 141.11 32.99 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.912 1.078 . . . . 0.34000000000000002 113.912 -177.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.0 m -130.97 115.36 16.4 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.664 -1.153 . . . . 0.64000000000000001 110.656 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.45 95.14 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.372 0 CA-C-O 121.101 0.477 . . . . 0.46000000000000002 110.728 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 67.26 -85.24 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 125.546 1.538 . . . . 1.5600000000000001 113.558 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.36 27.74 4.41 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.011 -0.541 . . . . 0.48999999999999999 113.404 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -131.38 128.4 39.52 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.444 0.698 . . . . 1.8200000000000001 110.77 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.8 p -118.29 130.01 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.343 0 CA-C-O 121.333 0.587 . . . . 1.02 111.185 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.8 m -149.85 -170.63 3.69 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.487 -0.778 . . . . 0.56000000000000005 110.446 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 11.4 t -101.76 141.42 34.65 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 112.792 0.664 . . . . 1.25 112.792 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -87.91 132.63 34.14 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.985 0.898 . . . . 0.28999999999999998 111.815 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.9 p -97.34 -164.3 1.13 Allowed 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 114.046 -1.433 . . . . 1.4199999999999999 109.395 177.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.59 7.52 68.79 Favored Glycine 0 CA--C 1.56 2.876 0 N-CA-C 116.937 1.535 . . . . 0.41999999999999998 116.937 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -160.11 152.53 20.86 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-O 121.7 0.762 . . . . 1.1000000000000001 111.421 178.517 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.587 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -109.3 136.09 49.32 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.307 -1.315 . . . . 0.67000000000000004 109.236 177.405 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.5 t -117.82 144.11 45.67 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.671 1.73 . . . . 0.35999999999999999 115.671 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.1 t -118.44 97.58 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.087 -1.82 . . . . 0.73999999999999999 106.087 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -114.12 121.48 43.93 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 115.905 -0.589 . . . . 1.6699999999999999 112.46 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.73 132.1 56.55 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-O 122.062 0.934 . . . . 1.8 111.238 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 14.0 t -107.25 143.74 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.991 0 CA-C-N 113.341 -1.754 . . . . 0.57999999999999996 110.01 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 163' ' ' ASP . 34.4 ttpt -71.49 149.98 45.3 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.939 1.696 . . . . 2.1800000000000002 114.665 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.1 -55.26 0.73 Allowed Glycine 0 CA--C 1.542 1.778 0 CA-C-N 115.26 -0.882 . . . . 1.02 114.378 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -130.18 -71.34 0.6 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.301 0.551 . . . . 2.8599999999999999 112.306 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.36 -44.7 2.66 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.513 0.561 . . . . 3.9100000000000001 112.513 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.508 ' O ' ' HG3' ' A' ' 159' ' ' LYS . 0.8 OUTLIER -98.99 171.24 8.17 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.773 0.829 . . . . 1.74 111.46 178.811 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . 0.285 56.7 t-20 -125.75 -93.15 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.451 0 CA-C-O 116.715 -1.612 . . . . 1.6799999999999999 109.993 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -87.1 -36.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.389 2.686 0 CA-C-N 124.851 2.768 . . . . 2.0600000000000001 114.757 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.2 tptm 80.29 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 126.2 1.8 . . . . 3.0 110.543 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.534 HG22 ' HB3' ' A' ' 64' ' ' GLU . 36.2 t -115.2 131.5 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.358 -1.349 . . . . 0.80000000000000004 107.358 175.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.1 t -136.21 124.96 23.87 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.489 -0.778 . . . . 0.87 112.196 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -115.27 51.46 0.92 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 116.366 1.988 . . . . 0.34000000000000002 116.366 -176.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 2.8 mm? -43.65 131.54 5.19 Favored 'General case' 0 N--CA 1.519 2.999 0 N-CA-C 116.368 1.988 . . . . 0.69999999999999996 116.368 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -154.45 104.04 2.54 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.825 -0.625 . . . . 0.20999999999999999 110.283 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.402 HD12 ' HG ' ' A' ' 85' ' ' LEU 0.307 6.2 tt -114.47 123.11 69.83 Favored 'Isoleucine or valine' 0 C--O 1.268 2.064 0 CA-C-O 122.125 0.964 . . . . 0.31 111.825 176.076 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -119.53 168.19 11.24 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.191 -1.368 . . . . 0.44 112.17 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -118.48 146.42 44.52 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 118.06 2.615 . . . . 1.26 118.06 -173.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.69 -41.02 2.26 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-N 110.605 -2.998 . . . . 0.17000000000000001 120.264 172.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.45 159.5 1.95 Allowed 'General case' 0 N--CA 1.517 2.904 0 CA-C-N 120.951 2.375 . . . . 0.14999999999999999 113.239 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -77.73 -14.17 59.68 Favored 'General case' 0 CA--C 1.582 2.185 0 C-N-CA 124.784 1.234 . . . . 0.17000000000000001 114.227 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.02 2.6 51.43 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 113.957 1.095 . . . . 0.55000000000000004 113.957 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.8 -8.73 21.42 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.761 1.023 . . . . 0.59999999999999998 113.761 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.386 0 C-N-CA 124.035 0.934 . . . . 0.94999999999999996 112.576 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.649 ' HG ' HD11 ' A' ' 27' ' ' ILE . 29.2 tp . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 112.116 0.413 . . . . 0.34999999999999998 112.116 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.05 -22.91 67.18 Favored 'General case' 0 CA--C 1.583 2.248 0 C-N-CA 125.663 1.585 . . . . 0.20000000000000001 114.029 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.9 -11.9 49.32 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 113.606 0.965 . . . . 0.32000000000000001 113.606 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 31.2 mttm -108.16 -19.33 13.52 Favored 'General case' 0 C--N 1.364 1.233 0 N-CA-C 113.716 1.006 . . . . 1.73 113.716 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.32 136.65 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.866 0 N-CA-C 114.967 1.469 . . . . 0.11 114.967 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.76 -31.33 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 115.295 -0.866 . . . . 0.16 111.998 178.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -161.05 119.53 2.47 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 111.954 0.353 . . . . 0.54000000000000004 111.954 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -139.81 129.66 24.72 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.673 -0.642 . . . . 0.19 111.366 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.61 140.75 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.764 0.793 . . . . 1.05 112.524 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.591 ' HB2' HD12 ' A' ' 60' ' ' LEU . 3.0 t-20 -114.43 110.24 19.55 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 106.599 -1.63 . . . . 2.1099999999999999 106.599 172.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.53 94.63 3.18 Favored 'General case' 0 C--O 1.274 2.386 0 CA-C-O 122.217 1.008 . . . . 0.63 110.859 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 159.27 -0.08 0.08 OUTLIER Glycine 0 C--N 1.362 2.008 0 CA-C-N 110.943 -2.844 . . . . 0.70999999999999996 117.983 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.52 -136.22 1.97 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-N 120.635 2.218 . . . . 0.80000000000000004 117.273 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -129.09 134.75 48.21 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 113.861 -1.17 . . . . 1.6299999999999999 111.218 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 26.2 m -14.14 122.28 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.958 0 N-CA-C 119.556 3.169 . . . . 1.0 119.556 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -140.83 141.91 34.65 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.132 0.968 . . . . 0.45000000000000001 112.446 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.259 10.0 p -106.01 119.4 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 CA-C-N 114.063 -1.426 . . . . 1.3899999999999999 110.36 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -86.72 169.04 13.0 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 114.77 -1.105 . . . . 1.8500000000000001 113.451 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -39.61 -52.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 C-N-CA 129.222 3.009 . . . . 0.71999999999999997 117.458 -174.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.432 ' HB2' HD23 ' A' ' 6' ' ' LEU . 63.1 m-70 -75.82 -20.59 58.05 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 112.888 0.699 . . . . 0.51000000000000001 112.888 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.8 44.36 0.76 Allowed Glycine 0 C--N 1.355 1.625 0 N-CA-C 115.194 0.838 . . . . 0.34000000000000002 115.194 176.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.649 HD11 ' HG ' ' A' ' 6' ' ' LEU . 33.5 mm -108.51 125.12 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 N-CA-C 110.088 -0.338 . . . . 0.55000000000000004 110.088 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -108.35 128.09 54.46 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 114.461 1.282 . . . . 1.3400000000000001 114.461 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -94.24 150.1 20.62 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 124.419 1.088 . . . . 2.79 110.604 177.366 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -105.88 147.3 28.88 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.574 1.324 . . . . 3.0 114.574 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -68.76 108.44 3.42 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 117.535 2.42 . . . . 2.2999999999999998 117.535 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.405 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 0.6 OUTLIER 39.85 54.42 5.9 Favored Pre-proline 0 N--CA 1.525 3.316 0 N-CA-C 118.767 2.877 . . . . 1.1699999999999999 118.767 175.077 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 0.5 OUTLIER . . . . . 0 CA--C 1.566 2.113 0 C-N-CA 123.014 2.476 . . . . 1.45 116.174 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 N--CA 1.509 2.409 0 N-CA-C 116.317 1.622 . . . . 1.3700000000000001 116.317 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.295 1.2 mp -86.84 121.05 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-O 121.818 0.818 . . . . 0.68999999999999995 109.866 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.534 ' HB2' HG22 ' A' ' 125' ' ' THR . 4.7 mt -76.67 -14.47 59.96 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.191 2.293 . . . . 1.28 117.191 -175.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -99.96 15.73 26.2 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.151 0.797 . . . . 1.51 113.151 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.501 ' HG ' ' HD2' ' A' ' 61' ' ' TYR . 1.9 t -132.31 -159.58 0.98 Allowed 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 121.659 0.742 . . . . 1.0900000000000001 111.773 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.11 168.75 9.72 Favored Pre-proline 0 CA--C 1.569 1.706 0 C-N-CA 125.11 1.364 . . . . 1.27 113.077 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -72.58 -30.29 12.25 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 123.266 2.644 . . . . 0.94999999999999996 113.34 176.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -85.32 -38.54 18.68 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.685 1.194 . . . . 2.04 112.272 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.39 1.83 56.84 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 114.574 1.324 . . . . 1.6200000000000001 114.574 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -68.36 -30.11 68.98 Favored 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 123.964 0.906 . . . . 1.77 110.999 176.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.37 -48.17 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.035 0 C-N-CA 126.03 1.732 . . . . 0.81000000000000005 109.054 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' ' 15' ' ' ASN . 17.6 tp -71.54 -13.34 61.77 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 113.952 1.093 . . . . 1.1499999999999999 113.952 177.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.501 ' HD2' ' HG ' ' A' ' 53' ' ' SER . 29.4 m-85 -123.23 21.69 9.56 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 113.233 0.827 . . . . 0.92000000000000004 113.233 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.5 -32.72 0.49 Allowed 'General case' 0 N--CA 1.513 2.679 0 N-CA-C 116.03 1.863 . . . . 1.3300000000000001 116.03 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.409 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 17.8 p -70.98 136.68 48.55 Favored 'General case' 0 N--CA 1.535 3.807 0 N-CA-C 115.008 1.485 . . . . 1.28 115.008 -177.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.455 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.3 pt-20 . . . . . 0 N--CA 1.508 2.438 0 N-CA-C 115.662 1.726 . . . . 1.53 115.662 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.435 0.636 . . . . 2.1499999999999999 111.527 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 1.6 t -88.51 97.83 11.3 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.18 0.992 . . . . 0.77000000000000002 108.477 175.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -136.75 146.11 45.4 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.181 1.178 . . . . 0.81000000000000005 114.181 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.04 -173.07 38.53 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 114.262 -1.335 . . . . 0.46999999999999997 115.325 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.55 162.63 12.88 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.599 1.333 . . . . 0.89000000000000001 114.599 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -120.98 124.74 45.62 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.181 -1.372 . . . . 0.51000000000000001 110.825 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.07 101.87 54.35 Favored Pre-proline 0 CA--C 1.564 1.514 0 CA-C-N 115.487 -0.779 . . . . 0.14999999999999999 110.305 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.41 122.67 3.68 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 121.831 1.687 . . . . 0.14999999999999999 114.862 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.42 163.45 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-N 114.986 -1.006 . . . . 0.19 110.899 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -151.82 24.51 0.67 Allowed 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 114.534 -1.212 . . . . 2.5299999999999998 111.666 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -133.24 156.85 46.79 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 123.09 0.556 . . . . 2.1200000000000001 111.111 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.5 OUTLIER -118.06 145.39 44.86 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.523 0.934 . . . . 0.41999999999999998 113.523 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.44 -136.48 4.43 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.189 -1.369 . . . . 0.23000000000000001 112.191 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 38.3 mm-40 -116.91 106.67 13.7 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 118.292 1.046 . . . . 1.75 110.927 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -100.99 132.19 46.52 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.295 0.569 . . . . 0.20999999999999999 110.994 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.7 122.98 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 121.709 0.766 . . . . 0.20000000000000001 110.947 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.66 106.11 16.52 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.063 -1.426 . . . . 0.78000000000000003 109.885 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.39 122.67 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.625 -0.509 . . . . 0.44 109.625 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.24 144.16 49.59 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.029 0.751 . . . . 1.25 113.029 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 4.5 tppt? -106.66 123.33 47.96 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.448 -0.796 . . . . 2.52 110.848 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 16.9 m-85 -106.15 135.48 47.54 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.733 -0.667 . . . . 0.40000000000000002 110.444 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.82 149.67 42.32 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 116.016 -0.538 . . . . 0.40999999999999998 111.944 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -148.13 121.52 9.05 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 123.167 0.587 . . . . 2.6099999999999999 110.724 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.26 72.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 112.24 0.459 . . . . 2.1299999999999999 112.24 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.14 -42.51 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.734 0.642 . . . . 2.27 112.734 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -117.54 131.85 56.63 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.61 0.596 . . . . 1.46 112.61 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -110.57 97.46 6.89 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 122.402 1.096 . . . . 0.83999999999999997 111.12 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -160.67 142.03 12.09 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.982 -1.008 . . . . 2.4500000000000002 112.054 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.8 m -122.16 124.06 42.98 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.596 -0.729 . . . . 1.6599999999999999 112.331 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 73.07 53.38 0.13 Allowed 'General case' 0 N--CA 1.512 2.629 0 C-N-CA 125.721 1.609 . . . . 1.8899999999999999 112.148 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -152.31 -41.85 0.11 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.541 1.136 . . . . 2.5600000000000001 110.025 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -106.9 82.26 1.67 Allowed 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.794 -0.817 . . . . 2.7599999999999998 108.794 177.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.34 126.01 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.605 -1.18 . . . . 0.68999999999999995 111.23 -177.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -113.86 176.99 4.79 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.404 1.631 . . . . 0.69999999999999996 115.404 -175.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -125.32 139.13 53.96 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 121.897 0.856 . . . . 1.3300000000000001 111.489 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.01 126.84 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.071 0 CA-C-N 114.181 -1.372 . . . . 0.47999999999999998 110.103 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -131.27 142.52 50.15 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.229 1.566 . . . . 1.6899999999999999 115.229 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.2 m -113.74 106.34 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 113.882 -1.508 . . . . 0.59999999999999998 112.199 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 65.21 25.87 12.32 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 126.479 1.912 . . . . 1.1200000000000001 113.367 -177.207 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.62 -10.82 56.29 Favored Glycine 0 CA--C 1.555 2.552 0 CA-C-N 116.055 -0.52 . . . . 0.32000000000000001 114.121 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -94.93 130.11 41.69 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 125.394 1.477 . . . . 0.56999999999999995 113.457 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -90.74 133.97 34.77 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 122.481 1.134 . . . . 0.55000000000000004 113.562 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.24 -47.42 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 112.818 -1.992 . . . . 1.0600000000000001 112.163 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.19 89.14 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.27 -1.011 . . . . 0.44 108.27 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -111.03 74.92 0.89 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-O 123.334 1.54 . . . . 2.2999999999999998 110.994 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 156.06 64.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 110.429 -3.078 . . . . 2.48 108.445 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.18 100.81 12.55 Favored 'General case' 0 C--N 1.36 1.056 0 N-CA-C 114.032 1.123 . . . . 1.1299999999999999 114.032 -178.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.56 101.49 8.65 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 112.815 -1.993 . . . . 2.3500000000000001 106.706 175.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.63 -29.4 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.48 0 C-N-CA 124.605 1.162 . . . . 0.68000000000000005 114.114 -176.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -76.94 -37.34 55.48 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.341 0.656 . . . . 0.77000000000000002 112.403 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -74.21 -26.44 60.26 Favored 'General case' 0 CA--C 1.576 1.946 0 C-N-CA 124.557 1.143 . . . . 0.91000000000000003 113.195 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -78.55 -56.26 4.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.327 0.862 . . . . 2.4300000000000002 113.327 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.79 -39.88 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 N-CA-C 113.998 1.11 . . . . 0.93000000000000005 113.998 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.85 -67.3 0.24 Allowed Glycine 0 C--N 1.358 1.777 0 CA-C-N 118.269 0.486 . . . . 0.84999999999999998 114.162 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -106.49 173.91 6.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.946 0.899 . . . . 3.1800000000000002 112.161 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 m -75.95 84.13 2.86 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.281 0.845 . . . . 2.0800000000000001 113.281 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 51' ' ' LEU . 23.4 p -135.7 -137.05 0.15 Allowed 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 114.414 -1.266 . . . . 0.62 109.127 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -115.96 132.69 56.57 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 113.315 0.857 . . . . 0.46000000000000002 113.315 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.452 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 7.4 t60 -108.37 138.2 45.06 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.109 -0.701 . . . . 0.38 109.109 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -141.49 130.95 23.78 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.696 0.998 . . . . 2.5 113.696 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -120.2 130.68 54.66 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-N 114.498 -1.228 . . . . 1.5600000000000001 110.87 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.51 124.14 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 114.455 -1.248 . . . . 0.45000000000000001 110.629 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.49 94.23 26.84 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-N 115.619 -0.719 . . . . 0.83999999999999997 110.859 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -74.65 139.32 25.13 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.977 2.452 . . . . 0.16 113.481 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.95 150.75 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.492 0 CA-C-O 121.654 0.74 . . . . 0.38 111.216 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.2 p -132.29 112.69 12.44 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.268 -0.878 . . . . 1.3100000000000001 111.323 178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.6 mt -112.01 123.18 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 108.505 -0.924 . . . . 0.25 108.505 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -139.24 127.99 23.35 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.102 -0.954 . . . . 2.0499999999999998 110.88 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? 66.05 15.52 10.11 Favored 'General case' 0 N--CA 1.517 2.89 0 N-CA-C 114.88 1.437 . . . . 3.5499999999999998 114.88 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.53 19.52 24.95 Favored Glycine 0 CA--C 1.55 2.271 0 CA-C-O 119.315 -0.714 . . . . 0.37 114.709 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 25.0 mtpp -126.77 141.83 51.72 Favored 'General case' 0 C--N 1.366 1.301 0 CA-C-N 118.181 0.991 . . . . 1.5600000000000001 112.2 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.68 136.85 39.9 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.487 0.921 . . . . 0.34000000000000002 113.487 -177.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.4 t -133.63 120.84 21.2 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.71 -0.677 . . . . 0.64000000000000001 111.843 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 p -105.47 95.05 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.674 0 CA-C-N 114.965 -1.016 . . . . 0.46000000000000002 110.087 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 69.46 -81.66 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 125.4 1.48 . . . . 1.5600000000000001 113.34 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -129.71 23.43 4.75 Favored Glycine 0 CA--C 1.544 1.899 0 CA-C-N 116.092 -0.504 . . . . 0.48999999999999999 113.685 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -125.04 121.92 35.74 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.33 0.652 . . . . 1.8200000000000001 110.78 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.8 134.24 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.466 0.65 . . . . 1.02 111.843 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 m -149.54 -170.27 3.59 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.918 -1.037 . . . . 0.56000000000000005 110.74 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.24 138.14 38.66 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.394 0.887 . . . . 1.25 113.394 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -94.45 119.88 33.84 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.493 -0.776 . . . . 0.28999999999999998 109.036 175.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.89 92.24 3.1 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.335 0.588 . . . . 1.4199999999999999 112.092 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.92 -71.51 2.98 Favored Glycine 0 C--N 1.358 1.779 0 N-CA-C 116.954 1.542 . . . . 0.41999999999999998 116.954 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.78 171.94 12.9 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 123.285 1.517 . . . . 1.1000000000000001 114.577 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.496 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -110.28 126.39 54.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 111.31 -2.677 . . . . 0.67000000000000004 107.439 176.559 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 154' ' ' SER . . . . . 0.457 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.6 t -117.18 122.23 43.45 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 118.309 -1.357 . . . . 0.35999999999999999 114.287 -175.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.79 101.36 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 114.676 -1.147 . . . . 0.73999999999999999 108.407 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -133.28 143.72 49.25 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.05 -0.977 . . . . 1.6699999999999999 111.386 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -115.59 142.5 46.64 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 114.546 -1.206 . . . . 1.8 112.72 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -102.73 137.0 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.247 -1.797 . . . . 0.57999999999999996 108.778 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -81.82 148.82 28.66 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 115.135 1.532 . . . . 2.1800000000000002 115.135 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -104.37 -29.94 5.2 Favored Glycine 0 CA--C 1.545 1.922 0 CA-C-N 114.675 -1.148 . . . . 1.02 114.143 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -128.49 -80.54 0.58 Allowed 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 117.258 0.529 . . . . 2.8599999999999999 110.919 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -171.88 48.92 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.87 0.468 . . . . 3.9100000000000001 112.036 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -160.04 -43.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.605 0.965 . . . . 1.74 113.605 -178.769 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 1.3 m-20 84.17 -173.16 0.02 OUTLIER Pre-proline 0 N--CA 1.511 2.607 0 C-N-CA 124.493 1.117 . . . . 1.6799999999999999 110.461 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -64.43 -19.19 65.1 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.586 2.191 . . . . 2.0600000000000001 115.74 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 31.0 tptt 82.69 -67.1 0.09 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 126.025 1.73 . . . . 3.0 115.045 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 45.0 t -100.2 131.03 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 119.062 0.846 . . . . 0.80000000000000004 110.034 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.3 t -134.06 126.8 30.9 Favored 'General case' 0 C--N 1.367 1.342 0 O-C-N 124.074 0.859 . . . . 0.87 111.635 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.256 . . -115.03 51.1 0.93 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.43 2.011 . . . . 0.34000000000000002 116.43 -176.194 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.84 128.18 8.65 Favored 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.702 1.601 . . . . 0.69999999999999996 115.053 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -149.14 98.17 2.78 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.777 -1.102 . . . . 0.20999999999999999 109.294 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.319 8.4 tt -112.9 122.68 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.808 0 CA-C-O 122.84 1.305 . . . . 0.31 112.276 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -123.56 167.61 13.7 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 113.094 -1.866 . . . . 0.44 111.131 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.9 ptmt -122.19 159.49 27.14 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 118.223 2.675 . . . . 1.26 118.223 -175.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.38 -42.53 1.87 Allowed Glycine 0 CA--C 1.542 1.781 0 CA-C-N 110.041 -3.254 . . . . 0.17000000000000001 118.779 174.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.37 153.92 0.78 Allowed 'General case' 0 N--CA 1.52 3.038 0 CA-C-N 120.296 2.048 . . . . 0.14999999999999999 112.94 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.79 -20.74 58.0 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 114.742 1.386 . . . . 0.17000000000000001 114.742 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.36 4.68 45.33 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.007 1.114 . . . . 0.55000000000000004 114.007 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.57 3.3 16.65 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.389 1.255 . . . . 0.59999999999999998 114.389 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . 0.257 1.6 m . . . . . 0 N--CA 1.525 3.298 0 N-CA-C 116.856 2.169 . . . . 0.94999999999999996 116.856 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.649 ' HG ' HD11 ' A' ' 27' ' ' ILE . 21.2 tp . . . . . 0 CA--C 1.564 1.483 0 N-CA-C 113.145 0.794 . . . . 0.34999999999999998 113.145 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.57 -23.81 64.94 Favored 'General case' 0 N--CA 1.506 2.331 0 C-N-CA 125.506 1.522 . . . . 0.20000000000000001 114.414 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.89 -9.92 54.59 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 113.606 0.965 . . . . 0.32000000000000001 113.606 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 48.8 mmtt -104.47 -27.02 12.16 Favored 'General case' 0 C--N 1.364 1.23 0 N-CA-C 113.327 0.862 . . . . 1.73 113.327 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.33 137.01 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.077 0 N-CA-C 115.764 1.764 . . . . 0.11 115.764 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pt -122.06 -30.09 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 115.559 -0.746 . . . . 0.16 112.409 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -164.36 116.7 1.32 Allowed 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 120.654 0.264 . . . . 0.54000000000000004 111.302 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.98 136.42 38.5 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.602 -0.686 . . . . 0.19 111.719 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.518 HG21 ' HG3' ' A' ' 33' ' ' PRO 0.304 14.9 p -150.02 137.65 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.555 0 N-CA-C 115.796 1.776 . . . . 1.05 115.796 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 59.2 t30 -114.18 111.34 21.4 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-N 115.264 -0.88 . . . . 2.1099999999999999 108.726 174.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.96 106.8 13.25 Favored 'General case' 0 C--O 1.271 2.211 0 CA-C-O 121.455 0.645 . . . . 0.63 110.323 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.512 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 171.92 -61.42 0.16 Allowed Glycine 0 C--N 1.362 1.998 0 CA-C-N 112.445 -2.161 . . . . 0.70999999999999996 114.358 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.01 -110.45 3.37 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 114.371 0.508 . . . . 0.80000000000000004 114.371 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -170.92 117.85 0.48 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.834 0.454 . . . . 1.6299999999999999 111.782 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.1 m 43.95 114.38 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.368 0 N-CA-C 119.235 3.05 . . . . 1.0 119.235 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 47.4 t-80 -144.97 139.81 27.77 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 113.399 0.888 . . . . 0.45000000000000001 113.399 177.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.267 8.2 p -106.02 114.23 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 CA-C-N 115.015 -0.993 . . . . 1.3899999999999999 110.124 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -84.59 162.7 19.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.776 -1.102 . . . . 1.8500000000000001 113.12 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 m -41.38 -28.79 0.18 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.266 0 N-CA-C 119.868 3.285 . . . . 0.71999999999999997 119.868 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -90.15 -19.76 23.88 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.856 0.753 . . . . 0.51000000000000001 111.87 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.65 39.32 1.47 Allowed Glycine 0 C--N 1.353 1.517 0 C-N-CA 124.443 1.021 . . . . 0.34000000000000002 113.868 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.649 HD11 ' HG ' ' A' ' 6' ' ' LEU . 30.1 mm -106.83 124.91 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 C-N-CA 123.096 0.558 . . . . 0.55000000000000004 109.597 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.1 t60 -110.26 130.7 55.5 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 114.656 1.354 . . . . 1.3400000000000001 114.656 -178.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -84.15 136.74 33.86 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 124.479 1.111 . . . . 2.79 110.413 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.89 100.34 12.82 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 124.78 1.3 . . . . 3.0 114.266 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -38.79 110.96 0.15 Allowed 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 128.133 2.573 . . . . 2.2999999999999998 117.846 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 46.34 76.16 0.58 Allowed Pre-proline 0 N--CA 1.525 3.317 0 N-CA-C 117.099 2.259 . . . . 1.1699999999999999 117.099 177.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.518 ' HG3' HG21 ' A' ' 14' ' ' VAL . 68.3 Cg_endo . . . . . 0 CA--C 1.56 1.803 0 N-CA-C 117.584 2.109 . . . . 1.45 117.584 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 51.1 Cg_exo . . . . . 0 N--CA 1.503 2.059 0 N-CA-C 117.196 1.96 . . . . 1.3700000000000001 117.196 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.279 1.2 mp -89.65 125.91 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.12 0 CA-C-N 114.98 -1.009 . . . . 0.68999999999999995 109.277 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.39 -19.01 43.53 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.478 2.029 . . . . 1.28 116.478 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.38 24.66 7.79 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 113.957 1.095 . . . . 1.51 113.957 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.36 -175.07 4.57 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-O 121.451 0.643 . . . . 1.0900000000000001 111.7 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.788 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.56 -176.87 0.58 Allowed Pre-proline 0 N--CA 1.511 2.588 0 C-N-CA 123.985 0.914 . . . . 1.27 109.198 177.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -68.86 -39.95 7.6 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.48 2.12 . . . . 0.94999999999999996 113.719 176.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -68.88 -49.18 60.43 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 125.298 1.439 . . . . 2.04 112.549 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -6.57 58.76 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-N 114.921 -1.036 . . . . 1.6200000000000001 112.57 177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.788 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 22.1 tt0 -73.54 -40.49 63.93 Favored 'General case' 0 C--N 1.381 1.952 0 C-N-CA 125.278 1.431 . . . . 1.77 108.075 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.5 t -61.35 -44.57 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.068 0 C-N-CA 124.353 1.061 . . . . 0.81000000000000005 109.094 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.9 tp -75.97 -11.91 60.04 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 114.77 1.396 . . . . 1.1499999999999999 114.77 177.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -124.22 22.16 8.66 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 123.672 0.789 . . . . 0.92000000000000004 112.534 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -143.89 -27.4 0.53 Allowed 'General case' 0 N--CA 1.52 3.032 0 N-CA-C 115.813 1.783 . . . . 1.3300000000000001 115.813 -177.763 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 p -75.29 130.82 39.72 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 113.614 0.968 . . . . 1.28 113.614 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.512 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.246 0 N-CA-C 115.306 1.595 . . . . 1.53 115.306 -176.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.45 -0.574 . . . . 2.1499999999999999 109.45 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.58 79.49 0.1 Allowed 'General case' 0 N--CA 1.515 2.778 0 C-N-CA 125.083 1.353 . . . . 0.77000000000000002 109.963 -177.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -135.44 141.31 45.39 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.276 -0.875 . . . . 0.81000000000000005 113.13 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -134.48 174.36 21.02 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 116.62 1.408 . . . . 0.46999999999999997 116.62 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -113.94 156.55 23.8 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 113.814 -1.193 . . . . 0.89000000000000001 113.375 -177.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.83 125.4 47.44 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.024 -0.989 . . . . 0.51000000000000001 111.904 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.77 102.69 38.09 Favored Pre-proline 0 CA--C 1.566 1.561 0 CA-C-N 115.458 -0.792 . . . . 0.14999999999999999 108.957 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -84.0 117.53 2.26 Favored 'Trans proline' 0 CA--C 1.562 1.884 0 C-N-CA 122.155 1.903 . . . . 0.14999999999999999 114.44 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.05 157.48 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 CA-C-O 122.068 0.937 . . . . 0.19 111.511 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -144.46 14.66 1.61 Allowed 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 114.542 -1.208 . . . . 2.5299999999999998 112.61 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -125.04 172.88 9.09 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-N 118.711 0.687 . . . . 2.1200000000000001 112.489 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -130.83 144.05 51.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.814 0.816 . . . . 0.41999999999999998 112.822 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.1 -135.4 4.29 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.436 -1.256 . . . . 0.23000000000000001 112.322 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.574 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 40.6 mm-40 -114.12 112.56 23.4 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 118.039 0.92 . . . . 1.75 111.266 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -104.64 133.57 49.26 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 122.075 -0.391 . . . . 0.20999999999999999 110.826 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -118.66 124.04 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.703 0.763 . . . . 0.20000000000000001 111.202 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.48 110.5 22.45 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.168 -1.378 . . . . 0.78000000000000003 110.699 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 0.2 OUTLIER -119.22 129.09 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 115.266 -0.879 . . . . 0.44 108.707 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.28 137.4 46.01 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.117 0.784 . . . . 1.25 113.117 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 127' ' ' HIS . 3.0 tppt? -101.69 114.06 27.77 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.759 -0.655 . . . . 2.52 109.907 176.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 11.6 m-85 -103.63 134.46 46.94 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.381 -0.827 . . . . 0.40000000000000002 110.339 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.44 151.54 47.53 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.629 -0.714 . . . . 0.40999999999999998 111.253 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -128.16 142.93 51.04 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-O 121.271 0.558 . . . . 2.6099999999999999 112.254 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.18 -36.02 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 115.59 -0.732 . . . . 2.1299999999999999 112.678 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.62 142.04 51.43 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.192 0.597 . . . . 2.27 111.707 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 92.75 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 126.477 1.911 . . . . 1.46 111.248 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.17 85.39 2.65 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-O 123.002 1.382 . . . . 0.83999999999999997 111.529 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -151.17 145.04 25.15 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.318 -1.31 . . . . 2.4500000000000002 112.292 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.1 m -120.84 120.27 35.08 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.507 -0.769 . . . . 1.6599999999999999 112.223 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 72.33 56.64 0.15 Allowed 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 125.899 1.68 . . . . 1.8899999999999999 112.531 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -157.19 -41.97 0.07 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.286 1.434 . . . . 2.5600000000000001 109.092 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -105.1 83.39 1.97 Allowed 'General case' 0 C--N 1.361 1.086 0 N-CA-C 108.383 -0.969 . . . . 2.7599999999999998 108.383 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.85 132.71 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 114.748 -1.114 . . . . 0.68999999999999995 111.675 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -114.58 178.54 4.24 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.353 1.612 . . . . 0.69999999999999996 115.353 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -126.5 141.72 51.78 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.604 0.594 . . . . 1.3300000000000001 112.604 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.71 125.01 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.368 0 C-N-CA 123.686 0.794 . . . . 0.47999999999999998 109.302 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.61 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 25.6 mtt180 -124.51 146.91 48.71 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.097 1.518 . . . . 1.6899999999999999 115.097 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 2.5 m -120.21 106.8 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.833 0 N-CA-C 112.996 0.739 . . . . 0.59999999999999998 112.996 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 64.38 25.07 13.35 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 126.49 1.916 . . . . 1.1200000000000001 114.736 -178.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.85 -12.91 45.93 Favored Glycine 0 CA--C 1.55 2.261 0 CA-C-N 115.827 -0.624 . . . . 0.32000000000000001 113.446 -176.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.61 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 96.8 m-70 -87.35 169.34 12.35 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.078 1.751 . . . . 0.56999999999999995 112.784 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.28 133.6 55.14 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.573 0.702 . . . . 0.55000000000000004 112.462 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.94 -55.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 114.731 -1.122 . . . . 1.0600000000000001 112.898 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.14 88.89 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.021 -1.103 . . . . 0.44 108.021 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -111.14 77.6 1.05 Allowed 'General case' 0 C--N 1.354 0.775 0 CA-C-O 122.867 1.318 . . . . 2.2999999999999998 110.588 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 152.44 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 111.205 -2.725 . . . . 2.48 108.578 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.35 99.93 12.36 Favored 'General case' 0 C--N 1.362 1.117 0 N-CA-C 113.708 1.003 . . . . 1.1299999999999999 113.708 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -114.26 99.49 7.64 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 113.175 -1.83 . . . . 2.3500000000000001 107.565 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.74 -29.89 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.441 0 N-CA-C 114.313 1.227 . . . . 0.68000000000000005 114.313 -176.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -75.45 -37.17 60.49 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.539 0.736 . . . . 0.77000000000000002 112.415 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.54 -26.9 60.27 Favored 'General case' 0 CA--C 1.577 1.987 0 C-N-CA 124.533 1.133 . . . . 0.91000000000000003 113.262 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -77.33 -55.27 5.54 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.386 0.884 . . . . 2.4300000000000002 113.386 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.18 -39.04 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 N-CA-C 113.985 1.105 . . . . 0.93000000000000005 113.985 177.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.46 -70.86 0.21 Allowed Glycine 0 C--N 1.359 1.849 0 CA-C-N 118.206 0.457 . . . . 0.84999999999999998 113.556 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -106.28 175.56 5.46 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.467 1.107 . . . . 3.1800000000000002 111.232 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.1 m -70.87 85.95 0.69 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 113.692 0.997 . . . . 2.0800000000000001 113.692 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 126' ' ' ALA . 2.9 p -134.76 -156.64 0.74 Allowed 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 114.028 -1.442 . . . . 0.62 109.476 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.433 ' H ' ' HB ' ' A' ' 125' ' ' THR . . . -105.83 128.36 53.69 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 113.15 0.796 . . . . 0.46000000000000002 113.15 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 7.9 t60 -101.82 139.43 37.47 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.265 0.626 . . . . 0.38 109.322 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -144.79 130.43 19.01 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.28 0.845 . . . . 2.5 113.28 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -121.75 136.69 54.94 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 115.304 -0.862 . . . . 1.5600000000000001 111.317 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.81 126.45 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 114.718 -1.128 . . . . 0.45000000000000001 110.767 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.6 mp -132.88 92.53 25.92 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-N 115.472 -0.785 . . . . 0.83999999999999997 110.498 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -76.5 131.19 12.39 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 122.875 2.383 . . . . 0.16 113.175 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.23 153.34 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 C-N-CA 124.194 0.998 . . . . 0.38 111.115 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.1 p -136.09 117.62 14.83 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.633 0.605 . . . . 1.3100000000000001 112.633 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.5 mt -116.16 127.62 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 N-CA-C 108.769 -0.826 . . . . 0.25 108.769 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -140.84 126.0 18.48 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.923 -0.58 . . . . 2.0499999999999998 110.984 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? 68.8 14.91 8.98 Favored 'General case' 0 N--CA 1.516 2.853 0 C-N-CA 125.205 1.402 . . . . 3.5499999999999998 114.151 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.12 16.13 36.39 Favored Glycine 0 CA--C 1.546 1.988 0 CA-C-O 119.291 -0.727 . . . . 0.37 114.359 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 51.9 mtpt -125.38 144.57 50.44 Favored 'General case' 0 C--N 1.366 1.283 0 CA-C-N 118.175 0.988 . . . . 1.5600000000000001 112.48 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 148.21 23.28 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.798 1.406 . . . . 0.34000000000000002 114.798 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.6 114.12 9.71 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.234 -1.348 . . . . 0.64000000000000001 110.201 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.2 p -121.67 96.01 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.334 0 CA-C-N 115.999 -0.546 . . . . 0.46000000000000002 110.705 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 68.39 -83.94 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 C-N-CA 125.586 1.554 . . . . 1.5600000000000001 113.751 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.69 26.81 3.79 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.891 -0.595 . . . . 0.48999999999999999 113.129 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -130.12 123.56 30.66 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 123.532 0.733 . . . . 1.8200000000000001 110.346 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.4 p -118.4 130.05 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.237 0 CA-C-O 121.48 0.657 . . . . 1.02 111.51 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.9 p -151.49 -173.3 4.47 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.202 -0.908 . . . . 0.56000000000000005 110.344 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.272 14.3 t -104.35 138.29 40.98 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 113.661 0.986 . . . . 1.25 113.661 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -84.73 126.38 33.35 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.441 1.096 . . . . 0.28999999999999998 111.19 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.77 91.77 3.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.216 0.821 . . . . 1.4199999999999999 113.216 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.18 -64.8 3.69 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 119.192 2.437 . . . . 0.41999999999999998 119.192 176.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -135.33 159.28 42.05 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.466 0.913 . . . . 1.1000000000000001 113.466 -176.168 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.524 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -105.27 142.59 34.77 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.952 -1.476 . . . . 0.67000000000000004 109.816 177.319 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 t -124.53 127.22 47.1 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 114.023 1.119 . . . . 0.35999999999999999 114.023 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 16.3 t -106.59 97.19 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 105.862 -1.903 . . . . 0.73999999999999999 105.862 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.74 122.7 44.42 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.971 -1.013 . . . . 1.6699999999999999 112.594 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -107.13 119.03 38.28 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 114.474 -1.239 . . . . 1.8 109.766 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.14 137.31 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 CA-C-N 113.579 -1.646 . . . . 0.57999999999999996 109.649 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -58.37 151.2 20.33 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 127.509 2.323 . . . . 2.1800000000000002 116.756 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -109.5 -62.7 0.53 Allowed Glycine 0 CA--C 1.538 1.478 0 CA-C-N 115.193 -0.912 . . . . 1.02 113.365 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -135.13 -71.34 0.48 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.781 0.659 . . . . 2.8599999999999999 112.781 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -112.19 -59.29 2.02 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 122.775 0.43 . . . . 3.9100000000000001 112.056 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.4 156.33 16.39 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.692 0.797 . . . . 1.74 110.388 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -97.71 -94.8 0.0 OUTLIER Pre-proline 0 CA--C 1.58 2.126 0 CA-C-O 116.512 -1.708 . . . . 1.6799999999999999 110.898 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.51 -37.21 0.11 Allowed 'Trans proline' 0 C--N 1.402 3.355 0 CA-C-N 124.886 2.781 . . . . 2.0600000000000001 115.004 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.4 tptt 82.06 -81.74 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 126.261 1.825 . . . . 3.0 108.859 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 45.5 t -112.51 129.53 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.716 -1.216 . . . . 0.80000000000000004 107.716 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 8.8 t -135.37 116.79 14.69 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.928 0.768 . . . . 0.87 112.341 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . 0.274 . . -109.44 47.51 0.93 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.337 2.347 . . . . 0.34000000000000002 117.337 -176.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.25 134.1 1.68 Allowed 'General case' 0 N--CA 1.516 2.846 0 N-CA-C 116.109 1.892 . . . . 0.69999999999999996 116.109 177.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.418 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 3.1 t80 -151.6 100.46 2.71 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.068 -0.514 . . . . 0.20999999999999999 110.906 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.3 5.5 tt -111.52 121.87 64.88 Favored 'Isoleucine or valine' 0 C--O 1.269 2.088 0 CA-C-O 122.268 1.032 . . . . 0.31 110.969 176.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -122.34 168.68 11.77 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.528 -1.215 . . . . 0.44 112.08 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 24.9 tptp -113.4 141.67 46.8 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 118.298 2.703 . . . . 1.26 118.298 -173.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.12 -40.49 2.45 Favored Glycine 0 CA--C 1.542 1.735 0 N-CA-C 121.213 3.245 . . . . 0.17000000000000001 121.213 171.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.93 157.17 1.42 Allowed 'General case' 0 N--CA 1.525 3.291 0 CA-C-N 121.622 2.711 . . . . 0.14999999999999999 113.91 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.16 -13.22 59.95 Favored 'General case' 0 CA--C 1.58 2.108 0 C-N-CA 124.954 1.301 . . . . 0.17000000000000001 114.087 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.34 2.49 50.15 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 113.692 0.997 . . . . 0.55000000000000004 113.692 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.11 -8.89 17.23 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.98 0.912 . . . . 0.59999999999999998 113.29 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.223 0 C-N-CA 123.866 0.866 . . . . 0.94999999999999996 112.102 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.482 -0.247 . . . . 8.9299999999999997 112.482 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.92 129.88 56.03 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 121.588 0.709 . . . . 6.8200000000000003 111.979 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.5 mmt -132.1 111.19 11.26 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.686 -0.688 . . . . 7.6399999999999997 111.252 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 m -136.93 114.19 10.79 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.73 -0.668 . . . . 3.8599999999999999 111.592 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.22 93.37 0.09 OUTLIER Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.815 -0.63 . . . . 1.1100000000000001 113.219 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.548 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.6 tp -87.82 -48.73 7.6 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 123.637 0.775 . . . . 0.34999999999999998 113.041 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.28 -24.78 65.22 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.957 1.703 . . . . 0.20000000000000001 115.251 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.24 -12.02 47.97 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 113.665 0.987 . . . . 0.32000000000000001 113.665 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 47.4 mttm -107.45 -18.1 13.95 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 113.954 1.094 . . . . 1.73 113.954 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -56.93 135.93 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.88 0 N-CA-C 114.905 1.446 . . . . 0.11 114.905 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.49 -28.53 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 115.394 -0.821 . . . . 0.16 112.495 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 69.3 t90 -162.83 117.9 1.77 Allowed 'General case' 0 CA--C 1.559 1.325 0 CA-C-N 117.872 0.306 . . . . 0.54000000000000004 111.277 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -139.1 129.59 25.78 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.508 -0.745 . . . . 0.19 111.635 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.55 133.81 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 N-CA-C 112.928 0.714 . . . . 1.05 112.928 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 169' ' ' ALA . 6.0 t-20 -114.07 112.94 24.05 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.056 -1.461 . . . . 2.1099999999999999 107.056 172.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -79.88 97.5 6.72 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-O 121.577 0.704 . . . . 0.63 111.947 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.53 ' HA2' ' N ' ' A' ' 65' ' ' ARG . . . 176.28 -68.72 0.09 OUTLIER Glycine 0 C--N 1.358 1.758 0 CA-C-N 114.416 -1.266 . . . . 0.70999999999999996 115.369 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.65 -116.23 3.66 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 114.651 0.62 . . . . 0.80000000000000004 114.651 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -170.53 118.71 0.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.206 0.527 . . . . 1.6299999999999999 111.389 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER 51.47 107.75 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.525 2.417 . . . . 1.0 117.525 177.439 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.553 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 79.7 t60 -137.08 134.98 37.07 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.869 1.063 . . . . 0.45000000000000001 113.869 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.9 t -104.76 114.51 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 CA-C-N 113.813 -1.539 . . . . 1.3899999999999999 107.214 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.48 161.15 17.17 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 119.521 -0.276 . . . . 1.8500000000000001 111.558 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -45.06 -25.37 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.074 0 N-CA-C 119.12 3.007 . . . . 0.71999999999999997 119.12 -176.509 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -92.04 -21.12 20.66 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 118.082 0.401 . . . . 0.51000000000000001 111.427 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.86 39.64 1.28 Allowed Glycine 0 C--N 1.356 1.683 0 C-N-CA 124.288 0.947 . . . . 0.34000000000000002 113.983 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.548 HD11 ' HG ' ' A' ' 6' ' ' LEU . 19.9 mm -105.85 124.98 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 109.094 -0.706 . . . . 0.55000000000000004 109.094 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.553 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.7 t-160 -115.82 132.96 56.49 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 115.693 1.738 . . . . 1.3400000000000001 115.693 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.8 144.78 27.05 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.726 -1.125 . . . . 2.79 108.999 174.368 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -67.31 -104.78 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.317 1.969 . . . . 3.0 116.317 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.1 tttt 176.8 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.233 1.013 . . . . 2.2999999999999998 111.62 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.431 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 0.4 OUTLIER 46.46 58.09 16.6 Favored Pre-proline 0 N--CA 1.533 3.705 0 N-CA-C 117.152 2.279 . . . . 1.1699999999999999 117.152 177.021 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -98.53 33.51 0.11 Allowed 'Trans proline' 0 CA--C 1.563 1.937 0 C-N-CA 123.066 2.511 . . . . 1.45 117.146 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.08 -51.01 0.53 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.629 0.603 . . . . 1.9099999999999999 112.629 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -109.58 98.4 7.78 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.731 0.776 . . . . 4.8399999999999999 112.037 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.34 -30.8 9.49 Favored Glycine 0 CA--C 1.541 1.673 0 CA-C-N 114.304 -1.317 . . . . 2.3700000000000001 113.412 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 77.09 -46.08 0.49 Allowed 'General case' 0 N--CA 1.511 2.606 0 C-N-CA 126.476 1.91 . . . . 4.5 114.862 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.95 116.49 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 122.971 0.508 . . . . 2.7000000000000002 110.349 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.49 -133.77 1.56 Allowed Glycine 0 C--N 1.342 0.915 0 C-N-CA 120.99 -0.624 . . . . 1.95 114.246 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -138.04 -168.41 2.35 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 112.858 0.688 . . . . 5.3399999999999999 112.858 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.55 137.01 32.73 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.558 1.143 . . . . 1.6399999999999999 112.87 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.4 m -128.66 120.81 27.24 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.233 -0.894 . . . . 1.5700000000000001 110.413 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.29 100.76 5.29 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.84 -0.618 . . . . 2.3300000000000001 111.233 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -105.65 75.24 1.12 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.056 0.931 . . . . 3.1600000000000001 110.174 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.58 65.83 0.21 Allowed Glycine 0 CA--C 1.528 0.9 0 CA-C-N 113.945 -1.479 . . . . 1.52 110.416 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.1 ttt -92.21 1.19 57.37 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 115.452 1.649 . . . . 1.6699999999999999 115.452 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -111.7 47.13 1.06 Allowed 'General case' 0 CA--C 1.561 1.387 0 CA-C-O 121.779 0.799 . . . . 4.1799999999999997 111.709 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 tp -146.67 73.91 12.51 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 114.684 -1.143 . . . . 2.6299999999999999 108.186 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.401 ' HB3' ' CD ' ' A' ' 58' ' ' GLN . 38.7 Cg_exo -68.17 158.66 56.53 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.559 2.839 . . . . 1.3700000000000001 116.908 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.278 1.2 mp -86.95 133.21 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.273 0 CA-C-N 115.353 -0.839 . . . . 0.68999999999999995 109.791 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.39 -18.39 36.25 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.944 2.201 . . . . 1.28 116.944 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -103.97 23.78 12.38 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.1 1.148 . . . . 1.51 114.1 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -138.11 -166.85 2.05 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.018 0.914 . . . . 1.0900000000000001 112.803 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.658 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.3 t30 -94.69 -178.59 0.82 Allowed Pre-proline 0 CA--C 1.571 1.772 0 C-N-CA 125.586 1.555 . . . . 1.27 110.934 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.448 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.3 Cg_exo -72.31 -45.62 0.6 Allowed 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 122.91 2.406 . . . . 0.94999999999999996 112.018 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -68.71 -52.32 32.05 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 113.32 -1.764 . . . . 2.04 111.863 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -75.65 -6.71 51.79 Favored 'General case' 0 CA--C 1.589 2.471 0 CA-C-N 115.353 -0.84 . . . . 1.6200000000000001 112.692 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.658 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 4.2 tt0 -72.5 -42.31 65.0 Favored 'General case' 0 C--N 1.387 2.232 0 C-N-CA 125.631 1.573 . . . . 1.77 108.046 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.09 -42.34 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.045 0 C-N-CA 124.466 1.107 . . . . 0.81000000000000005 109.341 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.9 tp -81.37 -6.35 58.82 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 113.946 1.091 . . . . 1.1499999999999999 113.946 176.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -123.63 20.5 9.43 Favored 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 124.64 1.176 . . . . 0.92000000000000004 112.173 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.67 -35.04 0.31 Allowed 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 116.134 1.902 . . . . 1.3300000000000001 116.134 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.1 p -70.99 130.17 40.9 Favored 'General case' 0 N--CA 1.529 3.508 0 N-CA-C 115.011 1.486 . . . . 1.28 115.011 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.608 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.5 pt-20 -127.51 141.04 51.76 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 124.55 1.14 . . . . 1.53 111.019 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.53 ' N ' ' HA2' ' A' ' 17' ' ' GLY . 5.9 ptt180 -100.57 -81.3 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.165 0.802 . . . . 3.2200000000000002 113.165 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.73 165.83 34.75 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.238 0.926 . . . . 3.6600000000000001 113.069 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.495 HD21 ' H ' ' A' ' 166' ' ' LYS . 50.0 m-20 -131.67 159.46 38.28 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.317 0.858 . . . . 4.7000000000000002 113.317 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -141.43 -106.54 0.14 Allowed 'General case' 0 CA--C 1.564 1.489 0 CA-C-N 115.564 -0.743 . . . . 2.5499999999999998 111.002 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.66 121.56 3.73 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.017 0.527 . . . . 2.1499999999999999 111.073 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.665 ' H ' HD21 ' A' ' 164' ' ' ASN . 0.2 OUTLIER 55.03 89.51 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 125.805 1.642 . . . . 0.77000000000000002 113.648 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -150.45 160.9 43.43 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.114 1.153 . . . . 0.81000000000000005 114.114 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -176.93 -173.05 42.15 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 116.429 1.332 . . . . 0.46999999999999997 116.429 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -107.93 171.99 7.09 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.35 1.982 . . . . 0.89000000000000001 116.35 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.16 121.2 28.93 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 113.108 -1.86 . . . . 0.51000000000000001 111.188 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.82 106.41 49.97 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 123.339 0.656 . . . . 0.14999999999999999 109.262 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.05 117.54 2.24 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 122.08 1.853 . . . . 0.14999999999999999 114.825 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.78 157.47 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 122.084 0.945 . . . . 0.19 110.981 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -146.83 20.05 1.28 Allowed 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.667 -1.151 . . . . 2.5299999999999998 111.824 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -131.85 159.71 37.77 Favored 'General case' 0 C--N 1.362 1.15 0 CA-C-O 121.29 0.567 . . . . 2.1200000000000001 111.897 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -116.62 148.17 41.2 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.869 1.063 . . . . 0.41999999999999998 113.869 -178.591 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.78 -138.08 5.52 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.117 -1.401 . . . . 0.23000000000000001 112.38 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 36.4 mm-40 -115.56 104.05 11.34 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-N 118.082 0.941 . . . . 1.75 110.898 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -99.73 128.27 45.83 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.174 0.512 . . . . 0.20999999999999999 110.882 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -113.32 123.48 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.418 0.628 . . . . 0.20000000000000001 111.004 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.47 HD12 HD12 ' A' ' 172' ' ' ILE . 2.6 tt -108.69 105.26 14.78 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.728 -1.124 . . . . 0.78000000000000003 110.109 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 1.7 t -114.54 122.27 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.134 -1.393 . . . . 0.44 107.633 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -131.7 136.73 47.88 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.661 -0.7 . . . . 1.25 111.8 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 5.1 tppt? -97.66 123.64 41.66 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.622 0.725 . . . . 2.52 112.519 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -105.78 133.21 50.88 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.847 -1.07 . . . . 0.40000000000000002 109.887 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.15 158.99 43.21 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.792 -0.64 . . . . 0.40999999999999998 111.599 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -124.12 170.18 10.96 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-O 121.454 0.645 . . . . 2.6099999999999999 112.667 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.95 -73.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 115.884 -0.598 . . . . 2.1299999999999999 112.423 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.85 67.28 1.51 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.14 0.495 . . . . 2.27 111.927 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -144.59 102.32 3.8 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.866 -0.606 . . . . 1.46 110.279 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.88 100.51 10.01 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 122.329 1.061 . . . . 0.83999999999999997 111.856 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -166.43 139.88 4.02 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 114.73 -1.123 . . . . 2.4500000000000002 111.748 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.4 m -125.46 116.25 21.53 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.701 -0.681 . . . . 1.6599999999999999 111.81 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 73.24 49.45 0.15 Allowed 'General case' 0 N--CA 1.508 2.463 0 C-N-CA 125.673 1.589 . . . . 1.8899999999999999 113.055 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -151.36 -40.99 0.12 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.24 1.416 . . . . 2.5600000000000001 109.212 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -100.59 78.88 2.03 Favored 'General case' 0 C--N 1.365 1.268 0 N-CA-C 108.468 -0.938 . . . . 2.7599999999999998 108.468 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.8 130.19 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 114.677 -1.147 . . . . 0.68999999999999995 111.456 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -115.66 172.77 6.91 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.996 1.48 . . . . 0.69999999999999996 114.996 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -122.87 137.83 54.83 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.855 -0.611 . . . . 1.3300000000000001 111.702 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -131.75 128.04 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.483 0 CA-C-N 115.273 -0.876 . . . . 0.47999999999999998 110.012 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -129.22 151.81 49.48 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.366 1.617 . . . . 1.6899999999999999 115.366 -177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.3 OUTLIER -130.1 113.05 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 C-N-CA 123.355 0.662 . . . . 0.59999999999999998 112.382 177.101 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.11 25.61 12.49 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 127.013 2.125 . . . . 1.1200000000000001 114.095 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.53 -16.13 52.53 Favored Glycine 0 CA--C 1.548 2.154 0 CA-C-N 115.6 -0.727 . . . . 0.32000000000000001 113.682 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 94.0 m-70 -83.75 144.68 29.17 Favored 'General case' 0 C--N 1.365 1.241 0 C-N-CA 125.53 1.532 . . . . 0.56999999999999995 114.496 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.94 126.88 42.39 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.326 0.584 . . . . 0.55000000000000004 110.863 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.95 -58.63 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 115.098 -0.956 . . . . 1.0600000000000001 113.13 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.06 89.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.263 -1.014 . . . . 0.44 108.263 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.65 73.69 0.86 Allowed 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 123.134 1.445 . . . . 2.2999999999999998 112.317 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 p30 158.14 62.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 127.871 2.468 . . . . 2.48 107.243 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.2 tp -101.92 100.93 11.28 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.184 1.179 . . . . 1.1299999999999999 114.184 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -112.71 108.61 17.7 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-N 113.401 -1.727 . . . . 2.3500000000000001 109.675 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -26.69 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.547 0 N-CA-C 114.725 1.38 . . . . 0.68000000000000005 114.725 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -76.3 -42.73 44.29 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 123.303 0.641 . . . . 0.77000000000000002 112.335 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -73.91 -26.37 60.49 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 124.176 0.99 . . . . 0.91000000000000003 113.563 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -78.65 -57.7 3.63 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.765 1.024 . . . . 2.4300000000000002 113.765 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -31.45 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 114.712 1.375 . . . . 0.93000000000000005 114.712 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.23 -114.94 2.4 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 118.578 0.626 . . . . 0.84999999999999998 112.945 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -114.76 107.58 15.63 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.216 0.531 . . . . 3.1800000000000002 110.545 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 73.32 -128.62 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 125.59 1.556 . . . . 2.0800000000000001 111.933 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.3 p 58.26 -171.02 0.11 Allowed 'General case' 0 N--CA 1.535 3.798 0 C-N-CA 126.159 1.783 . . . . 0.62 115.474 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.77 129.29 54.66 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 112.968 0.729 . . . . 0.46000000000000002 112.968 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -105.72 136.54 45.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.249 0.619 . . . . 0.38 109.575 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -128.13 133.89 49.03 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.825 1.417 . . . . 2.5 114.825 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.16 118.74 32.7 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.418 -1.264 . . . . 1.5600000000000001 110.844 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.02 112.21 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 115.19 -0.913 . . . . 0.45000000000000001 110.636 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.75 93.01 43.38 Favored Pre-proline 0 CA--C 1.568 1.669 0 CA-C-N 115.532 -0.758 . . . . 0.83999999999999997 110.709 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -74.33 138.27 24.55 Favored 'Trans proline' 0 C--N 1.397 3.097 0 C-N-CA 123.032 2.488 . . . . 0.16 113.686 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.11 146.94 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 CA-C-N 115.276 -0.875 . . . . 0.38 110.504 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.8 p -131.75 111.83 11.99 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.566 -0.743 . . . . 1.3100000000000001 111.626 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.494 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.6 mt -111.59 122.83 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 108.539 -0.911 . . . . 0.25 108.539 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -142.5 130.24 21.56 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.857 -0.611 . . . . 2.0499999999999998 111.192 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt 67.54 15.25 9.77 Favored 'General case' 0 N--CA 1.515 2.822 0 C-N-CA 125.096 1.358 . . . . 3.5499999999999998 114.405 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.14 15.6 35.34 Favored Glycine 0 CA--C 1.549 2.17 0 CA-C-O 119.143 -0.809 . . . . 0.37 114.806 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 30.9 mtmt -128.89 155.6 45.0 Favored 'General case' 0 C--N 1.367 1.348 0 CA-C-N 118.442 1.121 . . . . 1.5600000000000001 112.924 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.46 148.52 26.36 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.36 1.244 . . . . 0.34000000000000002 114.36 -176.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.8 m -134.77 112.28 10.61 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.601 -1.181 . . . . 0.64000000000000001 110.573 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 p -112.21 92.42 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.636 0 CA-C-O 121.196 0.522 . . . . 0.46000000000000002 109.876 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 63.06 -84.26 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.866 0 C-N-CA 125.581 1.553 . . . . 1.5600000000000001 114.241 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.64 28.1 4.53 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 116.206 -0.452 . . . . 0.48999999999999999 113.768 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -137.05 119.23 15.54 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.25 0.62 . . . . 1.8200000000000001 110.048 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.75 132.6 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 CA-C-O 121.57 0.7 . . . . 1.02 112.185 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -150.53 -179.31 7.12 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.043 -0.98 . . . . 0.56000000000000005 109.818 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.262 12.8 t -103.14 138.22 40.26 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 113.628 0.974 . . . . 1.25 113.628 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -82.8 123.72 29.61 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.396 1.078 . . . . 0.28999999999999998 111.288 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.19 91.22 3.28 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.804 0.668 . . . . 1.4199999999999999 112.804 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.81 -63.87 3.41 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 119.014 2.366 . . . . 0.41999999999999998 119.014 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.539 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -132.85 161.16 34.91 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.834 1.05 . . . . 1.1000000000000001 113.834 -176.269 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.539 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -107.09 143.32 35.4 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 113.764 -1.562 . . . . 0.67000000000000004 109.593 177.033 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 t -124.81 142.63 51.3 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.643 1.349 . . . . 0.35999999999999999 114.643 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.446 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.93 97.43 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 106.926 -1.509 . . . . 0.73999999999999999 106.926 176.091 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -113.72 118.44 34.33 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.758 -0.655 . . . . 1.6699999999999999 111.968 -177.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.41 133.09 55.98 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-O 122.31 1.052 . . . . 1.8 111.191 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.22 145.77 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 113.018 -1.901 . . . . 0.57999999999999996 110.548 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.437 ' HB3' ' OD1' ' A' ' 164' ' ' ASN . 41.0 pttt -58.16 151.17 19.63 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 116.97 2.211 . . . . 2.1800000000000002 116.97 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.67 -60.34 0.56 Allowed Glycine 0 CA--C 1.539 1.533 0 CA-C-N 115.093 -0.958 . . . . 1.02 113.68 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -141.52 -61.0 0.47 Allowed 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.967 0.384 . . . . 2.8599999999999999 111.717 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -117.49 -49.49 2.56 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.939 0.496 . . . . 3.9100000000000001 112.077 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.35 178.57 4.55 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.464 0.705 . . . . 1.74 111.459 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.665 HD21 ' H ' ' A' ' 70' ' ' SER . 5.3 m-20 -118.28 -85.93 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.045 0 CA-C-O 117.356 -1.307 . . . . 1.6799999999999999 110.275 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -87.49 -37.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.398 3.176 0 CA-C-N 123.648 2.338 . . . . 2.0600000000000001 114.436 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.495 ' H ' HD21 ' A' ' 67' ' ' ASN . 3.1 ttpm? 79.86 -94.02 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 126.495 1.918 . . . . 3.0 110.366 -177.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 64' ' ' GLU . 17.5 t -106.42 131.29 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.413 -1.328 . . . . 0.80000000000000004 107.413 174.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.2 t -134.59 129.94 35.74 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.94 -1.027 . . . . 0.87 112.841 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.268 . . -122.87 47.89 1.88 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.71 1.745 . . . . 0.34000000000000002 115.71 -177.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -40.38 127.26 2.34 Favored 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 116.051 1.871 . . . . 0.69999999999999996 116.051 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.475 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 4.8 t80 -147.55 100.88 3.29 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.912 -0.585 . . . . 0.20999999999999999 111.101 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.47 HD12 HD12 ' A' ' 85' ' ' LEU 0.305 10.1 tt -109.86 121.3 62.55 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.061 0 CA-C-O 122.427 1.108 . . . . 0.31 111.011 175.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -123.34 165.35 17.15 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 113.873 -1.512 . . . . 0.44 110.734 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 18.7 ptmt -122.14 159.35 27.37 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 118.139 2.644 . . . . 1.26 118.139 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.62 -41.59 2.11 Favored Glycine 0 CA--C 1.544 1.859 0 CA-C-N 110.11 -3.223 . . . . 0.17000000000000001 119.053 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.61 154.18 0.94 Allowed 'General case' 0 N--CA 1.52 3.058 0 CA-C-N 120.782 2.291 . . . . 0.14999999999999999 113.156 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.77 -13.33 59.87 Favored 'General case' 0 CA--C 1.58 2.125 0 C-N-CA 124.836 1.255 . . . . 0.17000000000000001 114.353 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.55 4.78 45.59 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 113.86 1.059 . . . . 0.55000000000000004 113.86 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.704 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -108.58 -9.89 15.28 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 114.312 1.227 . . . . 0.59999999999999998 114.312 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.9 95.15 0.27 Allowed Pre-proline 0 N--CA 1.516 2.847 0 C-N-CA 124.424 1.09 . . . . 0.94999999999999996 113.358 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.704 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 72.7 Cg_endo -95.83 140.39 0.9 Allowed 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 122.822 2.348 . . . . 1.8 114.306 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 15.0 ptt? -142.81 111.25 6.18 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.754 -0.657 . . . . 4.96 111.568 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.7 mt -136.95 162.9 31.99 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 122.063 0.935 . . . . 4.0 112.572 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -104.4 154.47 38.33 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-N 114.606 -1.179 . . . . 6.2699999999999996 110.532 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.18 121.4 8.7 Favored 'Trans proline' 0 C--N 1.394 2.963 0 C-N-CA 122.544 2.163 . . . . 6.5899999999999999 115.338 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -136.18 135.33 20.99 Favored Pre-proline 0 CA--C 1.568 1.662 0 CA-C-N 114.618 -1.174 . . . . 5.5099999999999998 111.01 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.82 -27.26 7.34 Favored 'Trans proline' 0 C--N 1.394 2.956 0 C-N-CA 123.534 2.823 . . . . 6.7699999999999996 116.388 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -118.8 129.39 8.11 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 114.433 0.533 . . . . 7.0199999999999996 114.433 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.3 mt -118.45 103.83 10.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.723 0.409 . . . . 8.9900000000000002 112.006 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.182 -0.913 . . . . 10.6 110.456 179.691 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.575 -0.21 . . . . 8.9299999999999997 112.575 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.85 -39.92 5.19 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.136 0.791 . . . . 6.8200000000000003 113.136 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -118.87 -68.56 0.91 Allowed 'General case' 0 C--N 1.363 1.171 0 C-N-CA 122.647 0.379 . . . . 7.6399999999999997 111.782 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 m -135.98 -69.77 0.48 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.595 0.358 . . . . 3.8599999999999999 111.908 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.11 95.47 0.11 Allowed Glycine 0 C--N 1.349 1.285 0 C-N-CA 121.411 -0.423 . . . . 1.1100000000000001 113.224 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.508 ' HG ' HD11 ' A' ' 27' ' ' ILE . 15.0 tp -88.36 -49.91 6.66 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 123.815 0.846 . . . . 0.34999999999999998 112.947 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.4 -23.09 65.56 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 126.101 1.76 . . . . 0.20000000000000001 115.274 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -11.65 51.71 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.727 1.01 . . . . 0.32000000000000001 113.727 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 2.1 mmpt? -108.57 -19.23 13.51 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 113.514 0.931 . . . . 1.73 113.514 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.03 135.75 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.936 0 N-CA-C 115.257 1.577 . . . . 0.11 115.257 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.5 -29.83 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 115.287 -0.869 . . . . 0.16 112.095 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -163.07 123.3 2.28 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-O 120.572 0.225 . . . . 0.54000000000000004 110.953 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -140.93 128.55 21.46 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.351 -0.843 . . . . 0.19 110.777 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.1 t -136.57 131.06 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.507 0.928 . . . . 1.05 113.507 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -116.7 110.88 19.03 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.304 -0.999 . . . . 2.1099999999999999 108.304 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.59 100.11 9.95 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-O 122.223 1.011 . . . . 0.63 110.437 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.51 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -179.74 -57.54 0.08 OUTLIER Glycine 0 C--N 1.348 1.232 0 CA-C-N 113.594 -1.639 . . . . 0.70999999999999996 115.528 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.4 -115.9 3.29 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 120.038 -0.312 . . . . 0.80000000000000004 113.795 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -165.11 117.73 1.2 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.359 0.264 . . . . 1.6299999999999999 111.565 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 2.8 m 41.71 106.04 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.155 0 N-CA-C 118.075 2.62 . . . . 1.0 118.075 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.636 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 82.7 t60 -134.07 138.3 45.21 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.041 1.126 . . . . 0.45000000000000001 114.041 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.261 8.0 p -108.64 117.48 54.2 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.073 0 CA-C-N 114.202 -1.363 . . . . 1.3899999999999999 110.254 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.07 156.97 23.05 Favored 'General case' 0 CA--C 1.571 1.757 0 CA-C-N 114.343 -1.298 . . . . 1.8500000000000001 110.676 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 m -41.4 -32.69 0.36 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.153 0 N-CA-C 119.113 3.005 . . . . 0.71999999999999997 119.113 -176.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.41 ' HB2' HD23 ' A' ' 6' ' ' LEU . 63.8 m-70 -88.42 -26.87 21.9 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.312 0.505 . . . . 0.51000000000000001 110.909 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.94 43.43 0.41 Allowed Glycine 0 C--N 1.35 1.334 0 CA-C-N 114.994 -1.003 . . . . 0.34000000000000002 114.701 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.508 HD11 ' HG ' ' A' ' 6' ' ' LEU . 15.8 mm -106.79 112.66 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 N-CA-C 109.687 -0.486 . . . . 0.55000000000000004 109.687 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.636 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.74 134.85 48.19 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 115.189 1.552 . . . . 1.3400000000000001 115.189 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -96.14 143.09 27.57 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.731 -1.122 . . . . 2.79 110.08 176.378 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -97.44 103.37 15.3 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.226 1.011 . . . . 3.0 113.381 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -33.79 116.7 0.28 Allowed 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 118.51 2.781 . . . . 2.2999999999999998 118.51 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 40.37 73.43 0.85 Allowed Pre-proline 0 N--CA 1.525 3.318 0 N-CA-C 118.178 2.658 . . . . 1.1699999999999999 118.178 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -99.9 -12.21 0.26 Allowed 'Trans proline' 0 CA--C 1.56 1.777 0 C-N-CA 122.281 1.987 . . . . 1.45 116.69 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.4 tp -133.91 -52.13 0.85 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.574 0.583 . . . . 1.9099999999999999 112.574 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -91.29 97.75 11.3 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.983 0.896 . . . . 4.8399999999999999 112.44 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.2 -31.81 6.93 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-N 113.604 -1.635 . . . . 2.3700000000000001 112.908 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 74.99 -56.13 0.64 Allowed 'General case' 0 N--CA 1.511 2.576 0 C-N-CA 126.428 1.891 . . . . 4.5 114.408 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.58 116.64 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 123.46 0.704 . . . . 2.7000000000000002 110.222 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.87 -132.24 1.71 Allowed Glycine 0 C--N 1.341 0.858 0 C-N-CA 121.216 -0.516 . . . . 1.95 113.729 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -150.25 -126.07 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 111.969 0.359 . . . . 5.3399999999999999 111.969 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.88 136.7 47.99 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.801 0.84 . . . . 1.6399999999999999 112.396 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.9 m -132.9 99.05 4.47 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.333 -0.849 . . . . 1.5700000000000001 109.953 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.91 107.77 18.72 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 112.892 0.701 . . . . 2.3300000000000001 112.892 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -110.42 75.34 0.92 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.913 0.863 . . . . 3.1600000000000001 110.072 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.99 71.66 0.37 Allowed Glycine 0 C--N 1.344 0.992 0 CA-C-N 114.306 -1.316 . . . . 1.52 110.566 -177.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -92.35 0.66 57.46 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 115.615 1.709 . . . . 1.6699999999999999 115.615 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.81 42.02 1.95 Allowed 'General case' 0 CA--C 1.561 1.387 0 CA-C-O 121.872 0.844 . . . . 4.1799999999999997 112.434 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.4 mt -140.0 75.77 29.06 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 125.057 1.343 . . . . 2.6299999999999999 107.794 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.35 167.06 17.74 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.956 2.437 . . . . 1.3700000000000001 117.042 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.25 1.3 mp -91.45 136.72 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.243 0 CA-C-N 114.748 -1.114 . . . . 0.68999999999999995 110.039 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.1 -10.45 33.3 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 115.991 1.848 . . . . 1.28 115.991 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -108.25 20.94 18.03 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 114.302 1.223 . . . . 1.51 114.302 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.53 -166.63 2.1 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 121.71 0.767 . . . . 1.0900000000000001 112.789 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.85 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.8 t30 -90.25 177.7 2.25 Favored Pre-proline 0 N--CA 1.498 1.952 0 C-N-CA 125.411 1.484 . . . . 1.27 110.959 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -71.71 -46.99 0.51 Allowed 'Trans proline' 0 C--N 1.394 2.942 0 C-N-CA 122.998 2.465 . . . . 0.94999999999999996 112.592 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 56' ' ' GLU . 3.6 pt-20 -69.75 -44.11 70.87 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 113.786 -1.552 . . . . 2.04 112.034 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -80.14 -7.21 58.81 Favored 'General case' 0 CA--C 1.587 2.371 0 CA-C-N 115.11 -0.95 . . . . 1.6200000000000001 111.758 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.85 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.6 tt0 -73.31 -37.81 66.05 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 125.684 1.594 . . . . 1.77 108.737 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -64.01 -47.78 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.871 0 C-N-CA 125.777 1.631 . . . . 0.81000000000000005 109.042 173.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.611 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 1.6 tp -80.12 -4.58 53.48 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.69 1.366 . . . . 1.1499999999999999 114.69 177.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -113.17 3.46 16.06 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 124.639 1.176 . . . . 0.92000000000000004 110.222 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.77 -115.95 0.14 Allowed 'General case' 0 CA--C 1.568 1.658 0 C-N-CA 124.479 1.112 . . . . 1.3300000000000001 111.703 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.289 2.9 p 56.67 -84.48 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.12 0 C-N-CA 127.33 2.252 . . . . 1.28 116.144 -174.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.532 ' HB2' HG22 ' A' ' 167' ' ' VAL . 20.6 tt0 82.08 133.7 0.06 Allowed 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 125.361 1.465 . . . . 1.53 114.227 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 35.7 mtp85 -100.23 -75.48 0.58 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 111.92 0.341 . . . . 3.2200000000000002 111.92 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.06 161.78 33.99 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.748 0.785 . . . . 3.6600000000000001 112.886 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.484 ' OD1' ' HA ' ' A' ' 166' ' ' LYS . 1.3 m-20 -119.88 134.02 55.38 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.126 -0.943 . . . . 4.7000000000000002 111.133 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -157.12 -62.62 0.09 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.395 1.257 . . . . 2.5499999999999998 114.395 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.1 -160.07 1.12 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.575 0.625 . . . . 2.1499999999999999 112.355 -175.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.51 107.62 1.17 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 124.522 1.129 . . . . 0.77000000000000002 112.35 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -100.45 129.28 46.39 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.403 -1.271 . . . . 0.81000000000000005 110.651 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -133.73 132.88 6.64 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 118.716 2.247 . . . . 0.46999999999999997 118.716 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -103.1 145.61 29.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.28 0.844 . . . . 0.89000000000000001 113.28 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.9 117.96 32.13 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.383 -1.281 . . . . 0.51000000000000001 111.897 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.45 HG21 HG21 ' A' ' 172' ' ' ILE . 3.2 mp -117.51 97.69 51.01 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.275 -0.875 . . . . 0.14999999999999999 109.048 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -83.03 118.84 2.74 Favored 'Trans proline' 0 CA--C 1.558 1.705 0 C-N-CA 122.16 1.906 . . . . 0.14999999999999999 114.755 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.92 159.18 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 CA-C-O 122.119 0.962 . . . . 0.19 111.433 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -146.36 17.97 1.35 Allowed 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 114.315 -1.311 . . . . 2.5299999999999998 111.935 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -128.99 163.22 25.83 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 121.269 0.557 . . . . 2.1200000000000001 111.466 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -124.18 146.65 48.55 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.8 1.037 . . . . 0.41999999999999998 113.8 -178.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.72 -133.93 3.61 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.068 -1.423 . . . . 0.23000000000000001 112.094 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 21.5 mt-10 -118.52 106.46 12.69 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 118.479 1.139 . . . . 1.75 111.106 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -98.97 128.85 45.21 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.485 0.66 . . . . 0.20999999999999999 111.331 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.46 118.23 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-N 115.328 -0.851 . . . . 0.20000000000000001 111.045 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.535 HD12 HD12 ' A' ' 172' ' ' ILE . 1.6 tt -107.83 105.06 14.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.228 -1.351 . . . . 0.78000000000000003 109.81 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.88 125.41 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 114.229 -1.35 . . . . 0.44 108.741 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.14 137.17 54.16 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 112.762 0.652 . . . . 1.25 112.762 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 5.3 tptp -101.17 115.73 31.17 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.076 -0.965 . . . . 2.52 110.196 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -105.01 134.38 48.22 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.957 -0.565 . . . . 0.40000000000000002 110.156 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.72 152.75 51.66 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.614 0.721 . . . . 0.40999999999999998 111.899 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -126.1 150.59 48.09 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.3 -0.863 . . . . 2.6099999999999999 110.449 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.96 -76.03 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 114.186 1.18 . . . . 2.1299999999999999 114.186 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -124.27 73.17 1.22 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.059 0.763 . . . . 2.27 113.059 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -154.29 109.29 3.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.711 0.804 . . . . 1.46 109.668 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.42 104.78 14.21 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 122.192 0.996 . . . . 0.83999999999999997 112.495 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -171.84 140.02 1.23 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.884 -1.053 . . . . 2.4500000000000002 111.716 179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.4 m -129.07 118.57 22.72 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.571 -0.74 . . . . 1.6599999999999999 111.835 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 72.97 49.94 0.15 Allowed 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 125.793 1.637 . . . . 1.8899999999999999 112.508 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -151.33 -40.48 0.12 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.476 1.111 . . . . 2.5600000000000001 110.278 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -109.04 83.73 1.8 Allowed 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.464 -0.939 . . . . 2.7599999999999998 108.464 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.85 126.57 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 113.888 -1.505 . . . . 0.68999999999999995 111.651 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.54 -176.4 3.07 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.205 1.558 . . . . 0.69999999999999996 115.205 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -128.42 136.98 51.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.092 -0.38 . . . . 1.3300000000000001 111.29 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.9 t -130.23 125.26 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.279 0 C-N-CA 123.482 0.713 . . . . 0.47999999999999998 109.918 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.3 mtt180 -121.97 153.26 38.76 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.406 1.632 . . . . 1.6899999999999999 115.406 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.55 102.83 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 114.928 -1.033 . . . . 0.59999999999999998 112.373 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.5 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.31 27.21 13.76 Favored 'General case' 0 N--CA 1.524 3.252 0 C-N-CA 126.876 2.07 . . . . 1.1200000000000001 113.895 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.32 -18.59 35.63 Favored Glycine 0 CA--C 1.547 2.032 0 C-N-CA 121.375 -0.441 . . . . 0.32000000000000001 113.235 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -86.07 173.8 9.62 Favored 'General case' 0 C--N 1.368 1.384 0 C-N-CA 125.491 1.517 . . . . 0.56999999999999995 113.53 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.7 p -126.57 126.24 43.32 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.175 0.512 . . . . 0.55000000000000004 111.278 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.263 9.1 p -112.41 -45.12 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 CA-C-N 115.263 -0.88 . . . . 1.0600000000000001 111.072 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.66 89.19 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 109.013 -0.736 . . . . 0.44 109.013 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -105.74 90.68 3.47 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-O 122.986 1.374 . . . . 2.2999999999999998 110.366 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 127.65 78.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 110.01 -3.268 . . . . 2.48 108.508 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.06 110.86 22.94 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 121.744 0.783 . . . . 1.1299999999999999 112.916 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -119.0 98.84 6.38 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 106.899 -1.519 . . . . 2.3500000000000001 106.899 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -25.54 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.32 0 N-CA-C 113.925 1.083 . . . . 0.68000000000000005 113.925 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -75.71 -40.29 55.93 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.022 0.929 . . . . 0.77000000000000002 112.311 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -73.26 -26.85 61.26 Favored 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 124.672 1.189 . . . . 0.91000000000000003 113.388 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -80.66 -57.77 3.41 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.692 0.997 . . . . 2.4300000000000002 113.692 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.33 -34.7 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 N-CA-C 114.864 1.431 . . . . 0.93000000000000005 114.864 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 123.68 -109.22 1.28 Allowed Glycine 0 C--N 1.356 1.669 0 CA-C-N 118.764 0.711 . . . . 0.84999999999999998 113.578 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -114.61 106.87 14.75 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.757 0.313 . . . . 3.1800000000000002 110.707 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.8 m 68.09 -124.09 0.18 Allowed 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 125.379 1.471 . . . . 2.0800000000000001 112.825 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.3 p 56.07 -164.09 0.14 Allowed 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 126.461 1.904 . . . . 0.62 115.134 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.449 ' HB1' ' HZ2' ' A' ' 88' ' ' LYS . . . -111.34 132.3 54.51 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 113.102 0.778 . . . . 0.46000000000000002 113.102 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -107.72 143.69 35.89 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.035 0.534 . . . . 0.38 109.829 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.28 131.85 19.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.185 1.18 . . . . 2.5 114.185 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -119.94 134.14 55.34 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 115.145 -0.934 . . . . 1.5600000000000001 110.827 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.47 122.36 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 114.652 -1.158 . . . . 0.45000000000000001 110.835 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.78 86.24 58.78 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-N 115.361 -0.836 . . . . 0.83999999999999997 110.823 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -73.88 126.23 10.52 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 123.015 2.477 . . . . 0.16 112.634 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -112.21 149.45 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.565 0 CA-C-N 115.153 -0.931 . . . . 0.38 111.428 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 p -130.33 110.63 11.67 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.1 -0.954 . . . . 1.3100000000000001 111.661 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.2 mt -114.15 122.73 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 N-CA-C 108.477 -0.934 . . . . 0.25 108.477 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -141.04 127.36 19.78 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.658 -0.701 . . . . 2.0499999999999998 110.76 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp 68.0 14.35 9.33 Favored 'General case' 0 N--CA 1.514 2.759 0 C-N-CA 125.287 1.435 . . . . 3.5499999999999998 113.961 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 17.47 30.1 Favored Glycine 0 CA--C 1.547 2.059 0 CA-C-O 119.213 -0.771 . . . . 0.37 114.786 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 55.5 mtpt -124.42 146.38 48.93 Favored 'General case' 0 C--N 1.367 1.35 0 CA-C-N 118.378 1.089 . . . . 1.5600000000000001 112.46 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.18 144.7 30.39 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.275 1.213 . . . . 0.34000000000000002 114.275 -175.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.27 113.44 11.29 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.824 -1.08 . . . . 0.64000000000000001 110.467 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.3 p -107.81 94.0 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.571 0 CA-C-N 115.929 -0.578 . . . . 0.46000000000000002 110.226 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 66.95 -83.29 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.778 0 C-N-CA 125.527 1.531 . . . . 1.5600000000000001 113.871 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.24 26.05 4.76 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 116.094 -0.503 . . . . 0.48999999999999999 113.628 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -128.71 131.79 47.95 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 123.364 0.666 . . . . 1.8200000000000001 110.57 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -116.14 130.62 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 CA-C-O 121.64 0.733 . . . . 1.02 111.981 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m -150.84 -179.1 6.99 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.975 -1.011 . . . . 0.56000000000000005 109.592 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.271 14.1 t -104.25 138.79 40.19 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 113.425 0.898 . . . . 1.25 113.425 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -82.53 122.03 27.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 124.18 0.992 . . . . 0.28999999999999998 111.349 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.79 90.53 3.26 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.48 0.548 . . . . 1.4199999999999999 112.48 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.5 -62.69 2.69 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 118.92 2.328 . . . . 0.41999999999999998 118.92 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.51 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -134.0 158.86 42.45 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.079 1.14 . . . . 1.1000000000000001 114.079 -176.605 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.51 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -104.61 137.75 41.97 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.523 -1.671 . . . . 0.67000000000000004 109.107 176.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.407 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.0 t -124.13 128.29 49.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.772 1.397 . . . . 0.35999999999999999 114.772 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 3.2 t -106.56 101.42 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 106.689 -1.597 . . . . 0.73999999999999999 106.689 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -117.64 120.71 38.84 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.882 -1.054 . . . . 1.6699999999999999 112.746 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -113.74 126.93 55.78 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-O 122.177 0.989 . . . . 1.8 111.223 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.78 146.02 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-N 112.947 -1.933 . . . . 0.57999999999999996 111.242 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -91.14 149.94 21.59 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 114.853 -1.067 . . . . 2.1800000000000002 113.165 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -89.41 -43.98 5.09 Favored Glycine 0 CA--C 1.545 1.954 0 CA-C-N 115.634 -0.712 . . . . 1.02 114.859 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -128.99 -71.99 0.62 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.694 0.398 . . . . 2.8599999999999999 110.992 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.605 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 6.8 t80 -146.65 120.42 9.24 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.319 0.647 . . . . 3.9100000000000001 109.5 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 0.5 OUTLIER 90.64 151.93 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 125.033 1.333 . . . . 1.74 112.067 -178.183 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.65 -168.32 0.15 Allowed Pre-proline 0 CA--C 1.572 1.795 0 CA-C-N 113.994 -1.457 . . . . 1.6799999999999999 109.434 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -57.76 -17.92 31.57 Favored 'Trans proline' 0 C--N 1.403 3.436 0 C-N-CA 122.937 2.425 . . . . 2.0600000000000001 115.181 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.484 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 63.0 tttt 81.91 -63.99 0.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 126.665 1.986 . . . . 3.0 115.513 174.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 64' ' ' GLU . 4.0 t -102.61 134.27 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.602 1.092 . . . . 0.80000000000000004 110.594 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.57 132.33 38.96 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 114.779 -1.101 . . . . 0.87 113.262 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -128.68 48.48 2.32 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.081 1.511 . . . . 0.34000000000000002 115.081 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.93 135.36 4.15 Favored 'General case' 0 N--CA 1.515 2.808 0 N-CA-C 116.663 2.097 . . . . 0.69999999999999996 116.663 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -150.02 108.84 3.86 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.804 -0.635 . . . . 0.20999999999999999 111.068 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.535 HD12 HD12 ' A' ' 85' ' ' LEU 0.308 6.6 tt -117.49 123.26 71.51 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.15 0 CA-C-O 122.439 1.114 . . . . 0.31 111.685 175.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 10.5 ptm -123.33 166.79 14.71 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 113.924 -1.489 . . . . 0.44 111.274 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.2 ptmm? -123.16 157.59 32.64 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 118.2 2.667 . . . . 1.26 118.2 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.65 -42.36 1.91 Allowed Glycine 0 CA--C 1.542 1.728 0 CA-C-N 110.604 -2.998 . . . . 0.17000000000000001 119.085 173.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.57 152.44 0.81 Allowed 'General case' 0 N--CA 1.516 2.864 0 CA-C-N 120.419 2.11 . . . . 0.14999999999999999 112.762 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.91 -15.5 59.66 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.437 1.273 . . . . 0.17000000000000001 114.437 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.62 4.5 43.59 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.101 1.148 . . . . 0.55000000000000004 114.101 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.619 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -103.99 -10.87 17.77 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 113.624 0.972 . . . . 0.59999999999999998 113.624 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.52 98.9 0.29 Allowed Pre-proline 0 N--CA 1.516 2.871 0 C-N-CA 125.325 1.45 . . . . 0.94999999999999996 111.489 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.619 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 93.6 Cg_endo -95.63 103.92 0.1 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.799 2.333 . . . . 1.8 114.397 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.95 118.23 7.84 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.53 -0.759 . . . . 4.96 110.899 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.2 mt -130.28 168.9 16.14 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.082 0.944 . . . . 4.0 112.79 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -105.09 154.93 38.41 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-N 114.577 -1.192 . . . . 6.2699999999999996 110.841 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.73 120.66 7.42 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 122.29 1.993 . . . . 6.5899999999999999 114.413 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -135.71 143.68 45.73 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-N 114.672 -1.149 . . . . 5.5099999999999998 111.355 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -88.07 -154.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 122.944 2.429 . . . . 6.7699999999999996 113.905 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 168.31 101.11 0.15 Allowed Glycine 0 C--N 1.341 0.839 0 C-N-CA 121.049 -0.596 . . . . 7.0199999999999996 113.258 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.82 121.25 39.59 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.154 0.502 . . . . 8.9900000000000002 112.074 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.28 -0.867 . . . . 10.6 111.055 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.48 -0.248 . . . . 8.9299999999999997 112.48 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.86 131.94 55.03 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.557 0.694 . . . . 6.8200000000000003 111.881 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.5 mtt -126.9 -67.9 0.83 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.716 -0.675 . . . . 7.6399999999999997 111.63 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.9 m -137.9 107.25 6.11 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.943 0.402 . . . . 3.8599999999999999 111.241 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.73 91.02 0.1 OUTLIER Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.753 -0.658 . . . . 1.1100000000000001 113.09 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.559 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.6 tp -88.07 -47.37 8.56 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 113.248 0.833 . . . . 0.34999999999999998 113.248 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.37 -22.77 61.85 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 125.951 1.7 . . . . 0.20000000000000001 115.161 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.46 -12.34 49.29 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 113.596 0.961 . . . . 0.32000000000000001 113.596 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -105.65 -21.64 13.15 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.285 0.846 . . . . 1.73 113.285 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.24 135.68 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.926 0 N-CA-C 115.317 1.599 . . . . 0.11 115.317 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -124.13 -29.39 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 115.24 -0.891 . . . . 0.16 112.258 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 62.5 t90 -162.38 116.99 1.83 Allowed 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 120.545 0.212 . . . . 0.54000000000000004 111.328 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.82 129.0 31.77 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.483 -0.761 . . . . 0.19 111.365 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -136.81 130.99 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 113.214 0.82 . . . . 1.05 113.214 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 8.2 t-20 -114.1 105.33 13.08 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 107.663 -1.236 . . . . 2.1099999999999999 107.663 172.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.22 105.56 11.59 Favored 'General case' 0 C--O 1.274 2.38 0 CA-C-O 121.802 0.811 . . . . 0.63 110.39 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.596 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 168.98 -58.32 0.2 Allowed Glycine 0 C--N 1.358 1.786 0 CA-C-N 112.026 -2.352 . . . . 0.70999999999999996 114.037 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -106.96 -128.24 5.94 Favored Glycine 0 N--CA 1.478 1.464 0 CA-C-O 119.303 -0.721 . . . . 0.80000000000000004 113.121 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.496 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 40.3 mt-10 -162.09 117.22 1.93 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.645 0.723 . . . . 1.6299999999999999 111.86 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 55.61 108.94 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 117.358 2.355 . . . . 1.0 117.358 177.634 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 52.2 t-80 -144.59 139.05 27.87 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 114.071 1.137 . . . . 0.45000000000000001 114.071 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.268 9.9 p -107.63 118.84 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.085 0 CA-C-N 114.829 -1.078 . . . . 1.3899999999999999 110.886 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.23 156.01 22.21 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 114.395 -1.275 . . . . 1.8500000000000001 110.856 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 m -41.82 -32.16 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.258 0 N-CA-C 119.087 2.995 . . . . 0.71999999999999997 119.087 -176.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -87.16 -23.84 24.68 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.413 0.551 . . . . 0.51000000000000001 111.374 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.73 40.94 0.69 Allowed Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.114 -0.948 . . . . 0.34000000000000002 114.403 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.559 HD11 ' HG ' ' A' ' 6' ' ' LEU . 22.7 mm -106.91 113.35 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 N-CA-C 109.755 -0.461 . . . . 0.55000000000000004 109.755 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.3 132.67 51.21 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 115.34 1.608 . . . . 1.3400000000000001 115.34 -177.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.496 ' OH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -93.17 146.65 23.51 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 114.849 -1.069 . . . . 2.79 109.911 175.247 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -58.16 -111.71 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 127.505 2.322 . . . . 3.0 116.688 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -178.63 79.63 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 113.229 0.826 . . . . 2.2999999999999998 113.229 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.454 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 0.3 OUTLIER 65.14 46.31 0.53 Allowed Pre-proline 0 N--CA 1.517 2.894 0 N-CA-C 117.695 2.48 . . . . 1.1699999999999999 117.695 176.55 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 43.0 Cg_endo -107.87 154.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 123.072 2.515 . . . . 1.45 114.579 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.05 -85.74 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.453 -1.249 . . . . 1.9099999999999999 109.796 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -151.98 52.99 0.81 Allowed 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 113.402 0.89 . . . . 4.8399999999999999 113.402 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.72 2.57 30.55 Favored Glycine 0 CA--C 1.545 1.943 0 N-CA-C 115.735 1.054 . . . . 2.3700000000000001 115.735 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.435 ' H ' ' HG2' ' A' ' 37' ' ' ARG . 7.2 ptp180 -117.52 87.45 2.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.719 0.808 . . . . 4.5 112.33 -176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.88 128.55 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.343 0 CA-C-N 115.025 -0.989 . . . . 2.7000000000000002 110.978 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.49 -108.78 0.32 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.742 -0.663 . . . . 1.95 113.613 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -133.76 -174.27 3.48 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 121.565 0.698 . . . . 5.3399999999999999 112.785 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.12 132.49 34.69 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.283 1.033 . . . . 1.6399999999999999 112.807 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.0 m -120.61 125.07 46.83 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.254 -0.884 . . . . 1.5700000000000001 111.652 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.51 94.49 3.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.492 -0.776 . . . . 2.3300000000000001 110.673 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -104.72 76.14 1.26 Allowed 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 122.039 0.923 . . . . 3.1600000000000001 110.084 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 122.84 69.07 0.23 Allowed Glycine 0 C--N 1.342 0.912 0 CA-C-N 113.991 -1.459 . . . . 1.52 110.191 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -92.15 0.23 57.45 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 115.477 1.658 . . . . 1.6699999999999999 115.477 -177.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -111.06 64.15 0.61 Allowed 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.918 0.866 . . . . 4.1799999999999997 110.941 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 tp -167.48 73.68 0.98 Allowed Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 114.591 -1.186 . . . . 2.6299999999999999 108.075 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 31.8 Cg_exo -66.49 157.86 58.4 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.729 2.953 . . . . 1.3700000000000001 117.051 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.273 1.1 mp -87.75 124.51 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.09 0 CA-C-N 115.22 -0.9 . . . . 0.68999999999999995 108.981 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -81.19 -19.34 43.52 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.421 2.008 . . . . 1.28 116.421 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -94.97 24.0 5.16 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 113.736 1.013 . . . . 1.51 113.736 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.16 -173.18 4.18 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.828 0.851 . . . . 1.0900000000000001 110.954 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.696 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.87 -176.91 0.58 Allowed Pre-proline 0 N--CA 1.512 2.64 0 CA-C-O 118.449 -0.786 . . . . 1.27 109.421 178.128 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -69.17 -39.49 7.56 Favored 'Trans proline' 0 C--N 1.398 3.165 0 C-N-CA 122.613 2.209 . . . . 0.94999999999999996 113.279 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 56' ' ' GLU . 6.3 pt-20 -69.25 -49.24 58.05 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 125.322 1.449 . . . . 2.04 112.015 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -79.65 -5.42 55.06 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 114.914 -1.039 . . . . 1.6200000000000001 112.625 177.232 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.696 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 1.1 tt0 -74.02 -41.84 61.22 Favored 'General case' 0 C--N 1.38 1.929 0 C-N-CA 125.617 1.567 . . . . 1.77 107.952 173.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.8 t -61.4 -45.04 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 C-N-CA 124.304 1.042 . . . . 0.81000000000000005 109.541 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 1.5 tp -79.98 -5.56 55.92 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 114.35 1.241 . . . . 1.1499999999999999 114.35 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 6.5 m-30 -123.81 20.66 9.27 Favored 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 124.477 1.111 . . . . 0.92000000000000004 111.909 176.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -148.16 -28.04 0.33 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 116.878 2.177 . . . . 1.3300000000000001 116.878 -176.272 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.0 p -73.29 137.54 44.92 Favored 'General case' 0 N--CA 1.533 3.725 0 N-CA-C 114.206 1.187 . . . . 1.28 114.206 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.596 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 7.9 pt-20 -112.6 139.4 48.22 Favored 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 117.004 2.224 . . . . 1.53 117.004 -175.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -127.11 114.75 18.15 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 114.692 -1.14 . . . . 3.2200000000000002 109.034 175.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -122.4 147.26 46.51 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.225 0.824 . . . . 3.6600000000000001 113.225 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -127.47 -93.77 0.46 Allowed 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 115.454 -0.794 . . . . 4.7000000000000002 111.64 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -161.31 -48.59 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.221 1.934 . . . . 2.5499999999999998 116.221 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.6 -160.05 0.86 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.678 0.992 . . . . 2.1499999999999999 113.678 -175.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.31 109.94 1.12 Allowed 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 124.957 1.303 . . . . 0.77000000000000002 112.091 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.63 154.06 49.78 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 114.942 -1.026 . . . . 0.81000000000000005 112.965 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.84 -174.63 37.63 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.077 -0.965 . . . . 0.46999999999999997 115.124 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.47 171.67 7.38 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 114.782 1.401 . . . . 0.89000000000000001 114.782 -177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.15 129.33 49.94 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 113.573 -1.649 . . . . 0.51000000000000001 111.768 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -122.87 100.93 39.85 Favored Pre-proline 0 CA--C 1.568 1.666 0 C-N-CA 123.011 0.524 . . . . 0.14999999999999999 109.597 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -83.5 116.85 2.34 Favored 'Trans proline' 0 CA--C 1.566 2.097 0 C-N-CA 122.251 1.967 . . . . 0.14999999999999999 114.729 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.59 158.37 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.979 0.895 . . . . 0.19 110.851 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -143.02 19.86 1.95 Allowed 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 114.844 -1.071 . . . . 2.5299999999999998 112.13 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -125.84 161.71 26.8 Favored 'General case' 0 C--N 1.362 1.114 0 CA-C-O 121.297 0.57 . . . . 2.1200000000000001 111.786 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.5 OUTLIER -120.29 140.59 51.01 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.445 0.906 . . . . 0.41999999999999998 113.445 -179.044 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.14 -137.77 4.92 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.123 -1.399 . . . . 0.23000000000000001 112.332 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.1 mt-10 -117.66 106.37 13.01 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 118.334 1.067 . . . . 1.75 111.105 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -99.36 129.9 45.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.179 0.514 . . . . 0.20999999999999999 111.256 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.99 118.94 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.798 0.808 . . . . 0.20000000000000001 110.731 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.472 HD12 HD12 ' A' ' 172' ' ' ILE . 1.5 tt -106.98 105.3 15.26 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.118 -1.401 . . . . 0.78000000000000003 109.956 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.05 127.57 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 114.471 -1.241 . . . . 0.44 108.705 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.95 137.49 52.28 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.04 0.756 . . . . 1.25 113.04 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 17.7 tptt -102.96 115.99 31.67 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.361 -0.836 . . . . 2.52 110.723 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 15.0 m-85 -105.74 134.87 48.16 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.95 -0.568 . . . . 0.40000000000000002 110.379 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.6 156.34 48.17 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.248 0.547 . . . . 0.40999999999999998 112.26 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -121.33 133.19 55.11 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.803 0.841 . . . . 2.6099999999999999 111.147 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.49 27.04 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 114.645 1.35 . . . . 2.1299999999999999 114.645 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.19 -37.11 0.06 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 114.535 1.309 . . . . 2.27 114.535 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.31 130.44 56.03 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.075 0.768 . . . . 1.46 113.075 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.17 95.28 5.21 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-O 122.494 1.14 . . . . 0.83999999999999997 110.805 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -154.15 149.36 26.99 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.107 -0.951 . . . . 2.4500000000000002 112.661 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.0 m -124.97 125.96 44.72 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.649 -0.705 . . . . 1.6599999999999999 112.865 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 68.16 49.06 0.87 Allowed 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 125.695 1.598 . . . . 1.8899999999999999 113.179 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -145.8 -41.14 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.602 1.161 . . . . 2.5600000000000001 109.788 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -112.13 82.68 1.67 Allowed 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.462 -0.94 . . . . 2.7599999999999998 108.462 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.59 115.3 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 113.997 -1.456 . . . . 0.68999999999999995 110.321 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.443 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 34.1 m-85 -97.46 175.97 6.04 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.381 1.623 . . . . 0.69999999999999996 115.381 -175.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -123.0 135.16 54.36 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 116.531 -0.304 . . . . 1.3300000000000001 110.509 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.12 124.99 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.35 0 CA-C-O 121.338 0.589 . . . . 0.47999999999999998 110.144 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 37.3 mtt180 -122.57 153.37 39.35 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.028 1.492 . . . . 1.6899999999999999 115.028 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.0 OUTLIER -132.71 104.54 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 115.334 -0.848 . . . . 0.59999999999999998 112.831 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.537 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.78 27.0 13.03 Favored 'General case' 0 N--CA 1.522 3.14 0 C-N-CA 126.9 2.08 . . . . 1.1200000000000001 113.689 -179.004 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.63 -19.66 33.23 Favored Glycine 0 CA--C 1.547 2.05 0 CA-C-N 116.107 -0.497 . . . . 0.32000000000000001 113.317 -176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 93.3 m-70 -82.95 171.59 13.69 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 125.345 1.458 . . . . 0.56999999999999995 113.848 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.85 123.08 39.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 122.182 -0.324 . . . . 0.55000000000000004 110.94 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.279 9.9 p -113.36 -48.65 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.144 0 CA-C-N 116.209 -0.451 . . . . 1.0600000000000001 111.533 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.47 90.53 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-O 121.324 0.583 . . . . 0.44 109.741 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -107.13 90.44 3.3 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-O 123.013 1.387 . . . . 2.2999999999999998 111.232 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 127.27 77.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 129.845 3.258 . . . . 2.48 106.828 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -107.14 104.81 14.55 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.963 -1.017 . . . . 1.1299999999999999 113.541 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -114.62 111.33 21.17 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 113.61 -1.632 . . . . 2.3500000000000001 108.579 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.58 -33.54 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 114.628 1.344 . . . . 0.68000000000000005 114.628 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -75.1 -34.97 61.79 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 112.905 0.705 . . . . 0.77000000000000002 112.905 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -75.05 -27.46 60.02 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 124.12 0.968 . . . . 0.91000000000000003 113.285 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -79.06 -55.51 5.07 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.35 0.871 . . . . 2.4300000000000002 113.35 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.52 -40.18 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 N-CA-C 114.021 1.119 . . . . 0.93000000000000005 114.021 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.65 -72.05 0.2 Allowed Glycine 0 C--N 1.359 1.849 0 CA-C-N 118.217 0.462 . . . . 0.84999999999999998 113.919 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -102.16 174.79 5.77 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.31 1.044 . . . . 3.1800000000000002 111.709 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.6 m -70.43 90.85 0.73 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.784 1.031 . . . . 2.0800000000000001 113.784 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 126' ' ' ALA . 0.6 OUTLIER -143.78 -162.68 1.51 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.745 -1.57 . . . . 0.62 109.888 -178.293 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.401 ' H ' ' HB ' ' A' ' 125' ' ' THR . . . -99.89 134.08 43.31 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 113.509 0.929 . . . . 0.46000000000000002 113.509 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 6.1 t60 -105.87 142.92 34.77 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.194 0.598 . . . . 0.38 110.115 177.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -146.41 137.66 24.45 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.928 1.085 . . . . 2.5 113.928 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -128.34 135.36 49.47 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.928 -1.033 . . . . 1.5600000000000001 110.774 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.93 125.18 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.02 -0.991 . . . . 0.45000000000000001 111.107 -178.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -129.05 89.01 49.84 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-N 115.464 -0.789 . . . . 0.83999999999999997 110.927 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -74.95 129.82 12.75 Favored 'Trans proline' 0 C--N 1.394 2.953 0 C-N-CA 122.984 2.456 . . . . 0.16 112.943 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.53 149.51 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.507 0 CA-C-N 115.177 -0.92 . . . . 0.38 111.107 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.3 t -134.26 117.16 16.14 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.553 0.692 . . . . 1.3100000000000001 111.106 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.477 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.4 mt -115.61 126.35 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 CA-C-N 114.69 -1.141 . . . . 0.25 108.381 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -140.15 125.3 18.67 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.479 -0.782 . . . . 2.0499999999999998 110.995 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? 66.56 15.21 10.05 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 125.297 1.439 . . . . 3.5499999999999998 114.548 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.65 19.44 22.53 Favored Glycine 0 CA--C 1.547 2.053 0 CA-C-O 119.165 -0.797 . . . . 0.37 114.923 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 23.3 mtpp -126.61 143.82 51.1 Favored 'General case' 0 C--N 1.368 1.385 0 CA-C-N 118.435 1.117 . . . . 1.5600000000000001 112.399 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.38 146.3 27.78 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.262 1.208 . . . . 0.34000000000000002 114.262 -175.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.3 t -140.93 117.32 10.76 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.916 -1.038 . . . . 0.64000000000000001 110.625 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.253 2.3 p -110.56 98.98 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.514 0 CA-C-N 115.325 -0.852 . . . . 0.46000000000000002 110.302 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 69.47 -81.91 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 125.324 1.45 . . . . 1.5600000000000001 113.488 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.95 26.07 3.3 Favored Glycine 0 CA--C 1.543 1.802 0 CA-C-N 116.022 -0.536 . . . . 0.48999999999999999 113.668 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -129.72 118.52 22.01 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.079 0.552 . . . . 1.8200000000000001 110.5 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.46 137.37 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.759 0.79 . . . . 1.02 112.626 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 m -153.88 -170.75 3.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.31 -1.314 . . . . 0.56000000000000005 108.792 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.259 6.3 t -103.12 146.16 28.81 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 113.216 0.821 . . . . 1.25 113.216 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.408 ' H ' ' HA ' ' A' ' 139' ' ' LYS . 41.5 t80 -89.88 132.67 35.16 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.098 0.951 . . . . 0.28999999999999998 111.596 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.2 p -97.73 -163.09 1.01 Allowed 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 113.9 -1.5 . . . . 1.4199999999999999 108.888 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.45 7.29 65.19 Favored Glycine 0 CA--C 1.56 2.855 0 O-C-N 120.236 -1.54 . . . . 0.41999999999999998 116.895 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.466 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -160.45 152.89 20.71 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-O 122.303 1.049 . . . . 1.1000000000000001 112.499 178.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.537 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -108.42 137.62 46.07 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 113.81 -1.541 . . . . 0.67000000000000004 108.854 177.009 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 t -118.56 145.12 45.61 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.438 1.644 . . . . 0.35999999999999999 115.438 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.05 97.3 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 106.225 -1.769 . . . . 0.73999999999999999 106.225 174.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -117.97 124.42 48.15 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 112.645 0.609 . . . . 1.6699999999999999 112.645 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.21 134.81 54.69 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-O 122.356 1.074 . . . . 1.8 112.321 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.2 t -107.3 144.51 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 112.77 -2.013 . . . . 0.57999999999999996 110.326 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -93.02 150.15 20.73 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.785 1.031 . . . . 2.1800000000000002 113.785 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.04 -36.03 4.85 Favored Glycine 0 CA--C 1.545 1.962 0 CA-C-N 115.149 -0.932 . . . . 1.02 114.923 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -127.48 -80.87 0.6 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 117.466 0.633 . . . . 2.8599999999999999 112.256 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -127.96 -50.72 1.33 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.034 0.534 . . . . 3.9100000000000001 111.827 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.443 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -85.76 150.04 24.85 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.806 1.243 . . . . 1.74 112.124 178.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -112.11 -171.28 0.21 Allowed Pre-proline 0 CA--C 1.561 1.393 0 CA-C-N 113.384 -1.735 . . . . 1.6799999999999999 108.236 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -65.27 96.88 0.29 Allowed 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.141 1.894 . . . . 2.0600000000000001 111.567 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -51.08 -57.33 8.97 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 127.104 2.162 . . . . 3.0 116.619 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.95 131.55 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 118.96 0.8 . . . . 0.80000000000000004 108.899 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.9 t -132.86 125.06 29.13 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 124.004 0.815 . . . . 0.87 112.146 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.289 . . -120.53 48.33 1.62 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.279 1.955 . . . . 0.34000000000000002 116.279 -177.082 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.77 134.51 2.51 Favored 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 116.238 1.94 . . . . 0.69999999999999996 116.238 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -151.02 102.6 2.98 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.421 -0.809 . . . . 0.20999999999999999 110.821 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.472 HD12 HD12 ' A' ' 85' ' ' LEU 0.296 7.7 tt -112.77 121.77 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.186 0 CA-C-O 122.276 1.036 . . . . 0.31 111.361 176.033 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -124.4 165.59 17.46 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.057 -1.429 . . . . 0.44 110.479 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -122.24 159.16 27.89 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 118.914 2.931 . . . . 1.26 118.914 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.27 -41.47 2.14 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-N 109.9 -3.318 . . . . 0.17000000000000001 118.973 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.35 154.54 1.03 Allowed 'General case' 0 N--CA 1.516 2.851 0 CA-C-N 120.211 2.005 . . . . 0.14999999999999999 113.011 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.49 -15.22 59.95 Favored 'General case' 0 CA--C 1.581 2.148 0 C-N-CA 124.859 1.264 . . . . 0.17000000000000001 114.354 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.9 3.19 49.44 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 113.921 1.082 . . . . 0.55000000000000004 113.921 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.652 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 1.0 OUTLIER -109.45 -2.38 17.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.435 0.902 . . . . 0.59999999999999998 113.435 179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.18 92.64 0.48 Allowed Pre-proline 0 N--CA 1.508 2.468 0 C-N-CA 124.552 1.141 . . . . 0.94999999999999996 110.998 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 57.0 Cg_endo -93.5 145.09 2.13 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 122.827 2.351 . . . . 1.8 114.654 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 12.8 tpt -146.27 113.63 6.28 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.925 -0.58 . . . . 4.96 111.311 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 12.5 mt -134.42 156.25 48.88 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.703 0.764 . . . . 4.0 111.864 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -101.29 160.35 26.85 Favored Pre-proline 0 CA--C 1.561 1.381 0 CA-C-N 115.341 -0.845 . . . . 6.2699999999999996 111.896 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -64.39 121.95 9.72 Favored 'Trans proline' 0 C--N 1.399 3.205 0 C-N-CA 122.987 2.458 . . . . 6.5899999999999999 114.963 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -135.34 142.2 40.58 Favored Pre-proline 0 CA--C 1.565 1.554 0 CA-C-N 115.044 -0.98 . . . . 5.5099999999999998 111.096 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -87.39 -156.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 122.999 2.466 . . . . 6.7699999999999996 114.128 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 164.87 102.15 0.16 Allowed Glycine 0 C--N 1.34 0.778 0 C-N-CA 120.96 -0.638 . . . . 7.0199999999999996 113.211 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.9 mt -118.44 101.58 8.27 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.002 0.429 . . . . 8.9900000000000002 111.577 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.282 -0.866 . . . . 10.6 111.062 -179.827 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.521 -0.232 . . . . 8.9299999999999997 112.521 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.46 131.0 55.53 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.54 0.686 . . . . 6.8200000000000003 112.022 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.1 ttt -137.03 -66.67 0.51 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.704 -0.68 . . . . 7.6399999999999997 111.465 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.4 m -134.34 118.93 18.04 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.635 0.374 . . . . 3.8599999999999999 111.682 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.65 86.46 0.11 Allowed Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.769 -0.65 . . . . 1.1100000000000001 113.325 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.52 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.3 tp -88.69 -48.02 7.83 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 123.921 0.889 . . . . 0.34999999999999998 113.148 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.46 -24.58 63.68 Favored 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 126.005 1.722 . . . . 0.20000000000000001 115.504 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.59 -9.53 55.88 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.582 0.956 . . . . 0.32000000000000001 113.582 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 26.0 mmtp -107.16 -24.97 11.74 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.561 0.948 . . . . 1.73 113.561 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.69 134.91 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.056 0 N-CA-C 115.494 1.665 . . . . 0.11 115.494 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -120.09 -30.65 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 115.244 -0.889 . . . . 0.16 112.123 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -161.37 119.48 2.36 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 120.507 0.194 . . . . 0.54000000000000004 111.177 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -138.22 127.85 25.02 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.158 -0.964 . . . . 0.19 111.301 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.3 t -137.22 129.74 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.098 0 N-CA-C 113.679 0.992 . . . . 1.05 113.679 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -115.9 106.1 13.42 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.582 -1.266 . . . . 2.1099999999999999 107.582 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.48 100.48 6.89 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.06 0.933 . . . . 0.63 111.592 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.517 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 178.16 -55.86 0.09 OUTLIER Glycine 0 C--N 1.349 1.295 0 CA-C-N 113.946 -1.479 . . . . 0.70999999999999996 115.859 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -111.6 -116.18 3.55 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 114.297 0.479 . . . . 0.80000000000000004 114.297 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 13.9 mt-10 -165.45 116.26 1.09 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.011 0.524 . . . . 1.6299999999999999 111.55 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER 43.73 108.62 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 118.452 2.76 . . . . 1.0 118.452 178.227 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.634 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 74.0 t60 -135.27 132.91 38.37 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.939 1.088 . . . . 0.45000000000000001 113.939 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.5 p -108.01 114.64 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.003 0 CA-C-N 113.884 -1.507 . . . . 1.3899999999999999 109.022 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -84.62 167.29 16.39 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-N 115.322 -0.854 . . . . 1.8500000000000001 113.039 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -43.47 -34.48 0.78 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 N-CA-C 118.716 2.858 . . . . 0.71999999999999997 118.716 -176.324 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -87.31 -26.53 23.36 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.204 0.526 . . . . 0.51000000000000001 110.95 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.64 45.16 0.48 Allowed Glycine 0 C--N 1.354 1.541 0 CA-C-N 114.854 -1.066 . . . . 0.34000000000000002 114.346 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.52 HD11 ' HG ' ' A' ' 6' ' ' LEU . 15.7 mm -107.11 116.25 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 CA-C-O 120.94 0.4 . . . . 0.55000000000000004 110.085 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.634 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.1 t-160 -108.44 133.58 52.41 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 115.095 1.517 . . . . 1.3400000000000001 115.095 -177.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.33 140.56 31.61 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-N 114.794 -1.093 . . . . 2.79 110.718 176.558 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -90.24 130.46 36.36 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 124.974 1.31 . . . . 3.0 112.4 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -56.61 115.26 2.43 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 118.996 2.961 . . . . 2.2999999999999998 118.996 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 40.59 57.46 7.97 Favored Pre-proline 0 N--CA 1.526 3.349 0 N-CA-C 118.549 2.796 . . . . 1.1699999999999999 118.549 176.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -102.64 59.64 0.03 OUTLIER 'Trans proline' 0 CA--C 1.569 2.232 0 C-N-CA 122.79 2.327 . . . . 1.45 116.218 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.72 -66.01 0.31 Allowed 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 112.684 0.624 . . . . 1.9099999999999999 112.684 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.676 ' H ' HH22 ' A' ' 65' ' ' ARG . 12.1 mt-10 -106.98 96.8 6.69 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.504 0.669 . . . . 4.8399999999999999 112.667 -178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.31 -30.8 8.88 Favored Glycine 0 CA--C 1.543 1.834 0 CA-C-N 114.674 -1.148 . . . . 2.3700000000000001 113.962 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? 77.91 -19.36 0.44 Allowed 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 115.833 1.79 . . . . 4.5 115.833 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.99 117.08 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.072 0.549 . . . . 2.7000000000000002 110.61 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.65 -139.87 2.74 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.085 -0.579 . . . . 1.95 114.182 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.69 -171.62 3.19 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 121.53 0.681 . . . . 5.3399999999999999 112.306 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.93 130.93 44.16 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.923 0.889 . . . . 1.6399999999999999 111.983 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -121.28 130.08 53.47 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.288 -0.869 . . . . 1.5700000000000001 111.405 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -129.51 103.38 6.85 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.885 -0.598 . . . . 2.3300000000000001 112.026 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -113.49 65.52 0.65 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.437 -0.801 . . . . 3.1600000000000001 110.142 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.04 71.7 0.1 Allowed Glycine 0 C--N 1.344 1.015 0 CA-C-N 114.615 -1.175 . . . . 1.52 111.444 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.61 -25.14 18.44 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.116 1.154 . . . . 1.6699999999999999 114.116 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.45 71.11 1.07 Allowed 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 122.138 0.97 . . . . 4.1799999999999997 111.037 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.91 72.72 0.55 Allowed Pre-proline 0 CA--C 1.552 1.057 0 CA-C-N 113.312 -1.767 . . . . 2.6299999999999999 107.406 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 44.7 Cg_exo -65.01 159.21 47.57 Favored 'Trans proline' 0 N--CA 1.513 2.633 0 C-N-CA 124.534 3.489 . . . . 1.3700000000000001 117.522 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.75 130.05 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.291 0 CA-C-N 114.815 -1.084 . . . . 0.68999999999999995 108.125 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.44 ' HB2' HG22 ' A' ' 125' ' ' THR . 7.1 mt -83.48 -9.68 58.83 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.719 2.118 . . . . 1.28 116.719 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -105.88 8.02 32.47 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 114.329 1.233 . . . . 1.51 114.329 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.8 -177.82 4.6 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-O 121.7 0.762 . . . . 1.0900000000000001 112.309 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.701 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -93.85 169.48 9.93 Favored Pre-proline 0 N--CA 1.514 2.768 0 C-N-CA 124.606 1.162 . . . . 1.27 110.044 178.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.78 -41.86 51.11 Favored 'Trans proline' 0 N--CA 1.53 3.642 0 C-N-CA 123.289 2.66 . . . . 0.94999999999999996 116.298 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -68.03 -52.51 34.64 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 124.439 1.095 . . . . 2.04 112.119 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 5.8 t0 -78.11 -1.97 35.13 Favored 'General case' 0 CA--C 1.59 2.505 0 CA-C-N 115.225 -0.898 . . . . 1.6200000000000001 112.174 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.701 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 14.5 tt0 -75.69 -40.66 55.49 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 126.132 1.773 . . . . 1.77 108.122 174.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.5 t -63.71 -43.1 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.106 0 C-N-CA 124.635 1.174 . . . . 0.81000000000000005 108.574 172.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.467 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.4 tp -79.86 -5.27 55.16 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 113.59 0.959 . . . . 1.1499999999999999 113.59 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 4.2 m-30 -122.46 20.08 10.41 Favored 'General case' 0 CA--C 1.577 1.995 0 C-N-CA 124.786 1.235 . . . . 0.92000000000000004 111.887 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -148.01 -29.01 0.32 Allowed 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 116.399 2.0 . . . . 1.3300000000000001 116.399 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.4 p -74.99 132.0 41.05 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 115.085 1.513 . . . . 1.28 115.085 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.517 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -123.05 148.38 45.64 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 124.221 1.008 . . . . 1.53 112.687 -178.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.676 HH22 ' H ' ' A' ' 35' ' ' GLU . 13.5 mtp180 -98.73 -84.83 0.39 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 112.759 0.651 . . . . 3.2200000000000002 112.759 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.88 167.76 28.61 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.526 0.679 . . . . 3.6600000000000001 112.742 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -126.63 139.93 52.81 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 115.612 -0.722 . . . . 4.7000000000000002 112.733 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -138.63 -109.42 0.17 Allowed 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 115.831 -0.622 . . . . 2.5499999999999998 110.939 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.19 121.14 3.83 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 118.351 0.523 . . . . 2.1499999999999999 111.354 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.24 88.3 0.04 OUTLIER 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 125.722 1.609 . . . . 0.77000000000000002 114.067 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -148.58 156.22 42.14 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.283 0.846 . . . . 0.81000000000000005 113.283 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -173.14 -171.99 38.29 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 116.039 1.176 . . . . 0.46999999999999997 116.039 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.56 173.17 6.45 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.866 1.432 . . . . 0.89000000000000001 114.866 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -129.38 133.48 47.4 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 114.219 -1.355 . . . . 0.51000000000000001 111.992 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.57 100.47 34.79 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 109.074 -0.713 . . . . 0.14999999999999999 109.074 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.38 118.06 2.19 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.084 1.856 . . . . 0.14999999999999999 115.036 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.67 159.71 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 122.043 0.925 . . . . 0.19 111.134 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -143.91 20.18 1.8 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.888 -1.051 . . . . 2.5299999999999998 112.331 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -128.58 158.45 38.44 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-O 121.963 0.887 . . . . 2.1200000000000001 111.117 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.89 139.85 50.14 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.887 1.069 . . . . 0.41999999999999998 113.887 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.9 -125.35 1.35 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 113.961 -1.472 . . . . 0.23000000000000001 112.393 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -126.31 118.63 25.48 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.085 0.469 . . . . 1.75 111.178 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -118.83 139.92 50.81 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.788 -0.642 . . . . 0.20999999999999999 109.907 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 172' ' ' ILE . 2.5 t -120.59 127.59 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.366 0.603 . . . . 0.20000000000000001 110.896 -177.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.7 107.9 18.96 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.068 -0.969 . . . . 0.78000000000000003 109.861 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.64 128.5 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 109.045 -0.724 . . . . 0.44 109.045 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.64 146.31 49.42 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.81 1.041 . . . . 1.25 113.81 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -108.75 122.47 47.21 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 115.441 -0.8 . . . . 2.52 110.314 176.145 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -109.28 136.72 48.27 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.871 -1.059 . . . . 0.40000000000000002 110.415 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.598 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . -143.77 157.14 44.59 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 124.192 0.997 . . . . 0.40999999999999998 111.307 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -169.92 127.38 0.88 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.353 0.661 . . . . 2.6099999999999999 110.917 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.83 73.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.664 -0.698 . . . . 2.1299999999999999 111.27 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -160.19 -47.35 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.959 -0.564 . . . . 2.27 112.126 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -115.19 116.87 29.07 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.803 0.441 . . . . 1.46 111.169 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.24 99.06 8.9 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.646 1.213 . . . . 0.83999999999999997 112.11 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -159.19 160.66 35.71 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.465 -1.243 . . . . 2.4500000000000002 111.061 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 m -108.31 -78.66 0.59 Allowed 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.047 1.128 . . . . 1.6599999999999999 114.047 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -95.47 70.47 3.11 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.296 1.046 . . . . 1.8899999999999999 111.407 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -159.23 -40.06 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.639 -1.619 . . . . 2.5600000000000001 109.346 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -106.02 79.25 1.39 Allowed 'General case' 0 C--N 1.368 1.375 0 CA-C-O 121.838 0.828 . . . . 2.7599999999999998 109.086 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.24 123.09 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 114.439 -1.255 . . . . 0.68999999999999995 111.395 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.554 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 30.2 m-85 -106.1 171.41 7.36 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 114.395 1.257 . . . . 0.69999999999999996 114.395 -177.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -124.88 135.71 53.13 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.828 -0.434 . . . . 1.3300000000000001 109.828 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.0 t -130.07 125.8 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 CA-C-N 116.104 -0.498 . . . . 0.47999999999999998 109.846 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.66 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 23.0 mtt180 -124.55 148.57 47.72 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.236 1.569 . . . . 1.6899999999999999 115.236 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 154' ' ' SER . 5.1 m -125.56 112.38 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 113.095 0.776 . . . . 0.59999999999999998 113.095 177.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.465 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 63.62 25.99 14.49 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 126.551 1.94 . . . . 1.1200000000000001 113.894 -178.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.36 -14.33 54.59 Favored Glycine 0 CA--C 1.552 2.389 0 C-N-CA 121.456 -0.402 . . . . 0.32000000000000001 113.804 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.66 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 91.3 m-70 -87.93 172.56 9.5 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 126.059 1.744 . . . . 0.56999999999999995 113.362 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.89 132.31 54.5 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.584 0.707 . . . . 0.55000000000000004 112.082 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.75 -55.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 114.775 -1.102 . . . . 1.0600000000000001 113.141 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.23 89.46 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.877 . . . . 0.44 108.631 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -106.45 108.68 20.31 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.905 1.336 . . . . 2.2999999999999998 110.572 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 105.14 70.63 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 110.868 -2.878 . . . . 2.48 108.259 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.27 99.5 12.47 Favored 'General case' 0 C--N 1.359 0.983 0 CA-C-N 115.333 -0.849 . . . . 1.1299999999999999 112.36 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -109.83 91.84 3.81 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.545 -1.661 . . . . 2.3500000000000001 108.755 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -31.25 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 N-CA-C 116.746 2.128 . . . . 0.68000000000000005 116.746 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -74.0 -40.54 62.87 Favored 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 124.014 0.926 . . . . 0.77000000000000002 112.445 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -26.1 59.97 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 124.443 1.097 . . . . 0.91000000000000003 113.374 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -78.21 -58.09 3.44 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.573 0.953 . . . . 2.4300000000000002 113.573 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.26 -32.91 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 N-CA-C 114.921 1.452 . . . . 0.93000000000000005 114.921 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.23 -118.11 2.74 Favored Glycine 0 C--N 1.356 1.639 0 CA-C-N 118.757 0.708 . . . . 0.84999999999999998 113.006 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -115.1 107.44 15.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.297 0.57 . . . . 3.1800000000000002 111.173 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.0 m 70.69 -134.57 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 125.592 1.557 . . . . 2.0800000000000001 113.128 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.44 HG22 ' HB2' ' A' ' 51' ' ' LEU . 67.8 p 60.4 -151.48 0.4 Allowed 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 126.179 1.792 . . . . 0.62 114.382 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -112.13 130.37 55.92 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 114.141 1.163 . . . . 0.46000000000000002 114.141 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -108.65 124.38 50.43 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.402 -0.962 . . . . 0.38 108.402 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.41 129.18 24.7 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.038 0.755 . . . . 2.5 113.038 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -116.03 134.91 54.45 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.047 -0.978 . . . . 1.5600000000000001 111.492 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.25 114.01 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 113.884 -1.507 . . . . 0.45000000000000001 109.999 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.23 98.0 33.54 Favored Pre-proline 0 CA--C 1.574 1.866 0 CA-C-N 115.871 -0.604 . . . . 0.83999999999999997 111.146 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -73.59 144.55 35.96 Favored 'Trans proline' 0 C--N 1.399 3.205 0 C-N-CA 123.293 2.662 . . . . 0.16 114.652 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.59 146.38 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 CA-C-N 115.135 -0.938 . . . . 0.38 110.854 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 p -131.41 112.58 12.82 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.495 -0.775 . . . . 1.3100000000000001 111.406 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.98 121.64 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 CA-C-N 115.38 -0.827 . . . . 0.25 108.882 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -141.94 130.74 22.91 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 116.274 -0.421 . . . . 2.0499999999999998 111.273 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp 70.67 9.04 6.78 Favored 'General case' 0 N--CA 1.518 2.972 0 C-N-CA 125.033 1.333 . . . . 3.5499999999999998 114.219 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.07 18.1 25.53 Favored Glycine 0 CA--C 1.544 1.859 0 C-N-CA 124.19 0.9 . . . . 0.37 113.997 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -127.16 146.68 50.31 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-N 117.768 0.784 . . . . 1.5600000000000001 112.746 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.08 141.72 31.48 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.234 1.198 . . . . 0.34000000000000002 114.234 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.8 m -130.01 113.42 14.55 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.626 -1.17 . . . . 0.64000000000000001 110.155 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.252 9.1 p -121.48 97.03 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.369 0 CA-C-N 116.004 -0.544 . . . . 0.46000000000000002 110.901 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 67.55 -85.45 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.682 0 C-N-CA 125.658 1.583 . . . . 1.5600000000000001 113.874 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.03 29.3 3.53 Favored Glycine 0 CA--C 1.542 1.737 0 CA-C-N 115.994 -0.548 . . . . 0.48999999999999999 112.979 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -133.17 125.72 30.06 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 123.507 0.723 . . . . 1.8200000000000001 110.651 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.11 126.02 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.303 0 CA-C-O 121.46 0.648 . . . . 1.02 111.07 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 m -145.93 -178.89 6.35 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.285 -0.871 . . . . 0.56000000000000005 109.969 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.273 12.4 t -103.14 137.03 41.85 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 113.414 0.894 . . . . 1.25 113.414 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -83.43 125.37 31.64 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.434 1.094 . . . . 0.28999999999999998 112.011 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.81 91.22 2.95 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 112.649 0.611 . . . . 1.4199999999999999 112.649 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.46 -66.22 3.53 Favored Glycine 0 C--N 1.358 1.786 0 N-CA-C 119.03 2.372 . . . . 0.41999999999999998 119.03 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.17 156.87 44.57 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.142 1.164 . . . . 1.1000000000000001 114.142 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.465 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -105.98 133.45 50.68 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 113.035 -1.893 . . . . 0.67000000000000004 108.545 176.236 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.6 t -120.14 143.7 48.05 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.737 1.754 . . . . 0.35999999999999999 115.737 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.451 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -115.51 100.29 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.945 -1.132 . . . . 0.73999999999999999 107.945 176.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.81 125.28 49.21 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.978 -0.555 . . . . 1.6699999999999999 111.952 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.81 132.73 56.62 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.09 0.947 . . . . 1.8 111.771 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 t -110.35 143.28 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.911 0 CA-C-N 113.381 -1.736 . . . . 0.57999999999999996 109.674 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 151.85 22.19 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.756 1.391 . . . . 2.1800000000000002 114.756 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.78 -26.64 7.05 Favored Glycine 0 CA--C 1.55 2.253 0 CA-C-N 115.027 -0.988 . . . . 1.02 115.254 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -132.01 -78.81 0.51 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.045 0.922 . . . . 2.8599999999999999 112.616 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -135.87 -49.41 0.69 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.078 0.551 . . . . 3.9100000000000001 111.518 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.554 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -94.42 135.43 35.85 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.591 1.156 . . . . 1.74 111.521 178.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -94.26 -169.83 0.21 Allowed Pre-proline 0 CA--C 1.568 1.667 0 CA-C-N 113.979 -1.464 . . . . 1.6799999999999999 108.576 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -66.55 99.99 0.46 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 CA-C-N 122.311 1.861 . . . . 2.0600000000000001 111.3 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -57.18 -49.92 74.48 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.498 1.666 . . . . 3.0 115.498 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 64' ' ' GLU . 19.0 t -110.56 130.99 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.076 -0.713 . . . . 0.80000000000000004 109.076 177.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -136.9 124.72 22.56 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 113.597 -1.638 . . . . 0.87 111.482 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.256 . . -121.31 49.97 1.44 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.75 1.759 . . . . 0.34000000000000002 115.75 -176.655 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.69 135.15 2.98 Favored 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 116.175 1.917 . . . . 0.69999999999999996 116.175 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -153.6 100.67 2.42 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.38 -0.827 . . . . 0.20999999999999999 110.6 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 84' ' ' VAL 0.308 5.2 tt -109.26 122.48 63.96 Favored 'Isoleucine or valine' 0 C--O 1.27 2.156 0 CA-C-O 122.346 1.069 . . . . 0.31 111.383 176.136 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -120.27 154.2 35.28 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 113.755 -1.566 . . . . 0.44 112.221 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 50.5 tttm -105.92 150.0 26.07 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 118.09 2.626 . . . . 1.26 118.09 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.43 -39.59 2.77 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 110.98 -2.827 . . . . 0.17000000000000001 119.805 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.73 164.12 1.21 Allowed 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 121.218 2.509 . . . . 0.14999999999999999 112.571 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.88 -16.07 48.98 Favored 'General case' 0 CA--C 1.579 2.085 0 C-N-CA 124.722 1.209 . . . . 0.17000000000000001 113.8 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.36 4.65 45.42 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.363 1.246 . . . . 0.55000000000000004 114.363 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.527 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -103.3 -11.89 17.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.27 1.211 . . . . 0.59999999999999998 114.27 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.44 99.82 0.7 Allowed Pre-proline 0 N--CA 1.513 2.713 0 C-N-CA 124.036 0.934 . . . . 0.94999999999999996 113.08 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 8.7 Cg_exo -79.64 131.23 9.2 Favored 'Trans proline' 0 C--N 1.401 3.308 0 C-N-CA 123.025 2.483 . . . . 1.8 114.309 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 15.6 ttt -145.69 117.63 8.25 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.818 -0.628 . . . . 4.96 111.058 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.1 mt -131.04 163.48 27.52 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 122.058 0.932 . . . . 4.0 112.665 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -104.72 158.05 32.83 Favored Pre-proline 0 CA--C 1.558 1.28 0 CA-C-N 114.608 -1.178 . . . . 6.2699999999999996 110.841 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.5 121.67 8.79 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 122.479 2.119 . . . . 6.5899999999999999 115.034 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -135.79 136.49 23.54 Favored Pre-proline 0 CA--C 1.569 1.675 0 CA-C-N 114.86 -1.063 . . . . 5.5099999999999998 111.134 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.52 -19.21 13.22 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 123.702 2.935 . . . . 6.7699999999999996 116.674 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.6 -69.71 0.66 Allowed Glycine 0 CA--C 1.534 1.258 0 N-CA-C 115.07 0.788 . . . . 7.0199999999999996 115.07 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.0 tp -117.6 133.65 55.72 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.226 0.536 . . . . 8.9900000000000002 112.205 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.332 -0.842 . . . . 10.6 111.267 -179.784 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.514 -0.234 . . . . 8.9299999999999997 112.514 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.47 127.96 55.85 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.631 0.729 . . . . 6.8200000000000003 111.945 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -133.42 110.14 9.8 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.6 -0.727 . . . . 7.6399999999999997 111.194 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 m -135.96 117.38 14.72 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.781 -0.645 . . . . 3.8599999999999999 111.789 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.26 92.65 0.09 OUTLIER Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.683 -0.689 . . . . 1.1100000000000001 113.158 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.57 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.6 tp -87.73 -45.43 10.36 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.22 0.822 . . . . 0.34999999999999998 113.22 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.51 -23.07 64.26 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 125.807 1.643 . . . . 0.20000000000000001 114.965 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.49 -12.53 48.65 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 113.632 0.975 . . . . 0.32000000000000001 113.632 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -104.19 -23.58 13.24 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-O 118.211 -0.9 . . . . 1.73 113.227 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.49 133.36 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 N-CA-C 115.094 1.516 . . . . 0.11 115.094 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pt -120.52 -28.28 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.183 -0.917 . . . . 0.16 112.264 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -163.97 116.91 1.43 Allowed 'General case' 0 CA--C 1.558 1.27 0 CA-C-O 120.583 0.23 . . . . 0.54000000000000004 111.141 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.32 130.87 35.71 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.569 -0.707 . . . . 0.19 111.202 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.74 129.69 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.422 0.897 . . . . 1.05 113.422 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -117.05 105.23 12.06 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.01 -1.478 . . . . 2.1099999999999999 107.01 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.17 108.22 12.51 Favored 'General case' 0 C--O 1.254 1.305 0 CA-C-O 121.639 0.733 . . . . 0.63 111.553 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.2 -43.71 0.37 Allowed Glycine 0 C--N 1.351 1.374 0 CA-C-N 114.265 -1.334 . . . . 0.70999999999999996 115.652 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -115.15 -121.25 3.45 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 117.564 0.682 . . . . 0.80000000000000004 113.892 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 18.1 mt-10 -164.83 115.36 1.16 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.295 0.638 . . . . 1.6299999999999999 111.133 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 1.1 m 42.85 110.15 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 118.589 2.811 . . . . 1.0 118.589 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.586 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 78.1 t60 -136.58 131.79 34.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.358 1.244 . . . . 0.45000000000000001 114.358 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.6 p -104.93 114.48 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 113.958 -1.474 . . . . 1.3899999999999999 108.967 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -85.21 165.83 17.06 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 115.107 -0.951 . . . . 1.8500000000000001 113.155 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -44.59 -30.46 0.67 Allowed 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 N-CA-C 118.667 2.84 . . . . 0.71999999999999997 118.667 -176.532 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -89.17 -27.04 20.96 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.233 0.539 . . . . 0.51000000000000001 110.936 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.54 42.66 0.57 Allowed Glycine 0 C--N 1.351 1.393 0 CA-C-N 114.82 -1.082 . . . . 0.34000000000000002 114.059 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.57 HD11 ' HG ' ' A' ' 6' ' ' LEU . 20.2 mm -107.54 117.05 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-O 121.107 0.48 . . . . 0.55000000000000004 110.195 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.4 t60 -106.52 131.61 53.48 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.882 1.438 . . . . 1.3400000000000001 114.882 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -93.07 137.41 32.45 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 124.058 0.943 . . . . 2.79 109.639 175.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.473 ' O ' ' HG3' ' A' ' 33' ' ' PRO . 12.9 ptm180 -99.0 105.86 18.06 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 114.54 -1.209 . . . . 3.0 113.335 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -23.14 119.84 0.04 OUTLIER 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 120.57 3.545 . . . . 2.2999999999999998 120.57 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 34.42 54.17 1.59 Allowed Pre-proline 0 N--CA 1.536 3.868 0 N-CA-C 119.576 3.176 . . . . 1.1699999999999999 119.576 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.473 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -110.65 104.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.569 2.268 0 C-N-CA 123.423 2.749 . . . . 1.45 116.908 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.64 -90.58 0.53 Allowed 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.598 -0.728 . . . . 1.9099999999999999 110.253 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.42 58.81 0.95 Allowed 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 112.755 0.65 . . . . 4.8399999999999999 112.755 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.94 1.62 28.57 Favored Glycine 0 CA--C 1.547 2.041 0 N-CA-C 115.594 0.997 . . . . 2.3700000000000001 115.594 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.41 ' N ' ' HD2' ' A' ' 37' ' ' ARG . 2.6 mpt_? -104.42 77.35 1.38 Allowed 'General case' 0 C--N 1.356 0.87 0 CA-C-N 117.793 0.797 . . . . 4.5 111.841 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.73 116.08 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 115.769 -0.651 . . . . 2.7000000000000002 112.405 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.01 50.43 0.73 Allowed Glycine 0 CA--C 1.538 1.523 0 N-CA-C 115.233 0.853 . . . . 1.95 115.233 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -162.14 97.3 1.02 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 117.625 0.713 . . . . 5.3399999999999999 111.102 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.66 136.64 46.1 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.565 0.746 . . . . 1.6399999999999999 111.602 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.1 m -122.6 107.97 12.59 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-O 121.313 0.577 . . . . 1.5700000000000001 112.382 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -124.66 71.39 1.16 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.365 -0.834 . . . . 2.3300000000000001 110.616 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -110.82 72.72 0.79 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.99 -1.004 . . . . 3.1600000000000001 110.527 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.85 63.37 0.02 OUTLIER Glycine 0 CA--C 1.528 0.861 0 CA-C-N 114.933 -1.03 . . . . 1.52 113.334 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 5.8 mmt -92.75 -0.09 57.33 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.149 0.796 . . . . 1.6699999999999999 113.149 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -105.91 24.21 12.72 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 113.679 0.992 . . . . 4.1799999999999997 113.679 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.0 mt -139.59 74.59 33.38 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.888 -1.152 . . . . 2.6299999999999999 107.888 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -62.45 166.65 12.8 Favored 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 124.666 3.577 . . . . 1.3700000000000001 117.288 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.437 HG23 ' HB2' ' A' ' 126' ' ' ALA 0.262 1.0 OUTLIER -93.85 123.28 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.777 0 CA-C-N 115.237 -0.892 . . . . 0.68999999999999995 109.472 178.908 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 7.3 mt -89.22 101.71 14.37 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.871 0.843 . . . . 1.28 112.374 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 1.5 mpt_? 148.01 -13.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.158 2.183 . . . . 1.51 110.578 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -116.54 -179.01 3.56 Favored 'General case' 0 CA--C 1.567 1.599 0 C-N-CA 123.767 0.827 . . . . 1.0900000000000001 113.09 -179.135 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -95.77 -176.88 0.58 Allowed Pre-proline 0 N--CA 1.51 2.556 0 C-N-CA 124.402 1.081 . . . . 1.27 109.421 178.467 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.456 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 31.3 Cg_exo -68.51 -39.13 9.91 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.679 2.253 . . . . 0.94999999999999996 113.963 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -67.2 -54.28 22.55 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 125.04 1.336 . . . . 2.04 112.124 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.413 ' HB3' ' OG ' ' A' ' 53' ' ' SER . 0.4 OUTLIER -76.55 -5.37 47.34 Favored 'General case' 0 CA--C 1.576 1.947 0 CA-C-N 114.979 -1.01 . . . . 1.6200000000000001 112.746 178.144 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.514 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 27.5 tt0 -71.64 -44.14 64.86 Favored 'General case' 0 C--N 1.382 2.015 0 C-N-CA 125.539 1.536 . . . . 1.77 108.07 173.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.37 -38.89 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 C-N-CA 124.055 0.942 . . . . 0.81000000000000005 109.481 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -82.54 -8.36 59.61 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 114.116 1.154 . . . . 1.1499999999999999 114.116 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.415 ' O ' HG12 ' A' ' 50' ' ' ILE . 20.4 m-85 -125.02 21.36 8.16 Favored 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.222 1.009 . . . . 0.92000000000000004 112.928 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.416 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -143.8 -31.53 0.46 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 115.27 1.582 . . . . 1.3300000000000001 115.27 -177.311 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.8 p -73.12 134.23 44.4 Favored 'General case' 0 N--CA 1.524 3.231 0 N-CA-C 114.3 1.222 . . . . 1.28 114.3 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.94 140.49 52.94 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 114.672 1.36 . . . . 1.53 114.672 -176.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 ttp85 -110.24 142.45 41.82 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.617 -1.174 . . . . 3.2200000000000002 111.151 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -108.21 130.9 55.12 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.545 0.572 . . . . 3.6600000000000001 112.545 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -125.1 -89.52 0.57 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.491 -0.777 . . . . 4.7000000000000002 111.339 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -162.58 -79.27 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 112.398 0.518 . . . . 2.5499999999999998 112.398 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -170.45 123.52 0.67 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.283 1.033 . . . . 2.1499999999999999 109.337 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.83 86.53 0.12 Allowed 'General case' 0 N--CA 1.517 2.885 0 C-N-CA 124.717 1.207 . . . . 0.77000000000000002 111.674 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -140.51 149.74 42.85 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.998 0.904 . . . . 0.81000000000000005 112.68 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.87 -176.75 31.27 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 114.303 -1.317 . . . . 0.46999999999999997 115.821 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 169.55 10.16 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 114.117 -1.042 . . . . 0.89000000000000001 113.729 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.06 131.16 52.2 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.662 -1.154 . . . . 0.51000000000000001 111.895 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.1 103.12 33.47 Favored Pre-proline 0 CA--C 1.57 1.719 0 C-N-CA 123.107 0.563 . . . . 0.14999999999999999 109.567 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -84.15 117.18 2.16 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.264 1.976 . . . . 0.14999999999999999 114.657 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.26 157.94 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.625 0 CA-C-O 122.053 0.93 . . . . 0.19 111.112 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -146.13 24.38 1.3 Allowed 'General case' 0 CA--C 1.557 1.236 0 CA-C-N 114.654 -1.157 . . . . 2.5299999999999998 112.008 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -128.62 160.16 33.3 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 121.268 0.556 . . . . 2.1200000000000001 111.194 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -121.04 142.02 50.21 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.069 1.137 . . . . 0.41999999999999998 114.069 -178.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.85 -137.34 4.91 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 113.696 -1.593 . . . . 0.23000000000000001 112.121 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.3 mt-10 -115.63 112.13 21.67 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 118.436 1.118 . . . . 1.75 111.276 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -104.49 128.37 52.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.147 -0.479 . . . . 0.20999999999999999 110.896 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -110.35 119.33 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 121.977 0.894 . . . . 0.20000000000000001 110.427 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 tt -107.34 104.61 14.24 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.79 -1.55 . . . . 0.78000000000000003 109.648 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.95 126.42 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 CA-C-N 114.367 -1.288 . . . . 0.44 108.57 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.52 135.52 49.52 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.594 -0.73 . . . . 1.25 112.418 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 4.4 tppt? -101.5 118.2 36.46 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.447 0.641 . . . . 2.52 110.556 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -105.54 134.54 48.5 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.256 -0.884 . . . . 0.40000000000000002 110.571 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.39 151.53 41.94 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.182 0.515 . . . . 0.40999999999999998 112.266 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -147.83 135.23 20.65 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.118 0.567 . . . . 2.6099999999999999 110.967 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.275 7.5 p -147.06 86.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.388 0 CA-C-O 121.591 0.71 . . . . 2.1299999999999999 111.851 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -175.12 -46.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.602 -0.726 . . . . 2.27 112.139 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -115.56 139.52 50.0 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 121.193 0.52 . . . . 1.46 112.008 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -112.85 99.68 8.08 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.191 0.996 . . . . 0.83999999999999997 111.004 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -158.74 140.85 13.89 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.317 -0.856 . . . . 2.4500000000000002 112.313 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.7 m -120.74 130.45 54.05 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.341 -0.845 . . . . 1.6599999999999999 112.219 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 80.53 10.51 1.09 Allowed 'General case' 0 N--CA 1.519 2.987 0 C-N-CA 125.857 1.663 . . . . 1.8899999999999999 114.494 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -117.49 -25.71 6.88 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.711 0.804 . . . . 2.5600000000000001 112.259 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -107.03 79.41 1.32 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.484 0.714 . . . . 2.7599999999999998 109.393 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 114' ' ' ASP 0.261 1.2 t -109.81 126.6 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 CA-C-N 114.998 -1.001 . . . . 0.68999999999999995 110.091 -177.173 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -118.87 174.31 6.37 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 114.652 1.352 . . . . 0.69999999999999996 114.652 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.93 136.34 54.92 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.921 -0.487 . . . . 1.3300000000000001 111.19 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.2 t -124.99 123.65 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 C-N-CA 123.056 0.543 . . . . 0.47999999999999998 110.07 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -121.14 147.13 45.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.653 1.353 . . . . 1.6899999999999999 114.653 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 154' ' ' SER . 50.8 t -130.56 109.75 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.252 0 N-CA-C 107.68 -1.23 . . . . 0.59999999999999998 107.68 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.43 26.89 16.03 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 126.992 2.117 . . . . 1.1200000000000001 114.574 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.12 -19.58 40.14 Favored Glycine 0 CA--C 1.548 2.097 0 N-CA-C 114.554 0.582 . . . . 0.32000000000000001 114.554 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -91.01 154.51 19.38 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 124.837 1.255 . . . . 0.56999999999999995 113.375 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.3 p -102.93 127.9 49.95 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.609 0.718 . . . . 0.55000000000000004 111.638 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.07 -50.63 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.582 -1.19 . . . . 1.0600000000000001 110.342 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.43 88.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 119.996 -0.682 . . . . 0.44 110.237 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -106.92 119.23 38.79 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-O 122.41 1.1 . . . . 2.2999999999999998 110.076 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.479 ' HA ' HG13 ' A' ' 101' ' ' VAL . 1.0 OUTLIER 102.96 59.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 128.434 2.694 . . . . 2.48 107.6 -175.414 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.34 96.9 10.76 Favored 'General case' 0 C--N 1.373 1.596 0 CA-C-O 121.634 0.731 . . . . 1.1299999999999999 112.714 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -107.64 97.81 7.49 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 113.652 -1.613 . . . . 2.3500000000000001 107.448 175.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.08 -30.01 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.458 0 N-CA-C 114.244 1.201 . . . . 0.68000000000000005 114.244 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -73.89 -41.88 61.5 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 123.481 0.712 . . . . 0.77000000000000002 112.218 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -72.24 -25.84 61.78 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 124.537 1.135 . . . . 0.91000000000000003 113.55 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -79.53 -57.8 3.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 113.701 1.0 . . . . 2.4300000000000002 113.701 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.48 -37.89 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.515 0 N-CA-C 114.516 1.302 . . . . 0.93000000000000005 114.516 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.62 -115.36 1.89 Allowed Glycine 0 C--N 1.354 1.557 0 C-N-CA 121.194 -0.527 . . . . 0.84999999999999998 113.38 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -114.87 108.06 16.23 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.957 0.408 . . . . 3.1800000000000002 110.422 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.7 m 73.33 -126.2 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 125.466 1.506 . . . . 2.0800000000000001 111.845 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.6 p 57.54 -165.6 0.15 Allowed 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 126.066 1.746 . . . . 0.62 115.343 177.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' A' ' 50' ' ' ILE . . . -113.99 127.57 56.01 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 112.684 0.624 . . . . 0.46000000000000002 112.684 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -103.53 138.83 39.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.465 -0.569 . . . . 0.38 109.465 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -144.59 129.37 18.28 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.78 1.03 . . . . 2.5 113.78 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -117.41 129.94 56.17 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-N 114.759 -1.11 . . . . 1.5600000000000001 110.939 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.53 111.59 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 114.493 -1.231 . . . . 0.45000000000000001 110.658 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.5 mm -115.8 92.11 32.97 Favored Pre-proline 0 CA--C 1.582 2.178 0 CA-C-N 115.639 -0.71 . . . . 0.83999999999999997 110.706 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -77.19 126.33 8.47 Favored 'Trans proline' 0 C--N 1.392 2.824 0 C-N-CA 122.568 2.178 . . . . 0.16 113.032 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.88 150.81 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 C-N-CA 123.991 0.916 . . . . 0.38 111.067 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.0 t -136.7 118.0 14.6 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.524 0.678 . . . . 1.3100000000000001 111.775 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -116.98 126.05 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 CA-C-N 114.759 -1.11 . . . . 0.25 108.446 178.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -139.37 122.74 17.13 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.622 -0.717 . . . . 2.0499999999999998 110.817 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt 67.67 16.16 9.78 Favored 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 125.279 1.432 . . . . 3.5499999999999998 114.431 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.75 15.93 35.37 Favored Glycine 0 CA--C 1.547 2.067 0 CA-C-O 119.348 -0.696 . . . . 0.37 114.67 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 36.8 mtpt -122.02 145.34 48.23 Favored 'General case' 0 C--N 1.363 1.19 0 CA-C-N 118.088 0.944 . . . . 1.5600000000000001 111.759 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.31 150.81 23.4 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.116 1.525 . . . . 0.34000000000000002 115.116 -175.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.32 109.81 6.6 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 113.92 -1.491 . . . . 0.64000000000000001 109.335 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.1 p -111.1 94.84 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.5 0 CA-C-N 116.025 -0.534 . . . . 0.46000000000000002 110.625 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 67.81 -84.73 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.74 0 C-N-CA 125.416 1.486 . . . . 1.5600000000000001 113.799 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.09 24.62 5.35 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 115.981 -0.554 . . . . 0.48999999999999999 113.263 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -125.7 147.07 49.48 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.726 0.811 . . . . 1.8200000000000001 111.606 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.0 p -129.18 125.87 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.157 0 CA-C-N 115.583 -0.735 . . . . 1.02 110.936 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.4 m -149.23 -175.72 5.09 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.225 -0.898 . . . . 0.56000000000000005 110.129 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.0 p -103.8 138.16 40.8 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 112.95 0.722 . . . . 1.25 112.95 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -85.93 123.75 31.61 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 123.548 0.739 . . . . 0.28999999999999998 111.114 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.0 t -129.21 90.94 3.1 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.533 0.682 . . . . 1.4199999999999999 112.733 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.35 -63.36 2.96 Favored Glycine 0 C--N 1.359 1.832 0 N-CA-C 119.043 2.377 . . . . 0.41999999999999998 119.043 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.543 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -130.64 157.15 43.53 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.277 1.214 . . . . 1.1000000000000001 114.277 -176.029 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.543 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 1.8 tp -104.13 140.81 37.27 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 112.805 -1.998 . . . . 0.67000000000000004 109.41 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.6 t -122.95 144.03 49.51 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.939 1.459 . . . . 0.35999999999999999 114.939 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.3 96.57 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.764 -1.199 . . . . 0.73999999999999999 107.764 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -118.92 123.5 44.78 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 112.537 0.569 . . . . 1.6699999999999999 112.537 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -115.07 130.64 56.98 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 122.273 1.035 . . . . 1.8 111.416 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.14 144.8 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-N 112.724 -2.035 . . . . 0.57999999999999996 110.867 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.6 150.2 25.34 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 113.991 -1.459 . . . . 2.1800000000000002 114.38 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -100.71 -55.58 0.94 Allowed Glycine 0 CA--C 1.541 1.676 0 CA-C-N 115.281 -0.872 . . . . 1.02 114.004 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -128.13 -85.98 0.57 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.031 0.416 . . . . 2.8599999999999999 111.535 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.563 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 61.6 m-85 -133.82 120.6 20.67 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.391 0.676 . . . . 3.9100000000000001 109.792 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 1.0 OUTLIER 87.68 136.54 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 124.86 1.264 . . . . 1.74 111.233 -177.569 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.52 -168.56 0.19 Allowed Pre-proline 0 CA--C 1.58 2.104 0 CA-C-N 114.621 -1.172 . . . . 1.6799999999999999 110.404 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.07 -15.51 34.1 Favored 'Trans proline' 0 N--CA 1.523 3.206 0 C-N-CA 122.675 2.25 . . . . 2.0600000000000001 115.581 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 77.6 tttt 79.91 -65.1 0.19 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 126.444 1.897 . . . . 3.0 114.229 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 38.9 t -106.76 132.27 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 109.791 -0.448 . . . . 0.80000000000000004 109.791 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -135.95 120.58 18.3 Favored 'General case' 0 C--N 1.358 0.943 0 CA-C-N 114.413 -1.267 . . . . 0.87 111.052 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -115.23 49.22 1.08 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.276 1.954 . . . . 0.34000000000000002 116.276 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.75 132.34 3.8 Favored 'General case' 0 N--CA 1.514 2.725 0 N-CA-C 116.069 1.877 . . . . 0.69999999999999996 116.069 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -150.43 100.35 2.86 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.368 -0.833 . . . . 0.20999999999999999 110.525 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.308 13.7 tt -110.3 121.81 63.77 Favored 'Isoleucine or valine' 0 C--O 1.266 1.929 0 CA-C-O 122.42 1.105 . . . . 0.31 111.42 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -123.5 155.06 38.26 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 113.675 -1.602 . . . . 0.44 111.325 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -104.91 148.21 26.93 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 119.252 3.056 . . . . 1.26 119.252 -173.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.02 -42.36 1.92 Allowed Glycine 0 CA--C 1.541 1.715 0 CA-C-N 110.316 -3.129 . . . . 0.17000000000000001 120.582 171.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.73 157.78 1.25 Allowed 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 121.177 2.489 . . . . 0.14999999999999999 113.371 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.7 -13.09 60.07 Favored 'General case' 0 CA--C 1.581 2.172 0 C-N-CA 124.897 1.279 . . . . 0.17000000000000001 114.421 177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.0 2.42 51.81 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 113.953 1.094 . . . . 0.55000000000000004 113.953 177.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.602 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.9 OUTLIER -107.26 -5.78 17.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.629 0.974 . . . . 0.59999999999999998 113.629 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.31 93.35 0.66 Allowed Pre-proline 0 N--CA 1.506 2.346 0 C-N-CA 124.265 1.026 . . . . 0.94999999999999996 111.916 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 68.8 Cg_endo -92.05 149.36 3.17 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 122.92 2.413 . . . . 1.8 114.578 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 8.6 tpt -135.86 119.9 17.59 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.766 -0.652 . . . . 4.96 111.278 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.1 mt -129.78 164.31 24.33 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 122.051 0.929 . . . . 4.0 112.637 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -107.02 160.86 24.82 Favored Pre-proline 0 CA--C 1.564 1.514 0 CA-C-N 114.658 -1.155 . . . . 6.2699999999999996 110.857 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -66.73 122.3 9.66 Favored 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 122.593 2.195 . . . . 6.5899999999999999 114.722 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -135.7 133.42 20.11 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-N 115.32 -0.855 . . . . 5.5099999999999998 111.242 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -85.53 -156.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.387 2.725 . . . . 6.7699999999999996 114.069 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 169.6 104.71 0.18 Allowed Glycine 0 C--N 1.341 0.829 0 C-N-CA 121.084 -0.579 . . . . 7.0199999999999996 113.149 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.6 mt -118.49 109.58 16.38 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.025 0.44 . . . . 8.9900000000000002 111.773 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.268 -0.872 . . . . 10.6 111.024 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 112.487 -0.245 . . . . 8.9299999999999997 112.487 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.56 132.32 54.62 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.509 0.671 . . . . 6.8200000000000003 111.835 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.5 mtt -130.11 113.49 14.57 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.825 -0.625 . . . . 7.6399999999999997 111.595 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 m -136.51 109.68 7.78 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.597 -0.729 . . . . 3.8599999999999999 111.571 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.86 89.51 0.08 OUTLIER Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.628 -0.714 . . . . 1.1100000000000001 112.897 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.587 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.6 tp -87.93 -45.67 10.04 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 113.323 0.86 . . . . 0.34999999999999998 113.323 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.64 -23.45 63.04 Favored 'General case' 0 N--CA 1.509 2.505 0 C-N-CA 125.899 1.68 . . . . 0.20000000000000001 114.971 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.39 -11.96 50.53 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 113.621 0.971 . . . . 0.32000000000000001 113.621 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 46.2 mmtt -105.39 -22.25 13.07 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 113.342 0.867 . . . . 1.73 113.342 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.02 135.7 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 115.103 1.52 . . . . 0.11 115.103 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.86 -28.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.455 -0.793 . . . . 0.16 112.035 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 66.4 t90 -162.52 118.81 1.93 Allowed 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 120.657 0.265 . . . . 0.54000000000000004 111.116 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.72 129.63 24.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.41 -0.806 . . . . 0.19 111.62 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 t -133.36 124.55 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.404 0.621 . . . . 1.05 110.064 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -113.96 88.71 2.91 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.105 -1.072 . . . . 2.1099999999999999 108.105 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -72.66 114.02 10.33 Favored 'General case' 0 C--O 1.274 2.356 0 N-CA-C 115.833 1.79 . . . . 0.63 115.833 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.61 -46.28 0.63 Allowed Glycine 0 C--N 1.368 2.309 0 CA-C-N 112.079 -2.328 . . . . 0.70999999999999996 114.438 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.44 -123.96 3.04 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 123.641 0.639 . . . . 0.80000000000000004 114.029 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -170.0 112.33 0.46 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.809 1.243 . . . . 1.6299999999999999 108.951 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 1.1 m 40.85 97.21 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.11 0 N-CA-C 116.968 2.211 . . . . 1.0 116.968 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.546 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 70.4 t60 -126.92 132.16 50.94 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.705 1.372 . . . . 0.45000000000000001 114.705 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 27' ' ' ILE 0.255 8.8 p -106.33 114.07 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.867 0 CA-C-N 114.135 -1.393 . . . . 1.3899999999999999 110.023 177.536 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.407 ' OD2' ' HB ' ' A' ' 27' ' ' ILE . 1.7 p-10 -82.85 160.78 22.11 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.674 -1.148 . . . . 1.8500000000000001 113.063 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 m -43.51 -24.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 N-CA-C 118.816 2.895 . . . . 0.71999999999999997 118.816 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -90.7 -29.54 17.64 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 121.164 0.507 . . . . 0.51000000000000001 110.695 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 41.09 0.57 Allowed Glycine 0 C--N 1.353 1.512 0 CA-C-N 114.953 -1.021 . . . . 0.34000000000000002 114.606 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.587 HD11 ' HG ' ' A' ' 6' ' ' LEU . 30.7 mm -107.95 124.33 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 N-CA-C 109.504 -0.554 . . . . 0.55000000000000004 109.504 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.4 t-160 -114.02 130.48 56.55 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.201 1.556 . . . . 1.3400000000000001 115.201 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.601 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -83.87 136.93 33.92 Favored 'General case' 0 C--N 1.372 1.573 0 C-N-CA 124.019 0.928 . . . . 2.79 110.778 175.117 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -88.89 101.98 14.59 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.716 1.26 . . . . 3.0 112.86 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -31.06 98.28 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 129.07 2.948 . . . . 2.2999999999999998 118.792 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.599 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.3 OUTLIER 44.64 72.45 1.21 Allowed Pre-proline 0 N--CA 1.523 3.219 0 N-CA-C 117.489 2.403 . . . . 1.1699999999999999 117.489 178.283 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -101.65 15.85 0.33 Allowed 'Trans proline' 0 CA--C 1.564 1.983 0 C-N-CA 122.556 2.171 . . . . 1.45 116.812 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 24.2 tp -143.01 -60.5 0.43 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.518 0.932 . . . . 1.9099999999999999 113.518 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -90.33 84.77 6.07 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.408 0.892 . . . . 4.8399999999999999 113.408 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.89 -32.17 7.8 Favored Glycine 0 CA--C 1.542 1.744 0 CA-C-N 114.2 -1.364 . . . . 2.3700000000000001 114.083 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 45.77 53.18 9.02 Favored 'General case' 0 N--CA 1.518 2.965 0 C-N-CA 127.498 2.319 . . . . 4.5 116.077 -179.511 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.92 179.29 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 124.386 1.074 . . . . 2.7000000000000002 110.829 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.35 81.45 0.85 Allowed Glycine 0 C--N 1.353 1.51 0 N-CA-C 114.4 0.52 . . . . 1.95 114.4 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -154.27 136.31 14.68 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.311 0.576 . . . . 5.3399999999999999 111.591 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.29 136.65 41.74 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.858 0.863 . . . . 1.6399999999999999 111.688 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.485 ' H ' HH21 ' A' ' 65' ' ' ARG . 29.9 m -113.28 104.05 11.94 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.825 -0.625 . . . . 1.5700000000000001 110.995 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.2 90.35 3.25 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.198 -0.91 . . . . 2.3300000000000001 110.345 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -94.92 -36.96 11.4 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.705 0.632 . . . . 3.1600000000000001 112.705 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.22 68.07 0.24 Allowed Glycine 0 C--N 1.353 1.478 0 N-CA-C 111.329 -0.708 . . . . 1.52 111.329 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.3 ttt -93.25 1.12 57.17 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 115.11 1.522 . . . . 1.6699999999999999 115.11 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.1 36.14 2.89 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 112.878 0.696 . . . . 4.1799999999999997 112.878 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.2 mt -152.08 72.92 7.82 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.639 1.175 . . . . 2.6299999999999999 108.344 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -65.08 162.14 34.1 Favored 'Trans proline' 0 N--CA 1.514 2.709 0 C-N-CA 124.421 3.414 . . . . 1.3700000000000001 116.818 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.261 1.2 mp -88.72 131.16 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.158 0 CA-C-O 121.779 0.799 . . . . 0.68999999999999995 110.156 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.517 ' HB2' HG22 ' A' ' 125' ' ' THR . 4.5 mt -90.83 -11.6 38.87 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 116.384 1.994 . . . . 1.28 116.384 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -101.12 9.04 42.47 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 114.414 1.264 . . . . 1.51 114.414 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.97 -169.79 2.23 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 121.426 0.631 . . . . 1.0900000000000001 112.603 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.797 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -94.23 -179.84 1.08 Allowed Pre-proline 0 N--CA 1.516 2.831 0 C-N-CA 124.453 1.101 . . . . 1.27 109.351 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -69.63 -39.57 6.59 Favored 'Trans proline' 0 C--N 1.398 3.166 0 C-N-CA 122.637 2.224 . . . . 0.94999999999999996 112.772 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -66.56 -52.84 41.11 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 125.988 1.715 . . . . 2.04 111.73 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.61 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -80.69 3.95 20.4 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 113.166 -1.834 . . . . 1.6200000000000001 113.183 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.797 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 32.4 tt0 -85.99 -40.71 15.54 Favored 'General case' 0 C--N 1.371 1.513 0 C-N-CA 125.868 1.667 . . . . 1.77 107.773 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -63.17 -43.02 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 C-N-CA 125.038 1.335 . . . . 0.81000000000000005 110.12 174.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.25 -42.9 54.13 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 118.441 0.564 . . . . 1.1499999999999999 111.786 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 2.8 m-30 -74.47 1.08 12.69 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 124.456 1.103 . . . . 0.92000000000000004 112.822 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.439 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 3.2 tt0 -131.98 -127.13 0.19 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.538 0.735 . . . . 1.3300000000000001 110.51 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.6 p 52.15 -145.59 0.54 Allowed 'General case' 0 N--CA 1.533 3.713 0 C-N-CA 126.076 1.751 . . . . 1.28 112.98 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 175.28 123.13 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.69 0 CA-C-N 120.633 1.561 . . . . 1.53 114.036 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.485 HH21 ' H ' ' A' ' 42' ' ' SER . 0.3 OUTLIER -117.35 125.24 50.7 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.634 -1.166 . . . . 3.2200000000000002 110.355 177.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -133.76 145.96 50.3 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.942 0.719 . . . . 3.6600000000000001 112.942 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -130.01 -87.29 0.52 Allowed 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.695 -0.684 . . . . 4.7000000000000002 112.406 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -150.52 -87.76 0.07 Allowed 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 113.227 0.825 . . . . 2.5499999999999998 113.227 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -161.31 125.96 3.51 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.436 0.695 . . . . 2.1499999999999999 110.921 -176.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 69.58 83.31 0.15 Allowed 'General case' 0 N--CA 1.511 2.607 0 C-N-CA 125.147 1.379 . . . . 0.77000000000000002 112.399 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -147.61 153.41 39.36 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.873 0.694 . . . . 0.81000000000000005 112.873 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -176.61 179.4 47.63 Favored Glycine 0 C--N 1.349 1.282 0 N-CA-C 116.259 1.264 . . . . 0.46999999999999997 116.259 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -100.35 173.64 6.5 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 117.357 2.354 . . . . 0.89000000000000001 117.357 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.02 120.95 23.11 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 112.617 -2.083 . . . . 0.51000000000000001 111.006 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.03 109.4 52.29 Favored Pre-proline 0 CA--C 1.568 1.672 0 C-N-CA 123.371 0.668 . . . . 0.14999999999999999 109.606 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -84.79 118.2 2.07 Favored 'Trans proline' 0 CA--C 1.566 2.125 0 C-N-CA 121.918 1.746 . . . . 0.14999999999999999 114.427 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.97 159.23 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 CA-C-O 122.052 0.93 . . . . 0.19 111.638 -179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -150.33 23.19 0.83 Allowed 'General case' 0 CA--C 1.56 1.343 0 CA-C-N 114.51 -1.223 . . . . 2.5299999999999998 111.859 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -129.25 158.74 38.21 Favored 'General case' 0 C--N 1.362 1.136 0 CA-C-O 121.166 0.508 . . . . 2.1200000000000001 111.344 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -120.33 144.3 47.92 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.743 1.016 . . . . 0.41999999999999998 113.743 -178.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.86 -135.64 4.01 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 113.751 -1.568 . . . . 0.23000000000000001 111.953 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -118.73 107.31 13.51 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 118.23 1.015 . . . . 1.75 111.101 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -99.35 128.38 45.46 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.252 0.549 . . . . 0.20999999999999999 111.041 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 t -112.02 124.01 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 115.674 -0.694 . . . . 0.20000000000000001 110.548 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.412 HD12 HD12 ' A' ' 172' ' ' ILE . 1.1 tt -107.87 106.44 16.72 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.675 -1.148 . . . . 0.78000000000000003 109.858 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.62 128.06 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 113.947 -1.479 . . . . 0.44 108.492 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.58 141.34 47.64 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.432 -0.804 . . . . 1.25 112.6 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -107.11 123.52 48.36 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 122.022 0.915 . . . . 2.52 110.331 176.093 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.53 137.07 46.22 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 114.16 -1.382 . . . . 0.40000000000000002 110.238 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.627 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . -131.14 151.84 51.04 Favored 'General case' 0 C--O 1.266 1.922 0 CA-C-N 114.979 -1.009 . . . . 0.40999999999999998 110.916 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -124.12 123.89 41.31 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 123.788 0.835 . . . . 2.6099999999999999 110.705 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.265 5.4 p -138.02 41.19 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.766 0 N-CA-C 112.567 0.58 . . . . 2.1299999999999999 112.567 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -161.8 -42.86 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.75 0.648 . . . . 2.27 112.75 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -115.36 119.48 36.42 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.218 0.451 . . . . 1.46 112.218 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.81 86.17 2.35 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-O 122.73 1.253 . . . . 0.83999999999999997 111.134 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -158.57 160.57 36.76 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.89 -1.05 . . . . 2.4500000000000002 112.034 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.3 m -121.84 125.52 46.65 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.6 -0.727 . . . . 1.6599999999999999 112.625 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 74.49 56.7 0.08 Allowed 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 125.878 1.671 . . . . 1.8899999999999999 113.074 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -157.73 -41.76 0.07 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.709 -1.132 . . . . 2.5600000000000001 109.41 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -105.83 82.78 1.83 Allowed 'General case' 0 C--N 1.361 1.1 0 CA-C-O 121.79 0.805 . . . . 2.7599999999999998 108.848 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.88 122.5 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 114.397 -1.274 . . . . 0.68999999999999995 111.729 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -107.36 164.09 12.48 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.9 1.444 . . . . 0.69999999999999996 114.9 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -120.23 136.51 54.62 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.379 0.609 . . . . 1.3300000000000001 111.109 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.0 t -126.13 127.12 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.205 0 CA-C-N 115.411 -0.813 . . . . 0.47999999999999998 109.828 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 57.9 mtt180 -127.33 148.89 50.25 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.509 1.67 . . . . 1.6899999999999999 115.509 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.8 m -129.48 113.5 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 N-CA-C 112.783 0.66 . . . . 0.59999999999999998 112.783 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.34 25.05 14.5 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 126.306 1.842 . . . . 1.1200000000000001 114.164 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.54 -17.29 46.86 Favored Glycine 0 CA--C 1.551 2.282 0 CA-C-N 115.896 -0.593 . . . . 0.32000000000000001 113.626 -176.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 95.2 m-70 -85.79 175.98 8.38 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.544 1.537 . . . . 0.56999999999999995 114.0 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.48 139.83 51.45 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.948 0.88 . . . . 0.55000000000000004 112.171 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.84 -57.16 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 114.016 -1.447 . . . . 1.0600000000000001 112.792 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.81 89.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.57 0.7 . . . . 0.44 109.35 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -100.55 119.45 38.54 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 114.651 -1.159 . . . . 2.2999999999999998 110.531 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 88.29 62.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 127.395 2.278 . . . . 2.48 110.78 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.13 105.05 15.57 Favored 'General case' 0 C--N 1.366 1.286 0 N-CA-C 113.425 0.898 . . . . 1.1299999999999999 113.425 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -111.46 99.31 8.11 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 113.781 -1.554 . . . . 2.3500000000000001 107.426 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -32.15 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 N-CA-C 114.675 1.361 . . . . 0.68000000000000005 114.675 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -75.01 -37.49 61.79 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.495 0.718 . . . . 0.77000000000000002 112.892 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -74.06 -26.7 60.54 Favored 'General case' 0 CA--C 1.575 1.911 0 C-N-CA 124.359 1.064 . . . . 0.91000000000000003 113.477 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -80.99 -57.92 3.31 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.246 0.832 . . . . 2.4300000000000002 113.246 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.43 -38.94 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 N-CA-C 114.091 1.145 . . . . 0.93000000000000005 114.091 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.04 -66.41 0.24 Allowed Glycine 0 C--N 1.358 1.794 0 CA-C-N 118.372 0.533 . . . . 0.84999999999999998 114.222 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -106.6 173.3 6.38 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.016 0.927 . . . . 3.1800000000000002 111.78 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.1 m -81.14 84.22 6.59 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.641 0.978 . . . . 2.0800000000000001 113.641 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.517 HG22 ' HB2' ' A' ' 51' ' ' LEU . 22.2 p -131.56 -131.37 0.19 Allowed 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 114.264 -1.335 . . . . 0.62 108.315 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.64 130.29 56.78 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 114.425 1.269 . . . . 0.46000000000000002 114.425 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -107.52 129.46 54.96 Favored 'General case' 0 C--N 1.371 1.526 0 N-CA-C 108.697 -0.853 . . . . 0.38 108.697 174.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.1 129.06 18.5 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.014 0.746 . . . . 2.5 113.014 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -112.92 129.27 56.53 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 115.081 -0.963 . . . . 1.5600000000000001 111.361 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.97 110.34 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 114.27 -1.332 . . . . 0.45000000000000001 109.429 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.6 102.16 29.61 Favored Pre-proline 0 CA--C 1.571 1.761 0 N-CA-C 112.482 0.549 . . . . 0.83999999999999997 112.482 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -74.77 144.3 30.96 Favored 'Trans proline' 0 C--N 1.398 3.16 0 C-N-CA 123.096 2.531 . . . . 0.16 114.882 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.09 147.99 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 C-N-CA 124.567 1.147 . . . . 0.38 109.043 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 t -134.3 116.97 15.88 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.438 0.637 . . . . 1.3100000000000001 112.003 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.2 mt -114.47 127.19 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 114.836 -1.075 . . . . 0.25 108.826 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -138.8 123.29 18.4 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.463 -0.789 . . . . 2.0499999999999998 110.756 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt 67.88 13.65 9.22 Favored 'General case' 0 N--CA 1.521 3.092 0 N-CA-C 115.226 1.565 . . . . 3.5499999999999998 115.226 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.94 15.13 31.96 Favored Glycine 0 CA--C 1.548 2.109 0 N-CA-C 114.732 0.653 . . . . 0.37 114.732 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 98.4 mttt -121.8 145.27 48.22 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 117.87 0.835 . . . . 1.5600000000000001 112.194 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.84 146.64 27.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.439 1.274 . . . . 0.34000000000000002 114.439 -176.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.24 111.02 9.91 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.38 -1.282 . . . . 0.64000000000000001 110.077 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.0 p -111.4 93.28 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.619 0 CA-C-N 115.598 -0.728 . . . . 0.46000000000000002 110.11 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 66.33 -83.48 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.882 0 C-N-CA 125.288 1.435 . . . . 1.5600000000000001 113.689 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.73 25.94 3.9 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 115.996 -0.547 . . . . 0.48999999999999999 113.741 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -133.2 118.58 18.79 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.18 0.592 . . . . 1.8200000000000001 110.128 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.7 p -105.92 132.76 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.329 0 CA-C-O 121.55 0.691 . . . . 1.02 112.07 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.8 m -148.33 -175.42 4.9 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.014 -0.994 . . . . 0.56000000000000005 110.106 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.418 HG22 ' HG2' ' A' ' 139' ' ' LYS . 35.6 p -101.81 137.94 39.45 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 113.055 0.761 . . . . 1.25 113.055 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -87.1 122.76 31.36 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.469 0.707 . . . . 0.28999999999999998 110.447 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.9 t -129.24 91.65 3.23 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 113.006 0.743 . . . . 1.4199999999999999 113.006 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.22 -64.09 3.8 Favored Glycine 0 C--N 1.357 1.725 0 N-CA-C 119.007 2.363 . . . . 0.41999999999999998 119.007 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.14 158.05 43.78 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.3 1.222 . . . . 1.1000000000000001 114.3 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.68 141.0 37.88 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.308 -1.769 . . . . 0.67000000000000004 109.332 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.9 t -123.95 141.61 51.88 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.972 1.471 . . . . 0.35999999999999999 114.972 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -116.56 100.45 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.33 -1.359 . . . . 0.73999999999999999 107.33 176.666 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -113.48 126.3 55.17 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.77 -0.65 . . . . 1.6699999999999999 112.375 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.6 124.61 52.75 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.503 -0.771 . . . . 1.8 110.406 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.45 ' C ' ' HB3' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -107.99 144.85 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 113.982 -1.463 . . . . 0.57999999999999996 111.027 -177.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.678 ' HB3' ' ND2' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -78.25 149.18 33.64 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 125.224 1.41 . . . . 2.1800000000000002 114.673 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.42 -53.09 0.57 Allowed Glycine 0 CA--C 1.537 1.464 0 CA-C-N 115.097 -0.956 . . . . 1.02 113.392 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -128.39 -48.52 1.3 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 122.937 0.495 . . . . 2.8599999999999999 112.049 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.78 -46.32 0.54 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.814 0.672 . . . . 3.9100000000000001 112.814 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.46 160.5 17.71 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.437 0.637 . . . . 1.74 112.569 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.678 ' ND2' ' HB3' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -120.17 -51.81 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 115.751 -0.658 . . . . 1.6799999999999999 111.296 -179.042 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -103.49 -59.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.669 2.246 . . . . 2.0600000000000001 115.143 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.0 tptm 88.34 -106.22 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 126.823 2.049 . . . . 3.0 110.492 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.07 134.1 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.005 -1.109 . . . . 0.80000000000000004 108.005 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 4.0 t -132.65 137.64 47.05 Favored 'General case' 0 C--N 1.366 1.297 0 N-CA-C 115.159 1.54 . . . . 0.87 115.159 -174.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.256 . . -130.15 47.27 2.53 Favored 'General case' 0 CA--C 1.589 2.465 0 N-CA-C 115.524 1.675 . . . . 0.34000000000000002 115.524 -179.262 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.85 137.07 5.84 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 116.506 2.039 . . . . 0.69999999999999996 116.506 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -154.06 106.04 2.78 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 115.668 -0.696 . . . . 0.20999999999999999 111.298 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.412 HD12 HD12 ' A' ' 85' ' ' LEU 0.325 7.8 tt -114.65 122.3 68.49 Favored 'Isoleucine or valine' 0 C--O 1.27 2.165 0 CA-C-O 122.44 1.114 . . . . 0.31 111.465 175.369 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -124.31 165.26 17.98 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 113.924 -1.489 . . . . 0.44 111.146 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.3 ptmm? -121.87 157.46 31.1 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 118.223 2.675 . . . . 1.26 118.223 -175.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.04 -40.96 2.27 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 110.343 -3.117 . . . . 0.17000000000000001 118.967 173.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.04 159.43 1.67 Allowed 'General case' 0 N--CA 1.514 2.77 0 CA-C-N 120.412 2.106 . . . . 0.14999999999999999 113.059 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.79 -13.64 59.7 Favored 'General case' 0 CA--C 1.58 2.118 0 C-N-CA 125.141 1.376 . . . . 0.17000000000000001 114.046 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.01 3.28 49.39 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 113.663 0.986 . . . . 0.55000000000000004 113.663 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.633 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -103.87 -8.94 19.34 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.575 0.954 . . . . 0.59999999999999998 113.575 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.72 90.54 0.43 Allowed Pre-proline 0 N--CA 1.51 2.537 0 C-N-CA 123.971 0.908 . . . . 0.94999999999999996 112.457 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.633 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 43.8 Cg_endo -94.66 149.2 1.8 Allowed 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.764 2.31 . . . . 1.8 114.924 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 65.1 mtt -133.54 101.05 4.99 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.733 -0.667 . . . . 4.96 110.805 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.3 mt -136.98 172.16 13.43 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.175 0.988 . . . . 4.0 112.883 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -112.46 159.95 32.17 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 114.52 -1.218 . . . . 6.2699999999999996 110.775 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.71 120.64 7.24 Favored 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 122.338 2.026 . . . . 6.5899999999999999 114.63 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -136.5 144.17 46.25 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-N 114.506 -1.225 . . . . 5.5099999999999998 111.222 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -87.68 -153.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 122.845 2.363 . . . . 6.7699999999999996 113.704 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 171.73 86.77 0.06 OUTLIER Glycine 0 C--N 1.34 0.798 0 C-N-CA 120.837 -0.697 . . . . 7.0199999999999996 113.349 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.5 mt -119.41 116.76 26.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.767 0.427 . . . . 8.9900000000000002 112.005 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.198 -0.906 . . . . 10.6 111.064 179.913 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.597 -0.201 . . . . 8.9299999999999997 112.597 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.7 128.32 56.04 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.52 0.676 . . . . 6.8200000000000003 111.854 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.0 mtt -134.84 110.95 9.51 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.757 -0.656 . . . . 7.6399999999999997 111.376 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -140.85 116.69 10.37 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.925 -0.579 . . . . 3.8599999999999999 111.836 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.19 87.57 0.07 OUTLIER Glycine 0 C--N 1.341 0.81 0 CA-C-N 115.788 -0.642 . . . . 1.1100000000000001 113.084 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.462 ' HG ' HD11 ' A' ' 27' ' ' ILE . 15.2 tp -88.22 -49.29 7.09 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.558 0.947 . . . . 0.34999999999999998 113.558 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -22.48 61.35 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 115.412 1.634 . . . . 0.20000000000000001 115.412 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.46 -12.51 48.8 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 113.751 1.019 . . . . 0.32000000000000001 113.751 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 16.4 mtpt -108.38 -18.91 13.63 Favored 'General case' 0 C--N 1.365 1.274 0 N-CA-C 113.583 0.957 . . . . 1.73 113.583 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.25 138.84 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.967 0 N-CA-C 115.156 1.539 . . . . 0.11 115.156 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -122.34 -28.09 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 115.34 -0.846 . . . . 0.16 112.124 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -165.32 119.7 1.26 Allowed 'General case' 0 CA--C 1.563 1.443 0 N-CA-C 111.543 0.201 . . . . 0.54000000000000004 111.543 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -138.31 130.51 28.7 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.302 -0.874 . . . . 0.19 111.724 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -138.9 134.59 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 N-CA-C 113.642 0.978 . . . . 1.05 113.642 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.427 HD22 ' HA ' ' A' ' 169' ' ' ALA . 6.1 t-20 -115.93 106.0 13.3 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.595 -1.261 . . . . 2.1099999999999999 107.595 172.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.99 106.64 9.99 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 121.525 0.678 . . . . 0.63 111.683 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.459 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 165.84 -47.73 0.27 Allowed Glycine 0 C--N 1.355 1.588 0 CA-C-N 114.613 -1.176 . . . . 0.70999999999999996 115.689 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.58 -119.09 3.07 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-O 119.743 -0.476 . . . . 0.80000000000000004 113.368 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.407 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 6.8 pt-20 -167.51 117.64 0.84 Allowed 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 117.311 0.555 . . . . 1.6299999999999999 112.214 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER 48.07 112.01 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 118.339 2.718 . . . . 1.0 118.339 178.22 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 54.3 t-80 -144.83 137.4 26.32 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.049 1.129 . . . . 0.45000000000000001 114.049 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.39 119.93 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-N 114.423 -1.262 . . . . 1.3899999999999999 110.172 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.57 157.86 24.61 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-N 114.707 -1.133 . . . . 1.8500000000000001 110.302 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 m -42.19 -28.15 0.23 Allowed 'Isoleucine or valine' 1 N--CA 1.543 4.186 0 N-CA-C 119.261 3.06 . . . . 0.71999999999999997 119.261 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -93.47 -16.41 24.55 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 118.281 0.491 . . . . 0.51000000000000001 111.513 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.68 41.88 1.29 Allowed Glycine 0 C--N 1.357 1.719 0 C-N-CA 124.391 0.996 . . . . 0.34000000000000002 114.561 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.462 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.8 mm -106.21 117.97 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 N-CA-C 109.335 -0.617 . . . . 0.55000000000000004 109.335 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.448 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.74 135.49 47.06 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.846 1.795 . . . . 1.3400000000000001 115.846 -175.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.3 137.71 33.98 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.261 -1.336 . . . . 2.79 110.157 175.094 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.442 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 31.8 mtt180 -99.48 107.05 19.15 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.581 -1.191 . . . . 3.0 112.898 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -28.08 113.75 0.07 Allowed 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 120.2 3.407 . . . . 2.2999999999999998 120.2 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.581 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 6.9 m-20 32.25 58.72 1.33 Allowed Pre-proline 0 N--CA 1.535 3.796 0 N-CA-C 117.883 2.549 . . . . 1.1699999999999999 117.883 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 20.4 Cg_endo -95.05 49.8 0.2 Allowed 'Trans proline' 0 CA--C 1.563 1.961 0 C-N-CA 123.071 2.514 . . . . 1.45 116.303 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.4 mp -122.92 -68.11 0.91 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.286 0.847 . . . . 1.9099999999999999 113.286 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -109.46 96.52 6.33 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.078 0.77 . . . . 4.8399999999999999 113.078 -177.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.55 -31.46 8.67 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-N 114.928 -1.033 . . . . 2.3700000000000001 114.631 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 69.37 63.98 0.27 Allowed 'General case' 0 N--CA 1.504 2.228 0 C-N-CA 126.047 1.739 . . . . 4.5 113.208 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.581 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -127.9 179.64 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-N 115.436 -0.802 . . . . 2.7000000000000002 111.907 -178.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.85 98.09 0.57 Allowed Glycine 0 C--N 1.348 1.229 0 C-N-CA 121.287 -0.482 . . . . 1.95 113.707 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -154.73 136.75 14.65 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.355 0.598 . . . . 5.3399999999999999 111.941 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.95 137.1 40.68 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.691 0.796 . . . . 1.6399999999999999 111.448 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.7 m -115.62 -73.34 0.65 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.101 -0.499 . . . . 1.5700000000000001 112.144 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 77.91 99.21 0.06 Allowed 'General case' 0 N--CA 1.504 2.265 0 C-N-CA 125.106 1.362 . . . . 2.3300000000000001 113.499 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -107.02 68.87 0.74 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.925 0.869 . . . . 3.1600000000000001 110.067 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.29 70.31 0.19 Allowed Glycine 0 C--N 1.343 0.952 0 CA-C-N 114.133 -1.394 . . . . 1.52 110.623 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.6 ttt -92.31 1.53 57.17 Favored 'General case' 0 CA--C 1.563 1.443 0 N-CA-C 115.231 1.567 . . . . 1.6699999999999999 115.231 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HD3' ' H ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -109.58 35.09 3.46 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 112.513 0.56 . . . . 4.1799999999999997 112.513 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.73 73.48 54.1 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.386 1.074 . . . . 2.6299999999999999 108.516 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . 31.0 Cg_exo -68.77 157.04 63.47 Favored 'Trans proline' 0 C--N 1.389 2.694 0 C-N-CA 124.274 3.316 . . . . 1.3700000000000001 116.371 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 61' ' ' TYR 0.269 1.4 mp -88.65 135.97 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.342 0 C-N-CA 123.69 0.796 . . . . 0.68999999999999995 110.113 179.095 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.41 -20.55 23.81 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 116.791 2.145 . . . . 1.28 116.791 -176.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -99.03 18.64 16.8 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.15 1.167 . . . . 1.51 114.15 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.66 -175.7 4.04 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-O 121.426 0.631 . . . . 1.0900000000000001 111.934 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.779 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -93.56 -177.83 0.75 Allowed Pre-proline 0 N--CA 1.511 2.625 0 C-N-CA 123.889 0.876 . . . . 1.27 109.543 178.301 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -68.93 -39.28 8.4 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.54 2.16 . . . . 0.94999999999999996 113.588 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.59 -50.95 47.72 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 125.309 1.444 . . . . 2.04 112.167 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -6.29 55.19 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-N 115.018 -0.992 . . . . 1.6200000000000001 112.667 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.779 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.0 tt0 -74.29 -39.96 62.6 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 125.162 1.385 . . . . 1.77 108.408 173.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.77 -43.55 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 C-N-CA 124.213 1.005 . . . . 0.81000000000000005 108.939 173.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.45 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 tp -80.37 -6.21 57.66 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 114.546 1.313 . . . . 1.1499999999999999 114.546 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.426 ' O ' HG12 ' A' ' 50' ' ' ILE . 18.9 m-85 -125.22 21.8 7.95 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 123.777 0.831 . . . . 0.92000000000000004 112.865 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 29.0 tt0 -143.86 -37.36 0.33 Allowed 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 115.338 1.607 . . . . 1.3300000000000001 115.338 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.1 p -68.57 133.79 49.05 Favored 'General case' 0 N--CA 1.53 3.558 0 N-CA-C 114.849 1.425 . . . . 1.28 114.849 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.52 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.7 pt-20 -122.13 144.92 48.64 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.012 1.486 . . . . 1.53 115.012 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -113.38 136.79 52.38 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 113.992 -1.458 . . . . 3.2200000000000002 111.111 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -119.63 135.66 54.71 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.235 0.457 . . . . 3.6600000000000001 112.235 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.55 -86.52 0.33 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 112.49 0.552 . . . . 4.7000000000000002 112.49 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -147.06 -101.53 0.09 Allowed 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 113.144 0.794 . . . . 2.5499999999999998 113.144 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -155.45 129.4 8.69 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.512 0.725 . . . . 2.1499999999999999 110.704 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.69 82.13 0.16 Allowed 'General case' 0 N--CA 1.515 2.812 0 C-N-CA 124.762 1.225 . . . . 0.77000000000000002 110.869 -178.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -144.85 153.9 42.08 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.78 -0.646 . . . . 0.81000000000000005 112.654 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.79 -163.91 16.58 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 116.007 1.163 . . . . 0.46999999999999997 116.007 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -122.76 164.94 17.4 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 113.607 -1.296 . . . . 0.89000000000000001 113.413 -177.427 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.22 130.37 52.66 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.425 -1.261 . . . . 0.51000000000000001 112.126 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.21 102.07 37.42 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.504 0.722 . . . . 0.14999999999999999 109.426 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -84.32 121.03 2.6 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.003 1.802 . . . . 0.14999999999999999 114.691 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.39 161.99 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 CA-C-O 122.099 0.952 . . . . 0.19 110.946 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -153.63 22.45 0.53 Allowed 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 114.55 -1.205 . . . . 2.5299999999999998 111.626 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.14 156.78 44.0 Favored 'General case' 0 C--N 1.362 1.127 0 C-N-CA 123.167 0.587 . . . . 2.1200000000000001 110.788 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -118.37 147.41 43.56 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.388 1.255 . . . . 0.41999999999999998 114.388 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.12 -137.64 5.15 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 113.619 -1.628 . . . . 0.23000000000000001 111.885 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.0 mt-10 -116.22 106.42 13.67 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-N 118.728 1.264 . . . . 1.75 110.819 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -99.58 128.4 45.68 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.251 0.548 . . . . 0.20999999999999999 110.893 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.53 121.77 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.807 0.813 . . . . 0.20000000000000001 110.835 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.36 106.99 17.85 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.118 -1.401 . . . . 0.78000000000000003 109.854 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.06 125.67 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.755 -0.657 . . . . 0.44 110.927 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.73 144.64 51.12 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.449 0.907 . . . . 1.25 113.449 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 4.5 tppt? -104.94 120.57 41.77 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.71 -0.677 . . . . 2.52 111.383 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 7.5 m-85 -105.56 134.48 48.6 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.561 -0.745 . . . . 0.40000000000000002 109.994 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.68 155.3 47.47 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.252 0.548 . . . . 0.40999999999999998 111.784 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.9 171.85 7.4 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.561 0.745 . . . . 2.6099999999999999 112.281 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.84 -77.61 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 112.498 0.555 . . . . 2.1299999999999999 112.498 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -129.69 70.17 1.43 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.311 0.577 . . . . 2.27 111.76 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -148.42 109.83 4.4 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.747 -0.66 . . . . 1.46 110.943 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.22 88.02 2.63 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 123.171 1.463 . . . . 0.83999999999999997 111.271 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -169.12 155.41 6.55 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 113.886 -1.506 . . . . 2.4500000000000002 110.475 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.3 m -118.61 -68.49 0.91 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.44 1.274 . . . . 1.6599999999999999 114.44 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -98.56 68.61 1.84 Allowed 'General case' 0 CA--C 1.558 1.281 0 CA-C-O 121.998 0.904 . . . . 1.8899999999999999 111.366 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -154.32 -45.41 0.09 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.142 -1.39 . . . . 2.5600000000000001 109.34 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -113.56 86.96 2.5 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 121.683 0.754 . . . . 2.7599999999999998 109.022 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.05 131.4 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 114.524 -1.216 . . . . 0.68999999999999995 111.651 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -103.86 166.93 10.1 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.975 1.472 . . . . 0.69999999999999996 114.975 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.17 137.15 54.93 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.91 -0.586 . . . . 1.3300000000000001 111.353 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.8 t -134.52 129.49 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.278 0 CA-C-N 115.941 -0.572 . . . . 0.47999999999999998 111.116 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -133.82 144.58 49.06 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.681 1.363 . . . . 1.6899999999999999 114.681 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.8 m -115.91 106.53 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 114.228 -1.351 . . . . 0.59999999999999998 112.783 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 6.0 t30 62.75 27.03 15.93 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 126.906 2.082 . . . . 1.1200000000000001 114.417 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.93 -20.47 31.24 Favored Glycine 0 CA--C 1.549 2.185 0 CA-C-N 115.503 -0.771 . . . . 0.32000000000000001 113.773 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -84.82 137.55 33.1 Favored 'General case' 0 C--N 1.365 1.254 0 C-N-CA 125.59 1.556 . . . . 0.56999999999999995 114.018 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.69 129.22 42.97 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.694 0.759 . . . . 0.55000000000000004 112.433 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.13 -51.46 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 114.389 -1.278 . . . . 1.0600000000000001 113.21 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.6 89.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.97 -0.752 . . . . 0.44 108.97 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -110.78 75.69 0.94 Allowed 'General case' 0 C--N 1.361 1.07 0 CA-C-O 123.68 1.705 . . . . 2.2999999999999998 112.446 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 152.89 67.16 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 110.094 -3.23 . . . . 2.48 108.23 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.29 101.62 13.36 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 122.161 0.981 . . . . 1.1299999999999999 112.824 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.64 100.09 8.94 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 112.865 -1.971 . . . . 2.3500000000000001 107.701 176.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.22 -22.11 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.379 0 N-CA-C 114.109 1.151 . . . . 0.68000000000000005 114.109 -176.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -77.28 -42.95 35.05 Favored 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 123.978 0.911 . . . . 0.77000000000000002 112.012 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.32 -27.23 60.61 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.892 1.071 . . . . 0.91000000000000003 113.892 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -80.18 -53.07 7.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.926 1.084 . . . . 2.4300000000000002 113.926 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.277 4.1 p -102.61 -36.24 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.99 0 N-CA-C 113.997 1.11 . . . . 0.93000000000000005 113.997 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.5 -121.1 3.03 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-N 118.691 0.678 . . . . 0.84999999999999998 113.047 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -113.27 107.65 16.19 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.252 0.549 . . . . 3.1800000000000002 110.826 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.3 m 72.81 -121.21 0.06 Allowed 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 125.558 1.543 . . . . 2.0800000000000001 111.669 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.6 p 51.55 -165.88 0.05 OUTLIER 'General case' 0 N--CA 1.535 3.795 0 N-CA-C 116.315 1.968 . . . . 0.62 116.315 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -109.08 127.06 53.82 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.128 0.788 . . . . 0.46000000000000002 113.128 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 8.8 t60 -105.0 140.41 38.23 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.423 0.689 . . . . 0.38 109.506 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -144.6 128.5 17.41 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.656 0.613 . . . . 2.5 112.656 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -116.14 136.83 52.67 Favored 'General case' 0 C--O 1.255 1.371 0 CA-C-N 115.019 -0.991 . . . . 1.5600000000000001 111.348 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.92 118.92 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 CA-C-N 113.719 -1.582 . . . . 0.45000000000000001 110.741 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.19 88.79 50.04 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-N 115.498 -0.774 . . . . 0.83999999999999997 109.724 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -73.54 139.26 28.16 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 123.183 2.589 . . . . 0.16 113.921 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -122.35 150.83 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-N 115.348 -0.842 . . . . 0.38 110.825 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.4 t -135.15 109.32 8.28 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.157 -0.929 . . . . 1.3100000000000001 110.525 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.536 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -108.9 124.75 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.569 0 CA-C-N 115.057 -0.974 . . . . 0.25 108.811 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -141.27 125.56 17.5 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.245 -0.889 . . . . 2.0499999999999998 110.778 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp 67.23 16.0 10.09 Favored 'General case' 0 N--CA 1.51 2.574 0 C-N-CA 125.444 1.498 . . . . 3.5499999999999998 114.23 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.68 16.83 32.63 Favored Glycine 0 CA--C 1.549 2.203 0 CA-C-O 119.323 -0.71 . . . . 0.37 114.591 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 58.2 mttt -120.74 142.56 49.43 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-N 118.003 0.902 . . . . 1.5600000000000001 112.847 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.54 132.51 47.13 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.271 0.841 . . . . 0.34000000000000002 113.271 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.08 112.81 18.2 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.2 -0.909 . . . . 0.64000000000000001 110.74 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.68 93.13 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.646 0 CA-C-N 115.44 -0.8 . . . . 0.46000000000000002 110.096 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 64.67 -85.17 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.949 0 C-N-CA 125.36 1.464 . . . . 1.5600000000000001 113.711 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.41 29.93 3.95 Favored Glycine 0 CA--C 1.544 1.898 0 CA-C-N 116.004 -0.544 . . . . 0.48999999999999999 113.288 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -133.77 119.96 19.92 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 123.74 0.816 . . . . 1.8200000000000001 110.544 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.9 p -107.76 133.19 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.351 0 CA-C-O 121.481 0.658 . . . . 1.02 111.806 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m -151.39 -177.04 5.83 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.161 -0.927 . . . . 0.56000000000000005 110.403 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.8 p -101.87 137.03 40.71 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.282 0.845 . . . . 1.25 113.282 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -86.74 121.47 29.29 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.456 0.702 . . . . 0.28999999999999998 110.144 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.2 t -126.39 91.25 3.33 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 113.03 0.752 . . . . 1.4199999999999999 113.03 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.56 -62.7 3.11 Favored Glycine 0 C--N 1.36 1.885 0 N-CA-C 118.542 2.177 . . . . 0.41999999999999998 118.542 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.49 159.89 38.08 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 122.061 0.934 . . . . 1.1000000000000001 113.31 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.523 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -106.46 134.12 50.09 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.448 -1.705 . . . . 0.67000000000000004 108.721 176.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.417 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.6 t -121.52 123.45 42.03 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 114.521 1.304 . . . . 0.35999999999999999 114.521 -176.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.51 102.81 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.567 -0.901 . . . . 0.73999999999999999 108.567 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.15 150.15 52.27 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.061 0.934 . . . . 1.6699999999999999 111.633 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.23 141.72 48.66 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 114.198 -1.365 . . . . 1.8 112.274 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.97 145.53 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-N 112.704 -2.044 . . . . 0.57999999999999996 110.769 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.493 ' HB3' ' ND2' ' A' ' 164' ' ' ASN . 21.0 pttp -70.3 150.04 46.77 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 115.803 1.779 . . . . 2.1800000000000002 115.803 -178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.3 -55.62 0.5 Allowed Glycine 0 CA--C 1.538 1.484 0 CA-C-N 114.89 -1.05 . . . . 1.02 112.606 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.86 -56.14 0.99 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.38 0.672 . . . . 2.8599999999999999 111.049 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -132.27 -41.67 0.98 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.253 0.621 . . . . 3.9100000000000001 112.394 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.37 155.25 24.46 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.33 0.652 . . . . 1.74 112.303 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.493 ' ND2' ' HB3' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -118.1 -48.02 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 115.693 -0.685 . . . . 1.6799999999999999 110.212 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -106.62 -69.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.553 2.169 . . . . 2.0600000000000001 115.939 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt 92.72 -92.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 127.47 2.308 . . . . 3.0 109.32 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 64' ' ' GLU . 41.9 t -113.42 131.62 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 107.775 -1.194 . . . . 0.80000000000000004 107.775 174.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.8 t -136.34 127.04 27.23 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 115.667 -0.697 . . . . 0.87 112.515 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.26 . . -119.43 50.2 1.27 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.858 1.799 . . . . 0.34000000000000002 115.858 -177.374 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -41.01 131.52 2.53 Favored 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 115.887 1.81 . . . . 0.69999999999999996 115.887 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -151.13 100.84 2.81 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.186 -0.916 . . . . 0.20999999999999999 110.275 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.312 8.5 tt -110.12 123.14 65.77 Favored 'Isoleucine or valine' 0 C--O 1.267 2.001 0 CA-C-O 122.412 1.101 . . . . 0.31 112.025 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -124.08 162.96 22.45 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 113.553 -1.658 . . . . 0.44 110.862 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 18.0 ptmt -121.56 159.99 25.24 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 118.585 2.809 . . . . 1.26 118.585 -175.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.51 -42.04 2.0 Allowed Glycine 0 CA--C 1.541 1.685 0 CA-C-N 110.001 -3.272 . . . . 0.17000000000000001 118.688 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.07 153.27 0.97 Allowed 'General case' 0 N--CA 1.515 2.815 0 CA-C-N 120.131 1.966 . . . . 0.14999999999999999 112.678 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.68 -12.89 60.04 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.631 1.345 . . . . 0.17000000000000001 114.631 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.42 4.56 45.97 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 114.349 1.24 . . . . 0.55000000000000004 114.349 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.488 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -107.11 -13.27 15.21 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 114.445 1.276 . . . . 0.59999999999999998 114.445 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.08 100.24 0.4 Allowed Pre-proline 0 N--CA 1.519 3.004 0 C-N-CA 124.238 1.015 . . . . 0.94999999999999996 112.944 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 4.2 Cg_exo -81.83 143.31 13.11 Favored 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 123.027 2.485 . . . . 1.8 114.383 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 11.0 tpt -145.08 113.03 6.41 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.804 -0.635 . . . . 4.96 111.012 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.25 166.96 21.57 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 122.085 0.945 . . . . 4.0 112.782 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -110.29 159.55 31.65 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-N 114.509 -1.223 . . . . 6.2699999999999996 110.973 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.68 123.41 11.02 Favored 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.779 2.32 . . . . 6.5899999999999999 115.221 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.552 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 26.5 t60 -134.54 134.22 22.15 Favored Pre-proline 0 CA--C 1.568 1.659 0 CA-C-N 114.976 -1.011 . . . . 5.5099999999999998 111.278 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.552 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 86.4 Cg_endo -76.3 -23.49 11.69 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 123.584 2.856 . . . . 6.7699999999999996 116.462 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -123.14 -141.3 5.86 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 114.748 0.659 . . . . 7.0199999999999996 114.748 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.2 mt -119.36 115.38 24.0 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.1 0.407 . . . . 8.9900000000000002 112.1 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.135 -0.936 . . . . 10.6 110.484 179.639 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.122 0 N-CA-C 112.599 -0.201 . . . . 8.9299999999999997 112.599 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.85 -42.19 4.07 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 112.955 0.724 . . . . 6.8200000000000003 112.955 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.0 mmt -134.28 -73.74 0.48 Allowed 'General case' 0 C--N 1.362 1.151 0 CA-C-N 118.092 0.405 . . . . 7.6399999999999997 111.558 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -140.45 117.13 10.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.983 0.421 . . . . 3.8599999999999999 111.706 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.58 84.42 0.14 Allowed Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.705 -0.68 . . . . 1.1100000000000001 112.926 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.64 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.8 tp -87.97 -46.79 9.06 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 113.505 0.928 . . . . 0.34999999999999998 113.505 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.99 -23.11 61.54 Favored 'General case' 0 N--CA 1.511 2.601 0 C-N-CA 125.704 1.602 . . . . 0.20000000000000001 115.209 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.82 -12.17 48.77 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 113.661 0.986 . . . . 0.32000000000000001 113.661 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 47.8 mmtt -104.69 -22.02 13.29 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.399 0.889 . . . . 1.73 113.399 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.21 134.69 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 N-CA-C 115.172 1.545 . . . . 0.11 115.172 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -122.88 -29.95 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-N 115.575 -0.739 . . . . 0.16 112.343 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 73.9 t90 -161.16 117.49 2.22 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 121.029 0.442 . . . . 0.54000000000000004 111.244 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.8 142.25 40.85 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.621 -0.674 . . . . 0.19 111.316 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.44 HG21 ' HG3' ' A' ' 33' ' ' PRO 0.334 8.9 p -145.38 134.03 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.937 0 CA-C-O 122.425 1.107 . . . . 1.05 113.461 178.053 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.47 ' N ' ' HB3' ' A' ' 29' ' ' TYR . 28.8 p-10 -100.92 91.02 4.39 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-N 113.195 -1.82 . . . . 2.1099999999999999 109.325 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -82.02 103.24 11.52 Favored 'General case' 0 C--O 1.265 1.88 0 CA-C-O 123.414 1.578 . . . . 0.63 113.158 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 162.99 -50.48 0.31 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-N 111.394 -2.639 . . . . 0.70999999999999996 111.374 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.63 -126.03 4.16 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.497 -1.041 . . . . 0.80000000000000004 110.497 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -168.4 117.36 0.73 Allowed 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 117.666 0.733 . . . . 1.6299999999999999 112.095 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.679 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 6.3 m 62.8 115.68 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 116.896 2.184 . . . . 1.0 116.896 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -159.8 139.57 11.46 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.369 0.604 . . . . 0.45000000000000001 112.176 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.14 122.66 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-N 115.57 -0.741 . . . . 1.3899999999999999 110.651 176.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -85.2 155.98 21.19 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.562 -0.745 . . . . 1.8500000000000001 111.183 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . 0.265 0.7 OUTLIER -45.1 -16.9 0.07 OUTLIER 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 N-CA-C 119.99 3.33 . . . . 0.71999999999999997 119.99 -175.39 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -95.8 -20.85 18.51 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 118.766 0.712 . . . . 0.51000000000000001 111.295 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.68 38.8 1.26 Allowed Glycine 0 C--N 1.356 1.652 0 C-N-CA 124.414 1.007 . . . . 0.34000000000000002 114.488 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.64 HD11 ' HG ' ' A' ' 6' ' ' LEU . 38.8 mm -105.6 121.58 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 N-CA-C 108.994 -0.743 . . . . 0.55000000000000004 108.994 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -101.23 125.29 47.84 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.641 0.608 . . . . 1.3400000000000001 112.641 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 20' ' ' SER . 41.7 m-85 -95.77 137.97 34.08 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.275 -0.875 . . . . 2.79 111.09 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -72.26 159.97 33.18 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.929 2.196 . . . . 3.0 116.929 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -94.92 87.19 4.88 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.001 -1.909 . . . . 2.2999999999999998 115.399 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.615 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER 49.41 78.29 0.41 Allowed Pre-proline 0 N--CA 1.529 3.489 0 N-CA-C 115.594 1.701 . . . . 1.1699999999999999 115.594 177.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HG3' HG21 ' A' ' 14' ' ' VAL . 44.9 Cg_endo -90.45 3.88 4.7 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 N-CA-C 118.971 2.643 . . . . 1.45 118.971 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.7 -33.28 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.176 1.917 . . . . 1.9099999999999999 116.176 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.517 ' HB3' ' OD1' ' A' ' 67' ' ' ASN . 8.3 pt-20 -89.21 65.52 7.34 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 120.533 1.515 . . . . 4.8399999999999999 113.51 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.54 -21.47 43.96 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-N 115.813 -0.631 . . . . 2.3700000000000001 113.949 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.615 ' HA ' ' O ' ' A' ' 32' ' ' ASP 0.25 0.0 OUTLIER 56.76 56.66 5.3 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 127.617 2.367 . . . . 4.5 114.432 -178.981 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.22 179.99 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-N 114.109 -1.405 . . . . 2.7000000000000002 110.616 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.26 93.1 1.85 Allowed Glycine 0 C--N 1.355 1.594 0 N-CA-C 115.101 0.8 . . . . 1.95 115.101 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -143.08 117.61 9.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.23 0.612 . . . . 5.3399999999999999 111.516 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.41 137.68 45.96 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.662 0.785 . . . . 1.6399999999999999 111.732 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 m -125.81 135.07 51.58 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.693 -0.685 . . . . 1.5700000000000001 112.192 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.8 -66.88 0.74 Allowed 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.378 -0.828 . . . . 2.3300000000000001 111.333 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.2 t80 80.57 -68.62 0.11 Allowed 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 125.917 1.687 . . . . 3.1600000000000001 111.653 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.88 91.33 0.57 Allowed Glycine 0 C--N 1.351 1.384 0 N-CA-C 109.965 -1.254 . . . . 1.52 109.965 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.5 ttm -87.26 1.91 51.73 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 115.694 1.739 . . . . 1.6699999999999999 115.694 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.34 39.34 1.76 Allowed 'General case' 0 CA--C 1.564 1.498 0 CA-C-O 121.742 0.782 . . . . 4.1799999999999997 112.916 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.84 76.86 64.48 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.111 1.364 . . . . 2.6299999999999999 107.809 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.65 162.43 19.06 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.135 2.557 . . . . 1.3700000000000001 116.906 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.26 1.3 mp -87.51 134.8 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.317 0 C-N-CA 123.82 0.848 . . . . 0.68999999999999995 109.892 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.404 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.3 mm? -90.69 -18.34 25.22 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.106 1.891 . . . . 1.28 116.106 -176.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -103.55 26.02 8.99 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 114.427 1.269 . . . . 1.51 114.427 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.449 ' HG ' ' HD2' ' A' ' 61' ' ' TYR . 1.0 OUTLIER -140.37 -165.56 1.94 Allowed 'General case' 0 CA--C 1.565 1.537 0 CA-C-O 122.32 1.057 . . . . 1.0900000000000001 112.725 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.888 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 2.1 t30 -88.85 172.6 7.26 Favored Pre-proline 0 CA--C 1.569 1.699 0 C-N-CA 126.488 1.915 . . . . 1.27 110.54 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.48 -43.31 1.01 Allowed 'Trans proline' 0 N--CA 1.513 2.63 0 C-N-CA 122.444 2.096 . . . . 0.94999999999999996 113.822 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.37 -41.57 47.57 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 125.223 1.409 . . . . 2.04 111.893 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -86.47 3.96 41.74 Favored 'General case' 0 CA--C 1.578 2.047 0 CA-C-N 114.443 -1.253 . . . . 1.6200000000000001 111.708 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.888 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.3 tt0 -83.25 -40.36 19.69 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 126.659 1.984 . . . . 1.77 106.08 171.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.93 -45.99 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.283 0 C-N-CA 125.296 1.438 . . . . 0.81000000000000005 109.52 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -39.42 68.81 Favored 'General case' 0 CA--C 1.601 2.907 0 N-CA-C 112.781 0.659 . . . . 1.1499999999999999 112.781 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.449 ' HD2' ' HG ' ' A' ' 53' ' ' SER . 12.2 m-30 -90.88 20.48 4.77 Favored 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 114.746 1.387 . . . . 0.92000000000000004 114.746 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.08 -42.01 0.65 Allowed 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 115.408 1.633 . . . . 1.3300000000000001 115.408 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.426 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 48.1 p -63.2 137.71 58.31 Favored 'General case' 0 N--CA 1.537 3.882 0 N-CA-C 114.989 1.477 . . . . 1.28 114.989 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.536 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 14.9 pt-20 -114.68 144.73 42.97 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.08 1.511 . . . . 1.53 115.08 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.8 mtp-105 -113.99 157.08 22.94 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 115.001 -1.0 . . . . 3.2200000000000002 111.787 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -129.99 140.25 50.93 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 112.759 0.652 . . . . 3.6600000000000001 112.759 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.517 ' OD1' ' HB3' ' A' ' 35' ' ' GLU . 0.9 OUTLIER -135.61 -95.16 0.25 Allowed 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.853 -0.612 . . . . 4.7000000000000002 111.62 179.365 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -160.19 -92.11 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 118.159 0.436 . . . . 2.5499999999999998 112.071 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -155.62 124.4 6.05 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.483 0.713 . . . . 2.1499999999999999 110.373 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 68.82 87.7 0.12 Allowed 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 125.341 1.456 . . . . 0.77000000000000002 111.802 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -149.14 163.35 37.84 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.445 0.906 . . . . 0.81000000000000005 113.445 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.48 -155.09 10.82 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 116.912 1.525 . . . . 0.46999999999999997 116.912 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.15 168.61 15.88 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.099 1.148 . . . . 0.89000000000000001 114.099 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -126.05 133.68 51.64 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.357 -1.292 . . . . 0.51000000000000001 112.082 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -126.07 100.52 30.05 Favored Pre-proline 0 CA--C 1.569 1.695 0 C-N-CA 123.167 0.587 . . . . 0.14999999999999999 109.642 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.16 117.54 2.2 Favored 'Trans proline' 0 CA--C 1.563 1.925 0 C-N-CA 122.187 1.925 . . . . 0.14999999999999999 114.978 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.18 160.66 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 CA-C-O 122.04 0.924 . . . . 0.19 111.409 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -148.51 23.18 1.02 Allowed 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 114.56 -1.2 . . . . 2.5299999999999998 111.528 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -128.85 158.94 37.32 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-O 121.14 0.495 . . . . 2.1200000000000001 110.892 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -120.6 144.94 47.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.601 1.334 . . . . 0.41999999999999998 114.601 -177.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.36 -138.56 5.44 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 113.674 -1.603 . . . . 0.23000000000000001 112.401 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.5 mt-10 -113.7 105.47 13.34 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 118.521 1.16 . . . . 1.75 111.294 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -99.1 128.43 45.23 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.116 0.484 . . . . 0.20999999999999999 110.899 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 t -113.58 123.79 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.34 0.591 . . . . 0.20000000000000001 110.509 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.408 HD12 HD12 ' A' ' 172' ' ' ILE . 3.4 tt -108.0 107.6 18.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.982 -1.008 . . . . 0.78000000000000003 110.401 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.66 125.79 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 114.004 -1.453 . . . . 0.44 107.968 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.45 140.23 44.71 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 116.043 -0.526 . . . . 1.25 112.292 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 16.8 tptt -95.32 120.77 36.12 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.664 -0.698 . . . . 2.52 112.693 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -107.05 132.99 52.35 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.055 -0.975 . . . . 0.40000000000000002 109.977 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.15 149.96 47.63 Favored 'General case' 0 C--O 1.262 1.719 0 CA-C-O 121.333 0.587 . . . . 0.40999999999999998 111.372 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -118.52 142.0 48.02 Favored 'General case' 0 C--N 1.36 1.028 0 CA-C-N 115.175 -0.921 . . . . 2.6099999999999999 111.844 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 -45.58 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-N 115.617 -0.72 . . . . 2.1299999999999999 112.632 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -121.11 137.9 54.44 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.126 0.417 . . . . 2.27 112.126 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 89.41 104.6 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 126.356 1.863 . . . . 1.46 111.43 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.13 87.19 4.14 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 123.295 1.521 . . . . 0.83999999999999997 111.929 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -146.04 157.47 43.86 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.73 -1.577 . . . . 2.4500000000000002 111.726 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.4 m -115.05 -74.39 0.61 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.063 1.134 . . . . 1.6599999999999999 114.063 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.28 64.12 1.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.225 1.012 . . . . 1.8899999999999999 111.918 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -151.92 -41.66 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.573 1.549 . . . . 2.5600000000000001 109.033 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -108.28 79.3 1.24 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-O 121.96 0.886 . . . . 2.7599999999999998 109.137 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.38 120.88 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 114.564 -1.198 . . . . 0.68999999999999995 110.639 -178.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -101.51 170.7 8.03 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.362 1.615 . . . . 0.69999999999999996 115.362 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.22 136.72 54.86 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.063 0.458 . . . . 1.3300000000000001 111.052 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.18 125.73 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.306 0 CA-C-N 115.826 -0.625 . . . . 0.47999999999999998 109.899 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 46.2 mtt180 -125.72 151.34 46.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.645 1.72 . . . . 1.6899999999999999 115.645 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.7 m -127.46 110.92 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 123.24 0.616 . . . . 0.59999999999999998 112.577 177.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.506 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.51 26.43 13.38 Favored 'General case' 0 N--CA 1.526 3.374 0 C-N-CA 126.664 1.986 . . . . 1.1200000000000001 113.95 -178.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.43 -11.93 56.79 Favored Glycine 0 CA--C 1.552 2.367 0 C-N-CA 121.482 -0.39 . . . . 0.32000000000000001 113.834 -176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.492 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 89.3 m-70 -89.72 164.89 14.5 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 125.944 1.698 . . . . 0.56999999999999995 113.488 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.04 134.89 54.32 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.494 0.664 . . . . 0.55000000000000004 112.016 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.51 -58.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 114.916 -1.038 . . . . 1.0600000000000001 112.784 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.06 88.64 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.881 -1.155 . . . . 0.44 107.881 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -107.74 100.16 9.57 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-O 123.11 1.433 . . . . 2.2999999999999998 111.778 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 117.62 72.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 129.438 3.095 . . . . 2.48 108.015 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.11 104.96 16.85 Favored 'General case' 0 C--N 1.359 0.98 0 CA-C-O 121.979 0.895 . . . . 1.1299999999999999 112.713 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -112.11 99.15 7.84 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 112.851 -1.977 . . . . 2.3500000000000001 107.973 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -24.11 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.364 0 N-CA-C 113.964 1.098 . . . . 0.68000000000000005 113.964 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -75.65 -41.35 54.29 Favored 'General case' 0 CA--C 1.568 1.668 0 C-N-CA 124.108 0.963 . . . . 0.77000000000000002 111.96 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.75 -26.38 59.74 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.278 1.031 . . . . 0.91000000000000003 113.444 176.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -77.39 -57.93 3.55 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.555 0.946 . . . . 2.4300000000000002 113.555 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.84 -32.07 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 N-CA-C 114.906 1.447 . . . . 0.93000000000000005 114.906 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.46 -115.77 2.35 Favored Glycine 0 C--N 1.357 1.729 0 CA-C-N 118.655 0.661 . . . . 0.84999999999999998 113.011 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -114.8 107.5 15.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.246 0.546 . . . . 3.1800000000000002 110.716 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.0 m 72.51 -130.52 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 125.487 1.515 . . . . 2.0800000000000001 112.313 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 51' ' ' LEU . 73.2 p 58.15 -162.13 0.22 Allowed 'General case' 0 N--CA 1.53 3.528 0 C-N-CA 126.237 1.815 . . . . 0.62 115.017 178.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.91 135.71 53.69 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 113.495 0.924 . . . . 0.46000000000000002 113.495 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -109.32 144.91 36.86 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.542 0.737 . . . . 0.38 109.163 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.15 124.19 18.88 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.704 1.001 . . . . 2.5 113.704 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -112.72 120.33 41.15 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.288 -0.869 . . . . 1.5600000000000001 111.538 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.47 115.68 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-N 114.742 -1.117 . . . . 0.45000000000000001 110.499 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 100.76 15.88 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 119.075 -0.488 . . . . 0.83999999999999997 111.791 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -74.6 142.47 29.26 Favored 'Trans proline' 0 C--N 1.4 3.266 0 C-N-CA 123.062 2.508 . . . . 0.16 114.281 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.29 146.24 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.597 0 C-N-CA 123.934 0.894 . . . . 0.38 109.983 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.1 p -128.89 110.42 12.1 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.222 0.534 . . . . 1.3100000000000001 112.145 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.0 mt -112.83 124.31 69.35 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.57 0 CA-C-N 115.277 -0.874 . . . . 0.25 108.952 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -140.22 124.22 17.53 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.47 -0.786 . . . . 2.0499999999999998 111.223 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt 65.75 16.24 10.4 Favored 'General case' 0 N--CA 1.516 2.843 0 C-N-CA 125.43 1.492 . . . . 3.5499999999999998 114.886 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.93 21.78 17.46 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 114.512 0.565 . . . . 0.37 114.512 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 19.0 ttmm -129.81 137.84 50.71 Favored 'General case' 0 C--N 1.363 1.159 0 CA-C-N 117.636 0.718 . . . . 1.5600000000000001 111.545 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.36 141.7 31.8 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.077 1.14 . . . . 0.34000000000000002 114.077 -176.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.21 114.53 13.92 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.704 -1.135 . . . . 0.64000000000000001 110.109 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.253 8.7 p -119.58 95.55 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 CA-C-N 115.841 -0.618 . . . . 0.46000000000000002 111.019 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 67.23 -85.18 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 125.714 1.606 . . . . 1.5600000000000001 113.968 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.44 28.38 3.81 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.093 -0.503 . . . . 0.48999999999999999 113.156 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -134.75 127.23 30.53 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 123.647 0.779 . . . . 1.8200000000000001 110.473 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.3 p -114.27 139.72 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.361 0 CA-C-O 121.278 0.561 . . . . 1.02 111.451 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.8 m -158.73 176.04 12.87 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.577 0.751 . . . . 0.56000000000000005 109.87 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.3 p -101.32 137.32 39.81 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.073 0.768 . . . . 1.25 113.073 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -82.8 124.86 30.67 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.074 0.949 . . . . 0.28999999999999998 112.016 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.9 t -131.32 91.08 2.96 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-O 121.643 0.735 . . . . 1.4199999999999999 112.574 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.0 -65.37 3.27 Favored Glycine 0 C--N 1.358 1.752 0 N-CA-C 118.986 2.355 . . . . 0.41999999999999998 118.986 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.511 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -131.16 156.6 45.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.291 1.219 . . . . 1.1000000000000001 114.291 -175.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.511 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -107.15 137.95 44.25 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 113.133 -1.849 . . . . 0.67000000000000004 109.071 176.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.1 t -120.61 143.34 48.71 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.411 1.634 . . . . 0.35999999999999999 115.411 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.38 99.04 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.169 -1.419 . . . . 0.73999999999999999 107.169 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -117.58 123.17 45.56 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.996 -0.547 . . . . 1.6699999999999999 112.316 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.01 136.24 53.13 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 122.53 1.157 . . . . 1.8 112.029 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.51 144.78 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 CA-C-N 112.529 -2.123 . . . . 0.57999999999999996 109.814 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.535 ' HB3' HD22 ' A' ' 164' ' ' ASN . 22.1 pttp -58.8 150.84 22.76 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.504 2.038 . . . . 2.1800000000000002 116.504 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.91 -63.95 0.51 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 115.541 -0.754 . . . . 1.02 114.028 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -130.7 -64.85 0.82 Allowed 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.962 0.381 . . . . 2.8599999999999999 111.811 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -120.17 -46.56 2.41 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.769 0.428 . . . . 3.9100000000000001 111.953 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -100.99 177.09 5.05 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.47 0.708 . . . . 1.74 111.222 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.535 HD22 ' HB3' ' A' ' 159' ' ' LYS . 0.9 OUTLIER -115.0 -85.46 0.0 OUTLIER Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 117.441 -1.266 . . . . 1.6799999999999999 110.679 179.662 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -88.59 -36.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.393 2.911 0 CA-C-N 123.774 2.384 . . . . 2.0600000000000001 114.256 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm 79.79 -88.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 126.845 2.058 . . . . 3.0 110.675 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.511 HG22 ' HB3' ' A' ' 64' ' ' GLU . 22.8 t -111.77 131.81 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.327 -0.99 . . . . 0.80000000000000004 108.327 175.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 3.8 t -138.26 132.49 31.8 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.052 -0.977 . . . . 0.87 111.801 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -129.6 51.11 2.1 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 114.96 1.467 . . . . 0.34000000000000002 114.96 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.25 138.14 1.25 Allowed 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 117.803 2.52 . . . . 0.69999999999999996 117.803 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -153.78 104.22 2.67 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 115.666 -0.697 . . . . 0.20999999999999999 111.504 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.408 HD12 HD12 ' A' ' 85' ' ' LEU 0.316 10.3 tt -113.88 122.06 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.183 0 CA-C-O 122.384 1.088 . . . . 0.31 111.119 175.049 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -122.7 165.47 16.48 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.145 -1.389 . . . . 0.44 111.092 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.6 ptmt -121.74 157.89 29.97 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 118.239 2.681 . . . . 1.26 118.239 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.24 -40.39 2.45 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 110.212 -3.176 . . . . 0.17000000000000001 119.066 173.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.11 157.64 1.85 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 120.265 2.033 . . . . 0.14999999999999999 113.101 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.86 -11.52 59.58 Favored 'General case' 0 CA--C 1.58 2.132 0 C-N-CA 124.91 1.284 . . . . 0.17000000000000001 113.984 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.68 3.52 47.57 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.0 1.111 . . . . 0.55000000000000004 114.0 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.02 -20.47 14.78 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.388 0.885 . . . . 0.59999999999999998 113.388 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.56 152.14 59.88 Favored Pre-proline 0 CA--C 1.579 2.072 0 C-N-CA 124.343 1.057 . . . . 0.94999999999999996 112.262 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -60.06 117.89 4.7 Favored 'Trans proline' 0 N--CA 1.522 3.168 0 C-N-CA 124.935 3.757 . . . . 1.8 115.87 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 14.8 ttt -145.52 118.28 8.67 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.974 -0.557 . . . . 4.96 111.345 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.6 mt -130.9 159.58 37.0 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.956 0.884 . . . . 4.0 112.492 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -105.85 162.35 19.99 Favored Pre-proline 0 CA--C 1.562 1.43 0 CA-C-N 114.768 -1.105 . . . . 6.2699999999999996 110.929 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -65.15 122.16 9.83 Favored 'Trans proline' 0 C--N 1.397 3.09 0 C-N-CA 122.696 2.264 . . . . 6.5899999999999999 114.425 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -135.23 134.75 21.66 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-N 115.452 -0.795 . . . . 5.5099999999999998 111.374 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.76 -29.41 7.1 Favored 'Trans proline' 0 C--N 1.394 2.95 0 C-N-CA 123.555 2.837 . . . . 6.7699999999999996 116.318 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -135.25 121.52 2.58 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 121.21 -0.519 . . . . 7.0199999999999996 114.324 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.4 mt -118.79 111.39 18.39 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.879 0.472 . . . . 8.9900000000000002 111.821 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.33 -0.843 . . . . 10.6 111.073 -179.962 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.092 0 N-CA-C 112.466 -0.254 . . . . 8.9299999999999997 112.466 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.13 -39.72 4.67 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 113.014 0.746 . . . . 6.8200000000000003 113.014 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 mmt -133.0 115.14 14.82 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-O 120.978 0.418 . . . . 7.6399999999999997 111.567 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 m -137.65 106.5 5.94 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.772 -0.649 . . . . 3.8599999999999999 111.448 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.32 81.37 0.05 OUTLIER Glycine 0 C--N 1.341 0.842 0 CA-C-N 115.726 -0.67 . . . . 1.1100000000000001 113.123 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.445 ' HG ' HD11 ' A' ' 27' ' ' ILE . 17.6 tp -88.37 -45.84 9.67 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 113.328 0.862 . . . . 0.34999999999999998 113.328 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.99 -23.32 63.54 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 125.896 1.678 . . . . 0.20000000000000001 115.269 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.69 -12.17 49.11 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 113.575 0.954 . . . . 0.32000000000000001 113.575 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -106.13 -19.36 13.74 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 113.324 0.861 . . . . 1.73 113.324 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -56.67 134.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.851 0 N-CA-C 114.705 1.372 . . . . 0.11 114.705 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -119.7 -29.77 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 115.581 -0.736 . . . . 0.16 112.214 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -160.43 115.95 2.3 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 120.696 0.284 . . . . 0.54000000000000004 110.951 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.08 122.19 22.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.602 -0.686 . . . . 0.19 111.397 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 30.8 t -131.25 116.63 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 122.097 0.951 . . . . 1.05 109.663 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.549 HD22 ' HB1' ' A' ' 169' ' ' ALA . 11.4 m120 -114.01 88.01 2.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.828 -1.078 . . . . 2.1099999999999999 108.996 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.6 120.13 17.79 Favored 'General case' 0 C--O 1.277 2.516 0 N-CA-C 115.757 1.762 . . . . 0.63 115.757 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.505 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 151.88 -10.22 0.67 Allowed Glycine 0 C--N 1.359 1.816 0 CA-C-N 111.731 -2.486 . . . . 0.70999999999999996 115.693 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.12 -119.81 1.23 Allowed Glycine 0 N--CA 1.468 0.82 0 CA-C-N 117.645 0.723 . . . . 0.80000000000000004 112.511 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -169.07 118.08 0.67 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.068 0.547 . . . . 1.6299999999999999 110.697 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.668 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 68.1 p 42.95 100.45 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.681 0 N-CA-C 117.92 2.563 . . . . 1.0 117.92 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 54.6 t-80 -132.94 136.24 46.0 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 118.615 -1.234 . . . . 0.45000000000000001 114.171 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.267 10.0 p -103.39 117.76 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 CA-C-N 114.117 -1.401 . . . . 1.3899999999999999 110.917 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -83.12 152.51 25.27 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-N 113.578 -1.646 . . . . 1.8500000000000001 110.046 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.7 m -41.25 -28.77 0.16 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.27 0 N-CA-C 119.192 3.034 . . . . 0.71999999999999997 119.192 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -87.36 -25.96 23.59 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.184 0.516 . . . . 0.51000000000000001 111.277 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.63 38.85 0.75 Allowed Glycine 0 C--N 1.352 1.422 0 CA-C-N 114.983 -1.008 . . . . 0.34000000000000002 114.445 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.445 HD11 ' HG ' ' A' ' 6' ' ' LEU . 20.6 mm -107.09 114.16 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 N-CA-C 109.68 -0.489 . . . . 0.55000000000000004 109.68 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.537 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -107.08 132.46 52.95 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 115.359 1.614 . . . . 1.3400000000000001 115.359 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -89.12 147.27 24.3 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.871 0.869 . . . . 2.79 109.93 174.274 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 20' ' ' SER . 0.0 OUTLIER -60.49 -107.88 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 117.075 2.25 . . . . 3.0 117.075 -177.116 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -175.72 71.55 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 124.221 1.008 . . . . 2.2999999999999998 112.958 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.415 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 19.3 m-20 65.52 47.57 0.58 Allowed Pre-proline 0 N--CA 1.519 3.009 0 N-CA-C 118.291 2.7 . . . . 1.1699999999999999 118.291 175.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 41.4 Cg_endo -106.77 160.44 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.214 2.609 . . . . 1.45 114.391 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.45 -86.77 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.5 1.12 . . . . 1.9099999999999999 110.039 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 72' ' ' GLY . 45.6 mt-10 -141.26 60.48 1.5 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.514 0.561 . . . . 4.8399999999999999 112.514 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.79 0.33 60.53 Favored Glycine 0 CA--C 1.549 2.158 0 N-CA-C 115.886 1.115 . . . . 2.3700000000000001 115.886 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.49 87.68 2.56 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 121.737 0.78 . . . . 4.5 111.763 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.46 117.01 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 114.545 -1.207 . . . . 2.7000000000000002 110.901 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.96 -103.63 0.18 Allowed Glycine 0 C--N 1.342 0.899 0 C-N-CA 120.866 -0.683 . . . . 1.95 114.018 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -120.7 177.02 5.23 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.512 0.93 . . . . 5.3399999999999999 113.512 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.63 147.45 24.3 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.481 1.112 . . . . 1.6399999999999999 112.638 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.0 m -113.77 84.62 2.06 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-O 121.411 0.624 . . . . 1.5700000000000001 111.639 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.67 82.93 1.96 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.468 -0.787 . . . . 2.3300000000000001 111.226 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.2 81.1 1.67 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 122.003 0.906 . . . . 3.1600000000000001 110.213 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.42 70.11 0.19 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 113.886 -1.506 . . . . 1.52 109.999 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.06 0.63 57.47 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 115.591 1.7 . . . . 1.6699999999999999 115.591 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -112.71 67.61 0.66 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.203 1.001 . . . . 4.1799999999999997 110.849 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.7 tp -163.66 72.2 1.82 Allowed Pre-proline 0 C--O 1.238 0.483 0 CA-C-N 114.179 -1.373 . . . . 2.6299999999999999 107.516 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -66.98 158.38 57.07 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.697 2.932 . . . . 1.3700000000000001 117.379 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.265 1.2 mp -89.8 128.11 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.226 0 CA-C-N 114.986 -1.006 . . . . 0.68999999999999995 109.191 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mp -85.49 -12.01 52.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.924 1.824 . . . . 1.28 115.924 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -102.63 22.59 13.36 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 113.694 0.998 . . . . 1.51 113.694 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -143.03 -163.33 1.61 Allowed 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 121.773 0.797 . . . . 1.0900000000000001 111.993 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.2 t30 -95.55 -179.96 1.04 Allowed Pre-proline 0 CA--C 1.572 1.823 0 C-N-CA 125.302 1.441 . . . . 1.27 111.138 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.575 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 24.5 Cg_exo -71.82 -45.64 0.7 Allowed 'Trans proline' 0 C--N 1.394 2.969 0 C-N-CA 123.076 2.518 . . . . 0.94999999999999996 111.891 174.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -70.07 -43.78 70.45 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.438 -1.71 . . . . 2.04 111.56 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.01 1.51 43.45 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 114.912 -1.04 . . . . 1.6200000000000001 112.438 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.595 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 3.4 tt0 -77.71 -42.94 32.65 Favored 'General case' 0 C--N 1.381 1.938 0 C-N-CA 125.853 1.661 . . . . 1.77 106.853 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.07 -44.45 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.869 0 C-N-CA 124.519 1.127 . . . . 0.81000000000000005 109.108 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.9 tp -68.22 -29.67 68.55 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 114.723 1.379 . . . . 1.1499999999999999 114.723 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -105.53 14.88 27.92 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 114.121 1.156 . . . . 0.92000000000000004 114.121 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.14 -23.48 1.13 Allowed 'General case' 0 N--CA 1.513 2.713 0 N-CA-C 115.883 1.809 . . . . 1.3300000000000001 115.883 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.473 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 41.7 p -80.88 135.95 36.0 Favored 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 113.378 0.881 . . . . 1.28 113.378 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.505 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.1 pt-20 -117.57 145.38 44.32 Favored 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 115.894 1.813 . . . . 1.53 115.894 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -130.22 105.91 8.23 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.611 -1.177 . . . . 3.2200000000000002 109.75 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -119.9 140.77 50.35 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.246 0.546 . . . . 3.6600000000000001 112.398 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -113.87 -76.49 0.58 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.099 0.778 . . . . 4.7000000000000002 113.099 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -142.69 -91.6 0.13 Allowed 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 113.094 0.776 . . . . 2.5499999999999998 113.094 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -159.54 125.99 4.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.479 0.712 . . . . 2.1499999999999999 110.58 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.499 ' H ' HD21 ' A' ' 164' ' ' ASN . 0.3 OUTLIER 72.72 83.99 0.12 Allowed 'General case' 0 N--CA 1.514 2.75 0 C-N-CA 124.952 1.301 . . . . 0.77000000000000002 111.042 -178.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -147.29 152.84 38.93 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.502 -0.772 . . . . 0.81000000000000005 113.062 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.532 ' O ' ' HG3' ' A' ' 35' ' ' GLU . . . -165.51 -171.68 32.01 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 115.842 1.097 . . . . 0.46999999999999997 115.842 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.27 172.43 7.08 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.438 1.273 . . . . 0.89000000000000001 114.438 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.09 132.33 51.92 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.393 -1.276 . . . . 0.51000000000000001 112.228 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.27 102.22 30.65 Favored Pre-proline 0 CA--C 1.567 1.613 0 C-N-CA 123.446 0.698 . . . . 0.14999999999999999 109.408 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.84 119.58 2.22 Favored 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 122.098 1.865 . . . . 0.14999999999999999 114.925 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.36 162.7 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.654 0 CA-C-O 122.003 0.906 . . . . 0.19 111.089 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -150.63 19.76 0.82 Allowed 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 114.716 -1.129 . . . . 2.5299999999999998 111.781 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.53 159.78 35.25 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-O 121.32 0.581 . . . . 2.1200000000000001 111.572 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.517 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -118.32 147.96 42.96 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.199 1.185 . . . . 0.41999999999999998 114.199 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.82 -139.6 6.26 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 113.827 -1.533 . . . . 0.23000000000000001 112.165 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.9 mt-10 -115.1 104.63 12.06 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 118.46 1.13 . . . . 1.75 110.823 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -98.88 128.4 45.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.159 0.504 . . . . 0.20999999999999999 110.759 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -112.93 122.91 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-O 121.612 0.72 . . . . 0.20000000000000001 110.848 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.468 HD12 HD12 ' A' ' 172' ' ' ILE . 2.0 tt -108.34 105.35 14.99 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.391 -1.277 . . . . 0.78000000000000003 110.304 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.19 125.13 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 114.082 -1.417 . . . . 0.44 107.913 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -135.52 135.34 40.33 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.728 -0.669 . . . . 1.25 111.837 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -96.09 121.21 37.62 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.498 -0.774 . . . . 2.52 112.051 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -107.34 133.96 51.11 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.058 -0.974 . . . . 0.40000000000000002 109.945 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.33 152.92 48.92 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.433 0.635 . . . . 0.40999999999999998 112.499 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.68 157.12 16.7 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.41 1.084 . . . . 2.6099999999999999 112.309 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.257 4.4 p -144.52 -39.48 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.585 0 N-CA-C 114.227 1.195 . . . . 2.1299999999999999 114.227 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -130.01 -2.04 4.63 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 115.442 1.645 . . . . 2.27 115.442 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -128.6 114.0 16.14 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.537 1.062 . . . . 1.46 112.311 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.0 92.7 4.15 Favored 'General case' 0 CA--C 1.563 1.471 0 CA-C-O 122.617 1.198 . . . . 0.83999999999999997 111.061 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -152.12 149.62 29.0 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.815 -1.084 . . . . 2.4500000000000002 112.103 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.1 m -123.71 117.83 25.85 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.585 0.587 . . . . 1.6599999999999999 112.585 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 71.47 55.38 0.2 Allowed 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 126.244 1.818 . . . . 1.8899999999999999 113.058 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -154.56 -40.08 0.09 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.194 -1.366 . . . . 2.5600000000000001 109.579 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -107.61 80.84 1.44 Allowed 'General case' 0 C--N 1.364 1.237 0 N-CA-C 108.643 -0.873 . . . . 2.7599999999999998 108.643 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.52 129.3 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 114.627 -1.169 . . . . 0.68999999999999995 111.466 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -115.51 171.76 7.52 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.014 1.487 . . . . 0.69999999999999996 115.014 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.52 136.12 54.01 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.415 0.626 . . . . 1.3300000000000001 111.774 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.2 123.32 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.936 0 CA-C-N 115.315 -0.857 . . . . 0.47999999999999998 110.102 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -129.83 149.42 51.57 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.953 1.464 . . . . 1.6899999999999999 114.953 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.3 OUTLIER -126.56 108.26 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 114.636 -1.165 . . . . 0.59999999999999998 111.704 176.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.49 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 65.18 26.08 12.37 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 126.759 2.023 . . . . 1.1200000000000001 113.277 -177.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.41 -13.91 51.06 Favored Glycine 0 CA--C 1.553 2.435 0 CA-C-N 116.157 -0.474 . . . . 0.32000000000000001 114.139 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -89.85 131.21 35.9 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 125.456 1.502 . . . . 0.56999999999999995 114.044 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -97.85 126.0 43.0 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.429 -0.794 . . . . 0.55000000000000004 112.705 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.26 -48.2 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-N 114.214 -1.357 . . . . 1.0600000000000001 110.256 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.06 88.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 120.26 -0.576 . . . . 0.44 109.744 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.02 72.27 0.81 Allowed 'General case' 0 C--N 1.36 1.03 0 CA-C-O 123.494 1.616 . . . . 2.2999999999999998 111.411 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.7 p30 160.07 60.4 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 111.005 -2.816 . . . . 2.48 108.52 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.89 103.18 15.75 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 113.749 1.018 . . . . 1.1299999999999999 113.749 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -119.07 102.87 9.05 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 112.88 -1.963 . . . . 2.3500000000000001 106.067 175.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -27.05 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.319 0 N-CA-C 114.547 1.314 . . . . 0.68000000000000005 114.547 -176.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.59 -37.77 55.96 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.684 0.793 . . . . 0.77000000000000002 112.194 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.22 -26.58 60.33 Favored 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 124.665 1.186 . . . . 0.91000000000000003 113.229 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -80.22 -57.96 3.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.482 0.919 . . . . 2.4300000000000002 113.482 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.28 -36.22 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.532 0 N-CA-C 114.196 1.184 . . . . 0.93000000000000005 114.196 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.01 -73.12 0.2 Allowed Glycine 0 C--N 1.361 1.922 0 CA-C-N 118.306 0.503 . . . . 0.84999999999999998 113.969 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -102.76 175.43 5.49 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.345 1.058 . . . . 3.1800000000000002 111.753 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 m -71.6 87.68 0.93 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.997 0.903 . . . . 2.0800000000000001 113.428 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.34 -162.22 1.3 Allowed 'General case' 0 CA--C 1.563 1.445 0 CA-C-N 113.918 -1.492 . . . . 0.62 110.024 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.94 130.3 45.3 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 113.421 0.897 . . . . 0.46000000000000002 113.421 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.431 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 22.4 t60 -103.51 141.72 35.51 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.463 -0.569 . . . . 0.38 109.463 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -134.15 124.17 25.62 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.377 1.251 . . . . 2.5 114.377 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -111.39 118.84 36.93 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.748 -1.114 . . . . 1.5600000000000001 110.684 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.62 120.91 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.735 -1.12 . . . . 0.45000000000000001 111.448 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.29 95.45 27.49 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-N 115.842 -0.617 . . . . 0.83999999999999997 111.062 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -75.37 131.91 14.37 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.787 2.324 . . . . 0.16 112.711 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.3 mt -115.1 146.7 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 CA-C-N 115.443 -0.799 . . . . 0.38 111.137 -176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.6 p -129.18 109.94 11.57 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.264 -0.88 . . . . 1.3100000000000001 111.515 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.517 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.5 mt -112.14 123.33 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.502 0 N-CA-C 108.336 -0.987 . . . . 0.25 108.336 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -138.78 124.43 19.62 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.373 -0.83 . . . . 2.0499999999999998 110.792 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.28 17.86 10.25 Favored 'General case' 0 N--CA 1.515 2.784 0 C-N-CA 125.35 1.46 . . . . 3.5499999999999998 114.168 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.54 13.8 43.2 Favored Glycine 0 CA--C 1.546 2.01 0 CA-C-O 119.163 -0.798 . . . . 0.37 115.025 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 54.8 mtpt -122.46 147.02 46.83 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-N 118.523 1.161 . . . . 1.5600000000000001 112.57 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.82 143.98 31.74 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.125 1.157 . . . . 0.34000000000000002 114.125 -175.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.43 114.65 11.59 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.919 -1.037 . . . . 0.64000000000000001 110.653 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.278 0.4 OUTLIER -116.81 105.17 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-O 121.144 0.497 . . . . 0.46000000000000002 110.382 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 66.32 -84.29 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.706 0 C-N-CA 125.701 1.601 . . . . 1.5600000000000001 113.981 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.75 31.82 2.52 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.001 -0.545 . . . . 0.48999999999999999 112.859 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -134.85 126.66 29.24 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 123.603 0.761 . . . . 1.8200000000000001 110.239 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -112.5 133.02 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 CA-C-O 121.673 0.749 . . . . 1.02 112.21 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.2 m -149.95 179.54 7.97 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.83 -1.077 . . . . 0.56000000000000005 109.346 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.275 15.1 t -104.15 139.05 39.76 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 113.476 0.917 . . . . 1.25 113.476 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -82.87 122.19 27.92 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.068 0.947 . . . . 0.28999999999999998 111.367 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.56 91.24 3.26 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 112.556 0.576 . . . . 1.4199999999999999 112.556 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.96 -64.82 3.33 Favored Glycine 0 C--N 1.358 1.802 0 N-CA-C 118.715 2.246 . . . . 0.41999999999999998 118.715 177.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.52 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -132.38 157.79 43.63 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 114.251 1.204 . . . . 1.1000000000000001 114.251 -176.495 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.52 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -104.62 139.04 40.06 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.202 -1.817 . . . . 0.67000000000000004 109.063 176.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 t -121.35 142.48 49.94 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.352 1.612 . . . . 0.35999999999999999 115.352 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.419 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.14 97.27 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.451 -1.314 . . . . 0.73999999999999999 107.451 176.267 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 33.4 mt-10 -112.65 128.04 56.28 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.384 0.883 . . . . 1.6699999999999999 113.384 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -114.05 126.18 54.83 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 115.738 -0.664 . . . . 1.8 110.192 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.07 144.37 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 114.652 -1.158 . . . . 0.57999999999999996 110.53 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -72.45 150.45 43.3 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.646 2.091 . . . . 2.1800000000000002 116.646 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -114.97 -47.88 0.55 Allowed Glycine 0 CA--C 1.541 1.691 0 CA-C-N 114.066 -1.424 . . . . 1.02 112.941 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -131.88 -76.82 0.51 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 122.739 0.415 . . . . 2.8599999999999999 111.951 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -138.17 -53.97 0.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.949 0.5 . . . . 3.9100000000000001 111.421 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.05 119.66 31.39 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.606 1.162 . . . . 1.74 110.772 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.499 HD21 ' H ' ' A' ' 70' ' ' SER . 1.3 m-20 -81.13 -170.67 0.26 Allowed Pre-proline 0 CA--C 1.572 1.809 0 C-N-CA 124.848 1.259 . . . . 1.6799999999999999 110.524 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -61.8 104.93 0.34 Allowed 'Trans proline' 0 C--N 1.394 2.922 0 CA-C-N 122.304 1.858 . . . . 2.0600000000000001 112.215 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -63.52 1.27 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.336 1.976 . . . . 3.0 116.336 -174.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 66.0 t -96.38 131.44 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 CA-C-N 119.367 0.985 . . . . 0.80000000000000004 109.991 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.25 123.27 23.99 Favored 'General case' 0 C--N 1.363 1.169 0 CA-C-N 114.443 -1.253 . . . . 0.87 111.834 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.549 ' HB1' HD22 ' A' ' 15' ' ' ASN . . . -120.72 48.02 1.69 Allowed 'General case' 0 CA--C 1.585 2.302 0 N-CA-C 115.643 1.719 . . . . 0.34000000000000002 115.643 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.642 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -45.23 131.74 7.73 Favored 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 116.64 2.089 . . . . 0.69999999999999996 116.64 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -151.31 105.4 3.19 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 115.19 -0.914 . . . . 0.20999999999999999 111.051 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.468 HD12 HD12 ' A' ' 85' ' ' LEU 0.298 9.1 tt -113.66 122.32 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 CA-C-O 122.283 1.04 . . . . 0.31 111.258 175.651 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -122.67 165.24 16.82 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 113.906 -1.497 . . . . 0.44 110.789 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -122.13 158.93 28.22 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 118.283 2.698 . . . . 1.26 118.283 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.89 -41.31 2.17 Favored Glycine 0 CA--C 1.541 1.7 0 CA-C-N 110.351 -3.113 . . . . 0.17000000000000001 119.256 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.59 154.53 1.25 Allowed 'General case' 0 N--CA 1.518 2.927 0 CA-C-N 120.494 2.147 . . . . 0.14999999999999999 113.227 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.25 -14.43 58.42 Favored 'General case' 0 CA--C 1.581 2.169 0 C-N-CA 124.75 1.22 . . . . 0.17000000000000001 114.092 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.8 2.99 49.9 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.143 1.164 . . . . 0.55000000000000004 114.143 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.661 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -110.0 -5.79 15.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.726 1.01 . . . . 0.59999999999999998 113.726 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.51 93.69 0.41 Allowed Pre-proline 0 N--CA 1.511 2.622 0 C-N-CA 124.397 1.079 . . . . 0.94999999999999996 111.752 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.661 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 53.7 Cg_endo -95.26 146.54 1.46 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.988 2.459 . . . . 1.8 114.717 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 24.0 mmt -138.01 111.6 8.16 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.901 -0.591 . . . . 4.96 111.4 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.8 161.06 38.46 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.982 0.896 . . . . 4.0 112.656 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -111.26 161.14 26.47 Favored Pre-proline 0 CA--C 1.56 1.332 0 CA-C-N 114.774 -1.103 . . . . 6.2699999999999996 110.934 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.6 120.51 7.81 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.791 2.328 . . . . 6.5899999999999999 114.771 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -136.86 141.76 36.17 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-N 114.861 -1.063 . . . . 5.5099999999999998 111.071 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.97 -28.58 3.83 Favored 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 123.098 2.532 . . . . 6.7699999999999996 116.15 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -135.06 -140.35 4.21 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 114.34 0.496 . . . . 7.0199999999999996 114.34 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.8 mt -119.2 115.5 24.34 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.021 0.378 . . . . 8.9900000000000002 112.021 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.165 -0.921 . . . . 10.6 110.639 179.73 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.641 -0.184 . . . . 8.9299999999999997 112.641 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.2 117.81 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 127.546 2.338 . . . . 6.8200000000000003 114.984 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.8 tpt -141.37 115.84 9.53 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.469 -0.787 . . . . 7.6399999999999997 111.007 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.6 m -131.2 -66.41 0.74 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.911 -0.586 . . . . 3.8599999999999999 112.254 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.27 95.95 0.1 Allowed Glycine 0 C--N 1.348 1.222 0 C-N-CA 121.426 -0.416 . . . . 1.1100000000000001 113.225 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.657 ' HG ' HD11 ' A' ' 27' ' ' ILE . 19.4 tp -87.42 -42.4 12.86 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 112.938 0.718 . . . . 0.34999999999999998 112.938 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.43 63.56 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 125.855 1.662 . . . . 0.20000000000000001 114.797 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.7 -11.43 51.24 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 113.667 0.988 . . . . 0.32000000000000001 113.667 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 20.8 mmtp -105.47 -23.28 12.84 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.379 0.881 . . . . 1.73 113.379 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.67 136.55 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 N-CA-C 115.472 1.656 . . . . 0.11 115.472 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.9 -28.4 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 115.195 -0.911 . . . . 0.16 112.236 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -163.09 118.76 1.76 Allowed 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 117.929 0.331 . . . . 0.54000000000000004 111.882 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.26 131.82 30.76 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.273 -0.892 . . . . 0.19 111.876 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -139.75 130.66 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 N-CA-C 113.113 0.783 . . . . 1.05 113.113 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -115.83 106.61 14.03 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.117 -1.438 . . . . 2.1099999999999999 107.117 171.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.33 105.83 9.84 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.614 0.721 . . . . 0.63 111.664 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 168.79 -63.54 0.19 Allowed Glycine 0 C--N 1.355 1.635 0 CA-C-N 114.189 -1.369 . . . . 0.70999999999999996 114.821 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -95.16 -116.3 2.96 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 114.716 0.646 . . . . 0.80000000000000004 114.716 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 18.4 mt-10 -170.08 114.16 0.49 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.889 0.876 . . . . 1.6299999999999999 109.884 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 46.39 111.95 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.003 0 N-CA-C 118.328 2.714 . . . . 1.0 118.328 178.831 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.483 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 56.8 t-80 -136.59 136.4 39.19 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.97 1.1 . . . . 0.45000000000000001 113.97 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.82 109.29 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 CA-C-N 113.765 -1.561 . . . . 1.3899999999999999 107.04 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.67 160.1 18.26 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 112.171 0.434 . . . . 1.8500000000000001 112.171 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -41.48 -26.41 0.11 Allowed 'Isoleucine or valine' 1 N--CA 1.547 4.383 0 N-CA-C 120.072 3.36 . . . . 0.71999999999999997 120.072 -174.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -93.35 -11.33 32.59 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 118.84 0.746 . . . . 0.51000000000000001 112.44 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.82 38.0 3.28 Favored Glycine 0 C--N 1.361 1.929 0 C-N-CA 124.16 0.886 . . . . 0.34000000000000002 114.158 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.657 HD11 ' HG ' ' A' ' 6' ' ' LEU . 28.6 mm -105.38 135.55 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.618 0 N-CA-C 108.555 -0.906 . . . . 0.55000000000000004 108.555 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.483 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.9 t-160 -123.34 132.38 53.97 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.612 1.338 . . . . 1.3400000000000001 114.612 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -93.73 137.21 33.22 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.123 -0.944 . . . . 2.79 109.94 175.436 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -100.29 104.76 16.25 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 113.465 0.913 . . . . 3.0 113.465 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HG3' ' OG ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -36.6 122.12 0.77 Allowed 'General case' 0 N--CA 1.528 3.434 0 N-CA-C 119.051 2.982 . . . . 2.2999999999999998 119.051 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER 39.03 64.69 3.66 Favored Pre-proline 0 N--CA 1.529 3.49 0 N-CA-C 117.131 2.271 . . . . 1.1699999999999999 117.131 177.571 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -89.73 -8.09 4.46 Favored 'Trans proline' 0 CA--C 1.563 1.957 0 C-N-CA 122.755 2.303 . . . . 1.45 118.058 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.91 -26.86 0.78 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.468 1.655 . . . . 1.9099999999999999 115.468 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -99.11 76.01 2.07 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 119.702 1.137 . . . . 4.8399999999999999 112.306 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.37 -30.04 10.86 Favored Glycine 0 CA--C 1.543 1.785 0 CA-C-N 115.396 -0.82 . . . . 2.3700000000000001 114.521 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 50.3 55.31 9.66 Favored 'General case' 0 N--CA 1.516 2.859 0 C-N-CA 127.328 2.251 . . . . 4.5 115.779 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.48 179.6 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-N 114.686 -1.143 . . . . 2.7000000000000002 110.654 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.2 82.27 0.87 Allowed Glycine 0 CA--C 1.538 1.498 0 O-C-N 121.756 -0.59 . . . . 1.95 114.449 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -148.38 134.5 19.29 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.372 0.606 . . . . 5.3399999999999999 112.355 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.25 132.71 53.38 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.965 0.906 . . . . 1.6399999999999999 111.012 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 m -116.91 107.25 14.36 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.689 -0.687 . . . . 1.5700000000000001 111.328 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.68 109.83 8.87 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.564 -0.744 . . . . 2.3300000000000001 111.552 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -105.45 -33.58 8.09 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.248 -0.887 . . . . 3.1600000000000001 111.891 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -114.39 75.67 0.24 Allowed Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.337 -0.705 . . . . 1.52 111.337 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.95 -19.8 22.05 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 114.451 1.278 . . . . 1.6699999999999999 114.451 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -104.22 35.18 2.78 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 112.84 0.681 . . . . 4.1799999999999997 112.84 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.29 71.7 71.96 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.635 1.574 . . . . 2.6299999999999999 106.972 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -67.81 158.77 55.78 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 124.175 3.25 . . . . 1.3700000000000001 117.45 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.256 1.3 mp -86.76 124.89 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.466 0 C-N-CA 124.366 1.066 . . . . 0.68999999999999995 108.389 177.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.62 -11.71 59.01 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.602 2.075 . . . . 1.28 116.602 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -102.5 17.08 24.52 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 113.745 1.017 . . . . 1.51 113.745 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.425 ' OG ' ' HD2' ' A' ' 61' ' ' TYR . 1.2 t -137.32 -164.04 1.53 Allowed 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.856 0.836 . . . . 1.0900000000000001 112.578 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.732 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.5 t30 -95.95 -179.27 0.89 Allowed Pre-proline 0 CA--C 1.573 1.858 0 C-N-CA 125.617 1.567 . . . . 1.27 111.367 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.517 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.5 Cg_exo -72.34 -46.44 0.49 Allowed 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 123.175 2.584 . . . . 0.94999999999999996 112.535 174.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -70.01 -47.02 63.81 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 113.905 -1.498 . . . . 2.04 111.731 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -8.88 58.12 Favored 'General case' 0 CA--C 1.585 2.324 0 CA-C-N 114.916 -1.038 . . . . 1.6200000000000001 111.955 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.732 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 13.4 tt0 -70.81 -42.28 70.46 Favored 'General case' 0 C--N 1.39 2.354 0 C-N-CA 125.716 1.607 . . . . 1.77 108.187 172.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -59.69 -42.56 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.217 0 C-N-CA 124.663 1.185 . . . . 0.81000000000000005 109.463 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.9 tp -80.02 -8.81 59.56 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 114.328 1.233 . . . . 1.1499999999999999 114.328 176.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.425 ' HD2' ' OG ' ' A' ' 53' ' ' SER . 20.3 m-85 -125.05 22.75 7.9 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.98 0.912 . . . . 0.92000000000000004 113.357 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -143.38 -38.24 0.33 Allowed 'General case' 0 N--CA 1.513 2.686 0 N-CA-C 115.245 1.572 . . . . 1.3300000000000001 115.245 -177.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.8 p -67.85 134.02 50.18 Favored 'General case' 0 N--CA 1.533 3.716 0 N-CA-C 114.456 1.28 . . . . 1.28 114.456 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.449 ' HB3' HG22 ' A' ' 167' ' ' VAL . 2.7 pt-20 -123.63 141.77 51.69 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 115.386 1.624 . . . . 1.53 115.386 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -124.2 121.4 34.97 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 113.965 -1.47 . . . . 3.2200000000000002 110.496 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -128.02 137.43 52.2 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.992 0.425 . . . . 3.6600000000000001 112.032 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.42 -70.92 0.75 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.62 0.97 . . . . 4.7000000000000002 113.62 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -135.4 -87.59 0.35 Allowed 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 114.054 1.131 . . . . 2.5499999999999998 114.054 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -173.6 124.72 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.657 0.783 . . . . 2.1499999999999999 109.691 -175.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 71.66 84.67 0.13 Allowed 'General case' 0 N--CA 1.51 2.546 0 C-N-CA 124.86 1.264 . . . . 0.77000000000000002 111.962 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.62 141.77 45.12 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.978 0.894 . . . . 0.81000000000000005 112.176 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -140.03 175.93 21.58 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 116.407 1.323 . . . . 0.46999999999999997 116.407 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.86 163.17 17.3 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.839 -1.18 . . . . 0.89000000000000001 113.227 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -122.21 129.33 52.16 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.604 -1.18 . . . . 0.51000000000000001 112.435 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -123.21 101.42 38.18 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 108.91 -0.774 . . . . 0.14999999999999999 108.91 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -84.26 119.64 2.43 Favored 'Trans proline' 0 CA--C 1.563 1.945 0 C-N-CA 121.998 1.799 . . . . 0.14999999999999999 114.747 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.84 160.42 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 CA-C-O 122.035 0.922 . . . . 0.19 111.308 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -148.66 21.02 1.03 Allowed 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.605 -1.179 . . . . 2.5299999999999998 111.865 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.06 160.35 33.98 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-O 121.312 0.577 . . . . 2.1200000000000001 111.415 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -119.29 145.51 46.06 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.437 0.903 . . . . 0.41999999999999998 113.437 -179.203 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.5 -138.3 5.45 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.341 -1.299 . . . . 0.23000000000000001 112.498 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 30.6 mm-40 -114.8 105.0 12.51 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 118.228 1.014 . . . . 1.75 111.144 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -99.45 127.51 45.5 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.321 0.582 . . . . 0.20999999999999999 110.853 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -109.22 121.5 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-O 121.894 0.854 . . . . 0.20000000000000001 110.878 -176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.34 107.41 18.41 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 113.801 -1.545 . . . . 0.78000000000000003 110.446 178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 t -115.64 125.2 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.91 -0.774 . . . . 0.44 108.91 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.92 141.79 48.56 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.756 0.65 . . . . 1.25 112.756 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.4 OUTLIER -107.07 119.3 39.01 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.668 -0.696 . . . . 2.52 111.277 177.63 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.436 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 12.4 m-85 -106.68 134.61 49.56 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.467 -0.788 . . . . 0.40000000000000002 110.581 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.23 146.6 42.78 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.246 0.546 . . . . 0.40999999999999998 111.527 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -136.23 120.64 18.08 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.253 0.621 . . . . 2.6099999999999999 110.893 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 76.21 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 112.828 0.677 . . . . 2.1299999999999999 112.828 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -171.95 -52.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.735 0.643 . . . . 2.27 112.735 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -115.27 142.77 46.22 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.622 0.601 . . . . 1.46 112.622 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.53 101.18 10.15 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.513 1.149 . . . . 0.83999999999999997 111.656 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -163.55 150.75 12.49 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 114.603 -1.181 . . . . 2.4500000000000002 111.047 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.2 m -110.77 -75.19 0.62 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.954 1.094 . . . . 1.6599999999999999 113.954 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -94.44 70.08 3.64 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.103 0.954 . . . . 1.8899999999999999 111.159 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -156.22 -41.95 0.08 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.936 -1.484 . . . . 2.5600000000000001 109.207 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -109.83 82.47 1.6 Allowed 'General case' 0 C--N 1.364 1.22 0 CA-C-O 121.827 0.823 . . . . 2.7599999999999998 109.172 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.78 121.26 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 114.375 -1.284 . . . . 0.68999999999999995 110.557 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -106.94 173.54 6.28 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.317 1.599 . . . . 0.69999999999999996 115.317 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -124.64 136.98 54.38 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 122.065 0.936 . . . . 1.3300000000000001 111.019 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.82 124.81 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-N 114.145 -1.389 . . . . 0.47999999999999998 109.499 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.8 mtt180 -119.61 143.3 47.74 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.384 1.624 . . . . 1.6899999999999999 115.384 -176.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 5.8 m -120.71 101.01 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 115.345 -0.843 . . . . 0.59999999999999998 112.184 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.563 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.2 t30 64.9 28.74 12.66 Favored 'General case' 0 N--CA 1.52 3.059 0 C-N-CA 126.494 1.917 . . . . 1.1200000000000001 114.561 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.38 -18.83 32.51 Favored Glycine 0 CA--C 1.549 2.199 0 CA-C-N 115.831 -0.622 . . . . 0.32000000000000001 113.602 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -86.34 161.76 18.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.092 1.757 . . . . 0.56999999999999995 113.125 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -118.68 129.69 55.43 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.166 0.984 . . . . 0.55000000000000004 111.249 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.07 -47.07 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 113.518 -1.673 . . . . 1.0600000000000001 112.825 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.74 89.32 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.904 -1.147 . . . . 0.44 107.904 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.98 75.49 0.92 Allowed 'General case' 0 C--N 1.359 0.988 0 CA-C-O 123.577 1.655 . . . . 2.2999999999999998 112.522 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 p30 154.79 63.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 110.474 -3.057 . . . . 2.48 108.032 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.69 99.65 12.51 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 113.563 0.949 . . . . 1.1299999999999999 113.563 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 3.6 p30 -112.6 94.56 4.97 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 113.017 -1.901 . . . . 2.3500000000000001 107.786 175.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -26.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 N-CA-C 114.739 1.385 . . . . 0.68000000000000005 114.739 -176.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -74.61 -39.39 62.2 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.828 0.851 . . . . 0.77000000000000002 112.042 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.72 -26.68 59.98 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.71 1.204 . . . . 0.91000000000000003 113.376 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 23.6 mmm180 -77.81 -55.05 5.65 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 113.639 0.978 . . . . 2.4300000000000002 113.639 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.65 -37.5 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 114.59 1.33 . . . . 0.93000000000000005 114.59 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.64 -109.44 1.11 Allowed Glycine 0 C--N 1.354 1.558 0 CA-C-N 118.391 0.541 . . . . 0.84999999999999998 113.271 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -114.52 107.46 15.54 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.517 0.327 . . . . 3.1800000000000002 110.433 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 t 70.11 -130.61 0.07 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 125.301 1.441 . . . . 2.0800000000000001 112.304 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.9 p 56.68 -174.39 0.07 Allowed 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 116.635 2.087 . . . . 0.62 116.635 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -100.05 128.45 46.14 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.312 0.856 . . . . 0.46000000000000002 113.312 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.436 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 9.1 t60 -102.79 139.34 38.5 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.141 -0.688 . . . . 0.38 109.141 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -137.51 125.85 23.31 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.273 1.212 . . . . 2.5 114.273 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -119.75 127.16 52.56 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 115.077 -0.965 . . . . 1.5600000000000001 110.602 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.99 126.58 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 114.141 -1.39 . . . . 0.45000000000000001 111.115 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.56 92.22 28.1 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-N 115.263 -0.881 . . . . 0.83999999999999997 110.567 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -75.02 132.77 15.77 Favored 'Trans proline' 0 C--N 1.394 2.934 0 C-N-CA 122.917 2.412 . . . . 0.16 113.074 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.82 150.26 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 CA-C-N 115.446 -0.797 . . . . 0.38 111.145 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.7 p -132.9 109.24 9.46 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.326 -0.852 . . . . 1.3100000000000001 111.799 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.5 mt -109.19 124.46 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 108.566 -0.901 . . . . 0.25 108.566 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.71 126.13 21.77 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.532 -0.758 . . . . 2.0499999999999998 110.75 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt 66.6 16.93 10.53 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 125.272 1.429 . . . . 3.5499999999999998 114.595 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.29 14.77 40.54 Favored Glycine 0 CA--C 1.547 2.056 0 CA-C-O 119.183 -0.787 . . . . 0.37 114.803 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 23.6 mtpp -123.9 147.3 47.79 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 118.225 1.012 . . . . 1.5600000000000001 112.419 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.47 139.07 37.63 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.994 1.109 . . . . 0.34000000000000002 113.994 -176.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.49 115.47 18.93 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.929 -1.032 . . . . 0.64000000000000001 109.989 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.46 93.58 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.486 0 CA-C-N 115.716 -0.675 . . . . 0.46000000000000002 110.878 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 64.75 -84.94 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 125.555 1.542 . . . . 1.5600000000000001 114.135 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.06 26.2 4.25 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-N 116.234 -0.439 . . . . 0.48999999999999999 113.835 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -137.88 117.58 13.11 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.19 0.596 . . . . 1.8200000000000001 109.983 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.25 133.74 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.374 0 CA-C-O 121.65 0.738 . . . . 1.02 112.152 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 m -147.62 -179.46 6.89 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.841 -1.072 . . . . 0.56000000000000005 109.543 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.276 14.9 t -103.98 138.89 39.89 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 113.456 0.91 . . . . 1.25 113.456 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -81.96 122.55 27.92 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.233 1.013 . . . . 0.28999999999999998 111.493 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.97 90.98 3.29 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.762 0.653 . . . . 1.4199999999999999 112.762 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.96 -63.78 2.77 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 118.597 2.199 . . . . 0.41999999999999998 118.597 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.552 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -130.58 161.93 30.44 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.837 0.827 . . . . 1.1000000000000001 113.128 -177.095 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.563 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -111.15 137.52 48.72 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.841 -1.527 . . . . 0.67000000000000004 109.221 177.187 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.6 t -116.93 142.31 47.1 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.64 1.348 . . . . 0.35999999999999999 114.64 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 39.6 t -121.57 97.25 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.22 -2.141 . . . . 0.73999999999999999 105.22 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -113.62 124.92 53.49 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.138 -0.937 . . . . 1.6699999999999999 112.913 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -111.68 128.75 56.17 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 122.233 1.016 . . . . 1.8 112.058 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.8 144.34 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-N 112.859 -1.973 . . . . 0.57999999999999996 110.362 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -78.88 149.46 32.43 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 115.659 1.725 . . . . 2.1800000000000002 115.659 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -103.8 -35.25 3.54 Favored Glycine 0 CA--C 1.545 1.921 0 CA-C-N 114.525 -1.216 . . . . 1.02 113.132 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -130.57 -83.6 0.53 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.213 0.605 . . . . 2.8599999999999999 110.435 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -170.65 64.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.279 0.631 . . . . 3.9100000000000001 110.656 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -166.98 -39.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.926 0.713 . . . . 1.74 112.926 -178.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 4.3 m-20 84.32 -177.77 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.439 0 C-N-CA 124.58 1.152 . . . . 1.6799999999999999 110.838 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -65.38 -9.55 22.65 Favored 'Trans proline' 0 N--CA 1.522 3.2 0 C-N-CA 122.641 2.227 . . . . 2.0600000000000001 116.385 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.0 mttm 80.05 -73.6 0.06 Allowed 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 126.442 1.897 . . . . 3.0 114.065 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 64' ' ' GLU . 21.3 t -103.37 132.04 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.048 0.452 . . . . 0.80000000000000004 110.237 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.0 t -137.34 121.65 18.14 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 114.114 -1.403 . . . . 0.87 110.889 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.506 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -115.6 49.78 1.06 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.138 1.903 . . . . 0.34000000000000002 116.138 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -41.06 129.23 2.79 Favored 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 116.061 1.875 . . . . 0.69999999999999996 116.061 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -150.71 103.09 3.06 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.703 -0.681 . . . . 0.20999999999999999 110.305 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.315 7.2 tt -113.92 122.83 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 CA-C-O 122.262 1.03 . . . . 0.31 112.169 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -123.53 163.6 20.61 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.849 -1.523 . . . . 0.44 111.023 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.6 ptmm? -121.91 159.92 25.86 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 118.489 2.774 . . . . 1.26 118.489 -175.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.62 -42.06 1.99 Allowed Glycine 0 CA--C 1.543 1.803 0 CA-C-N 110.007 -3.27 . . . . 0.17000000000000001 118.929 174.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.5 153.83 0.94 Allowed 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 120.31 2.055 . . . . 0.14999999999999999 112.924 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.49 -11.71 59.92 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 114.72 1.378 . . . . 0.17000000000000001 114.72 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.95 3.39 48.83 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.081 1.141 . . . . 0.55000000000000004 114.081 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.641 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -106.28 -10.34 16.44 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 113.749 1.018 . . . . 0.59999999999999998 113.749 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.66 94.12 0.51 Allowed Pre-proline 0 N--CA 1.51 2.526 0 C-N-CA 124.078 0.951 . . . . 0.94999999999999996 112.216 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.641 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 51.7 Cg_endo -94.94 162.2 1.71 Allowed 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 122.757 2.305 . . . . 1.8 114.998 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.8 mmt -131.85 118.76 20.29 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.459 -0.792 . . . . 4.96 111.25 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.6 mt -127.37 162.37 26.46 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 122.055 0.931 . . . . 4.0 112.818 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -103.61 158.49 31.74 Favored Pre-proline 0 CA--C 1.559 1.291 0 CA-C-N 114.505 -1.225 . . . . 6.2699999999999996 110.728 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.54 121.27 8.35 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.449 2.099 . . . . 6.5899999999999999 115.267 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -136.11 135.95 22.07 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-N 114.846 -1.07 . . . . 5.5099999999999998 111.122 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -78.13 -19.17 12.31 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 123.637 2.892 . . . . 6.7699999999999996 116.665 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -111.79 -68.24 0.54 Allowed Glycine 0 CA--C 1.534 1.266 0 N-CA-C 115.327 0.891 . . . . 7.0199999999999996 115.327 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.9 tp -116.28 130.97 57.05 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.244 0.545 . . . . 8.9900000000000002 112.438 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.331 -0.843 . . . . 10.6 111.25 -179.857 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.471 -0.252 . . . . 8.9299999999999997 112.471 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.19 125.55 54.26 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-O 121.692 0.758 . . . . 6.8200000000000003 111.876 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.1 mtt -139.05 115.19 10.28 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.554 -0.748 . . . . 7.6399999999999997 111.182 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.5 m -134.58 117.95 16.72 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.846 -0.615 . . . . 3.8599999999999999 111.773 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.32 -51.96 0.04 OUTLIER Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.685 -0.689 . . . . 1.1100000000000001 114.089 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.549 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.9 tp -85.67 -43.89 13.04 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.495 0.718 . . . . 0.34999999999999998 112.411 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.9 -22.74 65.83 Favored 'General case' 0 CA--C 1.583 2.244 0 C-N-CA 125.63 1.572 . . . . 0.20000000000000001 114.436 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.15 -12.05 50.96 Favored 'General case' 0 C--N 1.375 1.695 0 N-CA-C 113.638 0.977 . . . . 0.32000000000000001 113.638 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 45.3 mmtt -105.67 -22.62 12.93 Favored 'General case' 0 C--N 1.364 1.212 0 CA-C-O 118.353 -0.832 . . . . 1.73 113.203 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.34 135.91 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.844 0 N-CA-C 115.221 1.563 . . . . 0.11 115.221 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -122.22 -29.1 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.227 -0.897 . . . . 0.16 111.908 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 64.1 t90 -163.68 116.95 1.5 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 120.738 0.304 . . . . 0.54000000000000004 111.414 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -135.19 128.91 32.89 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.296 -0.877 . . . . 0.19 110.226 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.2 t -137.84 133.56 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 113.203 0.816 . . . . 1.05 113.203 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -118.99 111.09 17.89 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.082 -1.451 . . . . 2.1099999999999999 107.082 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.37 101.75 10.02 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.387 1.089 . . . . 0.63 111.436 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.58 -32.61 0.17 Allowed Glycine 0 C--N 1.344 1.018 0 CA-C-N 113.345 -1.752 . . . . 0.70999999999999996 116.011 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -135.22 -128.33 2.78 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.233 -0.984 . . . . 0.80000000000000004 114.643 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.461 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 63.0 mt-10 -151.04 115.33 5.08 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.455 0.169 . . . . 1.6299999999999999 111.3 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.665 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.6 m 31.82 116.01 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.887 0 N-CA-C 120.286 3.439 . . . . 1.0 120.286 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 62.0 t60 -138.67 139.02 38.31 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.15 0.976 . . . . 0.45000000000000001 112.636 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.89 117.18 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 114.049 -1.432 . . . . 1.3899999999999999 109.714 177.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -83.21 166.1 18.88 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.646 -0.707 . . . . 1.8500000000000001 112.238 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -43.09 -29.15 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.547 4.41 0 N-CA-C 119.225 3.046 . . . . 0.71999999999999997 119.225 -176.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -93.38 -14.68 26.53 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 118.357 0.526 . . . . 0.51000000000000001 111.691 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.04 42.69 1.62 Allowed Glycine 0 C--N 1.358 1.764 0 C-N-CA 124.393 0.997 . . . . 0.34000000000000002 114.461 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.549 HD11 ' HG ' ' A' ' 6' ' ' LEU . 14.2 mm -105.72 120.26 56.27 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.738 0 N-CA-C 109.51 -0.552 . . . . 0.55000000000000004 109.51 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.0 t60 -104.62 128.19 52.57 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.796 1.406 . . . . 1.3400000000000001 114.796 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.665 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -98.04 148.2 23.75 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.254 -0.885 . . . . 2.79 110.645 176.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -96.64 168.37 10.57 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.696 1.236 . . . . 3.0 113.613 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -84.38 100.22 11.15 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.401 2.0 . . . . 2.2999999999999998 116.401 -174.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.755 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 37.4 m-20 28.63 56.62 0.6 Allowed Pre-proline 1 N--CA 1.543 4.176 0 C-N-CA 128.066 2.546 . . . . 1.1699999999999999 117.468 177.403 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -94.44 81.31 0.15 Allowed 'Trans proline' 0 CA--C 1.569 2.246 0 N-CA-C 119.637 2.899 . . . . 1.45 119.637 -174.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -151.73 -80.72 0.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.338 0.655 . . . . 1.9099999999999999 109.971 174.126 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.4 116.66 6.94 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 122.837 0.455 . . . . 4.8399999999999999 110.486 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.14 5.64 26.59 Favored Glycine 0 CA--C 1.545 1.964 0 C-N-CA 120.699 -0.762 . . . . 2.3700000000000001 114.068 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.755 ' HB3' ' O ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -72.03 64.56 0.53 Allowed 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.272 1.952 . . . . 4.5 116.272 -177.347 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.96 115.23 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 114.937 -1.028 . . . . 2.7000000000000002 109.528 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.19 -111.43 0.95 Allowed Glycine 0 C--N 1.343 0.936 0 C-N-CA 121.216 -0.516 . . . . 1.95 113.742 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -151.59 -146.36 0.2 Allowed 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 120.996 0.427 . . . . 5.3399999999999999 111.956 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.51 137.33 36.62 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.617 1.167 . . . . 1.6399999999999999 112.156 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.5 m -118.68 130.15 55.68 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.456 -0.793 . . . . 1.5700000000000001 110.996 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -131.26 110.73 11.32 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.307 0.575 . . . . 2.3300000000000001 112.468 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -115.15 70.62 0.74 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.455 -0.793 . . . . 3.1600000000000001 110.125 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.62 69.42 0.17 Allowed Glycine 0 C--N 1.344 0.979 0 CA-C-N 114.598 -1.183 . . . . 1.52 111.303 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.62 -24.43 18.68 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.515 1.302 . . . . 1.6699999999999999 114.515 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.59 ' HE2' ' O ' ' A' ' 47' ' ' LYS . 4.6 ttpt -100.45 66.29 1.25 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 121.83 0.824 . . . . 4.1799999999999997 111.824 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.1 72.96 1.71 Allowed Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 107.041 -1.466 . . . . 2.6299999999999999 107.041 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 50.0 Cg_exo -61.65 155.03 56.04 Favored 'Trans proline' 0 N--CA 1.515 2.765 0 C-N-CA 124.661 3.574 . . . . 1.3700000000000001 117.681 -177.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 mp -92.72 130.4 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.214 0 CA-C-N 114.883 -1.053 . . . . 0.68999999999999995 108.486 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mt -86.03 -10.14 55.54 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.567 2.062 . . . . 1.28 116.567 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -103.49 8.59 37.83 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 114.299 1.222 . . . . 1.51 114.299 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.44 -164.73 1.52 Allowed 'General case' 0 CA--C 1.566 1.579 0 CA-C-O 121.544 0.687 . . . . 1.0900000000000001 112.096 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.841 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.8 t30 -95.69 179.17 1.21 Allowed Pre-proline 0 CA--C 1.575 1.91 0 C-N-CA 124.715 1.206 . . . . 1.27 111.17 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -71.61 -44.77 0.93 Allowed 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 123.202 2.601 . . . . 0.94999999999999996 112.474 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -71.16 -47.4 57.96 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 113.894 -1.503 . . . . 2.04 111.545 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -77.25 -6.0 51.45 Favored 'General case' 0 CA--C 1.595 2.68 0 CA-C-N 115.466 -0.788 . . . . 1.6200000000000001 111.536 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.841 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 11.5 tt0 -72.68 -39.25 67.2 Favored 'General case' 0 C--N 1.387 2.217 0 C-N-CA 126.167 1.787 . . . . 1.77 108.463 173.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.0 t -65.59 -41.05 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.151 0 CA-C-N 114.538 -1.21 . . . . 0.81000000000000005 108.712 172.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 tt -75.74 -9.43 58.58 Favored 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 112.662 0.616 . . . . 1.1499999999999999 112.662 174.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.492 ' O ' ' HE3' ' A' ' 88' ' ' LYS . 3.5 m-30 -121.24 17.34 11.51 Favored 'General case' 0 CA--C 1.578 2.027 0 C-N-CA 125.175 1.39 . . . . 0.92000000000000004 113.233 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -146.74 -21.36 0.42 Allowed 'General case' 0 N--CA 1.51 2.533 0 N-CA-C 116.656 2.095 . . . . 1.3300000000000001 116.656 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.3 p -79.5 127.79 32.57 Favored 'General case' 0 N--CA 1.518 2.947 0 N-CA-C 115.71 1.744 . . . . 1.28 115.71 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.496 ' HB3' HG22 ' A' ' 167' ' ' VAL . 5.2 pt-20 -123.33 148.98 45.44 Favored 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 124.876 1.27 . . . . 1.53 111.847 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.401 ' HD2' ' CG ' ' A' ' 32' ' ' ASP . 2.0 ptm180 -104.0 -93.64 0.34 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 112.582 0.586 . . . . 3.2200000000000002 112.582 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.66 157.55 44.57 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.545 0.688 . . . . 3.6600000000000001 112.414 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -122.5 141.15 51.96 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.095 0.776 . . . . 4.7000000000000002 113.095 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -134.78 -103.67 0.23 Allowed 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 115.447 -0.797 . . . . 2.5499999999999998 110.479 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -163.9 121.73 1.82 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.085 0.554 . . . . 2.1499999999999999 110.764 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.23 86.55 0.11 Allowed 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.368 1.467 . . . . 0.77000000000000002 113.639 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -150.78 154.76 37.91 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.754 0.788 . . . . 0.81000000000000005 112.993 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 34' ' ' LEU . . . -172.99 -172.51 38.66 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 114.788 -1.097 . . . . 0.46999999999999997 115.279 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.23 172.55 6.82 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.465 1.283 . . . . 0.89000000000000001 114.465 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -129.47 133.9 47.53 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 114.113 -1.403 . . . . 0.51000000000000001 111.846 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.67 102.24 32.55 Favored Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 123.538 0.735 . . . . 0.14999999999999999 109.495 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -84.79 120.58 2.36 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 121.97 1.78 . . . . 0.14999999999999999 114.641 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.09 161.48 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.61 0 CA-C-O 122.093 0.949 . . . . 0.19 111.281 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -148.82 19.24 1.01 Allowed 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.553 -1.203 . . . . 2.5299999999999998 111.922 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -129.93 159.21 37.34 Favored 'General case' 0 C--N 1.363 1.169 0 CA-C-O 121.313 0.577 . . . . 2.1200000000000001 111.423 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -119.12 147.86 43.7 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.23 1.196 . . . . 0.41999999999999998 114.23 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.85 -137.53 5.24 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 113.883 -1.508 . . . . 0.23000000000000001 112.333 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.4 mm-40 -114.86 105.62 13.22 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-N 118.345 1.073 . . . . 1.75 110.848 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -99.66 130.34 45.87 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.129 0.49 . . . . 0.20999999999999999 111.174 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -113.24 121.87 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.666 0.746 . . . . 0.20000000000000001 110.748 -176.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -109.43 104.92 14.09 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.346 -1.297 . . . . 0.78000000000000003 110.313 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.29 129.72 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 114.825 -1.08 . . . . 0.44 108.766 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.61 139.56 50.41 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.077 0.769 . . . . 1.25 113.077 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.69 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 6.0 tmtm? -105.82 118.41 36.53 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.945 0.879 . . . . 2.52 110.145 176.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.41 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 21.5 m-85 -106.39 134.45 49.51 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 114.728 -1.124 . . . . 0.40000000000000002 109.487 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.409 ' HB2' ' NZ ' ' A' ' 88' ' ' LYS . . . -133.52 146.83 51.42 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 123.079 0.551 . . . . 0.40999999999999998 111.736 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -139.71 108.91 6.08 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 116.003 -0.544 . . . . 2.6099999999999999 110.726 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.22 69.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 116.153 -0.476 . . . . 2.1299999999999999 111.594 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -162.74 -52.28 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.976 -0.556 . . . . 2.27 111.829 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -119.1 130.15 55.43 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 122.889 0.476 . . . . 1.46 111.407 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.03 104.92 14.95 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 122.152 0.977 . . . . 0.83999999999999997 111.958 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -162.01 145.21 11.91 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.178 -0.919 . . . . 2.4500000000000002 112.153 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -125.27 123.81 40.3 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.654 -0.703 . . . . 1.6599999999999999 112.187 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 72.16 53.87 0.18 Allowed 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 125.73 1.612 . . . . 1.8899999999999999 112.787 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -152.38 -40.87 0.11 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.383 -1.281 . . . . 2.5600000000000001 109.719 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -108.19 80.91 1.41 Allowed 'General case' 0 C--N 1.361 1.096 0 CA-C-O 121.892 0.853 . . . . 2.7599999999999998 108.716 177.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.99 121.82 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 114.249 -1.341 . . . . 0.68999999999999995 111.142 -177.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -109.37 165.55 11.55 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.587 1.699 . . . . 0.69999999999999996 115.587 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.52 135.58 53.94 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.829 -0.544 . . . . 1.3300000000000001 110.828 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.79 126.93 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.475 0 CA-C-N 115.918 -0.583 . . . . 0.47999999999999998 109.908 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 46.7 mtt180 -125.9 151.63 46.66 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.621 1.712 . . . . 1.6899999999999999 115.621 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.2 m -126.71 109.97 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.569 0 N-CA-C 113.047 0.758 . . . . 0.59999999999999998 113.047 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.464 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 62.43 26.53 15.81 Favored 'General case' 0 N--CA 1.524 3.275 0 C-N-CA 126.669 1.988 . . . . 1.1200000000000001 114.271 -179.113 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.8 -22.17 28.52 Favored Glycine 0 CA--C 1.548 2.109 0 C-N-CA 121.259 -0.496 . . . . 0.32000000000000001 113.546 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.458 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 90.2 m-70 -80.71 160.5 24.94 Favored 'General case' 0 C--N 1.366 1.312 0 C-N-CA 125.829 1.651 . . . . 0.56999999999999995 114.157 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.77 132.49 54.15 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.238 0.542 . . . . 0.55000000000000004 111.154 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.62 -60.89 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 115.233 -0.894 . . . . 1.0600000000000001 113.172 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.76 88.85 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.44 108.2 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -107.72 96.74 6.6 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 123.155 1.455 . . . . 2.2999999999999998 111.551 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 121.09 75.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 110.488 -3.051 . . . . 2.48 107.783 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.33 104.77 16.83 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 113.111 0.782 . . . . 1.1299999999999999 113.111 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -117.16 102.49 9.34 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 113.723 -1.58 . . . . 2.3500000000000001 106.974 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.25 -31.28 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 C-N-CA 125.003 1.321 . . . . 0.68000000000000005 114.262 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -74.63 -40.84 61.26 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.685 0.794 . . . . 0.77000000000000002 112.484 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -73.82 -25.83 60.3 Favored 'General case' 0 CA--C 1.578 2.048 0 C-N-CA 124.357 1.063 . . . . 0.91000000000000003 113.487 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -78.62 -56.61 4.29 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.618 0.97 . . . . 2.4300000000000002 113.618 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.11 -34.84 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 N-CA-C 114.593 1.331 . . . . 0.93000000000000005 114.593 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.07 -114.07 1.98 Allowed Glycine 0 C--N 1.354 1.537 0 CA-C-N 118.25 0.477 . . . . 0.84999999999999998 112.935 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -115.47 106.69 14.25 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.929 0.395 . . . . 3.1800000000000002 110.4 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.48 -143.26 0.09 Allowed 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 125.466 1.507 . . . . 2.0800000000000001 113.416 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.9 p 66.76 -158.96 0.24 Allowed 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 126.234 1.814 . . . . 0.62 113.718 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.536 ' HA ' ' HZ3' ' A' ' 88' ' ' LYS . . . -108.58 128.96 55.28 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 114.55 1.315 . . . . 0.46000000000000002 114.55 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.536 ' H ' ' HZ3' ' A' ' 88' ' ' LYS . 5.5 t60 -104.52 122.65 46.0 Favored 'General case' 0 C--N 1.369 1.432 0 N-CA-C 108.08 -1.082 . . . . 0.38 108.08 174.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.55 127.05 20.09 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.417 0.895 . . . . 2.5 113.417 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -114.51 134.73 54.81 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-N 115.033 -0.985 . . . . 1.5600000000000001 111.369 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.45 111.31 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 114.369 -1.287 . . . . 0.45000000000000001 110.374 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.4 mm -115.52 91.23 28.45 Favored Pre-proline 0 CA--C 1.579 2.077 0 CA-C-N 115.287 -0.87 . . . . 0.83999999999999997 110.421 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -73.11 137.93 27.16 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 122.996 2.464 . . . . 0.16 113.883 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.81 149.89 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 C-N-CA 123.573 0.749 . . . . 0.38 110.842 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.2 p -133.88 111.48 10.51 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.638 -0.71 . . . . 1.3100000000000001 111.856 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.4 mt -112.69 124.68 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 N-CA-C 108.59 -0.892 . . . . 0.25 108.59 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -141.83 126.45 17.92 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.838 -0.619 . . . . 2.0499999999999998 110.992 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 67.97 15.71 9.52 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 125.432 1.493 . . . . 3.5499999999999998 114.109 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.55 14.87 39.4 Favored Glycine 0 CA--C 1.547 2.089 0 CA-C-O 119.181 -0.788 . . . . 0.37 114.773 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 56.4 mtpt -122.59 148.19 45.52 Favored 'General case' 0 C--N 1.365 1.252 0 CA-C-N 118.413 1.107 . . . . 1.5600000000000001 112.429 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.66 141.94 35.18 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.058 1.133 . . . . 0.34000000000000002 114.058 -176.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 m -133.55 110.44 9.93 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 114.504 -1.226 . . . . 0.64000000000000001 110.301 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.272 2.4 p -106.23 90.52 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.589 2.467 0 CA-C-O 121.621 0.724 . . . . 0.46000000000000002 110.068 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 59.68 -81.4 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 126.077 1.751 . . . . 1.5600000000000001 115.06 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -118.45 26.74 7.59 Favored Glycine 0 CA--C 1.547 2.076 0 N-CA-C 114.2 0.44 . . . . 0.48999999999999999 114.2 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -135.14 140.79 45.7 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.533 0.733 . . . . 1.8200000000000001 110.996 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.18 130.82 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.294 0 CA-C-O 121.513 0.673 . . . . 1.02 111.867 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 m -154.6 -179.43 7.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.157 -0.929 . . . . 0.56000000000000005 109.537 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.274 14.8 t -104.76 139.37 39.65 Favored 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 113.365 0.876 . . . . 1.25 113.365 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -82.72 122.1 27.72 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 123.959 0.904 . . . . 0.28999999999999998 111.523 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.38 90.91 3.15 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.336 0.495 . . . . 1.4199999999999999 112.336 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.22 -65.45 3.33 Favored Glycine 0 C--N 1.358 1.784 0 N-CA-C 118.652 2.221 . . . . 0.41999999999999998 118.652 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 156.25 46.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.199 1.185 . . . . 1.1000000000000001 114.199 -176.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.464 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -103.27 135.36 45.06 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 113.064 -1.88 . . . . 0.67000000000000004 108.585 176.574 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.8 t -120.67 142.29 49.61 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.529 1.678 . . . . 0.35999999999999999 115.529 -176.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.59 99.19 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.334 -1.358 . . . . 0.73999999999999999 107.334 176.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -118.52 126.99 53.19 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.779 -0.646 . . . . 1.6699999999999999 112.314 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.86 129.08 56.64 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-O 122.278 1.037 . . . . 1.8 111.278 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.17 145.48 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 112.722 -2.035 . . . . 0.57999999999999996 110.762 -177.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.93 149.64 32.3 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.934 1.457 . . . . 2.1800000000000002 114.934 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -115.64 -28.11 2.84 Favored Glycine 0 CA--C 1.545 1.931 0 CA-C-N 115.064 -0.971 . . . . 1.02 114.932 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -130.42 -67.07 0.74 Allowed 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 117.746 0.773 . . . . 2.8599999999999999 111.88 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -140.81 -52.45 0.47 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 112.341 0.497 . . . . 3.9100000000000001 112.341 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -104.06 178.02 4.68 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.161 0.981 . . . . 1.74 112.742 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -116.79 -177.92 0.49 Allowed Pre-proline 0 CA--C 1.568 1.638 0 CA-C-N 114.389 -1.278 . . . . 1.6799999999999999 109.273 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.67 131.36 43.71 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.947 2.431 . . . . 2.0600000000000001 113.968 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -72.18 -62.59 1.38 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.81 1.411 . . . . 3.0 114.81 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 64' ' ' GLU . 43.0 t -108.49 132.36 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 118.376 0.535 . . . . 0.80000000000000004 109.713 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.3 t -133.41 116.09 15.62 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 113.911 -1.495 . . . . 0.87 110.618 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.69 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -115.02 49.51 1.05 Allowed 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.183 1.919 . . . . 0.34000000000000002 116.183 -174.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.56 137.75 2.77 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 116.653 2.094 . . . . 0.69999999999999996 116.653 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -152.75 100.3 2.52 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.271 -0.877 . . . . 0.20999999999999999 110.526 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.319 12.6 tt -110.61 121.86 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-O 122.546 1.165 . . . . 0.31 111.553 175.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -123.67 165.03 17.92 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 113.572 -1.649 . . . . 0.44 110.554 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.4 ptmt -121.71 159.98 25.46 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 118.734 2.864 . . . . 1.26 118.734 -174.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.22 -42.54 1.87 Allowed Glycine 0 CA--C 1.542 1.737 0 CA-C-N 109.815 -3.357 . . . . 0.17000000000000001 118.66 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.37 156.74 0.75 Allowed 'General case' 0 N--CA 1.52 3.061 0 CA-C-N 119.973 1.886 . . . . 0.14999999999999999 112.565 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.32 -15.79 60.47 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.547 1.314 . . . . 0.17000000000000001 114.547 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.06 4.04 46.73 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.066 1.135 . . . . 0.55000000000000004 114.066 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.678 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.1 OUTLIER -107.71 -3.86 18.74 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 114.031 1.123 . . . . 0.59999999999999998 114.031 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.37 93.05 0.41 Allowed Pre-proline 0 N--CA 1.51 2.543 0 C-N-CA 124.48 1.112 . . . . 0.94999999999999996 111.63 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.678 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 56.9 Cg_endo -95.38 119.98 0.25 Allowed 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 122.875 2.384 . . . . 1.8 114.777 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 44.1 mtt -144.36 109.82 5.2 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.823 -0.626 . . . . 4.96 111.224 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.6 163.56 29.85 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 122.16 0.981 . . . . 4.0 112.641 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -108.55 159.74 29.75 Favored Pre-proline 0 CA--C 1.557 1.247 0 CA-C-N 114.463 -1.244 . . . . 6.2699999999999996 110.806 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.86 122.11 9.41 Favored 'Trans proline' 0 C--N 1.394 2.939 0 C-N-CA 122.566 2.178 . . . . 6.5899999999999999 115.18 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -135.69 135.55 22.14 Favored Pre-proline 0 CA--C 1.564 1.5 0 CA-C-N 114.76 -1.109 . . . . 5.5099999999999998 111.062 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -85.02 -157.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.389 2.659 0 C-N-CA 123.398 2.732 . . . . 6.7699999999999996 114.239 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.69 -128.88 1.55 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 121.113 -0.565 . . . . 7.0199999999999996 113.421 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.0 mt -118.84 124.19 46.57 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.008 0.433 . . . . 8.9900000000000002 111.976 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.263 -0.875 . . . . 10.6 111.222 179.996 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.439 -0.265 . . . . 8.9299999999999997 112.439 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.06 117.54 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.453 0 C-N-CA 127.556 2.342 . . . . 6.8200000000000003 114.97 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.0 tpt -141.67 105.1 4.66 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.45 -0.795 . . . . 7.6399999999999997 110.731 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 m -138.06 113.16 9.22 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.804 -0.635 . . . . 3.8599999999999999 111.605 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.6 86.26 0.07 OUTLIER Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.787 -0.642 . . . . 1.1100000000000001 113.109 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.535 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.6 tp -88.32 -46.5 9.14 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.9 0.88 . . . . 0.34999999999999998 113.282 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -25.0 63.84 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 125.982 1.713 . . . . 0.20000000000000001 115.388 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.65 -10.01 54.76 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.577 0.954 . . . . 0.32000000000000001 113.577 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 25.3 mmtp -104.67 -25.61 12.64 Favored 'General case' 0 C--N 1.363 1.168 0 N-CA-C 113.243 0.831 . . . . 1.73 113.243 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -52.93 135.22 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 N-CA-C 115.541 1.682 . . . . 0.11 115.541 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -123.07 -28.46 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 115.01 -0.995 . . . . 0.16 112.229 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -162.95 116.93 1.67 Allowed 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 118.055 0.389 . . . . 0.54000000000000004 111.558 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -136.55 130.73 32.85 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.156 -0.965 . . . . 0.19 111.649 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.3 t -136.26 130.96 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 CA-C-O 121.036 0.446 . . . . 1.05 112.149 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -114.71 100.46 8.27 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.819 -1.178 . . . . 2.1099999999999999 107.819 173.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.96 104.18 7.31 Favored 'General case' 0 C--O 1.274 2.365 0 CA-C-O 122.005 0.907 . . . . 0.63 111.623 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 169.07 -49.51 0.22 Allowed Glycine 0 C--N 1.36 1.893 0 CA-C-N 111.964 -2.38 . . . . 0.70999999999999996 114.693 -178.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.53 -116.65 3.05 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 114.476 0.551 . . . . 0.80000000000000004 114.476 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -168.62 118.79 0.74 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.377 0.51 . . . . 1.6299999999999999 112.377 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.9 m 42.39 111.74 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.226 0 N-CA-C 118.515 2.783 . . . . 1.0 118.515 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.601 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 43.1 t60 -137.26 139.43 40.96 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.768 1.025 . . . . 0.45000000000000001 113.768 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.3 t -106.36 111.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 N-CA-C 106.791 -1.559 . . . . 1.3899999999999999 106.791 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.38 163.07 15.46 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 112.768 0.655 . . . . 1.8500000000000001 112.768 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -43.3 -34.59 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 118.811 2.893 . . . . 0.71999999999999997 118.811 -175.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -90.76 -17.31 26.88 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 120.924 0.393 . . . . 0.51000000000000001 111.509 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.18 41.85 1.24 Allowed Glycine 0 C--N 1.357 1.736 0 C-N-CA 124.361 0.981 . . . . 0.34000000000000002 113.742 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.535 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.9 mm -105.88 121.96 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 N-CA-C 109.391 -0.596 . . . . 0.55000000000000004 109.391 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 6.9 t-160 -110.27 132.8 53.85 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 115.32 1.6 . . . . 1.3400000000000001 115.32 -175.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -97.76 138.01 35.77 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.638 -1.164 . . . . 2.79 109.302 175.442 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -102.68 100.7 10.77 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 113.544 0.942 . . . . 3.0 113.544 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -28.69 115.44 0.09 Allowed 'General case' 0 N--CA 1.517 2.888 0 N-CA-C 118.687 2.847 . . . . 2.2999999999999998 118.687 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 41.59 74.97 0.66 Allowed Pre-proline 0 N--CA 1.528 3.446 0 N-CA-C 117.169 2.285 . . . . 1.1699999999999999 117.169 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -94.45 -12.26 1.07 Allowed 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 122.509 2.14 . . . . 1.45 117.434 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.44 -22.89 0.81 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 114.447 1.277 . . . . 1.9099999999999999 114.447 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -96.96 73.25 2.56 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.277 0.56 . . . . 4.8399999999999999 112.422 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.07 -29.12 13.12 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 115.56 -0.746 . . . . 2.3700000000000001 114.4 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.7 49.53 20.63 Favored 'General case' 0 N--CA 1.516 2.831 0 C-N-CA 127.176 2.19 . . . . 4.5 115.465 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.77 -179.8 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 124.977 1.311 . . . . 2.7000000000000002 110.251 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.81 86.05 1.25 Allowed Glycine 0 CA--C 1.539 1.58 0 O-C-N 121.695 -0.628 . . . . 1.95 114.488 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -144.57 128.42 17.37 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.482 0.658 . . . . 5.3399999999999999 112.488 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.65 138.24 51.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.309 1.044 . . . . 1.6399999999999999 110.783 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m -118.78 97.05 5.53 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 115.603 -0.726 . . . . 1.5700000000000001 110.772 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -114.28 62.96 0.66 Allowed 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 115.638 -0.71 . . . . 2.3300000000000001 111.457 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -102.1 73.1 1.35 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 122.054 0.93 . . . . 3.1600000000000001 109.831 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.38 52.74 0.07 OUTLIER Glycine 0 CA--C 1.529 0.965 0 CA-C-N 113.79 -1.55 . . . . 1.52 111.237 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.2 ttt -92.59 -0.07 57.36 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 113.805 1.039 . . . . 1.6699999999999999 113.805 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.18 64.35 0.62 Allowed 'General case' 0 CA--C 1.557 1.249 0 CA-C-O 122.431 1.11 . . . . 4.1799999999999997 110.303 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 mt -166.78 70.41 1.06 Allowed Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 113.456 -1.702 . . . . 2.6299999999999999 107.111 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.92 157.86 57.02 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 124.349 3.366 . . . . 1.3700000000000001 116.939 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.4 133.86 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.354 0 CA-C-N 115.074 -0.966 . . . . 0.68999999999999995 108.691 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.5 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.9 mt -82.24 -9.28 59.55 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.816 2.154 . . . . 1.28 116.816 -176.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -109.17 16.67 22.32 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 114.111 1.152 . . . . 1.51 114.111 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.04 177.37 8.02 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 121.755 0.788 . . . . 1.0900000000000001 113.06 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 5.7 p-10 -88.96 178.83 1.83 Allowed Pre-proline 0 N--CA 1.51 2.57 0 C-N-CA 124.978 1.311 . . . . 1.27 111.094 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 52.3 Cg_exo -64.57 -43.01 14.4 Favored 'Trans proline' 0 N--CA 1.527 3.449 0 C-N-CA 122.824 2.349 . . . . 0.94999999999999996 114.989 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -69.41 -41.94 75.71 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 124.471 1.108 . . . . 2.04 111.978 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.701 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 18.7 t0 -86.93 -0.71 57.0 Favored 'General case' 0 CA--C 1.583 2.232 0 CA-C-N 115.857 -0.611 . . . . 1.6200000000000001 111.983 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 27.8 tt0 -74.28 -46.02 43.97 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 125.195 1.398 . . . . 1.77 108.025 173.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.253 11.7 p -71.21 -37.75 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.982 0 CA-C-N 115.161 -0.927 . . . . 0.81000000000000005 111.042 174.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.7 tp -83.41 -3.25 57.38 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 114.194 1.183 . . . . 1.1499999999999999 114.194 177.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.701 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 3.8 m-30 -113.67 -2.01 13.87 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.002 1.321 . . . . 0.92000000000000004 109.831 174.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -130.48 -130.82 0.2 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.331 1.052 . . . . 1.3300000000000001 110.739 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.514 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 43.15 120.86 0.0 OUTLIER 'General case' 1 N--CA 1.548 4.458 0 C-N-CA 127.775 2.43 . . . . 1.28 115.48 -172.755 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.695 ' HB3' HG22 ' A' ' 167' ' ' VAL . 12.9 pt-20 -110.37 142.19 42.38 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.338 1.977 . . . . 1.53 116.338 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -114.12 152.45 31.09 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 114.972 -1.013 . . . . 3.2200000000000002 111.8 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -124.62 129.83 51.3 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.911 -0.586 . . . . 3.6600000000000001 112.085 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.36 -86.28 0.34 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.737 -0.665 . . . . 4.7000000000000002 111.693 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -154.18 -91.32 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 113.122 0.786 . . . . 2.5499999999999998 113.122 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -174.74 136.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.755 0.822 . . . . 2.1499999999999999 110.796 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.442 ' H ' HD21 ' A' ' 164' ' ' ASN . 3.4 t 70.38 76.72 0.2 Allowed 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 124.464 1.106 . . . . 0.77000000000000002 110.939 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.7 135.87 48.23 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.004 -0.998 . . . . 0.81000000000000005 112.285 -176.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.56 163.01 24.13 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 116.216 1.246 . . . . 0.46999999999999997 116.216 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.427 ' HB2' HG23 ' A' ' 155' ' ' VAL . 1.4 m-85 -111.17 160.7 16.68 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.023 -1.089 . . . . 0.89000000000000001 113.062 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.48 126.66 48.32 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.895 -1.048 . . . . 0.51000000000000001 112.652 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.25 98.07 42.07 Favored Pre-proline 0 CA--C 1.566 1.589 0 N-CA-C 108.668 -0.864 . . . . 0.14999999999999999 108.668 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -82.82 116.27 2.5 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 122.06 1.84 . . . . 0.14999999999999999 115.322 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.07 155.64 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 CA-C-O 121.938 0.875 . . . . 0.19 110.648 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -141.86 24.35 2.03 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 114.774 -1.103 . . . . 2.5299999999999998 112.034 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.88 152.67 49.1 Favored 'General case' 0 C--N 1.359 1.009 0 CA-C-O 121.231 0.539 . . . . 2.1200000000000001 111.305 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.07 137.73 50.98 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.097 1.147 . . . . 0.41999999999999998 114.097 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.47 -127.48 1.63 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 114.018 -1.447 . . . . 0.23000000000000001 112.597 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -123.55 118.62 27.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.264 0.554 . . . . 1.75 111.398 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -118.58 137.74 53.04 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.463 -0.789 . . . . 0.20999999999999999 109.639 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 172' ' ' ILE . 1.9 t -117.82 126.5 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.466 0.65 . . . . 0.20000000000000001 111.004 -177.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.06 105.13 15.38 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.753 -1.112 . . . . 0.78000000000000003 109.731 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.75 117.64 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.077 -1.083 . . . . 0.44 108.077 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -130.16 135.05 47.76 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.503 0.668 . . . . 1.25 112.384 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 14.3 tptt -98.29 122.96 42.1 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 114.959 -1.019 . . . . 2.52 111.307 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -106.95 136.12 47.35 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.58 -0.737 . . . . 0.40000000000000002 110.948 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.94 150.12 52.19 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 115.681 -0.69 . . . . 0.40999999999999998 111.367 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -146.88 113.68 6.08 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.36 0.664 . . . . 2.6099999999999999 110.076 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.33 68.12 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 112.711 0.634 . . . . 2.1299999999999999 112.711 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -167.07 -45.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.58 0.585 . . . . 2.27 112.58 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -112.89 126.67 55.72 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.102 0.477 . . . . 1.46 112.219 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.16 96.07 6.11 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.486 1.136 . . . . 0.83999999999999997 111.241 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.45 ' OE1' ' HD3' ' A' ' 100' ' ' LYS . 9.5 pt20 -160.79 143.74 13.02 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.89 -1.05 . . . . 2.4500000000000002 112.152 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.8 m -122.57 125.27 45.36 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.426 -0.806 . . . . 1.6599999999999999 112.267 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 73.03 51.74 0.14 Allowed 'General case' 0 N--CA 1.512 2.636 0 C-N-CA 125.644 1.577 . . . . 1.8899999999999999 112.697 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -150.99 -42.02 0.12 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.384 1.074 . . . . 2.5600000000000001 110.076 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.45 ' HD3' ' OE1' ' A' ' 96' ' ' GLN . 14.0 mptt -108.27 83.49 1.79 Allowed 'General case' 0 C--N 1.36 1.06 0 N-CA-C 108.691 -0.855 . . . . 2.7599999999999998 108.691 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.45 126.54 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 114.488 -1.233 . . . . 0.68999999999999995 111.214 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -114.07 174.48 5.92 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.405 1.631 . . . . 0.69999999999999996 115.405 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.22 137.05 54.97 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.372 0.606 . . . . 1.3300000000000001 111.974 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.6 t -132.71 126.0 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.247 0 CA-C-N 115.161 -0.927 . . . . 0.47999999999999998 109.671 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -125.56 149.39 48.39 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.653 1.353 . . . . 1.6899999999999999 114.653 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.55 104.28 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 115.389 -0.823 . . . . 0.59999999999999998 112.802 178.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.584 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 6.9 t30 64.28 26.48 13.71 Favored 'General case' 0 N--CA 1.518 2.952 0 C-N-CA 126.636 1.974 . . . . 1.1200000000000001 114.31 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.92 -22.22 23.83 Favored Glycine 0 CA--C 1.548 2.117 0 CA-C-N 115.582 -0.735 . . . . 0.32000000000000001 113.603 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -79.94 148.03 31.39 Favored 'General case' 0 C--N 1.367 1.365 0 C-N-CA 125.63 1.572 . . . . 0.56999999999999995 114.007 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.44 127.52 49.44 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.283 0.563 . . . . 0.55000000000000004 110.977 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -120.22 -57.2 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 115.256 -0.884 . . . . 1.0600000000000001 113.254 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.33 88.26 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.165 -1.05 . . . . 0.44 108.165 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -111.17 75.77 0.94 Allowed 'General case' 0 C--N 1.354 0.779 0 CA-C-O 123.37 1.557 . . . . 2.2999999999999998 112.133 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.9 p30 157.78 61.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 110.789 -2.914 . . . . 2.48 108.117 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.94 101.04 13.38 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 114.095 1.146 . . . . 1.1299999999999999 114.095 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 1.2 t70 -116.75 97.2 5.85 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 113.132 -1.849 . . . . 2.3500000000000001 106.582 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -28.56 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.477 0 N-CA-C 114.569 1.322 . . . . 0.68000000000000005 114.569 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -75.84 -36.78 59.51 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.24 0.616 . . . . 0.77000000000000002 112.323 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -74.72 -26.74 60.01 Favored 'General case' 0 CA--C 1.577 1.99 0 C-N-CA 124.466 1.106 . . . . 0.91000000000000003 113.096 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 25.3 mmm180 -77.66 -55.09 5.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.236 0.828 . . . . 2.4300000000000002 113.236 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.82 -40.59 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 N-CA-C 113.966 1.098 . . . . 0.93000000000000005 113.966 177.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.84 -69.51 0.21 Allowed Glycine 0 C--N 1.359 1.844 0 CA-C-N 118.186 0.448 . . . . 0.84999999999999998 113.652 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -104.72 175.27 5.55 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.447 1.099 . . . . 3.1800000000000002 111.381 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 m -73.55 84.31 1.54 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 122.007 0.908 . . . . 2.0800000000000001 113.214 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 51' ' ' LEU . 17.9 p -131.24 -154.35 0.62 Allowed 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 113.92 -1.491 . . . . 0.62 109.301 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.49 129.38 54.46 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 121.468 -0.77 . . . . 0.46000000000000002 112.324 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -100.43 142.39 31.97 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.645 -0.502 . . . . 0.38 109.645 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -135.5 128.2 30.95 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.711 1.374 . . . . 2.5 114.711 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -118.0 118.1 31.04 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 114.36 -1.291 . . . . 1.5600000000000001 109.905 176.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.11 121.05 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 114.644 -1.162 . . . . 0.45000000000000001 111.513 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.12 95.11 19.0 Favored Pre-proline 0 CA--C 1.572 1.819 0 CA-C-N 115.49 -0.777 . . . . 0.83999999999999997 110.694 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -75.87 137.55 19.97 Favored 'Trans proline' 0 C--N 1.395 3.003 0 C-N-CA 122.802 2.335 . . . . 0.16 113.325 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.49 145.62 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.393 0 CA-C-O 121.737 0.78 . . . . 0.38 111.665 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.9 p -129.86 112.29 13.42 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.85 -1.068 . . . . 1.3100000000000001 110.817 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.6 mt -113.64 121.43 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.511 0 CA-C-N 115.228 -0.896 . . . . 0.25 108.841 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -141.76 129.64 21.81 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.128 0.489 . . . . 2.0499999999999998 111.903 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 66.38 15.19 10.02 Favored 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 114.827 1.417 . . . . 3.5499999999999998 114.827 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 17.91 28.79 Favored Glycine 0 CA--C 1.548 2.149 0 CA-C-O 119.385 -0.675 . . . . 0.37 114.562 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -128.73 143.38 50.91 Favored 'General case' 0 C--N 1.364 1.239 0 CA-C-N 118.036 0.918 . . . . 1.5600000000000001 112.426 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.09 143.34 29.48 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.823 1.046 . . . . 0.34000000000000002 113.823 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 114.0 12.61 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.864 -1.062 . . . . 0.64000000000000001 110.865 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.271 0.3 OUTLIER -118.14 108.17 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.257 0 CA-C-N 115.989 -0.551 . . . . 0.46000000000000002 110.533 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 67.06 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.745 0 C-N-CA 125.588 1.555 . . . . 1.5600000000000001 113.762 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -140.9 31.79 2.17 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-N 115.777 -0.647 . . . . 0.48999999999999999 112.765 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -133.73 128.14 34.3 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.641 0.776 . . . . 1.8200000000000001 110.573 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -115.68 131.23 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.298 0 CA-C-O 121.551 0.691 . . . . 1.02 111.786 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 m -147.18 -169.09 3.22 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.094 -0.957 . . . . 0.56000000000000005 110.174 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.5 t -101.79 141.09 35.18 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 112.998 0.74 . . . . 1.25 112.998 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -88.44 133.0 34.24 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.875 0.845 . . . . 0.28999999999999998 111.894 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 p -98.27 -164.01 1.1 Allowed 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 113.976 -1.465 . . . . 1.4199999999999999 109.369 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.39 7.07 69.59 Favored Glycine 0 CA--C 1.561 2.929 0 N-CA-C 116.991 1.556 . . . . 0.41999999999999998 116.991 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.472 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -159.98 152.49 21.06 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-O 121.704 0.764 . . . . 1.1000000000000001 111.565 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.584 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -108.09 138.08 44.96 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.208 -1.36 . . . . 0.67000000000000004 109.163 177.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 t -119.41 145.72 45.99 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.966 1.839 . . . . 0.35999999999999999 115.966 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -120.09 97.96 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.672 -1.233 . . . . 0.73999999999999999 107.672 175.602 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -107.07 125.91 51.67 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.212 0.819 . . . . 1.6699999999999999 113.212 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -107.46 120.89 43.42 Favored 'General case' 0 C--O 1.25 1.126 0 CA-C-N 115.177 -0.919 . . . . 1.8 110.247 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.46 143.66 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 114.588 -1.187 . . . . 0.57999999999999996 109.587 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -85.77 150.38 24.61 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.681 1.734 . . . . 2.1800000000000002 115.681 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.04 -32.45 4.99 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-N 114.178 -1.374 . . . . 1.02 113.048 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -131.01 -84.06 0.52 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.494 0.718 . . . . 2.8599999999999999 110.511 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -170.99 66.27 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.123 0.569 . . . . 3.9100000000000001 110.927 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -166.51 -45.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.071 0.767 . . . . 1.74 113.071 -179.35 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.442 HD21 ' H ' ' A' ' 70' ' ' SER . 1.4 m-20 82.75 -177.47 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.695 0 C-N-CA 124.546 1.138 . . . . 1.6799999999999999 110.796 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.93 -21.35 70.75 Favored 'Trans proline' 0 N--CA 1.524 3.322 0 C-N-CA 122.977 2.451 . . . . 2.0600000000000001 115.992 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? 83.58 -68.69 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 126.36 1.864 . . . . 3.0 115.085 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.695 HG22 ' HB3' ' A' ' 64' ' ' GLU . 3.1 t -102.4 133.57 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-N 118.984 0.811 . . . . 0.80000000000000004 111.301 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.6 t -132.9 138.44 46.98 Favored 'General case' 0 C--N 1.367 1.362 0 N-CA-C 114.11 1.152 . . . . 0.87 114.11 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -130.17 45.07 2.87 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.547 1.684 . . . . 0.34000000000000002 115.547 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.92 132.72 3.85 Favored 'General case' 0 N--CA 1.524 3.241 0 N-CA-C 116.233 1.938 . . . . 0.69999999999999996 116.233 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -152.45 102.95 2.78 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 116.054 -0.521 . . . . 0.20999999999999999 111.329 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 84' ' ' VAL 0.313 4.9 tt -110.03 123.25 65.76 Favored 'Isoleucine or valine' 0 C--O 1.27 2.168 0 CA-C-O 122.28 1.038 . . . . 0.31 111.406 175.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -123.62 152.69 41.67 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 113.389 -1.732 . . . . 0.44 112.025 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 75.9 tttt -104.27 152.51 22.13 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 118.28 2.696 . . . . 1.26 118.28 -174.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.62 -41.47 2.14 Favored Glycine 0 CA--C 1.541 1.694 0 CA-C-N 110.704 -2.953 . . . . 0.17000000000000001 119.86 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 178.06 164.44 0.69 Allowed 'General case' 0 N--CA 1.519 2.981 0 CA-C-N 121.165 2.482 . . . . 0.14999999999999999 112.228 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.95 -16.09 54.46 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 113.915 1.08 . . . . 0.17000000000000001 113.915 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.53 3.51 50.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.151 1.167 . . . . 0.55000000000000004 114.151 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.622 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 1.0 OUTLIER -106.84 -3.07 20.74 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.205 1.187 . . . . 0.59999999999999998 114.205 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.5 96.53 0.59 Allowed Pre-proline 0 N--CA 1.511 2.586 0 C-N-CA 124.375 1.07 . . . . 0.94999999999999996 111.643 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.622 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 81.0 Cg_endo -94.03 150.21 2.12 Favored 'Trans proline' 0 C--N 1.387 2.59 0 C-N-CA 122.85 2.367 . . . . 1.8 114.783 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.7 ttt -142.49 119.49 11.32 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.622 -0.717 . . . . 4.96 111.069 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.8 mt -131.35 164.9 24.63 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.001 0.905 . . . . 4.0 112.747 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -105.37 158.7 31.62 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-N 114.626 -1.17 . . . . 6.2699999999999996 110.887 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.8 120.63 7.38 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.321 2.014 . . . . 6.5899999999999999 114.966 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -136.15 142.15 38.9 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-N 114.261 -1.336 . . . . 5.5099999999999998 110.585 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.37 -29.95 3.58 Favored 'Trans proline' 0 C--N 1.393 2.877 0 C-N-CA 123.082 2.521 . . . . 6.7699999999999996 116.308 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -137.64 -144.39 4.72 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 114.598 0.599 . . . . 7.0199999999999996 114.598 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.9 mt -119.56 124.9 47.5 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.214 0.45 . . . . 8.9900000000000002 112.214 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.423 -0.798 . . . . 10.6 110.647 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.398 -0.281 . . . . 8.9299999999999997 112.398 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.38 130.72 55.6 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.503 0.668 . . . . 6.8200000000000003 112.053 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.9 mtt -132.19 106.18 7.8 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.796 -0.638 . . . . 7.6399999999999997 111.364 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.9 m -139.81 109.73 6.41 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.814 -0.63 . . . . 3.8599999999999999 111.527 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.47 84.08 0.05 OUTLIER Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.842 -0.617 . . . . 1.1100000000000001 113.148 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 tp -87.93 -47.69 8.37 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.344 0.868 . . . . 0.34999999999999998 113.344 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.27 -22.53 18.86 Favored 'General case' 0 CA--C 1.591 2.543 0 N-CA-C 115.176 1.547 . . . . 0.20000000000000001 115.176 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.17 -18.81 29.51 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 124.337 1.055 . . . . 0.32000000000000001 113.401 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 55.5 mttt -104.49 -8.87 18.77 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 113.958 1.096 . . . . 1.73 113.958 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.514 HG21 HG23 ' A' ' 27' ' ' ILE . 11.3 p -61.44 135.11 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.794 0 C-N-CA 124.027 0.931 . . . . 0.11 112.797 176.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -118.52 -28.59 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 113.357 0.873 . . . . 0.16 113.357 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -163.94 119.0 1.55 Allowed 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 118.43 0.559 . . . . 0.54000000000000004 112.066 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.92 131.53 33.2 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.658 -0.651 . . . . 0.19 111.958 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.27 133.21 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 CA-C-O 121.42 0.629 . . . . 1.05 112.62 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -117.98 111.4 18.91 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.108 -1.441 . . . . 2.1099999999999999 107.108 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.84 102.59 8.27 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 121.898 0.856 . . . . 0.63 111.383 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.55 -14.12 0.35 Allowed Glycine 0 C--N 1.351 1.362 0 N-CA-C 117.127 1.611 . . . . 0.70999999999999996 117.127 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.04 -131.79 2.32 Favored Glycine 0 N--CA 1.472 1.059 0 C-N-CA 119.271 -1.442 . . . . 0.80000000000000004 116.06 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.541 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 19.9 tt0 -148.16 116.26 6.47 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 114.931 -0.634 . . . . 1.6299999999999999 110.89 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 14.7 m 21.78 120.4 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 120.199 3.407 . . . . 1.0 120.199 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -140.52 143.02 35.19 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.521 1.153 . . . . 0.45000000000000001 113.407 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.88 115.74 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-N 113.217 -1.811 . . . . 1.3899999999999999 110.789 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -74.99 155.65 37.12 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 113.341 -1.754 . . . . 1.8500000000000001 111.316 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -42.8 -23.92 0.1 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.152 0 N-CA-C 119.048 2.981 . . . . 0.71999999999999997 119.048 -178.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -96.88 -19.36 18.9 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 118.588 0.631 . . . . 0.51000000000000001 110.735 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.81 42.42 0.86 Allowed Glycine 0 C--N 1.358 1.8 0 C-N-CA 124.569 1.08 . . . . 0.34000000000000002 114.534 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.514 HG23 HG21 ' A' ' 10' ' ' VAL . 3.5 mt -105.73 121.55 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-O 120.883 0.373 . . . . 0.55000000000000004 110.002 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -102.85 125.99 49.82 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.286 1.217 . . . . 1.3400000000000001 114.286 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.47 152.68 18.19 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.793 -0.64 . . . . 2.79 111.755 176.838 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -100.35 149.34 23.73 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.006 1.113 . . . . 3.0 114.006 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' A' ' 31' ' ' LYS . 1.1 tmmt? -75.14 102.6 5.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.781 2.141 . . . . 2.2999999999999998 116.781 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.403 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 3.9 m-20 45.42 45.66 2.47 Favored Pre-proline 0 N--CA 1.526 3.355 0 N-CA-C 119.128 3.01 . . . . 1.1699999999999999 119.128 174.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.403 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 6.5 Cg_endo -100.72 63.85 0.04 OUTLIER 'Trans proline' 0 CA--C 1.566 2.093 0 C-N-CA 122.766 2.311 . . . . 1.45 116.209 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD12 ' HE ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -90.11 -71.88 0.59 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.594 0.357 . . . . 1.9099999999999999 111.281 177.204 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -142.21 47.51 1.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.374 1.25 . . . . 4.8399999999999999 114.374 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.27 1.84 47.81 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 115.647 1.019 . . . . 2.3700000000000001 115.647 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -92.05 65.94 4.87 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 113.162 0.801 . . . . 4.5 113.162 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.77 117.19 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 116.101 -0.499 . . . . 2.7000000000000002 111.658 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 166.92 -69.43 0.18 Allowed Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.687 -0.688 . . . . 1.95 113.735 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -124.48 158.51 32.68 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.507 0.929 . . . . 5.3399999999999999 113.507 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.08 142.79 33.53 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 114.822 -1.081 . . . . 1.6399999999999999 111.657 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.9 m -110.57 76.62 0.99 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.42 0.628 . . . . 1.5700000000000001 112.298 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.02 -61.53 1.46 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.345 -0.843 . . . . 2.3300000000000001 111.835 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 79.82 -64.19 0.22 Allowed 'General case' 0 N--CA 1.511 2.584 0 C-N-CA 125.567 1.547 . . . . 3.1600000000000001 113.307 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.63 121.0 2.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.048 -0.524 . . . . 1.52 112.459 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 59.9 mtt -91.9 3.87 54.21 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.73 1.011 . . . . 1.6699999999999999 113.73 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.91 24.87 0.86 Allowed 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 115.422 1.638 . . . . 4.1799999999999997 115.422 -178.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.69 75.98 78.0 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 106.652 -1.61 . . . . 2.6299999999999999 106.652 177.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.21 173.59 11.59 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.285 2.657 . . . . 1.3700000000000001 117.708 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.254 1.2 mp -98.11 132.82 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.27 0 CA-C-N 113.865 -1.516 . . . . 0.68999999999999995 108.269 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.456 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.8 mt -86.91 -10.91 52.21 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.743 2.127 . . . . 1.28 116.743 -176.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -106.75 22.21 16.27 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.532 0.938 . . . . 1.51 113.532 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -141.91 -172.81 3.64 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-O 121.432 0.634 . . . . 1.0900000000000001 111.294 178.56 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.633 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.88 -176.72 0.57 Allowed Pre-proline 0 N--CA 1.509 2.51 0 C-N-CA 123.819 0.848 . . . . 1.27 109.557 178.528 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.493 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 32.8 Cg_exo -69.52 -40.42 5.72 Favored 'Trans proline' 0 C--N 1.4 3.26 0 C-N-CA 122.679 2.253 . . . . 0.94999999999999996 113.045 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -67.98 -49.52 61.14 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.27 1.428 . . . . 2.04 111.866 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' HB3' ' OG ' ' A' ' 53' ' ' SER . 0.3 OUTLIER -80.19 -3.54 49.43 Favored 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 114.86 -1.064 . . . . 1.6200000000000001 112.812 177.438 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.633 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 3.4 tt0 -73.03 -42.41 63.19 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 125.649 1.579 . . . . 1.77 107.391 173.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.6 t -63.72 -40.29 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 C-N-CA 124.195 0.998 . . . . 0.81000000000000005 109.638 173.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -17.38 60.58 Favored 'General case' 0 CA--C 1.587 2.393 0 N-CA-C 114.247 1.203 . . . . 1.1499999999999999 114.247 174.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -123.65 22.75 9.0 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 114.372 1.249 . . . . 0.92000000000000004 114.372 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.43 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -137.89 -36.31 0.62 Allowed 'General case' 0 N--CA 1.51 2.558 0 N-CA-C 114.84 1.422 . . . . 1.3300000000000001 114.84 -178.275 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.1 p -65.94 126.31 28.15 Favored 'General case' 0 N--CA 1.526 3.353 0 N-CA-C 115.293 1.59 . . . . 1.28 115.293 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.41 148.06 42.93 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 113.463 0.912 . . . . 1.53 113.463 -178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.494 ' HE ' HD12 ' A' ' 34' ' ' LEU . 2.9 ttp85 -99.29 -150.76 0.38 Allowed 'General case' 0 CA--C 1.568 1.658 0 C-N-CA 124.08 0.952 . . . . 3.2200000000000002 111.355 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -107.08 136.64 46.59 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.557 -0.715 . . . . 3.6600000000000001 111.377 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -116.76 151.23 36.86 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.809 1.04 . . . . 4.7000000000000002 113.809 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -159.57 -66.37 0.08 Allowed 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 113.726 1.01 . . . . 2.5499999999999998 113.726 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.66 -162.99 1.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.434 0.901 . . . . 2.1499999999999999 113.434 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.28 109.87 3.29 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.608 1.163 . . . . 0.77000000000000002 112.344 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.81 157.34 43.93 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.739 -1.119 . . . . 0.81000000000000005 113.157 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -169.66 -176.27 39.34 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 115.739 1.055 . . . . 0.46999999999999997 115.739 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.6 172.31 6.92 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.357 1.243 . . . . 0.89000000000000001 114.357 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.06 130.32 50.89 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 114.092 -1.413 . . . . 0.51000000000000001 111.995 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.73 99.61 38.57 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 123.282 0.633 . . . . 0.14999999999999999 109.379 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -84.17 121.63 2.76 Favored 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 122.061 1.841 . . . . 0.14999999999999999 114.65 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.03 160.4 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 CA-C-O 122.016 0.913 . . . . 0.19 111.455 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -146.62 17.42 1.3 Allowed 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 114.616 -1.175 . . . . 2.5299999999999998 112.051 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -126.65 160.33 31.04 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-O 121.292 0.568 . . . . 2.1200000000000001 111.5 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -121.25 144.55 48.55 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.72 1.008 . . . . 0.41999999999999998 113.72 -178.816 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.32 -134.31 3.49 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 113.961 -1.472 . . . . 0.23000000000000001 112.012 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.7 mt-10 -119.1 106.91 12.86 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 118.521 1.16 . . . . 1.75 111.158 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -101.37 128.74 47.41 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.093 0.473 . . . . 0.20999999999999999 110.76 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.77 125.77 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.528 0.68 . . . . 0.20000000000000001 110.543 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.71 105.89 17.28 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 114.563 -1.199 . . . . 0.78000000000000003 109.687 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.23 123.31 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.044 -1.095 . . . . 0.44 108.044 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -138.37 140.24 39.34 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.973 0.731 . . . . 1.25 112.973 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -101.46 120.37 40.18 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.711 0.767 . . . . 2.52 111.794 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -105.07 133.5 49.74 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.399 -0.819 . . . . 0.40000000000000002 109.655 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.59 158.92 43.27 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.306 0.574 . . . . 0.40999999999999998 112.207 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -122.8 161.63 23.64 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.512 0.725 . . . . 2.6099999999999999 111.844 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.13 -69.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 112.579 0.585 . . . . 2.1299999999999999 112.579 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -132.11 63.38 1.62 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.621 0.6 . . . . 2.27 112.621 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -148.68 97.44 2.73 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.283 0.633 . . . . 1.46 109.707 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.37 105.91 16.22 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.171 0.986 . . . . 0.83999999999999997 112.397 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -167.4 140.54 3.45 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.874 -1.057 . . . . 2.4500000000000002 111.464 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.1 m -127.08 123.18 36.29 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.782 0.66 . . . . 1.6599999999999999 112.782 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 68.16 47.49 1.02 Allowed 'General case' 0 N--CA 1.51 2.56 0 C-N-CA 125.819 1.648 . . . . 1.8899999999999999 113.894 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -149.74 -39.27 0.14 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.589 1.156 . . . . 2.5600000000000001 110.053 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -107.81 79.61 1.3 Allowed 'General case' 0 C--N 1.362 1.118 0 N-CA-C 108.123 -1.066 . . . . 2.7599999999999998 108.123 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.24 120.71 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 114.111 -1.404 . . . . 0.68999999999999995 111.146 -176.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -99.41 176.62 5.45 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 114.166 -1.379 . . . . 0.69999999999999996 114.583 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.5 135.25 50.11 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 122.09 -0.381 . . . . 1.3300000000000001 110.332 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.79 124.22 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.439 0 CA-C-O 121.208 0.528 . . . . 0.47999999999999998 109.641 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.678 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 20.0 mtt180 -122.11 150.48 42.11 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.467 1.654 . . . . 1.6899999999999999 115.467 -176.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 154' ' ' SER . 7.2 m -126.05 111.87 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 N-CA-C 113.072 0.767 . . . . 0.59999999999999998 113.072 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.468 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 62.86 25.93 15.32 Favored 'General case' 0 N--CA 1.526 3.345 0 C-N-CA 126.607 1.963 . . . . 1.1200000000000001 114.06 -179.042 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.22 -14.05 51.7 Favored Glycine 0 CA--C 1.552 2.37 0 C-N-CA 121.348 -0.453 . . . . 0.32000000000000001 113.768 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.678 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 92.3 m-70 -89.29 173.99 8.08 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 125.914 1.686 . . . . 0.56999999999999995 113.185 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.66 133.56 54.51 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.582 0.706 . . . . 0.55000000000000004 112.047 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.69 -57.17 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-N 114.701 -1.136 . . . . 1.0600000000000001 113.038 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.09 88.98 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.295 -1.002 . . . . 0.44 108.295 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 13.4 ptpt -108.31 98.55 8.07 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 122.919 1.342 . . . . 2.2999999999999998 111.793 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 0.6 OUTLIER 121.48 74.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 129.245 3.018 . . . . 2.48 108.018 -179.409 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.47 106.61 18.66 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 113.228 0.825 . . . . 1.1299999999999999 113.228 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -116.86 102.53 9.47 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.728 -1.578 . . . . 2.3500000000000001 106.806 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -25.59 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.335 0 N-CA-C 114.4 1.259 . . . . 0.68000000000000005 114.4 -176.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -75.27 -41.96 56.09 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.831 0.853 . . . . 0.77000000000000002 112.324 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -73.9 -26.13 60.37 Favored 'General case' 0 CA--C 1.577 1.986 0 C-N-CA 124.403 1.081 . . . . 0.91000000000000003 113.497 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -78.19 -56.1 4.74 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 113.711 1.004 . . . . 2.4300000000000002 113.711 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.21 -36.95 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 N-CA-C 114.44 1.274 . . . . 0.93000000000000005 114.44 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.05 -109.29 1.07 Allowed Glycine 0 C--N 1.355 1.619 0 CA-C-N 118.523 0.601 . . . . 0.84999999999999998 113.25 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -114.94 106.95 14.75 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.731 0.301 . . . . 3.1800000000000002 110.63 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 67.56 -130.07 0.14 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 125.285 1.434 . . . . 2.0800000000000001 112.582 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.456 HG22 ' HB2' ' A' ' 51' ' ' LEU . 66.7 p 60.39 -163.24 0.25 Allowed 'General case' 0 N--CA 1.529 3.511 0 C-N-CA 126.293 1.837 . . . . 0.62 115.182 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -112.74 129.93 56.24 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 112.692 0.626 . . . . 0.46000000000000002 112.692 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -103.08 137.82 40.74 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.077 -0.712 . . . . 0.38 109.077 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -134.71 126.14 28.44 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.88 1.437 . . . . 2.5 114.88 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.06 125.32 52.27 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 115.138 -0.937 . . . . 1.5600000000000001 111.156 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.63 114.72 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 114.272 -1.331 . . . . 0.45000000000000001 110.199 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.3 101.4 17.69 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.953 -0.546 . . . . 0.83999999999999997 111.582 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -74.13 143.01 31.6 Favored 'Trans proline' 0 C--N 1.399 3.237 0 C-N-CA 123.049 2.499 . . . . 0.16 114.729 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.3 mt -124.9 150.46 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 CA-C-N 115.03 -0.987 . . . . 0.38 109.916 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.6 t -136.21 113.41 10.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.454 0.645 . . . . 1.3100000000000001 111.275 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -111.56 124.28 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-N 114.931 -1.031 . . . . 0.25 108.61 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -143.69 130.4 20.27 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.791 -0.64 . . . . 2.0499999999999998 110.979 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.35 14.24 9.14 Favored 'General case' 0 N--CA 1.515 2.803 0 C-N-CA 125.186 1.394 . . . . 3.5499999999999998 113.623 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.99 17.64 31.78 Favored Glycine 0 CA--C 1.549 2.162 0 CA-C-O 119.158 -0.801 . . . . 0.37 114.566 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 7.1 mtpm? -127.28 150.58 49.5 Favored 'General case' 0 C--N 1.367 1.364 0 CA-C-N 118.443 1.122 . . . . 1.5600000000000001 113.046 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.79 141.06 36.77 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.07 1.137 . . . . 0.34000000000000002 114.07 -176.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.73 112.32 11.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.884 -1.053 . . . . 0.64000000000000001 110.054 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.255 8.6 p -115.95 95.16 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.457 0 CA-C-O 121.309 0.576 . . . . 0.46000000000000002 111.314 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 67.81 -86.37 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 C-N-CA 125.673 1.589 . . . . 1.5600000000000001 113.608 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.83 26.68 5.32 Favored Glycine 0 CA--C 1.543 1.821 0 CA-C-N 115.923 -0.581 . . . . 0.48999999999999999 112.79 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -126.12 137.35 53.59 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 124.067 0.947 . . . . 1.8200000000000001 111.013 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.75 126.04 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.167 0 CA-C-O 121.516 0.675 . . . . 1.02 111.05 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 m -150.2 -179.72 7.42 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.188 -0.915 . . . . 0.56000000000000005 109.933 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.269 15.4 t -103.84 138.18 40.79 Favored 'General case' 0 CA--C 1.577 1.981 0 N-CA-C 113.152 0.797 . . . . 1.25 113.152 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -83.74 121.81 27.79 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.987 0.915 . . . . 0.28999999999999998 111.38 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.41 91.27 3.21 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 112.38 0.511 . . . . 1.4199999999999999 112.38 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.89 -66.29 3.4 Favored Glycine 0 C--N 1.357 1.74 0 N-CA-C 118.738 2.255 . . . . 0.41999999999999998 118.738 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.528 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -133.58 156.89 47.01 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.326 1.232 . . . . 1.1000000000000001 114.326 -176.365 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.528 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -104.84 137.3 42.84 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.107 -1.86 . . . . 0.67000000000000004 109.188 177.117 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.1 t -120.47 143.28 48.6 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.284 1.587 . . . . 0.35999999999999999 115.284 -177.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.411 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.92 97.44 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.986 -1.487 . . . . 0.73999999999999999 106.986 175.736 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -117.76 124.11 47.65 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.993 -0.549 . . . . 1.6699999999999999 112.077 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.91 135.27 54.15 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 122.329 1.062 . . . . 1.8 112.015 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.4 t -104.74 140.24 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-N 112.631 -2.077 . . . . 0.57999999999999996 109.283 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 150.32 21.77 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.741 1.386 . . . . 2.1800000000000002 114.741 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.91 -34.23 4.1 Favored Glycine 0 CA--C 1.545 1.964 0 CA-C-N 114.779 -1.1 . . . . 1.02 114.483 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -126.2 -88.01 0.59 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 117.357 0.579 . . . . 2.8599999999999999 112.372 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -131.04 -51.33 1.03 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.996 0.518 . . . . 3.9100000000000001 112.015 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.03 122.61 37.87 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.172 0.989 . . . . 1.74 111.245 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -81.97 -169.09 0.21 Allowed Pre-proline 0 CA--C 1.574 1.888 0 C-N-CA 125.54 1.536 . . . . 1.6799999999999999 110.554 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -62.7 99.98 0.22 Allowed 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 122.159 1.906 . . . . 2.0600000000000001 111.461 174.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -55.65 -55.18 35.21 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.295 1.961 . . . . 3.0 116.295 -173.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 38.8 t -105.61 130.02 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.52 -0.919 . . . . 0.80000000000000004 108.52 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.8 t -135.41 113.82 11.56 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.053 -1.431 . . . . 0.87 110.648 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -109.61 47.2 0.95 Allowed 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.688 2.107 . . . . 0.34000000000000002 116.688 -175.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.17 130.92 3.62 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 117.13 2.27 . . . . 0.69999999999999996 117.13 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -150.92 105.37 3.25 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.7 -1.136 . . . . 0.20999999999999999 109.597 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.298 7.2 tt -112.76 122.04 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-O 122.255 1.026 . . . . 0.31 111.091 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -116.3 164.29 14.74 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 113.707 -1.588 . . . . 0.44 111.153 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 8.6 ptmm? -123.0 156.18 35.32 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.577 2.436 . . . . 1.26 117.577 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.42 -41.57 2.11 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 110.55 -3.023 . . . . 0.17000000000000001 118.909 174.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.04 160.36 1.77 Allowed 'General case' 0 N--CA 1.517 2.885 0 CA-C-N 120.683 2.242 . . . . 0.14999999999999999 113.391 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -83.29 -13.65 54.71 Favored 'General case' 0 CA--C 1.578 2.03 0 C-N-CA 124.882 1.273 . . . . 0.17000000000000001 114.016 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.38 2.91 49.01 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 114.502 1.297 . . . . 0.55000000000000004 114.502 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.63 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.9 OUTLIER -107.55 -10.26 15.73 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.762 1.023 . . . . 0.59999999999999998 113.762 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.53 94.66 0.55 Allowed Pre-proline 0 N--CA 1.508 2.431 0 C-N-CA 123.917 0.887 . . . . 0.94999999999999996 112.727 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 65.5 Cg_endo -95.05 159.62 1.7 Allowed 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 122.713 2.275 . . . . 1.8 114.284 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.4 tpt -135.36 114.45 12.22 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.064 -0.517 . . . . 4.96 111.448 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.76 163.85 31.79 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.091 0.948 . . . . 4.0 112.524 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -111.24 161.75 23.82 Favored Pre-proline 0 CA--C 1.563 1.459 0 CA-C-N 114.538 -1.21 . . . . 6.2699999999999996 110.621 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -67.25 121.11 8.21 Favored 'Trans proline' 0 C--N 1.396 3.041 0 C-N-CA 122.356 2.037 . . . . 6.5899999999999999 114.453 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -136.62 134.77 19.73 Favored Pre-proline 0 CA--C 1.562 1.433 0 CA-C-N 115.374 -0.83 . . . . 5.5099999999999998 111.634 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -85.02 -155.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.257 2.638 . . . . 6.7699999999999996 113.845 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 170.01 87.63 0.07 OUTLIER Glycine 0 C--N 1.342 0.873 0 C-N-CA 120.846 -0.692 . . . . 7.0199999999999996 113.357 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.7 mt -119.13 115.34 24.05 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.726 0.41 . . . . 8.9900000000000002 111.877 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.292 -0.861 . . . . 10.6 111.143 179.958 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.473 -0.251 . . . . 8.9299999999999997 112.473 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.4 130.85 55.47 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.493 0.663 . . . . 6.8200000000000003 111.904 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.7 mtt -130.59 -67.67 0.72 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.751 -0.658 . . . . 7.6399999999999997 111.792 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.0 m -134.91 116.14 14.4 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.877 0.37 . . . . 3.8599999999999999 111.7 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.69 89.07 0.1 OUTLIER Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.783 -0.644 . . . . 1.1100000000000001 113.101 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 27' ' ' ILE . 17.3 tp -87.92 -45.02 10.62 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 113.314 0.857 . . . . 0.34999999999999998 113.314 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.46 -23.53 62.79 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.822 1.649 . . . . 0.20000000000000001 115.134 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.97 -10.46 53.15 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 113.62 0.97 . . . . 0.32000000000000001 113.62 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 54.9 mmtt -105.26 -25.21 12.53 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-O 118.235 -0.888 . . . . 1.73 113.349 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -51.03 133.8 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 N-CA-C 115.508 1.67 . . . . 0.11 115.508 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.26 -29.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 115.267 -0.879 . . . . 0.16 112.071 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -162.45 118.6 1.94 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.583 0.353 . . . . 0.54000000000000004 111.62 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.8 128.58 20.48 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.523 -0.735 . . . . 0.19 111.181 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.11 135.66 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 113.986 1.106 . . . . 1.05 113.986 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -116.04 102.34 9.55 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 106.906 -1.516 . . . . 2.1099999999999999 106.906 172.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -75.37 98.55 3.89 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.949 0.881 . . . . 0.63 111.764 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 172.3 -33.03 0.13 Allowed Glycine 0 C--N 1.348 1.234 0 N-CA-C 117.374 1.71 . . . . 0.70999999999999996 117.374 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.07 -114.87 1.9 Allowed Glycine 0 N--CA 1.471 1.01 0 C-N-CA 120.219 -0.991 . . . . 0.80000000000000004 115.288 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.75 117.04 1.07 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.118 0.567 . . . . 1.6299999999999999 110.593 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.4 m 33.25 108.01 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 118.593 2.812 . . . . 1.0 118.593 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.519 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 63.3 t60 -133.21 133.94 43.39 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.76 1.022 . . . . 0.45000000000000001 113.76 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.57 117.59 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 114.743 -1.117 . . . . 1.3899999999999999 109.143 175.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -86.37 163.25 17.75 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 115.157 -0.929 . . . . 1.8500000000000001 111.542 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -43.73 -24.96 0.21 Allowed 'Isoleucine or valine' 1 N--CA 1.541 4.092 0 N-CA-C 119.681 3.215 . . . . 0.71999999999999997 119.681 -175.035 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -98.02 -9.98 25.16 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 118.543 0.611 . . . . 0.51000000000000001 111.457 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.8 40.32 2.73 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.811 1.196 . . . . 0.34000000000000002 114.036 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.55 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.6 mm -105.15 119.17 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.681 0 N-CA-C 109.21 -0.663 . . . . 0.55000000000000004 109.21 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.519 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.0 t-160 -105.7 135.28 47.4 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.579 1.696 . . . . 1.3400000000000001 115.579 -175.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -94.84 134.35 37.56 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.3 -1.318 . . . . 2.79 109.392 174.697 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.4 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 68.8 mtt180 -90.79 106.03 18.23 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.956 -1.02 . . . . 3.0 113.307 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -41.89 109.84 0.14 Allowed 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 118.374 2.731 . . . . 2.2999999999999998 118.374 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.08 59.75 16.33 Favored Pre-proline 0 N--CA 1.528 3.466 0 N-CA-C 118.325 2.713 . . . . 1.1699999999999999 118.325 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 10.0 Cg_endo -105.83 56.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.565 2.068 0 C-N-CA 122.992 2.461 . . . . 1.45 115.685 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.53 -67.88 0.46 Allowed 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 113.106 0.78 . . . . 1.9099999999999999 113.106 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -99.19 89.44 4.24 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 112.98 0.733 . . . . 4.8399999999999999 112.98 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.79 -29.63 11.67 Favored Glycine 0 CA--C 1.545 1.929 0 CA-C-N 115.458 -0.792 . . . . 2.3700000000000001 114.503 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 80.89 2.75 1.69 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 126.605 1.962 . . . . 4.5 114.816 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.93 117.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 123.923 0.889 . . . . 2.7000000000000002 109.807 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.84 -140.79 2.96 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 120.765 -0.731 . . . . 1.95 114.453 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -139.81 -177.86 5.17 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.893 0.854 . . . . 5.3399999999999999 112.831 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.49 129.81 45.08 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.234 1.013 . . . . 1.6399999999999999 111.878 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.4 m -126.37 122.92 36.74 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.244 -0.889 . . . . 1.5700000000000001 111.142 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.96 108.74 9.57 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.95 -0.568 . . . . 2.3300000000000001 111.458 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -105.59 72.18 0.95 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.88 0.848 . . . . 3.1600000000000001 110.299 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.17 75.74 0.48 Allowed Glycine 0 C--N 1.347 1.142 0 CA-C-N 114.399 -1.273 . . . . 1.52 110.716 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.33 0.31 57.44 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.766 1.765 . . . . 1.6699999999999999 115.766 -177.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.54 46.47 1.72 Allowed 'General case' 0 CA--C 1.559 1.315 0 CA-C-O 121.632 0.73 . . . . 4.1799999999999997 112.119 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -129.72 72.74 81.89 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.551 1.141 . . . . 2.6299999999999999 108.395 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 38.6 Cg_exo -67.4 159.78 50.79 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 124.03 3.153 . . . . 1.3700000000000001 117.211 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.3 136.87 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.951 0 CA-C-N 114.703 -1.135 . . . . 0.68999999999999995 109.405 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.55 ' HB2' HG22 ' A' ' 125' ' ' THR . 4.0 mt -79.52 -17.14 54.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.241 1.571 . . . . 1.28 115.241 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -101.49 7.41 42.43 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.478 0.918 . . . . 1.51 113.478 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.2 p -118.52 -177.98 3.42 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.14 1.163 . . . . 1.0900000000000001 114.14 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.717 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 2.6 t30 -97.44 -176.18 0.5 Allowed Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 125.652 1.581 . . . . 1.27 109.574 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -72.05 -43.99 1.02 Allowed 'Trans proline' 0 C--N 1.393 2.901 0 C-N-CA 122.766 2.311 . . . . 0.94999999999999996 111.414 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -69.31 -47.68 63.76 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.005 -1.907 . . . . 2.04 111.617 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 17.4 t0 -75.7 -12.27 60.16 Favored 'General case' 0 CA--C 1.583 2.241 0 CA-C-N 115.327 -0.851 . . . . 1.6200000000000001 112.378 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.717 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 10.8 tt0 -67.7 -43.16 80.76 Favored 'General case' 0 C--N 1.379 1.851 0 C-N-CA 125.432 1.493 . . . . 1.77 109.179 173.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.8 -45.06 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.338 0 C-N-CA 124.327 1.051 . . . . 0.81000000000000005 109.853 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.76 -5.18 49.83 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.227 1.195 . . . . 1.1499999999999999 114.227 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.496 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 4.6 m-30 -123.54 10.35 9.11 Favored 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 124.509 1.124 . . . . 0.92000000000000004 112.402 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -136.55 -28.64 0.99 Allowed 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 116.502 2.038 . . . . 1.3300000000000001 116.502 -176.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.7 p -74.74 131.85 41.16 Favored 'General case' 0 N--CA 1.519 2.99 0 N-CA-C 114.008 1.114 . . . . 1.28 114.008 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.597 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.5 pt-20 -127.53 144.93 51.01 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 114.95 1.463 . . . . 1.53 114.95 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.495 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 63.9 mtp180 -98.43 177.41 5.36 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.467 0.707 . . . . 3.2200000000000002 112.673 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -125.11 125.87 44.43 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.792 -0.64 . . . . 3.6600000000000001 111.067 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -132.36 -105.09 0.26 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 118.96 -0.543 . . . . 4.7000000000000002 112.236 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -164.62 -77.54 0.03 OUTLIER 'General case' 0 C--N 1.364 1.2 0 N-CA-C 113.564 0.95 . . . . 2.5499999999999998 113.564 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.65 124.69 0.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.188 0.595 . . . . 2.1499999999999999 111.368 -176.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.2 t 67.56 85.19 0.14 Allowed 'General case' 0 N--CA 1.513 2.714 0 C-N-CA 124.769 1.228 . . . . 0.77000000000000002 112.487 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.406 ' CE1' ' ND2' ' A' ' 164' ' ' ASN . 3.3 p90 -144.56 157.03 44.41 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.384 0.611 . . . . 0.81000000000000005 112.564 -178.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.52 174.47 44.47 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 115.571 0.989 . . . . 0.46999999999999997 115.571 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.99 166.32 10.46 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.482 1.289 . . . . 0.89000000000000001 114.482 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -120.74 132.08 54.86 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.15 -1.387 . . . . 0.51000000000000001 112.162 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -124.51 99.47 36.2 Favored Pre-proline 0 CA--C 1.567 1.627 0 C-N-CA 123.142 0.577 . . . . 0.14999999999999999 109.916 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.08 122.12 3.27 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.231 1.954 . . . . 0.14999999999999999 115.014 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.14 159.26 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.64 0 CA-C-O 121.997 0.904 . . . . 0.19 111.26 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -147.86 22.15 1.12 Allowed 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 114.632 -1.167 . . . . 2.5299999999999998 111.791 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -129.9 159.37 36.84 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 121.3 0.572 . . . . 2.1200000000000001 111.449 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -119.0 144.77 46.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.742 1.016 . . . . 0.41999999999999998 113.742 -178.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.48 -138.73 5.77 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 113.974 -1.467 . . . . 0.23000000000000001 112.17 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 54.3 mm-40 -113.65 108.26 16.89 Favored 'General case' 0 C--N 1.359 1.008 0 CA-C-N 118.113 0.956 . . . . 1.75 111.292 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -102.84 129.84 49.65 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.81 -0.556 . . . . 0.20999999999999999 110.599 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -110.02 122.36 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.841 0.829 . . . . 0.20000000000000001 111.013 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.61 105.75 16.3 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 113.907 -1.497 . . . . 0.78000000000000003 110.202 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.69 126.65 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.142 -0.688 . . . . 0.44 109.142 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 146.07 48.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.599 0.963 . . . . 1.25 113.599 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -105.18 121.54 44.05 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.311 -0.859 . . . . 2.52 111.296 177.466 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 15.6 m-85 -108.49 134.86 50.69 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.414 -0.812 . . . . 0.40000000000000002 109.735 176.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.51 ' HB2' ' HE3' ' A' ' 88' ' ' LYS . . . -136.18 148.5 48.18 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 123.868 0.867 . . . . 0.40999999999999998 110.425 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -106.38 -71.21 0.76 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.816 0.447 . . . . 2.6099999999999999 111.768 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.325 2.8 m 48.29 53.57 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 C-N-CA 127.113 2.165 . . . . 2.1299999999999999 116.677 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.98 -53.63 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.79 0.663 . . . . 2.27 112.79 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -118.29 139.23 51.64 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.31 0.576 . . . . 1.46 112.349 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.18 103.31 12.47 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-O 122.209 1.004 . . . . 0.83999999999999997 111.987 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -162.83 140.89 8.27 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.125 -0.943 . . . . 2.4500000000000002 111.642 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 m -123.45 122.38 38.1 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.962 0.727 . . . . 1.6599999999999999 112.962 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 69.2 58.21 0.35 Allowed 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 125.933 1.693 . . . . 1.8899999999999999 113.266 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -156.96 -40.94 0.07 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.128 -1.396 . . . . 2.5600000000000001 108.606 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -103.42 82.67 2.07 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.361 -0.977 . . . . 2.7599999999999998 108.361 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.43 132.89 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 114.516 -1.22 . . . . 0.68999999999999995 111.509 -177.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.476 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 61.7 m-85 -115.5 174.26 6.1 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 115.185 1.55 . . . . 0.69999999999999996 115.185 -176.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.27 136.08 52.34 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.869 0.842 . . . . 1.3300000000000001 110.923 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.3 124.39 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.285 0 CA-C-N 114.361 -1.291 . . . . 0.47999999999999998 110.38 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.3 OUTLIER -121.02 141.56 50.63 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.473 1.286 . . . . 1.6899999999999999 114.473 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 m -117.72 99.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 115.111 -0.95 . . . . 0.59999999999999998 112.063 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.428 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.1 t30 64.85 26.89 12.92 Favored 'General case' 0 N--CA 1.522 3.169 0 C-N-CA 126.892 2.077 . . . . 1.1200000000000001 113.659 -177.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.89 -19.65 32.6 Favored Glycine 0 CA--C 1.549 2.19 0 CA-C-N 115.141 -0.936 . . . . 0.32000000000000001 113.702 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -88.32 121.93 31.27 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 125.505 1.522 . . . . 0.56999999999999995 113.669 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -87.7 125.69 34.55 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.591 1.186 . . . . 0.55000000000000004 113.134 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.22 -43.39 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 112.428 -2.169 . . . . 1.0600000000000001 112.916 -177.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.38 90.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.466 -0.568 . . . . 0.44 109.466 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -111.55 75.88 0.94 Allowed 'General case' 0 C--N 1.359 1.013 0 CA-C-O 123.944 1.831 . . . . 2.2999999999999998 112.52 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 154.46 61.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 109.818 -3.356 . . . . 2.48 107.48 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.3 tp -98.91 99.16 10.18 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 113.727 1.01 . . . . 1.1299999999999999 113.727 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -111.86 111.5 22.49 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 113.172 -1.831 . . . . 2.3500000000000001 109.742 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -34.26 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 114.545 1.313 . . . . 0.68000000000000005 114.545 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -76.32 -37.5 57.31 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.806 0.669 . . . . 0.77000000000000002 112.806 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -74.08 -27.0 60.68 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 124.371 1.068 . . . . 0.91000000000000003 113.422 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -80.33 -57.78 3.44 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.311 0.856 . . . . 2.4300000000000002 113.311 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.78 -36.79 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 N-CA-C 114.313 1.227 . . . . 0.93000000000000005 114.313 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.37 -71.13 0.21 Allowed Glycine 0 C--N 1.36 1.908 0 CA-C-N 118.534 0.606 . . . . 0.84999999999999998 113.999 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -102.97 174.39 5.89 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.25 1.02 . . . . 3.1800000000000002 111.802 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.0 m -75.9 81.26 2.8 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 113.846 1.054 . . . . 2.0800000000000001 113.846 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.55 HG22 ' HB2' ' A' ' 51' ' ' LEU . 46.6 p -127.99 -137.43 0.24 Allowed 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 114.708 -1.133 . . . . 0.62 109.139 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.8 128.09 56.27 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 114.055 1.132 . . . . 0.46000000000000002 114.055 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -106.2 126.68 52.51 Favored 'General case' 0 C--N 1.363 1.183 0 N-CA-C 108.399 -0.963 . . . . 0.38 108.399 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.25 136.76 36.84 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.5 0.926 . . . . 2.5 113.5 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -120.37 134.46 55.26 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 114.806 -1.088 . . . . 1.5600000000000001 111.174 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.8 115.66 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 CA-C-N 114.255 -1.339 . . . . 0.45000000000000001 109.833 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.9 90.86 49.49 Favored Pre-proline 0 CA--C 1.573 1.851 0 CA-C-N 115.208 -0.906 . . . . 0.83999999999999997 110.15 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -73.87 136.64 23.25 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 123.052 2.501 . . . . 0.16 113.71 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -119.04 151.38 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 115.167 -0.924 . . . . 0.38 111.053 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.5 p -134.21 108.73 8.43 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.215 -0.902 . . . . 1.3100000000000001 111.744 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.2 mt -108.82 122.79 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.593 0 N-CA-C 108.441 -0.948 . . . . 0.25 108.441 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -141.76 129.49 21.64 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.696 -0.684 . . . . 2.0499999999999998 110.996 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 67.49 14.87 9.73 Favored 'General case' 0 N--CA 1.515 2.821 0 C-N-CA 125.113 1.365 . . . . 3.5499999999999998 114.367 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.38 16.44 32.1 Favored Glycine 0 CA--C 1.549 2.168 0 CA-C-O 119.143 -0.809 . . . . 0.37 114.962 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 94.6 mttt -126.82 150.4 49.21 Favored 'General case' 0 C--N 1.367 1.329 0 CA-C-N 118.498 1.149 . . . . 1.5600000000000001 113.038 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.53 139.0 37.78 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.554 0.946 . . . . 0.34000000000000002 113.554 -176.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.67 112.42 14.82 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.128 -0.942 . . . . 0.64000000000000001 110.406 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.81 92.75 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.604 0 CA-C-N 115.589 -0.732 . . . . 0.46000000000000002 109.982 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 65.39 -83.75 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 C-N-CA 125.369 1.468 . . . . 1.5600000000000001 113.796 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -129.61 25.95 4.4 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-N 116.099 -0.5 . . . . 0.48999999999999999 113.866 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -132.38 119.31 20.51 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 123.165 0.586 . . . . 1.8200000000000001 110.078 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 p -105.74 131.61 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.298 0 CA-C-O 121.696 0.76 . . . . 1.02 112.415 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -149.08 -178.11 6.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.815 -1.084 . . . . 0.56000000000000005 109.565 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.268 13.0 t -103.48 138.65 39.9 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 113.547 0.943 . . . . 1.25 113.547 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -82.12 122.68 28.16 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 124.192 0.997 . . . . 0.28999999999999998 111.343 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.65 90.77 3.31 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.788 0.662 . . . . 1.4199999999999999 112.788 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.19 -61.74 2.64 Favored Glycine 0 C--N 1.362 2.005 0 N-CA-C 118.835 2.294 . . . . 0.41999999999999998 118.835 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.554 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -133.11 163.83 28.39 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.649 0.981 . . . . 1.1000000000000001 113.649 -176.813 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.554 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -112.14 134.6 53.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.692 -1.594 . . . . 0.67000000000000004 108.488 176.763 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.2 t -121.86 130.58 53.49 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 115.246 1.573 . . . . 0.35999999999999999 115.246 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.2 t -106.35 99.85 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.704 -1.591 . . . . 0.73999999999999999 106.704 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.2 tt0 -114.85 125.23 53.43 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 113.905 -1.498 . . . . 1.6699999999999999 111.9 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -116.15 131.97 56.79 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 122.217 1.008 . . . . 1.8 111.923 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.51 144.47 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 112.875 -1.966 . . . . 0.57999999999999996 110.83 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -95.19 150.45 20.2 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.676 -1.147 . . . . 2.1800000000000002 113.612 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.32 -32.65 5.98 Favored Glycine 0 CA--C 1.548 2.112 0 N-CA-C 115.236 0.855 . . . . 1.02 115.236 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -125.17 -80.56 0.62 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.606 0.703 . . . . 2.8599999999999999 112.395 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -132.2 -44.94 0.93 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.087 0.555 . . . . 3.9100000000000001 112.203 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.476 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -92.84 157.17 16.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.659 1.184 . . . . 1.74 112.109 179.085 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.406 ' ND2' ' CE1' ' A' ' 71' ' ' PHE . 1.2 m-20 -101.19 -167.45 0.13 Allowed Pre-proline 0 CA--C 1.572 1.809 0 CA-C-N 113.614 -1.63 . . . . 1.6799999999999999 108.979 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -61.26 -10.5 15.83 Favored 'Trans proline' 0 N--CA 1.52 3.081 0 C-N-CA 122.49 2.127 . . . . 2.0600000000000001 115.533 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? 78.93 -71.71 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 126.561 1.944 . . . . 3.0 114.211 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.597 HG22 ' HB3' ' A' ' 64' ' ' GLU . 25.2 t -106.34 132.72 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.621 -0.511 . . . . 0.80000000000000004 109.621 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.6 125.82 27.96 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 114.155 -1.384 . . . . 0.87 111.479 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.268 . . -120.34 50.88 1.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 115.744 1.757 . . . . 0.34000000000000002 115.744 -176.724 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.81 129.3 2.62 Favored 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 126.169 1.787 . . . . 0.69999999999999996 115.502 178.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -149.61 99.31 2.87 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.20999999999999999 110.019 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.311 8.0 tt -115.67 121.78 68.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.673 0 CA-C-O 122.651 1.215 . . . . 0.31 111.801 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -118.72 171.2 8.37 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 113.701 -1.59 . . . . 0.44 112.171 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 54.7 tttm -120.15 148.15 44.0 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 117.783 2.512 . . . . 1.26 117.783 -174.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.22 -41.74 2.08 Favored Glycine 0 CA--C 1.543 1.823 0 CA-C-N 110.786 -2.915 . . . . 0.17000000000000001 120.087 172.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.08 156.64 1.04 Allowed 'General case' 0 N--CA 1.521 3.115 0 CA-C-N 121.114 2.457 . . . . 0.14999999999999999 113.383 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.45 -12.12 59.99 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 114.478 1.288 . . . . 0.17000000000000001 114.478 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.1 4.47 45.25 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 113.694 0.998 . . . . 0.55000000000000004 113.694 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.617 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -107.13 -10.32 15.91 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 113.701 1.0 . . . . 0.59999999999999998 113.701 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.32 93.69 0.45 Allowed Pre-proline 0 N--CA 1.509 2.503 0 C-N-CA 123.932 0.893 . . . . 0.94999999999999996 112.74 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 2.7 Cg_exo -83.08 106.74 1.43 Allowed 'Trans proline' 0 C--N 1.398 3.159 0 C-N-CA 122.858 2.372 . . . . 1.8 114.083 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.8 mmt -138.39 110.54 7.33 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.642 -0.708 . . . . 4.96 111.206 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.1 mt -133.29 164.28 27.43 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.974 0.892 . . . . 4.0 112.557 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -104.76 154.43 38.57 Favored Pre-proline 0 CA--C 1.562 1.415 0 CA-C-N 114.629 -1.169 . . . . 6.2699999999999996 110.537 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.46 121.8 9.32 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.569 2.179 . . . . 6.5899999999999999 115.466 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -135.69 135.83 22.62 Favored Pre-proline 0 CA--C 1.565 1.531 0 CA-C-N 114.779 -1.1 . . . . 5.5099999999999998 111.165 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -84.88 -155.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.346 2.697 . . . . 6.7699999999999996 114.293 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.93 104.9 0.18 Allowed Glycine 0 C--N 1.341 0.806 0 C-N-CA 121.136 -0.555 . . . . 7.0199999999999996 113.036 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.5 mt -118.64 108.32 14.79 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.009 0.433 . . . . 8.9900000000000002 111.84 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.277 -0.868 . . . . 10.6 110.998 179.88 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.564 -0.214 . . . . 8.9299999999999997 112.564 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.67 128.1 56.3 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.604 0.716 . . . . 6.8200000000000003 111.884 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.7 mtt -134.19 106.3 7.09 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.626 -0.715 . . . . 7.6399999999999997 110.991 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 m -135.95 117.7 15.06 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.797 -0.638 . . . . 3.8599999999999999 111.741 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -165.93 87.29 0.1 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 115.665 -0.698 . . . . 1.1100000000000001 113.054 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.588 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.7 tp -87.54 -47.76 8.46 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 113.294 0.85 . . . . 0.34999999999999998 113.294 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.69 -23.15 62.89 Favored 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 125.647 1.579 . . . . 0.20000000000000001 114.979 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.1 -15.17 39.3 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 124.146 0.978 . . . . 0.32000000000000001 113.626 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -105.19 -18.05 14.27 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.907 1.077 . . . . 1.73 113.907 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.34 134.79 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.78 0 N-CA-C 114.625 1.343 . . . . 0.11 114.625 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -121.27 -28.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 115.328 -0.851 . . . . 0.16 112.446 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -162.63 117.08 1.77 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 117.827 0.285 . . . . 0.54000000000000004 111.493 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -136.84 130.85 32.42 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.516 -0.74 . . . . 0.19 111.445 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.0 t -137.97 129.32 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 N-CA-C 113.481 0.919 . . . . 1.05 113.481 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -116.44 104.22 11.23 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 106.946 -1.501 . . . . 2.1099999999999999 106.946 171.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.29 101.88 7.38 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.084 0.945 . . . . 0.63 111.861 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.526 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 175.59 -57.33 0.11 Allowed Glycine 0 C--N 1.349 1.305 0 CA-C-N 113.71 -1.587 . . . . 0.70999999999999996 114.349 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.13 -117.09 4.3 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-O 119.93 -0.372 . . . . 0.80000000000000004 113.975 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -172.12 118.88 0.4 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.172 0.589 . . . . 1.6299999999999999 111.17 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 48.39 107.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 117.205 2.298 . . . . 1.0 117.205 178.473 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.761 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 20.2 t-80 -142.41 132.51 24.6 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.461 -1.296 . . . . 0.45000000000000001 114.49 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -97.04 112.24 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.362 0 CA-C-N 114.28 -1.327 . . . . 1.3899999999999999 110.089 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.29 164.92 19.76 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.527 1.131 . . . . 1.8500000000000001 112.559 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 m -42.53 -35.17 0.63 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.159 0 N-CA-C 118.947 2.943 . . . . 0.71999999999999997 118.947 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -88.98 -23.32 22.66 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.213 0.53 . . . . 0.51000000000000001 111.26 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.85 41.06 0.73 Allowed Glycine 0 C--N 1.351 1.394 0 CA-C-N 114.817 -1.083 . . . . 0.34000000000000002 113.81 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.588 HD11 ' HG ' ' A' ' 6' ' ' LEU . 22.7 mm -108.45 112.8 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 C-N-CA 122.569 0.348 . . . . 0.55000000000000004 110.581 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.761 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 5.1 p-80 -109.29 147.83 32.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.983 1.845 . . . . 1.3400000000000001 115.983 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.8 151.31 20.32 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 112.467 -2.151 . . . . 2.79 109.419 176.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -70.27 -99.82 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 116.04 1.867 . . . . 3.0 116.04 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp 178.19 84.04 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.89 0.876 . . . . 2.2999999999999998 111.986 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 52.69 55.33 14.26 Favored Pre-proline 0 N--CA 1.528 3.457 0 N-CA-C 117.283 2.327 . . . . 1.1699999999999999 117.283 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -101.67 61.37 0.03 OUTLIER 'Trans proline' 0 CA--C 1.568 2.193 0 C-N-CA 123.307 2.672 . . . . 1.45 116.432 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.47 -60.8 0.41 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.345 0.498 . . . . 1.9099999999999999 112.345 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -114.22 98.69 7.1 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 121.329 0.585 . . . . 4.8399999999999999 111.639 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.21 -32.34 7.59 Favored Glycine 0 CA--C 1.542 1.772 0 CA-C-N 115.221 -0.899 . . . . 2.3700000000000001 115.128 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 64.46 40.68 6.12 Favored 'General case' 0 N--CA 1.509 2.519 0 C-N-CA 126.139 1.776 . . . . 4.5 114.616 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.61 177.46 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 C-N-CA 123.439 0.696 . . . . 2.7000000000000002 111.52 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -99.22 96.24 1.66 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 115.088 0.795 . . . . 1.95 115.088 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -144.08 115.28 7.95 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.313 0.645 . . . . 5.3399999999999999 110.877 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.66 134.23 46.37 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.508 0.67 . . . . 1.6399999999999999 112.65 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.3 m -131.89 88.41 2.56 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.686 -0.688 . . . . 1.5700000000000001 111.447 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.36 114.41 27.55 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.598 -0.728 . . . . 2.3300000000000001 110.99 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -104.2 -61.61 1.42 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 112.564 0.579 . . . . 3.1600000000000001 112.564 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -110.52 62.72 0.29 Allowed Glycine 0 C--N 1.354 1.565 0 N-CA-C 112.123 -0.391 . . . . 1.52 112.123 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.27 9.76 40.06 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.028 1.862 . . . . 1.6699999999999999 116.028 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -61.19 -77.97 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.786 1.773 . . . . 4.1799999999999997 115.786 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.64 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 1.7 pp -138.88 40.8 0.44 Allowed Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 113.52 0.933 . . . . 2.6299999999999999 113.52 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.64 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 21.7 Cg_exo -68.43 -37.51 13.17 Favored 'Trans proline' 0 C--N 1.377 2.037 0 N-CA-C 119.496 2.844 . . . . 1.3700000000000001 119.496 -177.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 126' ' ' ALA 0.319 1.8 mp -92.78 107.02 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 CA-C-O 123.085 1.421 . . . . 0.68999999999999995 109.59 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.459 ' HB2' HG22 ' A' ' 125' ' ' THR . 89.3 mt -90.24 -7.13 54.26 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 111.821 -2.445 . . . . 1.28 116.387 -175.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -103.86 16.46 26.29 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 112.263 0.468 . . . . 1.51 112.263 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.84 159.36 42.37 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.224 1.01 . . . . 1.0900000000000001 111.51 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.86 158.32 62.26 Favored Pre-proline 0 N--CA 1.517 2.876 0 CA-C-O 118.138 -0.934 . . . . 1.27 110.974 178.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -41.19 -40.13 4.08 Favored 'Trans proline' 0 N--CA 1.535 3.971 0 C-N-CA 125.162 3.908 . . . . 0.94999999999999996 120.05 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.79 -50.02 13.17 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.511 0.672 . . . . 2.04 111.96 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -78.23 -7.5 57.22 Favored 'General case' 0 CA--C 1.584 2.287 0 N-CA-C 113.121 0.786 . . . . 1.6200000000000001 113.121 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.66 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 7.7 tt0 -74.3 -37.06 63.75 Favored 'General case' 0 C--N 1.38 1.919 0 C-N-CA 125.923 1.689 . . . . 1.77 107.547 172.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.36 -43.88 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 C-N-CA 124.214 1.005 . . . . 0.81000000000000005 109.289 172.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.1 tp -79.93 -4.63 53.21 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 113.965 1.098 . . . . 1.1499999999999999 113.965 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.427 ' O ' HG12 ' A' ' 50' ' ' ILE . 6.8 m-30 -121.69 13.77 10.85 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 125.131 1.373 . . . . 0.92000000000000004 112.641 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.66 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 4.8 tt0 -140.8 -38.9 0.42 Allowed 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 117.175 2.287 . . . . 1.3300000000000001 117.175 -174.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.8 p -64.19 128.06 34.16 Favored 'General case' 0 N--CA 1.528 3.435 0 N-CA-C 115.343 1.609 . . . . 1.28 115.343 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.527 ' HB3' HG22 ' A' ' 167' ' ' VAL . 2.4 pt-20 -117.96 146.11 44.23 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 124.617 1.167 . . . . 1.53 112.58 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -102.22 -83.85 0.46 Allowed 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.355 0.872 . . . . 3.2200000000000002 113.355 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.22 163.73 38.81 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.541 0.686 . . . . 3.6600000000000001 112.842 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -127.41 138.94 53.11 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.442 -0.799 . . . . 4.7000000000000002 112.927 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -138.12 -119.83 0.14 Allowed 'General case' 0 CA--C 1.564 1.499 0 CA-C-N 115.472 -0.785 . . . . 2.5499999999999998 110.337 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -152.76 121.24 6.35 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.39 0.541 . . . . 2.1499999999999999 110.732 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.91 89.57 0.06 Allowed 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 125.383 1.473 . . . . 0.77000000000000002 113.692 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -153.53 159.24 42.18 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.841 1.052 . . . . 0.81000000000000005 113.841 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -175.7 -172.01 40.13 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 115.879 1.112 . . . . 0.46999999999999997 115.879 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -111.27 173.32 6.4 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.026 1.491 . . . . 0.89000000000000001 115.026 -176.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -127.61 132.2 49.82 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 113.98 -1.464 . . . . 0.51000000000000001 111.757 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.91 103.61 30.62 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.023 0.529 . . . . 0.14999999999999999 109.957 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -84.34 120.64 2.54 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 122.282 1.988 . . . . 0.14999999999999999 114.958 177.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.24 162.81 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 122.041 0.924 . . . . 0.19 110.931 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -152.13 27.95 0.59 Allowed 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 114.801 -1.091 . . . . 2.5299999999999998 111.816 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -132.71 155.62 48.5 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-O 121.24 0.543 . . . . 2.1200000000000001 110.965 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -116.77 141.87 47.65 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.009 1.114 . . . . 0.41999999999999998 114.009 -178.48 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.83 -139.08 5.69 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 113.712 -1.585 . . . . 0.23000000000000001 112.061 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.2 mt-10 -113.9 110.13 19.61 Favored 'General case' 0 C--N 1.36 1.023 0 CA-C-N 118.312 1.056 . . . . 1.75 111.299 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -104.41 131.2 52.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.996 0.427 . . . . 0.20999999999999999 110.523 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.81 124.46 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.408 0.623 . . . . 0.20000000000000001 110.551 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.429 HD12 HD12 ' A' ' 172' ' ' ILE . 2.2 tt -109.15 106.19 15.97 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.793 -1.094 . . . . 0.78000000000000003 109.806 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -112.48 129.17 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 113.929 -1.487 . . . . 0.44 108.543 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.72 139.11 50.26 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 115.684 -0.689 . . . . 1.25 112.502 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 4.9 tptm -104.33 114.75 29.19 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.295 -0.866 . . . . 2.52 109.855 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.491 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 11.1 m-85 -105.22 137.05 43.62 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.852 -0.613 . . . . 0.40000000000000002 111.255 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.79 151.54 45.84 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.757 -0.656 . . . . 0.40999999999999998 111.458 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -145.87 123.46 11.8 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.671 0.389 . . . . 2.6099999999999999 111.687 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.3 77.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 116.019 -0.537 . . . . 2.1299999999999999 111.727 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -171.05 -47.42 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.43 0.53 . . . . 2.27 112.43 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -116.19 127.34 54.7 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.65 0.38 . . . . 1.46 111.577 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.96 103.14 12.94 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.252 1.025 . . . . 0.83999999999999997 111.992 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -160.79 141.84 11.79 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.947 -1.024 . . . . 2.4500000000000002 111.651 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 m -127.7 122.09 32.05 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.764 0.653 . . . . 1.6599999999999999 112.764 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 67.85 55.62 0.58 Allowed 'General case' 0 N--CA 1.513 2.72 0 C-N-CA 125.724 1.61 . . . . 1.8899999999999999 113.142 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -157.68 -39.15 0.07 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.617 -1.174 . . . . 2.5600000000000001 109.44 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -108.06 83.24 1.76 Allowed 'General case' 0 C--N 1.361 1.097 0 N-CA-C 108.03 -1.1 . . . . 2.7599999999999998 108.03 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.41 130.45 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 114.419 -1.264 . . . . 0.68999999999999995 111.539 -176.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -108.02 170.53 7.94 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.331 1.604 . . . . 0.69999999999999996 115.331 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -119.85 136.65 54.4 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.236 -0.893 . . . . 1.3300000000000001 110.846 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.38 127.89 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.471 0 N-CA-C 109.58 -0.526 . . . . 0.47999999999999998 109.58 -178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 53.9 mtt180 -128.58 153.32 47.35 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.708 1.744 . . . . 1.6899999999999999 115.708 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.7 OUTLIER -129.73 112.32 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-N 115.545 -0.752 . . . . 0.59999999999999998 112.758 176.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.505 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 63.39 27.05 15.18 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 126.864 2.066 . . . . 1.1200000000000001 114.157 -178.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.31 -19.35 40.13 Favored Glycine 0 CA--C 1.548 2.136 0 C-N-CA 121.463 -0.399 . . . . 0.32000000000000001 113.8 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.481 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 86.7 m-70 -83.79 156.91 22.28 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.654 1.582 . . . . 0.56999999999999995 114.454 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.49 131.29 53.84 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.375 0.607 . . . . 0.55000000000000004 111.094 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.2 -57.86 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 115.129 -0.942 . . . . 1.0600000000000001 113.104 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.74 90.02 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.713 -0.847 . . . . 0.44 108.713 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -109.37 77.85 1.09 Allowed 'General case' 0 C--N 1.351 0.636 0 CA-C-O 122.835 1.303 . . . . 2.2999999999999998 111.985 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 152.34 65.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 128.523 2.729 . . . . 2.48 107.868 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.0 tp -105.17 99.35 8.96 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 113.782 1.03 . . . . 1.1299999999999999 113.782 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -113.32 107.05 15.35 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 113.24 -1.8 . . . . 2.3500000000000001 108.042 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.13 -33.25 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 114.542 1.312 . . . . 0.68000000000000005 114.542 -177.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -75.13 -36.1 61.64 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 123.376 0.671 . . . . 0.77000000000000002 112.242 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -74.71 -27.46 60.39 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 124.436 1.094 . . . . 0.91000000000000003 113.27 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.69 -56.93 4.17 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.163 0.801 . . . . 2.4300000000000002 113.163 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.9 -40.68 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 113.753 1.019 . . . . 0.93000000000000005 113.753 177.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.45 -64.09 0.3 Allowed Glycine 0 C--N 1.361 1.935 0 N-CA-C 114.353 0.501 . . . . 0.84999999999999998 114.353 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -103.26 174.2 5.97 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.316 1.046 . . . . 3.1800000000000002 111.634 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -73.35 89.86 1.63 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 123.543 0.737 . . . . 2.0800000000000001 112.249 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 51' ' ' LEU . 40.8 p -141.02 -146.25 0.19 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.115 0.966 . . . . 0.62 109.209 -176.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.534 ' HB2' HG23 ' A' ' 50' ' ' ILE . . . -113.94 134.8 54.6 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 113.475 0.917 . . . . 0.46000000000000002 113.475 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.491 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 10.4 t60 -110.75 145.79 37.47 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.884 0.474 . . . . 0.38 109.77 177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -145.33 143.97 30.46 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.881 1.067 . . . . 2.5 113.881 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -137.43 125.71 23.21 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 114.293 -1.321 . . . . 1.5600000000000001 110.471 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.45 121.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 114.896 -1.047 . . . . 0.45000000000000001 110.768 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.98 99.45 15.05 Favored Pre-proline 0 CA--C 1.571 1.759 0 CA-C-O 119.009 -0.52 . . . . 0.83999999999999997 112.208 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -74.7 143.95 30.8 Favored 'Trans proline' 0 C--N 1.4 3.277 0 C-N-CA 123.052 2.501 . . . . 0.16 114.326 176.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -124.28 149.25 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 124.023 0.929 . . . . 0.38 110.423 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.6 p -132.48 111.37 11.21 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.924 -0.58 . . . . 1.3100000000000001 112.349 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.4 mt -112.01 122.67 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 N-CA-C 108.492 -0.929 . . . . 0.25 108.492 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -142.56 130.09 21.32 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.66 -0.7 . . . . 2.0499999999999998 110.873 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt 69.38 10.14 7.61 Favored 'General case' 0 N--CA 1.518 2.963 0 N-CA-C 114.677 1.362 . . . . 3.5499999999999998 114.677 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.66 18.45 23.11 Favored Glycine 0 CA--C 1.548 2.108 0 C-N-CA 123.738 0.685 . . . . 0.37 114.384 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 95.4 mttt -128.25 151.09 49.69 Favored 'General case' 0 C--N 1.367 1.337 0 CA-C-N 117.978 0.889 . . . . 1.5600000000000001 112.799 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.75 144.9 30.5 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.811 1.041 . . . . 0.34000000000000002 113.811 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.1 m -134.35 114.09 12.6 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.783 -1.099 . . . . 0.64000000000000001 110.712 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.274 0.8 OUTLIER -114.54 96.12 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.568 0 CA-C-O 121.304 0.573 . . . . 0.46000000000000002 110.434 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 68.24 -85.34 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 125.41 1.484 . . . . 1.5600000000000001 113.594 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.08 26.74 4.16 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 115.969 -0.559 . . . . 0.48999999999999999 113.405 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -129.21 127.98 42.39 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.497 0.719 . . . . 1.8200000000000001 110.453 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.0 p -113.39 130.75 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.315 0 CA-C-O 121.649 0.738 . . . . 1.02 111.772 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 m -148.65 178.58 8.51 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.946 -1.025 . . . . 0.56000000000000005 109.735 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.27 13.4 t -103.34 137.61 41.22 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 113.366 0.876 . . . . 1.25 113.366 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -84.14 123.44 30.08 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.243 1.017 . . . . 0.28999999999999998 111.597 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.2 90.82 3.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.476 0.547 . . . . 1.4199999999999999 112.476 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.28 -64.64 3.15 Favored Glycine 0 C--N 1.359 1.816 0 N-CA-C 118.847 2.299 . . . . 0.41999999999999998 118.847 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.517 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -129.75 158.03 40.52 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.442 1.275 . . . . 1.1000000000000001 114.442 -176.246 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.517 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -106.98 138.97 42.13 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 113.285 -1.779 . . . . 0.67000000000000004 109.269 177.032 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 t -121.23 143.97 48.86 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.567 1.692 . . . . 0.35999999999999999 115.567 -177.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.421 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -116.26 98.2 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.308 -1.367 . . . . 0.73999999999999999 107.308 175.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -118.29 124.91 48.97 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.334 0.588 . . . . 1.6699999999999999 112.407 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.0 133.39 56.07 Favored 'General case' 0 C--O 1.252 1.211 0 CA-C-O 122.22 1.009 . . . . 1.8 111.482 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.4 t -106.36 143.91 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 113.094 -1.867 . . . . 0.57999999999999996 110.442 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.489 ' HD3' ' H ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -85.64 150.53 24.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.539 1.311 . . . . 2.1800000000000002 114.539 -178.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.93 -51.78 0.99 Allowed Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.055 -0.975 . . . . 1.02 113.928 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -129.49 -84.46 0.55 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.912 0.356 . . . . 2.8599999999999999 111.739 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.508 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 0.4 OUTLIER -140.64 122.7 15.64 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.984 0.514 . . . . 3.9100000000000001 110.224 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 0.9 OUTLIER 85.54 114.94 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 C-N-CA 124.975 1.31 . . . . 1.74 111.064 -177.862 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -82.32 -172.26 0.35 Allowed Pre-proline 0 CA--C 1.574 1.876 0 C-N-CA 124.536 1.134 . . . . 1.6799999999999999 110.464 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -61.64 101.06 0.2 Allowed 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 122.247 1.965 . . . . 2.0600000000000001 111.994 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -59.56 -49.42 77.83 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.199 1.926 . . . . 3.0 116.199 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 64' ' ' GLU . 25.8 t -108.43 131.88 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.777 -0.823 . . . . 0.80000000000000004 108.777 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.4 t -136.88 124.18 21.89 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.639 -1.164 . . . . 0.87 112.094 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.267 . . -119.84 48.32 1.57 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.897 1.814 . . . . 0.34000000000000002 115.897 -177.235 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.83 135.53 2.28 Favored 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.489 2.033 . . . . 0.69999999999999996 116.489 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -152.43 106.42 3.12 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.376 -0.829 . . . . 0.20999999999999999 110.974 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.429 HD12 HD12 ' A' ' 85' ' ' LEU 0.294 9.9 tt -115.72 122.68 69.96 Favored 'Isoleucine or valine' 0 C--O 1.27 2.15 0 CA-C-O 122.16 0.981 . . . . 0.31 111.147 175.689 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -120.42 167.83 11.94 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.322 -1.308 . . . . 0.44 111.859 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -118.58 145.63 45.23 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 117.813 2.523 . . . . 1.26 117.813 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.42 -40.99 2.28 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 110.672 -2.967 . . . . 0.17000000000000001 120.151 172.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.71 160.92 2.0 Favored 'General case' 0 N--CA 1.518 2.932 0 CA-C-N 121.265 2.533 . . . . 0.14999999999999999 113.587 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.37 -10.06 59.75 Favored 'General case' 0 CA--C 1.583 2.212 0 C-N-CA 124.994 1.318 . . . . 0.17000000000000001 114.126 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.1 1.64 52.31 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.234 1.198 . . . . 0.55000000000000004 114.234 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.606 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -107.05 -10.84 15.8 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.467 0.914 . . . . 0.59999999999999998 113.467 179.46 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.0 93.35 0.53 Allowed Pre-proline 0 N--CA 1.507 2.379 0 C-N-CA 124.119 0.968 . . . . 0.94999999999999996 112.424 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 68.7 Cg_endo -92.75 144.56 2.44 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 122.673 2.249 . . . . 1.8 114.428 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 24.1 mmt -129.38 122.16 28.9 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.825 -0.625 . . . . 4.96 111.785 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -118.28 179.64 4.05 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.985 0.898 . . . . 4.0 112.54 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -105.91 155.97 37.44 Favored Pre-proline 0 CA--C 1.558 1.276 0 CA-C-N 114.91 -1.041 . . . . 6.2699999999999996 110.539 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.96 120.45 7.35 Favored 'Trans proline' 0 C--N 1.393 2.877 0 C-N-CA 122.227 1.951 . . . . 6.5899999999999999 115.041 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -137.71 137.26 21.33 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-N 114.807 -1.088 . . . . 5.5099999999999998 111.53 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -84.08 -152.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.639 0 C-N-CA 123.363 2.709 . . . . 6.7699999999999996 113.326 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 166.96 -126.88 1.5 Allowed Glycine 0 C--N 1.341 0.861 0 C-N-CA 120.379 -0.915 . . . . 7.0199999999999996 114.229 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.2 mt -118.21 108.55 15.29 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.18 -0.51 . . . . 8.9900000000000002 111.744 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.334 -0.841 . . . . 10.6 111.017 179.967 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.486 -0.246 . . . . 8.9299999999999997 112.486 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.77 -37.7 5.58 Favored 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 112.969 0.729 . . . . 6.8200000000000003 112.969 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -129.22 106.24 8.7 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 122.624 0.37 . . . . 7.6399999999999997 111.06 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.4 m -133.7 -67.86 0.59 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.965 -0.561 . . . . 3.8599999999999999 112.403 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.62 95.25 0.1 OUTLIER Glycine 0 C--N 1.348 1.231 0 C-N-CA 121.312 -0.471 . . . . 1.1100000000000001 113.271 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.525 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.9 tp -87.86 -48.72 7.59 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 123.895 0.878 . . . . 0.34999999999999998 113.036 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.28 -22.91 63.68 Favored 'General case' 0 N--CA 1.508 2.462 0 C-N-CA 125.925 1.69 . . . . 0.20000000000000001 115.249 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -11.53 51.11 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 113.792 1.034 . . . . 0.32000000000000001 113.792 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -108.9 -19.37 13.42 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 113.728 1.01 . . . . 1.73 113.728 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.41 138.26 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 N-CA-C 115.142 1.534 . . . . 0.11 115.142 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -122.32 -30.33 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 115.717 -0.674 . . . . 0.16 112.44 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -162.02 116.29 1.88 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 120.815 0.34 . . . . 0.54000000000000004 111.07 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.07 135.57 35.95 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.397 -0.815 . . . . 0.19 111.526 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.269 5.3 p -148.17 146.15 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 N-CA-C 114.571 1.323 . . . . 1.05 114.571 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.623 ' HB2' HD12 ' A' ' 60' ' ' LEU . 1.9 t-20 -116.9 107.91 15.17 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.168 -1.378 . . . . 2.1099999999999999 108.145 175.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . . . -76.6 102.11 5.98 Favored 'General case' 0 C--O 1.268 2.078 0 CA-C-O 122.246 1.022 . . . . 0.63 111.668 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.496 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 153.98 -1.66 0.22 Allowed Glycine 0 C--N 1.353 1.5 0 CA-C-N 111.561 -2.563 . . . . 0.70999999999999996 115.998 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.51 -141.43 3.13 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 118.91 1.355 . . . . 0.80000000000000004 114.705 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -147.25 116.67 7.01 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 112.485 0.55 . . . . 1.6299999999999999 112.485 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 2.3 m 35.54 123.18 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.877 0 N-CA-C 121.087 3.736 . . . . 1.0 121.087 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.439 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 38.4 t60 -154.2 150.21 27.85 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.662 0.744 . . . . 0.45000000000000001 111.768 175.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.56 128.22 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 115.361 -0.836 . . . . 1.3899999999999999 111.71 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -85.73 153.36 22.38 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 113.994 -1.457 . . . . 1.8500000000000001 110.157 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.1 m -44.04 -22.77 0.15 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 118.956 2.947 . . . . 0.71999999999999997 118.956 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -94.19 -21.55 18.99 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 123.004 0.522 . . . . 0.51000000000000001 111.103 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.58 39.21 1.12 Allowed Glycine 0 C--N 1.353 1.501 0 C-N-CA 124.4 1.0 . . . . 0.34000000000000002 114.43 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.525 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.9 mm -105.98 119.68 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 109.239 -0.652 . . . . 0.55000000000000004 109.239 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -100.66 130.92 46.77 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.179 1.177 . . . . 1.3400000000000001 114.179 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.662 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -96.33 140.45 30.98 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.985 -1.007 . . . . 2.79 110.604 177.398 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -83.6 176.42 9.02 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 115.856 1.798 . . . . 3.0 115.856 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -107.53 96.97 6.78 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.83 1.789 . . . . 2.2999999999999998 115.83 -175.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.7 ' HB3' ' O ' ' A' ' 37' ' ' ARG . 0.4 OUTLIER 46.95 58.6 17.02 Favored Pre-proline 0 N--CA 1.52 3.036 0 N-CA-C 117.701 2.482 . . . . 1.1699999999999999 117.701 175.678 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -107.73 56.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.654 0 C-N-CA 122.62 2.213 . . . . 1.45 115.93 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.73 -87.35 0.33 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 116.718 -0.219 . . . . 1.9099999999999999 111.171 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 12.6 pt-20 -156.6 88.51 1.06 Allowed 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.107 1.151 . . . . 4.8399999999999999 114.107 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.3 58.26 Favored Glycine 0 CA--C 1.541 1.717 0 N-CA-C 116.362 1.305 . . . . 2.3700000000000001 116.362 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.7 ' O ' ' HB3' ' A' ' 32' ' ' ASP . 4.2 ptp180 -122.81 84.4 2.26 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 117.622 0.711 . . . . 4.5 112.828 -175.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.77 114.3 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.156 0.503 . . . . 2.7000000000000002 111.761 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.25 46.82 3.72 Favored Glycine 0 CA--C 1.544 1.878 0 N-CA-C 115.569 0.988 . . . . 1.95 115.569 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -157.58 118.92 3.61 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.862 0.831 . . . . 5.3399999999999999 112.188 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.26 129.74 54.84 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.689 0.796 . . . . 1.6399999999999999 110.846 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.4 p -115.1 82.62 1.77 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.582 0.706 . . . . 1.5700000000000001 112.062 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -116.56 97.28 5.92 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.094 -0.957 . . . . 2.3300000000000001 110.253 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -102.73 69.15 1.06 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.431 0.634 . . . . 3.1600000000000001 111.508 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.08 93.86 1.06 Allowed Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.291 -0.868 . . . . 1.52 112.956 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.0 mtt -92.4 0.99 57.49 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.22 0.822 . . . . 1.6699999999999999 113.22 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 27.25 3.64 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 114.366 1.247 . . . . 4.1799999999999997 114.366 -178.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.27 67.93 61.61 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 107.434 -1.321 . . . . 2.6299999999999999 107.434 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -77.11 178.03 8.14 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 123.746 2.964 . . . . 1.3700000000000001 116.053 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.257 1.1 mp -97.18 136.9 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.23 0 CA-C-N 114.6 -1.182 . . . . 0.68999999999999995 109.726 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.56 ' HB2' HG22 ' A' ' 125' ' ' THR . 5.7 mt -89.73 -12.27 39.89 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 116.381 1.993 . . . . 1.28 116.381 -177.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -100.48 15.86 26.53 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.87 1.063 . . . . 1.51 113.87 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -132.62 -165.46 1.6 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.29 0.636 . . . . 1.0900000000000001 111.433 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.18 174.09 3.68 Favored Pre-proline 0 N--CA 1.505 2.31 0 C-N-CA 123.087 0.555 . . . . 1.27 111.583 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -70.2 -28.14 23.51 Favored 'Trans proline' 0 C--N 1.401 3.32 0 C-N-CA 123.164 2.576 . . . . 0.94999999999999996 113.797 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.05 -37.22 19.12 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.954 0.902 . . . . 2.04 112.712 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.0 8.78 42.77 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.171 1.175 . . . . 1.6200000000000001 114.171 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -72.75 -26.21 61.47 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 123.751 0.82 . . . . 1.77 110.606 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.1 t -68.86 -50.55 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 C-N-CA 126.458 1.903 . . . . 0.81000000000000005 108.226 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' A' ' 15' ' ' ASN . 7.9 tp -74.39 -9.67 58.82 Favored 'General case' 0 C--N 1.383 2.047 0 N-CA-C 114.013 1.116 . . . . 1.1499999999999999 114.013 176.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -108.08 1.08 22.1 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.336 0.655 . . . . 0.92000000000000004 110.854 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -128.26 -115.0 0.26 Allowed 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.395 1.078 . . . . 1.3300000000000001 110.849 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.2 p 35.32 134.16 0.0 OUTLIER 'General case' 1 N--CA 1.56 5.06 0 C-N-CA 128.342 2.657 . . . . 1.28 117.928 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.5 ' HB3' HG12 ' A' ' 167' ' ' VAL . 5.8 pt-20 -113.39 132.95 55.42 Favored 'General case' 0 N--CA 1.516 2.873 0 N-CA-C 116.974 2.213 . . . . 1.53 116.974 -176.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 16' ' ' ALA . 7.5 ttm180 -123.79 95.77 4.7 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.679 -1.23 . . . . 3.2200000000000002 107.679 175.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -106.46 138.6 42.35 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.94 1.089 . . . . 3.6600000000000001 113.94 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -120.52 -87.72 0.63 Allowed 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 114.971 -1.013 . . . . 4.7000000000000002 110.747 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -164.9 -57.35 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 113.751 1.019 . . . . 2.5499999999999998 113.751 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -170.65 125.0 0.7 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.866 0.466 . . . . 2.1499999999999999 111.839 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 t 66.67 83.7 0.16 Allowed 'General case' 0 N--CA 1.506 2.331 0 C-N-CA 124.907 1.283 . . . . 0.77000000000000002 113.006 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -141.92 138.5 32.07 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 121.605 0.717 . . . . 0.81000000000000005 111.929 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.69 -167.63 15.7 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.603 1.401 . . . . 0.46999999999999997 116.603 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.1 172.27 8.68 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 113.499 -1.351 . . . . 0.89000000000000001 113.986 -177.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -128.22 134.14 48.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.399 -1.273 . . . . 0.51000000000000001 112.219 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.32 103.54 22.7 Favored Pre-proline 0 CA--C 1.567 1.607 0 C-N-CA 123.326 0.65 . . . . 0.14999999999999999 109.499 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -84.57 120.1 2.38 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.233 1.955 . . . . 0.14999999999999999 114.783 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.84 160.16 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 CA-C-O 121.977 0.894 . . . . 0.19 111.232 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -149.3 24.05 0.91 Allowed 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 114.748 -1.115 . . . . 2.5299999999999998 111.867 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -130.09 161.66 30.54 Favored 'General case' 0 C--N 1.364 1.238 0 CA-C-O 121.296 0.57 . . . . 2.1200000000000001 111.5 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -120.34 144.33 47.91 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.799 1.037 . . . . 0.41999999999999998 113.799 -178.821 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.29 -139.53 6.08 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 114.117 -1.401 . . . . 0.23000000000000001 112.596 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 80.9 mm-40 -113.65 105.0 12.8 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-N 118.092 0.946 . . . . 1.75 110.963 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -99.52 128.27 45.62 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.124 0.488 . . . . 0.20999999999999999 110.895 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -112.34 123.66 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.346 0.593 . . . . 0.20000000000000001 110.755 -176.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.417 HD12 HD12 ' A' ' 172' ' ' ILE . 2.5 tt -110.27 108.38 18.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.923 -1.035 . . . . 0.78000000000000003 110.069 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.25 132.26 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 114.199 -1.364 . . . . 0.44 108.557 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.21 140.79 47.73 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 115.514 -0.766 . . . . 1.25 112.394 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 15.4 tptt -104.01 113.33 26.8 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.043 -0.98 . . . . 2.52 109.657 177.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 11.4 m-85 -106.84 134.68 49.61 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.685 -0.689 . . . . 0.40000000000000002 111.146 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.76 148.05 38.34 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.4 0.619 . . . . 0.40999999999999998 111.24 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -132.36 117.9 18.71 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 116.171 -0.468 . . . . 2.6099999999999999 111.228 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.08 69.02 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 116.179 -0.464 . . . . 2.1299999999999999 112.048 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.39 -49.11 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.899 0.479 . . . . 2.27 111.995 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -123.14 129.64 51.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.711 0.404 . . . . 1.46 111.143 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.83 105.46 15.5 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 122.194 0.997 . . . . 0.83999999999999997 112.421 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -162.69 144.82 10.58 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.009 -0.996 . . . . 2.4500000000000002 112.179 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.9 m -122.8 125.68 45.94 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.495 -0.775 . . . . 1.6599999999999999 112.595 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 70.48 49.75 0.41 Allowed 'General case' 0 N--CA 1.515 2.777 0 C-N-CA 125.553 1.541 . . . . 1.8899999999999999 112.473 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -148.66 -45.72 0.15 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.679 1.192 . . . . 2.5600000000000001 109.565 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.98 87.54 2.53 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.679 -0.86 . . . . 2.7599999999999998 108.679 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.93 120.81 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 114.048 -1.433 . . . . 0.68999999999999995 110.743 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.52 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 45.5 m-85 -101.02 177.37 4.97 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.417 1.636 . . . . 0.69999999999999996 115.417 -175.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -128.21 136.9 51.71 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.214 0.531 . . . . 1.3300000000000001 111.483 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.95 126.09 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.448 0 CA-C-N 115.689 -0.687 . . . . 0.47999999999999998 109.994 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -132.43 151.34 51.92 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.083 1.512 . . . . 1.6899999999999999 115.083 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 154' ' ' SER . 1.2 m -125.08 113.32 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 C-N-CA 124.357 1.063 . . . . 0.59999999999999998 112.754 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.539 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 64.69 25.85 13.08 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 126.69 1.996 . . . . 1.1200000000000001 113.614 -178.326 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.99 -3.63 60.52 Favored Glycine 0 CA--C 1.555 2.577 0 CA-C-N 116.168 -0.469 . . . . 0.32000000000000001 114.099 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 86.0 m-70 -99.56 139.61 34.96 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 125.65 1.58 . . . . 0.56999999999999995 112.951 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.33 130.51 40.61 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.879 0.847 . . . . 0.55000000000000004 113.075 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.09 -56.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 114.0 -1.454 . . . . 1.0600000000000001 112.606 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.43 88.6 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.242 -1.022 . . . . 0.44 108.242 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -109.17 95.1 5.41 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 123.094 1.426 . . . . 2.2999999999999998 111.964 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 127.96 71.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 129.619 3.168 . . . . 2.48 107.865 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.26 103.41 15.26 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-O 121.863 0.839 . . . . 1.1299999999999999 112.481 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -111.59 94.71 5.1 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 113.538 -1.664 . . . . 2.3500000000000001 107.647 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -63.52 -28.73 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.496 0 C-N-CA 125.046 1.339 . . . . 0.68000000000000005 114.465 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -77.69 -37.08 50.42 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.31 0.644 . . . . 0.77000000000000002 112.469 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -74.45 -27.13 60.46 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 124.594 1.158 . . . . 0.91000000000000003 113.836 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -86.65 -50.57 6.7 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.455 0.909 . . . . 2.4300000000000002 113.455 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.282 1.4 p -91.53 -38.76 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.966 0 N-CA-C 113.383 0.883 . . . . 0.93000000000000005 113.383 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.37 -78.81 0.25 Allowed Glycine 0 C--N 1.36 1.883 0 CA-C-N 118.444 0.566 . . . . 0.84999999999999998 114.497 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -102.92 174.75 5.73 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.1 0.96 . . . . 3.1800000000000002 112.507 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.7 m -74.18 81.14 1.79 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.723 1.009 . . . . 2.0800000000000001 113.723 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.56 HG22 ' HB2' ' A' ' 51' ' ' LEU . 34.9 p -133.01 -137.49 0.18 Allowed 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 114.441 -1.254 . . . . 0.62 109.032 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -115.01 131.55 56.89 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.046 0.758 . . . . 0.46000000000000002 113.046 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 18.8 t60 -105.48 147.93 27.77 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.446 -0.576 . . . . 0.38 109.446 176.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -142.49 129.86 21.14 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.663 1.357 . . . . 2.5 114.663 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -123.77 123.92 41.55 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.737 -1.12 . . . . 1.5600000000000001 110.661 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.49 120.88 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-N 114.488 -1.233 . . . . 0.45000000000000001 110.899 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.62 99.99 15.22 Favored Pre-proline 0 CA--C 1.569 1.702 0 CA-C-O 119.024 -0.512 . . . . 0.83999999999999997 111.976 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -75.05 142.6 27.89 Favored 'Trans proline' 0 C--N 1.398 3.177 0 C-N-CA 123.082 2.521 . . . . 0.16 114.2 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.17 149.48 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 CA-C-N 115.125 -0.943 . . . . 0.38 109.971 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.9 t -136.0 117.16 14.44 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.502 0.668 . . . . 1.3100000000000001 111.365 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.4 mt -113.93 125.5 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 CA-C-N 114.713 -1.131 . . . . 0.25 108.286 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -138.97 124.33 19.25 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.599 -0.728 . . . . 2.0499999999999998 110.567 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 67.61 17.1 9.93 Favored 'General case' 0 N--CA 1.517 2.902 0 C-N-CA 125.341 1.456 . . . . 3.5499999999999998 114.121 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.51 13.18 45.48 Favored Glycine 0 CA--C 1.547 2.038 0 CA-C-O 119.203 -0.776 . . . . 0.37 114.936 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 52.8 mtpt -122.03 147.44 46.08 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-N 118.378 1.089 . . . . 1.5600000000000001 112.656 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.99 145.31 29.45 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.46 1.281 . . . . 0.34000000000000002 114.46 -175.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.83 114.32 10.34 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.689 -1.142 . . . . 0.64000000000000001 109.987 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.262 9.9 p -119.36 95.82 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.446 0 CA-C-O 121.287 0.565 . . . . 0.46000000000000002 111.357 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 67.88 -85.47 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 125.646 1.578 . . . . 1.5600000000000001 113.757 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.25 25.32 5.75 Favored Glycine 0 CA--C 1.543 1.813 0 CA-C-N 116.005 -0.543 . . . . 0.48999999999999999 112.999 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -125.27 141.18 52.24 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.856 0.862 . . . . 1.8200000000000001 111.376 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.6 p -130.7 124.85 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.132 0 CA-C-N 115.669 -0.696 . . . . 1.02 110.896 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -150.69 179.86 7.84 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.247 -0.888 . . . . 0.56000000000000005 109.848 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.269 15.2 t -103.93 137.65 41.62 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 113.203 0.816 . . . . 1.25 113.203 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -81.82 122.9 28.29 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.112 0.965 . . . . 0.28999999999999998 111.66 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.95 91.4 3.2 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.707 0.632 . . . . 1.4199999999999999 112.707 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.58 -65.33 3.45 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 118.79 2.276 . . . . 0.41999999999999998 118.79 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.53 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -132.44 158.45 42.0 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.143 1.164 . . . . 1.1000000000000001 114.143 -176.343 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.539 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -108.26 138.83 43.88 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.242 -1.799 . . . . 0.67000000000000004 109.097 176.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.6 t -120.5 143.11 48.72 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.301 1.593 . . . . 0.35999999999999999 115.301 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.62 99.42 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.348 -0.982 . . . . 0.73999999999999999 108.348 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.79 128.37 56.38 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.631 -0.713 . . . . 1.6699999999999999 112.847 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -118.79 125.81 50.43 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-O 122.198 0.999 . . . . 1.8 111.103 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.32 144.08 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 113.323 -1.762 . . . . 0.57999999999999996 110.699 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.29 150.28 21.13 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 113.102 0.778 . . . . 2.1800000000000002 113.102 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.69 -32.97 6.31 Favored Glycine 0 CA--C 1.547 2.053 0 N-CA-C 115.937 1.135 . . . . 1.02 115.937 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -123.5 -78.63 0.6 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.977 0.889 . . . . 2.8599999999999999 112.412 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -133.16 -44.35 0.85 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.113 0.565 . . . . 3.9100000000000001 112.132 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.52 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -94.88 158.08 15.64 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.462 1.105 . . . . 1.74 112.447 179.383 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.74 -166.58 0.1 OUTLIER Pre-proline 0 CA--C 1.576 1.97 0 CA-C-N 113.679 -1.601 . . . . 1.6799999999999999 108.334 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -62.51 -9.78 16.88 Favored 'Trans proline' 0 N--CA 1.523 3.217 0 CA-C-N 123.277 2.206 . . . . 2.0600000000000001 115.85 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.6 tttp 79.65 -76.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.639 1.976 . . . . 3.0 114.013 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' A' ' 64' ' ' GLU 0.259 3.8 m -108.4 135.24 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-N 119.678 1.126 . . . . 0.80000000000000004 111.278 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.437 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.5 t -127.8 132.06 49.52 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 113.105 0.78 . . . . 0.87 113.105 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -119.45 49.83 1.31 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.212 2.301 . . . . 0.34000000000000002 117.212 -175.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.27 138.81 2.9 Favored 'General case' 0 N--CA 1.518 2.965 0 N-CA-C 117.039 2.237 . . . . 0.69999999999999996 117.039 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -154.69 101.99 2.35 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.476 -0.784 . . . . 0.20999999999999999 111.038 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.417 HD12 HD12 ' A' ' 85' ' ' LEU 0.32 9.0 tt -111.97 121.7 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 CA-C-O 122.456 1.122 . . . . 0.31 111.369 175.554 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -124.12 164.27 19.79 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.017 -1.447 . . . . 0.44 110.74 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -121.73 159.21 27.09 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 118.225 2.676 . . . . 1.26 118.225 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.85 -41.48 2.14 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-N 110.043 -3.253 . . . . 0.17000000000000001 118.998 174.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -177.44 154.73 1.03 Allowed 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 120.673 2.236 . . . . 0.14999999999999999 113.425 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.14 -12.48 59.22 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 125.053 1.341 . . . . 0.17000000000000001 113.896 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.22 4.9 44.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.959 1.096 . . . . 0.55000000000000004 113.959 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.82 -16.22 14.37 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 114.065 1.135 . . . . 0.59999999999999998 114.065 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.75 149.39 74.23 Favored Pre-proline 0 CA--C 1.581 2.146 0 C-N-CA 124.108 0.963 . . . . 0.94999999999999996 112.851 178.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.64 119.53 6.71 Favored 'Trans proline' 0 N--CA 1.521 3.093 0 C-N-CA 125.133 3.889 . . . . 1.8 116.334 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 21.2 mmt -141.92 102.71 4.2 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.788 -0.642 . . . . 4.96 110.819 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.0 mt -136.73 171.66 14.16 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 122.114 0.959 . . . . 4.0 112.941 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -106.28 158.04 33.51 Favored Pre-proline 0 CA--C 1.559 1.292 0 CA-C-N 114.497 -1.229 . . . . 6.2699999999999996 110.71 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.56 121.85 8.98 Favored 'Trans proline' 0 C--N 1.394 2.937 0 C-N-CA 122.607 2.204 . . . . 6.5899999999999999 115.23 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -136.33 136.86 23.03 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-N 114.993 -1.003 . . . . 5.5099999999999998 111.483 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -84.5 -154.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 123.399 2.733 . . . . 6.7699999999999996 113.779 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 166.15 -129.75 2.0 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 120.82 -0.705 . . . . 7.0199999999999996 113.908 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.2 mt -118.52 112.66 20.2 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.83 0.452 . . . . 8.9900000000000002 111.656 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.351 -0.833 . . . . 10.6 111.173 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.522 -0.231 . . . . 8.9299999999999997 112.522 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.84 129.38 55.88 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.545 0.688 . . . . 6.8200000000000003 111.875 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 41.7 mtm -134.61 114.38 12.7 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.684 -0.689 . . . . 7.6399999999999997 111.635 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -141.89 115.87 9.3 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.856 -0.611 . . . . 3.8599999999999999 111.629 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.01 89.41 0.07 OUTLIER Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.923 -0.581 . . . . 1.1100000000000001 113.204 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.447 ' HG ' HD11 ' A' ' 27' ' ' ILE . 19.3 tp -88.31 -44.34 10.88 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 113.356 0.872 . . . . 0.34999999999999998 113.356 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.17 -23.38 62.16 Favored 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 125.863 1.665 . . . . 0.20000000000000001 115.087 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.72 -10.35 53.87 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 113.668 0.988 . . . . 0.32000000000000001 113.668 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -106.07 -22.02 12.98 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.315 0.858 . . . . 1.73 113.315 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -53.21 135.65 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 N-CA-C 115.288 1.588 . . . . 0.11 115.288 177.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.6 -31.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-N 115.335 -0.848 . . . . 0.16 112.161 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -159.33 117.46 2.81 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.888 0.475 . . . . 0.54000000000000004 110.751 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.86 128.96 20.87 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.482 -0.761 . . . . 0.19 112.15 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.76 138.68 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 CA-C-O 122.331 1.062 . . . . 1.05 113.183 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -116.17 102.56 9.7 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 113.373 -1.74 . . . . 2.1099999999999999 106.725 171.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.87 103.87 5.26 Favored 'General case' 0 C--O 1.254 1.34 0 CA-C-O 122.21 1.005 . . . . 0.63 111.363 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 172.54 -57.22 0.16 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 113.153 -1.84 . . . . 0.70999999999999996 114.937 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.95 -121.96 5.0 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 119.773 -0.459 . . . . 0.80000000000000004 113.506 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -165.05 117.81 1.21 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.598 0.759 . . . . 1.6299999999999999 110.809 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 49.35 110.14 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.959 0 N-CA-C 118.406 2.743 . . . . 1.0 118.406 178.045 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.494 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 70.3 t60 -140.95 132.46 26.96 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.026 0.751 . . . . 0.45000000000000001 113.026 177.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.272 9.8 p -105.95 116.04 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.881 0 CA-C-N 115.178 -0.919 . . . . 1.3899999999999999 109.531 176.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -87.62 160.94 17.97 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 114.684 -1.143 . . . . 1.8500000000000001 112.577 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -43.17 -32.05 0.55 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 N-CA-C 119.163 3.023 . . . . 0.71999999999999997 119.163 -175.589 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -88.37 -19.66 26.33 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 121.227 0.537 . . . . 0.51000000000000001 111.474 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.61 40.13 1.25 Allowed Glycine 0 C--N 1.354 1.551 0 C-N-CA 124.722 1.153 . . . . 0.34000000000000002 114.009 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.447 HD11 ' HG ' ' A' ' 6' ' ' LEU . 14.7 mm -106.84 114.49 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-O 121.124 0.487 . . . . 0.55000000000000004 110.088 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.8 t-160 -104.45 132.63 50.49 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 115.587 1.699 . . . . 1.3400000000000001 115.587 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -92.84 143.83 25.88 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 114.733 -1.121 . . . . 2.79 108.135 174.259 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 78.7 mtp180 -62.42 -105.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 116.9 2.185 . . . . 3.0 116.9 -177.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 30' ' ' ARG . 7.0 ttmm 176.23 71.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.549 0.74 . . . . 2.2999999999999998 111.712 -177.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 56.98 61.68 6.47 Favored Pre-proline 0 N--CA 1.534 3.732 0 C-N-CA 124.196 0.998 . . . . 1.1699999999999999 113.677 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -92.69 16.62 1.33 Allowed 'Trans proline' 0 CA--C 1.56 1.776 0 N-CA-C 120.154 3.098 . . . . 1.45 120.154 -174.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.313 0.0 OUTLIER -126.56 -41.33 1.87 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 120.505 1.502 . . . . 1.9099999999999999 114.431 178.203 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -126.89 105.0 8.33 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-N 119.275 0.943 . . . . 4.8399999999999999 112.184 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.3 -32.77 6.24 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-N 114.09 -1.414 . . . . 2.3700000000000001 113.564 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 74.69 -59.83 0.54 Allowed 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 126.679 1.992 . . . . 4.5 114.716 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.08 117.32 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.176 0.59 . . . . 2.7000000000000002 110.562 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.61 -120.09 0.61 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 121.084 -0.579 . . . . 1.95 113.932 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -137.88 -177.36 4.78 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 121.889 0.852 . . . . 5.3399999999999999 112.771 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.09 133.38 40.43 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.207 1.003 . . . . 1.6399999999999999 111.99 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 m -110.37 110.68 21.56 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.525 -0.761 . . . . 1.5700000000000001 111.046 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.7 103.24 5.15 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.721 -0.672 . . . . 2.3300000000000001 111.347 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -106.47 73.73 0.98 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.893 0.854 . . . . 3.1600000000000001 110.236 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 122.51 73.35 0.29 Allowed Glycine 0 C--N 1.344 1.004 0 CA-C-N 114.284 -1.325 . . . . 1.52 110.457 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.33 -0.02 57.41 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 115.609 1.707 . . . . 1.6699999999999999 115.609 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -116.29 57.9 0.76 Allowed 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 121.883 0.849 . . . . 4.1799999999999997 111.196 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.31 73.28 9.17 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 114.222 -1.354 . . . . 2.6299999999999999 107.63 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -67.73 164.09 32.72 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 123.673 2.916 . . . . 1.3700000000000001 117.048 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.65 143.12 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.201 0 CA-C-N 115.041 -0.981 . . . . 0.68999999999999995 109.444 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.53 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.9 mm? -78.51 -23.52 46.26 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.463 1.653 . . . . 1.28 115.463 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -106.27 20.81 18.4 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.917 1.08 . . . . 1.51 113.917 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.5 p -124.57 175.97 6.83 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.057 0.932 . . . . 1.0900000000000001 112.913 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.624 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.2 m-20 -97.46 -174.8 0.4 Allowed Pre-proline 0 N--CA 1.507 2.377 0 N-CA-C 107.74 -1.208 . . . . 1.27 107.74 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -70.16 -40.25 4.89 Favored 'Trans proline' 0 N--CA 1.518 2.946 0 CA-C-N 123.165 2.166 . . . . 0.94999999999999996 111.871 174.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -69.94 -50.98 36.6 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.266 -1.788 . . . . 2.04 111.982 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -75.93 -8.48 57.02 Favored 'General case' 0 CA--C 1.588 2.439 0 CA-C-N 114.789 -1.096 . . . . 1.6200000000000001 112.81 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.624 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 27.0 tt0 -72.42 -46.32 55.65 Favored 'General case' 0 C--N 1.378 1.835 0 C-N-CA 125.204 1.402 . . . . 1.77 107.962 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.12 -41.68 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 C-N-CA 124.44 1.096 . . . . 0.81000000000000005 110.417 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.93 -11.48 60.0 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.428 1.27 . . . . 1.1499999999999999 114.428 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -124.82 20.43 8.44 Favored 'General case' 0 CA--C 1.575 1.906 0 C-N-CA 123.332 0.653 . . . . 0.92000000000000004 112.494 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.42 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -137.95 -27.82 0.89 Allowed 'General case' 0 N--CA 1.51 2.56 0 N-CA-C 115.876 1.806 . . . . 1.3300000000000001 115.876 -177.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.2 p -77.94 131.17 37.32 Favored 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 113.66 0.985 . . . . 1.28 113.66 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.419 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.6 pt-20 -118.3 140.28 50.06 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 115.5 1.667 . . . . 1.53 115.5 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -116.13 129.52 56.37 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.888 -1.051 . . . . 3.2200000000000002 111.495 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -125.56 131.44 52.74 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.117 -0.492 . . . . 3.6600000000000001 111.322 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -134.9 -73.87 0.47 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.285 0.846 . . . . 4.7000000000000002 113.285 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -134.96 -118.56 0.18 Allowed 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 113.124 0.787 . . . . 2.5499999999999998 113.124 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -155.01 129.0 8.77 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.911 0.885 . . . . 2.1499999999999999 110.407 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.701 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.1 OUTLIER 74.8 80.86 0.11 Allowed 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 125.397 1.479 . . . . 0.77000000000000002 109.895 -177.611 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -142.84 156.51 44.95 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.284 0.846 . . . . 0.81000000000000005 113.284 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.73 -161.16 12.48 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.28 -0.873 . . . . 0.46999999999999997 115.056 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.32 163.66 28.84 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.782 0.801 . . . . 0.89000000000000001 112.796 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -117.87 131.36 56.55 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.603 -1.18 . . . . 0.51000000000000001 112.791 -178.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -124.5 99.9 35.72 Favored Pre-proline 0 CA--C 1.566 1.588 0 C-N-CA 123.19 0.596 . . . . 0.14999999999999999 109.742 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.26 118.1 2.57 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.14 1.894 . . . . 0.14999999999999999 114.501 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.89 157.35 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 CA-C-O 122.063 0.935 . . . . 0.19 111.369 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -144.97 16.15 1.56 Allowed 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.538 -1.21 . . . . 2.5299999999999998 111.954 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -128.29 162.47 26.96 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-O 121.334 0.588 . . . . 2.1200000000000001 111.754 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -120.95 148.8 43.59 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.665 0.987 . . . . 0.41999999999999998 113.665 -179.298 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.85 -134.16 3.9 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 113.981 -1.463 . . . . 0.23000000000000001 111.839 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -121.99 106.66 11.42 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 118.335 1.067 . . . . 1.75 111.231 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.682 ' O ' HG13 ' A' ' 133' ' ' ILE . 36.2 m-85 -99.4 127.8 45.46 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.623 0.725 . . . . 0.20999999999999999 110.687 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.67 130.13 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 115.31 -0.859 . . . . 0.20000000000000001 111.848 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.476 ' HG ' HD12 ' A' ' 172' ' ' ILE . 2.6 mp -107.62 110.26 22.1 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.376 -1.283 . . . . 0.78000000000000003 110.325 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.8 105.52 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.601 -1.259 . . . . 0.44 107.601 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.18 134.97 53.41 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.896 -0.593 . . . . 1.25 112.314 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -104.31 116.01 31.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.806 0.813 . . . . 2.52 111.343 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.67 134.04 48.5 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.067 -1.424 . . . . 0.40000000000000002 110.256 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.97 153.52 45.63 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.745 -0.661 . . . . 0.40999999999999998 111.627 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -139.54 131.58 27.92 Favored 'General case' 0 C--N 1.363 1.175 0 CA-C-N 116.031 -0.532 . . . . 2.6099999999999999 112.221 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.541 ' H ' ' NZ ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -140.96 63.2 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 115.962 -0.563 . . . . 2.1299999999999999 111.75 179.213 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -162.65 -49.5 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.562 0.579 . . . . 2.27 112.562 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.79 130.84 56.92 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.051 0.453 . . . . 1.46 112.212 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.29 96.11 5.93 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.339 1.066 . . . . 0.83999999999999997 111.016 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -162.31 146.65 12.18 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.148 -0.933 . . . . 2.4500000000000002 112.21 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.1 p -122.19 121.22 36.35 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.481 -0.782 . . . . 1.6599999999999999 111.903 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 75.12 57.26 0.07 Allowed 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 125.893 1.677 . . . . 1.8899999999999999 112.543 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -156.71 -43.62 0.07 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.284 -1.326 . . . . 2.5600000000000001 108.983 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -105.41 83.89 2.02 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-O 121.794 0.807 . . . . 2.7599999999999998 108.98 176.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.06 129.95 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 114.754 -1.112 . . . . 0.68999999999999995 111.63 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -114.37 170.99 7.89 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.065 1.505 . . . . 0.69999999999999996 115.065 -176.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.37 137.73 54.76 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.359 0.6 . . . . 1.3300000000000001 112.337 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -134.18 129.27 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.406 0 CA-C-N 115.34 -0.846 . . . . 0.47999999999999998 110.236 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.64 147.92 51.49 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 114.536 1.31 . . . . 1.6899999999999999 114.536 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.79 110.27 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 C-N-CA 123.73 0.812 . . . . 0.59999999999999998 112.93 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.83 26.64 14.39 Favored 'General case' 0 N--CA 1.523 3.181 0 C-N-CA 126.614 1.966 . . . . 1.1200000000000001 113.618 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.93 -20.06 39.51 Favored Glycine 0 CA--C 1.547 2.07 0 CA-C-N 116.344 -0.389 . . . . 0.32000000000000001 113.676 -176.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -83.24 139.04 33.34 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.417 1.487 . . . . 0.56999999999999995 113.673 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.57 129.73 44.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.603 0.715 . . . . 0.55000000000000004 112.43 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.19 -54.41 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 114.501 -1.227 . . . . 1.0600000000000001 113.355 -178.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.57 88.87 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.878 -0.786 . . . . 0.44 108.878 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -112.29 75.57 0.93 Allowed 'General case' 0 C--N 1.356 0.853 0 CA-C-O 123.709 1.718 . . . . 2.2999999999999998 112.147 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 157.26 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 110.238 -3.165 . . . . 2.48 108.216 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.72 97.88 11.06 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 113.702 1.001 . . . . 1.1299999999999999 113.702 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -113.52 96.54 5.93 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 113.073 -1.876 . . . . 2.3500000000000001 107.509 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.22 -26.06 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.56 0 N-CA-C 114.632 1.345 . . . . 0.68000000000000005 114.632 -176.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -75.71 -39.8 56.75 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.576 0.75 . . . . 0.77000000000000002 112.003 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -74.03 -26.35 60.37 Favored 'General case' 0 CA--C 1.577 1.989 0 C-N-CA 124.776 1.23 . . . . 0.91000000000000003 113.17 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -77.98 -56.37 4.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.651 0.982 . . . . 2.4300000000000002 113.651 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.76 -37.21 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 114.541 1.311 . . . . 0.93000000000000005 114.541 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.76 -107.62 0.92 Allowed Glycine 0 C--N 1.354 1.528 0 CA-C-N 118.465 0.575 . . . . 0.84999999999999998 113.426 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -114.95 107.07 14.9 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.588 0.355 . . . . 3.1800000000000002 110.919 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.1 m 66.69 -127.89 0.21 Allowed 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 125.392 1.477 . . . . 2.0800000000000001 112.92 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.53 HG22 ' HB2' ' A' ' 51' ' ' LEU . 43.5 p 58.6 -163.32 0.21 Allowed 'General case' 0 N--CA 1.526 3.363 0 C-N-CA 126.365 1.866 . . . . 0.62 115.375 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -109.75 130.19 55.54 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.293 0.637 . . . . 0.46000000000000002 112.69 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -104.44 135.57 45.62 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.436 -0.579 . . . . 0.38 109.436 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -129.95 128.42 42.08 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.494 1.294 . . . . 2.5 114.494 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -115.01 118.03 32.27 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 114.699 -1.137 . . . . 1.5600000000000001 110.279 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 114.84 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 114.798 -1.092 . . . . 0.45000000000000001 110.816 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.13 93.12 42.36 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-N 114.928 -1.033 . . . . 0.83999999999999997 109.994 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -82.82 136.18 8.12 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.577 2.185 . . . . 0.16 113.27 176.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.682 HG13 ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -120.95 149.93 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.626 0.727 . . . . 0.38 112.228 -179.52 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.1 t -126.1 113.35 16.95 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.079 -0.964 . . . . 1.3100000000000001 110.959 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.483 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.9 mt -110.94 122.99 66.42 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.605 0 CA-C-N 114.237 -1.347 . . . . 0.25 108.436 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -139.21 126.28 21.16 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.955 -0.566 . . . . 2.0499999999999998 111.068 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? 67.39 17.26 10.12 Favored 'General case' 0 N--CA 1.516 2.843 0 C-N-CA 125.312 1.445 . . . . 3.5499999999999998 114.324 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.64 12.68 46.73 Favored Glycine 0 CA--C 1.547 2.041 0 CA-C-O 119.147 -0.807 . . . . 0.37 114.893 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 27.2 mtmt -123.06 148.97 45.01 Favored 'General case' 0 C--N 1.365 1.268 0 CA-C-N 118.35 1.075 . . . . 1.5600000000000001 112.432 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.19 144.93 30.68 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.635 1.346 . . . . 0.34000000000000002 114.635 -175.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.51 109.09 8.48 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.903 -1.044 . . . . 0.64000000000000001 110.445 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.29 92.57 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.627 0 CA-C-N 115.808 -0.633 . . . . 0.46000000000000002 109.864 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 66.24 -82.1 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.784 0 C-N-CA 125.26 1.424 . . . . 1.5600000000000001 113.836 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.08 25.03 4.17 Favored Glycine 0 CA--C 1.545 1.969 0 CA-C-N 116.073 -0.512 . . . . 0.48999999999999999 113.869 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -130.48 118.42 21.1 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 117.339 0.569 . . . . 1.8200000000000001 110.053 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.1 p -105.91 131.45 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.32 0 CA-C-O 121.721 0.772 . . . . 1.02 112.479 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 m -151.9 -178.69 6.9 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.776 -1.102 . . . . 0.56000000000000005 109.624 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.261 12.8 t -103.04 139.11 39.01 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 113.57 0.952 . . . . 1.25 113.57 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -80.83 123.89 28.63 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 124.534 1.134 . . . . 0.28999999999999998 111.427 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.47 90.49 3.23 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.647 0.61 . . . . 1.4199999999999999 112.647 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.69 -61.75 2.43 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 119.412 2.525 . . . . 0.41999999999999998 119.412 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.494 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -135.92 157.26 47.28 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.254 1.205 . . . . 1.1000000000000001 114.254 -176.14 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.494 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 1.0 OUTLIER -103.61 140.05 38.08 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 113.527 -1.67 . . . . 0.67000000000000004 109.598 176.801 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.4 t -122.02 132.25 54.42 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.306 1.225 . . . . 0.35999999999999999 114.306 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.41 97.55 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.021 -1.844 . . . . 0.73999999999999999 106.021 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.0 132.43 56.71 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.311 -1.313 . . . . 1.6699999999999999 113.001 -176.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.83 135.93 54.92 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-O 122.448 1.118 . . . . 1.8 111.735 177.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.16 143.58 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-N 112.484 -2.144 . . . . 0.57999999999999996 110.325 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 150.11 26.13 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.509 1.3 . . . . 2.1800000000000002 114.509 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.32 -47.01 1.17 Allowed Glycine 0 CA--C 1.543 1.84 0 CA-C-N 115.196 -0.911 . . . . 1.02 114.035 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.3 -61.07 1.17 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.9 0.48 . . . . 2.8599999999999999 111.933 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -129.35 -43.57 1.28 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.757 0.651 . . . . 3.9100000000000001 112.757 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -107.92 173.81 6.16 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.509 0.724 . . . . 1.74 112.454 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.701 ' ND2' ' H ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -132.07 -58.27 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 CA-C-N 115.975 -0.557 . . . . 1.6799999999999999 109.994 178.638 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -101.56 -55.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.089 1.859 . . . . 2.0600000000000001 115.906 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.541 ' NZ ' ' H ' ' A' ' 92' ' ' VAL . 30.4 tttm 81.56 -90.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 127.076 2.15 . . . . 3.0 109.616 -176.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.89 129.11 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 106.976 -1.491 . . . . 0.80000000000000004 106.976 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.01 123.28 19.36 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 112.98 0.733 . . . . 0.87 112.98 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -116.76 49.67 1.14 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.637 1.575 . . . . 0.34000000000000002 113.922 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.9 tp -61.47 102.23 0.23 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 122.653 1.216 . . . . 0.69999999999999996 113.576 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -113.78 100.56 8.55 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 112.556 -2.111 . . . . 0.20999999999999999 110.008 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.476 HD12 ' HG ' ' A' ' 85' ' ' LEU 0.32 15.8 tt -108.34 121.78 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.155 0 CA-C-O 122.942 1.353 . . . . 0.31 111.945 177.408 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -121.09 170.47 9.51 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 113.291 -1.777 . . . . 0.44 111.284 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -123.23 158.5 30.73 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 118.45 2.759 . . . . 1.26 118.45 -176.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.72 -41.95 2.01 Favored Glycine 0 CA--C 1.541 1.688 0 CA-C-N 110.465 -3.061 . . . . 0.17000000000000001 119.208 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.21 157.02 1.31 Allowed 'General case' 0 N--CA 1.515 2.816 0 CA-C-N 120.449 2.125 . . . . 0.14999999999999999 112.942 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.03 -13.54 59.84 Favored 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 124.917 1.287 . . . . 0.17000000000000001 114.366 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.97 3.52 48.39 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 113.954 1.094 . . . . 0.55000000000000004 113.954 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.653 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -106.88 -7.6 17.02 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 113.815 1.043 . . . . 0.59999999999999998 113.815 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.51 91.51 0.43 Allowed Pre-proline 0 N--CA 1.51 2.544 0 C-N-CA 124.012 0.925 . . . . 0.94999999999999996 112.804 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.653 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 42.9 Cg_endo -96.14 147.4 1.2 Allowed 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.84 2.36 . . . . 1.8 114.447 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.25 110.37 6.23 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.217 0.532 . . . . 4.96 111.418 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.47 166.11 23.62 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.03 0.919 . . . . 4.0 112.636 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -106.42 161.57 22.43 Favored Pre-proline 0 CA--C 1.56 1.342 0 CA-C-N 114.729 -1.123 . . . . 6.2699999999999996 110.931 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.53 121.3 8.22 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 122.435 2.09 . . . . 6.5899999999999999 114.489 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -136.33 134.24 19.84 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-N 115.396 -0.82 . . . . 5.5099999999999998 111.279 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -84.99 -158.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 123.281 2.654 . . . . 6.7699999999999996 114.123 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 165.42 98.2 0.12 Allowed Glycine 0 C--N 1.34 0.753 0 C-N-CA 120.997 -0.62 . . . . 7.0199999999999996 113.216 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.7 tp -118.87 114.98 23.45 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.987 0.422 . . . . 8.9900000000000002 111.51 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.261 -0.876 . . . . 10.6 111.058 -179.848 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.551 -0.22 . . . . 8.9299999999999997 112.551 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.94 -36.61 5.84 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 113.02 0.748 . . . . 6.8200000000000003 113.02 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.4 ttt -131.64 106.62 8.28 Favored 'General case' 0 C--N 1.362 1.136 0 CA-C-O 120.932 0.396 . . . . 7.6399999999999997 110.945 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -137.85 109.47 7.04 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.727 -0.669 . . . . 3.8599999999999999 111.442 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.81 86.53 0.07 OUTLIER Glycine 0 C--N 1.34 0.782 0 CA-C-N 115.649 -0.705 . . . . 1.1100000000000001 113.023 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.537 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.1 tp -87.94 -44.35 11.09 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 113.454 0.909 . . . . 0.34999999999999998 113.454 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.33 63.48 Favored 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 125.766 1.626 . . . . 0.20000000000000001 115.105 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.06 -11.63 49.71 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 113.577 0.954 . . . . 0.32000000000000001 113.577 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -104.15 -23.9 13.23 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 113.298 0.851 . . . . 1.73 113.298 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.62 134.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 115.166 1.543 . . . . 0.11 115.166 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -121.83 -29.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 115.354 -0.839 . . . . 0.16 112.345 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -161.43 116.9 2.09 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 117.698 0.226 . . . . 0.54000000000000004 111.502 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.42 135.08 31.68 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.258 -0.901 . . . . 0.19 112.503 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 170' ' ' LEU 0.25 11.3 p -149.35 142.91 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 N-CA-C 113.756 1.021 . . . . 1.05 113.756 178.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.602 ' HB2' HD12 ' A' ' 60' ' ' LEU . 65.8 t30 -116.02 117.96 31.56 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.198 -1.408 . . . . 2.1099999999999999 107.198 173.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -81.73 97.09 7.78 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-O 121.784 0.802 . . . . 0.63 111.251 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.572 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 173.4 -37.67 0.13 Allowed Glycine 0 C--N 1.353 1.486 0 CA-C-N 114.102 -1.408 . . . . 0.70999999999999996 116.541 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -135.65 -125.6 2.51 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 117.873 0.837 . . . . 0.80000000000000004 114.318 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.518 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 34.8 mt-10 -150.13 116.34 5.7 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.812 0.445 . . . . 1.6299999999999999 111.701 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.2 m 31.69 124.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.121 0 N-CA-C 121.036 3.717 . . . . 1.0 121.036 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.456 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 23.3 t60 -149.89 148.51 29.22 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.853 0.835 . . . . 0.45000000000000001 112.092 176.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.2 126.6 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 114.916 -1.038 . . . . 1.3899999999999999 111.615 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -85.27 155.73 21.25 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 114.024 -1.443 . . . . 1.8500000000000001 110.234 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.5 m -44.8 -23.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 N-CA-C 118.943 2.942 . . . . 0.71999999999999997 118.943 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -95.57 -18.43 20.6 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 122.874 0.47 . . . . 0.51000000000000001 111.051 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.85 41.06 1.23 Allowed Glycine 0 C--N 1.356 1.668 0 C-N-CA 124.643 1.116 . . . . 0.34000000000000002 114.462 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.537 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.2 mm -106.06 120.5 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 N-CA-C 109.516 -0.55 . . . . 0.55000000000000004 109.516 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -102.25 129.18 48.59 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.256 1.206 . . . . 1.3400000000000001 114.256 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.623 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.3 142.36 27.79 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.299 -0.864 . . . . 2.79 110.596 177.024 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -88.12 168.43 12.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 115.662 1.727 . . . . 3.0 115.662 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -98.91 100.25 11.41 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.19 1.552 . . . . 2.2999999999999998 115.19 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 36.73 62.46 3.11 Favored Pre-proline 1 N--CA 1.542 4.134 0 N-CA-C 115.85 1.796 . . . . 1.1699999999999999 115.85 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -90.02 28.03 0.45 Allowed 'Trans proline' 0 CA--C 1.564 2.016 0 N-CA-C 119.591 2.881 . . . . 1.45 119.591 -175.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -142.25 -15.22 0.77 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.429 1.27 . . . . 1.9099999999999999 114.429 176.281 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -103.51 55.45 0.74 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-N 118.863 0.756 . . . . 4.8399999999999999 112.808 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . 111.52 -28.69 9.3 Favored Glycine 0 CA--C 1.542 1.76 0 N-CA-C 114.488 0.555 . . . . 2.3700000000000001 114.488 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 2.0 mpp_? 81.7 67.8 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 126.014 1.725 . . . . 4.5 112.528 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 p -148.42 176.93 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.593 2.614 0 CA-C-N 115.115 -0.948 . . . . 2.7000000000000002 110.108 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -113.0 103.58 1.43 Allowed Glycine 0 C--N 1.349 1.27 0 O-C-N 122.094 -0.378 . . . . 1.95 113.931 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -144.07 128.54 17.99 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.164 0.507 . . . . 5.3399999999999999 111.698 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.2 141.34 38.65 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.428 0.691 . . . . 1.6399999999999999 111.806 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 3.2 m -120.32 -62.0 1.52 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.976 0.732 . . . . 1.5700000000000001 112.976 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 42' ' ' SER . 0.4 OUTLIER 84.28 -81.06 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.422 0 C-N-CA 125.386 1.475 . . . . 2.3300000000000001 113.041 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 70.82 55.45 0.24 Allowed 'General case' 0 N--CA 1.513 2.689 0 C-N-CA 125.533 1.533 . . . . 3.1600000000000001 112.615 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 122.44 81.42 0.57 Allowed Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.04 -0.982 . . . . 1.52 110.786 -177.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.12 0.22 57.46 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 115.326 1.602 . . . . 1.6699999999999999 115.326 -177.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -117.15 39.16 3.32 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-O 121.504 0.669 . . . . 4.1799999999999997 112.432 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 mt -146.09 74.66 13.07 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.587 1.155 . . . . 2.6299999999999999 107.979 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.82 176.73 9.53 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.284 2.656 . . . . 1.3700000000000001 116.335 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 61' ' ' TYR 0.251 1.2 mp -89.74 135.64 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.823 0 C-N-CA 124.037 0.935 . . . . 0.68999999999999995 111.711 -178.771 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 5.1 mt -104.84 101.93 11.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.901 -1.045 . . . . 1.28 111.305 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER 150.12 -22.1 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.205 1.802 . . . . 1.51 110.891 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.657 ' HG ' ' HD2' ' A' ' 61' ' ' TYR . 2.3 t -101.27 -160.85 0.82 Allowed 'General case' 0 CA--C 1.575 1.929 0 C-N-CA 123.555 0.742 . . . . 1.0900000000000001 113.0 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -95.51 170.32 7.95 Favored Pre-proline 0 CA--C 1.573 1.838 0 C-N-CA 124.736 1.214 . . . . 1.27 112.569 -179.306 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -71.98 -34.82 7.99 Favored 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 123.25 2.633 . . . . 0.94999999999999996 112.835 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -85.25 -36.36 20.97 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.517 -1.22 . . . . 2.04 112.703 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.22 1.59 56.31 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.737 1.384 . . . . 1.6200000000000001 114.737 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 3.5 pt20 -71.19 -24.4 62.22 Favored 'General case' 0 C--N 1.381 1.945 0 O-C-N 121.822 -0.549 . . . . 1.77 110.369 175.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.35 -47.29 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.872 0 C-N-CA 125.957 1.703 . . . . 0.81000000000000005 108.853 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' A' ' 15' ' ' ASN . 14.1 tp -73.99 -12.85 60.76 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 113.435 0.902 . . . . 1.1499999999999999 113.435 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.657 ' HD2' ' HG ' ' A' ' 53' ' ' SER . 26.4 m-85 -122.47 20.53 10.37 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 113.557 0.947 . . . . 0.92000000000000004 113.557 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.581 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 12.1 tt0 -141.35 -36.48 0.44 Allowed 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 115.474 1.657 . . . . 1.3300000000000001 115.474 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.2 p -67.81 134.69 51.38 Favored 'General case' 0 N--CA 1.528 3.449 0 N-CA-C 115.272 1.582 . . . . 1.28 115.272 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.572 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 5.8 pt-20 -128.93 147.5 50.84 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 124.195 0.998 . . . . 1.53 112.479 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.41 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 32.7 mtm105 -89.13 -90.68 0.13 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 112.809 0.67 . . . . 3.2200000000000002 112.809 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -153.94 166.64 32.34 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.223 0.609 . . . . 3.6600000000000001 110.968 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -116.6 131.01 57.06 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.158 0.799 . . . . 4.7000000000000002 113.158 -178.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -133.81 -109.37 0.23 Allowed 'General case' 0 CA--C 1.56 1.335 0 CA-C-N 115.634 -0.712 . . . . 2.5499999999999998 111.028 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.05 122.36 1.32 Allowed 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 118.364 0.529 . . . . 2.1499999999999999 111.334 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.24 85.01 0.09 Allowed 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 125.555 1.542 . . . . 0.77000000000000002 114.397 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -143.52 152.94 42.08 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.531 0.682 . . . . 0.81000000000000005 112.242 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.24 -153.21 7.44 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 115.653 1.021 . . . . 0.46999999999999997 115.653 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.79 166.62 22.22 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 115.037 1.495 . . . . 0.89000000000000001 115.037 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.93 119.32 27.43 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.585 -1.643 . . . . 0.51000000000000001 111.144 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.48 100.36 53.49 Favored Pre-proline 0 CA--C 1.568 1.645 0 N-CA-C 109.581 -0.526 . . . . 0.14999999999999999 109.581 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -82.93 116.66 2.5 Favored 'Trans proline' 0 CA--C 1.563 1.926 0 C-N-CA 122.25 1.967 . . . . 0.14999999999999999 115.103 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.6 157.46 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.926 0.869 . . . . 0.19 111.038 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -143.27 24.01 1.8 Allowed 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 114.648 -1.16 . . . . 2.5299999999999998 112.084 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -127.84 157.36 40.67 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 121.347 0.594 . . . . 2.1200000000000001 111.134 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.73 136.65 53.22 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.713 1.005 . . . . 0.41999999999999998 113.713 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 166.55 -140.17 6.18 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 113.962 -1.472 . . . . 0.23000000000000001 112.569 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 23.8 mt-10 -112.36 109.02 18.4 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-N 118.473 1.136 . . . . 1.75 111.627 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -103.52 129.77 50.77 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.048 0.451 . . . . 0.20999999999999999 110.521 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.69 121.72 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.864 0.84 . . . . 0.20000000000000001 110.795 -176.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.402 ' HG ' HD12 ' A' ' 172' ' ' ILE . 0.3 OUTLIER -100.0 105.59 17.28 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 113.931 -1.486 . . . . 0.78000000000000003 109.572 177.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -111.9 124.96 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.8 -0.815 . . . . 0.44 108.8 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.94 140.2 43.82 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 112.735 0.643 . . . . 1.25 112.735 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -102.87 120.39 40.52 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.039 -0.982 . . . . 2.52 110.133 177.163 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -105.82 133.27 50.83 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.106 -0.497 . . . . 0.40000000000000002 110.392 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.37 152.32 50.51 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 112.549 0.574 . . . . 0.40999999999999998 112.549 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -138.71 119.64 14.35 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 123.662 0.785 . . . . 2.6099999999999999 111.102 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.18 65.33 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 112.597 0.592 . . . . 2.1299999999999999 112.597 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -171.3 -37.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 112.982 0.734 . . . . 2.27 112.982 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -115.94 130.81 56.98 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.226 0.454 . . . . 1.46 112.226 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.27 96.93 6.42 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.43 1.11 . . . . 0.83999999999999997 111.474 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -165.37 141.43 5.38 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 114.968 -1.014 . . . . 2.4500000000000002 112.323 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.5 m -122.41 124.93 44.79 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.382 -0.826 . . . . 1.6599999999999999 112.436 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 72.59 54.95 0.15 Allowed 'General case' 0 N--CA 1.514 2.725 0 C-N-CA 125.713 1.605 . . . . 1.8899999999999999 112.523 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -157.31 -38.43 0.07 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.803 -1.089 . . . . 2.5600000000000001 109.974 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -106.9 81.79 1.61 Allowed 'General case' 0 C--N 1.362 1.152 0 N-CA-C 108.384 -0.969 . . . . 2.7599999999999998 108.384 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.88 122.76 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 114.331 -1.304 . . . . 0.68999999999999995 111.306 -177.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -106.57 175.73 5.4 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 115.572 1.693 . . . . 0.69999999999999996 115.572 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -126.03 137.27 53.64 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.343 0.592 . . . . 1.3300000000000001 110.941 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.21 123.76 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.511 0 CA-C-N 115.237 -0.892 . . . . 0.47999999999999998 109.366 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.644 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 26.3 mtt180 -123.26 148.64 45.68 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.981 1.475 . . . . 1.6899999999999999 114.981 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 6.4 m -123.81 107.8 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 N-CA-C 113.437 0.903 . . . . 0.59999999999999998 113.437 177.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.587 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.9 t30 63.81 27.32 14.56 Favored 'General case' 0 N--CA 1.519 2.988 0 C-N-CA 126.845 2.058 . . . . 1.1200000000000001 114.456 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.87 -14.86 45.06 Favored Glycine 0 CA--C 1.55 2.264 0 CA-C-N 115.574 -0.739 . . . . 0.32000000000000001 113.612 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.644 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 94.6 m-70 -87.49 171.15 10.74 Favored 'General case' 0 C--N 1.361 1.088 0 C-N-CA 125.953 1.701 . . . . 0.56999999999999995 113.166 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.01 132.72 54.67 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.546 0.689 . . . . 0.55000000000000004 112.015 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.61 -58.96 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.82 -1.082 . . . . 1.0600000000000001 113.324 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.22 89.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.627 -0.879 . . . . 0.44 108.627 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -106.97 101.51 10.93 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 122.881 1.324 . . . . 2.2999999999999998 110.283 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 114.25 74.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 110.542 -3.026 . . . . 2.48 108.898 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.2 105.8 18.01 Favored 'General case' 0 C--N 1.361 1.084 0 CA-C-O 121.612 0.72 . . . . 1.1299999999999999 112.593 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -115.07 97.4 6.19 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 106.678 -1.601 . . . . 2.3500000000000001 106.678 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.06 -26.77 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.479 0 N-CA-C 114.028 1.122 . . . . 0.68000000000000005 114.028 -176.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -76.22 -38.83 55.93 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.629 0.771 . . . . 0.77000000000000002 112.095 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -72.95 -26.74 61.48 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.847 1.259 . . . . 0.91000000000000003 113.296 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -80.5 -56.25 4.3 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.767 1.025 . . . . 2.4300000000000002 113.767 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.73 -36.04 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 N-CA-C 114.592 1.33 . . . . 0.93000000000000005 114.592 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.2 -110.04 1.37 Allowed Glycine 0 C--N 1.354 1.581 0 CA-C-N 118.35 0.523 . . . . 0.84999999999999998 113.417 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -114.84 107.46 15.45 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.841 0.353 . . . . 3.1800000000000002 110.243 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 69.42 -133.69 0.07 Allowed 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 125.345 1.458 . . . . 2.0800000000000001 112.614 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.3 p 62.15 -163.38 0.26 Allowed 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 126.222 1.809 . . . . 0.62 114.578 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.8 130.94 56.4 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 112.899 0.703 . . . . 0.46000000000000002 112.899 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -101.66 147.21 26.71 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.262 -0.644 . . . . 0.38 109.262 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.6 124.68 25.79 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.994 1.479 . . . . 2.5 114.994 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -124.18 121.91 36.38 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 115.247 -0.888 . . . . 1.5600000000000001 110.305 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.83 128.48 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 114.27 -1.332 . . . . 0.45000000000000001 111.545 -178.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.21 93.77 19.03 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-N 115.637 -0.711 . . . . 0.83999999999999997 111.187 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -76.55 133.3 14.19 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 122.672 2.248 . . . . 0.16 113.103 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.62 148.81 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.592 0 CA-C-N 115.553 -0.749 . . . . 0.38 111.474 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.8 p -130.52 107.16 9.01 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.392 -0.822 . . . . 1.3100000000000001 111.82 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 mt -109.65 121.71 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 N-CA-C 108.518 -0.919 . . . . 0.25 108.518 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -143.1 130.72 21.29 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.681 -0.69 . . . . 2.0499999999999998 110.964 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp 69.8 7.87 6.44 Favored 'General case' 0 N--CA 1.519 3.016 0 N-CA-C 114.684 1.364 . . . . 3.5499999999999998 114.684 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.14 22.22 13.63 Favored Glycine 0 CA--C 1.548 2.128 0 C-N-CA 123.633 0.635 . . . . 0.37 113.802 -177.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -130.52 144.83 51.66 Favored 'General case' 0 C--N 1.366 1.299 0 CA-C-N 117.548 0.674 . . . . 1.5600000000000001 112.128 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.75 141.11 32.99 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.912 1.078 . . . . 0.34000000000000002 113.912 -177.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.0 m -130.97 115.36 16.4 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.664 -1.153 . . . . 0.64000000000000001 110.656 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.45 95.14 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.372 0 CA-C-O 121.101 0.477 . . . . 0.46000000000000002 110.728 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 67.26 -85.24 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 125.546 1.538 . . . . 1.5600000000000001 113.558 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.36 27.74 4.41 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.011 -0.541 . . . . 0.48999999999999999 113.404 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -131.38 128.4 39.52 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.444 0.698 . . . . 1.8200000000000001 110.77 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.8 p -118.29 130.01 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.343 0 CA-C-O 121.333 0.587 . . . . 1.02 111.185 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.8 m -149.85 -170.63 3.69 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.487 -0.778 . . . . 0.56000000000000005 110.446 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 11.4 t -101.76 141.42 34.65 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 112.792 0.664 . . . . 1.25 112.792 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -87.91 132.63 34.14 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.985 0.898 . . . . 0.28999999999999998 111.815 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.9 p -97.34 -164.3 1.13 Allowed 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 114.046 -1.433 . . . . 1.4199999999999999 109.395 177.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.59 7.52 68.79 Favored Glycine 0 CA--C 1.56 2.876 0 N-CA-C 116.937 1.535 . . . . 0.41999999999999998 116.937 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -160.11 152.53 20.86 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-O 121.7 0.762 . . . . 1.1000000000000001 111.421 178.517 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.587 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -109.3 136.09 49.32 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.307 -1.315 . . . . 0.67000000000000004 109.236 177.405 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.5 t -117.82 144.11 45.67 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.671 1.73 . . . . 0.35999999999999999 115.671 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.1 t -118.44 97.58 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.087 -1.82 . . . . 0.73999999999999999 106.087 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -114.12 121.48 43.93 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 115.905 -0.589 . . . . 1.6699999999999999 112.46 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.73 132.1 56.55 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-O 122.062 0.934 . . . . 1.8 111.238 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 14.0 t -107.25 143.74 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.991 0 CA-C-N 113.341 -1.754 . . . . 0.57999999999999996 110.01 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 163' ' ' ASP . 34.4 ttpt -71.49 149.98 45.3 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.939 1.696 . . . . 2.1800000000000002 114.665 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.1 -55.26 0.73 Allowed Glycine 0 CA--C 1.542 1.778 0 CA-C-N 115.26 -0.882 . . . . 1.02 114.378 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -130.18 -71.34 0.6 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.301 0.551 . . . . 2.8599999999999999 112.306 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.36 -44.7 2.66 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.513 0.561 . . . . 3.9100000000000001 112.513 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.508 ' O ' ' HG3' ' A' ' 159' ' ' LYS . 0.8 OUTLIER -98.99 171.24 8.17 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.773 0.829 . . . . 1.74 111.46 178.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . 0.285 56.7 t-20 -125.75 -93.15 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.451 0 CA-C-O 116.715 -1.612 . . . . 1.6799999999999999 109.993 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -87.1 -36.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.389 2.686 0 CA-C-N 124.851 2.768 . . . . 2.0600000000000001 114.757 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.2 tptm 80.29 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 126.2 1.8 . . . . 3.0 110.543 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.534 HG22 ' HB3' ' A' ' 64' ' ' GLU . 36.2 t -115.2 131.5 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.358 -1.349 . . . . 0.80000000000000004 107.358 175.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.1 t -136.21 124.96 23.87 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.489 -0.778 . . . . 0.87 112.196 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -115.27 51.46 0.92 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 116.366 1.988 . . . . 0.34000000000000002 116.366 -176.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 2.8 mm? -43.65 131.54 5.19 Favored 'General case' 0 N--CA 1.519 2.999 0 N-CA-C 116.368 1.988 . . . . 0.69999999999999996 116.368 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -154.45 104.04 2.54 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.825 -0.625 . . . . 0.20999999999999999 110.283 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.402 HD12 ' HG ' ' A' ' 85' ' ' LEU 0.307 6.2 tt -114.47 123.11 69.83 Favored 'Isoleucine or valine' 0 C--O 1.268 2.064 0 CA-C-O 122.125 0.964 . . . . 0.31 111.825 176.076 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -119.53 168.19 11.24 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.191 -1.368 . . . . 0.44 112.17 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -118.48 146.42 44.52 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 118.06 2.615 . . . . 1.26 118.06 -173.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.69 -41.02 2.26 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-N 110.605 -2.998 . . . . 0.17000000000000001 120.264 172.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.45 159.5 1.95 Allowed 'General case' 0 N--CA 1.517 2.904 0 CA-C-N 120.951 2.375 . . . . 0.14999999999999999 113.239 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -77.73 -14.17 59.68 Favored 'General case' 0 CA--C 1.582 2.185 0 C-N-CA 124.784 1.234 . . . . 0.17000000000000001 114.227 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.02 2.6 51.43 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 113.957 1.095 . . . . 0.55000000000000004 113.957 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.62 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -101.8 -8.73 21.42 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.761 1.023 . . . . 0.59999999999999998 113.761 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.78 90.87 0.45 Allowed Pre-proline 0 N--CA 1.507 2.386 0 C-N-CA 124.035 0.934 . . . . 0.94999999999999996 112.576 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.62 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 45.0 Cg_endo -94.59 149.37 1.84 Allowed 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.742 2.294 . . . . 1.8 114.37 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.9 mmt -132.18 107.99 8.96 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.018 -0.537 . . . . 4.96 111.436 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.1 mt -134.45 173.84 11.2 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 122.196 0.998 . . . . 4.0 112.584 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -109.61 156.81 39.02 Favored Pre-proline 0 CA--C 1.558 1.267 0 CA-C-N 114.548 -1.205 . . . . 6.2699999999999996 110.633 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.03 122.99 10.13 Favored 'Trans proline' 0 C--N 1.392 2.821 0 C-N-CA 122.626 2.217 . . . . 6.5899999999999999 114.717 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.419 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 21.5 t60 -133.87 129.82 20.34 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-N 115.113 -0.949 . . . . 5.5099999999999998 112.028 -178.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.419 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 8.2 Cg_endo -89.05 -157.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.691 0 C-N-CA 123.057 2.504 . . . . 6.7699999999999996 113.468 177.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 169.24 91.79 0.08 OUTLIER Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.122 -0.561 . . . . 7.0199999999999996 113.044 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.5 tp -118.9 114.67 22.97 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.875 0.369 . . . . 8.9900000000000002 111.763 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.218 -0.896 . . . . 10.6 110.979 179.717 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.57 -0.212 . . . . 8.9299999999999997 112.57 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.9 128.42 56.14 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.542 0.686 . . . . 6.8200000000000003 111.954 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.0 tpt -144.12 95.74 2.77 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.83 -0.623 . . . . 7.6399999999999997 110.885 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m -146.75 112.73 5.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.92 -0.582 . . . . 3.8599999999999999 111.498 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.34 -62.26 0.04 OUTLIER Glycine 0 C--N 1.341 0.812 0 CA-C-N 115.758 -0.655 . . . . 1.1100000000000001 113.777 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.649 ' HG ' HD11 ' A' ' 27' ' ' ILE . 29.2 tp -85.26 -40.89 16.09 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.076 0.55 . . . . 0.34999999999999998 112.116 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.05 -22.91 67.18 Favored 'General case' 0 CA--C 1.583 2.248 0 C-N-CA 125.663 1.585 . . . . 0.20000000000000001 114.029 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.9 -11.9 49.32 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 113.606 0.965 . . . . 0.32000000000000001 113.606 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 31.2 mttm -108.16 -19.33 13.52 Favored 'General case' 0 C--N 1.364 1.233 0 N-CA-C 113.716 1.006 . . . . 1.73 113.716 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.32 136.65 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.866 0 N-CA-C 114.967 1.469 . . . . 0.11 114.967 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.76 -31.33 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 115.295 -0.866 . . . . 0.16 111.998 178.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -161.05 119.53 2.47 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 111.954 0.353 . . . . 0.54000000000000004 111.954 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -139.81 129.66 24.72 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.673 -0.642 . . . . 0.19 111.366 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.61 140.75 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.764 0.793 . . . . 1.05 112.524 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.591 ' HB2' HD12 ' A' ' 60' ' ' LEU . 3.0 t-20 -114.43 110.24 19.55 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 106.599 -1.63 . . . . 2.1099999999999999 106.599 172.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.565 ' HA ' ' HE ' ' A' ' 65' ' ' ARG . . . -75.53 94.63 3.18 Favored 'General case' 0 C--O 1.274 2.386 0 CA-C-O 122.217 1.008 . . . . 0.63 110.859 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 159.27 -0.08 0.08 OUTLIER Glycine 0 C--N 1.362 2.008 0 CA-C-N 110.943 -2.844 . . . . 0.70999999999999996 117.983 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.52 -136.22 1.97 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-N 120.635 2.218 . . . . 0.80000000000000004 117.273 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -129.09 134.75 48.21 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 113.861 -1.17 . . . . 1.6299999999999999 111.218 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 26.2 m -14.14 122.28 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.958 0 N-CA-C 119.556 3.169 . . . . 1.0 119.556 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -140.83 141.91 34.65 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.132 0.968 . . . . 0.45000000000000001 112.446 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.259 10.0 p -106.01 119.4 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 CA-C-N 114.063 -1.426 . . . . 1.3899999999999999 110.36 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -86.72 169.04 13.0 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 114.77 -1.105 . . . . 1.8500000000000001 113.451 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -39.61 -52.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 C-N-CA 129.222 3.009 . . . . 0.71999999999999997 117.458 -174.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.432 ' HB2' HD23 ' A' ' 6' ' ' LEU . 63.1 m-70 -75.82 -20.59 58.05 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 112.888 0.699 . . . . 0.51000000000000001 112.888 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.8 44.36 0.76 Allowed Glycine 0 C--N 1.355 1.625 0 N-CA-C 115.194 0.838 . . . . 0.34000000000000002 115.194 176.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.649 HD11 ' HG ' ' A' ' 6' ' ' LEU . 33.5 mm -108.51 125.12 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 N-CA-C 110.088 -0.338 . . . . 0.55000000000000004 110.088 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -108.35 128.09 54.46 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 114.461 1.282 . . . . 1.3400000000000001 114.461 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -94.24 150.1 20.62 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 124.419 1.088 . . . . 2.79 110.604 177.366 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -105.88 147.3 28.88 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.574 1.324 . . . . 3.0 114.574 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -68.76 108.44 3.42 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 117.535 2.42 . . . . 2.2999999999999998 117.535 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER 39.85 54.42 5.9 Favored Pre-proline 0 N--CA 1.525 3.316 0 N-CA-C 118.767 2.877 . . . . 1.1699999999999999 118.767 175.077 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 0.5 OUTLIER -106.59 65.12 0.02 OUTLIER 'Trans proline' 0 CA--C 1.566 2.113 0 C-N-CA 123.014 2.476 . . . . 1.45 116.174 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.3 mt -98.26 -83.32 0.41 Allowed 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.901 -0.5 . . . . 1.9099999999999999 111.029 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -148.35 60.19 1.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 113.021 0.748 . . . . 4.8399999999999999 113.021 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.35 1.28 40.95 Favored Glycine 0 CA--C 1.542 1.727 0 N-CA-C 115.804 1.082 . . . . 2.3700000000000001 115.804 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.53 ' O ' ' HB3' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -96.92 72.44 2.54 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-N 117.806 0.803 . . . . 4.5 112.959 -178.368 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.22 116.8 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-N 115.455 -0.793 . . . . 2.7000000000000002 111.377 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 137.58 -58.18 0.64 Allowed Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.587 -0.733 . . . . 1.95 113.403 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -118.49 135.25 54.49 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.372 0.606 . . . . 5.3399999999999999 112.183 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.2 -40.92 10.19 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.662 0.986 . . . . 1.6399999999999999 113.662 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.6 m 78.7 81.54 0.07 Allowed 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 125.392 1.477 . . . . 1.5700000000000001 112.471 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -95.58 91.41 6.13 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.294 0.637 . . . . 2.3300000000000001 112.189 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -110.96 74.23 0.86 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.931 0.872 . . . . 3.1600000000000001 110.526 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.14 60.52 0.05 OUTLIER Glycine 0 CA--C 1.529 0.959 0 CA-C-N 114.088 -1.415 . . . . 1.52 111.605 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.19 -24.41 19.06 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.84 1.052 . . . . 1.6699999999999999 113.84 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -103.39 61.16 0.77 Allowed 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 122.429 1.109 . . . . 4.1799999999999997 110.883 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -169.92 70.66 0.63 Allowed Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 113.316 -1.765 . . . . 2.6299999999999999 107.252 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -66.44 164.69 27.53 Favored 'Trans proline' 0 C--N 1.389 2.665 0 C-N-CA 124.022 3.148 . . . . 1.3700000000000001 116.317 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.295 1.2 mp -86.84 121.05 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-O 121.818 0.818 . . . . 0.68999999999999995 109.866 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.534 ' HB2' HG22 ' A' ' 125' ' ' THR . 4.7 mt -76.67 -14.47 59.96 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.191 2.293 . . . . 1.28 117.191 -175.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -99.96 15.73 26.2 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.151 0.797 . . . . 1.51 113.151 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.501 ' HG ' ' HD2' ' A' ' 61' ' ' TYR . 1.9 t -132.31 -159.58 0.98 Allowed 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 121.659 0.742 . . . . 1.0900000000000001 111.773 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.11 168.75 9.72 Favored Pre-proline 0 CA--C 1.569 1.706 0 C-N-CA 125.11 1.364 . . . . 1.27 113.077 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -72.58 -30.29 12.25 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 123.266 2.644 . . . . 0.94999999999999996 113.34 176.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -85.32 -38.54 18.68 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.685 1.194 . . . . 2.04 112.272 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.39 1.83 56.84 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 114.574 1.324 . . . . 1.6200000000000001 114.574 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -68.36 -30.11 68.98 Favored 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 123.964 0.906 . . . . 1.77 110.999 176.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.37 -48.17 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.035 0 C-N-CA 126.03 1.732 . . . . 0.81000000000000005 109.054 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' ' 15' ' ' ASN . 17.6 tp -71.54 -13.34 61.77 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 113.952 1.093 . . . . 1.1499999999999999 113.952 177.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.501 ' HD2' ' HG ' ' A' ' 53' ' ' SER . 29.4 m-85 -123.23 21.69 9.56 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 113.233 0.827 . . . . 0.92000000000000004 113.233 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.5 -32.72 0.49 Allowed 'General case' 0 N--CA 1.513 2.679 0 N-CA-C 116.03 1.863 . . . . 1.3300000000000001 116.03 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.409 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 17.8 p -70.98 136.68 48.55 Favored 'General case' 0 N--CA 1.535 3.807 0 N-CA-C 115.008 1.485 . . . . 1.28 115.008 -177.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.455 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.3 pt-20 -123.0 145.64 48.32 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 115.662 1.726 . . . . 1.53 115.662 -176.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.565 ' HE ' ' HA ' ' A' ' 16' ' ' ALA . 12.4 mtm180 -105.25 150.08 25.44 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.055 0.942 . . . . 3.2200000000000002 109.983 176.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -105.42 130.63 53.47 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.402 1.63 . . . . 3.6600000000000001 115.402 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -170.07 -179.12 3.06 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.049 1.339 . . . . 4.7000000000000002 110.849 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -155.88 66.83 0.6 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.513 1.301 . . . . 2.5499999999999998 114.513 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.78 -160.68 0.12 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.435 0.636 . . . . 2.1499999999999999 111.527 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 1.6 t -88.51 97.83 11.3 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.18 0.992 . . . . 0.77000000000000002 108.477 175.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -136.75 146.11 45.4 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.181 1.178 . . . . 0.81000000000000005 114.181 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.04 -173.07 38.53 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 114.262 -1.335 . . . . 0.46999999999999997 115.325 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.55 162.63 12.88 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.599 1.333 . . . . 0.89000000000000001 114.599 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -120.98 124.74 45.62 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.181 -1.372 . . . . 0.51000000000000001 110.825 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.07 101.87 54.35 Favored Pre-proline 0 CA--C 1.564 1.514 0 CA-C-N 115.487 -0.779 . . . . 0.14999999999999999 110.305 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.41 122.67 3.68 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 121.831 1.687 . . . . 0.14999999999999999 114.862 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.42 163.45 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-N 114.986 -1.006 . . . . 0.19 110.899 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -151.82 24.51 0.67 Allowed 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 114.534 -1.212 . . . . 2.5299999999999998 111.666 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -133.24 156.85 46.79 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 123.09 0.556 . . . . 2.1200000000000001 111.111 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.5 OUTLIER -118.06 145.39 44.86 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.523 0.934 . . . . 0.41999999999999998 113.523 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.44 -136.48 4.43 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.189 -1.369 . . . . 0.23000000000000001 112.191 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 38.3 mm-40 -116.91 106.67 13.7 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 118.292 1.046 . . . . 1.75 110.927 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -100.99 132.19 46.52 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.295 0.569 . . . . 0.20999999999999999 110.994 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.7 122.98 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 121.709 0.766 . . . . 0.20000000000000001 110.947 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.66 106.11 16.52 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.063 -1.426 . . . . 0.78000000000000003 109.885 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.39 122.67 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.625 -0.509 . . . . 0.44 109.625 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.24 144.16 49.59 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.029 0.751 . . . . 1.25 113.029 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 4.5 tppt? -106.66 123.33 47.96 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.448 -0.796 . . . . 2.52 110.848 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 16.9 m-85 -106.15 135.48 47.54 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.733 -0.667 . . . . 0.40000000000000002 110.444 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.82 149.67 42.32 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 116.016 -0.538 . . . . 0.40999999999999998 111.944 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -148.13 121.52 9.05 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 123.167 0.587 . . . . 2.6099999999999999 110.724 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.26 72.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 112.24 0.459 . . . . 2.1299999999999999 112.24 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.14 -42.51 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.734 0.642 . . . . 2.27 112.734 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -117.54 131.85 56.63 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.61 0.596 . . . . 1.46 112.61 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -110.57 97.46 6.89 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 122.402 1.096 . . . . 0.83999999999999997 111.12 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -160.67 142.03 12.09 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.982 -1.008 . . . . 2.4500000000000002 112.054 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.8 m -122.16 124.06 42.98 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.596 -0.729 . . . . 1.6599999999999999 112.331 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 73.07 53.38 0.13 Allowed 'General case' 0 N--CA 1.512 2.629 0 C-N-CA 125.721 1.609 . . . . 1.8899999999999999 112.148 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -152.31 -41.85 0.11 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.541 1.136 . . . . 2.5600000000000001 110.025 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -106.9 82.26 1.67 Allowed 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.794 -0.817 . . . . 2.7599999999999998 108.794 177.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.34 126.01 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.605 -1.18 . . . . 0.68999999999999995 111.23 -177.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -113.86 176.99 4.79 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.404 1.631 . . . . 0.69999999999999996 115.404 -175.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -125.32 139.13 53.96 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 121.897 0.856 . . . . 1.3300000000000001 111.489 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.01 126.84 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.071 0 CA-C-N 114.181 -1.372 . . . . 0.47999999999999998 110.103 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -131.27 142.52 50.15 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.229 1.566 . . . . 1.6899999999999999 115.229 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.2 m -113.74 106.34 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 113.882 -1.508 . . . . 0.59999999999999998 112.199 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 65.21 25.87 12.32 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 126.479 1.912 . . . . 1.1200000000000001 113.367 -177.207 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.62 -10.82 56.29 Favored Glycine 0 CA--C 1.555 2.552 0 CA-C-N 116.055 -0.52 . . . . 0.32000000000000001 114.121 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -94.93 130.11 41.69 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 125.394 1.477 . . . . 0.56999999999999995 113.457 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -90.74 133.97 34.77 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 122.481 1.134 . . . . 0.55000000000000004 113.562 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.24 -47.42 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 112.818 -1.992 . . . . 1.0600000000000001 112.163 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.19 89.14 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.27 -1.011 . . . . 0.44 108.27 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -111.03 74.92 0.89 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-O 123.334 1.54 . . . . 2.2999999999999998 110.994 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 156.06 64.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 110.429 -3.078 . . . . 2.48 108.445 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.18 100.81 12.55 Favored 'General case' 0 C--N 1.36 1.056 0 N-CA-C 114.032 1.123 . . . . 1.1299999999999999 114.032 -178.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.56 101.49 8.65 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 112.815 -1.993 . . . . 2.3500000000000001 106.706 175.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.63 -29.4 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.48 0 C-N-CA 124.605 1.162 . . . . 0.68000000000000005 114.114 -176.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -76.94 -37.34 55.48 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.341 0.656 . . . . 0.77000000000000002 112.403 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -74.21 -26.44 60.26 Favored 'General case' 0 CA--C 1.576 1.946 0 C-N-CA 124.557 1.143 . . . . 0.91000000000000003 113.195 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -78.55 -56.26 4.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.327 0.862 . . . . 2.4300000000000002 113.327 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.79 -39.88 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 N-CA-C 113.998 1.11 . . . . 0.93000000000000005 113.998 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.85 -67.3 0.24 Allowed Glycine 0 C--N 1.358 1.777 0 CA-C-N 118.269 0.486 . . . . 0.84999999999999998 114.162 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -106.49 173.91 6.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.946 0.899 . . . . 3.1800000000000002 112.161 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 m -75.95 84.13 2.86 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.281 0.845 . . . . 2.0800000000000001 113.281 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 51' ' ' LEU . 23.4 p -135.7 -137.05 0.15 Allowed 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 114.414 -1.266 . . . . 0.62 109.127 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -115.96 132.69 56.57 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 113.315 0.857 . . . . 0.46000000000000002 113.315 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.452 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 7.4 t60 -108.37 138.2 45.06 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.109 -0.701 . . . . 0.38 109.109 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -141.49 130.95 23.78 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.696 0.998 . . . . 2.5 113.696 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -120.2 130.68 54.66 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-N 114.498 -1.228 . . . . 1.5600000000000001 110.87 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.51 124.14 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 114.455 -1.248 . . . . 0.45000000000000001 110.629 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.49 94.23 26.84 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-N 115.619 -0.719 . . . . 0.83999999999999997 110.859 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -74.65 139.32 25.13 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.977 2.452 . . . . 0.16 113.481 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.95 150.75 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.492 0 CA-C-O 121.654 0.74 . . . . 0.38 111.216 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.2 p -132.29 112.69 12.44 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.268 -0.878 . . . . 1.3100000000000001 111.323 178.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.6 mt -112.01 123.18 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 108.505 -0.924 . . . . 0.25 108.505 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -139.24 127.99 23.35 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.102 -0.954 . . . . 2.0499999999999998 110.88 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? 66.05 15.52 10.11 Favored 'General case' 0 N--CA 1.517 2.89 0 N-CA-C 114.88 1.437 . . . . 3.5499999999999998 114.88 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.53 19.52 24.95 Favored Glycine 0 CA--C 1.55 2.271 0 CA-C-O 119.315 -0.714 . . . . 0.37 114.709 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 25.0 mtpp -126.77 141.83 51.72 Favored 'General case' 0 C--N 1.366 1.301 0 CA-C-N 118.181 0.991 . . . . 1.5600000000000001 112.2 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.68 136.85 39.9 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.487 0.921 . . . . 0.34000000000000002 113.487 -177.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.4 t -133.63 120.84 21.2 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.71 -0.677 . . . . 0.64000000000000001 111.843 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 p -105.47 95.05 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.674 0 CA-C-N 114.965 -1.016 . . . . 0.46000000000000002 110.087 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 69.46 -81.66 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 125.4 1.48 . . . . 1.5600000000000001 113.34 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -129.71 23.43 4.75 Favored Glycine 0 CA--C 1.544 1.899 0 CA-C-N 116.092 -0.504 . . . . 0.48999999999999999 113.685 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -125.04 121.92 35.74 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.33 0.652 . . . . 1.8200000000000001 110.78 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.8 134.24 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.466 0.65 . . . . 1.02 111.843 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 m -149.54 -170.27 3.59 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.918 -1.037 . . . . 0.56000000000000005 110.74 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.24 138.14 38.66 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.394 0.887 . . . . 1.25 113.394 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -94.45 119.88 33.84 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.493 -0.776 . . . . 0.28999999999999998 109.036 175.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.89 92.24 3.1 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.335 0.588 . . . . 1.4199999999999999 112.092 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.92 -71.51 2.98 Favored Glycine 0 C--N 1.358 1.779 0 N-CA-C 116.954 1.542 . . . . 0.41999999999999998 116.954 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.78 171.94 12.9 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 123.285 1.517 . . . . 1.1000000000000001 114.577 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.496 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -110.28 126.39 54.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 111.31 -2.677 . . . . 0.67000000000000004 107.439 176.559 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' SER . . . . . 0.457 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.6 t -117.18 122.23 43.45 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 118.309 -1.357 . . . . 0.35999999999999999 114.287 -175.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.79 101.36 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 114.676 -1.147 . . . . 0.73999999999999999 108.407 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -133.28 143.72 49.25 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.05 -0.977 . . . . 1.6699999999999999 111.386 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -115.59 142.5 46.64 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 114.546 -1.206 . . . . 1.8 112.72 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -102.73 137.0 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.247 -1.797 . . . . 0.57999999999999996 108.778 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -81.82 148.82 28.66 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 115.135 1.532 . . . . 2.1800000000000002 115.135 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -104.37 -29.94 5.2 Favored Glycine 0 CA--C 1.545 1.922 0 CA-C-N 114.675 -1.148 . . . . 1.02 114.143 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -128.49 -80.54 0.58 Allowed 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 117.258 0.529 . . . . 2.8599999999999999 110.919 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -171.88 48.92 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.87 0.468 . . . . 3.9100000000000001 112.036 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -160.04 -43.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.605 0.965 . . . . 1.74 113.605 -178.769 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 1.3 m-20 84.17 -173.16 0.02 OUTLIER Pre-proline 0 N--CA 1.511 2.607 0 C-N-CA 124.493 1.117 . . . . 1.6799999999999999 110.461 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -64.43 -19.19 65.1 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.586 2.191 . . . . 2.0600000000000001 115.74 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 31.0 tptt 82.69 -67.1 0.09 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 126.025 1.73 . . . . 3.0 115.045 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 45.0 t -100.2 131.03 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 119.062 0.846 . . . . 0.80000000000000004 110.034 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.3 t -134.06 126.8 30.9 Favored 'General case' 0 C--N 1.367 1.342 0 O-C-N 124.074 0.859 . . . . 0.87 111.635 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.256 . . -115.03 51.1 0.93 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.43 2.011 . . . . 0.34000000000000002 116.43 -176.194 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.84 128.18 8.65 Favored 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.702 1.601 . . . . 0.69999999999999996 115.053 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -149.14 98.17 2.78 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.777 -1.102 . . . . 0.20999999999999999 109.294 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.319 8.4 tt -112.9 122.68 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.808 0 CA-C-O 122.84 1.305 . . . . 0.31 112.276 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -123.56 167.61 13.7 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 113.094 -1.866 . . . . 0.44 111.131 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.9 ptmt -122.19 159.49 27.14 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 118.223 2.675 . . . . 1.26 118.223 -175.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.38 -42.53 1.87 Allowed Glycine 0 CA--C 1.542 1.781 0 CA-C-N 110.041 -3.254 . . . . 0.17000000000000001 118.779 174.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.37 153.92 0.78 Allowed 'General case' 0 N--CA 1.52 3.038 0 CA-C-N 120.296 2.048 . . . . 0.14999999999999999 112.94 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.79 -20.74 58.0 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 114.742 1.386 . . . . 0.17000000000000001 114.742 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.36 4.68 45.33 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.007 1.114 . . . . 0.55000000000000004 114.007 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.57 3.3 16.65 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.389 1.255 . . . . 0.59999999999999998 114.389 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . 0.257 1.6 m -59.73 -35.77 32.7 Favored Pre-proline 0 N--CA 1.525 3.298 0 N-CA-C 116.856 2.169 . . . . 0.94999999999999996 116.856 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -97.58 167.01 0.84 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.382 2.055 . . . . 1.8 113.931 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 tpt -144.64 113.67 6.88 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.192 -0.458 . . . . 4.96 111.002 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 10.2 mt -132.26 167.54 19.65 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.1 0.952 . . . . 4.0 112.686 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -103.91 158.66 31.42 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-N 114.591 -1.186 . . . . 6.2699999999999996 111.098 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.24 122.28 9.53 Favored 'Trans proline' 0 C--N 1.394 2.962 0 C-N-CA 122.618 2.212 . . . . 6.5899999999999999 115.123 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -135.87 136.23 22.97 Favored Pre-proline 0 CA--C 1.564 1.502 0 CA-C-N 114.861 -1.063 . . . . 5.5099999999999998 111.16 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -84.45 -156.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 123.362 2.708 . . . . 6.7699999999999996 114.049 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 165.22 104.7 0.18 Allowed Glycine 0 C--N 1.341 0.812 0 C-N-CA 120.776 -0.726 . . . . 7.0199999999999996 113.442 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.75 119.73 35.27 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.029 0.442 . . . . 8.9900000000000002 111.714 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.403 -0.808 . . . . 10.6 111.164 -179.812 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.52 -0.232 . . . . 8.9299999999999997 112.52 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.27 129.82 55.86 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.528 0.68 . . . . 6.8200000000000003 111.818 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.5 mtt -132.4 120.09 21.54 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.77 -0.65 . . . . 7.6399999999999997 111.709 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 m -137.23 110.09 7.64 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.66 -0.7 . . . . 3.8599999999999999 111.311 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.11 -46.79 0.03 OUTLIER Glycine 0 C--N 1.341 0.818 0 N-CA-C 114.755 0.662 . . . . 1.1100000000000001 114.755 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.649 ' HG ' HD11 ' A' ' 27' ' ' ILE . 21.2 tp -85.29 -39.73 17.38 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.145 0.794 . . . . 0.34999999999999998 113.145 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.57 -23.81 64.94 Favored 'General case' 0 N--CA 1.506 2.331 0 C-N-CA 125.506 1.522 . . . . 0.20000000000000001 114.414 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.89 -9.92 54.59 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 113.606 0.965 . . . . 0.32000000000000001 113.606 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 48.8 mmtt -104.47 -27.02 12.16 Favored 'General case' 0 C--N 1.364 1.23 0 N-CA-C 113.327 0.862 . . . . 1.73 113.327 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.33 137.01 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.077 0 N-CA-C 115.764 1.764 . . . . 0.11 115.764 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pt -122.06 -30.09 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 115.559 -0.746 . . . . 0.16 112.409 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -164.36 116.7 1.32 Allowed 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 120.654 0.264 . . . . 0.54000000000000004 111.302 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.98 136.42 38.5 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.602 -0.686 . . . . 0.19 111.719 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.518 HG21 ' HG3' ' A' ' 33' ' ' PRO 0.304 14.9 p -150.02 137.65 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.555 0 N-CA-C 115.796 1.776 . . . . 1.05 115.796 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 59.2 t30 -114.18 111.34 21.4 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-N 115.264 -0.88 . . . . 2.1099999999999999 108.726 174.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.96 106.8 13.25 Favored 'General case' 0 C--O 1.271 2.211 0 CA-C-O 121.455 0.645 . . . . 0.63 110.323 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.512 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 171.92 -61.42 0.16 Allowed Glycine 0 C--N 1.362 1.998 0 CA-C-N 112.445 -2.161 . . . . 0.70999999999999996 114.358 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.01 -110.45 3.37 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 114.371 0.508 . . . . 0.80000000000000004 114.371 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -170.92 117.85 0.48 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.834 0.454 . . . . 1.6299999999999999 111.782 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.1 m 43.95 114.38 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.368 0 N-CA-C 119.235 3.05 . . . . 1.0 119.235 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 47.4 t-80 -144.97 139.81 27.77 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 113.399 0.888 . . . . 0.45000000000000001 113.399 177.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.267 8.2 p -106.02 114.23 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 CA-C-N 115.015 -0.993 . . . . 1.3899999999999999 110.124 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -84.59 162.7 19.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.776 -1.102 . . . . 1.8500000000000001 113.12 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 m -41.38 -28.79 0.18 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.266 0 N-CA-C 119.868 3.285 . . . . 0.71999999999999997 119.868 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -90.15 -19.76 23.88 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.856 0.753 . . . . 0.51000000000000001 111.87 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.65 39.32 1.47 Allowed Glycine 0 C--N 1.353 1.517 0 C-N-CA 124.443 1.021 . . . . 0.34000000000000002 113.868 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.649 HD11 ' HG ' ' A' ' 6' ' ' LEU . 30.1 mm -106.83 124.91 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 C-N-CA 123.096 0.558 . . . . 0.55000000000000004 109.597 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.1 t60 -110.26 130.7 55.5 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 114.656 1.354 . . . . 1.3400000000000001 114.656 -178.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -84.15 136.74 33.86 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 124.479 1.111 . . . . 2.79 110.413 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.89 100.34 12.82 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 124.78 1.3 . . . . 3.0 114.266 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -38.79 110.96 0.15 Allowed 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 128.133 2.573 . . . . 2.2999999999999998 117.846 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER 46.34 76.16 0.58 Allowed Pre-proline 0 N--CA 1.525 3.317 0 N-CA-C 117.099 2.259 . . . . 1.1699999999999999 117.099 177.376 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.518 ' HG3' HG21 ' A' ' 14' ' ' VAL . 68.3 Cg_endo -95.07 -12.15 0.9 Allowed 'Trans proline' 0 CA--C 1.56 1.803 0 N-CA-C 117.584 2.109 . . . . 1.45 117.584 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.7 -24.22 1.54 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.849 1.796 . . . . 1.9099999999999999 115.849 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -99.72 70.12 1.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 119.551 1.068 . . . . 4.8399999999999999 112.562 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . 105.85 -29.3 11.51 Favored Glycine 0 CA--C 1.542 1.752 0 CA-C-N 115.685 -0.689 . . . . 2.3700000000000001 114.782 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 52.64 53.08 12.79 Favored 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 127.219 2.208 . . . . 4.5 115.375 -179.064 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.18 179.82 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 C-N-CA 124.772 1.229 . . . . 2.7000000000000002 110.442 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.94 94.48 1.93 Allowed Glycine 0 N--CA 1.478 1.495 0 O-C-N 121.611 -0.68 . . . . 1.95 114.754 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 -153.41 131.75 12.03 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.312 0.577 . . . . 5.3399999999999999 111.963 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.34 137.19 50.84 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.181 0.992 . . . . 1.6399999999999999 111.323 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 m -124.62 121.7 35.47 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.711 -0.677 . . . . 1.5700000000000001 111.66 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.1 104.34 4.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.821 -0.627 . . . . 2.3300000000000001 110.559 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -97.77 -45.83 6.19 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.866 -0.606 . . . . 3.1600000000000001 111.875 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -108.99 73.07 0.2 Allowed Glycine 0 C--N 1.354 1.541 0 N-CA-C 111.053 -0.819 . . . . 1.52 111.053 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.9 ttt -92.78 0.07 57.35 Favored 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 115.473 1.657 . . . . 1.6699999999999999 115.473 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.06 35.24 3.33 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 112.936 0.717 . . . . 4.1799999999999997 112.936 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.6 tp -137.27 77.05 42.64 Favored Pre-proline 0 C--N 1.35 0.602 0 C-N-CA 124.171 0.988 . . . . 2.6299999999999999 108.431 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 51.1 Cg_exo -63.34 155.05 64.33 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.862 3.041 . . . . 1.3700000000000001 117.196 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.279 1.2 mp -89.65 125.91 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.12 0 CA-C-N 114.98 -1.009 . . . . 0.68999999999999995 109.277 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.39 -19.01 43.53 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.478 2.029 . . . . 1.28 116.478 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.38 24.66 7.79 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 113.957 1.095 . . . . 1.51 113.957 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.36 -175.07 4.57 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-O 121.451 0.643 . . . . 1.0900000000000001 111.7 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.788 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.56 -176.87 0.58 Allowed Pre-proline 0 N--CA 1.511 2.588 0 C-N-CA 123.985 0.914 . . . . 1.27 109.198 177.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -68.86 -39.95 7.6 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.48 2.12 . . . . 0.94999999999999996 113.719 176.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -68.88 -49.18 60.43 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 125.298 1.439 . . . . 2.04 112.549 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -6.57 58.76 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-N 114.921 -1.036 . . . . 1.6200000000000001 112.57 177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.788 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 22.1 tt0 -73.54 -40.49 63.93 Favored 'General case' 0 C--N 1.381 1.952 0 C-N-CA 125.278 1.431 . . . . 1.77 108.075 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.5 t -61.35 -44.57 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.068 0 C-N-CA 124.353 1.061 . . . . 0.81000000000000005 109.094 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.9 tp -75.97 -11.91 60.04 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 114.77 1.396 . . . . 1.1499999999999999 114.77 177.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -124.22 22.16 8.66 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 123.672 0.789 . . . . 0.92000000000000004 112.534 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -143.89 -27.4 0.53 Allowed 'General case' 0 N--CA 1.52 3.032 0 N-CA-C 115.813 1.783 . . . . 1.3300000000000001 115.813 -177.763 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 p -75.29 130.82 39.72 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 113.614 0.968 . . . . 1.28 113.614 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.512 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -116.71 139.64 50.32 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 115.306 1.595 . . . . 1.53 115.306 -176.576 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.49 128.45 55.0 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.11 -0.95 . . . . 3.2200000000000002 111.496 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -132.04 124.86 30.12 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 116.033 -0.53 . . . . 3.6600000000000001 110.963 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.9 -61.47 0.49 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 113.812 1.041 . . . . 4.7000000000000002 113.812 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -123.81 -135.14 0.28 Allowed 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 113.807 1.04 . . . . 2.5499999999999998 113.807 -177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.64 124.68 5.6 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.58 1.152 . . . . 2.1499999999999999 109.45 -177.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.58 79.49 0.1 Allowed 'General case' 0 N--CA 1.515 2.778 0 C-N-CA 125.083 1.353 . . . . 0.77000000000000002 109.963 -177.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -135.44 141.31 45.39 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.276 -0.875 . . . . 0.81000000000000005 113.13 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -134.48 174.36 21.02 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 116.62 1.408 . . . . 0.46999999999999997 116.62 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -113.94 156.55 23.8 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 113.814 -1.193 . . . . 0.89000000000000001 113.375 -177.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.83 125.4 47.44 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.024 -0.989 . . . . 0.51000000000000001 111.904 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.77 102.69 38.09 Favored Pre-proline 0 CA--C 1.566 1.561 0 CA-C-N 115.458 -0.792 . . . . 0.14999999999999999 108.957 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -84.0 117.53 2.26 Favored 'Trans proline' 0 CA--C 1.562 1.884 0 C-N-CA 122.155 1.903 . . . . 0.14999999999999999 114.44 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.05 157.48 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 CA-C-O 122.068 0.937 . . . . 0.19 111.511 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -144.46 14.66 1.61 Allowed 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 114.542 -1.208 . . . . 2.5299999999999998 112.61 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -125.04 172.88 9.09 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-N 118.711 0.687 . . . . 2.1200000000000001 112.489 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -130.83 144.05 51.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.814 0.816 . . . . 0.41999999999999998 112.822 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.1 -135.4 4.29 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.436 -1.256 . . . . 0.23000000000000001 112.322 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.574 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 40.6 mm-40 -114.12 112.56 23.4 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 118.039 0.92 . . . . 1.75 111.266 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -104.64 133.57 49.26 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 122.075 -0.391 . . . . 0.20999999999999999 110.826 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -118.66 124.04 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.703 0.763 . . . . 0.20000000000000001 111.202 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.48 110.5 22.45 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.168 -1.378 . . . . 0.78000000000000003 110.699 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 0.2 OUTLIER -119.22 129.09 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 115.266 -0.879 . . . . 0.44 108.707 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.28 137.4 46.01 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.117 0.784 . . . . 1.25 113.117 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 127' ' ' HIS . 3.0 tppt? -101.69 114.06 27.77 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.759 -0.655 . . . . 2.52 109.907 176.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 11.6 m-85 -103.63 134.46 46.94 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.381 -0.827 . . . . 0.40000000000000002 110.339 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.44 151.54 47.53 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.629 -0.714 . . . . 0.40999999999999998 111.253 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -128.16 142.93 51.04 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-O 121.271 0.558 . . . . 2.6099999999999999 112.254 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.18 -36.02 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 115.59 -0.732 . . . . 2.1299999999999999 112.678 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.62 142.04 51.43 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.192 0.597 . . . . 2.27 111.707 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 92.75 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 126.477 1.911 . . . . 1.46 111.248 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.17 85.39 2.65 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-O 123.002 1.382 . . . . 0.83999999999999997 111.529 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -151.17 145.04 25.15 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.318 -1.31 . . . . 2.4500000000000002 112.292 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.1 m -120.84 120.27 35.08 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.507 -0.769 . . . . 1.6599999999999999 112.223 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 72.33 56.64 0.15 Allowed 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 125.899 1.68 . . . . 1.8899999999999999 112.531 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -157.19 -41.97 0.07 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.286 1.434 . . . . 2.5600000000000001 109.092 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -105.1 83.39 1.97 Allowed 'General case' 0 C--N 1.361 1.086 0 N-CA-C 108.383 -0.969 . . . . 2.7599999999999998 108.383 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.85 132.71 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 114.748 -1.114 . . . . 0.68999999999999995 111.675 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -114.58 178.54 4.24 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.353 1.612 . . . . 0.69999999999999996 115.353 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -126.5 141.72 51.78 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.604 0.594 . . . . 1.3300000000000001 112.604 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.71 125.01 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.368 0 C-N-CA 123.686 0.794 . . . . 0.47999999999999998 109.302 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.61 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 25.6 mtt180 -124.51 146.91 48.71 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.097 1.518 . . . . 1.6899999999999999 115.097 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 2.5 m -120.21 106.8 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.833 0 N-CA-C 112.996 0.739 . . . . 0.59999999999999998 112.996 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.466 ' ND2' ' HA ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 64.38 25.07 13.35 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 126.49 1.916 . . . . 1.1200000000000001 114.736 -178.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.85 -12.91 45.93 Favored Glycine 0 CA--C 1.55 2.261 0 CA-C-N 115.827 -0.624 . . . . 0.32000000000000001 113.446 -176.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.61 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 96.8 m-70 -87.35 169.34 12.35 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.078 1.751 . . . . 0.56999999999999995 112.784 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.28 133.6 55.14 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.573 0.702 . . . . 0.55000000000000004 112.462 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.94 -55.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 114.731 -1.122 . . . . 1.0600000000000001 112.898 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.14 88.89 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.021 -1.103 . . . . 0.44 108.021 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -111.14 77.6 1.05 Allowed 'General case' 0 C--N 1.354 0.775 0 CA-C-O 122.867 1.318 . . . . 2.2999999999999998 110.588 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 152.44 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 111.205 -2.725 . . . . 2.48 108.578 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.35 99.93 12.36 Favored 'General case' 0 C--N 1.362 1.117 0 N-CA-C 113.708 1.003 . . . . 1.1299999999999999 113.708 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -114.26 99.49 7.64 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 113.175 -1.83 . . . . 2.3500000000000001 107.565 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.74 -29.89 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.441 0 N-CA-C 114.313 1.227 . . . . 0.68000000000000005 114.313 -176.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -75.45 -37.17 60.49 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.539 0.736 . . . . 0.77000000000000002 112.415 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.54 -26.9 60.27 Favored 'General case' 0 CA--C 1.577 1.987 0 C-N-CA 124.533 1.133 . . . . 0.91000000000000003 113.262 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -77.33 -55.27 5.54 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.386 0.884 . . . . 2.4300000000000002 113.386 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.18 -39.04 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 N-CA-C 113.985 1.105 . . . . 0.93000000000000005 113.985 177.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.46 -70.86 0.21 Allowed Glycine 0 C--N 1.359 1.849 0 CA-C-N 118.206 0.457 . . . . 0.84999999999999998 113.556 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -106.28 175.56 5.46 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.467 1.107 . . . . 3.1800000000000002 111.232 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.1 m -70.87 85.95 0.69 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 113.692 0.997 . . . . 2.0800000000000001 113.692 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 126' ' ' ALA . 2.9 p -134.76 -156.64 0.74 Allowed 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 114.028 -1.442 . . . . 0.62 109.476 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.433 ' H ' ' HB ' ' A' ' 125' ' ' THR . . . -105.83 128.36 53.69 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 113.15 0.796 . . . . 0.46000000000000002 113.15 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 7.9 t60 -101.82 139.43 37.47 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.265 0.626 . . . . 0.38 109.322 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -144.79 130.43 19.01 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.28 0.845 . . . . 2.5 113.28 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -121.75 136.69 54.94 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 115.304 -0.862 . . . . 1.5600000000000001 111.317 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.81 126.45 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 114.718 -1.128 . . . . 0.45000000000000001 110.767 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.6 mp -132.88 92.53 25.92 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-N 115.472 -0.785 . . . . 0.83999999999999997 110.498 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -76.5 131.19 12.39 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 122.875 2.383 . . . . 0.16 113.175 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.23 153.34 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 C-N-CA 124.194 0.998 . . . . 0.38 111.115 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.1 p -136.09 117.62 14.83 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.633 0.605 . . . . 1.3100000000000001 112.633 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.5 mt -116.16 127.62 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 N-CA-C 108.769 -0.826 . . . . 0.25 108.769 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -140.84 126.0 18.48 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.923 -0.58 . . . . 2.0499999999999998 110.984 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? 68.8 14.91 8.98 Favored 'General case' 0 N--CA 1.516 2.853 0 C-N-CA 125.205 1.402 . . . . 3.5499999999999998 114.151 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.12 16.13 36.39 Favored Glycine 0 CA--C 1.546 1.988 0 CA-C-O 119.291 -0.727 . . . . 0.37 114.359 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 51.9 mtpt -125.38 144.57 50.44 Favored 'General case' 0 C--N 1.366 1.283 0 CA-C-N 118.175 0.988 . . . . 1.5600000000000001 112.48 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 148.21 23.28 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.798 1.406 . . . . 0.34000000000000002 114.798 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.6 114.12 9.71 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.234 -1.348 . . . . 0.64000000000000001 110.201 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.2 p -121.67 96.01 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.334 0 CA-C-N 115.999 -0.546 . . . . 0.46000000000000002 110.705 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 68.39 -83.94 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 C-N-CA 125.586 1.554 . . . . 1.5600000000000001 113.751 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.69 26.81 3.79 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.891 -0.595 . . . . 0.48999999999999999 113.129 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -130.12 123.56 30.66 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 123.532 0.733 . . . . 1.8200000000000001 110.346 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.4 p -118.4 130.05 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.237 0 CA-C-O 121.48 0.657 . . . . 1.02 111.51 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.9 p -151.49 -173.3 4.47 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.202 -0.908 . . . . 0.56000000000000005 110.344 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.272 14.3 t -104.35 138.29 40.98 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 113.661 0.986 . . . . 1.25 113.661 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -84.73 126.38 33.35 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.441 1.096 . . . . 0.28999999999999998 111.19 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.77 91.77 3.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.216 0.821 . . . . 1.4199999999999999 113.216 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.18 -64.8 3.69 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 119.192 2.437 . . . . 0.41999999999999998 119.192 176.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -135.33 159.28 42.05 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.466 0.913 . . . . 1.1000000000000001 113.466 -176.168 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.524 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -105.27 142.59 34.77 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.952 -1.476 . . . . 0.67000000000000004 109.816 177.319 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 t -124.53 127.22 47.1 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 114.023 1.119 . . . . 0.35999999999999999 114.023 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 16.3 t -106.59 97.19 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 105.862 -1.903 . . . . 0.73999999999999999 105.862 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.74 122.7 44.42 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.971 -1.013 . . . . 1.6699999999999999 112.594 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -107.13 119.03 38.28 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 114.474 -1.239 . . . . 1.8 109.766 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.14 137.31 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 CA-C-N 113.579 -1.646 . . . . 0.57999999999999996 109.649 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -58.37 151.2 20.33 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 127.509 2.323 . . . . 2.1800000000000002 116.756 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -109.5 -62.7 0.53 Allowed Glycine 0 CA--C 1.538 1.478 0 CA-C-N 115.193 -0.912 . . . . 1.02 113.365 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -135.13 -71.34 0.48 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.781 0.659 . . . . 2.8599999999999999 112.781 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -112.19 -59.29 2.02 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 122.775 0.43 . . . . 3.9100000000000001 112.056 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.4 156.33 16.39 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.692 0.797 . . . . 1.74 110.388 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -97.71 -94.8 0.0 OUTLIER Pre-proline 0 CA--C 1.58 2.126 0 CA-C-O 116.512 -1.708 . . . . 1.6799999999999999 110.898 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.51 -37.21 0.11 Allowed 'Trans proline' 0 C--N 1.402 3.355 0 CA-C-N 124.886 2.781 . . . . 2.0600000000000001 115.004 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.4 tptt 82.06 -81.74 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 126.261 1.825 . . . . 3.0 108.859 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 45.5 t -112.51 129.53 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.716 -1.216 . . . . 0.80000000000000004 107.716 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 8.8 t -135.37 116.79 14.69 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.928 0.768 . . . . 0.87 112.341 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . 0.274 . . -109.44 47.51 0.93 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.337 2.347 . . . . 0.34000000000000002 117.337 -176.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.25 134.1 1.68 Allowed 'General case' 0 N--CA 1.516 2.846 0 N-CA-C 116.109 1.892 . . . . 0.69999999999999996 116.109 177.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.418 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 3.1 t80 -151.6 100.46 2.71 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.068 -0.514 . . . . 0.20999999999999999 110.906 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.3 5.5 tt -111.52 121.87 64.88 Favored 'Isoleucine or valine' 0 C--O 1.269 2.088 0 CA-C-O 122.268 1.032 . . . . 0.31 110.969 176.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -122.34 168.68 11.77 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.528 -1.215 . . . . 0.44 112.08 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 24.9 tptp -113.4 141.67 46.8 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 118.298 2.703 . . . . 1.26 118.298 -173.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.12 -40.49 2.45 Favored Glycine 0 CA--C 1.542 1.735 0 N-CA-C 121.213 3.245 . . . . 0.17000000000000001 121.213 171.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.93 157.17 1.42 Allowed 'General case' 0 N--CA 1.525 3.291 0 CA-C-N 121.622 2.711 . . . . 0.14999999999999999 113.91 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.16 -13.22 59.95 Favored 'General case' 0 CA--C 1.58 2.108 0 C-N-CA 124.954 1.301 . . . . 0.17000000000000001 114.087 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.34 2.49 50.15 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 113.692 0.997 . . . . 0.55000000000000004 113.692 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.561 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -106.11 -8.89 17.23 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.98 0.912 . . . . 0.59999999999999998 113.29 179.211 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.42 89.11 0.56 Allowed Pre-proline 0 N--CA 1.503 2.223 0 C-N-CA 123.866 0.866 . . . . 0.94999999999999996 112.102 178.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 41.4 Cg_endo -93.5 153.71 2.43 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.631 2.22 . . . . 1.8 114.88 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 67.6 mtt -133.18 104.91 6.72 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.708 -0.678 . . . . 4.96 110.863 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.7 mt -129.36 170.16 13.99 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.134 0.968 . . . . 4.0 113.029 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -111.21 159.52 32.5 Favored Pre-proline 0 CA--C 1.557 1.243 0 CA-C-N 114.456 -1.247 . . . . 6.2699999999999996 111.061 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.34 123.62 11.42 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 122.954 2.436 . . . . 6.5899999999999999 115.039 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.444 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 31.6 t60 -133.51 131.86 21.59 Favored Pre-proline 0 CA--C 1.565 1.542 0 CA-C-N 115.194 -0.912 . . . . 5.5099999999999998 111.912 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.444 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 11.8 Cg_endo -87.36 -157.58 0.07 OUTLIER 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 123.112 2.541 . . . . 6.7699999999999996 113.267 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 172.35 -130.96 2.02 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 120.697 -0.763 . . . . 7.0199999999999996 113.974 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.3 mt -118.95 111.65 18.62 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.163 0.431 . . . . 8.9900000000000002 112.163 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.449 -0.786 . . . . 10.6 110.53 179.608 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.548 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.6 tp . . . . . 0 CA--C 1.563 1.458 0 N-CA-C 113.041 0.756 . . . . 0.35 113.041 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.28 -24.78 65.22 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.957 1.703 . . . . 0.2 115.251 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.24 -12.02 47.97 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 113.665 0.987 . . . . 0.32 113.665 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 47.4 mttm -107.45 -18.1 13.95 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 113.954 1.094 . . . . 1.73 113.954 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -56.93 135.93 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.88 0 N-CA-C 114.905 1.446 . . . . 0.11 114.905 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.49 -28.53 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 115.394 -0.821 . . . . 0.16 112.495 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 69.3 t90 -162.83 117.9 1.77 Allowed 'General case' 0 CA--C 1.559 1.325 0 CA-C-N 117.872 0.306 . . . . 0.54 111.277 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -139.1 129.59 25.78 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.508 -0.745 . . . . 0.19 111.635 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.55 133.81 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 N-CA-C 112.928 0.714 . . . . 1.05 112.928 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 169' ' ' ALA . 6.0 t-20 -114.07 112.94 24.05 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.056 -1.461 . . . . 2.11 107.056 172.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -79.88 97.5 6.72 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-O 121.577 0.704 . . . . 0.63 111.947 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.434 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 176.28 -68.72 0.09 OUTLIER Glycine 0 C--N 1.358 1.758 0 CA-C-N 114.416 -1.266 . . . . 0.71 115.369 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.65 -116.23 3.66 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 114.651 0.62 . . . . 0.8 114.651 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -170.53 118.71 0.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.206 0.527 . . . . 1.63 111.389 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER 51.47 107.75 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.525 2.417 . . . . 1.0 117.525 177.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.553 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 79.7 t60 -137.08 134.98 37.07 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.869 1.063 . . . . 0.45 113.869 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.9 t -104.76 114.51 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 CA-C-N 113.813 -1.539 . . . . 1.39 107.214 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.48 161.15 17.17 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 119.521 -0.276 . . . . 1.85 111.558 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -45.06 -25.37 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.074 0 N-CA-C 119.12 3.007 . . . . 0.72 119.12 -176.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -92.04 -21.12 20.66 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 118.082 0.401 . . . . 0.51 111.427 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.86 39.64 1.28 Allowed Glycine 0 C--N 1.356 1.683 0 C-N-CA 124.288 0.947 . . . . 0.34 113.983 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.548 HD11 ' HG ' ' A' ' 6' ' ' LEU . 19.9 mm -105.85 124.98 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 109.094 -0.706 . . . . 0.55 109.094 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.553 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.7 t-160 -115.82 132.96 56.49 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 115.693 1.738 . . . . 1.34 115.693 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.8 144.78 27.05 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.726 -1.125 . . . . 2.79 108.999 174.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -67.31 -104.78 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.317 1.969 . . . . 3.0 116.317 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.1 tttt 176.8 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.233 1.013 . . . . 2.3 111.62 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 46.46 58.09 16.6 Favored Pre-proline 0 N--CA 1.533 3.705 0 N-CA-C 117.152 2.279 . . . . 1.17 117.152 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo . . . . . 0 CA--C 1.563 1.937 0 C-N-CA 123.066 2.511 . . . . 1.45 117.146 -177.501 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.401 ' HB3' ' CD ' ' A' ' 58' ' ' GLN . 38.7 Cg_exo . . . . . 0 N--CA 1.502 1.982 0 N-CA-C 116.908 1.849 . . . . 1.37 116.908 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.278 1.2 mp -86.95 133.21 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.273 0 CA-C-N 115.353 -0.839 . . . . 0.69 109.791 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.39 -18.39 36.25 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.944 2.201 . . . . 1.28 116.944 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -103.97 23.78 12.38 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.1 1.148 . . . . 1.51 114.1 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -138.11 -166.85 2.05 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.018 0.914 . . . . 1.09 112.803 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.658 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.3 t30 -94.69 -178.59 0.82 Allowed Pre-proline 0 CA--C 1.571 1.772 0 C-N-CA 125.586 1.555 . . . . 1.27 110.934 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.448 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.3 Cg_exo -72.31 -45.62 0.6 Allowed 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 122.91 2.406 . . . . 0.95 112.018 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -68.71 -52.32 32.05 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 113.32 -1.764 . . . . 2.04 111.863 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -75.65 -6.71 51.79 Favored 'General case' 0 CA--C 1.589 2.471 0 CA-C-N 115.353 -0.84 . . . . 1.62 112.692 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.658 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 4.2 tt0 -72.5 -42.31 65.0 Favored 'General case' 0 C--N 1.387 2.232 0 C-N-CA 125.631 1.573 . . . . 1.77 108.046 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.09 -42.34 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.045 0 C-N-CA 124.466 1.107 . . . . 0.81 109.341 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.9 tp -81.37 -6.35 58.82 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 113.946 1.091 . . . . 1.15 113.946 176.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -123.63 20.5 9.43 Favored 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 124.64 1.176 . . . . 0.92 112.173 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.67 -35.04 0.31 Allowed 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 116.134 1.902 . . . . 1.33 116.134 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.1 p -70.99 130.17 40.9 Favored 'General case' 0 N--CA 1.529 3.508 0 N-CA-C 115.011 1.486 . . . . 1.28 115.011 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.608 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.5 pt-20 . . . . . 0 N--CA 1.503 2.178 0 C-N-CA 124.55 1.14 . . . . 1.53 111.019 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 119.908 -0.092 . . . . 2.15 111.073 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.665 ' H ' HD21 ' A' ' 164' ' ' ASN . 0.2 OUTLIER 55.03 89.51 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 125.805 1.642 . . . . 0.77 113.648 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -150.45 160.9 43.43 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.114 1.153 . . . . 0.81 114.114 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -176.93 -173.05 42.15 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 116.429 1.332 . . . . 0.47 116.429 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -107.93 171.99 7.09 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.35 1.982 . . . . 0.89 116.35 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.16 121.2 28.93 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 113.108 -1.86 . . . . 0.51 111.188 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.82 106.41 49.97 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 123.339 0.656 . . . . 0.15 109.262 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.05 117.54 2.24 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 122.08 1.853 . . . . 0.15 114.825 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.78 157.47 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 122.084 0.945 . . . . 0.19 110.981 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -146.83 20.05 1.28 Allowed 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.667 -1.151 . . . . 2.53 111.824 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -131.85 159.71 37.77 Favored 'General case' 0 C--N 1.362 1.15 0 CA-C-O 121.29 0.567 . . . . 2.12 111.897 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -116.62 148.17 41.2 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.869 1.063 . . . . 0.42 113.869 -178.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.78 -138.08 5.52 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.117 -1.401 . . . . 0.23 112.38 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 36.4 mm-40 -115.56 104.05 11.34 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-N 118.082 0.941 . . . . 1.75 110.898 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -99.73 128.27 45.83 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.174 0.512 . . . . 0.21 110.882 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -113.32 123.48 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.418 0.628 . . . . 0.2 111.004 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.47 HD12 HD12 ' A' ' 172' ' ' ILE . 2.6 tt -108.69 105.26 14.78 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.728 -1.124 . . . . 0.78 110.109 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 1.7 t -114.54 122.27 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.134 -1.393 . . . . 0.44 107.633 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -131.7 136.73 47.88 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.661 -0.7 . . . . 1.25 111.8 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 5.1 tppt? -97.66 123.64 41.66 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.622 0.725 . . . . 2.52 112.519 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -105.78 133.21 50.88 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.847 -1.07 . . . . 0.4 109.887 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.15 158.99 43.21 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.792 -0.64 . . . . 0.41 111.599 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -124.12 170.18 10.96 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-O 121.454 0.645 . . . . 2.61 112.667 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.95 -73.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 115.884 -0.598 . . . . 2.13 112.423 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.85 67.28 1.51 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.14 0.495 . . . . 2.27 111.927 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -144.59 102.32 3.8 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.866 -0.606 . . . . 1.46 110.279 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.88 100.51 10.01 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 122.329 1.061 . . . . 0.84 111.856 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -166.43 139.88 4.02 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 114.73 -1.123 . . . . 2.45 111.748 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.4 m -125.46 116.25 21.53 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.701 -0.681 . . . . 1.66 111.81 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 73.24 49.45 0.15 Allowed 'General case' 0 N--CA 1.508 2.463 0 C-N-CA 125.673 1.589 . . . . 1.89 113.055 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -151.36 -40.99 0.12 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.24 1.416 . . . . 2.56 109.212 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -100.59 78.88 2.03 Favored 'General case' 0 C--N 1.365 1.268 0 N-CA-C 108.468 -0.938 . . . . 2.76 108.468 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.8 130.19 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 114.677 -1.147 . . . . 0.69 111.456 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -115.66 172.77 6.91 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.996 1.48 . . . . 0.7 114.996 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -122.87 137.83 54.83 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.855 -0.611 . . . . 1.33 111.702 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -131.75 128.04 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.483 0 CA-C-N 115.273 -0.876 . . . . 0.48 110.012 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -129.22 151.81 49.48 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.366 1.617 . . . . 1.69 115.366 -177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.3 OUTLIER -130.1 113.05 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 C-N-CA 123.355 0.662 . . . . 0.6 112.382 177.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.11 25.61 12.49 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 127.013 2.125 . . . . 1.12 114.095 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.53 -16.13 52.53 Favored Glycine 0 CA--C 1.548 2.154 0 CA-C-N 115.6 -0.727 . . . . 0.32 113.682 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 94.0 m-70 -83.75 144.68 29.17 Favored 'General case' 0 C--N 1.365 1.241 0 C-N-CA 125.53 1.532 . . . . 0.57 114.496 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.94 126.88 42.39 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.326 0.584 . . . . 0.55 110.863 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.95 -58.63 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 115.098 -0.956 . . . . 1.06 113.13 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.06 89.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.263 -1.014 . . . . 0.44 108.263 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.65 73.69 0.86 Allowed 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 123.134 1.445 . . . . 2.3 112.317 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 p30 158.14 62.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 127.871 2.468 . . . . 2.48 107.243 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.2 tp -101.92 100.93 11.28 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.184 1.179 . . . . 1.13 114.184 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -112.71 108.61 17.7 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-N 113.401 -1.727 . . . . 2.35 109.675 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -26.69 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.547 0 N-CA-C 114.725 1.38 . . . . 0.68 114.725 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -76.3 -42.73 44.29 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 123.303 0.641 . . . . 0.77 112.335 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -73.91 -26.37 60.49 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 124.176 0.99 . . . . 0.91 113.563 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -78.65 -57.7 3.63 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.765 1.024 . . . . 2.43 113.765 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -31.45 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 114.712 1.375 . . . . 0.93 114.712 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.23 -114.94 2.4 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 118.578 0.626 . . . . 0.85 112.945 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -114.76 107.58 15.63 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.216 0.531 . . . . 3.18 110.545 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 73.32 -128.62 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 125.59 1.556 . . . . 2.08 111.933 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.3 p 58.26 -171.02 0.11 Allowed 'General case' 0 N--CA 1.535 3.798 0 C-N-CA 126.159 1.783 . . . . 0.62 115.474 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.77 129.29 54.66 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 112.968 0.729 . . . . 0.46 112.968 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -105.72 136.54 45.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.249 0.619 . . . . 0.38 109.575 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -128.13 133.89 49.03 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.825 1.417 . . . . 2.5 114.825 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.16 118.74 32.7 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.418 -1.264 . . . . 1.56 110.844 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.02 112.21 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 115.19 -0.913 . . . . 0.45 110.636 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.75 93.01 43.38 Favored Pre-proline 0 CA--C 1.568 1.669 0 CA-C-N 115.532 -0.758 . . . . 0.84 110.709 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -74.33 138.27 24.55 Favored 'Trans proline' 0 C--N 1.397 3.097 0 C-N-CA 123.032 2.488 . . . . 0.16 113.686 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.11 146.94 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 CA-C-N 115.276 -0.875 . . . . 0.38 110.504 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.8 p -131.75 111.83 11.99 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.566 -0.743 . . . . 1.31 111.626 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.494 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.6 mt -111.59 122.83 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 108.539 -0.911 . . . . 0.25 108.539 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -142.5 130.24 21.56 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.857 -0.611 . . . . 2.05 111.192 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt 67.54 15.25 9.77 Favored 'General case' 0 N--CA 1.515 2.822 0 C-N-CA 125.096 1.358 . . . . 3.55 114.405 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.14 15.6 35.34 Favored Glycine 0 CA--C 1.549 2.17 0 CA-C-O 119.143 -0.809 . . . . 0.37 114.806 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 30.9 mtmt -128.89 155.6 45.0 Favored 'General case' 0 C--N 1.367 1.348 0 CA-C-N 118.442 1.121 . . . . 1.56 112.924 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.46 148.52 26.36 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.36 1.244 . . . . 0.34 114.36 -176.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.8 m -134.77 112.28 10.61 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.601 -1.181 . . . . 0.64 110.573 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 p -112.21 92.42 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.636 0 CA-C-O 121.196 0.522 . . . . 0.46 109.876 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 63.06 -84.26 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.866 0 C-N-CA 125.581 1.553 . . . . 1.56 114.241 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.64 28.1 4.53 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 116.206 -0.452 . . . . 0.49 113.768 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -137.05 119.23 15.54 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.25 0.62 . . . . 1.82 110.048 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.75 132.6 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 CA-C-O 121.57 0.7 . . . . 1.02 112.185 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -150.53 -179.31 7.12 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.043 -0.98 . . . . 0.56 109.818 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.262 12.8 t -103.14 138.22 40.26 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 113.628 0.974 . . . . 1.25 113.628 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -82.8 123.72 29.61 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.396 1.078 . . . . 0.29 111.288 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.19 91.22 3.28 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.804 0.668 . . . . 1.42 112.804 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.81 -63.87 3.41 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 119.014 2.366 . . . . 0.42 119.014 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.539 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -132.85 161.16 34.91 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.834 1.05 . . . . 1.1 113.834 -176.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.539 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -107.09 143.32 35.4 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 113.764 -1.562 . . . . 0.67 109.593 177.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 t -124.81 142.63 51.3 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.643 1.349 . . . . 0.36 114.643 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.446 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.93 97.43 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 106.926 -1.509 . . . . 0.74 106.926 176.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -113.72 118.44 34.33 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.758 -0.655 . . . . 1.67 111.968 -177.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.41 133.09 55.98 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-O 122.31 1.052 . . . . 1.8 111.191 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.22 145.77 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 113.018 -1.901 . . . . 0.58 110.548 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.437 ' HB3' ' OD1' ' A' ' 164' ' ' ASN . 41.0 pttt -58.16 151.17 19.63 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 116.97 2.211 . . . . 2.18 116.97 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.67 -60.34 0.56 Allowed Glycine 0 CA--C 1.539 1.533 0 CA-C-N 115.093 -0.958 . . . . 1.02 113.68 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -141.52 -61.0 0.47 Allowed 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.967 0.384 . . . . 2.86 111.717 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -117.49 -49.49 2.56 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.939 0.496 . . . . 3.91 112.077 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.35 178.57 4.55 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.464 0.705 . . . . 1.74 111.459 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.665 HD21 ' H ' ' A' ' 70' ' ' SER . 5.3 m-20 -118.28 -85.93 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.045 0 CA-C-O 117.356 -1.307 . . . . 1.68 110.275 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -87.49 -37.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.398 3.176 0 CA-C-N 123.648 2.338 . . . . 2.06 114.436 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.1 ttpm? 79.86 -94.02 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 126.495 1.918 . . . . 3.0 110.366 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 64' ' ' GLU . 17.5 t -106.42 131.29 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.413 -1.328 . . . . 0.8 107.413 174.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.2 t -134.59 129.94 35.74 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.94 -1.027 . . . . 0.87 112.841 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.268 . . -122.87 47.89 1.88 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.71 1.745 . . . . 0.34 115.71 -177.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -40.38 127.26 2.34 Favored 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 116.051 1.871 . . . . 0.7 116.051 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.475 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 4.8 t80 -147.55 100.88 3.29 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.912 -0.585 . . . . 0.21 111.101 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.47 HD12 HD12 ' A' ' 85' ' ' LEU 0.305 10.1 tt -109.86 121.3 62.55 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.061 0 CA-C-O 122.427 1.108 . . . . 0.31 111.011 175.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -123.34 165.35 17.15 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 113.873 -1.512 . . . . 0.44 110.734 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 18.7 ptmt -122.14 159.35 27.37 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 118.139 2.644 . . . . 1.26 118.139 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.62 -41.59 2.11 Favored Glycine 0 CA--C 1.544 1.859 0 CA-C-N 110.11 -3.223 . . . . 0.17 119.053 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.61 154.18 0.94 Allowed 'General case' 0 N--CA 1.52 3.058 0 CA-C-N 120.782 2.291 . . . . 0.15 113.156 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.77 -13.33 59.87 Favored 'General case' 0 CA--C 1.58 2.125 0 C-N-CA 124.836 1.255 . . . . 0.17 114.353 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.55 4.78 45.59 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 113.86 1.059 . . . . 0.55 113.86 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.58 -9.89 15.28 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 114.312 1.227 . . . . 0.6 114.312 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.516 2.847 0 C-N-CA 124.424 1.09 . . . . 0.95 113.358 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.508 ' HG ' HD11 ' A' ' 27' ' ' ILE . 15.0 tp . . . . . 0 CA--C 1.566 1.584 0 N-CA-C 112.947 0.721 . . . . 0.35 112.947 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.4 -23.09 65.56 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 126.101 1.76 . . . . 0.2 115.274 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -11.65 51.71 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.727 1.01 . . . . 0.32 113.727 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 2.1 mmpt? -108.57 -19.23 13.51 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 113.514 0.931 . . . . 1.73 113.514 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.03 135.75 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.936 0 N-CA-C 115.257 1.577 . . . . 0.11 115.257 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.5 -29.83 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 115.287 -0.869 . . . . 0.16 112.095 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -163.07 123.3 2.28 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-O 120.572 0.225 . . . . 0.54 110.953 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -140.93 128.55 21.46 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.351 -0.843 . . . . 0.19 110.777 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.1 t -136.57 131.06 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.507 0.928 . . . . 1.05 113.507 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -116.7 110.88 19.03 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.304 -0.999 . . . . 2.11 108.304 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.59 100.11 9.95 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-O 122.223 1.011 . . . . 0.63 110.437 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.51 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -179.74 -57.54 0.08 OUTLIER Glycine 0 C--N 1.348 1.232 0 CA-C-N 113.594 -1.639 . . . . 0.71 115.528 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.4 -115.9 3.29 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 120.038 -0.312 . . . . 0.8 113.795 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -165.11 117.73 1.2 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.359 0.264 . . . . 1.63 111.565 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 2.8 m 41.71 106.04 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.155 0 N-CA-C 118.075 2.62 . . . . 1.0 118.075 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.636 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 82.7 t60 -134.07 138.3 45.21 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.041 1.126 . . . . 0.45 114.041 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.261 8.0 p -108.64 117.48 54.2 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.073 0 CA-C-N 114.202 -1.363 . . . . 1.39 110.254 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.07 156.97 23.05 Favored 'General case' 0 CA--C 1.571 1.757 0 CA-C-N 114.343 -1.298 . . . . 1.85 110.676 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 m -41.4 -32.69 0.36 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.153 0 N-CA-C 119.113 3.005 . . . . 0.72 119.113 -176.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.41 ' HB2' HD23 ' A' ' 6' ' ' LEU . 63.8 m-70 -88.42 -26.87 21.9 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.312 0.505 . . . . 0.51 110.909 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.94 43.43 0.41 Allowed Glycine 0 C--N 1.35 1.334 0 CA-C-N 114.994 -1.003 . . . . 0.34 114.701 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.508 HD11 ' HG ' ' A' ' 6' ' ' LEU . 15.8 mm -106.79 112.66 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 N-CA-C 109.687 -0.486 . . . . 0.55 109.687 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.636 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.74 134.85 48.19 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 115.189 1.552 . . . . 1.34 115.189 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -96.14 143.09 27.57 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.731 -1.122 . . . . 2.79 110.08 176.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -97.44 103.37 15.3 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.226 1.011 . . . . 3.0 113.381 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -33.79 116.7 0.28 Allowed 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 118.51 2.781 . . . . 2.3 118.51 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 40.37 73.43 0.85 Allowed Pre-proline 0 N--CA 1.525 3.318 0 N-CA-C 118.178 2.658 . . . . 1.17 118.178 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 CA--C 1.56 1.777 0 C-N-CA 122.281 1.987 . . . . 1.45 116.69 179.404 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo . . . . . 0 N--CA 1.491 1.379 0 N-CA-C 117.042 1.901 . . . . 1.37 117.042 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.25 1.3 mp -91.45 136.72 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.243 0 CA-C-N 114.748 -1.114 . . . . 0.69 110.039 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.1 -10.45 33.3 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 115.991 1.848 . . . . 1.28 115.991 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -108.25 20.94 18.03 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 114.302 1.223 . . . . 1.51 114.302 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.53 -166.63 2.1 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 121.71 0.767 . . . . 1.09 112.789 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.85 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.8 t30 -90.25 177.7 2.25 Favored Pre-proline 0 N--CA 1.498 1.952 0 C-N-CA 125.411 1.484 . . . . 1.27 110.959 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -71.71 -46.99 0.51 Allowed 'Trans proline' 0 C--N 1.394 2.942 0 C-N-CA 122.998 2.465 . . . . 0.95 112.592 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 56' ' ' GLU . 3.6 pt-20 -69.75 -44.11 70.87 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 113.786 -1.552 . . . . 2.04 112.034 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -80.14 -7.21 58.81 Favored 'General case' 0 CA--C 1.587 2.371 0 CA-C-N 115.11 -0.95 . . . . 1.62 111.758 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.85 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.6 tt0 -73.31 -37.81 66.05 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 125.684 1.594 . . . . 1.77 108.737 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -64.01 -47.78 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.871 0 C-N-CA 125.777 1.631 . . . . 0.81 109.042 173.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.611 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 1.6 tp -80.12 -4.58 53.48 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.69 1.366 . . . . 1.15 114.69 177.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -113.17 3.46 16.06 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 124.639 1.176 . . . . 0.92 110.222 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.77 -115.95 0.14 Allowed 'General case' 0 CA--C 1.568 1.658 0 C-N-CA 124.479 1.112 . . . . 1.33 111.703 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.289 2.9 p 56.67 -84.48 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.12 0 C-N-CA 127.33 2.252 . . . . 1.28 116.144 -174.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.532 ' HB2' HG22 ' A' ' 167' ' ' VAL . 20.6 tt0 . . . . . 0 N--CA 1.526 3.351 0 C-N-CA 125.361 1.465 . . . . 1.53 114.227 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 112.355 0.502 . . . . 2.15 112.355 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.51 107.62 1.17 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 124.522 1.129 . . . . 0.77 112.35 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -100.45 129.28 46.39 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.403 -1.271 . . . . 0.81 110.651 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -133.73 132.88 6.64 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 118.716 2.247 . . . . 0.47 118.716 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -103.1 145.61 29.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.28 0.844 . . . . 0.89 113.28 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.9 117.96 32.13 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.383 -1.281 . . . . 0.51 111.897 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.45 HG21 HG21 ' A' ' 172' ' ' ILE . 3.2 mp -117.51 97.69 51.01 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.275 -0.875 . . . . 0.15 109.048 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -83.03 118.84 2.74 Favored 'Trans proline' 0 CA--C 1.558 1.705 0 C-N-CA 122.16 1.906 . . . . 0.15 114.755 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.92 159.18 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 CA-C-O 122.119 0.962 . . . . 0.19 111.433 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -146.36 17.97 1.35 Allowed 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 114.315 -1.311 . . . . 2.53 111.935 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -128.99 163.22 25.83 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 121.269 0.557 . . . . 2.12 111.466 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -124.18 146.65 48.55 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.8 1.037 . . . . 0.42 113.8 -178.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.72 -133.93 3.61 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.068 -1.423 . . . . 0.23 112.094 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 21.5 mt-10 -118.52 106.46 12.69 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 118.479 1.139 . . . . 1.75 111.106 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -98.97 128.85 45.21 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.485 0.66 . . . . 0.21 111.331 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.46 118.23 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-N 115.328 -0.851 . . . . 0.2 111.045 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.535 HD12 HD12 ' A' ' 172' ' ' ILE . 1.6 tt -107.83 105.06 14.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.228 -1.351 . . . . 0.78 109.81 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.88 125.41 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 114.229 -1.35 . . . . 0.44 108.741 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.14 137.17 54.16 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 112.762 0.652 . . . . 1.25 112.762 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 5.3 tptp -101.17 115.73 31.17 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.076 -0.965 . . . . 2.52 110.196 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -105.01 134.38 48.22 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.957 -0.565 . . . . 0.4 110.156 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.72 152.75 51.66 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.614 0.721 . . . . 0.41 111.899 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -126.1 150.59 48.09 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.3 -0.863 . . . . 2.61 110.449 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.96 -76.03 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 114.186 1.18 . . . . 2.13 114.186 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -124.27 73.17 1.22 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.059 0.763 . . . . 2.27 113.059 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -154.29 109.29 3.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.711 0.804 . . . . 1.46 109.668 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.42 104.78 14.21 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 122.192 0.996 . . . . 0.84 112.495 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -171.84 140.02 1.23 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.884 -1.053 . . . . 2.45 111.716 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.4 m -129.07 118.57 22.72 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.571 -0.74 . . . . 1.66 111.835 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 72.97 49.94 0.15 Allowed 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 125.793 1.637 . . . . 1.89 112.508 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -151.33 -40.48 0.12 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.476 1.111 . . . . 2.56 110.278 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -109.04 83.73 1.8 Allowed 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.464 -0.939 . . . . 2.76 108.464 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.85 126.57 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 113.888 -1.505 . . . . 0.69 111.651 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.54 -176.4 3.07 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.205 1.558 . . . . 0.7 115.205 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -128.42 136.98 51.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.092 -0.38 . . . . 1.33 111.29 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.9 t -130.23 125.26 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.279 0 C-N-CA 123.482 0.713 . . . . 0.48 109.918 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.3 mtt180 -121.97 153.26 38.76 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.406 1.632 . . . . 1.69 115.406 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.55 102.83 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 114.928 -1.033 . . . . 0.6 112.373 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.5 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.31 27.21 13.76 Favored 'General case' 0 N--CA 1.524 3.252 0 C-N-CA 126.876 2.07 . . . . 1.12 113.895 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.32 -18.59 35.63 Favored Glycine 0 CA--C 1.547 2.032 0 C-N-CA 121.375 -0.441 . . . . 0.32 113.235 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -86.07 173.8 9.62 Favored 'General case' 0 C--N 1.368 1.384 0 C-N-CA 125.491 1.517 . . . . 0.57 113.53 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.7 p -126.57 126.24 43.32 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.175 0.512 . . . . 0.55 111.278 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.263 9.1 p -112.41 -45.12 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 CA-C-N 115.263 -0.88 . . . . 1.06 111.072 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.66 89.19 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 109.013 -0.736 . . . . 0.44 109.013 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -105.74 90.68 3.47 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-O 122.986 1.374 . . . . 2.3 110.366 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 127.65 78.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 110.01 -3.268 . . . . 2.48 108.508 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.06 110.86 22.94 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 121.744 0.783 . . . . 1.13 112.916 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -119.0 98.84 6.38 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 106.899 -1.519 . . . . 2.35 106.899 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -25.54 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.32 0 N-CA-C 113.925 1.083 . . . . 0.68 113.925 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -75.71 -40.29 55.93 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.022 0.929 . . . . 0.77 112.311 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -73.26 -26.85 61.26 Favored 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 124.672 1.189 . . . . 0.91 113.388 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -80.66 -57.77 3.41 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.692 0.997 . . . . 2.43 113.692 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.33 -34.7 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 N-CA-C 114.864 1.431 . . . . 0.93 114.864 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 123.68 -109.22 1.28 Allowed Glycine 0 C--N 1.356 1.669 0 CA-C-N 118.764 0.711 . . . . 0.85 113.578 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -114.61 106.87 14.75 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.757 0.313 . . . . 3.18 110.707 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.8 m 68.09 -124.09 0.18 Allowed 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 125.379 1.471 . . . . 2.08 112.825 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.3 p 56.07 -164.09 0.14 Allowed 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 126.461 1.904 . . . . 0.62 115.134 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.449 ' HB1' ' HZ2' ' A' ' 88' ' ' LYS . . . -111.34 132.3 54.51 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 113.102 0.778 . . . . 0.46 113.102 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -107.72 143.69 35.89 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.035 0.534 . . . . 0.38 109.829 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.28 131.85 19.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.185 1.18 . . . . 2.5 114.185 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -119.94 134.14 55.34 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 115.145 -0.934 . . . . 1.56 110.827 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.47 122.36 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 114.652 -1.158 . . . . 0.45 110.835 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.78 86.24 58.78 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-N 115.361 -0.836 . . . . 0.84 110.823 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -73.88 126.23 10.52 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 123.015 2.477 . . . . 0.16 112.634 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -112.21 149.45 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.565 0 CA-C-N 115.153 -0.931 . . . . 0.38 111.428 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 p -130.33 110.63 11.67 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.1 -0.954 . . . . 1.31 111.661 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.2 mt -114.15 122.73 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 N-CA-C 108.477 -0.934 . . . . 0.25 108.477 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -141.04 127.36 19.78 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.658 -0.701 . . . . 2.05 110.76 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp 68.0 14.35 9.33 Favored 'General case' 0 N--CA 1.514 2.759 0 C-N-CA 125.287 1.435 . . . . 3.55 113.961 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 17.47 30.1 Favored Glycine 0 CA--C 1.547 2.059 0 CA-C-O 119.213 -0.771 . . . . 0.37 114.786 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 55.5 mtpt -124.42 146.38 48.93 Favored 'General case' 0 C--N 1.367 1.35 0 CA-C-N 118.378 1.089 . . . . 1.56 112.46 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.18 144.7 30.39 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.275 1.213 . . . . 0.34 114.275 -175.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.27 113.44 11.29 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.824 -1.08 . . . . 0.64 110.467 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.3 p -107.81 94.0 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.571 0 CA-C-N 115.929 -0.578 . . . . 0.46 110.226 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 66.95 -83.29 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.778 0 C-N-CA 125.527 1.531 . . . . 1.56 113.871 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.24 26.05 4.76 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 116.094 -0.503 . . . . 0.49 113.628 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -128.71 131.79 47.95 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 123.364 0.666 . . . . 1.82 110.57 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -116.14 130.62 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 CA-C-O 121.64 0.733 . . . . 1.02 111.981 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m -150.84 -179.1 6.99 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.975 -1.011 . . . . 0.56 109.592 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.271 14.1 t -104.25 138.79 40.19 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 113.425 0.898 . . . . 1.25 113.425 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -82.53 122.03 27.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 124.18 0.992 . . . . 0.29 111.349 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.79 90.53 3.26 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.48 0.548 . . . . 1.42 112.48 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.5 -62.69 2.69 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 118.92 2.328 . . . . 0.42 118.92 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.51 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -134.0 158.86 42.45 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.079 1.14 . . . . 1.1 114.079 -176.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.51 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -104.61 137.75 41.97 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.523 -1.671 . . . . 0.67 109.107 176.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.407 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.0 t -124.13 128.29 49.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.772 1.397 . . . . 0.36 114.772 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 3.2 t -106.56 101.42 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 106.689 -1.597 . . . . 0.74 106.689 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -117.64 120.71 38.84 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.882 -1.054 . . . . 1.67 112.746 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -113.74 126.93 55.78 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-O 122.177 0.989 . . . . 1.8 111.223 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.78 146.02 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-N 112.947 -1.933 . . . . 0.58 111.242 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -91.14 149.94 21.59 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 114.853 -1.067 . . . . 2.18 113.165 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -89.41 -43.98 5.09 Favored Glycine 0 CA--C 1.545 1.954 0 CA-C-N 115.634 -0.712 . . . . 1.02 114.859 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -128.99 -71.99 0.62 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.694 0.398 . . . . 2.86 110.992 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.605 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 6.8 t80 -146.65 120.42 9.24 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.319 0.647 . . . . 3.91 109.5 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 0.5 OUTLIER 90.64 151.93 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 125.033 1.333 . . . . 1.74 112.067 -178.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.65 -168.32 0.15 Allowed Pre-proline 0 CA--C 1.572 1.795 0 CA-C-N 113.994 -1.457 . . . . 1.68 109.434 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -57.76 -17.92 31.57 Favored 'Trans proline' 0 C--N 1.403 3.436 0 C-N-CA 122.937 2.425 . . . . 2.06 115.181 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 63.0 tttt 81.91 -63.99 0.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 126.665 1.986 . . . . 3.0 115.513 174.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 64' ' ' GLU . 4.0 t -102.61 134.27 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.602 1.092 . . . . 0.8 110.594 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.57 132.33 38.96 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 114.779 -1.101 . . . . 0.87 113.262 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -128.68 48.48 2.32 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.081 1.511 . . . . 0.34 115.081 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.93 135.36 4.15 Favored 'General case' 0 N--CA 1.515 2.808 0 N-CA-C 116.663 2.097 . . . . 0.7 116.663 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -150.02 108.84 3.86 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.804 -0.635 . . . . 0.21 111.068 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.535 HD12 HD12 ' A' ' 85' ' ' LEU 0.308 6.6 tt -117.49 123.26 71.51 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.15 0 CA-C-O 122.439 1.114 . . . . 0.31 111.685 175.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 10.5 ptm -123.33 166.79 14.71 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 113.924 -1.489 . . . . 0.44 111.274 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.2 ptmm? -123.16 157.59 32.64 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 118.2 2.667 . . . . 1.26 118.2 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.65 -42.36 1.91 Allowed Glycine 0 CA--C 1.542 1.728 0 CA-C-N 110.604 -2.998 . . . . 0.17 119.085 173.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.57 152.44 0.81 Allowed 'General case' 0 N--CA 1.516 2.864 0 CA-C-N 120.419 2.11 . . . . 0.15 112.762 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.91 -15.5 59.66 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.437 1.273 . . . . 0.17 114.437 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.62 4.5 43.59 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.101 1.148 . . . . 0.55 114.101 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -103.99 -10.87 17.77 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 113.624 0.972 . . . . 0.6 113.624 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.516 2.871 0 C-N-CA 125.325 1.45 . . . . 0.95 111.489 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.559 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.6 tp . . . . . 0 CA--C 1.564 1.49 0 N-CA-C 113.248 0.833 . . . . 0.35 113.248 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.37 -22.77 61.85 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 125.951 1.7 . . . . 0.2 115.161 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.46 -12.34 49.29 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 113.596 0.961 . . . . 0.32 113.596 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -105.65 -21.64 13.15 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.285 0.846 . . . . 1.73 113.285 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.24 135.68 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.926 0 N-CA-C 115.317 1.599 . . . . 0.11 115.317 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -124.13 -29.39 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 115.24 -0.891 . . . . 0.16 112.258 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 62.5 t90 -162.38 116.99 1.83 Allowed 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 120.545 0.212 . . . . 0.54 111.328 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.82 129.0 31.77 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.483 -0.761 . . . . 0.19 111.365 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -136.81 130.99 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 113.214 0.82 . . . . 1.05 113.214 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 8.2 t-20 -114.1 105.33 13.08 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 107.663 -1.236 . . . . 2.11 107.663 172.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.22 105.56 11.59 Favored 'General case' 0 C--O 1.274 2.38 0 CA-C-O 121.802 0.811 . . . . 0.63 110.39 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.596 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 168.98 -58.32 0.2 Allowed Glycine 0 C--N 1.358 1.786 0 CA-C-N 112.026 -2.352 . . . . 0.71 114.037 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -106.96 -128.24 5.94 Favored Glycine 0 N--CA 1.478 1.464 0 CA-C-O 119.303 -0.721 . . . . 0.8 113.121 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.496 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 40.3 mt-10 -162.09 117.22 1.93 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.645 0.723 . . . . 1.63 111.86 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 55.61 108.94 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 117.358 2.355 . . . . 1.0 117.358 177.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 83.8 t60 -144.59 139.05 27.87 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 114.071 1.137 . . . . 0.45 114.071 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.268 9.9 p -107.63 118.84 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.085 0 CA-C-N 114.829 -1.078 . . . . 1.39 110.886 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.23 156.01 22.21 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 114.395 -1.275 . . . . 1.85 110.856 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 m -41.82 -32.16 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.258 0 N-CA-C 119.087 2.995 . . . . 0.72 119.087 -176.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -87.16 -23.84 24.68 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.413 0.551 . . . . 0.51 111.374 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.73 40.94 0.69 Allowed Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.114 -0.948 . . . . 0.34 114.403 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.559 HD11 ' HG ' ' A' ' 6' ' ' LEU . 22.7 mm -106.91 113.35 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 N-CA-C 109.755 -0.461 . . . . 0.55 109.755 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.3 132.67 51.21 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 115.34 1.608 . . . . 1.34 115.34 -177.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.496 ' OH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -93.17 146.65 23.51 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 114.849 -1.069 . . . . 2.79 109.911 175.247 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -58.16 -111.71 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 127.505 2.322 . . . . 3.0 116.688 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -178.63 79.63 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 113.229 0.826 . . . . 2.3 113.229 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.454 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 0.3 OUTLIER 65.14 46.31 0.53 Allowed Pre-proline 0 N--CA 1.517 2.894 0 N-CA-C 117.695 2.48 . . . . 1.17 117.695 176.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 43.0 Cg_endo . . . . . 0 C--N 1.373 1.829 0 C-N-CA 123.072 2.515 . . . . 1.45 114.579 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 31.8 Cg_exo . . . . . 0 N--CA 1.501 1.963 0 N-CA-C 117.051 1.904 . . . . 1.37 117.051 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.273 1.1 mp -87.75 124.51 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.09 0 CA-C-N 115.22 -0.9 . . . . 0.69 108.981 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -81.19 -19.34 43.52 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.421 2.008 . . . . 1.28 116.421 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -94.97 24.0 5.16 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 113.736 1.013 . . . . 1.51 113.736 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.16 -173.18 4.18 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.828 0.851 . . . . 1.09 110.954 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.696 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.87 -176.91 0.58 Allowed Pre-proline 0 N--CA 1.512 2.64 0 CA-C-O 118.449 -0.786 . . . . 1.27 109.421 178.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -69.17 -39.49 7.56 Favored 'Trans proline' 0 C--N 1.398 3.165 0 C-N-CA 122.613 2.209 . . . . 0.95 113.279 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 56' ' ' GLU . 6.3 pt-20 -69.25 -49.24 58.05 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 125.322 1.449 . . . . 2.04 112.015 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -79.65 -5.42 55.06 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 114.914 -1.039 . . . . 1.62 112.625 177.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.696 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 1.1 tt0 -74.02 -41.84 61.22 Favored 'General case' 0 C--N 1.38 1.929 0 C-N-CA 125.617 1.567 . . . . 1.77 107.952 173.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.8 t -61.4 -45.04 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 C-N-CA 124.304 1.042 . . . . 0.81 109.541 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 1.5 tp -79.98 -5.56 55.92 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 114.35 1.241 . . . . 1.15 114.35 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 6.5 m-30 -123.81 20.66 9.27 Favored 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 124.477 1.111 . . . . 0.92 111.909 176.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -148.16 -28.04 0.33 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 116.878 2.177 . . . . 1.33 116.878 -176.272 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.0 p -73.29 137.54 44.92 Favored 'General case' 0 N--CA 1.533 3.725 0 N-CA-C 114.206 1.187 . . . . 1.28 114.206 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.596 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 7.9 pt-20 . . . . . 0 N--CA 1.507 2.387 0 N-CA-C 117.004 2.224 . . . . 1.53 117.004 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 113.678 0.992 . . . . 2.15 113.678 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.31 109.94 1.12 Allowed 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 124.957 1.303 . . . . 0.77 112.091 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.63 154.06 49.78 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 114.942 -1.026 . . . . 0.81 112.965 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.84 -174.63 37.63 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.077 -0.965 . . . . 0.47 115.124 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.47 171.67 7.38 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 114.782 1.401 . . . . 0.89 114.782 -177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.15 129.33 49.94 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 113.573 -1.649 . . . . 0.51 111.768 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -122.87 100.93 39.85 Favored Pre-proline 0 CA--C 1.568 1.666 0 C-N-CA 123.011 0.524 . . . . 0.15 109.597 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -83.5 116.85 2.34 Favored 'Trans proline' 0 CA--C 1.566 2.097 0 C-N-CA 122.251 1.967 . . . . 0.15 114.729 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.59 158.37 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.979 0.895 . . . . 0.19 110.851 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -143.02 19.86 1.95 Allowed 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 114.844 -1.071 . . . . 2.53 112.13 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -125.84 161.71 26.8 Favored 'General case' 0 C--N 1.362 1.114 0 CA-C-O 121.297 0.57 . . . . 2.12 111.786 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.5 OUTLIER -120.29 140.59 51.01 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.445 0.906 . . . . 0.42 113.445 -179.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.14 -137.77 4.92 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.123 -1.399 . . . . 0.23 112.332 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.1 mt-10 -117.66 106.37 13.01 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 118.334 1.067 . . . . 1.75 111.105 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -99.36 129.9 45.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.179 0.514 . . . . 0.21 111.256 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.99 118.94 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.798 0.808 . . . . 0.2 110.731 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.472 HD12 HD12 ' A' ' 172' ' ' ILE . 1.5 tt -106.98 105.3 15.26 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.118 -1.401 . . . . 0.78 109.956 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.05 127.57 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 114.471 -1.241 . . . . 0.44 108.705 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.95 137.49 52.28 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.04 0.756 . . . . 1.25 113.04 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 17.7 tptt -102.96 115.99 31.67 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.361 -0.836 . . . . 2.52 110.723 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 15.0 m-85 -105.74 134.87 48.16 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.95 -0.568 . . . . 0.4 110.379 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.6 156.34 48.17 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.248 0.547 . . . . 0.41 112.26 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -121.33 133.19 55.11 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.803 0.841 . . . . 2.61 111.147 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.49 27.04 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 114.645 1.35 . . . . 2.13 114.645 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.19 -37.11 0.06 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 114.535 1.309 . . . . 2.27 114.535 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.31 130.44 56.03 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.075 0.768 . . . . 1.46 113.075 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.17 95.28 5.21 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-O 122.494 1.14 . . . . 0.84 110.805 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -154.15 149.36 26.99 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.107 -0.951 . . . . 2.45 112.661 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.0 m -124.97 125.96 44.72 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.649 -0.705 . . . . 1.66 112.865 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 68.16 49.06 0.87 Allowed 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 125.695 1.598 . . . . 1.89 113.179 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -145.8 -41.14 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.602 1.161 . . . . 2.56 109.788 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -112.13 82.68 1.67 Allowed 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.462 -0.94 . . . . 2.76 108.462 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.59 115.3 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 113.997 -1.456 . . . . 0.69 110.321 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.443 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 34.1 m-85 -97.46 175.97 6.04 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.381 1.623 . . . . 0.7 115.381 -175.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -123.0 135.16 54.36 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 116.531 -0.304 . . . . 1.33 110.509 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.12 124.99 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.35 0 CA-C-O 121.338 0.589 . . . . 0.48 110.144 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 37.3 mtt180 -122.57 153.37 39.35 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.028 1.492 . . . . 1.69 115.028 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.0 OUTLIER -132.71 104.54 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 115.334 -0.848 . . . . 0.6 112.831 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.537 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.78 27.0 13.03 Favored 'General case' 0 N--CA 1.522 3.14 0 C-N-CA 126.9 2.08 . . . . 1.12 113.689 -179.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.63 -19.66 33.23 Favored Glycine 0 CA--C 1.547 2.05 0 CA-C-N 116.107 -0.497 . . . . 0.32 113.317 -176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 93.3 m-70 -82.95 171.59 13.69 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 125.345 1.458 . . . . 0.57 113.848 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.85 123.08 39.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 122.182 -0.324 . . . . 0.55 110.94 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.279 9.9 p -113.36 -48.65 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.144 0 CA-C-N 116.209 -0.451 . . . . 1.06 111.533 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.47 90.53 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-O 121.324 0.583 . . . . 0.44 109.741 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -107.13 90.44 3.3 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-O 123.013 1.387 . . . . 2.3 111.232 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 127.27 77.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 129.845 3.258 . . . . 2.48 106.828 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -107.14 104.81 14.55 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.963 -1.017 . . . . 1.13 113.541 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -114.62 111.33 21.17 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 113.61 -1.632 . . . . 2.35 108.579 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.58 -33.54 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 114.628 1.344 . . . . 0.68 114.628 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -75.1 -34.97 61.79 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 112.905 0.705 . . . . 0.77 112.905 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -75.05 -27.46 60.02 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 124.12 0.968 . . . . 0.91 113.285 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -79.06 -55.51 5.07 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.35 0.871 . . . . 2.43 113.35 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.52 -40.18 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 N-CA-C 114.021 1.119 . . . . 0.93 114.021 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.65 -72.05 0.2 Allowed Glycine 0 C--N 1.359 1.849 0 CA-C-N 118.217 0.462 . . . . 0.85 113.919 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -102.16 174.79 5.77 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.31 1.044 . . . . 3.18 111.709 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.6 m -70.43 90.85 0.73 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.784 1.031 . . . . 2.08 113.784 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 126' ' ' ALA . 0.6 OUTLIER -143.78 -162.68 1.51 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.745 -1.57 . . . . 0.62 109.888 -178.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.401 ' H ' ' HB ' ' A' ' 125' ' ' THR . . . -99.89 134.08 43.31 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 113.509 0.929 . . . . 0.46 113.509 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 6.1 t60 -105.87 142.92 34.77 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.194 0.598 . . . . 0.38 110.115 177.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -146.41 137.66 24.45 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.928 1.085 . . . . 2.5 113.928 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -128.34 135.36 49.47 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.928 -1.033 . . . . 1.56 110.774 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.93 125.18 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.02 -0.991 . . . . 0.45 111.107 -178.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -129.05 89.01 49.84 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-N 115.464 -0.789 . . . . 0.84 110.927 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -74.95 129.82 12.75 Favored 'Trans proline' 0 C--N 1.394 2.953 0 C-N-CA 122.984 2.456 . . . . 0.16 112.943 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.53 149.51 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.507 0 CA-C-N 115.177 -0.92 . . . . 0.38 111.107 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.3 t -134.26 117.16 16.14 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.553 0.692 . . . . 1.31 111.106 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.477 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.4 mt -115.61 126.35 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 CA-C-N 114.69 -1.141 . . . . 0.25 108.381 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -140.15 125.3 18.67 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.479 -0.782 . . . . 2.05 110.995 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? 66.56 15.21 10.05 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 125.297 1.439 . . . . 3.55 114.548 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.65 19.44 22.53 Favored Glycine 0 CA--C 1.547 2.053 0 CA-C-O 119.165 -0.797 . . . . 0.37 114.923 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 23.3 mtpp -126.61 143.82 51.1 Favored 'General case' 0 C--N 1.368 1.385 0 CA-C-N 118.435 1.117 . . . . 1.56 112.399 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.38 146.3 27.78 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.262 1.208 . . . . 0.34 114.262 -175.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.3 t -140.93 117.32 10.76 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.916 -1.038 . . . . 0.64 110.625 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.253 2.3 p -110.56 98.98 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.514 0 CA-C-N 115.325 -0.852 . . . . 0.46 110.302 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 69.47 -81.91 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 125.324 1.45 . . . . 1.56 113.488 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.95 26.07 3.3 Favored Glycine 0 CA--C 1.543 1.802 0 CA-C-N 116.022 -0.536 . . . . 0.49 113.668 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -129.72 118.52 22.01 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.079 0.552 . . . . 1.82 110.5 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.46 137.37 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.759 0.79 . . . . 1.02 112.626 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 m -153.88 -170.75 3.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.31 -1.314 . . . . 0.56 108.792 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.259 6.3 t -103.12 146.16 28.81 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 113.216 0.821 . . . . 1.25 113.216 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.408 ' H ' ' HA ' ' A' ' 139' ' ' LYS . 41.5 t80 -89.88 132.67 35.16 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.098 0.951 . . . . 0.29 111.596 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.2 p -97.73 -163.09 1.01 Allowed 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 113.9 -1.5 . . . . 1.42 108.888 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.45 7.29 65.19 Favored Glycine 0 CA--C 1.56 2.855 0 O-C-N 120.236 -1.54 . . . . 0.42 116.895 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.466 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -160.45 152.89 20.71 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-O 122.303 1.049 . . . . 1.1 112.499 178.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.537 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -108.42 137.62 46.07 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 113.81 -1.541 . . . . 0.67 108.854 177.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 t -118.56 145.12 45.61 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.438 1.644 . . . . 0.36 115.438 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.05 97.3 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 106.225 -1.769 . . . . 0.74 106.225 174.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -117.97 124.42 48.15 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 112.645 0.609 . . . . 1.67 112.645 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.21 134.81 54.69 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-O 122.356 1.074 . . . . 1.8 112.321 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.2 t -107.3 144.51 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 112.77 -2.013 . . . . 0.58 110.326 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -93.02 150.15 20.73 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.785 1.031 . . . . 2.18 113.785 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.04 -36.03 4.85 Favored Glycine 0 CA--C 1.545 1.962 0 CA-C-N 115.149 -0.932 . . . . 1.02 114.923 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -127.48 -80.87 0.6 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 117.466 0.633 . . . . 2.86 112.256 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -127.96 -50.72 1.33 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.034 0.534 . . . . 3.91 111.827 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.443 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -85.76 150.04 24.85 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.806 1.243 . . . . 1.74 112.124 178.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -112.11 -171.28 0.21 Allowed Pre-proline 0 CA--C 1.561 1.393 0 CA-C-N 113.384 -1.735 . . . . 1.68 108.236 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -65.27 96.88 0.29 Allowed 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.141 1.894 . . . . 2.06 111.567 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -51.08 -57.33 8.97 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 127.104 2.162 . . . . 3.0 116.619 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.95 131.55 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 118.96 0.8 . . . . 0.8 108.899 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.9 t -132.86 125.06 29.13 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 124.004 0.815 . . . . 0.87 112.146 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.289 . . -120.53 48.33 1.62 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.279 1.955 . . . . 0.34 116.279 -177.082 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.77 134.51 2.51 Favored 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 116.238 1.94 . . . . 0.7 116.238 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -151.02 102.6 2.98 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.421 -0.809 . . . . 0.21 110.821 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.472 HD12 HD12 ' A' ' 85' ' ' LEU 0.296 7.7 tt -112.77 121.77 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.186 0 CA-C-O 122.276 1.036 . . . . 0.31 111.361 176.033 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -124.4 165.59 17.46 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.057 -1.429 . . . . 0.44 110.479 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -122.24 159.16 27.89 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 118.914 2.931 . . . . 1.26 118.914 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.27 -41.47 2.14 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-N 109.9 -3.318 . . . . 0.17 118.973 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.35 154.54 1.03 Allowed 'General case' 0 N--CA 1.516 2.851 0 CA-C-N 120.211 2.005 . . . . 0.15 113.011 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.49 -15.22 59.95 Favored 'General case' 0 CA--C 1.581 2.148 0 C-N-CA 124.859 1.264 . . . . 0.17 114.354 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.9 3.19 49.44 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 113.921 1.082 . . . . 0.55 113.921 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.45 -2.38 17.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.435 0.902 . . . . 0.6 113.435 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.468 0 C-N-CA 124.552 1.141 . . . . 0.95 110.998 178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.52 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.3 tp . . . . . 0 CA--C 1.565 1.557 0 N-CA-C 113.148 0.796 . . . . 0.35 113.148 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.46 -24.58 63.68 Favored 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 126.005 1.722 . . . . 0.2 115.504 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.59 -9.53 55.88 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.582 0.956 . . . . 0.32 113.582 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 26.0 mmtp -107.16 -24.97 11.74 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.561 0.948 . . . . 1.73 113.561 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.69 134.91 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.056 0 N-CA-C 115.494 1.665 . . . . 0.11 115.494 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -120.09 -30.65 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 115.244 -0.889 . . . . 0.16 112.123 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -161.37 119.48 2.36 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 120.507 0.194 . . . . 0.54 111.177 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -138.22 127.85 25.02 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.158 -0.964 . . . . 0.19 111.301 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.3 t -137.22 129.74 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.098 0 N-CA-C 113.679 0.992 . . . . 1.05 113.679 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -115.9 106.1 13.42 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.582 -1.266 . . . . 2.11 107.582 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.48 100.48 6.89 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.06 0.933 . . . . 0.63 111.592 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.517 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 178.16 -55.86 0.09 OUTLIER Glycine 0 C--N 1.349 1.295 0 CA-C-N 113.946 -1.479 . . . . 0.71 115.859 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -111.6 -116.18 3.55 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 114.297 0.479 . . . . 0.8 114.297 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 13.9 mt-10 -165.45 116.26 1.09 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.011 0.524 . . . . 1.63 111.55 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER 43.73 108.62 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 118.452 2.76 . . . . 1.0 118.452 178.227 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.634 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 74.0 t60 -135.27 132.91 38.37 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.939 1.088 . . . . 0.45 113.939 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.5 p -108.01 114.64 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.003 0 CA-C-N 113.884 -1.507 . . . . 1.39 109.022 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -84.62 167.29 16.39 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-N 115.322 -0.854 . . . . 1.85 113.039 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -43.47 -34.48 0.78 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 N-CA-C 118.716 2.858 . . . . 0.72 118.716 -176.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -87.31 -26.53 23.36 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.204 0.526 . . . . 0.51 110.95 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.64 45.16 0.48 Allowed Glycine 0 C--N 1.354 1.541 0 CA-C-N 114.854 -1.066 . . . . 0.34 114.346 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.52 HD11 ' HG ' ' A' ' 6' ' ' LEU . 15.7 mm -107.11 116.25 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 CA-C-O 120.94 0.4 . . . . 0.55 110.085 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.634 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.1 t-160 -108.44 133.58 52.41 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 115.095 1.517 . . . . 1.34 115.095 -177.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.33 140.56 31.61 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-N 114.794 -1.093 . . . . 2.79 110.718 176.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -90.24 130.46 36.36 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 124.974 1.31 . . . . 3.0 112.4 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -56.61 115.26 2.43 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 118.996 2.961 . . . . 2.3 118.996 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 40.59 57.46 7.97 Favored Pre-proline 0 N--CA 1.526 3.349 0 N-CA-C 118.549 2.796 . . . . 1.17 118.549 176.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo . . . . . 0 CA--C 1.569 2.232 0 C-N-CA 122.79 2.327 . . . . 1.45 116.218 -179.39 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 44.7 Cg_exo . . . . . 0 N--CA 1.513 2.633 0 N-CA-C 117.522 2.085 . . . . 1.37 117.522 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.75 130.05 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.291 0 CA-C-N 114.815 -1.084 . . . . 0.69 108.125 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.44 ' HB2' HG22 ' A' ' 125' ' ' THR . 7.1 mt -83.48 -9.68 58.83 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.719 2.118 . . . . 1.28 116.719 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -105.88 8.02 32.47 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 114.329 1.233 . . . . 1.51 114.329 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.8 -177.82 4.6 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-O 121.7 0.762 . . . . 1.09 112.309 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.701 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -93.85 169.48 9.93 Favored Pre-proline 0 N--CA 1.514 2.768 0 C-N-CA 124.606 1.162 . . . . 1.27 110.044 178.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.78 -41.86 51.11 Favored 'Trans proline' 0 N--CA 1.53 3.642 0 C-N-CA 123.289 2.66 . . . . 0.95 116.298 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -68.03 -52.51 34.64 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 124.439 1.095 . . . . 2.04 112.119 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 5.8 t0 -78.11 -1.97 35.13 Favored 'General case' 0 CA--C 1.59 2.505 0 CA-C-N 115.225 -0.898 . . . . 1.62 112.174 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.701 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 14.5 tt0 -75.69 -40.66 55.49 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 126.132 1.773 . . . . 1.77 108.122 174.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.5 t -63.71 -43.1 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.106 0 C-N-CA 124.635 1.174 . . . . 0.81 108.574 172.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.467 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.4 tp -79.86 -5.27 55.16 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 113.59 0.959 . . . . 1.15 113.59 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 4.2 m-30 -122.46 20.08 10.41 Favored 'General case' 0 CA--C 1.577 1.995 0 C-N-CA 124.786 1.235 . . . . 0.92 111.887 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -148.01 -29.01 0.32 Allowed 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 116.399 2.0 . . . . 1.33 116.399 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.4 p -74.99 132.0 41.05 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 115.085 1.513 . . . . 1.28 115.085 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.517 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.09 0 C-N-CA 124.221 1.008 . . . . 1.53 112.687 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 111.354 0.131 . . . . 2.15 111.354 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.24 88.3 0.04 OUTLIER 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 125.722 1.609 . . . . 0.77 114.067 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -148.58 156.22 42.14 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.283 0.846 . . . . 0.81 113.283 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -173.14 -171.99 38.29 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 116.039 1.176 . . . . 0.47 116.039 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.56 173.17 6.45 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.866 1.432 . . . . 0.89 114.866 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -129.38 133.48 47.4 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 114.219 -1.355 . . . . 0.51 111.992 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.57 100.47 34.79 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 109.074 -0.713 . . . . 0.15 109.074 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.38 118.06 2.19 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.084 1.856 . . . . 0.15 115.036 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.67 159.71 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 122.043 0.925 . . . . 0.19 111.134 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -143.91 20.18 1.8 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.888 -1.051 . . . . 2.53 112.331 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -128.58 158.45 38.44 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-O 121.963 0.887 . . . . 2.12 111.117 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.89 139.85 50.14 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.887 1.069 . . . . 0.42 113.887 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.9 -125.35 1.35 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 113.961 -1.472 . . . . 0.23 112.393 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -126.31 118.63 25.48 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.085 0.469 . . . . 1.75 111.178 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -118.83 139.92 50.81 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.788 -0.642 . . . . 0.21 109.907 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 172' ' ' ILE . 2.5 t -120.59 127.59 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.366 0.603 . . . . 0.2 110.896 -177.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.7 107.9 18.96 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.068 -0.969 . . . . 0.78 109.861 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.64 128.5 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 109.045 -0.724 . . . . 0.44 109.045 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.64 146.31 49.42 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.81 1.041 . . . . 1.25 113.81 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -108.75 122.47 47.21 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 115.441 -0.8 . . . . 2.52 110.314 176.145 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -109.28 136.72 48.27 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.871 -1.059 . . . . 0.4 110.415 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.598 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . -143.77 157.14 44.59 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 124.192 0.997 . . . . 0.41 111.307 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -169.92 127.38 0.88 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.353 0.661 . . . . 2.61 110.917 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.83 73.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.664 -0.698 . . . . 2.13 111.27 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -160.19 -47.35 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.959 -0.564 . . . . 2.27 112.126 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -115.19 116.87 29.07 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.803 0.441 . . . . 1.46 111.169 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.24 99.06 8.9 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.646 1.213 . . . . 0.84 112.11 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -159.19 160.66 35.71 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.465 -1.243 . . . . 2.45 111.061 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 m -108.31 -78.66 0.59 Allowed 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.047 1.128 . . . . 1.66 114.047 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -95.47 70.47 3.11 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.296 1.046 . . . . 1.89 111.407 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -159.23 -40.06 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.639 -1.619 . . . . 2.56 109.346 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -106.02 79.25 1.39 Allowed 'General case' 0 C--N 1.368 1.375 0 CA-C-O 121.838 0.828 . . . . 2.76 109.086 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.24 123.09 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 114.439 -1.255 . . . . 0.69 111.395 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.554 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 30.2 m-85 -106.1 171.41 7.36 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 114.395 1.257 . . . . 0.7 114.395 -177.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -124.88 135.71 53.13 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.828 -0.434 . . . . 1.33 109.828 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.0 t -130.07 125.8 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 CA-C-N 116.104 -0.498 . . . . 0.48 109.846 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.66 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 23.0 mtt180 -124.55 148.57 47.72 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.236 1.569 . . . . 1.69 115.236 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 154' ' ' SER . 5.1 m -125.56 112.38 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 113.095 0.776 . . . . 0.6 113.095 177.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.465 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 63.62 25.99 14.49 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 126.551 1.94 . . . . 1.12 113.894 -178.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.36 -14.33 54.59 Favored Glycine 0 CA--C 1.552 2.389 0 C-N-CA 121.456 -0.402 . . . . 0.32 113.804 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.66 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 91.3 m-70 -87.93 172.56 9.5 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 126.059 1.744 . . . . 0.57 113.362 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.89 132.31 54.5 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.584 0.707 . . . . 0.55 112.082 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.75 -55.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 114.775 -1.102 . . . . 1.06 113.141 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.23 89.46 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.877 . . . . 0.44 108.631 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -106.45 108.68 20.31 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.905 1.336 . . . . 2.3 110.572 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 105.14 70.63 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 110.868 -2.878 . . . . 2.48 108.259 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.27 99.5 12.47 Favored 'General case' 0 C--N 1.359 0.983 0 CA-C-N 115.333 -0.849 . . . . 1.13 112.36 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -109.83 91.84 3.81 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.545 -1.661 . . . . 2.35 108.755 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -31.25 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 N-CA-C 116.746 2.128 . . . . 0.68 116.746 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -74.0 -40.54 62.87 Favored 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 124.014 0.926 . . . . 0.77 112.445 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -26.1 59.97 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 124.443 1.097 . . . . 0.91 113.374 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -78.21 -58.09 3.44 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.573 0.953 . . . . 2.43 113.573 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.26 -32.91 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 N-CA-C 114.921 1.452 . . . . 0.93 114.921 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.23 -118.11 2.74 Favored Glycine 0 C--N 1.356 1.639 0 CA-C-N 118.757 0.708 . . . . 0.85 113.006 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -115.1 107.44 15.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.297 0.57 . . . . 3.18 111.173 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.0 m 70.69 -134.57 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 125.592 1.557 . . . . 2.08 113.128 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.44 HG22 ' HB2' ' A' ' 51' ' ' LEU . 67.8 p 60.4 -151.48 0.4 Allowed 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 126.179 1.792 . . . . 0.62 114.382 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -112.13 130.37 55.92 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 114.141 1.163 . . . . 0.46 114.141 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -108.65 124.38 50.43 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.402 -0.962 . . . . 0.38 108.402 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.41 129.18 24.7 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.038 0.755 . . . . 2.5 113.038 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -116.03 134.91 54.45 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.047 -0.978 . . . . 1.56 111.492 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.25 114.01 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 113.884 -1.507 . . . . 0.45 109.999 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.23 98.0 33.54 Favored Pre-proline 0 CA--C 1.574 1.866 0 CA-C-N 115.871 -0.604 . . . . 0.84 111.146 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -73.59 144.55 35.96 Favored 'Trans proline' 0 C--N 1.399 3.205 0 C-N-CA 123.293 2.662 . . . . 0.16 114.652 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.59 146.38 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 CA-C-N 115.135 -0.938 . . . . 0.38 110.854 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 p -131.41 112.58 12.82 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.495 -0.775 . . . . 1.31 111.406 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.98 121.64 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 CA-C-N 115.38 -0.827 . . . . 0.25 108.882 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -141.94 130.74 22.91 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 116.274 -0.421 . . . . 2.05 111.273 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp 70.67 9.04 6.78 Favored 'General case' 0 N--CA 1.518 2.972 0 C-N-CA 125.033 1.333 . . . . 3.55 114.219 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.07 18.1 25.53 Favored Glycine 0 CA--C 1.544 1.859 0 C-N-CA 124.19 0.9 . . . . 0.37 113.997 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -127.16 146.68 50.31 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-N 117.768 0.784 . . . . 1.56 112.746 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.08 141.72 31.48 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.234 1.198 . . . . 0.34 114.234 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.8 m -130.01 113.42 14.55 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.626 -1.17 . . . . 0.64 110.155 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.252 9.1 p -121.48 97.03 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.369 0 CA-C-N 116.004 -0.544 . . . . 0.46 110.901 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 67.55 -85.45 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.682 0 C-N-CA 125.658 1.583 . . . . 1.56 113.874 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.03 29.3 3.53 Favored Glycine 0 CA--C 1.542 1.737 0 CA-C-N 115.994 -0.548 . . . . 0.49 112.979 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -133.17 125.72 30.06 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 123.507 0.723 . . . . 1.82 110.651 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.11 126.02 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.303 0 CA-C-O 121.46 0.648 . . . . 1.02 111.07 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 m -145.93 -178.89 6.35 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.285 -0.871 . . . . 0.56 109.969 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.273 12.4 t -103.14 137.03 41.85 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 113.414 0.894 . . . . 1.25 113.414 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -83.43 125.37 31.64 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.434 1.094 . . . . 0.29 112.011 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.81 91.22 2.95 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 112.649 0.611 . . . . 1.42 112.649 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.46 -66.22 3.53 Favored Glycine 0 C--N 1.358 1.786 0 N-CA-C 119.03 2.372 . . . . 0.42 119.03 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.17 156.87 44.57 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.142 1.164 . . . . 1.1 114.142 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.465 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -105.98 133.45 50.68 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 113.035 -1.893 . . . . 0.67 108.545 176.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.6 t -120.14 143.7 48.05 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.737 1.754 . . . . 0.36 115.737 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.451 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -115.51 100.29 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.945 -1.132 . . . . 0.74 107.945 176.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.81 125.28 49.21 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.978 -0.555 . . . . 1.67 111.952 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.81 132.73 56.62 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.09 0.947 . . . . 1.8 111.771 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 t -110.35 143.28 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.911 0 CA-C-N 113.381 -1.736 . . . . 0.58 109.674 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 151.85 22.19 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.756 1.391 . . . . 2.18 114.756 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.78 -26.64 7.05 Favored Glycine 0 CA--C 1.55 2.253 0 CA-C-N 115.027 -0.988 . . . . 1.02 115.254 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -132.01 -78.81 0.51 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.045 0.922 . . . . 2.86 112.616 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -135.87 -49.41 0.69 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.078 0.551 . . . . 3.91 111.518 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.554 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -94.42 135.43 35.85 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.591 1.156 . . . . 1.74 111.521 178.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -94.26 -169.83 0.21 Allowed Pre-proline 0 CA--C 1.568 1.667 0 CA-C-N 113.979 -1.464 . . . . 1.68 108.576 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -66.55 99.99 0.46 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 CA-C-N 122.311 1.861 . . . . 2.06 111.3 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -57.18 -49.92 74.48 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.498 1.666 . . . . 3.0 115.498 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 64' ' ' GLU . 19.0 t -110.56 130.99 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.076 -0.713 . . . . 0.8 109.076 177.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -136.9 124.72 22.56 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 113.597 -1.638 . . . . 0.87 111.482 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.256 . . -121.31 49.97 1.44 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.75 1.759 . . . . 0.34 115.75 -176.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.69 135.15 2.98 Favored 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 116.175 1.917 . . . . 0.7 116.175 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -153.6 100.67 2.42 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.38 -0.827 . . . . 0.21 110.6 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 84' ' ' VAL 0.308 5.2 tt -109.26 122.48 63.96 Favored 'Isoleucine or valine' 0 C--O 1.27 2.156 0 CA-C-O 122.346 1.069 . . . . 0.31 111.383 176.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -120.27 154.2 35.28 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 113.755 -1.566 . . . . 0.44 112.221 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 50.5 tttm -105.92 150.0 26.07 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 118.09 2.626 . . . . 1.26 118.09 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.43 -39.59 2.77 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 110.98 -2.827 . . . . 0.17 119.805 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.73 164.12 1.21 Allowed 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 121.218 2.509 . . . . 0.15 112.571 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.88 -16.07 48.98 Favored 'General case' 0 CA--C 1.579 2.085 0 C-N-CA 124.722 1.209 . . . . 0.17 113.8 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.36 4.65 45.42 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.363 1.246 . . . . 0.55 114.363 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.3 -11.89 17.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.27 1.211 . . . . 0.6 114.27 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.513 2.713 0 C-N-CA 124.036 0.934 . . . . 0.95 113.08 178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.57 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.6 tp . . . . . 0 CA--C 1.564 1.482 0 N-CA-C 113.22 0.822 . . . . 0.35 113.22 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.51 -23.07 64.26 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 125.807 1.643 . . . . 0.2 114.965 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.49 -12.53 48.65 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 113.632 0.975 . . . . 0.32 113.632 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -104.19 -23.58 13.24 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-O 118.211 -0.9 . . . . 1.73 113.227 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.49 133.36 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 N-CA-C 115.094 1.516 . . . . 0.11 115.094 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pt -120.52 -28.28 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.183 -0.917 . . . . 0.16 112.264 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -163.97 116.91 1.43 Allowed 'General case' 0 CA--C 1.558 1.27 0 CA-C-O 120.583 0.23 . . . . 0.54 111.141 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.32 130.87 35.71 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.569 -0.707 . . . . 0.19 111.202 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.74 129.69 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.422 0.897 . . . . 1.05 113.422 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -117.05 105.23 12.06 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.01 -1.478 . . . . 2.11 107.01 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.17 108.22 12.51 Favored 'General case' 0 C--O 1.254 1.305 0 CA-C-O 121.639 0.733 . . . . 0.63 111.553 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.2 -43.71 0.37 Allowed Glycine 0 C--N 1.351 1.374 0 CA-C-N 114.265 -1.334 . . . . 0.71 115.652 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -115.15 -121.25 3.45 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 117.564 0.682 . . . . 0.8 113.892 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 18.1 mt-10 -164.83 115.36 1.16 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.295 0.638 . . . . 1.63 111.133 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 1.1 m 42.85 110.15 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 118.589 2.811 . . . . 1.0 118.589 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.586 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 78.1 t60 -136.58 131.79 34.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.358 1.244 . . . . 0.45 114.358 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.6 p -104.93 114.48 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 113.958 -1.474 . . . . 1.39 108.967 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -85.21 165.83 17.06 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 115.107 -0.951 . . . . 1.85 113.155 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -44.59 -30.46 0.67 Allowed 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 N-CA-C 118.667 2.84 . . . . 0.72 118.667 -176.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -89.17 -27.04 20.96 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.233 0.539 . . . . 0.51 110.936 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.54 42.66 0.57 Allowed Glycine 0 C--N 1.351 1.393 0 CA-C-N 114.82 -1.082 . . . . 0.34 114.059 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.57 HD11 ' HG ' ' A' ' 6' ' ' LEU . 20.2 mm -107.54 117.05 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-O 121.107 0.48 . . . . 0.55 110.195 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.4 t60 -106.52 131.61 53.48 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.882 1.438 . . . . 1.34 114.882 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -93.07 137.41 32.45 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 124.058 0.943 . . . . 2.79 109.639 175.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.473 ' O ' ' HG3' ' A' ' 33' ' ' PRO . 12.9 ptm180 -99.0 105.86 18.06 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 114.54 -1.209 . . . . 3.0 113.335 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -23.14 119.84 0.04 OUTLIER 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 120.57 3.545 . . . . 2.3 120.57 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 34.42 54.17 1.59 Allowed Pre-proline 0 N--CA 1.536 3.868 0 N-CA-C 119.576 3.176 . . . . 1.17 119.576 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.473 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER . . . . . 0 CA--C 1.569 2.268 0 C-N-CA 123.423 2.749 . . . . 1.45 116.908 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo . . . . . 0 N--CA 1.512 2.603 0 N-CA-C 117.288 1.995 . . . . 1.37 117.288 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.437 HG23 ' HB2' ' A' ' 126' ' ' ALA 0.262 1.0 OUTLIER -93.85 123.28 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.777 0 CA-C-N 115.237 -0.892 . . . . 0.69 109.472 178.908 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 7.3 mt -89.22 101.71 14.37 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.871 0.843 . . . . 1.28 112.374 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 1.5 mpt_? 148.01 -13.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.158 2.183 . . . . 1.51 110.578 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -116.54 -179.01 3.56 Favored 'General case' 0 CA--C 1.567 1.599 0 C-N-CA 123.767 0.827 . . . . 1.09 113.09 -179.135 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -95.77 -176.88 0.58 Allowed Pre-proline 0 N--CA 1.51 2.556 0 C-N-CA 124.402 1.081 . . . . 1.27 109.421 178.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.456 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 31.3 Cg_exo -68.51 -39.13 9.91 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.679 2.253 . . . . 0.95 113.963 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -67.2 -54.28 22.55 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 125.04 1.336 . . . . 2.04 112.124 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.413 ' HB3' ' OG ' ' A' ' 53' ' ' SER . 0.4 OUTLIER -76.55 -5.37 47.34 Favored 'General case' 0 CA--C 1.576 1.947 0 CA-C-N 114.979 -1.01 . . . . 1.62 112.746 178.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.514 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 27.5 tt0 -71.64 -44.14 64.86 Favored 'General case' 0 C--N 1.382 2.015 0 C-N-CA 125.539 1.536 . . . . 1.77 108.07 173.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.37 -38.89 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 C-N-CA 124.055 0.942 . . . . 0.81 109.481 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -82.54 -8.36 59.61 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 114.116 1.154 . . . . 1.15 114.116 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.415 ' O ' HG12 ' A' ' 50' ' ' ILE . 20.4 m-85 -125.02 21.36 8.16 Favored 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.222 1.009 . . . . 0.92 112.928 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.455 HE21 HE21 ' A' ' 58' ' ' GLN . 0.0 OUTLIER -143.8 -31.53 0.46 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 115.27 1.582 . . . . 1.33 115.27 -177.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.8 p -73.12 134.23 44.4 Favored 'General case' 0 N--CA 1.524 3.231 0 N-CA-C 114.3 1.222 . . . . 1.28 114.3 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 114.672 1.36 . . . . 1.53 114.672 -176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.337 -0.616 . . . . 2.15 109.337 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.83 86.53 0.12 Allowed 'General case' 0 N--CA 1.517 2.885 0 C-N-CA 124.717 1.207 . . . . 0.77 111.674 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -140.51 149.74 42.85 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.998 0.904 . . . . 0.81 112.68 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.87 -176.75 31.27 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 114.303 -1.317 . . . . 0.47 115.821 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 169.55 10.16 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 114.117 -1.042 . . . . 0.89 113.729 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.06 131.16 52.2 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.662 -1.154 . . . . 0.51 111.895 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.1 103.12 33.47 Favored Pre-proline 0 CA--C 1.57 1.719 0 C-N-CA 123.107 0.563 . . . . 0.15 109.567 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -84.15 117.18 2.16 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.264 1.976 . . . . 0.15 114.657 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.26 157.94 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.625 0 CA-C-O 122.053 0.93 . . . . 0.19 111.112 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -146.13 24.38 1.3 Allowed 'General case' 0 CA--C 1.557 1.236 0 CA-C-N 114.654 -1.157 . . . . 2.53 112.008 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -128.62 160.16 33.3 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 121.268 0.556 . . . . 2.12 111.194 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -121.04 142.02 50.21 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.069 1.137 . . . . 0.42 114.069 -178.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.85 -137.34 4.91 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 113.696 -1.593 . . . . 0.23 112.121 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.3 mt-10 -115.63 112.13 21.67 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 118.436 1.118 . . . . 1.75 111.276 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -104.49 128.37 52.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.147 -0.479 . . . . 0.21 110.896 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -110.35 119.33 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 121.977 0.894 . . . . 0.2 110.427 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 tt -107.34 104.61 14.24 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.79 -1.55 . . . . 0.78 109.648 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.95 126.42 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 CA-C-N 114.367 -1.288 . . . . 0.44 108.57 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.52 135.52 49.52 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.594 -0.73 . . . . 1.25 112.418 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 4.4 tppt? -101.5 118.2 36.46 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.447 0.641 . . . . 2.52 110.556 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -105.54 134.54 48.5 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.256 -0.884 . . . . 0.4 110.571 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.39 151.53 41.94 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.182 0.515 . . . . 0.41 112.266 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -147.83 135.23 20.65 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.118 0.567 . . . . 2.61 110.967 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.275 7.5 p -147.06 86.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.388 0 CA-C-O 121.591 0.71 . . . . 2.13 111.851 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -175.12 -46.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.602 -0.726 . . . . 2.27 112.139 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -115.56 139.52 50.0 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 121.193 0.52 . . . . 1.46 112.008 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -112.85 99.68 8.08 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.191 0.996 . . . . 0.84 111.004 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -158.74 140.85 13.89 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.317 -0.856 . . . . 2.45 112.313 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.7 m -120.74 130.45 54.05 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.341 -0.845 . . . . 1.66 112.219 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 80.53 10.51 1.09 Allowed 'General case' 0 N--CA 1.519 2.987 0 C-N-CA 125.857 1.663 . . . . 1.89 114.494 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -117.49 -25.71 6.88 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.711 0.804 . . . . 2.56 112.259 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -107.03 79.41 1.32 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.484 0.714 . . . . 2.76 109.393 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 114' ' ' ASP 0.261 1.2 t -109.81 126.6 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 CA-C-N 114.998 -1.001 . . . . 0.69 110.091 -177.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -118.87 174.31 6.37 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 114.652 1.352 . . . . 0.7 114.652 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.93 136.34 54.92 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.921 -0.487 . . . . 1.33 111.19 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.2 t -124.99 123.65 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 C-N-CA 123.056 0.543 . . . . 0.48 110.07 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -121.14 147.13 45.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.653 1.353 . . . . 1.69 114.653 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 154' ' ' SER . 50.8 t -130.56 109.75 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.252 0 N-CA-C 107.68 -1.23 . . . . 0.6 107.68 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.43 26.89 16.03 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 126.992 2.117 . . . . 1.12 114.574 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.12 -19.58 40.14 Favored Glycine 0 CA--C 1.548 2.097 0 N-CA-C 114.554 0.582 . . . . 0.32 114.554 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -91.01 154.51 19.38 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 124.837 1.255 . . . . 0.57 113.375 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.3 p -102.93 127.9 49.95 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.609 0.718 . . . . 0.55 111.638 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.07 -50.63 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.582 -1.19 . . . . 1.06 110.342 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.43 88.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 119.996 -0.682 . . . . 0.44 110.237 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -106.92 119.23 38.79 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-O 122.41 1.1 . . . . 2.3 110.076 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.479 ' HA ' HG13 ' A' ' 101' ' ' VAL . 1.0 OUTLIER 102.96 59.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 128.434 2.694 . . . . 2.48 107.6 -175.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.34 96.9 10.76 Favored 'General case' 0 C--N 1.373 1.596 0 CA-C-O 121.634 0.731 . . . . 1.13 112.714 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -107.64 97.81 7.49 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 113.652 -1.613 . . . . 2.35 107.448 175.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.08 -30.01 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.458 0 N-CA-C 114.244 1.201 . . . . 0.68 114.244 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -73.89 -41.88 61.5 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 123.481 0.712 . . . . 0.77 112.218 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -72.24 -25.84 61.78 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 124.537 1.135 . . . . 0.91 113.55 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -79.53 -57.8 3.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 113.701 1.0 . . . . 2.43 113.701 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.48 -37.89 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.515 0 N-CA-C 114.516 1.302 . . . . 0.93 114.516 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.62 -115.36 1.89 Allowed Glycine 0 C--N 1.354 1.557 0 C-N-CA 121.194 -0.527 . . . . 0.85 113.38 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -114.87 108.06 16.23 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.957 0.408 . . . . 3.18 110.422 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.7 m 73.33 -126.2 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 125.466 1.506 . . . . 2.08 111.845 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.6 p 57.54 -165.6 0.15 Allowed 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 126.066 1.746 . . . . 0.62 115.343 177.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' A' ' 50' ' ' ILE . . . -113.99 127.57 56.01 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 112.684 0.624 . . . . 0.46 112.684 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -103.53 138.83 39.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.465 -0.569 . . . . 0.38 109.465 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -144.59 129.37 18.28 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.78 1.03 . . . . 2.5 113.78 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -117.41 129.94 56.17 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-N 114.759 -1.11 . . . . 1.56 110.939 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.53 111.59 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 114.493 -1.231 . . . . 0.45 110.658 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.5 mm -115.8 92.11 32.97 Favored Pre-proline 0 CA--C 1.582 2.178 0 CA-C-N 115.639 -0.71 . . . . 0.84 110.706 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -77.19 126.33 8.47 Favored 'Trans proline' 0 C--N 1.392 2.824 0 C-N-CA 122.568 2.178 . . . . 0.16 113.032 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.88 150.81 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 C-N-CA 123.991 0.916 . . . . 0.38 111.067 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.0 t -136.7 118.0 14.6 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.524 0.678 . . . . 1.31 111.775 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -116.98 126.05 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 CA-C-N 114.759 -1.11 . . . . 0.25 108.446 178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -139.37 122.74 17.13 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.622 -0.717 . . . . 2.05 110.817 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt 67.67 16.16 9.78 Favored 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 125.279 1.432 . . . . 3.55 114.431 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.75 15.93 35.37 Favored Glycine 0 CA--C 1.547 2.067 0 CA-C-O 119.348 -0.696 . . . . 0.37 114.67 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 36.8 mtpt -122.02 145.34 48.23 Favored 'General case' 0 C--N 1.363 1.19 0 CA-C-N 118.088 0.944 . . . . 1.56 111.759 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.31 150.81 23.4 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.116 1.525 . . . . 0.34 115.116 -175.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.32 109.81 6.6 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 113.92 -1.491 . . . . 0.64 109.335 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.1 p -111.1 94.84 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.5 0 CA-C-N 116.025 -0.534 . . . . 0.46 110.625 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 67.81 -84.73 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.74 0 C-N-CA 125.416 1.486 . . . . 1.56 113.799 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.09 24.62 5.35 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 115.981 -0.554 . . . . 0.49 113.263 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -125.7 147.07 49.48 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.726 0.811 . . . . 1.82 111.606 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.0 p -129.18 125.87 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.157 0 CA-C-N 115.583 -0.735 . . . . 1.02 110.936 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.4 m -149.23 -175.72 5.09 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.225 -0.898 . . . . 0.56 110.129 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.0 p -103.8 138.16 40.8 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 112.95 0.722 . . . . 1.25 112.95 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -85.93 123.75 31.61 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 123.548 0.739 . . . . 0.29 111.114 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.0 t -129.21 90.94 3.1 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.533 0.682 . . . . 1.42 112.733 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.35 -63.36 2.96 Favored Glycine 0 C--N 1.359 1.832 0 N-CA-C 119.043 2.377 . . . . 0.42 119.043 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.543 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -130.64 157.15 43.53 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.277 1.214 . . . . 1.1 114.277 -176.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.543 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 1.8 tp -104.13 140.81 37.27 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 112.805 -1.998 . . . . 0.67 109.41 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.6 t -122.95 144.03 49.51 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.939 1.459 . . . . 0.36 114.939 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.3 96.57 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.764 -1.199 . . . . 0.74 107.764 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -118.92 123.5 44.78 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 112.537 0.569 . . . . 1.67 112.537 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -115.07 130.64 56.98 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 122.273 1.035 . . . . 1.8 111.416 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.14 144.8 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-N 112.724 -2.035 . . . . 0.58 110.867 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.6 150.2 25.34 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 113.991 -1.459 . . . . 2.18 114.38 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -100.71 -55.58 0.94 Allowed Glycine 0 CA--C 1.541 1.676 0 CA-C-N 115.281 -0.872 . . . . 1.02 114.004 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -128.13 -85.98 0.57 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.031 0.416 . . . . 2.86 111.535 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.563 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 61.6 m-85 -133.82 120.6 20.67 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.391 0.676 . . . . 3.91 109.792 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 1.0 OUTLIER 87.68 136.54 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 124.86 1.264 . . . . 1.74 111.233 -177.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.52 -168.56 0.19 Allowed Pre-proline 0 CA--C 1.58 2.104 0 CA-C-N 114.621 -1.172 . . . . 1.68 110.404 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.07 -15.51 34.1 Favored 'Trans proline' 0 N--CA 1.523 3.206 0 C-N-CA 122.675 2.25 . . . . 2.06 115.581 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 77.6 tttt 79.91 -65.1 0.19 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 126.444 1.897 . . . . 3.0 114.229 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 38.9 t -106.76 132.27 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 109.791 -0.448 . . . . 0.8 109.791 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -135.95 120.58 18.3 Favored 'General case' 0 C--N 1.358 0.943 0 CA-C-N 114.413 -1.267 . . . . 0.87 111.052 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -115.23 49.22 1.08 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.276 1.954 . . . . 0.34 116.276 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.75 132.34 3.8 Favored 'General case' 0 N--CA 1.514 2.725 0 N-CA-C 116.069 1.877 . . . . 0.7 116.069 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -150.43 100.35 2.86 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.368 -0.833 . . . . 0.21 110.525 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.308 13.7 tt -110.3 121.81 63.77 Favored 'Isoleucine or valine' 0 C--O 1.266 1.929 0 CA-C-O 122.42 1.105 . . . . 0.31 111.42 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -123.5 155.06 38.26 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 113.675 -1.602 . . . . 0.44 111.325 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -104.91 148.21 26.93 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 119.252 3.056 . . . . 1.26 119.252 -173.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.02 -42.36 1.92 Allowed Glycine 0 CA--C 1.541 1.715 0 CA-C-N 110.316 -3.129 . . . . 0.17 120.582 171.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.73 157.78 1.25 Allowed 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 121.177 2.489 . . . . 0.15 113.371 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.7 -13.09 60.07 Favored 'General case' 0 CA--C 1.581 2.172 0 C-N-CA 124.897 1.279 . . . . 0.17 114.421 177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.0 2.42 51.81 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 113.953 1.094 . . . . 0.55 113.953 177.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.26 -5.78 17.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.629 0.974 . . . . 0.6 113.629 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.506 2.346 0 C-N-CA 124.265 1.026 . . . . 0.95 111.916 178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.587 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.6 tp . . . . . 0 CA--C 1.564 1.517 0 N-CA-C 113.323 0.86 . . . . 0.35 113.323 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.64 -23.45 63.04 Favored 'General case' 0 N--CA 1.509 2.505 0 C-N-CA 125.899 1.68 . . . . 0.2 114.971 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.39 -11.96 50.53 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 113.621 0.971 . . . . 0.32 113.621 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 46.2 mmtt -105.39 -22.25 13.07 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 113.342 0.867 . . . . 1.73 113.342 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.02 135.7 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 115.103 1.52 . . . . 0.11 115.103 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.86 -28.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.455 -0.793 . . . . 0.16 112.035 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 66.4 t90 -162.52 118.81 1.93 Allowed 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 120.657 0.265 . . . . 0.54 111.116 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.72 129.63 24.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.41 -0.806 . . . . 0.19 111.62 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 t -133.36 124.55 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.404 0.621 . . . . 1.05 110.064 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -113.96 88.71 2.91 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.105 -1.072 . . . . 2.11 108.105 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -72.66 114.02 10.33 Favored 'General case' 0 C--O 1.274 2.356 0 N-CA-C 115.833 1.79 . . . . 0.63 115.833 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.61 -46.28 0.63 Allowed Glycine 0 C--N 1.368 2.309 0 CA-C-N 112.079 -2.328 . . . . 0.71 114.438 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.44 -123.96 3.04 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 123.641 0.639 . . . . 0.8 114.029 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -170.0 112.33 0.46 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.809 1.243 . . . . 1.63 108.951 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 1.1 m 40.85 97.21 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.11 0 N-CA-C 116.968 2.211 . . . . 1.0 116.968 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.546 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 70.4 t60 -126.92 132.16 50.94 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.705 1.372 . . . . 0.45 114.705 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 27' ' ' ILE 0.255 8.8 p -106.33 114.07 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.867 0 CA-C-N 114.135 -1.393 . . . . 1.39 110.023 177.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.407 ' OD2' ' HB ' ' A' ' 27' ' ' ILE . 1.7 p-10 -82.85 160.78 22.11 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.674 -1.148 . . . . 1.85 113.063 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 m -43.51 -24.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 N-CA-C 118.816 2.895 . . . . 0.72 118.816 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -90.7 -29.54 17.64 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 121.164 0.507 . . . . 0.51 110.695 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 41.09 0.57 Allowed Glycine 0 C--N 1.353 1.512 0 CA-C-N 114.953 -1.021 . . . . 0.34 114.606 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.587 HD11 ' HG ' ' A' ' 6' ' ' LEU . 30.7 mm -107.95 124.33 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 N-CA-C 109.504 -0.554 . . . . 0.55 109.504 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.4 t-160 -114.02 130.48 56.55 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.201 1.556 . . . . 1.34 115.201 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.601 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -83.87 136.93 33.92 Favored 'General case' 0 C--N 1.372 1.573 0 C-N-CA 124.019 0.928 . . . . 2.79 110.778 175.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -88.89 101.98 14.59 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.716 1.26 . . . . 3.0 112.86 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -31.06 98.28 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 129.07 2.948 . . . . 2.3 118.792 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.64 72.45 1.21 Allowed Pre-proline 0 N--CA 1.523 3.219 0 N-CA-C 117.489 2.403 . . . . 1.17 117.489 178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo . . . . . 0 CA--C 1.564 1.983 0 C-N-CA 122.556 2.171 . . . . 1.45 116.812 179.61 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo . . . . . 0 N--CA 1.514 2.709 0 N-CA-C 116.818 1.815 . . . . 1.37 116.818 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.261 1.2 mp -88.72 131.16 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.158 0 CA-C-O 121.779 0.799 . . . . 0.69 110.156 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.517 ' HB2' HG22 ' A' ' 125' ' ' THR . 4.5 mt -90.83 -11.6 38.87 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 116.384 1.994 . . . . 1.28 116.384 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -101.12 9.04 42.47 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 114.414 1.264 . . . . 1.51 114.414 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.97 -169.79 2.23 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 121.426 0.631 . . . . 1.09 112.603 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.797 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -94.23 -179.84 1.08 Allowed Pre-proline 0 N--CA 1.516 2.831 0 C-N-CA 124.453 1.101 . . . . 1.27 109.351 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -69.63 -39.57 6.59 Favored 'Trans proline' 0 C--N 1.398 3.166 0 C-N-CA 122.637 2.224 . . . . 0.95 112.772 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -66.56 -52.84 41.11 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 125.988 1.715 . . . . 2.04 111.73 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.61 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -80.69 3.95 20.4 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 113.166 -1.834 . . . . 1.62 113.183 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.797 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 32.4 tt0 -85.99 -40.71 15.54 Favored 'General case' 0 C--N 1.371 1.513 0 C-N-CA 125.868 1.667 . . . . 1.77 107.773 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -63.17 -43.02 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 C-N-CA 125.038 1.335 . . . . 0.81 110.12 174.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.25 -42.9 54.13 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 118.441 0.564 . . . . 1.15 111.786 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 2.8 m-30 -74.47 1.08 12.69 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 124.456 1.103 . . . . 0.92 112.822 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.439 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 3.2 tt0 -131.98 -127.13 0.19 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.538 0.735 . . . . 1.33 110.51 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.6 p 52.15 -145.59 0.54 Allowed 'General case' 0 N--CA 1.533 3.713 0 C-N-CA 126.076 1.751 . . . . 1.28 112.98 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.513 2.69 0 CA-C-N 120.633 1.561 . . . . 1.53 114.036 176.824 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.402 ' HA ' HD21 ' A' ' 164' ' ' ASN . 6.0 m-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 120.231 0.062 . . . . 2.15 110.921 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.565 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER 69.58 83.31 0.15 Allowed 'General case' 0 N--CA 1.511 2.607 0 C-N-CA 125.147 1.379 . . . . 0.77 112.399 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -147.61 153.41 39.36 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.873 0.694 . . . . 0.81 112.873 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -176.61 179.4 47.63 Favored Glycine 0 C--N 1.349 1.282 0 N-CA-C 116.259 1.264 . . . . 0.47 116.259 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -100.35 173.64 6.5 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 117.357 2.354 . . . . 0.89 117.357 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.02 120.95 23.11 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 112.617 -2.083 . . . . 0.51 111.006 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.03 109.4 52.29 Favored Pre-proline 0 CA--C 1.568 1.672 0 C-N-CA 123.371 0.668 . . . . 0.15 109.606 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -84.79 118.2 2.07 Favored 'Trans proline' 0 CA--C 1.566 2.125 0 C-N-CA 121.918 1.746 . . . . 0.15 114.427 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.97 159.23 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 CA-C-O 122.052 0.93 . . . . 0.19 111.638 -179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -150.33 23.19 0.83 Allowed 'General case' 0 CA--C 1.56 1.343 0 CA-C-N 114.51 -1.223 . . . . 2.53 111.859 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -129.25 158.74 38.21 Favored 'General case' 0 C--N 1.362 1.136 0 CA-C-O 121.166 0.508 . . . . 2.12 111.344 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -120.33 144.3 47.92 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.743 1.016 . . . . 0.42 113.743 -178.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.86 -135.64 4.01 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 113.751 -1.568 . . . . 0.23 111.953 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -118.73 107.31 13.51 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 118.23 1.015 . . . . 1.75 111.101 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -99.35 128.38 45.46 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.252 0.549 . . . . 0.21 111.041 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 t -112.02 124.01 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 115.674 -0.694 . . . . 0.2 110.548 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.412 HD12 HD12 ' A' ' 172' ' ' ILE . 1.1 tt -107.87 106.44 16.72 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.675 -1.148 . . . . 0.78 109.858 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.62 128.06 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 113.947 -1.479 . . . . 0.44 108.492 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.58 141.34 47.64 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.432 -0.804 . . . . 1.25 112.6 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -107.11 123.52 48.36 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 122.022 0.915 . . . . 2.52 110.331 176.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.53 137.07 46.22 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 114.16 -1.382 . . . . 0.4 110.238 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.627 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . -131.14 151.84 51.04 Favored 'General case' 0 C--O 1.266 1.922 0 CA-C-N 114.979 -1.009 . . . . 0.41 110.916 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -124.12 123.89 41.31 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 123.788 0.835 . . . . 2.61 110.705 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.265 5.4 p -138.02 41.19 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.766 0 N-CA-C 112.567 0.58 . . . . 2.13 112.567 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -161.8 -42.86 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.75 0.648 . . . . 2.27 112.75 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -115.36 119.48 36.42 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.218 0.451 . . . . 1.46 112.218 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.81 86.17 2.35 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-O 122.73 1.253 . . . . 0.84 111.134 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -158.57 160.57 36.76 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.89 -1.05 . . . . 2.45 112.034 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.3 m -121.84 125.52 46.65 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.6 -0.727 . . . . 1.66 112.625 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 74.49 56.7 0.08 Allowed 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 125.878 1.671 . . . . 1.89 113.074 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -157.73 -41.76 0.07 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.709 -1.132 . . . . 2.56 109.41 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -105.83 82.78 1.83 Allowed 'General case' 0 C--N 1.361 1.1 0 CA-C-O 121.79 0.805 . . . . 2.76 108.848 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.88 122.5 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 114.397 -1.274 . . . . 0.69 111.729 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -107.36 164.09 12.48 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.9 1.444 . . . . 0.7 114.9 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -120.23 136.51 54.62 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.379 0.609 . . . . 1.33 111.109 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.0 t -126.13 127.12 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.205 0 CA-C-N 115.411 -0.813 . . . . 0.48 109.828 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 57.9 mtt180 -127.33 148.89 50.25 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.509 1.67 . . . . 1.69 115.509 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.8 m -129.48 113.5 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 N-CA-C 112.783 0.66 . . . . 0.6 112.783 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.34 25.05 14.5 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 126.306 1.842 . . . . 1.12 114.164 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.54 -17.29 46.86 Favored Glycine 0 CA--C 1.551 2.282 0 CA-C-N 115.896 -0.593 . . . . 0.32 113.626 -176.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 95.2 m-70 -85.79 175.98 8.38 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.544 1.537 . . . . 0.57 114.0 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.48 139.83 51.45 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.948 0.88 . . . . 0.55 112.171 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.84 -57.16 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 114.016 -1.447 . . . . 1.06 112.792 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.81 89.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.57 0.7 . . . . 0.44 109.35 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -100.55 119.45 38.54 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 114.651 -1.159 . . . . 2.3 110.531 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 88.29 62.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 127.395 2.278 . . . . 2.48 110.78 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.13 105.05 15.57 Favored 'General case' 0 C--N 1.366 1.286 0 N-CA-C 113.425 0.898 . . . . 1.13 113.425 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -111.46 99.31 8.11 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 113.781 -1.554 . . . . 2.35 107.426 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -32.15 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 N-CA-C 114.675 1.361 . . . . 0.68 114.675 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -75.01 -37.49 61.79 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.495 0.718 . . . . 0.77 112.892 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -74.06 -26.7 60.54 Favored 'General case' 0 CA--C 1.575 1.911 0 C-N-CA 124.359 1.064 . . . . 0.91 113.477 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -80.99 -57.92 3.31 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.246 0.832 . . . . 2.43 113.246 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.43 -38.94 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 N-CA-C 114.091 1.145 . . . . 0.93 114.091 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.04 -66.41 0.24 Allowed Glycine 0 C--N 1.358 1.794 0 CA-C-N 118.372 0.533 . . . . 0.85 114.222 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -106.6 173.3 6.38 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.016 0.927 . . . . 3.18 111.78 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.1 m -81.14 84.22 6.59 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.641 0.978 . . . . 2.08 113.641 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.517 HG22 ' HB2' ' A' ' 51' ' ' LEU . 22.2 p -131.56 -131.37 0.19 Allowed 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 114.264 -1.335 . . . . 0.62 108.315 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.64 130.29 56.78 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 114.425 1.269 . . . . 0.46 114.425 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -107.52 129.46 54.96 Favored 'General case' 0 C--N 1.371 1.526 0 N-CA-C 108.697 -0.853 . . . . 0.38 108.697 174.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.1 129.06 18.5 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.014 0.746 . . . . 2.5 113.014 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -112.92 129.27 56.53 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 115.081 -0.963 . . . . 1.56 111.361 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.97 110.34 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 114.27 -1.332 . . . . 0.45 109.429 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.6 102.16 29.61 Favored Pre-proline 0 CA--C 1.571 1.761 0 N-CA-C 112.482 0.549 . . . . 0.84 112.482 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -74.77 144.3 30.96 Favored 'Trans proline' 0 C--N 1.398 3.16 0 C-N-CA 123.096 2.531 . . . . 0.16 114.882 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.09 147.99 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 C-N-CA 124.567 1.147 . . . . 0.38 109.043 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 t -134.3 116.97 15.88 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.438 0.637 . . . . 1.31 112.003 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.2 mt -114.47 127.19 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 114.836 -1.075 . . . . 0.25 108.826 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -138.8 123.29 18.4 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.463 -0.789 . . . . 2.05 110.756 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt 67.88 13.65 9.22 Favored 'General case' 0 N--CA 1.521 3.092 0 N-CA-C 115.226 1.565 . . . . 3.55 115.226 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.94 15.13 31.96 Favored Glycine 0 CA--C 1.548 2.109 0 N-CA-C 114.732 0.653 . . . . 0.37 114.732 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 98.4 mttt -121.8 145.27 48.22 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 117.87 0.835 . . . . 1.56 112.194 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.84 146.64 27.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.439 1.274 . . . . 0.34 114.439 -176.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.24 111.02 9.91 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.38 -1.282 . . . . 0.64 110.077 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.0 p -111.4 93.28 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.619 0 CA-C-N 115.598 -0.728 . . . . 0.46 110.11 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 66.33 -83.48 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.882 0 C-N-CA 125.288 1.435 . . . . 1.56 113.689 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.73 25.94 3.9 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 115.996 -0.547 . . . . 0.49 113.741 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -133.2 118.58 18.79 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.18 0.592 . . . . 1.82 110.128 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.7 p -105.92 132.76 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.329 0 CA-C-O 121.55 0.691 . . . . 1.02 112.07 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.8 m -148.33 -175.42 4.9 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.014 -0.994 . . . . 0.56 110.106 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.418 HG22 ' HG2' ' A' ' 139' ' ' LYS . 35.6 p -101.81 137.94 39.45 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 113.055 0.761 . . . . 1.25 113.055 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -87.1 122.76 31.36 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.469 0.707 . . . . 0.29 110.447 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.9 t -129.24 91.65 3.23 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 113.006 0.743 . . . . 1.42 113.006 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.22 -64.09 3.8 Favored Glycine 0 C--N 1.357 1.725 0 N-CA-C 119.007 2.363 . . . . 0.42 119.007 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.14 158.05 43.78 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.3 1.222 . . . . 1.1 114.3 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.68 141.0 37.88 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.308 -1.769 . . . . 0.67 109.332 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.9 t -123.95 141.61 51.88 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.972 1.471 . . . . 0.36 114.972 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -116.56 100.45 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.33 -1.359 . . . . 0.74 107.33 176.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -113.48 126.3 55.17 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.77 -0.65 . . . . 1.67 112.375 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.6 124.61 52.75 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.503 -0.771 . . . . 1.8 110.406 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.45 ' C ' ' HB3' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -107.99 144.85 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 113.982 -1.463 . . . . 0.58 111.027 -177.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.519 ' HB3' ' OD1' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -78.25 149.18 33.64 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 125.224 1.41 . . . . 2.18 114.673 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.42 -53.09 0.57 Allowed Glycine 0 CA--C 1.537 1.464 0 CA-C-N 115.097 -0.956 . . . . 1.02 113.392 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -128.39 -48.52 1.3 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 122.937 0.495 . . . . 2.86 112.049 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.78 -46.32 0.54 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.814 0.672 . . . . 3.91 112.814 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.46 160.5 17.71 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.437 0.637 . . . . 1.74 112.569 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.565 ' ND2' ' H ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -120.17 -51.81 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 115.751 -0.658 . . . . 1.68 111.296 -179.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -103.49 -59.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.669 2.246 . . . . 2.06 115.143 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.0 tptm 88.34 -106.22 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 126.823 2.049 . . . . 3.0 110.492 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.07 134.1 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.005 -1.109 . . . . 0.8 108.005 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 4.0 t -132.65 137.64 47.05 Favored 'General case' 0 C--N 1.366 1.297 0 N-CA-C 115.159 1.54 . . . . 0.87 115.159 -174.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.256 . . -130.15 47.27 2.53 Favored 'General case' 0 CA--C 1.589 2.465 0 N-CA-C 115.524 1.675 . . . . 0.34 115.524 -179.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.85 137.07 5.84 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 116.506 2.039 . . . . 0.7 116.506 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -154.06 106.04 2.78 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 115.668 -0.696 . . . . 0.21 111.298 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.412 HD12 HD12 ' A' ' 85' ' ' LEU 0.325 7.8 tt -114.65 122.3 68.49 Favored 'Isoleucine or valine' 0 C--O 1.27 2.165 0 CA-C-O 122.44 1.114 . . . . 0.31 111.465 175.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -124.31 165.26 17.98 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 113.924 -1.489 . . . . 0.44 111.146 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.3 ptmm? -121.87 157.46 31.1 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 118.223 2.675 . . . . 1.26 118.223 -175.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.04 -40.96 2.27 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 110.343 -3.117 . . . . 0.17 118.967 173.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.04 159.43 1.67 Allowed 'General case' 0 N--CA 1.514 2.77 0 CA-C-N 120.412 2.106 . . . . 0.15 113.059 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.79 -13.64 59.7 Favored 'General case' 0 CA--C 1.58 2.118 0 C-N-CA 125.141 1.376 . . . . 0.17 114.046 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.01 3.28 49.39 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 113.663 0.986 . . . . 0.55 113.663 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.87 -8.94 19.34 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.575 0.954 . . . . 0.6 113.575 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.537 0 C-N-CA 123.971 0.908 . . . . 0.95 112.457 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.462 ' HG ' HD11 ' A' ' 27' ' ' ILE . 15.2 tp . . . . . 0 CA--C 1.565 1.538 0 N-CA-C 113.558 0.947 . . . . 0.35 113.558 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -22.48 61.35 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 115.412 1.634 . . . . 0.2 115.412 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.46 -12.51 48.8 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 113.751 1.019 . . . . 0.32 113.751 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 16.4 mtpt -108.38 -18.91 13.63 Favored 'General case' 0 C--N 1.365 1.274 0 N-CA-C 113.583 0.957 . . . . 1.73 113.583 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.25 138.84 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.967 0 N-CA-C 115.156 1.539 . . . . 0.11 115.156 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -122.34 -28.09 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 115.34 -0.846 . . . . 0.16 112.124 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -165.32 119.7 1.26 Allowed 'General case' 0 CA--C 1.563 1.443 0 N-CA-C 111.543 0.201 . . . . 0.54 111.543 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -138.31 130.51 28.7 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.302 -0.874 . . . . 0.19 111.724 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -138.9 134.59 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 N-CA-C 113.642 0.978 . . . . 1.05 113.642 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.427 HD22 ' HA ' ' A' ' 169' ' ' ALA . 6.1 t-20 -115.93 106.0 13.3 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.595 -1.261 . . . . 2.11 107.595 172.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.99 106.64 9.99 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 121.525 0.678 . . . . 0.63 111.683 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.459 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 165.84 -47.73 0.27 Allowed Glycine 0 C--N 1.355 1.588 0 CA-C-N 114.613 -1.176 . . . . 0.71 115.689 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.58 -119.09 3.07 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-O 119.743 -0.476 . . . . 0.8 113.368 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.407 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 6.8 pt-20 -167.51 117.64 0.84 Allowed 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 117.311 0.555 . . . . 1.63 112.214 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER 48.07 112.01 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 118.339 2.718 . . . . 1.0 118.339 178.22 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 82.3 t60 -144.83 137.4 26.32 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.049 1.129 . . . . 0.45 114.049 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.39 119.93 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-N 114.423 -1.262 . . . . 1.39 110.172 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.57 157.86 24.61 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-N 114.707 -1.133 . . . . 1.85 110.302 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 m -42.19 -28.15 0.23 Allowed 'Isoleucine or valine' 1 N--CA 1.543 4.186 0 N-CA-C 119.261 3.06 . . . . 0.72 119.261 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -93.47 -16.41 24.55 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 118.281 0.491 . . . . 0.51 111.513 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.68 41.88 1.29 Allowed Glycine 0 C--N 1.357 1.719 0 C-N-CA 124.391 0.996 . . . . 0.34 114.561 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.462 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.8 mm -106.21 117.97 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 N-CA-C 109.335 -0.617 . . . . 0.55 109.335 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.448 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.74 135.49 47.06 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.846 1.795 . . . . 1.34 115.846 -175.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.3 137.71 33.98 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.261 -1.336 . . . . 2.79 110.157 175.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.442 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 31.8 mtt180 -99.48 107.05 19.15 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.581 -1.191 . . . . 3.0 112.898 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -28.08 113.75 0.07 Allowed 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 120.2 3.407 . . . . 2.3 120.2 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 32.25 58.72 1.33 Allowed Pre-proline 0 N--CA 1.535 3.796 0 N-CA-C 117.883 2.549 . . . . 1.17 117.883 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 20.4 Cg_endo . . . . . 0 CA--C 1.563 1.961 0 C-N-CA 123.071 2.514 . . . . 1.45 116.303 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . 31.0 Cg_exo . . . . . 0 N--CA 1.511 2.552 0 N-CA-C 116.371 1.643 . . . . 1.37 116.371 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 61' ' ' TYR 0.269 1.4 mp -88.65 135.97 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.342 0 C-N-CA 123.69 0.796 . . . . 0.69 110.113 179.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.41 -20.55 23.81 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 116.791 2.145 . . . . 1.28 116.791 -176.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -99.03 18.64 16.8 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.15 1.167 . . . . 1.51 114.15 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.66 -175.7 4.04 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-O 121.426 0.631 . . . . 1.09 111.934 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.779 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -93.56 -177.83 0.75 Allowed Pre-proline 0 N--CA 1.511 2.625 0 C-N-CA 123.889 0.876 . . . . 1.27 109.543 178.301 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -68.93 -39.28 8.4 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.54 2.16 . . . . 0.95 113.588 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.59 -50.95 47.72 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 125.309 1.444 . . . . 2.04 112.167 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -6.29 55.19 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-N 115.018 -0.992 . . . . 1.62 112.667 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.779 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.0 tt0 -74.29 -39.96 62.6 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 125.162 1.385 . . . . 1.77 108.408 173.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.77 -43.55 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 C-N-CA 124.213 1.005 . . . . 0.81 108.939 173.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.45 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 tp -80.37 -6.21 57.66 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 114.546 1.313 . . . . 1.15 114.546 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.426 ' O ' HG12 ' A' ' 50' ' ' ILE . 18.9 m-85 -125.22 21.8 7.95 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 123.777 0.831 . . . . 0.92 112.865 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 29.0 tt0 -143.86 -37.36 0.33 Allowed 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 115.338 1.607 . . . . 1.33 115.338 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.1 p -68.57 133.79 49.05 Favored 'General case' 0 N--CA 1.53 3.558 0 N-CA-C 114.849 1.425 . . . . 1.28 114.849 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.52 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.7 pt-20 . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 115.012 1.486 . . . . 1.53 115.012 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.509 ' HA ' HD21 ' A' ' 164' ' ' ASN . 5.1 m-20 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 110.704 -0.11 . . . . 2.15 110.704 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.523 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.3 OUTLIER 70.69 82.13 0.16 Allowed 'General case' 0 N--CA 1.515 2.812 0 C-N-CA 124.762 1.225 . . . . 0.77 110.869 -178.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -144.85 153.9 42.08 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.78 -0.646 . . . . 0.81 112.654 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.79 -163.91 16.58 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 116.007 1.163 . . . . 0.47 116.007 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -122.76 164.94 17.4 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 113.607 -1.296 . . . . 0.89 113.413 -177.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.22 130.37 52.66 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.425 -1.261 . . . . 0.51 112.126 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.21 102.07 37.42 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.504 0.722 . . . . 0.15 109.426 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -84.32 121.03 2.6 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.003 1.802 . . . . 0.15 114.691 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.39 161.99 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 CA-C-O 122.099 0.952 . . . . 0.19 110.946 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -153.63 22.45 0.53 Allowed 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 114.55 -1.205 . . . . 2.53 111.626 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.14 156.78 44.0 Favored 'General case' 0 C--N 1.362 1.127 0 C-N-CA 123.167 0.587 . . . . 2.12 110.788 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -118.37 147.41 43.56 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.388 1.255 . . . . 0.42 114.388 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.12 -137.64 5.15 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 113.619 -1.628 . . . . 0.23 111.885 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.0 mt-10 -116.22 106.42 13.67 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-N 118.728 1.264 . . . . 1.75 110.819 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -99.58 128.4 45.68 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.251 0.548 . . . . 0.21 110.893 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.53 121.77 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.807 0.813 . . . . 0.2 110.835 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.36 106.99 17.85 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.118 -1.401 . . . . 0.78 109.854 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.06 125.67 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.755 -0.657 . . . . 0.44 110.927 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.73 144.64 51.12 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.449 0.907 . . . . 1.25 113.449 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 4.5 tppt? -104.94 120.57 41.77 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.71 -0.677 . . . . 2.52 111.383 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 7.5 m-85 -105.56 134.48 48.6 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.561 -0.745 . . . . 0.4 109.994 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.68 155.3 47.47 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.252 0.548 . . . . 0.41 111.784 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.9 171.85 7.4 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.561 0.745 . . . . 2.61 112.281 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.84 -77.61 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 112.498 0.555 . . . . 2.13 112.498 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -129.69 70.17 1.43 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.311 0.577 . . . . 2.27 111.76 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -148.42 109.83 4.4 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.747 -0.66 . . . . 1.46 110.943 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.22 88.02 2.63 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 123.171 1.463 . . . . 0.84 111.271 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -169.12 155.41 6.55 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 113.886 -1.506 . . . . 2.45 110.475 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.3 m -118.61 -68.49 0.91 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.44 1.274 . . . . 1.66 114.44 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -98.56 68.61 1.84 Allowed 'General case' 0 CA--C 1.558 1.281 0 CA-C-O 121.998 0.904 . . . . 1.89 111.366 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -154.32 -45.41 0.09 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.142 -1.39 . . . . 2.56 109.34 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -113.56 86.96 2.5 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 121.683 0.754 . . . . 2.76 109.022 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.05 131.4 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 114.524 -1.216 . . . . 0.69 111.651 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -103.86 166.93 10.1 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.975 1.472 . . . . 0.7 114.975 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.17 137.15 54.93 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.91 -0.586 . . . . 1.33 111.353 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.8 t -134.52 129.49 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.278 0 CA-C-N 115.941 -0.572 . . . . 0.48 111.116 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -133.82 144.58 49.06 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.681 1.363 . . . . 1.69 114.681 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.8 m -115.91 106.53 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 114.228 -1.351 . . . . 0.6 112.783 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 6.0 t30 62.75 27.03 15.93 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 126.906 2.082 . . . . 1.12 114.417 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.93 -20.47 31.24 Favored Glycine 0 CA--C 1.549 2.185 0 CA-C-N 115.503 -0.771 . . . . 0.32 113.773 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -84.82 137.55 33.1 Favored 'General case' 0 C--N 1.365 1.254 0 C-N-CA 125.59 1.556 . . . . 0.57 114.018 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.69 129.22 42.97 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.694 0.759 . . . . 0.55 112.433 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.13 -51.46 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 114.389 -1.278 . . . . 1.06 113.21 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.6 89.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.97 -0.752 . . . . 0.44 108.97 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -110.78 75.69 0.94 Allowed 'General case' 0 C--N 1.361 1.07 0 CA-C-O 123.68 1.705 . . . . 2.3 112.446 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 152.89 67.16 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 110.094 -3.23 . . . . 2.48 108.23 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.29 101.62 13.36 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 122.161 0.981 . . . . 1.13 112.824 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.64 100.09 8.94 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 112.865 -1.971 . . . . 2.35 107.701 176.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.22 -22.11 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.379 0 N-CA-C 114.109 1.151 . . . . 0.68 114.109 -176.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -77.28 -42.95 35.05 Favored 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 123.978 0.911 . . . . 0.77 112.012 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.32 -27.23 60.61 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.892 1.071 . . . . 0.91 113.892 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -80.18 -53.07 7.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.926 1.084 . . . . 2.43 113.926 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.277 4.1 p -102.61 -36.24 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.99 0 N-CA-C 113.997 1.11 . . . . 0.93 113.997 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.5 -121.1 3.03 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-N 118.691 0.678 . . . . 0.85 113.047 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -113.27 107.65 16.19 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.252 0.549 . . . . 3.18 110.826 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.3 m 72.81 -121.21 0.06 Allowed 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 125.558 1.543 . . . . 2.08 111.669 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.6 p 51.55 -165.88 0.05 OUTLIER 'General case' 0 N--CA 1.535 3.795 0 N-CA-C 116.315 1.968 . . . . 0.62 116.315 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -109.08 127.06 53.82 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.128 0.788 . . . . 0.46 113.128 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 8.8 t60 -105.0 140.41 38.23 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.423 0.689 . . . . 0.38 109.506 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -144.6 128.5 17.41 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.656 0.613 . . . . 2.5 112.656 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -116.14 136.83 52.67 Favored 'General case' 0 C--O 1.255 1.371 0 CA-C-N 115.019 -0.991 . . . . 1.56 111.348 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.92 118.92 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 CA-C-N 113.719 -1.582 . . . . 0.45 110.741 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.19 88.79 50.04 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-N 115.498 -0.774 . . . . 0.84 109.724 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -73.54 139.26 28.16 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 123.183 2.589 . . . . 0.16 113.921 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -122.35 150.83 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-N 115.348 -0.842 . . . . 0.38 110.825 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.4 t -135.15 109.32 8.28 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.157 -0.929 . . . . 1.31 110.525 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.536 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -108.9 124.75 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.569 0 CA-C-N 115.057 -0.974 . . . . 0.25 108.811 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -141.27 125.56 17.5 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.245 -0.889 . . . . 2.05 110.778 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp 67.23 16.0 10.09 Favored 'General case' 0 N--CA 1.51 2.574 0 C-N-CA 125.444 1.498 . . . . 3.55 114.23 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.68 16.83 32.63 Favored Glycine 0 CA--C 1.549 2.203 0 CA-C-O 119.323 -0.71 . . . . 0.37 114.591 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 58.2 mttt -120.74 142.56 49.43 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-N 118.003 0.902 . . . . 1.56 112.847 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.54 132.51 47.13 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.271 0.841 . . . . 0.34 113.271 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.08 112.81 18.2 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.2 -0.909 . . . . 0.64 110.74 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.68 93.13 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.646 0 CA-C-N 115.44 -0.8 . . . . 0.46 110.096 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 64.67 -85.17 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.949 0 C-N-CA 125.36 1.464 . . . . 1.56 113.711 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.41 29.93 3.95 Favored Glycine 0 CA--C 1.544 1.898 0 CA-C-N 116.004 -0.544 . . . . 0.49 113.288 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -133.77 119.96 19.92 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 123.74 0.816 . . . . 1.82 110.544 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.9 p -107.76 133.19 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.351 0 CA-C-O 121.481 0.658 . . . . 1.02 111.806 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m -151.39 -177.04 5.83 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.161 -0.927 . . . . 0.56 110.403 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.8 p -101.87 137.03 40.71 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.282 0.845 . . . . 1.25 113.282 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -86.74 121.47 29.29 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.456 0.702 . . . . 0.29 110.144 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.2 t -126.39 91.25 3.33 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 113.03 0.752 . . . . 1.42 113.03 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.56 -62.7 3.11 Favored Glycine 0 C--N 1.36 1.885 0 N-CA-C 118.542 2.177 . . . . 0.42 118.542 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.49 159.89 38.08 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 122.061 0.934 . . . . 1.1 113.31 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.523 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -106.46 134.12 50.09 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.448 -1.705 . . . . 0.67 108.721 176.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.417 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.6 t -121.52 123.45 42.03 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 114.521 1.304 . . . . 0.36 114.521 -176.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.51 102.81 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.567 -0.901 . . . . 0.74 108.567 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.15 150.15 52.27 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.061 0.934 . . . . 1.67 111.633 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.23 141.72 48.66 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 114.198 -1.365 . . . . 1.8 112.274 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.97 145.53 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-N 112.704 -2.044 . . . . 0.58 110.769 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -70.3 150.04 46.77 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 115.803 1.779 . . . . 2.18 115.803 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.3 -55.62 0.5 Allowed Glycine 0 CA--C 1.538 1.484 0 CA-C-N 114.89 -1.05 . . . . 1.02 112.606 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.86 -56.14 0.99 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.38 0.672 . . . . 2.86 111.049 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -132.27 -41.67 0.98 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.253 0.621 . . . . 3.91 112.394 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.37 155.25 24.46 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.33 0.652 . . . . 1.74 112.303 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.523 ' ND2' ' H ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -118.1 -48.02 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 115.693 -0.685 . . . . 1.68 110.212 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -106.62 -69.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.553 2.169 . . . . 2.06 115.939 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt 92.72 -92.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 127.47 2.308 . . . . 3.0 109.32 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 64' ' ' GLU . 41.9 t -113.42 131.62 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 107.775 -1.194 . . . . 0.8 107.775 174.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.8 t -136.34 127.04 27.23 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 115.667 -0.697 . . . . 0.87 112.515 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.26 . . -119.43 50.2 1.27 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.858 1.799 . . . . 0.34 115.858 -177.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -41.01 131.52 2.53 Favored 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 115.887 1.81 . . . . 0.7 115.887 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -151.13 100.84 2.81 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.186 -0.916 . . . . 0.21 110.275 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.312 8.5 tt -110.12 123.14 65.77 Favored 'Isoleucine or valine' 0 C--O 1.267 2.001 0 CA-C-O 122.412 1.101 . . . . 0.31 112.025 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -124.08 162.96 22.45 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 113.553 -1.658 . . . . 0.44 110.862 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 18.0 ptmt -121.56 159.99 25.24 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 118.585 2.809 . . . . 1.26 118.585 -175.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.51 -42.04 2.0 Allowed Glycine 0 CA--C 1.541 1.685 0 CA-C-N 110.001 -3.272 . . . . 0.17 118.688 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.07 153.27 0.97 Allowed 'General case' 0 N--CA 1.515 2.815 0 CA-C-N 120.131 1.966 . . . . 0.15 112.678 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.68 -12.89 60.04 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.631 1.345 . . . . 0.17 114.631 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.42 4.56 45.97 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 114.349 1.24 . . . . 0.55 114.349 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.11 -13.27 15.21 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 114.445 1.276 . . . . 0.6 114.445 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.519 3.004 0 C-N-CA 124.238 1.015 . . . . 0.95 112.944 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.64 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.8 tp . . . . . 0 CA--C 1.564 1.518 0 N-CA-C 113.505 0.928 . . . . 0.35 113.505 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.99 -23.11 61.54 Favored 'General case' 0 N--CA 1.511 2.601 0 C-N-CA 125.704 1.602 . . . . 0.2 115.209 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.82 -12.17 48.77 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 113.661 0.986 . . . . 0.32 113.661 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 47.8 mmtt -104.69 -22.02 13.29 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.399 0.889 . . . . 1.73 113.399 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.21 134.69 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 N-CA-C 115.172 1.545 . . . . 0.11 115.172 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -122.88 -29.95 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-N 115.575 -0.739 . . . . 0.16 112.343 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 73.9 t90 -161.16 117.49 2.22 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 121.029 0.442 . . . . 0.54 111.244 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.8 142.25 40.85 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.621 -0.674 . . . . 0.19 111.316 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.44 HG21 ' HG3' ' A' ' 33' ' ' PRO 0.334 8.9 p -145.38 134.03 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.937 0 CA-C-O 122.425 1.107 . . . . 1.05 113.461 178.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.761 HD22 ' H ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -100.92 91.02 4.39 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-N 113.195 -1.82 . . . . 2.11 109.325 178.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -82.02 103.24 11.52 Favored 'General case' 0 C--O 1.265 1.88 0 CA-C-O 123.414 1.578 . . . . 0.63 113.158 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.536 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 162.99 -50.48 0.31 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-N 111.394 -2.639 . . . . 0.71 111.374 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.63 -126.03 4.16 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.497 -1.041 . . . . 0.8 110.497 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -168.4 117.36 0.73 Allowed 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 117.666 0.733 . . . . 1.63 112.095 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.679 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 6.3 m 62.8 115.68 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 116.896 2.184 . . . . 1.0 116.896 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -159.8 139.57 11.46 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.369 0.604 . . . . 0.45 112.176 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.14 122.66 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-N 115.57 -0.741 . . . . 1.39 110.651 176.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -85.2 155.98 21.19 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.562 -0.745 . . . . 1.85 111.183 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . 0.265 0.7 OUTLIER -45.1 -16.9 0.07 OUTLIER 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 N-CA-C 119.99 3.33 . . . . 0.72 119.99 -175.39 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -95.8 -20.85 18.51 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 118.766 0.712 . . . . 0.51 111.295 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.68 38.8 1.26 Allowed Glycine 0 C--N 1.356 1.652 0 C-N-CA 124.414 1.007 . . . . 0.34 114.488 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.64 HD11 ' HG ' ' A' ' 6' ' ' LEU . 38.8 mm -105.6 121.58 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 N-CA-C 108.994 -0.743 . . . . 0.55 108.994 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -101.23 125.29 47.84 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.641 0.608 . . . . 1.34 112.641 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 20' ' ' SER . 41.7 m-85 -95.77 137.97 34.08 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.275 -0.875 . . . . 2.79 111.09 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -72.26 159.97 33.18 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.929 2.196 . . . . 3.0 116.929 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -94.92 87.19 4.88 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.001 -1.909 . . . . 2.3 115.399 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 49.41 78.29 0.41 Allowed Pre-proline 0 N--CA 1.529 3.489 0 N-CA-C 115.594 1.701 . . . . 1.17 115.594 177.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HG3' HG21 ' A' ' 14' ' ' VAL . 44.9 Cg_endo . . . . . 0 CA--C 1.563 1.939 0 N-CA-C 118.971 2.643 . . . . 1.45 118.971 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo . . . . . 0 N--CA 1.495 1.573 0 N-CA-C 116.906 1.849 . . . . 1.37 116.906 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.26 1.3 mp -87.51 134.8 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.317 0 C-N-CA 123.82 0.848 . . . . 0.69 109.892 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.404 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.3 mm? -90.69 -18.34 25.22 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.106 1.891 . . . . 1.28 116.106 -176.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -103.55 26.02 8.99 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 114.427 1.269 . . . . 1.51 114.427 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.449 ' HG ' ' HD2' ' A' ' 61' ' ' TYR . 1.0 OUTLIER -140.37 -165.56 1.94 Allowed 'General case' 0 CA--C 1.565 1.537 0 CA-C-O 122.32 1.057 . . . . 1.09 112.725 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.888 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 2.1 t30 -88.85 172.6 7.26 Favored Pre-proline 0 CA--C 1.569 1.699 0 C-N-CA 126.488 1.915 . . . . 1.27 110.54 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.48 -43.31 1.01 Allowed 'Trans proline' 0 N--CA 1.513 2.63 0 C-N-CA 122.444 2.096 . . . . 0.95 113.822 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.37 -41.57 47.57 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 125.223 1.409 . . . . 2.04 111.893 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -86.47 3.96 41.74 Favored 'General case' 0 CA--C 1.578 2.047 0 CA-C-N 114.443 -1.253 . . . . 1.62 111.708 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.888 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.3 tt0 -83.25 -40.36 19.69 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 126.659 1.984 . . . . 1.77 106.08 171.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.93 -45.99 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.283 0 C-N-CA 125.296 1.438 . . . . 0.81 109.52 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -39.42 68.81 Favored 'General case' 0 CA--C 1.601 2.907 0 N-CA-C 112.781 0.659 . . . . 1.15 112.781 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.449 ' HD2' ' HG ' ' A' ' 53' ' ' SER . 12.2 m-30 -90.88 20.48 4.77 Favored 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 114.746 1.387 . . . . 0.92 114.746 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.08 -42.01 0.65 Allowed 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 115.408 1.633 . . . . 1.33 115.408 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.426 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 48.1 p -63.2 137.71 58.31 Favored 'General case' 0 N--CA 1.537 3.882 0 N-CA-C 114.989 1.477 . . . . 1.28 114.989 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.536 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 14.9 pt-20 . . . . . 0 N--CA 1.5 2.055 0 N-CA-C 115.08 1.511 . . . . 1.53 115.08 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 110.373 -0.232 . . . . 2.15 110.373 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.68 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.3 OUTLIER 68.82 87.7 0.12 Allowed 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 125.341 1.456 . . . . 0.77 111.802 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -149.14 163.35 37.84 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.445 0.906 . . . . 0.81 113.445 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.48 -155.09 10.82 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 116.912 1.525 . . . . 0.47 116.912 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.15 168.61 15.88 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.099 1.148 . . . . 0.89 114.099 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -126.05 133.68 51.64 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.357 -1.292 . . . . 0.51 112.082 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -126.07 100.52 30.05 Favored Pre-proline 0 CA--C 1.569 1.695 0 C-N-CA 123.167 0.587 . . . . 0.15 109.642 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.16 117.54 2.2 Favored 'Trans proline' 0 CA--C 1.563 1.925 0 C-N-CA 122.187 1.925 . . . . 0.15 114.978 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.18 160.66 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 CA-C-O 122.04 0.924 . . . . 0.19 111.409 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -148.51 23.18 1.02 Allowed 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 114.56 -1.2 . . . . 2.53 111.528 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -128.85 158.94 37.32 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-O 121.14 0.495 . . . . 2.12 110.892 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -120.6 144.94 47.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.601 1.334 . . . . 0.42 114.601 -177.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.36 -138.56 5.44 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 113.674 -1.603 . . . . 0.23 112.401 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.5 mt-10 -113.7 105.47 13.34 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 118.521 1.16 . . . . 1.75 111.294 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -99.1 128.43 45.23 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.116 0.484 . . . . 0.21 110.899 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 t -113.58 123.79 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.34 0.591 . . . . 0.2 110.509 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.408 HD12 HD12 ' A' ' 172' ' ' ILE . 3.4 tt -108.0 107.6 18.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.982 -1.008 . . . . 0.78 110.401 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.66 125.79 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 114.004 -1.453 . . . . 0.44 107.968 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.45 140.23 44.71 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 116.043 -0.526 . . . . 1.25 112.292 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 16.8 tptt -95.32 120.77 36.12 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.664 -0.698 . . . . 2.52 112.693 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -107.05 132.99 52.35 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.055 -0.975 . . . . 0.4 109.977 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.15 149.96 47.63 Favored 'General case' 0 C--O 1.262 1.719 0 CA-C-O 121.333 0.587 . . . . 0.41 111.372 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -118.52 142.0 48.02 Favored 'General case' 0 C--N 1.36 1.028 0 CA-C-N 115.175 -0.921 . . . . 2.61 111.844 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 -45.58 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-N 115.617 -0.72 . . . . 2.13 112.632 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -121.11 137.9 54.44 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.126 0.417 . . . . 2.27 112.126 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 89.41 104.6 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 126.356 1.863 . . . . 1.46 111.43 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.13 87.19 4.14 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 123.295 1.521 . . . . 0.84 111.929 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -146.04 157.47 43.86 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.73 -1.577 . . . . 2.45 111.726 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.4 m -115.05 -74.39 0.61 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.063 1.134 . . . . 1.66 114.063 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.28 64.12 1.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.225 1.012 . . . . 1.89 111.918 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -151.92 -41.66 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.573 1.549 . . . . 2.56 109.033 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -108.28 79.3 1.24 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-O 121.96 0.886 . . . . 2.76 109.137 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.38 120.88 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 114.564 -1.198 . . . . 0.69 110.639 -178.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -101.51 170.7 8.03 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.362 1.615 . . . . 0.7 115.362 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.22 136.72 54.86 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.063 0.458 . . . . 1.33 111.052 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.18 125.73 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.306 0 CA-C-N 115.826 -0.625 . . . . 0.48 109.899 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 46.2 mtt180 -125.72 151.34 46.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.645 1.72 . . . . 1.69 115.645 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.7 m -127.46 110.92 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 123.24 0.616 . . . . 0.6 112.577 177.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.506 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.51 26.43 13.38 Favored 'General case' 0 N--CA 1.526 3.374 0 C-N-CA 126.664 1.986 . . . . 1.12 113.95 -178.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.43 -11.93 56.79 Favored Glycine 0 CA--C 1.552 2.367 0 C-N-CA 121.482 -0.39 . . . . 0.32 113.834 -176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.492 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 89.3 m-70 -89.72 164.89 14.5 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 125.944 1.698 . . . . 0.57 113.488 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.04 134.89 54.32 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.494 0.664 . . . . 0.55 112.016 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.51 -58.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 114.916 -1.038 . . . . 1.06 112.784 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.06 88.64 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.881 -1.155 . . . . 0.44 107.881 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -107.74 100.16 9.57 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-O 123.11 1.433 . . . . 2.3 111.778 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 117.62 72.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 129.438 3.095 . . . . 2.48 108.015 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.11 104.96 16.85 Favored 'General case' 0 C--N 1.359 0.98 0 CA-C-O 121.979 0.895 . . . . 1.13 112.713 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -112.11 99.15 7.84 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 112.851 -1.977 . . . . 2.35 107.973 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -24.11 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.364 0 N-CA-C 113.964 1.098 . . . . 0.68 113.964 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -75.65 -41.35 54.29 Favored 'General case' 0 CA--C 1.568 1.668 0 C-N-CA 124.108 0.963 . . . . 0.77 111.96 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.75 -26.38 59.74 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.278 1.031 . . . . 0.91 113.444 176.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -77.39 -57.93 3.55 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.555 0.946 . . . . 2.43 113.555 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.84 -32.07 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 N-CA-C 114.906 1.447 . . . . 0.93 114.906 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.46 -115.77 2.35 Favored Glycine 0 C--N 1.357 1.729 0 CA-C-N 118.655 0.661 . . . . 0.85 113.011 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -114.8 107.5 15.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.246 0.546 . . . . 3.18 110.716 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.0 m 72.51 -130.52 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 125.487 1.515 . . . . 2.08 112.313 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 51' ' ' LEU . 73.2 p 58.15 -162.13 0.22 Allowed 'General case' 0 N--CA 1.53 3.528 0 C-N-CA 126.237 1.815 . . . . 0.62 115.017 178.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.91 135.71 53.69 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 113.495 0.924 . . . . 0.46 113.495 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -109.32 144.91 36.86 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.542 0.737 . . . . 0.38 109.163 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.15 124.19 18.88 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.704 1.001 . . . . 2.5 113.704 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -112.72 120.33 41.15 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.288 -0.869 . . . . 1.56 111.538 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.47 115.68 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-N 114.742 -1.117 . . . . 0.45 110.499 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 100.76 15.88 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 119.075 -0.488 . . . . 0.84 111.791 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -74.6 142.47 29.26 Favored 'Trans proline' 0 C--N 1.4 3.266 0 C-N-CA 123.062 2.508 . . . . 0.16 114.281 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.29 146.24 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.597 0 C-N-CA 123.934 0.894 . . . . 0.38 109.983 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.1 p -128.89 110.42 12.1 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.222 0.534 . . . . 1.31 112.145 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.0 mt -112.83 124.31 69.35 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.57 0 CA-C-N 115.277 -0.874 . . . . 0.25 108.952 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -140.22 124.22 17.53 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.47 -0.786 . . . . 2.05 111.223 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt 65.75 16.24 10.4 Favored 'General case' 0 N--CA 1.516 2.843 0 C-N-CA 125.43 1.492 . . . . 3.55 114.886 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.93 21.78 17.46 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 114.512 0.565 . . . . 0.37 114.512 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 19.0 ttmm -129.81 137.84 50.71 Favored 'General case' 0 C--N 1.363 1.159 0 CA-C-N 117.636 0.718 . . . . 1.56 111.545 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.36 141.7 31.8 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.077 1.14 . . . . 0.34 114.077 -176.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.21 114.53 13.92 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.704 -1.135 . . . . 0.64 110.109 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.253 8.7 p -119.58 95.55 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 CA-C-N 115.841 -0.618 . . . . 0.46 111.019 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 67.23 -85.18 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 125.714 1.606 . . . . 1.56 113.968 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.44 28.38 3.81 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.093 -0.503 . . . . 0.49 113.156 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -134.75 127.23 30.53 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 123.647 0.779 . . . . 1.82 110.473 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.3 p -114.27 139.72 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.361 0 CA-C-O 121.278 0.561 . . . . 1.02 111.451 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.8 m -158.73 176.04 12.87 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.577 0.751 . . . . 0.56 109.87 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.3 p -101.32 137.32 39.81 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.073 0.768 . . . . 1.25 113.073 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -82.8 124.86 30.67 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.074 0.949 . . . . 0.29 112.016 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.9 t -131.32 91.08 2.96 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-O 121.643 0.735 . . . . 1.42 112.574 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.0 -65.37 3.27 Favored Glycine 0 C--N 1.358 1.752 0 N-CA-C 118.986 2.355 . . . . 0.42 118.986 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.511 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -131.16 156.6 45.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.291 1.219 . . . . 1.1 114.291 -175.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.511 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -107.15 137.95 44.25 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 113.133 -1.849 . . . . 0.67 109.071 176.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.1 t -120.61 143.34 48.71 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.411 1.634 . . . . 0.36 115.411 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.38 99.04 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.169 -1.419 . . . . 0.74 107.169 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -117.58 123.17 45.56 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.996 -0.547 . . . . 1.67 112.316 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.01 136.24 53.13 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 122.53 1.157 . . . . 1.8 112.029 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.51 144.78 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 CA-C-N 112.529 -2.123 . . . . 0.58 109.814 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -58.8 150.84 22.76 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.504 2.038 . . . . 2.18 116.504 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.91 -63.95 0.51 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 115.541 -0.754 . . . . 1.02 114.028 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -130.7 -64.85 0.82 Allowed 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.962 0.381 . . . . 2.86 111.811 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -120.17 -46.56 2.41 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.769 0.428 . . . . 3.91 111.953 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -100.99 177.09 5.05 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.47 0.708 . . . . 1.74 111.222 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.68 ' ND2' ' H ' ' A' ' 70' ' ' SER . 4.5 m-20 -115.0 -85.46 0.0 OUTLIER Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 117.441 -1.266 . . . . 1.68 110.679 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -88.59 -36.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.393 2.911 0 CA-C-N 123.774 2.384 . . . . 2.06 114.256 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm 79.79 -88.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 126.845 2.058 . . . . 3.0 110.675 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.511 HG22 ' HB3' ' A' ' 64' ' ' GLU . 22.8 t -111.77 131.81 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.327 -0.99 . . . . 0.8 108.327 175.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 3.8 t -138.26 132.49 31.8 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.052 -0.977 . . . . 0.87 111.801 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -129.6 51.11 2.1 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 114.96 1.467 . . . . 0.34 114.96 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.25 138.14 1.25 Allowed 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 117.803 2.52 . . . . 0.7 117.803 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -153.78 104.22 2.67 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 115.666 -0.697 . . . . 0.21 111.504 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.408 HD12 HD12 ' A' ' 85' ' ' LEU 0.316 10.3 tt -113.88 122.06 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.183 0 CA-C-O 122.384 1.088 . . . . 0.31 111.119 175.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -122.7 165.47 16.48 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.145 -1.389 . . . . 0.44 111.092 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.6 ptmt -121.74 157.89 29.97 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 118.239 2.681 . . . . 1.26 118.239 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.24 -40.39 2.45 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 110.212 -3.176 . . . . 0.17 119.066 173.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.11 157.64 1.85 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 120.265 2.033 . . . . 0.15 113.101 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.86 -11.52 59.58 Favored 'General case' 0 CA--C 1.58 2.132 0 C-N-CA 124.91 1.284 . . . . 0.17 113.984 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.68 3.52 47.57 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.0 1.111 . . . . 0.55 114.0 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.02 -20.47 14.78 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.388 0.885 . . . . 0.6 113.388 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.579 2.072 0 C-N-CA 124.343 1.057 . . . . 0.95 112.262 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.445 ' HG ' HD11 ' A' ' 27' ' ' ILE . 17.6 tp . . . . . 0 CA--C 1.566 1.586 0 N-CA-C 113.328 0.862 . . . . 0.35 113.328 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.99 -23.32 63.54 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 125.896 1.678 . . . . 0.2 115.269 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.69 -12.17 49.11 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 113.575 0.954 . . . . 0.32 113.575 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -106.13 -19.36 13.74 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 113.324 0.861 . . . . 1.73 113.324 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -56.67 134.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.851 0 N-CA-C 114.705 1.372 . . . . 0.11 114.705 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -119.7 -29.77 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 115.581 -0.736 . . . . 0.16 112.214 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -160.43 115.95 2.3 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 120.696 0.284 . . . . 0.54 110.951 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.08 122.19 22.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.602 -0.686 . . . . 0.19 111.397 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 30.8 t -131.25 116.63 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 122.097 0.951 . . . . 1.05 109.663 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.549 HD22 ' HB1' ' A' ' 169' ' ' ALA . 11.4 m120 -114.01 88.01 2.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.828 -1.078 . . . . 2.11 108.996 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.6 120.13 17.79 Favored 'General case' 0 C--O 1.277 2.516 0 N-CA-C 115.757 1.762 . . . . 0.63 115.757 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.505 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 151.88 -10.22 0.67 Allowed Glycine 0 C--N 1.359 1.816 0 CA-C-N 111.731 -2.486 . . . . 0.71 115.693 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.12 -119.81 1.23 Allowed Glycine 0 N--CA 1.468 0.82 0 CA-C-N 117.645 0.723 . . . . 0.8 112.511 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -169.07 118.08 0.67 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.068 0.547 . . . . 1.63 110.697 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.668 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 68.1 p 42.95 100.45 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.681 0 N-CA-C 117.92 2.563 . . . . 1.0 117.92 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 84.0 t60 -132.94 136.24 46.0 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 118.615 -1.234 . . . . 0.45 114.171 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.267 10.0 p -103.39 117.76 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 CA-C-N 114.117 -1.401 . . . . 1.39 110.917 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -83.12 152.51 25.27 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-N 113.578 -1.646 . . . . 1.85 110.046 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.7 m -41.25 -28.77 0.16 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.27 0 N-CA-C 119.192 3.034 . . . . 0.72 119.192 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -87.36 -25.96 23.59 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.184 0.516 . . . . 0.51 111.277 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.63 38.85 0.75 Allowed Glycine 0 C--N 1.352 1.422 0 CA-C-N 114.983 -1.008 . . . . 0.34 114.445 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.445 HD11 ' HG ' ' A' ' 6' ' ' LEU . 20.6 mm -107.09 114.16 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 N-CA-C 109.68 -0.489 . . . . 0.55 109.68 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.537 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -107.08 132.46 52.95 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 115.359 1.614 . . . . 1.34 115.359 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -89.12 147.27 24.3 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.871 0.869 . . . . 2.79 109.93 174.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 20' ' ' SER . 0.0 OUTLIER -60.49 -107.88 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 117.075 2.25 . . . . 3.0 117.075 -177.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -175.72 71.55 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 124.221 1.008 . . . . 2.3 112.958 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.415 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 19.3 m-20 65.52 47.57 0.58 Allowed Pre-proline 0 N--CA 1.519 3.009 0 N-CA-C 118.291 2.7 . . . . 1.17 118.291 175.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 41.4 Cg_endo . . . . . 0 C--N 1.374 1.91 0 C-N-CA 123.214 2.609 . . . . 1.45 114.391 177.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo . . . . . 0 N--CA 1.501 1.921 0 N-CA-C 117.379 2.03 . . . . 1.37 117.379 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.265 1.2 mp -89.8 128.11 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.226 0 CA-C-N 114.986 -1.006 . . . . 0.69 109.191 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mp -85.49 -12.01 52.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.924 1.824 . . . . 1.28 115.924 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -102.63 22.59 13.36 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 113.694 0.998 . . . . 1.51 113.694 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -143.03 -163.33 1.61 Allowed 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 121.773 0.797 . . . . 1.09 111.993 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.2 t30 -95.55 -179.96 1.04 Allowed Pre-proline 0 CA--C 1.572 1.823 0 C-N-CA 125.302 1.441 . . . . 1.27 111.138 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.575 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 24.5 Cg_exo -71.82 -45.64 0.7 Allowed 'Trans proline' 0 C--N 1.394 2.969 0 C-N-CA 123.076 2.518 . . . . 0.95 111.891 174.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -70.07 -43.78 70.45 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.438 -1.71 . . . . 2.04 111.56 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.01 1.51 43.45 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 114.912 -1.04 . . . . 1.62 112.438 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.595 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 3.4 tt0 -77.71 -42.94 32.65 Favored 'General case' 0 C--N 1.381 1.938 0 C-N-CA 125.853 1.661 . . . . 1.77 106.853 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.07 -44.45 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.869 0 C-N-CA 124.519 1.127 . . . . 0.81 109.108 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.9 tp -68.22 -29.67 68.55 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 114.723 1.379 . . . . 1.15 114.723 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -105.53 14.88 27.92 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 114.121 1.156 . . . . 0.92 114.121 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.14 -23.48 1.13 Allowed 'General case' 0 N--CA 1.513 2.713 0 N-CA-C 115.883 1.809 . . . . 1.33 115.883 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.473 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 41.7 p -80.88 135.95 36.0 Favored 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 113.378 0.881 . . . . 1.28 113.378 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.505 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.1 pt-20 . . . . . 0 N--CA 1.511 2.606 0 N-CA-C 115.894 1.813 . . . . 1.53 115.894 -176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 110.58 -0.155 . . . . 2.15 110.58 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.499 ' H ' HD21 ' A' ' 164' ' ' ASN . 0.3 OUTLIER 72.72 83.99 0.12 Allowed 'General case' 0 N--CA 1.514 2.75 0 C-N-CA 124.952 1.301 . . . . 0.77 111.042 -178.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -147.29 152.84 38.93 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.502 -0.772 . . . . 0.81 113.062 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -165.51 -171.68 32.01 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 115.842 1.097 . . . . 0.47 115.842 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.27 172.43 7.08 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.438 1.273 . . . . 0.89 114.438 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.09 132.33 51.92 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.393 -1.276 . . . . 0.51 112.228 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.27 102.22 30.65 Favored Pre-proline 0 CA--C 1.567 1.613 0 C-N-CA 123.446 0.698 . . . . 0.15 109.408 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.84 119.58 2.22 Favored 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 122.098 1.865 . . . . 0.15 114.925 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.36 162.7 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.654 0 CA-C-O 122.003 0.906 . . . . 0.19 111.089 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -150.63 19.76 0.82 Allowed 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 114.716 -1.129 . . . . 2.53 111.781 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.53 159.78 35.25 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-O 121.32 0.581 . . . . 2.12 111.572 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.517 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -118.32 147.96 42.96 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.199 1.185 . . . . 0.42 114.199 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.82 -139.6 6.26 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 113.827 -1.533 . . . . 0.23 112.165 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.9 mt-10 -115.1 104.63 12.06 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 118.46 1.13 . . . . 1.75 110.823 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -98.88 128.4 45.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.159 0.504 . . . . 0.21 110.759 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -112.93 122.91 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-O 121.612 0.72 . . . . 0.2 110.848 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.468 HD12 HD12 ' A' ' 172' ' ' ILE . 2.0 tt -108.34 105.35 14.99 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.391 -1.277 . . . . 0.78 110.304 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.19 125.13 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 114.082 -1.417 . . . . 0.44 107.913 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -135.52 135.34 40.33 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.728 -0.669 . . . . 1.25 111.837 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -96.09 121.21 37.62 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.498 -0.774 . . . . 2.52 112.051 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -107.34 133.96 51.11 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.058 -0.974 . . . . 0.4 109.945 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.33 152.92 48.92 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.433 0.635 . . . . 0.41 112.499 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.68 157.12 16.7 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.41 1.084 . . . . 2.61 112.309 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.257 4.4 p -144.52 -39.48 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.585 0 N-CA-C 114.227 1.195 . . . . 2.13 114.227 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -130.01 -2.04 4.63 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 115.442 1.645 . . . . 2.27 115.442 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -128.6 114.0 16.14 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.537 1.062 . . . . 1.46 112.311 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.0 92.7 4.15 Favored 'General case' 0 CA--C 1.563 1.471 0 CA-C-O 122.617 1.198 . . . . 0.84 111.061 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -152.12 149.62 29.0 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.815 -1.084 . . . . 2.45 112.103 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.1 m -123.71 117.83 25.85 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.585 0.587 . . . . 1.66 112.585 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 71.47 55.38 0.2 Allowed 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 126.244 1.818 . . . . 1.89 113.058 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -154.56 -40.08 0.09 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.194 -1.366 . . . . 2.56 109.579 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -107.61 80.84 1.44 Allowed 'General case' 0 C--N 1.364 1.237 0 N-CA-C 108.643 -0.873 . . . . 2.76 108.643 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.52 129.3 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 114.627 -1.169 . . . . 0.69 111.466 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -115.51 171.76 7.52 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.014 1.487 . . . . 0.7 115.014 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.52 136.12 54.01 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.415 0.626 . . . . 1.33 111.774 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.2 123.32 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.936 0 CA-C-N 115.315 -0.857 . . . . 0.48 110.102 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -129.83 149.42 51.57 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.953 1.464 . . . . 1.69 114.953 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.3 OUTLIER -126.56 108.26 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 114.636 -1.165 . . . . 0.6 111.704 176.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.49 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 65.18 26.08 12.37 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 126.759 2.023 . . . . 1.12 113.277 -177.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.41 -13.91 51.06 Favored Glycine 0 CA--C 1.553 2.435 0 CA-C-N 116.157 -0.474 . . . . 0.32 114.139 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -89.85 131.21 35.9 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 125.456 1.502 . . . . 0.57 114.044 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -97.85 126.0 43.0 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.429 -0.794 . . . . 0.55 112.705 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.26 -48.2 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-N 114.214 -1.357 . . . . 1.06 110.256 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.06 88.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 120.26 -0.576 . . . . 0.44 109.744 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.02 72.27 0.81 Allowed 'General case' 0 C--N 1.36 1.03 0 CA-C-O 123.494 1.616 . . . . 2.3 111.411 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.7 p30 160.07 60.4 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 111.005 -2.816 . . . . 2.48 108.52 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.89 103.18 15.75 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 113.749 1.018 . . . . 1.13 113.749 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -119.07 102.87 9.05 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 112.88 -1.963 . . . . 2.35 106.067 175.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -27.05 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.319 0 N-CA-C 114.547 1.314 . . . . 0.68 114.547 -176.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.59 -37.77 55.96 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.684 0.793 . . . . 0.77 112.194 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.22 -26.58 60.33 Favored 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 124.665 1.186 . . . . 0.91 113.229 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -80.22 -57.96 3.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.482 0.919 . . . . 2.43 113.482 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.28 -36.22 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.532 0 N-CA-C 114.196 1.184 . . . . 0.93 114.196 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.01 -73.12 0.2 Allowed Glycine 0 C--N 1.361 1.922 0 CA-C-N 118.306 0.503 . . . . 0.85 113.969 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -102.76 175.43 5.49 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.345 1.058 . . . . 3.18 111.753 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 m -71.6 87.68 0.93 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.997 0.903 . . . . 2.08 113.428 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.34 -162.22 1.3 Allowed 'General case' 0 CA--C 1.563 1.445 0 CA-C-N 113.918 -1.492 . . . . 0.62 110.024 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.94 130.3 45.3 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 113.421 0.897 . . . . 0.46 113.421 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.431 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 22.4 t60 -103.51 141.72 35.51 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.463 -0.569 . . . . 0.38 109.463 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -134.15 124.17 25.62 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.377 1.251 . . . . 2.5 114.377 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -111.39 118.84 36.93 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.748 -1.114 . . . . 1.56 110.684 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.62 120.91 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.735 -1.12 . . . . 0.45 111.448 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.29 95.45 27.49 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-N 115.842 -0.617 . . . . 0.84 111.062 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -75.37 131.91 14.37 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.787 2.324 . . . . 0.16 112.711 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.3 mt -115.1 146.7 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 CA-C-N 115.443 -0.799 . . . . 0.38 111.137 -176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.6 p -129.18 109.94 11.57 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.264 -0.88 . . . . 1.31 111.515 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.517 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.5 mt -112.14 123.33 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.502 0 N-CA-C 108.336 -0.987 . . . . 0.25 108.336 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -138.78 124.43 19.62 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.373 -0.83 . . . . 2.05 110.792 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.28 17.86 10.25 Favored 'General case' 0 N--CA 1.515 2.784 0 C-N-CA 125.35 1.46 . . . . 3.55 114.168 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.54 13.8 43.2 Favored Glycine 0 CA--C 1.546 2.01 0 CA-C-O 119.163 -0.798 . . . . 0.37 115.025 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 54.8 mtpt -122.46 147.02 46.83 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-N 118.523 1.161 . . . . 1.56 112.57 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.82 143.98 31.74 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.125 1.157 . . . . 0.34 114.125 -175.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.43 114.65 11.59 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.919 -1.037 . . . . 0.64 110.653 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.278 0.4 OUTLIER -116.81 105.17 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-O 121.144 0.497 . . . . 0.46 110.382 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 66.32 -84.29 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.706 0 C-N-CA 125.701 1.601 . . . . 1.56 113.981 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.75 31.82 2.52 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.001 -0.545 . . . . 0.49 112.859 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -134.85 126.66 29.24 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 123.603 0.761 . . . . 1.82 110.239 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -112.5 133.02 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 CA-C-O 121.673 0.749 . . . . 1.02 112.21 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.2 m -149.95 179.54 7.97 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.83 -1.077 . . . . 0.56 109.346 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.275 15.1 t -104.15 139.05 39.76 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 113.476 0.917 . . . . 1.25 113.476 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -82.87 122.19 27.92 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.068 0.947 . . . . 0.29 111.367 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.56 91.24 3.26 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 112.556 0.576 . . . . 1.42 112.556 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.96 -64.82 3.33 Favored Glycine 0 C--N 1.358 1.802 0 N-CA-C 118.715 2.246 . . . . 0.42 118.715 177.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.52 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -132.38 157.79 43.63 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 114.251 1.204 . . . . 1.1 114.251 -176.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.52 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -104.62 139.04 40.06 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.202 -1.817 . . . . 0.67 109.063 176.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 t -121.35 142.48 49.94 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.352 1.612 . . . . 0.36 115.352 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.419 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.14 97.27 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.451 -1.314 . . . . 0.74 107.451 176.267 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 33.4 mt-10 -112.65 128.04 56.28 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.384 0.883 . . . . 1.67 113.384 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -114.05 126.18 54.83 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 115.738 -0.664 . . . . 1.8 110.192 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.07 144.37 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 114.652 -1.158 . . . . 0.58 110.53 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -72.45 150.45 43.3 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.646 2.091 . . . . 2.18 116.646 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -114.97 -47.88 0.55 Allowed Glycine 0 CA--C 1.541 1.691 0 CA-C-N 114.066 -1.424 . . . . 1.02 112.941 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -131.88 -76.82 0.51 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 122.739 0.415 . . . . 2.86 111.951 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -138.17 -53.97 0.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.949 0.5 . . . . 3.91 111.421 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.05 119.66 31.39 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.606 1.162 . . . . 1.74 110.772 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.499 HD21 ' H ' ' A' ' 70' ' ' SER . 1.3 m-20 -81.13 -170.67 0.26 Allowed Pre-proline 0 CA--C 1.572 1.809 0 C-N-CA 124.848 1.259 . . . . 1.68 110.524 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -61.8 104.93 0.34 Allowed 'Trans proline' 0 C--N 1.394 2.922 0 CA-C-N 122.304 1.858 . . . . 2.06 112.215 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -63.52 1.27 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.336 1.976 . . . . 3.0 116.336 -174.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 66.0 t -96.38 131.44 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 CA-C-N 119.367 0.985 . . . . 0.8 109.991 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.25 123.27 23.99 Favored 'General case' 0 C--N 1.363 1.169 0 CA-C-N 114.443 -1.253 . . . . 0.87 111.834 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.549 ' HB1' HD22 ' A' ' 15' ' ' ASN . . . -120.72 48.02 1.69 Allowed 'General case' 0 CA--C 1.585 2.302 0 N-CA-C 115.643 1.719 . . . . 0.34 115.643 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.642 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -45.23 131.74 7.73 Favored 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 116.64 2.089 . . . . 0.7 116.64 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -151.31 105.4 3.19 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 115.19 -0.914 . . . . 0.21 111.051 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.468 HD12 HD12 ' A' ' 85' ' ' LEU 0.298 9.1 tt -113.66 122.32 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 CA-C-O 122.283 1.04 . . . . 0.31 111.258 175.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -122.67 165.24 16.82 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 113.906 -1.497 . . . . 0.44 110.789 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -122.13 158.93 28.22 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 118.283 2.698 . . . . 1.26 118.283 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.89 -41.31 2.17 Favored Glycine 0 CA--C 1.541 1.7 0 CA-C-N 110.351 -3.113 . . . . 0.17 119.256 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.59 154.53 1.25 Allowed 'General case' 0 N--CA 1.518 2.927 0 CA-C-N 120.494 2.147 . . . . 0.15 113.227 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.25 -14.43 58.42 Favored 'General case' 0 CA--C 1.581 2.169 0 C-N-CA 124.75 1.22 . . . . 0.17 114.092 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.8 2.99 49.9 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.143 1.164 . . . . 0.55 114.143 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.0 -5.79 15.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.726 1.01 . . . . 0.6 113.726 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.622 0 C-N-CA 124.397 1.079 . . . . 0.95 111.752 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.657 ' HG ' HD11 ' A' ' 27' ' ' ILE . 19.4 tp . . . . . 0 CA--C 1.565 1.553 0 N-CA-C 112.938 0.718 . . . . 0.35 112.938 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.43 63.56 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 125.855 1.662 . . . . 0.2 114.797 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.7 -11.43 51.24 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 113.667 0.988 . . . . 0.32 113.667 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 20.8 mmtp -105.47 -23.28 12.84 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.379 0.881 . . . . 1.73 113.379 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.67 136.55 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 N-CA-C 115.472 1.656 . . . . 0.11 115.472 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.9 -28.4 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 115.195 -0.911 . . . . 0.16 112.236 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -163.09 118.76 1.76 Allowed 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 117.929 0.331 . . . . 0.54 111.882 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.26 131.82 30.76 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.273 -0.892 . . . . 0.19 111.876 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -139.75 130.66 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 N-CA-C 113.113 0.783 . . . . 1.05 113.113 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -115.83 106.61 14.03 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.117 -1.438 . . . . 2.11 107.117 171.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.33 105.83 9.84 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.614 0.721 . . . . 0.63 111.664 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 168.79 -63.54 0.19 Allowed Glycine 0 C--N 1.355 1.635 0 CA-C-N 114.189 -1.369 . . . . 0.71 114.821 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -95.16 -116.3 2.96 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 114.716 0.646 . . . . 0.8 114.716 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 18.4 mt-10 -170.08 114.16 0.49 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.889 0.876 . . . . 1.63 109.884 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 46.39 111.95 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.003 0 N-CA-C 118.328 2.714 . . . . 1.0 118.328 178.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.483 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 82.1 t60 -136.59 136.4 39.19 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.97 1.1 . . . . 0.45 113.97 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.82 109.29 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 CA-C-N 113.765 -1.561 . . . . 1.39 107.04 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.67 160.1 18.26 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 112.171 0.434 . . . . 1.85 112.171 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -41.48 -26.41 0.11 Allowed 'Isoleucine or valine' 1 N--CA 1.547 4.383 0 N-CA-C 120.072 3.36 . . . . 0.72 120.072 -174.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -93.35 -11.33 32.59 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 118.84 0.746 . . . . 0.51 112.44 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.82 38.0 3.28 Favored Glycine 0 C--N 1.361 1.929 0 C-N-CA 124.16 0.886 . . . . 0.34 114.158 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.657 HD11 ' HG ' ' A' ' 6' ' ' LEU . 28.6 mm -105.38 135.55 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.618 0 N-CA-C 108.555 -0.906 . . . . 0.55 108.555 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.483 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.9 t-160 -123.34 132.38 53.97 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.612 1.338 . . . . 1.34 114.612 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -93.73 137.21 33.22 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.123 -0.944 . . . . 2.79 109.94 175.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -100.29 104.76 16.25 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 113.465 0.913 . . . . 3.0 113.465 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HG3' ' OG ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -36.6 122.12 0.77 Allowed 'General case' 0 N--CA 1.528 3.434 0 N-CA-C 119.051 2.982 . . . . 2.3 119.051 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 39.03 64.69 3.66 Favored Pre-proline 0 N--CA 1.529 3.49 0 N-CA-C 117.131 2.271 . . . . 1.17 117.131 177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo . . . . . 0 CA--C 1.563 1.957 0 C-N-CA 122.755 2.303 . . . . 1.45 118.058 -178.82 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo . . . . . 0 N--CA 1.511 2.529 0 N-CA-C 117.45 2.058 . . . . 1.37 117.45 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.256 1.3 mp -86.76 124.89 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.466 0 C-N-CA 124.366 1.066 . . . . 0.69 108.389 177.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.62 -11.71 59.01 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.602 2.075 . . . . 1.28 116.602 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -102.5 17.08 24.52 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 113.745 1.017 . . . . 1.51 113.745 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.425 ' OG ' ' HD2' ' A' ' 61' ' ' TYR . 1.2 t -137.32 -164.04 1.53 Allowed 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.856 0.836 . . . . 1.09 112.578 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.732 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.5 t30 -95.95 -179.27 0.89 Allowed Pre-proline 0 CA--C 1.573 1.858 0 C-N-CA 125.617 1.567 . . . . 1.27 111.367 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.517 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.5 Cg_exo -72.34 -46.44 0.49 Allowed 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 123.175 2.584 . . . . 0.95 112.535 174.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -70.01 -47.02 63.81 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 113.905 -1.498 . . . . 2.04 111.731 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -8.88 58.12 Favored 'General case' 0 CA--C 1.585 2.324 0 CA-C-N 114.916 -1.038 . . . . 1.62 111.955 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.732 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 3.3 tt0 -70.81 -42.28 70.46 Favored 'General case' 0 C--N 1.39 2.354 0 C-N-CA 125.716 1.607 . . . . 1.77 108.187 172.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -59.69 -42.56 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.217 0 C-N-CA 124.663 1.185 . . . . 0.81 109.463 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.9 tp -80.02 -8.81 59.56 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 114.328 1.233 . . . . 1.15 114.328 176.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.425 ' HD2' ' OG ' ' A' ' 53' ' ' SER . 20.3 m-85 -125.05 22.75 7.9 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.98 0.912 . . . . 0.92 113.357 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.38 -38.24 0.33 Allowed 'General case' 0 N--CA 1.513 2.686 0 N-CA-C 115.245 1.572 . . . . 1.33 115.245 -177.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.8 p -67.85 134.02 50.18 Favored 'General case' 0 N--CA 1.533 3.716 0 N-CA-C 114.456 1.28 . . . . 1.28 114.456 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.449 ' HB3' HG22 ' A' ' 167' ' ' VAL . 2.7 pt-20 . . . . . 0 N--CA 1.502 2.149 0 N-CA-C 115.386 1.624 . . . . 1.53 115.386 -177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.691 -0.485 . . . . 2.15 109.691 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 71.66 84.67 0.13 Allowed 'General case' 0 N--CA 1.51 2.546 0 C-N-CA 124.86 1.264 . . . . 0.77 111.962 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.62 141.77 45.12 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.978 0.894 . . . . 0.81 112.176 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -140.03 175.93 21.58 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 116.407 1.323 . . . . 0.47 116.407 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.86 163.17 17.3 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.839 -1.18 . . . . 0.89 113.227 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -122.21 129.33 52.16 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.604 -1.18 . . . . 0.51 112.435 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -123.21 101.42 38.18 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 108.91 -0.774 . . . . 0.15 108.91 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -84.26 119.64 2.43 Favored 'Trans proline' 0 CA--C 1.563 1.945 0 C-N-CA 121.998 1.799 . . . . 0.15 114.747 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.84 160.42 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 CA-C-O 122.035 0.922 . . . . 0.19 111.308 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -148.66 21.02 1.03 Allowed 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.605 -1.179 . . . . 2.53 111.865 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.06 160.35 33.98 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-O 121.312 0.577 . . . . 2.12 111.415 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -119.29 145.51 46.06 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.437 0.903 . . . . 0.42 113.437 -179.203 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.5 -138.3 5.45 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.341 -1.299 . . . . 0.23 112.498 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 30.6 mm-40 -114.8 105.0 12.51 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 118.228 1.014 . . . . 1.75 111.144 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -99.45 127.51 45.5 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.321 0.582 . . . . 0.21 110.853 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -109.22 121.5 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-O 121.894 0.854 . . . . 0.2 110.878 -176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.34 107.41 18.41 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 113.801 -1.545 . . . . 0.78 110.446 178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 t -115.64 125.2 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.91 -0.774 . . . . 0.44 108.91 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.92 141.79 48.56 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.756 0.65 . . . . 1.25 112.756 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.4 OUTLIER -107.07 119.3 39.01 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.668 -0.696 . . . . 2.52 111.277 177.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.436 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 12.4 m-85 -106.68 134.61 49.56 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.467 -0.788 . . . . 0.4 110.581 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.23 146.6 42.78 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.246 0.546 . . . . 0.41 111.527 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -136.23 120.64 18.08 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.253 0.621 . . . . 2.61 110.893 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 76.21 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 112.828 0.677 . . . . 2.13 112.828 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -171.95 -52.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.735 0.643 . . . . 2.27 112.735 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -115.27 142.77 46.22 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.622 0.601 . . . . 1.46 112.622 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.53 101.18 10.15 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.513 1.149 . . . . 0.84 111.656 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -163.55 150.75 12.49 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 114.603 -1.181 . . . . 2.45 111.047 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.2 m -110.77 -75.19 0.62 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.954 1.094 . . . . 1.66 113.954 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -94.44 70.08 3.64 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.103 0.954 . . . . 1.89 111.159 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -156.22 -41.95 0.08 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.936 -1.484 . . . . 2.56 109.207 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -109.83 82.47 1.6 Allowed 'General case' 0 C--N 1.364 1.22 0 CA-C-O 121.827 0.823 . . . . 2.76 109.172 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.78 121.26 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 114.375 -1.284 . . . . 0.69 110.557 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -106.94 173.54 6.28 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.317 1.599 . . . . 0.7 115.317 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -124.64 136.98 54.38 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 122.065 0.936 . . . . 1.33 111.019 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.82 124.81 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-N 114.145 -1.389 . . . . 0.48 109.499 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.8 mtt180 -119.61 143.3 47.74 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.384 1.624 . . . . 1.69 115.384 -176.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 5.8 m -120.71 101.01 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 115.345 -0.843 . . . . 0.6 112.184 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.563 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.2 t30 64.9 28.74 12.66 Favored 'General case' 0 N--CA 1.52 3.059 0 C-N-CA 126.494 1.917 . . . . 1.12 114.561 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.38 -18.83 32.51 Favored Glycine 0 CA--C 1.549 2.199 0 CA-C-N 115.831 -0.622 . . . . 0.32 113.602 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -86.34 161.76 18.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.092 1.757 . . . . 0.57 113.125 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -118.68 129.69 55.43 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.166 0.984 . . . . 0.55 111.249 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.07 -47.07 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 113.518 -1.673 . . . . 1.06 112.825 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.74 89.32 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.904 -1.147 . . . . 0.44 107.904 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.98 75.49 0.92 Allowed 'General case' 0 C--N 1.359 0.988 0 CA-C-O 123.577 1.655 . . . . 2.3 112.522 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 p30 154.79 63.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 110.474 -3.057 . . . . 2.48 108.032 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.69 99.65 12.51 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 113.563 0.949 . . . . 1.13 113.563 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 3.6 p30 -112.6 94.56 4.97 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 113.017 -1.901 . . . . 2.35 107.786 175.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -26.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 N-CA-C 114.739 1.385 . . . . 0.68 114.739 -176.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -74.61 -39.39 62.2 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.828 0.851 . . . . 0.77 112.042 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.72 -26.68 59.98 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.71 1.204 . . . . 0.91 113.376 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 23.6 mmm180 -77.81 -55.05 5.65 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 113.639 0.978 . . . . 2.43 113.639 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.65 -37.5 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 114.59 1.33 . . . . 0.93 114.59 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.64 -109.44 1.11 Allowed Glycine 0 C--N 1.354 1.558 0 CA-C-N 118.391 0.541 . . . . 0.85 113.271 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -114.52 107.46 15.54 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.517 0.327 . . . . 3.18 110.433 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 t 70.11 -130.61 0.07 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 125.301 1.441 . . . . 2.08 112.304 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.9 p 56.68 -174.39 0.07 Allowed 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 116.635 2.087 . . . . 0.62 116.635 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -100.05 128.45 46.14 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.312 0.856 . . . . 0.46 113.312 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.436 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 9.1 t60 -102.79 139.34 38.5 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.141 -0.688 . . . . 0.38 109.141 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -137.51 125.85 23.31 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.273 1.212 . . . . 2.5 114.273 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -119.75 127.16 52.56 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 115.077 -0.965 . . . . 1.56 110.602 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.99 126.58 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 114.141 -1.39 . . . . 0.45 111.115 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.56 92.22 28.1 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-N 115.263 -0.881 . . . . 0.84 110.567 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -75.02 132.77 15.77 Favored 'Trans proline' 0 C--N 1.394 2.934 0 C-N-CA 122.917 2.412 . . . . 0.16 113.074 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.82 150.26 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 CA-C-N 115.446 -0.797 . . . . 0.38 111.145 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.7 p -132.9 109.24 9.46 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.326 -0.852 . . . . 1.31 111.799 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.5 mt -109.19 124.46 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 108.566 -0.901 . . . . 0.25 108.566 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.71 126.13 21.77 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.532 -0.758 . . . . 2.05 110.75 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt 66.6 16.93 10.53 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 125.272 1.429 . . . . 3.55 114.595 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.29 14.77 40.54 Favored Glycine 0 CA--C 1.547 2.056 0 CA-C-O 119.183 -0.787 . . . . 0.37 114.803 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 23.6 mtpp -123.9 147.3 47.79 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 118.225 1.012 . . . . 1.56 112.419 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.47 139.07 37.63 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.994 1.109 . . . . 0.34 113.994 -176.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.49 115.47 18.93 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.929 -1.032 . . . . 0.64 109.989 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.46 93.58 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.486 0 CA-C-N 115.716 -0.675 . . . . 0.46 110.878 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 64.75 -84.94 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 125.555 1.542 . . . . 1.56 114.135 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.06 26.2 4.25 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-N 116.234 -0.439 . . . . 0.49 113.835 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -137.88 117.58 13.11 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.19 0.596 . . . . 1.82 109.983 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.25 133.74 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.374 0 CA-C-O 121.65 0.738 . . . . 1.02 112.152 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 m -147.62 -179.46 6.89 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.841 -1.072 . . . . 0.56 109.543 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.276 14.9 t -103.98 138.89 39.89 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 113.456 0.91 . . . . 1.25 113.456 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -81.96 122.55 27.92 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.233 1.013 . . . . 0.29 111.493 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.97 90.98 3.29 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.762 0.653 . . . . 1.42 112.762 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.96 -63.78 2.77 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 118.597 2.199 . . . . 0.42 118.597 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.552 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -130.58 161.93 30.44 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.837 0.827 . . . . 1.1 113.128 -177.095 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.563 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -111.15 137.52 48.72 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.841 -1.527 . . . . 0.67 109.221 177.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.6 t -116.93 142.31 47.1 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.64 1.348 . . . . 0.36 114.64 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 39.6 t -121.57 97.25 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.22 -2.141 . . . . 0.74 105.22 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -113.62 124.92 53.49 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.138 -0.937 . . . . 1.67 112.913 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -111.68 128.75 56.17 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 122.233 1.016 . . . . 1.8 112.058 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.8 144.34 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-N 112.859 -1.973 . . . . 0.58 110.362 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -78.88 149.46 32.43 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 115.659 1.725 . . . . 2.18 115.659 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -103.8 -35.25 3.54 Favored Glycine 0 CA--C 1.545 1.921 0 CA-C-N 114.525 -1.216 . . . . 1.02 113.132 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -130.57 -83.6 0.53 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.213 0.605 . . . . 2.86 110.435 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -170.65 64.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.279 0.631 . . . . 3.91 110.656 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -166.98 -39.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.926 0.713 . . . . 1.74 112.926 -178.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 4.3 m-20 84.32 -177.77 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.439 0 C-N-CA 124.58 1.152 . . . . 1.68 110.838 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -65.38 -9.55 22.65 Favored 'Trans proline' 0 N--CA 1.522 3.2 0 C-N-CA 122.641 2.227 . . . . 2.06 116.385 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.0 mttm 80.05 -73.6 0.06 Allowed 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 126.442 1.897 . . . . 3.0 114.065 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 64' ' ' GLU . 21.3 t -103.37 132.04 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.048 0.452 . . . . 0.8 110.237 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.0 t -137.34 121.65 18.14 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 114.114 -1.403 . . . . 0.87 110.889 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.506 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -115.6 49.78 1.06 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.138 1.903 . . . . 0.34 116.138 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -41.06 129.23 2.79 Favored 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 116.061 1.875 . . . . 0.7 116.061 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -150.71 103.09 3.06 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.703 -0.681 . . . . 0.21 110.305 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.315 7.2 tt -113.92 122.83 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 CA-C-O 122.262 1.03 . . . . 0.31 112.169 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -123.53 163.6 20.61 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.849 -1.523 . . . . 0.44 111.023 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.6 ptmm? -121.91 159.92 25.86 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 118.489 2.774 . . . . 1.26 118.489 -175.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.62 -42.06 1.99 Allowed Glycine 0 CA--C 1.543 1.803 0 CA-C-N 110.007 -3.27 . . . . 0.17 118.929 174.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.5 153.83 0.94 Allowed 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 120.31 2.055 . . . . 0.15 112.924 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.49 -11.71 59.92 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 114.72 1.378 . . . . 0.17 114.72 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.95 3.39 48.83 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.081 1.141 . . . . 0.55 114.081 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.28 -10.34 16.44 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 113.749 1.018 . . . . 0.6 113.749 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.526 0 C-N-CA 124.078 0.951 . . . . 0.95 112.216 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.549 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.9 tp . . . . . 0 CA--C 1.563 1.46 0 N-CA-C 112.411 0.523 . . . . 0.35 112.411 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.9 -22.74 65.83 Favored 'General case' 0 CA--C 1.583 2.244 0 C-N-CA 125.63 1.572 . . . . 0.2 114.436 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.15 -12.05 50.96 Favored 'General case' 0 C--N 1.375 1.695 0 N-CA-C 113.638 0.977 . . . . 0.32 113.638 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 45.3 mmtt -105.67 -22.62 12.93 Favored 'General case' 0 C--N 1.364 1.212 0 CA-C-O 118.353 -0.832 . . . . 1.73 113.203 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.34 135.91 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.844 0 N-CA-C 115.221 1.563 . . . . 0.11 115.221 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -122.22 -29.1 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.227 -0.897 . . . . 0.16 111.908 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 64.1 t90 -163.68 116.95 1.5 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 120.738 0.304 . . . . 0.54 111.414 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -135.19 128.91 32.89 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.296 -0.877 . . . . 0.19 110.226 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.2 t -137.84 133.56 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 113.203 0.816 . . . . 1.05 113.203 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -118.99 111.09 17.89 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.082 -1.451 . . . . 2.11 107.082 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.37 101.75 10.02 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.387 1.089 . . . . 0.63 111.436 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.58 -32.61 0.17 Allowed Glycine 0 C--N 1.344 1.018 0 CA-C-N 113.345 -1.752 . . . . 0.71 116.011 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -135.22 -128.33 2.78 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.233 -0.984 . . . . 0.8 114.643 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.461 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 63.0 mt-10 -151.04 115.33 5.08 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.455 0.169 . . . . 1.63 111.3 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.665 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.6 m 31.82 116.01 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.887 0 N-CA-C 120.286 3.439 . . . . 1.0 120.286 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 62.0 t60 -138.67 139.02 38.31 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.15 0.976 . . . . 0.45 112.636 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.89 117.18 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 114.049 -1.432 . . . . 1.39 109.714 177.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -83.21 166.1 18.88 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.646 -0.707 . . . . 1.85 112.238 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -43.09 -29.15 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.547 4.41 0 N-CA-C 119.225 3.046 . . . . 0.72 119.225 -176.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -93.38 -14.68 26.53 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 118.357 0.526 . . . . 0.51 111.691 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.04 42.69 1.62 Allowed Glycine 0 C--N 1.358 1.764 0 C-N-CA 124.393 0.997 . . . . 0.34 114.461 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.549 HD11 ' HG ' ' A' ' 6' ' ' LEU . 14.2 mm -105.72 120.26 56.27 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.738 0 N-CA-C 109.51 -0.552 . . . . 0.55 109.51 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.0 t60 -104.62 128.19 52.57 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.796 1.406 . . . . 1.34 114.796 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.665 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -98.04 148.2 23.75 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.254 -0.885 . . . . 2.79 110.645 176.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -96.64 168.37 10.57 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.696 1.236 . . . . 3.0 113.613 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -84.38 100.22 11.15 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.401 2.0 . . . . 2.3 116.401 -174.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 28.63 56.62 0.6 Allowed Pre-proline 1 N--CA 1.543 4.176 0 C-N-CA 128.066 2.546 . . . . 1.17 117.468 177.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 CA--C 1.569 2.246 0 N-CA-C 119.637 2.899 . . . . 1.45 119.637 -174.251 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 50.0 Cg_exo . . . . . 0 N--CA 1.515 2.765 0 N-CA-C 117.681 2.147 . . . . 1.37 117.681 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 mp -92.72 130.4 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.214 0 CA-C-N 114.883 -1.053 . . . . 0.69 108.486 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mt -86.03 -10.14 55.54 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.567 2.062 . . . . 1.28 116.567 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -103.49 8.59 37.83 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 114.299 1.222 . . . . 1.51 114.299 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.44 -164.73 1.52 Allowed 'General case' 0 CA--C 1.566 1.579 0 CA-C-O 121.544 0.687 . . . . 1.09 112.096 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.841 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.8 t30 -95.69 179.17 1.21 Allowed Pre-proline 0 CA--C 1.575 1.91 0 C-N-CA 124.715 1.206 . . . . 1.27 111.17 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -71.61 -44.77 0.93 Allowed 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 123.202 2.601 . . . . 0.95 112.474 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -71.16 -47.4 57.96 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 113.894 -1.503 . . . . 2.04 111.545 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -77.25 -6.0 51.45 Favored 'General case' 0 CA--C 1.595 2.68 0 CA-C-N 115.466 -0.788 . . . . 1.62 111.536 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.841 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 11.5 tt0 -72.68 -39.25 67.2 Favored 'General case' 0 C--N 1.387 2.217 0 C-N-CA 126.167 1.787 . . . . 1.77 108.463 173.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.0 t -65.59 -41.05 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.151 0 CA-C-N 114.538 -1.21 . . . . 0.81 108.712 172.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 tt -75.74 -9.43 58.58 Favored 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 112.662 0.616 . . . . 1.15 112.662 174.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.492 ' O ' ' HE3' ' A' ' 88' ' ' LYS . 3.5 m-30 -121.24 17.34 11.51 Favored 'General case' 0 CA--C 1.578 2.027 0 C-N-CA 125.175 1.39 . . . . 0.92 113.233 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -146.74 -21.36 0.42 Allowed 'General case' 0 N--CA 1.51 2.533 0 N-CA-C 116.656 2.095 . . . . 1.33 116.656 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.3 p -79.5 127.79 32.57 Favored 'General case' 0 N--CA 1.518 2.947 0 N-CA-C 115.71 1.744 . . . . 1.28 115.71 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.496 ' HB3' HG22 ' A' ' 167' ' ' VAL . 5.2 pt-20 . . . . . 0 N--CA 1.507 2.394 0 C-N-CA 124.876 1.27 . . . . 1.53 111.847 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 N-CA-C 110.764 -0.088 . . . . 2.15 110.764 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.23 86.55 0.11 Allowed 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.368 1.467 . . . . 0.77 113.639 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -150.78 154.76 37.91 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.754 0.788 . . . . 0.81 112.993 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.99 -172.51 38.66 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 114.788 -1.097 . . . . 0.47 115.279 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.23 172.55 6.82 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.465 1.283 . . . . 0.89 114.465 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -129.47 133.9 47.53 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 114.113 -1.403 . . . . 0.51 111.846 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.67 102.24 32.55 Favored Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 123.538 0.735 . . . . 0.15 109.495 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -84.79 120.58 2.36 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 121.97 1.78 . . . . 0.15 114.641 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.09 161.48 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.61 0 CA-C-O 122.093 0.949 . . . . 0.19 111.281 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -148.82 19.24 1.01 Allowed 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.553 -1.203 . . . . 2.53 111.922 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -129.93 159.21 37.34 Favored 'General case' 0 C--N 1.363 1.169 0 CA-C-O 121.313 0.577 . . . . 2.12 111.423 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -119.12 147.86 43.7 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.23 1.196 . . . . 0.42 114.23 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.85 -137.53 5.24 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 113.883 -1.508 . . . . 0.23 112.333 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.4 mm-40 -114.86 105.62 13.22 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-N 118.345 1.073 . . . . 1.75 110.848 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -99.66 130.34 45.87 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.129 0.49 . . . . 0.21 111.174 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -113.24 121.87 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.666 0.746 . . . . 0.2 110.748 -176.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -109.43 104.92 14.09 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.346 -1.297 . . . . 0.78 110.313 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.29 129.72 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 114.825 -1.08 . . . . 0.44 108.766 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.61 139.56 50.41 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.077 0.769 . . . . 1.25 113.077 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.69 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 6.0 tmtm? -105.82 118.41 36.53 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.945 0.879 . . . . 2.52 110.145 176.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.41 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 21.5 m-85 -106.39 134.45 49.51 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 114.728 -1.124 . . . . 0.4 109.487 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.409 ' HB2' ' NZ ' ' A' ' 88' ' ' LYS . . . -133.52 146.83 51.42 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 123.079 0.551 . . . . 0.41 111.736 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -139.71 108.91 6.08 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 116.003 -0.544 . . . . 2.61 110.726 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.22 69.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 116.153 -0.476 . . . . 2.13 111.594 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -162.74 -52.28 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.976 -0.556 . . . . 2.27 111.829 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -119.1 130.15 55.43 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 122.889 0.476 . . . . 1.46 111.407 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.03 104.92 14.95 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 122.152 0.977 . . . . 0.84 111.958 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -162.01 145.21 11.91 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.178 -0.919 . . . . 2.45 112.153 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -125.27 123.81 40.3 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.654 -0.703 . . . . 1.66 112.187 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 72.16 53.87 0.18 Allowed 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 125.73 1.612 . . . . 1.89 112.787 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -152.38 -40.87 0.11 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.383 -1.281 . . . . 2.56 109.719 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -108.19 80.91 1.41 Allowed 'General case' 0 C--N 1.361 1.096 0 CA-C-O 121.892 0.853 . . . . 2.76 108.716 177.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.99 121.82 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 114.249 -1.341 . . . . 0.69 111.142 -177.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -109.37 165.55 11.55 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.587 1.699 . . . . 0.7 115.587 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.52 135.58 53.94 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.829 -0.544 . . . . 1.33 110.828 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.79 126.93 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.475 0 CA-C-N 115.918 -0.583 . . . . 0.48 109.908 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 46.7 mtt180 -125.9 151.63 46.66 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.621 1.712 . . . . 1.69 115.621 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.2 m -126.71 109.97 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.569 0 N-CA-C 113.047 0.758 . . . . 0.6 113.047 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.464 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 62.43 26.53 15.81 Favored 'General case' 0 N--CA 1.524 3.275 0 C-N-CA 126.669 1.988 . . . . 1.12 114.271 -179.113 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.8 -22.17 28.52 Favored Glycine 0 CA--C 1.548 2.109 0 C-N-CA 121.259 -0.496 . . . . 0.32 113.546 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.458 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 90.2 m-70 -80.71 160.5 24.94 Favored 'General case' 0 C--N 1.366 1.312 0 C-N-CA 125.829 1.651 . . . . 0.57 114.157 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.77 132.49 54.15 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.238 0.542 . . . . 0.55 111.154 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.62 -60.89 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 115.233 -0.894 . . . . 1.06 113.172 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.76 88.85 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.44 108.2 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -107.72 96.74 6.6 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 123.155 1.455 . . . . 2.3 111.551 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 121.09 75.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 110.488 -3.051 . . . . 2.48 107.783 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.33 104.77 16.83 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 113.111 0.782 . . . . 1.13 113.111 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -117.16 102.49 9.34 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 113.723 -1.58 . . . . 2.35 106.974 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.25 -31.28 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 C-N-CA 125.003 1.321 . . . . 0.68 114.262 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -74.63 -40.84 61.26 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.685 0.794 . . . . 0.77 112.484 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -73.82 -25.83 60.3 Favored 'General case' 0 CA--C 1.578 2.048 0 C-N-CA 124.357 1.063 . . . . 0.91 113.487 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -78.62 -56.61 4.29 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.618 0.97 . . . . 2.43 113.618 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.11 -34.84 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 N-CA-C 114.593 1.331 . . . . 0.93 114.593 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.07 -114.07 1.98 Allowed Glycine 0 C--N 1.354 1.537 0 CA-C-N 118.25 0.477 . . . . 0.85 112.935 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -115.47 106.69 14.25 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.929 0.395 . . . . 3.18 110.4 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.48 -143.26 0.09 Allowed 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 125.466 1.507 . . . . 2.08 113.416 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.9 p 66.76 -158.96 0.24 Allowed 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 126.234 1.814 . . . . 0.62 113.718 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.536 ' HA ' ' HZ3' ' A' ' 88' ' ' LYS . . . -108.58 128.96 55.28 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 114.55 1.315 . . . . 0.46 114.55 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.536 ' H ' ' HZ3' ' A' ' 88' ' ' LYS . 5.5 t60 -104.52 122.65 46.0 Favored 'General case' 0 C--N 1.369 1.432 0 N-CA-C 108.08 -1.082 . . . . 0.38 108.08 174.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.55 127.05 20.09 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.417 0.895 . . . . 2.5 113.417 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -114.51 134.73 54.81 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-N 115.033 -0.985 . . . . 1.56 111.369 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.45 111.31 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 114.369 -1.287 . . . . 0.45 110.374 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.4 mm -115.52 91.23 28.45 Favored Pre-proline 0 CA--C 1.579 2.077 0 CA-C-N 115.287 -0.87 . . . . 0.84 110.421 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -73.11 137.93 27.16 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 122.996 2.464 . . . . 0.16 113.883 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.81 149.89 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 C-N-CA 123.573 0.749 . . . . 0.38 110.842 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.2 p -133.88 111.48 10.51 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.638 -0.71 . . . . 1.31 111.856 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.4 mt -112.69 124.68 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 N-CA-C 108.59 -0.892 . . . . 0.25 108.59 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -141.83 126.45 17.92 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.838 -0.619 . . . . 2.05 110.992 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 67.97 15.71 9.52 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 125.432 1.493 . . . . 3.55 114.109 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.55 14.87 39.4 Favored Glycine 0 CA--C 1.547 2.089 0 CA-C-O 119.181 -0.788 . . . . 0.37 114.773 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 56.4 mtpt -122.59 148.19 45.52 Favored 'General case' 0 C--N 1.365 1.252 0 CA-C-N 118.413 1.107 . . . . 1.56 112.429 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.66 141.94 35.18 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.058 1.133 . . . . 0.34 114.058 -176.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 m -133.55 110.44 9.93 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 114.504 -1.226 . . . . 0.64 110.301 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.272 2.4 p -106.23 90.52 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.589 2.467 0 CA-C-O 121.621 0.724 . . . . 0.46 110.068 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 59.68 -81.4 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 126.077 1.751 . . . . 1.56 115.06 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -118.45 26.74 7.59 Favored Glycine 0 CA--C 1.547 2.076 0 N-CA-C 114.2 0.44 . . . . 0.49 114.2 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -135.14 140.79 45.7 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.533 0.733 . . . . 1.82 110.996 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.18 130.82 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.294 0 CA-C-O 121.513 0.673 . . . . 1.02 111.867 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 m -154.6 -179.43 7.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.157 -0.929 . . . . 0.56 109.537 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.274 14.8 t -104.76 139.37 39.65 Favored 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 113.365 0.876 . . . . 1.25 113.365 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -82.72 122.1 27.72 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 123.959 0.904 . . . . 0.29 111.523 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.38 90.91 3.15 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.336 0.495 . . . . 1.42 112.336 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.22 -65.45 3.33 Favored Glycine 0 C--N 1.358 1.784 0 N-CA-C 118.652 2.221 . . . . 0.42 118.652 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 156.25 46.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.199 1.185 . . . . 1.1 114.199 -176.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.464 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -103.27 135.36 45.06 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 113.064 -1.88 . . . . 0.67 108.585 176.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.8 t -120.67 142.29 49.61 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.529 1.678 . . . . 0.36 115.529 -176.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.59 99.19 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.334 -1.358 . . . . 0.74 107.334 176.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -118.52 126.99 53.19 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.779 -0.646 . . . . 1.67 112.314 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.86 129.08 56.64 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-O 122.278 1.037 . . . . 1.8 111.278 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.17 145.48 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 112.722 -2.035 . . . . 0.58 110.762 -177.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.93 149.64 32.3 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.934 1.457 . . . . 2.18 114.934 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -115.64 -28.11 2.84 Favored Glycine 0 CA--C 1.545 1.931 0 CA-C-N 115.064 -0.971 . . . . 1.02 114.932 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -130.42 -67.07 0.74 Allowed 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 117.746 0.773 . . . . 2.86 111.88 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -140.81 -52.45 0.47 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 112.341 0.497 . . . . 3.91 112.341 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -104.06 178.02 4.68 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.161 0.981 . . . . 1.74 112.742 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -116.79 -177.92 0.49 Allowed Pre-proline 0 CA--C 1.568 1.638 0 CA-C-N 114.389 -1.278 . . . . 1.68 109.273 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.67 131.36 43.71 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.947 2.431 . . . . 2.06 113.968 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -72.18 -62.59 1.38 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.81 1.411 . . . . 3.0 114.81 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 64' ' ' GLU . 43.0 t -108.49 132.36 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 118.376 0.535 . . . . 0.8 109.713 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.3 t -133.41 116.09 15.62 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 113.911 -1.495 . . . . 0.87 110.618 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.69 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -115.02 49.51 1.05 Allowed 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.183 1.919 . . . . 0.34 116.183 -174.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.56 137.75 2.77 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 116.653 2.094 . . . . 0.7 116.653 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -152.75 100.3 2.52 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.271 -0.877 . . . . 0.21 110.526 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.319 12.6 tt -110.61 121.86 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-O 122.546 1.165 . . . . 0.31 111.553 175.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -123.67 165.03 17.92 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 113.572 -1.649 . . . . 0.44 110.554 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.4 ptmt -121.71 159.98 25.46 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 118.734 2.864 . . . . 1.26 118.734 -174.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.22 -42.54 1.87 Allowed Glycine 0 CA--C 1.542 1.737 0 CA-C-N 109.815 -3.357 . . . . 0.17 118.66 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.37 156.74 0.75 Allowed 'General case' 0 N--CA 1.52 3.061 0 CA-C-N 119.973 1.886 . . . . 0.15 112.565 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.32 -15.79 60.47 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.547 1.314 . . . . 0.17 114.547 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.06 4.04 46.73 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.066 1.135 . . . . 0.55 114.066 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.71 -3.86 18.74 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 114.031 1.123 . . . . 0.6 114.031 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.543 0 C-N-CA 124.48 1.112 . . . . 0.95 111.63 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.535 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.6 tp . . . . . 0 CA--C 1.566 1.586 0 N-CA-C 113.282 0.845 . . . . 0.35 113.282 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -25.0 63.84 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 125.982 1.713 . . . . 0.2 115.388 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.65 -10.01 54.76 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.577 0.954 . . . . 0.32 113.577 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 25.3 mmtp -104.67 -25.61 12.64 Favored 'General case' 0 C--N 1.363 1.168 0 N-CA-C 113.243 0.831 . . . . 1.73 113.243 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -52.93 135.22 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 N-CA-C 115.541 1.682 . . . . 0.11 115.541 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -123.07 -28.46 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 115.01 -0.995 . . . . 0.16 112.229 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -162.95 116.93 1.67 Allowed 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 118.055 0.389 . . . . 0.54 111.558 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -136.55 130.73 32.85 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.156 -0.965 . . . . 0.19 111.649 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.3 t -136.26 130.96 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 CA-C-O 121.036 0.446 . . . . 1.05 112.149 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -114.71 100.46 8.27 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.819 -1.178 . . . . 2.11 107.819 173.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.96 104.18 7.31 Favored 'General case' 0 C--O 1.274 2.365 0 CA-C-O 122.005 0.907 . . . . 0.63 111.623 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 169.07 -49.51 0.22 Allowed Glycine 0 C--N 1.36 1.893 0 CA-C-N 111.964 -2.38 . . . . 0.71 114.693 -178.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.53 -116.65 3.05 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 114.476 0.551 . . . . 0.8 114.476 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -168.62 118.79 0.74 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.377 0.51 . . . . 1.63 112.377 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.9 m 42.39 111.74 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.226 0 N-CA-C 118.515 2.783 . . . . 1.0 118.515 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.601 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 43.1 t60 -137.26 139.43 40.96 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.768 1.025 . . . . 0.45 113.768 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.3 t -106.36 111.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 N-CA-C 106.791 -1.559 . . . . 1.39 106.791 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.38 163.07 15.46 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 112.768 0.655 . . . . 1.85 112.768 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -43.3 -34.59 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 118.811 2.893 . . . . 0.72 118.811 -175.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -90.76 -17.31 26.88 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 120.924 0.393 . . . . 0.51 111.509 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.18 41.85 1.24 Allowed Glycine 0 C--N 1.357 1.736 0 C-N-CA 124.361 0.981 . . . . 0.34 113.742 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.535 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.9 mm -105.88 121.96 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 N-CA-C 109.391 -0.596 . . . . 0.55 109.391 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 6.9 t-160 -110.27 132.8 53.85 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 115.32 1.6 . . . . 1.34 115.32 -175.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -97.76 138.01 35.77 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.638 -1.164 . . . . 2.79 109.302 175.442 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -102.68 100.7 10.77 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 113.544 0.942 . . . . 3.0 113.544 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -28.69 115.44 0.09 Allowed 'General case' 0 N--CA 1.517 2.888 0 N-CA-C 118.687 2.847 . . . . 2.3 118.687 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 41.59 74.97 0.66 Allowed Pre-proline 0 N--CA 1.528 3.446 0 N-CA-C 117.169 2.285 . . . . 1.17 117.169 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo . . . . . 0 CA--C 1.56 1.787 0 C-N-CA 122.509 2.14 . . . . 1.45 117.434 -178.839 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo . . . . . 0 N--CA 1.508 2.357 0 N-CA-C 116.939 1.861 . . . . 1.37 116.939 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.4 133.86 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.354 0 CA-C-N 115.074 -0.966 . . . . 0.69 108.691 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.5 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.9 mt -82.24 -9.28 59.55 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.816 2.154 . . . . 1.28 116.816 -176.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -109.17 16.67 22.32 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 114.111 1.152 . . . . 1.51 114.111 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.04 177.37 8.02 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 121.755 0.788 . . . . 1.09 113.06 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 5.7 p-10 -88.96 178.83 1.83 Allowed Pre-proline 0 N--CA 1.51 2.57 0 C-N-CA 124.978 1.311 . . . . 1.27 111.094 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 52.3 Cg_exo -64.57 -43.01 14.4 Favored 'Trans proline' 0 N--CA 1.527 3.449 0 C-N-CA 122.824 2.349 . . . . 0.95 114.989 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -69.41 -41.94 75.71 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 124.471 1.108 . . . . 2.04 111.978 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.701 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 18.7 t0 -86.93 -0.71 57.0 Favored 'General case' 0 CA--C 1.583 2.232 0 CA-C-N 115.857 -0.611 . . . . 1.62 111.983 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 5.3 tt0 -74.28 -46.02 43.97 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 125.195 1.398 . . . . 1.77 108.025 173.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.253 11.7 p -71.21 -37.75 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.982 0 CA-C-N 115.161 -0.927 . . . . 0.81 111.042 174.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.7 tp -83.41 -3.25 57.38 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 114.194 1.183 . . . . 1.15 114.194 177.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.701 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 3.8 m-30 -113.67 -2.01 13.87 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.002 1.321 . . . . 0.92 109.831 174.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -130.48 -130.82 0.2 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.331 1.052 . . . . 1.33 110.739 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.514 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 43.15 120.86 0.0 OUTLIER 'General case' 1 N--CA 1.548 4.458 0 C-N-CA 127.775 2.43 . . . . 1.28 115.48 -172.755 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.695 ' HB3' HG22 ' A' ' 167' ' ' VAL . 12.9 pt-20 . . . . . 0 N--CA 1.5 2.071 0 N-CA-C 116.338 1.977 . . . . 1.53 116.338 -175.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 p30 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.318 0.104 . . . . 2.15 110.796 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.442 ' H ' HD21 ' A' ' 164' ' ' ASN . 3.4 t 70.38 76.72 0.2 Allowed 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 124.464 1.106 . . . . 0.77 110.939 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.7 135.87 48.23 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.004 -0.998 . . . . 0.81 112.285 -176.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.56 163.01 24.13 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 116.216 1.246 . . . . 0.47 116.216 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.427 ' HB2' HG23 ' A' ' 155' ' ' VAL . 1.4 m-85 -111.17 160.7 16.68 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.023 -1.089 . . . . 0.89 113.062 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.48 126.66 48.32 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.895 -1.048 . . . . 0.51 112.652 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.25 98.07 42.07 Favored Pre-proline 0 CA--C 1.566 1.589 0 N-CA-C 108.668 -0.864 . . . . 0.15 108.668 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -82.82 116.27 2.5 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 122.06 1.84 . . . . 0.15 115.322 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.07 155.64 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 CA-C-O 121.938 0.875 . . . . 0.19 110.648 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -141.86 24.35 2.03 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 114.774 -1.103 . . . . 2.53 112.034 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.88 152.67 49.1 Favored 'General case' 0 C--N 1.359 1.009 0 CA-C-O 121.231 0.539 . . . . 2.12 111.305 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.07 137.73 50.98 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.097 1.147 . . . . 0.42 114.097 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.47 -127.48 1.63 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 114.018 -1.447 . . . . 0.23 112.597 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -123.55 118.62 27.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.264 0.554 . . . . 1.75 111.398 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -118.58 137.74 53.04 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.463 -0.789 . . . . 0.21 109.639 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 172' ' ' ILE . 1.9 t -117.82 126.5 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.466 0.65 . . . . 0.2 111.004 -177.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.06 105.13 15.38 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.753 -1.112 . . . . 0.78 109.731 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.75 117.64 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.077 -1.083 . . . . 0.44 108.077 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -130.16 135.05 47.76 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.503 0.668 . . . . 1.25 112.384 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 14.3 tptt -98.29 122.96 42.1 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 114.959 -1.019 . . . . 2.52 111.307 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -106.95 136.12 47.35 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.58 -0.737 . . . . 0.4 110.948 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.94 150.12 52.19 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 115.681 -0.69 . . . . 0.41 111.367 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -146.88 113.68 6.08 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.36 0.664 . . . . 2.61 110.076 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.33 68.12 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 112.711 0.634 . . . . 2.13 112.711 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -167.07 -45.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.58 0.585 . . . . 2.27 112.58 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -112.89 126.67 55.72 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.102 0.477 . . . . 1.46 112.219 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.16 96.07 6.11 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.486 1.136 . . . . 0.84 111.241 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.45 ' OE1' ' HD3' ' A' ' 100' ' ' LYS . 9.5 pt20 -160.79 143.74 13.02 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.89 -1.05 . . . . 2.45 112.152 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.8 m -122.57 125.27 45.36 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.426 -0.806 . . . . 1.66 112.267 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 73.03 51.74 0.14 Allowed 'General case' 0 N--CA 1.512 2.636 0 C-N-CA 125.644 1.577 . . . . 1.89 112.697 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -150.99 -42.02 0.12 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.384 1.074 . . . . 2.56 110.076 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.45 ' HD3' ' OE1' ' A' ' 96' ' ' GLN . 14.0 mptt -108.27 83.49 1.79 Allowed 'General case' 0 C--N 1.36 1.06 0 N-CA-C 108.691 -0.855 . . . . 2.76 108.691 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.45 126.54 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 114.488 -1.233 . . . . 0.69 111.214 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -114.07 174.48 5.92 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.405 1.631 . . . . 0.7 115.405 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.22 137.05 54.97 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.372 0.606 . . . . 1.33 111.974 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.6 t -132.71 126.0 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.247 0 CA-C-N 115.161 -0.927 . . . . 0.48 109.671 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -125.56 149.39 48.39 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.653 1.353 . . . . 1.69 114.653 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.55 104.28 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 115.389 -0.823 . . . . 0.6 112.802 178.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.584 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 6.9 t30 64.28 26.48 13.71 Favored 'General case' 0 N--CA 1.518 2.952 0 C-N-CA 126.636 1.974 . . . . 1.12 114.31 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.92 -22.22 23.83 Favored Glycine 0 CA--C 1.548 2.117 0 CA-C-N 115.582 -0.735 . . . . 0.32 113.603 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -79.94 148.03 31.39 Favored 'General case' 0 C--N 1.367 1.365 0 C-N-CA 125.63 1.572 . . . . 0.57 114.007 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.44 127.52 49.44 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.283 0.563 . . . . 0.55 110.977 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -120.22 -57.2 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 115.256 -0.884 . . . . 1.06 113.254 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.33 88.26 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.165 -1.05 . . . . 0.44 108.165 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -111.17 75.77 0.94 Allowed 'General case' 0 C--N 1.354 0.779 0 CA-C-O 123.37 1.557 . . . . 2.3 112.133 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.9 p30 157.78 61.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 110.789 -2.914 . . . . 2.48 108.117 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.94 101.04 13.38 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 114.095 1.146 . . . . 1.13 114.095 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 1.2 t70 -116.75 97.2 5.85 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 113.132 -1.849 . . . . 2.35 106.582 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -28.56 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.477 0 N-CA-C 114.569 1.322 . . . . 0.68 114.569 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -75.84 -36.78 59.51 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.24 0.616 . . . . 0.77 112.323 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -74.72 -26.74 60.01 Favored 'General case' 0 CA--C 1.577 1.99 0 C-N-CA 124.466 1.106 . . . . 0.91 113.096 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 25.3 mmm180 -77.66 -55.09 5.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.236 0.828 . . . . 2.43 113.236 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.82 -40.59 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 N-CA-C 113.966 1.098 . . . . 0.93 113.966 177.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.84 -69.51 0.21 Allowed Glycine 0 C--N 1.359 1.844 0 CA-C-N 118.186 0.448 . . . . 0.85 113.652 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -104.72 175.27 5.55 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.447 1.099 . . . . 3.18 111.381 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 m -73.55 84.31 1.54 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 122.007 0.908 . . . . 2.08 113.214 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 51' ' ' LEU . 17.9 p -131.24 -154.35 0.62 Allowed 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 113.92 -1.491 . . . . 0.62 109.301 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.49 129.38 54.46 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 121.468 -0.77 . . . . 0.46 112.324 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -100.43 142.39 31.97 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.645 -0.502 . . . . 0.38 109.645 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -135.5 128.2 30.95 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.711 1.374 . . . . 2.5 114.711 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -118.0 118.1 31.04 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 114.36 -1.291 . . . . 1.56 109.905 176.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.11 121.05 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 114.644 -1.162 . . . . 0.45 111.513 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.12 95.11 19.0 Favored Pre-proline 0 CA--C 1.572 1.819 0 CA-C-N 115.49 -0.777 . . . . 0.84 110.694 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -75.87 137.55 19.97 Favored 'Trans proline' 0 C--N 1.395 3.003 0 C-N-CA 122.802 2.335 . . . . 0.16 113.325 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.49 145.62 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.393 0 CA-C-O 121.737 0.78 . . . . 0.38 111.665 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.9 p -129.86 112.29 13.42 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.85 -1.068 . . . . 1.31 110.817 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.6 mt -113.64 121.43 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.511 0 CA-C-N 115.228 -0.896 . . . . 0.25 108.841 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -141.76 129.64 21.81 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.128 0.489 . . . . 2.05 111.903 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 66.38 15.19 10.02 Favored 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 114.827 1.417 . . . . 3.55 114.827 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 17.91 28.79 Favored Glycine 0 CA--C 1.548 2.149 0 CA-C-O 119.385 -0.675 . . . . 0.37 114.562 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -128.73 143.38 50.91 Favored 'General case' 0 C--N 1.364 1.239 0 CA-C-N 118.036 0.918 . . . . 1.56 112.426 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.09 143.34 29.48 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.823 1.046 . . . . 0.34 113.823 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 114.0 12.61 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.864 -1.062 . . . . 0.64 110.865 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.271 0.3 OUTLIER -118.14 108.17 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.257 0 CA-C-N 115.989 -0.551 . . . . 0.46 110.533 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 67.06 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.745 0 C-N-CA 125.588 1.555 . . . . 1.56 113.762 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -140.9 31.79 2.17 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-N 115.777 -0.647 . . . . 0.49 112.765 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -133.73 128.14 34.3 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.641 0.776 . . . . 1.82 110.573 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -115.68 131.23 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.298 0 CA-C-O 121.551 0.691 . . . . 1.02 111.786 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 m -147.18 -169.09 3.22 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.094 -0.957 . . . . 0.56 110.174 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.5 t -101.79 141.09 35.18 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 112.998 0.74 . . . . 1.25 112.998 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -88.44 133.0 34.24 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.875 0.845 . . . . 0.29 111.894 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 p -98.27 -164.01 1.1 Allowed 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 113.976 -1.465 . . . . 1.42 109.369 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.39 7.07 69.59 Favored Glycine 0 CA--C 1.561 2.929 0 N-CA-C 116.991 1.556 . . . . 0.42 116.991 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.472 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -159.98 152.49 21.06 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-O 121.704 0.764 . . . . 1.1 111.565 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.584 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -108.09 138.08 44.96 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.208 -1.36 . . . . 0.67 109.163 177.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 t -119.41 145.72 45.99 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.966 1.839 . . . . 0.36 115.966 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -120.09 97.96 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.672 -1.233 . . . . 0.74 107.672 175.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -107.07 125.91 51.67 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.212 0.819 . . . . 1.67 113.212 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -107.46 120.89 43.42 Favored 'General case' 0 C--O 1.25 1.126 0 CA-C-N 115.177 -0.919 . . . . 1.8 110.247 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.46 143.66 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 114.588 -1.187 . . . . 0.58 109.587 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -85.77 150.38 24.61 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.681 1.734 . . . . 2.18 115.681 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.04 -32.45 4.99 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-N 114.178 -1.374 . . . . 1.02 113.048 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -131.01 -84.06 0.52 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.494 0.718 . . . . 2.86 110.511 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -170.99 66.27 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.123 0.569 . . . . 3.91 110.927 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -166.51 -45.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.071 0.767 . . . . 1.74 113.071 -179.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.442 HD21 ' H ' ' A' ' 70' ' ' SER . 1.4 m-20 82.75 -177.47 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.695 0 C-N-CA 124.546 1.138 . . . . 1.68 110.796 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.93 -21.35 70.75 Favored 'Trans proline' 0 N--CA 1.524 3.322 0 C-N-CA 122.977 2.451 . . . . 2.06 115.992 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? 83.58 -68.69 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 126.36 1.864 . . . . 3.0 115.085 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.695 HG22 ' HB3' ' A' ' 64' ' ' GLU . 3.1 t -102.4 133.57 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-N 118.984 0.811 . . . . 0.8 111.301 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.6 t -132.9 138.44 46.98 Favored 'General case' 0 C--N 1.367 1.362 0 N-CA-C 114.11 1.152 . . . . 0.87 114.11 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -130.17 45.07 2.87 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.547 1.684 . . . . 0.34 115.547 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.92 132.72 3.85 Favored 'General case' 0 N--CA 1.524 3.241 0 N-CA-C 116.233 1.938 . . . . 0.7 116.233 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -152.45 102.95 2.78 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 116.054 -0.521 . . . . 0.21 111.329 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 84' ' ' VAL 0.313 4.9 tt -110.03 123.25 65.76 Favored 'Isoleucine or valine' 0 C--O 1.27 2.168 0 CA-C-O 122.28 1.038 . . . . 0.31 111.406 175.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -123.62 152.69 41.67 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 113.389 -1.732 . . . . 0.44 112.025 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 75.9 tttt -104.27 152.51 22.13 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 118.28 2.696 . . . . 1.26 118.28 -174.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.62 -41.47 2.14 Favored Glycine 0 CA--C 1.541 1.694 0 CA-C-N 110.704 -2.953 . . . . 0.17 119.86 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 178.06 164.44 0.69 Allowed 'General case' 0 N--CA 1.519 2.981 0 CA-C-N 121.165 2.482 . . . . 0.15 112.228 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.95 -16.09 54.46 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 113.915 1.08 . . . . 0.17 113.915 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.53 3.51 50.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.151 1.167 . . . . 0.55 114.151 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.84 -3.07 20.74 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.205 1.187 . . . . 0.6 114.205 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.511 2.586 0 C-N-CA 124.375 1.07 . . . . 0.95 111.643 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 tp . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 113.344 0.868 . . . . 0.35 113.344 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.27 -22.53 18.86 Favored 'General case' 0 CA--C 1.591 2.543 0 N-CA-C 115.176 1.547 . . . . 0.2 115.176 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.17 -18.81 29.51 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 124.337 1.055 . . . . 0.32 113.401 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 55.5 mttt -104.49 -8.87 18.77 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 113.958 1.096 . . . . 1.73 113.958 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.514 HG21 HG23 ' A' ' 27' ' ' ILE . 11.3 p -61.44 135.11 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.794 0 C-N-CA 124.027 0.931 . . . . 0.11 112.797 176.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -118.52 -28.59 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 113.357 0.873 . . . . 0.16 113.357 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -163.94 119.0 1.55 Allowed 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 118.43 0.559 . . . . 0.54 112.066 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.92 131.53 33.2 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.658 -0.651 . . . . 0.19 111.958 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.27 133.21 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 CA-C-O 121.42 0.629 . . . . 1.05 112.62 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -117.98 111.4 18.91 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.108 -1.441 . . . . 2.11 107.108 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.84 102.59 8.27 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 121.898 0.856 . . . . 0.63 111.383 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.55 -14.12 0.35 Allowed Glycine 0 C--N 1.351 1.362 0 N-CA-C 117.127 1.611 . . . . 0.71 117.127 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.04 -131.79 2.32 Favored Glycine 0 N--CA 1.472 1.059 0 C-N-CA 119.271 -1.442 . . . . 0.8 116.06 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.541 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 19.9 tt0 -148.16 116.26 6.47 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 114.931 -0.634 . . . . 1.63 110.89 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 14.7 m 21.78 120.4 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 120.199 3.407 . . . . 1.0 120.199 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -140.52 143.02 35.19 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.521 1.153 . . . . 0.45 113.407 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.88 115.74 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-N 113.217 -1.811 . . . . 1.39 110.789 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -74.99 155.65 37.12 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 113.341 -1.754 . . . . 1.85 111.316 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -42.8 -23.92 0.1 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.152 0 N-CA-C 119.048 2.981 . . . . 0.72 119.048 -178.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -96.88 -19.36 18.9 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 118.588 0.631 . . . . 0.51 110.735 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.81 42.42 0.86 Allowed Glycine 0 C--N 1.358 1.8 0 C-N-CA 124.569 1.08 . . . . 0.34 114.534 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.514 HG23 HG21 ' A' ' 10' ' ' VAL . 3.5 mt -105.73 121.55 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-O 120.883 0.373 . . . . 0.55 110.002 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -102.85 125.99 49.82 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.286 1.217 . . . . 1.34 114.286 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.47 152.68 18.19 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.793 -0.64 . . . . 2.79 111.755 176.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -100.35 149.34 23.73 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.006 1.113 . . . . 3.0 114.006 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' A' ' 31' ' ' LYS . 1.1 tmmt? -75.14 102.6 5.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.781 2.141 . . . . 2.3 116.781 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.403 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 3.9 m-20 45.42 45.66 2.47 Favored Pre-proline 0 N--CA 1.526 3.355 0 N-CA-C 119.128 3.01 . . . . 1.17 119.128 174.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.403 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 6.5 Cg_endo . . . . . 0 CA--C 1.566 2.093 0 C-N-CA 122.766 2.311 . . . . 1.45 116.209 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo . . . . . 0 N--CA 1.494 1.54 0 N-CA-C 117.708 2.157 . . . . 1.37 117.708 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.254 1.2 mp -98.11 132.82 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.27 0 CA-C-N 113.865 -1.516 . . . . 0.69 108.269 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.456 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.8 mt -86.91 -10.91 52.21 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.743 2.127 . . . . 1.28 116.743 -176.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -106.75 22.21 16.27 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.532 0.938 . . . . 1.51 113.532 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -141.91 -172.81 3.64 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-O 121.432 0.634 . . . . 1.09 111.294 178.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.633 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.88 -176.72 0.57 Allowed Pre-proline 0 N--CA 1.509 2.51 0 C-N-CA 123.819 0.848 . . . . 1.27 109.557 178.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.493 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 32.8 Cg_exo -69.52 -40.42 5.72 Favored 'Trans proline' 0 C--N 1.4 3.26 0 C-N-CA 122.679 2.253 . . . . 0.95 113.045 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -67.98 -49.52 61.14 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.27 1.428 . . . . 2.04 111.866 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.409 ' HB3' ' OG ' ' A' ' 53' ' ' SER . 0.3 OUTLIER -80.19 -3.54 49.43 Favored 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 114.86 -1.064 . . . . 1.62 112.812 177.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.633 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 3.4 tt0 -73.03 -42.41 63.19 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 125.649 1.579 . . . . 1.77 107.391 173.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.6 t -63.72 -40.29 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 C-N-CA 124.195 0.998 . . . . 0.81 109.638 173.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -17.38 60.58 Favored 'General case' 0 CA--C 1.587 2.393 0 N-CA-C 114.247 1.203 . . . . 1.15 114.247 174.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -123.65 22.75 9.0 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 114.372 1.249 . . . . 0.92 114.372 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.43 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -137.89 -36.31 0.62 Allowed 'General case' 0 N--CA 1.51 2.558 0 N-CA-C 114.84 1.422 . . . . 1.33 114.84 -178.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.1 p -65.94 126.31 28.15 Favored 'General case' 0 N--CA 1.526 3.353 0 N-CA-C 115.293 1.59 . . . . 1.28 115.293 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.127 0 N-CA-C 113.463 0.912 . . . . 1.53 113.463 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 113.434 0.901 . . . . 2.15 113.434 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.28 109.87 3.29 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.608 1.163 . . . . 0.77 112.344 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.81 157.34 43.93 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.739 -1.119 . . . . 0.81 113.157 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -169.66 -176.27 39.34 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 115.739 1.055 . . . . 0.47 115.739 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.6 172.31 6.92 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.357 1.243 . . . . 0.89 114.357 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.06 130.32 50.89 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 114.092 -1.413 . . . . 0.51 111.995 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.73 99.61 38.57 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 123.282 0.633 . . . . 0.15 109.379 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -84.17 121.63 2.76 Favored 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 122.061 1.841 . . . . 0.15 114.65 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.03 160.4 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 CA-C-O 122.016 0.913 . . . . 0.19 111.455 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -146.62 17.42 1.3 Allowed 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 114.616 -1.175 . . . . 2.53 112.051 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -126.65 160.33 31.04 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-O 121.292 0.568 . . . . 2.12 111.5 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -121.25 144.55 48.55 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.72 1.008 . . . . 0.42 113.72 -178.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.32 -134.31 3.49 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 113.961 -1.472 . . . . 0.23 112.012 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.7 mt-10 -119.1 106.91 12.86 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 118.521 1.16 . . . . 1.75 111.158 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -101.37 128.74 47.41 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.093 0.473 . . . . 0.21 110.76 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.77 125.77 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.528 0.68 . . . . 0.2 110.543 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.71 105.89 17.28 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 114.563 -1.199 . . . . 0.78 109.687 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.23 123.31 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.044 -1.095 . . . . 0.44 108.044 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -138.37 140.24 39.34 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.973 0.731 . . . . 1.25 112.973 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -101.46 120.37 40.18 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.711 0.767 . . . . 2.52 111.794 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -105.07 133.5 49.74 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.399 -0.819 . . . . 0.4 109.655 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.59 158.92 43.27 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.306 0.574 . . . . 0.41 112.207 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -122.8 161.63 23.64 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.512 0.725 . . . . 2.61 111.844 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.13 -69.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 112.579 0.585 . . . . 2.13 112.579 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -132.11 63.38 1.62 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.621 0.6 . . . . 2.27 112.621 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -148.68 97.44 2.73 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.283 0.633 . . . . 1.46 109.707 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.37 105.91 16.22 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.171 0.986 . . . . 0.84 112.397 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -167.4 140.54 3.45 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.874 -1.057 . . . . 2.45 111.464 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.1 m -127.08 123.18 36.29 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.782 0.66 . . . . 1.66 112.782 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 68.16 47.49 1.02 Allowed 'General case' 0 N--CA 1.51 2.56 0 C-N-CA 125.819 1.648 . . . . 1.89 113.894 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -149.74 -39.27 0.14 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.589 1.156 . . . . 2.56 110.053 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -107.81 79.61 1.3 Allowed 'General case' 0 C--N 1.362 1.118 0 N-CA-C 108.123 -1.066 . . . . 2.76 108.123 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.24 120.71 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 114.111 -1.404 . . . . 0.69 111.146 -176.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -99.41 176.62 5.45 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 114.166 -1.379 . . . . 0.7 114.583 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.5 135.25 50.11 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 122.09 -0.381 . . . . 1.33 110.332 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.79 124.22 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.439 0 CA-C-O 121.208 0.528 . . . . 0.48 109.641 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.678 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 20.0 mtt180 -122.11 150.48 42.11 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.467 1.654 . . . . 1.69 115.467 -176.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 154' ' ' SER . 7.2 m -126.05 111.87 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 N-CA-C 113.072 0.767 . . . . 0.6 113.072 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.468 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 62.86 25.93 15.32 Favored 'General case' 0 N--CA 1.526 3.345 0 C-N-CA 126.607 1.963 . . . . 1.12 114.06 -179.042 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.22 -14.05 51.7 Favored Glycine 0 CA--C 1.552 2.37 0 C-N-CA 121.348 -0.453 . . . . 0.32 113.768 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.678 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 92.3 m-70 -89.29 173.99 8.08 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 125.914 1.686 . . . . 0.57 113.185 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.66 133.56 54.51 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.582 0.706 . . . . 0.55 112.047 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.69 -57.17 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-N 114.701 -1.136 . . . . 1.06 113.038 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.09 88.98 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.295 -1.002 . . . . 0.44 108.295 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 13.4 ptpt -108.31 98.55 8.07 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 122.919 1.342 . . . . 2.3 111.793 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 0.6 OUTLIER 121.48 74.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 129.245 3.018 . . . . 2.48 108.018 -179.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.47 106.61 18.66 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 113.228 0.825 . . . . 1.13 113.228 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -116.86 102.53 9.47 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.728 -1.578 . . . . 2.35 106.806 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -25.59 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.335 0 N-CA-C 114.4 1.259 . . . . 0.68 114.4 -176.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -75.27 -41.96 56.09 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.831 0.853 . . . . 0.77 112.324 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -73.9 -26.13 60.37 Favored 'General case' 0 CA--C 1.577 1.986 0 C-N-CA 124.403 1.081 . . . . 0.91 113.497 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -78.19 -56.1 4.74 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 113.711 1.004 . . . . 2.43 113.711 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.21 -36.95 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 N-CA-C 114.44 1.274 . . . . 0.93 114.44 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.05 -109.29 1.07 Allowed Glycine 0 C--N 1.355 1.619 0 CA-C-N 118.523 0.601 . . . . 0.85 113.25 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -114.94 106.95 14.75 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.731 0.301 . . . . 3.18 110.63 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 67.56 -130.07 0.14 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 125.285 1.434 . . . . 2.08 112.582 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.456 HG22 ' HB2' ' A' ' 51' ' ' LEU . 66.7 p 60.39 -163.24 0.25 Allowed 'General case' 0 N--CA 1.529 3.511 0 C-N-CA 126.293 1.837 . . . . 0.62 115.182 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -112.74 129.93 56.24 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 112.692 0.626 . . . . 0.46 112.692 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -103.08 137.82 40.74 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.077 -0.712 . . . . 0.38 109.077 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -134.71 126.14 28.44 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.88 1.437 . . . . 2.5 114.88 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.06 125.32 52.27 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 115.138 -0.937 . . . . 1.56 111.156 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.63 114.72 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 114.272 -1.331 . . . . 0.45 110.199 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.3 101.4 17.69 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.953 -0.546 . . . . 0.84 111.582 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -74.13 143.01 31.6 Favored 'Trans proline' 0 C--N 1.399 3.237 0 C-N-CA 123.049 2.499 . . . . 0.16 114.729 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.3 mt -124.9 150.46 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 CA-C-N 115.03 -0.987 . . . . 0.38 109.916 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.6 t -136.21 113.41 10.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.454 0.645 . . . . 1.31 111.275 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -111.56 124.28 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-N 114.931 -1.031 . . . . 0.25 108.61 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -143.69 130.4 20.27 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.791 -0.64 . . . . 2.05 110.979 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.35 14.24 9.14 Favored 'General case' 0 N--CA 1.515 2.803 0 C-N-CA 125.186 1.394 . . . . 3.55 113.623 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.99 17.64 31.78 Favored Glycine 0 CA--C 1.549 2.162 0 CA-C-O 119.158 -0.801 . . . . 0.37 114.566 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 7.1 mtpm? -127.28 150.58 49.5 Favored 'General case' 0 C--N 1.367 1.364 0 CA-C-N 118.443 1.122 . . . . 1.56 113.046 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.79 141.06 36.77 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.07 1.137 . . . . 0.34 114.07 -176.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.73 112.32 11.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.884 -1.053 . . . . 0.64 110.054 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.255 8.6 p -115.95 95.16 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.457 0 CA-C-O 121.309 0.576 . . . . 0.46 111.314 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 67.81 -86.37 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 C-N-CA 125.673 1.589 . . . . 1.56 113.608 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.83 26.68 5.32 Favored Glycine 0 CA--C 1.543 1.821 0 CA-C-N 115.923 -0.581 . . . . 0.49 112.79 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -126.12 137.35 53.59 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 124.067 0.947 . . . . 1.82 111.013 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.75 126.04 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.167 0 CA-C-O 121.516 0.675 . . . . 1.02 111.05 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 m -150.2 -179.72 7.42 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.188 -0.915 . . . . 0.56 109.933 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.269 15.4 t -103.84 138.18 40.79 Favored 'General case' 0 CA--C 1.577 1.981 0 N-CA-C 113.152 0.797 . . . . 1.25 113.152 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -83.74 121.81 27.79 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.987 0.915 . . . . 0.29 111.38 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.41 91.27 3.21 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 112.38 0.511 . . . . 1.42 112.38 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.89 -66.29 3.4 Favored Glycine 0 C--N 1.357 1.74 0 N-CA-C 118.738 2.255 . . . . 0.42 118.738 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.528 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -133.58 156.89 47.01 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.326 1.232 . . . . 1.1 114.326 -176.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.528 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -104.84 137.3 42.84 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.107 -1.86 . . . . 0.67 109.188 177.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.1 t -120.47 143.28 48.6 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.284 1.587 . . . . 0.36 115.284 -177.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.411 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.92 97.44 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.986 -1.487 . . . . 0.74 106.986 175.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -117.76 124.11 47.65 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.993 -0.549 . . . . 1.67 112.077 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.91 135.27 54.15 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 122.329 1.062 . . . . 1.8 112.015 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.4 t -104.74 140.24 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-N 112.631 -2.077 . . . . 0.58 109.283 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 150.32 21.77 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.741 1.386 . . . . 2.18 114.741 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.91 -34.23 4.1 Favored Glycine 0 CA--C 1.545 1.964 0 CA-C-N 114.779 -1.1 . . . . 1.02 114.483 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -126.2 -88.01 0.59 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 117.357 0.579 . . . . 2.86 112.372 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -131.04 -51.33 1.03 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.996 0.518 . . . . 3.91 112.015 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.03 122.61 37.87 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.172 0.989 . . . . 1.74 111.245 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -81.97 -169.09 0.21 Allowed Pre-proline 0 CA--C 1.574 1.888 0 C-N-CA 125.54 1.536 . . . . 1.68 110.554 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -62.7 99.98 0.22 Allowed 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 122.159 1.906 . . . . 2.06 111.461 174.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -55.65 -55.18 35.21 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.295 1.961 . . . . 3.0 116.295 -173.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 38.8 t -105.61 130.02 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.52 -0.919 . . . . 0.8 108.52 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.8 t -135.41 113.82 11.56 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.053 -1.431 . . . . 0.87 110.648 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -109.61 47.2 0.95 Allowed 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.688 2.107 . . . . 0.34 116.688 -175.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.17 130.92 3.62 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 117.13 2.27 . . . . 0.7 117.13 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -150.92 105.37 3.25 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.7 -1.136 . . . . 0.21 109.597 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.298 7.2 tt -112.76 122.04 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-O 122.255 1.026 . . . . 0.31 111.091 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -116.3 164.29 14.74 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 113.707 -1.588 . . . . 0.44 111.153 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 8.6 ptmm? -123.0 156.18 35.32 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.577 2.436 . . . . 1.26 117.577 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.42 -41.57 2.11 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 110.55 -3.023 . . . . 0.17 118.909 174.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.04 160.36 1.77 Allowed 'General case' 0 N--CA 1.517 2.885 0 CA-C-N 120.683 2.242 . . . . 0.15 113.391 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -83.29 -13.65 54.71 Favored 'General case' 0 CA--C 1.578 2.03 0 C-N-CA 124.882 1.273 . . . . 0.17 114.016 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.38 2.91 49.01 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 114.502 1.297 . . . . 0.55 114.502 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.55 -10.26 15.73 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.762 1.023 . . . . 0.6 113.762 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.508 2.431 0 C-N-CA 123.917 0.887 . . . . 0.95 112.727 178.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 27' ' ' ILE . 17.3 tp . . . . . 0 CA--C 1.564 1.506 0 N-CA-C 113.314 0.857 . . . . 0.35 113.314 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.46 -23.53 62.79 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.822 1.649 . . . . 0.2 115.134 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.97 -10.46 53.15 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 113.62 0.97 . . . . 0.32 113.62 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 54.9 mmtt -105.26 -25.21 12.53 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-O 118.235 -0.888 . . . . 1.73 113.349 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -51.03 133.8 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 N-CA-C 115.508 1.67 . . . . 0.11 115.508 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.26 -29.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 115.267 -0.879 . . . . 0.16 112.071 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -162.45 118.6 1.94 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.583 0.353 . . . . 0.54 111.62 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.8 128.58 20.48 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.523 -0.735 . . . . 0.19 111.181 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.11 135.66 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 113.986 1.106 . . . . 1.05 113.986 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -116.04 102.34 9.55 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 106.906 -1.516 . . . . 2.11 106.906 172.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -75.37 98.55 3.89 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.949 0.881 . . . . 0.63 111.764 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 172.3 -33.03 0.13 Allowed Glycine 0 C--N 1.348 1.234 0 N-CA-C 117.374 1.71 . . . . 0.71 117.374 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.07 -114.87 1.9 Allowed Glycine 0 N--CA 1.471 1.01 0 C-N-CA 120.219 -0.991 . . . . 0.8 115.288 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.75 117.04 1.07 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.118 0.567 . . . . 1.63 110.593 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.4 m 33.25 108.01 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 118.593 2.812 . . . . 1.0 118.593 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.519 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 63.3 t60 -133.21 133.94 43.39 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.76 1.022 . . . . 0.45 113.76 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.57 117.59 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 114.743 -1.117 . . . . 1.39 109.143 175.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -86.37 163.25 17.75 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 115.157 -0.929 . . . . 1.85 111.542 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -43.73 -24.96 0.21 Allowed 'Isoleucine or valine' 1 N--CA 1.541 4.092 0 N-CA-C 119.681 3.215 . . . . 0.72 119.681 -175.035 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -98.02 -9.98 25.16 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 118.543 0.611 . . . . 0.51 111.457 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.8 40.32 2.73 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.811 1.196 . . . . 0.34 114.036 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.55 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.6 mm -105.15 119.17 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.681 0 N-CA-C 109.21 -0.663 . . . . 0.55 109.21 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.519 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.0 t-160 -105.7 135.28 47.4 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.579 1.696 . . . . 1.34 115.579 -175.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -94.84 134.35 37.56 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.3 -1.318 . . . . 2.79 109.392 174.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.4 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 68.8 mtt180 -90.79 106.03 18.23 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.956 -1.02 . . . . 3.0 113.307 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -41.89 109.84 0.14 Allowed 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 118.374 2.731 . . . . 2.3 118.374 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.08 59.75 16.33 Favored Pre-proline 0 N--CA 1.528 3.466 0 N-CA-C 118.325 2.713 . . . . 1.17 118.325 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 10.0 Cg_endo . . . . . 0 CA--C 1.565 2.068 0 C-N-CA 122.992 2.461 . . . . 1.45 115.685 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 38.6 Cg_exo . . . . . 0 N--CA 1.509 2.389 0 N-CA-C 117.211 1.966 . . . . 1.37 117.211 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.3 136.87 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.951 0 CA-C-N 114.703 -1.135 . . . . 0.69 109.405 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.55 ' HB2' HG22 ' A' ' 125' ' ' THR . 4.0 mt -79.52 -17.14 54.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.241 1.571 . . . . 1.28 115.241 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -101.49 7.41 42.43 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.478 0.918 . . . . 1.51 113.478 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.2 p -118.52 -177.98 3.42 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.14 1.163 . . . . 1.09 114.14 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.717 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 2.6 t30 -97.44 -176.18 0.5 Allowed Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 125.652 1.581 . . . . 1.27 109.574 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -72.05 -43.99 1.02 Allowed 'Trans proline' 0 C--N 1.393 2.901 0 C-N-CA 122.766 2.311 . . . . 0.95 111.414 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -69.31 -47.68 63.76 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.005 -1.907 . . . . 2.04 111.617 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 17.4 t0 -75.7 -12.27 60.16 Favored 'General case' 0 CA--C 1.583 2.241 0 CA-C-N 115.327 -0.851 . . . . 1.62 112.378 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.717 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 10.8 tt0 -67.7 -43.16 80.76 Favored 'General case' 0 C--N 1.379 1.851 0 C-N-CA 125.432 1.493 . . . . 1.77 109.179 173.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.8 -45.06 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.338 0 C-N-CA 124.327 1.051 . . . . 0.81 109.853 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.76 -5.18 49.83 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.227 1.195 . . . . 1.15 114.227 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.496 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 4.6 m-30 -123.54 10.35 9.11 Favored 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 124.509 1.124 . . . . 0.92 112.402 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -136.55 -28.64 0.99 Allowed 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 116.502 2.038 . . . . 1.33 116.502 -176.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.7 p -74.74 131.85 41.16 Favored 'General case' 0 N--CA 1.519 2.99 0 N-CA-C 114.008 1.114 . . . . 1.28 114.008 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.597 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.5 pt-20 . . . . . 0 N--CA 1.505 2.3 0 N-CA-C 114.95 1.463 . . . . 1.53 114.95 -176.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 111.368 0.136 . . . . 2.15 111.368 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.2 t 67.56 85.19 0.14 Allowed 'General case' 0 N--CA 1.513 2.714 0 C-N-CA 124.769 1.228 . . . . 0.77 112.487 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.406 ' CE1' ' ND2' ' A' ' 164' ' ' ASN . 3.3 p90 -144.56 157.03 44.41 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.384 0.611 . . . . 0.81 112.564 -178.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.52 174.47 44.47 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 115.571 0.989 . . . . 0.47 115.571 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.99 166.32 10.46 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.482 1.289 . . . . 0.89 114.482 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -120.74 132.08 54.86 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.15 -1.387 . . . . 0.51 112.162 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -124.51 99.47 36.2 Favored Pre-proline 0 CA--C 1.567 1.627 0 C-N-CA 123.142 0.577 . . . . 0.15 109.916 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.08 122.12 3.27 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.231 1.954 . . . . 0.15 115.014 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.14 159.26 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.64 0 CA-C-O 121.997 0.904 . . . . 0.19 111.26 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -147.86 22.15 1.12 Allowed 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 114.632 -1.167 . . . . 2.53 111.791 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -129.9 159.37 36.84 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 121.3 0.572 . . . . 2.12 111.449 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -119.0 144.77 46.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.742 1.016 . . . . 0.42 113.742 -178.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.48 -138.73 5.77 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 113.974 -1.467 . . . . 0.23 112.17 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 54.3 mm-40 -113.65 108.26 16.89 Favored 'General case' 0 C--N 1.359 1.008 0 CA-C-N 118.113 0.956 . . . . 1.75 111.292 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -102.84 129.84 49.65 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.81 -0.556 . . . . 0.21 110.599 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -110.02 122.36 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.841 0.829 . . . . 0.2 111.013 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.61 105.75 16.3 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 113.907 -1.497 . . . . 0.78 110.202 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.69 126.65 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.142 -0.688 . . . . 0.44 109.142 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 146.07 48.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.599 0.963 . . . . 1.25 113.599 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -105.18 121.54 44.05 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.311 -0.859 . . . . 2.52 111.296 177.466 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 15.6 m-85 -108.49 134.86 50.69 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.414 -0.812 . . . . 0.4 109.735 176.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.51 ' HB2' ' HE3' ' A' ' 88' ' ' LYS . . . -136.18 148.5 48.18 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 123.868 0.867 . . . . 0.41 110.425 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -106.38 -71.21 0.76 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.816 0.447 . . . . 2.61 111.768 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.325 2.8 m 48.29 53.57 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 C-N-CA 127.113 2.165 . . . . 2.13 116.677 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.98 -53.63 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.79 0.663 . . . . 2.27 112.79 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -118.29 139.23 51.64 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.31 0.576 . . . . 1.46 112.349 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.18 103.31 12.47 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-O 122.209 1.004 . . . . 0.84 111.987 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -162.83 140.89 8.27 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.125 -0.943 . . . . 2.45 111.642 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 m -123.45 122.38 38.1 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.962 0.727 . . . . 1.66 112.962 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 69.2 58.21 0.35 Allowed 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 125.933 1.693 . . . . 1.89 113.266 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -156.96 -40.94 0.07 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.128 -1.396 . . . . 2.56 108.606 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -103.42 82.67 2.07 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.361 -0.977 . . . . 2.76 108.361 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.43 132.89 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 114.516 -1.22 . . . . 0.69 111.509 -177.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.476 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 61.7 m-85 -115.5 174.26 6.1 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 115.185 1.55 . . . . 0.7 115.185 -176.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.27 136.08 52.34 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.869 0.842 . . . . 1.33 110.923 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.3 124.39 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.285 0 CA-C-N 114.361 -1.291 . . . . 0.48 110.38 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.3 OUTLIER -121.02 141.56 50.63 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.473 1.286 . . . . 1.69 114.473 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 m -117.72 99.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 115.111 -0.95 . . . . 0.6 112.063 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.428 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.1 t30 64.85 26.89 12.92 Favored 'General case' 0 N--CA 1.522 3.169 0 C-N-CA 126.892 2.077 . . . . 1.12 113.659 -177.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.89 -19.65 32.6 Favored Glycine 0 CA--C 1.549 2.19 0 CA-C-N 115.141 -0.936 . . . . 0.32 113.702 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -88.32 121.93 31.27 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 125.505 1.522 . . . . 0.57 113.669 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -87.7 125.69 34.55 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.591 1.186 . . . . 0.55 113.134 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.22 -43.39 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 112.428 -2.169 . . . . 1.06 112.916 -177.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.38 90.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.466 -0.568 . . . . 0.44 109.466 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -111.55 75.88 0.94 Allowed 'General case' 0 C--N 1.359 1.013 0 CA-C-O 123.944 1.831 . . . . 2.3 112.52 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 154.46 61.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 109.818 -3.356 . . . . 2.48 107.48 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.3 tp -98.91 99.16 10.18 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 113.727 1.01 . . . . 1.13 113.727 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -111.86 111.5 22.49 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 113.172 -1.831 . . . . 2.35 109.742 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -34.26 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 114.545 1.313 . . . . 0.68 114.545 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -76.32 -37.5 57.31 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.806 0.669 . . . . 0.77 112.806 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -74.08 -27.0 60.68 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 124.371 1.068 . . . . 0.91 113.422 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -80.33 -57.78 3.44 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.311 0.856 . . . . 2.43 113.311 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.78 -36.79 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 N-CA-C 114.313 1.227 . . . . 0.93 114.313 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.37 -71.13 0.21 Allowed Glycine 0 C--N 1.36 1.908 0 CA-C-N 118.534 0.606 . . . . 0.85 113.999 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -102.97 174.39 5.89 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.25 1.02 . . . . 3.18 111.802 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.0 m -75.9 81.26 2.8 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 113.846 1.054 . . . . 2.08 113.846 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.55 HG22 ' HB2' ' A' ' 51' ' ' LEU . 46.6 p -127.99 -137.43 0.24 Allowed 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 114.708 -1.133 . . . . 0.62 109.139 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.8 128.09 56.27 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 114.055 1.132 . . . . 0.46 114.055 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -106.2 126.68 52.51 Favored 'General case' 0 C--N 1.363 1.183 0 N-CA-C 108.399 -0.963 . . . . 0.38 108.399 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.25 136.76 36.84 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.5 0.926 . . . . 2.5 113.5 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -120.37 134.46 55.26 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 114.806 -1.088 . . . . 1.56 111.174 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.8 115.66 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 CA-C-N 114.255 -1.339 . . . . 0.45 109.833 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.9 90.86 49.49 Favored Pre-proline 0 CA--C 1.573 1.851 0 CA-C-N 115.208 -0.906 . . . . 0.84 110.15 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -73.87 136.64 23.25 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 123.052 2.501 . . . . 0.16 113.71 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -119.04 151.38 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 115.167 -0.924 . . . . 0.38 111.053 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.5 p -134.21 108.73 8.43 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.215 -0.902 . . . . 1.31 111.744 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.2 mt -108.82 122.79 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.593 0 N-CA-C 108.441 -0.948 . . . . 0.25 108.441 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -141.76 129.49 21.64 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.696 -0.684 . . . . 2.05 110.996 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 67.49 14.87 9.73 Favored 'General case' 0 N--CA 1.515 2.821 0 C-N-CA 125.113 1.365 . . . . 3.55 114.367 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.38 16.44 32.1 Favored Glycine 0 CA--C 1.549 2.168 0 CA-C-O 119.143 -0.809 . . . . 0.37 114.962 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 94.6 mttt -126.82 150.4 49.21 Favored 'General case' 0 C--N 1.367 1.329 0 CA-C-N 118.498 1.149 . . . . 1.56 113.038 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.53 139.0 37.78 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.554 0.946 . . . . 0.34 113.554 -176.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.67 112.42 14.82 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.128 -0.942 . . . . 0.64 110.406 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.81 92.75 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.604 0 CA-C-N 115.589 -0.732 . . . . 0.46 109.982 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 65.39 -83.75 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 C-N-CA 125.369 1.468 . . . . 1.56 113.796 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -129.61 25.95 4.4 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-N 116.099 -0.5 . . . . 0.49 113.866 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -132.38 119.31 20.51 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 123.165 0.586 . . . . 1.82 110.078 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 p -105.74 131.61 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.298 0 CA-C-O 121.696 0.76 . . . . 1.02 112.415 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -149.08 -178.11 6.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.815 -1.084 . . . . 0.56 109.565 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.268 13.0 t -103.48 138.65 39.9 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 113.547 0.943 . . . . 1.25 113.547 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -82.12 122.68 28.16 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 124.192 0.997 . . . . 0.29 111.343 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.65 90.77 3.31 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.788 0.662 . . . . 1.42 112.788 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.19 -61.74 2.64 Favored Glycine 0 C--N 1.362 2.005 0 N-CA-C 118.835 2.294 . . . . 0.42 118.835 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.554 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -133.11 163.83 28.39 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.649 0.981 . . . . 1.1 113.649 -176.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.554 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -112.14 134.6 53.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.692 -1.594 . . . . 0.67 108.488 176.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.2 t -121.86 130.58 53.49 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 115.246 1.573 . . . . 0.36 115.246 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.2 t -106.35 99.85 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.704 -1.591 . . . . 0.74 106.704 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.2 tt0 -114.85 125.23 53.43 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 113.905 -1.498 . . . . 1.67 111.9 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -116.15 131.97 56.79 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 122.217 1.008 . . . . 1.8 111.923 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.51 144.47 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 112.875 -1.966 . . . . 0.58 110.83 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -95.19 150.45 20.2 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.676 -1.147 . . . . 2.18 113.612 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.32 -32.65 5.98 Favored Glycine 0 CA--C 1.548 2.112 0 N-CA-C 115.236 0.855 . . . . 1.02 115.236 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -125.17 -80.56 0.62 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.606 0.703 . . . . 2.86 112.395 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -132.2 -44.94 0.93 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.087 0.555 . . . . 3.91 112.203 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.476 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -92.84 157.17 16.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.659 1.184 . . . . 1.74 112.109 179.085 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.406 ' ND2' ' CE1' ' A' ' 71' ' ' PHE . 1.2 m-20 -101.19 -167.45 0.13 Allowed Pre-proline 0 CA--C 1.572 1.809 0 CA-C-N 113.614 -1.63 . . . . 1.68 108.979 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -61.26 -10.5 15.83 Favored 'Trans proline' 0 N--CA 1.52 3.081 0 C-N-CA 122.49 2.127 . . . . 2.06 115.533 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? 78.93 -71.71 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 126.561 1.944 . . . . 3.0 114.211 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.597 HG22 ' HB3' ' A' ' 64' ' ' GLU . 25.2 t -106.34 132.72 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.621 -0.511 . . . . 0.8 109.621 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.6 125.82 27.96 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 114.155 -1.384 . . . . 0.87 111.479 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.268 . . -120.34 50.88 1.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 115.744 1.757 . . . . 0.34 115.744 -176.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.81 129.3 2.62 Favored 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 126.169 1.787 . . . . 0.7 115.502 178.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -149.61 99.31 2.87 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.21 110.019 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.311 8.0 tt -115.67 121.78 68.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.673 0 CA-C-O 122.651 1.215 . . . . 0.31 111.801 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -118.72 171.2 8.37 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 113.701 -1.59 . . . . 0.44 112.171 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 54.7 tttm -120.15 148.15 44.0 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 117.783 2.512 . . . . 1.26 117.783 -174.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.22 -41.74 2.08 Favored Glycine 0 CA--C 1.543 1.823 0 CA-C-N 110.786 -2.915 . . . . 0.17 120.087 172.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.08 156.64 1.04 Allowed 'General case' 0 N--CA 1.521 3.115 0 CA-C-N 121.114 2.457 . . . . 0.15 113.383 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.45 -12.12 59.99 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 114.478 1.288 . . . . 0.17 114.478 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.1 4.47 45.25 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 113.694 0.998 . . . . 0.55 113.694 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.13 -10.32 15.91 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 113.701 1.0 . . . . 0.6 113.701 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.509 2.503 0 C-N-CA 123.932 0.893 . . . . 0.95 112.74 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.588 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.7 tp . . . . . 0 CA--C 1.561 1.382 0 N-CA-C 113.294 0.85 . . . . 0.35 113.294 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.69 -23.15 62.89 Favored 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 125.647 1.579 . . . . 0.2 114.979 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.1 -15.17 39.3 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 124.146 0.978 . . . . 0.32 113.626 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -105.19 -18.05 14.27 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.907 1.077 . . . . 1.73 113.907 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.34 134.79 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.78 0 N-CA-C 114.625 1.343 . . . . 0.11 114.625 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -121.27 -28.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 115.328 -0.851 . . . . 0.16 112.446 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -162.63 117.08 1.77 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 117.827 0.285 . . . . 0.54 111.493 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -136.84 130.85 32.42 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.516 -0.74 . . . . 0.19 111.445 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.0 t -137.97 129.32 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 N-CA-C 113.481 0.919 . . . . 1.05 113.481 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -116.44 104.22 11.23 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 106.946 -1.501 . . . . 2.11 106.946 171.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.29 101.88 7.38 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.084 0.945 . . . . 0.63 111.861 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.526 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 175.59 -57.33 0.11 Allowed Glycine 0 C--N 1.349 1.305 0 CA-C-N 113.71 -1.587 . . . . 0.71 114.349 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.13 -117.09 4.3 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-O 119.93 -0.372 . . . . 0.8 113.975 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -172.12 118.88 0.4 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.172 0.589 . . . . 1.63 111.17 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 48.39 107.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 117.205 2.298 . . . . 1.0 117.205 178.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.761 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 25.7 t60 -142.41 132.51 24.6 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.461 -1.296 . . . . 0.45 114.49 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -97.04 112.24 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.362 0 CA-C-N 114.28 -1.327 . . . . 1.39 110.089 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.29 164.92 19.76 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.527 1.131 . . . . 1.85 112.559 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 m -42.53 -35.17 0.63 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.159 0 N-CA-C 118.947 2.943 . . . . 0.72 118.947 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -88.98 -23.32 22.66 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.213 0.53 . . . . 0.51 111.26 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.85 41.06 0.73 Allowed Glycine 0 C--N 1.351 1.394 0 CA-C-N 114.817 -1.083 . . . . 0.34 113.81 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.588 HD11 ' HG ' ' A' ' 6' ' ' LEU . 22.7 mm -108.45 112.8 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 C-N-CA 122.569 0.348 . . . . 0.55 110.581 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.761 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 5.1 p-80 -109.29 147.83 32.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.983 1.845 . . . . 1.34 115.983 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.8 151.31 20.32 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 112.467 -2.151 . . . . 2.79 109.419 176.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -70.27 -99.82 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 116.04 1.867 . . . . 3.0 116.04 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp 178.19 84.04 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.89 0.876 . . . . 2.3 111.986 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 52.69 55.33 14.26 Favored Pre-proline 0 N--CA 1.528 3.457 0 N-CA-C 117.283 2.327 . . . . 1.17 117.283 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 CA--C 1.568 2.193 0 C-N-CA 123.307 2.672 . . . . 1.45 116.432 -179.195 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.539 ' HD2' ' NE2' ' A' ' 62' ' ' GLN . 21.7 Cg_exo . . . . . 0 N--CA 1.495 1.577 0 N-CA-C 119.496 2.844 . . . . 1.37 119.496 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 126' ' ' ALA 0.319 1.8 mp -92.78 107.02 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 CA-C-O 123.085 1.421 . . . . 0.69 109.59 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.459 ' HB2' HG22 ' A' ' 125' ' ' THR . 89.3 mt -90.24 -7.13 54.26 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 111.821 -2.445 . . . . 1.28 116.387 -175.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -103.86 16.46 26.29 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 112.263 0.468 . . . . 1.51 112.263 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.84 159.36 42.37 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.224 1.01 . . . . 1.09 111.51 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.86 158.32 62.26 Favored Pre-proline 0 N--CA 1.517 2.876 0 CA-C-O 118.138 -0.934 . . . . 1.27 110.974 178.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -41.19 -40.13 4.08 Favored 'Trans proline' 0 N--CA 1.535 3.971 0 C-N-CA 125.162 3.908 . . . . 0.95 120.05 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.79 -50.02 13.17 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.511 0.672 . . . . 2.04 111.96 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -78.23 -7.5 57.22 Favored 'General case' 0 CA--C 1.584 2.287 0 N-CA-C 113.121 0.786 . . . . 1.62 113.121 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.66 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 7.7 tt0 -74.3 -37.06 63.75 Favored 'General case' 0 C--N 1.38 1.919 0 C-N-CA 125.923 1.689 . . . . 1.77 107.547 172.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.36 -43.88 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 C-N-CA 124.214 1.005 . . . . 0.81 109.289 172.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.1 tp -79.93 -4.63 53.21 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 113.965 1.098 . . . . 1.15 113.965 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.427 ' O ' HG12 ' A' ' 50' ' ' ILE . 6.8 m-30 -121.69 13.77 10.85 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 125.131 1.373 . . . . 0.92 112.641 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.66 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 4.8 tt0 -140.8 -38.9 0.42 Allowed 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 117.175 2.287 . . . . 1.33 117.175 -174.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.8 p -64.19 128.06 34.16 Favored 'General case' 0 N--CA 1.528 3.435 0 N-CA-C 115.343 1.609 . . . . 1.28 115.343 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.527 ' HB3' HG22 ' A' ' 167' ' ' VAL . 2.4 pt-20 . . . . . 0 N--CA 1.503 2.213 0 C-N-CA 124.617 1.167 . . . . 1.53 112.58 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 110.732 -0.099 . . . . 2.15 110.732 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.91 89.57 0.06 Allowed 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 125.383 1.473 . . . . 0.77 113.692 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -153.53 159.24 42.18 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.841 1.052 . . . . 0.81 113.841 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -175.7 -172.01 40.13 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 115.879 1.112 . . . . 0.47 115.879 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -111.27 173.32 6.4 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.026 1.491 . . . . 0.89 115.026 -176.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -127.61 132.2 49.82 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 113.98 -1.464 . . . . 0.51 111.757 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.91 103.61 30.62 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.023 0.529 . . . . 0.15 109.957 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -84.34 120.64 2.54 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 122.282 1.988 . . . . 0.15 114.958 177.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.24 162.81 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 122.041 0.924 . . . . 0.19 110.931 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -152.13 27.95 0.59 Allowed 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 114.801 -1.091 . . . . 2.53 111.816 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -132.71 155.62 48.5 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-O 121.24 0.543 . . . . 2.12 110.965 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -116.77 141.87 47.65 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.009 1.114 . . . . 0.42 114.009 -178.48 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.83 -139.08 5.69 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 113.712 -1.585 . . . . 0.23 112.061 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.2 mt-10 -113.9 110.13 19.61 Favored 'General case' 0 C--N 1.36 1.023 0 CA-C-N 118.312 1.056 . . . . 1.75 111.299 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -104.41 131.2 52.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.996 0.427 . . . . 0.21 110.523 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.81 124.46 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.408 0.623 . . . . 0.2 110.551 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.429 HD12 HD12 ' A' ' 172' ' ' ILE . 2.2 tt -109.15 106.19 15.97 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.793 -1.094 . . . . 0.78 109.806 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -112.48 129.17 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 113.929 -1.487 . . . . 0.44 108.543 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.72 139.11 50.26 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 115.684 -0.689 . . . . 1.25 112.502 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 4.9 tptm -104.33 114.75 29.19 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.295 -0.866 . . . . 2.52 109.855 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.491 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 11.1 m-85 -105.22 137.05 43.62 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.852 -0.613 . . . . 0.4 111.255 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.79 151.54 45.84 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.757 -0.656 . . . . 0.41 111.458 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -145.87 123.46 11.8 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.671 0.389 . . . . 2.61 111.687 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.3 77.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 116.019 -0.537 . . . . 2.13 111.727 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -171.05 -47.42 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.43 0.53 . . . . 2.27 112.43 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -116.19 127.34 54.7 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.65 0.38 . . . . 1.46 111.577 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.96 103.14 12.94 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.252 1.025 . . . . 0.84 111.992 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -160.79 141.84 11.79 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.947 -1.024 . . . . 2.45 111.651 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 m -127.7 122.09 32.05 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.764 0.653 . . . . 1.66 112.764 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 67.85 55.62 0.58 Allowed 'General case' 0 N--CA 1.513 2.72 0 C-N-CA 125.724 1.61 . . . . 1.89 113.142 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -157.68 -39.15 0.07 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.617 -1.174 . . . . 2.56 109.44 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -108.06 83.24 1.76 Allowed 'General case' 0 C--N 1.361 1.097 0 N-CA-C 108.03 -1.1 . . . . 2.76 108.03 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.41 130.45 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 114.419 -1.264 . . . . 0.69 111.539 -176.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -108.02 170.53 7.94 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.331 1.604 . . . . 0.7 115.331 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -119.85 136.65 54.4 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.236 -0.893 . . . . 1.33 110.846 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.38 127.89 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.471 0 N-CA-C 109.58 -0.526 . . . . 0.48 109.58 -178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 53.9 mtt180 -128.58 153.32 47.35 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.708 1.744 . . . . 1.69 115.708 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.7 OUTLIER -129.73 112.32 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-N 115.545 -0.752 . . . . 0.6 112.758 176.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.505 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 63.39 27.05 15.18 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 126.864 2.066 . . . . 1.12 114.157 -178.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.31 -19.35 40.13 Favored Glycine 0 CA--C 1.548 2.136 0 C-N-CA 121.463 -0.399 . . . . 0.32 113.8 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.481 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 86.7 m-70 -83.79 156.91 22.28 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.654 1.582 . . . . 0.57 114.454 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.49 131.29 53.84 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.375 0.607 . . . . 0.55 111.094 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.2 -57.86 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 115.129 -0.942 . . . . 1.06 113.104 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.74 90.02 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.713 -0.847 . . . . 0.44 108.713 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -109.37 77.85 1.09 Allowed 'General case' 0 C--N 1.351 0.636 0 CA-C-O 122.835 1.303 . . . . 2.3 111.985 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 152.34 65.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 128.523 2.729 . . . . 2.48 107.868 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.0 tp -105.17 99.35 8.96 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 113.782 1.03 . . . . 1.13 113.782 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -113.32 107.05 15.35 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 113.24 -1.8 . . . . 2.35 108.042 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.13 -33.25 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 114.542 1.312 . . . . 0.68 114.542 -177.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -75.13 -36.1 61.64 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 123.376 0.671 . . . . 0.77 112.242 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -74.71 -27.46 60.39 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 124.436 1.094 . . . . 0.91 113.27 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.69 -56.93 4.17 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.163 0.801 . . . . 2.43 113.163 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.9 -40.68 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 113.753 1.019 . . . . 0.93 113.753 177.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.45 -64.09 0.3 Allowed Glycine 0 C--N 1.361 1.935 0 N-CA-C 114.353 0.501 . . . . 0.85 114.353 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -103.26 174.2 5.97 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.316 1.046 . . . . 3.18 111.634 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -73.35 89.86 1.63 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 123.543 0.737 . . . . 2.08 112.249 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 51' ' ' LEU . 40.8 p -141.02 -146.25 0.19 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.115 0.966 . . . . 0.62 109.209 -176.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.534 ' HB2' HG23 ' A' ' 50' ' ' ILE . . . -113.94 134.8 54.6 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 113.475 0.917 . . . . 0.46 113.475 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.491 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 10.4 t60 -110.75 145.79 37.47 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.884 0.474 . . . . 0.38 109.77 177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -145.33 143.97 30.46 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.881 1.067 . . . . 2.5 113.881 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -137.43 125.71 23.21 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 114.293 -1.321 . . . . 1.56 110.471 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.45 121.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 114.896 -1.047 . . . . 0.45 110.768 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.98 99.45 15.05 Favored Pre-proline 0 CA--C 1.571 1.759 0 CA-C-O 119.009 -0.52 . . . . 0.84 112.208 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -74.7 143.95 30.8 Favored 'Trans proline' 0 C--N 1.4 3.277 0 C-N-CA 123.052 2.501 . . . . 0.16 114.326 176.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -124.28 149.25 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 124.023 0.929 . . . . 0.38 110.423 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.6 p -132.48 111.37 11.21 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.924 -0.58 . . . . 1.31 112.349 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.4 mt -112.01 122.67 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 N-CA-C 108.492 -0.929 . . . . 0.25 108.492 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -142.56 130.09 21.32 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.66 -0.7 . . . . 2.05 110.873 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt 69.38 10.14 7.61 Favored 'General case' 0 N--CA 1.518 2.963 0 N-CA-C 114.677 1.362 . . . . 3.55 114.677 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.66 18.45 23.11 Favored Glycine 0 CA--C 1.548 2.108 0 C-N-CA 123.738 0.685 . . . . 0.37 114.384 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 95.4 mttt -128.25 151.09 49.69 Favored 'General case' 0 C--N 1.367 1.337 0 CA-C-N 117.978 0.889 . . . . 1.56 112.799 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.75 144.9 30.5 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.811 1.041 . . . . 0.34 113.811 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.1 m -134.35 114.09 12.6 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.783 -1.099 . . . . 0.64 110.712 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.274 0.8 OUTLIER -114.54 96.12 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.568 0 CA-C-O 121.304 0.573 . . . . 0.46 110.434 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 68.24 -85.34 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 125.41 1.484 . . . . 1.56 113.594 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.08 26.74 4.16 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 115.969 -0.559 . . . . 0.49 113.405 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -129.21 127.98 42.39 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.497 0.719 . . . . 1.82 110.453 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.0 p -113.39 130.75 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.315 0 CA-C-O 121.649 0.738 . . . . 1.02 111.772 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 m -148.65 178.58 8.51 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.946 -1.025 . . . . 0.56 109.735 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.27 13.4 t -103.34 137.61 41.22 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 113.366 0.876 . . . . 1.25 113.366 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -84.14 123.44 30.08 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.243 1.017 . . . . 0.29 111.597 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.2 90.82 3.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.476 0.547 . . . . 1.42 112.476 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.28 -64.64 3.15 Favored Glycine 0 C--N 1.359 1.816 0 N-CA-C 118.847 2.299 . . . . 0.42 118.847 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.517 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -129.75 158.03 40.52 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.442 1.275 . . . . 1.1 114.442 -176.246 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.517 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -106.98 138.97 42.13 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 113.285 -1.779 . . . . 0.67 109.269 177.032 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 t -121.23 143.97 48.86 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.567 1.692 . . . . 0.36 115.567 -177.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.421 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -116.26 98.2 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.308 -1.367 . . . . 0.74 107.308 175.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -118.29 124.91 48.97 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.334 0.588 . . . . 1.67 112.407 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.0 133.39 56.07 Favored 'General case' 0 C--O 1.252 1.211 0 CA-C-O 122.22 1.009 . . . . 1.8 111.482 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.4 t -106.36 143.91 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 113.094 -1.867 . . . . 0.58 110.442 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.489 ' H ' ' HD3' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -85.64 150.53 24.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.539 1.311 . . . . 2.18 114.539 -178.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.93 -51.78 0.99 Allowed Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.055 -0.975 . . . . 1.02 113.928 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -129.49 -84.46 0.55 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.912 0.356 . . . . 2.86 111.739 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.508 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 0.4 OUTLIER -140.64 122.7 15.64 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.984 0.514 . . . . 3.91 110.224 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 0.9 OUTLIER 85.54 114.94 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 C-N-CA 124.975 1.31 . . . . 1.74 111.064 -177.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -82.32 -172.26 0.35 Allowed Pre-proline 0 CA--C 1.574 1.876 0 C-N-CA 124.536 1.134 . . . . 1.68 110.464 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -61.64 101.06 0.2 Allowed 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 122.247 1.965 . . . . 2.06 111.994 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -59.56 -49.42 77.83 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.199 1.926 . . . . 3.0 116.199 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 64' ' ' GLU . 25.8 t -108.43 131.88 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.777 -0.823 . . . . 0.8 108.777 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.4 t -136.88 124.18 21.89 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.639 -1.164 . . . . 0.87 112.094 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.267 . . -119.84 48.32 1.57 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.897 1.814 . . . . 0.34 115.897 -177.235 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.83 135.53 2.28 Favored 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.489 2.033 . . . . 0.7 116.489 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -152.43 106.42 3.12 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.376 -0.829 . . . . 0.21 110.974 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.429 HD12 HD12 ' A' ' 85' ' ' LEU 0.294 9.9 tt -115.72 122.68 69.96 Favored 'Isoleucine or valine' 0 C--O 1.27 2.15 0 CA-C-O 122.16 0.981 . . . . 0.31 111.147 175.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -120.42 167.83 11.94 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.322 -1.308 . . . . 0.44 111.859 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -118.58 145.63 45.23 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 117.813 2.523 . . . . 1.26 117.813 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.42 -40.99 2.28 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 110.672 -2.967 . . . . 0.17 120.151 172.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.71 160.92 2.0 Favored 'General case' 0 N--CA 1.518 2.932 0 CA-C-N 121.265 2.533 . . . . 0.15 113.587 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.37 -10.06 59.75 Favored 'General case' 0 CA--C 1.583 2.212 0 C-N-CA 124.994 1.318 . . . . 0.17 114.126 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.1 1.64 52.31 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.234 1.198 . . . . 0.55 114.234 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.05 -10.84 15.8 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.467 0.914 . . . . 0.6 113.467 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.379 0 C-N-CA 124.119 0.968 . . . . 0.95 112.424 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.525 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.9 tp . . . . . 0 CA--C 1.565 1.553 0 N-CA-C 113.036 0.754 . . . . 0.35 113.036 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.28 -22.91 63.68 Favored 'General case' 0 N--CA 1.508 2.462 0 C-N-CA 125.925 1.69 . . . . 0.2 115.249 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -11.53 51.11 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 113.792 1.034 . . . . 0.32 113.792 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -108.9 -19.37 13.42 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 113.728 1.01 . . . . 1.73 113.728 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.41 138.26 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 N-CA-C 115.142 1.534 . . . . 0.11 115.142 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -122.32 -30.33 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 115.717 -0.674 . . . . 0.16 112.44 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -162.02 116.29 1.88 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 120.815 0.34 . . . . 0.54 111.07 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.07 135.57 35.95 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.397 -0.815 . . . . 0.19 111.526 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.269 5.3 p -148.17 146.15 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 N-CA-C 114.571 1.323 . . . . 1.05 114.571 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.623 ' HB2' HD12 ' A' ' 60' ' ' LEU . 1.9 t-20 -116.9 107.91 15.17 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.168 -1.378 . . . . 2.11 108.145 175.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.6 102.11 5.98 Favored 'General case' 0 C--O 1.268 2.078 0 CA-C-O 122.246 1.022 . . . . 0.63 111.668 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.496 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 153.98 -1.66 0.22 Allowed Glycine 0 C--N 1.353 1.5 0 CA-C-N 111.561 -2.563 . . . . 0.71 115.998 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.51 -141.43 3.13 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 118.91 1.355 . . . . 0.8 114.705 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -147.25 116.67 7.01 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 112.485 0.55 . . . . 1.63 112.485 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 2.3 m 35.54 123.18 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.877 0 N-CA-C 121.087 3.736 . . . . 1.0 121.087 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.439 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 38.4 t60 -154.2 150.21 27.85 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.662 0.744 . . . . 0.45 111.768 175.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.56 128.22 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 115.361 -0.836 . . . . 1.39 111.71 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -85.73 153.36 22.38 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 113.994 -1.457 . . . . 1.85 110.157 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.1 m -44.04 -22.77 0.15 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 118.956 2.947 . . . . 0.72 118.956 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -94.19 -21.55 18.99 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 123.004 0.522 . . . . 0.51 111.103 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.58 39.21 1.12 Allowed Glycine 0 C--N 1.353 1.501 0 C-N-CA 124.4 1.0 . . . . 0.34 114.43 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.525 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.9 mm -105.98 119.68 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 109.239 -0.652 . . . . 0.55 109.239 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -100.66 130.92 46.77 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.179 1.177 . . . . 1.34 114.179 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.662 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -96.33 140.45 30.98 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.985 -1.007 . . . . 2.79 110.604 177.398 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -83.6 176.42 9.02 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 115.856 1.798 . . . . 3.0 115.856 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -107.53 96.97 6.78 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.83 1.789 . . . . 2.3 115.83 -175.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 46.95 58.6 17.02 Favored Pre-proline 0 N--CA 1.52 3.036 0 N-CA-C 117.701 2.482 . . . . 1.17 117.701 175.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 CA--C 1.557 1.654 0 C-N-CA 122.62 2.213 . . . . 1.45 115.93 179.592 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo . . . . . 0 N--CA 1.499 1.816 0 N-CA-C 116.053 1.52 . . . . 1.37 116.053 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.257 1.1 mp -97.18 136.9 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.23 0 CA-C-N 114.6 -1.182 . . . . 0.69 109.726 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.56 ' HB2' HG22 ' A' ' 125' ' ' THR . 5.7 mt -89.73 -12.27 39.89 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 116.381 1.993 . . . . 1.28 116.381 -177.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -100.48 15.86 26.53 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.87 1.063 . . . . 1.51 113.87 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -132.62 -165.46 1.6 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.29 0.636 . . . . 1.09 111.433 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.18 174.09 3.68 Favored Pre-proline 0 N--CA 1.505 2.31 0 C-N-CA 123.087 0.555 . . . . 1.27 111.583 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -70.2 -28.14 23.51 Favored 'Trans proline' 0 C--N 1.401 3.32 0 C-N-CA 123.164 2.576 . . . . 0.95 113.797 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.05 -37.22 19.12 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.954 0.902 . . . . 2.04 112.712 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.0 8.78 42.77 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.171 1.175 . . . . 1.62 114.171 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -72.75 -26.21 61.47 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 123.751 0.82 . . . . 1.77 110.606 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.1 t -68.86 -50.55 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 C-N-CA 126.458 1.903 . . . . 0.81 108.226 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' A' ' 15' ' ' ASN . 7.9 tp -74.39 -9.67 58.82 Favored 'General case' 0 C--N 1.383 2.047 0 N-CA-C 114.013 1.116 . . . . 1.15 114.013 176.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -108.08 1.08 22.1 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.336 0.655 . . . . 0.92 110.854 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -128.26 -115.0 0.26 Allowed 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.395 1.078 . . . . 1.33 110.849 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.2 p 35.32 134.16 0.0 OUTLIER 'General case' 1 N--CA 1.56 5.06 0 C-N-CA 128.342 2.657 . . . . 1.28 117.928 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.5 ' HB3' HG12 ' A' ' 167' ' ' VAL . 5.8 pt-20 . . . . . 0 N--CA 1.516 2.873 0 N-CA-C 116.974 2.213 . . . . 1.53 116.974 -176.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 111.839 0.311 . . . . 2.15 111.839 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 t 66.67 83.7 0.16 Allowed 'General case' 0 N--CA 1.506 2.331 0 C-N-CA 124.907 1.283 . . . . 0.77 113.006 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -141.92 138.5 32.07 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 121.605 0.717 . . . . 0.81 111.929 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.69 -167.63 15.7 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.603 1.401 . . . . 0.47 116.603 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.1 172.27 8.68 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 113.499 -1.351 . . . . 0.89 113.986 -177.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -128.22 134.14 48.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.399 -1.273 . . . . 0.51 112.219 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.32 103.54 22.7 Favored Pre-proline 0 CA--C 1.567 1.607 0 C-N-CA 123.326 0.65 . . . . 0.15 109.499 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -84.57 120.1 2.38 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.233 1.955 . . . . 0.15 114.783 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.84 160.16 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 CA-C-O 121.977 0.894 . . . . 0.19 111.232 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -149.3 24.05 0.91 Allowed 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 114.748 -1.115 . . . . 2.53 111.867 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -130.09 161.66 30.54 Favored 'General case' 0 C--N 1.364 1.238 0 CA-C-O 121.296 0.57 . . . . 2.12 111.5 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -120.34 144.33 47.91 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.799 1.037 . . . . 0.42 113.799 -178.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.29 -139.53 6.08 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 114.117 -1.401 . . . . 0.23 112.596 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 80.9 mm-40 -113.65 105.0 12.8 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-N 118.092 0.946 . . . . 1.75 110.963 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -99.52 128.27 45.62 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.124 0.488 . . . . 0.21 110.895 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -112.34 123.66 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.346 0.593 . . . . 0.2 110.755 -176.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.417 HD12 HD12 ' A' ' 172' ' ' ILE . 2.5 tt -110.27 108.38 18.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.923 -1.035 . . . . 0.78 110.069 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.25 132.26 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 114.199 -1.364 . . . . 0.44 108.557 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.21 140.79 47.73 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 115.514 -0.766 . . . . 1.25 112.394 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 15.4 tptt -104.01 113.33 26.8 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.043 -0.98 . . . . 2.52 109.657 177.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 11.4 m-85 -106.84 134.68 49.61 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.685 -0.689 . . . . 0.4 111.146 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.76 148.05 38.34 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.4 0.619 . . . . 0.41 111.24 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -132.36 117.9 18.71 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 116.171 -0.468 . . . . 2.61 111.228 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.08 69.02 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 116.179 -0.464 . . . . 2.13 112.048 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.39 -49.11 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.899 0.479 . . . . 2.27 111.995 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -123.14 129.64 51.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.711 0.404 . . . . 1.46 111.143 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.83 105.46 15.5 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 122.194 0.997 . . . . 0.84 112.421 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -162.69 144.82 10.58 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.009 -0.996 . . . . 2.45 112.179 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.9 m -122.8 125.68 45.94 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.495 -0.775 . . . . 1.66 112.595 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 70.48 49.75 0.41 Allowed 'General case' 0 N--CA 1.515 2.777 0 C-N-CA 125.553 1.541 . . . . 1.89 112.473 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -148.66 -45.72 0.15 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.679 1.192 . . . . 2.56 109.565 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.98 87.54 2.53 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.679 -0.86 . . . . 2.76 108.679 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.93 120.81 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 114.048 -1.433 . . . . 0.69 110.743 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.52 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 45.5 m-85 -101.02 177.37 4.97 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.417 1.636 . . . . 0.7 115.417 -175.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -128.21 136.9 51.71 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.214 0.531 . . . . 1.33 111.483 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.95 126.09 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.448 0 CA-C-N 115.689 -0.687 . . . . 0.48 109.994 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -132.43 151.34 51.92 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.083 1.512 . . . . 1.69 115.083 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 154' ' ' SER . 1.2 m -125.08 113.32 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 C-N-CA 124.357 1.063 . . . . 0.6 112.754 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.539 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 64.69 25.85 13.08 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 126.69 1.996 . . . . 1.12 113.614 -178.326 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.99 -3.63 60.52 Favored Glycine 0 CA--C 1.555 2.577 0 CA-C-N 116.168 -0.469 . . . . 0.32 114.099 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 86.0 m-70 -99.56 139.61 34.96 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 125.65 1.58 . . . . 0.57 112.951 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.33 130.51 40.61 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.879 0.847 . . . . 0.55 113.075 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.09 -56.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 114.0 -1.454 . . . . 1.06 112.606 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.43 88.6 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.242 -1.022 . . . . 0.44 108.242 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -109.17 95.1 5.41 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 123.094 1.426 . . . . 2.3 111.964 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 127.96 71.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 129.619 3.168 . . . . 2.48 107.865 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.26 103.41 15.26 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-O 121.863 0.839 . . . . 1.13 112.481 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -111.59 94.71 5.1 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 113.538 -1.664 . . . . 2.35 107.647 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -63.52 -28.73 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.496 0 C-N-CA 125.046 1.339 . . . . 0.68 114.465 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -77.69 -37.08 50.42 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.31 0.644 . . . . 0.77 112.469 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -74.45 -27.13 60.46 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 124.594 1.158 . . . . 0.91 113.836 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -86.65 -50.57 6.7 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.455 0.909 . . . . 2.43 113.455 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.282 1.4 p -91.53 -38.76 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.966 0 N-CA-C 113.383 0.883 . . . . 0.93 113.383 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.37 -78.81 0.25 Allowed Glycine 0 C--N 1.36 1.883 0 CA-C-N 118.444 0.566 . . . . 0.85 114.497 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -102.92 174.75 5.73 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.1 0.96 . . . . 3.18 112.507 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.7 m -74.18 81.14 1.79 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.723 1.009 . . . . 2.08 113.723 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.56 HG22 ' HB2' ' A' ' 51' ' ' LEU . 34.9 p -133.01 -137.49 0.18 Allowed 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 114.441 -1.254 . . . . 0.62 109.032 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -115.01 131.55 56.89 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.046 0.758 . . . . 0.46 113.046 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 18.8 t60 -105.48 147.93 27.77 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.446 -0.576 . . . . 0.38 109.446 176.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -142.49 129.86 21.14 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.663 1.357 . . . . 2.5 114.663 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -123.77 123.92 41.55 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.737 -1.12 . . . . 1.56 110.661 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.49 120.88 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-N 114.488 -1.233 . . . . 0.45 110.899 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.62 99.99 15.22 Favored Pre-proline 0 CA--C 1.569 1.702 0 CA-C-O 119.024 -0.512 . . . . 0.84 111.976 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -75.05 142.6 27.89 Favored 'Trans proline' 0 C--N 1.398 3.177 0 C-N-CA 123.082 2.521 . . . . 0.16 114.2 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.17 149.48 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 CA-C-N 115.125 -0.943 . . . . 0.38 109.971 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.9 t -136.0 117.16 14.44 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.502 0.668 . . . . 1.31 111.365 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.4 mt -113.93 125.5 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 CA-C-N 114.713 -1.131 . . . . 0.25 108.286 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -138.97 124.33 19.25 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.599 -0.728 . . . . 2.05 110.567 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 67.61 17.1 9.93 Favored 'General case' 0 N--CA 1.517 2.902 0 C-N-CA 125.341 1.456 . . . . 3.55 114.121 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.51 13.18 45.48 Favored Glycine 0 CA--C 1.547 2.038 0 CA-C-O 119.203 -0.776 . . . . 0.37 114.936 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 52.8 mtpt -122.03 147.44 46.08 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-N 118.378 1.089 . . . . 1.56 112.656 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.99 145.31 29.45 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.46 1.281 . . . . 0.34 114.46 -175.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.83 114.32 10.34 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.689 -1.142 . . . . 0.64 109.987 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.262 9.9 p -119.36 95.82 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.446 0 CA-C-O 121.287 0.565 . . . . 0.46 111.357 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 67.88 -85.47 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 125.646 1.578 . . . . 1.56 113.757 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.25 25.32 5.75 Favored Glycine 0 CA--C 1.543 1.813 0 CA-C-N 116.005 -0.543 . . . . 0.49 112.999 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -125.27 141.18 52.24 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.856 0.862 . . . . 1.82 111.376 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.6 p -130.7 124.85 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.132 0 CA-C-N 115.669 -0.696 . . . . 1.02 110.896 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -150.69 179.86 7.84 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.247 -0.888 . . . . 0.56 109.848 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.269 15.2 t -103.93 137.65 41.62 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 113.203 0.816 . . . . 1.25 113.203 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -81.82 122.9 28.29 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.112 0.965 . . . . 0.29 111.66 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.95 91.4 3.2 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.707 0.632 . . . . 1.42 112.707 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.58 -65.33 3.45 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 118.79 2.276 . . . . 0.42 118.79 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.53 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -132.44 158.45 42.0 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.143 1.164 . . . . 1.1 114.143 -176.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.539 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -108.26 138.83 43.88 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.242 -1.799 . . . . 0.67 109.097 176.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.6 t -120.5 143.11 48.72 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.301 1.593 . . . . 0.36 115.301 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.62 99.42 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.348 -0.982 . . . . 0.74 108.348 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.79 128.37 56.38 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.631 -0.713 . . . . 1.67 112.847 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -118.79 125.81 50.43 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-O 122.198 0.999 . . . . 1.8 111.103 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.32 144.08 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 113.323 -1.762 . . . . 0.58 110.699 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.29 150.28 21.13 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 113.102 0.778 . . . . 2.18 113.102 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.69 -32.97 6.31 Favored Glycine 0 CA--C 1.547 2.053 0 N-CA-C 115.937 1.135 . . . . 1.02 115.937 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -123.5 -78.63 0.6 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.977 0.889 . . . . 2.86 112.412 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -133.16 -44.35 0.85 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.113 0.565 . . . . 3.91 112.132 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.52 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -94.88 158.08 15.64 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.462 1.105 . . . . 1.74 112.447 179.383 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.74 -166.58 0.1 OUTLIER Pre-proline 0 CA--C 1.576 1.97 0 CA-C-N 113.679 -1.601 . . . . 1.68 108.334 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -62.51 -9.78 16.88 Favored 'Trans proline' 0 N--CA 1.523 3.217 0 CA-C-N 123.277 2.206 . . . . 2.06 115.85 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.6 tttp 79.65 -76.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.639 1.976 . . . . 3.0 114.013 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' A' ' 64' ' ' GLU 0.259 3.8 m -108.4 135.24 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-N 119.678 1.126 . . . . 0.8 111.278 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.437 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.5 t -127.8 132.06 49.52 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 113.105 0.78 . . . . 0.87 113.105 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -119.45 49.83 1.31 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.212 2.301 . . . . 0.34 117.212 -175.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.27 138.81 2.9 Favored 'General case' 0 N--CA 1.518 2.965 0 N-CA-C 117.039 2.237 . . . . 0.7 117.039 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -154.69 101.99 2.35 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.476 -0.784 . . . . 0.21 111.038 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.417 HD12 HD12 ' A' ' 85' ' ' LEU 0.32 9.0 tt -111.97 121.7 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 CA-C-O 122.456 1.122 . . . . 0.31 111.369 175.554 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -124.12 164.27 19.79 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.017 -1.447 . . . . 0.44 110.74 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -121.73 159.21 27.09 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 118.225 2.676 . . . . 1.26 118.225 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.85 -41.48 2.14 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-N 110.043 -3.253 . . . . 0.17 118.998 174.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -177.44 154.73 1.03 Allowed 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 120.673 2.236 . . . . 0.15 113.425 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.14 -12.48 59.22 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 125.053 1.341 . . . . 0.17 113.896 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.22 4.9 44.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.959 1.096 . . . . 0.55 113.959 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.82 -16.22 14.37 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 114.065 1.135 . . . . 0.6 114.065 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.581 2.146 0 C-N-CA 124.108 0.963 . . . . 0.95 112.851 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.447 ' HG ' HD11 ' A' ' 27' ' ' ILE . 19.3 tp . . . . . 0 CA--C 1.566 1.577 0 N-CA-C 113.356 0.872 . . . . 0.35 113.356 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.17 -23.38 62.16 Favored 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 125.863 1.665 . . . . 0.2 115.087 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.72 -10.35 53.87 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 113.668 0.988 . . . . 0.32 113.668 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -106.07 -22.02 12.98 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.315 0.858 . . . . 1.73 113.315 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -53.21 135.65 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 N-CA-C 115.288 1.588 . . . . 0.11 115.288 177.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.6 -31.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-N 115.335 -0.848 . . . . 0.16 112.161 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -159.33 117.46 2.81 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.888 0.475 . . . . 0.54 110.751 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.86 128.96 20.87 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.482 -0.761 . . . . 0.19 112.15 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.76 138.68 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 CA-C-O 122.331 1.062 . . . . 1.05 113.183 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -116.17 102.56 9.7 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 113.373 -1.74 . . . . 2.11 106.725 171.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.87 103.87 5.26 Favored 'General case' 0 C--O 1.254 1.34 0 CA-C-O 122.21 1.005 . . . . 0.63 111.363 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 172.54 -57.22 0.16 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 113.153 -1.84 . . . . 0.71 114.937 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.95 -121.96 5.0 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 119.773 -0.459 . . . . 0.8 113.506 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -165.05 117.81 1.21 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.598 0.759 . . . . 1.63 110.809 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 49.35 110.14 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.959 0 N-CA-C 118.406 2.743 . . . . 1.0 118.406 178.045 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.494 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 70.3 t60 -140.95 132.46 26.96 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.026 0.751 . . . . 0.45 113.026 177.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.272 9.8 p -105.95 116.04 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.881 0 CA-C-N 115.178 -0.919 . . . . 1.39 109.531 176.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -87.62 160.94 17.97 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 114.684 -1.143 . . . . 1.85 112.577 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -43.17 -32.05 0.55 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 N-CA-C 119.163 3.023 . . . . 0.72 119.163 -175.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -88.37 -19.66 26.33 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 121.227 0.537 . . . . 0.51 111.474 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.61 40.13 1.25 Allowed Glycine 0 C--N 1.354 1.551 0 C-N-CA 124.722 1.153 . . . . 0.34 114.009 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.447 HD11 ' HG ' ' A' ' 6' ' ' LEU . 14.7 mm -106.84 114.49 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-O 121.124 0.487 . . . . 0.55 110.088 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.8 t-160 -104.45 132.63 50.49 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 115.587 1.699 . . . . 1.34 115.587 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -92.84 143.83 25.88 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 114.733 -1.121 . . . . 2.79 108.135 174.259 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 78.7 mtp180 -62.42 -105.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 116.9 2.185 . . . . 3.0 116.9 -177.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 30' ' ' ARG . 7.0 ttmm 176.23 71.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.549 0.74 . . . . 2.3 111.712 -177.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 56.98 61.68 6.47 Favored Pre-proline 0 N--CA 1.534 3.732 0 C-N-CA 124.196 0.998 . . . . 1.17 113.677 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo . . . . . 0 CA--C 1.56 1.776 0 N-CA-C 120.154 3.098 . . . . 1.45 120.154 -174.509 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo . . . . . 0 N--CA 1.504 2.134 0 N-CA-C 117.048 1.903 . . . . 1.37 117.048 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.65 143.12 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.201 0 CA-C-N 115.041 -0.981 . . . . 0.69 109.444 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.53 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.9 mm? -78.51 -23.52 46.26 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.463 1.653 . . . . 1.28 115.463 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -106.27 20.81 18.4 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.917 1.08 . . . . 1.51 113.917 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.5 p -124.57 175.97 6.83 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.057 0.932 . . . . 1.09 112.913 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.624 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.2 m-20 -97.46 -174.8 0.4 Allowed Pre-proline 0 N--CA 1.507 2.377 0 N-CA-C 107.74 -1.208 . . . . 1.27 107.74 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -70.16 -40.25 4.89 Favored 'Trans proline' 0 N--CA 1.518 2.946 0 CA-C-N 123.165 2.166 . . . . 0.95 111.871 174.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -69.94 -50.98 36.6 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.266 -1.788 . . . . 2.04 111.982 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -75.93 -8.48 57.02 Favored 'General case' 0 CA--C 1.588 2.439 0 CA-C-N 114.789 -1.096 . . . . 1.62 112.81 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.668 HE21 HE21 ' A' ' 62' ' ' GLN . 27.0 tt0 -72.42 -46.32 55.65 Favored 'General case' 0 C--N 1.378 1.835 0 C-N-CA 125.204 1.402 . . . . 1.77 107.962 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.12 -41.68 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 C-N-CA 124.44 1.096 . . . . 0.81 110.417 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.93 -11.48 60.0 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.428 1.27 . . . . 1.15 114.428 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -124.82 20.43 8.44 Favored 'General case' 0 CA--C 1.575 1.906 0 C-N-CA 123.332 0.653 . . . . 0.92 112.494 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.668 HE21 HE21 ' A' ' 58' ' ' GLN . 0.0 OUTLIER -137.95 -27.82 0.89 Allowed 'General case' 0 N--CA 1.51 2.56 0 N-CA-C 115.876 1.806 . . . . 1.33 115.876 -177.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.2 p -77.94 131.17 37.32 Favored 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 113.66 0.985 . . . . 1.28 113.66 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.419 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.6 pt-20 . . . . . 0 N--CA 1.505 2.284 0 N-CA-C 115.5 1.667 . . . . 1.53 115.5 -176.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 110.407 -0.22 . . . . 2.15 110.407 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.701 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.1 OUTLIER 74.8 80.86 0.11 Allowed 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 125.397 1.479 . . . . 0.77 109.895 -177.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -142.84 156.51 44.95 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.284 0.846 . . . . 0.81 113.284 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.73 -161.16 12.48 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.28 -0.873 . . . . 0.47 115.056 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.32 163.66 28.84 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.782 0.801 . . . . 0.89 112.796 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -117.87 131.36 56.55 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.603 -1.18 . . . . 0.51 112.791 -178.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -124.5 99.9 35.72 Favored Pre-proline 0 CA--C 1.566 1.588 0 C-N-CA 123.19 0.596 . . . . 0.15 109.742 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.26 118.1 2.57 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.14 1.894 . . . . 0.15 114.501 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.89 157.35 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 CA-C-O 122.063 0.935 . . . . 0.19 111.369 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -144.97 16.15 1.56 Allowed 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.538 -1.21 . . . . 2.53 111.954 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -128.29 162.47 26.96 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-O 121.334 0.588 . . . . 2.12 111.754 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -120.95 148.8 43.59 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.665 0.987 . . . . 0.42 113.665 -179.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.85 -134.16 3.9 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 113.981 -1.463 . . . . 0.23 111.839 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -121.99 106.66 11.42 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 118.335 1.067 . . . . 1.75 111.231 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.682 ' O ' HG13 ' A' ' 133' ' ' ILE . 36.2 m-85 -99.4 127.8 45.46 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.623 0.725 . . . . 0.21 110.687 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.67 130.13 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 115.31 -0.859 . . . . 0.2 111.848 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.476 ' HG ' HD12 ' A' ' 172' ' ' ILE . 2.6 mp -107.62 110.26 22.1 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.376 -1.283 . . . . 0.78 110.325 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.8 105.52 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.601 -1.259 . . . . 0.44 107.601 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.18 134.97 53.41 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.896 -0.593 . . . . 1.25 112.314 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -104.31 116.01 31.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.806 0.813 . . . . 2.52 111.343 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.67 134.04 48.5 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.067 -1.424 . . . . 0.4 110.256 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.97 153.52 45.63 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.745 -0.661 . . . . 0.41 111.627 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -139.54 131.58 27.92 Favored 'General case' 0 C--N 1.363 1.175 0 CA-C-N 116.031 -0.532 . . . . 2.61 112.221 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.541 ' H ' ' NZ ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -140.96 63.2 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 115.962 -0.563 . . . . 2.13 111.75 179.213 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -162.65 -49.5 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.562 0.579 . . . . 2.27 112.562 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.79 130.84 56.92 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.051 0.453 . . . . 1.46 112.212 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.29 96.11 5.93 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.339 1.066 . . . . 0.84 111.016 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -162.31 146.65 12.18 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.148 -0.933 . . . . 2.45 112.21 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.1 p -122.19 121.22 36.35 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.481 -0.782 . . . . 1.66 111.903 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 75.12 57.26 0.07 Allowed 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 125.893 1.677 . . . . 1.89 112.543 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -156.71 -43.62 0.07 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.284 -1.326 . . . . 2.56 108.983 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -105.41 83.89 2.02 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-O 121.794 0.807 . . . . 2.76 108.98 176.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.06 129.95 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 114.754 -1.112 . . . . 0.69 111.63 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -114.37 170.99 7.89 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.065 1.505 . . . . 0.7 115.065 -176.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.37 137.73 54.76 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.359 0.6 . . . . 1.33 112.337 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -134.18 129.27 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.406 0 CA-C-N 115.34 -0.846 . . . . 0.48 110.236 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.64 147.92 51.49 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 114.536 1.31 . . . . 1.69 114.536 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.79 110.27 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 C-N-CA 123.73 0.812 . . . . 0.6 112.93 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.83 26.64 14.39 Favored 'General case' 0 N--CA 1.523 3.181 0 C-N-CA 126.614 1.966 . . . . 1.12 113.618 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.93 -20.06 39.51 Favored Glycine 0 CA--C 1.547 2.07 0 CA-C-N 116.344 -0.389 . . . . 0.32 113.676 -176.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -83.24 139.04 33.34 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.417 1.487 . . . . 0.57 113.673 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.57 129.73 44.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.603 0.715 . . . . 0.55 112.43 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.19 -54.41 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 114.501 -1.227 . . . . 1.06 113.355 -178.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.57 88.87 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.878 -0.786 . . . . 0.44 108.878 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -112.29 75.57 0.93 Allowed 'General case' 0 C--N 1.356 0.853 0 CA-C-O 123.709 1.718 . . . . 2.3 112.147 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 157.26 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 110.238 -3.165 . . . . 2.48 108.216 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.72 97.88 11.06 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 113.702 1.001 . . . . 1.13 113.702 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -113.52 96.54 5.93 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 113.073 -1.876 . . . . 2.35 107.509 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.22 -26.06 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.56 0 N-CA-C 114.632 1.345 . . . . 0.68 114.632 -176.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -75.71 -39.8 56.75 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.576 0.75 . . . . 0.77 112.003 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -74.03 -26.35 60.37 Favored 'General case' 0 CA--C 1.577 1.989 0 C-N-CA 124.776 1.23 . . . . 0.91 113.17 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -77.98 -56.37 4.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.651 0.982 . . . . 2.43 113.651 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.76 -37.21 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 114.541 1.311 . . . . 0.93 114.541 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.76 -107.62 0.92 Allowed Glycine 0 C--N 1.354 1.528 0 CA-C-N 118.465 0.575 . . . . 0.85 113.426 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -114.95 107.07 14.9 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.588 0.355 . . . . 3.18 110.919 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.1 m 66.69 -127.89 0.21 Allowed 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 125.392 1.477 . . . . 2.08 112.92 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.53 HG22 ' HB2' ' A' ' 51' ' ' LEU . 43.5 p 58.6 -163.32 0.21 Allowed 'General case' 0 N--CA 1.526 3.363 0 C-N-CA 126.365 1.866 . . . . 0.62 115.375 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -109.75 130.19 55.54 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.293 0.637 . . . . 0.46 112.69 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -104.44 135.57 45.62 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.436 -0.579 . . . . 0.38 109.436 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -129.95 128.42 42.08 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.494 1.294 . . . . 2.5 114.494 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -115.01 118.03 32.27 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 114.699 -1.137 . . . . 1.56 110.279 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 114.84 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 114.798 -1.092 . . . . 0.45 110.816 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.13 93.12 42.36 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-N 114.928 -1.033 . . . . 0.84 109.994 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -82.82 136.18 8.12 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.577 2.185 . . . . 0.16 113.27 176.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.682 HG13 ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -120.95 149.93 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.626 0.727 . . . . 0.38 112.228 -179.52 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.1 t -126.1 113.35 16.95 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.079 -0.964 . . . . 1.31 110.959 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.483 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.9 mt -110.94 122.99 66.42 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.605 0 CA-C-N 114.237 -1.347 . . . . 0.25 108.436 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -139.21 126.28 21.16 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.955 -0.566 . . . . 2.05 111.068 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? 67.39 17.26 10.12 Favored 'General case' 0 N--CA 1.516 2.843 0 C-N-CA 125.312 1.445 . . . . 3.55 114.324 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.64 12.68 46.73 Favored Glycine 0 CA--C 1.547 2.041 0 CA-C-O 119.147 -0.807 . . . . 0.37 114.893 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 27.2 mtmt -123.06 148.97 45.01 Favored 'General case' 0 C--N 1.365 1.268 0 CA-C-N 118.35 1.075 . . . . 1.56 112.432 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.19 144.93 30.68 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.635 1.346 . . . . 0.34 114.635 -175.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.51 109.09 8.48 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.903 -1.044 . . . . 0.64 110.445 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.29 92.57 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.627 0 CA-C-N 115.808 -0.633 . . . . 0.46 109.864 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 66.24 -82.1 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.784 0 C-N-CA 125.26 1.424 . . . . 1.56 113.836 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.08 25.03 4.17 Favored Glycine 0 CA--C 1.545 1.969 0 CA-C-N 116.073 -0.512 . . . . 0.49 113.869 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -130.48 118.42 21.1 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 117.339 0.569 . . . . 1.82 110.053 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.1 p -105.91 131.45 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.32 0 CA-C-O 121.721 0.772 . . . . 1.02 112.479 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 m -151.9 -178.69 6.9 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.776 -1.102 . . . . 0.56 109.624 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.261 12.8 t -103.04 139.11 39.01 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 113.57 0.952 . . . . 1.25 113.57 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -80.83 123.89 28.63 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 124.534 1.134 . . . . 0.29 111.427 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.47 90.49 3.23 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.647 0.61 . . . . 1.42 112.647 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.69 -61.75 2.43 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 119.412 2.525 . . . . 0.42 119.412 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.494 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -135.92 157.26 47.28 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.254 1.205 . . . . 1.1 114.254 -176.14 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.494 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 1.0 OUTLIER -103.61 140.05 38.08 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 113.527 -1.67 . . . . 0.67 109.598 176.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.4 t -122.02 132.25 54.42 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.306 1.225 . . . . 0.36 114.306 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.41 97.55 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.021 -1.844 . . . . 0.74 106.021 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.0 132.43 56.71 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.311 -1.313 . . . . 1.67 113.001 -176.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.83 135.93 54.92 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-O 122.448 1.118 . . . . 1.8 111.735 177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.16 143.58 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-N 112.484 -2.144 . . . . 0.58 110.325 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 150.11 26.13 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.509 1.3 . . . . 2.18 114.509 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.32 -47.01 1.17 Allowed Glycine 0 CA--C 1.543 1.84 0 CA-C-N 115.196 -0.911 . . . . 1.02 114.035 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.3 -61.07 1.17 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.9 0.48 . . . . 2.86 111.933 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -129.35 -43.57 1.28 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.757 0.651 . . . . 3.91 112.757 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -107.92 173.81 6.16 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.509 0.724 . . . . 1.74 112.454 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.701 ' ND2' ' H ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -132.07 -58.27 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 CA-C-N 115.975 -0.557 . . . . 1.68 109.994 178.638 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -101.56 -55.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.089 1.859 . . . . 2.06 115.906 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.541 ' NZ ' ' H ' ' A' ' 92' ' ' VAL . 30.4 tttm 81.56 -90.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 127.076 2.15 . . . . 3.0 109.616 -176.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.89 129.11 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 106.976 -1.491 . . . . 0.8 106.976 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.01 123.28 19.36 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 112.98 0.733 . . . . 0.87 112.98 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -116.76 49.67 1.14 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.637 1.575 . . . . 0.34 113.922 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.9 tp -61.47 102.23 0.23 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 122.653 1.216 . . . . 0.7 113.576 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -113.78 100.56 8.55 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 112.556 -2.111 . . . . 0.21 110.008 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.476 HD12 ' HG ' ' A' ' 85' ' ' LEU 0.32 15.8 tt -108.34 121.78 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.155 0 CA-C-O 122.942 1.353 . . . . 0.31 111.945 177.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -121.09 170.47 9.51 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 113.291 -1.777 . . . . 0.44 111.284 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -123.23 158.5 30.73 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 118.45 2.759 . . . . 1.26 118.45 -176.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.72 -41.95 2.01 Favored Glycine 0 CA--C 1.541 1.688 0 CA-C-N 110.465 -3.061 . . . . 0.17 119.208 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.21 157.02 1.31 Allowed 'General case' 0 N--CA 1.515 2.816 0 CA-C-N 120.449 2.125 . . . . 0.15 112.942 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.03 -13.54 59.84 Favored 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 124.917 1.287 . . . . 0.17 114.366 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.97 3.52 48.39 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 113.954 1.094 . . . . 0.55 113.954 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.88 -7.6 17.02 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 113.815 1.043 . . . . 0.6 113.815 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.51 2.544 0 C-N-CA 124.012 0.925 . . . . 0.95 112.804 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.537 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.1 tp . . . . . 0 CA--C 1.565 1.546 0 N-CA-C 113.454 0.909 . . . . 0.35 113.454 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.33 63.48 Favored 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 125.766 1.626 . . . . 0.2 115.105 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.06 -11.63 49.71 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 113.577 0.954 . . . . 0.32 113.577 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -104.15 -23.9 13.23 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 113.298 0.851 . . . . 1.73 113.298 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.62 134.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 115.166 1.543 . . . . 0.11 115.166 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -121.83 -29.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 115.354 -0.839 . . . . 0.16 112.345 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -161.43 116.9 2.09 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 117.698 0.226 . . . . 0.54 111.502 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.42 135.08 31.68 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.258 -0.901 . . . . 0.19 112.503 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 170' ' ' LEU 0.25 11.3 p -149.35 142.91 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 N-CA-C 113.756 1.021 . . . . 1.05 113.756 178.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.602 ' HB2' HD12 ' A' ' 60' ' ' LEU . 65.8 t30 -116.02 117.96 31.56 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.198 -1.408 . . . . 2.11 107.198 173.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -81.73 97.09 7.78 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-O 121.784 0.802 . . . . 0.63 111.251 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.572 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 173.4 -37.67 0.13 Allowed Glycine 0 C--N 1.353 1.486 0 CA-C-N 114.102 -1.408 . . . . 0.71 116.541 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -135.65 -125.6 2.51 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 117.873 0.837 . . . . 0.8 114.318 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.518 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 34.8 mt-10 -150.13 116.34 5.7 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.812 0.445 . . . . 1.63 111.701 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.2 m 31.69 124.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.121 0 N-CA-C 121.036 3.717 . . . . 1.0 121.036 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.456 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 23.3 t60 -149.89 148.51 29.22 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.853 0.835 . . . . 0.45 112.092 176.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.2 126.6 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 114.916 -1.038 . . . . 1.39 111.615 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -85.27 155.73 21.25 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 114.024 -1.443 . . . . 1.85 110.234 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.5 m -44.8 -23.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 N-CA-C 118.943 2.942 . . . . 0.72 118.943 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -95.57 -18.43 20.6 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 122.874 0.47 . . . . 0.51 111.051 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.85 41.06 1.23 Allowed Glycine 0 C--N 1.356 1.668 0 C-N-CA 124.643 1.116 . . . . 0.34 114.462 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.537 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.2 mm -106.06 120.5 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 N-CA-C 109.516 -0.55 . . . . 0.55 109.516 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -102.25 129.18 48.59 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.256 1.206 . . . . 1.34 114.256 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.623 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.3 142.36 27.79 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.299 -0.864 . . . . 2.79 110.596 177.024 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -88.12 168.43 12.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 115.662 1.727 . . . . 3.0 115.662 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -98.91 100.25 11.41 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.19 1.552 . . . . 2.3 115.19 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 36.73 62.46 3.11 Favored Pre-proline 1 N--CA 1.542 4.134 0 N-CA-C 115.85 1.796 . . . . 1.17 115.85 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo . . . . . 0 CA--C 1.564 2.016 0 N-CA-C 119.591 2.881 . . . . 1.45 119.591 -175.537 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo . . . . . 0 N--CA 1.498 1.759 0 N-CA-C 116.335 1.629 . . . . 1.37 116.335 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 61' ' ' TYR 0.251 1.2 mp -89.74 135.64 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.823 0 C-N-CA 124.037 0.935 . . . . 0.69 111.711 -178.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 5.1 mt -104.84 101.93 11.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.901 -1.045 . . . . 1.28 111.305 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER 150.12 -22.1 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.205 1.802 . . . . 1.51 110.891 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.657 ' HG ' ' HD2' ' A' ' 61' ' ' TYR . 2.3 t -101.27 -160.85 0.82 Allowed 'General case' 0 CA--C 1.575 1.929 0 C-N-CA 123.555 0.742 . . . . 1.09 113.0 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -95.51 170.32 7.95 Favored Pre-proline 0 CA--C 1.573 1.838 0 C-N-CA 124.736 1.214 . . . . 1.27 112.569 -179.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -71.98 -34.82 7.99 Favored 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 123.25 2.633 . . . . 0.95 112.835 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -85.25 -36.36 20.97 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.517 -1.22 . . . . 2.04 112.703 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.22 1.59 56.31 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.737 1.384 . . . . 1.62 114.737 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 3.5 pt20 -71.19 -24.4 62.22 Favored 'General case' 0 C--N 1.381 1.945 0 O-C-N 121.822 -0.549 . . . . 1.77 110.369 175.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.35 -47.29 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.872 0 C-N-CA 125.957 1.703 . . . . 0.81 108.853 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' A' ' 15' ' ' ASN . 14.1 tp -73.99 -12.85 60.76 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 113.435 0.902 . . . . 1.15 113.435 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.657 ' HD2' ' HG ' ' A' ' 53' ' ' SER . 26.4 m-85 -122.47 20.53 10.37 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 113.557 0.947 . . . . 0.92 113.557 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.581 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 12.1 tt0 -141.35 -36.48 0.44 Allowed 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 115.474 1.657 . . . . 1.33 115.474 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.2 p -67.81 134.69 51.38 Favored 'General case' 0 N--CA 1.528 3.449 0 N-CA-C 115.272 1.582 . . . . 1.28 115.272 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.572 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 5.8 pt-20 . . . . . 0 N--CA 1.505 2.285 0 C-N-CA 124.195 0.998 . . . . 1.53 112.479 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.427 0.156 . . . . 2.15 111.334 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.24 85.01 0.09 Allowed 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 125.555 1.542 . . . . 0.77 114.397 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -143.52 152.94 42.08 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.531 0.682 . . . . 0.81 112.242 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.24 -153.21 7.44 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 115.653 1.021 . . . . 0.47 115.653 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.79 166.62 22.22 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 115.037 1.495 . . . . 0.89 115.037 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.93 119.32 27.43 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.585 -1.643 . . . . 0.51 111.144 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.48 100.36 53.49 Favored Pre-proline 0 CA--C 1.568 1.645 0 N-CA-C 109.581 -0.526 . . . . 0.15 109.581 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -82.93 116.66 2.5 Favored 'Trans proline' 0 CA--C 1.563 1.926 0 C-N-CA 122.25 1.967 . . . . 0.15 115.103 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.6 157.46 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.926 0.869 . . . . 0.19 111.038 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -143.27 24.01 1.8 Allowed 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 114.648 -1.16 . . . . 2.53 112.084 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -127.84 157.36 40.67 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 121.347 0.594 . . . . 2.12 111.134 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.73 136.65 53.22 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.713 1.005 . . . . 0.42 113.713 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 166.55 -140.17 6.18 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 113.962 -1.472 . . . . 0.23 112.569 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 23.8 mt-10 -112.36 109.02 18.4 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-N 118.473 1.136 . . . . 1.75 111.627 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -103.52 129.77 50.77 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.048 0.451 . . . . 0.21 110.521 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.69 121.72 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.864 0.84 . . . . 0.2 110.795 -176.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.402 ' HG ' HD12 ' A' ' 172' ' ' ILE . 0.3 OUTLIER -100.0 105.59 17.28 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 113.931 -1.486 . . . . 0.78 109.572 177.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -111.9 124.96 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.8 -0.815 . . . . 0.44 108.8 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.94 140.2 43.82 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 112.735 0.643 . . . . 1.25 112.735 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -102.87 120.39 40.52 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.039 -0.982 . . . . 2.52 110.133 177.163 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -105.82 133.27 50.83 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.106 -0.497 . . . . 0.4 110.392 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.37 152.32 50.51 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 112.549 0.574 . . . . 0.41 112.549 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -138.71 119.64 14.35 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 123.662 0.785 . . . . 2.61 111.102 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.18 65.33 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 112.597 0.592 . . . . 2.13 112.597 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -171.3 -37.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 112.982 0.734 . . . . 2.27 112.982 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -115.94 130.81 56.98 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.226 0.454 . . . . 1.46 112.226 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.27 96.93 6.42 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.43 1.11 . . . . 0.84 111.474 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.4 ' NE2' ' NE2' ' A' ' 99' ' ' GLN . 3.4 pt20 -165.37 141.43 5.38 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 114.968 -1.014 . . . . 2.45 112.323 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.5 m -122.41 124.93 44.79 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.382 -0.826 . . . . 1.66 112.436 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 72.59 54.95 0.15 Allowed 'General case' 0 N--CA 1.514 2.725 0 C-N-CA 125.713 1.605 . . . . 1.89 112.523 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.4 ' NE2' ' NE2' ' A' ' 96' ' ' GLN . 4.4 tt0 -157.31 -38.43 0.07 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.803 -1.089 . . . . 2.56 109.974 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -106.9 81.79 1.61 Allowed 'General case' 0 C--N 1.362 1.152 0 N-CA-C 108.384 -0.969 . . . . 2.76 108.384 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.88 122.76 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 114.331 -1.304 . . . . 0.69 111.306 -177.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -106.57 175.73 5.4 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 115.572 1.693 . . . . 0.7 115.572 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -126.03 137.27 53.64 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.343 0.592 . . . . 1.33 110.941 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.21 123.76 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.511 0 CA-C-N 115.237 -0.892 . . . . 0.48 109.366 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.644 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 26.3 mtt180 -123.26 148.64 45.68 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.981 1.475 . . . . 1.69 114.981 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 6.4 m -123.81 107.8 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 N-CA-C 113.437 0.903 . . . . 0.6 113.437 177.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.587 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.9 t30 63.81 27.32 14.56 Favored 'General case' 0 N--CA 1.519 2.988 0 C-N-CA 126.845 2.058 . . . . 1.12 114.456 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.87 -14.86 45.06 Favored Glycine 0 CA--C 1.55 2.264 0 CA-C-N 115.574 -0.739 . . . . 0.32 113.612 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.644 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 94.6 m-70 -87.49 171.15 10.74 Favored 'General case' 0 C--N 1.361 1.088 0 C-N-CA 125.953 1.701 . . . . 0.57 113.166 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.01 132.72 54.67 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.546 0.689 . . . . 0.55 112.015 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.61 -58.96 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.82 -1.082 . . . . 1.06 113.324 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.22 89.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.627 -0.879 . . . . 0.44 108.627 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -106.97 101.51 10.93 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 122.881 1.324 . . . . 2.3 110.283 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 114.25 74.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 110.542 -3.026 . . . . 2.48 108.898 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.2 105.8 18.01 Favored 'General case' 0 C--N 1.361 1.084 0 CA-C-O 121.612 0.72 . . . . 1.13 112.593 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -115.07 97.4 6.19 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 106.678 -1.601 . . . . 2.35 106.678 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.06 -26.77 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.479 0 N-CA-C 114.028 1.122 . . . . 0.68 114.028 -176.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -76.22 -38.83 55.93 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.629 0.771 . . . . 0.77 112.095 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -72.95 -26.74 61.48 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.847 1.259 . . . . 0.91 113.296 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -80.5 -56.25 4.3 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.767 1.025 . . . . 2.43 113.767 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.73 -36.04 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 N-CA-C 114.592 1.33 . . . . 0.93 114.592 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.2 -110.04 1.37 Allowed Glycine 0 C--N 1.354 1.581 0 CA-C-N 118.35 0.523 . . . . 0.85 113.417 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -114.84 107.46 15.45 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.841 0.353 . . . . 3.18 110.243 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 69.42 -133.69 0.07 Allowed 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 125.345 1.458 . . . . 2.08 112.614 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.3 p 62.15 -163.38 0.26 Allowed 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 126.222 1.809 . . . . 0.62 114.578 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.8 130.94 56.4 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 112.899 0.703 . . . . 0.46 112.899 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -101.66 147.21 26.71 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.262 -0.644 . . . . 0.38 109.262 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.6 124.68 25.79 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.994 1.479 . . . . 2.5 114.994 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -124.18 121.91 36.38 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 115.247 -0.888 . . . . 1.56 110.305 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.83 128.48 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 114.27 -1.332 . . . . 0.45 111.545 -178.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.21 93.77 19.03 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-N 115.637 -0.711 . . . . 0.84 111.187 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -76.55 133.3 14.19 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 122.672 2.248 . . . . 0.16 113.103 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.62 148.81 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.592 0 CA-C-N 115.553 -0.749 . . . . 0.38 111.474 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.8 p -130.52 107.16 9.01 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.392 -0.822 . . . . 1.31 111.82 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 mt -109.65 121.71 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 N-CA-C 108.518 -0.919 . . . . 0.25 108.518 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -143.1 130.72 21.29 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.681 -0.69 . . . . 2.05 110.964 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp 69.8 7.87 6.44 Favored 'General case' 0 N--CA 1.519 3.016 0 N-CA-C 114.684 1.364 . . . . 3.55 114.684 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.14 22.22 13.63 Favored Glycine 0 CA--C 1.548 2.128 0 C-N-CA 123.633 0.635 . . . . 0.37 113.802 -177.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -130.52 144.83 51.66 Favored 'General case' 0 C--N 1.366 1.299 0 CA-C-N 117.548 0.674 . . . . 1.56 112.128 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.75 141.11 32.99 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.912 1.078 . . . . 0.34 113.912 -177.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.0 m -130.97 115.36 16.4 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.664 -1.153 . . . . 0.64 110.656 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.45 95.14 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.372 0 CA-C-O 121.101 0.477 . . . . 0.46 110.728 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 67.26 -85.24 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 125.546 1.538 . . . . 1.56 113.558 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.36 27.74 4.41 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.011 -0.541 . . . . 0.49 113.404 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -131.38 128.4 39.52 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.444 0.698 . . . . 1.82 110.77 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.8 p -118.29 130.01 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.343 0 CA-C-O 121.333 0.587 . . . . 1.02 111.185 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.8 m -149.85 -170.63 3.69 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.487 -0.778 . . . . 0.56 110.446 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 11.4 t -101.76 141.42 34.65 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 112.792 0.664 . . . . 1.25 112.792 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -87.91 132.63 34.14 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.985 0.898 . . . . 0.29 111.815 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.9 p -97.34 -164.3 1.13 Allowed 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 114.046 -1.433 . . . . 1.42 109.395 177.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.59 7.52 68.79 Favored Glycine 0 CA--C 1.56 2.876 0 N-CA-C 116.937 1.535 . . . . 0.42 116.937 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -160.11 152.53 20.86 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-O 121.7 0.762 . . . . 1.1 111.421 178.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.587 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -109.3 136.09 49.32 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.307 -1.315 . . . . 0.67 109.236 177.405 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.5 t -117.82 144.11 45.67 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.671 1.73 . . . . 0.36 115.671 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.1 t -118.44 97.58 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.087 -1.82 . . . . 0.74 106.087 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -114.12 121.48 43.93 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 115.905 -0.589 . . . . 1.67 112.46 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.73 132.1 56.55 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-O 122.062 0.934 . . . . 1.8 111.238 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 14.0 t -107.25 143.74 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.991 0 CA-C-N 113.341 -1.754 . . . . 0.58 110.01 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 163' ' ' ASP . 34.4 ttpt -71.49 149.98 45.3 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.939 1.696 . . . . 2.18 114.665 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.1 -55.26 0.73 Allowed Glycine 0 CA--C 1.542 1.778 0 CA-C-N 115.26 -0.882 . . . . 1.02 114.378 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -130.18 -71.34 0.6 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.301 0.551 . . . . 2.86 112.306 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.36 -44.7 2.66 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.513 0.561 . . . . 3.91 112.513 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.508 ' O ' ' HG3' ' A' ' 159' ' ' LYS . 0.8 OUTLIER -98.99 171.24 8.17 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.773 0.829 . . . . 1.74 111.46 178.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . 0.285 56.7 t-20 -125.75 -93.15 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.451 0 CA-C-O 116.715 -1.612 . . . . 1.68 109.993 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -87.1 -36.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.389 2.686 0 CA-C-N 124.851 2.768 . . . . 2.06 114.757 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.2 tptm 80.29 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 126.2 1.8 . . . . 3.0 110.543 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.534 HG22 ' HB3' ' A' ' 64' ' ' GLU . 36.2 t -115.2 131.5 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.358 -1.349 . . . . 0.8 107.358 175.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.1 t -136.21 124.96 23.87 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.489 -0.778 . . . . 0.87 112.196 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -115.27 51.46 0.92 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 116.366 1.988 . . . . 0.34 116.366 -176.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 2.8 mm? -43.65 131.54 5.19 Favored 'General case' 0 N--CA 1.519 2.999 0 N-CA-C 116.368 1.988 . . . . 0.7 116.368 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -154.45 104.04 2.54 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.825 -0.625 . . . . 0.21 110.283 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.402 HD12 ' HG ' ' A' ' 85' ' ' LEU 0.307 6.2 tt -114.47 123.11 69.83 Favored 'Isoleucine or valine' 0 C--O 1.268 2.064 0 CA-C-O 122.125 0.964 . . . . 0.31 111.825 176.076 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -119.53 168.19 11.24 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.191 -1.368 . . . . 0.44 112.17 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -118.48 146.42 44.52 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 118.06 2.615 . . . . 1.26 118.06 -173.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.69 -41.02 2.26 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-N 110.605 -2.998 . . . . 0.17 120.264 172.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.45 159.5 1.95 Allowed 'General case' 0 N--CA 1.517 2.904 0 CA-C-N 120.951 2.375 . . . . 0.15 113.239 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -77.73 -14.17 59.68 Favored 'General case' 0 CA--C 1.582 2.185 0 C-N-CA 124.784 1.234 . . . . 0.17 114.227 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.02 2.6 51.43 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 113.957 1.095 . . . . 0.55 113.957 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.8 -8.73 21.42 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.761 1.023 . . . . 0.6 113.761 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.386 0 C-N-CA 124.035 0.934 . . . . 0.95 112.576 178.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.649 ' HG ' HD11 ' A' ' 27' ' ' ILE . 29.2 tp . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 112.116 0.413 . . . . 0.35 112.116 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.05 -22.91 67.18 Favored 'General case' 0 CA--C 1.583 2.248 0 C-N-CA 125.663 1.585 . . . . 0.2 114.029 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.9 -11.9 49.32 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 113.606 0.965 . . . . 0.32 113.606 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 31.2 mttm -108.16 -19.33 13.52 Favored 'General case' 0 C--N 1.364 1.233 0 N-CA-C 113.716 1.006 . . . . 1.73 113.716 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.32 136.65 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.866 0 N-CA-C 114.967 1.469 . . . . 0.11 114.967 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.76 -31.33 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 115.295 -0.866 . . . . 0.16 111.998 178.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -161.05 119.53 2.47 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 111.954 0.353 . . . . 0.54 111.954 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -139.81 129.66 24.72 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.673 -0.642 . . . . 0.19 111.366 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.61 140.75 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.764 0.793 . . . . 1.05 112.524 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.591 ' HB2' HD12 ' A' ' 60' ' ' LEU . 3.0 t-20 -114.43 110.24 19.55 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 106.599 -1.63 . . . . 2.11 106.599 172.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.53 94.63 3.18 Favored 'General case' 0 C--O 1.274 2.386 0 CA-C-O 122.217 1.008 . . . . 0.63 110.859 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 159.27 -0.08 0.08 OUTLIER Glycine 0 C--N 1.362 2.008 0 CA-C-N 110.943 -2.844 . . . . 0.71 117.983 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.52 -136.22 1.97 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-N 120.635 2.218 . . . . 0.8 117.273 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -129.09 134.75 48.21 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 113.861 -1.17 . . . . 1.63 111.218 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 26.2 m -14.14 122.28 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.958 0 N-CA-C 119.556 3.169 . . . . 1.0 119.556 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -140.83 141.91 34.65 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.132 0.968 . . . . 0.45 112.446 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.259 10.0 p -106.01 119.4 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 CA-C-N 114.063 -1.426 . . . . 1.39 110.36 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -86.72 169.04 13.0 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 114.77 -1.105 . . . . 1.85 113.451 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -39.61 -52.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 C-N-CA 129.222 3.009 . . . . 0.72 117.458 -174.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.432 ' HB2' HD23 ' A' ' 6' ' ' LEU . 63.1 m-70 -75.82 -20.59 58.05 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 112.888 0.699 . . . . 0.51 112.888 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.8 44.36 0.76 Allowed Glycine 0 C--N 1.355 1.625 0 N-CA-C 115.194 0.838 . . . . 0.34 115.194 176.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.649 HD11 ' HG ' ' A' ' 6' ' ' LEU . 33.5 mm -108.51 125.12 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 N-CA-C 110.088 -0.338 . . . . 0.55 110.088 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -108.35 128.09 54.46 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 114.461 1.282 . . . . 1.34 114.461 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -94.24 150.1 20.62 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 124.419 1.088 . . . . 2.79 110.604 177.366 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -105.88 147.3 28.88 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.574 1.324 . . . . 3.0 114.574 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -68.76 108.44 3.42 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 117.535 2.42 . . . . 2.3 117.535 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.405 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 0.6 OUTLIER 39.85 54.42 5.9 Favored Pre-proline 0 N--CA 1.525 3.316 0 N-CA-C 118.767 2.877 . . . . 1.17 118.767 175.077 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 0.5 OUTLIER . . . . . 0 CA--C 1.566 2.113 0 C-N-CA 123.014 2.476 . . . . 1.45 116.174 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo . . . . . 0 N--CA 1.509 2.409 0 N-CA-C 116.317 1.622 . . . . 1.37 116.317 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.295 1.2 mp -86.84 121.05 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-O 121.818 0.818 . . . . 0.69 109.866 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.534 ' HB2' HG22 ' A' ' 125' ' ' THR . 4.7 mt -76.67 -14.47 59.96 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.191 2.293 . . . . 1.28 117.191 -175.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -99.96 15.73 26.2 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.151 0.797 . . . . 1.51 113.151 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.501 ' HG ' ' HD2' ' A' ' 61' ' ' TYR . 1.9 t -132.31 -159.58 0.98 Allowed 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 121.659 0.742 . . . . 1.09 111.773 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.11 168.75 9.72 Favored Pre-proline 0 CA--C 1.569 1.706 0 C-N-CA 125.11 1.364 . . . . 1.27 113.077 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -72.58 -30.29 12.25 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 123.266 2.644 . . . . 0.95 113.34 176.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -85.32 -38.54 18.68 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.685 1.194 . . . . 2.04 112.272 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.39 1.83 56.84 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 114.574 1.324 . . . . 1.62 114.574 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -68.36 -30.11 68.98 Favored 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 123.964 0.906 . . . . 1.77 110.999 176.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.37 -48.17 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.035 0 C-N-CA 126.03 1.732 . . . . 0.81 109.054 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' ' 15' ' ' ASN . 17.6 tp -71.54 -13.34 61.77 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 113.952 1.093 . . . . 1.15 113.952 177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.501 ' HD2' ' HG ' ' A' ' 53' ' ' SER . 29.4 m-85 -123.23 21.69 9.56 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 113.233 0.827 . . . . 0.92 113.233 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.5 -32.72 0.49 Allowed 'General case' 0 N--CA 1.513 2.679 0 N-CA-C 116.03 1.863 . . . . 1.33 116.03 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.409 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 17.8 p -70.98 136.68 48.55 Favored 'General case' 0 N--CA 1.535 3.807 0 N-CA-C 115.008 1.485 . . . . 1.28 115.008 -177.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.455 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.3 pt-20 . . . . . 0 N--CA 1.508 2.438 0 N-CA-C 115.662 1.726 . . . . 1.53 115.662 -176.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.435 0.636 . . . . 2.15 111.527 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 1.6 t -88.51 97.83 11.3 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.18 0.992 . . . . 0.77 108.477 175.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -136.75 146.11 45.4 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.181 1.178 . . . . 0.81 114.181 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.04 -173.07 38.53 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 114.262 -1.335 . . . . 0.47 115.325 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.55 162.63 12.88 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.599 1.333 . . . . 0.89 114.599 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -120.98 124.74 45.62 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.181 -1.372 . . . . 0.51 110.825 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.07 101.87 54.35 Favored Pre-proline 0 CA--C 1.564 1.514 0 CA-C-N 115.487 -0.779 . . . . 0.15 110.305 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.41 122.67 3.68 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 121.831 1.687 . . . . 0.15 114.862 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.42 163.45 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-N 114.986 -1.006 . . . . 0.19 110.899 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -151.82 24.51 0.67 Allowed 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 114.534 -1.212 . . . . 2.53 111.666 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -133.24 156.85 46.79 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 123.09 0.556 . . . . 2.12 111.111 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.5 OUTLIER -118.06 145.39 44.86 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.523 0.934 . . . . 0.42 113.523 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.44 -136.48 4.43 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.189 -1.369 . . . . 0.23 112.191 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 38.3 mm-40 -116.91 106.67 13.7 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 118.292 1.046 . . . . 1.75 110.927 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -100.99 132.19 46.52 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.295 0.569 . . . . 0.21 110.994 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.7 122.98 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 121.709 0.766 . . . . 0.2 110.947 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.66 106.11 16.52 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.063 -1.426 . . . . 0.78 109.885 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.39 122.67 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.625 -0.509 . . . . 0.44 109.625 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.24 144.16 49.59 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.029 0.751 . . . . 1.25 113.029 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 4.5 tppt? -106.66 123.33 47.96 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.448 -0.796 . . . . 2.52 110.848 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 16.9 m-85 -106.15 135.48 47.54 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.733 -0.667 . . . . 0.4 110.444 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.82 149.67 42.32 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 116.016 -0.538 . . . . 0.41 111.944 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -148.13 121.52 9.05 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 123.167 0.587 . . . . 2.61 110.724 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.26 72.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 112.24 0.459 . . . . 2.13 112.24 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.14 -42.51 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.734 0.642 . . . . 2.27 112.734 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -117.54 131.85 56.63 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.61 0.596 . . . . 1.46 112.61 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -110.57 97.46 6.89 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 122.402 1.096 . . . . 0.84 111.12 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -160.67 142.03 12.09 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.982 -1.008 . . . . 2.45 112.054 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.8 m -122.16 124.06 42.98 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.596 -0.729 . . . . 1.66 112.331 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 73.07 53.38 0.13 Allowed 'General case' 0 N--CA 1.512 2.629 0 C-N-CA 125.721 1.609 . . . . 1.89 112.148 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -152.31 -41.85 0.11 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.541 1.136 . . . . 2.56 110.025 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -106.9 82.26 1.67 Allowed 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.794 -0.817 . . . . 2.76 108.794 177.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.34 126.01 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.605 -1.18 . . . . 0.69 111.23 -177.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -113.86 176.99 4.79 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.404 1.631 . . . . 0.7 115.404 -175.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -125.32 139.13 53.96 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 121.897 0.856 . . . . 1.33 111.489 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.01 126.84 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.071 0 CA-C-N 114.181 -1.372 . . . . 0.48 110.103 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -131.27 142.52 50.15 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.229 1.566 . . . . 1.69 115.229 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.2 m -113.74 106.34 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 113.882 -1.508 . . . . 0.6 112.199 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 65.21 25.87 12.32 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 126.479 1.912 . . . . 1.12 113.367 -177.207 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.62 -10.82 56.29 Favored Glycine 0 CA--C 1.555 2.552 0 CA-C-N 116.055 -0.52 . . . . 0.32 114.121 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -94.93 130.11 41.69 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 125.394 1.477 . . . . 0.57 113.457 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -90.74 133.97 34.77 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 122.481 1.134 . . . . 0.55 113.562 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.24 -47.42 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 112.818 -1.992 . . . . 1.06 112.163 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.19 89.14 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.27 -1.011 . . . . 0.44 108.27 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -111.03 74.92 0.89 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-O 123.334 1.54 . . . . 2.3 110.994 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 156.06 64.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 110.429 -3.078 . . . . 2.48 108.445 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.18 100.81 12.55 Favored 'General case' 0 C--N 1.36 1.056 0 N-CA-C 114.032 1.123 . . . . 1.13 114.032 -178.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.56 101.49 8.65 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 112.815 -1.993 . . . . 2.35 106.706 175.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.63 -29.4 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.48 0 C-N-CA 124.605 1.162 . . . . 0.68 114.114 -176.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -76.94 -37.34 55.48 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.341 0.656 . . . . 0.77 112.403 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -74.21 -26.44 60.26 Favored 'General case' 0 CA--C 1.576 1.946 0 C-N-CA 124.557 1.143 . . . . 0.91 113.195 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -78.55 -56.26 4.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.327 0.862 . . . . 2.43 113.327 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.79 -39.88 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 N-CA-C 113.998 1.11 . . . . 0.93 113.998 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.85 -67.3 0.24 Allowed Glycine 0 C--N 1.358 1.777 0 CA-C-N 118.269 0.486 . . . . 0.85 114.162 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -106.49 173.91 6.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.946 0.899 . . . . 3.18 112.161 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 m -75.95 84.13 2.86 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.281 0.845 . . . . 2.08 113.281 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 51' ' ' LEU . 23.4 p -135.7 -137.05 0.15 Allowed 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 114.414 -1.266 . . . . 0.62 109.127 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -115.96 132.69 56.57 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 113.315 0.857 . . . . 0.46 113.315 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.452 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 7.4 t60 -108.37 138.2 45.06 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.109 -0.701 . . . . 0.38 109.109 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -141.49 130.95 23.78 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.696 0.998 . . . . 2.5 113.696 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -120.2 130.68 54.66 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-N 114.498 -1.228 . . . . 1.56 110.87 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.51 124.14 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 114.455 -1.248 . . . . 0.45 110.629 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.49 94.23 26.84 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-N 115.619 -0.719 . . . . 0.84 110.859 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -74.65 139.32 25.13 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.977 2.452 . . . . 0.16 113.481 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.95 150.75 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.492 0 CA-C-O 121.654 0.74 . . . . 0.38 111.216 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.2 p -132.29 112.69 12.44 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.268 -0.878 . . . . 1.31 111.323 178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.6 mt -112.01 123.18 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 108.505 -0.924 . . . . 0.25 108.505 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -139.24 127.99 23.35 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.102 -0.954 . . . . 2.05 110.88 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? 66.05 15.52 10.11 Favored 'General case' 0 N--CA 1.517 2.89 0 N-CA-C 114.88 1.437 . . . . 3.55 114.88 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.53 19.52 24.95 Favored Glycine 0 CA--C 1.55 2.271 0 CA-C-O 119.315 -0.714 . . . . 0.37 114.709 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 25.0 mtpp -126.77 141.83 51.72 Favored 'General case' 0 C--N 1.366 1.301 0 CA-C-N 118.181 0.991 . . . . 1.56 112.2 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.68 136.85 39.9 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.487 0.921 . . . . 0.34 113.487 -177.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.4 t -133.63 120.84 21.2 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.71 -0.677 . . . . 0.64 111.843 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 p -105.47 95.05 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.674 0 CA-C-N 114.965 -1.016 . . . . 0.46 110.087 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 69.46 -81.66 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 125.4 1.48 . . . . 1.56 113.34 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -129.71 23.43 4.75 Favored Glycine 0 CA--C 1.544 1.899 0 CA-C-N 116.092 -0.504 . . . . 0.49 113.685 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -125.04 121.92 35.74 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.33 0.652 . . . . 1.82 110.78 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.8 134.24 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.466 0.65 . . . . 1.02 111.843 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 m -149.54 -170.27 3.59 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.918 -1.037 . . . . 0.56 110.74 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.24 138.14 38.66 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.394 0.887 . . . . 1.25 113.394 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -94.45 119.88 33.84 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.493 -0.776 . . . . 0.29 109.036 175.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.89 92.24 3.1 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.335 0.588 . . . . 1.42 112.092 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.92 -71.51 2.98 Favored Glycine 0 C--N 1.358 1.779 0 N-CA-C 116.954 1.542 . . . . 0.42 116.954 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.78 171.94 12.9 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 123.285 1.517 . . . . 1.1 114.577 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.496 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -110.28 126.39 54.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 111.31 -2.677 . . . . 0.67 107.439 176.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . 0.457 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.6 t -117.18 122.23 43.45 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 118.309 -1.357 . . . . 0.36 114.287 -175.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.79 101.36 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 114.676 -1.147 . . . . 0.74 108.407 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -133.28 143.72 49.25 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.05 -0.977 . . . . 1.67 111.386 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -115.59 142.5 46.64 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 114.546 -1.206 . . . . 1.8 112.72 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -102.73 137.0 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.247 -1.797 . . . . 0.58 108.778 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -81.82 148.82 28.66 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 115.135 1.532 . . . . 2.18 115.135 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -104.37 -29.94 5.2 Favored Glycine 0 CA--C 1.545 1.922 0 CA-C-N 114.675 -1.148 . . . . 1.02 114.143 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -128.49 -80.54 0.58 Allowed 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 117.258 0.529 . . . . 2.86 110.919 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -171.88 48.92 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.87 0.468 . . . . 3.91 112.036 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -160.04 -43.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.605 0.965 . . . . 1.74 113.605 -178.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 1.3 m-20 84.17 -173.16 0.02 OUTLIER Pre-proline 0 N--CA 1.511 2.607 0 C-N-CA 124.493 1.117 . . . . 1.68 110.461 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -64.43 -19.19 65.1 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.586 2.191 . . . . 2.06 115.74 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 31.0 tptt 82.69 -67.1 0.09 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 126.025 1.73 . . . . 3.0 115.045 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 45.0 t -100.2 131.03 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 119.062 0.846 . . . . 0.8 110.034 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.3 t -134.06 126.8 30.9 Favored 'General case' 0 C--N 1.367 1.342 0 O-C-N 124.074 0.859 . . . . 0.87 111.635 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.256 . . -115.03 51.1 0.93 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.43 2.011 . . . . 0.34 116.43 -176.194 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.84 128.18 8.65 Favored 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.702 1.601 . . . . 0.7 115.053 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -149.14 98.17 2.78 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.777 -1.102 . . . . 0.21 109.294 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.319 8.4 tt -112.9 122.68 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.808 0 CA-C-O 122.84 1.305 . . . . 0.31 112.276 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -123.56 167.61 13.7 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 113.094 -1.866 . . . . 0.44 111.131 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.9 ptmt -122.19 159.49 27.14 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 118.223 2.675 . . . . 1.26 118.223 -175.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.38 -42.53 1.87 Allowed Glycine 0 CA--C 1.542 1.781 0 CA-C-N 110.041 -3.254 . . . . 0.17 118.779 174.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.37 153.92 0.78 Allowed 'General case' 0 N--CA 1.52 3.038 0 CA-C-N 120.296 2.048 . . . . 0.15 112.94 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.79 -20.74 58.0 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 114.742 1.386 . . . . 0.17 114.742 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.36 4.68 45.33 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.007 1.114 . . . . 0.55 114.007 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.57 3.3 16.65 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.389 1.255 . . . . 0.6 114.389 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . 0.257 1.6 m . . . . . 0 N--CA 1.525 3.298 0 N-CA-C 116.856 2.169 . . . . 0.95 116.856 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.649 ' HG ' HD11 ' A' ' 27' ' ' ILE . 21.2 tp . . . . . 0 CA--C 1.564 1.483 0 N-CA-C 113.145 0.794 . . . . 0.35 113.145 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.57 -23.81 64.94 Favored 'General case' 0 N--CA 1.506 2.331 0 C-N-CA 125.506 1.522 . . . . 0.2 114.414 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.89 -9.92 54.59 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 113.606 0.965 . . . . 0.32 113.606 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 48.8 mmtt -104.47 -27.02 12.16 Favored 'General case' 0 C--N 1.364 1.23 0 N-CA-C 113.327 0.862 . . . . 1.73 113.327 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.33 137.01 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.077 0 N-CA-C 115.764 1.764 . . . . 0.11 115.764 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pt -122.06 -30.09 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 115.559 -0.746 . . . . 0.16 112.409 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -164.36 116.7 1.32 Allowed 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 120.654 0.264 . . . . 0.54 111.302 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.98 136.42 38.5 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.602 -0.686 . . . . 0.19 111.719 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.518 HG21 ' HG3' ' A' ' 33' ' ' PRO 0.304 14.9 p -150.02 137.65 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.555 0 N-CA-C 115.796 1.776 . . . . 1.05 115.796 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 59.2 t30 -114.18 111.34 21.4 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-N 115.264 -0.88 . . . . 2.11 108.726 174.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.96 106.8 13.25 Favored 'General case' 0 C--O 1.271 2.211 0 CA-C-O 121.455 0.645 . . . . 0.63 110.323 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.512 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 171.92 -61.42 0.16 Allowed Glycine 0 C--N 1.362 1.998 0 CA-C-N 112.445 -2.161 . . . . 0.71 114.358 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.01 -110.45 3.37 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 114.371 0.508 . . . . 0.8 114.371 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -170.92 117.85 0.48 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.834 0.454 . . . . 1.63 111.782 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.1 m 43.95 114.38 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.368 0 N-CA-C 119.235 3.05 . . . . 1.0 119.235 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 80.2 t60 -144.97 139.81 27.77 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 113.399 0.888 . . . . 0.45 113.399 177.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.267 8.2 p -106.02 114.23 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 CA-C-N 115.015 -0.993 . . . . 1.39 110.124 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -84.59 162.7 19.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.776 -1.102 . . . . 1.85 113.12 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 m -41.38 -28.79 0.18 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.266 0 N-CA-C 119.868 3.285 . . . . 0.72 119.868 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -90.15 -19.76 23.88 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.856 0.753 . . . . 0.51 111.87 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.65 39.32 1.47 Allowed Glycine 0 C--N 1.353 1.517 0 C-N-CA 124.443 1.021 . . . . 0.34 113.868 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.649 HD11 ' HG ' ' A' ' 6' ' ' LEU . 30.1 mm -106.83 124.91 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 C-N-CA 123.096 0.558 . . . . 0.55 109.597 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.1 t60 -110.26 130.7 55.5 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 114.656 1.354 . . . . 1.34 114.656 -178.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -84.15 136.74 33.86 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 124.479 1.111 . . . . 2.79 110.413 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.89 100.34 12.82 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 124.78 1.3 . . . . 3.0 114.266 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -38.79 110.96 0.15 Allowed 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 128.133 2.573 . . . . 2.3 117.846 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 46.34 76.16 0.58 Allowed Pre-proline 0 N--CA 1.525 3.317 0 N-CA-C 117.099 2.259 . . . . 1.17 117.099 177.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.518 ' HG3' HG21 ' A' ' 14' ' ' VAL . 68.3 Cg_endo . . . . . 0 CA--C 1.56 1.803 0 N-CA-C 117.584 2.109 . . . . 1.45 117.584 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 51.1 Cg_exo . . . . . 0 N--CA 1.503 2.059 0 N-CA-C 117.196 1.96 . . . . 1.37 117.196 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.279 1.2 mp -89.65 125.91 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.12 0 CA-C-N 114.98 -1.009 . . . . 0.69 109.277 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.39 -19.01 43.53 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.478 2.029 . . . . 1.28 116.478 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.38 24.66 7.79 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 113.957 1.095 . . . . 1.51 113.957 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.36 -175.07 4.57 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-O 121.451 0.643 . . . . 1.09 111.7 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.788 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.56 -176.87 0.58 Allowed Pre-proline 0 N--CA 1.511 2.588 0 C-N-CA 123.985 0.914 . . . . 1.27 109.198 177.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -68.86 -39.95 7.6 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.48 2.12 . . . . 0.95 113.719 176.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -68.88 -49.18 60.43 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 125.298 1.439 . . . . 2.04 112.549 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -6.57 58.76 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-N 114.921 -1.036 . . . . 1.62 112.57 177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.788 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 22.1 tt0 -73.54 -40.49 63.93 Favored 'General case' 0 C--N 1.381 1.952 0 C-N-CA 125.278 1.431 . . . . 1.77 108.075 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.5 t -61.35 -44.57 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.068 0 C-N-CA 124.353 1.061 . . . . 0.81 109.094 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.9 tp -75.97 -11.91 60.04 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 114.77 1.396 . . . . 1.15 114.77 177.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -124.22 22.16 8.66 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 123.672 0.789 . . . . 0.92 112.534 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -143.89 -27.4 0.53 Allowed 'General case' 0 N--CA 1.52 3.032 0 N-CA-C 115.813 1.783 . . . . 1.33 115.813 -177.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 p -75.29 130.82 39.72 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 113.614 0.968 . . . . 1.28 113.614 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.512 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.246 0 N-CA-C 115.306 1.595 . . . . 1.53 115.306 -176.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.45 -0.574 . . . . 2.15 109.45 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.626 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.3 OUTLIER 75.58 79.49 0.1 Allowed 'General case' 0 N--CA 1.515 2.778 0 C-N-CA 125.083 1.353 . . . . 0.77 109.963 -177.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -135.44 141.31 45.39 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.276 -0.875 . . . . 0.81 113.13 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -134.48 174.36 21.02 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 116.62 1.408 . . . . 0.47 116.62 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -113.94 156.55 23.8 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 113.814 -1.193 . . . . 0.89 113.375 -177.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.83 125.4 47.44 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.024 -0.989 . . . . 0.51 111.904 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.77 102.69 38.09 Favored Pre-proline 0 CA--C 1.566 1.561 0 CA-C-N 115.458 -0.792 . . . . 0.15 108.957 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -84.0 117.53 2.26 Favored 'Trans proline' 0 CA--C 1.562 1.884 0 C-N-CA 122.155 1.903 . . . . 0.15 114.44 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.05 157.48 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 CA-C-O 122.068 0.937 . . . . 0.19 111.511 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -144.46 14.66 1.61 Allowed 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 114.542 -1.208 . . . . 2.53 112.61 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -125.04 172.88 9.09 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-N 118.711 0.687 . . . . 2.12 112.489 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -130.83 144.05 51.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.814 0.816 . . . . 0.42 112.822 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.1 -135.4 4.29 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.436 -1.256 . . . . 0.23 112.322 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.574 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 40.6 mm-40 -114.12 112.56 23.4 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 118.039 0.92 . . . . 1.75 111.266 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -104.64 133.57 49.26 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 122.075 -0.391 . . . . 0.21 110.826 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -118.66 124.04 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.703 0.763 . . . . 0.2 111.202 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.48 110.5 22.45 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.168 -1.378 . . . . 0.78 110.699 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 0.2 OUTLIER -119.22 129.09 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 115.266 -0.879 . . . . 0.44 108.707 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.28 137.4 46.01 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.117 0.784 . . . . 1.25 113.117 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 127' ' ' HIS . 3.0 tppt? -101.69 114.06 27.77 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.759 -0.655 . . . . 2.52 109.907 176.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 11.6 m-85 -103.63 134.46 46.94 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.381 -0.827 . . . . 0.4 110.339 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.44 151.54 47.53 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.629 -0.714 . . . . 0.41 111.253 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -128.16 142.93 51.04 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-O 121.271 0.558 . . . . 2.61 112.254 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.18 -36.02 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 115.59 -0.732 . . . . 2.13 112.678 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.62 142.04 51.43 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.192 0.597 . . . . 2.27 111.707 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 92.75 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 126.477 1.911 . . . . 1.46 111.248 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.17 85.39 2.65 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-O 123.002 1.382 . . . . 0.84 111.529 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -151.17 145.04 25.15 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.318 -1.31 . . . . 2.45 112.292 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.1 m -120.84 120.27 35.08 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.507 -0.769 . . . . 1.66 112.223 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 72.33 56.64 0.15 Allowed 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 125.899 1.68 . . . . 1.89 112.531 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -157.19 -41.97 0.07 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.286 1.434 . . . . 2.56 109.092 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -105.1 83.39 1.97 Allowed 'General case' 0 C--N 1.361 1.086 0 N-CA-C 108.383 -0.969 . . . . 2.76 108.383 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.85 132.71 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 114.748 -1.114 . . . . 0.69 111.675 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -114.58 178.54 4.24 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.353 1.612 . . . . 0.7 115.353 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -126.5 141.72 51.78 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.604 0.594 . . . . 1.33 112.604 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.71 125.01 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.368 0 C-N-CA 123.686 0.794 . . . . 0.48 109.302 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.61 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 25.6 mtt180 -124.51 146.91 48.71 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.097 1.518 . . . . 1.69 115.097 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 2.5 m -120.21 106.8 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.833 0 N-CA-C 112.996 0.739 . . . . 0.6 112.996 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.38 25.07 13.35 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 126.49 1.916 . . . . 1.12 114.736 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.85 -12.91 45.93 Favored Glycine 0 CA--C 1.55 2.261 0 CA-C-N 115.827 -0.624 . . . . 0.32 113.446 -176.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.61 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 96.8 m-70 -87.35 169.34 12.35 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.078 1.751 . . . . 0.57 112.784 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.28 133.6 55.14 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.573 0.702 . . . . 0.55 112.462 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.94 -55.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 114.731 -1.122 . . . . 1.06 112.898 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.14 88.89 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.021 -1.103 . . . . 0.44 108.021 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -111.14 77.6 1.05 Allowed 'General case' 0 C--N 1.354 0.775 0 CA-C-O 122.867 1.318 . . . . 2.3 110.588 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 152.44 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 111.205 -2.725 . . . . 2.48 108.578 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.35 99.93 12.36 Favored 'General case' 0 C--N 1.362 1.117 0 N-CA-C 113.708 1.003 . . . . 1.13 113.708 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -114.26 99.49 7.64 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 113.175 -1.83 . . . . 2.35 107.565 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.74 -29.89 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.441 0 N-CA-C 114.313 1.227 . . . . 0.68 114.313 -176.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -75.45 -37.17 60.49 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.539 0.736 . . . . 0.77 112.415 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.54 -26.9 60.27 Favored 'General case' 0 CA--C 1.577 1.987 0 C-N-CA 124.533 1.133 . . . . 0.91 113.262 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -77.33 -55.27 5.54 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.386 0.884 . . . . 2.43 113.386 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.18 -39.04 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 N-CA-C 113.985 1.105 . . . . 0.93 113.985 177.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.46 -70.86 0.21 Allowed Glycine 0 C--N 1.359 1.849 0 CA-C-N 118.206 0.457 . . . . 0.85 113.556 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -106.28 175.56 5.46 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.467 1.107 . . . . 3.18 111.232 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.1 m -70.87 85.95 0.69 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 113.692 0.997 . . . . 2.08 113.692 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 126' ' ' ALA . 2.9 p -134.76 -156.64 0.74 Allowed 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 114.028 -1.442 . . . . 0.62 109.476 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.433 ' H ' ' HB ' ' A' ' 125' ' ' THR . . . -105.83 128.36 53.69 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 113.15 0.796 . . . . 0.46 113.15 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 7.9 t60 -101.82 139.43 37.47 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.265 0.626 . . . . 0.38 109.322 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -144.79 130.43 19.01 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.28 0.845 . . . . 2.5 113.28 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -121.75 136.69 54.94 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 115.304 -0.862 . . . . 1.56 111.317 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.81 126.45 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 114.718 -1.128 . . . . 0.45 110.767 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.6 mp -132.88 92.53 25.92 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-N 115.472 -0.785 . . . . 0.84 110.498 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -76.5 131.19 12.39 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 122.875 2.383 . . . . 0.16 113.175 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.23 153.34 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 C-N-CA 124.194 0.998 . . . . 0.38 111.115 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.1 p -136.09 117.62 14.83 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.633 0.605 . . . . 1.31 112.633 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.5 mt -116.16 127.62 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 N-CA-C 108.769 -0.826 . . . . 0.25 108.769 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -140.84 126.0 18.48 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.923 -0.58 . . . . 2.05 110.984 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? 68.8 14.91 8.98 Favored 'General case' 0 N--CA 1.516 2.853 0 C-N-CA 125.205 1.402 . . . . 3.55 114.151 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.12 16.13 36.39 Favored Glycine 0 CA--C 1.546 1.988 0 CA-C-O 119.291 -0.727 . . . . 0.37 114.359 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 51.9 mtpt -125.38 144.57 50.44 Favored 'General case' 0 C--N 1.366 1.283 0 CA-C-N 118.175 0.988 . . . . 1.56 112.48 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 148.21 23.28 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.798 1.406 . . . . 0.34 114.798 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.6 114.12 9.71 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.234 -1.348 . . . . 0.64 110.201 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.2 p -121.67 96.01 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.334 0 CA-C-N 115.999 -0.546 . . . . 0.46 110.705 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 68.39 -83.94 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 C-N-CA 125.586 1.554 . . . . 1.56 113.751 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.69 26.81 3.79 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.891 -0.595 . . . . 0.49 113.129 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -130.12 123.56 30.66 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 123.532 0.733 . . . . 1.82 110.346 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.4 p -118.4 130.05 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.237 0 CA-C-O 121.48 0.657 . . . . 1.02 111.51 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.9 p -151.49 -173.3 4.47 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.202 -0.908 . . . . 0.56 110.344 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.272 14.3 t -104.35 138.29 40.98 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 113.661 0.986 . . . . 1.25 113.661 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -84.73 126.38 33.35 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.441 1.096 . . . . 0.29 111.19 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.77 91.77 3.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.216 0.821 . . . . 1.42 113.216 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.18 -64.8 3.69 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 119.192 2.437 . . . . 0.42 119.192 176.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -135.33 159.28 42.05 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.466 0.913 . . . . 1.1 113.466 -176.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.524 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -105.27 142.59 34.77 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.952 -1.476 . . . . 0.67 109.816 177.319 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 t -124.53 127.22 47.1 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 114.023 1.119 . . . . 0.36 114.023 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 16.3 t -106.59 97.19 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 105.862 -1.903 . . . . 0.74 105.862 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.74 122.7 44.42 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.971 -1.013 . . . . 1.67 112.594 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -107.13 119.03 38.28 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 114.474 -1.239 . . . . 1.8 109.766 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.14 137.31 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 CA-C-N 113.579 -1.646 . . . . 0.58 109.649 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -58.37 151.2 20.33 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 127.509 2.323 . . . . 2.18 116.756 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -109.5 -62.7 0.53 Allowed Glycine 0 CA--C 1.538 1.478 0 CA-C-N 115.193 -0.912 . . . . 1.02 113.365 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -135.13 -71.34 0.48 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.781 0.659 . . . . 2.86 112.781 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -112.19 -59.29 2.02 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 122.775 0.43 . . . . 3.91 112.056 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.4 156.33 16.39 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.692 0.797 . . . . 1.74 110.388 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.626 ' ND2' ' H ' ' A' ' 70' ' ' SER . 11.9 m-20 -97.71 -94.8 0.0 OUTLIER Pre-proline 0 CA--C 1.58 2.126 0 CA-C-O 116.512 -1.708 . . . . 1.68 110.898 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.51 -37.21 0.11 Allowed 'Trans proline' 0 C--N 1.402 3.355 0 CA-C-N 124.886 2.781 . . . . 2.06 115.004 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.4 tptt 82.06 -81.74 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 126.261 1.825 . . . . 3.0 108.859 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 45.5 t -112.51 129.53 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.716 -1.216 . . . . 0.8 107.716 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 8.8 t -135.37 116.79 14.69 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.928 0.768 . . . . 0.87 112.341 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . 0.274 . . -109.44 47.51 0.93 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.337 2.347 . . . . 0.34 117.337 -176.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.25 134.1 1.68 Allowed 'General case' 0 N--CA 1.516 2.846 0 N-CA-C 116.109 1.892 . . . . 0.7 116.109 177.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.418 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 3.1 t80 -151.6 100.46 2.71 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.068 -0.514 . . . . 0.21 110.906 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.3 5.5 tt -111.52 121.87 64.88 Favored 'Isoleucine or valine' 0 C--O 1.269 2.088 0 CA-C-O 122.268 1.032 . . . . 0.31 110.969 176.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -122.34 168.68 11.77 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.528 -1.215 . . . . 0.44 112.08 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 24.9 tptp -113.4 141.67 46.8 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 118.298 2.703 . . . . 1.26 118.298 -173.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.12 -40.49 2.45 Favored Glycine 0 CA--C 1.542 1.735 0 N-CA-C 121.213 3.245 . . . . 0.17 121.213 171.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.93 157.17 1.42 Allowed 'General case' 0 N--CA 1.525 3.291 0 CA-C-N 121.622 2.711 . . . . 0.15 113.91 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.16 -13.22 59.95 Favored 'General case' 0 CA--C 1.58 2.108 0 C-N-CA 124.954 1.301 . . . . 0.17 114.087 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.34 2.49 50.15 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 113.692 0.997 . . . . 0.55 113.692 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.11 -8.89 17.23 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.98 0.912 . . . . 0.6 113.29 179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.223 0 C-N-CA 123.866 0.866 . . . . 0.95 112.102 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.482 -0.247 . . . . 8.93 112.482 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.92 129.88 56.03 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 121.588 0.709 . . . . 6.82 111.979 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.5 mmt -132.1 111.19 11.26 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.686 -0.688 . . . . 7.64 111.252 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 m -136.93 114.19 10.79 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.73 -0.668 . . . . 3.86 111.592 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.22 93.37 0.09 OUTLIER Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.815 -0.63 . . . . 1.11 113.219 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.548 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.6 tp -87.82 -48.73 7.6 Favored 'General case' 0 CA--C 1.563 1.458 0 C-N-CA 123.637 0.775 . . . . 0.35 113.041 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.28 -24.78 65.22 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.957 1.703 . . . . 0.2 115.251 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.24 -12.02 47.97 Favored 'General case' 0 CA--C 1.564 1.487 0 N-CA-C 113.665 0.987 . . . . 0.32 113.665 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.493 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 47.4 mttm -107.45 -18.1 13.95 Favored 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 113.954 1.094 . . . . 1.73 113.954 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -56.93 135.93 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.88 0 N-CA-C 114.905 1.446 . . . . 0.11 114.905 176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -121.49 -28.53 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 115.394 -0.821 . . . . 0.16 112.495 178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 69.3 t90 -162.83 117.9 1.77 Allowed 'General case' 0 CA--C 1.559 1.325 0 CA-C-N 117.872 0.306 . . . . 0.54 111.277 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -139.1 129.59 25.78 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.508 -0.745 . . . . 0.19 111.635 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.2 t -138.55 133.81 42.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 N-CA-C 112.928 0.714 . . . . 1.05 112.928 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 169' ' ' ALA . 6.0 t-20 -114.07 112.94 24.05 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 107.056 -1.461 . . . . 2.11 107.056 172.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -79.88 97.5 6.72 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-O 121.577 0.704 . . . . 0.63 111.947 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.53 ' HA2' ' N ' ' A' ' 65' ' ' ARG . . . 176.28 -68.72 0.09 OUTLIER Glycine 0 C--N 1.358 1.758 0 CA-C-N 114.416 -1.266 . . . . 0.71 115.369 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -98.65 -116.23 3.66 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 114.651 0.62 . . . . 0.8 114.651 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -170.53 118.71 0.54 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.206 0.527 . . . . 1.63 111.389 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.561 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER 51.47 107.75 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 117.525 2.417 . . . . 1.0 117.525 177.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.553 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 79.7 t60 -137.08 134.98 37.07 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.869 1.063 . . . . 0.45 113.869 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 70.9 t -104.76 114.51 44.55 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 CA-C-N 113.813 -1.539 . . . . 1.39 107.214 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -88.48 161.15 17.17 Favored 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 119.521 -0.276 . . . . 1.85 111.558 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -45.06 -25.37 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.074 0 N-CA-C 119.12 3.007 . . . . 0.72 119.12 -176.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 58.0 m-70 -92.04 -21.12 20.66 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-N 118.082 0.401 . . . . 0.51 111.427 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.86 39.64 1.28 Allowed Glycine 0 C--N 1.356 1.683 0 C-N-CA 124.288 0.947 . . . . 0.34 113.983 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.548 HD11 ' HG ' ' A' ' 6' ' ' LEU . 19.9 mm -105.85 124.98 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.449 0 N-CA-C 109.094 -0.706 . . . . 0.55 109.094 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.553 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.7 t-160 -115.82 132.96 56.49 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 115.693 1.738 . . . . 1.34 115.693 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.561 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.8 144.78 27.05 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-N 114.726 -1.125 . . . . 2.79 108.999 174.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -67.31 -104.78 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.317 1.969 . . . . 3.0 116.317 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 80.1 tttt 176.8 93.81 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.233 1.013 . . . . 2.3 111.62 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.431 ' HA ' ' NH1' ' A' ' 65' ' ' ARG . 0.4 OUTLIER 46.46 58.09 16.6 Favored Pre-proline 0 N--CA 1.533 3.705 0 N-CA-C 117.152 2.279 . . . . 1.17 117.152 177.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -98.53 33.51 0.11 Allowed 'Trans proline' 0 CA--C 1.563 1.937 0 C-N-CA 123.066 2.511 . . . . 1.45 117.146 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.08 -51.01 0.53 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.629 0.603 . . . . 1.91 112.629 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -109.58 98.4 7.78 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.731 0.776 . . . . 4.84 112.037 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.34 -30.8 9.49 Favored Glycine 0 CA--C 1.541 1.673 0 CA-C-N 114.304 -1.317 . . . . 2.37 113.412 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 77.09 -46.08 0.49 Allowed 'General case' 0 N--CA 1.511 2.606 0 C-N-CA 126.476 1.91 . . . . 4.5 114.862 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.95 116.49 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 122.971 0.508 . . . . 2.7 110.349 178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -165.49 -133.77 1.56 Allowed Glycine 0 C--N 1.342 0.915 0 C-N-CA 120.99 -0.624 . . . . 1.95 114.246 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -138.04 -168.41 2.35 Favored 'General case' 0 CA--C 1.559 1.314 0 N-CA-C 112.858 0.688 . . . . 5.34 112.858 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.55 137.01 32.73 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.558 1.143 . . . . 1.64 112.87 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.4 m -128.66 120.81 27.24 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.233 -0.894 . . . . 1.57 110.413 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.29 100.76 5.29 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 115.84 -0.618 . . . . 2.33 111.233 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -105.65 75.24 1.12 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 122.056 0.931 . . . . 3.16 110.174 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.58 65.83 0.21 Allowed Glycine 0 CA--C 1.528 0.9 0 CA-C-N 113.945 -1.479 . . . . 1.52 110.416 -177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.1 ttt -92.21 1.19 57.37 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 115.452 1.649 . . . . 1.67 115.452 -177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -111.7 47.13 1.06 Allowed 'General case' 0 CA--C 1.561 1.387 0 CA-C-O 121.779 0.799 . . . . 4.18 111.709 179.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 tp -146.67 73.91 12.51 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 114.684 -1.143 . . . . 2.63 108.186 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.401 ' HB3' ' CD ' ' A' ' 58' ' ' GLN . 38.7 Cg_exo -68.17 158.66 56.53 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 123.559 2.839 . . . . 1.37 116.908 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.278 1.2 mp -86.95 133.21 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.273 0 CA-C-N 115.353 -0.839 . . . . 0.69 109.791 178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.39 -18.39 36.25 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.944 2.201 . . . . 1.28 116.944 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -103.97 23.78 12.38 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.1 1.148 . . . . 1.51 114.1 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -138.11 -166.85 2.05 Favored 'General case' 0 CA--C 1.564 1.502 0 CA-C-O 122.018 0.914 . . . . 1.09 112.803 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.658 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.3 t30 -94.69 -178.59 0.82 Allowed Pre-proline 0 CA--C 1.571 1.772 0 C-N-CA 125.586 1.555 . . . . 1.27 110.934 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.448 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.3 Cg_exo -72.31 -45.62 0.6 Allowed 'Trans proline' 0 C--N 1.391 2.785 0 C-N-CA 122.91 2.406 . . . . 0.95 112.018 174.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -68.71 -52.32 32.05 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 113.32 -1.764 . . . . 2.04 111.863 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -75.65 -6.71 51.79 Favored 'General case' 0 CA--C 1.589 2.471 0 CA-C-N 115.353 -0.84 . . . . 1.62 112.692 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.658 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 4.2 tt0 -72.5 -42.31 65.0 Favored 'General case' 0 C--N 1.387 2.232 0 C-N-CA 125.631 1.573 . . . . 1.77 108.046 172.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.9 t -61.09 -42.34 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.045 0 C-N-CA 124.466 1.107 . . . . 0.81 109.341 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 3.9 tp -81.37 -6.35 58.82 Favored 'General case' 0 CA--C 1.576 1.957 0 N-CA-C 113.946 1.091 . . . . 1.15 113.946 176.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 12.4 m-30 -123.63 20.5 9.43 Favored 'General case' 0 CA--C 1.573 1.845 0 C-N-CA 124.64 1.176 . . . . 0.92 112.173 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.67 -35.04 0.31 Allowed 'General case' 0 N--CA 1.511 2.578 0 N-CA-C 116.134 1.902 . . . . 1.33 116.134 -177.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.1 p -70.99 130.17 40.9 Favored 'General case' 0 N--CA 1.529 3.508 0 N-CA-C 115.011 1.486 . . . . 1.28 115.011 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.608 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.5 pt-20 -127.51 141.04 51.76 Favored 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 124.55 1.14 . . . . 1.53 111.019 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.53 ' N ' ' HA2' ' A' ' 17' ' ' GLY . 5.9 ptt180 -100.57 -81.3 0.47 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.165 0.802 . . . . 3.22 113.165 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -153.73 165.83 34.75 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 119.238 0.926 . . . . 3.66 113.069 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.495 HD21 ' H ' ' A' ' 166' ' ' LYS . 50.0 m-20 -131.67 159.46 38.28 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.317 0.858 . . . . 4.7 113.317 -179.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -141.43 -106.54 0.14 Allowed 'General case' 0 CA--C 1.564 1.489 0 CA-C-N 115.564 -0.743 . . . . 2.55 111.002 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.66 121.56 3.73 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.017 0.527 . . . . 2.15 111.073 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.665 ' H ' HD21 ' A' ' 164' ' ' ASN . 0.2 OUTLIER 55.03 89.51 0.04 OUTLIER 'General case' 0 N--CA 1.521 3.087 0 C-N-CA 125.805 1.642 . . . . 0.77 113.648 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -150.45 160.9 43.43 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 114.114 1.153 . . . . 0.81 114.114 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -176.93 -173.05 42.15 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 116.429 1.332 . . . . 0.47 116.429 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -107.93 171.99 7.09 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 116.35 1.982 . . . . 0.89 116.35 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.16 121.2 28.93 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 113.108 -1.86 . . . . 0.51 111.188 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.82 106.41 49.97 Favored Pre-proline 0 CA--C 1.565 1.556 0 C-N-CA 123.339 0.656 . . . . 0.15 109.262 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.05 117.54 2.24 Favored 'Trans proline' 0 CA--C 1.563 1.944 0 C-N-CA 122.08 1.853 . . . . 0.15 114.825 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.78 157.47 32.94 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.544 0 CA-C-O 122.084 0.945 . . . . 0.19 110.981 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -146.83 20.05 1.28 Allowed 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 114.667 -1.151 . . . . 2.53 111.824 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -131.85 159.71 37.77 Favored 'General case' 0 C--N 1.362 1.15 0 CA-C-O 121.29 0.567 . . . . 2.12 111.897 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -116.62 148.17 41.2 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.869 1.063 . . . . 0.42 113.869 -178.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.78 -138.08 5.52 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-N 114.117 -1.401 . . . . 0.23 112.38 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 36.4 mm-40 -115.56 104.05 11.34 Favored 'General case' 0 C--N 1.36 1.032 0 CA-C-N 118.082 0.941 . . . . 1.75 110.898 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -99.73 128.27 45.83 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.174 0.512 . . . . 0.21 110.882 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -113.32 123.48 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.418 0.628 . . . . 0.2 111.004 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.47 HD12 HD12 ' A' ' 172' ' ' ILE . 2.6 tt -108.69 105.26 14.78 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.728 -1.124 . . . . 0.78 110.109 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 1.7 t -114.54 122.27 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.134 -1.393 . . . . 0.44 107.633 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -131.7 136.73 47.88 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.661 -0.7 . . . . 1.25 111.8 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 5.1 tppt? -97.66 123.64 41.66 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.622 0.725 . . . . 2.52 112.519 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -105.78 133.21 50.88 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.847 -1.07 . . . . 0.4 109.887 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.15 158.99 43.21 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.792 -0.64 . . . . 0.41 111.599 -177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -124.12 170.18 10.96 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-O 121.454 0.645 . . . . 2.61 112.667 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.95 -73.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 CA-C-N 115.884 -0.598 . . . . 2.13 112.423 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.85 67.28 1.51 Allowed 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.14 0.495 . . . . 2.27 111.927 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -144.59 102.32 3.8 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.866 -0.606 . . . . 1.46 110.279 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.88 100.51 10.01 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-O 122.329 1.061 . . . . 0.84 111.856 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -166.43 139.88 4.02 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 114.73 -1.123 . . . . 2.45 111.748 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.4 m -125.46 116.25 21.53 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.701 -0.681 . . . . 1.66 111.81 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 73.24 49.45 0.15 Allowed 'General case' 0 N--CA 1.508 2.463 0 C-N-CA 125.673 1.589 . . . . 1.89 113.055 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -151.36 -40.99 0.12 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.24 1.416 . . . . 2.56 109.212 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -100.59 78.88 2.03 Favored 'General case' 0 C--N 1.365 1.268 0 N-CA-C 108.468 -0.938 . . . . 2.76 108.468 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.8 130.19 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-N 114.677 -1.147 . . . . 0.69 111.456 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -115.66 172.77 6.91 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.996 1.48 . . . . 0.7 114.996 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -122.87 137.83 54.83 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 115.855 -0.611 . . . . 1.33 111.702 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -131.75 128.04 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.483 0 CA-C-N 115.273 -0.876 . . . . 0.48 110.012 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -129.22 151.81 49.48 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 115.366 1.617 . . . . 1.69 115.366 -177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.3 OUTLIER -130.1 113.05 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 C-N-CA 123.355 0.662 . . . . 0.6 112.382 177.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.11 25.61 12.49 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 127.013 2.125 . . . . 1.12 114.095 -178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.53 -16.13 52.53 Favored Glycine 0 CA--C 1.548 2.154 0 CA-C-N 115.6 -0.727 . . . . 0.32 113.682 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 94.0 m-70 -83.75 144.68 29.17 Favored 'General case' 0 C--N 1.365 1.241 0 C-N-CA 125.53 1.532 . . . . 0.57 114.496 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.94 126.88 42.39 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.326 0.584 . . . . 0.55 110.863 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.95 -58.63 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-N 115.098 -0.956 . . . . 1.06 113.13 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.06 89.67 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 108.263 -1.014 . . . . 0.44 108.263 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.65 73.69 0.86 Allowed 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 123.134 1.445 . . . . 2.3 112.317 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.1 p30 158.14 62.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 127.871 2.468 . . . . 2.48 107.243 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.2 tp -101.92 100.93 11.28 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 114.184 1.179 . . . . 1.13 114.184 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -112.71 108.61 17.7 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-N 113.401 -1.727 . . . . 2.35 109.675 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -70.04 -26.69 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.547 0 N-CA-C 114.725 1.38 . . . . 0.68 114.725 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -76.3 -42.73 44.29 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 123.303 0.641 . . . . 0.77 112.335 178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -73.91 -26.37 60.49 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 124.176 0.99 . . . . 0.91 113.563 176.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -78.65 -57.7 3.63 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.765 1.024 . . . . 2.43 113.765 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -31.45 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 114.712 1.375 . . . . 0.93 114.712 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.23 -114.94 2.4 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 118.578 0.626 . . . . 0.85 112.945 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -114.76 107.58 15.63 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.216 0.531 . . . . 3.18 110.545 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 73.32 -128.62 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 125.59 1.556 . . . . 2.08 111.933 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.3 p 58.26 -171.02 0.11 Allowed 'General case' 0 N--CA 1.535 3.798 0 C-N-CA 126.159 1.783 . . . . 0.62 115.474 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.77 129.29 54.66 Favored 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 112.968 0.729 . . . . 0.46 112.968 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -105.72 136.54 45.14 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.249 0.619 . . . . 0.38 109.575 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -128.13 133.89 49.03 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.825 1.417 . . . . 2.5 114.825 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -118.16 118.74 32.7 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.418 -1.264 . . . . 1.56 110.844 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.02 112.21 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 115.19 -0.913 . . . . 0.45 110.636 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.75 93.01 43.38 Favored Pre-proline 0 CA--C 1.568 1.669 0 CA-C-N 115.532 -0.758 . . . . 0.84 110.709 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -74.33 138.27 24.55 Favored 'Trans proline' 0 C--N 1.397 3.097 0 C-N-CA 123.032 2.488 . . . . 0.16 113.686 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.11 146.94 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 CA-C-N 115.276 -0.875 . . . . 0.38 110.504 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.8 p -131.75 111.83 11.99 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.566 -0.743 . . . . 1.31 111.626 178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.494 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.6 mt -111.59 122.83 66.7 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 108.539 -0.911 . . . . 0.25 108.539 179.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -142.5 130.24 21.56 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.857 -0.611 . . . . 2.05 111.192 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt 67.54 15.25 9.77 Favored 'General case' 0 N--CA 1.515 2.822 0 C-N-CA 125.096 1.358 . . . . 3.55 114.405 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.14 15.6 35.34 Favored Glycine 0 CA--C 1.549 2.17 0 CA-C-O 119.143 -0.809 . . . . 0.37 114.806 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 30.9 mtmt -128.89 155.6 45.0 Favored 'General case' 0 C--N 1.367 1.348 0 CA-C-N 118.442 1.121 . . . . 1.56 112.924 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.46 148.52 26.36 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.36 1.244 . . . . 0.34 114.36 -176.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.8 m -134.77 112.28 10.61 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.601 -1.181 . . . . 0.64 110.573 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 p -112.21 92.42 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.636 0 CA-C-O 121.196 0.522 . . . . 0.46 109.876 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 63.06 -84.26 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.866 0 C-N-CA 125.581 1.553 . . . . 1.56 114.241 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.64 28.1 4.53 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 116.206 -0.452 . . . . 0.49 113.768 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -137.05 119.23 15.54 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.25 0.62 . . . . 1.82 110.048 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.2 p -105.75 132.6 52.35 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.347 0 CA-C-O 121.57 0.7 . . . . 1.02 112.185 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -150.53 -179.31 7.12 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.043 -0.98 . . . . 0.56 109.818 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.262 12.8 t -103.14 138.22 40.26 Favored 'General case' 0 CA--C 1.578 2.033 0 N-CA-C 113.628 0.974 . . . . 1.25 113.628 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -82.8 123.72 29.61 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.396 1.078 . . . . 0.29 111.288 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.19 91.22 3.28 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 112.804 0.668 . . . . 1.42 112.804 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.81 -63.87 3.41 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 119.014 2.366 . . . . 0.42 119.014 176.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.539 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -132.85 161.16 34.91 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 113.834 1.05 . . . . 1.1 113.834 -176.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.539 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -107.09 143.32 35.4 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 113.764 -1.562 . . . . 0.67 109.593 177.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.4 t -124.81 142.63 51.3 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.643 1.349 . . . . 0.36 114.643 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.446 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.93 97.43 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 106.926 -1.509 . . . . 0.74 106.926 176.091 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -113.72 118.44 34.33 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.758 -0.655 . . . . 1.67 111.968 -177.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.41 133.09 55.98 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-O 122.31 1.052 . . . . 1.8 111.191 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.22 145.77 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-N 113.018 -1.901 . . . . 0.58 110.548 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.437 ' HB3' ' OD1' ' A' ' 164' ' ' ASN . 41.0 pttt -58.16 151.17 19.63 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 116.97 2.211 . . . . 2.18 116.97 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -107.67 -60.34 0.56 Allowed Glycine 0 CA--C 1.539 1.533 0 CA-C-N 115.093 -0.958 . . . . 1.02 113.68 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -141.52 -61.0 0.47 Allowed 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.967 0.384 . . . . 2.86 111.717 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -117.49 -49.49 2.56 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.939 0.496 . . . . 3.91 112.077 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -102.35 178.57 4.55 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.464 0.705 . . . . 1.74 111.459 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.665 HD21 ' H ' ' A' ' 70' ' ' SER . 5.3 m-20 -118.28 -85.93 0.0 OUTLIER Pre-proline 0 CA--C 1.578 2.045 0 CA-C-O 117.356 -1.307 . . . . 1.68 110.275 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -87.49 -37.76 0.08 OUTLIER 'Trans proline' 0 C--N 1.398 3.176 0 CA-C-N 123.648 2.338 . . . . 2.06 114.436 176.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.495 ' H ' HD21 ' A' ' 67' ' ' ASN . 3.1 ttpm? 79.86 -94.02 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 126.495 1.918 . . . . 3.0 110.366 -177.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.608 HG22 ' HB3' ' A' ' 64' ' ' GLU . 17.5 t -106.42 131.29 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.413 -1.328 . . . . 0.8 107.413 174.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.2 t -134.59 129.94 35.74 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.94 -1.027 . . . . 0.87 112.841 -177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.268 . . -122.87 47.89 1.88 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.71 1.745 . . . . 0.34 115.71 -177.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -40.38 127.26 2.34 Favored 'General case' 0 N--CA 1.515 2.789 0 N-CA-C 116.051 1.871 . . . . 0.7 116.051 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.475 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 4.8 t80 -147.55 100.88 3.29 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.912 -0.585 . . . . 0.21 111.101 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.47 HD12 HD12 ' A' ' 85' ' ' LEU 0.305 10.1 tt -109.86 121.3 62.55 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.061 0 CA-C-O 122.427 1.108 . . . . 0.31 111.011 175.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -123.34 165.35 17.15 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 113.873 -1.512 . . . . 0.44 110.734 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 18.7 ptmt -122.14 159.35 27.37 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 118.139 2.644 . . . . 1.26 118.139 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.62 -41.59 2.11 Favored Glycine 0 CA--C 1.544 1.859 0 CA-C-N 110.11 -3.223 . . . . 0.17 119.053 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.61 154.18 0.94 Allowed 'General case' 0 N--CA 1.52 3.058 0 CA-C-N 120.782 2.291 . . . . 0.15 113.156 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.77 -13.33 59.87 Favored 'General case' 0 CA--C 1.58 2.125 0 C-N-CA 124.836 1.255 . . . . 0.17 114.353 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.55 4.78 45.59 Favored 'General case' 0 CA--C 1.578 2.039 0 N-CA-C 113.86 1.059 . . . . 0.55 113.86 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.704 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -108.58 -9.89 15.28 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 114.312 1.227 . . . . 0.6 114.312 -179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.9 95.15 0.27 Allowed Pre-proline 0 N--CA 1.516 2.847 0 C-N-CA 124.424 1.09 . . . . 0.95 113.358 178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.704 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 72.7 Cg_endo -95.83 140.39 0.9 Allowed 'Trans proline' 0 C--N 1.388 2.607 0 C-N-CA 122.822 2.348 . . . . 1.8 114.306 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 15.0 ptt? -142.81 111.25 6.18 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.754 -0.657 . . . . 4.96 111.568 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.7 mt -136.95 162.9 31.99 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 122.063 0.935 . . . . 4.0 112.572 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -104.4 154.47 38.33 Favored Pre-proline 0 CA--C 1.563 1.455 0 CA-C-N 114.606 -1.179 . . . . 6.27 110.532 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.18 121.4 8.7 Favored 'Trans proline' 0 C--N 1.394 2.963 0 C-N-CA 122.544 2.163 . . . . 6.59 115.338 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -136.18 135.33 20.99 Favored Pre-proline 0 CA--C 1.568 1.662 0 CA-C-N 114.618 -1.174 . . . . 5.51 111.01 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.82 -27.26 7.34 Favored 'Trans proline' 0 C--N 1.394 2.956 0 C-N-CA 123.534 2.823 . . . . 6.77 116.388 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -118.8 129.39 8.11 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 114.433 0.533 . . . . 7.02 114.433 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.3 mt -118.45 103.83 10.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.723 0.409 . . . . 8.99 112.006 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.182 -0.913 . . . . 10.6 110.456 179.691 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.575 -0.21 . . . . 8.93 112.575 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.85 -39.92 5.19 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.136 0.791 . . . . 6.82 113.136 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -118.87 -68.56 0.91 Allowed 'General case' 0 C--N 1.363 1.171 0 C-N-CA 122.647 0.379 . . . . 7.64 111.782 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 m -135.98 -69.77 0.48 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.595 0.358 . . . . 3.86 111.908 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 163.11 95.47 0.11 Allowed Glycine 0 C--N 1.349 1.285 0 C-N-CA 121.411 -0.423 . . . . 1.11 113.224 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.508 ' HG ' HD11 ' A' ' 27' ' ' ILE . 15.0 tp -88.36 -49.91 6.66 Favored 'General case' 0 CA--C 1.566 1.584 0 C-N-CA 123.815 0.846 . . . . 0.35 112.947 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.4 -23.09 65.56 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 126.101 1.76 . . . . 0.2 115.274 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -11.65 51.71 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 113.727 1.01 . . . . 0.32 113.727 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 2.1 mmpt? -108.57 -19.23 13.51 Favored 'General case' 0 CA--C 1.554 1.112 0 N-CA-C 113.514 0.931 . . . . 1.73 113.514 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.03 135.75 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.936 0 N-CA-C 115.257 1.577 . . . . 0.11 115.257 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -121.5 -29.83 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 115.287 -0.869 . . . . 0.16 112.095 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -163.07 123.3 2.28 Favored 'General case' 0 CA--C 1.558 1.272 0 CA-C-O 120.572 0.225 . . . . 0.54 110.953 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -140.93 128.55 21.46 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.351 -0.843 . . . . 0.19 110.777 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.1 t -136.57 131.06 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 113.507 0.928 . . . . 1.05 113.507 -178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -116.7 110.88 19.03 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.304 -0.999 . . . . 2.11 108.304 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.59 100.11 9.95 Favored 'General case' 0 C--O 1.256 1.436 0 CA-C-O 122.223 1.011 . . . . 0.63 110.437 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.51 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . -179.74 -57.54 0.08 OUTLIER Glycine 0 C--N 1.348 1.232 0 CA-C-N 113.594 -1.639 . . . . 0.71 115.528 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -113.4 -115.9 3.29 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 120.038 -0.312 . . . . 0.8 113.795 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -165.11 117.73 1.2 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 122.359 0.264 . . . . 1.63 111.565 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 2.8 m 41.71 106.04 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.155 0 N-CA-C 118.075 2.62 . . . . 1.0 118.075 178.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.636 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 82.7 t60 -134.07 138.3 45.21 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 114.041 1.126 . . . . 0.45 114.041 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.261 8.0 p -108.64 117.48 54.2 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.073 0 CA-C-N 114.202 -1.363 . . . . 1.39 110.254 177.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.07 156.97 23.05 Favored 'General case' 0 CA--C 1.571 1.757 0 CA-C-N 114.343 -1.298 . . . . 1.85 110.676 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.6 m -41.4 -32.69 0.36 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.153 0 N-CA-C 119.113 3.005 . . . . 0.72 119.113 -176.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.41 ' HB2' HD23 ' A' ' 6' ' ' LEU . 63.8 m-70 -88.42 -26.87 21.9 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 118.312 0.505 . . . . 0.51 110.909 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.94 43.43 0.41 Allowed Glycine 0 C--N 1.35 1.334 0 CA-C-N 114.994 -1.003 . . . . 0.34 114.701 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.508 HD11 ' HG ' ' A' ' 6' ' ' LEU . 15.8 mm -106.79 112.66 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 N-CA-C 109.687 -0.486 . . . . 0.55 109.687 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.636 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.74 134.85 48.19 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 115.189 1.552 . . . . 1.34 115.189 -177.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.592 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -96.14 143.09 27.57 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.731 -1.122 . . . . 2.79 110.08 176.378 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.8 mtp180 -97.44 103.37 15.3 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.226 1.011 . . . . 3.0 113.381 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ttpp -33.79 116.7 0.28 Allowed 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 118.51 2.781 . . . . 2.3 118.51 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 40.37 73.43 0.85 Allowed Pre-proline 0 N--CA 1.525 3.318 0 N-CA-C 118.178 2.658 . . . . 1.17 118.178 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -99.9 -12.21 0.26 Allowed 'Trans proline' 0 CA--C 1.56 1.777 0 C-N-CA 122.281 1.987 . . . . 1.45 116.69 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 11.4 tp -133.91 -52.13 0.85 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.574 0.583 . . . . 1.91 112.574 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -91.29 97.75 11.3 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 121.983 0.896 . . . . 4.84 112.44 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.2 -31.81 6.93 Favored Glycine 0 CA--C 1.54 1.602 0 CA-C-N 113.604 -1.635 . . . . 2.37 112.908 -177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 74.99 -56.13 0.64 Allowed 'General case' 0 N--CA 1.511 2.576 0 C-N-CA 126.428 1.891 . . . . 4.5 114.408 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.58 116.64 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 C-N-CA 123.46 0.704 . . . . 2.7 110.222 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -178.87 -132.24 1.71 Allowed Glycine 0 C--N 1.341 0.858 0 C-N-CA 121.216 -0.516 . . . . 1.95 113.729 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -150.25 -126.07 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 111.969 0.359 . . . . 5.34 111.969 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.88 136.7 47.99 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.801 0.84 . . . . 1.64 112.396 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.9 m -132.9 99.05 4.47 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.333 -0.849 . . . . 1.57 109.953 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.91 107.77 18.72 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 112.892 0.701 . . . . 2.33 112.892 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -110.42 75.34 0.92 Allowed 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.913 0.863 . . . . 3.16 110.072 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.99 71.66 0.37 Allowed Glycine 0 C--N 1.344 0.992 0 CA-C-N 114.306 -1.316 . . . . 1.52 110.566 -177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -92.35 0.66 57.46 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 115.615 1.709 . . . . 1.67 115.615 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.81 42.02 1.95 Allowed 'General case' 0 CA--C 1.561 1.387 0 CA-C-O 121.872 0.844 . . . . 4.18 112.434 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.4 mt -140.0 75.77 29.06 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 125.057 1.343 . . . . 2.63 107.794 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.35 167.06 17.74 Favored 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 122.956 2.437 . . . . 1.37 117.042 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.25 1.3 mp -91.45 136.72 23.59 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.243 0 CA-C-N 114.748 -1.114 . . . . 0.69 110.039 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mt -94.1 -10.45 33.3 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 115.991 1.848 . . . . 1.28 115.991 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -108.25 20.94 18.03 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 114.302 1.223 . . . . 1.51 114.302 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.53 -166.63 2.1 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-O 121.71 0.767 . . . . 1.09 112.789 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.85 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.8 t30 -90.25 177.7 2.25 Favored Pre-proline 0 N--CA 1.498 1.952 0 C-N-CA 125.411 1.484 . . . . 1.27 110.959 178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -71.71 -46.99 0.51 Allowed 'Trans proline' 0 C--N 1.394 2.942 0 C-N-CA 122.998 2.465 . . . . 0.95 112.592 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 56' ' ' GLU . 3.6 pt-20 -69.75 -44.11 70.87 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 113.786 -1.552 . . . . 2.04 112.034 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -80.14 -7.21 58.81 Favored 'General case' 0 CA--C 1.587 2.371 0 CA-C-N 115.11 -0.95 . . . . 1.62 111.758 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.85 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.6 tt0 -73.31 -37.81 66.05 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 125.684 1.594 . . . . 1.77 108.737 174.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.5 t -64.01 -47.78 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.871 0 C-N-CA 125.777 1.631 . . . . 0.81 109.042 173.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.611 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 1.6 tp -80.12 -4.58 53.48 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.69 1.366 . . . . 1.15 114.69 177.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.0 m-30 -113.17 3.46 16.06 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 124.639 1.176 . . . . 0.92 110.222 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -139.77 -115.95 0.14 Allowed 'General case' 0 CA--C 1.568 1.658 0 C-N-CA 124.479 1.112 . . . . 1.33 111.703 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.289 2.9 p 56.67 -84.48 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.12 0 C-N-CA 127.33 2.252 . . . . 1.28 116.144 -174.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.532 ' HB2' HG22 ' A' ' 167' ' ' VAL . 20.6 tt0 82.08 133.7 0.06 Allowed 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 125.361 1.465 . . . . 1.53 114.227 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 35.7 mtp85 -100.23 -75.48 0.58 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 111.92 0.341 . . . . 3.22 111.92 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -160.06 161.78 33.99 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.748 0.785 . . . . 3.66 112.886 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.484 ' OD1' ' HA ' ' A' ' 166' ' ' LYS . 1.3 m-20 -119.88 134.02 55.38 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.126 -0.943 . . . . 4.7 111.133 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -157.12 -62.62 0.09 Allowed 'General case' 0 CA--C 1.551 0.996 0 N-CA-C 114.395 1.257 . . . . 2.55 114.395 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -149.1 -160.07 1.12 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.575 0.625 . . . . 2.15 112.355 -175.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.51 107.62 1.17 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 124.522 1.129 . . . . 0.77 112.35 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -100.45 129.28 46.39 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.403 -1.271 . . . . 0.81 110.651 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -133.73 132.88 6.64 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 118.716 2.247 . . . . 0.47 118.716 -176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -103.1 145.61 29.63 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.28 0.844 . . . . 0.89 113.28 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.9 117.96 32.13 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.383 -1.281 . . . . 0.51 111.897 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.45 HG21 HG21 ' A' ' 172' ' ' ILE . 3.2 mp -117.51 97.69 51.01 Favored Pre-proline 0 CA--C 1.565 1.555 0 CA-C-N 115.275 -0.875 . . . . 0.15 109.048 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -83.03 118.84 2.74 Favored 'Trans proline' 0 CA--C 1.558 1.705 0 C-N-CA 122.16 1.906 . . . . 0.15 114.755 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -121.92 159.18 24.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.669 0 CA-C-O 122.119 0.962 . . . . 0.19 111.433 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 54.0 mmtt -146.36 17.97 1.35 Allowed 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 114.315 -1.311 . . . . 2.53 111.935 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -128.99 163.22 25.83 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 121.269 0.557 . . . . 2.12 111.466 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -124.18 146.65 48.55 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.8 1.037 . . . . 0.42 113.8 -178.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.72 -133.93 3.61 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 114.068 -1.423 . . . . 0.23 112.094 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 21.5 mt-10 -118.52 106.46 12.69 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 118.479 1.139 . . . . 1.75 111.106 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -98.97 128.85 45.21 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.485 0.66 . . . . 0.21 111.331 -179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.46 118.23 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 CA-C-N 115.328 -0.851 . . . . 0.2 111.045 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.535 HD12 HD12 ' A' ' 172' ' ' ILE . 1.6 tt -107.83 105.06 14.7 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.228 -1.351 . . . . 0.78 109.81 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.88 125.41 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-N 114.229 -1.35 . . . . 0.44 108.741 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.14 137.17 54.16 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 112.762 0.652 . . . . 1.25 112.762 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 5.3 tptp -101.17 115.73 31.17 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.076 -0.965 . . . . 2.52 110.196 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -105.01 134.38 48.22 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.957 -0.565 . . . . 0.4 110.156 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.72 152.75 51.66 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.614 0.721 . . . . 0.41 111.899 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -126.1 150.59 48.09 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 115.3 -0.863 . . . . 2.61 110.449 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -111.96 -76.03 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 114.186 1.18 . . . . 2.13 114.186 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -124.27 73.17 1.22 Allowed 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.059 0.763 . . . . 2.27 113.059 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -154.29 109.29 3.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.711 0.804 . . . . 1.46 109.668 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.42 104.78 14.21 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 122.192 0.996 . . . . 0.84 112.495 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -171.84 140.02 1.23 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 114.884 -1.053 . . . . 2.45 111.716 179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.4 m -129.07 118.57 22.72 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.571 -0.74 . . . . 1.66 111.835 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.1 tp-100 72.97 49.94 0.15 Allowed 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 125.793 1.637 . . . . 1.89 112.508 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -151.33 -40.48 0.12 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.476 1.111 . . . . 2.56 110.278 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -109.04 83.73 1.8 Allowed 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.464 -0.939 . . . . 2.76 108.464 177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.85 126.57 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 113.888 -1.505 . . . . 0.69 111.651 -176.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -104.54 -176.4 3.07 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.205 1.558 . . . . 0.7 115.205 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -128.42 136.98 51.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.092 -0.38 . . . . 1.33 111.29 178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 13.9 t -130.23 125.26 59.48 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.279 0 C-N-CA 123.482 0.713 . . . . 0.48 109.918 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.3 mtt180 -121.97 153.26 38.76 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.406 1.632 . . . . 1.69 115.406 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.55 102.83 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 114.928 -1.033 . . . . 0.6 112.373 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.5 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.31 27.21 13.76 Favored 'General case' 0 N--CA 1.524 3.252 0 C-N-CA 126.876 2.07 . . . . 1.12 113.895 -178.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.32 -18.59 35.63 Favored Glycine 0 CA--C 1.547 2.032 0 C-N-CA 121.375 -0.441 . . . . 0.32 113.235 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -86.07 173.8 9.62 Favored 'General case' 0 C--N 1.368 1.384 0 C-N-CA 125.491 1.517 . . . . 0.57 113.53 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 6.7 p -126.57 126.24 43.32 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.175 0.512 . . . . 0.55 111.278 177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.263 9.1 p -112.41 -45.12 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.113 0 CA-C-N 115.263 -0.88 . . . . 1.06 111.072 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.66 89.19 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 109.013 -0.736 . . . . 0.44 109.013 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -105.74 90.68 3.47 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-O 122.986 1.374 . . . . 2.3 110.366 178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 127.65 78.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 110.01 -3.268 . . . . 2.48 108.508 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.06 110.86 22.94 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 121.744 0.783 . . . . 1.13 112.916 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -119.0 98.84 6.38 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 106.899 -1.519 . . . . 2.35 106.899 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.47 -25.54 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.32 0 N-CA-C 113.925 1.083 . . . . 0.68 113.925 -177.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -75.71 -40.29 55.93 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.022 0.929 . . . . 0.77 112.311 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -73.26 -26.85 61.26 Favored 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 124.672 1.189 . . . . 0.91 113.388 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -80.66 -57.77 3.41 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 113.692 0.997 . . . . 2.43 113.692 179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.33 -34.7 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 N-CA-C 114.864 1.431 . . . . 0.93 114.864 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 123.68 -109.22 1.28 Allowed Glycine 0 C--N 1.356 1.669 0 CA-C-N 118.764 0.711 . . . . 0.85 113.578 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 -114.61 106.87 14.75 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-O 120.757 0.313 . . . . 3.18 110.707 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.8 m 68.09 -124.09 0.18 Allowed 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 125.379 1.471 . . . . 2.08 112.825 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.3 p 56.07 -164.09 0.14 Allowed 'General case' 0 N--CA 1.531 3.583 0 C-N-CA 126.461 1.904 . . . . 0.62 115.134 178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.449 ' HB1' ' HZ2' ' A' ' 88' ' ' LYS . . . -111.34 132.3 54.51 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 113.102 0.778 . . . . 0.46 113.102 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -107.72 143.69 35.89 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 123.035 0.534 . . . . 0.38 109.829 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.28 131.85 19.84 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.185 1.18 . . . . 2.5 114.185 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -119.94 134.14 55.34 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-N 115.145 -0.934 . . . . 1.56 110.827 174.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.47 122.36 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 CA-C-N 114.652 -1.158 . . . . 0.45 110.835 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -127.78 86.24 58.78 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-N 115.361 -0.836 . . . . 0.84 110.823 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -73.88 126.23 10.52 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 123.015 2.477 . . . . 0.16 112.634 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -112.21 149.45 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.565 0 CA-C-N 115.153 -0.931 . . . . 0.38 111.428 -176.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 p -130.33 110.63 11.67 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 115.1 -0.954 . . . . 1.31 111.661 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.2 mt -114.15 122.73 68.85 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.488 0 N-CA-C 108.477 -0.934 . . . . 0.25 108.477 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -141.04 127.36 19.78 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 115.658 -0.701 . . . . 2.05 110.76 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp 68.0 14.35 9.33 Favored 'General case' 0 N--CA 1.514 2.759 0 C-N-CA 125.287 1.435 . . . . 3.55 113.961 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 17.47 30.1 Favored Glycine 0 CA--C 1.547 2.059 0 CA-C-O 119.213 -0.771 . . . . 0.37 114.786 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 55.5 mtpt -124.42 146.38 48.93 Favored 'General case' 0 C--N 1.367 1.35 0 CA-C-N 118.378 1.089 . . . . 1.56 112.46 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.18 144.7 30.39 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.275 1.213 . . . . 0.34 114.275 -175.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.27 113.44 11.29 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 114.824 -1.08 . . . . 0.64 110.467 178.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.3 p -107.81 94.0 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.571 0 CA-C-N 115.929 -0.578 . . . . 0.46 110.226 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 66.95 -83.29 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.778 0 C-N-CA 125.527 1.531 . . . . 1.56 113.871 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.24 26.05 4.76 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 116.094 -0.503 . . . . 0.49 113.628 177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -128.71 131.79 47.95 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 123.364 0.666 . . . . 1.82 110.57 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -116.14 130.62 70.57 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 CA-C-O 121.64 0.733 . . . . 1.02 111.981 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m -150.84 -179.1 6.99 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.975 -1.011 . . . . 0.56 109.592 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.271 14.1 t -104.25 138.79 40.19 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 113.425 0.898 . . . . 1.25 113.425 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -82.53 122.03 27.54 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 124.18 0.992 . . . . 0.29 111.349 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.79 90.53 3.26 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.48 0.548 . . . . 1.42 112.48 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.5 -62.69 2.69 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 118.92 2.328 . . . . 0.42 118.92 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.51 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -134.0 158.86 42.45 Favored 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 114.079 1.14 . . . . 1.1 114.079 -176.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.51 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -104.61 137.75 41.97 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.523 -1.671 . . . . 0.67 109.107 176.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.407 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.0 t -124.13 128.29 49.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.772 1.397 . . . . 0.36 114.772 -177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 3.2 t -106.56 101.42 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 106.689 -1.597 . . . . 0.74 106.689 176.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -117.64 120.71 38.84 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.882 -1.054 . . . . 1.67 112.746 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -113.74 126.93 55.78 Favored 'General case' 0 C--O 1.247 0.937 0 CA-C-O 122.177 0.989 . . . . 1.8 111.223 177.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.78 146.02 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-N 112.947 -1.933 . . . . 0.58 111.242 -176.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -91.14 149.94 21.59 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-N 114.853 -1.067 . . . . 2.18 113.165 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -89.41 -43.98 5.09 Favored Glycine 0 CA--C 1.545 1.954 0 CA-C-N 115.634 -0.712 . . . . 1.02 114.859 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -128.99 -71.99 0.62 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.694 0.398 . . . . 2.86 110.992 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.605 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 6.8 t80 -146.65 120.42 9.24 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.319 0.647 . . . . 3.91 109.5 178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.605 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 0.5 OUTLIER 90.64 151.93 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 125.033 1.333 . . . . 1.74 112.067 -178.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.65 -168.32 0.15 Allowed Pre-proline 0 CA--C 1.572 1.795 0 CA-C-N 113.994 -1.457 . . . . 1.68 109.434 179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -57.76 -17.92 31.57 Favored 'Trans proline' 0 C--N 1.403 3.436 0 C-N-CA 122.937 2.425 . . . . 2.06 115.181 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.484 ' HA ' ' OD1' ' A' ' 67' ' ' ASN . 63.0 tttt 81.91 -63.99 0.14 Allowed 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 126.665 1.986 . . . . 3.0 115.513 174.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.532 HG22 ' HB2' ' A' ' 64' ' ' GLU . 4.0 t -102.61 134.27 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 CA-C-N 119.602 1.092 . . . . 0.8 110.594 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.57 132.33 38.96 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 114.779 -1.101 . . . . 0.87 113.262 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -128.68 48.48 2.32 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.081 1.511 . . . . 0.34 115.081 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -43.93 135.36 4.15 Favored 'General case' 0 N--CA 1.515 2.808 0 N-CA-C 116.663 2.097 . . . . 0.7 116.663 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -150.02 108.84 3.86 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.804 -0.635 . . . . 0.21 111.068 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.535 HD12 HD12 ' A' ' 85' ' ' LEU 0.308 6.6 tt -117.49 123.26 71.51 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.15 0 CA-C-O 122.439 1.114 . . . . 0.31 111.685 175.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 10.5 ptm -123.33 166.79 14.71 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 113.924 -1.489 . . . . 0.44 111.274 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.2 ptmm? -123.16 157.59 32.64 Favored 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 118.2 2.667 . . . . 1.26 118.2 -176.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.65 -42.36 1.91 Allowed Glycine 0 CA--C 1.542 1.728 0 CA-C-N 110.604 -2.998 . . . . 0.17 119.085 173.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.57 152.44 0.81 Allowed 'General case' 0 N--CA 1.516 2.864 0 CA-C-N 120.419 2.11 . . . . 0.15 112.762 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.91 -15.5 59.66 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 114.437 1.273 . . . . 0.17 114.437 177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.62 4.5 43.59 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 114.101 1.148 . . . . 0.55 114.101 177.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.619 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.2 OUTLIER -103.99 -10.87 17.77 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 113.624 0.972 . . . . 0.6 113.624 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.52 98.9 0.29 Allowed Pre-proline 0 N--CA 1.516 2.871 0 C-N-CA 125.325 1.45 . . . . 0.95 111.489 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.619 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 93.6 Cg_endo -95.63 103.92 0.1 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.799 2.333 . . . . 1.8 114.397 178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.95 118.23 7.84 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.53 -0.759 . . . . 4.96 110.899 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.2 mt -130.28 168.9 16.14 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.082 0.944 . . . . 4.0 112.79 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -105.09 154.93 38.41 Favored Pre-proline 0 CA--C 1.561 1.378 0 CA-C-N 114.577 -1.192 . . . . 6.27 110.841 178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.73 120.66 7.42 Favored 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 122.29 1.993 . . . . 6.59 114.413 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 -135.71 143.68 45.73 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-N 114.672 -1.149 . . . . 5.51 111.355 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -88.07 -154.06 0.05 OUTLIER 'Trans proline' 0 C--N 1.39 2.759 0 C-N-CA 122.944 2.429 . . . . 6.77 113.905 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 168.31 101.11 0.15 Allowed Glycine 0 C--N 1.341 0.839 0 C-N-CA 121.049 -0.596 . . . . 7.02 113.258 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.82 121.25 39.59 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.154 0.502 . . . . 8.99 112.074 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 . . . . . 0 C--O 1.251 1.134 0 CA-C-O 118.28 -0.867 . . . . 10.6 111.055 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.48 -0.248 . . . . 8.93 112.48 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.86 131.94 55.03 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 121.557 0.694 . . . . 6.82 111.881 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.5 mtt -126.9 -67.9 0.83 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.716 -0.675 . . . . 7.64 111.63 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.9 m -137.9 107.25 6.11 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.943 0.402 . . . . 3.86 111.241 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.73 91.02 0.1 OUTLIER Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.753 -0.658 . . . . 1.11 113.09 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.559 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.6 tp -88.07 -47.37 8.56 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 113.248 0.833 . . . . 0.35 113.248 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.37 -22.77 61.85 Favored 'General case' 0 N--CA 1.508 2.47 0 C-N-CA 125.951 1.7 . . . . 0.2 115.161 176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.46 -12.34 49.29 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 113.596 0.961 . . . . 0.32 113.596 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.1 mmtt -105.65 -21.64 13.15 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 113.285 0.846 . . . . 1.73 113.285 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.24 135.68 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.926 0 N-CA-C 115.317 1.599 . . . . 0.11 115.317 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -124.13 -29.39 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-N 115.24 -0.891 . . . . 0.16 112.258 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 62.5 t90 -162.38 116.99 1.83 Allowed 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 120.545 0.212 . . . . 0.54 111.328 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.82 129.0 31.77 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.483 -0.761 . . . . 0.19 111.365 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.6 t -136.81 130.99 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 113.214 0.82 . . . . 1.05 113.214 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.418 ' OD1' ' HA ' ' A' ' 60' ' ' LEU . 8.2 t-20 -114.1 105.33 13.08 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 107.663 -1.236 . . . . 2.11 107.663 172.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.22 105.56 11.59 Favored 'General case' 0 C--O 1.274 2.38 0 CA-C-O 121.802 0.811 . . . . 0.63 110.39 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.596 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 168.98 -58.32 0.2 Allowed Glycine 0 C--N 1.358 1.786 0 CA-C-N 112.026 -2.352 . . . . 0.71 114.037 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -106.96 -128.24 5.94 Favored Glycine 0 N--CA 1.478 1.464 0 CA-C-O 119.303 -0.721 . . . . 0.8 113.121 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.496 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 40.3 mt-10 -162.09 117.22 1.93 Allowed 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 117.645 0.723 . . . . 1.63 111.86 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 55.61 108.94 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 117.358 2.355 . . . . 1.0 117.358 177.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 83.8 t60 -144.59 139.05 27.87 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 114.071 1.137 . . . . 0.45 114.071 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.268 9.9 p -107.63 118.84 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.085 0 CA-C-N 114.829 -1.078 . . . . 1.39 110.886 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.23 156.01 22.21 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 114.395 -1.275 . . . . 1.85 110.856 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.4 m -41.82 -32.16 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.258 0 N-CA-C 119.087 2.995 . . . . 0.72 119.087 -176.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -87.16 -23.84 24.68 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.413 0.551 . . . . 0.51 111.374 177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.73 40.94 0.69 Allowed Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.114 -0.948 . . . . 0.34 114.403 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.559 HD11 ' HG ' ' A' ' 6' ' ' LEU . 22.7 mm -106.91 113.35 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 N-CA-C 109.755 -0.461 . . . . 0.55 109.755 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.3 132.67 51.21 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 115.34 1.608 . . . . 1.34 115.34 -177.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.496 ' OH ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -93.17 146.65 23.51 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-N 114.849 -1.069 . . . . 2.79 109.911 175.247 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -58.16 -111.71 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 127.505 2.322 . . . . 3.0 116.688 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -178.63 79.63 0.01 OUTLIER 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 113.229 0.826 . . . . 2.3 113.229 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.454 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 0.3 OUTLIER 65.14 46.31 0.53 Allowed Pre-proline 0 N--CA 1.517 2.894 0 N-CA-C 117.695 2.48 . . . . 1.17 117.695 176.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 43.0 Cg_endo -107.87 154.82 0.09 OUTLIER 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 123.072 2.515 . . . . 1.45 114.579 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.05 -85.74 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.453 -1.249 . . . . 1.91 109.796 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -151.98 52.99 0.81 Allowed 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 113.402 0.89 . . . . 4.84 113.402 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.72 2.57 30.55 Favored Glycine 0 CA--C 1.545 1.943 0 N-CA-C 115.735 1.054 . . . . 2.37 115.735 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.435 ' H ' ' HG2' ' A' ' 37' ' ' ARG . 7.2 ptp180 -117.52 87.45 2.71 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.719 0.808 . . . . 4.5 112.33 -176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.88 128.55 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.343 0 CA-C-N 115.025 -0.989 . . . . 2.7 110.978 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -154.49 -108.78 0.32 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.742 -0.663 . . . . 1.95 113.613 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -133.76 -174.27 3.48 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-O 121.565 0.698 . . . . 5.34 112.785 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.12 132.49 34.69 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 124.283 1.033 . . . . 1.64 112.807 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.0 m -120.61 125.07 46.83 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.254 -0.884 . . . . 1.57 111.652 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.51 94.49 3.11 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.492 -0.776 . . . . 2.33 110.673 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -104.72 76.14 1.26 Allowed 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 122.039 0.923 . . . . 3.16 110.084 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 122.84 69.07 0.23 Allowed Glycine 0 C--N 1.342 0.912 0 CA-C-N 113.991 -1.459 . . . . 1.52 110.191 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -92.15 0.23 57.45 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 115.477 1.658 . . . . 1.67 115.477 -177.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -111.06 64.15 0.61 Allowed 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 121.918 0.866 . . . . 4.18 110.941 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 tp -167.48 73.68 0.98 Allowed Pre-proline 0 C--O 1.238 0.452 0 CA-C-N 114.591 -1.186 . . . . 2.63 108.075 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 31.8 Cg_exo -66.49 157.86 58.4 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 123.729 2.953 . . . . 1.37 117.051 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.273 1.1 mp -87.75 124.51 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.09 0 CA-C-N 115.22 -0.9 . . . . 0.69 108.981 177.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.2 mp -81.19 -19.34 43.52 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.421 2.008 . . . . 1.28 116.421 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -94.97 24.0 5.16 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 113.736 1.013 . . . . 1.51 113.736 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.16 -173.18 4.18 Favored 'General case' 0 CA--C 1.564 1.494 0 C-N-CA 123.828 0.851 . . . . 1.09 110.954 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.696 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.87 -176.91 0.58 Allowed Pre-proline 0 N--CA 1.512 2.64 0 CA-C-O 118.449 -0.786 . . . . 1.27 109.421 178.128 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -69.17 -39.49 7.56 Favored 'Trans proline' 0 C--N 1.398 3.165 0 C-N-CA 122.613 2.209 . . . . 0.95 113.279 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.406 ' HG2' ' H ' ' A' ' 56' ' ' GLU . 6.3 pt-20 -69.25 -49.24 58.05 Favored 'General case' 0 N--CA 1.503 2.179 0 C-N-CA 125.322 1.449 . . . . 2.04 112.015 177.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.2 OUTLIER -79.65 -5.42 55.06 Favored 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 114.914 -1.039 . . . . 1.62 112.625 177.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.696 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 1.1 tt0 -74.02 -41.84 61.22 Favored 'General case' 0 C--N 1.38 1.929 0 C-N-CA 125.617 1.567 . . . . 1.77 107.952 173.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.8 t -61.4 -45.04 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 C-N-CA 124.304 1.042 . . . . 0.81 109.541 174.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 1.5 tp -79.98 -5.56 55.92 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 114.35 1.241 . . . . 1.15 114.35 176.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 6.5 m-30 -123.81 20.66 9.27 Favored 'General case' 0 CA--C 1.575 1.93 0 C-N-CA 124.477 1.111 . . . . 0.92 111.909 176.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -148.16 -28.04 0.33 Allowed 'General case' 0 N--CA 1.52 3.053 0 N-CA-C 116.878 2.177 . . . . 1.33 116.878 -176.272 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.0 p -73.29 137.54 44.92 Favored 'General case' 0 N--CA 1.533 3.725 0 N-CA-C 114.206 1.187 . . . . 1.28 114.206 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.596 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 7.9 pt-20 -112.6 139.4 48.22 Favored 'General case' 0 N--CA 1.507 2.387 0 N-CA-C 117.004 2.224 . . . . 1.53 117.004 -175.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.3 mtp85 -127.11 114.75 18.15 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 114.692 -1.14 . . . . 3.22 109.034 175.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -122.4 147.26 46.51 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 113.225 0.824 . . . . 3.66 113.225 -177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -127.47 -93.77 0.46 Allowed 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 115.454 -0.794 . . . . 4.7 111.64 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -161.31 -48.59 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.221 1.934 . . . . 2.55 116.221 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.6 -160.05 0.86 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.678 0.992 . . . . 2.15 113.678 -175.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.31 109.94 1.12 Allowed 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 124.957 1.303 . . . . 0.77 112.091 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.63 154.06 49.78 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 114.942 -1.026 . . . . 0.81 112.965 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -168.84 -174.63 37.63 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-N 115.077 -0.965 . . . . 0.47 115.124 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -112.47 171.67 7.38 Favored 'General case' 0 CA--C 1.55 0.977 0 N-CA-C 114.782 1.401 . . . . 0.89 114.782 -177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -125.15 129.33 49.94 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 113.573 -1.649 . . . . 0.51 111.768 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -122.87 100.93 39.85 Favored Pre-proline 0 CA--C 1.568 1.666 0 C-N-CA 123.011 0.524 . . . . 0.15 109.597 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -83.5 116.85 2.34 Favored 'Trans proline' 0 CA--C 1.566 2.097 0 C-N-CA 122.251 1.967 . . . . 0.15 114.729 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -125.59 158.37 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.979 0.895 . . . . 0.19 110.851 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -143.02 19.86 1.95 Allowed 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 114.844 -1.071 . . . . 2.53 112.13 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -125.84 161.71 26.8 Favored 'General case' 0 C--N 1.362 1.114 0 CA-C-O 121.297 0.57 . . . . 2.12 111.786 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.5 OUTLIER -120.29 140.59 51.01 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.445 0.906 . . . . 0.42 113.445 -179.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.14 -137.77 4.92 Favored Glycine 0 CA--C 1.528 0.851 0 CA-C-N 114.123 -1.399 . . . . 0.23 112.332 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.1 mt-10 -117.66 106.37 13.01 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 118.334 1.067 . . . . 1.75 111.105 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -99.36 129.9 45.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.179 0.514 . . . . 0.21 111.256 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.99 118.94 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.798 0.808 . . . . 0.2 110.731 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.472 HD12 HD12 ' A' ' 172' ' ' ILE . 1.5 tt -106.98 105.3 15.26 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.118 -1.401 . . . . 0.78 109.956 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -113.05 127.57 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 114.471 -1.241 . . . . 0.44 108.705 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.95 137.49 52.28 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.04 0.756 . . . . 1.25 113.04 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 17.7 tptt -102.96 115.99 31.67 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.361 -0.836 . . . . 2.52 110.723 177.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 15.0 m-85 -105.74 134.87 48.16 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.95 -0.568 . . . . 0.4 110.379 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.6 156.34 48.17 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.248 0.547 . . . . 0.41 112.26 -178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -121.33 133.19 55.11 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.803 0.841 . . . . 2.61 111.147 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.49 27.04 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 114.645 1.35 . . . . 2.13 114.645 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -159.19 -37.11 0.06 Allowed 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 114.535 1.309 . . . . 2.27 114.535 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -118.31 130.44 56.03 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 113.075 0.768 . . . . 1.46 113.075 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.17 95.28 5.21 Favored 'General case' 0 CA--C 1.562 1.428 0 CA-C-O 122.494 1.14 . . . . 0.84 110.805 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -154.15 149.36 26.99 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.107 -0.951 . . . . 2.45 112.661 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.0 m -124.97 125.96 44.72 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.649 -0.705 . . . . 1.66 112.865 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 68.16 49.06 0.87 Allowed 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 125.695 1.598 . . . . 1.89 113.179 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -145.8 -41.14 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.602 1.161 . . . . 2.56 109.788 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -112.13 82.68 1.67 Allowed 'General case' 0 C--N 1.359 1.011 0 N-CA-C 108.462 -0.94 . . . . 2.76 108.462 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.59 115.3 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 113.997 -1.456 . . . . 0.69 110.321 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.443 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 34.1 m-85 -97.46 175.97 6.04 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.381 1.623 . . . . 0.7 115.381 -175.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -123.0 135.16 54.36 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 116.531 -0.304 . . . . 1.33 110.509 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.5 t -130.12 124.99 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.35 0 CA-C-O 121.338 0.589 . . . . 0.48 110.144 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 37.3 mtt180 -122.57 153.37 39.35 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 115.028 1.492 . . . . 1.69 115.028 -177.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.0 OUTLIER -132.71 104.54 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 115.334 -0.848 . . . . 0.6 112.831 179.352 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.537 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.78 27.0 13.03 Favored 'General case' 0 N--CA 1.522 3.14 0 C-N-CA 126.9 2.08 . . . . 1.12 113.689 -179.004 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.63 -19.66 33.23 Favored Glycine 0 CA--C 1.547 2.05 0 CA-C-N 116.107 -0.497 . . . . 0.32 113.317 -176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 93.3 m-70 -82.95 171.59 13.69 Favored 'General case' 0 C--N 1.368 1.385 0 C-N-CA 125.345 1.458 . . . . 0.57 113.848 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -123.85 123.08 39.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 122.182 -0.324 . . . . 0.55 110.94 178.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . 0.279 9.9 p -113.36 -48.65 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.144 0 CA-C-N 116.209 -0.451 . . . . 1.06 111.533 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.47 90.53 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-O 121.324 0.583 . . . . 0.44 109.741 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -107.13 90.44 3.3 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-O 123.013 1.387 . . . . 2.3 111.232 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 127.27 77.06 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 129.845 3.258 . . . . 2.48 106.828 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.3 tp -107.14 104.81 14.55 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.963 -1.017 . . . . 1.13 113.541 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -114.62 111.33 21.17 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-N 113.61 -1.632 . . . . 2.35 108.579 177.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.58 -33.54 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.402 0 N-CA-C 114.628 1.344 . . . . 0.68 114.628 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -75.1 -34.97 61.79 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 112.905 0.705 . . . . 0.77 112.905 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -75.05 -27.46 60.02 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 124.12 0.968 . . . . 0.91 113.285 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -79.06 -55.51 5.07 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.35 0.871 . . . . 2.43 113.35 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -89.52 -40.18 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.561 0 N-CA-C 114.021 1.119 . . . . 0.93 114.021 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.65 -72.05 0.2 Allowed Glycine 0 C--N 1.359 1.849 0 CA-C-N 118.217 0.462 . . . . 0.85 113.919 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -102.16 174.79 5.77 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.31 1.044 . . . . 3.18 111.709 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.6 m -70.43 90.85 0.73 Allowed 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.784 1.031 . . . . 2.08 113.784 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 126' ' ' ALA . 0.6 OUTLIER -143.78 -162.68 1.51 Allowed 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.745 -1.57 . . . . 0.62 109.888 -178.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.401 ' H ' ' HB ' ' A' ' 125' ' ' THR . . . -99.89 134.08 43.31 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 113.509 0.929 . . . . 0.46 113.509 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.416 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 6.1 t60 -105.87 142.92 34.77 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.194 0.598 . . . . 0.38 110.115 177.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -146.41 137.66 24.45 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.928 1.085 . . . . 2.5 113.928 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -128.34 135.36 49.47 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.928 -1.033 . . . . 1.56 110.774 175.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.93 125.18 65.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 CA-C-N 115.02 -0.991 . . . . 0.45 111.107 -178.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -129.05 89.01 49.84 Favored Pre-proline 0 CA--C 1.572 1.815 0 CA-C-N 115.464 -0.789 . . . . 0.84 110.927 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -74.95 129.82 12.75 Favored 'Trans proline' 0 C--N 1.394 2.953 0 C-N-CA 122.984 2.456 . . . . 0.16 112.943 175.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -116.53 149.51 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.507 0 CA-C-N 115.177 -0.92 . . . . 0.38 111.107 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.3 t -134.26 117.16 16.14 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-O 121.553 0.692 . . . . 1.31 111.106 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.477 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.4 mt -115.61 126.35 73.12 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.56 0 CA-C-N 114.69 -1.141 . . . . 0.25 108.381 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -140.15 125.3 18.67 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.479 -0.782 . . . . 2.05 110.995 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? 66.56 15.21 10.05 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 125.297 1.439 . . . . 3.55 114.548 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.65 19.44 22.53 Favored Glycine 0 CA--C 1.547 2.053 0 CA-C-O 119.165 -0.797 . . . . 0.37 114.923 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 23.3 mtpp -126.61 143.82 51.1 Favored 'General case' 0 C--N 1.368 1.385 0 CA-C-N 118.435 1.117 . . . . 1.56 112.399 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.38 146.3 27.78 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.262 1.208 . . . . 0.34 114.262 -175.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.3 t -140.93 117.32 10.76 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.916 -1.038 . . . . 0.64 110.625 177.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.253 2.3 p -110.56 98.98 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.514 0 CA-C-N 115.325 -0.852 . . . . 0.46 110.302 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 69.47 -81.91 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.753 0 C-N-CA 125.324 1.45 . . . . 1.56 113.488 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -134.95 26.07 3.3 Favored Glycine 0 CA--C 1.543 1.802 0 CA-C-N 116.022 -0.536 . . . . 0.49 113.668 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -129.72 118.52 22.01 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 123.079 0.552 . . . . 1.82 110.5 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.46 137.37 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.759 0.79 . . . . 1.02 112.626 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 m -153.88 -170.75 3.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 114.31 -1.314 . . . . 0.56 108.792 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.259 6.3 t -103.12 146.16 28.81 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 113.216 0.821 . . . . 1.25 113.216 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.408 ' H ' ' HA ' ' A' ' 139' ' ' LYS . 41.5 t80 -89.88 132.67 35.16 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 122.098 0.951 . . . . 0.29 111.596 178.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.2 p -97.73 -163.09 1.01 Allowed 'General case' 0 CA--C 1.563 1.474 0 CA-C-N 113.9 -1.5 . . . . 1.42 108.888 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -82.45 7.29 65.19 Favored Glycine 0 CA--C 1.56 2.855 0 O-C-N 120.236 -1.54 . . . . 0.42 116.895 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.466 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -160.45 152.89 20.71 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-O 122.303 1.049 . . . . 1.1 112.499 178.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.537 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.5 OUTLIER -108.42 137.62 46.07 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 113.81 -1.541 . . . . 0.67 108.854 177.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 t -118.56 145.12 45.61 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.438 1.644 . . . . 0.36 115.438 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.05 97.3 5.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 106.225 -1.769 . . . . 0.74 106.225 174.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -117.97 124.42 48.15 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 112.645 0.609 . . . . 1.67 112.645 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.21 134.81 54.69 Favored 'General case' 0 C--O 1.249 1.057 0 CA-C-O 122.356 1.074 . . . . 1.8 112.321 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.2 t -107.3 144.51 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 112.77 -2.013 . . . . 0.58 110.326 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -93.02 150.15 20.73 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 113.785 1.031 . . . . 2.18 113.785 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.04 -36.03 4.85 Favored Glycine 0 CA--C 1.545 1.962 0 CA-C-N 115.149 -0.932 . . . . 1.02 114.923 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -127.48 -80.87 0.6 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 117.466 0.633 . . . . 2.86 112.256 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -127.96 -50.72 1.33 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.034 0.534 . . . . 3.91 111.827 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.443 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.8 OUTLIER -85.76 150.04 24.85 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 124.806 1.243 . . . . 1.74 112.124 178.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -112.11 -171.28 0.21 Allowed Pre-proline 0 CA--C 1.561 1.393 0 CA-C-N 113.384 -1.735 . . . . 1.68 108.236 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -65.27 96.88 0.29 Allowed 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.141 1.894 . . . . 2.06 111.567 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.7 ttmp? -51.08 -57.33 8.97 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 127.104 2.162 . . . . 3.0 116.619 -174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 59.0 t -106.95 131.55 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-N 118.96 0.8 . . . . 0.8 108.899 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.9 t -132.86 125.06 29.13 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 124.004 0.815 . . . . 0.87 112.146 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.507 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.289 . . -120.53 48.33 1.62 Allowed 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.279 1.955 . . . . 0.34 116.279 -177.082 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.77 134.51 2.51 Favored 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 116.238 1.94 . . . . 0.7 116.238 177.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -151.02 102.6 2.98 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.421 -0.809 . . . . 0.21 110.821 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.472 HD12 HD12 ' A' ' 85' ' ' LEU 0.296 7.7 tt -112.77 121.77 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.186 0 CA-C-O 122.276 1.036 . . . . 0.31 111.361 176.033 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -124.4 165.59 17.46 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.057 -1.429 . . . . 0.44 110.479 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.8 ptmm? -122.24 159.16 27.89 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 118.914 2.931 . . . . 1.26 118.914 -174.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.27 -41.47 2.14 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-N 109.9 -3.318 . . . . 0.17 118.973 173.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.35 154.54 1.03 Allowed 'General case' 0 N--CA 1.516 2.851 0 CA-C-N 120.211 2.005 . . . . 0.15 113.011 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.49 -15.22 59.95 Favored 'General case' 0 CA--C 1.581 2.148 0 C-N-CA 124.859 1.264 . . . . 0.17 114.354 176.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.9 3.19 49.44 Favored 'General case' 0 CA--C 1.574 1.866 0 N-CA-C 113.921 1.082 . . . . 0.55 113.921 177.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.652 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 1.0 OUTLIER -109.45 -2.38 17.74 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 113.435 0.902 . . . . 0.6 113.435 179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.18 92.64 0.48 Allowed Pre-proline 0 N--CA 1.508 2.468 0 C-N-CA 124.552 1.141 . . . . 0.95 110.998 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 57.0 Cg_endo -93.5 145.09 2.13 Favored 'Trans proline' 0 C--N 1.386 2.547 0 C-N-CA 122.827 2.351 . . . . 1.8 114.654 179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 12.8 tpt -146.27 113.63 6.28 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.925 -0.58 . . . . 4.96 111.311 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 12.5 mt -134.42 156.25 48.88 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.703 0.764 . . . . 4.0 111.864 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -101.29 160.35 26.85 Favored Pre-proline 0 CA--C 1.561 1.381 0 CA-C-N 115.341 -0.845 . . . . 6.27 111.896 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -64.39 121.95 9.72 Favored 'Trans proline' 0 C--N 1.399 3.205 0 C-N-CA 122.987 2.458 . . . . 6.59 114.963 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -135.34 142.2 40.58 Favored Pre-proline 0 CA--C 1.565 1.554 0 CA-C-N 115.044 -0.98 . . . . 5.51 111.096 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -87.39 -156.08 0.06 OUTLIER 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 122.999 2.466 . . . . 6.77 114.128 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 164.87 102.15 0.16 Allowed Glycine 0 C--N 1.34 0.778 0 C-N-CA 120.96 -0.638 . . . . 7.02 113.211 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.9 mt -118.44 101.58 8.27 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.002 0.429 . . . . 8.99 111.577 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.282 -0.866 . . . . 10.6 111.062 -179.827 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.521 -0.232 . . . . 8.93 112.521 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.46 131.0 55.53 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.54 0.686 . . . . 6.82 112.022 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.1 ttt -137.03 -66.67 0.51 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 115.704 -0.68 . . . . 7.64 111.465 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.4 m -134.34 118.93 18.04 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.635 0.374 . . . . 3.86 111.682 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.65 86.46 0.11 Allowed Glycine 0 C--N 1.342 0.904 0 CA-C-N 115.769 -0.65 . . . . 1.11 113.325 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.52 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.3 tp -88.69 -48.02 7.83 Favored 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 123.921 0.889 . . . . 0.35 113.148 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.46 -24.58 63.68 Favored 'General case' 0 N--CA 1.51 2.535 0 C-N-CA 126.005 1.722 . . . . 0.2 115.504 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.59 -9.53 55.88 Favored 'General case' 0 CA--C 1.565 1.556 0 N-CA-C 113.582 0.956 . . . . 0.32 113.582 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 26.0 mmtp -107.16 -24.97 11.74 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.561 0.948 . . . . 1.73 113.561 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.69 134.91 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.056 0 N-CA-C 115.494 1.665 . . . . 0.11 115.494 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -120.09 -30.65 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 115.244 -0.889 . . . . 0.16 112.123 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 61.9 t90 -161.37 119.48 2.36 Favored 'General case' 0 CA--C 1.559 1.314 0 CA-C-O 120.507 0.194 . . . . 0.54 111.177 -178.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -138.22 127.85 25.02 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.158 -0.964 . . . . 0.19 111.301 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.3 t -137.22 129.74 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.098 0 N-CA-C 113.679 0.992 . . . . 1.05 113.679 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -115.9 106.1 13.42 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.582 -1.266 . . . . 2.11 107.582 173.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.48 100.48 6.89 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 122.06 0.933 . . . . 0.63 111.592 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.517 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 178.16 -55.86 0.09 OUTLIER Glycine 0 C--N 1.349 1.295 0 CA-C-N 113.946 -1.479 . . . . 0.71 115.859 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -111.6 -116.18 3.55 Favored Glycine 0 C--N 1.346 1.102 0 N-CA-C 114.297 0.479 . . . . 0.8 114.297 -177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 13.9 mt-10 -165.45 116.26 1.09 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.011 0.524 . . . . 1.63 111.55 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.8 OUTLIER 43.73 108.62 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 118.452 2.76 . . . . 1.0 118.452 178.227 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.634 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 74.0 t60 -135.27 132.91 38.37 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.939 1.088 . . . . 0.45 113.939 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.5 p -108.01 114.64 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.003 0 CA-C-N 113.884 -1.507 . . . . 1.39 109.022 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -84.62 167.29 16.39 Favored 'General case' 0 CA--C 1.564 1.486 0 CA-C-N 115.322 -0.854 . . . . 1.85 113.039 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -43.47 -34.48 0.78 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.039 0 N-CA-C 118.716 2.858 . . . . 0.72 118.716 -176.324 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -87.31 -26.53 23.36 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.204 0.526 . . . . 0.51 110.95 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.64 45.16 0.48 Allowed Glycine 0 C--N 1.354 1.541 0 CA-C-N 114.854 -1.066 . . . . 0.34 114.346 177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.52 HD11 ' HG ' ' A' ' 6' ' ' LEU . 15.7 mm -107.11 116.25 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 CA-C-O 120.94 0.4 . . . . 0.55 110.085 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.634 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.1 t-160 -108.44 133.58 52.41 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 115.095 1.517 . . . . 1.34 115.095 -177.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.571 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.33 140.56 31.61 Favored 'General case' 0 CA--C 1.56 1.354 0 CA-C-N 114.794 -1.093 . . . . 2.79 110.718 176.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -90.24 130.46 36.36 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 124.974 1.31 . . . . 3.0 112.4 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -56.61 115.26 2.43 Favored 'General case' 0 N--CA 1.509 2.517 0 N-CA-C 118.996 2.961 . . . . 2.3 118.996 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 40.59 57.46 7.97 Favored Pre-proline 0 N--CA 1.526 3.349 0 N-CA-C 118.549 2.796 . . . . 1.17 118.549 176.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -102.64 59.64 0.03 OUTLIER 'Trans proline' 0 CA--C 1.569 2.232 0 C-N-CA 122.79 2.327 . . . . 1.45 116.218 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.72 -66.01 0.31 Allowed 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 112.684 0.624 . . . . 1.91 112.684 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.676 ' H ' HH22 ' A' ' 65' ' ' ARG . 12.1 mt-10 -106.98 96.8 6.69 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.504 0.669 . . . . 4.84 112.667 -178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.31 -30.8 8.88 Favored Glycine 0 CA--C 1.543 1.834 0 CA-C-N 114.674 -1.148 . . . . 2.37 113.962 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? 77.91 -19.36 0.44 Allowed 'General case' 0 N--CA 1.508 2.464 0 N-CA-C 115.833 1.79 . . . . 4.5 115.833 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.99 117.08 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 123.072 0.549 . . . . 2.7 110.61 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.65 -139.87 2.74 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.085 -0.579 . . . . 1.95 114.182 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -139.69 -171.62 3.19 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 121.53 0.681 . . . . 5.34 112.306 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.93 130.93 44.16 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.923 0.889 . . . . 1.64 111.983 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -121.28 130.08 53.47 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.288 -0.869 . . . . 1.57 111.405 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -129.51 103.38 6.85 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 115.885 -0.598 . . . . 2.33 112.026 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -113.49 65.52 0.65 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.437 -0.801 . . . . 3.16 110.142 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.04 71.7 0.1 Allowed Glycine 0 C--N 1.344 1.015 0 CA-C-N 114.615 -1.175 . . . . 1.52 111.444 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.61 -25.14 18.44 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.116 1.154 . . . . 1.67 114.116 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.45 71.11 1.07 Allowed 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 122.138 0.97 . . . . 4.18 111.037 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.91 72.72 0.55 Allowed Pre-proline 0 CA--C 1.552 1.057 0 CA-C-N 113.312 -1.767 . . . . 2.63 107.406 -179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 44.7 Cg_exo -65.01 159.21 47.57 Favored 'Trans proline' 0 N--CA 1.513 2.633 0 C-N-CA 124.534 3.489 . . . . 1.37 117.522 -178.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.75 130.05 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.291 0 CA-C-N 114.815 -1.084 . . . . 0.69 108.125 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.44 ' HB2' HG22 ' A' ' 125' ' ' THR . 7.1 mt -83.48 -9.68 58.83 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.719 2.118 . . . . 1.28 116.719 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -105.88 8.02 32.47 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 114.329 1.233 . . . . 1.51 114.329 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.8 -177.82 4.6 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-O 121.7 0.762 . . . . 1.09 112.309 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.701 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -93.85 169.48 9.93 Favored Pre-proline 0 N--CA 1.514 2.768 0 C-N-CA 124.606 1.162 . . . . 1.27 110.044 178.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.78 -41.86 51.11 Favored 'Trans proline' 0 N--CA 1.53 3.642 0 C-N-CA 123.289 2.66 . . . . 0.95 116.298 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -68.03 -52.51 34.64 Favored 'General case' 0 N--CA 1.502 2.14 0 C-N-CA 124.439 1.095 . . . . 2.04 112.119 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 5.8 t0 -78.11 -1.97 35.13 Favored 'General case' 0 CA--C 1.59 2.505 0 CA-C-N 115.225 -0.898 . . . . 1.62 112.174 177.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.701 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 14.5 tt0 -75.69 -40.66 55.49 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 126.132 1.773 . . . . 1.77 108.122 174.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.5 t -63.71 -43.1 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.106 0 C-N-CA 124.635 1.174 . . . . 0.81 108.574 172.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.467 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.4 tp -79.86 -5.27 55.16 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 113.59 0.959 . . . . 1.15 113.59 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 4.2 m-30 -122.46 20.08 10.41 Favored 'General case' 0 CA--C 1.577 1.995 0 C-N-CA 124.786 1.235 . . . . 0.92 111.887 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -148.01 -29.01 0.32 Allowed 'General case' 0 N--CA 1.509 2.519 0 N-CA-C 116.399 2.0 . . . . 1.33 116.399 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.4 p -74.99 132.0 41.05 Favored 'General case' 0 N--CA 1.521 3.107 0 N-CA-C 115.085 1.513 . . . . 1.28 115.085 -176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.517 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -123.05 148.38 45.64 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 124.221 1.008 . . . . 1.53 112.687 -178.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.676 HH22 ' H ' ' A' ' 35' ' ' GLU . 13.5 mtp180 -98.73 -84.83 0.39 Allowed 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 112.759 0.651 . . . . 3.22 112.759 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.88 167.76 28.61 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.526 0.679 . . . . 3.66 112.742 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -126.63 139.93 52.81 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 115.612 -0.722 . . . . 4.7 112.733 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -138.63 -109.42 0.17 Allowed 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 115.831 -0.622 . . . . 2.55 110.939 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.19 121.14 3.83 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 118.351 0.523 . . . . 2.15 111.354 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.24 88.3 0.04 OUTLIER 'General case' 0 N--CA 1.52 3.04 0 C-N-CA 125.722 1.609 . . . . 0.77 114.067 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -148.58 156.22 42.14 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.283 0.846 . . . . 0.81 113.283 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -173.14 -171.99 38.29 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 116.039 1.176 . . . . 0.47 116.039 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.56 173.17 6.45 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 114.866 1.432 . . . . 0.89 114.866 -177.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -129.38 133.48 47.4 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 114.219 -1.355 . . . . 0.51 111.992 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.57 100.47 34.79 Favored Pre-proline 0 CA--C 1.567 1.623 0 N-CA-C 109.074 -0.713 . . . . 0.15 109.074 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -84.38 118.06 2.19 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.084 1.856 . . . . 0.15 115.036 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.67 159.71 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.549 0 CA-C-O 122.043 0.925 . . . . 0.19 111.134 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -143.91 20.18 1.8 Allowed 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 114.888 -1.051 . . . . 2.53 112.331 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -128.58 158.45 38.44 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-O 121.963 0.887 . . . . 2.12 111.117 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.89 139.85 50.14 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.887 1.069 . . . . 0.42 113.887 -178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.9 -125.35 1.35 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 113.961 -1.472 . . . . 0.23 112.393 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -126.31 118.63 25.48 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.085 0.469 . . . . 1.75 111.178 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -118.83 139.92 50.81 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-N 115.788 -0.642 . . . . 0.21 109.907 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 172' ' ' ILE . 2.5 t -120.59 127.59 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-O 121.366 0.603 . . . . 0.2 110.896 -177.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.7 107.9 18.96 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-N 115.068 -0.969 . . . . 0.78 109.861 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.4 t -117.64 128.5 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 109.045 -0.724 . . . . 0.44 109.045 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.64 146.31 49.42 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.81 1.041 . . . . 1.25 113.81 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -108.75 122.47 47.21 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 115.441 -0.8 . . . . 2.52 110.314 176.145 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -109.28 136.72 48.27 Favored 'General case' 0 CA--C 1.556 1.184 0 CA-C-N 114.871 -1.059 . . . . 0.4 110.415 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.598 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . -143.77 157.14 44.59 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 124.192 0.997 . . . . 0.41 111.307 -178.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -169.92 127.38 0.88 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.353 0.661 . . . . 2.61 110.917 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.83 73.62 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-N 115.664 -0.698 . . . . 2.13 111.27 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -160.19 -47.35 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 115.959 -0.564 . . . . 2.27 112.126 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -115.19 116.87 29.07 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.803 0.441 . . . . 1.46 111.169 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.24 99.06 8.9 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-O 122.646 1.213 . . . . 0.84 112.11 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -159.19 160.66 35.71 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 114.465 -1.243 . . . . 2.45 111.061 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 m -108.31 -78.66 0.59 Allowed 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 114.047 1.128 . . . . 1.66 114.047 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -95.47 70.47 3.11 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.296 1.046 . . . . 1.89 111.407 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -159.23 -40.06 0.06 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 113.639 -1.619 . . . . 2.56 109.346 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -106.02 79.25 1.39 Allowed 'General case' 0 C--N 1.368 1.375 0 CA-C-O 121.838 0.828 . . . . 2.76 109.086 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.24 123.09 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 114.439 -1.255 . . . . 0.69 111.395 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.554 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 30.2 m-85 -106.1 171.41 7.36 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 114.395 1.257 . . . . 0.7 114.395 -177.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -124.88 135.71 53.13 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 109.828 -0.434 . . . . 1.33 109.828 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.0 t -130.07 125.8 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 CA-C-N 116.104 -0.498 . . . . 0.48 109.846 -177.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.66 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 23.0 mtt180 -124.55 148.57 47.72 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 115.236 1.569 . . . . 1.69 115.236 -176.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 154' ' ' SER . 5.1 m -125.56 112.38 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.699 0 N-CA-C 113.095 0.776 . . . . 0.6 113.095 177.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.465 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 63.62 25.99 14.49 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 126.551 1.94 . . . . 1.12 113.894 -178.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 103.36 -14.33 54.59 Favored Glycine 0 CA--C 1.552 2.389 0 C-N-CA 121.456 -0.402 . . . . 0.32 113.804 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.66 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 91.3 m-70 -87.93 172.56 9.5 Favored 'General case' 0 C--N 1.361 1.087 0 C-N-CA 126.059 1.744 . . . . 0.57 113.362 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.89 132.31 54.5 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.584 0.707 . . . . 0.55 112.082 178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.75 -55.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 CA-C-N 114.775 -1.102 . . . . 1.06 113.141 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.23 89.46 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.631 -0.877 . . . . 0.44 108.631 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -106.45 108.68 20.31 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-O 122.905 1.336 . . . . 2.3 110.572 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 105.14 70.63 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 110.868 -2.878 . . . . 2.48 108.259 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.27 99.5 12.47 Favored 'General case' 0 C--N 1.359 0.983 0 CA-C-N 115.333 -0.849 . . . . 1.13 112.36 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -109.83 91.84 3.81 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 113.545 -1.661 . . . . 2.35 108.755 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -31.25 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.711 0 N-CA-C 116.746 2.128 . . . . 0.68 116.746 -177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -74.0 -40.54 62.87 Favored 'General case' 0 CA--C 1.569 1.706 0 C-N-CA 124.014 0.926 . . . . 0.77 112.445 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -26.1 59.97 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 124.443 1.097 . . . . 0.91 113.374 176.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -78.21 -58.09 3.44 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.573 0.953 . . . . 2.43 113.573 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.26 -32.91 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 N-CA-C 114.921 1.452 . . . . 0.93 114.921 178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 128.23 -118.11 2.74 Favored Glycine 0 C--N 1.356 1.639 0 CA-C-N 118.757 0.708 . . . . 0.85 113.006 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -115.1 107.44 15.34 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.297 0.57 . . . . 3.18 111.173 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.0 m 70.69 -134.57 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 C-N-CA 125.592 1.557 . . . . 2.08 113.128 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.44 HG22 ' HB2' ' A' ' 51' ' ' LEU . 67.8 p 60.4 -151.48 0.4 Allowed 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 126.179 1.792 . . . . 0.62 114.382 178.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -112.13 130.37 55.92 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 114.141 1.163 . . . . 0.46 114.141 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -108.65 124.38 50.43 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.402 -0.962 . . . . 0.38 108.402 174.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.41 129.18 24.7 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.038 0.755 . . . . 2.5 113.038 -177.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -116.03 134.91 54.45 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 115.047 -0.978 . . . . 1.56 111.492 177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.25 114.01 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 113.884 -1.507 . . . . 0.45 109.999 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.23 98.0 33.54 Favored Pre-proline 0 CA--C 1.574 1.866 0 CA-C-N 115.871 -0.604 . . . . 0.84 111.146 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -73.59 144.55 35.96 Favored 'Trans proline' 0 C--N 1.399 3.205 0 C-N-CA 123.293 2.662 . . . . 0.16 114.652 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.59 146.38 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 CA-C-N 115.135 -0.938 . . . . 0.38 110.854 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.8 p -131.41 112.58 12.82 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.495 -0.775 . . . . 1.31 111.406 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 3.2 mt -111.98 121.64 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 CA-C-N 115.38 -0.827 . . . . 0.25 108.882 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -141.94 130.74 22.91 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 116.274 -0.421 . . . . 2.05 111.273 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp 70.67 9.04 6.78 Favored 'General case' 0 N--CA 1.518 2.972 0 C-N-CA 125.033 1.333 . . . . 3.55 114.219 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.07 18.1 25.53 Favored Glycine 0 CA--C 1.544 1.859 0 C-N-CA 124.19 0.9 . . . . 0.37 113.997 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -127.16 146.68 50.31 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-N 117.768 0.784 . . . . 1.56 112.746 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.08 141.72 31.48 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 114.234 1.198 . . . . 0.34 114.234 -176.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.8 m -130.01 113.42 14.55 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.626 -1.17 . . . . 0.64 110.155 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.252 9.1 p -121.48 97.03 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.369 0 CA-C-N 116.004 -0.544 . . . . 0.46 110.901 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 67.55 -85.45 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.682 0 C-N-CA 125.658 1.583 . . . . 1.56 113.874 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.03 29.3 3.53 Favored Glycine 0 CA--C 1.542 1.737 0 CA-C-N 115.994 -0.548 . . . . 0.49 112.979 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -133.17 125.72 30.06 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 123.507 0.723 . . . . 1.82 110.651 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.11 126.02 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.303 0 CA-C-O 121.46 0.648 . . . . 1.02 111.07 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 m -145.93 -178.89 6.35 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.285 -0.871 . . . . 0.56 109.969 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.273 12.4 t -103.14 137.03 41.85 Favored 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 113.414 0.894 . . . . 1.25 113.414 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -83.43 125.37 31.64 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.434 1.094 . . . . 0.29 112.011 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.81 91.22 2.95 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 112.649 0.611 . . . . 1.42 112.649 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.46 -66.22 3.53 Favored Glycine 0 C--N 1.358 1.786 0 N-CA-C 119.03 2.372 . . . . 0.42 119.03 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.17 156.87 44.57 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.142 1.164 . . . . 1.1 114.142 -175.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.465 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -105.98 133.45 50.68 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 113.035 -1.893 . . . . 0.67 108.545 176.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.6 t -120.14 143.7 48.05 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.737 1.754 . . . . 0.36 115.737 -175.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.451 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -115.51 100.29 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.945 -1.132 . . . . 0.74 107.945 176.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -118.81 125.28 49.21 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.978 -0.555 . . . . 1.67 111.952 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.81 132.73 56.62 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 122.09 0.947 . . . . 1.8 111.771 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 t -110.35 143.28 20.64 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.911 0 CA-C-N 113.381 -1.736 . . . . 0.58 109.674 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.65 151.85 22.19 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 114.756 1.391 . . . . 2.18 114.756 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.78 -26.64 7.05 Favored Glycine 0 CA--C 1.55 2.253 0 CA-C-N 115.027 -0.988 . . . . 1.02 115.254 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -132.01 -78.81 0.51 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.045 0.922 . . . . 2.86 112.616 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -135.87 -49.41 0.69 Allowed 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.078 0.551 . . . . 3.91 111.518 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.554 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -94.42 135.43 35.85 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 124.591 1.156 . . . . 1.74 111.521 178.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -94.26 -169.83 0.21 Allowed Pre-proline 0 CA--C 1.568 1.667 0 CA-C-N 113.979 -1.464 . . . . 1.68 108.576 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -66.55 99.99 0.46 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 CA-C-N 122.311 1.861 . . . . 2.06 111.3 175.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.4 ttpt -57.18 -49.92 74.48 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 115.498 1.666 . . . . 3.0 115.498 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 64' ' ' GLU . 19.0 t -110.56 130.99 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.076 -0.713 . . . . 0.8 109.076 177.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -136.9 124.72 22.56 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 113.597 -1.638 . . . . 0.87 111.482 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.256 . . -121.31 49.97 1.44 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.75 1.759 . . . . 0.34 115.75 -176.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.69 135.15 2.98 Favored 'General case' 0 N--CA 1.511 2.615 0 N-CA-C 116.175 1.917 . . . . 0.7 116.175 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -153.6 100.67 2.42 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.38 -0.827 . . . . 0.21 110.6 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 84' ' ' VAL 0.308 5.2 tt -109.26 122.48 63.96 Favored 'Isoleucine or valine' 0 C--O 1.27 2.156 0 CA-C-O 122.346 1.069 . . . . 0.31 111.383 176.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -120.27 154.2 35.28 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 113.755 -1.566 . . . . 0.44 112.221 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 50.5 tttm -105.92 150.0 26.07 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 118.09 2.626 . . . . 1.26 118.09 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.43 -39.59 2.77 Favored Glycine 0 CA--C 1.538 1.488 0 CA-C-N 110.98 -2.827 . . . . 0.17 119.805 172.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.73 164.12 1.21 Allowed 'General case' 0 N--CA 1.513 2.696 0 CA-C-N 121.218 2.509 . . . . 0.15 112.571 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -82.88 -16.07 48.98 Favored 'General case' 0 CA--C 1.579 2.085 0 C-N-CA 124.722 1.209 . . . . 0.17 113.8 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.36 4.65 45.42 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 114.363 1.246 . . . . 0.55 114.363 178.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.527 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -103.3 -11.89 17.63 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.27 1.211 . . . . 0.6 114.27 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -82.44 99.82 0.7 Allowed Pre-proline 0 N--CA 1.513 2.713 0 C-N-CA 124.036 0.934 . . . . 0.95 113.08 178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.527 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 8.7 Cg_exo -79.64 131.23 9.2 Favored 'Trans proline' 0 C--N 1.401 3.308 0 C-N-CA 123.025 2.483 . . . . 1.8 114.309 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 15.6 ttt -145.69 117.63 8.25 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.818 -0.628 . . . . 4.96 111.058 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.1 mt -131.04 163.48 27.52 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 122.058 0.932 . . . . 4.0 112.665 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -104.72 158.05 32.83 Favored Pre-proline 0 CA--C 1.558 1.28 0 CA-C-N 114.608 -1.178 . . . . 6.27 110.841 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.5 121.67 8.79 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 122.479 2.119 . . . . 6.59 115.034 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -135.79 136.49 23.54 Favored Pre-proline 0 CA--C 1.569 1.675 0 CA-C-N 114.86 -1.063 . . . . 5.51 111.134 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.52 -19.21 13.22 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 123.702 2.935 . . . . 6.77 116.674 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -108.6 -69.71 0.66 Allowed Glycine 0 CA--C 1.534 1.258 0 N-CA-C 115.07 0.788 . . . . 7.02 115.07 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.0 tp -117.6 133.65 55.72 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 121.226 0.536 . . . . 8.99 112.205 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.332 -0.842 . . . . 10.6 111.267 -179.784 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.514 -0.234 . . . . 8.93 112.514 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.47 127.96 55.85 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.631 0.729 . . . . 6.82 111.945 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -133.42 110.14 9.8 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.6 -0.727 . . . . 7.64 111.194 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 m -135.96 117.38 14.72 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.781 -0.645 . . . . 3.86 111.789 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.26 92.65 0.09 OUTLIER Glycine 0 C--N 1.341 0.836 0 CA-C-N 115.683 -0.689 . . . . 1.11 113.158 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.57 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.6 tp -87.73 -45.43 10.36 Favored 'General case' 0 CA--C 1.564 1.482 0 N-CA-C 113.22 0.822 . . . . 0.35 113.22 179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.51 -23.07 64.26 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 125.807 1.643 . . . . 0.2 114.965 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.49 -12.53 48.65 Favored 'General case' 0 CA--C 1.565 1.557 0 N-CA-C 113.632 0.975 . . . . 0.32 113.632 178.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.1 mmtp -104.19 -23.58 13.24 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-O 118.211 -0.9 . . . . 1.73 113.227 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.49 133.36 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.895 0 N-CA-C 115.094 1.516 . . . . 0.11 115.094 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pt -120.52 -28.28 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.183 -0.917 . . . . 0.16 112.264 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 62.4 t90 -163.97 116.91 1.43 Allowed 'General case' 0 CA--C 1.558 1.27 0 CA-C-O 120.583 0.23 . . . . 0.54 111.141 -177.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.32 130.87 35.71 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.569 -0.707 . . . . 0.19 111.202 179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -137.74 129.69 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 113.422 0.897 . . . . 1.05 113.422 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -117.05 105.23 12.06 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.01 -1.478 . . . . 2.11 107.01 171.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.17 108.22 12.51 Favored 'General case' 0 C--O 1.254 1.305 0 CA-C-O 121.639 0.733 . . . . 0.63 111.553 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.2 -43.71 0.37 Allowed Glycine 0 C--N 1.351 1.374 0 CA-C-N 114.265 -1.334 . . . . 0.71 115.652 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.435 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -115.15 -121.25 3.45 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 117.564 0.682 . . . . 0.8 113.892 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 18.1 mt-10 -164.83 115.36 1.16 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.295 0.638 . . . . 1.63 111.133 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 1.1 m 42.85 110.15 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 118.589 2.811 . . . . 1.0 118.589 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.586 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 78.1 t60 -136.58 131.79 34.25 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 114.358 1.244 . . . . 0.45 114.358 177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.6 p -104.93 114.48 44.65 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.907 0 CA-C-N 113.958 -1.474 . . . . 1.39 108.967 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -85.21 165.83 17.06 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 115.107 -0.951 . . . . 1.85 113.155 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -44.59 -30.46 0.67 Allowed 'Isoleucine or valine' 1 N--CA 1.539 4.014 0 N-CA-C 118.667 2.84 . . . . 0.72 118.667 -176.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 80.1 m-70 -89.17 -27.04 20.96 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.233 0.539 . . . . 0.51 110.936 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.54 42.66 0.57 Allowed Glycine 0 C--N 1.351 1.393 0 CA-C-N 114.82 -1.082 . . . . 0.34 114.059 177.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.57 HD11 ' HG ' ' A' ' 6' ' ' LEU . 20.2 mm -107.54 117.05 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-O 121.107 0.48 . . . . 0.55 110.195 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.4 t60 -106.52 131.61 53.48 Favored 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.882 1.438 . . . . 1.34 114.882 -177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.536 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -93.07 137.41 32.45 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 124.058 0.943 . . . . 2.79 109.639 175.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.473 ' O ' ' HG3' ' A' ' 33' ' ' PRO . 12.9 ptm180 -99.0 105.86 18.06 Favored 'General case' 0 CA--C 1.559 1.298 0 CA-C-N 114.54 -1.209 . . . . 3.0 113.335 -178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -23.14 119.84 0.04 OUTLIER 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 120.57 3.545 . . . . 2.3 120.57 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 34.42 54.17 1.59 Allowed Pre-proline 0 N--CA 1.536 3.868 0 N-CA-C 119.576 3.176 . . . . 1.17 119.576 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.473 ' HG3' ' O ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -110.65 104.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.569 2.268 0 C-N-CA 123.423 2.749 . . . . 1.45 116.908 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.64 -90.58 0.53 Allowed 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.598 -0.728 . . . . 1.91 110.253 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.42 58.81 0.95 Allowed 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 112.755 0.65 . . . . 4.84 112.755 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 110.94 1.62 28.57 Favored Glycine 0 CA--C 1.547 2.041 0 N-CA-C 115.594 0.997 . . . . 2.37 115.594 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' A' ' 37' ' ' ARG . 2.6 mpt_? -104.42 77.35 1.38 Allowed 'General case' 0 C--N 1.356 0.87 0 CA-C-N 117.793 0.797 . . . . 4.5 111.841 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.73 116.08 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 115.769 -0.651 . . . . 2.7 112.405 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.01 50.43 0.73 Allowed Glycine 0 CA--C 1.538 1.523 0 N-CA-C 115.233 0.853 . . . . 1.95 115.233 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -162.14 97.3 1.02 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 117.625 0.713 . . . . 5.34 111.102 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.66 136.64 46.1 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.565 0.746 . . . . 1.64 111.602 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.1 m -122.6 107.97 12.59 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-O 121.313 0.577 . . . . 1.57 112.382 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -124.66 71.39 1.16 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.365 -0.834 . . . . 2.33 110.616 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 37.9 t80 -110.82 72.72 0.79 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.99 -1.004 . . . . 3.16 110.527 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.85 63.37 0.02 OUTLIER Glycine 0 CA--C 1.528 0.861 0 CA-C-N 114.933 -1.03 . . . . 1.52 113.334 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 5.8 mmt -92.75 -0.09 57.33 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 113.149 0.796 . . . . 1.67 113.149 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -105.91 24.21 12.72 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 113.679 0.992 . . . . 4.18 113.679 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.0 mt -139.59 74.59 33.38 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 107.888 -1.152 . . . . 2.63 107.888 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -62.45 166.65 12.8 Favored 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 124.666 3.577 . . . . 1.37 117.288 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.437 HG23 ' HB2' ' A' ' 126' ' ' ALA 0.262 1.0 OUTLIER -93.85 123.28 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.777 0 CA-C-N 115.237 -0.892 . . . . 0.69 109.472 178.908 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 7.3 mt -89.22 101.71 14.37 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.871 0.843 . . . . 1.28 112.374 -179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 1.5 mpt_? 148.01 -13.87 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 127.158 2.183 . . . . 1.51 110.578 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' A' ' 57' ' ' ASP . 1.0 OUTLIER -116.54 -179.01 3.56 Favored 'General case' 0 CA--C 1.567 1.599 0 C-N-CA 123.767 0.827 . . . . 1.09 113.09 -179.135 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.1 OUTLIER -95.77 -176.88 0.58 Allowed Pre-proline 0 N--CA 1.51 2.556 0 C-N-CA 124.402 1.081 . . . . 1.27 109.421 178.467 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.456 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 31.3 Cg_exo -68.51 -39.13 9.91 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.679 2.253 . . . . 0.95 113.963 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -67.2 -54.28 22.55 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 125.04 1.336 . . . . 2.04 112.124 178.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.413 ' HB3' ' OG ' ' A' ' 53' ' ' SER . 0.4 OUTLIER -76.55 -5.37 47.34 Favored 'General case' 0 CA--C 1.576 1.947 0 CA-C-N 114.979 -1.01 . . . . 1.62 112.746 178.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.514 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 27.5 tt0 -71.64 -44.14 64.86 Favored 'General case' 0 C--N 1.382 2.015 0 C-N-CA 125.539 1.536 . . . . 1.77 108.07 173.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.37 -38.89 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.095 0 C-N-CA 124.055 0.942 . . . . 0.81 109.481 174.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -82.54 -8.36 59.61 Favored 'General case' 0 CA--C 1.574 1.873 0 N-CA-C 114.116 1.154 . . . . 1.15 114.116 176.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.415 ' O ' HG12 ' A' ' 50' ' ' ILE . 20.4 m-85 -125.02 21.36 8.16 Favored 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.222 1.009 . . . . 0.92 112.928 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.455 HE21 HE21 ' A' ' 58' ' ' GLN . 0.0 OUTLIER -143.8 -31.53 0.46 Allowed 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 115.27 1.582 . . . . 1.33 115.27 -177.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.8 p -73.12 134.23 44.4 Favored 'General case' 0 N--CA 1.524 3.231 0 N-CA-C 114.3 1.222 . . . . 1.28 114.3 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.94 140.49 52.94 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 114.672 1.36 . . . . 1.53 114.672 -176.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.6 ttp85 -110.24 142.45 41.82 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.617 -1.174 . . . . 3.22 111.151 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -108.21 130.9 55.12 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 112.545 0.572 . . . . 3.66 112.545 -178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -125.1 -89.52 0.57 Allowed 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.491 -0.777 . . . . 4.7 111.339 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -162.58 -79.27 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 112.398 0.518 . . . . 2.55 112.398 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -170.45 123.52 0.67 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.283 1.033 . . . . 2.15 109.337 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 70.83 86.53 0.12 Allowed 'General case' 0 N--CA 1.517 2.885 0 C-N-CA 124.717 1.207 . . . . 0.77 111.674 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -140.51 149.74 42.85 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-O 121.998 0.904 . . . . 0.81 112.68 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -158.87 -176.75 31.27 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 114.303 -1.317 . . . . 0.47 115.821 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -120.29 169.55 10.16 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-N 114.117 -1.042 . . . . 0.89 113.729 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -126.06 131.16 52.2 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 114.662 -1.154 . . . . 0.51 111.895 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.1 103.12 33.47 Favored Pre-proline 0 CA--C 1.57 1.719 0 C-N-CA 123.107 0.563 . . . . 0.15 109.567 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -84.15 117.18 2.16 Favored 'Trans proline' 0 CA--C 1.562 1.91 0 C-N-CA 122.264 1.976 . . . . 0.15 114.657 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.26 157.94 33.79 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.625 0 CA-C-O 122.053 0.93 . . . . 0.19 111.112 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -146.13 24.38 1.3 Allowed 'General case' 0 CA--C 1.557 1.236 0 CA-C-N 114.654 -1.157 . . . . 2.53 112.008 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -128.62 160.16 33.3 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-O 121.268 0.556 . . . . 2.12 111.194 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -121.04 142.02 50.21 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.069 1.137 . . . . 0.42 114.069 -178.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.85 -137.34 4.91 Favored Glycine 0 CA--C 1.526 0.73 0 CA-C-N 113.696 -1.593 . . . . 0.23 112.121 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.3 mt-10 -115.63 112.13 21.67 Favored 'General case' 0 C--N 1.359 1.021 0 CA-C-N 118.436 1.118 . . . . 1.75 111.276 178.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -104.49 128.37 52.4 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.147 -0.479 . . . . 0.21 110.896 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -110.35 119.33 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-O 121.977 0.894 . . . . 0.2 110.427 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.6 tt -107.34 104.61 14.24 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.79 -1.55 . . . . 0.78 109.648 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -111.95 126.42 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 CA-C-N 114.367 -1.288 . . . . 0.44 108.57 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -128.52 135.52 49.52 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.594 -0.73 . . . . 1.25 112.418 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 4.4 tppt? -101.5 118.2 36.46 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.447 0.641 . . . . 2.52 110.556 176.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -105.54 134.54 48.5 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.256 -0.884 . . . . 0.4 110.571 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -142.39 151.53 41.94 Favored 'General case' 0 N--CA 1.501 2.116 0 CA-C-O 121.182 0.515 . . . . 0.41 112.266 -178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -147.83 135.23 20.65 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.118 0.567 . . . . 2.61 110.967 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.275 7.5 p -147.06 86.65 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.587 2.388 0 CA-C-O 121.591 0.71 . . . . 2.13 111.851 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -175.12 -46.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.602 -0.726 . . . . 2.27 112.139 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -115.56 139.52 50.0 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 121.193 0.52 . . . . 1.46 112.008 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -112.85 99.68 8.08 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.191 0.996 . . . . 0.84 111.004 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -158.74 140.85 13.89 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 115.317 -0.856 . . . . 2.45 112.313 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.7 m -120.74 130.45 54.05 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.341 -0.845 . . . . 1.66 112.219 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 80.53 10.51 1.09 Allowed 'General case' 0 N--CA 1.519 2.987 0 C-N-CA 125.857 1.663 . . . . 1.89 114.494 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -117.49 -25.71 6.88 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.711 0.804 . . . . 2.56 112.259 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -107.03 79.41 1.32 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 123.484 0.714 . . . . 2.76 109.393 178.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.479 HG13 ' HA ' ' A' ' 114' ' ' ASP 0.261 1.2 t -109.81 126.6 66.99 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.91 0 CA-C-N 114.998 -1.001 . . . . 0.69 110.091 -177.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -118.87 174.31 6.37 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 114.652 1.352 . . . . 0.7 114.652 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.93 136.34 54.92 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.921 -0.487 . . . . 1.33 111.19 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 57.2 t -124.99 123.65 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.025 0 C-N-CA 123.056 0.543 . . . . 0.48 110.07 -177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -121.14 147.13 45.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.653 1.353 . . . . 1.69 114.653 -178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 154' ' ' SER . 50.8 t -130.56 109.75 17.56 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.252 0 N-CA-C 107.68 -1.23 . . . . 0.6 107.68 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.43 26.89 16.03 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 126.992 2.117 . . . . 1.12 114.574 -178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.12 -19.58 40.14 Favored Glycine 0 CA--C 1.548 2.097 0 N-CA-C 114.554 0.582 . . . . 0.32 114.554 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -91.01 154.51 19.38 Favored 'General case' 0 C--N 1.364 1.22 0 C-N-CA 124.837 1.255 . . . . 0.57 113.375 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.3 p -102.93 127.9 49.95 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.609 0.718 . . . . 0.55 111.638 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -115.07 -50.63 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.582 -1.19 . . . . 1.06 110.342 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.43 88.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 119.996 -0.682 . . . . 0.44 110.237 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -106.92 119.23 38.79 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-O 122.41 1.1 . . . . 2.3 110.076 177.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.479 ' HA ' HG13 ' A' ' 101' ' ' VAL . 1.0 OUTLIER 102.96 59.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 128.434 2.694 . . . . 2.48 107.6 -175.414 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.34 96.9 10.76 Favored 'General case' 0 C--N 1.373 1.596 0 CA-C-O 121.634 0.731 . . . . 1.13 112.714 -178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -107.64 97.81 7.49 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 113.652 -1.613 . . . . 2.35 107.448 175.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.08 -30.01 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.458 0 N-CA-C 114.244 1.201 . . . . 0.68 114.244 -176.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -73.89 -41.88 61.5 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 123.481 0.712 . . . . 0.77 112.218 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -72.24 -25.84 61.78 Favored 'General case' 0 CA--C 1.578 2.04 0 C-N-CA 124.537 1.135 . . . . 0.91 113.55 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -79.53 -57.8 3.51 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 113.701 1.0 . . . . 2.43 113.701 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -93.48 -37.89 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.515 0 N-CA-C 114.516 1.302 . . . . 0.93 114.516 178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 129.62 -115.36 1.89 Allowed Glycine 0 C--N 1.354 1.557 0 C-N-CA 121.194 -0.527 . . . . 0.85 113.38 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -114.87 108.06 16.23 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 120.957 0.408 . . . . 3.18 110.422 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.7 m 73.33 -126.2 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 125.466 1.506 . . . . 2.08 111.845 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 68.6 p 57.54 -165.6 0.15 Allowed 'General case' 0 N--CA 1.533 3.718 0 C-N-CA 126.066 1.746 . . . . 0.62 115.343 177.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' A' ' 50' ' ' ILE . . . -113.99 127.57 56.01 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 112.684 0.624 . . . . 0.46 112.684 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -103.53 138.83 39.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.465 -0.569 . . . . 0.38 109.465 176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -144.59 129.37 18.28 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.78 1.03 . . . . 2.5 113.78 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -117.41 129.94 56.17 Favored 'General case' 0 C--O 1.249 1.069 0 CA-C-N 114.759 -1.11 . . . . 1.56 110.939 176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.53 111.59 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 114.493 -1.231 . . . . 0.45 110.658 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 13.5 mm -115.8 92.11 32.97 Favored Pre-proline 0 CA--C 1.582 2.178 0 CA-C-N 115.639 -0.71 . . . . 0.84 110.706 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -77.19 126.33 8.47 Favored 'Trans proline' 0 C--N 1.392 2.824 0 C-N-CA 122.568 2.178 . . . . 0.16 113.032 174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.88 150.81 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 C-N-CA 123.991 0.916 . . . . 0.38 111.067 -177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.0 t -136.7 118.0 14.6 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.524 0.678 . . . . 1.31 111.775 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.461 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -116.98 126.05 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 CA-C-N 114.759 -1.11 . . . . 0.25 108.446 178.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -139.37 122.74 17.13 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.622 -0.717 . . . . 2.05 110.817 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt 67.67 16.16 9.78 Favored 'General case' 0 N--CA 1.517 2.891 0 C-N-CA 125.279 1.432 . . . . 3.55 114.431 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.75 15.93 35.37 Favored Glycine 0 CA--C 1.547 2.067 0 CA-C-O 119.348 -0.696 . . . . 0.37 114.67 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 36.8 mtpt -122.02 145.34 48.23 Favored 'General case' 0 C--N 1.363 1.19 0 CA-C-N 118.088 0.944 . . . . 1.56 111.759 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.31 150.81 23.4 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.116 1.525 . . . . 0.34 115.116 -175.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.32 109.81 6.6 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 113.92 -1.491 . . . . 0.64 109.335 177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 8.1 p -111.1 94.84 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.5 0 CA-C-N 116.025 -0.534 . . . . 0.46 110.625 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 67.81 -84.73 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.74 0 C-N-CA 125.416 1.486 . . . . 1.56 113.799 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -127.09 24.62 5.35 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 115.981 -0.554 . . . . 0.49 113.263 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -125.7 147.07 49.48 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 123.726 0.811 . . . . 1.82 111.606 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.0 p -129.18 125.87 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.157 0 CA-C-N 115.583 -0.735 . . . . 1.02 110.936 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.4 m -149.23 -175.72 5.09 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.225 -0.898 . . . . 0.56 110.129 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 41.0 p -103.8 138.16 40.8 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 112.95 0.722 . . . . 1.25 112.95 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -85.93 123.75 31.61 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 123.548 0.739 . . . . 0.29 111.114 178.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.0 t -129.21 90.94 3.1 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 121.533 0.682 . . . . 1.42 112.733 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.35 -63.36 2.96 Favored Glycine 0 C--N 1.359 1.832 0 N-CA-C 119.043 2.377 . . . . 0.42 119.043 176.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.543 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -130.64 157.15 43.53 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 114.277 1.214 . . . . 1.1 114.277 -176.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.543 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 1.8 tp -104.13 140.81 37.27 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 112.805 -1.998 . . . . 0.67 109.41 177.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.6 t -122.95 144.03 49.51 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.939 1.459 . . . . 0.36 114.939 -178.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.3 96.57 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 107.764 -1.199 . . . . 0.74 107.764 176.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -118.92 123.5 44.78 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 112.537 0.569 . . . . 1.67 112.537 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -115.07 130.64 56.98 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 122.273 1.035 . . . . 1.8 111.416 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.14 144.8 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 CA-C-N 112.724 -2.035 . . . . 0.58 110.867 -177.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.6 150.2 25.34 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 113.991 -1.459 . . . . 2.18 114.38 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -100.71 -55.58 0.94 Allowed Glycine 0 CA--C 1.541 1.676 0 CA-C-N 115.281 -0.872 . . . . 1.02 114.004 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -128.13 -85.98 0.57 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 117.031 0.416 . . . . 2.86 111.535 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.563 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 61.6 m-85 -133.82 120.6 20.67 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.391 0.676 . . . . 3.91 109.792 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 1.0 OUTLIER 87.68 136.54 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.836 0 C-N-CA 124.86 1.264 . . . . 1.74 111.233 -177.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.52 -168.56 0.19 Allowed Pre-proline 0 CA--C 1.58 2.104 0 CA-C-N 114.621 -1.172 . . . . 1.68 110.404 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.07 -15.51 34.1 Favored 'Trans proline' 0 N--CA 1.523 3.206 0 C-N-CA 122.675 2.25 . . . . 2.06 115.581 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 77.6 tttt 79.91 -65.1 0.19 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 126.444 1.897 . . . . 3.0 114.229 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 38.9 t -106.76 132.27 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 N-CA-C 109.791 -0.448 . . . . 0.8 109.791 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.2 t -135.95 120.58 18.3 Favored 'General case' 0 C--N 1.358 0.943 0 CA-C-N 114.413 -1.267 . . . . 0.87 111.052 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -115.23 49.22 1.08 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 116.276 1.954 . . . . 0.34 116.276 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -42.75 132.34 3.8 Favored 'General case' 0 N--CA 1.514 2.725 0 N-CA-C 116.069 1.877 . . . . 0.7 116.069 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -150.43 100.35 2.86 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.368 -0.833 . . . . 0.21 110.525 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.308 13.7 tt -110.3 121.81 63.77 Favored 'Isoleucine or valine' 0 C--O 1.266 1.929 0 CA-C-O 122.42 1.105 . . . . 0.31 111.42 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -123.5 155.06 38.26 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 113.675 -1.602 . . . . 0.44 111.325 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -104.91 148.21 26.93 Favored 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 119.252 3.056 . . . . 1.26 119.252 -173.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.02 -42.36 1.92 Allowed Glycine 0 CA--C 1.541 1.715 0 CA-C-N 110.316 -3.129 . . . . 0.17 120.582 171.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.73 157.78 1.25 Allowed 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 121.177 2.489 . . . . 0.15 113.371 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.7 -13.09 60.07 Favored 'General case' 0 CA--C 1.581 2.172 0 C-N-CA 124.897 1.279 . . . . 0.17 114.421 177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.0 2.42 51.81 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 113.953 1.094 . . . . 0.55 113.953 177.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.602 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.9 OUTLIER -107.26 -5.78 17.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 113.629 0.974 . . . . 0.6 113.629 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.31 93.35 0.66 Allowed Pre-proline 0 N--CA 1.506 2.346 0 C-N-CA 124.265 1.026 . . . . 0.95 111.916 178.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 68.8 Cg_endo -92.05 149.36 3.17 Favored 'Trans proline' 0 C--N 1.387 2.567 0 C-N-CA 122.92 2.413 . . . . 1.8 114.578 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 8.6 tpt -135.86 119.9 17.59 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.766 -0.652 . . . . 4.96 111.278 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.1 mt -129.78 164.31 24.33 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 122.051 0.929 . . . . 4.0 112.637 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -107.02 160.86 24.82 Favored Pre-proline 0 CA--C 1.564 1.514 0 CA-C-N 114.658 -1.155 . . . . 6.27 110.857 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -66.73 122.3 9.66 Favored 'Trans proline' 0 C--N 1.396 3.039 0 C-N-CA 122.593 2.195 . . . . 6.59 114.722 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -135.7 133.42 20.11 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-N 115.32 -0.855 . . . . 5.51 111.242 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -85.53 -156.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.387 2.725 . . . . 6.77 114.069 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 169.6 104.71 0.18 Allowed Glycine 0 C--N 1.341 0.829 0 C-N-CA 121.084 -0.579 . . . . 7.02 113.149 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.6 mt -118.49 109.58 16.38 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.025 0.44 . . . . 8.99 111.773 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.268 -0.872 . . . . 10.6 111.024 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 112.487 -0.245 . . . . 8.93 112.487 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.56 132.32 54.62 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.509 0.671 . . . . 6.82 111.835 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.5 mtt -130.11 113.49 14.57 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.825 -0.625 . . . . 7.64 111.595 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 m -136.51 109.68 7.78 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.597 -0.729 . . . . 3.86 111.571 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.86 89.51 0.08 OUTLIER Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.628 -0.714 . . . . 1.11 112.897 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.587 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.6 tp -87.93 -45.67 10.04 Favored 'General case' 0 CA--C 1.564 1.517 0 N-CA-C 113.323 0.86 . . . . 0.35 113.323 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.64 -23.45 63.04 Favored 'General case' 0 N--CA 1.509 2.505 0 C-N-CA 125.899 1.68 . . . . 0.2 114.971 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.39 -11.96 50.53 Favored 'General case' 0 CA--C 1.566 1.575 0 N-CA-C 113.621 0.971 . . . . 0.32 113.621 178.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 46.2 mmtt -105.39 -22.25 13.07 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 113.342 0.867 . . . . 1.73 113.342 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.02 135.7 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 115.103 1.52 . . . . 0.11 115.103 177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.86 -28.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-N 115.455 -0.793 . . . . 0.16 112.035 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 66.4 t90 -162.52 118.81 1.93 Allowed 'General case' 0 CA--C 1.552 1.042 0 CA-C-O 120.657 0.265 . . . . 0.54 111.116 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.72 129.63 24.82 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.41 -0.806 . . . . 0.19 111.62 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.8 t -133.36 124.55 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.404 0.621 . . . . 1.05 110.064 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -113.96 88.71 2.91 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 108.105 -1.072 . . . . 2.11 108.105 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -72.66 114.02 10.33 Favored 'General case' 0 C--O 1.274 2.356 0 N-CA-C 115.833 1.79 . . . . 0.63 115.833 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 150.61 -46.28 0.63 Allowed Glycine 0 C--N 1.368 2.309 0 CA-C-N 112.079 -2.328 . . . . 0.71 114.438 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -91.44 -123.96 3.04 Favored Glycine 0 N--CA 1.486 1.998 0 C-N-CA 123.641 0.639 . . . . 0.8 114.029 -178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -170.0 112.33 0.46 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.809 1.243 . . . . 1.63 108.951 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 1.1 m 40.85 97.21 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.11 0 N-CA-C 116.968 2.211 . . . . 1.0 116.968 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.546 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 70.4 t60 -126.92 132.16 50.94 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.705 1.372 . . . . 0.45 114.705 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 27' ' ' ILE 0.255 8.8 p -106.33 114.07 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.867 0 CA-C-N 114.135 -1.393 . . . . 1.39 110.023 177.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.407 ' OD2' ' HB ' ' A' ' 27' ' ' ILE . 1.7 p-10 -82.85 160.78 22.11 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 114.674 -1.148 . . . . 1.85 113.063 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.2 m -43.51 -24.81 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.538 3.969 0 N-CA-C 118.816 2.895 . . . . 0.72 118.816 -176.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -90.7 -29.54 17.64 Favored 'General case' 0 CA--C 1.564 1.508 0 CA-C-O 121.164 0.507 . . . . 0.51 110.695 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 41.09 0.57 Allowed Glycine 0 C--N 1.353 1.512 0 CA-C-N 114.953 -1.021 . . . . 0.34 114.606 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.587 HD11 ' HG ' ' A' ' 6' ' ' LEU . 30.7 mm -107.95 124.33 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 N-CA-C 109.504 -0.554 . . . . 0.55 109.504 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.546 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.4 t-160 -114.02 130.48 56.55 Favored 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.201 1.556 . . . . 1.34 115.201 -177.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.601 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -83.87 136.93 33.92 Favored 'General case' 0 C--N 1.372 1.573 0 C-N-CA 124.019 0.928 . . . . 2.79 110.778 175.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -88.89 101.98 14.59 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 124.716 1.26 . . . . 3.0 112.86 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -31.06 98.28 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 129.07 2.948 . . . . 2.3 118.792 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.599 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.3 OUTLIER 44.64 72.45 1.21 Allowed Pre-proline 0 N--CA 1.523 3.219 0 N-CA-C 117.489 2.403 . . . . 1.17 117.489 178.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -101.65 15.85 0.33 Allowed 'Trans proline' 0 CA--C 1.564 1.983 0 C-N-CA 122.556 2.171 . . . . 1.45 116.812 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 24.2 tp -143.01 -60.5 0.43 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 113.518 0.932 . . . . 1.91 113.518 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -90.33 84.77 6.07 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.408 0.892 . . . . 4.84 113.408 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.89 -32.17 7.8 Favored Glycine 0 CA--C 1.542 1.744 0 CA-C-N 114.2 -1.364 . . . . 2.37 114.083 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 45.77 53.18 9.02 Favored 'General case' 0 N--CA 1.518 2.965 0 C-N-CA 127.498 2.319 . . . . 4.5 116.077 -179.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.92 179.29 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 124.386 1.074 . . . . 2.7 110.829 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.35 81.45 0.85 Allowed Glycine 0 C--N 1.353 1.51 0 N-CA-C 114.4 0.52 . . . . 1.95 114.4 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 37.8 ttp180 -154.27 136.31 14.68 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.311 0.576 . . . . 5.34 111.591 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.29 136.65 41.74 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.858 0.863 . . . . 1.64 111.688 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.485 ' H ' HH21 ' A' ' 65' ' ' ARG . 29.9 m -113.28 104.05 11.94 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.825 -0.625 . . . . 1.57 110.995 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.2 90.35 3.25 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.198 -0.91 . . . . 2.33 110.345 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -94.92 -36.96 11.4 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 112.705 0.632 . . . . 3.16 112.705 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.22 68.07 0.24 Allowed Glycine 0 C--N 1.353 1.478 0 N-CA-C 111.329 -0.708 . . . . 1.52 111.329 177.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.3 ttt -93.25 1.12 57.17 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 115.11 1.522 . . . . 1.67 115.11 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.1 36.14 2.89 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 112.878 0.696 . . . . 4.18 112.878 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.2 mt -152.08 72.92 7.82 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.639 1.175 . . . . 2.63 108.344 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -65.08 162.14 34.1 Favored 'Trans proline' 0 N--CA 1.514 2.709 0 C-N-CA 124.421 3.414 . . . . 1.37 116.818 -178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.261 1.2 mp -88.72 131.16 36.84 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.158 0 CA-C-O 121.779 0.799 . . . . 0.69 110.156 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.517 ' HB2' HG22 ' A' ' 125' ' ' THR . 4.5 mt -90.83 -11.6 38.87 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 116.384 1.994 . . . . 1.28 116.384 -176.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -101.12 9.04 42.47 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 114.414 1.264 . . . . 1.51 114.414 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.97 -169.79 2.23 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-O 121.426 0.631 . . . . 1.09 112.603 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.797 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.5 OUTLIER -94.23 -179.84 1.08 Allowed Pre-proline 0 N--CA 1.516 2.831 0 C-N-CA 124.453 1.101 . . . . 1.27 109.351 178.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -69.63 -39.57 6.59 Favored 'Trans proline' 0 C--N 1.398 3.166 0 C-N-CA 122.637 2.224 . . . . 0.95 112.772 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -66.56 -52.84 41.11 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 125.988 1.715 . . . . 2.04 111.73 177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.61 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 0.6 OUTLIER -80.69 3.95 20.4 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 113.166 -1.834 . . . . 1.62 113.183 178.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.797 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 32.4 tt0 -85.99 -40.71 15.54 Favored 'General case' 0 C--N 1.371 1.513 0 C-N-CA 125.868 1.667 . . . . 1.77 107.773 174.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.4 t -63.17 -43.02 98.61 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 C-N-CA 125.038 1.335 . . . . 0.81 110.12 174.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.25 -42.9 54.13 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 118.441 0.564 . . . . 1.15 111.786 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.61 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 2.8 m-30 -74.47 1.08 12.69 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 124.456 1.103 . . . . 0.92 112.822 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.439 ' CB ' ' O ' ' A' ' 58' ' ' GLN . 3.2 tt0 -131.98 -127.13 0.19 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.538 0.735 . . . . 1.33 110.51 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.6 p 52.15 -145.59 0.54 Allowed 'General case' 0 N--CA 1.533 3.713 0 C-N-CA 126.076 1.751 . . . . 1.28 112.98 -172.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 175.28 123.13 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.69 0 CA-C-N 120.633 1.561 . . . . 1.53 114.036 176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.485 HH21 ' H ' ' A' ' 42' ' ' SER . 0.3 OUTLIER -117.35 125.24 50.7 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.634 -1.166 . . . . 3.22 110.355 177.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -133.76 145.96 50.3 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 112.942 0.719 . . . . 3.66 112.942 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -130.01 -87.29 0.52 Allowed 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 115.695 -0.684 . . . . 4.7 112.406 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -150.52 -87.76 0.07 Allowed 'General case' 0 CA--C 1.555 1.145 0 N-CA-C 113.227 0.825 . . . . 2.55 113.227 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.402 ' HA ' HD21 ' A' ' 164' ' ' ASN . 6.0 m-20 -161.31 125.96 3.51 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.436 0.695 . . . . 2.15 110.921 -176.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.565 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER 69.58 83.31 0.15 Allowed 'General case' 0 N--CA 1.511 2.607 0 C-N-CA 125.147 1.379 . . . . 0.77 112.399 -179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.1 p90 -147.61 153.41 39.36 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 112.873 0.694 . . . . 0.81 112.873 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -176.61 179.4 47.63 Favored Glycine 0 C--N 1.349 1.282 0 N-CA-C 116.259 1.264 . . . . 0.47 116.259 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -100.35 173.64 6.5 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 117.357 2.354 . . . . 0.89 117.357 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.02 120.95 23.11 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 112.617 -2.083 . . . . 0.51 111.006 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.03 109.4 52.29 Favored Pre-proline 0 CA--C 1.568 1.672 0 C-N-CA 123.371 0.668 . . . . 0.15 109.606 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -84.79 118.2 2.07 Favored 'Trans proline' 0 CA--C 1.566 2.125 0 C-N-CA 121.918 1.746 . . . . 0.15 114.427 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -125.97 159.23 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.615 0 CA-C-O 122.052 0.93 . . . . 0.19 111.638 -179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -150.33 23.19 0.83 Allowed 'General case' 0 CA--C 1.56 1.343 0 CA-C-N 114.51 -1.223 . . . . 2.53 111.859 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -129.25 158.74 38.21 Favored 'General case' 0 C--N 1.362 1.136 0 CA-C-O 121.166 0.508 . . . . 2.12 111.344 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -120.33 144.3 47.92 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.743 1.016 . . . . 0.42 113.743 -178.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.86 -135.64 4.01 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 113.751 -1.568 . . . . 0.23 111.953 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -118.73 107.31 13.51 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 118.23 1.015 . . . . 1.75 111.101 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -99.35 128.38 45.46 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-O 121.252 0.549 . . . . 0.21 111.041 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.9 t -112.02 124.01 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 115.674 -0.694 . . . . 0.2 110.548 -176.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.412 HD12 HD12 ' A' ' 172' ' ' ILE . 1.1 tt -107.87 106.44 16.72 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.675 -1.148 . . . . 0.78 109.858 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.4 t -112.62 128.06 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-N 113.947 -1.479 . . . . 0.44 108.492 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.58 141.34 47.64 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.432 -0.804 . . . . 1.25 112.6 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -107.11 123.52 48.36 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 122.022 0.915 . . . . 2.52 110.331 176.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -107.53 137.07 46.22 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 114.16 -1.382 . . . . 0.4 110.238 178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.627 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . -131.14 151.84 51.04 Favored 'General case' 0 C--O 1.266 1.922 0 CA-C-N 114.979 -1.009 . . . . 0.41 110.916 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -124.12 123.89 41.31 Favored 'General case' 0 C--N 1.361 1.078 0 C-N-CA 123.788 0.835 . . . . 2.61 110.705 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.265 5.4 p -138.02 41.19 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.597 2.766 0 N-CA-C 112.567 0.58 . . . . 2.13 112.567 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -161.8 -42.86 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.75 0.648 . . . . 2.27 112.75 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -115.36 119.48 36.42 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.218 0.451 . . . . 1.46 112.218 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -113.81 86.17 2.35 Favored 'General case' 0 CA--C 1.565 1.553 0 CA-C-O 122.73 1.253 . . . . 0.84 111.134 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -158.57 160.57 36.76 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 114.89 -1.05 . . . . 2.45 112.034 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.3 m -121.84 125.52 46.65 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 115.6 -0.727 . . . . 1.66 112.625 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 74.49 56.7 0.08 Allowed 'General case' 0 N--CA 1.511 2.613 0 C-N-CA 125.878 1.671 . . . . 1.89 113.074 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -157.73 -41.76 0.07 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.709 -1.132 . . . . 2.56 109.41 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -105.83 82.78 1.83 Allowed 'General case' 0 C--N 1.361 1.1 0 CA-C-O 121.79 0.805 . . . . 2.76 108.848 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.88 122.5 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 114.397 -1.274 . . . . 0.69 111.729 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.0 m-30 -107.36 164.09 12.48 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.9 1.444 . . . . 0.7 114.9 -176.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -120.23 136.51 54.62 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.379 0.609 . . . . 1.33 111.109 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.0 t -126.13 127.12 70.61 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.205 0 CA-C-N 115.411 -0.813 . . . . 0.48 109.828 -176.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.44 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 57.9 mtt180 -127.33 148.89 50.25 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.509 1.67 . . . . 1.69 115.509 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.8 m -129.48 113.5 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.666 0 N-CA-C 112.783 0.66 . . . . 0.6 112.783 176.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.34 25.05 14.5 Favored 'General case' 0 N--CA 1.526 3.371 0 C-N-CA 126.306 1.842 . . . . 1.12 114.164 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.54 -17.29 46.86 Favored Glycine 0 CA--C 1.551 2.282 0 CA-C-N 115.896 -0.593 . . . . 0.32 113.626 -176.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.426 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 95.2 m-70 -85.79 175.98 8.38 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 125.544 1.537 . . . . 0.57 114.0 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -119.48 139.83 51.45 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.948 0.88 . . . . 0.55 112.171 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.84 -57.16 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 114.016 -1.447 . . . . 1.06 112.792 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.81 89.33 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.57 0.7 . . . . 0.44 109.35 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -100.55 119.45 38.54 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 114.651 -1.159 . . . . 2.3 110.531 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 88.29 62.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 127.395 2.278 . . . . 2.48 110.78 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.13 105.05 15.57 Favored 'General case' 0 C--N 1.366 1.286 0 N-CA-C 113.425 0.898 . . . . 1.13 113.425 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -111.46 99.31 8.11 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 113.781 -1.554 . . . . 2.35 107.426 175.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -32.15 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 N-CA-C 114.675 1.361 . . . . 0.68 114.675 -176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -75.01 -37.49 61.79 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 123.495 0.718 . . . . 0.77 112.892 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -74.06 -26.7 60.54 Favored 'General case' 0 CA--C 1.575 1.911 0 C-N-CA 124.359 1.064 . . . . 0.91 113.477 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -80.99 -57.92 3.31 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.246 0.832 . . . . 2.43 113.246 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -88.43 -38.94 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 N-CA-C 114.091 1.145 . . . . 0.93 114.091 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.04 -66.41 0.24 Allowed Glycine 0 C--N 1.358 1.794 0 CA-C-N 118.372 0.533 . . . . 0.85 114.222 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -106.6 173.3 6.38 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.016 0.927 . . . . 3.18 111.78 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 12.1 m -81.14 84.22 6.59 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.641 0.978 . . . . 2.08 113.641 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.517 HG22 ' HB2' ' A' ' 51' ' ' LEU . 22.2 p -131.56 -131.37 0.19 Allowed 'General case' 0 CA--C 1.564 1.505 0 CA-C-N 114.264 -1.335 . . . . 0.62 108.315 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -114.64 130.29 56.78 Favored 'General case' 0 CA--C 1.559 1.308 0 N-CA-C 114.425 1.269 . . . . 0.46 114.425 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -107.52 129.46 54.96 Favored 'General case' 0 C--N 1.371 1.526 0 N-CA-C 108.697 -0.853 . . . . 0.38 108.697 174.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -144.1 129.06 18.5 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.014 0.746 . . . . 2.5 113.014 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -112.92 129.27 56.53 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 115.081 -0.963 . . . . 1.56 111.361 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.97 110.34 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 CA-C-N 114.27 -1.332 . . . . 0.45 109.429 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.6 102.16 29.61 Favored Pre-proline 0 CA--C 1.571 1.761 0 N-CA-C 112.482 0.549 . . . . 0.84 112.482 -178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -74.77 144.3 30.96 Favored 'Trans proline' 0 C--N 1.398 3.16 0 C-N-CA 123.096 2.531 . . . . 0.16 114.882 176.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -126.09 147.99 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 C-N-CA 124.567 1.147 . . . . 0.38 109.043 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 t -134.3 116.97 15.88 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.438 0.637 . . . . 1.31 112.003 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.2 mt -114.47 127.19 72.05 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.668 0 CA-C-N 114.836 -1.075 . . . . 0.25 108.826 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.8 mmtt -138.8 123.29 18.4 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.463 -0.789 . . . . 2.05 110.756 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt 67.88 13.65 9.22 Favored 'General case' 0 N--CA 1.521 3.092 0 N-CA-C 115.226 1.565 . . . . 3.55 115.226 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.94 15.13 31.96 Favored Glycine 0 CA--C 1.548 2.109 0 N-CA-C 114.732 0.653 . . . . 0.37 114.732 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 98.4 mttt -121.8 145.27 48.22 Favored 'General case' 0 C--N 1.361 1.093 0 CA-C-N 117.87 0.835 . . . . 1.56 112.194 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.84 146.64 27.04 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.439 1.274 . . . . 0.34 114.439 -176.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.24 111.02 9.91 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.38 -1.282 . . . . 0.64 110.077 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 10.0 p -111.4 93.28 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.619 0 CA-C-N 115.598 -0.728 . . . . 0.46 110.11 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 66.33 -83.48 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.882 0 C-N-CA 125.288 1.435 . . . . 1.56 113.689 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.73 25.94 3.9 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 115.996 -0.547 . . . . 0.49 113.741 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -133.2 118.58 18.79 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.18 0.592 . . . . 1.82 110.128 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.7 p -105.92 132.76 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.329 0 CA-C-O 121.55 0.691 . . . . 1.02 112.07 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.8 m -148.33 -175.42 4.9 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.014 -0.994 . . . . 0.56 110.106 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.418 HG22 ' HG2' ' A' ' 139' ' ' LYS . 35.6 p -101.81 137.94 39.45 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 113.055 0.761 . . . . 1.25 113.055 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -87.1 122.76 31.36 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 123.469 0.707 . . . . 0.29 110.447 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.9 t -129.24 91.65 3.23 Favored 'General case' 0 CA--C 1.566 1.589 0 N-CA-C 113.006 0.743 . . . . 1.42 113.006 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.22 -64.09 3.8 Favored Glycine 0 C--N 1.357 1.725 0 N-CA-C 119.007 2.363 . . . . 0.42 119.007 176.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.14 158.05 43.78 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.3 1.222 . . . . 1.1 114.3 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.68 141.0 37.88 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.308 -1.769 . . . . 0.67 109.332 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.9 t -123.95 141.61 51.88 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.972 1.471 . . . . 0.36 114.972 -177.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 0.0 OUTLIER -116.56 100.45 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.33 -1.359 . . . . 0.74 107.33 176.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -113.48 126.3 55.17 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.77 -0.65 . . . . 1.67 112.375 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.6 124.61 52.75 Favored 'General case' 0 C--O 1.251 1.175 0 CA-C-N 115.503 -0.771 . . . . 1.8 110.406 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.45 ' C ' ' HB3' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -107.99 144.85 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-N 113.982 -1.463 . . . . 0.58 111.027 -177.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.519 ' HB3' ' OD1' ' A' ' 164' ' ' ASN . 0.0 OUTLIER -78.25 149.18 33.64 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 125.224 1.41 . . . . 2.18 114.673 -178.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.42 -53.09 0.57 Allowed Glycine 0 CA--C 1.537 1.464 0 CA-C-N 115.097 -0.956 . . . . 1.02 113.392 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -128.39 -48.52 1.3 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 122.937 0.495 . . . . 2.86 112.049 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.78 -46.32 0.54 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 112.814 0.672 . . . . 3.91 112.814 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.46 160.5 17.71 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.437 0.637 . . . . 1.74 112.569 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.565 ' ND2' ' H ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -120.17 -51.81 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 115.751 -0.658 . . . . 1.68 111.296 -179.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -103.49 -59.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.669 2.246 . . . . 2.06 115.143 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 20.0 tptm 88.34 -106.22 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 126.823 2.049 . . . . 3.0 110.492 -179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.07 134.1 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 108.005 -1.109 . . . . 0.8 108.005 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 4.0 t -132.65 137.64 47.05 Favored 'General case' 0 C--N 1.366 1.297 0 N-CA-C 115.159 1.54 . . . . 0.87 115.159 -174.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.256 . . -130.15 47.27 2.53 Favored 'General case' 0 CA--C 1.589 2.465 0 N-CA-C 115.524 1.675 . . . . 0.34 115.524 -179.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.85 137.07 5.84 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 116.506 2.039 . . . . 0.7 116.506 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -154.06 106.04 2.78 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 115.668 -0.696 . . . . 0.21 111.298 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.412 HD12 HD12 ' A' ' 85' ' ' LEU 0.325 7.8 tt -114.65 122.3 68.49 Favored 'Isoleucine or valine' 0 C--O 1.27 2.165 0 CA-C-O 122.44 1.114 . . . . 0.31 111.465 175.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -124.31 165.26 17.98 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 113.924 -1.489 . . . . 0.44 111.146 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.3 ptmm? -121.87 157.46 31.1 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 118.223 2.675 . . . . 1.26 118.223 -175.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.04 -40.96 2.27 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-N 110.343 -3.117 . . . . 0.17 118.967 173.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.04 159.43 1.67 Allowed 'General case' 0 N--CA 1.514 2.77 0 CA-C-N 120.412 2.106 . . . . 0.15 113.059 -179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.79 -13.64 59.7 Favored 'General case' 0 CA--C 1.58 2.118 0 C-N-CA 125.141 1.376 . . . . 0.17 114.046 177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.01 3.28 49.39 Favored 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 113.663 0.986 . . . . 0.55 113.663 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.633 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -103.87 -8.94 19.34 Favored 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.575 0.954 . . . . 0.6 113.575 179.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.72 90.54 0.43 Allowed Pre-proline 0 N--CA 1.51 2.537 0 C-N-CA 123.971 0.908 . . . . 0.95 112.457 178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.633 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 43.8 Cg_endo -94.66 149.2 1.8 Allowed 'Trans proline' 0 C--N 1.385 2.473 0 C-N-CA 122.764 2.31 . . . . 1.8 114.924 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 65.1 mtt -133.54 101.05 4.99 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.733 -0.667 . . . . 4.96 110.805 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.3 mt -136.98 172.16 13.43 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-O 122.175 0.988 . . . . 4.0 112.883 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -112.46 159.95 32.17 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-N 114.52 -1.218 . . . . 6.27 110.775 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.71 120.64 7.24 Favored 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 122.338 2.026 . . . . 6.59 114.63 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -136.5 144.17 46.25 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-N 114.506 -1.225 . . . . 5.51 111.222 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -87.68 -153.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.391 2.775 0 C-N-CA 122.845 2.363 . . . . 6.77 113.704 178.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 171.73 86.77 0.06 OUTLIER Glycine 0 C--N 1.34 0.798 0 C-N-CA 120.837 -0.697 . . . . 7.02 113.349 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.5 mt -119.41 116.76 26.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 122.767 0.427 . . . . 8.99 112.005 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.198 -0.906 . . . . 10.6 111.064 179.913 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.597 -0.201 . . . . 8.93 112.597 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.7 128.32 56.04 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.52 0.676 . . . . 6.82 111.854 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.0 mtt -134.84 110.95 9.51 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.757 -0.656 . . . . 7.64 111.376 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.5 m -140.85 116.69 10.37 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.925 -0.579 . . . . 3.86 111.836 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.19 87.57 0.07 OUTLIER Glycine 0 C--N 1.341 0.81 0 CA-C-N 115.788 -0.642 . . . . 1.11 113.084 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.462 ' HG ' HD11 ' A' ' 27' ' ' ILE . 15.2 tp -88.22 -49.29 7.09 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 113.558 0.947 . . . . 0.35 113.558 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -22.48 61.35 Favored 'General case' 0 N--CA 1.511 2.607 0 N-CA-C 115.412 1.634 . . . . 0.2 115.412 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.46 -12.51 48.8 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 113.751 1.019 . . . . 0.32 113.751 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 16.4 mtpt -108.38 -18.91 13.63 Favored 'General case' 0 C--N 1.365 1.274 0 N-CA-C 113.583 0.957 . . . . 1.73 113.583 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.25 138.84 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.967 0 N-CA-C 115.156 1.539 . . . . 0.11 115.156 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -122.34 -28.09 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 115.34 -0.846 . . . . 0.16 112.124 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -165.32 119.7 1.26 Allowed 'General case' 0 CA--C 1.563 1.443 0 N-CA-C 111.543 0.201 . . . . 0.54 111.543 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -138.31 130.51 28.7 Favored 'General case' 0 N--CA 1.509 2.52 0 O-C-N 121.302 -0.874 . . . . 0.19 111.724 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -138.9 134.59 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 N-CA-C 113.642 0.978 . . . . 1.05 113.642 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.427 HD22 ' HA ' ' A' ' 169' ' ' ALA . 6.1 t-20 -115.93 106.0 13.3 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.595 -1.261 . . . . 2.11 107.595 172.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -77.99 106.64 9.99 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 121.525 0.678 . . . . 0.63 111.683 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.459 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 165.84 -47.73 0.27 Allowed Glycine 0 C--N 1.355 1.588 0 CA-C-N 114.613 -1.176 . . . . 0.71 115.689 -178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -116.58 -119.09 3.07 Favored Glycine 0 N--CA 1.476 1.365 0 CA-C-O 119.743 -0.476 . . . . 0.8 113.368 -178.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.407 ' HA ' ' OH ' ' A' ' 29' ' ' TYR . 6.8 pt-20 -167.51 117.64 0.84 Allowed 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 117.311 0.555 . . . . 1.63 112.214 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER 48.07 112.01 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.004 0 N-CA-C 118.339 2.718 . . . . 1.0 118.339 178.22 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 82.3 t60 -144.83 137.4 26.32 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.049 1.129 . . . . 0.45 114.049 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.39 119.93 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-N 114.423 -1.262 . . . . 1.39 110.172 176.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -81.57 157.86 24.61 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-N 114.707 -1.133 . . . . 1.85 110.302 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.6 m -42.19 -28.15 0.23 Allowed 'Isoleucine or valine' 1 N--CA 1.543 4.186 0 N-CA-C 119.261 3.06 . . . . 0.72 119.261 -177.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 59.2 m-70 -93.47 -16.41 24.55 Favored 'General case' 0 CA--C 1.566 1.568 0 CA-C-N 118.281 0.491 . . . . 0.51 111.513 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.68 41.88 1.29 Allowed Glycine 0 C--N 1.357 1.719 0 C-N-CA 124.391 0.996 . . . . 0.34 114.561 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.462 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.8 mm -106.21 117.97 52.96 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 N-CA-C 109.335 -0.617 . . . . 0.55 109.335 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.448 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -105.74 135.49 47.06 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 115.846 1.795 . . . . 1.34 115.846 -175.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.3 137.71 33.98 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 114.261 -1.336 . . . . 2.79 110.157 175.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.442 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 31.8 mtt180 -99.48 107.05 19.15 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 114.581 -1.191 . . . . 3.0 112.898 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -28.08 113.75 0.07 Allowed 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 120.2 3.407 . . . . 2.3 120.2 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.581 ' HB2' ' O ' ' A' ' 38' ' ' VAL . 6.9 m-20 32.25 58.72 1.33 Allowed Pre-proline 0 N--CA 1.535 3.796 0 N-CA-C 117.883 2.549 . . . . 1.17 117.883 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 20.4 Cg_endo -95.05 49.8 0.2 Allowed 'Trans proline' 0 CA--C 1.563 1.961 0 C-N-CA 123.071 2.514 . . . . 1.45 116.303 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.4 mp -122.92 -68.11 0.91 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.286 0.847 . . . . 1.91 113.286 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -109.46 96.52 6.33 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.078 0.77 . . . . 4.84 113.078 -177.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.55 -31.46 8.67 Favored Glycine 0 CA--C 1.541 1.657 0 CA-C-N 114.928 -1.033 . . . . 2.37 114.631 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 69.37 63.98 0.27 Allowed 'General case' 0 N--CA 1.504 2.228 0 C-N-CA 126.047 1.739 . . . . 4.5 113.208 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.581 ' O ' ' HB2' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -127.9 179.64 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-N 115.436 -0.802 . . . . 2.7 111.907 -178.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -123.85 98.09 0.57 Allowed Glycine 0 C--N 1.348 1.229 0 C-N-CA 121.287 -0.482 . . . . 1.95 113.707 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -154.73 136.75 14.65 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.355 0.598 . . . . 5.34 111.941 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -101.95 137.1 40.68 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.691 0.796 . . . . 1.64 111.448 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.7 m -115.62 -73.34 0.65 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.101 -0.499 . . . . 1.57 112.144 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 77.91 99.21 0.06 Allowed 'General case' 0 N--CA 1.504 2.265 0 C-N-CA 125.106 1.362 . . . . 2.33 113.499 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -107.02 68.87 0.74 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.925 0.869 . . . . 3.16 110.067 178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.29 70.31 0.19 Allowed Glycine 0 C--N 1.343 0.952 0 CA-C-N 114.133 -1.394 . . . . 1.52 110.623 -177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.6 ttt -92.31 1.53 57.17 Favored 'General case' 0 CA--C 1.563 1.443 0 N-CA-C 115.231 1.567 . . . . 1.67 115.231 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -109.58 35.09 3.46 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 112.513 0.56 . . . . 4.18 112.513 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.73 73.48 54.1 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.386 1.074 . . . . 2.63 108.516 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HA ' ' OE1' ' A' ' 62' ' ' GLN . 31.0 Cg_exo -68.77 157.04 63.47 Favored 'Trans proline' 0 C--N 1.389 2.694 0 C-N-CA 124.274 3.316 . . . . 1.37 116.371 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 61' ' ' TYR 0.269 1.4 mp -88.65 135.97 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.342 0 C-N-CA 123.69 0.796 . . . . 0.69 110.113 179.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.41 -20.55 23.81 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 116.791 2.145 . . . . 1.28 116.791 -176.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.6 mmm180 -99.03 18.64 16.8 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 114.15 1.167 . . . . 1.51 114.15 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.66 -175.7 4.04 Favored 'General case' 0 CA--C 1.565 1.547 0 CA-C-O 121.426 0.631 . . . . 1.09 111.934 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.779 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -93.56 -177.83 0.75 Allowed Pre-proline 0 N--CA 1.511 2.625 0 C-N-CA 123.889 0.876 . . . . 1.27 109.543 178.301 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -68.93 -39.28 8.4 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.54 2.16 . . . . 0.95 113.588 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -68.59 -50.95 47.72 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 125.309 1.444 . . . . 2.04 112.167 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.59 -6.29 55.19 Favored 'General case' 0 CA--C 1.573 1.829 0 CA-C-N 115.018 -0.992 . . . . 1.62 112.667 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.779 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.0 tt0 -74.29 -39.96 62.6 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 125.162 1.385 . . . . 1.77 108.408 173.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.77 -43.55 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.08 0 C-N-CA 124.213 1.005 . . . . 0.81 108.939 173.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.45 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 2.7 tp -80.37 -6.21 57.66 Favored 'General case' 0 CA--C 1.579 2.088 0 N-CA-C 114.546 1.313 . . . . 1.15 114.546 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.426 ' O ' HG12 ' A' ' 50' ' ' ILE . 18.9 m-85 -125.22 21.8 7.95 Favored 'General case' 0 CA--C 1.566 1.591 0 C-N-CA 123.777 0.831 . . . . 0.92 112.865 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.54 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 29.0 tt0 -143.86 -37.36 0.33 Allowed 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 115.338 1.607 . . . . 1.33 115.338 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.1 p -68.57 133.79 49.05 Favored 'General case' 0 N--CA 1.53 3.558 0 N-CA-C 114.849 1.425 . . . . 1.28 114.849 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.52 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.7 pt-20 -122.13 144.92 48.64 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 115.012 1.486 . . . . 1.53 115.012 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -113.38 136.79 52.38 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 113.992 -1.458 . . . . 3.22 111.111 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -119.63 135.66 54.71 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.235 0.457 . . . . 3.66 112.235 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -136.55 -86.52 0.33 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 112.49 0.552 . . . . 4.7 112.49 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -147.06 -101.53 0.09 Allowed 'General case' 0 CA--C 1.558 1.281 0 N-CA-C 113.144 0.794 . . . . 2.55 113.144 -179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.509 ' HA ' HD21 ' A' ' 164' ' ' ASN . 5.1 m-20 -155.45 129.4 8.69 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 123.512 0.725 . . . . 2.15 110.704 -177.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.523 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.3 OUTLIER 70.69 82.13 0.16 Allowed 'General case' 0 N--CA 1.515 2.812 0 C-N-CA 124.762 1.225 . . . . 0.77 110.869 -178.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -144.85 153.9 42.08 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.78 -0.646 . . . . 0.81 112.654 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -162.79 -163.91 16.58 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 116.007 1.163 . . . . 0.47 116.007 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -122.76 164.94 17.4 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 113.607 -1.296 . . . . 0.89 113.413 -177.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -123.22 130.37 52.66 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.425 -1.261 . . . . 0.51 112.126 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.21 102.07 37.42 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.504 0.722 . . . . 0.15 109.426 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -84.32 121.03 2.6 Favored 'Trans proline' 0 C--N 1.374 1.869 0 C-N-CA 122.003 1.802 . . . . 0.15 114.691 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.39 161.99 33.64 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 CA-C-O 122.099 0.952 . . . . 0.19 110.946 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -153.63 22.45 0.53 Allowed 'General case' 0 CA--C 1.559 1.301 0 CA-C-N 114.55 -1.205 . . . . 2.53 111.626 179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -130.14 156.78 44.0 Favored 'General case' 0 C--N 1.362 1.127 0 C-N-CA 123.167 0.587 . . . . 2.12 110.788 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.506 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -118.37 147.41 43.56 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.388 1.255 . . . . 0.42 114.388 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.12 -137.64 5.15 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 113.619 -1.628 . . . . 0.23 111.885 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.0 mt-10 -116.22 106.42 13.67 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-N 118.728 1.264 . . . . 1.75 110.819 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -99.58 128.4 45.68 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.251 0.548 . . . . 0.21 110.893 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -108.53 121.77 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-O 121.807 0.813 . . . . 0.2 110.835 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.36 106.99 17.85 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.118 -1.401 . . . . 0.78 109.854 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.06 125.67 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.755 -0.657 . . . . 0.44 110.927 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.73 144.64 51.12 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.449 0.907 . . . . 1.25 113.449 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 4.5 tppt? -104.94 120.57 41.77 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.71 -0.677 . . . . 2.52 111.383 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 7.5 m-85 -105.56 134.48 48.6 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.561 -0.745 . . . . 0.4 109.994 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.68 155.3 47.47 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.252 0.548 . . . . 0.41 111.784 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -114.9 171.85 7.4 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.561 0.745 . . . . 2.61 112.281 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.84 -77.61 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 112.498 0.555 . . . . 2.13 112.498 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -129.69 70.17 1.43 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.311 0.577 . . . . 2.27 111.76 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -148.42 109.83 4.4 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.747 -0.66 . . . . 1.46 110.943 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.22 88.02 2.63 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-O 123.171 1.463 . . . . 0.84 111.271 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -169.12 155.41 6.55 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 113.886 -1.506 . . . . 2.45 110.475 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.3 m -118.61 -68.49 0.91 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.44 1.274 . . . . 1.66 114.44 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -98.56 68.61 1.84 Allowed 'General case' 0 CA--C 1.558 1.281 0 CA-C-O 121.998 0.904 . . . . 1.89 111.366 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -154.32 -45.41 0.09 Allowed 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 114.142 -1.39 . . . . 2.56 109.34 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -113.56 86.96 2.5 Favored 'General case' 0 C--N 1.362 1.113 0 CA-C-O 121.683 0.754 . . . . 2.76 109.022 177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.05 131.4 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 CA-C-N 114.524 -1.216 . . . . 0.69 111.651 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -103.86 166.93 10.1 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.975 1.472 . . . . 0.7 114.975 -176.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -122.17 137.15 54.93 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.91 -0.586 . . . . 1.33 111.353 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.8 t -134.52 129.49 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.278 0 CA-C-N 115.941 -0.572 . . . . 0.48 111.116 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -133.82 144.58 49.06 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.681 1.363 . . . . 1.69 114.681 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.8 m -115.91 106.53 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-N 114.228 -1.351 . . . . 0.6 112.783 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.523 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 6.0 t30 62.75 27.03 15.93 Favored 'General case' 0 N--CA 1.526 3.337 0 C-N-CA 126.906 2.082 . . . . 1.12 114.417 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.93 -20.47 31.24 Favored Glycine 0 CA--C 1.549 2.185 0 CA-C-N 115.503 -0.771 . . . . 0.32 113.773 -177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -84.82 137.55 33.1 Favored 'General case' 0 C--N 1.365 1.254 0 C-N-CA 125.59 1.556 . . . . 0.57 114.018 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.69 129.22 42.97 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.694 0.759 . . . . 0.55 112.433 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.13 -51.46 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 114.389 -1.278 . . . . 1.06 113.21 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.6 89.05 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.97 -0.752 . . . . 0.44 108.97 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -110.78 75.69 0.94 Allowed 'General case' 0 C--N 1.361 1.07 0 CA-C-O 123.68 1.705 . . . . 2.3 112.446 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 152.89 67.16 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 110.094 -3.23 . . . . 2.48 108.23 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.29 101.62 13.36 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 122.161 0.981 . . . . 1.13 112.824 -178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.64 100.09 8.94 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 112.865 -1.971 . . . . 2.35 107.701 176.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.22 -22.11 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.379 0 N-CA-C 114.109 1.151 . . . . 0.68 114.109 -176.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -77.28 -42.95 35.05 Favored 'General case' 0 CA--C 1.57 1.732 0 C-N-CA 123.978 0.911 . . . . 0.77 112.012 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.32 -27.23 60.61 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 113.892 1.071 . . . . 0.91 113.892 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -80.18 -53.07 7.01 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.926 1.084 . . . . 2.43 113.926 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.277 4.1 p -102.61 -36.24 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.99 0 N-CA-C 113.997 1.11 . . . . 0.93 113.997 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 131.5 -121.1 3.03 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-N 118.691 0.678 . . . . 0.85 113.047 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -113.27 107.65 16.19 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.252 0.549 . . . . 3.18 110.826 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.3 m 72.81 -121.21 0.06 Allowed 'General case' 0 N--CA 1.504 2.27 0 C-N-CA 125.558 1.543 . . . . 2.08 111.669 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.6 p 51.55 -165.88 0.05 OUTLIER 'General case' 0 N--CA 1.535 3.795 0 N-CA-C 116.315 1.968 . . . . 0.62 116.315 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -109.08 127.06 53.82 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.128 0.788 . . . . 0.46 113.128 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.419 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 8.8 t60 -105.0 140.41 38.23 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.423 0.689 . . . . 0.38 109.506 177.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -144.6 128.5 17.41 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.656 0.613 . . . . 2.5 112.656 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -116.14 136.83 52.67 Favored 'General case' 0 C--O 1.255 1.371 0 CA-C-N 115.019 -0.991 . . . . 1.56 111.348 177.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.92 118.92 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 CA-C-N 113.719 -1.582 . . . . 0.45 110.741 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -129.19 88.79 50.04 Favored Pre-proline 0 CA--C 1.572 1.821 0 CA-C-N 115.498 -0.774 . . . . 0.84 109.724 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -73.54 139.26 28.16 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 123.183 2.589 . . . . 0.16 113.921 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -122.35 150.83 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 CA-C-N 115.348 -0.842 . . . . 0.38 110.825 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.4 t -135.15 109.32 8.28 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.157 -0.929 . . . . 1.31 110.525 177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.536 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -108.9 124.75 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.569 0 CA-C-N 115.057 -0.974 . . . . 0.25 108.811 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -141.27 125.56 17.5 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.245 -0.889 . . . . 2.05 110.778 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp 67.23 16.0 10.09 Favored 'General case' 0 N--CA 1.51 2.574 0 C-N-CA 125.444 1.498 . . . . 3.55 114.23 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.68 16.83 32.63 Favored Glycine 0 CA--C 1.549 2.203 0 CA-C-O 119.323 -0.71 . . . . 0.37 114.591 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 58.2 mttt -120.74 142.56 49.43 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-N 118.003 0.902 . . . . 1.56 112.847 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.54 132.51 47.13 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.271 0.841 . . . . 0.34 113.271 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.08 112.81 18.2 Favored 'General case' 0 C--O 1.243 0.734 0 CA-C-N 115.2 -0.909 . . . . 0.64 110.74 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.68 93.13 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.646 0 CA-C-N 115.44 -0.8 . . . . 0.46 110.096 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 64.67 -85.17 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.949 0 C-N-CA 125.36 1.464 . . . . 1.56 113.711 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.41 29.93 3.95 Favored Glycine 0 CA--C 1.544 1.898 0 CA-C-N 116.004 -0.544 . . . . 0.49 113.288 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -133.77 119.96 19.92 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 123.74 0.816 . . . . 1.82 110.544 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.9 p -107.76 133.19 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.351 0 CA-C-O 121.481 0.658 . . . . 1.02 111.806 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.1 m -151.39 -177.04 5.83 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.161 -0.927 . . . . 0.56 110.403 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 32.8 p -101.87 137.03 40.71 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 113.282 0.845 . . . . 1.25 113.282 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -86.74 121.47 29.29 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.456 0.702 . . . . 0.29 110.144 177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.2 t -126.39 91.25 3.33 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 113.03 0.752 . . . . 1.42 113.03 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 76.56 -62.7 3.11 Favored Glycine 0 C--N 1.36 1.885 0 N-CA-C 118.542 2.177 . . . . 0.42 118.542 176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.49 159.89 38.08 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 122.061 0.934 . . . . 1.1 113.31 -176.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.523 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -106.46 134.12 50.09 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 113.448 -1.705 . . . . 0.67 108.721 176.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.417 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 1.6 t -121.52 123.45 42.03 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 114.521 1.304 . . . . 0.36 114.521 -176.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.3 t -110.51 102.81 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.567 -0.901 . . . . 0.74 108.567 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.15 150.15 52.27 Favored 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.061 0.934 . . . . 1.67 111.633 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.23 141.72 48.66 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-N 114.198 -1.365 . . . . 1.8 112.274 -178.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.97 145.53 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-N 112.704 -2.044 . . . . 0.58 110.769 -178.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -70.3 150.04 46.77 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 115.803 1.779 . . . . 2.18 115.803 -178.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -111.3 -55.62 0.5 Allowed Glycine 0 CA--C 1.538 1.484 0 CA-C-N 114.89 -1.05 . . . . 1.02 112.606 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -131.86 -56.14 0.99 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.38 0.672 . . . . 2.86 111.049 178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -132.27 -41.67 0.98 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.253 0.621 . . . . 3.91 112.394 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.37 155.25 24.46 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.33 0.652 . . . . 1.74 112.303 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.523 ' ND2' ' H ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -118.1 -48.02 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.664 0 CA-C-N 115.693 -0.685 . . . . 1.68 110.212 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -106.62 -69.34 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.553 2.169 . . . . 2.06 115.939 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt 92.72 -92.68 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 127.47 2.308 . . . . 3.0 109.32 -177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 64' ' ' GLU . 41.9 t -113.42 131.62 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 N-CA-C 107.775 -1.194 . . . . 0.8 107.775 174.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.8 t -136.34 127.04 27.23 Favored 'General case' 0 C--N 1.358 0.938 0 CA-C-N 115.667 -0.697 . . . . 0.87 112.515 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.553 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.26 . . -119.43 50.2 1.27 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 115.858 1.799 . . . . 0.34 115.858 -177.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -41.01 131.52 2.53 Favored 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 115.887 1.81 . . . . 0.7 115.887 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -151.13 100.84 2.81 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.186 -0.916 . . . . 0.21 110.275 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.312 8.5 tt -110.12 123.14 65.77 Favored 'Isoleucine or valine' 0 C--O 1.267 2.001 0 CA-C-O 122.412 1.101 . . . . 0.31 112.025 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -124.08 162.96 22.45 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 113.553 -1.658 . . . . 0.44 110.862 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 18.0 ptmt -121.56 159.99 25.24 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 118.585 2.809 . . . . 1.26 118.585 -175.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.51 -42.04 2.0 Allowed Glycine 0 CA--C 1.541 1.685 0 CA-C-N 110.001 -3.272 . . . . 0.17 118.688 174.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.07 153.27 0.97 Allowed 'General case' 0 N--CA 1.515 2.815 0 CA-C-N 120.131 1.966 . . . . 0.15 112.678 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.68 -12.89 60.04 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 114.631 1.345 . . . . 0.17 114.631 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.42 4.56 45.97 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 114.349 1.24 . . . . 0.55 114.349 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.488 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -107.11 -13.27 15.21 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 114.445 1.276 . . . . 0.6 114.445 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -76.08 100.24 0.4 Allowed Pre-proline 0 N--CA 1.519 3.004 0 C-N-CA 124.238 1.015 . . . . 0.95 112.944 178.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 4.2 Cg_exo -81.83 143.31 13.11 Favored 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 123.027 2.485 . . . . 1.8 114.383 178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 11.0 tpt -145.08 113.03 6.41 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.804 -0.635 . . . . 4.96 111.012 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.25 166.96 21.57 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 122.085 0.945 . . . . 4.0 112.782 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -110.29 159.55 31.65 Favored Pre-proline 0 CA--C 1.559 1.295 0 CA-C-N 114.509 -1.223 . . . . 6.27 110.973 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.68 123.41 11.02 Favored 'Trans proline' 0 C--N 1.394 2.923 0 C-N-CA 122.779 2.32 . . . . 6.59 115.221 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.552 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 26.5 t60 -134.54 134.22 22.15 Favored Pre-proline 0 CA--C 1.568 1.659 0 CA-C-N 114.976 -1.011 . . . . 5.51 111.278 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.552 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 86.4 Cg_endo -76.3 -23.49 11.69 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 123.584 2.856 . . . . 6.77 116.462 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -123.14 -141.3 5.86 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 114.748 0.659 . . . . 7.02 114.748 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.2 mt -119.36 115.38 24.0 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 112.1 0.407 . . . . 8.99 112.1 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.135 -0.936 . . . . 10.6 110.484 179.639 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.122 0 N-CA-C 112.599 -0.201 . . . . 8.93 112.599 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.85 -42.19 4.07 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 112.955 0.724 . . . . 6.82 112.955 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.0 mmt -134.28 -73.74 0.48 Allowed 'General case' 0 C--N 1.362 1.151 0 CA-C-N 118.092 0.405 . . . . 7.64 111.558 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -140.45 117.13 10.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.983 0.421 . . . . 3.86 111.706 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.58 84.42 0.14 Allowed Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.705 -0.68 . . . . 1.11 112.926 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.64 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.8 tp -87.97 -46.79 9.06 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 113.505 0.928 . . . . 0.35 113.505 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.99 -23.11 61.54 Favored 'General case' 0 N--CA 1.511 2.601 0 C-N-CA 125.704 1.602 . . . . 0.2 115.209 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.82 -12.17 48.77 Favored 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 113.661 0.986 . . . . 0.32 113.661 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 47.8 mmtt -104.69 -22.02 13.29 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 113.399 0.889 . . . . 1.73 113.399 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.0 p -54.21 134.69 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.958 0 N-CA-C 115.172 1.545 . . . . 0.11 115.172 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -122.88 -29.95 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 CA-C-N 115.575 -0.739 . . . . 0.16 112.343 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 73.9 t90 -161.16 117.49 2.22 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-O 121.029 0.442 . . . . 0.54 111.244 -178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.8 142.25 40.85 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.621 -0.674 . . . . 0.19 111.316 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.44 HG21 ' HG3' ' A' ' 33' ' ' PRO 0.334 8.9 p -145.38 134.03 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.937 0 CA-C-O 122.425 1.107 . . . . 1.05 113.461 178.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.761 HD22 ' H ' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -100.92 91.02 4.39 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-N 113.195 -1.82 . . . . 2.11 109.325 178.041 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 168' ' ' CYS . . . -82.02 103.24 11.52 Favored 'General case' 0 C--O 1.265 1.88 0 CA-C-O 123.414 1.578 . . . . 0.63 113.158 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 162.99 -50.48 0.31 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-N 111.394 -2.639 . . . . 0.71 111.374 -177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -114.63 -126.03 4.16 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 110.497 -1.041 . . . . 0.8 110.497 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -168.4 117.36 0.73 Allowed 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 117.666 0.733 . . . . 1.63 112.095 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.679 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 6.3 m 62.8 115.68 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 116.896 2.184 . . . . 1.0 116.896 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -159.8 139.57 11.46 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.369 0.604 . . . . 0.45 112.176 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.14 122.66 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-N 115.57 -0.741 . . . . 1.39 110.651 176.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -85.2 155.98 21.19 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.562 -0.745 . . . . 1.85 111.183 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . 0.265 0.7 OUTLIER -45.1 -16.9 0.07 OUTLIER 'Isoleucine or valine' 1 N--CA 1.545 4.302 0 N-CA-C 119.99 3.33 . . . . 0.72 119.99 -175.39 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -95.8 -20.85 18.51 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-N 118.766 0.712 . . . . 0.51 111.295 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.68 38.8 1.26 Allowed Glycine 0 C--N 1.356 1.652 0 C-N-CA 124.414 1.007 . . . . 0.34 114.488 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.64 HD11 ' HG ' ' A' ' 6' ' ' LEU . 38.8 mm -105.6 121.58 58.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 N-CA-C 108.994 -0.743 . . . . 0.55 108.994 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -101.23 125.29 47.84 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.641 0.608 . . . . 1.34 112.641 -178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 20' ' ' SER . 41.7 m-85 -95.77 137.97 34.08 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.275 -0.875 . . . . 2.79 111.09 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 39.8 mtp180 -72.26 159.97 33.18 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 116.929 2.196 . . . . 3.0 116.929 -175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.2 ttmm -94.92 87.19 4.88 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 113.001 -1.909 . . . . 2.3 115.399 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.615 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER 49.41 78.29 0.41 Allowed Pre-proline 0 N--CA 1.529 3.489 0 N-CA-C 115.594 1.701 . . . . 1.17 115.594 177.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HG3' HG21 ' A' ' 14' ' ' VAL . 44.9 Cg_endo -90.45 3.88 4.7 Favored 'Trans proline' 0 CA--C 1.563 1.939 0 N-CA-C 118.971 2.643 . . . . 1.45 118.971 -177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.7 -33.28 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 116.176 1.917 . . . . 1.91 116.176 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.517 ' HB3' ' OD1' ' A' ' 67' ' ' ASN . 8.3 pt-20 -89.21 65.52 7.34 Favored 'General case' 0 N--CA 1.505 2.301 0 CA-C-N 120.533 1.515 . . . . 4.84 113.51 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.54 -21.47 43.96 Favored Glycine 0 CA--C 1.546 2.002 0 CA-C-N 115.813 -0.631 . . . . 2.37 113.949 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.615 ' HA ' ' O ' ' A' ' 32' ' ' ASP 0.25 0.0 OUTLIER 56.76 56.66 5.3 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 127.617 2.367 . . . . 4.5 114.432 -178.981 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.22 179.99 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 CA-C-N 114.109 -1.405 . . . . 2.7 110.616 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.26 93.1 1.85 Allowed Glycine 0 C--N 1.355 1.594 0 N-CA-C 115.101 0.8 . . . . 1.95 115.101 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -143.08 117.61 9.74 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.23 0.612 . . . . 5.34 111.516 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.41 137.68 45.96 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.662 0.785 . . . . 1.64 111.732 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 m -125.81 135.07 51.58 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.693 -0.685 . . . . 1.57 112.192 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.8 -66.88 0.74 Allowed 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.378 -0.828 . . . . 2.33 111.333 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.2 t80 80.57 -68.62 0.11 Allowed 'General case' 0 N--CA 1.513 2.712 0 C-N-CA 125.917 1.687 . . . . 3.16 111.653 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -113.88 91.33 0.57 Allowed Glycine 0 C--N 1.351 1.384 0 N-CA-C 109.965 -1.254 . . . . 1.52 109.965 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.5 ttm -87.26 1.91 51.73 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 115.694 1.739 . . . . 1.67 115.694 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.34 39.34 1.76 Allowed 'General case' 0 CA--C 1.564 1.498 0 CA-C-O 121.742 0.782 . . . . 4.18 112.916 179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.8 mt -133.84 76.86 64.48 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.111 1.364 . . . . 2.63 107.809 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -81.65 162.43 19.06 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 123.135 2.557 . . . . 1.37 116.906 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.26 1.3 mp -87.51 134.8 26.85 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.317 0 C-N-CA 123.82 0.848 . . . . 0.69 109.892 178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.404 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.3 mm? -90.69 -18.34 25.22 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.106 1.891 . . . . 1.28 116.106 -176.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -103.55 26.02 8.99 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 114.427 1.269 . . . . 1.51 114.427 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.449 ' HG ' ' HD2' ' A' ' 61' ' ' TYR . 1.0 OUTLIER -140.37 -165.56 1.94 Allowed 'General case' 0 CA--C 1.565 1.537 0 CA-C-O 122.32 1.057 . . . . 1.09 112.725 179.062 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.888 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 2.1 t30 -88.85 172.6 7.26 Favored Pre-proline 0 CA--C 1.569 1.699 0 C-N-CA 126.488 1.915 . . . . 1.27 110.54 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.48 -43.31 1.01 Allowed 'Trans proline' 0 N--CA 1.513 2.63 0 C-N-CA 122.444 2.096 . . . . 0.95 113.822 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -76.37 -41.57 47.57 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 125.223 1.409 . . . . 2.04 111.893 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -86.47 3.96 41.74 Favored 'General case' 0 CA--C 1.578 2.047 0 CA-C-N 114.443 -1.253 . . . . 1.62 111.708 177.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.888 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 34.3 tt0 -83.25 -40.36 19.69 Favored 'General case' 0 C--N 1.381 1.948 0 C-N-CA 126.659 1.984 . . . . 1.77 106.08 171.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.93 -45.99 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.283 0 C-N-CA 125.296 1.438 . . . . 0.81 109.52 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -39.42 68.81 Favored 'General case' 0 CA--C 1.601 2.907 0 N-CA-C 112.781 0.659 . . . . 1.15 112.781 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.449 ' HD2' ' HG ' ' A' ' 53' ' ' SER . 12.2 m-30 -90.88 20.48 4.77 Favored 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 114.746 1.387 . . . . 0.92 114.746 178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.08 -42.01 0.65 Allowed 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 115.408 1.633 . . . . 1.33 115.408 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.426 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 48.1 p -63.2 137.71 58.31 Favored 'General case' 0 N--CA 1.537 3.882 0 N-CA-C 114.989 1.477 . . . . 1.28 114.989 -177.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.536 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 14.9 pt-20 -114.68 144.73 42.97 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.08 1.511 . . . . 1.53 115.08 -177.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.8 mtp-105 -113.99 157.08 22.94 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 115.001 -1.0 . . . . 3.22 111.787 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -129.99 140.25 50.93 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 112.759 0.652 . . . . 3.66 112.759 -178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.517 ' OD1' ' HB3' ' A' ' 35' ' ' GLU . 0.9 OUTLIER -135.61 -95.16 0.25 Allowed 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.853 -0.612 . . . . 4.7 111.62 179.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -160.19 -92.11 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.16 0 CA-C-N 118.159 0.436 . . . . 2.55 112.071 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -155.62 124.4 6.05 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.483 0.713 . . . . 2.15 110.373 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.68 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.3 OUTLIER 68.82 87.7 0.12 Allowed 'General case' 0 N--CA 1.512 2.659 0 C-N-CA 125.341 1.456 . . . . 0.77 111.802 -178.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -149.14 163.35 37.84 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 113.445 0.906 . . . . 0.81 113.445 -176.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.48 -155.09 10.82 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 116.912 1.525 . . . . 0.47 116.912 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -129.15 168.61 15.88 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.099 1.148 . . . . 0.89 114.099 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -126.05 133.68 51.64 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.357 -1.292 . . . . 0.51 112.082 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -126.07 100.52 30.05 Favored Pre-proline 0 CA--C 1.569 1.695 0 C-N-CA 123.167 0.587 . . . . 0.15 109.642 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -84.16 117.54 2.2 Favored 'Trans proline' 0 CA--C 1.563 1.925 0 C-N-CA 122.187 1.925 . . . . 0.15 114.978 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -127.18 160.66 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 CA-C-O 122.04 0.924 . . . . 0.19 111.409 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.7 mmmt -148.51 23.18 1.02 Allowed 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 114.56 -1.2 . . . . 2.53 111.528 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -128.85 158.94 37.32 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-O 121.14 0.495 . . . . 2.12 110.892 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -120.6 144.94 47.85 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 114.601 1.334 . . . . 0.42 114.601 -177.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.36 -138.56 5.44 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 113.674 -1.603 . . . . 0.23 112.401 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 25.5 mt-10 -113.7 105.47 13.34 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 118.521 1.16 . . . . 1.75 111.294 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -99.1 128.43 45.23 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 121.116 0.484 . . . . 0.21 110.899 -179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 t -113.58 123.79 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.34 0.591 . . . . 0.2 110.509 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.408 HD12 HD12 ' A' ' 172' ' ' ILE . 3.4 tt -108.0 107.6 18.35 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.982 -1.008 . . . . 0.78 110.401 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.66 125.79 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 CA-C-N 114.004 -1.453 . . . . 0.44 107.968 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -135.45 140.23 44.71 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 116.043 -0.526 . . . . 1.25 112.292 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 16.8 tptt -95.32 120.77 36.12 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.664 -0.698 . . . . 2.52 112.693 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -107.05 132.99 52.35 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.055 -0.975 . . . . 0.4 109.977 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -137.15 149.96 47.63 Favored 'General case' 0 C--O 1.262 1.719 0 CA-C-O 121.333 0.587 . . . . 0.41 111.372 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -118.52 142.0 48.02 Favored 'General case' 0 C--N 1.36 1.028 0 CA-C-N 115.175 -0.921 . . . . 2.61 111.844 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.33 -45.58 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-N 115.617 -0.72 . . . . 2.13 112.632 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -121.11 137.9 54.44 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.126 0.417 . . . . 2.27 112.126 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 89.41 104.6 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 126.356 1.863 . . . . 1.46 111.43 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -97.13 87.19 4.14 Favored 'General case' 0 CA--C 1.564 1.501 0 CA-C-O 123.295 1.521 . . . . 0.84 111.929 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -146.04 157.47 43.86 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 113.73 -1.577 . . . . 2.45 111.726 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.4 m -115.05 -74.39 0.61 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.063 1.134 . . . . 1.66 114.063 -178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -99.28 64.12 1.34 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.225 1.012 . . . . 1.89 111.918 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -151.92 -41.66 0.11 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.573 1.549 . . . . 2.56 109.033 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -108.28 79.3 1.24 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-O 121.96 0.886 . . . . 2.76 109.137 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.38 120.88 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-N 114.564 -1.198 . . . . 0.69 110.639 -178.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -101.51 170.7 8.03 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 115.362 1.615 . . . . 0.7 115.362 -175.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -123.22 136.72 54.86 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.063 0.458 . . . . 1.33 111.052 177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.18 125.73 64.86 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.306 0 CA-C-N 115.826 -0.625 . . . . 0.48 109.899 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.492 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 46.2 mtt180 -125.72 151.34 46.77 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.645 1.72 . . . . 1.69 115.645 -176.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.7 m -127.46 110.92 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 C-N-CA 123.24 0.616 . . . . 0.6 112.577 177.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.506 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 64.51 26.43 13.38 Favored 'General case' 0 N--CA 1.526 3.374 0 C-N-CA 126.664 1.986 . . . . 1.12 113.95 -178.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.43 -11.93 56.79 Favored Glycine 0 CA--C 1.552 2.367 0 C-N-CA 121.482 -0.39 . . . . 0.32 113.834 -176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.492 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 89.3 m-70 -89.72 164.89 14.5 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 125.944 1.698 . . . . 0.57 113.488 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -113.04 134.89 54.32 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.494 0.664 . . . . 0.55 112.016 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -126.51 -58.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 114.916 -1.038 . . . . 1.06 112.784 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.06 88.64 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 107.881 -1.155 . . . . 0.44 107.881 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -107.74 100.16 9.57 Favored 'General case' 0 C--N 1.349 0.564 0 CA-C-O 123.11 1.433 . . . . 2.3 111.778 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 117.62 72.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 129.438 3.095 . . . . 2.48 108.015 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.11 104.96 16.85 Favored 'General case' 0 C--N 1.359 0.98 0 CA-C-O 121.979 0.895 . . . . 1.13 112.713 -178.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -112.11 99.15 7.84 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 112.851 -1.977 . . . . 2.35 107.973 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -24.11 28.48 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.364 0 N-CA-C 113.964 1.098 . . . . 0.68 113.964 -177.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -75.65 -41.35 54.29 Favored 'General case' 0 CA--C 1.568 1.668 0 C-N-CA 124.108 0.963 . . . . 0.77 111.96 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.75 -26.38 59.74 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.278 1.031 . . . . 0.91 113.444 176.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -77.39 -57.93 3.55 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.555 0.946 . . . . 2.43 113.555 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.84 -32.07 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.388 0 N-CA-C 114.906 1.447 . . . . 0.93 114.906 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.46 -115.77 2.35 Favored Glycine 0 C--N 1.357 1.729 0 CA-C-N 118.655 0.661 . . . . 0.85 113.011 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -114.8 107.5 15.51 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.246 0.546 . . . . 3.18 110.716 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.0 m 72.51 -130.52 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 C-N-CA 125.487 1.515 . . . . 2.08 112.313 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 51' ' ' LEU . 73.2 p 58.15 -162.13 0.22 Allowed 'General case' 0 N--CA 1.53 3.528 0 C-N-CA 126.237 1.815 . . . . 0.62 115.017 178.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.91 135.71 53.69 Favored 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 113.495 0.924 . . . . 0.46 113.495 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -109.32 144.91 36.86 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.542 0.737 . . . . 0.38 109.163 177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.15 124.19 18.88 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.704 1.001 . . . . 2.5 113.704 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -112.72 120.33 41.15 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.288 -0.869 . . . . 1.56 111.538 177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.47 115.68 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 CA-C-N 114.742 -1.117 . . . . 0.45 110.499 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.79 100.76 15.88 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-O 119.075 -0.488 . . . . 0.84 111.791 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -74.6 142.47 29.26 Favored 'Trans proline' 0 C--N 1.4 3.266 0 C-N-CA 123.062 2.508 . . . . 0.16 114.281 176.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.2 mt -124.29 146.24 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.597 0 C-N-CA 123.934 0.894 . . . . 0.38 109.983 -178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.1 p -128.89 110.42 12.1 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.222 0.534 . . . . 1.31 112.145 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.442 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.0 mt -112.83 124.31 69.35 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.57 0 CA-C-N 115.277 -0.874 . . . . 0.25 108.952 178.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -140.22 124.22 17.53 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.47 -0.786 . . . . 2.05 111.223 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt 65.75 16.24 10.4 Favored 'General case' 0 N--CA 1.516 2.843 0 C-N-CA 125.43 1.492 . . . . 3.55 114.886 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.93 21.78 17.46 Favored Glycine 0 CA--C 1.548 2.135 0 N-CA-C 114.512 0.565 . . . . 0.37 114.512 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 19.0 ttmm -129.81 137.84 50.71 Favored 'General case' 0 C--N 1.363 1.159 0 CA-C-N 117.636 0.718 . . . . 1.56 111.545 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.36 141.7 31.8 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.077 1.14 . . . . 0.34 114.077 -176.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.21 114.53 13.92 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.704 -1.135 . . . . 0.64 110.109 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.253 8.7 p -119.58 95.55 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 CA-C-N 115.841 -0.618 . . . . 0.46 111.019 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 67.23 -85.18 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.735 0 C-N-CA 125.714 1.606 . . . . 1.56 113.968 179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.44 28.38 3.81 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.093 -0.503 . . . . 0.49 113.156 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -134.75 127.23 30.53 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 123.647 0.779 . . . . 1.82 110.473 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.3 p -114.27 139.72 38.71 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.361 0 CA-C-O 121.278 0.561 . . . . 1.02 111.451 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.8 m -158.73 176.04 12.87 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.577 0.751 . . . . 0.56 109.87 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 21.3 p -101.32 137.32 39.81 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.073 0.768 . . . . 1.25 113.073 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -82.8 124.86 30.67 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 124.074 0.949 . . . . 0.29 112.016 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 9.9 t -131.32 91.08 2.96 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-O 121.643 0.735 . . . . 1.42 112.574 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.0 -65.37 3.27 Favored Glycine 0 C--N 1.358 1.752 0 N-CA-C 118.986 2.355 . . . . 0.42 118.986 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.511 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -131.16 156.6 45.03 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.291 1.219 . . . . 1.1 114.291 -175.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.511 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -107.15 137.95 44.25 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 113.133 -1.849 . . . . 0.67 109.071 176.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.1 t -120.61 143.34 48.71 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.411 1.634 . . . . 0.36 115.411 -177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.38 99.04 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.169 -1.419 . . . . 0.74 107.169 175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -117.58 123.17 45.56 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-N 115.996 -0.547 . . . . 1.67 112.316 -177.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -114.01 136.24 53.13 Favored 'General case' 0 C--O 1.253 1.243 0 CA-C-O 122.53 1.157 . . . . 1.8 112.029 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.7 t -104.51 144.78 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.765 0 CA-C-N 112.529 -2.123 . . . . 0.58 109.814 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -58.8 150.84 22.76 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 116.504 2.038 . . . . 2.18 116.504 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -110.91 -63.95 0.51 Allowed Glycine 0 CA--C 1.537 1.448 0 CA-C-N 115.541 -0.754 . . . . 1.02 114.028 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -130.7 -64.85 0.82 Allowed 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 116.962 0.381 . . . . 2.86 111.811 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -120.17 -46.56 2.41 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.769 0.428 . . . . 3.91 111.953 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -100.99 177.09 5.05 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.47 0.708 . . . . 1.74 111.222 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.68 ' ND2' ' H ' ' A' ' 70' ' ' SER . 4.5 m-20 -115.0 -85.46 0.0 OUTLIER Pre-proline 0 CA--C 1.573 1.852 0 CA-C-O 117.441 -1.266 . . . . 1.68 110.679 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -88.59 -36.72 0.08 OUTLIER 'Trans proline' 0 C--N 1.393 2.911 0 CA-C-N 123.774 2.384 . . . . 2.06 114.256 176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.4 ttmm 79.79 -88.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 126.845 2.058 . . . . 3.0 110.675 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.511 HG22 ' HB3' ' A' ' 64' ' ' GLU . 22.8 t -111.77 131.81 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.327 -0.99 . . . . 0.8 108.327 175.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . 3.8 t -138.26 132.49 31.8 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.052 -0.977 . . . . 0.87 111.801 -178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -129.6 51.11 2.1 Favored 'General case' 0 CA--C 1.579 2.065 0 N-CA-C 114.96 1.467 . . . . 0.34 114.96 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.25 138.14 1.25 Allowed 'General case' 0 N--CA 1.522 3.167 0 N-CA-C 117.803 2.52 . . . . 0.7 117.803 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -153.78 104.22 2.67 Favored 'General case' 0 CA--C 1.557 1.212 0 CA-C-N 115.666 -0.697 . . . . 0.21 111.504 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.408 HD12 HD12 ' A' ' 85' ' ' LEU 0.316 10.3 tt -113.88 122.06 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.183 0 CA-C-O 122.384 1.088 . . . . 0.31 111.119 175.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -122.7 165.47 16.48 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.145 -1.389 . . . . 0.44 111.092 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.6 ptmt -121.74 157.89 29.97 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 118.239 2.681 . . . . 1.26 118.239 -175.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.24 -40.39 2.45 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 110.212 -3.176 . . . . 0.17 119.066 173.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.11 157.64 1.85 Allowed 'General case' 0 N--CA 1.515 2.777 0 CA-C-N 120.265 2.033 . . . . 0.15 113.101 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.86 -11.52 59.58 Favored 'General case' 0 CA--C 1.58 2.132 0 C-N-CA 124.91 1.284 . . . . 0.17 113.984 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.68 3.52 47.57 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 114.0 1.111 . . . . 0.55 114.0 178.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.02 -20.47 14.78 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 113.388 0.885 . . . . 0.6 113.388 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.56 152.14 59.88 Favored Pre-proline 0 CA--C 1.579 2.072 0 C-N-CA 124.343 1.057 . . . . 0.95 112.262 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -60.06 117.89 4.7 Favored 'Trans proline' 0 N--CA 1.522 3.168 0 C-N-CA 124.935 3.757 . . . . 1.8 115.87 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 14.8 ttt -145.52 118.28 8.67 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.974 -0.557 . . . . 4.96 111.345 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.6 mt -130.9 159.58 37.0 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.956 0.884 . . . . 4.0 112.492 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -105.85 162.35 19.99 Favored Pre-proline 0 CA--C 1.562 1.43 0 CA-C-N 114.768 -1.105 . . . . 6.27 110.929 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -65.15 122.16 9.83 Favored 'Trans proline' 0 C--N 1.397 3.09 0 C-N-CA 122.696 2.264 . . . . 6.59 114.425 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -135.23 134.75 21.66 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-N 115.452 -0.795 . . . . 5.51 111.374 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -75.76 -29.41 7.1 Favored 'Trans proline' 0 C--N 1.394 2.95 0 C-N-CA 123.555 2.837 . . . . 6.77 116.318 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -135.25 121.52 2.58 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 121.21 -0.519 . . . . 7.02 114.324 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.4 mt -118.79 111.39 18.39 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.879 0.472 . . . . 8.99 111.821 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.33 -0.843 . . . . 10.6 111.073 -179.962 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.092 0 N-CA-C 112.466 -0.254 . . . . 8.93 112.466 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.13 -39.72 4.67 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 113.014 0.746 . . . . 6.82 113.014 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.3 mmt -133.0 115.14 14.82 Favored 'General case' 0 C--N 1.362 1.13 0 CA-C-O 120.978 0.418 . . . . 7.64 111.567 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 m -137.65 106.5 5.94 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.772 -0.649 . . . . 3.86 111.448 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.32 81.37 0.05 OUTLIER Glycine 0 C--N 1.341 0.842 0 CA-C-N 115.726 -0.67 . . . . 1.11 113.123 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.445 ' HG ' HD11 ' A' ' 27' ' ' ILE . 17.6 tp -88.37 -45.84 9.67 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 113.328 0.862 . . . . 0.35 113.328 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.99 -23.32 63.54 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 125.896 1.678 . . . . 0.2 115.269 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.69 -12.17 49.11 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 113.575 0.954 . . . . 0.32 113.575 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -106.13 -19.36 13.74 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 113.324 0.861 . . . . 1.73 113.324 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 p -56.67 134.99 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.851 0 N-CA-C 114.705 1.372 . . . . 0.11 114.705 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -119.7 -29.77 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 CA-C-N 115.581 -0.736 . . . . 0.16 112.214 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 75.7 t90 -160.43 115.95 2.3 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 120.696 0.284 . . . . 0.54 110.951 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.08 122.19 22.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.602 -0.686 . . . . 0.19 111.397 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.642 ' O ' ' HB2' ' A' ' 170' ' ' LEU . 30.8 t -131.25 116.63 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 122.097 0.951 . . . . 1.05 109.663 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.549 HD22 ' HB1' ' A' ' 169' ' ' ALA . 11.4 m120 -114.01 88.01 2.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.828 -1.078 . . . . 2.11 108.996 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -72.6 120.13 17.79 Favored 'General case' 0 C--O 1.277 2.516 0 N-CA-C 115.757 1.762 . . . . 0.63 115.757 -175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.505 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 151.88 -10.22 0.67 Allowed Glycine 0 C--N 1.359 1.816 0 CA-C-N 111.731 -2.486 . . . . 0.71 115.693 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.12 -119.81 1.23 Allowed Glycine 0 N--CA 1.468 0.82 0 CA-C-N 117.645 0.723 . . . . 0.8 112.511 -178.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -169.07 118.08 0.67 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.068 0.547 . . . . 1.63 110.697 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.668 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 68.1 p 42.95 100.45 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.681 0 N-CA-C 117.92 2.563 . . . . 1.0 117.92 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.537 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 84.0 t60 -132.94 136.24 46.0 Favored 'General case' 0 N--CA 1.506 2.368 0 C-N-CA 118.615 -1.234 . . . . 0.45 114.171 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.267 10.0 p -103.39 117.76 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.886 0 CA-C-N 114.117 -1.401 . . . . 1.39 110.917 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -83.12 152.51 25.27 Favored 'General case' 0 CA--C 1.568 1.661 0 CA-C-N 113.578 -1.646 . . . . 1.85 110.046 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.7 m -41.25 -28.77 0.16 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.27 0 N-CA-C 119.192 3.034 . . . . 0.72 119.192 -177.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -87.36 -25.96 23.59 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.184 0.516 . . . . 0.51 111.277 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.63 38.85 0.75 Allowed Glycine 0 C--N 1.352 1.422 0 CA-C-N 114.983 -1.008 . . . . 0.34 114.445 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.445 HD11 ' HG ' ' A' ' 6' ' ' LEU . 20.6 mm -107.09 114.16 45.38 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.781 0 N-CA-C 109.68 -0.489 . . . . 0.55 109.68 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.537 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.9 t-160 -107.08 132.46 52.95 Favored 'General case' 0 CA--C 1.554 1.115 0 N-CA-C 115.359 1.614 . . . . 1.34 115.359 -177.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -89.12 147.27 24.3 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 123.871 0.869 . . . . 2.79 109.93 174.274 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 20' ' ' SER . 0.0 OUTLIER -60.49 -107.88 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 117.075 2.25 . . . . 3.0 117.075 -177.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -175.72 71.55 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.364 0 C-N-CA 124.221 1.008 . . . . 2.3 112.958 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.415 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 19.3 m-20 65.52 47.57 0.58 Allowed Pre-proline 0 N--CA 1.519 3.009 0 N-CA-C 118.291 2.7 . . . . 1.17 118.291 175.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 41.4 Cg_endo -106.77 160.44 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 123.214 2.609 . . . . 1.45 114.391 177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -165.45 -86.77 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.5 1.12 . . . . 1.91 110.039 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 72' ' ' GLY . 45.6 mt-10 -141.26 60.48 1.5 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 112.514 0.561 . . . . 4.84 112.514 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.79 0.33 60.53 Favored Glycine 0 CA--C 1.549 2.158 0 N-CA-C 115.886 1.115 . . . . 2.37 115.886 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.49 87.68 2.56 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 121.737 0.78 . . . . 4.5 111.763 -178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.46 117.01 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-N 114.545 -1.207 . . . . 2.7 110.901 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -163.96 -103.63 0.18 Allowed Glycine 0 C--N 1.342 0.899 0 C-N-CA 120.866 -0.683 . . . . 1.95 114.018 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -120.7 177.02 5.23 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.512 0.93 . . . . 5.34 113.512 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.63 147.45 24.3 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.481 1.112 . . . . 1.64 112.638 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.0 m -113.77 84.62 2.06 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-O 121.411 0.624 . . . . 1.57 111.639 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.67 82.93 1.96 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.468 -0.787 . . . . 2.33 111.226 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.2 81.1 1.67 Allowed 'General case' 0 N--CA 1.481 1.091 0 CA-C-O 122.003 0.906 . . . . 3.16 110.213 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.42 70.11 0.19 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 113.886 -1.506 . . . . 1.52 109.999 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.06 0.63 57.47 Favored 'General case' 0 CA--C 1.559 1.295 0 N-CA-C 115.591 1.7 . . . . 1.67 115.591 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 ttpp -112.71 67.61 0.66 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.203 1.001 . . . . 4.18 110.849 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.7 tp -163.66 72.2 1.82 Allowed Pre-proline 0 C--O 1.238 0.483 0 CA-C-N 114.179 -1.373 . . . . 2.63 107.516 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -66.98 158.38 57.07 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.697 2.932 . . . . 1.37 117.379 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.265 1.2 mp -89.8 128.11 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.226 0 CA-C-N 114.986 -1.006 . . . . 0.69 109.191 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.2 mp -85.49 -12.01 52.85 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.924 1.824 . . . . 1.28 115.924 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -102.63 22.59 13.36 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 113.694 0.998 . . . . 1.51 113.694 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 t -143.03 -163.33 1.61 Allowed 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 121.773 0.797 . . . . 1.09 111.993 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.595 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.2 t30 -95.55 -179.96 1.04 Allowed Pre-proline 0 CA--C 1.572 1.823 0 C-N-CA 125.302 1.441 . . . . 1.27 111.138 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.575 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 24.5 Cg_exo -71.82 -45.64 0.7 Allowed 'Trans proline' 0 C--N 1.394 2.969 0 C-N-CA 123.076 2.518 . . . . 0.95 111.891 174.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -70.07 -43.78 70.45 Favored 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 113.438 -1.71 . . . . 2.04 111.56 177.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.01 1.51 43.45 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 114.912 -1.04 . . . . 1.62 112.438 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.595 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 3.4 tt0 -77.71 -42.94 32.65 Favored 'General case' 0 C--N 1.381 1.938 0 C-N-CA 125.853 1.661 . . . . 1.77 106.853 172.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -61.07 -44.45 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.869 0 C-N-CA 124.519 1.127 . . . . 0.81 109.108 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.9 tp -68.22 -29.67 68.55 Favored 'General case' 0 CA--C 1.581 2.172 0 N-CA-C 114.723 1.379 . . . . 1.15 114.723 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -105.53 14.88 27.92 Favored 'General case' 0 CA--C 1.577 2.017 0 N-CA-C 114.121 1.156 . . . . 0.92 114.121 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.14 -23.48 1.13 Allowed 'General case' 0 N--CA 1.513 2.713 0 N-CA-C 115.883 1.809 . . . . 1.33 115.883 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.473 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 41.7 p -80.88 135.95 36.0 Favored 'General case' 0 N--CA 1.523 3.196 0 N-CA-C 113.378 0.881 . . . . 1.28 113.378 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.505 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.1 pt-20 -117.57 145.38 44.32 Favored 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 115.894 1.813 . . . . 1.53 115.894 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.528 HH12 HD21 ' A' ' 67' ' ' ASN . 38.0 ttt-85 -130.22 105.91 8.23 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.611 -1.177 . . . . 3.22 109.75 176.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -119.9 140.77 50.35 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.246 0.546 . . . . 3.66 112.398 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.528 HD21 HH12 ' A' ' 65' ' ' ARG . 3.9 m-80 -113.87 -76.49 0.58 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.099 0.778 . . . . 4.7 113.099 -178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -142.69 -91.6 0.13 Allowed 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 113.094 0.776 . . . . 2.55 113.094 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -159.54 125.99 4.45 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.479 0.712 . . . . 2.15 110.58 -177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.499 ' H ' HD21 ' A' ' 164' ' ' ASN . 0.3 OUTLIER 72.72 83.99 0.12 Allowed 'General case' 0 N--CA 1.514 2.75 0 C-N-CA 124.952 1.301 . . . . 0.77 111.042 -178.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -147.29 152.84 38.93 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.502 -0.772 . . . . 0.81 113.062 -176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.532 ' O ' ' HG3' ' A' ' 35' ' ' GLU . . . -165.51 -171.68 32.01 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 115.842 1.097 . . . . 0.47 115.842 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.27 172.43 7.08 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.438 1.273 . . . . 0.89 114.438 -176.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -126.09 132.33 51.92 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.393 -1.276 . . . . 0.51 112.228 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.27 102.22 30.65 Favored Pre-proline 0 CA--C 1.567 1.613 0 C-N-CA 123.446 0.698 . . . . 0.15 109.408 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.84 119.58 2.22 Favored 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 122.098 1.865 . . . . 0.15 114.925 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.36 162.7 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.654 0 CA-C-O 122.003 0.906 . . . . 0.19 111.089 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -150.63 19.76 0.82 Allowed 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 114.716 -1.129 . . . . 2.53 111.781 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -129.53 159.78 35.25 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-O 121.32 0.581 . . . . 2.12 111.572 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.517 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.8 OUTLIER -118.32 147.96 42.96 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.199 1.185 . . . . 0.42 114.199 -178.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.82 -139.6 6.26 Favored Glycine 0 CA--C 1.526 0.744 0 CA-C-N 113.827 -1.533 . . . . 0.23 112.165 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.9 mt-10 -115.1 104.63 12.06 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 118.46 1.13 . . . . 1.75 110.823 177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -98.88 128.4 45.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.159 0.504 . . . . 0.21 110.759 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -112.93 122.91 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-O 121.612 0.72 . . . . 0.2 110.848 -176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.468 HD12 HD12 ' A' ' 172' ' ' ILE . 2.0 tt -108.34 105.35 14.99 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.391 -1.277 . . . . 0.78 110.304 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.19 125.13 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 114.082 -1.417 . . . . 0.44 107.913 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -135.52 135.34 40.33 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.728 -0.669 . . . . 1.25 111.837 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.511 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.5 OUTLIER -96.09 121.21 37.62 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.498 -0.774 . . . . 2.52 112.051 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -107.34 133.96 51.11 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 115.058 -0.974 . . . . 0.4 109.945 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.33 152.92 48.92 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 121.433 0.635 . . . . 0.41 112.499 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.68 157.12 16.7 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.41 1.084 . . . . 2.61 112.309 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.257 4.4 p -144.52 -39.48 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.592 2.585 0 N-CA-C 114.227 1.195 . . . . 2.13 114.227 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -130.01 -2.04 4.63 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 115.442 1.645 . . . . 2.27 115.442 -177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -128.6 114.0 16.14 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.537 1.062 . . . . 1.46 112.311 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.0 92.7 4.15 Favored 'General case' 0 CA--C 1.563 1.471 0 CA-C-O 122.617 1.198 . . . . 0.84 111.061 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -152.12 149.62 29.0 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.815 -1.084 . . . . 2.45 112.103 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 14.1 m -123.71 117.83 25.85 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.585 0.587 . . . . 1.66 112.585 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 71.47 55.38 0.2 Allowed 'General case' 0 N--CA 1.503 2.225 0 C-N-CA 126.244 1.818 . . . . 1.89 113.058 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -154.56 -40.08 0.09 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.194 -1.366 . . . . 2.56 109.579 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -107.61 80.84 1.44 Allowed 'General case' 0 C--N 1.364 1.237 0 N-CA-C 108.643 -0.873 . . . . 2.76 108.643 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.52 129.3 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 CA-C-N 114.627 -1.169 . . . . 0.69 111.466 -177.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -115.51 171.76 7.52 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.014 1.487 . . . . 0.7 115.014 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -118.52 136.12 54.01 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-O 121.415 0.626 . . . . 1.33 111.774 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.2 123.32 60.04 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.936 0 CA-C-N 115.315 -0.857 . . . . 0.48 110.102 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.0 OUTLIER -129.83 149.42 51.57 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.953 1.464 . . . . 1.69 114.953 -179.097 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.3 OUTLIER -126.56 108.26 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 114.636 -1.165 . . . . 0.6 111.704 176.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.49 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 65.18 26.08 12.37 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 126.759 2.023 . . . . 1.12 113.277 -177.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.41 -13.91 51.06 Favored Glycine 0 CA--C 1.553 2.435 0 CA-C-N 116.157 -0.474 . . . . 0.32 114.139 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -89.85 131.21 35.9 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 125.456 1.502 . . . . 0.57 114.044 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 p -97.85 126.0 43.0 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.429 -0.794 . . . . 0.55 112.705 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.26 -48.2 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-N 114.214 -1.357 . . . . 1.06 110.256 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.06 88.9 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 120.26 -0.576 . . . . 0.44 109.744 -179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.02 72.27 0.81 Allowed 'General case' 0 C--N 1.36 1.03 0 CA-C-O 123.494 1.616 . . . . 2.3 111.411 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.7 p30 160.07 60.4 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 111.005 -2.816 . . . . 2.48 108.52 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.89 103.18 15.75 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 113.749 1.018 . . . . 1.13 113.749 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -119.07 102.87 9.05 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 112.88 -1.963 . . . . 2.35 106.067 175.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -27.05 36.29 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.319 0 N-CA-C 114.547 1.314 . . . . 0.68 114.547 -176.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -76.59 -37.77 55.96 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 123.684 0.793 . . . . 0.77 112.194 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.22 -26.58 60.33 Favored 'General case' 0 CA--C 1.576 1.967 0 C-N-CA 124.665 1.186 . . . . 0.91 113.229 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -80.22 -57.96 3.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 113.482 0.919 . . . . 2.43 113.482 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -90.28 -36.22 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.532 0 N-CA-C 114.196 1.184 . . . . 0.93 114.196 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.01 -73.12 0.2 Allowed Glycine 0 C--N 1.361 1.922 0 CA-C-N 118.306 0.503 . . . . 0.85 113.969 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -102.76 175.43 5.49 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.345 1.058 . . . . 3.18 111.753 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 m -71.6 87.68 0.93 Allowed 'General case' 0 N--CA 1.501 2.09 0 CA-C-O 121.997 0.903 . . . . 2.08 113.428 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.34 -162.22 1.3 Allowed 'General case' 0 CA--C 1.563 1.445 0 CA-C-N 113.918 -1.492 . . . . 0.62 110.024 -178.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -98.94 130.3 45.3 Favored 'General case' 0 CA--C 1.564 1.518 0 N-CA-C 113.421 0.897 . . . . 0.46 113.421 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.431 ' O ' ' HD3' ' A' ' 88' ' ' LYS . 22.4 t60 -103.51 141.72 35.51 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.463 -0.569 . . . . 0.38 109.463 177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -134.15 124.17 25.62 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.377 1.251 . . . . 2.5 114.377 -176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -111.39 118.84 36.93 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.748 -1.114 . . . . 1.56 110.684 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.62 120.91 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.735 -1.12 . . . . 0.45 111.448 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.29 95.45 27.49 Favored Pre-proline 0 CA--C 1.572 1.811 0 CA-C-N 115.842 -0.617 . . . . 0.84 111.062 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -75.37 131.91 14.37 Favored 'Trans proline' 0 C--N 1.395 2.986 0 C-N-CA 122.787 2.324 . . . . 0.16 112.711 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.3 mt -115.1 146.7 19.19 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.49 0 CA-C-N 115.443 -0.799 . . . . 0.38 111.137 -176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.6 p -129.18 109.94 11.57 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.264 -0.88 . . . . 1.31 111.515 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.517 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.5 mt -112.14 123.33 67.79 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.502 0 N-CA-C 108.336 -0.987 . . . . 0.25 108.336 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.7 mmtp -138.78 124.43 19.62 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.373 -0.83 . . . . 2.05 110.792 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 67.28 17.86 10.25 Favored 'General case' 0 N--CA 1.515 2.784 0 C-N-CA 125.35 1.46 . . . . 3.55 114.168 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.54 13.8 43.2 Favored Glycine 0 CA--C 1.546 2.01 0 CA-C-O 119.163 -0.798 . . . . 0.37 115.025 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 54.8 mtpt -122.46 147.02 46.83 Favored 'General case' 0 C--N 1.365 1.279 0 CA-C-N 118.523 1.161 . . . . 1.56 112.57 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.82 143.98 31.74 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.125 1.157 . . . . 0.34 114.125 -175.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.43 114.65 11.59 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 114.919 -1.037 . . . . 0.64 110.653 178.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.278 0.4 OUTLIER -116.81 105.17 17.75 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.197 0 CA-C-O 121.144 0.497 . . . . 0.46 110.382 179.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 66.32 -84.29 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.706 0 C-N-CA 125.701 1.601 . . . . 1.56 113.981 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -136.75 31.82 2.52 Favored Glycine 0 CA--C 1.543 1.798 0 CA-C-N 116.001 -0.545 . . . . 0.49 112.859 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -134.85 126.66 29.24 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 123.603 0.761 . . . . 1.82 110.239 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -112.5 133.02 59.58 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 CA-C-O 121.673 0.749 . . . . 1.02 112.21 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.2 m -149.95 179.54 7.97 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.83 -1.077 . . . . 0.56 109.346 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.275 15.1 t -104.15 139.05 39.76 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 113.476 0.917 . . . . 1.25 113.476 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -82.87 122.19 27.92 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.068 0.947 . . . . 0.29 111.367 178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.56 91.24 3.26 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 112.556 0.576 . . . . 1.42 112.556 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.96 -64.82 3.33 Favored Glycine 0 C--N 1.358 1.802 0 N-CA-C 118.715 2.246 . . . . 0.42 118.715 177.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.52 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -132.38 157.79 43.63 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 114.251 1.204 . . . . 1.1 114.251 -176.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.52 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -104.62 139.04 40.06 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.202 -1.817 . . . . 0.67 109.063 176.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.5 t -121.35 142.48 49.94 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.352 1.612 . . . . 0.36 115.352 -177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.419 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.14 97.27 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.451 -1.314 . . . . 0.74 107.451 176.267 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 33.4 mt-10 -112.65 128.04 56.28 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.384 0.883 . . . . 1.67 113.384 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -114.05 126.18 54.83 Favored 'General case' 0 C--O 1.247 0.969 0 CA-C-N 115.738 -0.664 . . . . 1.8 110.192 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -101.07 144.37 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 114.652 -1.158 . . . . 0.58 110.53 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -72.45 150.45 43.3 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.646 2.091 . . . . 2.18 116.646 -177.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -114.97 -47.88 0.55 Allowed Glycine 0 CA--C 1.541 1.691 0 CA-C-N 114.066 -1.424 . . . . 1.02 112.941 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -131.88 -76.82 0.51 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 122.739 0.415 . . . . 2.86 111.951 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -138.17 -53.97 0.63 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.949 0.5 . . . . 3.91 111.421 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.05 119.66 31.39 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 124.606 1.162 . . . . 1.74 110.772 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.499 HD21 ' H ' ' A' ' 70' ' ' SER . 1.3 m-20 -81.13 -170.67 0.26 Allowed Pre-proline 0 CA--C 1.572 1.809 0 C-N-CA 124.848 1.259 . . . . 1.68 110.524 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_exo -61.8 104.93 0.34 Allowed 'Trans proline' 0 C--N 1.394 2.922 0 CA-C-N 122.304 1.858 . . . . 2.06 112.215 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -63.52 1.27 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.336 1.976 . . . . 3.0 116.336 -174.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 66.0 t -96.38 131.44 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 CA-C-N 119.367 0.985 . . . . 0.8 109.991 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -134.25 123.27 23.99 Favored 'General case' 0 C--N 1.363 1.169 0 CA-C-N 114.443 -1.253 . . . . 0.87 111.834 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.549 ' HB1' HD22 ' A' ' 15' ' ' ASN . . . -120.72 48.02 1.69 Allowed 'General case' 0 CA--C 1.585 2.302 0 N-CA-C 115.643 1.719 . . . . 0.34 115.643 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.642 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -45.23 131.74 7.73 Favored 'General case' 0 N--CA 1.526 3.358 0 N-CA-C 116.64 2.089 . . . . 0.7 116.64 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -151.31 105.4 3.19 Favored 'General case' 0 CA--C 1.554 1.096 0 CA-C-N 115.19 -0.914 . . . . 0.21 111.051 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.468 HD12 HD12 ' A' ' 85' ' ' LEU 0.298 9.1 tt -113.66 122.32 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.03 0 CA-C-O 122.283 1.04 . . . . 0.31 111.258 175.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -122.67 165.24 16.82 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 113.906 -1.497 . . . . 0.44 110.789 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -122.13 158.93 28.22 Favored 'General case' 0 CA--C 1.553 1.071 0 N-CA-C 118.283 2.698 . . . . 1.26 118.283 -175.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 103.89 -41.31 2.17 Favored Glycine 0 CA--C 1.541 1.7 0 CA-C-N 110.351 -3.113 . . . . 0.17 119.256 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.59 154.53 1.25 Allowed 'General case' 0 N--CA 1.518 2.927 0 CA-C-N 120.494 2.147 . . . . 0.15 113.227 -178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.25 -14.43 58.42 Favored 'General case' 0 CA--C 1.581 2.169 0 C-N-CA 124.75 1.22 . . . . 0.17 114.092 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.8 2.99 49.9 Favored 'General case' 0 CA--C 1.573 1.84 0 N-CA-C 114.143 1.164 . . . . 0.55 114.143 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.661 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -110.0 -5.79 15.34 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.726 1.01 . . . . 0.6 113.726 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.51 93.69 0.41 Allowed Pre-proline 0 N--CA 1.511 2.622 0 C-N-CA 124.397 1.079 . . . . 0.95 111.752 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.661 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 53.7 Cg_endo -95.26 146.54 1.46 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 122.988 2.459 . . . . 1.8 114.717 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 24.0 mmt -138.01 111.6 8.16 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.901 -0.591 . . . . 4.96 111.4 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.8 161.06 38.46 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.982 0.896 . . . . 4.0 112.656 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -111.26 161.14 26.47 Favored Pre-proline 0 CA--C 1.56 1.332 0 CA-C-N 114.774 -1.103 . . . . 6.27 110.934 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.6 120.51 7.81 Favored 'Trans proline' 0 C--N 1.397 3.125 0 C-N-CA 122.791 2.328 . . . . 6.59 114.771 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -136.86 141.76 36.17 Favored Pre-proline 0 CA--C 1.567 1.603 0 CA-C-N 114.861 -1.063 . . . . 5.51 111.071 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.97 -28.58 3.83 Favored 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 123.098 2.532 . . . . 6.77 116.15 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -135.06 -140.35 4.21 Favored Glycine 0 CA--C 1.53 1.004 0 N-CA-C 114.34 0.496 . . . . 7.02 114.34 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 9.8 mt -119.2 115.5 24.34 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.021 0.378 . . . . 8.99 112.021 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.165 -0.921 . . . . 10.6 110.639 179.73 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.641 -0.184 . . . . 8.93 112.641 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.2 117.81 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.45 0 C-N-CA 127.546 2.338 . . . . 6.82 114.984 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.8 tpt -141.37 115.84 9.53 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.469 -0.787 . . . . 7.64 111.007 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.6 m -131.2 -66.41 0.74 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.911 -0.586 . . . . 3.86 112.254 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.27 95.95 0.1 Allowed Glycine 0 C--N 1.348 1.222 0 C-N-CA 121.426 -0.416 . . . . 1.11 113.225 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.657 ' HG ' HD11 ' A' ' 27' ' ' ILE . 19.4 tp -87.42 -42.4 12.86 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 112.938 0.718 . . . . 0.35 112.938 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.43 63.56 Favored 'General case' 0 N--CA 1.508 2.469 0 C-N-CA 125.855 1.662 . . . . 0.2 114.797 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.7 -11.43 51.24 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 113.667 0.988 . . . . 0.32 113.667 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 20.8 mmtp -105.47 -23.28 12.84 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.379 0.881 . . . . 1.73 113.379 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -53.67 136.55 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.969 0 N-CA-C 115.472 1.656 . . . . 0.11 115.472 177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -123.9 -28.4 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 115.195 -0.911 . . . . 0.16 112.236 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 64.7 t90 -163.09 118.76 1.76 Allowed 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 117.929 0.331 . . . . 0.54 111.882 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.26 131.82 30.76 Favored 'General case' 0 N--CA 1.511 2.622 0 O-C-N 121.273 -0.892 . . . . 0.19 111.876 178.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -139.75 130.66 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.497 0 N-CA-C 113.113 0.783 . . . . 1.05 113.113 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -115.83 106.61 14.03 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.117 -1.438 . . . . 2.11 107.117 171.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.33 105.83 9.84 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-O 121.614 0.721 . . . . 0.63 111.664 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 168.79 -63.54 0.19 Allowed Glycine 0 C--N 1.355 1.635 0 CA-C-N 114.189 -1.369 . . . . 0.71 114.821 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.449 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -95.16 -116.3 2.96 Favored Glycine 0 N--CA 1.481 1.67 0 N-CA-C 114.716 0.646 . . . . 0.8 114.716 -178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 18' ' ' GLY . 18.4 mt-10 -170.08 114.16 0.49 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 123.889 0.876 . . . . 1.63 109.884 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 46.39 111.95 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.003 0 N-CA-C 118.328 2.714 . . . . 1.0 118.328 178.831 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.483 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 82.1 t60 -136.59 136.4 39.19 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 113.97 1.1 . . . . 0.45 113.97 177.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 75.3 t -104.82 109.29 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.632 0 CA-C-N 113.765 -1.561 . . . . 1.39 107.04 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -87.67 160.1 18.26 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 112.171 0.434 . . . . 1.85 112.171 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -41.48 -26.41 0.11 Allowed 'Isoleucine or valine' 1 N--CA 1.547 4.383 0 N-CA-C 120.072 3.36 . . . . 0.72 120.072 -174.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -93.35 -11.33 32.59 Favored 'General case' 0 CA--C 1.567 1.599 0 CA-C-N 118.84 0.746 . . . . 0.51 112.44 177.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.82 38.0 3.28 Favored Glycine 0 C--N 1.361 1.929 0 C-N-CA 124.16 0.886 . . . . 0.34 114.158 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.657 HD11 ' HG ' ' A' ' 6' ' ' LEU . 28.6 mm -105.38 135.55 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.618 0 N-CA-C 108.555 -0.906 . . . . 0.55 108.555 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.483 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 7.9 t-160 -123.34 132.38 53.97 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 114.612 1.338 . . . . 1.34 114.612 -176.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.518 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -93.73 137.21 33.22 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.123 -0.944 . . . . 2.79 109.94 175.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -100.29 104.76 16.25 Favored 'General case' 0 CA--C 1.559 1.3 0 N-CA-C 113.465 0.913 . . . . 3.0 113.465 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HG3' ' OG ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -36.6 122.12 0.77 Allowed 'General case' 0 N--CA 1.528 3.434 0 N-CA-C 119.051 2.982 . . . . 2.3 119.051 179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.7 OUTLIER 39.03 64.69 3.66 Favored Pre-proline 0 N--CA 1.529 3.49 0 N-CA-C 117.131 2.271 . . . . 1.17 117.131 177.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -89.73 -8.09 4.46 Favored 'Trans proline' 0 CA--C 1.563 1.957 0 C-N-CA 122.755 2.303 . . . . 1.45 118.058 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.91 -26.86 0.78 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.468 1.655 . . . . 1.91 115.468 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -99.11 76.01 2.07 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 119.702 1.137 . . . . 4.84 112.306 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 104.37 -30.04 10.86 Favored Glycine 0 CA--C 1.543 1.785 0 CA-C-N 115.396 -0.82 . . . . 2.37 114.521 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.582 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 50.3 55.31 9.66 Favored 'General case' 0 N--CA 1.516 2.859 0 C-N-CA 127.328 2.251 . . . . 4.5 115.779 -179.46 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.48 179.6 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-N 114.686 -1.143 . . . . 2.7 110.654 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -95.2 82.27 0.87 Allowed Glycine 0 CA--C 1.538 1.498 0 O-C-N 121.756 -0.59 . . . . 1.95 114.449 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -148.38 134.5 19.29 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.372 0.606 . . . . 5.34 112.355 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -108.25 132.71 53.38 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.965 0.906 . . . . 1.64 111.012 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 m -116.91 107.25 14.36 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.689 -0.687 . . . . 1.57 111.328 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.68 109.83 8.87 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.564 -0.744 . . . . 2.33 111.552 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -105.45 -33.58 8.09 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 115.248 -0.887 . . . . 3.16 111.891 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -114.39 75.67 0.24 Allowed Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.337 -0.705 . . . . 1.52 111.337 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.95 -19.8 22.05 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 114.451 1.278 . . . . 1.67 114.451 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' H ' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -104.22 35.18 2.78 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 112.84 0.681 . . . . 4.18 112.84 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.29 71.7 71.96 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.635 1.574 . . . . 2.63 106.972 178.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -67.81 158.77 55.78 Favored 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 124.175 3.25 . . . . 1.37 117.45 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.256 1.3 mp -86.76 124.89 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.466 0 C-N-CA 124.366 1.066 . . . . 0.69 108.389 177.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 mp -81.62 -11.71 59.01 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 116.602 2.075 . . . . 1.28 116.602 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -102.5 17.08 24.52 Favored 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 113.745 1.017 . . . . 1.51 113.745 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.425 ' OG ' ' HD2' ' A' ' 61' ' ' TYR . 1.2 t -137.32 -164.04 1.53 Allowed 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 121.856 0.836 . . . . 1.09 112.578 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.732 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.5 t30 -95.95 -179.27 0.89 Allowed Pre-proline 0 CA--C 1.573 1.858 0 C-N-CA 125.617 1.567 . . . . 1.27 111.367 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.517 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 23.5 Cg_exo -72.34 -46.44 0.49 Allowed 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 123.175 2.584 . . . . 0.95 112.535 174.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -70.01 -47.02 63.81 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 113.905 -1.498 . . . . 2.04 111.731 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -8.88 58.12 Favored 'General case' 0 CA--C 1.585 2.324 0 CA-C-N 114.916 -1.038 . . . . 1.62 111.955 176.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.732 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 3.3 tt0 -70.81 -42.28 70.46 Favored 'General case' 0 C--N 1.39 2.354 0 C-N-CA 125.716 1.607 . . . . 1.77 108.187 172.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -59.69 -42.56 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.217 0 C-N-CA 124.663 1.185 . . . . 0.81 109.463 173.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 4.9 tp -80.02 -8.81 59.56 Favored 'General case' 0 CA--C 1.58 2.117 0 N-CA-C 114.328 1.233 . . . . 1.15 114.328 176.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.425 ' HD2' ' OG ' ' A' ' 53' ' ' SER . 20.3 m-85 -125.05 22.75 7.9 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.98 0.912 . . . . 0.92 113.357 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.38 -38.24 0.33 Allowed 'General case' 0 N--CA 1.513 2.686 0 N-CA-C 115.245 1.572 . . . . 1.33 115.245 -177.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.8 p -67.85 134.02 50.18 Favored 'General case' 0 N--CA 1.533 3.716 0 N-CA-C 114.456 1.28 . . . . 1.28 114.456 -177.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.449 ' HB3' HG22 ' A' ' 167' ' ' VAL . 2.7 pt-20 -123.63 141.77 51.69 Favored 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 115.386 1.624 . . . . 1.53 115.386 -177.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -124.2 121.4 34.97 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 113.965 -1.47 . . . . 3.22 110.496 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -128.02 137.43 52.2 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-O 120.992 0.425 . . . . 3.66 112.032 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.42 -70.92 0.75 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 113.62 0.97 . . . . 4.7 113.62 -178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -135.4 -87.59 0.35 Allowed 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 114.054 1.131 . . . . 2.55 114.054 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -173.6 124.72 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.657 0.783 . . . . 2.15 109.691 -175.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 71.66 84.67 0.13 Allowed 'General case' 0 N--CA 1.51 2.546 0 C-N-CA 124.86 1.264 . . . . 0.77 111.962 -179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -135.62 141.77 45.12 Favored 'General case' 0 C--O 1.247 0.935 0 CA-C-O 121.978 0.894 . . . . 0.81 112.176 -178.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -140.03 175.93 21.58 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 116.407 1.323 . . . . 0.47 116.407 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -118.86 163.17 17.3 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.839 -1.18 . . . . 0.89 113.227 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -122.21 129.33 52.16 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 114.604 -1.18 . . . . 0.51 112.435 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -123.21 101.42 38.18 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 108.91 -0.774 . . . . 0.15 108.91 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -84.26 119.64 2.43 Favored 'Trans proline' 0 CA--C 1.563 1.945 0 C-N-CA 121.998 1.799 . . . . 0.15 114.747 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.84 160.42 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 CA-C-O 122.035 0.922 . . . . 0.19 111.308 -179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -148.66 21.02 1.03 Allowed 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 114.605 -1.179 . . . . 2.53 111.865 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -130.06 160.35 33.98 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-O 121.312 0.577 . . . . 2.12 111.415 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.7 OUTLIER -119.29 145.51 46.06 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.437 0.903 . . . . 0.42 113.437 -179.203 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.5 -138.3 5.45 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 114.341 -1.299 . . . . 0.23 112.498 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 30.6 mm-40 -114.8 105.0 12.51 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 118.228 1.014 . . . . 1.75 111.144 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -99.45 127.51 45.5 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.321 0.582 . . . . 0.21 110.853 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -109.22 121.5 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-O 121.894 0.854 . . . . 0.2 110.878 -176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.34 107.41 18.41 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 113.801 -1.545 . . . . 0.78 110.446 178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.9 t -115.64 125.2 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.91 -0.774 . . . . 0.44 108.91 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.92 141.79 48.56 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 112.756 0.65 . . . . 1.25 112.756 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.4 OUTLIER -107.07 119.3 39.01 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.668 -0.696 . . . . 2.52 111.277 177.63 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.436 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 12.4 m-85 -106.68 134.61 49.56 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.467 -0.788 . . . . 0.4 110.581 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.23 146.6 42.78 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.246 0.546 . . . . 0.41 111.527 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -136.23 120.64 18.08 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.253 0.621 . . . . 2.61 110.893 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.09 76.21 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 112.828 0.677 . . . . 2.13 112.828 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -171.95 -52.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 112.735 0.643 . . . . 2.27 112.735 178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -115.27 142.77 46.22 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.622 0.601 . . . . 1.46 112.622 -179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -109.53 101.18 10.15 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 122.513 1.149 . . . . 0.84 111.656 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -163.55 150.75 12.49 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 114.603 -1.181 . . . . 2.45 111.047 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.2 m -110.77 -75.19 0.62 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.954 1.094 . . . . 1.66 113.954 -177.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -94.44 70.08 3.64 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.103 0.954 . . . . 1.89 111.159 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -156.22 -41.95 0.08 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 113.936 -1.484 . . . . 2.56 109.207 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -109.83 82.47 1.6 Allowed 'General case' 0 C--N 1.364 1.22 0 CA-C-O 121.827 0.823 . . . . 2.76 109.172 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.78 121.26 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 114.375 -1.284 . . . . 0.69 110.557 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -106.94 173.54 6.28 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.317 1.599 . . . . 0.7 115.317 -175.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -124.64 136.98 54.38 Favored 'General case' 0 CA--C 1.557 1.248 0 CA-C-O 122.065 0.936 . . . . 1.33 111.019 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.82 124.81 61.98 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.929 0 CA-C-N 114.145 -1.389 . . . . 0.48 109.499 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 54.8 mtt180 -119.61 143.3 47.74 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.384 1.624 . . . . 1.69 115.384 -176.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 5.8 m -120.71 101.01 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 115.345 -0.843 . . . . 0.6 112.184 176.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.563 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.2 t30 64.9 28.74 12.66 Favored 'General case' 0 N--CA 1.52 3.059 0 C-N-CA 126.494 1.917 . . . . 1.12 114.561 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 108.38 -18.83 32.51 Favored Glycine 0 CA--C 1.549 2.199 0 CA-C-N 115.831 -0.622 . . . . 0.32 113.602 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -86.34 161.76 18.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.092 1.757 . . . . 0.57 113.125 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -118.68 129.69 55.43 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 122.166 0.984 . . . . 0.55 111.249 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.07 -47.07 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 CA-C-N 113.518 -1.673 . . . . 1.06 112.825 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.74 89.32 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 N-CA-C 107.904 -1.147 . . . . 0.44 107.904 178.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.98 75.49 0.92 Allowed 'General case' 0 C--N 1.359 0.988 0 CA-C-O 123.577 1.655 . . . . 2.3 112.522 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 p30 154.79 63.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 110.474 -3.057 . . . . 2.48 108.032 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.69 99.65 12.51 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 113.563 0.949 . . . . 1.13 113.563 -178.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 3.6 p30 -112.6 94.56 4.97 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 113.017 -1.901 . . . . 2.35 107.786 175.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -63.31 -26.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 N-CA-C 114.739 1.385 . . . . 0.68 114.739 -176.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -74.61 -39.39 62.2 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 123.828 0.851 . . . . 0.77 112.042 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.72 -26.68 59.98 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.71 1.204 . . . . 0.91 113.376 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 23.6 mmm180 -77.81 -55.05 5.65 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 113.639 0.978 . . . . 2.43 113.639 179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.65 -37.5 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 N-CA-C 114.59 1.33 . . . . 0.93 114.59 178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.64 -109.44 1.11 Allowed Glycine 0 C--N 1.354 1.558 0 CA-C-N 118.391 0.541 . . . . 0.85 113.271 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -114.52 107.46 15.54 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.517 0.327 . . . . 3.18 110.433 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 t 70.11 -130.61 0.07 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 125.301 1.441 . . . . 2.08 112.304 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.9 p 56.68 -174.39 0.07 Allowed 'General case' 0 N--CA 1.53 3.538 0 N-CA-C 116.635 2.087 . . . . 0.62 116.635 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -100.05 128.45 46.14 Favored 'General case' 0 CA--C 1.563 1.457 0 N-CA-C 113.312 0.856 . . . . 0.46 113.312 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.436 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 9.1 t60 -102.79 139.34 38.5 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 109.141 -0.688 . . . . 0.38 109.141 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -137.51 125.85 23.31 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 114.273 1.212 . . . . 2.5 114.273 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -119.75 127.16 52.56 Favored 'General case' 0 C--O 1.25 1.122 0 CA-C-N 115.077 -0.965 . . . . 1.56 110.602 175.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.99 126.58 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 CA-C-N 114.141 -1.39 . . . . 0.45 111.115 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -132.56 92.22 28.1 Favored Pre-proline 0 CA--C 1.573 1.845 0 CA-C-N 115.263 -0.881 . . . . 0.84 110.567 -179.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -75.02 132.77 15.77 Favored 'Trans proline' 0 C--N 1.394 2.934 0 C-N-CA 122.917 2.412 . . . . 0.16 113.074 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.82 150.26 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 CA-C-N 115.446 -0.797 . . . . 0.38 111.145 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.7 p -132.9 109.24 9.46 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.326 -0.852 . . . . 1.31 111.799 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.5 mt -109.19 124.46 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 108.566 -0.901 . . . . 0.25 108.566 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.71 126.13 21.77 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.532 -0.758 . . . . 2.05 110.75 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt 66.6 16.93 10.53 Favored 'General case' 0 N--CA 1.515 2.79 0 C-N-CA 125.272 1.429 . . . . 3.55 114.595 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.29 14.77 40.54 Favored Glycine 0 CA--C 1.547 2.056 0 CA-C-O 119.183 -0.787 . . . . 0.37 114.803 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 23.6 mtpp -123.9 147.3 47.79 Favored 'General case' 0 C--N 1.364 1.206 0 CA-C-N 118.225 1.012 . . . . 1.56 112.419 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.47 139.07 37.63 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 113.994 1.109 . . . . 0.34 113.994 -176.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.49 115.47 18.93 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 114.929 -1.032 . . . . 0.64 109.989 178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.46 93.58 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.486 0 CA-C-N 115.716 -0.675 . . . . 0.46 110.878 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 64.75 -84.94 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.772 0 C-N-CA 125.555 1.542 . . . . 1.56 114.135 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.06 26.2 4.25 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-N 116.234 -0.439 . . . . 0.49 113.835 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -137.88 117.58 13.11 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 123.19 0.596 . . . . 1.82 109.983 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 p -106.25 133.74 49.85 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.374 0 CA-C-O 121.65 0.738 . . . . 1.02 112.152 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.4 m -147.62 -179.46 6.89 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.841 -1.072 . . . . 0.56 109.543 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.276 14.9 t -103.98 138.89 39.89 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 113.456 0.91 . . . . 1.25 113.456 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -81.96 122.55 27.92 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 124.233 1.013 . . . . 0.29 111.493 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.97 90.98 3.29 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.762 0.653 . . . . 1.42 112.762 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.96 -63.78 2.77 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 118.597 2.199 . . . . 0.42 118.597 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.552 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -130.58 161.93 30.44 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-O 121.837 0.827 . . . . 1.1 113.128 -177.095 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.563 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -111.15 137.52 48.72 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 113.841 -1.527 . . . . 0.67 109.221 177.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.6 t -116.93 142.31 47.1 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.64 1.348 . . . . 0.36 114.64 -178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 39.6 t -121.57 97.25 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 105.22 -2.141 . . . . 0.74 105.22 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -113.62 124.92 53.49 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.138 -0.937 . . . . 1.67 112.913 -176.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -111.68 128.75 56.17 Favored 'General case' 0 C--O 1.252 1.229 0 CA-C-O 122.233 1.016 . . . . 1.8 112.058 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.8 144.34 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-N 112.859 -1.973 . . . . 0.58 110.362 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -78.88 149.46 32.43 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 115.659 1.725 . . . . 2.18 115.659 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -103.8 -35.25 3.54 Favored Glycine 0 CA--C 1.545 1.921 0 CA-C-N 114.525 -1.216 . . . . 1.02 113.132 177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -130.57 -83.6 0.53 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.213 0.605 . . . . 2.86 110.435 178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -170.65 64.26 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.279 0.631 . . . . 3.91 110.656 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -166.98 -39.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 112.926 0.713 . . . . 1.74 112.926 -178.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.53 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 4.3 m-20 84.32 -177.77 0.03 OUTLIER Pre-proline 0 N--CA 1.508 2.439 0 C-N-CA 124.58 1.152 . . . . 1.68 110.838 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -65.38 -9.55 22.65 Favored 'Trans proline' 0 N--CA 1.522 3.2 0 C-N-CA 122.641 2.227 . . . . 2.06 116.385 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 59.0 mttm 80.05 -73.6 0.06 Allowed 'General case' 0 N--CA 1.504 2.239 0 C-N-CA 126.442 1.897 . . . . 3.0 114.065 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 64' ' ' GLU . 21.3 t -103.37 132.04 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 CA-C-O 121.048 0.452 . . . . 0.8 110.237 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.0 t -137.34 121.65 18.14 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 114.114 -1.403 . . . . 0.87 110.889 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.506 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -115.6 49.78 1.06 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 116.138 1.903 . . . . 0.34 116.138 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -41.06 129.23 2.79 Favored 'General case' 0 N--CA 1.515 2.804 0 N-CA-C 116.061 1.875 . . . . 0.7 116.061 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -150.71 103.09 3.06 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.703 -0.681 . . . . 0.21 110.305 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.315 7.2 tt -113.92 122.83 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 CA-C-O 122.262 1.03 . . . . 0.31 112.169 176.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -123.53 163.6 20.61 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 113.849 -1.523 . . . . 0.44 111.023 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 9.6 ptmm? -121.91 159.92 25.86 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 118.489 2.774 . . . . 1.26 118.489 -175.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.62 -42.06 1.99 Allowed Glycine 0 CA--C 1.543 1.803 0 CA-C-N 110.007 -3.27 . . . . 0.17 118.929 174.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.5 153.83 0.94 Allowed 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 120.31 2.055 . . . . 0.15 112.924 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.49 -11.71 59.92 Favored 'General case' 0 CA--C 1.581 2.146 0 N-CA-C 114.72 1.378 . . . . 0.17 114.72 177.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.95 3.39 48.83 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 114.081 1.141 . . . . 0.55 114.081 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.641 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -106.28 -10.34 16.44 Favored 'General case' 0 CA--C 1.562 1.439 0 N-CA-C 113.749 1.018 . . . . 0.6 113.749 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.66 94.12 0.51 Allowed Pre-proline 0 N--CA 1.51 2.526 0 C-N-CA 124.078 0.951 . . . . 0.95 112.216 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.641 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 51.7 Cg_endo -94.94 162.2 1.71 Allowed 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 122.757 2.305 . . . . 1.8 114.998 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.8 mmt -131.85 118.76 20.29 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.459 -0.792 . . . . 4.96 111.25 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.6 mt -127.37 162.37 26.46 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 122.055 0.931 . . . . 4.0 112.818 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -103.61 158.49 31.74 Favored Pre-proline 0 CA--C 1.559 1.291 0 CA-C-N 114.505 -1.225 . . . . 6.27 110.728 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -67.54 121.27 8.35 Favored 'Trans proline' 0 C--N 1.391 2.804 0 C-N-CA 122.449 2.099 . . . . 6.59 115.267 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -136.11 135.95 22.07 Favored Pre-proline 0 CA--C 1.568 1.647 0 CA-C-N 114.846 -1.07 . . . . 5.51 111.122 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -78.13 -19.17 12.31 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 123.637 2.892 . . . . 6.77 116.665 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -111.79 -68.24 0.54 Allowed Glycine 0 CA--C 1.534 1.266 0 N-CA-C 115.327 0.891 . . . . 7.02 115.327 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.9 tp -116.28 130.97 57.05 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.244 0.545 . . . . 8.99 112.438 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.331 -0.843 . . . . 10.6 111.25 -179.857 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.471 -0.252 . . . . 8.93 112.471 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.19 125.55 54.26 Favored 'General case' 0 CA--C 1.558 1.254 0 CA-C-O 121.692 0.758 . . . . 6.82 111.876 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.1 mtt -139.05 115.19 10.28 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.554 -0.748 . . . . 7.64 111.182 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.5 m -134.58 117.95 16.72 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.846 -0.615 . . . . 3.86 111.773 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.32 -51.96 0.04 OUTLIER Glycine 0 C--N 1.341 0.826 0 CA-C-N 115.685 -0.689 . . . . 1.11 114.089 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.549 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.9 tp -85.67 -43.89 13.04 Favored 'General case' 0 CA--C 1.563 1.46 0 C-N-CA 123.495 0.718 . . . . 0.35 112.411 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.9 -22.74 65.83 Favored 'General case' 0 CA--C 1.583 2.244 0 C-N-CA 125.63 1.572 . . . . 0.2 114.436 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.15 -12.05 50.96 Favored 'General case' 0 C--N 1.375 1.695 0 N-CA-C 113.638 0.977 . . . . 0.32 113.638 178.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 45.3 mmtt -105.67 -22.62 12.93 Favored 'General case' 0 C--N 1.364 1.212 0 CA-C-O 118.353 -0.832 . . . . 1.73 113.203 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.0 p -55.34 135.91 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.844 0 N-CA-C 115.221 1.563 . . . . 0.11 115.221 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -122.22 -29.1 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.227 -0.897 . . . . 0.16 111.908 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 64.1 t90 -163.68 116.95 1.5 Allowed 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 120.738 0.304 . . . . 0.54 111.414 -178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -135.19 128.91 32.89 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.296 -0.877 . . . . 0.19 110.226 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 69.2 t -137.84 133.56 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 113.203 0.816 . . . . 1.05 113.203 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -118.99 111.09 17.89 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.082 -1.451 . . . . 2.11 107.082 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -81.37 101.75 10.02 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 122.387 1.089 . . . . 0.63 111.436 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.58 -32.61 0.17 Allowed Glycine 0 C--N 1.344 1.018 0 CA-C-N 113.345 -1.752 . . . . 0.71 116.011 -178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -135.22 -128.33 2.78 Favored Glycine 0 C--N 1.337 0.639 0 C-N-CA 120.233 -0.984 . . . . 0.8 114.643 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.461 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 63.0 mt-10 -151.04 115.33 5.08 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.455 0.169 . . . . 1.63 111.3 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.665 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.6 m 31.82 116.01 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.887 0 N-CA-C 120.286 3.439 . . . . 1.0 120.286 177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 62.0 t60 -138.67 139.02 38.31 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-O 122.15 0.976 . . . . 0.45 112.636 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.89 117.18 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 CA-C-N 114.049 -1.432 . . . . 1.39 109.714 177.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -83.21 166.1 18.88 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.646 -0.707 . . . . 1.85 112.238 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -43.09 -29.15 0.38 Allowed 'Isoleucine or valine' 1 N--CA 1.547 4.41 0 N-CA-C 119.225 3.046 . . . . 0.72 119.225 -176.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -93.38 -14.68 26.53 Favored 'General case' 0 CA--C 1.565 1.522 0 CA-C-N 118.357 0.526 . . . . 0.51 111.691 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.04 42.69 1.62 Allowed Glycine 0 C--N 1.358 1.764 0 C-N-CA 124.393 0.997 . . . . 0.34 114.461 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.549 HD11 ' HG ' ' A' ' 6' ' ' LEU . 14.2 mm -105.72 120.26 56.27 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.738 0 N-CA-C 109.51 -0.552 . . . . 0.55 109.51 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.455 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.0 t60 -104.62 128.19 52.57 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.796 1.406 . . . . 1.34 114.796 -176.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.665 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -98.04 148.2 23.75 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.254 -0.885 . . . . 2.79 110.645 176.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -96.64 168.37 10.57 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.696 1.236 . . . . 3.0 113.613 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -84.38 100.22 11.15 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 116.401 2.0 . . . . 2.3 116.401 -174.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.755 ' O ' ' HB3' ' A' ' 37' ' ' ARG . 37.4 m-20 28.63 56.62 0.6 Allowed Pre-proline 1 N--CA 1.543 4.176 0 C-N-CA 128.066 2.546 . . . . 1.17 117.468 177.403 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -94.44 81.31 0.15 Allowed 'Trans proline' 0 CA--C 1.569 2.246 0 N-CA-C 119.637 2.899 . . . . 1.45 119.637 -174.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -151.73 -80.72 0.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.338 0.655 . . . . 1.91 109.971 174.126 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -147.4 116.66 6.94 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 122.837 0.455 . . . . 4.84 110.486 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.14 5.64 26.59 Favored Glycine 0 CA--C 1.545 1.964 0 C-N-CA 120.699 -0.762 . . . . 2.37 114.068 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.755 ' HB3' ' O ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -72.03 64.56 0.53 Allowed 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.272 1.952 . . . . 4.5 116.272 -177.347 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.96 115.23 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-N 114.937 -1.028 . . . . 2.7 109.528 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.19 -111.43 0.95 Allowed Glycine 0 C--N 1.343 0.936 0 C-N-CA 121.216 -0.516 . . . . 1.95 113.742 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -151.59 -146.36 0.2 Allowed 'General case' 0 CA--C 1.563 1.479 0 CA-C-O 120.996 0.427 . . . . 5.34 111.956 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.51 137.33 36.62 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.617 1.167 . . . . 1.64 112.156 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.5 m -118.68 130.15 55.68 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.456 -0.793 . . . . 1.57 110.996 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -131.26 110.73 11.32 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 121.307 0.575 . . . . 2.33 112.468 -179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -115.15 70.62 0.74 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 115.455 -0.793 . . . . 3.16 110.125 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 126.62 69.42 0.17 Allowed Glycine 0 C--N 1.344 0.979 0 CA-C-N 114.598 -1.183 . . . . 1.52 111.303 -178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.62 -24.43 18.68 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.515 1.302 . . . . 1.67 114.515 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.59 ' HE2' ' O ' ' A' ' 47' ' ' LYS . 4.6 ttpt -100.45 66.29 1.25 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 121.83 0.824 . . . . 4.18 111.824 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.1 72.96 1.71 Allowed Pre-proline 0 CA--C 1.548 0.898 0 N-CA-C 107.041 -1.466 . . . . 2.63 107.041 179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 50.0 Cg_exo -61.65 155.03 56.04 Favored 'Trans proline' 0 N--CA 1.515 2.765 0 C-N-CA 124.661 3.574 . . . . 1.37 117.681 -177.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.5 mp -92.72 130.4 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.214 0 CA-C-N 114.883 -1.053 . . . . 0.69 108.486 178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mt -86.03 -10.14 55.54 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 116.567 2.062 . . . . 1.28 116.567 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -103.49 8.59 37.83 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 114.299 1.222 . . . . 1.51 114.299 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.44 -164.73 1.52 Allowed 'General case' 0 CA--C 1.566 1.579 0 CA-C-O 121.544 0.687 . . . . 1.09 112.096 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.841 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.8 t30 -95.69 179.17 1.21 Allowed Pre-proline 0 CA--C 1.575 1.91 0 C-N-CA 124.715 1.206 . . . . 1.27 111.17 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -71.61 -44.77 0.93 Allowed 'Trans proline' 0 C--N 1.398 3.144 0 C-N-CA 123.202 2.601 . . . . 0.95 112.474 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -71.16 -47.4 57.96 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 113.894 -1.503 . . . . 2.04 111.545 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -77.25 -6.0 51.45 Favored 'General case' 0 CA--C 1.595 2.68 0 CA-C-N 115.466 -0.788 . . . . 1.62 111.536 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.841 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 11.5 tt0 -72.68 -39.25 67.2 Favored 'General case' 0 C--N 1.387 2.217 0 C-N-CA 126.167 1.787 . . . . 1.77 108.463 173.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.0 t -65.59 -41.05 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.151 0 CA-C-N 114.538 -1.21 . . . . 0.81 108.712 172.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 tt -75.74 -9.43 58.58 Favored 'General case' 0 N--CA 1.512 2.67 0 N-CA-C 112.662 0.616 . . . . 1.15 112.662 174.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.492 ' O ' ' HE3' ' A' ' 88' ' ' LYS . 3.5 m-30 -121.24 17.34 11.51 Favored 'General case' 0 CA--C 1.578 2.027 0 C-N-CA 125.175 1.39 . . . . 0.92 113.233 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -146.74 -21.36 0.42 Allowed 'General case' 0 N--CA 1.51 2.533 0 N-CA-C 116.656 2.095 . . . . 1.33 116.656 -178.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.3 p -79.5 127.79 32.57 Favored 'General case' 0 N--CA 1.518 2.947 0 N-CA-C 115.71 1.744 . . . . 1.28 115.71 -176.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.496 ' HB3' HG22 ' A' ' 167' ' ' VAL . 5.2 pt-20 -123.33 148.98 45.44 Favored 'General case' 0 N--CA 1.507 2.394 0 C-N-CA 124.876 1.27 . . . . 1.53 111.847 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.401 ' HD2' ' CG ' ' A' ' 32' ' ' ASP . 2.0 ptm180 -104.0 -93.64 0.34 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 112.582 0.586 . . . . 3.22 112.582 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.66 157.55 44.57 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-O 121.545 0.688 . . . . 3.66 112.414 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.9 m-20 -122.5 141.15 51.96 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.095 0.776 . . . . 4.7 113.095 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -134.78 -103.67 0.23 Allowed 'General case' 0 CA--C 1.558 1.268 0 CA-C-N 115.447 -0.797 . . . . 2.55 110.479 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -163.9 121.73 1.82 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.085 0.554 . . . . 2.15 110.764 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 62.23 86.55 0.11 Allowed 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.368 1.467 . . . . 0.77 113.639 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -150.78 154.76 37.91 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-O 121.754 0.788 . . . . 0.81 112.993 -178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 34' ' ' LEU . . . -172.99 -172.51 38.66 Favored Glycine 0 C--N 1.341 0.851 0 CA-C-N 114.788 -1.097 . . . . 0.47 115.279 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.23 172.55 6.82 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.465 1.283 . . . . 0.89 114.465 -178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -129.47 133.9 47.53 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 114.113 -1.403 . . . . 0.51 111.846 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.0 mp -124.67 102.24 32.55 Favored Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 123.538 0.735 . . . . 0.15 109.495 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -84.79 120.58 2.36 Favored 'Trans proline' 0 CA--C 1.562 1.909 0 C-N-CA 121.97 1.78 . . . . 0.15 114.641 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.09 161.48 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.61 0 CA-C-O 122.093 0.949 . . . . 0.19 111.281 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -148.82 19.24 1.01 Allowed 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 114.553 -1.203 . . . . 2.53 111.922 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -129.93 159.21 37.34 Favored 'General case' 0 C--N 1.363 1.169 0 CA-C-O 121.313 0.577 . . . . 2.12 111.423 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 1.2 mp0 -119.12 147.86 43.7 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.23 1.196 . . . . 0.42 114.23 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.85 -137.53 5.24 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 113.883 -1.508 . . . . 0.23 112.333 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.55 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 27.4 mm-40 -114.86 105.62 13.22 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-N 118.345 1.073 . . . . 1.75 110.848 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -99.66 130.34 45.87 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.129 0.49 . . . . 0.21 111.174 -179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -113.24 121.87 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.666 0.746 . . . . 0.2 110.748 -176.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.5 tt -109.43 104.92 14.09 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.346 -1.297 . . . . 0.78 110.313 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.29 129.72 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-N 114.825 -1.08 . . . . 0.44 108.766 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.61 139.56 50.41 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.077 0.769 . . . . 1.25 113.077 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.69 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 6.0 tmtm? -105.82 118.41 36.53 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.945 0.879 . . . . 2.52 110.145 176.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.41 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 21.5 m-85 -106.39 134.45 49.51 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 114.728 -1.124 . . . . 0.4 109.487 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.409 ' HB2' ' NZ ' ' A' ' 88' ' ' LYS . . . -133.52 146.83 51.42 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 123.079 0.551 . . . . 0.41 111.736 -178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -139.71 108.91 6.08 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 116.003 -0.544 . . . . 2.61 110.726 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.22 69.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-N 116.153 -0.476 . . . . 2.13 111.594 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -162.74 -52.28 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 115.976 -0.556 . . . . 2.27 111.829 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -119.1 130.15 55.43 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 122.889 0.476 . . . . 1.46 111.407 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.03 104.92 14.95 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-O 122.152 0.977 . . . . 0.84 111.958 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -162.01 145.21 11.91 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.178 -0.919 . . . . 2.45 112.153 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.7 m -125.27 123.81 40.3 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.654 -0.703 . . . . 1.66 112.187 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 72.16 53.87 0.18 Allowed 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 125.73 1.612 . . . . 1.89 112.787 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -152.38 -40.87 0.11 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.383 -1.281 . . . . 2.56 109.719 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -108.19 80.91 1.41 Allowed 'General case' 0 C--N 1.361 1.096 0 CA-C-O 121.892 0.853 . . . . 2.76 108.716 177.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.99 121.82 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 CA-C-N 114.249 -1.341 . . . . 0.69 111.142 -177.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -109.37 165.55 11.55 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.587 1.699 . . . . 0.7 115.587 -175.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -115.52 135.58 53.94 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.829 -0.544 . . . . 1.33 110.828 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.79 126.93 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.475 0 CA-C-N 115.918 -0.583 . . . . 0.48 109.908 -177.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.458 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 46.7 mtt180 -125.9 151.63 46.66 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.621 1.712 . . . . 1.69 115.621 -176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 154' ' ' SER . 2.2 m -126.71 109.97 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.569 0 N-CA-C 113.047 0.758 . . . . 0.6 113.047 177.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.464 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 62.43 26.53 15.81 Favored 'General case' 0 N--CA 1.524 3.275 0 C-N-CA 126.669 1.988 . . . . 1.12 114.271 -179.113 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.8 -22.17 28.52 Favored Glycine 0 CA--C 1.548 2.109 0 C-N-CA 121.259 -0.496 . . . . 0.32 113.546 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.458 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 90.2 m-70 -80.71 160.5 24.94 Favored 'General case' 0 C--N 1.366 1.312 0 C-N-CA 125.829 1.651 . . . . 0.57 114.157 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.77 132.49 54.15 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.238 0.542 . . . . 0.55 111.154 177.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.62 -60.89 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 CA-C-N 115.233 -0.894 . . . . 1.06 113.172 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.76 88.85 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.44 108.2 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -107.72 96.74 6.6 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 123.155 1.455 . . . . 2.3 111.551 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 121.09 75.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 110.488 -3.051 . . . . 2.48 107.783 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.33 104.77 16.83 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 113.111 0.782 . . . . 1.13 113.111 -178.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -117.16 102.49 9.34 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 113.723 -1.58 . . . . 2.35 106.974 175.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -65.25 -31.28 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.426 0 C-N-CA 125.003 1.321 . . . . 0.68 114.262 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -74.63 -40.84 61.26 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.685 0.794 . . . . 0.77 112.484 178.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -73.82 -25.83 60.3 Favored 'General case' 0 CA--C 1.578 2.048 0 C-N-CA 124.357 1.063 . . . . 0.91 113.487 176.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -78.62 -56.61 4.29 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.618 0.97 . . . . 2.43 113.618 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -97.11 -34.84 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 N-CA-C 114.593 1.331 . . . . 0.93 114.593 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.07 -114.07 1.98 Allowed Glycine 0 C--N 1.354 1.537 0 CA-C-N 118.25 0.477 . . . . 0.85 112.935 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -115.47 106.69 14.25 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.929 0.395 . . . . 3.18 110.4 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 69.48 -143.26 0.09 Allowed 'General case' 0 N--CA 1.504 2.274 0 C-N-CA 125.466 1.507 . . . . 2.08 113.416 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.9 p 66.76 -158.96 0.24 Allowed 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 126.234 1.814 . . . . 0.62 113.718 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.536 ' HA ' ' HZ3' ' A' ' 88' ' ' LYS . . . -108.58 128.96 55.28 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 114.55 1.315 . . . . 0.46 114.55 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.536 ' H ' ' HZ3' ' A' ' 88' ' ' LYS . 5.5 t60 -104.52 122.65 46.0 Favored 'General case' 0 C--N 1.369 1.432 0 N-CA-C 108.08 -1.082 . . . . 0.38 108.08 174.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -140.55 127.05 20.09 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.417 0.895 . . . . 2.5 113.417 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -114.51 134.73 54.81 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-N 115.033 -0.985 . . . . 1.56 111.369 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -106.45 111.31 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 114.369 -1.287 . . . . 0.45 110.374 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.4 mm -115.52 91.23 28.45 Favored Pre-proline 0 CA--C 1.579 2.077 0 CA-C-N 115.287 -0.87 . . . . 0.84 110.421 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -73.11 137.93 27.16 Favored 'Trans proline' 0 C--N 1.39 2.741 0 C-N-CA 122.996 2.464 . . . . 0.16 113.883 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -123.81 149.89 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.636 0 C-N-CA 123.573 0.749 . . . . 0.38 110.842 -177.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.2 p -133.88 111.48 10.51 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.638 -0.71 . . . . 1.31 111.856 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.4 mt -112.69 124.68 69.59 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.55 0 N-CA-C 108.59 -0.892 . . . . 0.25 108.59 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -141.83 126.45 17.92 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.838 -0.619 . . . . 2.05 110.992 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 67.97 15.71 9.52 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 125.432 1.493 . . . . 3.55 114.109 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.55 14.87 39.4 Favored Glycine 0 CA--C 1.547 2.089 0 CA-C-O 119.181 -0.788 . . . . 0.37 114.773 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 56.4 mtpt -122.59 148.19 45.52 Favored 'General case' 0 C--N 1.365 1.252 0 CA-C-N 118.413 1.107 . . . . 1.56 112.429 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.66 141.94 35.18 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 114.058 1.133 . . . . 0.34 114.058 -176.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.8 m -133.55 110.44 9.93 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 114.504 -1.226 . . . . 0.64 110.301 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.272 2.4 p -106.23 90.52 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.589 2.467 0 CA-C-O 121.621 0.724 . . . . 0.46 110.068 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 59.68 -81.4 0.02 OUTLIER 'General case' 0 N--CA 1.514 2.767 0 C-N-CA 126.077 1.751 . . . . 1.56 115.06 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -118.45 26.74 7.59 Favored Glycine 0 CA--C 1.547 2.076 0 N-CA-C 114.2 0.44 . . . . 0.49 114.2 177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -135.14 140.79 45.7 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.533 0.733 . . . . 1.82 110.996 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.2 p -126.18 130.82 72.08 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.294 0 CA-C-O 121.513 0.673 . . . . 1.02 111.867 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 m -154.6 -179.43 7.97 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.157 -0.929 . . . . 0.56 109.537 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.274 14.8 t -104.76 139.37 39.65 Favored 'General case' 0 CA--C 1.578 2.025 0 N-CA-C 113.365 0.876 . . . . 1.25 113.365 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -82.72 122.1 27.72 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 123.959 0.904 . . . . 0.29 111.523 178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.38 90.91 3.15 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.336 0.495 . . . . 1.42 112.336 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.22 -65.45 3.33 Favored Glycine 0 C--N 1.358 1.784 0 N-CA-C 118.652 2.221 . . . . 0.42 118.652 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.29 156.25 46.89 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.199 1.185 . . . . 1.1 114.199 -176.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.464 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -103.27 135.36 45.06 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 113.064 -1.88 . . . . 0.67 108.585 176.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.8 t -120.67 142.29 49.61 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 115.529 1.678 . . . . 0.36 115.529 -176.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.59 99.19 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.334 -1.358 . . . . 0.74 107.334 176.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -118.52 126.99 53.19 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.779 -0.646 . . . . 1.67 112.314 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.86 129.08 56.64 Favored 'General case' 0 C--O 1.251 1.155 0 CA-C-O 122.278 1.037 . . . . 1.8 111.278 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.17 145.48 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-N 112.722 -2.035 . . . . 0.58 110.762 -177.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.93 149.64 32.3 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.934 1.457 . . . . 2.18 114.934 -178.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -115.64 -28.11 2.84 Favored Glycine 0 CA--C 1.545 1.931 0 CA-C-N 115.064 -0.971 . . . . 1.02 114.932 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -130.42 -67.07 0.74 Allowed 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 117.746 0.773 . . . . 2.86 111.88 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -140.81 -52.45 0.47 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 112.341 0.497 . . . . 3.91 112.341 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -104.06 178.02 4.68 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.161 0.981 . . . . 1.74 112.742 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -116.79 -177.92 0.49 Allowed Pre-proline 0 CA--C 1.568 1.638 0 CA-C-N 114.389 -1.278 . . . . 1.68 109.273 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.67 131.36 43.71 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 122.947 2.431 . . . . 2.06 113.968 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.6 mmmm -72.18 -62.59 1.38 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.81 1.411 . . . . 3.0 114.81 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 64' ' ' GLU . 43.0 t -108.49 132.36 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 118.376 0.535 . . . . 0.8 109.713 178.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.3 t -133.41 116.09 15.62 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 113.911 -1.495 . . . . 0.87 110.618 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.69 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -115.02 49.51 1.05 Allowed 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.183 1.919 . . . . 0.34 116.183 -174.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.56 137.75 2.77 Favored 'General case' 0 N--CA 1.515 2.822 0 N-CA-C 116.653 2.094 . . . . 0.7 116.653 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -152.75 100.3 2.52 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.271 -0.877 . . . . 0.21 110.526 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.319 12.6 tt -110.61 121.86 64.12 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.999 0 CA-C-O 122.546 1.165 . . . . 0.31 111.553 175.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -123.67 165.03 17.92 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 113.572 -1.649 . . . . 0.44 110.554 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.4 ptmt -121.71 159.98 25.46 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 118.734 2.864 . . . . 1.26 118.734 -174.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.22 -42.54 1.87 Allowed Glycine 0 CA--C 1.542 1.737 0 CA-C-N 109.815 -3.357 . . . . 0.17 118.66 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -179.37 156.74 0.75 Allowed 'General case' 0 N--CA 1.52 3.061 0 CA-C-N 119.973 1.886 . . . . 0.15 112.565 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.32 -15.79 60.47 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.547 1.314 . . . . 0.17 114.547 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.06 4.04 46.73 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 114.066 1.135 . . . . 0.55 114.066 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.678 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.1 OUTLIER -107.71 -3.86 18.74 Favored 'General case' 0 CA--C 1.565 1.552 0 N-CA-C 114.031 1.123 . . . . 0.6 114.031 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.37 93.05 0.41 Allowed Pre-proline 0 N--CA 1.51 2.543 0 C-N-CA 124.48 1.112 . . . . 0.95 111.63 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.678 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 56.9 Cg_endo -95.38 119.98 0.25 Allowed 'Trans proline' 0 C--N 1.388 2.62 0 C-N-CA 122.875 2.384 . . . . 1.8 114.777 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 44.1 mtt -144.36 109.82 5.2 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.823 -0.626 . . . . 4.96 111.224 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.6 163.56 29.85 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 122.16 0.981 . . . . 4.0 112.641 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -108.55 159.74 29.75 Favored Pre-proline 0 CA--C 1.557 1.247 0 CA-C-N 114.463 -1.244 . . . . 6.27 110.806 179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.86 122.11 9.41 Favored 'Trans proline' 0 C--N 1.394 2.939 0 C-N-CA 122.566 2.178 . . . . 6.59 115.18 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -135.69 135.55 22.14 Favored Pre-proline 0 CA--C 1.564 1.5 0 CA-C-N 114.76 -1.109 . . . . 5.51 111.062 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -85.02 -157.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.389 2.659 0 C-N-CA 123.398 2.732 . . . . 6.77 114.239 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.69 -128.88 1.55 Allowed Glycine 0 C--N 1.339 0.743 0 C-N-CA 121.113 -0.565 . . . . 7.02 113.421 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 10.0 mt -118.84 124.19 46.57 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.008 0.433 . . . . 8.99 111.976 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.263 -0.875 . . . . 10.6 111.222 179.996 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.439 -0.265 . . . . 8.93 112.439 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.06 117.54 0.02 OUTLIER 'General case' 0 N--CA 1.528 3.453 0 C-N-CA 127.556 2.342 . . . . 6.82 114.97 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.0 tpt -141.67 105.1 4.66 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.45 -0.795 . . . . 7.64 110.731 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 m -138.06 113.16 9.22 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.804 -0.635 . . . . 3.86 111.605 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.6 86.26 0.07 OUTLIER Glycine 0 C--N 1.34 0.79 0 CA-C-N 115.787 -0.642 . . . . 1.11 113.109 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.535 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.6 tp -88.32 -46.5 9.14 Favored 'General case' 0 CA--C 1.566 1.586 0 C-N-CA 123.9 0.88 . . . . 0.35 113.282 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.34 -25.0 63.84 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 125.982 1.713 . . . . 0.2 115.388 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.65 -10.01 54.76 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 113.577 0.954 . . . . 0.32 113.577 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 25.3 mmtp -104.67 -25.61 12.64 Favored 'General case' 0 C--N 1.363 1.168 0 N-CA-C 113.243 0.831 . . . . 1.73 113.243 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.5 p -52.93 135.22 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 N-CA-C 115.541 1.682 . . . . 0.11 115.541 178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pt -123.07 -28.46 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 115.01 -0.995 . . . . 0.16 112.229 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 72.2 t90 -162.95 116.93 1.67 Allowed 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 118.055 0.389 . . . . 0.54 111.558 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -136.55 130.73 32.85 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.156 -0.965 . . . . 0.19 111.649 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.3 t -136.26 130.96 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 CA-C-O 121.036 0.446 . . . . 1.05 112.149 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -114.71 100.46 8.27 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.819 -1.178 . . . . 2.11 107.819 173.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -76.96 104.18 7.31 Favored 'General case' 0 C--O 1.274 2.365 0 CA-C-O 122.005 0.907 . . . . 0.63 111.623 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 63' ' ' THR . . . 169.07 -49.51 0.22 Allowed Glycine 0 C--N 1.36 1.893 0 CA-C-N 111.964 -2.38 . . . . 0.71 114.693 -178.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -115.53 -116.65 3.05 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 114.476 0.551 . . . . 0.8 114.476 -177.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -168.62 118.79 0.74 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 112.377 0.51 . . . . 1.63 112.377 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.9 m 42.39 111.74 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.226 0 N-CA-C 118.515 2.783 . . . . 1.0 118.515 177.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.601 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 43.1 t60 -137.26 139.43 40.96 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.768 1.025 . . . . 0.45 113.768 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.3 t -106.36 111.66 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.62 0 N-CA-C 106.791 -1.559 . . . . 1.39 106.791 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.38 163.07 15.46 Favored 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 112.768 0.655 . . . . 1.85 112.768 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -43.3 -34.59 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 118.811 2.893 . . . . 0.72 118.811 -175.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 67.3 m-70 -90.76 -17.31 26.88 Favored 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 120.924 0.393 . . . . 0.51 111.509 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.18 41.85 1.24 Allowed Glycine 0 C--N 1.357 1.736 0 C-N-CA 124.361 0.981 . . . . 0.34 113.742 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.535 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.9 mm -105.88 121.96 58.86 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 N-CA-C 109.391 -0.596 . . . . 0.55 109.391 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 6.9 t-160 -110.27 132.8 53.85 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 115.32 1.6 . . . . 1.34 115.32 -175.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.587 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -97.76 138.01 35.77 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 114.638 -1.164 . . . . 2.79 109.302 175.442 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -102.68 100.7 10.77 Favored 'General case' 0 CA--C 1.557 1.244 0 N-CA-C 113.544 0.942 . . . . 3.0 113.544 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -28.69 115.44 0.09 Allowed 'General case' 0 N--CA 1.517 2.888 0 N-CA-C 118.687 2.847 . . . . 2.3 118.687 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 41.59 74.97 0.66 Allowed Pre-proline 0 N--CA 1.528 3.446 0 N-CA-C 117.169 2.285 . . . . 1.17 117.169 177.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -94.45 -12.26 1.07 Allowed 'Trans proline' 0 CA--C 1.56 1.787 0 C-N-CA 122.509 2.14 . . . . 1.45 117.434 -178.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.44 -22.89 0.81 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 114.447 1.277 . . . . 1.91 114.447 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -96.96 73.25 2.56 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.277 0.56 . . . . 4.84 112.422 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.07 -29.12 13.12 Favored Glycine 0 CA--C 1.541 1.695 0 CA-C-N 115.56 -0.746 . . . . 2.37 114.4 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.7 49.53 20.63 Favored 'General case' 0 N--CA 1.516 2.831 0 C-N-CA 127.176 2.19 . . . . 4.5 115.465 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.77 -179.8 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 C-N-CA 124.977 1.311 . . . . 2.7 110.251 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.81 86.05 1.25 Allowed Glycine 0 CA--C 1.539 1.58 0 O-C-N 121.695 -0.628 . . . . 1.95 114.488 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -144.57 128.42 17.37 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.482 0.658 . . . . 5.34 112.488 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.65 138.24 51.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 124.309 1.044 . . . . 1.64 110.783 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.5 m -118.78 97.05 5.53 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 115.603 -0.726 . . . . 1.57 110.772 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -114.28 62.96 0.66 Allowed 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 115.638 -0.71 . . . . 2.33 111.457 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -102.1 73.1 1.35 Allowed 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 122.054 0.93 . . . . 3.16 109.831 179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.38 52.74 0.07 OUTLIER Glycine 0 CA--C 1.529 0.965 0 CA-C-N 113.79 -1.55 . . . . 1.52 111.237 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 4.2 ttt -92.59 -0.07 57.36 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 113.805 1.039 . . . . 1.67 113.805 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.18 64.35 0.62 Allowed 'General case' 0 CA--C 1.557 1.249 0 CA-C-O 122.431 1.11 . . . . 4.18 110.303 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 mt -166.78 70.41 1.06 Allowed Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 113.456 -1.702 . . . . 2.63 107.111 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -65.92 157.86 57.02 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 124.349 3.366 . . . . 1.37 116.939 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.4 133.86 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.354 0 CA-C-N 115.074 -0.966 . . . . 0.69 108.691 177.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.5 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.9 mt -82.24 -9.28 59.55 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 116.816 2.154 . . . . 1.28 116.816 -176.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -109.17 16.67 22.32 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 114.111 1.152 . . . . 1.51 114.111 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.04 177.37 8.02 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-O 121.755 0.788 . . . . 1.09 113.06 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 5.7 p-10 -88.96 178.83 1.83 Allowed Pre-proline 0 N--CA 1.51 2.57 0 C-N-CA 124.978 1.311 . . . . 1.27 111.094 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 52.3 Cg_exo -64.57 -43.01 14.4 Favored 'Trans proline' 0 N--CA 1.527 3.449 0 C-N-CA 122.824 2.349 . . . . 0.95 114.989 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -69.41 -41.94 75.71 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 124.471 1.108 . . . . 2.04 111.978 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.701 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 18.7 t0 -86.93 -0.71 57.0 Favored 'General case' 0 CA--C 1.583 2.232 0 CA-C-N 115.857 -0.611 . . . . 1.62 111.983 177.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 5.3 tt0 -74.28 -46.02 43.97 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 125.195 1.398 . . . . 1.77 108.025 173.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . 0.253 11.7 p -71.21 -37.75 67.56 Favored 'Isoleucine or valine' 0 CA--C 1.603 2.982 0 CA-C-N 115.161 -0.927 . . . . 0.81 111.042 174.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 5.7 tp -83.41 -3.25 57.38 Favored 'General case' 0 CA--C 1.577 2.018 0 N-CA-C 114.194 1.183 . . . . 1.15 114.194 177.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.701 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 3.8 m-30 -113.67 -2.01 13.87 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.002 1.321 . . . . 0.92 109.831 174.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -130.48 -130.82 0.2 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.331 1.052 . . . . 1.33 110.739 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.514 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 0.2 OUTLIER 43.15 120.86 0.0 OUTLIER 'General case' 1 N--CA 1.548 4.458 0 C-N-CA 127.775 2.43 . . . . 1.28 115.48 -172.755 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.695 ' HB3' HG22 ' A' ' 167' ' ' VAL . 12.9 pt-20 -110.37 142.19 42.38 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.338 1.977 . . . . 1.53 116.338 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.1 mtp85 -114.12 152.45 31.09 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 114.972 -1.013 . . . . 3.22 111.8 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -124.62 129.83 51.3 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.911 -0.586 . . . . 3.66 112.085 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.36 -86.28 0.34 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.737 -0.665 . . . . 4.7 111.693 179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -154.18 -91.32 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 113.122 0.786 . . . . 2.55 113.122 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -174.74 136.76 0.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.755 0.822 . . . . 2.15 110.796 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.442 ' H ' HD21 ' A' ' 164' ' ' ASN . 3.4 t 70.38 76.72 0.2 Allowed 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 124.464 1.106 . . . . 0.77 110.939 -179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.7 135.87 48.23 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.004 -0.998 . . . . 0.81 112.285 -176.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -132.56 163.01 24.13 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 116.216 1.246 . . . . 0.47 116.216 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.427 ' HB2' HG23 ' A' ' 155' ' ' VAL . 1.4 m-85 -111.17 160.7 16.68 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 114.023 -1.089 . . . . 0.89 113.062 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.48 126.66 48.32 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.895 -1.048 . . . . 0.51 112.652 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.2 mp -123.25 98.07 42.07 Favored Pre-proline 0 CA--C 1.566 1.589 0 N-CA-C 108.668 -0.864 . . . . 0.15 108.668 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -82.82 116.27 2.5 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 122.06 1.84 . . . . 0.15 115.322 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.07 155.64 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.436 0 CA-C-O 121.938 0.875 . . . . 0.19 110.648 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -141.86 24.35 2.03 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 114.774 -1.103 . . . . 2.53 112.034 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.88 152.67 49.1 Favored 'General case' 0 C--N 1.359 1.009 0 CA-C-O 121.231 0.539 . . . . 2.12 111.305 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.07 137.73 50.98 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.097 1.147 . . . . 0.42 114.097 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.47 -127.48 1.63 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 114.018 -1.447 . . . . 0.23 112.597 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -123.55 118.62 27.78 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.264 0.554 . . . . 1.75 111.398 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -118.58 137.74 53.04 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.463 -0.789 . . . . 0.21 109.639 178.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 172' ' ' ILE . 1.9 t -117.82 126.5 74.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.466 0.65 . . . . 0.2 111.004 -177.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.06 105.13 15.38 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.753 -1.112 . . . . 0.78 109.731 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -114.75 117.64 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.077 -1.083 . . . . 0.44 108.077 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -130.16 135.05 47.76 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.503 0.668 . . . . 1.25 112.384 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 14.3 tptt -98.29 122.96 42.1 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 114.959 -1.019 . . . . 2.52 111.307 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -106.95 136.12 47.35 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.58 -0.737 . . . . 0.4 110.948 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -132.94 150.12 52.19 Favored 'General case' 0 CA--C 1.567 1.617 0 CA-C-N 115.681 -0.69 . . . . 0.41 111.367 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -146.88 113.68 6.08 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 123.36 0.664 . . . . 2.61 110.076 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.33 68.12 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 112.711 0.634 . . . . 2.13 112.711 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -167.07 -45.29 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 112.58 0.585 . . . . 2.27 112.58 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -112.89 126.67 55.72 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.102 0.477 . . . . 1.46 112.219 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.16 96.07 6.11 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.486 1.136 . . . . 0.84 111.241 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.45 ' OE1' ' HD3' ' A' ' 100' ' ' LYS . 9.5 pt20 -160.79 143.74 13.02 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.89 -1.05 . . . . 2.45 112.152 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 20.8 m -122.57 125.27 45.36 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.426 -0.806 . . . . 1.66 112.267 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 73.03 51.74 0.14 Allowed 'General case' 0 N--CA 1.512 2.636 0 C-N-CA 125.644 1.577 . . . . 1.89 112.697 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -150.99 -42.02 0.12 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.384 1.074 . . . . 2.56 110.076 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.45 ' HD3' ' OE1' ' A' ' 96' ' ' GLN . 14.0 mptt -108.27 83.49 1.79 Allowed 'General case' 0 C--N 1.36 1.06 0 N-CA-C 108.691 -0.855 . . . . 2.76 108.691 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.45 126.54 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 114.488 -1.233 . . . . 0.69 111.214 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -114.07 174.48 5.92 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 115.405 1.631 . . . . 0.7 115.405 -175.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.22 137.05 54.97 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 121.372 0.606 . . . . 1.33 111.974 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.6 t -132.71 126.0 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.247 0 CA-C-N 115.161 -0.927 . . . . 0.48 109.671 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -125.56 149.39 48.39 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 114.653 1.353 . . . . 1.69 114.653 -177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.5 m -123.55 104.28 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 CA-C-N 115.389 -0.823 . . . . 0.6 112.802 178.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.584 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 6.9 t30 64.28 26.48 13.71 Favored 'General case' 0 N--CA 1.518 2.952 0 C-N-CA 126.636 1.974 . . . . 1.12 114.31 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.92 -22.22 23.83 Favored Glycine 0 CA--C 1.548 2.117 0 CA-C-N 115.582 -0.735 . . . . 0.32 113.603 -177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -79.94 148.03 31.39 Favored 'General case' 0 C--N 1.367 1.365 0 C-N-CA 125.63 1.572 . . . . 0.57 114.007 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.44 127.52 49.44 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.283 0.563 . . . . 0.55 110.977 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -120.22 -57.2 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 115.256 -0.884 . . . . 1.06 113.254 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.33 88.26 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.165 -1.05 . . . . 0.44 108.165 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -111.17 75.77 0.94 Allowed 'General case' 0 C--N 1.354 0.779 0 CA-C-O 123.37 1.557 . . . . 2.3 112.133 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.9 p30 157.78 61.57 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 110.789 -2.914 . . . . 2.48 108.117 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.94 101.04 13.38 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 114.095 1.146 . . . . 1.13 114.095 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.475 ' O ' ' HG2' ' A' ' 120' ' ' ARG . 1.2 t70 -116.75 97.2 5.85 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 113.132 -1.849 . . . . 2.35 106.582 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -63.45 -28.56 45.25 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.477 0 N-CA-C 114.569 1.322 . . . . 0.68 114.569 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -75.84 -36.78 59.51 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 123.24 0.616 . . . . 0.77 112.323 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -74.72 -26.74 60.01 Favored 'General case' 0 CA--C 1.577 1.99 0 C-N-CA 124.466 1.106 . . . . 0.91 113.096 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 116' ' ' ASP . 25.3 mmm180 -77.66 -55.09 5.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.236 0.828 . . . . 2.43 113.236 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -92.82 -40.59 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 N-CA-C 113.966 1.098 . . . . 0.93 113.966 177.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 109.84 -69.51 0.21 Allowed Glycine 0 C--N 1.359 1.844 0 CA-C-N 118.186 0.448 . . . . 0.85 113.652 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -104.72 175.27 5.55 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.447 1.099 . . . . 3.18 111.381 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 31.2 m -73.55 84.31 1.54 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 122.007 0.908 . . . . 2.08 113.214 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.5 HG22 ' HB2' ' A' ' 51' ' ' LEU . 17.9 p -131.24 -154.35 0.62 Allowed 'General case' 0 CA--C 1.571 1.756 0 CA-C-N 113.92 -1.491 . . . . 0.62 109.301 -178.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -106.49 129.38 54.46 Favored 'General case' 0 CA--C 1.562 1.435 0 O-C-N 121.468 -0.77 . . . . 0.46 112.324 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -100.43 142.39 31.97 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 109.645 -0.502 . . . . 0.38 109.645 177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -135.5 128.2 30.95 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.711 1.374 . . . . 2.5 114.711 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -118.0 118.1 31.04 Favored 'General case' 0 C--O 1.247 0.94 0 CA-C-N 114.36 -1.291 . . . . 1.56 109.905 176.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -109.11 121.05 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-N 114.644 -1.162 . . . . 0.45 111.513 -178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.12 95.11 19.0 Favored Pre-proline 0 CA--C 1.572 1.819 0 CA-C-N 115.49 -0.777 . . . . 0.84 110.694 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -75.87 137.55 19.97 Favored 'Trans proline' 0 C--N 1.395 3.003 0 C-N-CA 122.802 2.335 . . . . 0.16 113.325 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -118.49 145.62 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.393 0 CA-C-O 121.737 0.78 . . . . 0.38 111.665 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.9 p -129.86 112.29 13.42 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.85 -1.068 . . . . 1.31 110.817 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.6 mt -113.64 121.43 65.8 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.511 0 CA-C-N 115.228 -0.896 . . . . 0.25 108.841 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -141.76 129.64 21.81 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 121.128 0.489 . . . . 2.05 111.903 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.5 mtmm 66.38 15.19 10.02 Favored 'General case' 0 N--CA 1.516 2.836 0 N-CA-C 114.827 1.417 . . . . 3.55 114.827 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.92 17.91 28.79 Favored Glycine 0 CA--C 1.548 2.149 0 CA-C-O 119.385 -0.675 . . . . 0.37 114.562 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -128.73 143.38 50.91 Favored 'General case' 0 C--N 1.364 1.239 0 CA-C-N 118.036 0.918 . . . . 1.56 112.426 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.09 143.34 29.48 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.823 1.046 . . . . 0.34 113.823 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 114.0 12.61 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.864 -1.062 . . . . 0.64 110.865 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.271 0.3 OUTLIER -118.14 108.17 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.257 0 CA-C-N 115.989 -0.551 . . . . 0.46 110.533 179.055 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 67.06 -82.15 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.745 0 C-N-CA 125.588 1.555 . . . . 1.56 113.762 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -140.9 31.79 2.17 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-N 115.777 -0.647 . . . . 0.49 112.765 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -133.73 128.14 34.3 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.641 0.776 . . . . 1.82 110.573 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.8 p -115.68 131.23 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.298 0 CA-C-O 121.551 0.691 . . . . 1.02 111.786 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 m -147.18 -169.09 3.22 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.094 -0.957 . . . . 0.56 110.174 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.5 t -101.79 141.09 35.18 Favored 'General case' 0 CA--C 1.573 1.834 0 N-CA-C 112.998 0.74 . . . . 1.25 112.998 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -88.44 133.0 34.24 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 121.875 0.845 . . . . 0.29 111.894 178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.2 p -98.27 -164.01 1.1 Allowed 'General case' 0 CA--C 1.564 1.488 0 CA-C-N 113.976 -1.465 . . . . 1.42 109.369 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.39 7.07 69.59 Favored Glycine 0 CA--C 1.561 2.929 0 N-CA-C 116.991 1.556 . . . . 0.42 116.991 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.472 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -159.98 152.49 21.06 Favored 'General case' 0 C--N 1.355 0.83 0 CA-C-O 121.704 0.764 . . . . 1.1 111.565 178.471 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.584 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -108.09 138.08 44.96 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.208 -1.36 . . . . 0.67 109.163 177.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.7 t -119.41 145.72 45.99 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 115.966 1.839 . . . . 0.36 115.966 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -120.09 97.96 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 107.672 -1.233 . . . . 0.74 107.672 175.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -107.07 125.91 51.67 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.212 0.819 . . . . 1.67 113.212 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -107.46 120.89 43.42 Favored 'General case' 0 C--O 1.25 1.126 0 CA-C-N 115.177 -0.919 . . . . 1.8 110.247 178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -105.46 143.66 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-N 114.588 -1.187 . . . . 0.58 109.587 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.7 pttp -85.77 150.38 24.61 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.681 1.734 . . . . 2.18 115.681 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.04 -32.45 4.99 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-N 114.178 -1.374 . . . . 1.02 113.048 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -131.01 -84.06 0.52 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.494 0.718 . . . . 2.86 110.511 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -170.99 66.27 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.123 0.569 . . . . 3.91 110.927 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -166.51 -45.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 113.071 0.767 . . . . 1.74 113.071 -179.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.442 HD21 ' H ' ' A' ' 70' ' ' SER . 1.4 m-20 82.75 -177.47 0.03 OUTLIER Pre-proline 0 N--CA 1.513 2.695 0 C-N-CA 124.546 1.138 . . . . 1.68 110.796 -177.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.93 -21.35 70.75 Favored 'Trans proline' 0 N--CA 1.524 3.322 0 C-N-CA 122.977 2.451 . . . . 2.06 115.992 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 12.9 tppt? 83.58 -68.69 0.06 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 126.36 1.864 . . . . 3.0 115.085 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.695 HG22 ' HB3' ' A' ' 64' ' ' GLU . 3.1 t -102.4 133.57 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 CA-C-N 118.984 0.811 . . . . 0.8 111.301 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.6 t -132.9 138.44 46.98 Favored 'General case' 0 C--N 1.367 1.362 0 N-CA-C 114.11 1.152 . . . . 0.87 114.11 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -130.17 45.07 2.87 Favored 'General case' 0 CA--C 1.581 2.158 0 N-CA-C 115.547 1.684 . . . . 0.34 115.547 -178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -42.92 132.72 3.85 Favored 'General case' 0 N--CA 1.524 3.241 0 N-CA-C 116.233 1.938 . . . . 0.7 116.233 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -152.45 102.95 2.78 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 116.054 -0.521 . . . . 0.21 111.329 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 84' ' ' VAL 0.313 4.9 tt -110.03 123.25 65.76 Favored 'Isoleucine or valine' 0 C--O 1.27 2.168 0 CA-C-O 122.28 1.038 . . . . 0.31 111.406 175.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -123.62 152.69 41.67 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 113.389 -1.732 . . . . 0.44 112.025 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.434 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 75.9 tttt -104.27 152.51 22.13 Favored 'General case' 0 CA--C 1.563 1.451 0 N-CA-C 118.28 2.696 . . . . 1.26 118.28 -174.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 104.62 -41.47 2.14 Favored Glycine 0 CA--C 1.541 1.694 0 CA-C-N 110.704 -2.953 . . . . 0.17 119.86 172.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 178.06 164.44 0.69 Allowed 'General case' 0 N--CA 1.519 2.981 0 CA-C-N 121.165 2.482 . . . . 0.15 112.228 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.95 -16.09 54.46 Favored 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 113.915 1.08 . . . . 0.17 113.915 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.53 3.51 50.06 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.151 1.167 . . . . 0.55 114.151 177.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.622 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 1.0 OUTLIER -106.84 -3.07 20.74 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.205 1.187 . . . . 0.6 114.205 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.5 96.53 0.59 Allowed Pre-proline 0 N--CA 1.511 2.586 0 C-N-CA 124.375 1.07 . . . . 0.95 111.643 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.622 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 81.0 Cg_endo -94.03 150.21 2.12 Favored 'Trans proline' 0 C--N 1.387 2.59 0 C-N-CA 122.85 2.367 . . . . 1.8 114.783 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 20.7 ttt -142.49 119.49 11.32 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.622 -0.717 . . . . 4.96 111.069 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.8 mt -131.35 164.9 24.63 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 122.001 0.905 . . . . 4.0 112.747 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -105.37 158.7 31.62 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-N 114.626 -1.17 . . . . 6.27 110.887 179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.8 120.63 7.38 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 122.321 2.014 . . . . 6.59 114.966 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -136.15 142.15 38.9 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-N 114.261 -1.336 . . . . 5.51 110.585 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.37 -29.95 3.58 Favored 'Trans proline' 0 C--N 1.393 2.877 0 C-N-CA 123.082 2.521 . . . . 6.77 116.308 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -137.64 -144.39 4.72 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 114.598 0.599 . . . . 7.02 114.598 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.9 mt -119.56 124.9 47.5 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.214 0.45 . . . . 8.99 112.214 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.423 -0.798 . . . . 10.6 110.647 179.97 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.398 -0.281 . . . . 8.93 112.398 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.38 130.72 55.6 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.503 0.668 . . . . 6.82 112.053 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.9 mtt -132.19 106.18 7.8 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.796 -0.638 . . . . 7.64 111.364 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.9 m -139.81 109.73 6.41 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.814 -0.63 . . . . 3.86 111.527 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.47 84.08 0.05 OUTLIER Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.842 -0.617 . . . . 1.11 113.148 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 tp -87.93 -47.69 8.37 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.344 0.868 . . . . 0.35 113.344 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.27 -22.53 18.86 Favored 'General case' 0 CA--C 1.591 2.543 0 N-CA-C 115.176 1.547 . . . . 0.2 115.176 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.17 -18.81 29.51 Favored 'General case' 0 CA--C 1.567 1.605 0 C-N-CA 124.337 1.055 . . . . 0.32 113.401 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 55.5 mttt -104.49 -8.87 18.77 Favored 'General case' 0 CA--C 1.56 1.357 0 N-CA-C 113.958 1.096 . . . . 1.73 113.958 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.514 HG21 HG23 ' A' ' 27' ' ' ILE . 11.3 p -61.44 135.11 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.794 0 C-N-CA 124.027 0.931 . . . . 0.11 112.797 176.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pt -118.52 -28.59 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.275 0 N-CA-C 113.357 0.873 . . . . 0.16 113.357 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -163.94 119.0 1.55 Allowed 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 118.43 0.559 . . . . 0.54 112.066 -177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.92 131.53 33.2 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.658 -0.651 . . . . 0.19 111.958 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.27 133.21 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.508 0 CA-C-O 121.42 0.629 . . . . 1.05 112.62 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -117.98 111.4 18.91 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.108 -1.441 . . . . 2.11 107.108 171.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.84 102.59 8.27 Favored 'General case' 0 C--O 1.255 1.361 0 CA-C-O 121.898 0.856 . . . . 0.63 111.383 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.55 -14.12 0.35 Allowed Glycine 0 C--N 1.351 1.362 0 N-CA-C 117.127 1.611 . . . . 0.71 117.127 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -146.04 -131.79 2.32 Favored Glycine 0 N--CA 1.472 1.059 0 C-N-CA 119.271 -1.442 . . . . 0.8 116.06 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.541 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 19.9 tt0 -148.16 116.26 6.47 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 114.931 -0.634 . . . . 1.63 110.89 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 14.7 m 21.78 120.4 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.688 0 N-CA-C 120.199 3.407 . . . . 1.0 120.199 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -140.52 143.02 35.19 Favored 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.521 1.153 . . . . 0.45 113.407 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.88 115.74 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 CA-C-N 113.217 -1.811 . . . . 1.39 110.789 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -74.99 155.65 37.12 Favored 'General case' 0 CA--C 1.566 1.579 0 CA-C-N 113.341 -1.754 . . . . 1.85 111.316 179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 m -42.8 -23.92 0.1 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.152 0 N-CA-C 119.048 2.981 . . . . 0.72 119.048 -178.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -96.88 -19.36 18.9 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 118.588 0.631 . . . . 0.51 110.735 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.81 42.42 0.86 Allowed Glycine 0 C--N 1.358 1.8 0 C-N-CA 124.569 1.08 . . . . 0.34 114.534 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.514 HG23 HG21 ' A' ' 10' ' ' VAL . 3.5 mt -105.73 121.55 58.14 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.73 0 CA-C-O 120.883 0.373 . . . . 0.55 110.002 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -102.85 125.99 49.82 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.286 1.217 . . . . 1.34 114.286 -177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.47 152.68 18.19 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 115.793 -0.64 . . . . 2.79 111.755 176.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -100.35 149.34 23.73 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 114.006 1.113 . . . . 3.0 114.006 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HD2' ' O ' ' A' ' 31' ' ' LYS . 1.1 tmmt? -75.14 102.6 5.0 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.781 2.141 . . . . 2.3 116.781 -177.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.403 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 3.9 m-20 45.42 45.66 2.47 Favored Pre-proline 0 N--CA 1.526 3.355 0 N-CA-C 119.128 3.01 . . . . 1.17 119.128 174.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.403 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 6.5 Cg_endo -100.72 63.85 0.04 OUTLIER 'Trans proline' 0 CA--C 1.566 2.093 0 C-N-CA 122.766 2.311 . . . . 1.45 116.209 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD12 ' HE ' ' A' ' 65' ' ' ARG . 0.6 OUTLIER -90.11 -71.88 0.59 Allowed 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 122.594 0.357 . . . . 1.91 111.281 177.204 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -142.21 47.51 1.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.374 1.25 . . . . 4.84 114.374 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 103.27 1.84 47.81 Favored Glycine 0 CA--C 1.542 1.74 0 N-CA-C 115.647 1.019 . . . . 2.37 115.647 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -92.05 65.94 4.87 Favored 'General case' 0 CA--C 1.556 1.191 0 N-CA-C 113.162 0.801 . . . . 4.5 113.162 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.77 117.19 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 116.101 -0.499 . . . . 2.7 111.658 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 166.92 -69.43 0.18 Allowed Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.687 -0.688 . . . . 1.95 113.735 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -124.48 158.51 32.68 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.507 0.929 . . . . 5.34 113.507 -178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.08 142.79 33.53 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 114.822 -1.081 . . . . 1.64 111.657 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.9 m -110.57 76.62 0.99 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.42 0.628 . . . . 1.57 112.298 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.02 -61.53 1.46 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 115.345 -0.843 . . . . 2.33 111.835 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 79.82 -64.19 0.22 Allowed 'General case' 0 N--CA 1.511 2.584 0 C-N-CA 125.567 1.547 . . . . 3.16 113.307 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -131.63 121.0 2.98 Favored Glycine 0 C--N 1.347 1.148 0 CA-C-N 116.048 -0.524 . . . . 1.52 112.459 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 59.9 mtt -91.9 3.87 54.21 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 113.73 1.011 . . . . 1.67 113.73 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.91 24.87 0.86 Allowed 'General case' 0 CA--C 1.581 2.138 0 N-CA-C 115.422 1.638 . . . . 4.18 115.422 -178.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.69 75.98 78.0 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 106.652 -1.61 . . . . 2.63 106.652 177.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.21 173.59 11.59 Favored 'Trans proline' 0 C--N 1.383 2.349 0 C-N-CA 123.285 2.657 . . . . 1.37 117.708 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.254 1.2 mp -98.11 132.82 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.27 0 CA-C-N 113.865 -1.516 . . . . 0.69 108.269 178.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.456 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.8 mt -86.91 -10.91 52.21 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.743 2.127 . . . . 1.28 116.743 -176.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -106.75 22.21 16.27 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 113.532 0.938 . . . . 1.51 113.532 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -141.91 -172.81 3.64 Favored 'General case' 0 CA--C 1.564 1.5 0 CA-C-O 121.432 0.634 . . . . 1.09 111.294 178.56 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.633 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.88 -176.72 0.57 Allowed Pre-proline 0 N--CA 1.509 2.51 0 C-N-CA 123.819 0.848 . . . . 1.27 109.557 178.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.493 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 32.8 Cg_exo -69.52 -40.42 5.72 Favored 'Trans proline' 0 C--N 1.4 3.26 0 C-N-CA 122.679 2.253 . . . . 0.95 113.045 175.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -67.98 -49.52 61.14 Favored 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 125.27 1.428 . . . . 2.04 111.866 177.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.409 ' HB3' ' OG ' ' A' ' 53' ' ' SER . 0.3 OUTLIER -80.19 -3.54 49.43 Favored 'General case' 0 CA--C 1.574 1.885 0 CA-C-N 114.86 -1.064 . . . . 1.62 112.812 177.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.633 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 3.4 tt0 -73.03 -42.41 63.19 Favored 'General case' 0 C--N 1.378 1.829 0 C-N-CA 125.649 1.579 . . . . 1.77 107.391 173.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.6 t -63.72 -40.29 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 C-N-CA 124.195 0.998 . . . . 0.81 109.638 173.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.91 -17.38 60.58 Favored 'General case' 0 CA--C 1.587 2.393 0 N-CA-C 114.247 1.203 . . . . 1.15 114.247 174.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -123.65 22.75 9.0 Favored 'General case' 0 CA--C 1.571 1.788 0 N-CA-C 114.372 1.249 . . . . 0.92 114.372 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.43 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 0.3 OUTLIER -137.89 -36.31 0.62 Allowed 'General case' 0 N--CA 1.51 2.558 0 N-CA-C 114.84 1.422 . . . . 1.33 114.84 -178.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.1 p -65.94 126.31 28.15 Favored 'General case' 0 N--CA 1.526 3.353 0 N-CA-C 115.293 1.59 . . . . 1.28 115.293 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.41 148.06 42.93 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 113.463 0.912 . . . . 1.53 113.463 -178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.494 ' HE ' HD12 ' A' ' 34' ' ' LEU . 2.9 ttp85 -99.29 -150.76 0.38 Allowed 'General case' 0 CA--C 1.568 1.658 0 C-N-CA 124.08 0.952 . . . . 3.22 111.355 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -107.08 136.64 46.59 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.557 -0.715 . . . . 3.66 111.377 178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -116.76 151.23 36.86 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.809 1.04 . . . . 4.7 113.809 -177.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -159.57 -66.37 0.08 Allowed 'General case' 0 CA--C 1.557 1.248 0 N-CA-C 113.726 1.01 . . . . 2.55 113.726 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -130.66 -162.99 1.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 113.434 0.901 . . . . 2.15 113.434 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.28 109.87 3.29 Favored 'General case' 0 N--CA 1.506 2.365 0 C-N-CA 124.608 1.163 . . . . 0.77 112.344 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.81 157.34 43.93 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.739 -1.119 . . . . 0.81 113.157 -176.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -169.66 -176.27 39.34 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 115.739 1.055 . . . . 0.47 115.739 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -108.6 172.31 6.92 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.357 1.243 . . . . 0.89 114.357 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -126.06 130.32 50.89 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 114.092 -1.413 . . . . 0.51 111.995 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.73 99.61 38.57 Favored Pre-proline 0 CA--C 1.567 1.603 0 C-N-CA 123.282 0.633 . . . . 0.15 109.379 178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -84.17 121.63 2.76 Favored 'Trans proline' 0 CA--C 1.561 1.83 0 C-N-CA 122.061 1.841 . . . . 0.15 114.65 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.03 160.4 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.658 0 CA-C-O 122.016 0.913 . . . . 0.19 111.455 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -146.62 17.42 1.3 Allowed 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 114.616 -1.175 . . . . 2.53 112.051 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -126.65 160.33 31.04 Favored 'General case' 0 C--N 1.362 1.146 0 CA-C-O 121.292 0.568 . . . . 2.12 111.5 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.475 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -121.25 144.55 48.55 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 113.72 1.008 . . . . 0.42 113.72 -178.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.32 -134.31 3.49 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 113.961 -1.472 . . . . 0.23 112.012 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.7 mt-10 -119.1 106.91 12.86 Favored 'General case' 0 C--N 1.359 0.99 0 CA-C-N 118.521 1.16 . . . . 1.75 111.158 177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -101.37 128.74 47.41 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.093 0.473 . . . . 0.21 110.76 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.77 125.77 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-O 121.528 0.68 . . . . 0.2 110.543 -176.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.71 105.89 17.28 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 114.563 -1.199 . . . . 0.78 109.687 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.23 123.31 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 108.044 -1.095 . . . . 0.44 108.044 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -138.37 140.24 39.34 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.973 0.731 . . . . 1.25 112.973 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -101.46 120.37 40.18 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-O 121.711 0.767 . . . . 2.52 111.794 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -105.07 133.5 49.74 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.399 -0.819 . . . . 0.4 109.655 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.59 158.92 43.27 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.306 0.574 . . . . 0.41 112.207 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -122.8 161.63 23.64 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.512 0.725 . . . . 2.61 111.844 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.13 -69.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 112.579 0.585 . . . . 2.13 112.579 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -132.11 63.38 1.62 Allowed 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 112.621 0.6 . . . . 2.27 112.621 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -148.68 97.44 2.73 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.283 0.633 . . . . 1.46 109.707 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.37 105.91 16.22 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 122.171 0.986 . . . . 0.84 112.397 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -167.4 140.54 3.45 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.874 -1.057 . . . . 2.45 111.464 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.1 m -127.08 123.18 36.29 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.782 0.66 . . . . 1.66 112.782 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 68.16 47.49 1.02 Allowed 'General case' 0 N--CA 1.51 2.56 0 C-N-CA 125.819 1.648 . . . . 1.89 113.894 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -149.74 -39.27 0.14 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.589 1.156 . . . . 2.56 110.053 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -107.81 79.61 1.3 Allowed 'General case' 0 C--N 1.362 1.118 0 N-CA-C 108.123 -1.066 . . . . 2.76 108.123 177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.24 120.71 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 114.111 -1.404 . . . . 0.69 111.146 -176.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -99.41 176.62 5.45 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 114.166 -1.379 . . . . 0.7 114.583 -176.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -127.5 135.25 50.11 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 122.09 -0.381 . . . . 1.33 110.332 176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 3.2 t -127.79 124.22 62.67 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.439 0 CA-C-O 121.208 0.528 . . . . 0.48 109.641 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.678 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 20.0 mtt180 -122.11 150.48 42.11 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.467 1.654 . . . . 1.69 115.467 -176.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 154' ' ' SER . 7.2 m -126.05 111.87 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.71 0 N-CA-C 113.072 0.767 . . . . 0.6 113.072 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.468 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 62.86 25.93 15.32 Favored 'General case' 0 N--CA 1.526 3.345 0 C-N-CA 126.607 1.963 . . . . 1.12 114.06 -179.042 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.22 -14.05 51.7 Favored Glycine 0 CA--C 1.552 2.37 0 C-N-CA 121.348 -0.453 . . . . 0.32 113.768 -176.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.678 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 92.3 m-70 -89.29 173.99 8.08 Favored 'General case' 0 C--N 1.363 1.154 0 C-N-CA 125.914 1.686 . . . . 0.57 113.185 -179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.66 133.56 54.51 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.582 0.706 . . . . 0.55 112.047 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.69 -57.17 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-N 114.701 -1.136 . . . . 1.06 113.038 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.09 88.98 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.295 -1.002 . . . . 0.44 108.295 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 114' ' ' ASP . 13.4 ptpt -108.31 98.55 8.07 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-O 122.919 1.342 . . . . 2.3 111.793 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 113' ' ' LYS . 0.6 OUTLIER 121.48 74.39 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 129.245 3.018 . . . . 2.48 108.018 -179.409 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.47 106.61 18.66 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 113.228 0.825 . . . . 1.13 113.228 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -116.86 102.53 9.47 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 113.728 -1.578 . . . . 2.35 106.806 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -68.44 -25.59 31.56 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.335 0 N-CA-C 114.4 1.259 . . . . 0.68 114.4 -176.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -75.27 -41.96 56.09 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 123.831 0.853 . . . . 0.77 112.324 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -73.9 -26.13 60.37 Favored 'General case' 0 CA--C 1.577 1.986 0 C-N-CA 124.403 1.081 . . . . 0.91 113.497 176.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -78.19 -56.1 4.74 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 113.711 1.004 . . . . 2.43 113.711 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.21 -36.95 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.428 0 N-CA-C 114.44 1.274 . . . . 0.93 114.44 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 127.05 -109.29 1.07 Allowed Glycine 0 C--N 1.355 1.619 0 CA-C-N 118.523 0.601 . . . . 0.85 113.25 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -114.94 106.95 14.75 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.731 0.301 . . . . 3.18 110.63 179.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 67.56 -130.07 0.14 Allowed 'General case' 0 N--CA 1.505 2.304 0 C-N-CA 125.285 1.434 . . . . 2.08 112.582 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.456 HG22 ' HB2' ' A' ' 51' ' ' LEU . 66.7 p 60.39 -163.24 0.25 Allowed 'General case' 0 N--CA 1.529 3.511 0 C-N-CA 126.293 1.837 . . . . 0.62 115.182 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -112.74 129.93 56.24 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 112.692 0.626 . . . . 0.46 112.692 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -103.08 137.82 40.74 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.077 -0.712 . . . . 0.38 109.077 177.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -134.71 126.14 28.44 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.88 1.437 . . . . 2.5 114.88 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -116.06 125.32 52.27 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 115.138 -0.937 . . . . 1.56 111.156 175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.63 114.72 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 114.272 -1.331 . . . . 0.45 110.199 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.3 101.4 17.69 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.953 -0.546 . . . . 0.84 111.582 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -74.13 143.01 31.6 Favored 'Trans proline' 0 C--N 1.399 3.237 0 C-N-CA 123.049 2.499 . . . . 0.16 114.729 176.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.3 mt -124.9 150.46 29.9 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.588 0 CA-C-N 115.03 -0.987 . . . . 0.38 109.916 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.6 t -136.21 113.41 10.59 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-O 121.454 0.645 . . . . 1.31 111.275 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.3 mt -111.56 124.28 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.69 0 CA-C-N 114.931 -1.031 . . . . 0.25 108.61 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -143.69 130.4 20.27 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.791 -0.64 . . . . 2.05 110.979 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 68.35 14.24 9.14 Favored 'General case' 0 N--CA 1.515 2.803 0 C-N-CA 125.186 1.394 . . . . 3.55 113.623 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 96.99 17.64 31.78 Favored Glycine 0 CA--C 1.549 2.162 0 CA-C-O 119.158 -0.801 . . . . 0.37 114.566 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 7.1 mtpm? -127.28 150.58 49.5 Favored 'General case' 0 C--N 1.367 1.364 0 CA-C-N 118.443 1.122 . . . . 1.56 113.046 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.79 141.06 36.77 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.07 1.137 . . . . 0.34 114.07 -176.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.73 112.32 11.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.884 -1.053 . . . . 0.64 110.054 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.255 8.6 p -115.95 95.16 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.457 0 CA-C-O 121.309 0.576 . . . . 0.46 111.314 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 67.81 -86.37 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.76 0 C-N-CA 125.673 1.589 . . . . 1.56 113.608 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.83 26.68 5.32 Favored Glycine 0 CA--C 1.543 1.821 0 CA-C-N 115.923 -0.581 . . . . 0.49 112.79 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -126.12 137.35 53.59 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 124.067 0.947 . . . . 1.82 111.013 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.5 p -126.75 126.04 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.167 0 CA-C-O 121.516 0.675 . . . . 1.02 111.05 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.0 m -150.2 -179.72 7.42 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.188 -0.915 . . . . 0.56 109.933 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.269 15.4 t -103.84 138.18 40.79 Favored 'General case' 0 CA--C 1.577 1.981 0 N-CA-C 113.152 0.797 . . . . 1.25 113.152 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -83.74 121.81 27.79 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 123.987 0.915 . . . . 0.29 111.38 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.41 91.27 3.21 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 112.38 0.511 . . . . 1.42 112.38 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.89 -66.29 3.4 Favored Glycine 0 C--N 1.357 1.74 0 N-CA-C 118.738 2.255 . . . . 0.42 118.738 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.528 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -133.58 156.89 47.01 Favored 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 114.326 1.232 . . . . 1.1 114.326 -176.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.528 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.3 OUTLIER -104.84 137.3 42.84 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 113.107 -1.86 . . . . 0.67 109.188 177.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 3.1 t -120.47 143.28 48.6 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 115.284 1.587 . . . . 0.36 115.284 -177.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.411 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -114.92 97.44 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 106.986 -1.487 . . . . 0.74 106.986 175.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -117.76 124.11 47.65 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.993 -0.549 . . . . 1.67 112.077 -177.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.91 135.27 54.15 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 122.329 1.062 . . . . 1.8 112.015 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.4 t -104.74 140.24 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-N 112.631 -2.077 . . . . 0.58 109.283 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.6 150.32 21.77 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.741 1.386 . . . . 2.18 114.741 -178.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.91 -34.23 4.1 Favored Glycine 0 CA--C 1.545 1.964 0 CA-C-N 114.779 -1.1 . . . . 1.02 114.483 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 35.4 m-85 -126.2 -88.01 0.59 Allowed 'General case' 0 CA--C 1.553 1.092 0 CA-C-N 117.357 0.579 . . . . 2.86 112.372 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -131.04 -51.33 1.03 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.996 0.518 . . . . 3.91 112.015 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.03 122.61 37.87 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.172 0.989 . . . . 1.74 111.245 178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -81.97 -169.09 0.21 Allowed Pre-proline 0 CA--C 1.574 1.888 0 C-N-CA 125.54 1.536 . . . . 1.68 110.554 178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -62.7 99.98 0.22 Allowed 'Trans proline' 0 C--N 1.397 3.082 0 C-N-CA 122.159 1.906 . . . . 2.06 111.461 174.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -55.65 -55.18 35.21 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 116.295 1.961 . . . . 3.0 116.295 -173.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 38.8 t -105.61 130.02 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.52 -0.919 . . . . 0.8 108.52 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.8 t -135.41 113.82 11.56 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 114.053 -1.431 . . . . 0.87 110.648 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -109.61 47.2 0.95 Allowed 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.688 2.107 . . . . 0.34 116.688 -175.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.17 130.92 3.62 Favored 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 117.13 2.27 . . . . 0.7 117.13 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -150.92 105.37 3.25 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.7 -1.136 . . . . 0.21 109.597 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.298 7.2 tt -112.76 122.04 66.19 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.037 0 CA-C-O 122.255 1.026 . . . . 0.31 111.091 175.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -116.3 164.29 14.74 Favored 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 113.707 -1.588 . . . . 0.44 111.153 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 8.6 ptmm? -123.0 156.18 35.32 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.577 2.436 . . . . 1.26 117.577 -177.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.42 -41.57 2.11 Favored Glycine 0 CA--C 1.541 1.718 0 CA-C-N 110.55 -3.023 . . . . 0.17 118.909 174.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.04 160.36 1.77 Allowed 'General case' 0 N--CA 1.517 2.885 0 CA-C-N 120.683 2.242 . . . . 0.15 113.391 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -83.29 -13.65 54.71 Favored 'General case' 0 CA--C 1.578 2.03 0 C-N-CA 124.882 1.273 . . . . 0.17 114.016 176.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.38 2.91 49.01 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 114.502 1.297 . . . . 0.55 114.502 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.63 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.9 OUTLIER -107.55 -10.26 15.73 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.762 1.023 . . . . 0.6 113.762 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.53 94.66 0.55 Allowed Pre-proline 0 N--CA 1.508 2.431 0 C-N-CA 123.917 0.887 . . . . 0.95 112.727 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.63 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 65.5 Cg_endo -95.05 159.62 1.7 Allowed 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 122.713 2.275 . . . . 1.8 114.284 178.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.4 tpt -135.36 114.45 12.22 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.064 -0.517 . . . . 4.96 111.448 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.76 163.85 31.79 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 122.091 0.948 . . . . 4.0 112.524 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -111.24 161.75 23.82 Favored Pre-proline 0 CA--C 1.563 1.459 0 CA-C-N 114.538 -1.21 . . . . 6.27 110.621 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -67.25 121.11 8.21 Favored 'Trans proline' 0 C--N 1.396 3.041 0 C-N-CA 122.356 2.037 . . . . 6.59 114.453 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 36.9 t-80 -136.62 134.77 19.73 Favored Pre-proline 0 CA--C 1.562 1.433 0 CA-C-N 115.374 -0.83 . . . . 5.51 111.634 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -85.02 -155.5 0.06 OUTLIER 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.257 2.638 . . . . 6.77 113.845 178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 170.01 87.63 0.07 OUTLIER Glycine 0 C--N 1.342 0.873 0 C-N-CA 120.846 -0.692 . . . . 7.02 113.357 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 8.7 mt -119.13 115.34 24.05 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 122.726 0.41 . . . . 8.99 111.877 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.292 -0.861 . . . . 10.6 111.143 179.958 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.473 -0.251 . . . . 8.93 112.473 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.4 130.85 55.47 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.493 0.663 . . . . 6.82 111.904 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.7 mtt -130.59 -67.67 0.72 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.751 -0.658 . . . . 7.64 111.792 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.0 m -134.91 116.14 14.4 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.877 0.37 . . . . 3.86 111.7 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.69 89.07 0.1 OUTLIER Glycine 0 C--N 1.341 0.852 0 CA-C-N 115.783 -0.644 . . . . 1.11 113.101 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.55 ' HG ' HD11 ' A' ' 27' ' ' ILE . 17.3 tp -87.92 -45.02 10.62 Favored 'General case' 0 CA--C 1.564 1.506 0 N-CA-C 113.314 0.857 . . . . 0.35 113.314 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.46 -23.53 62.79 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.822 1.649 . . . . 0.2 115.134 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.97 -10.46 53.15 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 113.62 0.97 . . . . 0.32 113.62 177.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 54.9 mmtt -105.26 -25.21 12.53 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-O 118.235 -0.888 . . . . 1.73 113.349 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -51.03 133.8 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.956 0 N-CA-C 115.508 1.67 . . . . 0.11 115.508 177.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -120.26 -29.84 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 115.267 -0.879 . . . . 0.16 112.071 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -162.45 118.6 1.94 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.583 0.353 . . . . 0.54 111.62 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.8 128.58 20.48 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.523 -0.735 . . . . 0.19 111.181 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.11 135.66 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 113.986 1.106 . . . . 1.05 113.986 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -116.04 102.34 9.55 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 106.906 -1.516 . . . . 2.11 106.906 172.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -75.37 98.55 3.89 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.949 0.881 . . . . 0.63 111.764 -179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.495 ' N ' ' HG3' ' A' ' 65' ' ' ARG . . . 172.3 -33.03 0.13 Allowed Glycine 0 C--N 1.348 1.234 0 N-CA-C 117.374 1.71 . . . . 0.71 117.374 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -127.07 -114.87 1.9 Allowed Glycine 0 N--CA 1.471 1.01 0 C-N-CA 120.219 -0.991 . . . . 0.8 115.288 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.75 117.04 1.07 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.118 0.567 . . . . 1.63 110.593 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.4 m 33.25 108.01 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 118.593 2.812 . . . . 1.0 118.593 177.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.519 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 63.3 t60 -133.21 133.94 43.39 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 113.76 1.022 . . . . 0.45 113.76 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.57 117.59 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 114.743 -1.117 . . . . 1.39 109.143 175.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -86.37 163.25 17.75 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 115.157 -0.929 . . . . 1.85 111.542 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -43.73 -24.96 0.21 Allowed 'Isoleucine or valine' 1 N--CA 1.541 4.092 0 N-CA-C 119.681 3.215 . . . . 0.72 119.681 -175.035 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -98.02 -9.98 25.16 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 118.543 0.611 . . . . 0.51 111.457 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.8 40.32 2.73 Favored Glycine 0 C--N 1.36 1.864 0 C-N-CA 124.811 1.196 . . . . 0.34 114.036 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.55 HD11 ' HG ' ' A' ' 6' ' ' LEU . 13.6 mm -105.15 119.17 53.82 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.681 0 N-CA-C 109.21 -0.663 . . . . 0.55 109.21 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.519 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.0 t-160 -105.7 135.28 47.4 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 115.579 1.696 . . . . 1.34 115.579 -175.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.562 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -94.84 134.35 37.56 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 114.3 -1.318 . . . . 2.79 109.392 174.697 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.4 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 68.8 mtt180 -90.79 106.03 18.23 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.956 -1.02 . . . . 3.0 113.307 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -41.89 109.84 0.14 Allowed 'General case' 0 N--CA 1.511 2.583 0 N-CA-C 118.374 2.731 . . . . 2.3 118.374 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.08 59.75 16.33 Favored Pre-proline 0 N--CA 1.528 3.466 0 N-CA-C 118.325 2.713 . . . . 1.17 118.325 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 10.0 Cg_endo -105.83 56.97 0.02 OUTLIER 'Trans proline' 0 CA--C 1.565 2.068 0 C-N-CA 122.992 2.461 . . . . 1.45 115.685 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.53 -67.88 0.46 Allowed 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 113.106 0.78 . . . . 1.91 113.106 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -99.19 89.44 4.24 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 112.98 0.733 . . . . 4.84 112.98 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.79 -29.63 11.67 Favored Glycine 0 CA--C 1.545 1.929 0 CA-C-N 115.458 -0.792 . . . . 2.37 114.503 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 80.89 2.75 1.69 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 126.605 1.962 . . . . 4.5 114.816 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.93 117.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 123.923 0.889 . . . . 2.7 109.807 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -160.84 -140.79 2.96 Favored Glycine 0 C--N 1.342 0.887 0 C-N-CA 120.765 -0.731 . . . . 1.95 114.453 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -139.81 -177.86 5.17 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 121.893 0.854 . . . . 5.34 112.831 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.49 129.81 45.08 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.234 1.013 . . . . 1.64 111.878 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.4 m -126.37 122.92 36.74 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.244 -0.889 . . . . 1.57 111.142 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -131.96 108.74 9.57 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.95 -0.568 . . . . 2.33 111.458 -179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -105.59 72.18 0.95 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.88 0.848 . . . . 3.16 110.299 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.17 75.74 0.48 Allowed Glycine 0 C--N 1.347 1.142 0 CA-C-N 114.399 -1.273 . . . . 1.52 110.716 -177.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.33 0.31 57.44 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 115.766 1.765 . . . . 1.67 115.766 -177.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.54 46.47 1.72 Allowed 'General case' 0 CA--C 1.559 1.315 0 CA-C-O 121.632 0.73 . . . . 4.18 112.119 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -129.72 72.74 81.89 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 124.551 1.141 . . . . 2.63 108.395 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 38.6 Cg_exo -67.4 159.78 50.79 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 124.03 3.153 . . . . 1.37 117.211 -177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.3 136.87 29.77 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.951 0 CA-C-N 114.703 -1.135 . . . . 0.69 109.405 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.55 ' HB2' HG22 ' A' ' 125' ' ' THR . 4.0 mt -79.52 -17.14 54.71 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.241 1.571 . . . . 1.28 115.241 -179.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -101.49 7.41 42.43 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 113.478 0.918 . . . . 1.51 113.478 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.2 p -118.52 -177.98 3.42 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.14 1.163 . . . . 1.09 114.14 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.717 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 2.6 t30 -97.44 -176.18 0.5 Allowed Pre-proline 0 CA--C 1.577 1.99 0 C-N-CA 125.652 1.581 . . . . 1.27 109.574 177.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -72.05 -43.99 1.02 Allowed 'Trans proline' 0 C--N 1.393 2.901 0 C-N-CA 122.766 2.311 . . . . 0.95 111.414 174.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -69.31 -47.68 63.76 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 113.005 -1.907 . . . . 2.04 111.617 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 61' ' ' TYR . 17.4 t0 -75.7 -12.27 60.16 Favored 'General case' 0 CA--C 1.583 2.241 0 CA-C-N 115.327 -0.851 . . . . 1.62 112.378 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.717 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 10.8 tt0 -67.7 -43.16 80.76 Favored 'General case' 0 C--N 1.379 1.851 0 C-N-CA 125.432 1.493 . . . . 1.77 109.179 173.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.8 -45.06 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.338 0 C-N-CA 124.327 1.051 . . . . 0.81 109.853 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.5 tp -77.76 -5.18 49.83 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.227 1.195 . . . . 1.15 114.227 178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.496 ' HB2' ' O ' ' A' ' 57' ' ' ASP . 4.6 m-30 -123.54 10.35 9.11 Favored 'General case' 0 CA--C 1.572 1.805 0 C-N-CA 124.509 1.124 . . . . 0.92 112.402 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -136.55 -28.64 0.99 Allowed 'General case' 0 N--CA 1.506 2.336 0 N-CA-C 116.502 2.038 . . . . 1.33 116.502 -176.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 46.7 p -74.74 131.85 41.16 Favored 'General case' 0 N--CA 1.519 2.99 0 N-CA-C 114.008 1.114 . . . . 1.28 114.008 -176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.597 ' HB3' HG22 ' A' ' 167' ' ' VAL . 3.5 pt-20 -127.53 144.93 51.01 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 114.95 1.463 . . . . 1.53 114.95 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.495 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 63.9 mtp180 -98.43 177.41 5.36 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 123.467 0.707 . . . . 3.22 112.673 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -125.11 125.87 44.43 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.792 -0.64 . . . . 3.66 111.067 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -132.36 -105.09 0.26 Allowed 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 118.96 -0.543 . . . . 4.7 112.236 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -164.62 -77.54 0.03 OUTLIER 'General case' 0 C--N 1.364 1.2 0 N-CA-C 113.564 0.95 . . . . 2.55 113.564 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -168.65 124.69 0.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 123.188 0.595 . . . . 2.15 111.368 -176.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.2 t 67.56 85.19 0.14 Allowed 'General case' 0 N--CA 1.513 2.714 0 C-N-CA 124.769 1.228 . . . . 0.77 112.487 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.406 ' CE1' ' ND2' ' A' ' 164' ' ' ASN . 3.3 p90 -144.56 157.03 44.41 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-O 121.384 0.611 . . . . 0.81 112.564 -178.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.52 174.47 44.47 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 115.571 0.989 . . . . 0.47 115.571 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.99 166.32 10.46 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 114.482 1.289 . . . . 0.89 114.482 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -120.74 132.08 54.86 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.15 -1.387 . . . . 0.51 112.162 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.5 mp -124.51 99.47 36.2 Favored Pre-proline 0 CA--C 1.567 1.627 0 C-N-CA 123.142 0.577 . . . . 0.15 109.916 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -83.08 122.12 3.27 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.231 1.954 . . . . 0.15 115.014 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.14 159.26 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.64 0 CA-C-O 121.997 0.904 . . . . 0.19 111.26 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -147.86 22.15 1.12 Allowed 'General case' 0 CA--C 1.558 1.286 0 CA-C-N 114.632 -1.167 . . . . 2.53 111.791 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -129.9 159.37 36.84 Favored 'General case' 0 C--N 1.361 1.095 0 CA-C-O 121.3 0.572 . . . . 2.12 111.449 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -119.0 144.77 46.32 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.742 1.016 . . . . 0.42 113.742 -178.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.48 -138.73 5.77 Favored Glycine 0 CA--C 1.526 0.777 0 CA-C-N 113.974 -1.467 . . . . 0.23 112.17 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 54.3 mm-40 -113.65 108.26 16.89 Favored 'General case' 0 C--N 1.359 1.008 0 CA-C-N 118.113 0.956 . . . . 1.75 111.292 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -102.84 129.84 49.65 Favored 'General case' 0 N--CA 1.48 1.071 0 O-C-N 121.81 -0.556 . . . . 0.21 110.599 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.3 t -110.02 122.36 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 CA-C-O 121.841 0.829 . . . . 0.2 111.013 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.61 105.75 16.3 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-N 113.907 -1.497 . . . . 0.78 110.202 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -118.69 126.65 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.142 -0.688 . . . . 0.44 109.142 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 146.07 48.42 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.599 0.963 . . . . 1.25 113.599 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -105.18 121.54 44.05 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.311 -0.859 . . . . 2.52 111.296 177.466 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 88' ' ' LYS . 15.6 m-85 -108.49 134.86 50.69 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.414 -0.812 . . . . 0.4 109.735 176.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.51 ' HB2' ' HE3' ' A' ' 88' ' ' LYS . . . -136.18 148.5 48.18 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 123.868 0.867 . . . . 0.41 110.425 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -106.38 -71.21 0.76 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.816 0.447 . . . . 2.61 111.768 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . 0.325 2.8 m 48.29 53.57 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 C-N-CA 127.113 2.165 . . . . 2.13 116.677 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -163.98 -53.63 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.79 0.663 . . . . 2.27 112.79 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -118.29 139.23 51.64 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.31 0.576 . . . . 1.46 112.349 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.18 103.31 12.47 Favored 'General case' 0 CA--C 1.56 1.345 0 CA-C-O 122.209 1.004 . . . . 0.84 111.987 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 9.0 tp60 -162.83 140.89 8.27 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 115.125 -0.943 . . . . 2.45 111.642 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.7 m -123.45 122.38 38.1 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.962 0.727 . . . . 1.66 112.962 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 69.2 58.21 0.35 Allowed 'General case' 0 N--CA 1.511 2.582 0 C-N-CA 125.933 1.693 . . . . 1.89 113.266 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -156.96 -40.94 0.07 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 114.128 -1.396 . . . . 2.56 108.606 -179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -103.42 82.67 2.07 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.361 -0.977 . . . . 2.76 108.361 176.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.43 132.89 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-N 114.516 -1.22 . . . . 0.69 111.509 -177.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.476 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 61.7 m-85 -115.5 174.26 6.1 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 115.185 1.55 . . . . 0.7 115.185 -176.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -126.27 136.08 52.34 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 121.869 0.842 . . . . 1.33 110.923 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.3 124.39 57.6 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.285 0 CA-C-N 114.361 -1.291 . . . . 0.48 110.38 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 156' ' ' GLU . 0.3 OUTLIER -121.02 141.56 50.63 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 114.473 1.286 . . . . 1.69 114.473 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.5 m -117.72 99.33 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-N 115.111 -0.95 . . . . 0.6 112.063 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.428 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.1 t30 64.85 26.89 12.92 Favored 'General case' 0 N--CA 1.522 3.169 0 C-N-CA 126.892 2.077 . . . . 1.12 113.659 -177.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.89 -19.65 32.6 Favored Glycine 0 CA--C 1.549 2.19 0 CA-C-N 115.141 -0.936 . . . . 0.32 113.702 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -88.32 121.93 31.27 Favored 'General case' 0 C--N 1.365 1.273 0 C-N-CA 125.505 1.522 . . . . 0.57 113.669 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.4 p -87.7 125.69 34.55 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-O 122.591 1.186 . . . . 0.55 113.134 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.22 -43.39 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 CA-C-N 112.428 -2.169 . . . . 1.06 112.916 -177.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.38 90.77 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 109.466 -0.568 . . . . 0.44 109.466 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -111.55 75.88 0.94 Allowed 'General case' 0 C--N 1.359 1.013 0 CA-C-O 123.944 1.831 . . . . 2.3 112.52 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 154.46 61.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 109.818 -3.356 . . . . 2.48 107.48 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.3 tp -98.91 99.16 10.18 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 113.727 1.01 . . . . 1.13 113.727 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -111.86 111.5 22.49 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 113.172 -1.831 . . . . 2.35 109.742 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.97 -34.26 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 N-CA-C 114.545 1.313 . . . . 0.68 114.545 -177.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -76.32 -37.5 57.31 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.806 0.669 . . . . 0.77 112.806 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -74.08 -27.0 60.68 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 124.371 1.068 . . . . 0.91 113.422 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -80.33 -57.78 3.44 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 113.311 0.856 . . . . 2.43 113.311 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.78 -36.79 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 N-CA-C 114.313 1.227 . . . . 0.93 114.313 178.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 108.37 -71.13 0.21 Allowed Glycine 0 C--N 1.36 1.908 0 CA-C-N 118.534 0.606 . . . . 0.85 113.999 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -102.97 174.39 5.89 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.25 1.02 . . . . 3.18 111.802 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 57.0 m -75.9 81.26 2.8 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 113.846 1.054 . . . . 2.08 113.846 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.55 HG22 ' HB2' ' A' ' 51' ' ' LEU . 46.6 p -127.99 -137.43 0.24 Allowed 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 114.708 -1.133 . . . . 0.62 109.139 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.8 128.09 56.27 Favored 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 114.055 1.132 . . . . 0.46 114.055 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -106.2 126.68 52.51 Favored 'General case' 0 C--N 1.363 1.183 0 N-CA-C 108.399 -0.963 . . . . 0.38 108.399 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.25 136.76 36.84 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 113.5 0.926 . . . . 2.5 113.5 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -120.37 134.46 55.26 Favored 'General case' 0 C--O 1.25 1.118 0 CA-C-N 114.806 -1.088 . . . . 1.56 111.174 177.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.8 115.66 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 CA-C-N 114.255 -1.339 . . . . 0.45 109.833 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -125.9 90.86 49.49 Favored Pre-proline 0 CA--C 1.573 1.851 0 CA-C-N 115.208 -0.906 . . . . 0.84 110.15 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -73.87 136.64 23.25 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 123.052 2.501 . . . . 0.16 113.71 176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -119.04 151.38 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.522 0 CA-C-N 115.167 -0.924 . . . . 0.38 111.053 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.5 p -134.21 108.73 8.43 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.215 -0.902 . . . . 1.31 111.744 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.2 mt -108.82 122.79 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.593 0 N-CA-C 108.441 -0.948 . . . . 0.25 108.441 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -141.76 129.49 21.64 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 115.696 -0.684 . . . . 2.05 110.996 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm 67.49 14.87 9.73 Favored 'General case' 0 N--CA 1.515 2.821 0 C-N-CA 125.113 1.365 . . . . 3.55 114.367 -179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 98.38 16.44 32.1 Favored Glycine 0 CA--C 1.549 2.168 0 CA-C-O 119.143 -0.809 . . . . 0.37 114.962 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 94.6 mttt -126.82 150.4 49.21 Favored 'General case' 0 C--N 1.367 1.329 0 CA-C-N 118.498 1.149 . . . . 1.56 113.038 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.53 139.0 37.78 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.554 0.946 . . . . 0.34 113.554 -176.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.67 112.42 14.82 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.128 -0.942 . . . . 0.64 110.406 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.81 92.75 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.604 0 CA-C-N 115.589 -0.732 . . . . 0.46 109.982 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 65.39 -83.75 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 C-N-CA 125.369 1.468 . . . . 1.56 113.796 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -129.61 25.95 4.4 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-N 116.099 -0.5 . . . . 0.49 113.866 178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -132.38 119.31 20.51 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 123.165 0.586 . . . . 1.82 110.078 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.0 p -105.74 131.61 54.77 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.298 0 CA-C-O 121.696 0.76 . . . . 1.02 112.415 -178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -149.08 -178.11 6.2 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.815 -1.084 . . . . 0.56 109.565 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.268 13.0 t -103.48 138.65 39.9 Favored 'General case' 0 CA--C 1.578 2.032 0 N-CA-C 113.547 0.943 . . . . 1.25 113.547 178.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -82.12 122.68 28.16 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 124.192 0.997 . . . . 0.29 111.343 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.65 90.77 3.31 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.788 0.662 . . . . 1.42 112.788 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 75.19 -61.74 2.64 Favored Glycine 0 C--N 1.362 2.005 0 N-CA-C 118.835 2.294 . . . . 0.42 118.835 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.554 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -133.11 163.83 28.39 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 113.649 0.981 . . . . 1.1 113.649 -176.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.554 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.4 OUTLIER -112.14 134.6 53.59 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.692 -1.594 . . . . 0.67 108.488 176.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.2 t -121.86 130.58 53.49 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 115.246 1.573 . . . . 0.36 115.246 -177.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.2 t -106.35 99.85 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.704 -1.591 . . . . 0.74 106.704 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.534 ' O ' ' HG3' ' A' ' 105' ' ' ARG . 3.2 tt0 -114.85 125.23 53.43 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 113.905 -1.498 . . . . 1.67 111.9 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -116.15 131.97 56.79 Favored 'General case' 0 C--O 1.252 1.206 0 CA-C-O 122.217 1.008 . . . . 1.8 111.923 179.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.51 144.47 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 112.875 -1.966 . . . . 0.58 110.83 -177.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.474 ' HD3' ' O ' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -95.19 150.45 20.2 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 114.676 -1.147 . . . . 2.18 113.612 -179.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -98.32 -32.65 5.98 Favored Glycine 0 CA--C 1.548 2.112 0 N-CA-C 115.236 0.855 . . . . 1.02 115.236 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -125.17 -80.56 0.62 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.606 0.703 . . . . 2.86 112.395 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -132.2 -44.94 0.93 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.087 0.555 . . . . 3.91 112.203 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.476 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -92.84 157.17 16.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.659 1.184 . . . . 1.74 112.109 179.085 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.406 ' ND2' ' CE1' ' A' ' 71' ' ' PHE . 1.2 m-20 -101.19 -167.45 0.13 Allowed Pre-proline 0 CA--C 1.572 1.809 0 CA-C-N 113.614 -1.63 . . . . 1.68 108.979 178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -61.26 -10.5 15.83 Favored 'Trans proline' 0 N--CA 1.52 3.081 0 C-N-CA 122.49 2.127 . . . . 2.06 115.533 177.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? 78.93 -71.71 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 126.561 1.944 . . . . 3.0 114.211 176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.597 HG22 ' HB3' ' A' ' 64' ' ' GLU . 25.2 t -106.34 132.72 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.621 -0.511 . . . . 0.8 109.621 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.8 t -134.6 125.82 27.96 Favored 'General case' 0 C--N 1.357 0.904 0 CA-C-N 114.155 -1.384 . . . . 0.87 111.479 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.526 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.268 . . -120.34 50.88 1.26 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 115.744 1.757 . . . . 0.34 115.744 -176.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.81 129.3 2.62 Favored 'General case' 0 N--CA 1.515 2.814 0 C-N-CA 126.169 1.787 . . . . 0.7 115.502 178.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -149.61 99.31 2.87 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.433 -0.803 . . . . 0.21 110.019 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.311 8.0 tt -115.67 121.78 68.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.673 0 CA-C-O 122.651 1.215 . . . . 0.31 111.801 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -118.72 171.2 8.37 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 113.701 -1.59 . . . . 0.44 112.171 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 9' ' ' LYS . 54.7 tttm -120.15 148.15 44.0 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 117.783 2.512 . . . . 1.26 117.783 -174.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.22 -41.74 2.08 Favored Glycine 0 CA--C 1.543 1.823 0 CA-C-N 110.786 -2.915 . . . . 0.17 120.087 172.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.08 156.64 1.04 Allowed 'General case' 0 N--CA 1.521 3.115 0 CA-C-N 121.114 2.457 . . . . 0.15 113.383 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.45 -12.12 59.99 Favored 'General case' 0 N--CA 1.502 2.168 0 N-CA-C 114.478 1.288 . . . . 0.17 114.478 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.1 4.47 45.25 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 113.694 0.998 . . . . 0.55 113.694 177.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.617 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -107.13 -10.32 15.91 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 113.701 1.0 . . . . 0.6 113.701 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.32 93.69 0.45 Allowed Pre-proline 0 N--CA 1.509 2.503 0 C-N-CA 123.932 0.893 . . . . 0.95 112.74 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 2.7 Cg_exo -83.08 106.74 1.43 Allowed 'Trans proline' 0 C--N 1.398 3.159 0 C-N-CA 122.858 2.372 . . . . 1.8 114.083 178.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.8 mmt -138.39 110.54 7.33 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.642 -0.708 . . . . 4.96 111.206 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.1 mt -133.29 164.28 27.43 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.974 0.892 . . . . 4.0 112.557 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -104.76 154.43 38.57 Favored Pre-proline 0 CA--C 1.562 1.415 0 CA-C-N 114.629 -1.169 . . . . 6.27 110.537 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.46 121.8 9.32 Favored 'Trans proline' 0 C--N 1.394 2.943 0 C-N-CA 122.569 2.179 . . . . 6.59 115.466 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -135.69 135.83 22.62 Favored Pre-proline 0 CA--C 1.565 1.531 0 CA-C-N 114.779 -1.1 . . . . 5.51 111.165 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -84.88 -155.9 0.07 OUTLIER 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.346 2.697 . . . . 6.77 114.293 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 173.93 104.9 0.18 Allowed Glycine 0 C--N 1.341 0.806 0 C-N-CA 121.136 -0.555 . . . . 7.02 113.036 177.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.5 mt -118.64 108.32 14.79 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.009 0.433 . . . . 8.99 111.84 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.277 -0.868 . . . . 10.6 110.998 179.88 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.564 -0.214 . . . . 8.93 112.564 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.67 128.1 56.3 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.604 0.716 . . . . 6.82 111.884 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.7 mtt -134.19 106.3 7.09 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.626 -0.715 . . . . 7.64 110.991 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.2 m -135.95 117.7 15.06 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.797 -0.638 . . . . 3.86 111.741 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -165.93 87.29 0.1 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 115.665 -0.698 . . . . 1.11 113.054 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.588 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.7 tp -87.54 -47.76 8.46 Favored 'General case' 0 CA--C 1.561 1.382 0 N-CA-C 113.294 0.85 . . . . 0.35 113.294 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.69 -23.15 62.89 Favored 'General case' 0 N--CA 1.511 2.579 0 C-N-CA 125.647 1.579 . . . . 0.2 114.979 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.1 -15.17 39.3 Favored 'General case' 0 CA--C 1.564 1.508 0 C-N-CA 124.146 0.978 . . . . 0.32 113.626 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -105.19 -18.05 14.27 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 113.907 1.077 . . . . 1.73 113.907 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -55.34 134.79 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.78 0 N-CA-C 114.625 1.343 . . . . 0.11 114.625 176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -121.27 -28.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 115.328 -0.851 . . . . 0.16 112.446 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 65.4 t90 -162.63 117.08 1.77 Allowed 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 117.827 0.285 . . . . 0.54 111.493 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -136.84 130.85 32.42 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.516 -0.74 . . . . 0.19 111.445 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.0 t -137.97 129.32 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 N-CA-C 113.481 0.919 . . . . 1.05 113.481 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -116.44 104.22 11.23 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 106.946 -1.501 . . . . 2.11 106.946 171.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -78.29 101.88 7.38 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-O 122.084 0.945 . . . . 0.63 111.861 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.526 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 175.59 -57.33 0.11 Allowed Glycine 0 C--N 1.349 1.305 0 CA-C-N 113.71 -1.587 . . . . 0.71 114.349 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -105.13 -117.09 4.3 Favored Glycine 0 C--N 1.351 1.393 0 CA-C-O 119.93 -0.372 . . . . 0.8 113.975 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -172.12 118.88 0.4 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.172 0.589 . . . . 1.63 111.17 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 48.39 107.63 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 N-CA-C 117.205 2.298 . . . . 1.0 117.205 178.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.761 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 25.7 t60 -142.41 132.51 24.6 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 118.461 -1.296 . . . . 0.45 114.49 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -97.04 112.24 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.362 0 CA-C-N 114.28 -1.327 . . . . 1.39 110.089 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.29 164.92 19.76 Favored 'General case' 0 CA--C 1.562 1.438 0 C-N-CA 124.527 1.131 . . . . 1.85 112.559 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 m -42.53 -35.17 0.63 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.159 0 N-CA-C 118.947 2.943 . . . . 0.72 118.947 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -88.98 -23.32 22.66 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.213 0.53 . . . . 0.51 111.26 176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.85 41.06 0.73 Allowed Glycine 0 C--N 1.351 1.394 0 CA-C-N 114.817 -1.083 . . . . 0.34 113.81 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.588 HD11 ' HG ' ' A' ' 6' ' ' LEU . 22.7 mm -108.45 112.8 41.93 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.438 0 C-N-CA 122.569 0.348 . . . . 0.55 110.581 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.761 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 5.1 p-80 -109.29 147.83 32.01 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.983 1.845 . . . . 1.34 115.983 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.589 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -97.8 151.31 20.32 Favored 'General case' 0 CA--C 1.564 1.504 0 CA-C-N 112.467 -2.151 . . . . 2.79 109.419 176.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 90.5 mtt-85 -70.27 -99.82 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 116.04 1.867 . . . . 3.0 116.04 -177.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp 178.19 84.04 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.89 0.876 . . . . 2.3 111.986 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 52.69 55.33 14.26 Favored Pre-proline 0 N--CA 1.528 3.457 0 N-CA-C 117.283 2.327 . . . . 1.17 117.283 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -101.67 61.37 0.03 OUTLIER 'Trans proline' 0 CA--C 1.568 2.193 0 C-N-CA 123.307 2.672 . . . . 1.45 116.432 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.47 -60.8 0.41 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.345 0.498 . . . . 1.91 112.345 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -114.22 98.69 7.1 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-O 121.329 0.585 . . . . 4.84 111.639 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 101.21 -32.34 7.59 Favored Glycine 0 CA--C 1.542 1.772 0 CA-C-N 115.221 -0.899 . . . . 2.37 115.128 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 64.46 40.68 6.12 Favored 'General case' 0 N--CA 1.509 2.519 0 C-N-CA 126.139 1.776 . . . . 4.5 114.616 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.61 177.46 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 C-N-CA 123.439 0.696 . . . . 2.7 111.52 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -99.22 96.24 1.66 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 115.088 0.795 . . . . 1.95 115.088 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -144.08 115.28 7.95 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.313 0.645 . . . . 5.34 110.877 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.66 134.23 46.37 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.508 0.67 . . . . 1.64 112.65 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.3 m -131.89 88.41 2.56 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.686 -0.688 . . . . 1.57 111.447 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.36 114.41 27.55 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 115.598 -0.728 . . . . 2.33 110.99 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -104.2 -61.61 1.42 Allowed 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 112.564 0.579 . . . . 3.16 112.564 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -110.52 62.72 0.29 Allowed Glycine 0 C--N 1.354 1.565 0 N-CA-C 112.123 -0.391 . . . . 1.52 112.123 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.27 9.76 40.06 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 116.028 1.862 . . . . 1.67 116.028 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -61.19 -77.97 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.786 1.773 . . . . 4.18 115.786 -178.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.64 ' N ' ' HD3' ' A' ' 49' ' ' PRO . 1.7 pp -138.88 40.8 0.44 Allowed Pre-proline 0 CA--C 1.551 1.002 0 N-CA-C 113.52 0.933 . . . . 2.63 113.52 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.64 ' HD3' ' N ' ' A' ' 48' ' ' LEU . 21.7 Cg_exo -68.43 -37.51 13.17 Favored 'Trans proline' 0 C--N 1.377 2.037 0 N-CA-C 119.496 2.844 . . . . 1.37 119.496 -177.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 126' ' ' ALA 0.319 1.8 mp -92.78 107.02 18.54 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.399 0 CA-C-O 123.085 1.421 . . . . 0.69 109.59 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.459 ' HB2' HG22 ' A' ' 125' ' ' THR . 89.3 mt -90.24 -7.13 54.26 Favored 'General case' 0 CA--C 1.553 1.096 0 CA-C-N 111.821 -2.445 . . . . 1.28 116.387 -175.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.1 mpt_? -103.86 16.46 26.29 Favored 'General case' 0 CA--C 1.564 1.497 0 N-CA-C 112.263 0.468 . . . . 1.51 112.263 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.84 159.36 42.37 Favored 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 124.224 1.01 . . . . 1.09 111.51 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.86 158.32 62.26 Favored Pre-proline 0 N--CA 1.517 2.876 0 CA-C-O 118.138 -0.934 . . . . 1.27 110.974 178.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -41.19 -40.13 4.08 Favored 'Trans proline' 0 N--CA 1.535 3.971 0 C-N-CA 125.162 3.908 . . . . 0.95 120.05 -176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.79 -50.02 13.17 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.511 0.672 . . . . 2.04 111.96 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.6 p30 -78.23 -7.5 57.22 Favored 'General case' 0 CA--C 1.584 2.287 0 N-CA-C 113.121 0.786 . . . . 1.62 113.121 177.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.66 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 7.7 tt0 -74.3 -37.06 63.75 Favored 'General case' 0 C--N 1.38 1.919 0 C-N-CA 125.923 1.689 . . . . 1.77 107.547 172.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.36 -43.88 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.118 0 C-N-CA 124.214 1.005 . . . . 0.81 109.289 172.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 8.1 tp -79.93 -4.63 53.21 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 113.965 1.098 . . . . 1.15 113.965 176.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.427 ' O ' HG12 ' A' ' 50' ' ' ILE . 6.8 m-30 -121.69 13.77 10.85 Favored 'General case' 0 CA--C 1.568 1.647 0 C-N-CA 125.131 1.373 . . . . 0.92 112.641 178.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.66 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 4.8 tt0 -140.8 -38.9 0.42 Allowed 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 117.175 2.287 . . . . 1.33 117.175 -174.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.8 p -64.19 128.06 34.16 Favored 'General case' 0 N--CA 1.528 3.435 0 N-CA-C 115.343 1.609 . . . . 1.28 115.343 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.527 ' HB3' HG22 ' A' ' 167' ' ' VAL . 2.4 pt-20 -117.96 146.11 44.23 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 124.617 1.167 . . . . 1.53 112.58 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -102.22 -83.85 0.46 Allowed 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.355 0.872 . . . . 3.22 113.355 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -152.22 163.73 38.81 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.541 0.686 . . . . 3.66 112.842 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -127.41 138.94 53.11 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.442 -0.799 . . . . 4.7 112.927 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -138.12 -119.83 0.14 Allowed 'General case' 0 CA--C 1.564 1.499 0 CA-C-N 115.472 -0.785 . . . . 2.55 110.337 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -152.76 121.24 6.35 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 118.39 0.541 . . . . 2.15 110.732 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 59.91 89.57 0.06 Allowed 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 125.383 1.473 . . . . 0.77 113.692 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -153.53 159.24 42.18 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.841 1.052 . . . . 0.81 113.841 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 155' ' ' VAL . . . -175.7 -172.01 40.13 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 115.879 1.112 . . . . 0.47 115.879 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -111.27 173.32 6.4 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.026 1.491 . . . . 0.89 115.026 -176.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -127.61 132.2 49.82 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 113.98 -1.464 . . . . 0.51 111.757 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mp -124.91 103.61 30.62 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.023 0.529 . . . . 0.15 109.957 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -84.34 120.64 2.54 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 122.282 1.988 . . . . 0.15 114.958 177.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.24 162.81 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 CA-C-O 122.041 0.924 . . . . 0.19 110.931 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -152.13 27.95 0.59 Allowed 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 114.801 -1.091 . . . . 2.53 111.816 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -132.71 155.62 48.5 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-O 121.24 0.543 . . . . 2.12 110.965 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.9 OUTLIER -116.77 141.87 47.65 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.009 1.114 . . . . 0.42 114.009 -178.48 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.83 -139.08 5.69 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 113.712 -1.585 . . . . 0.23 112.061 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 24.2 mt-10 -113.9 110.13 19.61 Favored 'General case' 0 C--N 1.36 1.023 0 CA-C-N 118.312 1.056 . . . . 1.75 111.299 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -104.41 131.2 52.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 120.996 0.427 . . . . 0.21 110.523 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.81 124.46 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.408 0.623 . . . . 0.2 110.551 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.429 HD12 HD12 ' A' ' 172' ' ' ILE . 2.2 tt -109.15 106.19 15.97 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.793 -1.094 . . . . 0.78 109.806 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -112.48 129.17 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 CA-C-N 113.929 -1.487 . . . . 0.44 108.543 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.72 139.11 50.26 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 115.684 -0.689 . . . . 1.25 112.502 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 4.9 tptm -104.33 114.75 29.19 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.295 -0.866 . . . . 2.52 109.855 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.491 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 11.1 m-85 -105.22 137.05 43.62 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.852 -0.613 . . . . 0.4 111.255 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -139.79 151.54 45.84 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.757 -0.656 . . . . 0.41 111.458 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -145.87 123.46 11.8 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.671 0.389 . . . . 2.61 111.687 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.3 77.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 CA-C-N 116.019 -0.537 . . . . 2.13 111.727 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -171.05 -47.42 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.43 0.53 . . . . 2.27 112.43 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -116.19 127.34 54.7 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.65 0.38 . . . . 1.46 111.577 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.96 103.14 12.94 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.252 1.025 . . . . 0.84 111.992 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -160.79 141.84 11.79 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 114.947 -1.024 . . . . 2.45 111.651 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 m -127.7 122.09 32.05 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 112.764 0.653 . . . . 1.66 112.764 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 67.85 55.62 0.58 Allowed 'General case' 0 N--CA 1.513 2.72 0 C-N-CA 125.724 1.61 . . . . 1.89 113.142 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -157.68 -39.15 0.07 Allowed 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.617 -1.174 . . . . 2.56 109.44 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -108.06 83.24 1.76 Allowed 'General case' 0 C--N 1.361 1.097 0 N-CA-C 108.03 -1.1 . . . . 2.76 108.03 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.41 130.45 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 114.419 -1.264 . . . . 0.69 111.539 -176.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -108.02 170.53 7.94 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 115.331 1.604 . . . . 0.7 115.331 -176.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -119.85 136.65 54.4 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.236 -0.893 . . . . 1.33 110.846 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.2 t -131.38 127.89 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.471 0 N-CA-C 109.58 -0.526 . . . . 0.48 109.58 -178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.481 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 53.9 mtt180 -128.58 153.32 47.35 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.708 1.744 . . . . 1.69 115.708 -176.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 154' ' ' SER . 0.7 OUTLIER -129.73 112.32 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-N 115.545 -0.752 . . . . 0.6 112.758 176.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.505 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER 63.39 27.05 15.18 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 126.864 2.066 . . . . 1.12 114.157 -178.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.31 -19.35 40.13 Favored Glycine 0 CA--C 1.548 2.136 0 C-N-CA 121.463 -0.399 . . . . 0.32 113.8 -177.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.481 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 86.7 m-70 -83.79 156.91 22.28 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 125.654 1.582 . . . . 0.57 114.454 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.49 131.29 53.84 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.375 0.607 . . . . 0.55 111.094 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.2 -57.86 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 CA-C-N 115.129 -0.942 . . . . 1.06 113.104 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.74 90.02 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.713 -0.847 . . . . 0.44 108.713 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -109.37 77.85 1.09 Allowed 'General case' 0 C--N 1.351 0.636 0 CA-C-O 122.835 1.303 . . . . 2.3 111.985 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 47.4 p-10 152.34 65.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 128.523 2.729 . . . . 2.48 107.868 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.0 tp -105.17 99.35 8.96 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 113.782 1.03 . . . . 1.13 113.782 -177.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -113.32 107.05 15.35 Favored 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 113.24 -1.8 . . . . 2.35 108.042 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.13 -33.25 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 114.542 1.312 . . . . 0.68 114.542 -177.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -75.13 -36.1 61.64 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 123.376 0.671 . . . . 0.77 112.242 178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -74.71 -27.46 60.39 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 124.436 1.094 . . . . 0.91 113.27 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.69 -56.93 4.17 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.163 0.801 . . . . 2.43 113.163 179.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.9 -40.68 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.357 0 N-CA-C 113.753 1.019 . . . . 0.93 113.753 177.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 105.45 -64.09 0.3 Allowed Glycine 0 C--N 1.361 1.935 0 N-CA-C 114.353 0.501 . . . . 0.85 114.353 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -103.26 174.2 5.97 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.316 1.046 . . . . 3.18 111.634 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 58.2 m -73.35 89.86 1.63 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 123.543 0.737 . . . . 2.08 112.249 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 51' ' ' LEU . 40.8 p -141.02 -146.25 0.19 Allowed 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.115 0.966 . . . . 0.62 109.209 -176.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.534 ' HB2' HG23 ' A' ' 50' ' ' ILE . . . -113.94 134.8 54.6 Favored 'General case' 0 CA--C 1.567 1.635 0 N-CA-C 113.475 0.917 . . . . 0.46 113.475 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.491 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 10.4 t60 -110.75 145.79 37.47 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 122.884 0.474 . . . . 0.38 109.77 177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -145.33 143.97 30.46 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.881 1.067 . . . . 2.5 113.881 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -137.43 125.71 23.21 Favored 'General case' 0 C--O 1.246 0.914 0 CA-C-N 114.293 -1.321 . . . . 1.56 110.471 176.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.45 121.73 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 114.896 -1.047 . . . . 0.45 110.768 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.98 99.45 15.05 Favored Pre-proline 0 CA--C 1.571 1.759 0 CA-C-O 119.009 -0.52 . . . . 0.84 112.208 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -74.7 143.95 30.8 Favored 'Trans proline' 0 C--N 1.4 3.277 0 C-N-CA 123.052 2.501 . . . . 0.16 114.326 176.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -124.28 149.25 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 C-N-CA 124.023 0.929 . . . . 0.38 110.423 -178.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.6 p -132.48 111.37 11.21 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.924 -0.58 . . . . 1.31 112.349 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.4 mt -112.01 122.67 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.578 0 N-CA-C 108.492 -0.929 . . . . 0.25 108.492 178.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -142.56 130.09 21.32 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.66 -0.7 . . . . 2.05 110.873 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt 69.38 10.14 7.61 Favored 'General case' 0 N--CA 1.518 2.963 0 N-CA-C 114.677 1.362 . . . . 3.55 114.677 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.66 18.45 23.11 Favored Glycine 0 CA--C 1.548 2.108 0 C-N-CA 123.738 0.685 . . . . 0.37 114.384 -177.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 95.4 mttt -128.25 151.09 49.69 Favored 'General case' 0 C--N 1.367 1.337 0 CA-C-N 117.978 0.889 . . . . 1.56 112.799 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.75 144.9 30.5 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.811 1.041 . . . . 0.34 113.811 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.1 m -134.35 114.09 12.6 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-N 114.783 -1.099 . . . . 0.64 110.712 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.274 0.8 OUTLIER -114.54 96.12 4.38 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.568 0 CA-C-O 121.304 0.573 . . . . 0.46 110.434 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 68.24 -85.34 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 125.41 1.484 . . . . 1.56 113.594 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -130.08 26.74 4.16 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 115.969 -0.559 . . . . 0.49 113.405 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -129.21 127.98 42.39 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 123.497 0.719 . . . . 1.82 110.453 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 7.0 p -113.39 130.75 66.82 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.315 0 CA-C-O 121.649 0.738 . . . . 1.02 111.772 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 m -148.65 178.58 8.51 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.946 -1.025 . . . . 0.56 109.735 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.27 13.4 t -103.34 137.61 41.22 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 113.366 0.876 . . . . 1.25 113.366 178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -84.14 123.44 30.08 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 124.243 1.017 . . . . 0.29 111.597 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.2 90.82 3.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 112.476 0.547 . . . . 1.42 112.476 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.28 -64.64 3.15 Favored Glycine 0 C--N 1.359 1.816 0 N-CA-C 118.847 2.299 . . . . 0.42 118.847 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.517 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -129.75 158.03 40.52 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.442 1.275 . . . . 1.1 114.442 -176.246 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.517 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -106.98 138.97 42.13 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 113.285 -1.779 . . . . 0.67 109.269 177.032 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.7 t -121.23 143.97 48.86 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 115.567 1.692 . . . . 0.36 115.567 -177.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.421 ' O ' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -116.26 98.2 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.308 -1.367 . . . . 0.74 107.308 175.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -118.29 124.91 48.97 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.334 0.588 . . . . 1.67 112.407 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.0 133.39 56.07 Favored 'General case' 0 C--O 1.252 1.211 0 CA-C-O 122.22 1.009 . . . . 1.8 111.482 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 1.4 t -106.36 143.91 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-N 113.094 -1.867 . . . . 0.58 110.442 -177.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.489 ' H ' ' HD3' ' A' ' 159' ' ' LYS . 0.0 OUTLIER -85.64 150.53 24.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.539 1.311 . . . . 2.18 114.539 -178.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -102.93 -51.78 0.99 Allowed Glycine 0 CA--C 1.542 1.727 0 CA-C-N 115.055 -0.975 . . . . 1.02 113.928 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -129.49 -84.46 0.55 Allowed 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 116.912 0.356 . . . . 2.86 111.739 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.508 ' O ' ' HB2' ' A' ' 163' ' ' ASP . 0.4 OUTLIER -140.64 122.7 15.64 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.984 0.514 . . . . 3.91 110.224 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 162' ' ' TYR . 0.9 OUTLIER 85.54 114.94 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.654 0 C-N-CA 124.975 1.31 . . . . 1.74 111.064 -177.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -82.32 -172.26 0.35 Allowed Pre-proline 0 CA--C 1.574 1.876 0 C-N-CA 124.536 1.134 . . . . 1.68 110.464 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -61.64 101.06 0.2 Allowed 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 122.247 1.965 . . . . 2.06 111.994 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -59.56 -49.42 77.83 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 116.199 1.926 . . . . 3.0 116.199 -174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.527 HG22 ' HB3' ' A' ' 64' ' ' GLU . 25.8 t -108.43 131.88 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.777 -0.823 . . . . 0.8 108.777 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 2.4 t -136.88 124.18 21.89 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.639 -1.164 . . . . 0.87 112.094 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.267 . . -119.84 48.32 1.57 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.897 1.814 . . . . 0.34 115.897 -177.235 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -41.83 135.53 2.28 Favored 'General case' 0 N--CA 1.514 2.759 0 N-CA-C 116.489 2.033 . . . . 0.7 116.489 177.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -152.43 106.42 3.12 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.376 -0.829 . . . . 0.21 110.974 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.429 HD12 HD12 ' A' ' 85' ' ' LEU 0.294 9.9 tt -115.72 122.68 69.96 Favored 'Isoleucine or valine' 0 C--O 1.27 2.15 0 CA-C-O 122.16 0.981 . . . . 0.31 111.147 175.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -120.42 167.83 11.94 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.322 -1.308 . . . . 0.44 111.859 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -118.58 145.63 45.23 Favored 'General case' 0 CA--C 1.56 1.341 0 N-CA-C 117.813 2.523 . . . . 1.26 117.813 -173.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.42 -40.99 2.28 Favored Glycine 0 CA--C 1.542 1.748 0 CA-C-N 110.672 -2.967 . . . . 0.17 120.151 172.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.71 160.92 2.0 Favored 'General case' 0 N--CA 1.518 2.932 0 CA-C-N 121.265 2.533 . . . . 0.15 113.587 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -80.37 -10.06 59.75 Favored 'General case' 0 CA--C 1.583 2.212 0 C-N-CA 124.994 1.318 . . . . 0.17 114.126 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.1 1.64 52.31 Favored 'General case' 0 CA--C 1.573 1.854 0 N-CA-C 114.234 1.198 . . . . 0.55 114.234 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.606 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.5 OUTLIER -107.05 -10.84 15.8 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 113.467 0.914 . . . . 0.6 113.467 179.46 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.0 93.35 0.53 Allowed Pre-proline 0 N--CA 1.507 2.379 0 C-N-CA 124.119 0.968 . . . . 0.95 112.424 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 68.7 Cg_endo -92.75 144.56 2.44 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 122.673 2.249 . . . . 1.8 114.428 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 24.1 mmt -129.38 122.16 28.9 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.825 -0.625 . . . . 4.96 111.785 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -118.28 179.64 4.05 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.985 0.898 . . . . 4.0 112.54 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -105.91 155.97 37.44 Favored Pre-proline 0 CA--C 1.558 1.276 0 CA-C-N 114.91 -1.041 . . . . 6.27 110.539 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -68.96 120.45 7.35 Favored 'Trans proline' 0 C--N 1.393 2.877 0 C-N-CA 122.227 1.951 . . . . 6.59 115.041 -179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -137.71 137.26 21.33 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-N 114.807 -1.088 . . . . 5.51 111.53 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -84.08 -152.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.639 0 C-N-CA 123.363 2.709 . . . . 6.77 113.326 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 166.96 -126.88 1.5 Allowed Glycine 0 C--N 1.341 0.861 0 C-N-CA 120.379 -0.915 . . . . 7.02 114.229 177.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 6.2 mt -118.21 108.55 15.29 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.18 -0.51 . . . . 8.99 111.744 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.334 -0.841 . . . . 10.6 111.017 179.967 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.119 0 N-CA-C 112.486 -0.246 . . . . 8.93 112.486 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.77 -37.7 5.58 Favored 'General case' 0 CA--C 1.565 1.549 0 N-CA-C 112.969 0.729 . . . . 6.82 112.969 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -129.22 106.24 8.7 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 122.624 0.37 . . . . 7.64 111.06 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.4 m -133.7 -67.86 0.59 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.965 -0.561 . . . . 3.86 112.403 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.62 95.25 0.1 OUTLIER Glycine 0 C--N 1.348 1.231 0 C-N-CA 121.312 -0.471 . . . . 1.11 113.271 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.525 ' HG ' HD11 ' A' ' 27' ' ' ILE . 16.9 tp -87.86 -48.72 7.59 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 123.895 0.878 . . . . 0.35 113.036 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.28 -22.91 63.68 Favored 'General case' 0 N--CA 1.508 2.462 0 C-N-CA 125.925 1.69 . . . . 0.2 115.249 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -11.53 51.11 Favored 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 113.792 1.034 . . . . 0.32 113.792 178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -108.9 -19.37 13.42 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 113.728 1.01 . . . . 1.73 113.728 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -55.41 138.26 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.021 0 N-CA-C 115.142 1.534 . . . . 0.11 115.142 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -122.32 -30.33 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 115.717 -0.674 . . . . 0.16 112.44 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 68.0 t90 -162.02 116.29 1.88 Allowed 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 120.815 0.34 . . . . 0.54 111.07 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.07 135.57 35.95 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.397 -0.815 . . . . 0.19 111.526 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . 0.269 5.3 p -148.17 146.15 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 N-CA-C 114.571 1.323 . . . . 1.05 114.571 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.623 ' HB2' HD12 ' A' ' 60' ' ' LEU . 1.9 t-20 -116.9 107.91 15.17 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 114.168 -1.378 . . . . 2.11 108.145 175.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 65' ' ' ARG . . . -76.6 102.11 5.98 Favored 'General case' 0 C--O 1.268 2.078 0 CA-C-O 122.246 1.022 . . . . 0.63 111.668 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.496 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 153.98 -1.66 0.22 Allowed Glycine 0 C--N 1.353 1.5 0 CA-C-N 111.561 -2.563 . . . . 0.71 115.998 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.51 -141.43 3.13 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 118.91 1.355 . . . . 0.8 114.705 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -147.25 116.67 7.01 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 112.485 0.55 . . . . 1.63 112.485 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 2.3 m 35.54 123.18 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.877 0 N-CA-C 121.087 3.736 . . . . 1.0 121.087 177.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.439 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 38.4 t60 -154.2 150.21 27.85 Favored 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.662 0.744 . . . . 0.45 111.768 175.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.56 128.22 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 115.361 -0.836 . . . . 1.39 111.71 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -85.73 153.36 22.38 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 113.994 -1.457 . . . . 1.85 110.157 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.1 m -44.04 -22.77 0.15 Allowed 'Isoleucine or valine' 1 N--CA 1.542 4.173 0 N-CA-C 118.956 2.947 . . . . 0.72 118.956 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.7 m-70 -94.19 -21.55 18.99 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 123.004 0.522 . . . . 0.51 111.103 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.58 39.21 1.12 Allowed Glycine 0 C--N 1.353 1.501 0 C-N-CA 124.4 1.0 . . . . 0.34 114.43 178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.525 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.9 mm -105.98 119.68 55.69 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.662 0 N-CA-C 109.239 -0.652 . . . . 0.55 109.239 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -100.66 130.92 46.77 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.179 1.177 . . . . 1.34 114.179 -177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.662 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -96.33 140.45 30.98 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 114.985 -1.007 . . . . 2.79 110.604 177.398 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -83.6 176.42 9.02 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 115.856 1.798 . . . . 3.0 115.856 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -107.53 96.97 6.78 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 115.83 1.789 . . . . 2.3 115.83 -175.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.7 ' HB3' ' O ' ' A' ' 37' ' ' ARG . 0.4 OUTLIER 46.95 58.6 17.02 Favored Pre-proline 0 N--CA 1.52 3.036 0 N-CA-C 117.701 2.482 . . . . 1.17 117.701 175.678 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -107.73 56.57 0.01 OUTLIER 'Trans proline' 0 CA--C 1.557 1.654 0 C-N-CA 122.62 2.213 . . . . 1.45 115.93 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.73 -87.35 0.33 Allowed 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 116.718 -0.219 . . . . 1.91 111.171 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.434 ' O ' ' HG3' ' A' ' 35' ' ' GLU . 12.6 pt-20 -156.6 88.51 1.06 Allowed 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.107 1.151 . . . . 4.84 114.107 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.3 58.26 Favored Glycine 0 CA--C 1.541 1.717 0 N-CA-C 116.362 1.305 . . . . 2.37 116.362 177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.7 ' O ' ' HB3' ' A' ' 32' ' ' ASP . 4.2 ptp180 -122.81 84.4 2.26 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 117.622 0.711 . . . . 4.5 112.828 -175.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.77 114.3 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.156 0.503 . . . . 2.7 111.761 179.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.25 46.82 3.72 Favored Glycine 0 CA--C 1.544 1.878 0 N-CA-C 115.569 0.988 . . . . 1.95 115.569 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -157.58 118.92 3.61 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 117.862 0.831 . . . . 5.34 112.188 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.26 129.74 54.84 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.689 0.796 . . . . 1.64 110.846 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 12.4 p -115.1 82.62 1.77 Allowed 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.582 0.706 . . . . 1.57 112.062 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -116.56 97.28 5.92 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.094 -0.957 . . . . 2.33 110.253 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -102.73 69.15 1.06 Allowed 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.431 0.634 . . . . 3.16 111.508 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.08 93.86 1.06 Allowed Glycine 0 C--N 1.344 1.022 0 CA-C-N 115.291 -0.868 . . . . 1.52 112.956 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 66.0 mtt -92.4 0.99 57.49 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.22 0.822 . . . . 1.67 113.22 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.89 27.25 3.64 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 114.366 1.247 . . . . 4.18 114.366 -178.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.27 67.93 61.61 Favored Pre-proline 0 CA--C 1.548 0.876 0 N-CA-C 107.434 -1.321 . . . . 2.63 107.434 177.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -77.11 178.03 8.14 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 123.746 2.964 . . . . 1.37 116.053 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.257 1.1 mp -97.18 136.9 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.23 0 CA-C-N 114.6 -1.182 . . . . 0.69 109.726 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.56 ' HB2' HG22 ' A' ' 125' ' ' THR . 5.7 mt -89.73 -12.27 39.89 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 116.381 1.993 . . . . 1.28 116.381 -177.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -100.48 15.86 26.53 Favored 'General case' 0 CA--C 1.567 1.608 0 N-CA-C 113.87 1.063 . . . . 1.51 113.87 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.7 t -132.62 -165.46 1.6 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 123.29 0.636 . . . . 1.09 111.433 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.18 174.09 3.68 Favored Pre-proline 0 N--CA 1.505 2.31 0 C-N-CA 123.087 0.555 . . . . 1.27 111.583 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -70.2 -28.14 23.51 Favored 'Trans proline' 0 C--N 1.401 3.32 0 C-N-CA 123.164 2.576 . . . . 0.95 113.797 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -86.05 -37.22 19.12 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.954 0.902 . . . . 2.04 112.712 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -96.0 8.78 42.77 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.171 1.175 . . . . 1.62 114.171 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -72.75 -26.21 61.47 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 123.751 0.82 . . . . 1.77 110.606 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.1 t -68.86 -50.55 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 C-N-CA 126.458 1.903 . . . . 0.81 108.226 174.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' A' ' 15' ' ' ASN . 7.9 tp -74.39 -9.67 58.82 Favored 'General case' 0 C--N 1.383 2.047 0 N-CA-C 114.013 1.116 . . . . 1.15 114.013 176.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -108.08 1.08 22.1 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 123.336 0.655 . . . . 0.92 110.854 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -128.26 -115.0 0.26 Allowed 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.395 1.078 . . . . 1.33 110.849 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.2 p 35.32 134.16 0.0 OUTLIER 'General case' 1 N--CA 1.56 5.06 0 C-N-CA 128.342 2.657 . . . . 1.28 117.928 -176.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.5 ' HB3' HG12 ' A' ' 167' ' ' VAL . 5.8 pt-20 -113.39 132.95 55.42 Favored 'General case' 0 N--CA 1.516 2.873 0 N-CA-C 116.974 2.213 . . . . 1.53 116.974 -176.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 16' ' ' ALA . 7.5 ttm180 -123.79 95.77 4.7 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.679 -1.23 . . . . 3.22 107.679 175.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -106.46 138.6 42.35 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.94 1.089 . . . . 3.66 113.94 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -120.52 -87.72 0.63 Allowed 'General case' 0 CA--C 1.561 1.391 0 CA-C-N 114.971 -1.013 . . . . 4.7 110.747 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -164.9 -57.35 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 113.751 1.019 . . . . 2.55 113.751 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -170.65 125.0 0.7 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.866 0.466 . . . . 2.15 111.839 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.7 t 66.67 83.7 0.16 Allowed 'General case' 0 N--CA 1.506 2.331 0 C-N-CA 124.907 1.283 . . . . 0.77 113.006 179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -141.92 138.5 32.07 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 121.605 0.717 . . . . 0.81 111.929 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -152.69 -167.63 15.7 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 116.603 1.401 . . . . 0.47 116.603 -177.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.1 172.27 8.68 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 113.499 -1.351 . . . . 0.89 113.986 -177.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -128.22 134.14 48.96 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 114.399 -1.273 . . . . 0.51 112.219 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.32 103.54 22.7 Favored Pre-proline 0 CA--C 1.567 1.607 0 C-N-CA 123.326 0.65 . . . . 0.15 109.499 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -84.57 120.1 2.38 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.233 1.955 . . . . 0.15 114.783 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.84 160.16 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.624 0 CA-C-O 121.977 0.894 . . . . 0.19 111.232 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -149.3 24.05 0.91 Allowed 'General case' 0 CA--C 1.56 1.351 0 CA-C-N 114.748 -1.115 . . . . 2.53 111.867 178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -130.09 161.66 30.54 Favored 'General case' 0 C--N 1.364 1.238 0 CA-C-O 121.296 0.57 . . . . 2.12 111.5 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -120.34 144.33 47.91 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.799 1.037 . . . . 0.42 113.799 -178.821 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.29 -139.53 6.08 Favored Glycine 0 CA--C 1.528 0.862 0 CA-C-N 114.117 -1.401 . . . . 0.23 112.596 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 80.9 mm-40 -113.65 105.0 12.8 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-N 118.092 0.946 . . . . 1.75 110.963 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -99.52 128.27 45.62 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.124 0.488 . . . . 0.21 110.895 -179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -112.34 123.66 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.346 0.593 . . . . 0.2 110.755 -176.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.417 HD12 HD12 ' A' ' 172' ' ' ILE . 2.5 tt -110.27 108.38 18.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.923 -1.035 . . . . 0.78 110.069 178.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.5 t -115.25 132.26 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 114.199 -1.364 . . . . 0.44 108.557 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.21 140.79 47.73 Favored 'General case' 0 C--O 1.247 0.929 0 CA-C-N 115.514 -0.766 . . . . 1.25 112.394 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 15.4 tptt -104.01 113.33 26.8 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 115.043 -0.98 . . . . 2.52 109.657 177.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 11.4 m-85 -106.84 134.68 49.61 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.685 -0.689 . . . . 0.4 111.146 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -141.76 148.05 38.34 Favored 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 121.4 0.619 . . . . 0.41 111.24 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -132.36 117.9 18.71 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-N 116.171 -0.468 . . . . 2.61 111.228 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.08 69.02 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 116.179 -0.464 . . . . 2.13 112.048 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -162.39 -49.11 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.899 0.479 . . . . 2.27 111.995 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -123.14 129.64 51.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 122.711 0.404 . . . . 1.46 111.143 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.83 105.46 15.5 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 122.194 0.997 . . . . 0.84 112.421 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -162.69 144.82 10.58 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.009 -0.996 . . . . 2.45 112.179 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.9 m -122.8 125.68 45.94 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.495 -0.775 . . . . 1.66 112.595 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 70.48 49.75 0.41 Allowed 'General case' 0 N--CA 1.515 2.777 0 C-N-CA 125.553 1.541 . . . . 1.89 112.473 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -148.66 -45.72 0.15 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.679 1.192 . . . . 2.56 109.565 -178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -106.98 87.54 2.53 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.679 -0.86 . . . . 2.76 108.679 177.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.93 120.81 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 CA-C-N 114.048 -1.433 . . . . 0.69 110.743 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.52 ' HE1' ' O ' ' A' ' 163' ' ' ASP . 45.5 m-85 -101.02 177.37 4.97 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.417 1.636 . . . . 0.7 115.417 -175.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -128.21 136.9 51.71 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.214 0.531 . . . . 1.33 111.483 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 t -131.95 126.09 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.448 0 CA-C-N 115.689 -0.687 . . . . 0.48 109.994 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -132.43 151.34 51.92 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 115.083 1.512 . . . . 1.69 115.083 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 154' ' ' SER . 1.2 m -125.08 113.32 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.445 0 C-N-CA 124.357 1.063 . . . . 0.6 112.754 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.539 ' OD1' ' HG ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 64.69 25.85 13.08 Favored 'General case' 0 N--CA 1.525 3.302 0 C-N-CA 126.69 1.996 . . . . 1.12 113.614 -178.326 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 97.99 -3.63 60.52 Favored Glycine 0 CA--C 1.555 2.577 0 CA-C-N 116.168 -0.469 . . . . 0.32 114.099 -176.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 106' ' ' VAL . 86.0 m-70 -99.56 139.61 34.96 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 125.65 1.58 . . . . 0.57 112.951 -178.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.33 130.51 40.61 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.879 0.847 . . . . 0.55 113.075 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.09 -56.64 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 114.0 -1.454 . . . . 1.06 112.606 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.43 88.6 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.242 -1.022 . . . . 0.44 108.242 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -109.17 95.1 5.41 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-O 123.094 1.426 . . . . 2.3 111.964 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 127.96 71.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 129.619 3.168 . . . . 2.48 107.865 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.26 103.41 15.26 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-O 121.863 0.839 . . . . 1.13 112.481 -179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -111.59 94.71 5.1 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 113.538 -1.664 . . . . 2.35 107.647 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -63.52 -28.73 45.6 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.496 0 C-N-CA 125.046 1.339 . . . . 0.68 114.465 -176.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -77.69 -37.08 50.42 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.31 0.644 . . . . 0.77 112.469 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -74.45 -27.13 60.46 Favored 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 124.594 1.158 . . . . 0.91 113.836 177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -86.65 -50.57 6.7 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.455 0.909 . . . . 2.43 113.455 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.282 1.4 p -91.53 -38.76 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.602 2.966 0 N-CA-C 113.383 0.883 . . . . 0.93 113.383 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.37 -78.81 0.25 Allowed Glycine 0 C--N 1.36 1.883 0 CA-C-N 118.444 0.566 . . . . 0.85 114.497 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -102.92 174.75 5.73 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.1 0.96 . . . . 3.18 112.507 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 29.7 m -74.18 81.14 1.79 Allowed 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 113.723 1.009 . . . . 2.08 113.723 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.56 HG22 ' HB2' ' A' ' 51' ' ' LEU . 34.9 p -133.01 -137.49 0.18 Allowed 'General case' 0 CA--C 1.572 1.794 0 CA-C-N 114.441 -1.254 . . . . 0.62 109.032 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -115.01 131.55 56.89 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.046 0.758 . . . . 0.46 113.046 178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.408 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 18.8 t60 -105.48 147.93 27.77 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.446 -0.576 . . . . 0.38 109.446 176.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -142.49 129.86 21.14 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.663 1.357 . . . . 2.5 114.663 -177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -123.77 123.92 41.55 Favored 'General case' 0 C--O 1.248 1.005 0 CA-C-N 114.737 -1.12 . . . . 1.56 110.661 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.49 120.88 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 CA-C-N 114.488 -1.233 . . . . 0.45 110.899 -178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.62 99.99 15.22 Favored Pre-proline 0 CA--C 1.569 1.702 0 CA-C-O 119.024 -0.512 . . . . 0.84 111.976 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -75.05 142.6 27.89 Favored 'Trans proline' 0 C--N 1.398 3.177 0 C-N-CA 123.082 2.521 . . . . 0.16 114.2 176.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -125.17 149.48 29.8 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 CA-C-N 115.125 -0.943 . . . . 0.38 109.971 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.9 t -136.0 117.16 14.44 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.502 0.668 . . . . 1.31 111.365 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.4 mt -113.93 125.5 71.23 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.558 0 CA-C-N 114.713 -1.131 . . . . 0.25 108.286 178.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -138.97 124.33 19.25 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.599 -0.728 . . . . 2.05 110.567 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 67.61 17.1 9.93 Favored 'General case' 0 N--CA 1.517 2.902 0 C-N-CA 125.341 1.456 . . . . 3.55 114.121 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.51 13.18 45.48 Favored Glycine 0 CA--C 1.547 2.038 0 CA-C-O 119.203 -0.776 . . . . 0.37 114.936 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 52.8 mtpt -122.03 147.44 46.08 Favored 'General case' 0 C--N 1.365 1.249 0 CA-C-N 118.378 1.089 . . . . 1.56 112.656 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.99 145.31 29.45 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 114.46 1.281 . . . . 0.34 114.46 -175.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.83 114.32 10.34 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.689 -1.142 . . . . 0.64 109.987 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . 0.262 9.9 p -119.36 95.82 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.446 0 CA-C-O 121.287 0.565 . . . . 0.46 111.357 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 67.88 -85.47 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.752 0 C-N-CA 125.646 1.578 . . . . 1.56 113.757 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -125.25 25.32 5.75 Favored Glycine 0 CA--C 1.543 1.813 0 CA-C-N 116.005 -0.543 . . . . 0.49 112.999 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -125.27 141.18 52.24 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 123.856 0.862 . . . . 1.82 111.376 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 6.6 p -130.7 124.85 57.57 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.132 0 CA-C-N 115.669 -0.696 . . . . 1.02 110.896 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.9 m -150.69 179.86 7.84 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.247 -0.888 . . . . 0.56 109.848 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.269 15.2 t -103.93 137.65 41.62 Favored 'General case' 0 CA--C 1.575 1.938 0 N-CA-C 113.203 0.816 . . . . 1.25 113.203 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -81.82 122.9 28.29 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.112 0.965 . . . . 0.29 111.66 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.95 91.4 3.2 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.707 0.632 . . . . 1.42 112.707 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 78.58 -65.33 3.45 Favored Glycine 0 N--CA 1.483 1.767 0 N-CA-C 118.79 2.276 . . . . 0.42 118.79 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.53 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -132.44 158.45 42.0 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 114.143 1.164 . . . . 1.1 114.143 -176.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.539 ' HG ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -108.26 138.83 43.88 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 113.242 -1.799 . . . . 0.67 109.097 176.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 106' ' ' VAL . 2.6 t -120.5 143.11 48.72 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.301 1.593 . . . . 0.36 115.301 -177.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.62 99.42 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 108.348 -0.982 . . . . 0.74 108.348 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.79 128.37 56.38 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.631 -0.713 . . . . 1.67 112.847 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -118.79 125.81 50.43 Favored 'General case' 0 C--O 1.246 0.891 0 CA-C-O 122.198 0.999 . . . . 1.8 111.103 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.32 144.08 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-N 113.323 -1.762 . . . . 0.58 110.699 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.29 150.28 21.13 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 113.102 0.778 . . . . 2.18 113.102 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -96.69 -32.97 6.31 Favored Glycine 0 CA--C 1.547 2.053 0 N-CA-C 115.937 1.135 . . . . 1.02 115.937 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -123.5 -78.63 0.6 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.977 0.889 . . . . 2.86 112.412 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -133.16 -44.35 0.85 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.113 0.565 . . . . 3.91 112.132 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.52 ' O ' ' HE1' ' A' ' 102' ' ' PHE . 0.5 OUTLIER -94.88 158.08 15.64 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.462 1.105 . . . . 1.74 112.447 179.383 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.74 -166.58 0.1 OUTLIER Pre-proline 0 CA--C 1.576 1.97 0 CA-C-N 113.679 -1.601 . . . . 1.68 108.334 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -62.51 -9.78 16.88 Favored 'Trans proline' 0 N--CA 1.523 3.217 0 CA-C-N 123.277 2.206 . . . . 2.06 115.85 178.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 38.6 tttp 79.65 -76.86 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 126.639 1.976 . . . . 3.0 114.013 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.5 HG12 ' HB3' ' A' ' 64' ' ' GLU 0.259 3.8 m -108.4 135.24 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 CA-C-N 119.678 1.126 . . . . 0.8 111.278 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.437 ' O ' ' ND2' ' A' ' 15' ' ' ASN . 7.5 t -127.8 132.06 49.52 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 113.105 0.78 . . . . 0.87 113.105 -177.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -119.45 49.83 1.31 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 117.212 2.301 . . . . 0.34 117.212 -175.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.27 138.81 2.9 Favored 'General case' 0 N--CA 1.518 2.965 0 N-CA-C 117.039 2.237 . . . . 0.7 117.039 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -154.69 101.99 2.35 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.476 -0.784 . . . . 0.21 111.038 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.417 HD12 HD12 ' A' ' 85' ' ' LEU 0.32 9.0 tt -111.97 121.7 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.169 0 CA-C-O 122.456 1.122 . . . . 0.31 111.369 175.554 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -124.12 164.27 19.79 Favored 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 114.017 -1.447 . . . . 0.44 110.74 179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -121.73 159.21 27.09 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 118.225 2.676 . . . . 1.26 118.225 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.54 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.85 -41.48 2.14 Favored Glycine 0 CA--C 1.54 1.648 0 CA-C-N 110.043 -3.253 . . . . 0.17 118.998 174.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -177.44 154.73 1.03 Allowed 'General case' 0 N--CA 1.518 2.943 0 CA-C-N 120.673 2.236 . . . . 0.15 113.425 -179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -81.14 -12.48 59.22 Favored 'General case' 0 CA--C 1.58 2.124 0 C-N-CA 125.053 1.341 . . . . 0.17 113.896 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.22 4.9 44.06 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.959 1.096 . . . . 0.55 113.959 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.82 -16.22 14.37 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 114.065 1.135 . . . . 0.6 114.065 -179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.75 149.39 74.23 Favored Pre-proline 0 CA--C 1.581 2.146 0 C-N-CA 124.108 0.963 . . . . 0.95 112.851 178.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -61.64 119.53 6.71 Favored 'Trans proline' 0 N--CA 1.521 3.093 0 C-N-CA 125.133 3.889 . . . . 1.8 116.334 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 21.2 mmt -141.92 102.71 4.2 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.788 -0.642 . . . . 4.96 110.819 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.0 mt -136.73 171.66 14.16 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-O 122.114 0.959 . . . . 4.0 112.941 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -106.28 158.04 33.51 Favored Pre-proline 0 CA--C 1.559 1.292 0 CA-C-N 114.497 -1.229 . . . . 6.27 110.71 178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.56 121.85 8.98 Favored 'Trans proline' 0 C--N 1.394 2.937 0 C-N-CA 122.607 2.204 . . . . 6.59 115.23 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -136.33 136.86 23.03 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-N 114.993 -1.003 . . . . 5.51 111.483 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -84.5 -154.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 123.399 2.733 . . . . 6.77 113.779 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 166.15 -129.75 2.0 Favored Glycine 0 C--N 1.341 0.814 0 C-N-CA 120.82 -0.705 . . . . 7.02 113.908 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.2 mt -118.52 112.66 20.2 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.83 0.452 . . . . 8.99 111.656 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.351 -0.833 . . . . 10.6 111.173 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.522 -0.231 . . . . 8.93 112.522 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.84 129.38 55.88 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.545 0.688 . . . . 6.82 111.875 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 41.7 mtm -134.61 114.38 12.7 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.684 -0.689 . . . . 7.64 111.635 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -141.89 115.87 9.3 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.856 -0.611 . . . . 3.86 111.629 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.01 89.41 0.07 OUTLIER Glycine 0 C--N 1.342 0.908 0 CA-C-N 115.923 -0.581 . . . . 1.11 113.204 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.447 ' HG ' HD11 ' A' ' 27' ' ' ILE . 19.3 tp -88.31 -44.34 10.88 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 113.356 0.872 . . . . 0.35 113.356 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.17 -23.38 62.16 Favored 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 125.863 1.665 . . . . 0.2 115.087 176.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.72 -10.35 53.87 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 113.668 0.988 . . . . 0.32 113.668 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -106.07 -22.02 12.98 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 113.315 0.858 . . . . 1.73 113.315 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -53.21 135.65 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.079 0 N-CA-C 115.288 1.588 . . . . 0.11 115.288 177.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.6 -31.68 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-N 115.335 -0.848 . . . . 0.16 112.161 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -159.33 117.46 2.81 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 122.888 0.475 . . . . 0.54 110.751 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.86 128.96 20.87 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.482 -0.761 . . . . 0.19 112.15 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.1 t -144.76 138.68 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 CA-C-O 122.331 1.062 . . . . 1.05 113.183 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -116.17 102.56 9.7 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 113.373 -1.74 . . . . 2.11 106.725 171.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -74.87 103.87 5.26 Favored 'General case' 0 C--O 1.254 1.34 0 CA-C-O 122.21 1.005 . . . . 0.63 111.363 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.419 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 172.54 -57.22 0.16 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 113.153 -1.84 . . . . 0.71 114.937 -179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -104.95 -121.96 5.0 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 119.773 -0.459 . . . . 0.8 113.506 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -165.05 117.81 1.21 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.598 0.759 . . . . 1.63 110.809 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 49.35 110.14 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.959 0 N-CA-C 118.406 2.743 . . . . 1.0 118.406 178.045 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.494 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 70.3 t60 -140.95 132.46 26.96 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 113.026 0.751 . . . . 0.45 113.026 177.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.272 9.8 p -105.95 116.04 48.9 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.881 0 CA-C-N 115.178 -0.919 . . . . 1.39 109.531 176.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -87.62 160.94 17.97 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-N 114.684 -1.143 . . . . 1.85 112.577 -178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -43.17 -32.05 0.55 Allowed 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 N-CA-C 119.163 3.023 . . . . 0.72 119.163 -175.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -88.37 -19.66 26.33 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 121.227 0.537 . . . . 0.51 111.474 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.61 40.13 1.25 Allowed Glycine 0 C--N 1.354 1.551 0 C-N-CA 124.722 1.153 . . . . 0.34 114.009 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.447 HD11 ' HG ' ' A' ' 6' ' ' LEU . 14.7 mm -106.84 114.49 46.08 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.645 0 CA-C-O 121.124 0.487 . . . . 0.55 110.088 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 1.8 t-160 -104.45 132.63 50.49 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 115.587 1.699 . . . . 1.34 115.587 -177.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -92.84 143.83 25.88 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 114.733 -1.121 . . . . 2.79 108.135 174.259 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 78.7 mtp180 -62.42 -105.39 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 116.9 2.185 . . . . 3.0 116.9 -177.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 30' ' ' ARG . 7.0 ttmm 176.23 71.54 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 123.549 0.74 . . . . 2.3 111.712 -177.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 56.98 61.68 6.47 Favored Pre-proline 0 N--CA 1.534 3.732 0 C-N-CA 124.196 0.998 . . . . 1.17 113.677 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -92.69 16.62 1.33 Allowed 'Trans proline' 0 CA--C 1.56 1.776 0 N-CA-C 120.154 3.098 . . . . 1.45 120.154 -174.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.313 0.0 OUTLIER -126.56 -41.33 1.87 Allowed 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 120.505 1.502 . . . . 1.91 114.431 178.203 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -126.89 105.0 8.33 Favored 'General case' 0 C--N 1.354 0.801 0 CA-C-N 119.275 0.943 . . . . 4.84 112.184 179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 111.3 -32.77 6.24 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-N 114.09 -1.414 . . . . 2.37 113.564 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 74.69 -59.83 0.54 Allowed 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 126.679 1.992 . . . . 4.5 114.716 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.08 117.32 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.176 0.59 . . . . 2.7 110.562 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -157.61 -120.09 0.61 Allowed Glycine 0 C--N 1.341 0.855 0 C-N-CA 121.084 -0.579 . . . . 1.95 113.932 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -137.88 -177.36 4.78 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-O 121.889 0.852 . . . . 5.34 112.771 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.09 133.38 40.43 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.207 1.003 . . . . 1.64 111.99 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.2 m -110.37 110.68 21.56 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.525 -0.761 . . . . 1.57 111.046 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.7 103.24 5.15 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 115.721 -0.672 . . . . 2.33 111.347 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -106.47 73.73 0.98 Allowed 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.893 0.854 . . . . 3.16 110.236 178.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 122.51 73.35 0.29 Allowed Glycine 0 C--N 1.344 1.004 0 CA-C-N 114.284 -1.325 . . . . 1.52 110.457 -177.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -92.33 -0.02 57.41 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 115.609 1.707 . . . . 1.67 115.609 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -116.29 57.9 0.76 Allowed 'General case' 0 CA--C 1.554 1.119 0 CA-C-O 121.883 0.849 . . . . 4.18 111.196 178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.31 73.28 9.17 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 114.222 -1.354 . . . . 2.63 107.63 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -67.73 164.09 32.72 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 123.673 2.916 . . . . 1.37 117.048 -177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.4 mp -93.65 143.12 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.201 0 CA-C-N 115.041 -0.981 . . . . 0.69 109.444 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.53 ' HB2' HG22 ' A' ' 125' ' ' THR . 3.9 mm? -78.51 -23.52 46.26 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.463 1.653 . . . . 1.28 115.463 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? -106.27 20.81 18.4 Favored 'General case' 0 CA--C 1.566 1.566 0 N-CA-C 113.917 1.08 . . . . 1.51 113.917 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 96.5 p -124.57 175.97 6.83 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-O 122.057 0.932 . . . . 1.09 112.913 179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.624 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 1.2 m-20 -97.46 -174.8 0.4 Allowed Pre-proline 0 N--CA 1.507 2.377 0 N-CA-C 107.74 -1.208 . . . . 1.27 107.74 176.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -70.16 -40.25 4.89 Favored 'Trans proline' 0 N--CA 1.518 2.946 0 CA-C-N 123.165 2.166 . . . . 0.95 111.871 174.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -69.94 -50.98 36.6 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 113.266 -1.788 . . . . 2.04 111.982 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -75.93 -8.48 57.02 Favored 'General case' 0 CA--C 1.588 2.439 0 CA-C-N 114.789 -1.096 . . . . 1.62 112.81 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.668 HE21 HE21 ' A' ' 62' ' ' GLN . 27.0 tt0 -72.42 -46.32 55.65 Favored 'General case' 0 C--N 1.378 1.835 0 C-N-CA 125.204 1.402 . . . . 1.77 107.962 173.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.12 -41.68 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.249 0 C-N-CA 124.44 1.096 . . . . 0.81 110.417 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 tp -78.93 -11.48 60.0 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 114.428 1.27 . . . . 1.15 114.428 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.7 m-30 -124.82 20.43 8.44 Favored 'General case' 0 CA--C 1.575 1.906 0 C-N-CA 123.332 0.653 . . . . 0.92 112.494 176.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.668 HE21 HE21 ' A' ' 58' ' ' GLN . 0.0 OUTLIER -137.95 -27.82 0.89 Allowed 'General case' 0 N--CA 1.51 2.56 0 N-CA-C 115.876 1.806 . . . . 1.33 115.876 -177.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.2 p -77.94 131.17 37.32 Favored 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 113.66 0.985 . . . . 1.28 113.66 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.419 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.6 pt-20 -118.3 140.28 50.06 Favored 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 115.5 1.667 . . . . 1.53 115.5 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.3 ttp85 -116.13 129.52 56.37 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 114.888 -1.051 . . . . 3.22 111.495 178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -125.56 131.44 52.74 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 116.117 -0.492 . . . . 3.66 111.322 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -134.9 -73.87 0.47 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.285 0.846 . . . . 4.7 113.285 -179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -134.96 -118.56 0.18 Allowed 'General case' 0 CA--C 1.565 1.53 0 N-CA-C 113.124 0.787 . . . . 2.55 113.124 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -155.01 129.0 8.77 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.911 0.885 . . . . 2.15 110.407 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.701 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.1 OUTLIER 74.8 80.86 0.11 Allowed 'General case' 0 N--CA 1.51 2.575 0 C-N-CA 125.397 1.479 . . . . 0.77 109.895 -177.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -142.84 156.51 44.95 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.284 0.846 . . . . 0.81 113.284 -175.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -163.73 -161.16 12.48 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.28 -0.873 . . . . 0.47 115.056 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.32 163.66 28.84 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.782 0.801 . . . . 0.89 112.796 -177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -117.87 131.36 56.55 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 114.603 -1.18 . . . . 0.51 112.791 -178.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -124.5 99.9 35.72 Favored Pre-proline 0 CA--C 1.566 1.588 0 C-N-CA 123.19 0.596 . . . . 0.15 109.742 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -83.26 118.1 2.57 Favored 'Trans proline' 0 C--N 1.373 1.858 0 C-N-CA 122.14 1.894 . . . . 0.15 114.501 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -118.89 157.35 20.61 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.67 0 CA-C-O 122.063 0.935 . . . . 0.19 111.369 -178.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -144.97 16.15 1.56 Allowed 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.538 -1.21 . . . . 2.53 111.954 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -128.29 162.47 26.96 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-O 121.334 0.588 . . . . 2.12 111.754 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -120.95 148.8 43.59 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 113.665 0.987 . . . . 0.42 113.665 -179.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.85 -134.16 3.9 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 113.981 -1.463 . . . . 0.23 111.839 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -121.99 106.66 11.42 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 118.335 1.067 . . . . 1.75 111.231 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.682 ' O ' HG13 ' A' ' 133' ' ' ILE . 36.2 m-85 -99.4 127.8 45.46 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-O 121.623 0.725 . . . . 0.21 110.687 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.4 t -111.67 130.13 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 115.31 -0.859 . . . . 0.2 111.848 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.476 ' HG ' HD12 ' A' ' 172' ' ' ILE . 2.6 mp -107.62 110.26 22.1 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.376 -1.283 . . . . 0.78 110.325 177.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.8 105.52 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.601 -1.259 . . . . 0.44 107.601 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.18 134.97 53.41 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.896 -0.593 . . . . 1.25 112.314 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -104.31 116.01 31.4 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 121.806 0.813 . . . . 2.52 111.343 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -104.67 134.04 48.5 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 114.067 -1.424 . . . . 0.4 110.256 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.97 153.52 45.63 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.745 -0.661 . . . . 0.41 111.627 -179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -139.54 131.58 27.92 Favored 'General case' 0 C--N 1.363 1.175 0 CA-C-N 116.031 -0.532 . . . . 2.61 112.221 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.541 ' H ' ' NZ ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -140.96 63.2 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-N 115.962 -0.563 . . . . 2.13 111.75 179.213 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -162.65 -49.5 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.562 0.579 . . . . 2.27 112.562 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -114.79 130.84 56.92 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.051 0.453 . . . . 1.46 112.212 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.29 96.11 5.93 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-O 122.339 1.066 . . . . 0.84 111.016 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -162.31 146.65 12.18 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.148 -0.933 . . . . 2.45 112.21 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.1 p -122.19 121.22 36.35 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.481 -0.782 . . . . 1.66 111.903 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 75.12 57.26 0.07 Allowed 'General case' 0 N--CA 1.508 2.449 0 C-N-CA 125.893 1.677 . . . . 1.89 112.543 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -156.71 -43.62 0.07 Allowed 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.284 -1.326 . . . . 2.56 108.983 -178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -105.41 83.89 2.02 Favored 'General case' 0 C--N 1.36 1.036 0 CA-C-O 121.794 0.807 . . . . 2.76 108.98 176.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.06 129.95 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 114.754 -1.112 . . . . 0.69 111.63 -177.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -114.37 170.99 7.89 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.065 1.505 . . . . 0.7 115.065 -176.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.37 137.73 54.76 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 121.359 0.6 . . . . 1.33 112.337 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -134.18 129.27 53.51 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.406 0 CA-C-N 115.34 -0.846 . . . . 0.48 110.236 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.64 147.92 51.49 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 114.536 1.31 . . . . 1.69 114.536 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.79 110.27 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 C-N-CA 123.73 0.812 . . . . 0.6 112.93 177.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.83 26.64 14.39 Favored 'General case' 0 N--CA 1.523 3.181 0 C-N-CA 126.614 1.966 . . . . 1.12 113.618 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 104.93 -20.06 39.51 Favored Glycine 0 CA--C 1.547 2.07 0 CA-C-N 116.344 -0.389 . . . . 0.32 113.676 -176.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -83.24 139.04 33.34 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 125.417 1.487 . . . . 0.57 113.673 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.57 129.73 44.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.603 0.715 . . . . 0.55 112.43 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.19 -54.41 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-N 114.501 -1.227 . . . . 1.06 113.355 -178.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.57 88.87 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.878 -0.786 . . . . 0.44 108.878 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -112.29 75.57 0.93 Allowed 'General case' 0 C--N 1.356 0.853 0 CA-C-O 123.709 1.718 . . . . 2.3 112.147 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 157.26 61.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 110.238 -3.165 . . . . 2.48 108.216 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.72 97.88 11.06 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 113.702 1.001 . . . . 1.13 113.702 -178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -113.52 96.54 5.93 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 113.073 -1.876 . . . . 2.35 107.509 175.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.22 -26.06 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.592 2.56 0 N-CA-C 114.632 1.345 . . . . 0.68 114.632 -176.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -75.71 -39.8 56.75 Favored 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 123.576 0.75 . . . . 0.77 112.003 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -74.03 -26.35 60.37 Favored 'General case' 0 CA--C 1.577 1.989 0 C-N-CA 124.776 1.23 . . . . 0.91 113.17 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -77.98 -56.37 4.55 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.651 0.982 . . . . 2.43 113.651 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -97.76 -37.21 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 N-CA-C 114.541 1.311 . . . . 0.93 114.541 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 126.76 -107.62 0.92 Allowed Glycine 0 C--N 1.354 1.528 0 CA-C-N 118.465 0.575 . . . . 0.85 113.426 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -114.95 107.07 14.9 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.588 0.355 . . . . 3.18 110.919 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.1 m 66.69 -127.89 0.21 Allowed 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 125.392 1.477 . . . . 2.08 112.92 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.53 HG22 ' HB2' ' A' ' 51' ' ' LEU . 43.5 p 58.6 -163.32 0.21 Allowed 'General case' 0 N--CA 1.526 3.363 0 C-N-CA 126.365 1.866 . . . . 0.62 115.375 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -109.75 130.19 55.54 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 123.293 0.637 . . . . 0.46 112.69 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -104.44 135.57 45.62 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 109.436 -0.579 . . . . 0.38 109.436 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -129.95 128.42 42.08 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.494 1.294 . . . . 2.5 114.494 -176.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -115.01 118.03 32.27 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-N 114.699 -1.137 . . . . 1.56 110.279 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.21 114.84 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 114.798 -1.092 . . . . 0.45 110.816 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.13 93.12 42.36 Favored Pre-proline 0 CA--C 1.573 1.854 0 CA-C-N 114.928 -1.033 . . . . 0.84 109.994 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -82.82 136.18 8.12 Favored 'Trans proline' 0 C--N 1.389 2.673 0 C-N-CA 122.577 2.185 . . . . 0.16 113.27 176.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.682 HG13 ' O ' ' A' ' 83' ' ' TYR . 0.0 OUTLIER -120.95 149.93 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-O 121.626 0.727 . . . . 0.38 112.228 -179.52 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.1 t -126.1 113.35 16.95 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.079 -0.964 . . . . 1.31 110.959 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.483 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.9 mt -110.94 122.99 66.42 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.605 0 CA-C-N 114.237 -1.347 . . . . 0.25 108.436 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -139.21 126.28 21.16 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.955 -0.566 . . . . 2.05 111.068 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? 67.39 17.26 10.12 Favored 'General case' 0 N--CA 1.516 2.843 0 C-N-CA 125.312 1.445 . . . . 3.55 114.324 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.64 12.68 46.73 Favored Glycine 0 CA--C 1.547 2.041 0 CA-C-O 119.147 -0.807 . . . . 0.37 114.893 -177.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 27.2 mtmt -123.06 148.97 45.01 Favored 'General case' 0 C--N 1.365 1.268 0 CA-C-N 118.35 1.075 . . . . 1.56 112.432 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.19 144.93 30.68 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.635 1.346 . . . . 0.34 114.635 -175.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.51 109.09 8.48 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.903 -1.044 . . . . 0.64 110.445 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.29 92.57 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.627 0 CA-C-N 115.808 -0.633 . . . . 0.46 109.864 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 66.24 -82.1 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.784 0 C-N-CA 125.26 1.424 . . . . 1.56 113.836 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.08 25.03 4.17 Favored Glycine 0 CA--C 1.545 1.969 0 CA-C-N 116.073 -0.512 . . . . 0.49 113.869 178.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -130.48 118.42 21.1 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 117.339 0.569 . . . . 1.82 110.053 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.1 p -105.91 131.45 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.32 0 CA-C-O 121.721 0.772 . . . . 1.02 112.479 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.9 m -151.9 -178.69 6.9 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.776 -1.102 . . . . 0.56 109.624 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.261 12.8 t -103.04 139.11 39.01 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 113.57 0.952 . . . . 1.25 113.57 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -80.83 123.89 28.63 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 124.534 1.134 . . . . 0.29 111.427 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.47 90.49 3.23 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 112.647 0.61 . . . . 1.42 112.647 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 74.69 -61.75 2.43 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 119.412 2.525 . . . . 0.42 119.412 176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.494 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -135.92 157.26 47.28 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.254 1.205 . . . . 1.1 114.254 -176.14 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.494 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 1.0 OUTLIER -103.61 140.05 38.08 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 113.527 -1.67 . . . . 0.67 109.598 176.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.4 t -122.02 132.25 54.42 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.306 1.225 . . . . 0.36 114.306 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.41 97.55 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 106.021 -1.844 . . . . 0.74 106.021 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.0 132.43 56.71 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 114.311 -1.313 . . . . 1.67 113.001 -176.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -121.83 135.93 54.92 Favored 'General case' 0 C--O 1.257 1.451 0 CA-C-O 122.448 1.118 . . . . 1.8 111.735 177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.16 143.58 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.8 0 CA-C-N 112.484 -2.144 . . . . 0.58 110.325 -177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.6 150.11 26.13 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.509 1.3 . . . . 2.18 114.509 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.32 -47.01 1.17 Allowed Glycine 0 CA--C 1.543 1.84 0 CA-C-N 115.196 -0.911 . . . . 1.02 114.035 179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -127.3 -61.07 1.17 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.9 0.48 . . . . 2.86 111.933 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -129.35 -43.57 1.28 Allowed 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.757 0.651 . . . . 3.91 112.757 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -107.92 173.81 6.16 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.509 0.724 . . . . 1.74 112.454 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.701 ' ND2' ' H ' ' A' ' 70' ' ' SER . 0.0 OUTLIER -132.07 -58.27 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.382 0 CA-C-N 115.975 -0.557 . . . . 1.68 109.994 178.638 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -101.56 -55.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 122.089 1.859 . . . . 2.06 115.906 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.541 ' NZ ' ' H ' ' A' ' 92' ' ' VAL . 30.4 tttm 81.56 -90.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 127.076 2.15 . . . . 3.0 109.616 -176.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.3 t -108.89 129.11 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 106.976 -1.491 . . . . 0.8 106.976 173.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.01 123.28 19.36 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 112.98 0.733 . . . . 0.87 112.98 -178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -116.76 49.67 1.14 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 125.637 1.575 . . . . 0.34 113.922 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 4.9 tp -61.47 102.23 0.23 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 122.653 1.216 . . . . 0.7 113.576 -178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -113.78 100.56 8.55 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 112.556 -2.111 . . . . 0.21 110.008 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.476 HD12 ' HG ' ' A' ' 85' ' ' LEU 0.32 15.8 tt -108.34 121.78 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.155 0 CA-C-O 122.942 1.353 . . . . 0.31 111.945 177.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.2 ppp? -121.09 170.47 9.51 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 113.291 -1.777 . . . . 0.44 111.284 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 ptmm? -123.23 158.5 30.73 Favored 'General case' 0 CA--C 1.555 1.168 0 N-CA-C 118.45 2.759 . . . . 1.26 118.45 -176.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.72 -41.95 2.01 Favored Glycine 0 CA--C 1.541 1.688 0 CA-C-N 110.465 -3.061 . . . . 0.17 119.208 173.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -177.21 157.02 1.31 Allowed 'General case' 0 N--CA 1.515 2.816 0 CA-C-N 120.449 2.125 . . . . 0.15 112.942 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.03 -13.54 59.84 Favored 'General case' 0 CA--C 1.58 2.097 0 C-N-CA 124.917 1.287 . . . . 0.17 114.366 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.97 3.52 48.39 Favored 'General case' 0 CA--C 1.573 1.831 0 N-CA-C 113.954 1.094 . . . . 0.55 113.954 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.653 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -106.88 -7.6 17.02 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 113.815 1.043 . . . . 0.6 113.815 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.51 91.51 0.43 Allowed Pre-proline 0 N--CA 1.51 2.544 0 C-N-CA 124.012 0.925 . . . . 0.95 112.804 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.653 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 42.9 Cg_endo -96.14 147.4 1.2 Allowed 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 122.84 2.36 . . . . 1.8 114.447 178.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.25 110.37 6.23 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.217 0.532 . . . . 4.96 111.418 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.47 166.11 23.62 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 122.03 0.919 . . . . 4.0 112.636 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -106.42 161.57 22.43 Favored Pre-proline 0 CA--C 1.56 1.342 0 CA-C-N 114.729 -1.123 . . . . 6.27 110.931 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -68.53 121.3 8.22 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 122.435 2.09 . . . . 6.59 114.489 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 -136.33 134.24 19.84 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-N 115.396 -0.82 . . . . 5.51 111.279 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -84.99 -158.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 123.281 2.654 . . . . 6.77 114.123 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 165.42 98.2 0.12 Allowed Glycine 0 C--N 1.34 0.753 0 C-N-CA 120.997 -0.62 . . . . 7.02 113.216 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 5.7 tp -118.87 114.98 23.45 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 120.987 0.422 . . . . 8.99 111.51 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.261 -0.876 . . . . 10.6 111.058 -179.848 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.551 -0.22 . . . . 8.93 112.551 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.94 -36.61 5.84 Favored 'General case' 0 CA--C 1.565 1.551 0 N-CA-C 113.02 0.748 . . . . 6.82 113.02 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.4 ttt -131.64 106.62 8.28 Favored 'General case' 0 C--N 1.362 1.136 0 CA-C-O 120.932 0.396 . . . . 7.64 110.945 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -137.85 109.47 7.04 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.727 -0.669 . . . . 3.86 111.442 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -175.81 86.53 0.07 OUTLIER Glycine 0 C--N 1.34 0.782 0 CA-C-N 115.649 -0.705 . . . . 1.11 113.023 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.537 ' HG ' HD11 ' A' ' 27' ' ' ILE . 18.1 tp -87.94 -44.35 11.09 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 113.454 0.909 . . . . 0.35 113.454 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.33 63.48 Favored 'General case' 0 N--CA 1.509 2.513 0 C-N-CA 125.766 1.626 . . . . 0.2 115.105 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.06 -11.63 49.71 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 113.577 0.954 . . . . 0.32 113.577 177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -104.15 -23.9 13.23 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 113.298 0.851 . . . . 1.73 113.298 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -52.62 134.79 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.026 0 N-CA-C 115.166 1.543 . . . . 0.11 115.166 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pt -121.83 -29.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 CA-C-N 115.354 -0.839 . . . . 0.16 112.345 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -161.43 116.9 2.09 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 117.698 0.226 . . . . 0.54 111.502 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.42 135.08 31.68 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.258 -0.901 . . . . 0.19 112.503 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.502 ' O ' ' HB2' ' A' ' 170' ' ' LEU 0.25 11.3 p -149.35 142.91 18.2 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 N-CA-C 113.756 1.021 . . . . 1.05 113.756 178.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.602 ' HB2' HD12 ' A' ' 60' ' ' LEU . 65.8 t30 -116.02 117.96 31.56 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 107.198 -1.408 . . . . 2.11 107.198 173.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 64' ' ' GLU . . . -81.73 97.09 7.78 Favored 'General case' 0 C--O 1.253 1.278 0 CA-C-O 121.784 0.802 . . . . 0.63 111.251 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.572 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 173.4 -37.67 0.13 Allowed Glycine 0 C--N 1.353 1.486 0 CA-C-N 114.102 -1.408 . . . . 0.71 116.541 -179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -135.65 -125.6 2.51 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 117.873 0.837 . . . . 0.8 114.318 -178.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.518 ' N ' ' OH ' ' A' ' 29' ' ' TYR . 34.8 mt-10 -150.13 116.34 5.7 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.812 0.445 . . . . 1.63 111.701 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.2 m 31.69 124.28 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.121 0 N-CA-C 121.036 3.717 . . . . 1.0 121.036 177.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.456 ' HB3' ' CD2' ' A' ' 29' ' ' TYR . 23.3 t60 -149.89 148.51 29.22 Favored 'General case' 0 N--CA 1.501 2.078 0 CA-C-O 121.853 0.835 . . . . 0.45 112.092 176.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.2 126.6 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 CA-C-N 114.916 -1.038 . . . . 1.39 111.615 178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -85.27 155.73 21.25 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 114.024 -1.443 . . . . 1.85 110.234 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.5 m -44.8 -23.18 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.537 3.899 0 N-CA-C 118.943 2.942 . . . . 0.72 118.943 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 68.1 m-70 -95.57 -18.43 20.6 Favored 'General case' 0 CA--C 1.564 1.513 0 C-N-CA 122.874 0.47 . . . . 0.51 111.051 176.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.85 41.06 1.23 Allowed Glycine 0 C--N 1.356 1.668 0 C-N-CA 124.643 1.116 . . . . 0.34 114.462 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.537 HD11 ' HG ' ' A' ' 6' ' ' LEU . 17.2 mm -106.06 120.5 57.11 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.672 0 N-CA-C 109.516 -0.55 . . . . 0.55 109.516 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -102.25 129.18 48.59 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 114.256 1.206 . . . . 1.34 114.256 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.623 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -95.3 142.36 27.79 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.299 -0.864 . . . . 2.79 110.596 177.024 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -88.12 168.43 12.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 115.662 1.727 . . . . 3.0 115.662 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -98.91 100.25 11.41 Favored 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 115.19 1.552 . . . . 2.3 115.19 -176.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 36.73 62.46 3.11 Favored Pre-proline 1 N--CA 1.542 4.134 0 N-CA-C 115.85 1.796 . . . . 1.17 115.85 178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -90.02 28.03 0.45 Allowed 'Trans proline' 0 CA--C 1.564 2.016 0 N-CA-C 119.591 2.881 . . . . 1.45 119.591 -175.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER -142.25 -15.22 0.77 Allowed 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.429 1.27 . . . . 1.91 114.429 176.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -103.51 55.45 0.74 Allowed 'General case' 0 CA--C 1.563 1.463 0 CA-C-N 118.863 0.756 . . . . 4.84 112.808 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 37' ' ' ARG . . . 111.52 -28.69 9.3 Favored Glycine 0 CA--C 1.542 1.76 0 N-CA-C 114.488 0.555 . . . . 2.37 114.488 -179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 36' ' ' GLY . 2.0 mpp_? 81.7 67.8 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 126.014 1.725 . . . . 4.5 112.528 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.3 p -148.42 176.93 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.593 2.614 0 CA-C-N 115.115 -0.948 . . . . 2.7 110.108 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -113.0 103.58 1.43 Allowed Glycine 0 C--N 1.349 1.27 0 O-C-N 122.094 -0.378 . . . . 1.95 113.931 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -144.07 128.54 17.99 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-O 121.164 0.507 . . . . 5.34 111.698 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.2 141.34 38.65 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.428 0.691 . . . . 1.64 111.806 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 43' ' ' ASP . 3.2 m -120.32 -62.0 1.52 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.976 0.732 . . . . 1.57 112.976 -179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 42' ' ' SER . 0.4 OUTLIER 84.28 -81.06 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.422 0 C-N-CA 125.386 1.475 . . . . 2.33 113.041 -179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 70.82 55.45 0.24 Allowed 'General case' 0 N--CA 1.513 2.689 0 C-N-CA 125.533 1.533 . . . . 3.16 112.615 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 122.44 81.42 0.57 Allowed Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.04 -0.982 . . . . 1.52 110.786 -177.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.12 0.22 57.46 Favored 'General case' 0 CA--C 1.56 1.339 0 N-CA-C 115.326 1.602 . . . . 1.67 115.326 -177.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -117.15 39.16 3.32 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-O 121.504 0.669 . . . . 4.18 112.432 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 mt -146.09 74.66 13.07 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.587 1.155 . . . . 2.63 107.979 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.82 176.73 9.53 Favored 'Trans proline' 0 C--N 1.385 2.498 0 C-N-CA 123.284 2.656 . . . . 1.37 116.335 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 61' ' ' TYR 0.251 1.2 mp -89.74 135.64 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.823 0 C-N-CA 124.037 0.935 . . . . 0.69 111.711 -178.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 5.1 mt -104.84 101.93 11.5 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.901 -1.045 . . . . 1.28 111.305 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.514 ' HB2' ' O ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER 150.12 -22.1 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.205 1.802 . . . . 1.51 110.891 -178.42 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.657 ' HG ' ' HD2' ' A' ' 61' ' ' TYR . 2.3 t -101.27 -160.85 0.82 Allowed 'General case' 0 CA--C 1.575 1.929 0 C-N-CA 123.555 0.742 . . . . 1.09 113.0 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.425 ' O ' ' HB3' ' A' ' 58' ' ' GLN . 1.0 OUTLIER -95.51 170.32 7.95 Favored Pre-proline 0 CA--C 1.573 1.838 0 C-N-CA 124.736 1.214 . . . . 1.27 112.569 -179.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -71.98 -34.82 7.99 Favored 'Trans proline' 0 C--N 1.398 3.155 0 C-N-CA 123.25 2.633 . . . . 0.95 112.835 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -85.25 -36.36 20.97 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 114.517 -1.22 . . . . 2.04 112.703 178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.22 1.59 56.31 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.737 1.384 . . . . 1.62 114.737 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.581 ' O ' ' HB3' ' A' ' 62' ' ' GLN . 3.5 pt20 -71.19 -24.4 62.22 Favored 'General case' 0 C--N 1.381 1.945 0 O-C-N 121.822 -0.549 . . . . 1.77 110.369 175.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.35 -47.29 92.66 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.872 0 C-N-CA 125.957 1.703 . . . . 0.81 108.853 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.602 HD12 ' HB2' ' A' ' 15' ' ' ASN . 14.1 tp -73.99 -12.85 60.76 Favored 'General case' 0 CA--C 1.578 2.029 0 N-CA-C 113.435 0.902 . . . . 1.15 113.435 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.657 ' HD2' ' HG ' ' A' ' 53' ' ' SER . 26.4 m-85 -122.47 20.53 10.37 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 113.557 0.947 . . . . 0.92 113.557 177.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.581 ' HB3' ' O ' ' A' ' 58' ' ' GLN . 12.1 tt0 -141.35 -36.48 0.44 Allowed 'General case' 0 N--CA 1.511 2.603 0 N-CA-C 115.474 1.657 . . . . 1.33 115.474 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.2 p -67.81 134.69 51.38 Favored 'General case' 0 N--CA 1.528 3.449 0 N-CA-C 115.272 1.582 . . . . 1.28 115.272 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.572 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 5.8 pt-20 -128.93 147.5 50.84 Favored 'General case' 0 N--CA 1.505 2.285 0 C-N-CA 124.195 0.998 . . . . 1.53 112.479 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.41 ' HG3' ' N ' ' A' ' 17' ' ' GLY . 32.7 mtm105 -89.13 -90.68 0.13 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 112.809 0.67 . . . . 3.22 112.809 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -153.94 166.64 32.34 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.223 0.609 . . . . 3.66 110.968 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.597 ' ND2' ' H ' ' A' ' 164' ' ' ASN . 8.6 m120 -116.6 131.01 57.06 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.158 0.799 . . . . 4.7 113.158 -178.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -133.81 -109.37 0.23 Allowed 'General case' 0 CA--C 1.56 1.335 0 CA-C-N 115.634 -0.712 . . . . 2.55 111.028 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -166.05 122.36 1.32 Allowed 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 118.364 0.529 . . . . 2.15 111.334 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.24 85.01 0.09 Allowed 'General case' 0 N--CA 1.511 2.594 0 C-N-CA 125.555 1.542 . . . . 0.77 114.397 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -143.52 152.94 42.08 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.531 0.682 . . . . 0.81 112.242 -178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.24 -153.21 7.44 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 115.653 1.021 . . . . 0.47 115.653 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -133.79 166.62 22.22 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 115.037 1.495 . . . . 0.89 115.037 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -125.93 119.32 27.43 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 113.585 -1.643 . . . . 0.51 111.144 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.48 100.36 53.49 Favored Pre-proline 0 CA--C 1.568 1.645 0 N-CA-C 109.581 -0.526 . . . . 0.15 109.581 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -82.93 116.66 2.5 Favored 'Trans proline' 0 CA--C 1.563 1.926 0 C-N-CA 122.25 1.967 . . . . 0.15 115.103 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.6 157.46 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.926 0.869 . . . . 0.19 111.038 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -143.27 24.01 1.8 Allowed 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 114.648 -1.16 . . . . 2.53 112.084 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -127.84 157.36 40.67 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 121.347 0.594 . . . . 2.12 111.134 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -117.73 136.65 53.22 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.713 1.005 . . . . 0.42 113.713 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 166.55 -140.17 6.18 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 113.962 -1.472 . . . . 0.23 112.569 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 23.8 mt-10 -112.36 109.02 18.4 Favored 'General case' 0 C--N 1.362 1.111 0 CA-C-N 118.473 1.136 . . . . 1.75 111.627 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -103.52 129.77 50.77 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.048 0.451 . . . . 0.21 110.521 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.0 t -111.69 121.72 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 CA-C-O 121.864 0.84 . . . . 0.2 110.795 -176.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.402 ' HG ' HD12 ' A' ' 172' ' ' ILE . 0.3 OUTLIER -100.0 105.59 17.28 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 113.931 -1.486 . . . . 0.78 109.572 177.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 t -111.9 124.96 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 108.8 -0.815 . . . . 0.44 108.8 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.94 140.2 43.82 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 112.735 0.643 . . . . 1.25 112.735 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 0.3 OUTLIER -102.87 120.39 40.52 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.039 -0.982 . . . . 2.52 110.133 177.163 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -105.82 133.27 50.83 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.106 -0.497 . . . . 0.4 110.392 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -136.37 152.32 50.51 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 112.549 0.574 . . . . 0.41 112.549 -178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -138.71 119.64 14.35 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 123.662 0.785 . . . . 2.61 111.102 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.18 65.33 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 112.597 0.592 . . . . 2.13 112.597 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -171.3 -37.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 112.982 0.734 . . . . 2.27 112.982 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -115.94 130.81 56.98 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.226 0.454 . . . . 1.46 112.226 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -111.27 96.93 6.42 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-O 122.43 1.11 . . . . 0.84 111.474 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.4 ' NE2' ' NE2' ' A' ' 99' ' ' GLN . 3.4 pt20 -165.37 141.43 5.38 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 114.968 -1.014 . . . . 2.45 112.323 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.5 m -122.41 124.93 44.79 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.382 -0.826 . . . . 1.66 112.436 -179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 72.59 54.95 0.15 Allowed 'General case' 0 N--CA 1.514 2.725 0 C-N-CA 125.713 1.605 . . . . 1.89 112.523 -179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.4 ' NE2' ' NE2' ' A' ' 96' ' ' GLN . 4.4 tt0 -157.31 -38.43 0.07 Allowed 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.803 -1.089 . . . . 2.56 109.974 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -106.9 81.79 1.61 Allowed 'General case' 0 C--N 1.362 1.152 0 N-CA-C 108.384 -0.969 . . . . 2.76 108.384 177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.88 122.76 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 CA-C-N 114.331 -1.304 . . . . 0.69 111.306 -177.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -106.57 175.73 5.4 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 115.572 1.693 . . . . 0.7 115.572 -175.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -126.03 137.27 53.64 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.343 0.592 . . . . 1.33 110.941 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.21 123.76 56.57 Favored 'Isoleucine or valine' 0 CA--C 1.59 2.511 0 CA-C-N 115.237 -0.892 . . . . 0.48 109.366 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.644 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 26.3 mtt180 -123.26 148.64 45.68 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.981 1.475 . . . . 1.69 114.981 -176.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 6.4 m -123.81 107.8 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.583 0 N-CA-C 113.437 0.903 . . . . 0.6 113.437 177.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.587 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 7.9 t30 63.81 27.32 14.56 Favored 'General case' 0 N--CA 1.519 2.988 0 C-N-CA 126.845 2.058 . . . . 1.12 114.456 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.87 -14.86 45.06 Favored Glycine 0 CA--C 1.55 2.264 0 CA-C-N 115.574 -0.739 . . . . 0.32 113.612 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.644 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 94.6 m-70 -87.49 171.15 10.74 Favored 'General case' 0 C--N 1.361 1.088 0 C-N-CA 125.953 1.701 . . . . 0.57 113.166 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.01 132.72 54.67 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-O 121.546 0.689 . . . . 0.55 112.015 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.61 -58.96 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 CA-C-N 114.82 -1.082 . . . . 1.06 113.324 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.22 89.49 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.627 -0.879 . . . . 0.44 108.627 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -106.97 101.51 10.93 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 122.881 1.324 . . . . 2.3 110.283 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 114.25 74.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 110.542 -3.026 . . . . 2.48 108.898 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.2 105.8 18.01 Favored 'General case' 0 C--N 1.361 1.084 0 CA-C-O 121.612 0.72 . . . . 1.13 112.593 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -115.07 97.4 6.19 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 106.678 -1.601 . . . . 2.35 106.678 175.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -67.06 -26.77 37.42 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.479 0 N-CA-C 114.028 1.122 . . . . 0.68 114.028 -176.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -76.22 -38.83 55.93 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.629 0.771 . . . . 0.77 112.095 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -72.95 -26.74 61.48 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 124.847 1.259 . . . . 0.91 113.296 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -80.5 -56.25 4.3 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 113.767 1.025 . . . . 2.43 113.767 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.73 -36.04 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.576 0 N-CA-C 114.592 1.33 . . . . 0.93 114.592 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 124.2 -110.04 1.37 Allowed Glycine 0 C--N 1.354 1.581 0 CA-C-N 118.35 0.523 . . . . 0.85 113.417 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -114.84 107.46 15.45 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 120.841 0.353 . . . . 3.18 110.243 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 69.42 -133.69 0.07 Allowed 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 125.345 1.458 . . . . 2.08 112.614 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.3 p 62.15 -163.38 0.26 Allowed 'General case' 0 N--CA 1.529 3.491 0 C-N-CA 126.222 1.809 . . . . 0.62 114.578 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -113.8 130.94 56.4 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 112.899 0.703 . . . . 0.46 112.899 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -101.66 147.21 26.71 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.262 -0.644 . . . . 0.38 109.262 176.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -134.6 124.68 25.79 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.994 1.479 . . . . 2.5 114.994 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -124.18 121.91 36.38 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-N 115.247 -0.888 . . . . 1.56 110.305 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.83 128.48 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 114.27 -1.332 . . . . 0.45 111.545 -178.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -134.21 93.77 19.03 Favored Pre-proline 0 CA--C 1.575 1.914 0 CA-C-N 115.637 -0.711 . . . . 0.84 111.187 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -76.55 133.3 14.19 Favored 'Trans proline' 0 C--N 1.395 2.997 0 C-N-CA 122.672 2.248 . . . . 0.16 113.103 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -115.62 148.81 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.592 0 CA-C-N 115.553 -0.749 . . . . 0.38 111.474 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.8 p -130.52 107.16 9.01 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.392 -0.822 . . . . 1.31 111.82 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 2.9 mt -109.65 121.71 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 N-CA-C 108.518 -0.919 . . . . 0.25 108.518 178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -143.1 130.72 21.29 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 115.681 -0.69 . . . . 2.05 110.964 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp 69.8 7.87 6.44 Favored 'General case' 0 N--CA 1.519 3.016 0 N-CA-C 114.684 1.364 . . . . 3.55 114.684 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 99.14 22.22 13.63 Favored Glycine 0 CA--C 1.548 2.128 0 C-N-CA 123.633 0.635 . . . . 0.37 113.802 -177.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -130.52 144.83 51.66 Favored 'General case' 0 C--N 1.366 1.299 0 CA-C-N 117.548 0.674 . . . . 1.56 112.128 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.75 141.11 32.99 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.912 1.078 . . . . 0.34 113.912 -177.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.0 m -130.97 115.36 16.4 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 114.664 -1.153 . . . . 0.64 110.656 178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.45 95.14 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.372 0 CA-C-O 121.101 0.477 . . . . 0.46 110.728 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 67.26 -85.24 0.03 OUTLIER 'General case' 0 N--CA 1.515 2.793 0 C-N-CA 125.546 1.538 . . . . 1.56 113.558 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -128.36 27.74 4.41 Favored Glycine 0 CA--C 1.542 1.756 0 CA-C-N 116.011 -0.541 . . . . 0.49 113.404 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -131.38 128.4 39.52 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.444 0.698 . . . . 1.82 110.77 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 8.8 p -118.29 130.01 73.76 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.343 0 CA-C-O 121.333 0.587 . . . . 1.02 111.185 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.8 m -149.85 -170.63 3.69 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.487 -0.778 . . . . 0.56 110.446 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 11.4 t -101.76 141.42 34.65 Favored 'General case' 0 CA--C 1.572 1.811 0 N-CA-C 112.792 0.664 . . . . 1.25 112.792 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -87.91 132.63 34.14 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-O 121.985 0.898 . . . . 0.29 111.815 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 5.9 p -97.34 -164.3 1.13 Allowed 'General case' 0 CA--C 1.565 1.531 0 CA-C-N 114.046 -1.433 . . . . 1.42 109.395 177.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -83.59 7.52 68.79 Favored Glycine 0 CA--C 1.56 2.876 0 N-CA-C 116.937 1.535 . . . . 0.42 116.937 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.439 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.1 OUTLIER -160.11 152.53 20.86 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-O 121.7 0.762 . . . . 1.1 111.421 178.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.587 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -109.3 136.09 49.32 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 114.307 -1.315 . . . . 0.67 109.236 177.405 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.5 t -117.82 144.11 45.67 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.671 1.73 . . . . 0.36 115.671 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.1 t -118.44 97.58 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.087 -1.82 . . . . 0.74 106.087 176.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -114.12 121.48 43.93 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 115.905 -0.589 . . . . 1.67 112.46 -177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.73 132.1 56.55 Favored 'General case' 0 C--O 1.25 1.131 0 CA-C-O 122.062 0.934 . . . . 1.8 111.238 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 14.0 t -107.25 143.74 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.991 0 CA-C-N 113.341 -1.754 . . . . 0.58 110.01 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.508 ' HG3' ' O ' ' A' ' 163' ' ' ASP . 34.4 ttpt -71.49 149.98 45.3 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.939 1.696 . . . . 2.18 114.665 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -105.1 -55.26 0.73 Allowed Glycine 0 CA--C 1.542 1.778 0 CA-C-N 115.26 -0.882 . . . . 1.02 114.378 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -130.18 -71.34 0.6 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.301 0.551 . . . . 2.86 112.306 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -118.36 -44.7 2.66 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.513 0.561 . . . . 3.91 112.513 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.508 ' O ' ' HG3' ' A' ' 159' ' ' LYS . 0.8 OUTLIER -98.99 171.24 8.17 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.773 0.829 . . . . 1.74 111.46 178.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.597 ' H ' ' ND2' ' A' ' 67' ' ' ASN 0.285 56.7 t-20 -125.75 -93.15 0.0 OUTLIER Pre-proline 0 CA--C 1.589 2.451 0 CA-C-O 116.715 -1.612 . . . . 1.68 109.993 -179.209 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -87.1 -36.57 0.1 OUTLIER 'Trans proline' 0 C--N 1.389 2.686 0 CA-C-N 124.851 2.768 . . . . 2.06 114.757 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 18.2 tptm 80.29 -87.32 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 126.2 1.8 . . . . 3.0 110.543 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.534 HG22 ' HB3' ' A' ' 64' ' ' GLU . 36.2 t -115.2 131.5 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 N-CA-C 107.358 -1.349 . . . . 0.8 107.358 175.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 1.1 t -136.21 124.96 23.87 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.489 -0.778 . . . . 0.87 112.196 -178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.457 ' HB3' ' HB3' ' A' ' 88' ' ' LYS . . . -115.27 51.46 0.92 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 116.366 1.988 . . . . 0.34 116.366 -176.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 14' ' ' VAL . 2.8 mm? -43.65 131.54 5.19 Favored 'General case' 0 N--CA 1.519 2.999 0 N-CA-C 116.368 1.988 . . . . 0.7 116.368 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -154.45 104.04 2.54 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.825 -0.625 . . . . 0.21 110.283 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.402 HD12 ' HG ' ' A' ' 85' ' ' LEU 0.307 6.2 tt -114.47 123.11 69.83 Favored 'Isoleucine or valine' 0 C--O 1.268 2.064 0 CA-C-O 122.125 0.964 . . . . 0.31 111.825 176.076 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -119.53 168.19 11.24 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.191 -1.368 . . . . 0.44 112.17 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -118.48 146.42 44.52 Favored 'General case' 0 CA--C 1.559 1.326 0 N-CA-C 118.06 2.615 . . . . 1.26 118.06 -173.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.69 -41.02 2.26 Favored Glycine 0 CA--C 1.54 1.613 0 CA-C-N 110.605 -2.998 . . . . 0.17 120.264 172.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.45 159.5 1.95 Allowed 'General case' 0 N--CA 1.517 2.904 0 CA-C-N 120.951 2.375 . . . . 0.15 113.239 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -77.73 -14.17 59.68 Favored 'General case' 0 CA--C 1.582 2.185 0 C-N-CA 124.784 1.234 . . . . 0.17 114.227 177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.02 2.6 51.43 Favored 'General case' 0 CA--C 1.572 1.793 0 N-CA-C 113.957 1.095 . . . . 0.55 113.957 177.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.62 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.6 OUTLIER -101.8 -8.73 21.42 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.761 1.023 . . . . 0.6 113.761 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.78 90.87 0.45 Allowed Pre-proline 0 N--CA 1.507 2.386 0 C-N-CA 124.035 0.934 . . . . 0.95 112.576 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.62 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 45.0 Cg_endo -94.59 149.37 1.84 Allowed 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.742 2.294 . . . . 1.8 114.37 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 22.9 mmt -132.18 107.99 8.96 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.018 -0.537 . . . . 4.96 111.436 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.1 mt -134.45 173.84 11.2 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 122.196 0.998 . . . . 4.0 112.584 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -109.61 156.81 39.02 Favored Pre-proline 0 CA--C 1.558 1.267 0 CA-C-N 114.548 -1.205 . . . . 6.27 110.633 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.03 122.99 10.13 Favored 'Trans proline' 0 C--N 1.392 2.821 0 C-N-CA 122.626 2.217 . . . . 6.59 114.717 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.419 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 21.5 t60 -133.87 129.82 20.34 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-N 115.113 -0.949 . . . . 5.51 112.028 -178.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.419 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 8.2 Cg_endo -89.05 -157.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.691 0 C-N-CA 123.057 2.504 . . . . 6.77 113.468 177.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 169.24 91.79 0.08 OUTLIER Glycine 0 C--N 1.34 0.761 0 C-N-CA 121.122 -0.561 . . . . 7.02 113.044 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.5 tp -118.9 114.67 22.97 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 120.875 0.369 . . . . 8.99 111.763 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.218 -0.896 . . . . 10.6 110.979 179.717 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.57 -0.212 . . . . 8.93 112.57 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.9 128.42 56.14 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.542 0.686 . . . . 6.82 111.954 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.0 tpt -144.12 95.74 2.77 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.83 -0.623 . . . . 7.64 110.885 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m -146.75 112.73 5.76 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.92 -0.582 . . . . 3.86 111.498 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -170.34 -62.26 0.04 OUTLIER Glycine 0 C--N 1.341 0.812 0 CA-C-N 115.758 -0.655 . . . . 1.11 113.777 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.649 ' HG ' HD11 ' A' ' 27' ' ' ILE . 29.2 tp -85.26 -40.89 16.09 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.076 0.55 . . . . 0.35 112.116 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.05 -22.91 67.18 Favored 'General case' 0 CA--C 1.583 2.248 0 C-N-CA 125.663 1.585 . . . . 0.2 114.029 175.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.9 -11.9 49.32 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 113.606 0.965 . . . . 0.32 113.606 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 31.2 mttm -108.16 -19.33 13.52 Favored 'General case' 0 C--N 1.364 1.233 0 N-CA-C 113.716 1.006 . . . . 1.73 113.716 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.9 p -54.32 136.65 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.866 0 N-CA-C 114.967 1.469 . . . . 0.11 114.967 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.76 -31.33 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-N 115.295 -0.866 . . . . 0.16 111.998 178.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -161.05 119.53 2.47 Favored 'General case' 0 CA--C 1.552 1.054 0 N-CA-C 111.954 0.353 . . . . 0.54 111.954 -178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 29' ' ' TYR . . . -139.81 129.66 24.72 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.673 -0.642 . . . . 0.19 111.366 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.61 140.75 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-O 121.764 0.793 . . . . 1.05 112.524 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.591 ' HB2' HD12 ' A' ' 60' ' ' LEU . 3.0 t-20 -114.43 110.24 19.55 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 106.599 -1.63 . . . . 2.11 106.599 172.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.565 ' HA ' ' HE ' ' A' ' 65' ' ' ARG . . . -75.53 94.63 3.18 Favored 'General case' 0 C--O 1.274 2.386 0 CA-C-O 122.217 1.008 . . . . 0.63 110.859 179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.455 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 159.27 -0.08 0.08 OUTLIER Glycine 0 C--N 1.362 2.008 0 CA-C-N 110.943 -2.844 . . . . 0.71 117.983 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.52 -136.22 1.97 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-N 120.635 2.218 . . . . 0.8 117.273 -179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -129.09 134.75 48.21 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 113.861 -1.17 . . . . 1.63 111.218 -178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 26.2 m -14.14 122.28 0.01 OUTLIER 'General case' 0 N--CA 1.518 2.958 0 N-CA-C 119.556 3.169 . . . . 1.0 119.556 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 34.6 t60 -140.83 141.91 34.65 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.132 0.968 . . . . 0.45 112.446 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.259 10.0 p -106.01 119.4 55.27 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 CA-C-N 114.063 -1.426 . . . . 1.39 110.36 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -86.72 169.04 13.0 Favored 'General case' 0 N--CA 1.484 1.27 0 CA-C-N 114.77 -1.105 . . . . 1.85 113.451 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -39.61 -52.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.521 3.085 0 C-N-CA 129.222 3.009 . . . . 0.72 117.458 -174.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.432 ' HB2' HD23 ' A' ' 6' ' ' LEU . 63.1 m-70 -75.82 -20.59 58.05 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 112.888 0.699 . . . . 0.51 112.888 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 113.8 44.36 0.76 Allowed Glycine 0 C--N 1.355 1.625 0 N-CA-C 115.194 0.838 . . . . 0.34 115.194 176.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.649 HD11 ' HG ' ' A' ' 6' ' ' LEU . 33.5 mm -108.51 125.12 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 N-CA-C 110.088 -0.338 . . . . 0.55 110.088 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -108.35 128.09 54.46 Favored 'General case' 0 CA--C 1.555 1.164 0 N-CA-C 114.461 1.282 . . . . 1.34 114.461 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -94.24 150.1 20.62 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 124.419 1.088 . . . . 2.79 110.604 177.366 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -105.88 147.3 28.88 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.574 1.324 . . . . 3.0 114.574 -177.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -68.76 108.44 3.42 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 117.535 2.42 . . . . 2.3 117.535 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.53 ' HB3' ' O ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER 39.85 54.42 5.9 Favored Pre-proline 0 N--CA 1.525 3.316 0 N-CA-C 118.767 2.877 . . . . 1.17 118.767 175.077 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 32' ' ' ASP . 0.5 OUTLIER -106.59 65.12 0.02 OUTLIER 'Trans proline' 0 CA--C 1.566 2.113 0 C-N-CA 123.014 2.476 . . . . 1.45 116.174 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.3 mt -98.26 -83.32 0.41 Allowed 'General case' 0 N--CA 1.485 1.306 0 O-C-N 121.901 -0.5 . . . . 1.91 111.029 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -148.35 60.19 1.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 113.021 0.748 . . . . 4.84 113.021 -179.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 105.35 1.28 40.95 Favored Glycine 0 CA--C 1.542 1.727 0 N-CA-C 115.804 1.082 . . . . 2.37 115.804 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.53 ' O ' ' HB3' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -96.92 72.44 2.54 Favored 'General case' 0 C--N 1.358 0.944 0 CA-C-N 117.806 0.803 . . . . 4.5 112.959 -178.368 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.22 116.8 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-N 115.455 -0.793 . . . . 2.7 111.377 179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 137.58 -58.18 0.64 Allowed Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.587 -0.733 . . . . 1.95 113.403 -179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -118.49 135.25 54.49 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.372 0.606 . . . . 5.34 112.183 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.2 -40.92 10.19 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 113.662 0.986 . . . . 1.64 113.662 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.6 m 78.7 81.54 0.07 Allowed 'General case' 0 N--CA 1.5 2.05 0 C-N-CA 125.392 1.477 . . . . 1.57 112.471 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -95.58 91.41 6.13 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.294 0.637 . . . . 2.33 112.189 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -110.96 74.23 0.86 Allowed 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.931 0.872 . . . . 3.16 110.526 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.14 60.52 0.05 OUTLIER Glycine 0 CA--C 1.529 0.959 0 CA-C-N 114.088 -1.415 . . . . 1.52 111.605 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.19 -24.41 19.06 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.84 1.052 . . . . 1.67 113.84 -179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -103.39 61.16 0.77 Allowed 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 122.429 1.109 . . . . 4.18 110.883 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -169.92 70.66 0.63 Allowed Pre-proline 0 CA--C 1.541 0.626 0 CA-C-N 113.316 -1.765 . . . . 2.63 107.252 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -66.44 164.69 27.53 Favored 'Trans proline' 0 C--N 1.389 2.665 0 C-N-CA 124.022 3.148 . . . . 1.37 116.317 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.295 1.2 mp -86.84 121.05 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.159 0 CA-C-O 121.818 0.818 . . . . 0.69 109.866 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.534 ' HB2' HG22 ' A' ' 125' ' ' THR . 4.7 mt -76.67 -14.47 59.96 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 117.191 2.293 . . . . 1.28 117.191 -175.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -99.96 15.73 26.2 Favored 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 113.151 0.797 . . . . 1.51 113.151 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.501 ' HG ' ' HD2' ' A' ' 61' ' ' TYR . 1.9 t -132.31 -159.58 0.98 Allowed 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 121.659 0.742 . . . . 1.09 111.773 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.11 168.75 9.72 Favored Pre-proline 0 CA--C 1.569 1.706 0 C-N-CA 125.11 1.364 . . . . 1.27 113.077 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -72.58 -30.29 12.25 Favored 'Trans proline' 0 C--N 1.394 2.973 0 C-N-CA 123.266 2.644 . . . . 0.95 113.34 176.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -85.32 -38.54 18.68 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.685 1.194 . . . . 2.04 112.272 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.39 1.83 56.84 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 114.574 1.324 . . . . 1.62 114.574 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -68.36 -30.11 68.98 Favored 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 123.964 0.906 . . . . 1.77 110.999 176.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.3 t -61.37 -48.17 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.035 0 C-N-CA 126.03 1.732 . . . . 0.81 109.054 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' ' 15' ' ' ASN . 17.6 tp -71.54 -13.34 61.77 Favored 'General case' 0 CA--C 1.578 2.024 0 N-CA-C 113.952 1.093 . . . . 1.15 113.952 177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.501 ' HD2' ' HG ' ' A' ' 53' ' ' SER . 29.4 m-85 -123.23 21.69 9.56 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 113.233 0.827 . . . . 0.92 113.233 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -142.5 -32.72 0.49 Allowed 'General case' 0 N--CA 1.513 2.679 0 N-CA-C 116.03 1.863 . . . . 1.33 116.03 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.409 ' C ' ' HA3' ' A' ' 17' ' ' GLY . 17.8 p -70.98 136.68 48.55 Favored 'General case' 0 N--CA 1.535 3.807 0 N-CA-C 115.008 1.485 . . . . 1.28 115.008 -177.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.455 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 1.3 pt-20 -123.0 145.64 48.32 Favored 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 115.662 1.726 . . . . 1.53 115.662 -176.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.565 ' HE ' ' HA ' ' A' ' 16' ' ' ALA . 12.4 mtm180 -105.25 150.08 25.44 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 124.055 0.942 . . . . 3.22 109.983 176.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -105.42 130.63 53.47 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 115.402 1.63 . . . . 3.66 115.402 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -170.07 -179.12 3.06 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 125.049 1.339 . . . . 4.7 110.849 177.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -155.88 66.83 0.6 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 114.513 1.301 . . . . 2.55 114.513 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -173.78 -160.68 0.12 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.435 0.636 . . . . 2.15 111.527 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 157' ' ' PHE . 1.6 t -88.51 97.83 11.3 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.18 0.992 . . . . 0.77 108.477 175.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -136.75 146.11 45.4 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 114.181 1.178 . . . . 0.81 114.181 -174.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.04 -173.07 38.53 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 114.262 -1.335 . . . . 0.47 115.325 177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.55 162.63 12.88 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.599 1.333 . . . . 0.89 114.599 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -120.98 124.74 45.62 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 114.181 -1.372 . . . . 0.51 110.825 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.07 101.87 54.35 Favored Pre-proline 0 CA--C 1.564 1.514 0 CA-C-N 115.487 -0.779 . . . . 0.15 110.305 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.41 122.67 3.68 Favored 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 121.831 1.687 . . . . 0.15 114.862 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.42 163.45 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.661 0 CA-C-N 114.986 -1.006 . . . . 0.19 110.899 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -151.82 24.51 0.67 Allowed 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 114.534 -1.212 . . . . 2.53 111.666 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -133.24 156.85 46.79 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 123.09 0.556 . . . . 2.12 111.111 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.5 OUTLIER -118.06 145.39 44.86 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.523 0.934 . . . . 0.42 113.523 -179.082 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.44 -136.48 4.43 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 114.189 -1.369 . . . . 0.23 112.191 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 38.3 mm-40 -116.91 106.67 13.7 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 118.292 1.046 . . . . 1.75 110.927 178.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -100.99 132.19 46.52 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-O 121.295 0.569 . . . . 0.21 110.994 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.7 122.98 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 121.709 0.766 . . . . 0.2 110.947 -176.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.66 106.11 16.52 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.063 -1.426 . . . . 0.78 109.885 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.0 t -116.39 122.67 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 109.625 -0.509 . . . . 0.44 109.625 -178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.24 144.16 49.59 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 113.029 0.751 . . . . 1.25 113.029 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 169' ' ' ALA . 4.5 tppt? -106.66 123.33 47.96 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 115.448 -0.796 . . . . 2.52 110.848 177.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 16.9 m-85 -106.15 135.48 47.54 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 115.733 -0.667 . . . . 0.4 110.444 178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -140.82 149.67 42.32 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 116.016 -0.538 . . . . 0.41 111.944 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -148.13 121.52 9.05 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 123.167 0.587 . . . . 2.61 110.724 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.26 72.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 112.24 0.459 . . . . 2.13 112.24 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -166.14 -42.51 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 112.734 0.642 . . . . 2.27 112.734 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -117.54 131.85 56.63 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 112.61 0.596 . . . . 1.46 112.61 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -110.57 97.46 6.89 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 122.402 1.096 . . . . 0.84 111.12 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -160.67 142.03 12.09 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.982 -1.008 . . . . 2.45 112.054 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.8 m -122.16 124.06 42.98 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.596 -0.729 . . . . 1.66 112.331 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 73.07 53.38 0.13 Allowed 'General case' 0 N--CA 1.512 2.629 0 C-N-CA 125.721 1.609 . . . . 1.89 112.148 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -152.31 -41.85 0.11 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.541 1.136 . . . . 2.56 110.025 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -106.9 82.26 1.67 Allowed 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.794 -0.817 . . . . 2.76 108.794 177.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.34 126.01 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-N 114.605 -1.18 . . . . 0.69 111.23 -177.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -113.86 176.99 4.79 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.404 1.631 . . . . 0.7 115.404 -175.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -125.32 139.13 53.96 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 121.897 0.856 . . . . 1.33 111.489 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 t -133.01 126.84 54.24 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.071 0 CA-C-N 114.181 -1.372 . . . . 0.48 110.103 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -131.27 142.52 50.15 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.229 1.566 . . . . 1.69 115.229 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 10.2 m -113.74 106.34 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-N 113.882 -1.508 . . . . 0.6 112.199 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.496 ' OD1' ' HA ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER 65.21 25.87 12.32 Favored 'General case' 0 N--CA 1.524 3.264 0 C-N-CA 126.479 1.912 . . . . 1.12 113.367 -177.207 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.62 -10.82 56.29 Favored Glycine 0 CA--C 1.555 2.552 0 CA-C-N 116.055 -0.52 . . . . 0.32 114.121 -176.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -94.93 130.11 41.69 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 125.394 1.477 . . . . 0.57 113.457 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 7.3 p -90.74 133.97 34.77 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 122.481 1.134 . . . . 0.55 113.562 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.24 -47.42 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 112.818 -1.992 . . . . 1.06 112.163 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.19 89.14 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.27 -1.011 . . . . 0.44 108.27 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 11.0 ttmm -111.03 74.92 0.89 Allowed 'General case' 0 C--N 1.356 0.858 0 CA-C-O 123.334 1.54 . . . . 2.3 110.994 179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 156.06 64.08 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 110.429 -3.078 . . . . 2.48 108.445 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.18 100.81 12.55 Favored 'General case' 0 C--N 1.36 1.056 0 N-CA-C 114.032 1.123 . . . . 1.13 114.032 -178.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.56 101.49 8.65 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 112.815 -1.993 . . . . 2.35 106.706 175.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -66.63 -29.4 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.48 0 C-N-CA 124.605 1.162 . . . . 0.68 114.114 -176.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -76.94 -37.34 55.48 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.341 0.656 . . . . 0.77 112.403 178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -74.21 -26.44 60.26 Favored 'General case' 0 CA--C 1.576 1.946 0 C-N-CA 124.557 1.143 . . . . 0.91 113.195 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -78.55 -56.26 4.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 113.327 0.862 . . . . 2.43 113.327 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -93.79 -39.88 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.409 0 N-CA-C 113.998 1.11 . . . . 0.93 113.998 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 112.85 -67.3 0.24 Allowed Glycine 0 C--N 1.358 1.777 0 CA-C-N 118.269 0.486 . . . . 0.85 114.162 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -106.49 173.91 6.11 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.946 0.899 . . . . 3.18 112.161 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 m -75.95 84.13 2.86 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.281 0.845 . . . . 2.08 113.281 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 51' ' ' LEU . 23.4 p -135.7 -137.05 0.15 Allowed 'General case' 0 CA--C 1.57 1.744 0 CA-C-N 114.414 -1.266 . . . . 0.62 109.127 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -115.96 132.69 56.57 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 113.315 0.857 . . . . 0.46 113.315 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.452 ' HB3' ' O ' ' A' ' 89' ' ' PHE . 7.4 t60 -108.37 138.2 45.06 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.109 -0.701 . . . . 0.38 109.109 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -141.49 130.95 23.78 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.696 0.998 . . . . 2.5 113.696 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -120.2 130.68 54.66 Favored 'General case' 0 C--O 1.252 1.199 0 CA-C-N 114.498 -1.228 . . . . 1.56 110.87 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.51 124.14 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 114.455 -1.248 . . . . 0.45 110.629 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.49 94.23 26.84 Favored Pre-proline 0 CA--C 1.574 1.884 0 CA-C-N 115.619 -0.719 . . . . 0.84 110.859 -178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -74.65 139.32 25.13 Favored 'Trans proline' 0 C--N 1.396 3.036 0 C-N-CA 122.977 2.452 . . . . 0.16 113.481 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.1 mt -121.95 150.75 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.492 0 CA-C-O 121.654 0.74 . . . . 0.38 111.216 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.2 p -132.29 112.69 12.44 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.268 -0.878 . . . . 1.31 111.323 178.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 80' ' ' GLU . 3.6 mt -112.01 123.18 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.431 0 N-CA-C 108.505 -0.924 . . . . 0.25 108.505 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -139.24 127.99 23.35 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.102 -0.954 . . . . 2.05 110.88 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? 66.05 15.52 10.11 Favored 'General case' 0 N--CA 1.517 2.89 0 N-CA-C 114.88 1.437 . . . . 3.55 114.88 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.53 19.52 24.95 Favored Glycine 0 CA--C 1.55 2.271 0 CA-C-O 119.315 -0.714 . . . . 0.37 114.709 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 25.0 mtpp -126.77 141.83 51.72 Favored 'General case' 0 C--N 1.366 1.301 0 CA-C-N 118.181 0.991 . . . . 1.56 112.2 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.68 136.85 39.9 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 113.487 0.921 . . . . 0.34 113.487 -177.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.4 t -133.63 120.84 21.2 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.71 -0.677 . . . . 0.64 111.843 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.8 p -105.47 95.05 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.674 0 CA-C-N 114.965 -1.016 . . . . 0.46 110.087 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 69.46 -81.66 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.876 0 C-N-CA 125.4 1.48 . . . . 1.56 113.34 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -129.71 23.43 4.75 Favored Glycine 0 CA--C 1.544 1.899 0 CA-C-N 116.092 -0.504 . . . . 0.49 113.685 177.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -125.04 121.92 35.74 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.33 0.652 . . . . 1.82 110.78 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.8 134.24 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.466 0.65 . . . . 1.02 111.843 -178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 m -149.54 -170.27 3.59 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.918 -1.037 . . . . 0.56 110.74 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.24 138.14 38.66 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 113.394 0.887 . . . . 1.25 113.394 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -94.45 119.88 33.84 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.493 -0.776 . . . . 0.29 109.036 175.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.89 92.24 3.1 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 121.335 0.588 . . . . 1.42 112.092 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.92 -71.51 2.98 Favored Glycine 0 C--N 1.358 1.779 0 N-CA-C 116.954 1.542 . . . . 0.42 116.954 178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.78 171.94 12.9 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 123.285 1.517 . . . . 1.1 114.577 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.496 ' HA ' ' OD1' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -110.28 126.39 54.14 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 111.31 -2.677 . . . . 0.67 107.439 176.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . 0.457 ' H ' ' HA ' ' A' ' 107' ' ' ASN . 2.6 t -117.18 122.23 43.45 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 118.309 -1.357 . . . . 0.36 114.287 -175.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.79 101.36 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 CA-C-N 114.676 -1.147 . . . . 0.74 108.407 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -133.28 143.72 49.25 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.05 -0.977 . . . . 1.67 111.386 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 70' ' ' SER . 0.1 OUTLIER -115.59 142.5 46.64 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 114.546 -1.206 . . . . 1.8 112.72 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -102.73 137.0 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 113.247 -1.797 . . . . 0.58 108.778 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -81.82 148.82 28.66 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 115.135 1.532 . . . . 2.18 115.135 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -104.37 -29.94 5.2 Favored Glycine 0 CA--C 1.545 1.922 0 CA-C-N 114.675 -1.148 . . . . 1.02 114.143 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -128.49 -80.54 0.58 Allowed 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 117.258 0.529 . . . . 2.86 110.919 178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -171.88 48.92 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.87 0.468 . . . . 3.91 112.036 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 0.2 OUTLIER -160.04 -43.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.605 0.965 . . . . 1.74 113.605 -178.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 163' ' ' ASP . 1.3 m-20 84.17 -173.16 0.02 OUTLIER Pre-proline 0 N--CA 1.511 2.607 0 C-N-CA 124.493 1.117 . . . . 1.68 110.461 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -64.43 -19.19 65.1 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.586 2.191 . . . . 2.06 115.74 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 31.0 tptt 82.69 -67.1 0.09 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 126.025 1.73 . . . . 3.0 115.045 176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 45.0 t -100.2 131.03 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.297 0 CA-C-N 119.062 0.846 . . . . 0.8 110.034 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 4.3 t -134.06 126.8 30.9 Favored 'General case' 0 C--N 1.367 1.342 0 O-C-N 124.074 0.859 . . . . 0.87 111.635 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 88' ' ' LYS 0.256 . . -115.03 51.1 0.93 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.43 2.011 . . . . 0.34 116.43 -176.194 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.84 128.18 8.65 Favored 'General case' 0 N--CA 1.516 2.828 0 C-N-CA 125.702 1.601 . . . . 0.7 115.053 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -149.14 98.17 2.78 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.777 -1.102 . . . . 0.21 109.294 179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.319 8.4 tt -112.9 122.68 67.51 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.808 0 CA-C-O 122.84 1.305 . . . . 0.31 112.276 177.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -123.56 167.61 13.7 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 113.094 -1.866 . . . . 0.44 111.131 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 9' ' ' LYS . 17.9 ptmt -122.19 159.49 27.14 Favored 'General case' 0 CA--C 1.555 1.144 0 N-CA-C 118.223 2.675 . . . . 1.26 118.223 -175.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 104.38 -42.53 1.87 Allowed Glycine 0 CA--C 1.542 1.781 0 CA-C-N 110.041 -3.254 . . . . 0.17 118.779 174.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -178.37 153.92 0.78 Allowed 'General case' 0 N--CA 1.52 3.038 0 CA-C-N 120.296 2.048 . . . . 0.15 112.94 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.79 -20.74 58.0 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 114.742 1.386 . . . . 0.17 114.742 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.36 4.68 45.33 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.007 1.114 . . . . 0.55 114.007 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -112.57 3.3 16.65 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.389 1.255 . . . . 0.6 114.389 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . 0.257 1.6 m -59.73 -35.77 32.7 Favored Pre-proline 0 N--CA 1.525 3.298 0 N-CA-C 116.856 2.169 . . . . 0.95 116.856 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -97.58 167.01 0.84 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.382 2.055 . . . . 1.8 113.931 178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 tpt -144.64 113.67 6.88 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.192 -0.458 . . . . 4.96 111.002 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 10.2 mt -132.26 167.54 19.65 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.1 0.952 . . . . 4.0 112.686 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -103.91 158.66 31.42 Favored Pre-proline 0 CA--C 1.558 1.259 0 CA-C-N 114.591 -1.186 . . . . 6.27 111.098 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.24 122.28 9.53 Favored 'Trans proline' 0 C--N 1.394 2.962 0 C-N-CA 122.618 2.212 . . . . 6.59 115.123 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -135.87 136.23 22.97 Favored Pre-proline 0 CA--C 1.564 1.502 0 CA-C-N 114.861 -1.063 . . . . 5.51 111.16 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -84.45 -156.55 0.07 OUTLIER 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 123.362 2.708 . . . . 6.77 114.049 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 165.22 104.7 0.18 Allowed Glycine 0 C--N 1.341 0.812 0 C-N-CA 120.776 -0.726 . . . . 7.02 113.442 177.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.75 119.73 35.27 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.029 0.442 . . . . 8.99 111.714 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.403 -0.808 . . . . 10.6 111.164 -179.812 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 112.52 -0.232 . . . . 8.93 112.52 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.27 129.82 55.86 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.528 0.68 . . . . 6.82 111.818 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.5 mtt -132.4 120.09 21.54 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.77 -0.65 . . . . 7.64 111.709 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.1 m -137.23 110.09 7.64 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.66 -0.7 . . . . 3.86 111.311 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -169.11 -46.79 0.03 OUTLIER Glycine 0 C--N 1.341 0.818 0 N-CA-C 114.755 0.662 . . . . 1.11 114.755 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.649 ' HG ' HD11 ' A' ' 27' ' ' ILE . 21.2 tp -85.29 -39.73 17.38 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 113.145 0.794 . . . . 0.35 113.145 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.57 -23.81 64.94 Favored 'General case' 0 N--CA 1.506 2.331 0 C-N-CA 125.506 1.522 . . . . 0.2 114.414 175.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.89 -9.92 54.59 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 113.606 0.965 . . . . 0.32 113.606 177.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 48.8 mmtt -104.47 -27.02 12.16 Favored 'General case' 0 C--N 1.364 1.23 0 N-CA-C 113.327 0.862 . . . . 1.73 113.327 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -51.33 137.01 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.077 0 N-CA-C 115.764 1.764 . . . . 0.11 115.764 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.0 pt -122.06 -30.09 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 CA-C-N 115.559 -0.746 . . . . 0.16 112.409 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 75.3 t90 -164.36 116.7 1.32 Allowed 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 120.654 0.264 . . . . 0.54 111.302 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.98 136.42 38.5 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.602 -0.686 . . . . 0.19 111.719 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.518 HG21 ' HG3' ' A' ' 33' ' ' PRO 0.304 14.9 p -150.02 137.65 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.555 0 N-CA-C 115.796 1.776 . . . . 1.05 115.796 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 168' ' ' CYS . 59.2 t30 -114.18 111.34 21.4 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-N 115.264 -0.88 . . . . 2.11 108.726 174.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.96 106.8 13.25 Favored 'General case' 0 C--O 1.271 2.211 0 CA-C-O 121.455 0.645 . . . . 0.63 110.323 178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.512 ' HA2' ' C ' ' A' ' 64' ' ' GLU . . . 171.92 -61.42 0.16 Allowed Glycine 0 C--N 1.362 1.998 0 CA-C-N 112.445 -2.161 . . . . 0.71 114.358 -178.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -109.01 -110.45 3.37 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 114.371 0.508 . . . . 0.8 114.371 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -170.92 117.85 0.48 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.834 0.454 . . . . 1.63 111.782 179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 29' ' ' TYR . 3.1 m 43.95 114.38 0.0 OUTLIER 'General case' 0 N--CA 1.526 3.368 0 N-CA-C 119.235 3.05 . . . . 1.0 119.235 177.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 28' ' ' HIS . 80.2 t60 -144.97 139.81 27.77 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 113.399 0.888 . . . . 0.45 113.399 177.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . 0.267 8.2 p -106.02 114.23 44.81 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.997 0 CA-C-N 115.015 -0.993 . . . . 1.39 110.124 177.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -84.59 162.7 19.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.776 -1.102 . . . . 1.85 113.12 -179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 m -41.38 -28.79 0.18 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.266 0 N-CA-C 119.868 3.285 . . . . 0.72 119.868 -175.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 83.4 m-70 -90.15 -19.76 23.88 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.856 0.753 . . . . 0.51 111.87 177.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 110.65 39.32 1.47 Allowed Glycine 0 C--N 1.353 1.517 0 C-N-CA 124.443 1.021 . . . . 0.34 113.868 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.649 HD11 ' HG ' ' A' ' 6' ' ' LEU . 30.1 mm -106.83 124.91 62.79 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.754 0 C-N-CA 123.096 0.558 . . . . 0.55 109.597 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.422 ' HA ' ' O ' ' A' ' 21' ' ' HIS . 2.1 t60 -110.26 130.7 55.5 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 114.656 1.354 . . . . 1.34 114.656 -178.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.528 ' O ' ' HA ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -84.15 136.74 33.86 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 124.479 1.111 . . . . 2.79 110.413 176.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -92.89 100.34 12.82 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 124.78 1.3 . . . . 3.0 114.266 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -38.79 110.96 0.15 Allowed 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 128.133 2.573 . . . . 2.3 117.846 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 0.5 OUTLIER 46.34 76.16 0.58 Allowed Pre-proline 0 N--CA 1.525 3.317 0 N-CA-C 117.099 2.259 . . . . 1.17 117.099 177.376 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.518 ' HG3' HG21 ' A' ' 14' ' ' VAL . 68.3 Cg_endo -95.07 -12.15 0.9 Allowed 'Trans proline' 0 CA--C 1.56 1.803 0 N-CA-C 117.584 2.109 . . . . 1.45 117.584 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.7 -24.22 1.54 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.849 1.796 . . . . 1.91 115.849 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -99.72 70.12 1.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 119.551 1.068 . . . . 4.84 112.562 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.428 ' O ' ' HG2' ' A' ' 37' ' ' ARG . . . 105.85 -29.3 11.51 Favored Glycine 0 CA--C 1.542 1.752 0 CA-C-N 115.685 -0.689 . . . . 2.37 114.782 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 0.0 OUTLIER 52.64 53.08 12.79 Favored 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 127.219 2.208 . . . . 4.5 115.375 -179.064 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.18 179.82 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 C-N-CA 124.772 1.229 . . . . 2.7 110.442 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -91.94 94.48 1.93 Allowed Glycine 0 N--CA 1.478 1.495 0 O-C-N 121.611 -0.68 . . . . 1.95 114.754 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.1 ttt180 -153.41 131.75 12.03 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-O 121.312 0.577 . . . . 5.34 111.963 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.34 137.19 50.84 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.181 0.992 . . . . 1.64 111.323 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 m -124.62 121.7 35.47 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.711 -0.677 . . . . 1.57 111.66 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -140.1 104.34 4.81 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.821 -0.627 . . . . 2.33 110.559 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -97.77 -45.83 6.19 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.866 -0.606 . . . . 3.16 111.875 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -108.99 73.07 0.2 Allowed Glycine 0 C--N 1.354 1.541 0 N-CA-C 111.053 -0.819 . . . . 1.52 111.053 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 1.9 ttt -92.78 0.07 57.35 Favored 'General case' 0 CA--C 1.561 1.366 0 N-CA-C 115.473 1.657 . . . . 1.67 115.473 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.06 35.24 3.33 Favored 'General case' 0 CA--C 1.563 1.469 0 N-CA-C 112.936 0.717 . . . . 4.18 112.936 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.6 tp -137.27 77.05 42.64 Favored Pre-proline 0 C--N 1.35 0.602 0 C-N-CA 124.171 0.988 . . . . 2.63 108.431 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HB3' ' OE1' ' A' ' 58' ' ' GLN . 51.1 Cg_exo -63.34 155.05 64.33 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.862 3.041 . . . . 1.37 117.196 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . 0.279 1.2 mp -89.65 125.91 42.59 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.12 0 CA-C-N 114.98 -1.009 . . . . 0.69 109.277 178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.39 -19.01 43.53 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.478 2.029 . . . . 1.28 116.478 -176.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -99.38 24.66 7.79 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 113.957 1.095 . . . . 1.51 113.957 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.36 -175.07 4.57 Favored 'General case' 0 CA--C 1.565 1.554 0 CA-C-O 121.451 0.643 . . . . 1.09 111.7 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.788 ' O ' ' HB2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -95.56 -176.87 0.58 Allowed Pre-proline 0 N--CA 1.511 2.588 0 C-N-CA 123.985 0.914 . . . . 1.27 109.198 177.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -68.86 -39.95 7.6 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.48 2.12 . . . . 0.95 113.719 176.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -68.88 -49.18 60.43 Favored 'General case' 0 N--CA 1.503 2.213 0 C-N-CA 125.298 1.439 . . . . 2.04 112.549 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.83 -6.57 58.76 Favored 'General case' 0 CA--C 1.57 1.749 0 CA-C-N 114.921 -1.036 . . . . 1.62 112.57 177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.788 ' HB2' ' O ' ' A' ' 54' ' ' ASN . 22.1 tt0 -73.54 -40.49 63.93 Favored 'General case' 0 C--N 1.381 1.952 0 C-N-CA 125.278 1.431 . . . . 1.77 108.075 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.5 t -61.35 -44.57 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.068 0 C-N-CA 124.353 1.061 . . . . 0.81 109.094 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 6.9 tp -75.97 -11.91 60.04 Favored 'General case' 0 CA--C 1.578 2.03 0 N-CA-C 114.77 1.396 . . . . 1.15 114.77 177.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -124.22 22.16 8.66 Favored 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 123.672 0.789 . . . . 0.92 112.534 177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -143.89 -27.4 0.53 Allowed 'General case' 0 N--CA 1.52 3.032 0 N-CA-C 115.813 1.783 . . . . 1.33 115.813 -177.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.4 p -75.29 130.82 39.72 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 113.614 0.968 . . . . 1.28 113.614 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.512 ' C ' ' HA2' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -116.71 139.64 50.32 Favored 'General case' 0 N--CA 1.504 2.246 0 N-CA-C 115.306 1.595 . . . . 1.53 115.306 -176.576 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.49 128.45 55.0 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 115.11 -0.95 . . . . 3.22 111.496 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -132.04 124.86 30.12 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 116.033 -0.53 . . . . 3.66 110.963 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.9 -61.47 0.49 Allowed 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 113.812 1.041 . . . . 4.7 113.812 -179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -123.81 -135.14 0.28 Allowed 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 113.807 1.04 . . . . 2.55 113.807 -177.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -156.64 124.68 5.6 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.58 1.152 . . . . 2.15 109.45 -177.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.626 ' H ' ' ND2' ' A' ' 164' ' ' ASN . 0.3 OUTLIER 75.58 79.49 0.1 Allowed 'General case' 0 N--CA 1.515 2.778 0 C-N-CA 125.083 1.353 . . . . 0.77 109.963 -177.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -135.44 141.31 45.39 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.276 -0.875 . . . . 0.81 113.13 -176.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -134.48 174.36 21.02 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 116.62 1.408 . . . . 0.47 116.62 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -113.94 156.55 23.8 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 113.814 -1.193 . . . . 0.89 113.375 -177.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.83 125.4 47.44 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.024 -0.989 . . . . 0.51 111.904 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.6 mp -122.77 102.69 38.09 Favored Pre-proline 0 CA--C 1.566 1.561 0 CA-C-N 115.458 -0.792 . . . . 0.15 108.957 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -84.0 117.53 2.26 Favored 'Trans proline' 0 CA--C 1.562 1.884 0 C-N-CA 122.155 1.903 . . . . 0.15 114.44 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -122.05 157.48 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.757 0 CA-C-O 122.068 0.937 . . . . 0.19 111.511 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -144.46 14.66 1.61 Allowed 'General case' 0 CA--C 1.56 1.357 0 CA-C-N 114.542 -1.208 . . . . 2.53 112.61 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -125.04 172.88 9.09 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-N 118.711 0.687 . . . . 2.12 112.489 -179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 135' ' ' ILE . 0.6 OUTLIER -130.83 144.05 51.18 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.814 0.816 . . . . 0.42 112.822 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.1 -135.4 4.29 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 114.436 -1.256 . . . . 0.23 112.322 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.574 ' HB2' ' O ' ' A' ' 175' ' ' GLY . 40.6 mm-40 -114.12 112.56 23.4 Favored 'General case' 0 C--N 1.359 0.979 0 CA-C-N 118.039 0.92 . . . . 1.75 111.266 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -104.64 133.57 49.26 Favored 'General case' 0 N--CA 1.481 1.076 0 O-C-N 122.075 -0.391 . . . . 0.21 110.826 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 t -118.66 124.04 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 121.703 0.763 . . . . 0.2 111.202 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.48 110.5 22.45 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 114.168 -1.378 . . . . 0.78 110.699 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 171' ' ' PHE . 0.2 OUTLIER -119.22 129.09 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-N 115.266 -0.879 . . . . 0.44 108.707 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.28 137.4 46.01 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 113.117 0.784 . . . . 1.25 113.117 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 127' ' ' HIS . 3.0 tppt? -101.69 114.06 27.77 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.759 -0.655 . . . . 2.52 109.907 176.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.43 ' O ' ' HB3' ' A' ' 127' ' ' HIS . 11.6 m-85 -103.63 134.46 46.94 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.381 -0.827 . . . . 0.4 110.339 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -138.44 151.54 47.53 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.629 -0.714 . . . . 0.41 111.253 -178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -128.16 142.93 51.04 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-O 121.271 0.558 . . . . 2.61 112.254 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.18 -36.02 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 CA-C-N 115.59 -0.732 . . . . 2.13 112.678 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -123.62 142.04 51.43 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.192 0.597 . . . . 2.27 111.707 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 92.75 99.54 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 C-N-CA 126.477 1.911 . . . . 1.46 111.248 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -102.17 85.39 2.65 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-O 123.002 1.382 . . . . 0.84 111.529 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -151.17 145.04 25.15 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.318 -1.31 . . . . 2.45 112.292 179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.1 m -120.84 120.27 35.08 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.507 -0.769 . . . . 1.66 112.223 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 72.33 56.64 0.15 Allowed 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 125.899 1.68 . . . . 1.89 112.531 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -157.19 -41.97 0.07 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.286 1.434 . . . . 2.56 109.092 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -105.1 83.39 1.97 Allowed 'General case' 0 C--N 1.361 1.086 0 N-CA-C 108.383 -0.969 . . . . 2.76 108.383 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -108.85 132.71 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 CA-C-N 114.748 -1.114 . . . . 0.69 111.675 -177.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -114.58 178.54 4.24 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.353 1.612 . . . . 0.7 115.353 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -126.5 141.72 51.78 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 112.604 0.594 . . . . 1.33 112.604 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 t -135.71 125.01 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.368 0 C-N-CA 123.686 0.794 . . . . 0.48 109.302 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.61 ' HB3' ' O ' ' A' ' 109' ' ' HIS . 25.6 mtt180 -124.51 146.91 48.71 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.097 1.518 . . . . 1.69 115.097 -176.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 109' ' ' HIS . 2.5 m -120.21 106.8 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.833 0 N-CA-C 112.996 0.739 . . . . 0.6 112.996 177.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.38 25.07 13.35 Favored 'General case' 0 N--CA 1.529 3.505 0 C-N-CA 126.49 1.916 . . . . 1.12 114.736 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.85 -12.91 45.93 Favored Glycine 0 CA--C 1.55 2.261 0 CA-C-N 115.827 -0.624 . . . . 0.32 113.446 -176.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.61 ' O ' ' HB3' ' A' ' 105' ' ' ARG . 96.8 m-70 -87.35 169.34 12.35 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 126.078 1.751 . . . . 0.57 112.784 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.28 133.6 55.14 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.573 0.702 . . . . 0.55 112.462 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.94 -55.99 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 CA-C-N 114.731 -1.122 . . . . 1.06 112.898 -179.09 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.14 88.89 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 N-CA-C 108.021 -1.103 . . . . 0.44 108.021 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.2 ttmt -111.14 77.6 1.05 Allowed 'General case' 0 C--N 1.354 0.775 0 CA-C-O 122.867 1.318 . . . . 2.3 110.588 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 p30 152.44 61.52 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 111.205 -2.725 . . . . 2.48 108.578 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.35 99.93 12.36 Favored 'General case' 0 C--N 1.362 1.117 0 N-CA-C 113.708 1.003 . . . . 1.13 113.708 -178.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -114.26 99.49 7.64 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 113.175 -1.83 . . . . 2.35 107.565 175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.74 -29.89 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.441 0 N-CA-C 114.313 1.227 . . . . 0.68 114.313 -176.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -75.45 -37.17 60.49 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 123.539 0.736 . . . . 0.77 112.415 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -74.54 -26.9 60.27 Favored 'General case' 0 CA--C 1.577 1.987 0 C-N-CA 124.533 1.133 . . . . 0.91 113.262 176.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -77.33 -55.27 5.54 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 113.386 0.884 . . . . 2.43 113.386 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.18 -39.04 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 N-CA-C 113.985 1.105 . . . . 0.93 113.985 177.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 110.46 -70.86 0.21 Allowed Glycine 0 C--N 1.359 1.849 0 CA-C-N 118.206 0.457 . . . . 0.85 113.556 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -106.28 175.56 5.46 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.467 1.107 . . . . 3.18 111.232 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.1 m -70.87 85.95 0.69 Allowed 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 113.692 0.997 . . . . 2.08 113.692 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 126' ' ' ALA . 2.9 p -134.76 -156.64 0.74 Allowed 'General case' 0 CA--C 1.567 1.626 0 CA-C-N 114.028 -1.442 . . . . 0.62 109.476 -178.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.433 ' H ' ' HB ' ' A' ' 125' ' ' THR . . . -105.83 128.36 53.69 Favored 'General case' 0 CA--C 1.566 1.579 0 N-CA-C 113.15 0.796 . . . . 0.46 113.15 179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 7.9 t60 -101.82 139.43 37.47 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.265 0.626 . . . . 0.38 109.322 177.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -144.79 130.43 19.01 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.28 0.845 . . . . 2.5 113.28 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -121.75 136.69 54.94 Favored 'General case' 0 C--O 1.249 1.03 0 CA-C-N 115.304 -0.862 . . . . 1.56 111.317 176.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.81 126.45 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 CA-C-N 114.718 -1.128 . . . . 0.45 110.767 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.6 mp -132.88 92.53 25.92 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-N 115.472 -0.785 . . . . 0.84 110.498 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -76.5 131.19 12.39 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 122.875 2.383 . . . . 0.16 113.175 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -117.23 153.34 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 C-N-CA 124.194 0.998 . . . . 0.38 111.115 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.1 p -136.09 117.62 14.83 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 112.633 0.605 . . . . 1.31 112.633 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 139' ' ' LYS . 3.5 mt -116.16 127.62 73.71 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.643 0 N-CA-C 108.769 -0.826 . . . . 0.25 108.769 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -140.84 126.0 18.48 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.923 -0.58 . . . . 2.05 110.984 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? 68.8 14.91 8.98 Favored 'General case' 0 N--CA 1.516 2.853 0 C-N-CA 125.205 1.402 . . . . 3.55 114.151 -178.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 97.12 16.13 36.39 Favored Glycine 0 CA--C 1.546 1.988 0 CA-C-O 119.291 -0.727 . . . . 0.37 114.359 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 135' ' ' ILE . 51.9 mtpt -125.38 144.57 50.44 Favored 'General case' 0 C--N 1.366 1.283 0 CA-C-N 118.175 0.988 . . . . 1.56 112.48 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 148.21 23.28 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.798 1.406 . . . . 0.34 114.798 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.6 114.12 9.71 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.234 -1.348 . . . . 0.64 110.201 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 9.2 p -121.67 96.01 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.334 0 CA-C-N 115.999 -0.546 . . . . 0.46 110.705 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 68.39 -83.94 0.03 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 C-N-CA 125.586 1.554 . . . . 1.56 113.751 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -131.69 26.81 3.79 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.891 -0.595 . . . . 0.49 113.129 177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -130.12 123.56 30.66 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 123.532 0.733 . . . . 1.82 110.346 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 5.4 p -118.4 130.05 73.81 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.237 0 CA-C-O 121.48 0.657 . . . . 1.02 111.51 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.9 p -151.49 -173.3 4.47 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.202 -0.908 . . . . 0.56 110.344 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . 0.272 14.3 t -104.35 138.29 40.98 Favored 'General case' 0 CA--C 1.578 2.035 0 N-CA-C 113.661 0.986 . . . . 1.25 113.661 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -84.73 126.38 33.35 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.441 1.096 . . . . 0.29 111.19 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.77 91.77 3.2 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.216 0.821 . . . . 1.42 113.216 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 79.18 -64.8 3.69 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 119.192 2.437 . . . . 0.42 119.192 176.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.524 ' HG2' ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -135.33 159.28 42.05 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.466 0.913 . . . . 1.1 113.466 -176.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.524 ' N ' ' HG2' ' A' ' 152' ' ' LYS . 0.5 OUTLIER -105.27 142.59 34.77 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 113.952 -1.476 . . . . 0.67 109.816 177.319 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 t -124.53 127.22 47.1 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 114.023 1.119 . . . . 0.36 114.023 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 105' ' ' ARG . 16.3 t -106.59 97.19 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 105.862 -1.903 . . . . 0.74 105.862 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -101.74 122.7 44.42 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.971 -1.013 . . . . 1.67 112.594 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -107.13 119.03 38.28 Favored 'General case' 0 C--O 1.249 1.066 0 CA-C-N 114.474 -1.239 . . . . 1.8 109.766 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 2.2 t -104.14 137.31 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 CA-C-N 113.579 -1.646 . . . . 0.58 109.649 -178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -58.37 151.2 20.33 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 127.509 2.323 . . . . 2.18 116.756 -177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -109.5 -62.7 0.53 Allowed Glycine 0 CA--C 1.538 1.478 0 CA-C-N 115.193 -0.912 . . . . 1.02 113.365 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -135.13 -71.34 0.48 Allowed 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.781 0.659 . . . . 2.86 112.781 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -112.19 -59.29 2.02 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 122.775 0.43 . . . . 3.91 112.056 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -96.4 156.33 16.39 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.692 0.797 . . . . 1.74 110.388 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.626 ' ND2' ' H ' ' A' ' 70' ' ' SER . 11.9 m-20 -97.71 -94.8 0.0 OUTLIER Pre-proline 0 CA--C 1.58 2.126 0 CA-C-O 116.512 -1.708 . . . . 1.68 110.898 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -85.51 -37.21 0.11 Allowed 'Trans proline' 0 C--N 1.402 3.355 0 CA-C-N 124.886 2.781 . . . . 2.06 115.004 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 30.4 tptt 82.06 -81.74 0.02 OUTLIER 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 126.261 1.825 . . . . 3.0 108.859 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 45.5 t -112.51 129.53 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.716 -1.216 . . . . 0.8 107.716 175.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 15' ' ' ASN . 8.8 t -135.37 116.79 14.69 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.928 0.768 . . . . 0.87 112.341 -178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . 0.274 . . -109.44 47.51 0.93 Allowed 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 117.337 2.347 . . . . 0.34 117.337 -176.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.25 134.1 1.68 Allowed 'General case' 0 N--CA 1.516 2.846 0 N-CA-C 116.109 1.892 . . . . 0.7 116.109 177.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.418 ' HB3' ' O ' ' A' ' 86' ' ' VAL . 3.1 t80 -151.6 100.46 2.71 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 116.068 -0.514 . . . . 0.21 110.906 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . 0.3 5.5 tt -111.52 121.87 64.88 Favored 'Isoleucine or valine' 0 C--O 1.269 2.088 0 CA-C-O 122.268 1.032 . . . . 0.31 110.969 176.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -122.34 168.68 11.77 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.528 -1.215 . . . . 0.44 112.08 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 24.9 tptp -113.4 141.67 46.8 Favored 'General case' 0 CA--C 1.559 1.327 0 N-CA-C 118.298 2.703 . . . . 1.26 118.298 -173.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.574 ' O ' ' HB2' ' A' ' 82' ' ' GLU . . . 105.12 -40.49 2.45 Favored Glycine 0 CA--C 1.542 1.735 0 N-CA-C 121.213 3.245 . . . . 0.17 121.213 171.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -176.93 157.17 1.42 Allowed 'General case' 0 N--CA 1.525 3.291 0 CA-C-N 121.622 2.711 . . . . 0.15 113.91 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -78.16 -13.22 59.95 Favored 'General case' 0 CA--C 1.58 2.108 0 C-N-CA 124.954 1.301 . . . . 0.17 114.087 177.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.34 2.49 50.15 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 113.692 0.997 . . . . 0.55 113.692 177.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.561 ' O ' ' HD3' ' A' ' 181' ' ' PRO . 0.7 OUTLIER -106.11 -8.89 17.23 Favored 'General case' 0 CA--C 1.562 1.423 0 C-N-CA 123.98 0.912 . . . . 0.6 113.29 179.211 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -96.42 89.11 0.56 Allowed Pre-proline 0 N--CA 1.503 2.223 0 C-N-CA 123.866 0.866 . . . . 0.95 112.102 178.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 179' ' ' ASP . 41.4 Cg_endo -93.5 153.71 2.43 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.631 2.22 . . . . 1.8 114.88 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 67.6 mtt -133.18 104.91 6.72 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.708 -0.678 . . . . 4.96 110.863 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.7 mt -129.36 170.16 13.99 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 122.134 0.968 . . . . 4.0 113.029 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -111.21 159.52 32.5 Favored Pre-proline 0 CA--C 1.557 1.243 0 CA-C-N 114.456 -1.247 . . . . 6.27 111.061 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.34 123.62 11.42 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 122.954 2.436 . . . . 6.59 115.039 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.444 ' ND1' ' HD2' ' A' ' 187' ' ' PRO . 31.6 t60 -133.51 131.86 21.59 Favored Pre-proline 0 CA--C 1.565 1.542 0 CA-C-N 115.194 -0.912 . . . . 5.51 111.912 -178.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.444 ' HD2' ' ND1' ' A' ' 186' ' ' HIS . 11.8 Cg_endo -87.36 -157.58 0.07 OUTLIER 'Trans proline' 0 C--N 1.39 2.755 0 C-N-CA 123.112 2.541 . . . . 6.77 113.267 177.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 172.35 -130.96 2.02 Favored Glycine 0 C--N 1.34 0.803 0 C-N-CA 120.697 -0.763 . . . . 7.02 113.974 177.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 7.3 mt -118.95 111.65 18.62 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 112.163 0.431 . . . . 8.99 112.163 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.449 -0.786 . . . . 10.6 110.53 179.608 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' BGC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_